<SEC-DOCUMENT>0000917520-23-000015.txt : 20230222
<SEC-HEADER>0000917520-23-000015.hdr.sgml : 20230222
<ACCEPTANCE-DATETIME>20230222161243
ACCESSION NUMBER:		0000917520-23-000015
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		130
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230222
DATE AS OF CHANGE:		20230222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		23653241

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>iart-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1,d:43d6bdf9742e4131bcef4d4155aafb89--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:iart="http://integralife.com/20221231" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY180LTEtMS0xLTkyNDc5_79098c7d-2f9e-41f1-aaa1-f7f619f69102">false</ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY182LTEtMS0xLTkyNDc5_b25ecd61-9112-48e9-afed-1cd706789aa5">2022</ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY183LTEtMS0xLTkyNDc5_82e47d3a-113f-4bc0-a96d-a4ea00b6cd1b">FY</ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY18xMC0xLTEtMS05MjQ3OQ_a6baf893-2bea-4902-9c2e-22c21509882e">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="i81ce5b6ba46d42db9fa6ce1b391412da_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTAtMS0xLTkyNDc5_fd33942e-365d-48e5-a960-5082c1a3fb96">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTAtMS0xLTkyNDc5_880a3f30-49ba-438a-9220-7840c10c5bc7">http://integralife.com/20221231#AccountingStandardUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="i788f04f5fed04ca38e49ba6f03024c26_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzEtMS0xLTEtOTI0Nzk_bd1074c8-ad33-4088-bf3d-7aee497f1926">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i62d0e2aa67744845818cbd175cd7bd78_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzItMS0xLTEtOTI0Nzk_951d2ed1-a9fb-42fb-b04f-ceb4e1ced936">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ib26e758da29c45679df8f4e5da71fe89_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzMtMS0xLTEtOTI0Nzk_9c935d34-9b6d-40dd-afbd-9fe5898f14ce">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i82ca03a161874505a112365ab91a423d_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzQtMS0xLTEtOTI0Nzk_bab0a1e6-1246-479e-9999-322833e2d0a0">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i6e5866b5e8ee438997795a5f34fffc50_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzUtMS0xLTEtOTI0Nzk_5545b871-a16b-4fac-82d6-0e2bb0a4c95a">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i9b08269188a34d6fbb7031826cb0bdc9_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzYtMS0xLTEtOTI0Nzk_d293a8f5-32b7-47f6-aea9-858e39e48f19">P1Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTA2L2ZyYWc6ODY5ZmQ0NGRhZTljNGY1YWIxNWI0NDY0OWZkYzNiMzgvdGV4dHJlZ2lvbjo4NjlmZDQ0ZGFlOWM0ZjVhYjE1YjQ0NjQ5ZmRjM2IzOF80Mzk4MDQ2NTExMTQ1_3db81233-2aea-444c-aa23-e56fec2bd931">0.0135739</ix:nonFraction><ix:nonNumeric contextRef="ibe01e5177d5c4b008c60877d84f5c6e1_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMDY_22acb8fc-f2cb-409d-a273-b3b42a7cc9db">P6Y</ix:nonNumeric><ix:nonNumeric contextRef="i0a2ee4a702a04c05a03330fdec68ebd2_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMTI_d4b35179-5c95-4990-bea5-db80dcb363e7">P10Y</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMS0xLTEtOTI0Nzk_2b547c6a-7751-48ff-ab01-b1a9e48209ee">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMi0xLTEtOTI0Nzk_43a359fb-b260-46b3-a729-b6685e632936">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMy0xLTEtOTI0Nzk_c93e0401-d608-4805-a380-09eb1a4c293a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMS0xLTEtOTI0Nzk_0c66b039-e411-43a9-b442-a4e094ca252b">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMi0xLTEtOTI0Nzk_b551fbb8-84c4-4783-a820-2fa1da06ef99">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMy0xLTEtOTI0Nzk_ceab9d37-549e-492a-9b3c-d8a5a6ae7910">&#8212;</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied522dc9e3e142338801a4d51273b10e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i92465366760c4177b8742406cf6fbd07_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5c0443956aba4287a79da88ad2b1f789_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i071a60b60a9b46a18aa0d12355c2d684_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4ed22898bc64d24b7765e593f891985_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb43d094e8824032961a8ec85d76affb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55ce9af062df477e959977ef29770b62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d722c9ae87d4ebf9e2f34d8f1a61b79_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia304241c7950452cbb025f7ee427babc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059e8d7474364db9884d18f168a39eb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4d9ca5a4da49c0a179fc3d4ace01d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19c3c07994f4ba2b78daf3355acf271_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54587714353d43c59304abf93aa9c270_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ce5b6ba46d42db9fa6ce1b391412da_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47471b2931934e4b9698fc87efb42f3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d4c24857e248099e323a764be5a960_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icacf91222c56450a94535b8158c1f9fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a7ad2dd7fe145e9a775191f346885f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e2e1c7c56e4e6f96b757b450e3d8a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7005821211dc4a61bc033d8dc246f9e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d58570b6055411d8462693d39b49056_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie068465acf624179b0d91e83e4d97156_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51546d1efdb4b37baab40ff76fdddc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b86be08e5641848e8d7b427009e157_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i076755c4427e4d259078e6b2d89e580a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03d921a6dbf4c6ab60982b0658b2bc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i923e26b254024ce191a077d3ad910d88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac1f6a25383842738c3f81f79c901726_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f2148b01b24348b1bcaceec81f6c73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00df800819924b1db728d5624c35f949_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f29af258c2049d09523a55767d03678_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff7c2d092db46b2bab82d2bfbb65a49_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77173b4d8e484fb39e318247f8305f57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38626384e0824b86a26dc5567021967f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaacd778bd0c149d084dfccd55a63c987_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieded6749710f48979f351fb7d3fa9e12_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb931d5ad83741a294637a95707f41cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie966000a0e4342acbb440309c555baad_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfaecd31c89f44a49d37ff888379adec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe44e0a022f4f34bf03594794a50963_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i885964e8d4134704bda0cee1a82823e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i274e28de1007483189af177cc3870bed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6c9d635e1847d0ba05f03bab83deb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3b59f71e3dc40bc95ec22429582ce92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba62f965ad2b4becaf6a2924ce7b0f73_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e2bf9b2ca64e639101cdb95fe9623d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c4c516f7c341e9a8f12da7fb0fd730_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d9e34be34c14c778773f8253aa5b1d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf4de01512a54f9d9da0d18e3f50daaa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9de9f6897f4cf8b49ff88e72733606_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i984bcc2d66864df5a6560d75518fc627_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b3d8c4a94f44308b786dd3f41066c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43680e166a7d4ce19b5a76a38da03d1e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b0589ae7ac49299d4b947877639c7b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d08e87887a48e0b165068c172cc809_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51998c104a0a4b23907a5b4441ad2cae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4683a32a673b4995855a9b02edfd1323_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i967f27ce7a134d76a34a6939044881dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefbb9d43eec34673981c8410401d816e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34bd7649dc7b4061ad47ffc556c0863f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49b57ff79634c4b898da5b6df9ebfae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd06a7aec13e49f98328dc80014a401c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a50827ab9fc4774a1f76e9fc90eca28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a05a3ddc6e4c0ab4eecfb7744719f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0da2edd906ea41d685b94f3a559f2684_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7f274b6c2e4e4085e067a47ae84aee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i674366b7bb554504831c2da6e430dcab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i033684df3176485992b874699ab5bb9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iart:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="reporting_unit"><xbrli:measure>iart:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i555d4df7f3584d1999b47a099d28a436_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic15abc2db37946838e57984661763818_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6527f4ce21cc4fb5985ab238dad89309_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ClosureOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c7891a939ef417fab6925793610c6df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ReorganizationProjectsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ce9246a35c48fcbd5b84afbb181294_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ClosureOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>iart:Customer</xbrli:measure></xbrli:unit><xbrli:context id="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88cf6af5eb341929c94e3b43dcc7430_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004ed02bcbb14976ae0947b6a85dae0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2646e8ff9e9646a997ca1704e1a4e996_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b6e8c596ab499a89fcc3c6342d9939_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9efe6093f5ba46e79ed64d1fea198a87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788f04f5fed04ca38e49ba6f03024c26_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62d0e2aa67744845818cbd175cd7bd78_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib26e758da29c45679df8f4e5da71fe89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ca03a161874505a112365ab91a423d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5866b5e8ee438997795a5f34fffc50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b08269188a34d6fbb7031826cb0bdc9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05901fa55ec4ee09f5c084cb113c902_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc2622f83364440b73830f3831e70ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64babceb820449b89139cb878d8a8f48_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87809ef2efdc487696e6308247a226c3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e50fd25ffa4e698beda1f9680eb35f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc99fa3608f44f98cce93e770c68118_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c891096f6240ffa5a2ec5d793dc607_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba2c649e06d4bcb88d0734c5bc21568_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59d4599d6b184cfabebcd5b9dac65339_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8181903369c49f6a696fed66e9124df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie09260aeabcc4e98a91001d0c6fde98d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0915172f474032923692e256da33ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b28eef625f649cc9ee7ffdcd22e93e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320f932bbd4a4a02a374f45fe6f54046_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2b3cbf8d296491e89556ecdfff34761_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86566b09516e432dbffe19da79e048cd_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:RevenueBasedPerformanceMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28298ae5ed5e49418672ef5260b1c297_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:FDAApprovalOfPremarketApprovalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i547e9b738a9b4ffe8435a24e596115f8_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingentliability"><xbrli:measure>iart:contingentLiability</xbrli:measure></xbrli:unit><xbrli:context id="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-31</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87815c6804b84c35862ba8c044473b87_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3270d274846346d8aa67bdc8538e2741_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e69cd67efed4735a4e8f3d4b73198b8_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6455a748fe4bddb62d55fada8558ac_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58908f12479149769863fd3b128d144e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48c08cb5a2fd4655ae315c100c40b36f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45969f5e61c5407c8d95c866382a20f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e90ad876dbd48bc8aa7bf8b4a53d714_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1ccc070eda4191b4f93f11cd639a6c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11932035bfc943da83fdc9252c1de39c_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b4975b0f79844b99055d7ce6c50dec7_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i912619e1e3ea4282b49c25179ea048df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e031586a5ab4c2b9c733e84d2f186e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6392846dfe466d9d26314aee0a7510_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f0be0dc18542668776dac2419eacfc_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic745d752ec27419fbefffbb4a794e6e6_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f1b83ff3044f198627e9dcf14f8112_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2429c77787c540b481af5ad54734a36f_I20200714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if488a963db3a45d1a7ad2f45989c9458_I20200714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic13de93e77194c5db68428a880ecc0ea_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b119f3359044799a93e9eb51fb8011d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2cd7d3829a475eab3f41f1f7f63464_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16836d586c23438497ba4585606b71df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id05e07ddaf204365bde66fc72e4e8a56_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222fc417f0d442279085025ae2862e64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60510ed6729f49d58e204a789ec164fe_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc24dddff635440bb6fa7fef2e8c6bbb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a18546e2641432186ebea4fb82b0c97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b32bbe6d6646c68e6d64342fb37f83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab173f92572840f69a38fdd7ef02744a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide3a54a13b084e729f49c0c5be9ef158_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f118ad8379e472489d69365de281b5a_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987b954ec383404489ad7dd44db86461_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0627e2a89adb4de6b5f96b5c7cd98f0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a9e217820b47419ac62a665233d6e6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f78858143164e768c61bb467e5fdd70_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0437592feca04863946089d86b4469ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a060aa4a4944de1b51797e710f61a6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i145ff6e523744822b4b70f6a3b8ccc36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117d5a15f0484f8aa5ec486b255b30a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec02fd593094c019fc93fa310f36636_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929e86bd2d204984ba3a7acb41d6f92d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i268abcc1595c47e0822aa833a03ccaf5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc89a5aa659464192a833dc24455b76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic63c12c941ae4e8d81cabaff36570cd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53b93c1b49f4b1781184342d6d22de2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14428d26feb74f44b207c0596adab982_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1530f3523e91426ea8a8ea3fe39aea94_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082f3efc12d847f7bdbcda637deb820f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a51434e1d640819950dc39740d93e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad7bbbd6621f4001b504642d91a8cd31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf52b2b42e8342a186985ec5e5775ce3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb5285f5cc45407cbdd753e2c83bf644_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bbe580a52f944c98f0001a290f94063_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b7965703b77464bb1196cc27ff38536_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:context id="i008795d9432842aa84611f74c3eace23_I20220926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed0c764a1ef48f18d31ec981995213b_I20201221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36bbf9012cea408c93248b27bdf539bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc0c3a66d1b4b0598d21bd659f5221c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4295be0ac744563a7454ae58d217d0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7726647971046a491c61ebc43a4896f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8600ea8026004026a91ef4697aa5aa1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141946ba0694449bb9049b3e2a07dee5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66601e7294074670ad5e6aa5e725a874_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c728bb018c44941b1bfa6521c9c1244_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329398daa6384179aba8e533d27d2360_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd78859ef8848a999eb4a52492eef4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i997ddfe9c3304a9e9408563c2fd4c3d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec03638243c4669892b4eb299ae5ed2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0465a51e6df04b86963ff406fb55ea2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7523d880d9374a2481b72ce4679376f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3214317cf106471eb746ae95e24aea11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67557a94436f43d9bf40a6821f726802_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33212f0ed73438ea87f123c17695625_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844b7cae12554de8ba766bd5d0e34762_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaca32771dbc4bf086fdf4c473690023_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d27726f48242c888971f11c16fce73_I20221003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32190bd884274de3ad539b9552b10509_D20221003-20221003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-03</xbrli:startDate><xbrli:endDate>2022-10-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70886b0065374cab828ea261cdadbf4e_I20211004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e3c4b1748e496f95f812498d15e0d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i0d1829ef6ea84eaca05276c51c0606c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if061f0c8b11a4b0e9af9f2d1b0096dfc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if02c59d68ec54646a35d4af040a81a1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67adfefe5a8443c6b626a7bbf0761620_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5897d96d2c4f5496944a6fd6a162ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245c76d03fc54d94af94a58fba2d7466_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55466ef9ef12476299ceffdcdfee3a9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4142d8f488e94bcc8829564ba2e3adae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f429c0617e74d7eb2fd570e3c4023ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a59d109ca88487ba3a465148ff07ff4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf5643d36404495ea9dedee026b7689a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5b3abf28fae409ea406125cd090ebe5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i043cdbf94a754048b4b54ddd6eea2270_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7b61c995a64818b815e9e90c34fa77_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id601c28871b9412d9cb1392b237ce8a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde344ad1e464afcb71f8af811c85b13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac0855122ee48d1aa3a6ee317127bd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe3ee7c51fd49caa0539281dd6cf5c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae5a8365a26446a3a0dca3f7522aa7e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b78e51cfeea49168e5007a5a4cfcf0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie807adbb29e64c9cb05ae929d44792cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3e492d9a1944dbc88ed4e5773148fc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2b519b9bef40ce86b32e60f3e0c395_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dfa8444a4ff4c799d79806966a6a49e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eb10ee588794a879897fa8ebf06fbe5_I20220526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a01a2803854f15a4b2bdb0ad580cf3_D20220526-20220526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-26</xbrli:startDate><xbrli:endDate>2022-05-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a5b238cefd4ad4851f8db781417fb8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf30e04d2e234b5da6da9f923618a1d6_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6753166079c43ef87f10211fa41814f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc81409a88946a78bc0d4af0384c50c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7629ad2913ce4b8c8a3a007050c04b32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b1038cb45449bd8017c02b7e07bcbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e7b6826294643ee9255e0aef5bfe00c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic14509aa5da94573ae2e368395318395_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d11744ab624cb0b137eee60066f067_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2578085d407f4986b5c4f56a8f5378e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0774406054da4b54a1499e2e2203b073_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51b578e29f734d8da75403f33593ad57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f1ed4692244fb883cb0925404db697_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedc48383bf44714905c7aba0b7e7eff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78f2cc3007c4d01874f3559b01933a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02621b369e244009ba8077814770d363_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82dc831f0d8543a3babdcc95198b48d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7598ea197a08489d85d2ca1a1d75029f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40bd17782234cf0a42d79443632bd3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd2e8ae6d2b84ab289dc5a4f5f4cac96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6649d3266ef54cdea0866db034e7da0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i284332c0c59745a1bafecb41e59a8cbf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdafe514a0f427a9c65279378fdca48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27ad7a70040d43599f4f203940fb2c3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f179ad71894c39b72c41978bcf975f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib479a1abd4bf4dd598c12f1ade31cc64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic924cff55443463a8fa41f30829d128f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d7c68edd73b44ed90a88f720435dd5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8f45920e753432791e424ba5bde4c8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326dcdfdff4841f5b13090e062a83847_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4251186fc1f74fa98118a5b683fb8145_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740c386c824b47d9a8a3bdd39e134319_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf39968359d436db16110742b8c4283_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b747e04cef446c8bbd192b91223c454_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i408e91f814cb42ff97d90348c7ed6c52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaa8a61ecfd341d69a8f83de49c64cdb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc8a876bb2c64e86b657b3bae578a201_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e1d03cd5a24c73bec632484549eb64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc909923f63a42e9a92c1575f351c160_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571a678056af4243869d6bf87a39cca5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38353e1fdf1749048a5b705812d03489_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca92d0c0999415284527156e8006bce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8909f47c11f94a13b5b07c5424d9e86b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222c2a2c9bb74ffb8a6ede3f0fe2b07f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9344740008a49528124058c2083bc1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d23ab70c34f4db5b5a839db493e3059_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d3030c2e0049f8a3c5db01ea805895_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f18b3ff623a416ba0697a89389f4152_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191577736fc34ca8967de6fee9d82bed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife5b2da3f37e4fbcafc4fc5d9d3dde7d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647e1d0b571a474c98483e6c2526bb29_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfcd42c9d16743e891b05d6e22c839f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb11cdd18ef45a19a594c8b5a25ee96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a836c14502143549a1b9311fc3030f9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97f621bb1334d50b0248002c7710d81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58764c27ca344070860ba269f3f79103_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id05ba75e955c4e129ebec3073ef3f592_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i628a3e3f7d544ad2bc901d0888fe818d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0755e5e4a8746c7a194eab90915121d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c981ec865a242b8ae02ae0b9be850b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01193be6295c427585def8bb00fd4b04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb26a3f7b9af4d3988640472b2a1e3d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36770afe37b9412b9efea6344f408b74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dfa3992858f4edc84158ff91aeadc14_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4953d9327d47a9a45aba2fa3765106_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib098ed8c299c4a93a64d24447ab1a258_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e4d6b7a79746f78154e10fd0d645de_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6736862e35f49389ee83853dd59ba02_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b51dab47180467b905af4f67a4f4857_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67ed97c9d064b8186d3064a9654c6d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2198808263d444eca9e55e49e81d38c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbd5fe6a779428bb7005202e9c1d107_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dae331e508745f1a1fda5b78ee75393_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic53017849e8e46159900dda56c09d990_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca2000819ce47d49042fde9d9662400_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f88d140805d417980d8109777892eef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87d13a9a1b744ede92d09a5f4fa60167_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39e9e07281e41ffb52e9314446776a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee7ff54bebb490c9c43421a64840f58_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i276d4167cfbc4c96b387801968c415a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie593d306076f420796fbc6b3700364ae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d60814ab4eb454190610b8946c1a931_I20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6329920052fe4d068537fccf47a1bbd4_D20230126-20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-26</xbrli:startDate><xbrli:endDate>2023-01-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8d0e669cefa40dc80fd293f8b65128f_I20220426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b20187279a484aa7a8e9867ab6bc1c_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied552a010c034654a585ce6ab14a3070_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i464ce85ce14945ae9a2b1ea43a72e31f_I20220324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica7dcd824511481a8120c2a8389e9b5f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f325b8385ec4ba599bbdc2436aa2acf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibab792d7a62149d18dc8eb2dc3683f89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b6305eecf041d2b4ced862809aa250_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc191873f1dc42bc9a919b9154c27144_D20100501-20100531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-05-01</xbrli:startDate><xbrli:endDate>2010-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e0bc249d794d8c923d4baa7345c70c_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ad94a13328414ba507646767f3d728_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id35f0fa4951b44e5a8286675c32d2ef8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i503e4c87c0e04676afd28e1f2a991921_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7872cc732b34351b799a3c73f66289e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab05a5cd30cb455e944ffa624620cb14_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe01e5177d5c4b008c60877d84f5c6e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2ee4a702a04c05a03330fdec68ebd2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f13c95eae224327a6df76189d019f93_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53b4883a913450d88e67a5f653ed435_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49a4a983eba4b5d96ea47a0ec6b49e0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc2c9acfb5b4ad28b78589745d7729b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74db8baf10424ff7a6207881e5bae34e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5acbf0ad9ad4e0e886eb359677690b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d1807080364f69937de4b97dd9811e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8b178570f44cdba015566ce1f26691_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98af93cab614bf7b1d6207967773298_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59ae462fc304032a8aaaf9f74348093_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd1ab005148412cb072897f89bca249_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i418f7c9941e041f4853468578a5ef6fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cab4ce05dd94d62b94dadb5d8e736fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>iart:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="i63561c0bbfd64fc0bdb211203c2b0c9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4686279af17c417cbe3854bacf4ca2d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d95969939c540bca05d2319452bd5fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5eeedd89d64492bde19c2d733af117_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15d057605944eca816fd58aedd828b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfe81ea28a254d779986ec9672045e13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fd716a767d4b339ab1295c5bb147d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d17811ad9fc45df8bcef0f695f18e73_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279c573a91e74e11abd25958e204a2d2_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie93924bccec8412e903736f429992621_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79636bff7892448cb422c38278985e4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie487f52caa6d4416be07a10223ed0bce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb5085d40924d08b32a44ed38777fa8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5125356e34064ab5bdcb08a3dffbcee3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id65461d577a648fa84b432ba0d645aca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58370c21a3bf4fa9916b815ebacaabad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ae72f002374097b8ae052513a4d9af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a64401f57445e3889fffd6aa340e49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53bb7164178d4c7681938eae96f8dd7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b4f71bfb1a8422d95af5dd6760a64f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ea09ba91b94301bbbdc52ab73d8aa5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a4807908c54cb5b1a0dd1fd6665df2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2f742f6e864e72a554afa2da3a8c66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34c42773d35464d81a75564647fa0e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20e8046929194a0da3727cadcc6ce0a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454bba66f23b40d59081b4ed516cc56b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04eb6b26c7384b9090a435f6497f42ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51944049eb7b403aba8baf9a73574149_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idad9f7b57287472faa5da1db0498730f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a223d9d7454456aa04f06027515378_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1745e45c4754439b297f3e7d7347d24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9aecdb884ec42408aef9ceaf4f7631d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99410b6978f346d1962e9be3d588bb16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e03ef2f5ff4d8098cebaa20d010574_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib407e2307b7d4fc1817926031f1d8119_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ff087bc35f4f4f8a6bb3d6ac4b1e72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba83041b85dd4322beadedfbb737f04d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6416949c9d6642de911caf67ffe8aabb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e82c009c774de0bb05432b74102ae9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a5653a9fc64e90aa2fbdb1b8095a56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifde103a447ad47428323ce033718630c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61f82dd9bf0413b91c391c490e54d73_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf69e67cb3914b7097e58795099a96dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="liability"><xbrli:measure>iart:liability</xbrli:measure></xbrli:unit><xbrli:context id="i0a7b1feae529450e813237017e332bb6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4c5c321a5d4d579e4c7197fc75ffab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86a8f98051a4098a0c55718c503c35c_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ad6fdc92af64fb3a69eb22274101a61_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f62455b6c14446e8989b657790d2e88_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia332c4339d0d47d2adb4575e1fac651f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>iart:product</xbrli:measure></xbrli:unit><xbrli:context id="i148cca9d8e92463aa899bc73beb1ca6b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i814b998492a7444cbcd7886849cb6270_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib018f6bcc24a4b3dbe4ce6e3c97e8a0e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c96c89c8aef4dd0a52c23f78abe191e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6b3618e04d540f4b99ec989ee7e7234_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa67b71c6874d56a903eea0c00a39c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8beb115769fa4bde80a56f0d62b90c05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b167d370d54bac874817e7f8c82740_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc1ccf682b834d75acf993e77078be00_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035e179e3b8b4d64bfcfbf533913f64d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1659d84668436b978aebc30d320151_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f6ca02b71f444939da26d0171cf9a3d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1a52a97e10485aa9156603f0f12998_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7aa00ba8e0a4089b0402c6f812d9e90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a4eff2718b4181a3594c15f97693d6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2ba32f80384628b6d3da8a948107a4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be3e483d1fa4218b4739bff6b339aa3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bc8a1f80f84b31a8dbe8ec757a0ec6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5db6e94f32d64676a8e5222a7710ac27_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia647697a80af4c1a998c2f4501de7cec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88400ec8187435b94bf27f234e62310_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1021003fc387465985bb51c9d1963f10_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101af6c449e24243a977e3628cb006bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa59878bdb8a4814a9a4fcea4012a206_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i016f6830198948e4a83167888eedc5ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c47750f81947a3bd94f67736a169fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b9598bb29974c0eb5a1c729153672d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cf719a0faa4ece96aea8a2bae8fc0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34987c7e67424092b2a980a73d2196af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792da25db32e486d817b94438346f505_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0356b0dec6c415886e16716b8d764cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1045633e59945fc8f109a571dd0a894_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ2_5e4565e9-74c6-4346-b25b-e98f16e0f5d7">10-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZTFiYjRhZWM2YTIxNDgwZDliMzkzNzE1MTMzY2MzNGMvdGFibGVyYW5nZTplMWJiNGFlYzZhMjE0ODBkOWIzOTM3MTUxMzNjYzM0Y18wLTAtMS0xLTkyNDc5_42e46f0e-6d58-4a30-91bb-86dd070fa5e0">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8xMjg_5926e811-29ec-464d-b996-d12462f5f38f"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8xMjg_66c3b783-691a-4bae-93e5-7dcf202e3c89">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NjcwYzNlN2VhN2U1NDIxNzgyNmMxMTUyYTkxY2UwMDMvdGFibGVyYW5nZTo2NzBjM2U3ZWE3ZTU0MjE3ODI2YzExNTJhOTFjZTAwM18wLTAtMS0xLTkyNDc5_bada3559-b871-43d1-9e83-2d36c8fa9f7d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NO. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM4_af20e668-2c04-4611-9fc1-cf8c3d285cc3">000-26224</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM1_a34e6b03-1d3b-4256-8d8b-28570a37fe56">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8wLTAtMS0xLTkyNDc5_22f42b90-a4be-4cd4-bcbc-bd30e3065b7b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8wLTQtMS0xLTkyNDc5_b8ad6bcf-4b73-4da7-93d4-ee71efe61b08">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(STATE OR OTHER JURISDICTION OF<br/>INCORPORATION OR ORGANIZATION)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. EMPLOYER<br/>IDENTIFICATION NO.)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8zLTAtMS0xLTkyNDc5_0bcac0b9-57ae-4794-9ce4-ea4c84c5de7d">1100 Campus Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8zLTQtMS0xLTkyNDc5_c60488c4-69d6-4fdb-bb0d-48756907ac7e">08540</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV80LTAtMS0xLTkyNDc5_d7caef45-34b2-45ac-8d62-92d7f65e1dc2">Princeton</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV80LTItMS0xLTkyNDc5_fae842df-2a1b-41f1-8c87-23f43c266c04">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ZIP CODE)</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQz_49ec35f7-9182-4d9c-a65c-6f9f7cce3122">609</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM5_9a5c17c5-7914-4d90-8f4f-d55c7156eea3">275-0500</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:37.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTAtMS0xLTkyNDc5_a2a201a9-a1fe-4821-a6c9-308bd415e0d1">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTEtMS0xLTkyNDc5_dde8385f-6c13-4dab-bffc-59341137e30f">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTItMS0xLTkyNDc5_525ca9bb-6f2c-4a4c-b837-f1362bb57fb4">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NONE</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ0_a09440b9-f652-4b92-8120-73d0c2e56450">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQw_c5160dd2-8891-4c56-b2cd-edec19d89e71">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQx_d6b06997-de76-4a5e-a6dd-ff506acd4b10">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM2_e99d8ada-0e30-4e3a-bddb-e3ad1282831f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV8wLTAtMS0xLTkyNDc5_706266eb-d379-462e-8b41-6fe60588e8b3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV8yLTMtMS0xLTkyNDc5_1ec2e016-2436-425c-ab15-d69687709c52">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV80LTEtMS0xLTkyNDc5_f945b714-c9d0-4cbf-a743-818229d965d6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check if the registrant has elected not to use the extended transition period for complying with any new revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM3_3e19ebc8-44fe-4101-a48a-dab6a20aad67">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQy_d7d9fa8a-41b6-4b20-b81e-0a728069ef22">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2022, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approxim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ately $<ix:nonFraction unitRef="usd" contextRef="ied522dc9e3e142338801a4d51273b10e_I20220630" decimals="-5" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8yNjky_b6fbd33e-2a63-4481-b16a-e8d8dbb23091">3,916.0</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">based upon the closing sales price of the registrant&#8217;s common stock on The Nasdaq Global Select Market on such date. The number of shares of the registrant&#8217;s Common Stock, $0.01 par value, outstanding as of February&#160;21, 2023 was <ix:nonFraction unitRef="shares" contextRef="i92465366760c4177b8742406cf6fbd07_I20230221" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8yOTA5_149e90ad-1f16-4392-a468-b8a68929fb56">81,636,066</ix:nonFraction>.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ1_bffb7c89-2a8f-4ddf-949c-ec210f958616" escape="true">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;12, 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission, are incorporated by reference in Part III of this Annual Report on Form 10-K.</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:90.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_10">PART&#160;I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_13">Item 1.      Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_19">Item 1A.   Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_19">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_16">Item 1B.   Unresolved Staff Comment</a></span><span style="color:#1a3cbf;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_16">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_22">Item 2.      Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_22">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_25">Item 3.      Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_25">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_28">Item 4.      Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_28">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_31">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_34">Item 5.     Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_34">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_37">Item 6.     [</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reserved]</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_37">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_40">Item 7.     Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_40">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_67">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_67">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_73">Item 8.     Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_73">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_76">Item 9.     Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_76">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_79">Item 9A.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_79">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_82">Item 9B.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_82">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_85">Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_82">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">Item 10.   Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">Item 11.   Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matter</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">Item 13.   Certain Relationships, Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">Item 14.   Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_88">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_106">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_109">Item 15.    Exhibits and Financial Statements Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_109">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_112">Item 16.    Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_112">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_115">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_115">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company,&#8221; "Integra LifeSciences," and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries, unless the context suggests otherwise.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Integra LifeSciences is a global leader in regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue, Integra LifeSciences Holdings Corporation common stock trades on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;IART.&#8221; Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra products are sold in more than 130 countries through a direct sales force as well as distributors and wholesalers. We manufacture and sell medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We source most of our handheld surgical instruments and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vision</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aspire to continue to be a worldwide leader in neurosurgery and reconstructive surgery with a portfolio of leading businesses that delivers outstanding customer experiences through innovation, execution and teamwork to positively impact the lives of millions of patients and their families.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) enabling an execution-focused culture, 2) optimizing relevant scale, 3) advancing innovation and agility, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. An important part of the our strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. Our growth strategy includes the acquisition of businesses, assets or products lines to increase the breadth of our offerings, the reach of our product portfolios and drive relevant scale to our customers. On December 6, 2022, the Company completed the acquisition of Surgical Innovation Associates, Inc. ("SIA"), which develops, markets and sells DuraSorb&#174;, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition will advance Integra&#8217;s global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in implant-based breast reconstruction ("IBBR"). We also continued to expand our product offering of regenerative technologies from our 2021 acquisition of ACell, Inc. ("ACell"), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">an innovative regenerative medicine company specializing in the manufacturing of porcine urinary bladder extracellular matrices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for additional details. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Product Introductions and Portfolio Optimization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential technological innovations</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for significant returns on investment. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In addition to acquisitions and organic reinvestment, we continually look to optimize our portfolio towards higher growth and higher margin businesses. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, we may opportunistically divest businesses or discontinue products where we see limited runway for future value creation in line with our aspirations due in part to changes in the market, business fundamentals or the regulatory environment. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we completed the sale of our non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentall") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon the achievement of certain revenue-based performance milestones. In January 2021, we completed the sale of our Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"), a subsidiary of Smith &amp; Nephew plc, for approximately&#8239;$240&#8239;million in cash. Our portfolio optimization actions over the past two years have allowed us to increase our focus on Integra&#8217;s core portfolio of market-leading products in neurosurgery, surgical instrumentation and regenerative tissue and moves us closer to achieving our long-term organic growth and profitability targets. See Note 4, Acquisitions and Divestitures, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for additional details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. To support our commercial efforts in Tissue Technologies, we utilize a two-tier specialist model to increase our presence in focused segments to help serve the evolving needs of our customers. In addition, we continue to build upon our leadership brands across our product franchises in both CSS and TT to engage customers through enterprise-wide contracts with leading hospitals, integrated delivery networks and global purchasing organizations in the United States. Internationally, we have increased our commercial resources significantly in key emerging markets and are making investments to support our sales organization and maximize our commercial opportunities. Domestically, we have also increased our TT sales force in the United States to support the expanded regenerative tissue product portfolio that includes ACell products. These investments in our international and domestic sales channel position us well for expansion and long-term growth. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthening our relationships with all customers. We continue to invest in technologies, systems and processes to enhance the customer experience. In 2022, we outsourced certain transactional back-office finance and customer service activities to enhance customer quality, build scale for future growth, and capture cost efficiencies. We also launched digital tools and programs, resources and virtual product training to drive continued customer familiarity with our growing portfolio of medical technologies globally. .</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS SEGMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra currently manufactures and sells our products and technologies in the following two global reportable business segments: Codman Specialty Surgical and Tissue Technologies. We include financial information regarding our reportable business segments and certain geographic information under "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Codman Specialty Surgical</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Codman Specialty Surgical business consists of a broad portfolio of market-leading brands, such as Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, DuraSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mayfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,Bactiseal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Certas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plus,which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The growth in this business in the recent years has been fueled by geographic expansion and new product registrations in markets, such as China, Japan,&#8239;and&#8239;Europe, which we expect to continue in the near-to-long term. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In  2022, we made progress to several enhancements to our CUSA Clarity Tissue Ablation System. The extended laparoscopic tip was launched in the U.S. to enhance laparoscopic liver procedures. In addition, a single-sided bone tip received 510(k) clearance. Commercial launch is expected in the first quarter of 2023. We continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece and integrated electrosurgical capabilities. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we are expanding into&#8239;minimally invasive surgery ("MIS") and the surgical management of intracerebral hemorrhages ("ICH"), with the 2021 clinical launch of Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8239;Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a proprietary surgical solution with integrated visualization and capabilities designed specifically for use in&#8239;deep-seated&#8239;brain lesions. We continue to gather clinical evidence using this same technology for&#8239;early surgical intervention of ICH. We believe this technology offers the promise of transforming the standard of care in neurosurgery. In 2022, we launched the Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Evacuator with Coagulation device in the U.S., designed to be used in conjunction with our Aurora Surgiscope to safely address and evacuate blood in the brain caused by hemorrhagic stroke.&#8239;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rounding out the portfolio is a catalog of surgical headlamps and surgical instrumentation, as well as after-market service. With thousands of surgical instrument products, including specialty surgical instruments, we call on the central sterile processing unit of hospitals and acute care surgical centers. Additionally, through a strong U.S. distribution model, we serve the needs of hundreds of medical offices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also expanded our product offerings in 2021 with the launch of our new intracranial pressure ("ICP") monitoring system, CereLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and Europe and continued the global rollout in the first half of 2022. See additional discussion regarding certain matters with CereLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under "Item 1A. Risk Factors" under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to our Regulatory Environment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and under "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - General - FDA Matters" of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tissue Technologies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tissue Technologies segment consists of five unique regenerative technology areas - highly engineered bovine collagen, bovine dermis, porcine urinary bladder, human amniotic tissue, and resorbable synthetic mesh. This broad regenerative platform, which includes multiple leading brands such as Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Matrices, AmnioExcel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MicroMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and NeuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily addresses the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection. During 2022, we completed the acquisition of Surgical Innovation Associates, Inc. ("SIA"), which is seeking approval by the U.S Food and Drug Administration ("FDA") of the PMA application for its core technology, DuraSorb, for use in IBBR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a specialized sales organization composed of directly employed sales representatives, as well as specialty distributors, organized based upon their call point. Our wound reconstruction sales representatives call on surgeons doing procedures in limb salvage, trauma, wound reconstruction and burns, chronic wounds primarily in the inpatient wound care clinic setting. We also have a dedicated surgical reconstruction sales team focused on plastic and reconstructive surgery and hernia procedures with differentiated products. Finally, we have a distributor network focused on biologics. Outside the U.S., we have a combination of direct and indirect sales channels in international markets to sell certain product lines. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business segment also includes private-label sales of a broad set of our regenerative and wound care technologies. Our customers are other medical technology companies that sell to end markets primarily in spine, surgical and wound care.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate new product introductions and new clinical indications will continue to contribute to the growth of the segment. In 2022, we launched NeuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3D Nerve Guide Matrix, a resorbable implant for repair of peripheral nerve discontinuities and engineered to create an optimized environment for nerve regeneration. In the third quarter of 2021, we filed the PMA application for a specific indication for SurgiMend in the use of post-mastectomy breast reconstruction, for which we hope to obtain FDA approval in 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors for CSS are Medtronic, Inc., Stryker Corporation, Becton Dickinson and Company, and  B. Braun Medical, Inc. In addition, we compete with many smaller specialized companies and larger companies that do not otherwise focus on the offerings of Codman Specialty Surgical technologies. We rely on the depth and breadth of our sales and marketing organization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our competition for TT includes Smith &amp; Nephew plc, Organogenesis Holdings Inc., MiMedx Group, Inc., Allergan PLC, Becton Dickinson and Company, and Axogen, Inc. We compete with many additional companies who partially participate in soft tissue reconstruction of complex wounds, peripheral nerve repair and surgical reconstruction. In addition, our products also compete against medical practices that treat a condition without using a medical device or any particular product, such as medical practices that utilize autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products. Depending on the product line, we compete based on our products' features, strength of our sales force or distributors, sophistication of our technology and cost effectiveness of our solution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT STRATEGY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities focus on identifying unmet surgical needs and addressing those needs with innovative solutions and products. We apply our core competency in regenerative technology to innovate products for neurosurgical, wound applications, plastic surgery, and reconstructive surgery and we have extensive R&amp;D development programs for our core platforms of electromechanical technologies. Additionally, we conduct products and clinical studies to generate efficacy and health economic evidence.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regenerative Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra was the first company to receive a FDA claim for regeneration of dermal tissue and is a world leader in regenerative technology. Because regenerative technology products represent a fast-growing, high-margin opportunity for us, we allocate a large portion of our research and development budget to these projects. Our regenerative technology development program applies our expertise in bioengineering to a range of biomaterials including natural materials such as purified collagen, intact human or animal tissues, honey as well as resorbable synthetic polymers with our DuraSorb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and DuraSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product lines. These unique product designs are used for neurosurgical and reconstructive surgical applications, as well as dermal regeneration, including the healing of chronic and acute wounds, tendon and nerve repair. Our regenerative </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology platform includes our legacy Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Regeneration Template ("IDRT") products and complementary technologies that we have acquired. Our collagen manufacturing capability, combined with our history of innovation, including our launch of NeuraGen 3D, provides us with strong platform technologies for multiple indications. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we announced positive clinical and economic data on Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons look for ways to efficiently and effectively repair and close wounds, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients. In 2021, we completed one of the largest diabetic foot ulcers ("DFU"), randomized controlled trials of the PriMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermal Repair Scaffold for the management of DFU. This multi-center study enrolled more than 225 patients with chronic DFU's over the course of 12-week treatments and 4-week follow-up phases. The results of this study, which was published in the Journal of Wound Care, demonstrated that PriMatrix plus standard of care ("SOC") consisting of sharp debridement, infection elimination, use of dressings and offloading was significantly more likely to achieve complete wound closure compared with SOC alone, with a median number of one application of the product. Integra is currently pursuing pre-market approval for implant-based breast reconstruction with our Surgimend product.  In 2022, we acquired SIA, which is also pursuing a pre-market approval for IBBR. By offering two distinct product solutions, we believe we have the opportunity to build a leading position in the market. We completed design control activities in 2022 for a Q1 2023 launch of Cytal and MicroMatrix in Europe and a pilot launch of the Cardion Pericardial Patch to gain clinical experience for finding a private label partner for that product.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Electromechanical Technologies and Instrumentation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Because our electromechanical products and instruments address significant needs in surgical procedures and limit uncertainty for surgeons, we continue to invest in approvals for new indications and next generation improvements to our market-leading products. We have several active programs focused on life cycle management and innovation for capital and disposable products in our portfolio. Our product development efforts are focused on core clinical applications in cerebrospinal fluid ("CSF") management, neuro-critical care monitoring, minimally invasive instruments and electrosurgery and ultrasonic medical technologies, as well as our ambition to transform the standard of care in neurosurgery with product advancements in MIS and ICH. Our lighting franchise is among the most dynamic in the industry. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on the development of core clinical applications in our electromechanical technologies portfolio. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we made progress to several enhancements to our CUSA Clarity Tissue Ablation System. The extended laparoscopic tip was launched in the U.S. to enhance laparoscopic liver procedures. In addition, a single-sided bone tip received 510(k) approval. Commercial launch is expected in the first quarter of 2023. We continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece and integrated electrosurgical capabilities. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to work with several instrument partners to bring new surgical instrument platforms to the market. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on the development of core clinical applications in our electromechanical technologies portfolio. In June 2022, we launched the Neutus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EVD system, our first external ventricular drain (&#8220;EVD") in China. The Neutus EVD system is manufactured in China by Shanghai Haoju Medical Technology Co., Ltd. under an exclusive distribution arrangement. The device is used in the management of cerebrospinal fluid and is highly complementary to our Bactiseal</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> catheter and advanced intercranial pressure monitoring products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, we launched our CereLink ICP Monitor System in the U.S. and Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and continued the global rollout in the first half of 2022.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the Company, after consultation with the FDA and other regulatory authorities outside of the United States, initiated an immediate voluntary global product removal of all CereLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> intracranial pressure monitors.  See Item 1A. Risk Factors, under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to our Regulatory Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and under Item 7. General Management's Discussion and Analysis of Financial Condition and Results of Operations - FDA Matters of this Annual Report on Form 10-K for further discussion.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2022, we continued to advance the early-stage technology platforms we acquired in 2019. Through the acquisition of Arkis Biosciences, Inc. ("Arkis") we added a platform technology, CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> external ventricular drainage ("EVD"), catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. Our work to combine our bactiseal antimicrobial technology with the Endexo anti-occlusive technology obtained through our 2019 acquisition of Arkis continues to progress for both a silicone-based hydrocephalus and EVD project.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2019, we also acquired Rebound Therapeutics Corporation ("Rebound Therapeutics"), a company that specialized in single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In the third quarter of 2021, we conducted a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH. In 2022, we launched the Aurora</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Evacuator with Coagulation device in the U.S., designed to be used in conjunction with our Aurora Surgiscope to safely address and evacuate blood in the brain caused by hemorrhagic stroke.&#8239;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, raw materials essential to our businesses are readily available from multiple sources. For reasons of quality assurance, availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. Our practice is to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products, including but not limited to our dermal regeneration products, duraplasty products, wound care products, and nerve and tendon repair products, contain material derived from bovine tissue. We take great care to provide products that are safe and free of agents that can cause disease. In particular, the collagen used in the products that we manufacture is derived from the deep flexor tendon of cattle less than 24 months old from New Zealand, a country that has never had a reported case of bovine spongiform encephalopathy ("BSE") (otherwise known as mad cow disease), from the U.S. or from fetal bovine dermis. The World Health Organization classifies different types of cattle tissue for relative risk of BSE transmission. Deep flexor tendon and fetal bovine skin are in the lowest-risk category for BSE transmission, and therefore considered to have a negligible risk of containing the agent that causes BSE.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek patent and trademark protection for our key technology, products and product improvements, both in the U.S. and in selected foreign countries. When determined appropriate, we have enforced and plan to continue to enforce and defend our patent and trademark rights. In general, however, we do not rely solely on our patent and trademark estate to provide us with any significant competitive advantages as it relates to our existing product lines. We also rely upon trade secrets and continuing technological innovations to develop and maintain our competitive position. In an effort to protect our trade secrets, we have a policy requiring our employees, consultants and advisors to execute proprietary information and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements also provide that all confidential information developed or made known to the individual during the course of their relationship with us must be kept confidential, except in specified circumstances. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AccuDrain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, AmnioExcel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Aquasonic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Auragen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Aurora</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Surgiscope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Bactiseal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, BioDFence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, BioDOptix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Brainet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Budde</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Buzz&#8482;,  CereLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, CerebroFlo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> EVD Catheter with Endexo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Technology, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Accu-Flo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Bicol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Certas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Plus, Codman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Hakim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Programmable valve, Codman Holter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman ICP Express</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman Microsensor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman VersaTru</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Codman VPV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Contour-Flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Cranioplastic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> CRW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> CRW Precision&#8482;, Ctherm&#8482;, CUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Cytal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DirectLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DuraSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, DuraSorb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Gentrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliCote</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliPlug</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, HeliTape</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> HeliMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Helistat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Helitene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Hermetic&#8482;, Hy-Tape</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IntegraLink</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Isocool</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Jarit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Lead-Lok&#8482;, Licox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, LimiTorr&#8482;, Luxtec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Mayfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MatriStem UBM&#8482;, MediHone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">y&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  MicroFrance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MicroMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Miltex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Mischler&#8482;, MoniTorr ICP&#8482;,  Natus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, NeuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, NeuraWrap&#8482;, Nicolet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Omnigraft</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Omni-Tract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, OSV II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Padgett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, PriMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Pureflow&#8482;,  Q-Snor&#8482;,  Redmond&#8482;, Revize&#8482;, Ruggles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  Signacreme</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, TCC-EZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, TenoGlide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,  TissueMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Ultra VS&#8482;,  VersaTru</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Xtrasorb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> zRIP&#8482;, and the Integra logo are some of the material trademarks of Integra LifeSciences Corporation and its subsidiaries. MAYFIELD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is a registered trademark of SM USA, Inc., and is used by Integra under license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEASONALITY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues during our fourth quarter tend to be stronger than other quarters because many hospitals increase their purchases of our products during the fourth quarter to coincide with the end of their budget cycles in the U.S. In general, our first quarter usually has lower revenues than the preceding fourth quarter, the second and third quarters have higher revenues than the first quarter, and the fourth quarter revenues are the highest in the year. The main exceptions to this pattern occur because of material acquisitions as well as impacts of the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION AND COMPLIANCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a manufacturer and marketer of medical devices and Human Tissue and Cell Based Products ("HCT/Ps") and therefore are subject to extensive regulation by the FDA, the Center for Medicare Services of the U.S.&#160;Department of Health and Human Services, other federal governmental agencies and, in some jurisdictions, by state and foreign governmental authorities. These regulations govern the introduction of new medical devices and HCT/Ps, the observance of certain standards with respect to the design, manufacture, testing, labeling, promotion and sales of the products, the maintenance of certain records, the ability to track devices, the reporting of potential product defects, the import and export of products, and other matters. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Food and Drug Administration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our products are subject to extensive regulation particularly as to safety, efficacy and adherence to FDA Quality System Regulation, and related manufacturing standards. Medical device products are subject to rigorous FDA and other governmental agency regulations in the United States and similar regulations of foreign agencies abroad. The FDA regulates the design, development, research, preclinical and clinical testing, introduction, manufacture, advertising, labeling, packaging, marketing, distribution, import and export, and record keeping for such products, in order to ensure that medical products distributed in the United States are safe and effective for their intended use. In addition, the FDA is authorized to establish special controls to provide reasonable assurance of the safety and effectiveness of most devices. Non-compliance with applicable requirements can result in import detentions, fines, civil and administrative penalties, injunctions, suspensions or losses of regulatory approvals, recall or seizure of products, operating restrictions, refusal of the government to approve product export applications or allow us to enter into supply contracts, and criminal prosecution. The regulatory process for obtaining product approvals and clearances can be onerous and costly. The FDA requires, as a condition to marketing a medical device in the U.S., that we secure a Premarket Notification clearance pursuant to Section&#160;510(k) of the Federal Food, Drug and Cosmetic Act (the "FD&amp;C Act"), or an approved PMA application (or supplemental PMA application). Obtaining these approvals and clearances can take up to several years and may involve preclinical studies and clinical trials. The FDA also may require a post-approval clinical study as a condition of approval. To perform clinical trials for significant risk devices in the U.S. on an unapproved product, we are required to obtain an Investigational Device Exemption from the FDA. The FDA also may require a filing for approval prior to marketing products that are modifications of existing products or new indications for existing products. Moreover, after clearance/approval is given, if the product is shown to be hazardous or defective, the FDA and foreign regulatory agencies have the power to withdraw the clearance or approval, as the case may be, or require us to change the device, its manufacturing process or its labeling, to supply additional proof of its safety and effectiveness or to recall, repair, replace or refund the cost of the medical device. Because we currently export medical devices manufactured in the U.S. that have not been approved by the FDA for distribution in the U.S., we are required to obtain approval/registration in the country to which we are exporting and maintain </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">certain records relating to exports and make these available to the FDA for inspection, if required. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Cells, Tissues and Cellular and Tissue-Based Products </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, through its wholly-owned subsidiary BioD LLC ("BioD"), is involved with the recovery, processing, storage, transportation and distribution of donated amniotic tissue. The FDA has specific regulations governing HCT/Ps. An HCT/P is a product containing, or consisting of, human cells or tissue intended for transplantation into a human patient. Examples of HCT/Ps include bone, ligament, skin and cornea. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some HCT/Ps fall within the definition of a biological product, medical device or drug regulated under the FD&amp;C Act. These biologic, device or drug HCT/Ps must comply both with the requirements exclusively applicable to HCT/Ps and, in addition, with requirements applicable to biologics, devices or drugs, including premarket clearance or approval from the FDA. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;361 of the Public Health Service Act ("Section 361") authorizes the FDA to issue regulations to prevent the introduction, transmission or spread of communicable disease. HCT/Ps regulated as &#8220;361&#8221; HCT/Ps are subject to requirements relating to registering facilities and listing products with the FDA, screening and testing for tissue donor eligibility, and Good Tissue Practices when processing, storing, labeling, and distributing HCT/Ps, including required labeling information, stringent record keeping, and adverse event reporting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Association of Tissue Banks ("AATB") has issued operating standards for tissue banking. Compliance with these standards is a requirement in order to become an AATB-accredited tissue establishment. In addition, some states have their own tissue banking regulations. We are licensed or have permits for tissue banking in California, Delaware, Illinois, Maryland, New York, Oregon, and Tennessee. In Tennessee, we are registered with the FDA Center for Biological Evaluations and Research.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Procurement of certain human organs and tissue for transplantation is subject to the restrictions of the National Organ Transplant Act, which prohibits the transfer of certain human organs, including skin and related tissue for valuable </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consideration, but permits the reasonable payment associated with the removal, transportation, implantation, processing, preservation, quality control and storage of human tissue and skin. BioD is a registered Tissue Bank and is involved with the recovery, storage and transportation of donated human amniotic tissue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2015, the FDA issued an Untitled Letter (the "Untitled Letter") alleging that BioD's morselized amniotic membrane tissue-based products do not meet the criteria for regulation as HCT/Ps solely under Section 361  and that, as a result, BioD would need a biologics license to lawfully market those morselized products. Since the issuance of the Untitled Letter, BioD and the Company has made known to the FDA their disagreement with the FDA&#8217;s assertion that certain products are more than minimally manipulated. The FDA has not changed its position that certain of the BioD acquired products are not eligible for marketing solely under Section 361. In July 2020, the FDA issued the final guidance document related to human tissue titled, &#8220;Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use&#8221; (the &#8220;2020 HCT/P Final Guidance&#8221;). The 2020 HCT/P Final Guidance document supersedes the November 2017 guidance by the same title.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HCT/P Final Guidance maintains the FDA&#8217;s position that products such as the Company&#8217;s morselized amniotic membrane tissue-based products do not meet the criteria for regulation solely as HCT/Ps. In addition, in the November 2017 guidance, the FDA articulated a risk-based approach to enforcement and, while some uses for amniotic membrane tissue-based products would have as much as thirty-six months of enforcement discretion, other high risk uses could be subject to immediate enforcement action. The 2020 HCT/P Final Guidance maintained this approach and extended the discretionary enforcement period to May 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Considering the risk of enforcement action, the Company discontinued the manufacturing of all morselized amniotic membrane tissue-based products prior to May 31, 2021. We no longer distribute these products. As of December 31, 2022, the Company has not received any further notice of enforcement action from the FDA regarding its morselized amniotic membrane tissue-based products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Device Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, the FDA requires that a manufacturer introducing a new medical device or a new indication for use of an existing medical device obtain either a Section 510(k) premarket notification clearance or a PMA, before introducing it into the U.S. market. The type of marketing authorization is generally linked to the classification of the device. The FDA classifies medical devices into one of three classes (Class I, II or III) based on the degree of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device&#8217;s safety and effectiveness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining a Section 510(k) clearance generally requires the submission of performance data and often clinical data, which in some cases can be extensive, to demonstrate that the device is &#8220;substantially equivalent&#8221; to a device that was on the market before 1976 or to a device that has been found by the FDA to be &#8220;substantially equivalent&#8221; to such a pre-1976 device, a predecessor device is referred to as &#8220;predicate device.&#8221; As a result, FDA clearance requirements may extend the development process for a considerable length of time. In addition, in some cases, the FDA may require additional review by an advisory panel, which can further lengthen the process. The PMA process, which is reserved for new devices that are not substantially equivalent to any predicate device and for high-risk devices or those that are used to support or sustain human life, may take several years and requires the submission of extensive performance and clinical information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices can be marketed only for the indications for which they are cleared or approved. After a device has received 510(k) clearance for a specific intended use, any change or modification that significantly affects its safety or effectiveness, such as a significant change in the design, materials, method of manufacture or intended use, may require a new 510(k) clearance or PMA approval and payment of an FDA user fee. The determination as to whether or not a modification could significantly affect the device&#8217;s safety or effectiveness is initially left to the manufacturer using available FDA guidance; however, the FDA may review this determination to evaluate the regulatory status of the modified product at any time and may require the manufacturer to cease marketing and recall the modified device until 510(k) clearance or PMA approval is obtained. The manufacturer may also be subject to significant regulatory fines or penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are required to register with the FDA as a medical devic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e manufacturer and any devices we manufacture and distribute pursuant to clearance or approval by the FDA are subject to pervasive and continuing regulation by the FDA and certain state agencies. These include product listing and establishment registration requirements, which help facilitate FDA inspections and other regulatory actions,  and our manufacturing sites are subject to periodic inspection by the FDA for compliance with the FDA's Quality System Regulations. These regulations require that we manufacture our products and maintain our documents in a prescribed manner with respect to design, manufacturing, testing and control activities. Further, we are required to comply with various FDA requirements and other legal requirements for labeling and promotion. If the FDA believes that a company is not in compliance with applicable regulations, it may issue a warning letter, institute proceedings to detain or seize products, issue a recall order, impose operating restrictions, enjoin future violations and assess civil penalties against that company, its officers or its employees and may recommend criminal prosecution to the U.S. Department of Justice. All Integra manufacturing facilities participate in the Medical Device Single Audit Program and are audited annually for compliance with the Quality System for US FDA, Canada, Australia, Brazil, and Japan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device regulations also are in effect in many of the countries in which we do business outside the U.S. In the European Economic Area ("EEA"), which is comprised of the 27 member states of the European Union plus Norway, Iceland and Liechtenstein, medical devices need to comply with specific requirements. These requirements were previously known as "Essential Requirements" under the former EU Medical Devices Directive (Council Directive 93/42/EEC, or MDD) and are now defined "General Safety and Performance Requirements (GSPR)" under the new EU Medical Devices Regulation (Regulation (EU) 2017/745, or "EU MDR"). Although the requirements set forth in the EU MDR are generally consistent with those laid out in the MDD (with a few exceptions), the EU MDR is intended, among other things, to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation. These laws range from comprehensive medical device approval and Quality System requirements for some or all of our medical device products to simpler requests for product data or certifications. Under the European Union Medical Device Directive, medical devices must meet the Medical Device Directive standards and receive </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE Mark Certification prior to marketing in the EEA. Although we continue to transition our certification profile to meet the new EU MDR requirements, these stricter regulations set forth in the EU MDR may pose additional challenges for Integra to continue marketing products in the EU as these regulations come into force.  See &#8220;Item 1A. Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to stringent domestic and foreig</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n medical device regulations and oversight and any adverse action may adversely affect our ability to compete in the marketplace and our financial condition and business operations&#8221; of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE Mark Certification requires a comprehensive quality system program, technical documentation, clinical evaluation and data on the product which are then reviewed, by a Notified Body. A Notified Body is an organization designated by the national governments of the EU member states to make independent judgments about whether a product complies with the requirements established by each CE&#160;marking directive. The Medical Device Directive, Medical Device Regulation, ISO 9000 series and ISO 13485 are recognized international quality standards that are designed to ensure that we develop and manufacture quality medical devices. Other countries are also instituting regulations regarding medical devices or interpreting and enforcing existing regulations more strictly. Compliance with these regulations requires extensive documentation and clinical reports for our products, revisions to labeling, and other requirements such as facility inspections to comply with the registration requirements. A recognized Notified Body audits our facilities annually to verify our compliance with the ISO 13485 Quality System standard. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain countries, as well as the EU, have issued regulations that govern products that contain materials derived from animal sources. Regulatory authorities are particularly concerned with materials infected with the agent that causes BSE. These regulations affect our dermal regeneration products, duraplasty products, hernia repair products, biomaterial products for the spine, nerve and tendon repair products and certain other products, all of which contain material derived from bovine tissue. Although we take great care to provide that our products are safe and free of agents that can cause disease, products that contain materials derived from animals, including our products, may become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for prion transmission. Significant new regulations, a ban of our products, or a movement away from bovine-derived products because of an outbreak of BSE could have a material, adverse effect on our current business or our ability to expand our business. See &#8220;Item&#160;1A. Risk Factors&#160;&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risks Related to our Regulatory Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">" of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postmarket Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved for commercial distribution, numerous regulatory requirements apply. These include the FDA Quality System Regulations which cover the procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of medical devices; the FDA's general prohibition against promoting products for unapproved or 'off-label' uses; the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur; and the Reports of Corrections and Removals regulation, which require manufacturers to report recalls and field corrective actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a violation of the FD&amp;C Act. Postmarket requirements are also followed globally where our products are registered and approved. These foreign jurisdictions have similar requirements to the FDA which include reporting requirements such as adverse events and recalls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other regulations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Bribery Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the U.S., we are subject to laws and regulations pertaining to healthcare fraud and abuse, including anti-kickback laws and physician self-referral laws that regulate the means by which companies in the health care industry may market their products to hospitals and health care professionals and may compete by discounting the prices of their products. Similar anti-bribery laws exist in many of the countries in which we sell our products outside the U.S., as well as the United States Foreign Corrupt Practices Act (which addresses the activities of U.S. companies in foreign markets). Our products also are subject to regulation regarding reimbursement, and U.S. healthcare laws apply when a customer submits a claim for a product that is reimbursed under a federally funded healthcare program. These global laws require that we exercise care in designing our sales and marketing practices, including interactions with healthcare professionals, and customer discount arrangements. See &#8220;Item&#160;1A. Risk Factors &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> We are exposed to a variety of risks relating to our international sales and operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Annual Report on Form 10-K for further details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Import-export</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, and import-export. Among other things, these laws restrict, and in some cases can prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in our business dealings with entities in and from foreign countries. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hazardous materials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our research, development and manufacturing processes involve the controlled use of certain hazardous materials. We are subject to country-specific, federal, state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these materials and certain waste products. We believe that our environmental, health and safety procedures for handling and disposing of these materials comply with the standards prescribed by the controlling laws and regulations. However, risk of accidental releases or injury from these materials is possible. These risks are managed to minimize or eliminate associated business impacts. In the event of this type of accident, we could be held liable for damages </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and face a liability that could exceed our resources. We could be subject to a regulatory shutdown of a facility that could prevent the distribution and sale of products manufactured there for a significant period of time, and we could suffer a casualty loss that could require a shutdown of the facility in order to repair it, any of which could have a material, adverse effect on our business. Although we continuously strive to maintain full compliance with respect to all applicable global environmental, health and safety laws and regulations, we could incur substantial costs to fully comply with future laws and regulations, and our operations, business or assets may be negatively affected. Furthermore, global environmental, health and safety compliance is an ongoing process. Integra has compliance procedures in place for compliance with Employee Health &amp; Safety laws, driven by a centrally led organizational structure that ensures proper implementation, which is essential to our overall business objectives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above regulations, we are, and may be, subject to regulation under country-specific federal and state laws, including, but not limited to, requirements regarding record keeping, and the maintenance of personal information, including personal health information. As a public Company, we are subject to the securities laws and regulations, including the Sarbanes-Oxley Act of 2002. We also are subject to other present and could be subject to possible future, local, state, federal and foreign regulations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third-Party Reimbursement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers that purchase medical devices generally rely on third-party payors, including, in the U.S., the Medicare and Medicaid programs and private payors, such as indemnity insurers, employer group health insurance programs and managed care plans, to reimburse all or part of the cost of the products. As a result, demand for our products is and will continue to be dependent in part on the coverage and reimbursement policies of these payors. The manner in which reimbursement is sought and obtained varies based upon the type of payor involved and the setting in which the product is furnished and utilized. Reimbursement from Medicare, Medicaid and other third-party payors may be subject to periodic adjustments as a result of legislative, regulatory and policy changes, as well as budgetary pressures. Possible reductions in, or eliminations of, coverage or reimbursement by third-party payors, or denial of, or provision of uneconomical reimbursement for new products may affect our customers' revenue and ability to purchase our products. Any changes in the healthcare regulatory, payment or enforcement landscape relative to our customers' healthcare services have the potential to significantly affect our operations and revenue. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Privacy and Cybersecurity Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a business with a significant global footprint, compliance with evolving regulations and standards in data privacy and cybersecurity (relating to the confidentiality and security of our information technology systems, products such as medical devices, and other services provided by us) may result in increased costs, lower revenue, new complexities in compliance, new challenges for competition, and the threat of increased regulatory enforcement activity. Our business relies on the secure electronic transmission, storage and hosting of sensitive information, including personal information, financial information, intellectual property, and other sensitive information related to our customers and workforce.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For example, in the U.S., the collection, maintenance, protection, use, transmission, disclosure and disposal of certain personal information and the security of medical devices are regulated at the U.S. federal and state, and industry levels. U.S. federal and state laws protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information by health care providers. For example, in the U.S. we are obligated to comply with the requirements of the Health Insurance and Portability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (collectively, &#8220;HIPPA&#8221;). Under HIPAA, the Department of Health and Human Services has issued regulations, including the HIPAA Privacy, Security and Breach Notification Rules, to protect the privacy and security of protected health information used or disclosed by covered entities including health care providers and their business associates, as well as covered subcontractors. HIPAA also regulates standardization of data content, codes and formats used in health care transactions and standardization of identifiers for health plans and providers. Penalties for violations of HIPAA regulations include significant civil and criminal penalties for each violation. In addition, the FDA has issued guidance advising manufacturers to take cybersecurity risks into account in product design for connected medical devices and systems, to assure that appropriate safeguards are in place to reduce the risk of unauthorized access or modification to medical devices that contain software and reduce the risk of introducing threats into hospital systems that are connected to such devices. The FDA also issued guidance on post market management of cyber security in medical devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., we are impacted by the privacy and data security requirements at the international, national and regional level, and on an industry specific basis. Legal requirements in these countries relating to the collection, storage, handling and transfer of personal data and, potentially, intellectual property continue to evolve with increasingly strict enforcement regimes. In Europe, for example, we are subject to EU General Data Protection Regulation ("GDPR") which requires member states to impose minimum restrictions on the collection, use and transfer of personal data and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR also requires companies processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Please refer to &#8220;Item 1A. Risk Factors &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We are subject to requirements relating to information technology which could adversely affect our business&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of this Annual Report on Form 10-K for additional discussion of the risks accompanying compliance with data privacy and cybersecurity laws and regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations impact the ways in which we use and manage personal data, protected health information, and our information technology systems. They also impact our ability to move, store, and access data across geographic boundaries. Compliance with these requirements may require changes in business practices, complicate our operations, and add complexity and additional management and oversight needs. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMAN CAPITAL </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workforce Demographics</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#8239;December&#160;31, 2022, we had approximately 3,722 regular full and part time employees and 874 contingent, subcontracted, and outsourced partners. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70% of our employees are located in the United States, 21% in Europe, 2% in Latin America and Canada and 7% in Asia Pacific which includes Australia and New Zealand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="iart-20221231_g1.jpg" alt="iart-20221231_g1.jpg" style="height:353px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">A diverse workforce and an inclusive culture and work environment is a business priority and a key to our long-term success.   Our commitment to diversity and inclusion starts at the top with our Board of Directors and CEO.  At all levels of the Company, we focus on attracting, retaining, and developing our diverse talent.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Leadership Commitment and Accountability </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Executive leadership set diversity and inclusion goals for the Company on an annual basis. Advancing diversity and inclusion initiatives to build stronger teams has been a company-wide goal and the direct engagement of executive leadership in advancing diversity and inclusion initiatives helps to promote awareness throughout the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Leadership Councils, Employee Resource Groups and External Partnerships </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We are accountable to our diversity commitment through our leadership councils, employee resource groups, and external partnerships.   </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">The Women&#8217;s Leadership Council, established in 2017 and chaired by our President &amp; Chief Executive Officer, Jan De Witte, is a results-oriented advisory group comprised of ten of our senior women leaders across Integra.   The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">specific charter of the Council is to work together to identify ways to continue to attract and retain female talent, advance the development of our women into leadership roles, increase the cultural awareness of the value of inclusion and diversity in our Company, and create specific development forums for our high performing women at Integra.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Employee Resources Groups encourage a culture of awareness and inclusion, assist in the attraction and retention of diverse talent, and help colleagues develop leadership skills. Members of the Executive Leadership Team serve as sponsors for each of Integra&#8217;s employee resource groups. Integra currently has six Employee Resources Groups:  </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Women of Integra Networks (WIN) with 20+ chapters globally  </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">African American Affinity Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Veteran Employee Resource Group</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Indian American Network</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Asian American and Pacific Islander Network</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.46pt">Integra PRIDE (LGBTQ+ Employee Resource Group)</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">We reinforce our commitment to diversity by partnering with other organizations focused on driving inclusion in the workplace including the CEO Action for Diversity &amp; Inclusion, the largest CEO-driven business commitment to advance diversity and inclusion in the work place and Healthcare Businesswomen&#8217;s Association, an association dedicated to further the advancement and impact of women in the business of healthcare.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Promoting an inclusive culture through learning opportunities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">To help drive our culture of inclusion, our colleagues participate in programs focused on how to manage bias, value differences, and develop inclusive leadership skills.   </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Members of our executive leadership, senior management team, and larger scope leaders participated in a &#189; day Microinequities training.  The content includes understanding unconscious bias and microinequities, how to identify microinequities in day-to-day decisions and actions as leaders, and ways to mitigate microinequities on an individual and organizational level.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">In 2020, we launched two foundational programs to promote diversity and inclusion:  Introduction to Managing Unconscious Bias, a course that creates awareness of unconscious biases in the workplaces and tools to build-bias breaking skills and Practicing Inclusion which examines what practicing inclusion in the workplace looks like. These trainings are now mandatory for all new Integra hires. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">We regularly provide educational content and resources to aid our colleagues as they build cultural competency and inclusive leadership skills </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Gender Diversity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We believe that our company is stronger and will deliver strong operating results, when we build diverse teams and leverage broad perspectives to meet the needs of our shareholders, customers, colleagues, and communities we serve.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The breakout of our colleagues by gender: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">48% of Integra&#8217;s overall population is female, 52% male.   We continue to strive to ensure our diversity in our leadership ranks is representative of our overall population. Through mentorship, sponsorship, recruitment efforts, and development programs we look to continue to grow our population of females in leadership roles at Integra.   Currently, 38% of our executive leaders and 43% of senior leaders (non-executive vice presidents) are female.   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img src="iart-20221231_g2.jpg" alt="iart-20221231_g2.jpg" style="height:399px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In partnership with Leadership Edge, a company founded by women leaders and dedicated to growing and mentoring women.  Integra sponsors the Excel Women&#8217;s Leadership Program.  The program is designed to accelerate the development and advancement of high potential, mid-career female leaders into senior leadership roles.   The program has assisted in further building our pipeline of women leaders with 60% of the program&#8217;s graduates being promoted into roles with increased responsibility. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation and Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our compensation philosophy is designed to reinforce and align with our mission, business strategy, and financial needs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We invest in the physical, emotional and financial well-being of our employees through our robust compensation and benefit programs. We provide market-competitive compensation and benefits based on benchmarking surveys we conduct regularly for all position levels against relevant peer companies. Our annual and long-term incentive packages are linked directly to business and individual performance, with a balance of short- and long-term financial and strategic objectives. We have an employee stock purchase plan. Eligibility for non-salary benefits such as salary continuance, life insurance, health insurance, and similar benefits, follows local regulations and practices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is a pay-for-performance company committed to fair pay. All compensation decisions are made without regard to personal characteristics such as, but not limited to, gender, race, color, national or ethnic origin, age, disability, sexual orientation, gender identity or expression, genetic information, religion, or veteran status. As part of our commitment to compensation equity, Integra regularly conducts a pay equity analysis, reviewing how our organization compensates employees against external and internal data in conjunction with the role and scope of each position and making adjustments if necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Talent Development and Retention</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have comprehensive and effective human capital development programs in place because we believe that the personal success of our employees is critical to the overall success of our business. To build a diverse and talented organization, we have invested in honing our recruiting and hiring processes to attract top talent and engage new hires from the very beginning of their experience at Integra. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a variety of opportunities for our employees to learn and grow. Continued learning and development is a critical component of employee job satisfaction, retention, and career advancement&#8212;and ultimately, a driver of business success. We encourage and promote experiential, collaborative, and formal learning programs. Employees are also encouraged to discuss with their managers the skills, training, and experience needed to grow and develop. In addition to several skills-based trainings </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available (technical, sales, leadership ability) to all employees, managers may recommend external job-specific development programs to employees. These programs are paid for directly by Integra.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Health and Safety:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to providing a safe environment for all employees and visitors. We rely on our environmental, health and safety management systems as well as entrusting our managers to oversee and ensure health and safety at their respective sites and foster a workplace culture to achieve that end. We implement our approach globally by our systems and support at regional and country levels from colleagues that implement proper safety protocols, identify and correct hazards, and remain safety conscious at all times. Managers are expected to enforce health and safety regulations, including compliance with applicable federal, state and local laws. Our Environmental Health and Safety ("EH&amp;S") organizational structure incorporates both workplace EH&amp;S coordinators and compliance teams. We have developed an Incident Procedure Policy and General Safety Rules that guide our colleagues to improve our workplace environment, improve safety, and reduce risk and costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, we have placed a high priority on employee health, providing resources to support our workforce. At the outset of the pandemic, we sought to protect the health and safety of our employees unable to work remotely, including those in research and development, quality, manufacturing, distribution and sales roles. Such measures included the institution of robust hygiene practices, distribution of personal protective equipment, and the adoption of increased sanitation and social distancing protocols. We continue to actively monitor the COVID-19 pandemic and its variants and respond based on guidance from U.S. and global health organizations, relevant governmental guidance, and evolving practices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Engagement &amp; Wellbeing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly seek employee feedback and sentiment about our workplace through global engagement surveys conducted on a bi-annual basis. After each survey is complete, we share detailed results with senior management and all employees within each department. Each function or division appoints survey administrators who work with their respective teams to understand the feedback and establish action items. We believe this process enables us to monitor employee engagement and create a continuously improving, satisfying work environment for our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to improving the quality of life of our employees and their families. Our health and wellbeing programs differ by country and typical benefits include comprehensive health insurance, disability coverage, workplace accommodations, parental leave and other leaves of absence based on health or life events (e.g., bereavement), employee assistance programs, fitness reimbursement, and flu shots. We also provide on-demand health advocates to help employees navigate the health insurance system, access to digital health solutions, a weight management program, smoking cessation assistance, a substance use disorder helpline, a diabetes health program and other similar programs to drive healthy behaviors and awareness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FINANCIAL INFORMATION ABOUT GEOGRAPHIC AREAS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial information about our geographical areas is set forth in our financial statements Note&#160;16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act"). In accordance with the Exchange Act, we file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission, ("the SEC"). Our financial information may be viewed, including the information contained in this report, and other reports we file with the SEC, on the Internet, without charge as soon as reasonably practicable after we file them with the SEC, in the &#8220;SEC Filings&#8221; page of the Investor Relations section of our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.integralife.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A copy may also be obtained for any of these reports, without charge, from our Investor Relations department, 1100 Campus Road, Princeton, NJ 08540. Alternatively, reports filed may be viewed or obtained through the SEC's website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made statements in this report, including statements under &#8220;Business&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; that constitute forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, ("the Securities Act"), and Section&#160;21E of the Exchange Act. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about us including, among other things: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the on-going and possible future effects of the COVID-19 pandemic and associated economic disruptions, including supply chain constraints and inflation, on our business, financial condition, results of operations and cash flows;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">general economic and business conditions, both nationally and in our international markets, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">including the effect of the continuing worldwide macroeconomic uncertainty</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and estimates concerning future financial performance, financing plans and the impact of competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends in our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated demand for our products, particularly capital equipment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to produce and deliver products in sufficient quantities to meet sales demands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations concerning our ongoing restructuring, integration and manufacturing transfer and expansion activities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">existing and future regulations affecting our business, and enforcement of those regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to comply with the substantial regulation related to quality standards applicable to our manufacturing and quality processes could have an adverse effect on our business, financial condition, or results of operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional debt and equity financing to fund capital expenditures, working capital requirements and acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physicians' willingness to adopt our recently launched and planned products, third-party payors' willingness to provide or continue reimbursement for any of our products and our ability to secure regulatory approval for products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiatives launched by our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property, including trade secrets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, integrate operations post-acquisition and maintain relationships with customers of acquired entities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to remediate all matters identified in FDA observations and warning letters that we received or may receive; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">other risk factors described in Item 1A. "Risk Factors" in this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements can be identified by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions in this report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_19"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">GLOBAL CHALLENGES AND MACROECONOMIC CONDITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The continuing worldwide macroeconomic and geopolitical uncertainty may adversely affect our business and prospects.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Global economic disruptions, including the COVID-19 pandemic, have continued to impact the global supply chain, primarily through constraints on raw materials and electronic components. Additionally, we have observed a reduction in both inbound and outbound transportation capacity as a result of port closures and delays associated with the pandemic, which is causing longer lead times in receiving raw materials, as well as increased freight costs. These highly competitive and constrained supply chain conditions are increasing our cost of sales, which has and may continue to adversely impact our profitability. Given the ongoing uncertainty regarding the duration and extent of the COVID-19 pandemic, we are uncertain as to the duration and extent of constraint on our supply chain and are unable to predict the extent to which it will affect our global operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Continued concerns about the systemic impact of potential long-term and wide-spread recession and geopolitical issues, including the war in Ukraine, have contributed to increased market volatility and diminished expectations for economic growth in the world. Our business and results of operations have been and may continue to be adversely impacted by changes in macroeconomic conditions, including inflation, rising interest rates and the accessibility of capital markets. Uncertainty about global economic conditions may also cause decreased demand for our products and services and increased competition, which could result in lower sales volume and downward pressure on the prices for our products, longer sales cycles, and slower adoption of new technologies. A weakening of macroeconomic conditions may also adversely affect our suppliers, which could result in interruptions in supply.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Market acceptance of our medical products in the U.S. and other countries is dependent upon the medical equipment purchasing and procurement practices of our customers, patient need for our products and procedures and the reimbursement of patients' medical expenses by government healthcare programs and third-party payors. The continuing uncertainty surrounding global economic conditions and financial markets may cause the purchasers of medical equipment to decrease their procurement activities. Economic uncertainty, an increase in unemployment rates, as well as increasing health insurance premiums, co-payments and deductibles may adversely affect demand for our products and procedures. Furthermore, governments and other third-party payors around the world facing tightening budgets could move to further reduce the reimbursement rates or the scope of coverage offered, which could adversely affect sales of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public health crises, such as the COVID-19 pandemic, have had, and could in the future have, a negative effect on our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our global operations and interactions with healthcare systems, providers and patients around the world expose us to risks associated with public health crises, including epidemics and pandemics such as COVID-19. In particular, the COVID-19 pandemic continues to cause significant volatility and uncertainty in the global and regional economies, leading to changes in consumer and business behavior, market fluctuations, materials and product shortages and restrictions on business and individual activities, all of which are materially impacting supply and demand in broad sectors of the world markets. Additionally, the COVID-19 pandemic, together with general macroeconomic conditions, have led to disruptions in the global supply chain, primarily through a lack of availability of raw materials and electronic components. We have experienced challenges associated with material and component availability for certain product lines, longer shipping and delivery times for raw materials and components, constrained logistics capacity related to the movement of our products, availability of skilled labor and increased costs of raw materials, components, labor, and freight and courier services. Regional COVID-19 case volumes (including those related to subsequent variants), actions taken by governmental authorities, private businesses and individuals, such as &#8220;shelter-in-place&#8221; orders and restrictions on travel and access to our customers or temporary closures of our facilities or the facilities of our suppliers, disruption and/or higher costs to the Company&#8217;s supply chain, staffing shortages in hospitals and labor constraints in our facilities, could further impact our gross margins and our ability to ship our products and supply our customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The emergence of new variants, vaccinations and public health measures are driving the pace of economic recovery unevenly in various regions. The direct and indirect disruptions caused by the pandemic and the responses of both governments and individuals could negatively impact the number of surgical and medical intervention procedures performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows. The extent to which fear of exposure to or actual effects of COVID-19, new variants, disease outbreak, epidemic or a similar widespread health concern impacts our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the speed and extent of geographic spread of the disease, the duration of the outbreak, travel restrictions, the efficacy of vaccination and treatment; impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; the timing, scope and effectiveness of U.S. and international governmental response; and the impact on the health, well-being and productivity of our employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATING TO OUR BUSINESS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our operating results may fluctuate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operating results, including components of operating results such as gross margin and operating expenses, may fluctuate from time to time, and such fluctuations could affect our stock price. Our operating results have fluctuated in the past and can be expected to do so from time to time in the future. Some of the factors that may cause these fluctuations include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">economic conditions worldwide, which could affect the ability of hospitals and other customers to purchase our products and could result in a reduction in elective and non-reimbursed operative procedures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the impact of acquisitions, our ability to integrate acquisitions, and our restructuring activities including portfolio rationalization, and divestitures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">risks related to COVID-19 and other epidemics or similar widespread health concerns;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">expenditures for major initiatives, including acquired businesses and integrations thereof and restructuring;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the timing of significant customer orders, which tend to increase in the fourth quarter coinciding with the end of budget cycles; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">increased competition for a wide range of customers across all our product lines in the markets our products are sold;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">market acceptance of our existing products, as well as products in development; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">retention of current employees and recruiting of new employees in light of market competition for talent and relevant skills; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the timing of regulatory approvals as well as changes in country-specific regulatory requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in the exchange rates between the U.S. dollar and foreign currencies of countries in which we do business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in the variable interest rates of our debt instruments which could impact debt service requirements; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">potential backorders, lost sales and expenses incurred in connection with product recalls or field corrective actions; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">disruption of our operations and sales resulting from extreme weather conditions or natural disasters that damage our manufacturing, distribution, or infrastructure of those facilities, or the suppliers and service providers for those facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">our ability to manufacture and ship our products efficiently or in sufficient quantities to meet sales demands; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in the cost or decreases in the supply of raw materials and services, including sterilization, energy, steel and honey;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the timing of our research and development expenditures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">reimbursement for our products by third-party payors such as Medicare, Medicaid, private and public health insurers and foreign governmental health systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the ability to maintain existing distribution rights to and from certain third parties;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the ability to maintain business if or when we opt to convert such business from distributors to a direct sales model;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the ability of our commercial sales representatives to obtain sales targets in a reasonable time frame;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the impact of changes to our sales organization, continued channel expansion, including increased specialization;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">peer-reviewed publications discussing the clinical effectiveness of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">inspections of our manufacturing facilities for compliance with Quality System Regulations (Good Manufacturing Practices), which could result in Form 483 observations, warning letters, injunctions or other adverse findings from the FDA or from equivalent regulatory bodies, and corrective actions, procedural changes and other actions that we determine are necessary or appropriate to address the results of those inspections, any of which may affect production and our ability to supply our customers with our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in regulations or guidelines that impact the sales and marketing practices for products that we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the increased regulatory scrutiny of certain of our products, including products which we manufacture for others, could result in removal from the market or involve field corrective actions that could affect the marketability of our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">enforcement or defense of intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">changes in tax laws, or their interpretations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the impact of goodwill and intangible asset impairment charges if future operating results of the acquired businesses are significantly less than the results anticipated at the time of the acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The industry and market segments in which we operate are highly competitive, and we may be unable to compete effectively with other companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There is intense competition among medical device companies. We compete with established medical technology companies in many of our product areas. Competition also comes from early-stage companies, universities, research institutions and other non-profit entities. In certain cases, our products compete primarily against medical practices that treat a condition without using a device or any particular product, such as the medical practices that use autograft tissue instead of our dermal regeneration products, duraplasty products and nerve repair products, or that use other technologies that cost less than our products. Many of our competitors have access to greater financial, technical, research and development, marketing, manufacturing, sales, distribution, administrative, consulting and other resources than we do. Our competitors may be more effective at developing commercial products or navigating the regulatory approval process in the markets in which we operate. They may be able to gain market share by offering lower-cost products or products that enjoy better reimbursement from third-party payors and foreign governmental health systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our competitive position depends on our ability to achieve market acceptance for our products, develop new products, implement marketing plans, secure regulatory approval for products under development, demonstrate clinical and economic effectiveness, obtain and maintain reimbursement coverage and funding under third-party payors and foreign governmental health systems, obtain patent protection and produce products consistently in sufficient quantities to meet demand. We may need to develop new applications for our products to remain competitive. Technological advances by one or more of our current or future competitors or their achievement of superior reimbursement from third-party payors and foreign governmental health systems could render our present or future products obsolete or uneconomical. Our future success will depend upon our ability to compete effectively against current technology as well as to respond effectively to technological advances, changes in customers' requirements or in payor or regulatory evidence requirements. Additionally, purchasing decisions of our customers may be based on clinical evidence or comparative effectiveness studies and, because of our vast array of products, we might not be able to fund the studies necessary to gain entry or maintain our position or provide the required information to compete effectively. Other companies may have more resources available to fund such studies. For example, competitors have launched and are developing products to compete with our dural repair products, regenerative skin, neuro critical care monitors and ultrasonic tissue ablation devices, among others. In the current environment of managed care, consolidation among health care providers, increased competition, and declining reimbursement rates, we have been increasingly required to compete on the basis of price. Competitive pressures could adversely affect our profitability. Given these factors, we cannot guarantee that we will be able to compete effectively or continue our level of success in the areas in which we compete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in the healthcare industry may require us to decrease the selling price for our products, may reduce the size of the market for our products, or may eliminate a market, any of which could have a negative impact on our financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trends toward managed care, healthcare cost containment and other changes in government and private sector initiatives in the U.S. and other countries in which we do business are placing increased emphasis on the delivery of more cost-effective medical therapies that could adversely affect the sale and/or the prices of our products. For example:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">third-party payors of hospital services and hospital outpatient services, including Medicare, Medicaid, private and public health insurers and foreign governmental health systems, annually revise their payment methodologies, which can result in stricter standards for reimbursement of hospital charges for certain medical procedures or the elimination of reimbursement;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">several foreign countries have implemented reforms of their respective healthcare sectors in an effort to reduce healthcare spending, including restricting funding to only those medical technologies and procedures with proven effectiveness, increasing patient co-payments and providing for payback measures. Governmental health systems have revised and continue to consider revisions of healthcare budgets, which could result in stricter standards for implementing certain medical procedures, increased scrutiny of medical devices, and downward pricing pressure;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">Medicare, Medicaid, private and public health insurer and foreign governmental cutbacks could create downward pricing pressure on our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">in the U.S., Medicare and Medicaid coverage as well as commercial payor coverage determinations could reduce or eliminate reimbursement or coverage for certain of our wound matrix, amniotic, surgical reconstruction and advanced wound dressing products as well as other products in most regions, negatively affecting our market for these products, and future determinations could reduce or eliminate reimbursement or coverage for these products in other regions and could reduce or eliminate reimbursement or coverage for other products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">there has been a consolidation among healthcare facilities and purchasers of medical devices in the U.S., some of whom prefer to limit the number of suppliers from whom they purchase medical products, and these entities may decide to stop purchasing our products or demand discounts on our prices;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">in the U.S., we are party to contracts with group purchasing organizations, which negotiate pricing for many member hospitals, require us to discount our prices for certain of our products and limit our ability to raise prices for certain of our products, particularly surgical instruments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">there is economic pressure to contain healthcare costs in domestic and international markets, and, regardless of the consolidation discussed above, providers generally are exploring ways to cut costs by eliminating purchases or driving reductions in the prices that they pay for medical devices, or increasing clinical or economic evidence thresholds for product formularies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">there are proposed and existing laws, regulations and industry policies in domestic and international markets regulating the sales and marketing practices and the pricing and profitability of companies in the healthcare industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">proposed laws or regulations may permit hospitals to provide financial incentives to doctors for reducing hospital costs, will award physician efficiency, and will encourage partnerships with healthcare service and goods providers to reduce prices; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">there have been initiatives by third-party payors and foreign governmental health systems to challenge the prices charged for medical products that could affect our ability to sell products on a competitive basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any and all of the above factors could materially and adversely affect our levels of revenue and our profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our current strategy involves growth through acquisitions, which requires us to incur substantial costs and potential liabilities for which we may never realize the anticipated benefits, and also requires us to successfully integrate acquired businesses into our business operations in order to avoid our business being materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to internally generated growth, our current strategy involves growth through acquisitions. Between January 1, 2020 and December&#160;31, 2022, we have acquired two businesses at a total cost of approximately $358.4 million which amount includes our acquisition of ACell, Inc. in January 2021 for $306.9 million and our acquisition of Surgical Innovation Associates, Inc. for $51.5 million in December 2022. Both of these acquisitions added products to our complex wound management and plastic and reconstructive surgery product portfolios, respectively, and provides additional growth opportunities for our TT segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We may be unable to continue to implement our growth strategy and it may ultimately be unsuccessful. A significant portion of our growth in revenues has resulted from, and is expected to continue to result from, the acquisition of businesses or products complementary to our own. We engage in evaluations of potential acquisitions and are in various stages of discussion regarding possible acquisitions, certain of which, if consummated, could be significant to us. Any new acquisition could result in material transaction expenses, increased operating, amortization and interest expenses, and possible in-process research and development charges for acquisitions that do not meet the definition of a &#8220;business,&#8221; any of which could have a material, adverse effect on our operating results. Certain businesses that we acquire may not have adequate financial, disclosure, regulatory, quality or other compliance controls at the time we acquire them and could require significant expenditures to address those controls or subject us to increased risk. As we grow by acquisition, we must manage and integrate the new businesses to bring them into our systems for financial, disclosure, compliance, regulatory and quality control, realize economies of scale, and control costs. Failure to integrate acquired businesses and operations (including acquired employees and systems), retain key customers and suppliers of any acquired business or manage the cost of providing our products or price our products appropriately could preclude realization of the full benefits that we expect from there transactions. Our failure to meet the challenges involved in integrating the business in order to realize the anticipated benefits of the acquisitions could cause an interruption of, or loss of momentum in, our activities and could materially and adversely affect our results of operations. In addition, acquisitions involve other risks, including diversion of management resources otherwise available for the running of our business and the development of our business as well as risks associated with entering markets in which our marketing teams and sales force has limited experience or where experienced distribution alliances are not available. Some acquisitions may include the need for ongoing product development to occur consistent with time sensitive milestones in order for the Company to achieve its commercial projections for the acquisition. Our future profitability will depend in part upon our ability to develop our resources to adapt to these new products or business areas and to identify and enter into or maintain satisfactory distribution networks. As a result of our acquisitions of other healthcare businesses, we may be subject to the risk of unanticipated business uncertainties, regulatory and other compliance matters or legal liabilities relating to those acquired businesses for which the sellers of the acquired businesses may not indemnify us, for which we may not be able to obtain insurance (or adequate insurance), or for which the indemnification may not be sufficient to cover the ultimate liabilities. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">may not be able to identify suitable acquisition candidates in the future, obtain acceptable financing or consummate any future acquisitions. Certain potential acquisitions are subject to antitrust and competition laws, which laws could impact our ability to pursue strategic acquisitions and could result in mandated divestitures. If we are unsuccessful in our acquisition strategy, we may be unable to meet our financial targets and our financial performance could be materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These risks may be heightened in cases where the majority of the former businesses&#8217; operations, employees and customers are located outside the U.S. Any one or all of these factors could increase operating costs or lower anticipated financial performance. Many of these factors are also outside of our control. In addition, dispositions of certain key products, technologies and other rights, including pursuant to conditions imposed on us to obtain regulatory approvals, may affect our business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if the operations of the businesses are integrated successfully, we may not realize the full benefits of the acquisition, including the synergies, cost savings or sales or growth opportunities that we expect. These benefits may not be achieved within the anticipated time frame, or at all. Additional unanticipated costs could be incurred in the integration of the businesses. All of these factors could cause a reduction to our earnings per share, decrease or delay the expected accretive effect of the transaction, and negatively impact the price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our future financial results could be adversely affected by impairments or other charges. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are required to test both goodwill and indefinite-lived intangible assets for impairment on an annual basis based upon a fair value approach, rather than amortizing them over time. We are also required to test goodwill and indefinite-lived intangible assets for impairment between annual tests if an event occurs such as a significant decline in revenues or cash flows for certain products, or the discount rates used in the calculations of discounted cash flows change significantly, or circumstances change that would more likely than not reduce our enterprise fair value below its book value. If such a decline, rate change or circumstance were to materialize, we may record an impairment of these intangible assets that could be material to the financial statements. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates&#8221; of this report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The guidance on long-lived assets requires that we assess the impairment of our long-lived assets, including finite-lived intangible assets, whenever events or changes in circumstances indicate that the carrying value may not be recoverable as measured by the sum of the expected future undiscounted cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Also, Company decisions and other economic factors relating to our trade names may occur over time. For instance, we may discontinue certain products in the future as we continue to assess the profitability of our product lines. As a result, we may need to record impairment c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">harges or accelerate amortization on certain trade names or technology-related intangible assets in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The value of a medical device business is often volatile, and the assumptions underlying our estimates made in connection with our assessments under the guidance may change as a result of that volatility or other factors outside our control and may result in impairment charges. The amount of any such impairment charges could be significant and have a material, adverse effect on our reported financial results for the period in which the charge is taken and could have an adverse effect on the market price of our securities, including the notes and the common stock into which they may be converted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Lack of market acceptance for our products or market preference for technologies that compete with our products could reduce our revenues and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Market acceptance of our products depends on many factors, including our ability to convince prospective customers that our technology is an attractive alternative to other technologies, to manufacture products in sufficient quantities and at acceptable costs, and to supply and service sufficient quantities of our products directly or through our distribution alliances. For example, the use of autograft tissue is a well-established means for repairing the dermis, and it competes for acceptance in the market with our collagen-based wound care products. In addition, unfavorable payment amounts or adverse coverage determinations of third-party payors, including Medicare, Medicaid, private and public health insurers, and foreign governmental health systems, regarding our products or third-party determinations that favor a competitor&#8217;s product over ours, could harm acceptance or continued use of our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For example, greater market acceptance of our wound graft products may ultimately depend on our ability to demonstrate that coverage and reimbursement are available and favorable, or because they are an attractive, cost-effective alternative to other treatment options. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If there are negative events in the healthcare industry, whether real or perceived, there could be a negative impact on the industry as a whole. The industry is subject to rapid and continuous change arising from, among other things, consolidation, technological improvements, the pressure on governments, third-party payors and providers to reduce healthcare costs, and healthcare reform legislation and initiatives domestically and internationally. In addition, our future success depends, in part, on our ability to license and develop additional products. Even if we determine that a product candidate has medical benefits, the cost of commercializing, either through internal development or payments associated with licensing arrangements, could be too high to justify development and we could ultimately face competitors with more effective products and better reimbursement status that cost less and are ready for commercial introduction before our products. If we are unable to develop additional commercially viable products, our future prospects could be materially and adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">One or more of these factors could vary unpredictably, and such variations could have a material, adverse effect on our competitive position. We may not be able to adjust our contemplated plan of development to meet changing market demands.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">It could be difficult to replace some of our suppliers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Outside vendors, some of whom are sole-source suppliers, provide key components and raw materials used in the manufacture of our products. Although we believe that alternative sources for many of these components and raw materials are available, any interruption in supply of a limited or sole-source component or raw material could harm our ability to manufacture our products until a new or alternative source of supply is identified and qualified. In addition, an uncorrected defect or supplier&#8217;s variation in a component or raw material, either unknown to us or incompatible with our manufacturing process, could harm our ability to manufacture products. We may not be able to find a sufficient alternative supplier in a reasonable time period, or on commercially reasonable terms, if at all, and our ability to produce and supply our products could be impaired. We believe that these factors are most likely to affect the following products that we sell:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">our collagen-based products and bovine-based products, such as the Integra Dermal Regeneration Template and wound matrix products, the DuraGen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> family of products, our Absorbable Collagen Sponges, PriMatrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and SurgiMend products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">our products made from silicone, such as our neurosurgical shunts and drainage systems and hemodynamic shunts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">products which use many different specialty parts, electrical components, or chemicals from numerous suppliers, such as our intracranial monitors, shunts, catheters, tissue ablation, and headlights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">our biosynthetic products, including the DuraSeal sealant system and DuraSorb biosynthetic mesh scaffold;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">products which are amniotic tissue-based</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">products which are porcine tissue-based;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">products that use medical grade leptospermum honey, such as our Medihoney products; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">our TCC-EZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> total contact cast system products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The availability of amniotic tissue-based products depends upon, among other factors, the availability of tissue from human donors. Access to donated amniotic tissue could also be adversely impacted by regulatory changes or evolving public perceptions of the donor process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, many of our products require sterilization by third-party suppliers. To the extent these suppliers are unable to provide sterilization services, whether due to lack of capacity, regulatory requirements, environmental concerns such as those relating to ethylene oxide or otherwise, we may be unable to transition sterilization to other suppliers in a timely or cost effective manner, or at all, which could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our supply chain and our cost of goods also may be negatively impacted by unanticipated price increases due to factors such as global economic disruptions, electronic component shortages, fear of future or ongoing pandemics, inflation, including wage inflation, recessionary conditions and geopolitical events, including the war in Ukraine, all of which are beyond our control or the control of our suppliers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While it is our policy to maintain sufficient inventory of components so that our production will not be significantly disrupted even if a particular component or material is not available for a period of time, we remain at risk that we will not be able to qualify new components or materials quickly enough to prevent a disruption if one or more of our suppliers ceases production of important components or materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may experience difficulties, delays, performance impact or unexpected costs from consolidation of facilities and transfer of manufacturing facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In recent years, we consolidated several facilities or transferred manufacturing operations from third parties to our existing internal manufacturing facilities and may further undertake similar consolidations or transfers in the future in order to improve our cost structure, achieve increased operating efficiencies, and improve our competitive standing or results of operations and/or to address unfavorable economic conditions. As part of these initiatives, we may also lose favorable tax incentives or not be able to renew leases on acceptable terms. We may further reduce staff, make changes to certain capital projects, close certain production operations and abandon leases for certain facilities that will not be used in our operations. In conjunction with any actions, we will continue to make significant investments and build the framework for our future growth. We may not realize, in full or in part, the anticipated benefits and savings from these efforts because of unforeseen difficulties, delays, implementation issues or unexpected costs. If we are unable to achieve or maintain all of the resulting savings or benefits to our business or other unforeseen events occur, our business and results of operations may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may have significant product liability exposure and our insurance may not cover all potential claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are exposed to product liability and other claims if our technologies or products are alleged to have caused harm. We may not be able to obtain insurance for the potential liability on acceptable terms with adequate coverage or at reasonable costs. Any potential product liability claims could exceed the amount of our insurance coverage or may be excluded from coverage under the terms of the policy. Our insurance may not be renewed at a cost and level of coverage comparable to that then in effect.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Economic and political instability around the world could adversely affect the ability of hospitals, other customers, suppliers and distributors to access funds or otherwise have available liquidity, which could reduce orders for our products or interrupt our production or distribution or result in a reduction in elective and non-reimbursed operative procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Economic and political instability around the world could adversely affect the ability of hospitals and other customers to access funds to enable them to fund their operating and capital budgets. As a result, hospitals and other customers could reduce budgets or put all or part of their budgets on hold or close their operations, which could have a negative effect on our sales, particularly the sales of capital equipment such as our ultrasonic surgical aspirators, neuromonitors and cranial stabilization products, or result in a reduction in elective and non-reimbursed procedures. The occurrence of those economic conditions could make it more difficult for us to accurately forecast and plan our future business activities and depending on their severity, could have a material, adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our private-label product lines depend significantly on key relationships with third parties, which we could be unable to establish and maintain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our private-label business depends in part on entering into and maintaining long-term supply agreements with third parties. The third parties with whom we have entered into agreements might terminate these agreements for a variety of reasons, including developing other sources for the products that we supply. Termination of our most important relationships could adversely affect our expectations for the growth of private-label products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR REGULATORY ENVIRONMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The adoption of healthcare reform in the U.S. and initiatives sponsored by other governments may adversely affect our business, results of operations and/or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations may be substantially affected by potential fundamental changes in the global political, economic and regulatory landscape of the healthcare industry. Government and private sector initiatives to limit the growth of healthcare costs are continuing in the U.S., and in many other countries in which we do business, causing the marketplace to put increased emphasis on the delivery of more cost-effective treatments. These initiatives include price regulation, competitive pricing, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements. The adoption of some or all of these initiatives could have a material, adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the United States, the Patient Protection and Affordable Care Act (the &#8220;ACA&#8221;), signed into law in March 2010, includes several provisions that impact our businesses in the U.S. The ACA includes provisions that, among other things, reduce and/or limit Medicare reimbursement, require all individuals to have health insurance (with limited exceptions), and require detailed disclosure of transfers of value made to healthcare professionals. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted, including The Budget Control Act of 2011, The American Taxpayer Relief Act of 2012 and Medicare Access and CHIP Reauthorization Act of 2015, which, among other things, have reduced payments under Medicare and Medicaid to certain healthcare providers or altered the formula by which Medicare makes annual payment adjustments. Congress also drafts and introduces, from time to time, legislation that could significantly change the statutory provisions governing the regulation of medical devices. In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of our future products under development or impact our ability to modify our currently cleared products on a timely basis. For example, over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We cannot predict what impact ongoing uncertainty regarding federal and state health reform proposals, including the implementation or repeal of the ACA, judicial review and interpretation of the ACA and other healthcare laws, instability of the insurance markets, changes in the U.S. administration and policy, an expansion in government&#8217;s role in and/or additional proposals and/or changes to the U.S. health care system or its legislation will have on our customer&#8217;s purchasing decisions and/or reimbursement which could have a material adverse effect on our business. We expect that additional state and federal health care reform measures will be adopted in the future, including those initiatives affecting coverage and reimbursement for our products, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could adversely affect the growth of the market for our products or demand for our products, or result in additional pricing pressures. We cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us. We continue to monitor the implementation of such legislation and, to the extent new market or industry trends or new governmental programs evolve, we will consider implementing or implement programs in response.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to stringent domestic and foreign medical device regulations and oversight and any adverse action may adversely affect our ability to compete in the marketplace and our financial condition and business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our products, development activities and manufacturing processes are subject to extensive and rigorous regulation by numerous government agencies, including the FDA and comparable foreign agencies, as discussed in &#8220;Part 1, Item 1. Business &#8211; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Government Regulation.&#8221; To varying degrees, each of these agencies monitors and enforces our compliance with laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of our medical devices. We are also subject to regulations that may apply to certain of our products that are Drug/Device Combination products or are considered to be subject to pharmaceutical regulations outside the U.S. The process of obtaining marketing approval or clearance from the FDA and comparable foreign regulatory agencies for new products, or for enhancements or modifications to existing products could be costly, time consuming and burdensome, lead to failed clinical trials or weakened clinical evidence, involve modifications, repairs or replacements of our products and result in limitations on the indicated use of our products, which may negatively impact our ability to market our products and services, result in delays or prevent full commercial realization of future products or service. Furthermore, failure to obtain timely approvals or renewals may result in significant penalties and fines. Additional regulations govern the approval, initiation, conduct, monitoring, documentation and reporting of clinical studies to regulatory agencies in the countries or regions in which they are conducted. Failure to comply, could subject us to significant enforcement actions and sanctions, including halting the study, rejection of data generated in the study, seizure of investigational devices or data, sanctions against investigators, civil or criminal penalties, and other actions. In addition, without the data from one or more clinical studies, it may not be possible for us to secure the data necessary to support certain regulatory submissions, to secure reimbursement or demonstrate other requirements. We cannot assure that access to clinical investigators, sites and subjects, documentation and data will be available on the terms and timeframes necessary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to extensive complex regulatory requirements by domestic and foreign government agencies and any failure to comply with our ongoing responsibilities under their applicable laws and regulations could result in a material adverse impact on our business. Failure to comply with applicable regulations could result in future product recalls, injunctions preventing the shipment of products or other enforcement actions that could have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also are subject to the European Medical Device Regulation, which was adopted by the European Union (&#8220;EU&#8221;) as a common legal framework for all EU member states. The implementation for Class I products occurred on May 26, 2021 and the EUDAMED Database was implemented on May 26, 2022. Under this regulation, companies that wish to manufacture and distribute medical devices in EU member states must meet certain quality system, and safety requirements as well as ongoing product monitoring responsibilities. Companies must also obtain a &#8220;CE&#8221; marking (i.e., a mandatory conformity marking for certain products sold within the European Economic Area) for their products. Complying with the requirements of these regulations may require us to incur significant expenditures. Expenditures for </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">European Union Medical Device Regulation compliance activities amounted to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> $45.1 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for the year ended December 31, 2022 and we anticipate incurring additional expenditures in connection with our on-going efforts to obtain certification for our products under the European Medical Device Regulation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Various penalties exist for non-compliance with the laws implementing the European Medical Device Regulations which if incurred, could have a material adverse impact on our business, results of operations and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, the regulatory environment in China continues to evolve, and officials in the Chinese government exercise broad discretion in deciding how to interpret and apply regulations. It is possible that the Chinese government's current or future interpretation and application of existing or new regulations will negatively impact our China operations, result in regulatory investigations or lead to fines or penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we are subject to laws and regulations that govern the means by which companies in the healthcare industry may market their products to healthcare professionals and may compete by discounting the prices of their products, including for example, the federal Anti-Kickback Statute, the federal False Claims Act, the federal Health Insurance Portability and Accountability Act of 1996, state law equivalents to these federal laws that are meant to protect against fraud and abuse and analogous laws in foreign countries. Violations of these laws are punishable by criminal and civil sanctions, including, but not limited to, in some instances civil and criminal penalties, damages, fines, and exclusion from participation in federal and state healthcare programs, including Medicare and Medicaid. Although we exercise care in structuring our sales and marketing practices and customer discount arrangements to comply with those laws and regulations, we cannot assure that:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">government officials charged with responsibility for enforcing those laws will not assert that our sales and marketing practices or customer discount arrangements are in violation of those laws or regulations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">government regulators or courts will interpret those laws or regulations in a manner consistent with our interpretation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have in place policies and procedures for compliance that we believe are at least as stringent as those set forth in the AdvaMed Code of Ethics which was developed by AdvaMed, a trade association that represents the medical device industry, and which is intended to represent best practices with respect to medical device companies' interactions with healthcare providers. We regularly train our sales and marketing personnel on our policies regarding sales and marketing practices. Pursuant to the AdvaMed Code, we have certified our adoption of the AdvaMed Code. The sales and marketing practices of our industry have been the subject of increased scrutiny from federal and state government agencies, and we believe that this trend will continue. Various hospital organizations, medical societies and trade associations are establishing their own practices that may require detailed disclosures of relationships between healthcare professionals and medical device companies or ban or restrict certain marketing and sales practices such as gifts and business meals. Since these laws, regulations and ultimate enforcement continue to evolve, we cannot predict with certainty, what, if any, impact, changes to them may have on our business or our customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Outside of the U.S. we are subject to privacy and data security regulations at the international, national and regional level, as well as on an industry specific basis. For example, in Europe, we are subject to the EU General Data Protection Regulation ("GDPR") which is related to the collection, processing, storage, transfer and use of personal data. In the U.S., we are subject to the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;) and other similar laws in the United States, at both the federal and state level. Noncompliance with GDPR could trigger fines of up to 4% of global annual revenues. In addition, we are subject to the new China Personal Information Protection Law that went into effect November 1, 2021 which focuses on protecting personal information and cross border transfers of the information. Compliance with these requirements, either individually or in the aggregate, may require changes in business practices added complexity and additional management oversight. They also may complicate our clinical research activities, as well as product offerings that involve transmission or use of clinical data. Non-compliance may result in proceedings against us by governmental or other entities and/or significant fines which could negatively impact our reputation and adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Should we delay or fail to comply with one or more of the regulatory requirements we could have reduced sales, increased costs, delays to new product introductions, enhancements or our strategic plans, or harm to our reputation or competitiveness, which could have a material adverse effect on our business and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Our medical device products are subject to reporting requirements and recalls, even after receiving regulatory clearance, approval or certification, which could harm our reputation, business and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">After a device is placed on the market, numerous regulatory requirements apply, which require manufacturers to follow, among other things, design, testing, production, control, documentation and other quality assurance procedures during the manufacturing process; labeling regulations, which prohibit the promotion of products for unapproved or &#8220;off-label&#8221; uses and impose other restrictions on labeling; and medical device reporting regulations that require us to report to FDA or similar governmental bodies in other countries if our products may have caused or contributed to a death or serious injury or malfunction in a way that would be reasonably likely to contribute to death or serious injury if the malfunction were to recur. The FDA and similar governmental bodies in other countries have the authority to require the recall of our products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. We may, under own initiative, recall a product if a reasonable possibility of serious injury or any material deficiency in a device is found, or withdraw a product to improve device performance or for other reasons. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recalls of any of our products may divert managerial and financial resources and have an adverse effect on our financial condition and results of operations. A recall could harm our reputation with customers and consumers which could reduce the sales of our products. In addition, the FDA or other foreign governmental agencies may implement enforcement actions in connection with a recall which could impair our product offerings and be harmful to our business and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Certain of our products contain materials derived from animal sources and may become subject to additional regulation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain of our products are derived from bovine or porcine tissue sources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result, we may experience difficulties in processing and producing our bovine and porcine tissue products at scale, including problems related to yields, quality control and assurance, tissue availability, adequacy of control policies and procedures and availability of skilled personnel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With respect to bovine, among other products, our dermal regeneration products, duraplasty products, wound care products, bone void fillers, nerve and tendon repair products and certain other products, contain material derived from bovine tissue. In 2022, 43.3% of our revenues derived from products containing material derived from bovine tissue. Products that contain materials derived from animal sources, including food, pharmaceuticals and medical devices, are subject to scrutiny in the media and by regulatory authorities. Regulatory authorities are concerned about the potential for the transmission of disease from animals to humans via those materials. This public scrutiny has been particularly acute in Japan and Western Europe with respect to products derived from animal sources, because of concern that materials infected with the agent that causes bovine spongiform encephalopathy, otherwise known as BSE or mad cow disease, may, if ingested or implanted, cause a variant of the human Creutzfeldt-Jakob Disease, an ultimately fatal disease with no known cure. The World Organization for Animal Health recognizes the U.S. as having a negligible risk for BSE, which is the highest status available.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We take care to provide that our products are safe and free of agents that can cause disease. In particular, we qualified a source of collagen from a country outside the U.S. that is considered BSE/TSE-free. The World Health Organization classifies different types of bovine tissue for relative risk of BSE transmission. Deep flexor tendon and bovine fetal skin, which are used in our products, are in the lowest-risk categories for BSE transmission and are therefore considered to have a negligible risk of containing the agent that causes BSE (an improperly folded protein known as a prion). Nevertheless, products that contain materials derived from animals, including our products, could become subject to additional regulation, or even be banned in certain countries, because of concern over the potential for the transmission of prions. Significant new regulations, or a ban of our products, could have a material, adverse effect on our current business or our ability to expand our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain countries, such as Japan, China, Taiwan and Argentina, have issued regulations that require our collagen products be sourced from countries where no cases of BSE have occurred, and the EU has requested that our dural replacement products and other products that are used in neurological tissue be sourced from a country where no cases of BSE have occurred. Currently, we source bovine fetal hides from the U.S. and purchase tendon from the U.S. and New Zealand. New Zealand has </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">never had a case of BSE. We received approval in the U.S., the EU, Japan, Taiwan, China, Argentina as well as other countries for the use of New Zealand-sourced tendon in the manufacturing of our products. If we cannot continue to use or qualify a source of tendon from New Zealand or another country that has never had a case of BSE, we could be prohibited from selling our collagen products in certain countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to current and potential future requirements relating to protection of the environment, such as hazardous materials regulations, which may impose significant compliance or other costs on us. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain of our processes in manufacturing and research and development involve the controlled use of certain hazardous materials. In addition, we own and/or lease a number of facilities at which hazardous materials have been used in the past. Finally, we have acquired various companies that historically have used certain hazardous materials and that have owned and/or leased facilities at which hazardous materials have been used. For all of these reasons, we are subject to federal, state, foreign, and local laws and regulations governing the use, manufacture, storage, transportation, handling, treatment, remediation, and disposal of hazardous materials and certain waste products (&#8220;Environmental, Health, Safety and Transportation Laws&#8221;). Although we believe that our procedures for handling, transporting, and disposing of hazardous materials comply with the Environmental, Health, Safety and Transportation Laws, such laws may be amended in ways that increase our cost of compliance, perhaps materially.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Furthermore, the potential risk of accidental contamination or injury from these materials cannot be eliminated, and there is also a risk that such contamination previously has occurred in connection with one of our facilities or in connection with one of the companies we have purchased. In the event of such an accident or contamination, we could be held liable for any damages that result and any related liability could exceed the limits or fall outside the coverage of our insurance and could exceed our resources. We may not be able to maintain insurance on acceptable terms or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our business and operations are subject to risks related to climate change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The long-term effects of global climate change present both physical risks (from the increased frequency of extreme weather conditions or natural disasters) and transition risks (from regulatory requirements or technology changes). Such extreme weather conditions could pose physical risks to our facilities and disrupt operation of our supply chain and may impact operational costs. Concern over global climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. If such laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet the regulatory obligations and such measures may interrupt our operations or the operations of our suppliers, potentially leading to higher costs, and therefore negatively impact our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to requirements relating to information technology which could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to maintain reliable information technology systems and prevent disruptions, outages, or data breaches, we may suffer regulatory consequences in addition to business consequences. Our worldwide operations means that we are subject to laws and regulations, including data protection and cyber security laws and regulations, in many jurisdictions. The variety of U.S. and international privacy and cybersecurity laws and regulations impacting our operations are described in &#8220;Item 1. Business - Government Regulation - Other Factors - Data Privacy and Cybersecurity Laws and Regulations." We have programs to ensure compliance with such laws and regulations. However, there is no guarantee that we will avoid enforcement actions by governmental bodies. Enforcement actions may be costly and interrupt regular operations of our business. In addition, there has been a developing trend of civil lawsuits and class actions relating to breaches of consumer data held by large companies or incidents arising from other cyber-attacks. While Integra has not been named in any such suits, if a substantial breach or loss of data were to occur, we could become a target of such litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we do not retain our key personnel and attract and retain other highly skilled employees, our business could suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we fail to recruit, develop and retain the necessary personnel, our business and our ability to obtain new customers, develop new products and provide acceptable levels of customer service could suffer. The success of our business is heavily dependent on the leadership of our key management personnel. Our success also depends on our ability to recruit, develop and retain and motivate highly skilled sales, marketing, manufacturing and scientific personnel. Competition for these persons in our industry is intense, and we may not be able to successfully recruit, train or retain qualified personnel. We are experiencing increasing challenges in building and retaining our workforce in certain markets, where pressure from inflation and competition have exacerbated turnover and retention trends continuing from the COVID-19 pandemic. Labor shortages and competition for qualified personnel could cause disruptions in our business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO TAX AND DEBT</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may have additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the U.S. and many foreign jurisdictions and are commonly audited by various tax authorities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Significant judgment is required in determining our worldwide provision for income taxes. Although we believe that our tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from our historical income tax provisions and accruals. The results of an audit or litigation could have a material, adverse effect on our financial statements in the period or periods for which that determination is made.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company's operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes, as well as taxes that are not income-based, in both the U.S. and many foreign jurisdictions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Taxes could significantly increase due to changes in tax laws or changes in our interpretation of those laws. For example, the Organization for Economic Co-operation and Development, a global policy forum, is developing a global tax framework that, if implemented, includes a global minimum tax rate of 15%. Taxes could also significantly increase due to changes in accounting guidance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our future effective tax rate could be unfavorably affected by numerous factors including a change in, or the interpretation of, tax rules and regulations in the jurisdictions in which we operate (including changes in legislation currently being considered), a change in our geographic earnings mix, and/or to the jurisdictions in which we operate, or a change in the measurement of our deferred taxes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our leverage and debt service obligations could adversely affect our business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our leverage and debt service obligations could adversely affect our business. As of December 31, 2022, our total consolidated external debt was approximately $1.5 billion (See Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements  (Part IV, Item 15 of this Annual Report on Form 10-K) for a discussion of our consolidated external debt). We may also incur additional indebtedness in the future. Our substantial indebtedness could have material, adverse consequences, including:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">making it more difficult for us to satisfy our financial obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">increasing our vulnerability to adverse economic, regulatory and industry conditions, and placing us at a disadvantage compared to our competitors that are less leveraged;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">limiting our ability to compete and our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">limiting our ability to borrow additional funds for working capital, capital expenditures, acquisitions and general corporate or other purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt service obligations will require us to use a portion of our operating cash flow to pay interest and principal on indebtedness instead of for other corporate purposes, including funding future expansion of our business, acquisitions, and ongoing capital expenditures, which could impede our growth. In addition, our ability to comply with, renegotiate or extend the Company&#8217;s debt obligations will depend on our operating and financial performance, which in turn is subject to prevailing economic conditions and financial, business and other factors beyond our control. Any disruptions in our operations, the financial markets, or the overall economy, including as a result of COVID-19, may adversely affect the availability and cost of credit to us and/or our ability to comply with our existing obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the calculation and or complete replacement of LIBOR could have an impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s Financial Conduct Authority (&#8220;FCA&#8221;), which regulates LIBOR, announced in July 2017 that it will no longer persuade or require banks to submit rates for LIBOR. On March 5, 2021, the ICE Benchmark Administration, which administers LIBOR, and the FCA announced that all LIBOR settings will either cease to be provided by any administrator, or no longer be representative immediately after December 31, 2021, for all non-U.S. dollar LIBOR settings and one-week and two-month U.S. dollar LIBOR settings, and immediately after June 30, 2023 for the remaining U.S. dollar LIBOR settings. We have multiple debt facilities which utilizes a variable rate equal to Eurodollar LIBOR rate as a component of our interest rate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR INTELLECTUAL PROPERTY</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights may not provide meaningful commercial protection for our products, potentially enabling third parties to use our technology or very similar technology and could reduce our ability to compete in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To compete effectively, we depend, in part, on our ability to maintain the proprietary nature of our technologies and manufacturing processes, which includes the ability to obtain, protect and enforce patents on our technology and to protect our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trade secrets. We own or have licensed patents that cover aspects of some of our product lines. Our patents, however, may not provide us with any significant competitive advantage. Others may challenge our patents and, as a result, our patents could be narrowed, invalidated or rendered unenforceable. Competitors may develop products similar to ours that our patents do not cover. In addition, the approval or rejection of patent applications may take several years and our current and future patent applications may not result in the issuance of patents in the U.S. or foreign countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our competitive position depends, in part, upon unpatented trade secrets, which we may be unable to protect.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position also depends upon unpatented trade secrets, which are difficult to protect. We cannot assure that others will not independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets, that our trade secrets will not be disclosed or that we can effectively protect our rights to unpatented trade secrets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to protect our trade secrets, we require our employees, consultants and advisors to execute confidentiality and invention assignment agreements upon commencement of employment or consulting relationships with us. These agreements provide that, except in specified circumstances, all confidential information developed or made known to the individual during the course of their relationships with us must be kept confidential. We cannot assure, however, that these agreements will provide meaningful protection for our trade secrets or other proprietary information in the event of the unauthorized use or disclosure of confidential information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend partly on our ability to operate without infringing or misappropriating the proprietary rights of others.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be sued for infringing the intellectual property rights of others. In addition, we may find it necessary, if threatened, to initiate a lawsuit seeking a declaration from a court that we do not infringe the proprietary rights of others or that their rights are invalid or unenforceable. If we do not prevail in any litigation, in addition to any damages we might have to pay, we would be required to stop the infringing activity (which could include a cessation of selling the products in question) or obtain a license for the proprietary rights involved. Any required license may be unavailable to us on acceptable terms, if at all. In addition, some licenses may be nonexclusive and allow our competitors to access the same technology we license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain a required license or are unable to design our products so as not to infringe on the proprietary rights of others, we may be unable to sell some of our products, and this potential inability could have a material, adverse effect on our revenues and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits relating to our intellectual property rights and promotional practices, which may be expensive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect or enforce our intellectual property rights, we may have to initiate or defend legal proceedings, such as infringement suits or opposition proceedings, against or by third parties. In addition, we may have to institute proceedings regarding our competitors&#8217; promotional practices or defend proceedings regarding our promotional practices. Legal proceedings are costly, and, even if we prevail, the cost of the legal proceedings could affect our profitability. In addition, litigation is time-consuming and could divert management's attention and resources away from our business. Moreover, in response to our claims against other parties, those parties could assert counterclaims against us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO GLOBAL OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If any of our facilities or those of our suppliers were damaged and/or our manufacturing or business processes interrupted, we could experience lost revenues and our business could be seriously harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damage to our manufacturing, distribution, development and/or research facilities because of fire, extreme weather conditions, natural disaster, power loss, communications failure, geopolitical disruption, unauthorized entry or other events, such as a flu or other health epidemic, such as COVID-19, could significantly disrupt our operations, the operations of suppliers and critical infrastructure and delay or prevent product manufacture and shipment during the time required to repair, rebuild or replace the damaged facilities. Certain of our manufacturing facilities are located in Puerto Rico, which in the past has experienced both severe hurricanes and other natural disasters. Climate change may increase both the frequency and severity of extreme weather conditions and natural disasters and, consequently, risks to our operations and growth. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances, and we may not be able to renew or obtain such insurance in the future on acceptable terms with adequate coverage or at reasonable costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to a variety of risks relating to our international sales and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate significant revenues outside the U.S. in multiple foreign currencies, and in U.S. dollar-denominated transactions conducted with customers who generate revenue in currencies other than the U.S. dollar. For those foreign customers who purchase our products in U.S. dollars, currency fluctuations between the U.S. dollar and the currencies in which those </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers do business may have a negative impact on the demand for our products in foreign countries where the U.S. dollar has increased in value compared to the local currency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we have operations based outside the U.S. and we generate revenues and incur operating expenses in multiple foreign currencies, we experience currency exchange risk with respect to those foreign currency-denominated revenues and expenses. Our most significant currency exchange risk relates to transactions conducted in Australian dollars, British pounds, Canadian dollars, Chinese yuan, Euros, Japanese yen, and Swiss francs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the consolidated effects of exchange rate fluctuations upon our future operating results because of the number of currencies involved, the variability of currency exposure and the potential volatility of currency exchange rates. Although we address currency risk management through regular operating and financing activities, and, on a limited basis, through the use of derivative financial instruments, those actions may not prove to be fully effective. For a description of our use of derivative financial instruments, see Note 6, Derivative Instruments to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations subject us to laws regarding sanctioned countries, entities and persons, customs, import-export, laws regarding transactions in foreign countries, the U.S. Foreign Corrupt Practices Act and local anti-bribery and other laws regarding interactions with healthcare professionals, and product registration requirements. Among other things, these laws restrict, and in some cases prevent, U.S. companies from directly or indirectly selling goods, technology or services to people or entities in certain countries. In addition, these laws require that we exercise care in structuring our sales and marketing practices and effecting product registrations in foreign countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Russia-Ukraine conflict and resulting sanctions and export restrictions are creating barriers to doing business in Russia and adversely impacting global supply chains. While we have no manufacturing, distribution or direct material suppliers in the region, we are closely monitoring the potential raw material or supplier impact in both Russia and Ukraine. Materials like palladium and neon, which are both dependent on Russia supply, are part of broader semiconductor shortages in industry. Additional sanctions, export restrictions, and potential countermeasures within Russia may lead to greater uncertainty and geopolitical shifts in Asia that could cause additional adverse impacts on global supply chains and our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s (&#8220;UK&#8221;) exit from the European Union on January 31, 2020, commonly referred to as Brexit, has caused, and may continue to cause uncertainty in the global political markets. It is possible that Brexit could, among other things, affect the legal and regulatory environments, including the regulatory landscape concerning medical devices, to which our business is subject, impose greater restrictions on imports and exports between the UK and the EU and other parties, increase currency volatility and create economic and political uncertainty in the region.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we seek to continue to expand and strengthen our international operations, we may experience difficulty in growing our sales in certain new markets and other international markets in which we are attempting to increase our presence due to, among other things, customer acceptance, undeveloped and/or unfamiliar distribution channels, regulatory restrictions and changes, and business knowledge of these markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, proposals are made to significantly change existing trade agreements and relationships between the U.S. and other countries. In recent years, the U.S. government has implemented substantial changes to U.S. trade policies, including import restrictions, increased import tariffs and changes in U.S. participation in multilateral trade agreements, such as the United States-Mexico-Canada Agreement to replace the former North American Free Trade Agreement. The ongoing global economic competition and trade tensions between the U.S. and China has resulted in the U.S. government assessing supplemental tariffs on certain goods imported from China and China&#8217;s assessment of retaliatory tariffs on certain imports of U.S. goods into China. In addition, the United States has assessed or proposed supplemental tariffs and quantitative restrictions on U.S. imports of certain products from other countries as well. Owing to the complex relationships between the U.S. and such other countries, political, diplomatic, military, or other events could result in business disruptions, including increased regulatory enforcement against companies, tariffs, trade embargoes, export restrictions and the termination or modification of existing trade agreements. The imposition of such restrictions could increase the cost of the Company&#8217;s products and the components and raw materials that go into making them, require the Company to change its operations and the products it offers and negatively impact consumer confidence and spending, all of which, both individually and in the aggregate, could materially and adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyber-attacks or other disruptions to our information technology systems could adversely affect our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent on sophisticated information technology for our infrastructure and to support business decisions. Our information systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information, and changing customer </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patterns. An experienced third party maintains the enterprise business system used to support our transaction processing, accounting and financial reporting, and supply chain and manufacturing processes. Any significant breakdown, intrusion, interruption, corruption, or destruction of these systems, as well as any data breaches, could have a material, adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may attempt to breach our systems and may obtain data relating to patients, proprietary or sensitive information. As a result of the COVID-19 pandemic, we may face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. If we, or third parties on whom we rely, fail to maintain or protect our information systems and data integrity effectively, we could lose existing customers, have difficulty attracting new customers, suffer backlash from negative public relations, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach, or suffer other adverse consequences.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have programs, processes (including ongoing improvements) and technologies in place to prevent, detect, contain, respond to and mitigate security related threats and potential incidents. Because the techniques used to obtain unauthorized access or interrupt services change frequently and can be difficult to detect, anticipating, identifying or preventing these threats or mitigating them if and when they occur, may be challenging. We are also dependent on third party vendors to supply and/or support certain aspects of our information technology systems which may contain defects in design or manufacture or other problems that could result in system disruption or unexpectedly compromise the information security of our own systems. In addition, as we grow in part through new acquisitions we may face risks due to implementation, modification, or remediation of controls, procedures, and policies relating to data privacy and cybersecurity at the acquired business. We continue to consolidate and integrate the number of systems we operate, and to upgrade and expand our information system capabilities for stable and secure business operations. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our implementation of controls to protect our systems and sensitive, confidential or personal data or information, we may be vulnerable to material security breaches, theft, misplaced, lost or corrupted data, employee errors and/or malfeasance (including misappropriation by departing employees) that could potentially lead to the compromising of sensitive, confidential or personal data or information, improper use of our systems, software solutions or networks, unauthorized access, use, disclosure, modification or destruction of information, defective products, production downtimes and operational disruptions. In addition, a cyber-related attack could result in other negative consequences, including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> damage to our reputation or competitiveness, remediation or increased protection costs, litigation or regulatory action. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability, may have an adverse effect on our business, financial condition and results of operations and damage our reputation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is an increasing focus from certain investors, customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative pressure related to public companies&#8217; ESG practices continue to grow. Consistent with these developments, we published our inaugural ESG Report which includes performance highlights in key areas such as employee health and safety, diversity and inclusion, community impact, ethics and compliance, and environmental responsibility. In addition, we formally expanded Board oversight to include ESG strategy and reporting.  If, however, our ESG practices fail to meet regulatory requirements or investor, customer, consumer, employee or other stakeholders' evolving expectations and standards for responsible corporate citizenship in areas including environmental stewardship, support for local communities, Board of Director and employee diversity, human capital management, employee health and safety practices, product quality, supply chain management, corporate governance and transparency, our reputation, brand and employee retention may be negatively impacted, and our customers and suppliers may be unwilling to continue to do business with us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adapt to or comply with new regulations, or fail to meet evolving investor, industry or stakeholder expectations and concerns regarding ESG issues, investors may reconsider their capital investment in our Company, and customers may choose to stop purchasing our products, which could have a material adverse effect on our reputation, business or financial condition.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_16"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNRESOLVED STAFF COMMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Annual Report on Form 10-K, we had no unresolved comments from the staff of the Securities and Exchange Commission that were received not less than 180 days before the end of our 2022 fiscal year. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_22"></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">PROPERTIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we lease approximately 166,991 square feet of space in Princeton, NJ, where we house our principal headquarters, sales operations, and support functions. This lease expires in 2035.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. Our instrument procurement operations are located in Germany. Our primary distribution centers are located in Kentucky, Nevada, Australia, Belgium, Canada, Italy, Japan, and China. In addition, we lease several smaller facilities to support additional administrative, assembly, and distribution operations. Third parties own and operate the facilities in Nevada, Kentucky, Japan and Belgium. We own facilities in Saint Aubin Le Monial, France, Rietheim-Weilheim, Germany and Ohio and we lease all of our other facilities. We also have repair centers in Ohio, Australia, France, Japan, China and Germany, and field service presence in Canada, Dubai, India, Italy, Netherlands, Singapore, Thailand and United Kingdom. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing facilities are registered with the FDA. Our facilities are subject to FDA inspection to ensure compliance with Quality System regulations. For further information regarding the status of FDA inspections, see the Item 1. Business &#8211;Government Regulation and Compliance Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations &#8211; FDA Matters in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_25"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">LEGAL PROCEEDINGS</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitment and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K).</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_28"></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_31"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_34"></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information, Holders and Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on The Nasdaq Global Select Market under the symbol &#8220;IART.&#8221; The number of stockholders of record as of February&#160;21, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approximate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly 779,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stockholders whose shares were held in nominee name. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid any cash dividends on our common stock since our formation.  Our Senior Credit Facility (as defined below) limits the amount of dividends that we may pay.  Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of unregistered securities during the years ended December&#160;31, 2022, 2021 or 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Registered Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of registered securities during the years ended December&#160;31, 2022, 2021 or 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $125.0 million accelerated share repurchase ("2022 ASR") and received 1.48 million shares of the Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46 million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 26, 2022, the Board of Directors authorized the Company to repurchase up to $225.0 million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2024. This stock repurchase authorization replaces the previous $225 million stock repurchase authorization, of which $100 million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2022. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1 million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares of under the 2023 SAR.  The remaining repurchase transactions are expected to be completed in the first half of 2023. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for further details. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item regarding our equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The graph below compares the five-year total return to stockholders on our common stock with the return of the Standard &amp; Poor&#8217;s (S&amp;P) 500 Stock Index and the S&amp;P Healthcare Equipment Index. The Company&#8217;s cumulative shareholder return is based on an investment of $100 on December 31, 2017 and is compared to the cumulative total return of the S&amp;P indices mentioned above over the period with a like amount invested.</span></div><div><span><br/></span></div><div><img src="iart-20221231_g3.jpg" alt="iart-20221231_g3.jpg" style="height:410px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Note: The stock price performance shown on the graph above is not indicative of future price performance. This graph shall not be deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_37"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">[Reserved]</span></td></tr></table></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_40"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding our financial condition and results of operations. For a full understanding of financial condition and results of operations, it should be read together with the selected consolidated financial data and our financial statements with the related notes appearing elsewhere in this report. The discussion focuses on our financial results for the year ended December 31, 2022 and 2021. The comparison of fiscal 2021 to 2020 has been omitted from this Form 10-K, but can be referenced in our Form 10-K for the fiscal year ended December 31, 2021&#8212;&#8220;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; filed with the SEC on February 24, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We have made statements in this report which constitute forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. The Company&#8217;s actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under Item 1A. Risk Factors. We have made statements in this report which constitute forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters. Please refer to &#8220;Special Note Regarding Forward-Looking Statements&#8221; and Item 1A. Risk Factors for a discussion of the factors that could cause actual results to differ materially from those projected in these statements. The following information concerning our business, results of operations and financial condition should also be read in conjunction with the information included under Item 1. Business, Item 1A. Risk Factors and Item 15. Financial Statements and Supplementary Data.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_43"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra LifeSciences is a global leader in regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue, Integra LifeSciences Holdings Corporation common stock trades on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;IART.&#8221; Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra manufactures and sells medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We source most of our handheld surgical instruments and dural sealant products through specialized third-party vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra is committed to delivering high quality products that positively impact the lives of millions of patients and their families. We focus on four key pillars of our strategy: 1) enabling an execution-focused culture, 2) optimizing relevant scale, 3) advancing innovation and agility, and 4) leading in customer experience. We believe that by sharpening our focus on these areas through improved planning and communication, optimization of our infrastructure, and strategically aligned acquisitions, we can build scale, increase competitiveness and achieve our long-term goals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To this end, the executive leadership team has established the following key priorities aligned to the following areas of focus:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An important part of the Company's strategy is pursuing strategic transactions and licensing agreements that increase relevant scale in the clinical areas in which Integra competes. Our growth strategy includes the acquisition of businesses, assets or products lines to increase the breadth of our offerings, the reach of our product portfolios and drive relevant scale to our customers. On December 6, 2022, the Company completed the acquisition of SIA, which develops, markets and sells DuraSorb, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition will advance Integra&#8217;s global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in IBBR. We also continued to advance the development of pioneering neurosurgical technologies with the expansion our product offering of regenerative technologies from our 2021 ACell acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for additional details.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Optimization and New Product Introductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are investing in innovative product development to drive a multi-generational pipeline for our key product franchises. Our product development efforts span across our key global franchises focused on potential technological innovations</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for significant returns on investment. In addition to new product development, we are funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In addition to acquisitions and organic reinvestment, we continually look to optimize our portfolio towards higher growth and higher margin businesses. As such, we may opportunistically divest businesses or discontinue products where we see limited runway for future value creation in line with our aspirations due in part to changes in the market, business fundamentals or the regulatory environment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Channel Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Investing in our sales channels is a core part of our strategy to create specialization and greater focus on reaching new and existing customers and addressing their needs. To support our commercial efforts in Tissue Technologies, we utilize a two-tier specialist model to increase our presence in focused segments to help serve the evolving needs of our customers. In addition, we continue to build upon our leadership brands across our product franchises in both CSS and TT to engage customers through enterprise-wide contracts with leading hospitals, integrated delivery networks and global purchasing organizations in the United States. Internationally, we have increased our commercial resources significantly in key emerging markets and are making investments to support our sales organization and maximize our commercial opportunities. Domestically, we have also increased our TT sales force in the United States to support the expanded regenerative tissue product portfolio that includes ACell products. These investments in our international and domestic sales channel position us well for expansion and long-term growth. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We aspire to be ranked as a best-in-class provider and are committed to strengthening our relationships with all customers. We continue to invest in technologies, systems and processes to enhance the customer experience. In 2022, we outsourced certain transactional back-office finance and customer service activities to enhance customer quality, build scale for future growth, and capture cost efficiencies. We also launched digital tools and programs, resources and virtual product training to drive continued customer familiarity with our growing portfolio of medical technologies globally. .</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Product Introductions and Research and Development Updates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in collecting clinical evidence to support the Company's existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In  2022, we made progress to several enhancements to our CUSA Clarity Tissue Ablation System. The extended laparoscopic tip was launched in the U.S. to enhance laparoscopic liver procedures. In addition, a single-sided bone tip received 510(k) clearance. Commercial launch is expected in the first quarter of 2023. We continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece and integrated electrosurgical capabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each area, we continue to benefit from products launched over the past several years, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including our new electrosurgery generator and irrigator system, an innovative customer-centric toolkit for our Certas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus Programmable Valve along with additional shunt configurations. In Japan, we are experiencing strong growth as a result of the successful launch of DuraGen in mid-2019, which is the first and only collagen xenograft approved for use as a dural substitute in the country. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we continued to advance the two early-stage technology platforms we acquired in 2019. Through the acquisition of Arkiss, we added a platform technology, CerebroFlo EVD, which is a catheter with Endexo technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. In 2019, we also acquired Rebound Therapeutics which specialized in a single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In 2021, we began and continued to conduct a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH. In 2022, we have continued to execute on our growth initiatives. We launched the Aurora Evacuator with Coagulation device in the U.S., designed to be used in conjunction with our Aurora Surgiscope to safely address and evacuate blood in the brain caused by hemorrhagic stroke.&#8239;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on the development of core clinical applications in our electromechanical technologies portfolio. In June 2022, we launched the Neutus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EVD system, our first EVD in China. The Neutus EVD system is manufactured in China by Shanghai Haoju Medical Technology Co., Ltd. under an exclusive distribution arrangement. The device is used in the management of CSF and is highly complementary to our Bactiseal</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> catheter and advanced intercranial pressure monitoring products. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we launched our CereLink ICP Monitor System in the U.S. and Europe direct markets and continued the global rollout in the first half of 2022. CereLink provides enhanced accuracy, usability and advanced data presentation that provides clinicians with uncompromised, advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries. Refer below to the information appearing under the FDA Matters heading for additional information on the voluntary recall of the CereLink ICP Monitor System. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our TT segment, in 2022, we launched NeuraGen 3D Nerve Guide Matrix, a resorbable implant for repair of peripheral nerve discontinuities and engineered to create an optimized environment for nerve regeneration.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  During 2021, we completed one of the largest diabetic foot ulcers ("DFU"), randomized controlled trials of the PriMatrix Dermal Repair Scaffold for the management of DFU. This multi-center study enrolled more than 225 patients with chronic DFU's over the course of 12-week treatments and 4-week follow-up phases. The results of this study, which was published in the Journal of Wound Care, demonstrated that PriMatrix plus standard of care SOC consisting of sharp debridement, infection elimination, use of dressings and offloading was significantly more likely to achieve complete wound closure compared with SOC alone, with a median number of one application of the product. During 2020, we announced positive clinical and economic data on Integra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bilayer Wound Matrix ("IBWM") in complex lower extremity reconstruction based on two retrospective studies recently published in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. As surgeons look for ways to efficiently and effectively repair and close wounds, IBWM helps address the efficiency needed in operating rooms by reducing both the operating time and costs to hospitals and patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the Company, after consultation with the FDA and other regulatory authorities outside of the United States, initiated an immediate voluntary global product removal of all CereLink intracranial pressure monitors as a result of customer reports about monitors whose pressure readings were out of range. The Company believes that the out-of-range readings are principally caused by electrical interference from the external environment and/or interference from a component on the circuit board of the monitor. These out-of-range readings have occurred at a low incidence rate and at a limited number of sites; however, out of an abundance of caution, the Company removed all CereLink monitors from the field.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Is continuing its investigation into the matter in order to remedy the observed issue and plans to resume shipment of the CereLink monitors as soon as any such issues have been resolved. Based on outlook for returning the product to market and feedback from customers, the Company recorded a $1.9 million provision for product returns, as a reduction of net revenue, and a $0.8&#160;million rework accrual in cost of goods sold in 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and distribute products derived from human tissue for which FDA has specific regulations governing human cells, tissues and cellular and tissue-based products ("HCT/P"). An HCT/P is a product containing or consisting of human cells or tissue intended for transplantation into a human patient. Refer to Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details around these FDA regulations and their potential effect on the Company's portfolio of morselized amniotic material-based products as well as the impact on consolidated revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2019, TEI Biosciences, Inc. ("TEI"), a wholly-owned subsidiary of the Company received a Warning Letter (the &#8220;Warning Letter&#8221;), dated March 6, 2019, from the FDA. The warning letter related to quality systems issues at TEI's manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. The Company submitted its initial response to the FDA Warning Letter on March 28, 2019 and provides regular progress reports to the FDA as to its corrective actions and, since the conclusion of the inspection, has undertaken significant efforts to remediate the observations and continues to do so. On October 28, 2021 the FDA initiated an inspection of the facility and at the conclusion of the inspection issued a FDA Form 483 on November 12, 2021 (the "2021 Form 483"). The Company provided an initial response to the inspection observations and will continue to provide responses to FDA. The Warning Letter and the 2021 FDA Form 483 do not restrict the Company&#8217;s ability to manufacture or ship products or require the recall of any products, nor do they restrict our ability to seek FDA 510(k) clearance of products. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix products. We cannot give any assurances that the FDA will be satisfied with our response to the Warning Letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA&#8217;s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues of products manufactured in the TEI Boston facility for the year ended December&#160;31, 2022 were approximately 5.3% of consolidated revenues.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS &amp; DIVESTITURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r growth strategy includes the acquisition of businesses, assets or products lines to increase the breadth of our offerings and the reach of our product portfolios and drive relevant scale to our customers. As a result of several acquisitions from 2021 through 2022, our financial results for the year ended December&#160;31, 2022 may not be directly comparable to those of the corresponding prior-year perio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ds. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for a further discussion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Surgical Innovation Associates, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of SIA for an acquisition purchase price of $51.5 million. In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50M in additional payments), as well as 2) the approval by the FDA of the PMA application for DuraSorb for certain uses by certain timing targets (up to $40M in additional payments).  SIA was a privately-held company whose core technology, DuraSorb is a fully resorbable scaffold of a globally accepted polymer, cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#8217;s TT segment as part of its Wound Reconstruction and Care franchise.  See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell for an acquisition purchase price of $306.9 million plus contingent consideration obligations of up to $100 million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for additional details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestiture</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed the sale of its TWC business to Gentell for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proceeds from the sale of the TWC business of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$27.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other transaction fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction included the sale of the Company's TWC </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings. In connection with the sale, the Company recogniz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed $0.6&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a gain from the sale of business in the consolidated statement of operations for  year ended December 31, 2022. The transaction is subject to final working capital adjustments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business to Smith &amp; Nephew. The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0 million from Smith &amp; Nephew and concurrently paid $41.5 million to the Consortium of Focused Orthopedists, LLC ("CFO"), effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. The Company recognized a gain of $41.8 million in connection with the sale that is presented in "Gain from the sale of business" in the consolidated statement of operations for the year ended December, 31, 2021. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIMIZATION AND INTEGRATION ACTIVITIES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our ongoing acquisition strategy and significant growth in recent years, we have undertaken cost-saving initiatives to consolidate manufacturing operations, distribution facilities and transfer activities, eliminate duplicative positions, realign various sales and marketing activities, and expand and upgrade production capacity for our regenerative technology products. These efforts are expected to continue and while we expect a positive impact from ongoing restructuring, integration, and manufacturing transfer and expansion activities, such results remain uncertain.  In support of our continued focus on product margins during 2022, we closed a manufacturing facility located in France and began the transfer of production to the Company&#8217;s existing Switzerland facility</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The transfer  completed in the fourth quarter of 2022. In 2022, we outsourced certain transactional back-office finance and customer service activities to enhance customer quality, build scale for future growth, and capture cost efficiencies. This transition also completed in the fourth quarter of 2022.  While the transition was complete in 2022, we are continuing to work with our outsource provider to transform our processes and gain efficiencies.  </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_52"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the year ended December&#160;31, 2022 was $180.6 million, or $2.16 per diluted share, compared to $169.1 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or $1.98 per diluted share for the year ended December&#160;31, 2021.     </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes includes the following special charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, divestiture and integration-related charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,712)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural optimization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The items reported above</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are reflected in the consolidated statements of operations as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from the sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, divestiture, integration and restructuring activities, and for which the amounts are non-cash in nature, or for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, against the business model objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues and Gross Margin </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and gross margin on product revenues were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin on total revenues </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, total revenues increased by $15.2 million, or 1.0%, to $1,557.7 million from $1,542.4 million during the prior year. This increase is inclusive of an unfavorable foreign currency impact of $37.9 million, as well as a $10.2 million decrease that impacts both domestic and international revenues, related to the divestiture of the TWC business. Excluding the impacts of these items, domestic revenues increased by $41.6 million, or 3.8%. International revenues increased by $21.7 million or 4.8%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the CSS segment, revenues were $1,019.6 million which was a decrease of $5.7 million, or 0.6% as compared to the prior-year period. This increase is inclusive of a $34.1 million unfavorable foreign currency impact on revenue. Excluding the impact of foreign currency, the CSS segment revenues increased $28.4 million as compared to the prior year period. This increase was driven primarily by low single digits growth in both our Neurosurgery and Instruments portfolios as compared to the same period in the prior year. The increase in our Neurosurgery portfolio was driven primarily by growth in advanced energy and CSF management, partially offset by the voluntary recall of the CereLink ICP monitoring system.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the TT segment, revenues were $538.1 million, which was an increase of $20.9 million, or 4.0% as compared to the prior-year period.. Excluding the impact of foreign currency of $3.8 million and the divestiture impact of TWC of $10.2 million, the TT segment revenues in the third quarter increased by $34.9 million. This increase was driven by mid-single digit increases in our Wound Reconstruction business, led by Integra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Dermal Matrices, SurgiMend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and ACell MicroMatrix and low double digit increased in our Private Label business driven by higher customer demand and favorable order timing. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $970.3 million for the year ended December&#160;31, 2022, an increase of $25.7 million from $944.6 million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the same period last year. Gross margin as a percentage of revenues was 62.3% in 2022 and 61.2% in 2021. The increase in gross margin percentage was due to higher revenues and a reduction of inventory step up amortization in connection with the acquisition of ACell in the prior year. These were partially offset by CereLink recall impacts, unfavorable regional mix, and higher material and labor costs.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_55"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of operating expenses as a percent of total revenues:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses, which consist of research and development, selling, general and administrative, and intangible asset amortization expenses, decreased by $16.0 million or 2.1% to $731.4 million in 2022, compared to $747.4 million in the prior year. The decrease in operating expenses is due to lower selling, general and administrative costs and amortization partially offset by higher R&amp;D spending.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to manage and prioritize its operating costs to increase organic investments that will drive long-term growth including the support of new product development and introductions, clinical studies, geographic expansion and targeted U.S. sales channel expansion. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the year ended December&#160;31, 2022 increased by $8.1 million as compared to the prior year. This increase in spending resulted from additional spending on new product development, clinical studies and spending related to the  EU Medical Device Regulation compliance activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2022 decreased by $21.1 million as compared to the prior year driven primarily by the $18.1 million reduction in fair value of contingent consideration for ACell.  The remainder of the decrease is a result of reduced employee related costs and stock-based compensation, partially offset by increased selling costs on commissions and investment in sales force expansion.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset Amortization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (excluding amounts reported in cost of product revenues for technology-based intangible assets) in 2022 was $13.9 million compared to $16.9 million in 2021 primarily due to a reduction associated with the end of the amortization period for a certain customer relationship intangible asset. In addition, there was a decrease in amortization expense as a result of intangible assets sold with the TWC divestiture.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may discontinue certain products in the future as we continue to assess the profitability of our product lines. As our profitability assessment evolves, we may make further decisions about our trade names and incur additional impairment charges or accelerated amortization. We expect total annual amortization expense to be approximately $82.3 million in 2023, $81.7 million in 2024, $81.7 million in 2025, $81.5 million in 2026, $79.6 million in 2027 and $551.6 million thereafter. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Operating Income and Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of non-operating income and expenses:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,395)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income and expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,026)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the year ended December&#160;31, 2022 increased by $5.2 million as compared to the same period last year primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to higher interest rates in 2022 compared to 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December&#160;31, 2022 decreased by $0.8&#160;million as compared to the same period last year primarily from a lower outstanding borrowing on the Senior Secured Credit Facility partially offset by increased interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain from the sale of businesses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its previously announced sale of its TWC business to Gentell and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized $0.6 million as a gain from the sale of the business f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the year ended December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business and recognized a gain of $41.8 million in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the year ended December&#160;31, 2022 decreased by $7.3 million. This was primarily due to due unfavorable impact of foreign exchange, as well as lower income associated with the transition services agreement invoicing from the divestiture of the Extremity Orthopedics business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective inco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me tax rate was 15.6% and 21.2% of income before income taxes in 2022 and 2021, respectively. See Note 13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our consolidated financial statements for a reconciliation of the United States federal statutory rate to our effective tax rate. Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate could vary from year to year depending on, among other factors, tax law changes, the geographic and business mix and taxable earnings and losses. We consider these factors and others, including our history of generating taxable earnings, in assessing our ability to realize deferred tax assets. We estimate our worldwide effective income tax rate for 2023 to be approximately 20.7%, estimated based on existing tax laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company had $9.7 million of valuation allowance against the remaining $195.2 million of gross deferred tax assets recorded at December&#160;31, 2022. Our deferred tax asset valuation allowance decreased by $0.1 million in 2022, remaining substantially unchanged in 2021. This valuation allowance relates to deferred tax assets for which the Company does not believe it has satisfied the more likely than not threshold for realization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had net operating loss carryforwards of $79.5 million for federal income tax purposes, $75.5 million for foreign income tax purposes and $37.9 million for state income tax purposes to offset future taxable income. The federal net operating loss carryforwards increased during 2022 due to the acquisition of SIA. Of the total federal net operating loss carryforwards, $60.9 million expire through 2037 and $18.6 million have an indefinite carryforward period. Regarding the foreign net operating loss carryforwards, $16.4 million have an indefinite carryforwa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rd period. The state net operating loss carryforwards expire in 2036.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_58"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:72.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers that generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for the Company's products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic revenues increased by $37.3 million for the year ended December&#160;31, 2022 compared to the same period last year. These increases are inclusive of $4.4&#160;million related to the divestiture of the TWC business. European sales decreased by $20.4 million for the year ended December&#160;31, 2022 compared to the same period last year. Sales to customers in Asia Pacific decreased by $5.6 million for the year ended December&#160;31, 2022 compared to the same period last ye</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ar. The Rest of the World for the year ended December&#160;31, 2022 increased by $3.9 million compared to the same period last year. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The international revenues were impacted by a $37.9&#160;million unfavorable foreign exchange impact as well as $5.8&#160;million related to the divestiture of the TWC business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and December&#160;31, 2021, working capital was $840.6&#160;million and $813.7&#160;million, respectively. Working capital consists of total current assets less total current liabilities as presented in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Marketable Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents totaling approximately $456.7 million and $513.4 million&#160;at December&#160;31, 2022 and 2021, respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At December&#160;31, 2022, our non-U.S. subsidiaries held approximately $229.8 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:73.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used (provided) by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate fluctuations on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,787)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by Operating Activities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the year ended December&#160;31, 2022 decreased by $48.0 million compared to the same period in 2021. Net income after removing the impact of the gain on sale of businesses and non-cash adjustments increased for the year ended December&#160;31, 2022, by approximately $9.6 million as compared to 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to earnings from higher revenues</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The changes in assets and liabilities, net of business acquisitions, decreased cash flows by $39.4 million in 2022 as compared to the increase in cash flows of $18.2 million for the same period in 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in 2022 is mainly attributable to increases in inventory and accounts receivable. The increase in inventory is due to a build up of safety stock due to supply chain challenges. The increase in accounts receivable is due to increased sales as well as a decrease in days sales outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the year ended December&#160;31, 2021 increased by $108.6 million compared to the same period in 2020. Net income after removing the impact of the gain on sale of business and non-cash adjustments increased for the year ended December 31, 2021, by approximately $49.1 million as compared to the same period in 2020 primarily due to the continuing revenue recovery in the current year as compared to the height of the COVID-19 pandemic in the prior year. The changes in assets and liabilities, net of business acquisitions, increased cash flows from operating activities in the current year by $18.2 million compared to the decrease of $41.3 million for the same period in 2020. The improvement in 2021 working capital is attributable to a decrease in inventory of $5.4 million due to investments in building safety stock made in the prior year where inventory increased by $48.3 million as well as improved sales in 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, we paid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$42.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments, $51.5 million to acquire SIA, as well as the $4.7 million payment related to the final developmental milestone for Rebound Therapeutics Corporation.   This was partially offset by the net proceeds from the sale of the TWC business of $24.0 million. The proceeds from the sale of the TWC business of $27.8 million is presented net of cash transferred of $3.5 million and other transaction fees. Additionally, the Company also received $4.9 million proceeds on cross-currency swaps designated as net investment hedge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we paid a net cash amount of $303.9 million in relation to the acquisition of ACell and received net proceeds of $190.5 million for the sale of the Extremity Orthopedics business. The Company also paid for $48.0 million capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows (Used in) Provided by Financing </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uses of cash from financing activities for the year ended December&#160;31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily related to the purchase of treasury stock of $125.0&#160;million under the 2022 accelerated share repurchase agreement that was completed in the first quarter of 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, the Company had $24.6 million in cash taxes paid in net equity settlements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a result of the departure of the former chief executive officer of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company also had repayments of $148.6 million under our Senior Credit Facility and Securitization Facility offset by $40.8 million borrowings under our Senior Credit Facility and Securitization Facility. The Company also had $5.5 million proceeds from the exercise of stock options.  In this Annual Report on Form 10-K, we refer to the sixth amendment and restatement of our Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent as the "Senior Credit Facility."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uses of cash from financing activities for the year ended December&#160;31, 2021 were repayments of $125.5 million on the revolving portion of our Senior Credit Facility and Securitization Facility. In addition, the Company had $4.8 million in cash taxes paid in net equity settlements. These uses were offset by $6.8 million proceeds from the exercise of stock options and $25.5 million borrowings under our Senior Credit Facility and Securitization Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for a discussion of our Amended and Restated Senior Credit Agreement, the 2025 Notes and Securitization Facility and Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for discussion of our hedging activities. We are forecasting that sales and earnings for the next twelve months will be sufficient to remain in compliance with our financial covenants under the terms of the February 2020 Amendment and July 2020 Amendment to the Senior Credit Facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2022, the Company entered into a $125.0&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ASR") and received 1.48&#160;million shares of the Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 24, 2022, the early exercise provision was exercised by 2022 ASR counterparty. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon settlement on March 24, 2022, the Company received an additional 0.46 million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 26, 2022, the Board of Directors authorized the Company to repurchase up to $225.0 million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2024. This stock repurchase authorization replaces the previous $225 million stock repurchase authorization, of which $100 million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2022. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $150 million accelerated share repurchase agreement ("2023 ASR") and received 2.1 million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares of under the 2023 SAR.  The remaining repurchase transactions are expected to be completed in the first half of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the shar                                                      e repurchase authorization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for further details. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures over the next twelve months. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off&#8211;balance sheet financing arrangements during the year-ended December&#160;31, 2022 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to have cash requirements to support seasonal working capital needs and capital expenditures, to pay interest, to service debt, and to fund acquisitions. As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary obligations include principal and interest payments on revolving portion and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan component of the Senior Credit Facility, Securitization Facility and Convertible Securities. See Note 5</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Debt</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also leases some of our manufacturing facilities and office buildings which have future minimum lease payments associated. See Note 11, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Related Party Leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a schedule of our future minimum lease payments. Amounts related to the Company's other obligations, including employment agreements and purchase obligations were not material. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingent consideration obligations related to prior and current year acquisitions and future pension contribution obligations. See Note 10, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retirement Benefit Plans</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 15, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The associated obligations are not fixed. The Company also has a liability for uncertain tax benefits including interest and penalties. See Note 12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Termination Benefits </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred employee termination costs on restructuring activities associated with a closure of a manufacturing facility located in France, outsourcing plans for select transactional back office activities, and executive reorganization in the consolidated statement of operations for the year ended December 31, 2022. In 2021, the Company incurred employee termination costs on restructuring activities associated with the  closure of the manufacturing facility in France. Restructuring costs were included in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ccrued expenses and other current liabilities </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for further details. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_64"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND THE USE OF ESTIMATES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of financial conditions and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to navigate the COVID-19 pandemic and recent variants of the virus, as well as the adverse impacts to global economic conditions, supply chain and our operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following accounting policies, which form the basis for developing these estimates, are those that are most critical to the presentation of our consolidated financial statements and require the more difficult subjective and complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results could differ from these estimates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost (determined by the first-in, first-out method) or net realizable value. At each balance sheet date, we evaluate ending inventories for excess quantities, obsolescence or shelf-life expiration. Our evaluation includes an analysis of historical sales levels by product, projections of future demand by product, the risk of technological or competitive obsolescence for our products, general market conditions, a review of the shelf-life expiration dates for our products, and the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which we do not have excess quantities in inventory. To the extent that we determine there are excess or obsolete quantities or quantities with a shelf life that is too near its expiration for us to reasonably expect that we can sell those products prior to their expiration, we adjust their carrying value to estimated net realizable value. If future demand or market conditions are lower than our projections, or if we are unable to rework excess or obsolete quantities into other products, we may record further adjustments to the carrying value of inventory through a charge to cost of product revenues in the period the revision is made. As of December 31, 2022, our reserve for inventory obsolesce is 6% of total inventory on our consolidated balance sheets.        </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on the fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired in recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets, acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our most recent acquisition of SIA, the key areas of judgement relating to the valuation of the acquired definite-lived developed technology intangible assets were the net revenue growth rates, cost of sales, selling and marketing costs, discounts rates, and asset useful life.  The key areas of judgement relating to the valuation of the contingent consideration are the inputs to the Monte-Carlo model including revenue-adjusted discount rate, counterpart discount rate, revenue volatility and forecasted revenue, earnings before income taxes and fixed costs.  These assumptions were developed with the assistance of a third-party valuation expert.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent issuance, or validity and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for details. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. Key assumptions used to estimate the fair value of goodwill include the Company's discounts rate and forecasted operating results.  The Company had goodwill on the balance sheet of $1&#160;billion as of December 31, 2022. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("ASC Topic 350"),  and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Identifiable Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. There were no changes to identifiable intangible assets as a result of the Company's assessments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ("ASC Topic 360") when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment test involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company has $1.1 billion of identifiable intangible assets, net on the balance sheets.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we conduct operations on a global basis, our effective tax rate has and will depend upon the geographic distribution of our pre-tax earnings among locations with varying tax rates. Changes in the tax rates of the various jurisdictions in which we operate affect our profits. In addition, we maintain a reserve for uncertain tax benefits, changes to which could impact our effective tax rate in the period such changes are made. The effective tax rate can also be impacted by changes in valuation allowances of deferred tax assets, and tax law changes. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes may change period-to-period based on specific events, such as the settlement of income tax audits and changes in tax laws, as well as general factors, including the geographic mix of income before taxes, state and local taxes and the effects of the Company's global income tax strategies. We maintain strategic management and operational activities in overseas subsidiaries. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K), in our consolidated financial statements for disclosures related to foreign and domestic pretax income, foreign and domestic income tax expense (benefit) and the effect foreign taxes have on our overall effective tax rate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. The amount of the accrual for which an exposure exists is measured by determining the amount that has a greater than 50 percent likelihood of being realized upon ultimate settlement of the position. Components of the reserve are classified as a long-term liability in the consolidated balance sheets. We record interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have identified all reasonably identifiable exposures and that the reserve we have established for identifiable exposures is appropriate under the circumstances; however, it is possible that additional exposures exist and that exposures will be settled at amounts different from the amounts reserved. It is also possible that changes in facts and circumstances could cause us to either materially increase or reduce the carrying amount of our tax reserves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their basis for income tax purposes, and the temporary differences created by the tax effects of capital loss, net operating loss and tax credit carryforwards. We record valuation allowances when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We could recognize no benefit from our deferred tax assets or we could recognize some or all of the future benefit depending on the amount and timing of taxable income we generate in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to indefinitely reinvest substantially all of our foreign earnings in our foreign subsidiaries unless there is a tax&#8211;free manner under which to remit the earnings. The current analysis indicates that we have sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash.  One time or unusual items that may impact our ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary, and changes in tax laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Such taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K), to the consolidated financial statements for recently adopted accounting pronouncements.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_67"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange and Other Rate Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, British pounds, Swiss francs, Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity&#8217;s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part IV, Item 15 of this Annual Report on Form 10-K) for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations discussed herein have not been materially affected by inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis points movement in interest rates applicable to our cash and cash equivalents outstanding at December&#160;31, 2022 would increase interest income by approximately $5.1 million on an annual basis. No significant decrease in interest income would be expected as our cash balances are earning interest at rates of approximately one basis points. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our interest rate risk relates primarily to U.S. dollar LIBOR-indexed borrowings. We use interest rate swap derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected LIBOR-indexed floating-rate borrowings. The Company held the following interest rate swaps as of December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interest rate swaps were designated as cash flow hedges as of December&#160;31, 2022. The total notional amounts related to the Company&#8217;s interest rate swaps were $1.5&#160;billion and with $775.0&#160;million effective as of December&#160;31, 2022. Based on our outstanding borrowings at December&#160;31, 2022, a 100 basis points change in interest rates would have impacted interest expense on the unhedged p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ortion of the debt b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y $1.1 million o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n an annualized basis.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_73"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements and the financial statement schedule specified by this Item, together with the report thereon of PricewaterhouseCoopers LLP, are presented following Item 15. Exhibits and Financial Statement Schedule of this Annual Report on Form 10-K. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_76"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Exchange Act Rule 13a-15(b), we have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2022. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of December&#160;31, 2022 to provide such reasonable assurance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) under the Securities Exchange Act of 1934, as amended. Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). We recognize that because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies and procedures may deteriorate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To evaluate the effectiveness of our internal control over financial reporting, management used the criteria described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based upon this evaluation, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended December&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_82"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">OTHER INFORMATION</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following disclosure is intended to satisfy any obligation to provide disclosures pursuant to Item 5.03 of Form 8-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Effective as of February 21, 2023, based on the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the &#8220;Board&#8221;) of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), in connection with the new Securities and Exchange Commission rules and changes to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the "DGCL"), and a periodic review of corporate governance matters, the Board approved amendments to the Company&#8217;s Second Amended and Restated Bylaws, as amended (the &#8220;Third A&amp;R Bylaws&#8221;). </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Third A&amp;R Bylaws, among other things:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Address matters relating to Rule 14a-19 under the Exchange Act (the "Universal Proxy Rules"), including requiring: (a) the stockholder&#8217;s nomination notice to include a representation that it intends to solicit proxies from stockholders representing at least 67% of the voting power of shares entitled to vote on the election of directors; (b) the stockholder to comply with the Universal Proxy Rules and provide reasonable evidence thereof prior to the stockholder meeting; and (c) the stockholder to use a proxy card color other than white, which is reserved for the exclusive use of the Board. (Article 2, Sections 2.03, 2.08, and 2.10)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Enhance the informational and procedural requirements in connection with stockholder proposals and stockholder director nominations, including: (a) requiring additional information about the stockholder making the director </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">nomination or proposal; (b) requiring additional information about the stockholder proposed business and/or director nominee; and (c) providing that the number of nominees a stockholder may nominate for election at the annual meeting of the stockholders may not exceed the number of directors to be elected at such annual meeting. (Article 2, Sections 2.03 and 2.10)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Modify the provisions relating to adjournment procedures, availability of lists of stockholders entitled to vote at stockholder meetings, and electronic notices, in each case, to reflect amendments to the DGCL. (Article 2, Sections 2.04 and 2.05; Article 4, Section 4.01)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Provide that any proxies received for disqualified or withdrawn Board nominees will be treated as abstentions. (Article 2, Section 2.08)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Add a provision for stockholder actions by written consent that requires the Company to engage an independent inspector of election to perform a review of the validity of the applicable consents and revocations. (Article 2, Section 2.09)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Clarify the powers of the chair of a stockholder meeting, including with respect to the chair&#8217;s ability to prescribe rules and regulations for the conduct of the meeting. (Article 2, Section 2.11)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Add a federal forum provision to designate the federal district courts as the exclusive forum for matters arising under the Securities Act of 1933, as amended, and the Exchange Act. (Article 8, Section 8.02)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">Make various other updates, including ministerial and conforming changes and changes to clarify the Company&#8217;s ability to conduct business by means of remote communication. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Third A&amp;R Bylaws is qualified in its entirety by the full text of the Third A&amp;R Bylaws filed as Exhibit 3.3 hereto and incorporated herein by reference. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_85"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_88"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION BY REFERENCE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information called for by Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities relating to equity compensation plans, Item 10. Directors, Executive Officers and Corporate Governance, Item 11. Executive Compensation, Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters, Item 13. Certain Relationships and Related Transactions, and Director Independence and Item 14. Principal Accountant Fees and Services is incorporated herein by reference to the Company&#8217;s definitive proxy statement for its Annual Meeting of Stockholders sche</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duled to be held on May&#160;12, 2023, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich definitive proxy statement is expected to be filed with the Commission not later than 120 days after the end of the fiscal year to which this report relates. </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_91"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_94"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_97"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_100"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_103"></div><div><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_106"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_109"></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">EXHIBITS AND FINANCIAL STATEMENT SCHEDULE</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    (a) Documents filed as a part of this report: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The following financial statements and financial statement schedules are filed as a part of this report: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:92.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_121">Report of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, Florham Park, New Jersey, PCAOB ID# </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMDkvZnJhZzpjMzAwOTE1YjA5NGQ0ZjE3YTI5MWQwNWE4NzczNmQ0Yy90YWJsZTo2MDdiYmM5YzlmYTM0NDNhOTAwNjRjYjQzZThmNDE2ZC90YWJsZXJhbmdlOjYwN2JiYzljOWZhMzQ0M2E5MDA2NGNiNDNlOGY0MTZkXzAtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplNDI3YjZhYjMwOWU0OTQ4ODQyY2U5ZWQ2ZDBkMmQ1MV8xMjU_e15671ee-3e03-4111-b38d-2c5151587a22">238000</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_121">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_121">F-1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">Consolidated Statements of Operations for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_124">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_127">Consolidated Statements of Comprehensive Income for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_127">2, 2021 and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_127"> 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_127">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_127">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_130">Consolidated Balance Sheets as of December 31, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_130">2022 and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_130">2021 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_130">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_130">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133">Consolidated Statements of Cash Flows for the years ended December 31, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133">2022, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133">2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133"> and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133"> 2020 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_133">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_136">Consolidated Statements of Changes in Stockholders&#8217; Equity for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_136">2, 2021 and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_136"> 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_136">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_136">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_142">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_142">F-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43d6bdf9742e4131bcef4d4155aafb89_142">8</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules not listed above have been omitted, because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes thereto.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exhibits required to be filed by Item 601 of Regulation S-K.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000047/iart-20200930xexx21.htm">Put Option Agreement, dated September 29, 2020, between the Company and certain of its subsidiaries and Smith &amp; Nephew USD Limited, a subsidiary of Smith+Nephew (including the Purchase and Sale Agreement attached as Appendix 1 thereto) (Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000047/iart-20200930xexx21.htm">).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000018/iart-20201231xexx21b.htm">Agreement and Plan of Merger by among Integra LifeSciences Holdings Corporation and ACell Inc. dated as of December 15, 2020 (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex3-1aform10k031406.txt">Amended and Restated Certificate of Incorporation of the Company dated February 16, 1993 (Incorporated by reference to Exhibit 3.1(a) to the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-99-001063.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 22, 1998 (Incorporated by reference to Exhibit 3.1(b) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 1998)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv3w1wc.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 17, 1999 (Incorporated by reference to Exhibit 3.1(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752016000107/ex_3x1xfileddecember22x2016.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated December 21, 2016 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 22, 2016)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000042/ex3_1xsecondarbylawsxdec20.htm">Second Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of December 11, 2018 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-k filed on December 12, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx33.htm">Third Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of February 21, 2023 +</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex41.htm">Indenture, dated as of February 7, 2020, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee  (including Form of 0.50% Convertible Senior Notes due 2025) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000051/exhibit41.htm">First Supplemental Indenture, by and between Integra LifeSciences Holdings Corporation and Citibank, N.A., as trustee (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 9, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312519155388/d752260dex44.htm">Integra LifeSciences Deferred Compensation Plan, effective as of May 16, 2019 (Incorporated by reference to Exhibit 4.13 to the Company's Current Form S-8 Registration Statement filed on May 23, 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx44.htm">Description of Securities+</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993311000711/exhibit1.htm">Lease Modification #3 entered into as of March 2, 2011, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 3, 2011)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000017/exhibit101_leasemodificati.htm">Lease Modification #4 entered into as of April 20, 2017, by and between Plainsboro Associates and Integra LifeSciences Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 25, 2017)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000099/ex4-1forms8081205.txt">Employee Stock Purchase Plan (as amended on May 17, 2004) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 (Registration No. 333-127488) filed on August 12, 2005</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000099/ex4-1forms8081205.txt">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000110/ex10-1form8k102705.txt">First Amendment to Employee Stock Purchase Plan, dated October 26, 2005 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 1, 200</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752005000110/ex10-1form8k102705.txt">5)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310002081/exhibit1.htm">Second Amended and Restated 2003 Equity Incentive Plan effective May 19, 2010 (Incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed May 21, 2010</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000129993310002081/exhibit1.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex109.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective May 17, 2012 (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312512326115/d364710dex109.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit104amendmenttosecon.htm">Amendment to the Second Amended and Restated 2003 Equity Incentive Plan effective January 1, 2013 (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752013000041/exhibit104amendmenttosecon.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000025/exhibit101-thirdamendedand.htm">Third Amended and Restated 2003 Equity Incentive Plan effective May 22, 2015 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 29, 2015</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752015000025/exhibit101-thirdamendedand.htm">)*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x1.htm">Fourth Amended and Restated 2003 Equity Incentive Plan, effective May 23, 2017 (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x1.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000037/iart-20200630xexx101.htm">Amendment to the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000037/iart-20200630xexx101.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000029/ex101.htm">Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 18, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000029/ex101.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(h)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103h.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock Award Agreement &#8211; Directors*+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(i)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103i.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103i.htm"> Agreement &#8211; Executive Officers*+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(j)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103j.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Performance Stock Unit Award Agreement*+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(k)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103k.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Non-Qualified Stock Option Award Agreement*+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(l)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103l.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx103l.htm"> Award Agreement &#8211; OUS*+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752022000029/ex101indemnificationagreem.htm">Form of Indemnification Agreement, by and between Integra LifeSciences Holdings Corporation and each of its directors and executive officers (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on July 19, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752022000029/ex101indemnificationagreem.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752013000060/exhibit102-summaryofexecut.htm">Annual Executive Physical Medical Exam Arrangement (Incorporated by reference to the Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on July 29, 2013</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752013000060/exhibit102-summaryofexecut.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x2.htm">2018 Performance Incentive Compensation Plan, effective January 1, 2018 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 25, 2017</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752017000025/exhibit_10x2.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752022000061/changeinctrlseverancepro.htm">Integra LifeSciences Holdings Corporation Change in Control Severance Program (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 14, 2022)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w43wc.htm">Amended and Restated Management Incentive Compensation Plan, as of January 1, 2008 (Incorporated by reference to Exhibit 10.43(c) to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2007</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000095012308005803/y51439exv10w43wc.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/ex10_1xintegraemployment.htm">Employment Agreement, dated October 28, 2021, by and between Integra LifeSciences Holdings Corporation, Integra LifeSciences Corporation and Jan De Witte (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 28, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/ex10_1xintegraemployment.htm">)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752016000104/exhibit_10x2xdecemberx5x20.htm">Davis Promotion Summary, effective December 1, 2016 (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2016)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Coleman Promotion Summary, effective June 24, 2019 (Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/integra_separationagreemen.htm">Separation Agreement and General Release, dated September 23, 2022, by and between Glenn Coleman, Integra LifeSciences Corporation and Integra LifeSciences Holdings Corporation (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 23, 2022)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752019000026/form8kfiledjune242019.htm">Anderson Offer Summary, effective June 24, 2019(Incorporated by reference to the Current Report on Form 8-K filed on June 24, 2019)*</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-1.htm">Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Association, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 1 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of March 29, 2019, by and among Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, Committed Lender and Group Agent, Mizuho Bank, Ltd., as Committed Lender and Group Agent and PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 2 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of July 17, 2020, by and among, Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, Committed Lender and Group Agent, Mizuho Bank, Ltd., as Committed Lender and Group Agent and PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752021000039/iart-20210630xexx101.htm">Amendment No. 3 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of May 28, 2021, by and among, Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, Committed Lender and Group Agent, and certain lenders and group agents that are parties thereto from time to time (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000092963818001000/exhibit10-2.htm">Purchase and Sale Agreement, dated as of December 21, 2018, by and among Integra LifeSciences Sales LLC, Integra LifeSciences Corporation and Integra Receivables LLC (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex101.htm">Sixth Amended and Restated Credit Agreement, dated as of February 3, 2020, among Integra LifeSciences Holdings Corporation, the lenders party thereto, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., TD Bank, N.A. and Truist Bank, as Co-Documentation Agents. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752020000030/amendmentno1sixtharca.htm">Amendment, dated July 14, 2020, to that Sixth Amended and Restated Credit Agreement, among Integra LifeSciences Holdings Corporation, a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A. as Co-Syndication Agents, and PNC Bank, N.A., Bank of Nova Scotia, Bank of the West, BBVA USA, Capital One, National Association, Citizens Bank, N.A., DNB Capital LLC, Santander Bank, N.A., T.D. Bank, N.A. and Truist Bank, as Co-Documentation Agents (as amended, restated, modified and supplemented from time to time prior to the date hereof, the &#8220;Credit Agreement&#8221;) (Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on July 20, 2020).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex101.htm">Base Call Option Transaction Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520022927/d881437dex102.htm">Ratification Agreement, dated as of February&#160;3, 2020, between Integra LifeSciences Holdings Corporation, the Subsidiary Guarantors of Integra LifeSciences Holdings Corporation and Bank of America, N.A., as Administrative Agent (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex103.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. International plc. (Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex104.htm">Base Call Option Transaction Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex105.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex106.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs&#160;&amp; Co. LLC. (Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex107.htm">Base Warrant Confirmation, dated as of February&#160;4, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex108.htm">Base Warrant Confirmation, dated as of February 4, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex109.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1010.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.10 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1011.htm">Additional Call Option Transaction Confirmation, dated as of February&#160;5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley&#160;&amp; Co. International plc. (Incorporated by reference to Exhibit 10.11 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1012.htm">Additional Call Option Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.12 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1013.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Citibank, N.A. (Incorporated by reference to Exhibit 10.13 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020) </a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1014.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Goldman Sachs &amp; Co. LLC. (Incorporated by reference to Exhibit 10.14 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1015.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Morgan Stanley &amp; Co. plc. (Incorporated by reference to Exhibit 10.15 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1016.htm">Additional Warrant Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and Wells Fargo, National Association. (Incorporated by reference to Exhibit 10.16 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000119312520028314/d862844dex1017.htm">Issuer Forward Repurchase Transaction Confirmation, dated as of February 5, 2020, between Integra LifeSciences Holdings Corporation and JPMorgan Chase Bank, National Association, New York Branch. (Incorporated by reference to Exhibit 10.17 to the Company&#8217;s Current Report on Form 8-K filed on February 7, 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx211.htm">Subsidiaries of the Company+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx231.htm">Consent of PricewaterhouseCoopers LLP+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx311.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx312.htm">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx321.htm">Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20221231xexx322.htm">Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document+#</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates this document is filed as an exhibit herewith.</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial information of Integra LifeSciences Holdings Corporation Annual Report on Form 10-K for the year ended December 31, 2022 filed on February 22, 2023 formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statement of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) Parenthetical Data to the Consolidated Balance Sheets, (v) the Consolidated Statements of Cash Flows, (vi) the Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vii) Notes to Consolidated Financial Statements, is furnished electronically herewith.</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Commission File Number for Reports on Form 10-K, Form 10-Q and Form 8-K is 000-26224.</span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_112"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">FORM 10-K SUMMARY</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.146%"><tr><td style="width:1.0%"></td><td style="width:8.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.571%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jan De Witte</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;22, 2023 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant in the capacities indicated. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jan De Witte</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stuart M. Essig, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith Bradley, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shaundra Clay</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shaundra Clay</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara B. Hill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Renee Lo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renee Lo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald E. Morel, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond G. Murphy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian S. Schade</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_118"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Board of Directors and Stockholders of Integra LifeSciences Holdings Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Integra LifeSciences Holdings Corporation and its subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2022 and 2021, and the related consolidated statements of operations, of comprehensive income, of changes in stockholders&#8217; equity and of cash flows for each of the three years in the period ended December&#160;31, 2022, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2022 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Control - Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2013) issued by the COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Accounting Principle</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for convertible instruments in 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-indent:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Surgical Innovation Associates, Inc. Acquisition - Valuation of Developed Technology Intangible Asset</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Note 4 to the consolidated financial statements, on  December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. (SIA) for an acquisition purchase price of $51.5 million, and will pay up to an additional $50 million upon the achievement of certain revenue-based performance milestones in 2023, 2024, and 2025 and up to an additional $40.0M upon the approval by the FDA of the Premarketing Approval Application for DuraSorb. The acquisition also resulted in a $75 million developed technology intangible asset  being recorded. The estimated fair value of the developed technology acquired was determined by management using the multi-period excess earnings method of the income approach. Management&#8217;s significant assumptions used in the estimate of fair value included the estimated net cash flows, including net revenues, cost of sales, research and development costs, selling and marketing costs, working capital,  contributory asset charges, discount rate, the asset&#8217;s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal considerations for our determination that performing procedures relating to the valuation of developed technology intangible asset from the acquisition of Surgical Innovation Associates, Inc. is a critical audit matter are (i) the significant judgment  by management when developing the fair value estimate of the acquired developed technology intangible asset, (ii) a high degree of auditor judgment , subjectivity,  and effort  in performing procedures and evaluating management&#8217;s  significant assumptions related to net revenues, cost of sales, discount rate and the asset&#8217;s life cycle; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the acquisition accounting, including controls over management&#8217;s valuation of the acquired developed technology intangible asset and controls over the development of significant assumptions related to net revenues, cost of sales, discount rate and the asset&#8217;s life cycle. These procedures also included, among others (i) reading the purchase agreement and (ii) testing management&#8217;s process for developing the estimated fair value of the developed technology intangible asset. Testing management&#8217;s process included evaluating the appropriateness of the multi-period excess earnings method, testing the completeness and accuracy of underlying data used in the method, and evaluating the reasonableness of significant assumptions used by management related to net revenues, cost of sales, discount rate and the asset&#8217;s life cycle. Evaluating the reasonableness of management&#8217;s assumptions related to net revenues, cost of sales, and the asset&#8217;s life cycle involved considering (i) current and past performance of the product associated with the developed technology acquired; (ii) the consistency with external market and industry data; and (iii) whether the assumptions are consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the Company&#8217;s multi-period excess earnings method and (ii) the reasonableness of the discount rate and the asset&#8217;s life cycle assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjEvZnJhZzo0OTM2NjM1NWJmN2M0ZWMwYjU5MjdjMDMyZDA4NWIxOS90ZXh0cmVnaW9uOjQ5MzY2MzU1YmY3YzRlYzBiNTkyN2MwMzJkMDg1YjE5Xzk4OTk_794dacd2-b9b9-4e71-81e5-b083e4e1e876">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjEvZnJhZzo0OTM2NjM1NWJmN2M0ZWMwYjU5MjdjMDMyZDA4NWIxOS90ZXh0cmVnaW9uOjQ5MzY2MzU1YmY3YzRlYzBiNTkyN2MwMzJkMDg1YjE5Xzk5MDA_85f74c2c-de49-4784-9341-2705bfc3caa9">Florham Park, New Jersey</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;22, 2023 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1989.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItMS0xLTEtOTI0Nzk_15d6962e-13ce-43fe-a1fb-e970a09a7354">1,557,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItMy0xLTEtOTI0Nzk_a65319af-a8ff-4d2c-a25a-d70b4a750588">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItNS0xLTEtOTI0Nzk_4ea5d876-703e-466f-a67c-4fad90bfc198">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtMS0xLTEtOTI0Nzk_02e6690c-ce87-48c5-976b-d8ed2f0de32e">587,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtMy0xLTEtOTI0Nzk_3eb8181d-492c-428f-ada9-dce30b621489">597,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtNS0xLTEtOTI0Nzk_c7046d6e-6a34-44c4-9cc4-b7dab69e9616">520,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtMS0xLTEtOTI0Nzk_59b7810a-af5d-4e74-b36b-fc6cef17c1d7">101,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtMy0xLTEtOTI0Nzk_ad2b3621-706f-46a9-9b3f-08810417cb30">93,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtNS0xLTEtOTI0Nzk_6e5a43a3-cf48-44e0-9042-cd46651eaaa4">77,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtMS0xLTEtOTI0Nzk_99d8b363-929f-4d0b-a57b-50384d033db8">616,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtMy0xLTEtOTI0Nzk_c24e107e-1c46-469d-a228-261e9103c1bc">637,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtNS0xLTEtOTI0Nzk_7bd2ce9e-95a5-467a-a889-4b087f0759b6">594,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktMS0xLTEtOTI0Nzk_a3360774-5585-4ff2-ba20-bdca6c927cae">13,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktMy0xLTEtOTI0Nzk_27b57782-c5dc-46c6-8b32-93b8d07a9c18">16,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktNS0xLTEtOTI0Nzk_5c27764c-d3a4-4bac-b892-94d928b167d0">27,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTEtMS0xLTkyNDc5_02e0a100-2e35-40d4-a7b2-4a0086232a66">1,318,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTMtMS0xLTkyNDc5_a449f80e-ab0f-4868-a419-8b553652a152">1,345,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTUtMS0xLTkyNDc5_e9fbc8ce-35dc-4460-8ece-92f0560bd211">1,220,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTEtMS0xLTkyNDc5_92314d28-4a61-4684-a4f5-c8ea793391b6">238,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTMtMS0xLTkyNDc5_b49635c0-e7eb-4b08-8115-6b292e8741d4">197,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTUtMS0xLTkyNDc5_8bb27f4f-0b49-4edd-a5df-c210dbb57f39">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTEtMS0xLTkyNDc5_d2ee3858-d589-43d5-ab7e-b8e6dba4a0a6">11,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTMtMS0xLTkyNDc5_6f090de4-1e00-4c56-ad89-be8af070597c">6,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTUtMS0xLTkyNDc5_ce2eb6f7-064c-4d73-abab-a89ad5766a83">9,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTEtMS0xLTkyNDc5_abf71b6d-22fe-4d92-882e-4800655c776c">49,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTMtMS0xLTkyNDc5_77feaa81-8676-464c-98f5-ca511a160d49">50,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTUtMS0xLTkyNDc5_956fbea5-b05e-4d18-8618-fbe5e84fecbd">71,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from sale of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTEtMS0xLTkyNDc5_1fe4ffba-eb6c-4566-8cdb-1a3313292052">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTMtMS0xLTkyNDc5_3ddb63f3-c129-402a-95d7-21160282aa36">41,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTUtMS0xLTkyNDc5_8400d0f1-f39c-48dd-a5c7-4e735a611f28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTEtMS0xLTkyNDc5_435b5659-eb99-45b8-b1ba-9a166047dd62">12,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTMtMS0xLTkyNDc5_28d99693-cc0c-4a82-b66b-11597a686c42">19,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTUtMS0xLTkyNDc5_876793b2-4da4-4171-a3e9-e7b8083d68dc">4,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTEtMS0xLTkyNDc5_2b33a9cc-1596-440d-9cd4-8bcf4355972c">213,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTMtMS0xLTkyNDc5_88c49e2d-f5f8-4f32-97af-cc46e3026f71">214,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTUtMS0xLTkyNDc5_44fc5a4c-d41b-470e-922c-254c8f4efa6a">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTEtMS0xLTkyNDc5_40e8ec29-32ad-48db-bc25-46f2a2e6d7b5">33,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTMtMS0xLTkyNDc5_370d6da1-0a61-4886-8a59-117da68d7af4">45,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTUtMS0xLTkyNDc5_4018b69c-0b70-4c27-bdb2-09b62e9933e0">40,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTEtMS0xLTkyNDc5_82d649e3-897c-478e-8559-6b24da4c282c">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTMtMS0xLTkyNDc5_83eedb92-53f0-4dff-9663-227aa97d17ae">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTUtMS0xLTkyNDc5_0042ccdb-1f7b-46b5-af5a-58e9b2419c0f">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTEtMS0xLTkyNDc5_4f19c83a-f85d-4553-9913-8084470e2f68">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTMtMS0xLTkyNDc5_6495ea37-d73e-493a-ac99-a4176c46c684">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTUtMS0xLTkyNDc5_6650905b-fc7e-4714-9cb5-be5744cdc93d">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTEtMS0xLTkyNDc5_8005bd44-05d5-4e55-83ca-a8eda80f64e2">2.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTMtMS0xLTkyNDc5_57aab3be-b317-4dee-9664-f4316a77a1ca">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTUtMS0xLTkyNDc5_1a603aab-cf4b-468c-b459-8f29dc4c1992">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average common shares outstanding (See Note 13):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTEtMS0xLTkyNDc5_a56473ce-7fe9-4a74-b2d5-a2a8afcce829">82,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTMtMS0xLTkyNDc5_93674866-e72f-4616-84ef-496c54159e08">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTUtMS0xLTkyNDc5_16cb28ed-be5e-4569-9735-eb8757102921">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTEtMS0xLTkyNDc5_bfa0d503-b3f5-4d9f-8965-ebb62e48e4d4">83,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTMtMS0xLTkyNDc5_e28dc193-b52d-453f-9ddb-fc59298457d9">85,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTUtMS0xLTkyNDc5_844fdac0-9695-405c-be9f-9b37958214b3">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItMS0xLTEtOTI0Nzk_3ac172d4-5bc4-409e-af0e-1091e165d1c0">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItMy0xLTEtOTI0Nzk_b212d37b-72ed-4b9f-9def-6d3dcb906b47">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItNS0xLTEtOTI0Nzk_ec909e31-f447-4e9b-b131-ee868b0458e2">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtMS0xLTEtOTI0Nzk_7980fdba-a953-4d28-a193-7623b7b185e1">17,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtMy0xLTEtOTI0Nzk_c6a239d7-7984-4130-97ce-15812857c6a6">17,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtNS0xLTEtOTI0Nzk_836b0bc8-545c-4415-ad82-a89f86c1d698">53,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized derivative gain (loss) arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtMS0xLTEtOTI0Nzk_21140172-ad0f-4f96-821a-bdbf32b3043d">104,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtMy0xLTEtOTI0Nzk_5ed13feb-097b-42b4-93d3-e66f6694bdcd">68,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtNS0xLTEtOTI0Nzk_76117ae7-4f8d-43fa-a33e-09b696b6d634">96,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Reclassification adjustments for gain (loss) included in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktMS0xLTEtOTI0Nzk_ad4651d6-8286-467c-a0c5-db33029384be">18,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktMy0xLTEtOTI0Nzk_113cadf1-398f-4641-8b3d-a5daa16c0f2c">17,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktNS0xLTEtOTI0Nzk_ed45d33e-4a48-4270-95fc-2dd14a0f110f">24,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTEtMS0xLTkyNDc5_0a7bc537-75fd-4e4a-ba71-d4827455bf0a">85,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTMtMS0xLTkyNDc5_4d74aa27-3c5f-4260-b1b1-e29f8290a2e0">51,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTUtMS0xLTkyNDc5_9ed13e1e-4fcf-4b06-8b1a-ce2169f90d83">72,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension plan - net gain (loss) arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTEtMS0xLTkyNDc5_deafce14-f876-40d6-bbf2-3b360f47ec8e">7,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTMtMS0xLTkyNDc5_8536e541-0e85-46e8-bf62-49e59afafd7e">6,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTUtMS0xLTkyNDc5_e7cdb6f0-18ee-4f28-bf22-1f5e4c873625">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTEtMS0xLTkyNDc5_c22b92eb-f90d-4d99-870b-f89ed1f498de">75,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTMtMS0xLTkyNDc5_5094faf8-ffca-4428-9770-0c701485eb71">40,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTUtMS0xLTkyNDc5_0d9ed037-753d-4978-9acf-c2e16fd5542d">14,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense) benefit related to items in other comprehensive gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTEtMS0xLTkyNDc5_298782ca-fb99-4f61-9ef3-b9b1d665115d">19,694</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTMtMS0xLTkyNDc5_ea7ceb3a-c0b7-4614-a27b-555ee2a16ad8">11,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTUtMS0xLTkyNDc5_e67fd63a-9e49-4088-963f-e9442b1ed185">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTEtMS0xLTkyNDc5_ba8767ad-4ec2-473e-a75e-1cb0c807694d">55,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTMtMS0xLTkyNDc5_5d8049a3-67f0-4014-bcdb-1e4dd66b2755">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTUtMS0xLTkyNDc5_805e5703-2226-4b4e-b7a4-c47d83b44a6c">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTEtMS0xLTkyNDc5_a3df2a48-2109-4822-9d94-07a390faceeb">235,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTMtMS0xLTkyNDc5_6337a57e-f73e-4852-9bc3-bae4a81302ee">197,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTUtMS0xLTkyNDc5_31fb1e74-3cb9-475d-ab50-6cb62294894b">136,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQtMS0xLTEtOTI0Nzk_92af4861-6e53-4c93-bca0-517bb841e14b">456,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQtMy0xLTEtOTI0Nzk_cb8b63c1-c493-45d5-b916-fcaf9a580c3f">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NjllMjRjYTkxZDM0NmJjODI4OTdkOTA3OTIwNGQwMV81Mg_c2fec946-00ab-4623-8321-859a65f4ef12">4,304</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NjllMjRjYTkxZDM0NmJjODI4OTdkOTA3OTIwNGQwMV81OQ_260d787c-4816-4698-a3ad-2c2096055ff8">4,735</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMS0xLTEtOTI0Nzk_804ae5ca-49e8-44fe-95c6-96d8537fcf9f">263,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMy0xLTEtOTI0Nzk_f220a192-e268-42f5-b212-da3f6a83f535">231,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzYtMS0xLTEtOTI0Nzk_0911ca07-d5ad-4147-bfa3-295a38fabd24">324,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzYtMy0xLTEtOTI0Nzk_591fb0c1-e3fb-4734-8713-93be887dfee8">317,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzctMS0xLTEtOTI0Nzk_db0be88b-f0c0-45cc-8174-de52013fa94e">116,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzctMy0xLTEtOTI0Nzk_0f32d903-f0b4-4047-8f41-f2541a2c6dd1">91,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzktMS0xLTEtOTI0Nzk_0690fd1c-06fa-45a1-8505-91d260db7347">1,161,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzktMy0xLTEtOTI0Nzk_4beeed82-267a-4820-b3f6-7bfa84ef741c">1,153,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEwLTEtMS0xLTkyNDc5_9a2a14a6-8d50-4cbc-80e6-5619c4646bc4">311,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEwLTMtMS0xLTkyNDc5_3ba4b8af-65af-49ec-ba62-40a23428d5e0">311,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzExLTEtMS0xLTkyNDc5_c2866a8b-c963-4bcc-b68a-48f6d84b9442">148,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzExLTMtMS0xLTkyNDc5_f4a08e21-b9aa-4582-bbcf-1bd13f69bace">84,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEyLTEtMS0xLTkyNDc5_caf0ab64-503c-4fe4-bedc-fbc62e424680">1,126,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEyLTMtMS0xLTkyNDc5_10cbb45f-626e-4a39-abff-b910c862bb39">1,145,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEzLTEtMS0xLTkyNDc5_beceaac3-cdc2-4b01-a9ea-7cff4ba4841d">1,038,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEzLTMtMS0xLTkyNDc5_90f2ccca-14cb-4bbf-90c9-5bc942664832">1,013,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE0LTEtMS0xLTkyNDc5_68001736-166c-482f-a028-34294bfb35fa">45,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE0LTMtMS0xLTkyNDc5_347f8468-21fa-428c-988b-8e83c86a40b5">56,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE1LTEtMS0xLTkyNDc5_564d8a3b-0cd2-4cb5-84c4-f6261a4d7c26">57,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE1LTMtMS0xLTkyNDc5_20db0cba-b898-4512-b077-4c9dde286b9a">16,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE2LTEtMS0xLTkyNDc5_66f5c00b-dd8d-47d3-8e54-7b7490eb8ff9">3,889,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE2LTMtMS0xLTkyNDc5_7c87fc48-2372-42af-80d5-e572432d9f22">3,782,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under senior credit facility</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE5LTEtMS0xLTkyNDc5_65d02900-2369-4518-95ca-4ed202422626">38,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE5LTMtMS0xLTkyNDc5_e227afb1-9296-4bf6-8f59-ace8f8216b88">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIxLTEtMS0xLTkyNDc5_018d56f9-a417-4790-a5c3-3806f9ff7c4e">14,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIxLTMtMS0xLTkyNDc5_69d9bb0e-cb51-4138-8e3b-e1d409370990">14,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, trade</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIyLTEtMS0xLTkyNDc5_22f3b8e0-53b4-4587-9925-2e14deb4d700">102,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIyLTMtMS0xLTkyNDc5_33b44cf9-e831-4c61-b92c-64c2578de70b">61,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIzLTEtMS0xLTkyNDc5_6f626f10-6a66-447f-904a-9eefc6cab2fd">7,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIzLTMtMS0xLTkyNDc5_0b844089-26ce-4e83-b421-b8a16798e2bd">5,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI0LTEtMS0xLTkyNDc5_bbf8e867-c258-4736-8ab0-e295139c10c6">78,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI0LTMtMS0xLTkyNDc5_517be890-80a7-4eb9-be9f-e3e1c8201bf5">92,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI1LTEtMS0xLTkyNDc5_3ef7ed2a-b98c-442d-93b0-3146cdb59db3">80,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI1LTMtMS0xLTkyNDc5_e2fd0776-3706-4943-8cb5-7ce1c81fcfff">120,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI3LTEtMS0xLTkyNDc5_882aaad5-d77d-45a2-bd72-9c8b61124547">320,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI3LTMtMS0xLTkyNDc5_2d8ee40f-642d-4cfc-98da-f574c682d6f3">340,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under senior credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI4LTEtMS0xLTkyNDc5_507991a5-3288-43b1-b5bf-64de50379215">733,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI4LTMtMS0xLTkyNDc5_670b42b7-36c1-40e4-bb27-57170499a90b">824,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under securitization facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI5LTEtMS0xLTkyNDc5_77e6e2a4-4e1e-4717-bf4d-f8d52bc9fbbe">104,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI5LTMtMS0xLTkyNDc5_9d347e89-3e86-4c7f-9e26-e20a7f449095">112,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMwLTEtMS0xLTkyNDc5_2b8df40e-880e-4076-9044-1de99eb74cfe">567,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMwLTMtMS0xLTkyNDc5_04658f10-1242-44aa-80ab-2fc411abbbb1">564,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMxLTEtMS0xLTkyNDc5_27119cfe-1e54-4cbf-b2fd-7ddbaf70aaa7">157,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMxLTMtMS0xLTkyNDc5_fd186387-4198-4d3b-92e4-93ea919bc936">90,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMyLTEtMS0xLTkyNDc5_926dae8b-4845-4c3c-9a5e-cb958e40a66e">63,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMyLTMtMS0xLTkyNDc5_d25a3d2e-acf6-43b7-a3ee-19350c203075">45,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMzLTEtMS0xLTkyNDc5_7c80c4a3-a841-49cc-9d62-7883def82df1">138,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMzLTMtMS0xLTkyNDc5_4aefc469-e7fb-41b5-a4d1-8edeef416615">120,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM0LTEtMS0xLTkyNDc5_25c7041f-4fe5-4765-a321-06e61a8dabc1">2,085,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM0LTMtMS0xLTkyNDc5_96eb97f7-4003-4469-8c12-1774a860c126">2,097,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred Stock; <ix:nonFraction unitRef="usdPerShare" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:PreferredStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMjE_3c1ba92c-b179-4c0c-bc68-5cc8bb0e3ad1"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="INF" name="us-gaap:PreferredStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMjE_6a401d0b-ca91-495a-b949-edfb78d1ba5d">no</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMzU_121cdadd-9e55-4e51-a44c-f8efba777397"><ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMzU_5a062d88-9c01-4aca-b3cf-ac6b466fb7c9">15,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfNTc_25798ca3-e3f3-47cc-8730-955e9139ad34"><ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfNTc_b4d86bc9-c60c-4222-aff2-16dcbfe4ae6f">none</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTEtMS0xLTkyNDc5_d393f10e-ca9c-4f03-87be-989306819a54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTMtMS0xLTkyNDc5_1d3e9a72-b6fb-4eb4-903d-93af4f5ba437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMTg_5683ae67-9067-4451-be11-edadc258fd05"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMTg_9a281f58-0b4c-481f-8b72-3c3034eb5a77">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMzI_12554b1a-1d32-4d8e-9815-ab45bff13625"><ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMzI_81fe195a-fd62-405c-88a2-f1e46d1a7bbd">240,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfNTQ_0fd91db0-ada0-450d-b2df-1bf60c23cf16">90,477</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfNjE_ef495407-aea5-40b6-ac68-366da451cdfb">89,600</ix:nonFraction> issued at December&#160;31, 2022  and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTEtMS0xLTkyNDc5_bd2ba2f5-45ac-484f-92b6-70da8772c0a1">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTMtMS0xLTkyNDc5_93a16abb-6318-4d9f-be67-27c715755b00">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM4LTEtMS0xLTkyNDc5_b75a86fd-8ce5-4841-adfe-16a7d2dad89f">1,276,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM4LTMtMS0xLTkyNDc5_1341e279-7d1a-4c56-aa5f-710cf47cfac6">1,264,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjQ2OGQ5YzgwYjY4NGVmMDllNmY1NmFlNGNjOTA3NjBfMjk_713f763b-3007-406a-bacb-1ea7a0e5b943">6,823</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjQ2OGQ5YzgwYjY4NGVmMDllNmY1NmFlNGNjOTA3NjBfMzY_0525c308-011e-49ea-81a1-7bc1d4f94367">4,899</ix:nonFraction> shares at December&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTEtMS0xLTkyNDc5_0bd0e866-0af6-471a-a4f6-fc0367be7a71">362,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTMtMS0xLTkyNDc5_97a1638f-fe58-427a-99c0-49af399516c0">234,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQwLTEtMS0xLTkyNDc5_54bfbbc3-a9e2-4040-b69e-a20d71d32b54">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQwLTMtMS0xLTkyNDc5_9d9ed586-eba0-4099-895a-ba4dcb6ca9f1">45,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQxLTEtMS0xLTkyNDc5_886adb3e-a00e-4601-bcc9-ccef393024a3">879,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQxLTMtMS0xLTkyNDc5_4b0cd4eb-130f-4f33-beb2-2b2fd083a90b">698,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQyLTEtMS0xLTkyNDc5_627d1582-a876-4c54-abd9-60357a0237dc">1,804,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQyLTMtMS0xLTkyNDc5_884204c0-b042-493c-8d71-a10307fc2f6a">1,684,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQzLTEtMS0xLTkyNDc5_f3fa093a-ece7-4482-aeff-82b93ab8348c">3,889,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQzLTMtMS0xLTkyNDc5_6f83dd08-9800-442d-9b45-0bb30ce3b8e8">3,782,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_133"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtMS0xLTEtOTI0Nzk_a6ace266-98c5-477a-88fb-33eee314f2f2">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtMy0xLTEtOTI0Nzk_9b1dd40b-5418-48b4-a4b6-4cecd7c47e48">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtNS0xLTEtOTI0Nzk_c2ad988e-ef0b-403f-93f6-5c25a7c1ff37">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtMS0xLTEtOTI0Nzk_47358d5c-75a8-4f65-b5a3-e4b3dee1975f">118,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtMy0xLTEtOTI0Nzk_7ed2140a-8d35-4afc-a1de-ec33a04760eb">119,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtNS0xLTEtOTI0Nzk_3644886a-00b9-42fe-a08b-a06653811a2b">116,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash in-process research and development expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtMS0xLTEtOTI0Nzk_f44895ed-0732-458f-b2b2-d75aaae61fe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtMy0xLTEtOTI0Nzk_9239445e-3199-412c-ada9-1b88a9d241fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:NoncashOrPartNoncashInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtNS0xLTEtOTI0Nzk_69c8ab6a-fb79-4dba-b732-fa086987ec43">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctMS0xLTEtOTI0Nzk_fad1130f-e1ad-41cd-8d26-ea788059268d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctMy0xLTEtOTI0Nzk_98623e48-c841-43b1-8f94-0d3f2b1c9865">2,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctNS0xLTEtOTI0Nzk_0f0d5fe3-bdfb-40d0-949e-1c6abe534efe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtMS0xLTEtOTI0Nzk_3cdab8cc-a312-4211-a899-1cfdbfd2cff2">4,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtMy0xLTEtOTI0Nzk_0924c50a-d487-492e-b1ec-0e729499453a">2,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtNS0xLTEtOTI0Nzk_bbda10b9-2311-43a3-9a48-36ba685074fb">64,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktMS0xLTEtOTI0Nzk_48b53522-56a4-4524-871e-827bd299df5a">27,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktMy0xLTEtOTI0Nzk_8e90cc09-9e10-47c5-a3f2-c2e39caa6641">36,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktNS0xLTEtOTI0Nzk_cd54839b-44ec-43af-bd7f-2df3c14f8857">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and expenses associated with debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTEtMS0xLTkyNDc5_7807e9cc-235d-4e09-8746-1562d4259b9e">6,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTMtMS0xLTkyNDc5_3c4cee30-ae55-48d2-aebd-dd5f2ca457bd">7,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTUtMS0xLTkyNDc5_c7e51da9-6afe-460b-b53a-720ec80a1d44">12,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTEtMS0xLTkyNDc5_822adb00-b37a-40c8-99d3-e2cd174635ee">2,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTMtMS0xLTkyNDc5_114e7f28-2ff6-411e-b57b-58fd16b71076">3,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTUtMS0xLTkyNDc5_c8ac2141-dc66-4bcd-bece-47ba20067775">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accretion of bond issuance discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTEtMS0xLTkyNDc5_c9f4ff13-7dd4-4942-a770-5842058dfd2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTMtMS0xLTkyNDc5_a18ddb59-d2f7-4b56-bca2-abae1928031c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AccretionExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTUtMS0xLTkyNDc5_79e8aec8-78ec-4685-9a30-a8d53162bf07">15,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (Gain) on disposal of property and equipment and construction in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTEtMS0xLTkyNDc5_3932279a-e06b-46b4-90c6-5e664dfcc293">6,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTMtMS0xLTkyNDc5_d5b2a44f-b1cf-48cd-969f-fb02527ad3b7">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTUtMS0xLTkyNDc5_b2db279e-907d-4461-9166-c394e18540ab">7,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from the sale of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTEtMS0xLTkyNDc5_223e1e05-b669-427a-bf61-fc35f746cc42">644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTMtMS0xLTkyNDc5_a95a85ed-4ff1-4ec1-92a4-40bf4dab8e98">41,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTUtMS0xLTkyNDc5_fa4a33c7-a7a3-4181-b062-c4632b6038dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration and others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTEtMS0xLTkyNDc5_8d721a52-d29d-4923-a55b-4d796d959de2">20,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTMtMS0xLTkyNDc5_e18c2ed5-259b-450e-9412-08a96658de53">2,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTUtMS0xLTkyNDc5_5d5690e5-87ef-45e6-940c-e09fd6bdfb5c">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTEtMS0xLTkyNDc5_56bd206e-e4c5-4ce7-ab8b-4902aa1ad7cc">33,905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTMtMS0xLTkyNDc5_1bce51f3-44d7-41bc-baf7-954465ff475c">7,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTUtMS0xLTkyNDc5_fed3f875-9622-413d-89c3-a7ec94519d67">52,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTEtMS0xLTkyNDc5_6d55e907-5c03-4780-81de-5de3b281bb8d">29,124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTMtMS0xLTkyNDc5_5cfa324e-2a67-4e45-8647-8d5c8e11c9e0">5,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTUtMS0xLTkyNDc5_fc77ca5f-e259-4a0f-ba47-e96cd26ec81b">48,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTEtMS0xLTkyNDc5_4466ecb0-f259-46fe-b1ee-44871043d80a">8,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTMtMS0xLTkyNDc5_7735a8ff-a948-4795-8845-794aeed0c216">21,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTUtMS0xLTkyNDc5_05ff2479-de89-40a5-99fc-68be5df6f7bd">1,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTEtMS0xLTkyNDc5_b184190c-6806-4b6e-98df-48fbd1059d0a">2,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTMtMS0xLTkyNDc5_95c4b840-03c8-4f1f-ad60-0c08eb26aaf9">7,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTUtMS0xLTkyNDc5_1fb245ce-90a5-428b-8a1e-0868d1a8b865">13,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTEtMS0xLTkyNDc5_d5511ccc-f638-4464-8ac4-e740bfb7c064">17,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTMtMS0xLTkyNDc5_17500394-1366-44a9-889b-506a12f02143">32,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTUtMS0xLTkyNDc5_f755700f-b7cf-4e3f-b820-90e86dc06bfc">57,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTEtMS0xLTkyNDc5_4f1da3ed-94b4-4998-acbd-9f1e0e1ffe71">4,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTMtMS0xLTkyNDc5_00b3861e-b66a-4be6-a836-8baf630eaa65">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTUtMS0xLTkyNDc5_d177b897-b562-474a-89a5-549ec5bafc90">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTEtMS0xLTkyNDc5_c2335141-7590-4719-867a-2162f46f11cf">4,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTMtMS0xLTkyNDc5_b85d6f4a-4ef9-40ae-9d17-edeb9b77e70b">14,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTUtMS0xLTkyNDc5_56111292-a86c-4023-be7f-04f7670a1ecd">2,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTEtMS0xLTkyNDc5_266a9650-e499-4053-ab03-1644bcd3ebb1">264,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTMtMS0xLTkyNDc5_1d382c88-53ba-4de2-a231-ac82eddddd6b">312,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTUtMS0xLTkyNDc5_f2859748-08c2-4005-bd66-3b907b6140f0">203,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTEtMS0xLTkyNDc5_a5f85933-efa7-4a9c-ab0d-67a3fb4e0cf8">42,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTMtMS0xLTkyNDc5_53fef5ec-5b5b-4d8c-ad7b-6507b5076590">48,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTUtMS0xLTkyNDc5_99ba3823-8690-44cf-9c5e-d68787d18df4">38,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTEtMS0xLTkyNDc5_62a0ae28-b058-4d67-bcf2-f4327cebddf8">23,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTMtMS0xLTkyNDc5_fc5341ce-8a3b-4d26-83ae-7f9856cc1cc6">190,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTUtMS0xLTkyNDc5_55e38788-ccf3-4327-988d-bac5b6b2634c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in-process research and development and intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTEtMS0xLTkyNDc5_28cb1eb8-5d90-4b38-a28c-17ce14b5f53b">4,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTMtMS0xLTkyNDc5_e630f8bf-c103-4ed2-bf7e-f57e41baa62f">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTUtMS0xLTkyNDc5_9aea31fd-49af-47cc-bf5c-a50297e94dac">25,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTEtMS0xLTkyNDc5_1200ed96-64bd-48a4-90f5-042c1c0def6d">51,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTMtMS0xLTkyNDc5_45bf03ea-318c-4a2a-a2ca-15039da61bbb">303,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:PaymentsForProceedsFromBusinessAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTUtMS0xLTkyNDc5_8682db26-68f8-4109-b818-3a0b169cb2be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTEtMS0xLTkyNDc5_cbab66e5-deb8-4600-9a16-caacd4c95ed1">11,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTMtMS0xLTkyNDc5_c1fc3c2e-5617-4548-8251-22cab28fdd30">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTUtMS0xLTkyNDc5_09cad7be-93e9-4c5d-83a7-68aaca7abd6d">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds (payments) on swaps designated as net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTEtMS0xLTkyNDc5_0042b885-0ec9-425e-8c51-f76f2d2fcc2e">4,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTMtMS0xLTkyNDc5_6206bd4e-af84-496e-9970-d5220b8690f0">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTUtMS0xLTkyNDc5_1c612563-7902-4f00-8d97-cd562f33ad8c">7,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTEtMS0xLTkyNDc5_69d76f67-6ca3-4aa3-b889-9d73bf28fa8f">58,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTMtMS0xLTkyNDc5_c88b14d9-d084-4e7f-8670-129b6e8e7393">161,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTUtMS0xLTkyNDc5_92c4fb64-f894-4d96-aaba-1638f8eccf05">68,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings of long-term indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTEtMS0xLTkyNDc5_abffd2a7-149d-4ce8-9b51-3020cb3c79a9">40,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTMtMS0xLTkyNDc5_7261eeec-21e5-4efe-bcdd-12d2ea694dce">25,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTUtMS0xLTkyNDc5_b4fa7ef3-9f45-4fc6-9367-b8e348dcca51">171,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTEtMS0xLTkyNDc5_b25bf211-83fa-4c87-af77-e9dfa97792f0">148,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTMtMS0xLTkyNDc5_efae3edc-b1a4-4ca2-ae0f-0bedc25fd110">125,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTUtMS0xLTkyNDc5_c0d88130-0214-4ccb-b9ae-a4ccf3503cd1">441,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of option hedge on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTEtMS0xLTkyNDc5_7169043f-557d-4813-94c5-c579d927eb2a"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTEtMS0xLTkyNDc5_df146ec6-ca9a-4a5e-b6f9-7e3b679320b3">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTMtMS0xLTkyNDc5_90e9a305-0763-43b0-bbc0-23494aee5cbc"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTMtMS0xLTkyNDc5_9e7f5b22-fc53-4551-a399-96e1888eb962">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTUtMS0xLTkyNDc5_7c3854ad-b8f3-4d99-877c-7682de4ac721"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTUtMS0xLTkyNDc5_cdf95303-dddd-4c83-8057-b70dcab5fb43">104,248</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from convertible notes issuance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTEtMS0xLTkyNDc5_13c04d87-5c19-4f28-b369-c94a2122db58"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTEtMS0xLTkyNDc5_e89a3933-eb58-4e60-9cca-f036cb16b969">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTMtMS0xLTkyNDc5_29f5cc74-ecae-4a82-901f-c963644ae343"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTMtMS0xLTkyNDc5_8ecdea5d-0199-4138-80d3-c26a25b8550a">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTUtMS0xLTkyNDc5_4a768b6b-041c-4dbb-bab2-2f29e94548cc"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTUtMS0xLTkyNDc5_a421ac8f-9a16-42fb-af60-a5b8c504a2fd">575,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of stock purchase warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTEtMS0xLTkyNDc5_2ea33bda-59aa-4748-b668-64b398ea3474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTMtMS0xLTkyNDc5_96ba679b-f0d8-47f5-8b13-dd3edd02f51d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTUtMS0xLTkyNDc5_f456823c-7576-4ecc-8fb8-d86d0b377cdd">44,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTEtMS0xLTkyNDc5_b39fb58f-c29f-4100-b6fc-b237343d58f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTMtMS0xLTkyNDc5_1828653a-4741-4af1-b560-daffc8601e03">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTUtMS0xLTkyNDc5_0f40276c-2e39-4810-99ee-8f85ed457f33">24,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTEtMS0xLTkyNDc5_72fce25a-c10f-43c5-ad37-59b9a08904c3">125,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTMtMS0xLTkyNDc5_6a92ff4f-8f8b-4081-9b10-cc2af8e448c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTUtMS0xLTkyNDc5_3aa3cb56-90de-4902-88d1-499df80eb782">100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercised stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTEtMS0xLTkyNDc5_d8b1464b-7da6-4838-88ef-2f28a01eeddc">5,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTMtMS0xLTkyNDc5_f1fc0bf1-8042-4fbf-9987-d0d57743895c">6,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTUtMS0xLTkyNDc5_a0c4d1b0-a5dc-4dc2-b133-461588e8b340">5,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash taxes paid in net equity settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTEtMS0xLTkyNDc5_8bb18a66-da48-4284-87e7-997982918951">24,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTMtMS0xLTkyNDc5_c73b27d6-6c82-42e3-b674-f9d9b0aedea7">4,801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTUtMS0xLTkyNDc5_c36f19bd-e27c-40c8-bd62-2e052f28ea2a">5,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTEtMS0xLTkyNDc5_2e3bb28b-689e-40d4-905d-ab46866ebea5">251,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTMtMS0xLTkyNDc5_a5224373-fdce-4307-bb01-6ce50702cff5">98,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTUtMS0xLTkyNDc5_27832dbb-2690-4e7b-9acd-7fd14c38a906">121,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTEtMS0xLTkyNDc5_6073674d-0c77-4088-a626-6847f22fa568">10,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTMtMS0xLTkyNDc5_056592f7-8cab-4719-850f-8f47a358f09c">9,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTUtMS0xLTkyNDc5_93e391a2-6f09-4ec6-bad3-240c13bacb92">13,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTEtMS0xLTkyNDc5_9bed1ccf-6061-4acc-b932-73a74a570e8c">56,787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTMtMS0xLTkyNDc5_524cd568-7436-4699-ae74-659785926fa7">43,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTUtMS0xLTkyNDc5_823961cb-90bd-4e15-8197-0dca8fe0d731">271,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTEtMS0xLTkyNDc5_54ca2d14-4bea-495d-9046-4b20be021ffd">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTMtMS0xLTkyNDc5_46bf1276-0dcd-410f-a841-5d47c04efb80">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTUtMS0xLTkyNDc5_90b2c55f-d803-41af-915e-083eed834aba">198,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTEtMS0xLTkyNDc5_56b96c4a-b1cb-40d1-add4-db8c136ab309">456,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTMtMS0xLTkyNDc5_e376bd27-012e-4d2a-9c48-5f77c5f6db54">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTUtMS0xLTkyNDc5_0f907fa6-78e5-4c0e-88d5-191cccf6592b">470,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:29.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.552%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb43d094e8824032961a8ec85d76affb_I20191231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMS0xLTEtOTI0Nzk_abcb8321-446d-4cc8-9ec7-eef619da867d">88,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb43d094e8824032961a8ec85d76affb_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMy0xLTEtOTI0Nzk_193b019e-a925-40df-a0de-452d6c485e60">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i55ce9af062df477e959977ef29770b62_I20191231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtNS0xLTEtOTI0Nzk_9d2eb32b-878c-4bf4-86cb-eb601cf375b3">2,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55ce9af062df477e959977ef29770b62_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtNy0xLTEtOTI0Nzk_e78b8f53-0e92-4aa6-9b9a-080aaecf956b">119,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d722c9ae87d4ebf9e2f34d8f1a61b79_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtOS0xLTEtOTI0Nzk_6a212bcf-064f-47e0-ae2d-3dec0ed3355b">1,213,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia304241c7950452cbb025f7ee427babc_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTEtMS0xLTkyNDc5_8658cabd-6f6e-4dc6-abaa-160a5e6380e9">76,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059e8d7474364db9884d18f168a39eb5_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTMtMS0xLTkyNDc5_e479d7cf-6469-4990-a860-96e0fe62745c">398,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTUtMS0xLTkyNDc5_a4eb48a4-5a14-474d-8f83-d10542b483df">1,416,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4d9ca5a4da49c0a179fc3d4ace01d0_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzktMTMtMS0xLTkyNDc5_ea9af635-0def-4f07-843c-8cab22ad6a5b">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzktMTUtMS0xLTkyNDc5_d72ace63-4688-45e5-b1ed-ba66b5771b28">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19c3c07994f4ba2b78daf3355acf271_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEwLTExLTEtMS05MjQ3OQ_5bb06a3a-0927-491a-81c3-8eabf3cfde72">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEwLTE1LTEtMS05MjQ3OQ_9e5557a1-c6c2-402d-9892-87acf0372f63">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTEtMS0xLTkyNDc5_959a2b9f-7a80-4189-93f8-c1056de2b675">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTktMS0xLTkyNDc5_6830be54-f0b2-4260-858f-be34dba0b2a5">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTE1LTEtMS05MjQ3OQ_9f39329a-5aba-48fa-947c-0b35b80da147">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTEtMS0xLTkyNDc5_a3ac3dcf-67d7-4748-a0a4-d20293c4a881">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTMtMS0xLTkyNDc5_37a38b2e-0788-4c00-82f8-15213665b232">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTUtMS0xLTkyNDc5_5f6d1dfb-68b0-4ab7-9d3b-fa3591c4ccfd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTctMS0xLTkyNDc5_0fa8ded8-3908-4213-b326-412056236028">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTktMS0xLTkyNDc5_66480048-f939-48e3-8c0c-3384cff10359">1,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTE1LTEtMS05MjQ3OQ_477a7418-a6e3-415c-98d8-b91edbc2c263">538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTMtMS0xLTkyNDc5_e4c2046a-2e9e-45de-a729-ee9f9ff2254e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTktMS0xLTkyNDc5_8a4d313d-bba7-40a5-b954-99888a1433ae">19,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTE1LTEtMS05MjQ3OQ_79f4d96f-b99e-4a6f-b35f-5144ef2c699b">19,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase and equity component of the convertible note issuance, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE0LTktMS0xLTkyNDc5_8b948632-0107-4039-9459-300032760ba4">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE0LTE1LTEtMS05MjQ3OQ_6f506e12-f408-414f-83b7-7ceb1afffdb4">42,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTUtMS0xLTkyNDc5_06bb6616-0b2f-4cdb-9b03-f1007aa4c116">2,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTctMS0xLTkyNDc5_0a55983f-1887-44e5-82d1-245d41148484">115,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTktMS0xLTkyNDc5_37beb2cf-6f2a-48cb-a84c-6f2882f5a844">15,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTE1LTEtMS05MjQ3OQ_e554708c-aac4-4a31-aa87-cf012ed48165">100,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTAtMS0xLTkyNDc5_fd33942e-365d-48e5-a960-5082c1a3fb96">Adoption of Update No. 2016-13</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47471b2931934e4b9698fc87efb42f3a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTEzLTEtMS05MjQ3OQ_164ea807-e6e5-493f-a5ac-ecbcffad3437">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8d4c24857e248099e323a764be5a960_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTE1LTEtMS05MjQ3OQ_48f225a1-cb2e-445d-99df-0ec1487381af">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icacf91222c56450a94535b8158c1f9fe_I20201231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTEtMS0xLTkyNDc5_9ac18ffc-23fa-4af1-941f-048429a48fc9">89,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacf91222c56450a94535b8158c1f9fe_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTMtMS0xLTkyNDc5_e65835bb-6d3f-42bc-a0f9-8b8543bbadf3">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4a7ad2dd7fe145e9a775191f346885f2_I20201231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTUtMS0xLTkyNDc5_e1140ea7-b3b3-44a4-bdd9-f99d3945da98">4,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a7ad2dd7fe145e9a775191f346885f2_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTctMS0xLTkyNDc5_479a0d63-193e-4b46-a209-812c516a86b0">235,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e2e1c7c56e4e6f96b757b450e3d8a2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTktMS0xLTkyNDc5_03eace2f-1f9b-4688-a250-7cd50aeb406e">1,290,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7005821211dc4a61bc033d8dc246f9e9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTExLTEtMS05MjQ3OQ_989e7b53-524a-4b15-b001-2052858de82c">74,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d58570b6055411d8462693d39b49056_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTEzLTEtMS05MjQ3OQ_8c3f145d-725d-4aad-aae4-2f3c9212d4e6">532,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTE1LTEtMS05MjQ3OQ_a0a64987-4a08-4b96-9d47-1afe0e2ad804">1,514,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie068465acf624179b0d91e83e4d97156_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE4LTEzLTEtMS05MjQ3OQ_0f374ca9-3e27-480d-ad5a-28453405fc1d">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE4LTE1LTEtMS05MjQ3OQ_beb7ffcf-eb53-4389-9295-e16a133d5087">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51546d1efdb4b37baab40ff76fdddc7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE5LTExLTEtMS05MjQ3OQ_51a7a4b5-a839-458d-925e-bbc8bc48e9a5">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE5LTE1LTEtMS05MjQ3OQ_2aa5d52d-0ac4-455a-8eb1-63e2add41473">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTEtMS0xLTkyNDc5_8a6798af-6c79-47f1-80c9-3bc3723c8e97">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTktMS0xLTkyNDc5_e4fd36ca-5389-4714-bd35-ebfb7c6faea4">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTE1LTEtMS05MjQ3OQ_bfba02ea-efeb-432c-a38b-4b000b7ca0b1">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTkyNDc5_844c7dbc-725d-4413-beab-b1fab161760f">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTMtMS0xLTkyNDc5_1dbe7818-1ff2-4a0c-8538-c41017500867">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTUtMS0xLTkyNDc5_f336f367-7c41-4491-843b-6560c53a5c75">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTctMS0xLTkyNDc5_1516ed93-b8db-4fc4-b302-4127fa1cc8bd">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTkyNDc5_955ee27e-0d65-4d71-85e9-341af682cc27">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTE1LTEtMS05MjQ3OQ_df87f461-76af-4777-9053-d6a43edfbe6b">895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTMtMS0xLTkyNDc5_553e94df-60c6-449a-9209-461c1ed8a57c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTktMS0xLTkyNDc5_9a1e1df0-24a0-4de0-b762-94d0ee4a49e7">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTE1LTEtMS05MjQ3OQ_dd779b98-ae4b-4ad4-85bf-612630ed07ad">35,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTAtMS0xLTkyNDc5_880a3f30-49ba-438a-9220-7840c10c5bc7">Adoption of Update No. 2020-06</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i076755c4427e4d259078e6b2d89e580a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTktMS0xLTkyNDc5_6fe0ae4e-f1c8-4dd5-a9ce-aa5e235573d5">63,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03d921a6dbf4c6ab60982b0658b2bc7_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEzLTEtMS05MjQ3OQ_4f4efaef-3dc1-4984-9cf6-7d72bfd0e901">2,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i923e26b254024ce191a077d3ad910d88_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS05MjQ3OQ_a45376f1-72c4-40d1-ba7b-f972b4079196">66,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac1f6a25383842738c3f81f79c901726_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTEtMS0xLTkyNDc5_915b4dd4-7e01-41dd-a4e7-2bcc1474371a">89,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f6a25383842738c3f81f79c901726_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTMtMS0xLTkyNDc5_dc251049-fc9a-4214-80ec-f33aa80b0b3d">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i92f2148b01b24348b1bcaceec81f6c73_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTUtMS0xLTkyNDc5_a9c0987b-75d8-4abf-8cb0-d13935ffb067">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92f2148b01b24348b1bcaceec81f6c73_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTctMS0xLTkyNDc5_e396a42d-b9a9-4b48-9453-e692a80ceaff">234,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00df800819924b1db728d5624c35f949_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTktMS0xLTkyNDc5_78828a21-5a44-4924-b3a4-96fb703cfdf5">1,264,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTExLTEtMS05MjQ3OQ_35fba343-8a66-4922-a26e-7788c432ea0a">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f29af258c2049d09523a55767d03678_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTEzLTEtMS05MjQ3OQ_a82cb734-12dd-49f2-a9bc-1ba37a006dfe">698,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTE1LTEtMS05MjQ3OQ_ac57926f-755f-4162-8232-51f3e69cad12">1,684,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff7c2d092db46b2bab82d2bfbb65a49_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIwLTEzLTEtMS0xNDcxNTY_7611f95a-40b2-4136-94cc-847cb38f8aeb">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIwLTE1LTEtMS0xNTIyMTE_31adb377-9eaf-45f2-93b9-c03038c4fb03">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77173b4d8e484fb39e318247f8305f57_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTExLTEtMS0xNDcxNTY_92dd5fef-b58b-4b57-a4d2-673a3abbe5e9">55,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTE1LTEtMS0xNTIyMDg_f88f1a70-fb63-4ed2-a88f-ae36ac9423ad">55,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTE1MDU0OA_809e2216-310d-41ca-befe-829a12fa7ca0">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTE1MDU0OA_ab198af5-8542-4094-a546-2a102050c59e">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTE1LTEtMS0xNTIyMDU_7026bbe9-1dc0-4e47-b653-1f181477dbd4">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTE0NzE1Ng_25e5cd83-ccfe-4189-9092-525a3b88edb7">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTMtMS0xLTE0NzE1Ng_bb68fa88-2b40-4bbb-8e5c-67e25a49d1f8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTUtMS0xLTE0NzE1Ng_1354e470-c711-49b9-b3b0-84e51399f8f7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTctMS0xLTE0NzE1Ng_e1a72de6-90c0-411f-8302-4ec4426594f1">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTE0NzE1Ng_f3e1d61e-7fc3-4b0f-90a9-250c3760c9ae">20,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTE1LTEtMS0xNTIyMDE_99fff552-2cd3-491a-bc52-1ad90350486a">20,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTMtMS0xLTE0NzE1Ng_e4607535-e8f7-44fd-b8b8-256952366c9f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTktMS0xLTE0NzE1Ng_2860b435-aff6-4c3f-acd0-6744319eb0e8">27,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS0xNTIxOTc_2289579d-6eaf-4784-a134-12e04bdf9924">27,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTUtMS0xLTE1MDU5NA_915f82cd-5034-49cf-be34-13ff59eabcbd">1,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTctMS0xLTE1MDU5NA_72baad1b-4d28-47fb-b4d3-183adbe18a97">129,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTktMS0xLTE1MDU5NA_c0eb35cf-a5d9-4408-8e77-6c03f1f3527c">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTE1LTEtMS0xNTIxOTM_89cbc9ff-711b-4cbe-8aba-15f8f5f96d2c">125,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38626384e0824b86a26dc5567021967f_I20221231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEtMS0xLTE0ODc1Mg_729948eb-9268-46b7-97fe-aa6d4dad731e">90,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38626384e0824b86a26dc5567021967f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTMtMS0xLTE0ODc1Mg_3ad5238a-8de3-4d94-88bd-3c0afd86ec5b">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaacd778bd0c149d084dfccd55a63c987_I20221231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTUtMS0xLTE0ODc1Mg_323b6920-786d-4427-a2f6-20f23c1d5781">6,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaacd778bd0c149d084dfccd55a63c987_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTctMS0xLTE0ODc1Mg_a6975d2b-a7f9-4ab3-942d-47a802c2abbf">362,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieded6749710f48979f351fb7d3fa9e12_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTktMS0xLTE0ODc1Mg_75d1ac8a-0ae6-4b88-a481-b1a1af0c5f7c">1,276,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTExLTEtMS0xNDg3NTI_9c22084b-73c4-4943-b5fd-08b9c4f863bb">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb931d5ad83741a294637a95707f41cd_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEzLTEtMS0xNDg3NTI_fe520ee8-0f32-44f2-a3bc-d0a4c3929090">879,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS0xNDg3NTI_ec9d4662-e4de-45e7-a950-4279c8fcf849">1,804,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_145"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDUvZnJhZzo2NjJmNjU5ODU3N2Q0ZGQ2OGUzMWI0MTU3ODMzZDNlOS90ZXh0cmVnaW9uOjY2MmY2NTk4NTc3ZDRkZDY4ZTMxYjQxNTc4MzNkM2U5XzkwNA_067191ce-ad10-4114-8409-29b8221a1442" continuedAt="i11a9443de15f48c6bb1de888b10f920b" escape="true">BUSINESS</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i11a9443de15f48c6bb1de888b10f920b">Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</ix:continuation></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_148"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTI1_695bca3d-1a22-440b-a6af-00ffda177656" continuedAt="i2c5141f98f8c48f9a70621f5147354d4" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i2c5141f98f8c48f9a70621f5147354d4" continuedAt="i3d82b0acacae4b408b1d6c07efe75f45"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQ0_d7b46140-72ff-4fdd-8220-9c05803e8d1a" continuedAt="id9a433b7cdec408fa5de7f9bb4121f5d" escape="true">BASIS OF PRESENTATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id9a433b7cdec408fa5de7f9bb4121f5d">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</ix:continuation> </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQ2_a88935f3-444c-4e14-a011-b2a018a1b675" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTg1_522930d4-1679-41d9-a99a-004bcc669079" continuedAt="i560889a0e34f434b936b571335b29cd6" escape="true">USE OF ESTIMATES </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i560889a0e34f434b936b571335b29cd6" continuedAt="if42ccb28bffd424d8cca1c64ec3900cd">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if42ccb28bffd424d8cca1c64ec3900cd">on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</ix:continuation> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2Mjcw_6731be7a-c16d-4181-a8f0-c0a3de4e619b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjUy_1e0d6e47-f677-4f20-bade-0e6e512d9f0f" continuedAt="idb33709dbc1c4b07b7a32b30c77a5090" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i3d82b0acacae4b408b1d6c07efe75f45" continuedAt="i519a942c6d6a4044a1c8f05952808f33"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="idb33709dbc1c4b07b7a32b30c77a5090" continuedAt="ic3280b5e275344a0a902935d6d52f197"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3280b5e275344a0a902935d6d52f197">Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</ix:continuation> Provision for doubtful accounts, net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was charges of $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2Mzg_9ffbba21-068a-4d1e-9c71-202ec8e91841">0.2</ix:nonFraction> million for the year ended December&#160;31, 2022, recoveries of $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2Nzk_1ff85307-ea01-4afb-b8e0-8a207ee98247">1.1</ix:nonFraction> million, and charges of $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2ODc_0efea636-68bb-4634-89d1-115e30b268af">3.6</ix:nonFraction> million for the years ended December 31, 2021 and 2020, respectively. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1NjYzMzM_5b4c89a2-cbed-468d-bb35-49a2693fe161" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table shows the rollforward of the allowance for doubtful accounts for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtMS0xLTEtMTQ2MDcw_19ca4985-0214-405d-b786-07cedd5a746f">4,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtMy0xLTEtMTQ2MDcw_95bd2b02-134d-48b8-9e63-a8b82f761e1b">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtNS0xLTEtMTQ2MDcw_369f281b-cddf-4770-a1f4-290978c50174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtNy0xLTEtMTQ2MDcw_0087eda7-68fc-40a8-bb15-4f5bbda67495">669</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaecd31c89f44a49d37ff888379adec_I20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtOS0xLTEtMTQ2MDcw_ba757005-a964-4b1c-b468-28c88bd78703">4,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtMS0xLTEtMTQ2MDY1_d5e94576-dcb3-473b-992e-29e7cfa1588b">6,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtMy0xLTEtMTQ4NzYy_411195cc-7306-4260-8148-ee56ac7b0ed0">1,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtNS0xLTEtMTQ4NzY0_5bb7f7a0-76fc-4f7c-8120-c9534ee9eafc">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtNy0xLTEtMTQ4NzY2_061271f3-bc5d-4391-bba3-be9904dfee40">986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtOS0xLTEtMTQ4NzY4_07146c55-346d-421b-85ee-5d579fea6626">4,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe44e0a022f4f34bf03594794a50963_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtMS0xLTEtMTQ2MDQ1_b0692bec-6b4b-41da-886b-dde3dcd339a5">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtMy0xLTEtMTQ2MDUx_665f6925-cbc1-425f-9b56-402ea90d409f">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtNS0xLTEtMTQ2MDUx_e15b5b04-ec82-4d22-a067-f9efbc87cee3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtNy0xLTEtMTQ2MDUx_de3c74db-71bb-4bac-bc34-18d694aeff17">1,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtOS0xLTEtMTQ4NzY4_eaeea022-25b2-4b54-9008-a7ba06ae01da">6,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDkw_ee14a9f7-cede-4482-bc5f-b0afb77ac871" continuedAt="i683a3a94e9e14c1a88726f3089470e3d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTQ0_d16ec56a-5577-4795-8539-4b93f4b4c4ea" continuedAt="ia333b730bf1443d5acb85b1797b59a62" escape="true">Inventories consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:continuation id="ia333b730bf1443d5acb85b1797b59a62"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzItMS0xLTEtOTI0Nzk_6d56e0ba-0cd9-45bb-a091-f7a3c5101f2d">172,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzItMy0xLTEtOTI0Nzk_49d6f385-8495-4fac-8079-14b26a92d158">162,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzMtMS0xLTEtOTI0Nzk_b2389f43-242e-46de-9331-92083765e18a">70,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzMtMy0xLTEtOTI0Nzk_2dfd4ca5-f266-4122-92e9-44bd9c77418c">65,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzQtMS0xLTEtOTI0Nzk_6547ce71-c8e9-4c52-9426-6ba1f02ee8a7">81,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzQtMy0xLTEtOTI0Nzk_ea84d933-334b-49ac-90bf-18624756a4f2">89,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzUtMS0xLTEtOTI0Nzk_f37af6e1-ba70-439a-9ede-6e24fc67bd2f">324,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzUtMy0xLTEtOTI0Nzk_363f9534-735b-49a1-91ca-3a4a70bdaffd">317,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i683a3a94e9e14c1a88726f3089470e3d">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="INF" name="iart:InventoryCapitalizedExpenses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzc2MDU_78302952-c04a-429f-91e3-334e2071ee1d"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="iart:InventoryCapitalizedExpenses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzc2MDU_df9ccaec-51a5-484c-9806-3d29d053c8eb">No</ix:nonFraction></ix:nonFraction> such amounts were capitalized at December&#160;31, 2022 or 2021. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i519a942c6d6a4044a1c8f05952808f33" continuedAt="i2ba8180c7a554a52a9ba4f0f87838ce2"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDUz_447ec837-a259-419a-b858-097fa6c69724" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQw_1e8d534b-fb64-47f3-93f6-373515de891d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i885964e8d4134704bda0cee1a82823e9_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzItMS0xLTEtOTI0Nzk_d84c79d8-b1a0-4ca3-9ee1-5ce6f6fd6532">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274e28de1007483189af177cc3870bed_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzItMy0xLTEtOTI0Nzk_abfc25c7-94d1-420c-ad21-495c30deba90">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6c9d635e1847d0ba05f03bab83deb8_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtMS0xLTEtOTI0Nzk_e9abaa92-39fd-4f8e-91a1-d4139c2bcb75">14,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b59f71e3dc40bc95ec22429582ce92_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtMy0xLTEtOTI0Nzk_54bbea87-a410-4f62-9e37-137bd4e540b4">19,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iba62f965ad2b4becaf6a2924ce7b0f73_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1YzlmODRjYjVlZTY0MjdjOWU5YzI4MTk2YjVjNWU1OF80_135467b7-e519-4735-b59b-53c6ff451868">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i00e2bf9b2ca64e639101cdb95fe9623d_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1YzlmODRjYjVlZTY0MjdjOWU5YzI4MTk2YjVjNWU1OF83_7c20e690-8d35-4002-b003-d9ce277c0fec">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c4c516f7c341e9a8f12da7fb0fd730_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtMS0xLTEtOTI0Nzk_1c8237c5-d864-46c5-98aa-1408b478d239">164,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d9e34be34c14c778773f8253aa5b1d5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtMy0xLTEtOTI0Nzk_d3d70278-85ba-4592-a8d0-5474235e998c">155,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaf4de01512a54f9d9da0d18e3f50daaa_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyYzhiODVhMTUyZDE0NWJmYTZkNmRhM2FhZjA0NWQ5NV80_dbf8dc09-058e-4490-a3f9-fd8c61935180">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i0f9de9f6897f4cf8b49ff88e72733606_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyYzhiODVhMTUyZDE0NWJmYTZkNmRhM2FhZjA0NWQ5NV83_aa48ee1c-4ad1-4016-8126-cf72755f8c42">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984bcc2d66864df5a6560d75518fc627_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtMS0xLTEtOTI0Nzk_332fa55e-43d4-40cc-801a-f7a266fad0ee">181,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b3d8c4a94f44308b786dd3f41066c3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtMy0xLTEtOTI0Nzk_42469c18-1448-482c-ad32-a9497e0b8afb">183,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i43680e166a7d4ce19b5a76a38da03d1e_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoxNDczZjE3NjY0YzA0NDZiOWFlMDFiOGJjNTNmZTM3OF80_3eebc4dd-3f8b-4dc3-921e-516a570486d0">3</ix:nonNumeric>-<ix:nonNumeric contextRef="if9b0589ae7ac49299d4b947877639c7b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoxNDczZjE3NjY0YzA0NDZiOWFlMDFiOGJjNTNmZTM3OF83_a98bbd63-8ba0-43c6-a3b9-508a099072fd">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d08e87887a48e0b165068c172cc809_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtMS0xLTEtOTI0Nzk_5d34fbaa-0314-4ba5-8759-c5bdcb46268a">3,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51998c104a0a4b23907a5b4441ad2cae_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtMy0xLTEtOTI0Nzk_dfc75809-ecb2-490b-bba6-9d1f434da0f0">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4683a32a673b4995855a9b02edfd1323_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0MzU5NzE2OWMzYmU0NDFhYjlhMTgxN2Y4ZTJiYjdkMF80_b9f66ae3-5a98-4a29-83f0-353db04fa7f3">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i967f27ce7a134d76a34a6939044881dd_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0MzU5NzE2OWMzYmU0NDFhYjlhMTgxN2Y4ZTJiYjdkMF83_97abbaa3-998f-41a1-8e2c-a13b3c743698">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefbb9d43eec34673981c8410401d816e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctMS0xLTEtOTI0Nzk_49177752-2345-4f31-b20b-d7e221c48908">151,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34bd7649dc7b4061ad47ffc556c0863f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctMy0xLTEtOTI0Nzk_edfd9cc1-1b83-40ff-bf3d-60be0c01cf96">148,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic49b57ff79634c4b898da5b6df9ebfae_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpkODQyOGYyYmQ5MWM0M2FlODhhYTgyMmZkMGIyZWVmZl80_cf1b8147-94eb-4620-915e-0c2cef4c9d20">1</ix:nonNumeric>-<ix:nonNumeric contextRef="ifd06a7aec13e49f98328dc80014a401c_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpkODQyOGYyYmQ5MWM0M2FlODhhYTgyMmZkMGIyZWVmZl83_c32aa1d2-7bbf-4546-85bf-e772471534aa">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a50827ab9fc4774a1f76e9fc90eca28_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtMS0xLTEtOTI0Nzk_032af05b-0c96-4d19-b357-b2c9ad576b2d">20,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a05a3ddc6e4c0ab4eecfb7744719f8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtMy0xLTEtOTI0Nzk_f5fb943b-8a81-47fe-b1da-bf0374d03c3f">20,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0da2edd906ea41d685b94f3a559f2684_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjozZjFkNDk2NThkNGY0NzkwYmYxOGJkNGQxNzY4OTBiY180_30680f6b-0641-4f00-bb20-0ea925e154c8">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i7b7f274b6c2e4e4085e067a47ae84aee_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjozZjFkNDk2NThkNGY0NzkwYmYxOGJkNGQxNzY4OTBiY183_7e8b4428-d957-4aae-9f8a-ae8aac177bc6">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674366b7bb554504831c2da6e430dcab_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzktMS0xLTEtOTI0Nzk_da055df7-6b59-4f17-9eb1-4b21d93e901e">103,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033684df3176485992b874699ab5bb9b_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzktMy0xLTEtOTI0Nzk_28beb9a1-85a3-4b67-8a8c-6fe32d6fce07">94,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEwLTEtMS0xLTkyNDc5_68f4eb02-166c-4d41-a1e4-049e7ca27a3b">641,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEwLTMtMS0xLTkyNDc5_248cbb60-830a-4fb1-b7cb-b076753cb230">626,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzExLTEtMS0xLTkyNDc5_805e9e4c-86c9-4078-9847-20033b8d950d">329,729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzExLTMtMS0xLTkyNDc5_63e972b4-5706-414e-82be-3a6e05c62cb8">314,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEyLTEtMS0xLTkyNDc5_1826765d-7f6b-4113-b49c-0dc57583ff1a">311,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEyLTMtMS0xLTkyNDc5_1a0591d5-fd0a-4953-9303-6f3cabe97c1a">311,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NjE_95523daf-79e9-4c4c-8413-6b2101df191a">40.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NjU_a4ee00bc-2d81-4a34-a114-778ca33f39e1">39.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NzM_83701cce-7198-4ca7-b13a-c2def1406ef8">42.1</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:InterestCapitalizationPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTc5_2c7cebf0-a0cd-4753-a94a-a494729d6bda" continuedAt="icaab01b096ef47abb06b1ea06adf67a3" escape="true">CAPITALIZED INTEREST</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icaab01b096ef47abb06b1ea06adf67a3">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</ix:continuation> For the years ended December&#160;31, 2022 and 2021, respectively, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:InterestCostsCapitalizedAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzk2NjA_313c0d23-16d6-42ac-b265-fc148a5a29b4">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:InterestCostsCapitalizedAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzk2Njc_796a8fd2-2b54-4214-9092-92a7f114e761">1.2</ix:nonFraction> million of interest expense into property, plant and equipment. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjAx_30c519c3-5a0b-4e88-b7b7-6f53b95dd6dc" continuedAt="if7e21d0c36b94e118effc3a7486989cc" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i2ba8180c7a554a52a9ba4f0f87838ce2" continuedAt="i0e3e15d3d1e8442b8c2122da623a5fb8"><ix:continuation id="if7e21d0c36b94e118effc3a7486989cc" continuedAt="iaecdd0ed0e5d4ddfb2fd337a53d0a5af"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaecdd0ed0e5d4ddfb2fd337a53d0a5af">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</ix:continuation> Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjM0_6ff72280-1aec-4e4e-b54e-d2d7bc91d11c" continuedAt="ia1a3e72f840c467eb8e14bdf18119233" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 350") and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzE2NDky_affa7859-2f17-465e-8865-ae0ddac1f57a">two</ix:nonFraction> reportable segments with <ix:nonFraction unitRef="reporting_unit" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzE2NTIw_cdc8e955-3605-4251-8216-127030568284">three</ix:nonFraction> underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0e3e15d3d1e8442b8c2122da623a5fb8" continuedAt="ib9963e5ba632484ab7ad06070f704923"><ix:continuation id="ia1a3e72f840c467eb8e14bdf18119233"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of an indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC 350 Topic when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjU1_a78eacd1-c8f4-4474-8c34-f7af5c548e0c" continuedAt="ie0d7b32898264d78b842ba2aeb16006b" escape="true">LONG-LIVED ASSETS </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie0d7b32898264d78b842ba2aeb16006b">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:FoundationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDkz_b8368de8-bcf1-4c01-8280-9ee875454f8e" continuedAt="i0ea11d617ed04405a5e4e0962f10155a" escape="true">INTEGRA FOUNDATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0ea11d617ed04405a5e4e0962f10155a">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</ix:continuation> The Company contributed $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTIw_5c7c2294-3e8e-49a9-90cd-8fc057baed57">0.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="iart:CharitableContributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTMy_73803adf-dbb8-4e09-9be9-4ff35dd4f208">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="iart:CharitableContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTM5_05528838-ba64-4256-b5b5-60dea65d98a3">0.8</ix:nonFraction> million to the Integra Foundation during the years ended December&#160;31, 2022, 2021 and 2020, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTUx_b389b251-a542-44a0-9fee-f0dd4983c197" continuedAt="i624abdfcfab04fa4ad8e240bdf3bd068" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib9963e5ba632484ab7ad06070f704923" continuedAt="i9a4db44a13ac48948d11a65873477268"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i624abdfcfab04fa4ad8e240bdf3bd068">The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net, on the consolidated financial statements.</ix:continuation> Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjYx_4d97383b-e284-4f66-8edc-1800487179bf" continuedAt="i7a3bafc448d24e5984089cf0bb355aff" escape="true">FOREIGN CURRENCY </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a3bafc448d24e5984089cf0bb355aff">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</ix:continuation> Foreign currency transaction net losses of $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NDg3NzkxMjM3NTE_bcbcbe7a-aeea-4847-a9e1-6caeb362df8e">3.3</ix:nonFraction>&#160;million,  net gains of less than $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI0MTA3_037216e0-7001-4fd6-972c-a3c18833a0e7">0.1</ix:nonFraction> million, and net losses $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI0MTE0_e05a06a8-bb75-4b4f-816b-a25f77300ea2">1.6</ix:nonFraction> million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTgw_3217c633-d741-4ced-9244-852f86879041" continuedAt="i51357f4dc99441b49d74c08109cb26a8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i51357f4dc99441b49d74c08109cb26a8">The Company continues to indefinitely reinvest substantially all of its foreign earnings unless there is a manner under which to remit the earnings without a material tax cost. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws.</ix:continuation> </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTY5_d5f6bcf9-d481-4091-9685-7fc05dd7e664" continuedAt="i912251af4d464924a13667410c68434a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically <ix:nonNumeric contextRef="i555d4df7f3584d1999b47a099d28a436_D20220101-20221231" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NTk0_e3b2bb04-796a-4156-b2e6-169ae0f2f594">one month</ix:nonNumeric> to <ix:nonNumeric contextRef="ic15abc2db37946838e57984661763818_D20220101-20221231" name="iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NjAw_cbbd4ba8-44e5-4511-9c03-76fa47def498">three months</ix:nonNumeric>. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i9a4db44a13ac48948d11a65873477268" continuedAt="i5c5ff1ec7fff4dacb3ffe21ae2c6d40d"><div style="text-align:justify"><ix:continuation id="i912251af4d464924a13667410c68434a" continuedAt="i768436cf409044c4a91b102f50f597f3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.</span></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTk5_83eb9546-5ba7-4d6e-bdbb-ce291642c124" continuedAt="id535e184c7774794bac51901944a1b28" escape="true">RESEARCH AND DEVELOPMENT </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id535e184c7774794bac51901944a1b28">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQy_0fc26eb5-65a7-4ed2-aaa6-bbecc8745da8" continuedAt="i8578d0a56b034a868c2589db784da840" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8578d0a56b034a868c2589db784da840">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred employee termination costs on restructuring activities associated with a closure of a manufacturing facility in France and other reorganization projects in the consolidated statement of operations for the year ended December&#160;31, 2022. In 2021, the Company incurred employee termination costs on restructuring activities associated with the  closure of a manufacturing facility in France. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1NjYzMzQ_81d028f7-6aaf-4d44-80a4-33f07f64777c" continuedAt="i02dcf94ddafc45de91a457240b4de85e" escape="true">The following table summarizes our restructuring related accrual balances included within accrued expenses and other current liabilities in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="i02dcf94ddafc45de91a457240b4de85e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:47.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzItMi0xLTEtMTQ0NjUx_ef499f37-e5b3-41ae-ac5d-e90417405ef3">10,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzItNC0xLTEtMTQ0NzE2_b1dfe339-b331-49d1-8868-d977caf7ec15">6,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Goods Sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzQtMi0xLTEtMTQ0NjU4_8815be92-d8f1-4ed6-9d0d-57263f3ba504">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzQtNC0xLTEtMTQ0NzMx_6df19fc5-2fde-43be-96c2-f01de850c132">3,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzUtMi0xLTEtMTQ0NjU4_9b38cdc2-a03d-414c-942f-582e35efcdb9">72</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzUtNC0xLTEtMTQ0NzMx_1ccfb402-9b83-44d9-87c3-65616f755942">288</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzYtMi0xLTEtMTQ0NjU4_08c1aff0-e70c-4f12-a41c-324bc92053d6">5,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzYtNC0xLTEtMTQ0NzMx_9ff55fcf-0b42-4fa1-921f-2fc2ae400f8a">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzctMi0xLTEtMTQ0NjU4_e5b8c6e0-2630-447b-9d10-b02ae5f5bd9d">12,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzctNC0xLTEtMTQ0NzMx_f6775358-ce5a-4703-b26a-f1764a0712d8">336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzgtMi0xLTEtMTQ4Nzgz_a194066b-e48e-4047-97c7-fbe56cffaafe">5,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzgtNC0xLTEtMTQ4Nzgz_e7b50f8b-92bc-4c62-9ebd-cd8771e252e8">10,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the accrual balance as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December&#160;31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i6527f4ce21cc4fb5985ab238dad89309_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NDg3NzkxMTc2NzA_951e282e-3411-4742-ad4a-ec50e3cef0ce">2.0</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the closure o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f a manufacturing facility located in France, and other reorganization projects of $<ix:nonFraction unitRef="usd" contextRef="i6c7891a939ef417fab6925793610c6df_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1Njk0MDI_20b88dbd-0db2-4c48-811c-b60e3ccc1e0f">3.1</ix:nonFraction>M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the accrual balance as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December 31, 2021 is $<ix:nonFraction unitRef="usd" contextRef="ib3ce9246a35c48fcbd5b84afbb181294_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM4NDgyOTA3NTU1MjA_212f797e-f6d3-4e2b-9822-0aa559597131">10.2</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the closure o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f the manufacturing facility located in France. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTMw_b7608e53-8552-408a-bb6f-1701e6c0c48a" continuedAt="i12b93e148dce4732be6576f707623c54" escape="true">STOCK-BASED COMPENSATION </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i12b93e148dce4732be6576f707623c54">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</ix:continuation> Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i5c5ff1ec7fff4dacb3ffe21ae2c6d40d" continuedAt="ic7feedc046874269a536c3ed3435a90d"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjI3_bdddebde-afb3-44b5-a5c3-efb9db2aee2b" continuedAt="i1ada6e41e321423d96636b6cb244e8cb" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzMzODAx_45880501-8541-4524-b9c9-d4351a7b7b61">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzMzODM1_ae972b7f-7537-4f71-b42a-7e71a9da6734">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ada6e41e321423d96636b6cb244e8cb">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</ix:continuation> </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjE4_403e4885-37b7-46c3-a0dc-2dc6f7ec97e6" continuedAt="ie0c897a2b8094a3797241ce1e9e558f6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie0c897a2b8094a3797241ce1e9e558f6">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="customer" contextRef="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_45e6e57d-b398-4a3e-b30c-d1a0114b3444"><ix:nonFraction unitRef="customer" contextRef="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_4c804b15-f0cb-4d84-b4bb-c3a2f930454c"><ix:nonFraction unitRef="customer" contextRef="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231" decimals="INF" name="iart:ConcentrationRiskNumberofCustomersOverBenchmark" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_a60091fe-69c5-4610-bdd6-e40bea807d65">No</ix:nonFraction></ix:nonFraction></ix:nonFraction>ne of the Company's customers accounted for <ix:nonFraction unitRef="number" contextRef="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_611c0f39-b026-477c-aa67-9b55bd4d853b"><ix:nonFraction unitRef="number" contextRef="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_9021ad16-d956-41d7-a37b-cea65a5a3087"><ix:nonFraction unitRef="number" contextRef="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231" decimals="INF" name="iart:ConcentrationRiskThresholdPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_f1d13335-91df-44ea-a0b8-58b182732022">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% or more of the consolidated net sales during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDg4_fdbd1820-9352-4a81-8927-e34bc5dcf3ef" continuedAt="i40c8f8448c0b4deab76c5b99998e246a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic7feedc046874269a536c3ed3435a90d" continuedAt="i1ec42f8719334feca68759c656558c6f"><ix:continuation id="i40c8f8448c0b4deab76c5b99998e246a" continuedAt="i5d9a4797ecf04e5e8a2aa82a68fe2eaf"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. On October 5, 2022, the FASB approved an extension of the sunset date of the reference rate reform from December 31, 2022 to December 31, 2024, past LIBOR&#8217;s end date. The Company currently has contracts that are indexed to LIBOR and are continuing to evaluate the scope of impacted contracts and potential risk. The Company expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ie88cf6af5eb341929c94e3b43dcc7430_I20200204" decimals="-5" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQxMDY0_d2da02ec-78ca-49bc-beb5-79f9d500e617">575.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQxMTAx_14631548-2059-45d8-a73b-b72b9ab071ec">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDcx_ccc8ca9f-7d20-4c30-b681-661f4dcf43c3" continuedAt="ifa8deaf81d4944289222edeeaf84efed" escape="true">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt"><ix:continuation id="ifa8deaf81d4944289222edeeaf84efed"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i923e26b254024ce191a077d3ad910d88_I20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzEtNC0xLTEtOTI0Nzk_b50445a4-24e6-4dfe-b841-19941d736628">20.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004ed02bcbb14976ae0947b6a85dae0c_I20201231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzItNC0xLTEtOTI0Nzk_ff6600b2-401f-45a8-9c3e-03f12045c079">89.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2646e8ff9e9646a997ca1704e1a4e996_I20201231" decimals="-5" sign="-" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzMtNC0xLTEtOTI0Nzk_ee0d17a7-3e26-4fec-9b16-f7c5b6b745b0">2.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i923e26b254024ce191a077d3ad910d88_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzQtNC0xLTEtOTI0Nzk_d4fcf2f6-006e-49ed-b771-742b4ba8ed36">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i923e26b254024ce191a077d3ad910d88_I20201231" decimals="-5" sign="-" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzUtNC0xLTEtOTI0Nzk_fd2dfae4-f415-4343-8aa4-1c5e946780cb">63.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i1ec42f8719334feca68759c656558c6f"><ix:continuation id="i5d9a4797ecf04e5e8a2aa82a68fe2eaf"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MjU3_d05c5bc0-c65a-4f94-b2b2-c1ed90e5992e">42.2</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MjY4_708fe11d-b049-45df-9384-44801aa273b6">1.4</ix:nonFraction> million that was capitalized into construction in progress), $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MzI0_c227df92-f6e4-4529-bf97-e9c16a7e6a30">43.2</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MzM1_33019906-226d-4a8c-bfb7-7fa3830a56a3">1.2</ix:nonFraction> million that was capitalized into construction in progress) and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0Mzk0_4c1b89b0-8246-4941-9325-be3e0ed96ca3">47.3</ix:nonFraction> million (net of $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NDA1_f59e0045-595c-4816-94d7-f3ca09a5c64a">2.3</ix:nonFraction> million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2022, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTU3_746a111d-a6fb-4ec6-ade2-6e8e64ca6df8">35.9</ix:nonFraction> million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTYx_6bd71016-5589-4c70-81a1-9400d7043194">49.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTY4_f9ae47fb-4fa8-4c78-ba27-32353047cb31">29.8</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING AND FINANCING ACTIVITIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzEw_d8fa472d-384e-44e7-8d08-6ad37e30dbfe">10.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzE0_ca325518-515b-4faa-8da3-d65a91b25641">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzIx_06650f93-1934-4a74-85cf-c943418192a5">1.6</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i95b6e8c596ab499a89fcc3c6342d9939_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0ODQ4_22c56ee1-a074-4d1f-8587-960d32aad261">5.0</ix:nonFraction>&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i95b6e8c596ab499a89fcc3c6342d9939_I20211231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0OTY2_22c56ee1-a074-4d1f-8587-960d32aad261">5.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone was fully paid in 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $<ix:nonFraction unitRef="usd" contextRef="i9efe6093f5ba46e79ed64d1fea198a87_I20201231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzEzNzQzODk1NDA1NDc0_32b77e0c-4ad7-42b7-87b0-22b1ed5742c0">20.0</ix:nonFraction>&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i9efe6093f5ba46e79ed64d1fea198a87_I20201231" decimals="-5" name="iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzEzNzQzODk1NDA1NDgy_32b77e0c-4ad7-42b7-87b0-22b1ed5742c0">20.0</ix:nonFraction>&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_151"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTE_fe08ed07-4a7f-4b47-8579-805af13abe3a" continuedAt="iaefabfa2aac94268980fcc4771720b3d" escape="true">REVENUES FROM CONTRACTS WITH CUSTOMERS</ix:nonNumeric></span></div><ix:continuation id="iaefabfa2aac94268980fcc4771720b3d" continuedAt="i8043604967f0494fbcf181e848334282"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><ix:continuation id="i768436cf409044c4a91b102f50f597f3" continuedAt="ic42f291822e344d3adf4c2bc8fbe512f"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzE3NDc_8e9f5aa2-9dea-437a-b0d7-e42671a5bee5">90</ix:nonNumeric> days. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i8043604967f0494fbcf181e848334282" continuedAt="i68d54cc34023494c9cd93e0c88c7112d"><ix:continuation id="ic42f291822e344d3adf4c2bc8fbe512f" continuedAt="i6357c651ca62470e87f1b2db22b4e479"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div></ix:continuation><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTc_6874fa47-ba4d-4d19-8515-520ea2ad3d20" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:79.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzItMS0xLTEtOTI0Nzk_7a43f12b-8fee-44a8-9c78-d104a659d2c7">11,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzMtMS0xLTEtOTI0Nzk_1474763b-f48a-45c7-9e65-723daee9f0f4">11,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzQtMS0xLTEtOTI0Nzk_42556557-9671-4ce5-be97-fc14b2bd5b5b">10,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzUtMS0xLTEtOTI0Nzk_139ea966-a2c0-4fe8-b76c-8ea2112f36dc">10,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzgtMS0xLTEtOTI0Nzk_6687c940-bba4-4c2e-9b51-62461ec6928c">11,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzktMS0xLTEtOTI0Nzk_9159f691-ae51-4bd2-a424-f6a0335780f1">5,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzEwLTEtMS0xLTkyNDc5_bb34faec-2c8b-4e42-b42d-1894a351b8c3">9,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzExLTEtMS0xLTkyNDc5_89186fcc-8f58-499a-86d7-32bea5880759">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzEyLTEtMS0xLTkyNDc5_b4fd9acc-bdc7-4cd9-80e4-972a2bf6c136">16,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the short-term portion of the contract liability of $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMwMjM_fa8b8aea-0a35-40e0-a00a-2c934217895f">7.3</ix:nonFraction> million and the long-term portion of $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMwNjQ_a88db3b8-cc5b-41ea-a3eb-7974fc6fd8e4">8.8</ix:nonFraction> million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company is expected to recognize revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i788f04f5fed04ca38e49ba6f03024c26_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNTQ_9c4d9d8d-b8ff-4570-b345-f6451a2e1b57">7.3</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i62d0e2aa67744845818cbd175cd7bd78_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNjQ_070a7ebe-5757-4fb2-baae-597b105b82d0">4.2</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="ib26e758da29c45679df8f4e5da71fe89_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNzQ_f7ea9da6-4130-4b44-a952-148741a0305b">2.7</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="i82ca03a161874505a112365ab91a423d_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyODQ_7ec31c26-d333-4650-8f4f-46224f0f5349">1.1</ix:nonFraction> million in 2026, $<ix:nonFraction unitRef="usd" contextRef="i6e5866b5e8ee438997795a5f34fffc50_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyOTQ_9f2594ac-287d-4618-a660-2b554639e33c">0.7</ix:nonFraction> million in 2027, and $<ix:nonFraction unitRef="usd" contextRef="i9b08269188a34d6fbb7031826cb0bdc9_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMzMDg_c625331f-75ec-4e5b-a6f8-aed41ccece65">0.1</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:continuation id="i6357c651ca62470e87f1b2db22b4e479" continuedAt="ibcf8145dc10c42c0a1f45233617e4047">Shipping and Handling Fees</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibcf8145dc10c42c0a1f45233617e4047">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</ix:continuation> </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ExtendedProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTA_61c88063-c95e-4e93-aa44-6c3a25369084" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:RevenueProductWarrantyPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzQwMjI_8ea1295b-f438-433a-8146-e4c2d44cf206">two years</ix:nonNumeric> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTg_2b4d2944-fdf1-42be-b586-0c5818172ef8" continuedAt="i189c91423a6243d6bfdc1f35659ef35f" escape="true">Taxes Collected from Customers</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i189c91423a6243d6bfdc1f35659ef35f">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i68d54cc34023494c9cd93e0c88c7112d"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0ODk_1093ea3d-b09f-4036-8c26-0791234d9e9a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2022, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05901fa55ec4ee09f5c084cb113c902_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNC0xLTEtOTI0Nzk_6d140062-b0e9-4877-a778-30eac1a755b7">794,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc2622f83364440b73830f3831e70ee_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNS0xLTEtOTI0Nzk_590b6105-c059-4401-a1c3-938e8f356cf1">802,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64babceb820449b89139cb878d8a8f48_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNi0xLTEtOTI0Nzk_2be7d2a0-9001-43e0-9d7c-87f6f06b5f9a">716,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87809ef2efdc487696e6308247a226c3_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNC0xLTEtOTI0Nzk_840171f3-09f5-4178-ae04-0b45ec735b68">225,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e50fd25ffa4e698beda1f9680eb35f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNS0xLTEtOTI0Nzk_3c90cb09-f1cb-468b-8645-c87b0eac905e">222,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc99fa3608f44f98cce93e770c68118_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNi0xLTEtOTI0Nzk_832fc4c6-f8e7-4fac-85fd-5734d3626446">178,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNC0xLTEtOTI0Nzk_5a1b7d40-9c06-49a9-b7bf-b63b93014f90">1,019,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNS0xLTEtOTI0Nzk_0c4cb0d3-4683-4d3e-b0ac-dc4bb2b39ef0">1,025,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNi0xLTEtOTI0Nzk_2fd1246e-8b45-4544-95c1-658d3a65618e">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c891096f6240ffa5a2ec5d793dc607_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNC0xLTEtOTI0Nzk_61a67c30-35ed-44f4-ae8f-d542d4c37285">406,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2c649e06d4bcb88d0734c5bc21568_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNS0xLTEtOTI0Nzk_ab23679a-2ccf-4ec4-b86a-03b12bcf3511">392,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d4599d6b184cfabebcd5b9dac65339_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNi0xLTEtOTI0Nzk_1814449a-4a3e-4066-a8fc-b15a03a1b5a7">293,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8181903369c49f6a696fed66e9124df_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNC0xLTEtOTI0Nzk_1bf6e054-065a-4362-bf78-97077e6f574f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09260aeabcc4e98a91001d0c6fde98d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNS0xLTEtOTI0Nzk_b815cdb6-35ee-48da-b6b8-82fdf8f92352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0915172f474032923692e256da33ee_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNi0xLTEtOTI0Nzk_586fc595-b4fe-4301-8573-e99ba4a5ba82">78,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b28eef625f649cc9ee7ffdcd22e93e7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNC0xLTEtOTI0Nzk_e8d317fe-22fe-4c53-b691-7e8912dc47ec">131,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320f932bbd4a4a02a374f45fe6f54046_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNS0xLTEtOTI0Nzk_37e97346-bbc0-4935-90cc-6f706b48d6fc">124,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b3cbf8d296491e89556ecdfff34761_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNi0xLTEtOTI0Nzk_abf72ce7-fcc9-4a1e-885f-6cbf06ed7592">105,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNC0xLTEtOTI0Nzk_9ab7f135-8d36-4805-b8e4-7e781491d481">538,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNS0xLTEtOTI0Nzk_b1e63521-001d-43fc-ac33-176b1dab7ea2">517,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNi0xLTEtOTI0Nzk_399ec09d-b195-4c3e-92a2-1e4e6a542143">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNC0xLTEtOTI0Nzk_be887742-4df2-4195-9844-83182079096b">1,557,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNS0xLTEtOTI0Nzk_6810d40e-d27a-4551-88be-86cfbdd00231">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNi0xLTEtOTI0Nzk_662fa17c-9063-4633-b88d-62bd81cd109f">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for details</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Acquisitions and Divestitures</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div></ix:continuation><div id="i43d6bdf9742e4131bcef4d4155aafb89_157"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE1OTM5_2eb27b31-1d52-45d4-9260-7a5d4ead0107" continuedAt="i4cba0c44abe04a44af0bfff4a0559cc8" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="i4cba0c44abe04a44af0bfff4a0559cc8" continuedAt="i67c491b2e04d479ea3061944bba0a91e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Surgical Innovation Associates, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxMzg_c26fc0e0-473a-4da6-bb80-66c9ebe7a323">51.5</ix:nonFraction>&#160;million. In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $<ix:nonFraction unitRef="usd" contextRef="i86566b09516e432dbffe19da79e048cd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NjI_e19e0aa2-3a7a-4127-90f7-7dfa78893530">50.0</ix:nonFraction> million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#8220;PMA&#8221;) Application for DuraSorb for certain uses by certain timing targets (up to $<ix:nonFraction unitRef="usd" contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NzU_773fb407-f101-4672-b307-0af7ee8aef89">40.0</ix:nonFraction> million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#8217;s Tissue Technologies segment as part of its Wound Reconstruction and Care franchise.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i67c491b2e04d479ea3061944bba0a91e" continuedAt="ic2e116a958cb444eb8e72447d2ed2a37"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQzOTgwNDY1ODMzOTc_9da7c4dc-5b29-42e5-946a-b9f68491f4a6" continuedAt="ie6686b8c7ba44bac8364e6f09c430eb2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation as of December 6, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzItMS0xLTEtMTYxOTgy_9a9d9f8c-8a15-4304-955c-111f3e06445f">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzMtMS0xLTEtMTYxOTkw_56f11e75-938f-486a-aae2-882bad04fa6a">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzQtMS0xLTEtMTYyMTQy_fc4ffac8-45d1-40b7-9f31-a1319447fdae">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzUtMS0xLTEtMTYyMTQ5_6c594965-93df-4239-b986-6d57e71ee71a">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzYtMS0xLTEtMTY4NzM3_359a4368-c453-4cd1-a794-dfa4f9c36395">10,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzctMS0xLTEtMTYyMTY0_3ab3c324-ee0d-4ad5-b8bf-6de5c335653c">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzgtMy0xLTEtMTYxODYx_020f8685-0931-432a-b710-f45b55e5bc6a">14</ix:nonNumeric> years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzgtMS0xLTEtMTYyMTcz_6844f413-e969-4621-93f1-2838638b82ce">41,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzktMS0xLTEtMTY4OTc3_5c08283f-2a2c-4d2e-8e8c-539bd2d54fe0">127,397</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzEyLTEtMS0xLTE2MjE4MA_8378bc23-c9a1-4646-be08-a0d666382223">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzEzLTEtMS0xLTE2ODk4MA_07c758d2-0f25-4dfe-8771-60f1fc865be2">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE0LTEtMS0xLTE2MzU2Mg_71fecd52-de52-4345-845a-da40e5bcdaa8">11,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE0LTEtMS0xLTE2MjE4Nw_33cfc47c-0df0-4472-8001-06ad90a17df5">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE2LTEtMS0xLTE2ODk4MA_04f357b6-1173-4627-9166-41a80433e48e">71,450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE4LTEtMS0xLTE2ODk4NA_631f0d7b-8263-482d-a10e-0438fbfc7c9e">55,947</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Developed Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#8217;s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="2" name="iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk1ODQ_8a85609c-3c7c-491f-9169-2b8b47e9725f">18</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company allocated goodwill related to the SIA Acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#8217;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Contingent Consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As part of the acquisition, the Company is required to pay to the shareholder of SIA up to $<ix:nonFraction unitRef="usd" contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk1NjI_3676fdf5-e9ec-4f9e-8839-35ee46e93d4a">90.0</ix:nonFraction> million for <ix:nonFraction unitRef="contingentliability" contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206" decimals="INF" name="iart:BusinessAcquisitionNumberOfContingentLiabilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxNjU_5595e189-6d59-4c0b-b4d0-0cf4b5b5da7c">two</ix:nonFraction> separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $<ix:nonFraction unitRef="usd" contextRef="i86566b09516e432dbffe19da79e048cd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxNTM_6320d641-f225-474f-9204-28ab2f57e49f">50.0</ix:nonFraction>&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ic2e116a958cb444eb8e72447d2ed2a37" continuedAt="i97f0b4d745d7437aad98c91ac1886ec2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">certain timing targets (up to $<ix:nonFraction unitRef="usd" contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2MTg_99093f13-38e3-4b9a-a848-2ff7bec27419">40.0</ix:nonFraction>&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $<ix:nonFraction unitRef="usd" contextRef="i86566b09516e432dbffe19da79e048cd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2MzE_4e4759ad-7d3d-431e-8d8a-02276e6816b1">32.6</ix:nonFraction>&#160;million at the acquisition date and $<ix:nonFraction unitRef="usd" contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NTA_e4178661-b734-4360-9ca3-a5032c5d1326">25.0</ix:nonFraction>&#160;million for the PMA approval milestone.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of non-core traditional wound care business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $<ix:nonFraction unitRef="usd" contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNjc_057a6bf2-a192-452e-8553-12d25b20118f">28.8</ix:nonFraction> million, which consists of $<ix:nonFraction unitRef="usd" contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNzE_c97892b3-cff3-4601-abd3-a55b84301f1e">27.8</ix:nonFraction> million in cash plus $<ix:nonFraction unitRef="usd" contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNzU_f110e236-ac62-4595-bfa4-b41e0a3ce047">1.0</ix:nonFraction> million in contingent consideration which may be received upon achieving certain revenue-based performance milestones <ix:nonNumeric contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831" name="iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzOTU_4074e67b-8ba4-4c71-811b-7651588e6d97">two years</ix:nonNumeric> after the closing date. The proceeds from the sale of the TWC business of $<ix:nonFraction unitRef="usd" contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzODg_c97892b3-cff3-4601-abd3-a55b84301f1e">27.8</ix:nonFraction> million is presented in the consolidated statement of cash flows net of cash transferred of $<ix:nonFraction unitRef="usd" contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831" decimals="-5" name="us-gaap:CashDivestedFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MDI_478c4fa3-38d6-4f29-a40f-52f00155ffce">3.5</ix:nonFraction> million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's Tissue Technologies reportable business segment. In connection with the sale, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i87815c6804b84c35862ba8c044473b87_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MDk_1498bd99-33fc-408d-a3f3-cea83b76bf88">0.6</ix:nonFraction> million as a gain from the sale of the business in the consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#174; and TCC-EZ&#174; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $<ix:nonFraction unitRef="usd" contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831" decimals="-5" name="iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MTY_a06fa8f5-23f8-48e0-afef-b57964a3f587">11.1</ix:nonFraction> million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of December&#160;31, 2022, the Company had a deposit remaining of $<ix:nonFraction unitRef="usd" contextRef="i3270d274846346d8aa67bdc8538e2741_I20221231" decimals="-5" name="iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzU0OTc1NTgyMTA4NjY_4cf6d59a-ab69-4c5f-bbfe-1df0cc047c33">8.3</ix:nonFraction> million which is included in prepaid assets and recognized a payable due to Gentell of $<ix:nonFraction unitRef="usd" contextRef="i3270d274846346d8aa67bdc8538e2741_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzI3NDg3NzkxMTA4OTk_a2fd60b0-4f99-446f-ac33-75636f2636b8">2.7</ix:nonFraction> million, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i9e69cd67efed4735a4e8f3d4b73198b8_I20210104" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ1Mg_21ea793d-b69d-4b77-b9eb-e3740173b1b7">240.0</ix:nonFraction>&#160;million from Smith &amp; Nephew and concurrently paid $<ix:nonFraction unitRef="usd" contextRef="i7e6455a748fe4bddb62d55fada8558ac_D20210104-20210104" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ5Nw_765e3a74-33f2-44b2-9697-f60f5e6bb969">41.5</ix:nonFraction>&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i97f0b4d745d7437aad98c91ac1886ec2" continuedAt="ie90462a5d9724bd39f8681e859ae9172"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE1OTM1_e760fac7-06c5-4934-b360-f76db6003130" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"></td><td style="width:68.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzAtMS0xLTEtOTI0Nzk_a91bacd3-992e-463d-8742-c8d64e548016">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEtMS0xLTEtOTI0Nzk_d0145e4a-be59-4bc9-97b5-61fac67e3659">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzItMS0xLTEtOTI0Nzk_77570902-108c-48d4-8d2a-3976ea5e21d6">6,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzMtMS0xLTEtOTI0Nzk_673a331b-1246-48cc-89ff-89562b74a5e5">13,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzQtMS0xLTEtOTI0Nzk_f2bd4bb5-3205-4685-883e-16ead7448eef">37,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzUtMS0xLTEtOTI0Nzk_2b85005f-ea23-4346-b9cc-932463c67c0f">47,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzYtMS0xLTEtOTI0Nzk_111b6673-c9ce-4bc7-905e-67ba9a9847bd">52,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzctMS0xLTEtOTI0Nzk_5509e655-89b3-45a7-b251-f080b83697ec">162,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzktMS0xLTEtOTI0Nzk_4e020606-03d8-4ab3-b5ae-48a6a117d703">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEwLTEtMS0xLTkyNDc5_53654b13-5d9e-4813-9822-a77578e961e7">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzExLTEtMS0xLTkyNDc5_49c88d62-36d6-4546-b9ee-5900a7fef1db">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEyLTEtMS0xLTkyNDc5_5f081b10-4712-46a3-b8bb-1f332b1b5079">3,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEzLTEtMS0xLTkyNDc5_93b7fe67-5672-419b-81b7-4153ed6e6935">5,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58908f12479149769863fd3b128d144e_I20201231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzE0LTEtMS0xLTkyNDc5_f9f4b0d0-3d41-4bca-8447-b65428392c74">11,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i48c08cb5a2fd4655ae315c100c40b36f_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzExOTc_9cc0cd2d-80b4-4725-a79d-d223d0f19994">41.8</ix:nonFraction>&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December 31, 2021. The Company finalized the net working capital  to Smith &amp; Nephew as of December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into a transition services agreement ("TSA") with Smit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h &amp; Nephew which requires the Company to provide certain services on behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Smith &amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the TSA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a payable due to Smith &amp; Nephew of $<ix:nonFraction unitRef="usd" contextRef="i45969f5e61c5407c8d95c866382a20f2_I20221231" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE3NDE_c52e211a-7886-499c-b443-c72b4e32bbee">2.3</ix:nonFraction> million as of December&#160;31, 2022, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The TSA includes services such as invoicing and cash collections from customers on behalf of Smith &amp; Nephew. As of December&#160;31, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company has concluded the majority of the transition services agreement, pending final payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACell, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="i8e90ad876dbd48bc8aa7bf8b4a53d714_D20210120-20210120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE5OTM_5081321f-f18e-47fe-82b9-50f1a505e677">306.9</ix:nonFraction>&#160;million plus contingent considerations of up to $<ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzIwMzY_3a623a68-0198-4799-be56-c5f16d6ff36a">100</ix:nonFraction>&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $<ix:nonFraction unitRef="usd" contextRef="ibc1ccc070eda4191b4f93f11cd639a6c_I20210630" decimals="-5" name="iart:BusinessCombinationWorkingCapitalAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzIxODU_4ebdb604-0287-4eab-a1f8-dfb9de59cbbf">1.3</ix:nonFraction>&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie90462a5d9724bd39f8681e859ae9172" continuedAt="i31992b8ae27c44dfbf254ad5515c2461"><ix:continuation id="ie6686b8c7ba44bac8364e6f09c430eb2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzItMS0xLTEtOTI0Nzk_ee44085e-c11a-4f6e-8153-ac8ddfffdb06">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzMtMS0xLTEtOTI0Nzk_ed789510-cf0c-423d-9a12-d6a7d45f9f23">16,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzQtMS0xLTEtOTI0Nzk_cce4c002-f8d5-458f-b8c4-63e2fa30428a">18,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzUtMS0xLTEtOTI0Nzk_93db2ab9-faa3-469c-88e3-5d703d14138b">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzYtMS0xLTEtOTI0Nzk_464dcedc-5c28-446c-9cdd-e822f6dd9ca0">38,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzctMS0xLTEtOTI0Nzk_a015b9d7-d106-4b95-b1e9-bd00144c2e05">13,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMS0xLTEtOTI0Nzk_0c980184-49d3-4148-a6b6-bdf239c2b989">245,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11932035bfc943da83fdc9252c1de39c_D20210120-20210120" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMy0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzhkNTYzYmM0MzI0ZjY1ODQwY2E5NTcyOGMwMjU1OV80_a4a689aa-808f-4309-b65a-536b8cf2c629">13</ix:nonNumeric>-<ix:nonNumeric contextRef="i1b4975b0f79844b99055d7ce6c50dec7_D20210120-20210120" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMy0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzhkNTYzYmM0MzI0ZjY1ODQwY2E5NTcyOGMwMjU1OV83_9d73930e-8802-42e7-86e1-8afefa440eed">14</ix:nonNumeric> years</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzktMS0xLTEtOTI0Nzk_93500103-94fc-4758-9954-e974e35b5a59">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEwLTEtMS0xLTkyNDc5_a4052623-0627-42b5-8cc9-d6acccea1053">9,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzExLTEtMS0xLTkyNDc5_9f54b5b5-5065-42c1-a1b9-09fddb3be71c">7,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEyLTEtMS0xLTkyNDc5_3a53103f-d5a8-4d9e-8c6c-ffeab78e8f50">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEzLTEtMS0xLTkyNDc5_ef296fbb-5faf-45fb-b6a6-11f9fc1ebe62">408,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE2LTEtMS0xLTkyNDc5_d8c40dac-a0ad-4fad-8e4e-ec220a579ec9">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE3LTEtMS0xLTkyNDc5_2a6fa985-fe49-48e2-b1cb-a2760dc7a033">5,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE4LTEtMS0xLTkyNDc5_de44a320-007f-4f74-b765-bf7771eb4c22">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE5LTEtMS0xLTkyNDc5_872c94ff-bd5a-401d-87b2-fc1f0dac1ff5">8,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIwLTEtMS0xLTkyNDc5_b601a7fb-a498-48fb-a9da-c01d19ef8dc7">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIxLTEtMS0xLTkyNDc5_6195bcee-2d70-4476-96e4-9c4e2e00d087">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIyLTEtMS0xLTkyNDc5_cd7a699c-ff50-498c-b52f-4cf32bead720">61,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIzLTEtMS0xLTkyNDc5_768b3a27-7d04-4908-ae6f-7fc0f98034cd">23,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzI0LTEtMS0xLTkyNDc5_fd028208-6ddd-4b02-8ae4-9d71bc533135">101,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzI2LTEtMS0xLTkyNDc5_45ab92a4-36ee-448c-8ab1-8705dceff20f">306,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="3" name="iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM2OTM_646bdf8a-772d-4a27-84c6-a15d23b2c82c">8.5</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i31992b8ae27c44dfbf254ad5515c2461"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $<ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ2MzQ_4fae0d29-d649-4881-bb03-2e2355c5d7ac">100</ix:nonFraction>&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. Based on revenue performance in 2022, no payment will be made for the first performance milestone.  T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company used iterations of the Monte Carlo simulation to calculate the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzUwMTU_a271640a-69c0-48ba-a217-ea36bd2650fb">23.9</ix:nonFraction> million at the acquisition date. The Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i912619e1e3ea4282b49c25179ea048df_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzUwODE_9a732a37-9359-48ae-9158-b5d028dd1adf">3.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i1e031586a5ab4c2b9c733e84d2f186e3_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzI3NDg3NzkwOTg4NDY_b2b5c7ce-2b1a-431d-995f-1b5ee9e3a7c9">21.8</ix:nonFraction> million in other liabilities as of December&#160;31, 2022 and 2021, respectively, in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#8217;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_160"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTY1_239476e7-56f9-45e8-aef0-b1043eebaa06" continuedAt="i83481597bad641389e31b2f83991b62e" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i83481597bad641389e31b2f83991b62e" continuedAt="ia0b081c14d9d46cea42a3904fa1febb5"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUwMw_aa3f91a4-af0e-44ef-9f21-c535cfee8653">2.2</ix:nonFraction> billion available to it through the following facilities: (i) a $<ix:nonFraction unitRef="usd" contextRef="i7f6392846dfe466d9d26314aee0a7510_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2Mg_7192d129-0a06-4948-a118-e7eaaffbef8f">877.5</ix:nonFraction> million Term Loan facility, and (ii) a $<ix:nonFraction unitRef="usd" contextRef="i31f0be0dc18542668776dac2419eacfc_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU5Ng_99fb0411-ce84-4b2d-9e7a-c94aa28d215b">1.3</ix:nonFraction> billion revolving credit facility, which includes a $<ix:nonFraction unitRef="usd" contextRef="ic745d752ec27419fbefffbb4a794e6e6_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzY0Mw_f934bd3f-491e-4df6-bebb-6f6955f5e873">60</ix:nonFraction>&#160;million sublimit for the issuance of standby letters of credit and a $<ix:nonFraction unitRef="usd" contextRef="id1f1b83ff3044f198627e9dcf14f8112_I20200203" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzcwNw_9f04f5cc-da11-48bd-8888-4e280fe31976">60</ix:nonFraction>&#160;million sublimit for swingline loans.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTg1_85c3937c-1b96-4c6d-a703-77e7f60f62cc" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) is the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:75.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2429c77787c540b481af5ad54734a36f_I20200714" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTowYzE5YmJmYzczMDI0ZmE1ODNiM2RlNDEyMmMyNWY1OS90YWJsZXJhbmdlOjBjMTliYmZjNzMwMjRmYTU4M2IzZGU0MTIyYzI1ZjU5XzUtMi0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpiMzgyNTI5MjA2NGM0OTUzYWM2NzJlYTgyNzNmMjFmNl8zMjk4NTM0ODgzMzUz_bcd502f5-c9ff-4a89-9f94-ddfb0aa0f852">4.50</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if488a963db3a45d1a7ad2f45989c9458_I20200714" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTowYzE5YmJmYzczMDI0ZmE1ODNiM2RlNDEyMmMyNWY1OS90YWJsZXJhbmdlOjBjMTliYmZjNzMwMjRmYTU4M2IzZGU0MTIyYzI1ZjU5XzYtMi0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowOTdkOTJmYTYxODY0NDIxOGQ2M2Q5Mjg2N2MwNWRmY18zMjk4NTM0ODgzMzQz_90024ac0-86de-4362-95e2-3f7758d2a7c4">4.00</ix:nonFraction> to 1.00</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from <ix:nonFraction unitRef="number" contextRef="ic13de93e77194c5db68428a880ecc0ea_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE1NzM_ee677f3c-4ed1-484f-837a-f577658f0818">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9b119f3359044799a93e9eb51fb8011d_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE1Nzk_bada8667-bbba-43cc-a78c-063de984eed7">2.25</ix:nonFraction>%), or </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus <ix:nonFraction unitRef="number" contextRef="icc2cd7d3829a475eab3f41f1f7f63464_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE3MTU_5061a619-c833-4c0f-bc74-d0f00db108c3">0.50</ix:nonFraction>%</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus <ix:nonFraction unitRef="number" contextRef="i16836d586c23438497ba4585606b71df_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE4MDQ_d3ff913b-418a-4198-bfe6-aff47949da16">1.00</ix:nonFraction>% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia0b081c14d9d46cea42a3904fa1febb5" continuedAt="ie9943bbd245447f3976920353f92c0e1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from&#160;<ix:nonFraction unitRef="number" contextRef="id05e07ddaf204365bde66fc72e4e8a56_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzIyNTE_4769a990-aad0-41a8-a541-a30c436db889">0.15</ix:nonFraction>%&#160;to&#160;<ix:nonFraction unitRef="number" contextRef="i222fc417f0d442279085025ae2862e64_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzIyNTc_97fc0ff7-7fe3-45b7-ae32-9c463e277fdd">0.30</ix:nonFraction>%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2022, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzI3NjE_aa3c4815-4b88-4b86-9855-c956222c90bb">4.6</ix:nonFraction>&#160;million of financing costs in connection with modification </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Senior Credit Facility and wrote off $<ix:nonFraction unitRef="usd" contextRef="i60510ed6729f49d58e204a789ec164fe_D20200101-20200331" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzI4NjA_6a2c9477-9b92-467b-9dc5-e7ed29178169">1.2</ix:nonFraction>&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="idc24dddff635440bb6fa7fef2e8c6bbb_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMwMDQ_3125a586-5853-4543-9278-7856a9050560">3.3</ix:nonFraction>&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="usd" contextRef="i7a18546e2641432186ebea4fb82b0c97_I20221231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMxNjI_439277dc-a627-4cfe-88dc-75fd445d2c93">no</ix:nonFraction> balance outstanding at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the revolving portion of the Senior Credit Facility and as of December 31, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMxNjk_4ab54866-5401-4936-9f01-886236fffd31">31.3</ix:nonFraction> million, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzMDI_67dcdd5d-c762-4dff-9b84-145f5e6d1995">1.4</ix:nonFraction>%. At December&#160;31, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzNDQ_daeeb985-c58d-41bc-94dc-219a88373bd2">771.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzNTE_f303b551-9def-46c5-bd19-30b9d9c84d0a">843.8</ix:nonFraction>&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM0Nzk_d5379a15-31df-456b-8f4e-f12681ff95b2">5.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM0ODY_0ebd1837-98c8-4c89-b961-b44d4ea9c3b0">1.4</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. At December&#160;31, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231" decimals="-5" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM1Mjg_c879a472-8f09-44ed-960f-7c01bb1f86ff">38.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231" decimals="-5" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU3NzI_55b6c93a-0377-475e-ad6a-0384f708aefb">45.0</ix:nonFraction> million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan components at December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usd" contextRef="iab173f92572840f69a38fdd7ef02744a_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM4MDU_6a325b55-22b3-4d45-b1f0-d4e8a5c19337">800.8</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> totaled $<ix:nonFraction unitRef="usd" contextRef="ide3a54a13b084e729f49c0c5be9ef158_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQzOTk_051f8606-bde6-4d13-bd43-625ef8d3534d"><ix:nonFraction unitRef="usd" contextRef="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQzOTk_073fa599-afad-407a-b832-3dd63f8864ef">1.6</ix:nonFraction></ix:nonFraction> million. Ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e were <ix:nonFraction unitRef="usd" contextRef="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ0MjI_2d156304-37bf-47fe-9806-7f7a97128ba0">no</ix:nonFraction> amounts drawn as of December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTgz_5a62f27c-82a0-4346-a287-7d8cd7f5bea4" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzItMi0xLTEtOTI0Nzk_cb8d7061-f878-436b-8b04-4534343b7aff">38,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzMtMi0xLTEtOTI0Nzk_2ef0cff5-1285-4a85-b000-a620a5599f38">67,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzQtMi0xLTEtOTI0Nzk_0c73af93-74d7-41c8-8dc9-3c6a00340b30">669,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzYtMi0xLTEtOTI0Nzk_b691815b-4319-41e5-bc9a-2c31b78252db">775,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="iart:InterestPaymentsYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ2OTM_ccaca153-6fd8-4b6d-8c83-098dc48310e2">42.7</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="iart:InterestPaymentsYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ3MDU_7803e99a-ff69-4be8-b33e-0ee795c988f3">39.1</ix:nonFraction> million in 2024, and $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="iart:InterestPaymentsYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ3MTc_8f6912d0-f829-4075-95db-b4c2fac48fa6">3.6</ix:nonFraction> million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUxOTU_e55eadbe-b82d-472c-9663-e23e99d3d6c5">575.0</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUyMzI_8826bc25-40aa-455c-838e-e99458ea6b04">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUzNjY_b0a4a5bf-e4e2-4dfd-b6de-faf2dd700f4c">0.5</ix:nonFraction>% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $<ix:nonFraction unitRef="usd" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2MDI_3d0c7203-ac27-4aeb-a470-6de4e8372665">104.5</ix:nonFraction>&#160;million. The effective interest rate implicit in the liability component was <ix:nonFraction unitRef="number" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2NzQ_257f59ba-4ede-4554-a067-081d49e8b2a7">4.2</ix:nonFraction>%. In connection with this offering, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU3MzY_76b14185-de62-4bd4-9959-7c26c0acc13d">13.2</ix:nonFraction>&#160;million of financing fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYwNTA_c6958324-e221-49c9-a1a4-216489b6543b">73.67</ix:nonFraction> per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least <ix:nonFraction unitRef="number" contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYxOTg_4ff87eb1-7649-4750-851a-eb1db5fb92e9">130</ix:nonFraction>% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to <ix:nonFraction unitRef="number" contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumAverageConversionValueOfNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYzNDg_3721c911-7da7-4f0c-bcab-d5a03cd8e7e4">98</ix:nonFraction>% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2022, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie9943bbd245447f3976920353f92c0e1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $<ix:nonFraction unitRef="usd" contextRef="i6f118ad8379e472489d69365de281b5a_I20201209" decimals="INF" name="iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzczMjk_f6ef3ecf-bf82-4d8c-a22c-f9817b63e64c">1,000</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at <ix:nonFraction unitRef="number" contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzc0NTY_faa07b77-dfc5-4694-9271-303287608b5f">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $<ix:nonFraction unitRef="usd" contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204" decimals="-5" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzgxMjg_7a8fb285-ff9f-402b-8998-096fc14fd51e">104.2</ix:nonFraction>&#160;million for the 2025 Notes. The Company received $<ix:nonFraction unitRef="usd" contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzgxNzI_db8516ac-8ea5-45fa-a479-8fdaff6591bf">44.5</ix:nonFraction>&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzg1MjA_4b628520-2ad0-41f3-986a-50933bd6c2e9">73.67</ix:nonFraction>, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzg2Njg_76043590-25f0-4cdf-92b1-2fa13c6eb761">113.34</ix:nonFraction> for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the carrying amount of the liability was $<ix:nonFraction unitRef="usd" contextRef="i987b954ec383404489ad7dd44db86461_I20221231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU4MjQ_c4c77f34-ad7e-48f4-a435-1afe5ea75ab2">575.0</ix:nonFraction>&#160;million. The fair value of the 2025 Notes at December&#160;31, 2022 wa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s $<ix:nonFraction unitRef="usd" contextRef="i987b954ec383404489ad7dd44db86461_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU4MzI_fb68a719-ee0f-422c-8b70-7eb9f44498ef">560.5</ix:nonFraction>&#160;million.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the adoption of ASU 2020-06, for both the years ended December&#160;31, 2022 and 2021, the Company recognized only cash interest related to the contractual interest coupon on the 2025 Notes of $<ix:nonFraction unitRef="usd" contextRef="i0627e2a89adb4de6b5f96b5c7cd98f0c_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxNzg_411fadf8-b355-428e-8aad-919650bf9c5b"><ix:nonFraction unitRef="usd" contextRef="i24a9e217820b47419ac62a665233d6e6_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxNzg_93ccf701-d41d-4776-9285-8435dccd324d">2.9</ix:nonFraction></ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzEwNDg3_5e331db9-c868-4801-8906-8fcfc31cb02f">150.0</ix:nonFraction> million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2022, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company&#160;had $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxOTg_4c577257-fd8e-4ec0-9039-7cfba18b180e">104.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTA_7189eccc-8db8-46f1-974b-07913b217524">112.5</ix:nonFraction>&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTU_4b742791-d661-49cd-b983-495c46ce8054">5.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTk_4f46b0a9-5ebc-4b0a-ab7e-4ea4cafc546b">1.1</ix:nonFraction>%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i2f78858143164e768c61bb467e5fdd70_I20221231" decimals="-5" name="iart:SecuritizationFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMjQ_16e67cc7-8dfe-421e-80fa-f414d45aeb73">104.9</ix:nonFraction>&#160;million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjgz_a085dffd-4004-4b09-b328-b3582cb66d06" continuedAt="i33463bdbe9ab4407a5b257da820d488d" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i33463bdbe9ab4407a5b257da820d488d" continuedAt="i6c7712d5afaa415390f6b63c9707f6f6"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjk4_f5e3b5cd-df2c-4736-8b2b-79ea0793edcf" continuedAt="ib2e6dc2242b241228e43086ea3d9fb2a" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0437592feca04863946089d86b4469ac_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMi0xLTEtOTI0Nzk_ed86bfb6-a8df-4256-9a4f-bd26c5fdf54c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a060aa4a4944de1b51797e710f61a6a_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtNC0xLTEtOTI0Nzk_e71112ce-48aa-4188-8c40-f9db7f31563b">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0437592feca04863946089d86b4469ac_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTItMS0xLTkyNDc5_6d6e22d0-cb66-48f1-87c3-f401252c935a">2.201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0437592feca04863946089d86b4469ac_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTQtMS0xLTkyNDc5_ec776f65-4dc3-448f-8994-57d6e152d7a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a060aa4a4944de1b51797e710f61a6a_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTYtMS0xLTkyNDc5_502f888f-18b5-4a20-90bb-38d0e55e6665">5,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMi0xLTEtOTI0Nzk_9d63ec92-453f-4212-b26e-645ef4cd7928">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117d5a15f0484f8aa5ec486b255b30a3_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtNC0xLTEtOTI0Nzk_e955086d-7b7c-40d3-9f3d-b349a2b21fa5">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTItMS0xLTkyNDc5_d1663503-471b-4b2c-9d9b-6f0fba8dc6b8">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTQtMS0xLTkyNDc5_d4bf39aa-3393-4131-9572-461c4e0c3782">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117d5a15f0484f8aa5ec486b255b30a3_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTYtMS0xLTkyNDc5_f558826b-acc6-462d-944f-fd443a68e641">5,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMi0xLTEtOTI0Nzk_f9ce7a7e-68ed-45aa-b710-1a2e70f9dae9">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtNC0xLTEtOTI0Nzk_b9a4b539-2aaa-44d7-946f-9841faa898ae">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTItMS0xLTkyNDc5_236c4b9c-c982-44b2-8285-ae1d44f6a6c8">2.313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTQtMS0xLTkyNDc5_c91aa5ec-2079-4bca-9129-12d47d7fab1e">8,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTYtMS0xLTkyNDc5_e0016fce-6da0-4c0d-889c-c98b64092c44">7,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMi0xLTEtOTI0Nzk_4a726ebb-f8df-4594-a0af-9b8d99f2ba20">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929e86bd2d204984ba3a7acb41d6f92d_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctNC0xLTEtOTI0Nzk_5291cb34-666d-4137-8b69-3e6f3e42bced">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTItMS0xLTkyNDc5_5340cc22-cd8e-4e16-b272-2e8e47377ef0">3.220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTQtMS0xLTkyNDc5_c769d232-2356-4ac0-815f-86c34161160e">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i929e86bd2d204984ba3a7acb41d6f92d_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTYtMS0xLTkyNDc5_1a00e9a7-ff71-41e4-b572-f414801e50c5">5,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMi0xLTEtOTI0Nzk_213b4054-0a81-4fef-8c82-0298fadb0425">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtNC0xLTEtOTI0Nzk_f11abce9-b54c-4365-a5c5-682e4b656a81">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTItMS0xLTkyNDc5_ff959adf-7bc8-4671-9673-823b0aa0da99">3.199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTQtMS0xLTkyNDc5_df7b0cc2-fee8-438f-a272-6d0ce72a1fd6">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTYtMS0xLTkyNDc5_aa101439-60a9-417e-b01e-6e432f7fb137">5,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMi0xLTEtOTI0Nzk_24e01a07-08d1-4ba8-acd3-9f494f21134f">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic63c12c941ae4e8d81cabaff36570cd8_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktNC0xLTEtOTI0Nzk_11dad25f-ae85-4e80-acff-191cde396e67">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTItMS0xLTkyNDc5_c6f0e50d-8bb9-4be9-b553-e12e887af54c">3.209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTQtMS0xLTkyNDc5_c1905049-38a6-4e67-b4df-04b5b5f5d29e">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic63c12c941ae4e8d81cabaff36570cd8_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTYtMS0xLTkyNDc5_5f114b79-cd9f-4e54-a475-65e96614edbe">5,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTItMS0xLTkyNDc5_0fcdab56-8432-4ba6-b366-3f314faa4ee5">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14428d26feb74f44b207c0596adab982_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTQtMS0xLTkyNDc5_f472f022-2cac-40f3-8fa1-eabb1094186a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTEyLTEtMS05MjQ3OQ_f477b2f2-f7be-476c-8436-58691bda89d3">2.885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTE0LTEtMS05MjQ3OQ_a6072d65-7f89-4c8f-8713-4c7085f605a7">4,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14428d26feb74f44b207c0596adab982_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTE2LTEtMS05MjQ3OQ_bf4be8a9-adf5-4932-96c9-75016aa23ca8">6,886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTItMS0xLTkyNDc5_e10b4bbe-92e4-4391-9040-a60714ae8ca3">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082f3efc12d847f7bdbcda637deb820f_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTQtMS0xLTkyNDc5_ff075725-6908-4085-8b07-ca69a4576e97">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTEyLTEtMS05MjQ3OQ_8ce5800f-a301-4115-b1ae-828a5de4883f">2.867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTE0LTEtMS05MjQ3OQ_1ba35847-b14c-4c3f-b102-b365d6b051b1">4,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082f3efc12d847f7bdbcda637deb820f_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTE2LTEtMS05MjQ3OQ_1720e9ff-c187-456f-904d-3603a4e1d2c9">6,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTItMS0xLTkyNDc5_a33c2858-e161-4587-931f-f8383143f917">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a51434e1d640819950dc39740d93e1_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTQtMS0xLTkyNDc5_24d90a4f-afe9-468b-9bee-23e29c8a1fbd">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTEyLTEtMS05MjQ3OQ_98a92264-8033-4c43-b5c2-8fa864840d0f">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTE0LTEtMS05MjQ3OQ_287c01b3-3171-420a-9dd8-ac9f5a5b9785">23,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a51434e1d640819950dc39740d93e1_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTE2LTEtMS05MjQ3OQ_28fc5e12-6416-4696-be76-4245425a4828">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTItMS0xLTkyNDc5_e3b4f367-82c2-4990-b6b6-c43d28fd62bb">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf52b2b42e8342a186985ec5e5775ce3_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTQtMS0xLTkyNDc5_d4bbcf3f-b6dc-406f-bd4a-1393e893022e">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTEyLTEtMS05MjQ3OQ_d6fffdce-947c-41db-9e29-0683971d5808">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTE0LTEtMS05MjQ3OQ_b071e8eb-6d20-4dbe-8951-ff0feb9c105d">5,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf52b2b42e8342a186985ec5e5775ce3_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTE2LTEtMS05MjQ3OQ_7c34103a-80a1-4c90-afe2-1fc48fc45ee6">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5285f5cc45407cbdd753e2c83bf644_I20221231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTItMS0xLTkyNDc5_4b9a9869-d88e-4d15-a6d6-4bcf25ff598a">1,475,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTQtMS0xLTkyNDc5_c54a337b-6ef6-4ca5-9486-b66c034530c4">1,775,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5285f5cc45407cbdd753e2c83bf644_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTE0LTEtMS05MjQ3OQ_7e1bc6c2-2d10-4b51-8229-2d4b1748bf29">56,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTE2LTEtMS05MjQ3OQ_8b0126d0-297d-4e63-ac62-ba357bddfdf7">43,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive income (&#8220;AOCI&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCI to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCI, net of tax. Those amounts are subsequently reclassified to earnings from AOCI as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i5bbe580a52f944c98f0001a290f94063_I20171002" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ1MzM_dd7666ca-080a-4173-ab44-38b46ced1ffb">300.0</ix:nonFraction> million equivalent to <ix:nonFraction unitRef="chf" contextRef="i0b7965703b77464bb1196cc27ff38536_I20171002" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ1NTA_b72c169a-74ea-4ab0-b2af-da1d3b948bd9">291.2</ix:nonFraction> million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i008795d9432842aa84611f74c3eace23_I20220926" decimals="-5" name="iart:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE1MTQ_54782e07-b5fd-4a45-8389-b106613619ae">50.0</ix:nonFraction> million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF <ix:nonFraction unitRef="chf" contextRef="i008795d9432842aa84611f74c3eace23_I20220926" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE2Mjg_d0a34acf-e957-43e7-aad5-5df4864bfc74">48.5</ix:nonFraction> million equivalent to $<ix:nonFraction unitRef="usd" contextRef="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE2NDY_a3a6ae45-3458-421e-aceb-440aebbc1614">49.1</ix:nonFraction> million of this </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6c7712d5afaa415390f6b63c9707f6f6" continuedAt="i5118b54e53ad40e0a15121c597f44dc9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.   As of December 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzM4NDgyOTA3MzAwNzk_a3a6ae45-3458-421e-aceb-440aebbc1614">49.1</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="i5bbe580a52f944c98f0001a290f94063_I20171002" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzM4NDgyOTA3MzAxMjU_dd7666ca-080a-4173-ab44-38b46ced1ffb">300.0</ix:nonFraction> million notional amount remain outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i4ed0c764a1ef48f18d31ec981995213b_I20201221" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ4OTI_c8505cd9-ae95-41a8-a960-3029e7f6d6ed">471.6</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="chf" contextRef="i4ed0c764a1ef48f18d31ec981995213b_I20201221" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ5MDk_add965c1-f279-45c3-9f72-cf6949a28302">420.1</ix:nonFraction> million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF <ix:nonFraction unitRef="chf" contextRef="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231" decimals="-5" name="iart:IntercompanyLoanQuarterlyPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzUyMjQ_6ce3f50f-63e8-438d-a984-fdc938ec3b37">5.8</ix:nonFraction>&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><ix:continuation id="ib2e6dc2242b241228e43086ea3d9fb2a" continuedAt="i77ecccf15ac543628ec8b4e526fffce1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.897%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTYtMS0xLTE2Njg4NA_3a76e2e9-82ff-4e08-80b9-9758fbf2968e">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTktMS0xLTE2Njg4NA_2574077e-6bcc-49ab-9983-1915af4be836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i36bbf9012cea408c93248b27bdf539bf_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEwLTEtMS0xNjY4ODQ_3934e540-0557-4d1f-a326-a5d9a8ea9a96">145,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc0c3a66d1b4b0598d21bd659f5221c_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEyLTEtMS0xNjY4ODQ_fbbe33d0-4ebe-42a1-929f-ec1844a52c55">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4295be0ac744563a7454ae58d217d0b_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEzLTEtMS0xNjY4ODQ_f4e8e12f-78e2-4cb2-8f5e-eb91d4e3800c">8,283</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if7726647971046a491c61ebc43a4896f_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTYtMS0xLTE2Njg4NA_3434a002-ff06-47c7-919a-469eb5c5247b">4.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7726647971046a491c61ebc43a4896f_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTktMS0xLTE2Njg4NA_121aa003-6319-4ba4-b6a8-0344e9702198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8600ea8026004026a91ef4697aa5aa1e_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTEwLTEtMS0xNjY4ODQ_ee1f76da-2439-441c-ad4f-8b0ad7506d88">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i141946ba0694449bb9049b3e2a07dee5_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTYtMS0xLTE2NjkxMw_357a1476-5414-47cf-addb-9b03280f676f">3.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i141946ba0694449bb9049b3e2a07dee5_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTktMS0xLTE2NjkxMw_4a80c678-91cf-41dc-83ca-913e50abc95a">374,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i66601e7294074670ad5e6aa5e725a874_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEwLTEtMS0xNjY5MTM_dff67422-0422-4869-90fe-877fed1351a8">397,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c728bb018c44941b1bfa6521c9c1244_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEyLTEtMS0xNjY5MTM_2cd5dbf6-2f88-4743-86b2-3964aa6825d4">4,241</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329398daa6384179aba8e533d27d2360_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEzLTEtMS0xNjY5MTM_761faa4c-bc34-4290-8e56-5bb419ea8454">41</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6dd78859ef8848a999eb4a52492eef4b_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTYtMS0xLTE2NjkxMw_f322c0c2-e84c-4f56-9d55-ee9418e8a024">3.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd78859ef8848a999eb4a52492eef4b_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTktMS0xLTE2NjkxMw_8dd80e03-37f1-46f6-894b-4283fa4855c0">420,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997ddfe9c3304a9e9408563c2fd4c3d3_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTEwLTEtMS0xNjY5MTM_fc1a925f-06ba-45ca-bb6a-8ed694a544f5">445,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifec03638243c4669892b4eb299ae5ed2_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTYtMS0xLTkyNDc5_17eda191-48ed-4d8c-977f-5d8a59adc50c">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ifec03638243c4669892b4eb299ae5ed2_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTktMS0xLTkyNDc5_4e137efd-9f3a-46f5-9e52-cfe5d4064955">48,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i0465a51e6df04b86963ff406fb55ea2a_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEwLTEtMS05MjQ3OQ_ec3895e5-4566-4a5e-bce6-5f4a8e355364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7523d880d9374a2481b72ce4679376f9_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEyLTEtMS05MjQ3OQ_8ccf4b10-5cd4-4a8e-bdfc-665b5209b3f3">3,528</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3214317cf106471eb746ae95e24aea11_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEzLTEtMS05MjQ3OQ_2616b306-a627-4f34-a244-0262220d7d0a">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67557a94436f43d9bf40a6821f726802_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTYtMS0xLTkyNDc5_6e82a039-c37c-4780-9fb2-4cd743d0ba44">5.32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67557a94436f43d9bf40a6821f726802_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTktMS0xLTkyNDc5_40e51a92-faa7-46ff-a99a-ac7599b2b441">49,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33212f0ed73438ea87f123c17695625_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTEwLTEtMS05MjQ3OQ_6193d3df-92fc-41fd-80c7-13cfffed09aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i844b7cae12554de8ba766bd5d0e34762_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzIxLTEyLTEtMS05MjQ3OQ_3d4ada49-5f7c-4440-a67c-206b709bedd8">7,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaca32771dbc4bf086fdf4c473690023_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzIxLTEzLTEtMS05MjQ3OQ_b7463692-5c09-4091-aa75-0d283538e082">8,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 2022, in accordance with the termination date, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with aggregate notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ic1d27726f48242c888971f11c16fce73_I20221003" decimals="-6" name="iart:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE5OTg_9ca9aa4b-bfc2-4a09-81a3-24ecb17e3744">100</ix:nonFraction> million. Based on the closing exchange rates, the gain upon settlement of these swaps was approximately $<ix:nonFraction unitRef="usd" contextRef="i32190bd884274de3ad539b9552b10509_D20221003-20221003" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODIwOTg_4cb4f2eb-eefd-43e7-9d6f-8494eb7b7b9c">1.6</ix:nonFraction> million which was offset by the loss on the settlement of the intercompany loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i70886b0065374cab828ea261cdadbf4e_I20211004" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzYxNjg_c0c086dc-fc26-4fa2-a360-7ce1dbbb8380">50.0</ix:nonFraction>&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCI. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 ,December 16, 2020 and May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i5118b54e53ad40e0a15121c597f44dc9" continuedAt="if0d9f72ae33341a28b56447ac040ee52"><ix:continuation id="i77ecccf15ac543628ec8b4e526fffce1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:14.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02e3c4b1748e496f95f812498d15e0d3_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtNi0xLTEtOTI0Nzk_699e9658-acc8-4755-9dde-1aab5cb7d198">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i02e3c4b1748e496f95f812498d15e0d3_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtOS0xLTEtOTI0Nzk_1a177d2c-79d1-437a-bf21-446c5ee7efd1">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i0d1829ef6ea84eaca05276c51c0606c0_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzQtMTEtMS0xLTE0MzE4Mw_7f3c6c06-b0f9-4f02-a5bf-320d1832fe11">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if061f0c8b11a4b0e9af9f2d1b0096dfc_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtMTEtMS0xLTkyNDc5_207c6671-e1ba-4598-b927-a61739dff3dd">4,713</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if02c59d68ec54646a35d4af040a81a1a_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzQtMTUtMi0xLTE0NDIwMw_ff2fb6cc-f890-4672-9a3e-ba8ff7944771">2,503</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67adfefe5a8443c6b626a7bbf0761620_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctNi0xLTEtOTI0Nzk_65244af6-77dc-4c92-b4b2-0e7fde83d082">2.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67adfefe5a8443c6b626a7bbf0761620_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctOS0xLTEtOTI0Nzk_701e987e-16f8-46df-bb71-9c0ff0e5dd1c">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5897d96d2c4f5496944a6fd6a162ad_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzUtMTEtMS0xLTE0MzE4Mw_2248594b-4157-4f69-ae3a-76ef32d2751b">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i245c76d03fc54d94af94a58fba2d7466_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktNi0xLTEtOTI0Nzk_90802c3f-58bd-4416-87d9-4ea1c96561ea">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i245c76d03fc54d94af94a58fba2d7466_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktOS0xLTEtOTI0Nzk_6fb7d433-0d87-4d58-bfcc-577f9b904c8a">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55466ef9ef12476299ceffdcdfee3a9a_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctMTEtMS0xLTE0MzE5MQ_3b55aa52-5fbb-4582-b6b4-0cdd02766f85">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4142d8f488e94bcc8829564ba2e3adae_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktMTEtMS0xLTkyNDc5_96eb00cf-10b1-46a0-8a76-d05d3d92b26b">4,307</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f429c0617e74d7eb2fd570e3c4023ed_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctMTUtMi0xLTE0NDIwMw_98c47e4f-c63e-4c96-94e1-8438b05533fb">2,147</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a59d109ca88487ba3a465148ff07ff4_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTYtMS0xLTkyNDc5_00275585-b9ac-46a9-bbae-fa9270e20a87">2.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a59d109ca88487ba3a465148ff07ff4_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTktMS0xLTkyNDc5_b376287c-f2ee-4b34-aa37-ab9f059edccf">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5643d36404495ea9dedee026b7689a_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzgtMTEtMS0xLTE0MzE5MQ_bc294f0f-40d6-42e3-8a9b-147eac1a5c12">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5b3abf28fae409ea406125cd090ebe5_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTYtMS0xLTkyNDc5_b9e21299-27c1-4b57-888a-55d5e6179ab2">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ic5b3abf28fae409ea406125cd090ebe5_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTktMS0xLTkyNDc5_46ca287f-1051-4ee8-b197-542d0425b701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i043cdbf94a754048b4b54ddd6eea2270_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTExLTEtMS0xNDMxOTk_dd3f9b7e-925d-46bf-839a-c275b9f8b61a">222,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7b61c995a64818b815e9e90c34fa77_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTExLTEtMS05MjQ3OQ_489a60da-3590-4358-bda6-2262034c204e">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id601c28871b9412d9cb1392b237ce8a3_I20211231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTE1LTItMS0xNDQyMDM_83331067-27c5-4b44-a752-6b6ddade5743">792</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTYtMS0xLTkyNDc5_2a936c8a-8504-4cf7-9ff9-550d4d0ebddc">1.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTktMS0xLTkyNDc5_f0b3b803-5da4-4b73-a111-25b2458c5fac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde344ad1e464afcb71f8af811c85b13_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzExLTExLTEtMS0xNDMxOTk_ec7741dd-d12b-41aa-a873-340fb087c23a">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieac0855122ee48d1aa3a6ee317127bd5_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTYtMS0xLTE0NDE1OQ_fea3c4de-b5b9-482e-892a-d56cdde49704">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ieac0855122ee48d1aa3a6ee317127bd5_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTktMS0xLTE0MzIxNQ_c11ba38a-495c-40f9-933b-b478e49adc50">288,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i3fe3ee7c51fd49caa0539281dd6cf5c5_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTExLTEtMS0xNDMyMDc_6e03ec0a-dc96-405b-9eef-c0730033a4ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae5a8365a26446a3a0dca3f7522aa7e5_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTEzLTItMS0xNDQxNzc_1928b12d-193a-4dfd-8137-4795a0265119">14,663</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b78e51cfeea49168e5007a5a4cfcf0e_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTE1LTItMS0xNDQxNzc_3d78d61a-dcc3-48c0-8066-2d9897394ae8">&#8212;</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie807adbb29e64c9cb05ae929d44792cd_I20221231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTYtMS0xLTE0NDE1OQ_1d57c098-7bee-48a9-9b9b-8be0a7ae59dc">1.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie807adbb29e64c9cb05ae929d44792cd_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTktMS0xLTE0MzIxNQ_10ef85ba-fd7a-49eb-9391-d9f066495690">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e492d9a1944dbc88ed4e5773148fc2_I20211231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTExLTEtMS0xNDMyMDc_7b9a7b72-444b-45c4-a624-d13e56154220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac2b519b9bef40ce86b32e60f3e0c395_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE1LTExLTEtMS05MjQ3OQ_bd82ac84-3266-4d35-9b60-2847d8d9f4f9">5,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfa8444a4ff4c799d79806966a6a49e_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE1LTEyLTEtMS05MjQ3OQ_24fdc91d-8be2-4d10-bfeb-41361d686d31">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, the Company early settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2eb10ee588794a879897fa8ebf06fbe5_I20220526" decimals="-3" name="iart:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI2ODQ_07a19c43-db6c-4658-b95c-d12ec6ca1dad">250</ix:nonFraction> million equivalent to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="chf" contextRef="i2eb10ee588794a879897fa8ebf06fbe5_I20220526" decimals="-3" name="iart:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI3MDI_8c6cebd3-add9-4254-99cf-8cb87bae2fd0">222.3</ix:nonFraction> million CHF. The original settlement date was December 16, 2027. As a result of the settlement, the Company recorded a gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if4a01a2803854f15a4b2bdb0ad580cf3_D20220526-20220526" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI4MjU_1571003c-cf63-46b7-93ad-c6d01e99fad0">4.9</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in AOCI. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedge to replace these swaps with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI5OTU_b0b981ec-17a9-4f26-b601-d058d9053cc4">300</ix:nonFraction> million equivalent to <ix:nonFraction unitRef="chf" contextRef="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODMwMTM_b1ca298e-6ce1-45d6-aa07-b68ad7914a97">288</ix:nonFraction> million CHF. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="if2a5b238cefd4ad4851f8db781417fb8_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg2ODA_a055f86b-4861-47e9-a0da-94c5c4506cdb">52</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="eur" contextRef="if2a5b238cefd4ad4851f8db781417fb8_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg2OTc_83016c35-da19-4392-9c6d-79801932d13d">44.9</ix:nonFraction>&#160;million Euros. As a result of the settlement, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="ibf30e04d2e234b5da6da9f923618a1d6_D20210930-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg3Njk_93e02422-8432-4456-9603-f3936aa600c0">0.1</ix:nonFraction> million in AOCI.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded as unrealized gains or losses in AOCI. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="if0d9f72ae33341a28b56447ac040ee52" continuedAt="i4f9150a72e0844408f9087a3cbd0e06b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjkx_b2593f8f-f03c-4957-9c8e-d2e8f27eafc1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6753166079c43ef87f10211fa41814f_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzYtMS0xLTEtOTI0Nzk_28b15b8f-0c86-40ff-ac6b-0727f147beea">4,497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc81409a88946a78bc0d4af0384c50c_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzYtMy0xLTEtOTI0Nzk_fa9b01db-2052-4501-b568-1f4dd5243f78">4,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7629ad2913ce4b8c8a3a007050c04b32_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzctMS0xLTEtMTUxMTk2_526588b8-e6f4-482c-ab3e-a66390bff0c6">16,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b1038cb45449bd8017c02b7e07bcbe_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzctMy0xLTEtMTUyMDY4_2dab85ef-3929-49c6-b04e-fbdfebd794e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7b6826294643ee9255e0aef5bfe00c_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzgtMS0xLTEtOTI0Nzk_7595ad64-9d81-4e4b-a4fb-76889ac986f2">11,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14509aa5da94573ae2e368395318395_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzgtMy0xLTEtOTI0Nzk_a9d213e9-eb75-4465-a3d1-d4032ed3ee61">5,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d11744ab624cb0b137eee60066f067_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzExLTEtMS0xLTkyNDc5_12b42b73-d31c-42c9-8a01-944ad54b6086">40,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2578085d407f4986b5c4f56a8f5378e7_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzExLTMtMS0xLTkyNDc5_8c32ddd7-a305-407e-80eb-b30700f50f29">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0774406054da4b54a1499e2e2203b073_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzEzLTEtMS0xLTkyNDc5_2db0ae8d-2437-459f-b22e-6af84551ca5b">3,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b578e29f734d8da75403f33593ad57_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzEzLTMtMS0xLTkyNDc5_ac5dabdb-a2ef-4385-b240-c3ebc642444f">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f1ed4692244fb883cb0925404db697_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE0LTEtMS0xLTkyNDc5_8428b87a-d627-4ef4-94a1-9b0213cf39d0">76,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedc48383bf44714905c7aba0b7e7eff_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE0LTMtMS0xLTkyNDc5_fa2bd7f9-094d-482a-91a5-32de3933e277">16,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78f2cc3007c4d01874f3559b01933a6_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE5LTEtMS0xLTkyNDc5_9f188242-a752-458f-a15f-8d97d0ee9786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02621b369e244009ba8077814770d363_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE5LTMtMS0xLTkyNDc5_b08bf4d9-38ca-42e9-a408-16768fb88798">18,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82dc831f0d8543a3babdcc95198b48d0_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIwLTEtMS0xLTkyNDc5_4ff8135f-dd2a-459b-a849-0a69154e7ab2">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7598ea197a08489d85d2ca1a1d75029f_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIwLTMtMS0xLTkyNDc5_a902ec25-8be5-4776-a69b-16b8ec8358ab">8,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40bd17782234cf0a42d79443632bd3f_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIyLTEtMS0xLTkyNDc5_d2733a33-d724-4db0-a586-4cf9f6a6d883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2e8ae6d2b84ab289dc5a4f5f4cac96_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIyLTMtMS0xLTkyNDc5_0e1d157d-3889-43c6-bdd3-a70f4fdc7bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6649d3266ef54cdea0866db034e7da0f_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI1LTEtMS0xLTkyNDc5_ba528647-cb83-4f1f-ab5e-fba9b4d275bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i284332c0c59745a1bafecb41e59a8cbf_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI1LTMtMS0xLTkyNDc5_a078ac86-2756-40ee-866e-909870c3e116">30,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdafe514a0f427a9c65279378fdca48_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI2LTEtMS0xLTkyNDc5_e779dbaf-a43f-4ebb-865f-ef6dbceebf52">8,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ad7a70040d43599f4f203940fb2c3c_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI2LTMtMS0xLTkyNDc5_bc771f3d-eaa4-405c-9bf9-077721f6dc3d">4,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f179ad71894c39b72c41978bcf975f_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI4LTEtMS0xLTkyNDc5_5209647a-4f1d-4bb4-ba34-cdd4b28501ab">20,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib479a1abd4bf4dd598c12f1ade31cc64_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI4LTMtMS0xLTkyNDc5_daaa4619-b845-464f-a1ae-d235480056d2">3,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f1ed4692244fb883cb0925404db697_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI5LTEtMS0xLTkyNDc5_52bfd56a-0208-4477-af46-67e4bac7ed56">32,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedc48383bf44714905c7aba0b7e7eff_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI5LTMtMS0xLTkyNDc5_bfcff3b1-c524-48ae-9e2d-9ae6ce566c60">64,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2022 and 2021, the total notional amounts related to the Company&#8217;s interest rate swaps were $<ix:nonFraction unitRef="usd" contextRef="ic924cff55443463a8fa41f30829d128f_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzMyOTg1MzQ5MTA5NTU_805a42a1-b132-41e7-8969-ee0a89806133">1.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i2d7c68edd73b44ed90a88f720435dd5c_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNDQ5_a20f199e-9c95-403a-9f7a-c23ceb2c0e9d">1.8</ix:nonFraction>&#160;billion respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i4f9150a72e0844408f9087a3cbd0e06b" continuedAt="id7eb265bf2f04f359aea5cf7332807ff"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNzAz_fcbfe196-b2f0-4512-bc89-bcb68e55e984" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCI into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8f45920e753432791e424ba5bde4c8c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtMS0xLTEtOTI0Nzk_b07337d4-def7-4889-9cd1-2266d1f8dde8">43,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtMy0xLTEtOTI0Nzk_2133cae8-c6c3-4fe9-8413-1fec7c999e96">93,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtNS0xLTEtOTI0Nzk_a5c7410b-e39f-4238-ac00-7b13caf311b7">7,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326dcdfdff4841f5b13090e062a83847_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtNy0xLTEtOTI0Nzk_78117416-79e7-40eb-bd56-fa2e2075a4be">56,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251186fc1f74fa98118a5b683fb8145_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtMS0xLTEtOTI0Nzk_50d9a519-4f1a-4e62-97da-c1f623d5b06c">9,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtMy0xLTEtOTI0Nzk_c588d727-0085-4639-83a1-033b339ad97d">8,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtNS0xLTEtOTI0Nzk_bc669009-4037-4076-b464-90c8d1cb123c">19,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i740c386c824b47d9a8a3bdd39e134319_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtNy0xLTEtOTI0Nzk_41f6944a-acf1-467b-8024-3110629d39ef">20,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtMS0xLTEtOTI0Nzk_4cd5002f-3547-4c93-a2d9-50a39ac5b263">2,321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtMy0xLTEtOTI0Nzk_ed92db2b-8975-46b6-9dac-482268ab02ae">2,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtNS0xLTEtOTI0Nzk_3fa1fec6-655c-498c-a6ca-517aec64654b">6,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccf39968359d436db16110742b8c4283_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtNy0xLTEtOTI0Nzk_82845d42-5efc-449d-8e2c-14918ef7eaf0">6,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b747e04cef446c8bbd192b91223c454_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctMS0xLTEtOTI0Nzk_4c87653e-97ef-4632-ba06-a439a1be4ce5">55,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctMy0xLTEtOTI0Nzk_9fb2bc9e-fce8-4b7d-bb89-265bfd3eea73">104,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctNS0xLTEtOTI0Nzk_a4e584b9-72db-42b4-abc8-6d16536caaf0">18,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i408e91f814cb42ff97d90348c7ed6c52_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctNy0xLTEtOTI0Nzk_09f66e31-e306-4899-a903-2758c2ce2ad4">29,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaa8a61ecfd341d69a8f83de49c64cdb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTEtMS0xLTkyNDc5_cb951e49-1d40-4a13-8a4e-3502b0d83415">93,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTMtMS0xLTkyNDc5_9be5210a-4132-4f25-9922-062afd5c0249">27,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTUtMS0xLTkyNDc5_18bbf4fb-cd16-494c-aeef-8a8c9bd3d8b4">22,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8f45920e753432791e424ba5bde4c8c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTctMS0xLTkyNDc5_89859b41-a6a8-4b31-8469-ef79f535a76f">43,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc8a876bb2c64e86b657b3bae578a201_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTEtMS0xLTkyNDc5_2d977471-698b-4677-ad60-8811ebe89cad">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTMtMS0xLTkyNDc5_c632efc6-3c69-4d85-abfb-15b3ad08f958">24,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTUtMS0xLTkyNDc5_346ba36f-c904-4f31-b830-d66de61a2797">32,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251186fc1f74fa98118a5b683fb8145_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTctMS0xLTkyNDc5_33297290-2575-421c-804f-6161fcfd2c06">9,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54e1d03cd5a24c73bec632484549eb64_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTEtMS0xLTkyNDc5_6231a42b-b92f-4550-b85a-51df46aeb4ae">12,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTMtMS0xLTkyNDc5_083fb918-89f3-468d-9bd1-7f944a1ac1ba">16,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTUtMS0xLTkyNDc5_c73d6006-c31d-472d-bf77-5835b39ae7c8">6,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTctMS0xLTkyNDc5_3b3ed301-112e-4b87-b8ef-88eacc54d865">2,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc909923f63a42e9a92c1575f351c160_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTEtMS0xLTkyNDc5_9a98a191-66ef-45d5-b120-0321c5c342ee">107,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571a678056af4243869d6bf87a39cca5_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTMtMS0xLTkyNDc5_94a4df71-be87-483b-883b-0b87d1582c1b">68,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571a678056af4243869d6bf87a39cca5_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTUtMS0xLTkyNDc5_88025168-87d8-49cd-95d6-5a437fd7838d">17,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b747e04cef446c8bbd192b91223c454_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTctMS0xLTkyNDc5_df47dc6f-ca79-4fe5-b4dd-d55753423ce4">55,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i38353e1fdf1749048a5b705812d03489_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5MjQ_cd2aff41-174e-4095-a36d-63a5d7a0b1b6">11.1</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i4ca92d0c0999415284527156e8006bce_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5Mjg_7c145246-efc6-4918-8904-f109312d7389">23.8</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation of the cross-currency swaps, designated as cash flow hedges, to offset the gains or losses recognized on the intercompany loans.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded gains of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5NDY_645fadeb-6cd2-4727-bd81-1b46d1edbc9e">8.4</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $<ix:nonFraction unitRef="usd" contextRef="i8909f47c11f94a13b5b07c5424d9e86b_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5NDA_8dd5a536-447e-449c-91ba-3e83ed58872b">9.1</ix:nonFraction> million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps designated as cash flow hedges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain  that is expected to be reclassified to other income, net from AOCI as of December&#160;31, 2022, for the cross-currency swaps designated as cash flow hedges within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i222c2a2c9bb74ffb8a6ede3f0fe2b07f_I20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODUwNDE_8ed1f5e3-1f41-4991-aa94-a1582f51723d">4.5</ix:nonFraction> million. As of December&#160;31, 2022, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCI as of December&#160;31, 2022 for the c</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ross-currency swaps designated as net investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hedges, within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="iac2b519b9bef40ce86b32e60f3e0c395_I20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODU5ODk_bc4f2e90-2214-4280-8e99-cc49cc29ea9f">11.7</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments not designated hedges:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="id9344740008a49528124058c2083bc1e_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTQ5MjQ_8c9d7a48-1bb2-4497-b568-863cb5cfabc7">4.2</ix:nonFraction> million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD").  These contracts were settled in third quarter of 2022.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i3d23ab70c34f4db5b5a839db493e3059_I20210630" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTI0MDM_3e96b302-c7ee-4c5d-8f15-c5a6b261ec2b">7.3</ix:nonFraction> million, to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $<ix:nonFraction unitRef="usd" contextRef="i46d3030c2e0049f8a3c5db01ea805895_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTY3ODA_9c01d0a4-f65f-482e-b844-f9ad7d994ea6">6.4</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQzOTgwNDY1Mzg2OTU_0e59dde6-a6e1-4484-ba86-d6386398afb3" continuedAt="ie6d892748c6b438cb22e667e13cc6db2" escape="true">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:continuation id="id7eb265bf2f04f359aea5cf7332807ff"><ix:continuation id="ie6d892748c6b438cb22e667e13cc6db2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:43.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f18b3ff623a416ba0697a89389f4152_D20220101-20221231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzItNi0xLTEtMTQzNjU0_06fb7c31-4fdc-4db1-9e8d-1a1b36366d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191577736fc34ca8967de6fee9d82bed_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzItOC0xLTEtMTQzNjU0_1485730e-c077-41bb-91ed-bd90756a6f5a">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5b2da3f37e4fbcafc4fc5d9d3dde7d_D20220101-20221231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzMtNi0xLTEtMTQzNjU0_ba15ab7d-0f1d-4ebc-a045-69b52be166a2">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647e1d0b571a474c98483e6c2526bb29_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzMtOC0xLTEtMTQzNjU0_1d5473c6-410e-48ed-9926-eb8b37cb4464">629</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzQtMi0xLTEtMTQ0MTgz_0a6a77b1-6782-43a9-b23c-f05b34a47f67">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzQtNC0xLTEtMTQ0MTk2_0b81810d-fa81-45fb-afbd-7fdc965896ba">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_166"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDI_e3fccd34-63eb-4ccc-bcb6-8f2e23601dbc" continuedAt="i26caf97b0eb34455b35ac089db5738c8" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS </ix:nonNumeric></span></div><ix:continuation id="i26caf97b0eb34455b35ac089db5738c8" continuedAt="i94483239aa9641eb8ff539ce0b292da9"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;<ix:nonFraction unitRef="reporting_unit" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzU0Nw_b2a7859b-d5fa-4bc0-9e53-17d29b8a2a6f">three</ix:nonFraction>&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of the <ix:nonFraction unitRef="reporting_unit" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzc5Mw_b2a7859b-d5fa-4bc0-9e53-17d29b8a2a6f">three</ix:nonFraction> reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company elected to perform a qualitative analysis for its <ix:nonFraction unitRef="reporting_unit" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzI1NTg_9ee74d57-5509-414b-a223-b52107cc7cc6">three</ix:nonFraction> reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDY_ac27199a-bc25-42e2-9097-5ece9c61350a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2022 and 2021 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfcd42c9d16743e891b05d6e22c839f6_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtMS0xLTEtOTI0Nzk_177f8557-7a1c-474b-aca4-fa24ac4ae06d">671,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb11cdd18ef45a19a594c8b5a25ee96_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtMy0xLTEtOTI0Nzk_bb4bb00f-fe7c-4686-96e2-3dcf581737ed">260,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtNS0xLTEtOTI0Nzk_2b82b485-7f98-484c-856d-1eacf32a20b1">932,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a836c14502143549a1b9311fc3030f9_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItMS0xLTEtOTI0Nzk_a77f793e-0505-49fc-82fe-f3066d122e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97f621bb1334d50b0248002c7710d81_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItMy0xLTEtOTI0Nzk_adf4572d-03f2-40cb-ac1c-7bedd26a4132">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58764c27ca344070860ba269f3f79103_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItNS0xLTEtOTI0Nzk_f8e83582-753e-4b50-9c4c-9bb5808c0766">94,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtMS0xLTEtOTI0Nzk_acf22fc4-2b7d-4bf0-817e-dcd876eb2140">8,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtMy0xLTEtOTI0Nzk_14475828-5bba-4077-8bee-f22642b6d5bc">4,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtNS0xLTEtOTI0Nzk_b90d5169-474b-4afb-91cd-260808b5490c">13,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05ba75e955c4e129ebec3073ef3f592_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtMS0xLTEtOTI0Nzk_4e93b1c4-dc84-48d9-abb2-814dfd3210ea">663,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i628a3e3f7d544ad2bc901d0888fe818d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtMy0xLTEtOTI0Nzk_6414c4f2-ed7c-47cb-b2f5-c5f1333835fc">350,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtNS0xLTEtOTI0Nzk_ae49beea-e55d-44ad-9f0b-05382ad82021">1,013,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-core traditional wound care business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtMS0xLTEtOTI0Nzk_b6b0c3a6-5fef-4335-aa24-025fd103b3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtMy0xLTEtOTI0Nzk_f7fe5e5e-7653-4012-837e-b5b23ee9b8dd">5,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtNS0xLTEtOTI0Nzk_3ed1a494-4142-4367-a1fa-a63913d2b8dd">5,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SIA Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0755e5e4a8746c7a194eab90915121d_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMS0xLTEtMTYwNjIw_05bccbca-7036-45d6-bf8d-69379c1e6844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c981ec865a242b8ae02ae0b9be850b1_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMy0xLTEtMTYwNjI4_0963bb23-381c-40a5-b645-71ffb6e7abc8">41,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01193be6295c427585def8bb00fd4b04_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtNS0xLTEtMTY5MDE1_44ab3433-0dc9-4a2e-8b67-59443755a900">41,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMS0xLTEtOTI0Nzk_5df77023-184b-4881-9dd5-c49f0bfb275f">7,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMy0xLTEtOTI0Nzk_898b134e-36ec-4fd3-9c0e-a482459f5a9f">4,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtNS0xLTEtOTI0Nzk_ae04e19c-422b-43b6-b1c0-a7305e67a01a">11,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb26a3f7b9af4d3988640472b2a1e3d1_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctMS0xLTEtOTI0Nzk_4d38bf6d-625b-47da-a225-7872f53475bb">656,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36770afe37b9412b9efea6344f408b74_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctMy0xLTEtOTI0Nzk_67704099-6997-4003-9530-71977b056e52">382,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctNS0xLTEtOTI0Nzk_f0670f25-083c-458e-8268-0370b0d5b863">1,038,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i94483239aa9641eb8ff539ce0b292da9" continuedAt="i942df6c03a7246deaa33a798cd70951d"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDE_b300ad54-87e5-4da4-ade4-d4f781bd1813" escape="true"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDU_3a14f607-e747-4f81-8aea-3251c6971445" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:47.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dfa3992858f4edc84158ff91aeadc14_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplYzI0M2ZkMzBhNjg0OGE5OTA3ZDk3NDc1ZmY1MjQ0YV80_2ea55141-c99a-44ef-9ed8-2205f61fc531">18</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItMy0xLTEtOTI0Nzk_63ba5904-2fd3-4133-ab06-a564d69b9856">1,204,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItNS0xLTEtOTI0Nzk_2edc31e8-e135-4caf-adf6-4e79627941fe">370,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItNy0xLTEtOTI0Nzk_3b460615-5ee2-4b1a-ae41-67830a02924e">833,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iec4953d9327d47a9a45aba2fa3765106_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NzNkMjA5NWM3NGU0YTM3YTVlN2RhNWZmYmU3MmZhNV80_22b4c2ec-668c-404c-a1fb-316eeca3a041">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtMy0xLTEtOTI0Nzk_99f6de1a-bfd5-4cb5-809b-dd6b2bd630cd">193,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtNS0xLTEtOTI0Nzk_de39be3d-80e8-4eed-852a-6d1aa7df3ade">144,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtNy0xLTEtOTI0Nzk_f9a7807c-77c4-4ef1-a709-78527982df46">49,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1e4d6b7a79746f78154e10fd0d645de_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo3NDY0OTI0OTdmYTg0ZDY3YmMyNjQyYmY2NWRjZDAxYl80_be22b6f2-a572-43b2-9bd2-8053e2e83482">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtMy0xLTEtOTI0Nzk_63b19c48-5989-4761-895f-4c8108ea19c1">97,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtNS0xLTEtOTI0Nzk_1b621072-9762-44c4-87f1-5bbc6cca2cf4">34,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtNy0xLTEtOTI0Nzk_5bf80c48-8bde-47f0-a562-ccbd65b07b0c">62,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b51dab47180467b905af4f67a4f4857_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzUtMy0xLTEtOTI0Nzk_159c975b-ffdf-4739-a1d3-353f402d312e">166,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b51dab47180467b905af4f67a4f4857_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzUtNy0xLTEtOTI0Nzk_3c06ab58-fe0d-48d3-b1eb-85e37ab9f1b5">166,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic67ed97c9d064b8186d3064a9654c6d7_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1MWNhMjgzYmQxYzg0YjNkOWNjNTA3ZDljODBmY2VlNV80_d7052c80-f278-45e9-989f-ff0410d5c0d2">30</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtMy0xLTEtOTI0Nzk_a51f0de8-1d80-437e-ba8a-3e2a3d306384">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtNS0xLTEtOTI0Nzk_6568d676-e6ae-4479-acf6-a13d21c7fc22">17,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtNy0xLTEtOTI0Nzk_6677fd1d-193e-4add-a9f7-144a7aad2b28">13,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icfbd5fe6a779428bb7005202e9c1d107_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjphZDQ2NjQ5MzU1NDI0MmRhOTI4MTI2YzRjN2NmNTc1ZF80_cbd27f3b-e931-4a86-94da-3c6af89d04f4">11</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctMy0xLTEtOTI0Nzk_e4b0a565-afd1-4a72-a6f8-ba3ca4c26ce7">5,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctNS0xLTEtOTI0Nzk_41b9d61f-34bf-4f56-883a-5d08c6e0cc1c">4,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctNy0xLTEtOTI0Nzk_9ed3e57c-7c3f-459c-9a82-3add4bfbb506">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtMy0xLTEtOTI0Nzk_626621b2-90b4-4fe2-8cb3-1475b29c3dae">1,697,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtNS0xLTEtOTI0Nzk_287edbc8-22b9-42ef-88e7-104abafe6a25">570,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtNy0xLTEtOTI0Nzk_88d78458-05c4-45cd-9e95-61d451d85b55">1,126,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:47.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic53017849e8e46159900dda56c09d990_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowMDI3NjAwZDNlMDQ0NDkwYWYzNzlhNjcyNjExMjQyZF80_d236aded-63be-4623-bb0e-812fe520f76e">18</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItMy0xLTEtOTI0Nzk_a5ec423d-9108-4796-a665-adb5dd0de600">1,132,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItNS0xLTEtOTI0Nzk_d45bdbb5-c469-433a-988c-0eb84ab528f1">307,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItNy0xLTEtOTI0Nzk_d7b50ab0-a0cb-405c-b512-238a10eb9697">825,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ca2000819ce47d49042fde9d9662400_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyNTA3ZmUyODkwMWY0ZTFjOWQ1MDgzMWY4MzQ1Yjk5M180_5de5e909-6a57-4d38-88fd-5046e5cf05d1">12</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtMy0xLTEtOTI0Nzk_b57ca91b-959f-421d-849d-1f365183a3ba">211,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtNS0xLTEtOTI0Nzk_bf84e73d-4327-461c-bb73-05c430cdc55b">142,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtNy0xLTEtOTI0Nzk_0d72bbae-b6fb-47b6-aed5-268b19592f6f">68,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f88d140805d417980d8109777892eef_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplNzEwODMxOTljNDM0NTM5OGI1YzJlZTczOWYzMDU1OV80_07166439-be32-43f9-8263-762173219419">28</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtMy0xLTEtOTI0Nzk_1630e60a-a271-48ad-bca1-22a316d8f242">98,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtNS0xLTEtOTI0Nzk_3aeae328-2827-45c0-9dbd-6b8009d07cdc">31,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtNy0xLTEtOTI0Nzk_438b0982-7a87-4ad5-baea-2a9bfb8a31eb">66,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39e9e07281e41ffb52e9314446776a8_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzUtMy0xLTEtOTI0Nzk_3ef70cd9-f696-44e9-a413-18afb2ad7a46">167,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39e9e07281e41ffb52e9314446776a8_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzUtNy0xLTEtOTI0Nzk_5d7eab36-2b67-431a-93f7-f242043acb9f">167,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ee7ff54bebb490c9c43421a64840f58_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjphOWEwMWE4YmI2NDA0M2ZlOTczYWQzYThlYzFlMmI2Y180_07868625-0b6f-4a09-9484-efa8b5513214">30</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtMy0xLTEtOTI0Nzk_99448455-7bbb-4f93-8536-a1a4a1b3b57b">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtNS0xLTEtOTI0Nzk_cf5e4c2c-9fbe-404d-b25a-7ef0eae4d16f">16,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtNy0xLTEtOTI0Nzk_60dc0d5f-c4e2-4869-a20a-e33bf720c6e9">14,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie593d306076f420796fbc6b3700364ae_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzQ1Y2Q2OWJhM2U0MDI3YTYxMzZmZTYxZGU1ZGEwOV80_340e144f-b034-42f8-9f42-3b549fbf8ecc">11</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctMy0xLTEtOTI0Nzk_c5e6a19b-9aa9-48ac-a2f0-2781cf8da01e">6,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctNS0xLTEtOTI0Nzk_d1344fc9-2fdb-43e4-9a8c-0eb53072b84d">3,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctNy0xLTEtOTI0Nzk_c8033864-f296-46f1-9fd1-59c6e9a5dbb6">2,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtMy0xLTEtOTI0Nzk_4b54e878-c48b-435c-9ede-deee7c475696">1,646,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtNS0xLTEtOTI0Nzk_0be46868-0d29-4560-98e9-26ff43d01cd7">501,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtNy0xLTEtOTI0Nzk_b1a5ef4a-9bcb-4a58-b15b-3fb0bc1786e9">1,145,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets with Indefinite Lives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwNTU_3a4cf3f2-786f-438e-ae83-705fb344ae6a">78.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwNjc_5ecf8e98-2ae0-4cc2-b65e-b5adea6cfae7">83.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwODM_c7b65253-c6f9-40f9-ba14-1d18fda20a59">74.5</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i942df6c03a7246deaa33a798cd70951d">Annual amortization expense is expected to approximate $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYxNjY_cf99b830-5857-47ca-b388-74360808c084">82.3</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYxODU_51e8f988-bc2b-41b6-b426-d9fcda03a92f">81.7</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyMDQ_83ca46e9-7551-4af8-9c6d-e1422a6e52c5">81.7</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyMjM_18a9e875-58da-460c-a07f-a14060c24fa1">81.5</ix:nonFraction> million in 2026, $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyNDE_00091746-168e-4606-8f7b-b3d787a83fe8">79.6</ix:nonFraction> million in 2027 and $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyNjI_40a31735-ffa4-4fb6-aa4b-dc3e77a8b038">551.6</ix:nonFraction> million thereafter. Amortization of product technology based intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzNTM_744ae938-64cc-4b6e-ae6e-e04491964ab2">64.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzNjY_f97ed528-def7-4fe7-b614-ce44f33b041d">66.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzODI_346162a0-442e-4658-997f-4d41d2567708">46.7</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, and is presented by the Company within cost of goods sold.</ix:continuation></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_169"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;<ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI5MTQ_46136095-2370-46ba-b013-88e45793a285" continuedAt="if1db6c89c74b481f84b4293f9819a16d" escape="true">TREASURY STOCK</ix:nonNumeric></span></div><ix:continuation id="if1db6c89c74b481f84b4293f9819a16d" continuedAt="i83f599558953433fabb2c9129a60425b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzgzNTk_e835ba53-284c-4f3c-bc33-f4aec2a87780">6.8</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzgzNjc_f0a195e0-9f97-4115-af49-c118e677b957">4.9</ix:nonFraction> million shares of treasury stock outstanding with a cost of $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg0MjQ_f49d2ede-47dd-443c-b36e-7121fb3bb7dd">362.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg0NDE_536c1b11-2f2b-4bf0-810b-085e023e82c7">234.4</ix:nonFraction> million, respectively, at a weighted average cost per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg1MDg_e932dbed-4367-4599-9f91-7b7c2dddfc1a">53.18</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg1MTY_50ac14a6-eb7e-48cd-92f1-b6f823b400cb">47.86</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i5d60814ab4eb454190610b8946c1a931_I20230126" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzM4NDgyOTA3MDc3MDY_b897146b-de09-4a43-8aca-de398a23c42d">150</ix:nonFraction> million accelerated share repurchase ("2023 ASR") and received <ix:nonFraction unitRef="shares" contextRef="i6329920052fe4d068537fccf47a1bbd4_D20230126-20230126" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzQzOTgwNDY1MjMwNzU_6b2881ac-7961-4a42-9059-d33713287384">2.1</ix:nonFraction>&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="i5d60814ab4eb454190610b8946c1a931_I20230126" decimals="2" name="iart:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzM4NDgyOTA3MDc3MTM_acb90fa0-1078-465a-8c2f-3d400f624dea">80</ix:nonFraction>% of the expected total shares of under the 2023 SAR.  The remaining repurchase transactions are expected to be completed in the first half of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 26 2022, the Board of Directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzYxMTk_62d23fa6-3033-4080-8dbe-493251265a8e">225</ix:nonFraction>&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2024. This stock repurchase authorization replaces the previous $<ix:nonFraction unitRef="usd" contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzYzNjA_ebe99df2-3f32-420e-81b9-b6e4b07f571a">225</ix:nonFraction>&#160;million stock repurchase authorization, of which $<ix:nonFraction unitRef="usd" contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzY0MDU_c081b37d-32c9-4545-86f4-66fc451a1def">100</ix:nonFraction>&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2022. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 12, 2022, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i98b20187279a484aa7a8e9867ab6bc1c_I20220112" decimals="-5" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzEwMDY_5ddd0b6d-df47-4716-8149-5b70cbe69b0f">125</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ASR") and received <ix:nonFraction unitRef="shares" contextRef="i98b20187279a484aa7a8e9867ab6bc1c_I20220112" decimals="-3" name="iart:AcceleratedShareRepurchasesSharesReceivedAtInception" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzEwNjQ_625ea4af-63d1-4337-8218-7ce18415b1ff">1.48</ix:nonFraction>&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="ied552a010c034654a585ce6ab14a3070_D20220112-20220112" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzExNjA_c43c1a2b-ca4f-4e88-8793-d6a7b09170d9">80</ix:nonFraction>% of the expected total shares under the 2022 ASR. I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">n March 24, 2022, the early exercise provision was exercised by the 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i464ce85ce14945ae9a2b1ea43a72e31f_I20220324" decimals="-4" name="iart:AcceleratedShareRepurchasesAdditionalSharesReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzU2MjY_ae6ed58e-347a-4dde-930c-bb4a3e661680">0.46</ix:nonFraction>&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i83f599558953433fabb2c9129a60425b">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after.</ix:continuation> </span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_172"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODE_b381330b-8044-4153-9660-ded9c84131ac" continuedAt="i7a882800e50d4f348087db2df615ce42" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i7a882800e50d4f348087db2df615ce42" continuedAt="iedcb7cf99d004853b0f6fc461b2278e9"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2NzI_52aa3dcd-1d2c-49e7-ba8d-994231071fb3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItMS0xLTEtOTI0Nzk_8ed119e4-c47d-467a-b974-ab73417c40a2">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItMy0xLTEtOTI0Nzk_1c4b706f-a1ca-4495-935e-61190a33ae47">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7dcd824511481a8120c2a8389e9b5f_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItNS0xLTEtOTI0Nzk_93f341bd-b7b6-4758-8ec9-40b309dab151">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtMS0xLTEtOTI0Nzk_247633f9-edbd-4ab9-a033-92043614a072">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtMy0xLTEtOTI0Nzk_9e633646-faeb-4759-9493-d4d67bd6a138">1,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f325b8385ec4ba599bbdc2436aa2acf_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtNS0xLTEtOTI0Nzk_24e3ea5c-8501-44cb-ac63-32f5e4c92c8d">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtMS0xLTEtOTI0Nzk_c77f62fb-ba1b-43b2-bce5-7a16fad316e9">25,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtMy0xLTEtOTI0Nzk_a169c2c3-cbb4-4546-81ce-c41ddc52ff45">34,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibab792d7a62149d18dc8eb2dc3683f89_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtNS0xLTEtOTI0Nzk_ce2e9c76-7142-4292-939e-b5881283e74d">17,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtMS0xLTEtOTI0Nzk_739c6909-1c71-4635-8892-329c8582f60d">27,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtMy0xLTEtOTI0Nzk_c6f75721-877d-4c66-a5b6-33d95b24b358">36,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtNS0xLTEtOTI0Nzk_1632b614-a20c-4e8f-ae58-eba3bef99972">19,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtMS0xLTEtOTI0Nzk_e67f3bb3-5429-46cc-b1b2-4fb081e1f29a">10,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtMy0xLTEtOTI0Nzk_8ee1b504-dbdb-419a-b999-4c03e62f03ab">13,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtNS0xLTEtOTI0Nzk_f6af6577-c8da-4f6a-95e1-4c81719a2427">6,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctMS0xLTEtOTI0Nzk_44d039dc-0e85-4178-97e3-144c1c3cbbc5">17,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctMy0xLTEtOTI0Nzk_6585dbff-906e-4bb8-9653-7a60cadbc91c">22,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctNS0xLTEtOTI0Nzk_131ea7e6-134e-418c-81d0-aba78a845c46">13,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of <ix:nonFraction unitRef="shares" contextRef="i60b6305eecf041d2b4ced862809aa250_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUxOQ_0dec7da4-9c44-4979-b698-e55e163e8577">3.0</ix:nonFraction> million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i60b6305eecf041d2b4ced862809aa250_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzc2NA_135918c4-bffe-4d28-a8a1-2a36491083a4">2.0</ix:nonFraction> million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2022, 2021 and 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzg3Nw_227a6fc3-3c30-495d-9256-8f5f4aac1664">20,780</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzg4OA_f2e40807-1d81-4449-ad10-960b5cf9db97">16,948</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkwMg_7336fe98-a004-44ea-b204-9778d3028312">18,284</ix:nonFraction> shares under the ESPP for $<ix:nonFraction unitRef="usd" contextRef="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkzMQ_8c85e648-16fe-4e66-9f5d-87b12039ca47">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkzNQ_6f19a946-f1ba-47c2-8ae1-b7657db003bf">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231" decimals="-5" name="iart:EmployeeStockPurchasePlanProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzk0Mg_5b08640f-1d95-4e93-a436-ce76f8a7ed30">1.1</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iedcb7cf99d004853b0f6fc461b2278e9" continuedAt="i8542745afc8b41a9a7f102aaf1cec357"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="ibc191873f1dc42bc9a919b9154c27144_D20100501-20100531" decimals="INF" name="iart:IncreaseInAuthorizedShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE1MTA_5aa6e96e-2f18-4943-865c-abf3566ebfdd">3.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i77e0bc249d794d8c923d4baa7345c70c_D20170501-20170531" decimals="INF" name="iart:IncreaseInAuthorizedShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE1MTc_01ee3256-e1f7-4cb4-bcea-d3442ba2d029">1.7</ix:nonFraction> million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved <ix:nonFraction unitRef="shares" contextRef="i64ad94a13328414ba507646767f3d728_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2Mzc_a64bff00-3f4d-4906-aa15-c2af7a9ae54f"><ix:nonFraction unitRef="shares" contextRef="id35f0fa4951b44e5a8286675c32d2ef8_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2Mzc_ce117042-9d6a-494a-920a-2cc488d6a3de">4.0</ix:nonFraction></ix:nonFraction> million shares under each of the 2000 Plan and the 2001 Plan, and <ix:nonFraction unitRef="shares" contextRef="i503e4c87c0e04676afd28e1f2a991921_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2OTg_0e29ed95-dadf-4c9b-a63f-bb6d52cc6bfd">14.7</ix:nonFraction> million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan became exercisable over specified periods, generally within <ix:nonNumeric contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIwOTg_2154b747-aa19-469d-8e32-52b009bd5b8f">four years</ix:nonNumeric> from the date of grant for officers and employees, and within <ix:nonNumeric contextRef="id7872cc732b34351b799a3c73f66289e_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIxNjM_9b0d57fd-2eca-4ca9-9f61-249d7a9cbafb">one year</ix:nonNumeric> from the date of the grant for members of the Board of Directors. The awards generally expire <ix:nonNumeric contextRef="iab05a5cd30cb455e944ffa624620cb14_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIyNjA_e79685ef-c833-4574-92fb-3f03d7b65908">eight years</ix:nonNumeric> from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMDY_22acb8fc-f2cb-409d-a273-b3b42a7cc9db">six</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMTI_d4b35179-5c95-4990-bea5-db80dcb363e7">ten</span> for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally <ix:nonNumeric contextRef="i0f13c95eae224327a6df76189d019f93_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzI2MjA_64ae9572-4790-456e-bbe0-5326e6efa92c">three years</ix:nonNumeric> after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a <ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzMyOTQ_ea1951c0-f1f3-4369-a191-217e2d29dc92">0</ix:nonFraction>% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODk_6103f4fc-1f54-4d39-9b0a-d0f1bbcd5fc7" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItMS0xLTEtOTI0Nzk_fbb67b91-164b-4cb5-9951-ead0e4d98e9b">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItMy0xLTEtOTI0Nzk_2b5dc3bb-f99c-4c6b-a2a2-484867f5f50b">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItNS0xLTEtOTI0Nzk_cf906a46-217b-431c-9d4e-b373f92e8340">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtMS0xLTEtOTI0Nzk_815f70ee-afe1-4852-8d3d-fb6dce75c2c3">30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtMy0xLTEtOTI0Nzk_49008547-d8a3-4d8a-a98a-815d78893ccb">29</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtNS0xLTEtOTI0Nzk_3ed9fcda-38f3-432b-b427-ba0fe3f4e894">27</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtMS0xLTEtOTI0Nzk_44c6e95c-34ce-4cce-8025-7340c12541ef">2.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtMy0xLTEtOTI0Nzk_3dae282c-4462-419c-8fb5-18e6faa86c0c">1.30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtNS0xLTEtOTI0Nzk_2cfd45ee-de58-4e25-90a1-89c962f8ce35">0.89</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtMS0xLTEtOTI0Nzk_4fb48527-25d5-4339-9a69-c2ec023d328c">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtMy0xLTEtOTI0Nzk_2fd3213c-2cfc-4214-b0c0-290e93be05d7">7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtNS0xLTEtOTI0Nzk_09bc5c12-7d31-4853-863e-0fa1319a4dfd">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtMS0xLTEtOTI0Nzk_afa011d0-427a-4477-94e2-2bcba5f0bb77">23.15</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtMy0xLTEtOTI0Nzk_e313cb29-230f-4cdb-b90a-ea3c67d49339">22.59</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtNS0xLTEtOTI0Nzk_9cf90f49-d964-444d-a803-9f04ab13ae6c">13.03</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2Njk_d1742d5e-8f24-4d10-b95b-3ecc692d5610" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItMS0xLTEtOTI0Nzk_37d7aaf6-60ea-40b0-b87d-a3092284ab97">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItMy0xLTEtOTI0Nzk_e86af511-9409-4fb6-8309-086d983419fd">45.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItNS0xLTEtOTI0Nzk_ce2b2fd3-9500-4779-8c1f-0666d6996b1b">4.30</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItNy0xLTEtOTI0Nzk_c61eea87-6cc3-4d10-a179-4c31e6c5e2cb">26,970</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzMtMS0xLTEtOTI0Nzk_53de0238-8725-469c-a3f5-54fe4fbd0930">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzMtMy0xLTEtOTI0Nzk_ec58023e-4bc8-4f91-8eef-515ee61644f1">65.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzQtMS0xLTEtOTI0Nzk_e1e8f595-8625-406a-9394-440905e459aa">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzQtMy0xLTEtOTI0Nzk_44cff3f7-9a6e-4384-aff6-d6e6fdc54d16">28.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzUtMS0xLTEtOTI0Nzk_39a69831-cfbe-42b2-bd8b-5a45a36e8243">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzUtMy0xLTEtOTI0Nzk_620f6fc6-87a8-4191-95ba-4efbc7e75f8d">50.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtMS0xLTEtOTI0Nzk_9e7bf0aa-03bc-4488-939b-14b9982d3fdd">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtMy0xLTEtOTI0Nzk_24155ad3-d5fc-465c-8b95-7b99d2fdcb92">49.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtNS0xLTEtOTI0Nzk_ff0db64d-e9de-4d1f-92db-3ac11056f1d0">4.14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtNy0xLTEtOTI0Nzk_d7f752ba-df60-4ef8-8b38-8ed0a4828cf7">10,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctMS0xLTEtOTI0Nzk_59e51054-4686-4301-9584-123807c5ccf9">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctMy0xLTEtOTI0Nzk_d6015831-2230-499a-8070-7ec96abe2bde">45.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctNS0xLTEtOTI0Nzk_977552a9-1947-4098-8806-b50faaafa593">3.30</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctNy0xLTEtOTI0Nzk_f7b170b3-ff71-4119-9dbe-0b4687838484">9,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i8542745afc8b41a9a7f102aaf1cec357"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwMzY_2e146eb8-a888-4411-9d49-4a1baee93a27">3.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia53b4883a913450d88e67a5f653ed435_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwNDg_34558e03-a9f1-4ceb-a6c0-c4bb1aa77569">5.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib49a4a983eba4b5d96ea47a0ec6b49e0_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwNjM_61a0bfee-8e5b-4169-bb1a-edcf2eb58946">3.2</ix:nonFraction> million in expense related to stock options during the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNTU_84aef276-2fe0-4d5d-9d44-18aa1e4d8bf8">4.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNTk_e328e4f0-ab67-4931-bb73-e10620890c06">11.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNjY_847bec0d-6a10-4182-a155-861b86c8476c">8.7</ix:nonFraction> million, respectively. Cash received from option exercises and employee stock purchase plan was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNTc_8a73b7f8-8174-47f0-9678-b5c89fdb4cc5">5.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNjE_0f225023-ac72-49ed-909a-e34657bead78">6.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNjg_f96f15e3-884a-4961-a37d-c0fe6da6b548">5.2</ix:nonFraction> million, for the years ended December 31, 2022, 2021 and 2020, respectively. The realized tax benefit from options exercised w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ0ODc_6f63b8bd-40b5-4024-a7fc-2d8d6d546f22">0.6</ix:nonFraction> mi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llion, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ0OTk_ea2143e7-0bcb-439e-90c4-4981fe0bb0c0">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ1MTQ_cf0cc26a-179a-4905-be38-e17734219035">1.7</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i4cc2c9acfb5b4ad28b78589745d7729b_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ2MjE_ce75b161-34e3-4802-a45f-823a9eadb33c">3.5</ix:nonFraction> million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ3OTg_778a91c5-4c28-4a58-b531-458e5c61fc35">two years</ix:nonNumeric>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODA_b8754294-f8b4-46c1-a03c-eb69adf7afb8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2022. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74db8baf10424ff7a6207881e5bae34e_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtMS0xLTEtOTI0Nzk_64f93c29-d6d1-4af7-a390-8bd3a0d2b52f">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74db8baf10424ff7a6207881e5bae34e_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtMy0xLTEtOTI0Nzk_5332ab9a-3ac8-42f5-bc06-ecd66723f908">58.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5acbf0ad9ad4e0e886eb359677690b2_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtNS0xLTEtOTI0Nzk_07741d10-68f2-43ca-b554-40bcae304afa">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5acbf0ad9ad4e0e886eb359677690b2_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtNy0xLTEtOTI0Nzk_f7ddbb51-7bfb-4131-a611-7fb4917f17c5">60.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtMS0xLTEtOTI0Nzk_219a9f47-394e-4690-9f6a-81676a58a252">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtMy0xLTEtOTI0Nzk_76ffea01-fc50-4f76-89ae-18b54e3decd6">62.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtNS0xLTEtOTI0Nzk_2044814e-f7d1-4795-a6e7-594ab33b9e7e">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtNy0xLTEtOTI0Nzk_6af91dfb-c78e-45d3-87e0-279b68405af9">62.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtMS0xLTEtOTI0Nzk_043c5184-e1c7-469f-bfa5-9d814af93d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtMy0xLTEtOTI0Nzk_fa75d946-55f1-42ef-afe9-a1d0be5f2d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="-3" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtNS0xLTEtOTI0Nzk_dad1c25a-5cce-42d5-8ee1-456562bc4164">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="2" name="iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtNy0xLTEtOTI0Nzk_30042f91-2ac3-4b3f-afd2-6f8a24e63fdf">60.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtMS0xLTEtOTI0Nzk_1123c1e8-f321-42fc-8c3d-45cf3e500af5">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtMy0xLTEtOTI0Nzk_288f2ed7-978f-4f8e-a0b2-952981abf8be">62.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtNS0xLTEtOTI0Nzk_0c1556a6-4d3d-48c4-868f-48b4af30c29b">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtNy0xLTEtOTI0Nzk_f49518b8-5c6a-40c9-8878-e30c3f0e6a26">59.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctMS0xLTEtOTI0Nzk_92315720-c79d-48bd-aa1f-e8446f5305d5">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctMy0xLTEtOTI0Nzk_81761a6a-718d-4dfe-905e-f5bc750925f2">58.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctNS0xLTEtOTI0Nzk_f1aac565-d6e5-4cc5-abb4-05fc39b3ce4c">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctNy0xLTEtOTI0Nzk_0073122a-9bd0-4613-b54a-5ec08b05258a">59.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57d1807080364f69937de4b97dd9811e_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktMS0xLTEtOTI0Nzk_cfdd604f-784e-430f-bf5a-dd79ff007c11">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57d1807080364f69937de4b97dd9811e_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktMy0xLTEtOTI0Nzk_924f2476-f385-495d-8a0d-b6dfa34c5144">61.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice8b178570f44cdba015566ce1f26691_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktNS0xLTEtOTI0Nzk_c39249da-307b-43cb-84af-27ca46412639">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ice8b178570f44cdba015566ce1f26691_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktNy0xLTEtOTI0Nzk_a486add9-826e-4c61-b379-3b1b2b08ff93">62.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMjg_de00f004-387d-4d93-9843-8539fa938475">24.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMzI_6159a9c8-fec4-4fcd-b5e9-98eab0aaea81">31.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic98af93cab614bf7b1d6207967773298_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMzk_aaa81e05-fd73-4d64-b946-26b4b9494dd8">16.4</ix:nonFraction> million in expense related to such awards during the years ended December 31, 2022, 2021 and 2020, respectively. The total fair market value of shares vested and released in 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMjA_66690872-a163-498f-97d0-8fbddf3e7944">65.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMjQ_553ea0e8-ea62-489a-97e4-808eaa3f674c">15.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic98af93cab614bf7b1d6207967773298_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMzE_3c0f0b6f-13d1-4db4-b74d-be0ccf701b2a">17.3</ix:nonFraction> million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of <ix:nonNumeric contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU1MjM_6a3242d6-ca39-4902-a0b4-cd2ea28f11d3">three years</ix:nonNumeric>. The fair value of these awards is being expensed on a straight-line basis over the vesting period. As of December 31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ie59ae462fc304032a8aaaf9f74348093_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzEzNzQzODk1MzU1ODYx_43a6e2e1-76b0-4e63-83a9-2b6795b1571c">129,399</ix:nonFraction> performance stock units ("PSU's") subject to vest and be released based on 2022 performance achievement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i6bd1ab005148412cb072897f89bca249_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU2NzQ_d6df3262-ffb2-4f35-9b29-e339b997bf2b">29.7</ix:nonFraction> million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU4OTE_4691f5b1-508e-4f39-ab18-60119f7912dc">two years</ix:nonNumeric>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, there were approximately <ix:nonFraction unitRef="shares" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzYzNzY_35bbb5b7-46d1-4f6c-9eb1-3fbca525e8c3">3.1</ix:nonFraction> million shares available for grant under the 2003 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MDE_24c2613b-c3b8-4be1-8a39-f2c897b3a23a">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MDU_7d5ebd19-d472-4aaf-b70a-e02840bfe91a">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MTI_e7e55fa2-4360-4c3a-b40d-c1b65ae03dfc">0.4</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQzOTgwNDY1MTY1NDc_3a64a2c2-8b91-4220-b138-694088c6f269" continuedAt="iad6e764b0bdb4ac39410ac9986dfcbfd" escape="true">RETIREMENT BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="iad6e764b0bdb4ac39410ac9986dfcbfd" continuedAt="i7b81944e544f4744802ba2d80a05d5cf"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNzA_c39be4d1-cac5-47d8-ab61-934137edabc1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_0039426f-1024-4b74-9d3e-89efe84ee360"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_79f19b47-7a39-4b30-a558-12b8f8472fd7"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_a504fa6c-2a64-4cd7-a115-25899f6c90ea"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_c5074043-33cb-4ee6-84d5-a68bcafc77cb"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_d11e431d-7a7e-48cc-905d-a22e1c3bb15b">Net periodic benefit costs</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2022 and 2021 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzItMS0xLTEtOTI0Nzk_007cd7ef-9d24-47ae-80b5-5c59909dbc17">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzItMy0xLTEtOTI0Nzk_e78a7233-4002-456d-9df4-a37f0e3462c8">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzMtMS0xLTEtOTI0Nzk_7b7c2e55-5703-4ae9-bf74-3c002d81ad1a">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzMtMy0xLTEtOTI0Nzk_8671263f-4d45-4cd2-a467-a2f3f41a6516">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzQtMS0xLTEtOTI0Nzk_607a1640-2af5-4508-ae5c-19574bf02e35">1,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzQtMy0xLTEtOTI0Nzk_6a5cc9d3-75ed-4342-8d70-ea5f15344c35">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzUtMS0xLTEtOTI0Nzk_b9a30ca3-26d5-4ac3-b0f0-99d1d70d42db">326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzUtMy0xLTEtOTI0Nzk_37bc8b79-99e4-45ec-862f-c083c49c6cc5">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzYtMS0xLTEtOTI0Nzk_bf466372-5f5e-4482-9141-12a4ef0113a4">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzYtMy0xLTEtOTI0Nzk_1b74a160-ae6b-4179-973f-b9472b0f43f1">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzctMS0xLTEtOTI0Nzk_88049e25-fc88-44f3-a9e0-cfba6be8289c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzctMy0xLTEtOTI0Nzk_70a39ec9-ee30-4394-aa44-80c4dbe9b472">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzgtMS0xLTEtOTI0Nzk_9a5a5251-b0cf-476c-bff8-eef4ee2650f2">915</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzgtMy0xLTEtOTI0Nzk_571c5aca-8802-4c30-821c-1ecc6fb1a472">1,904</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzOTk_8a3bf254-a05d-4afd-b253-84217eec6b04" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzItMS0xLTEtOTI0Nzk_a0476850-e3cd-43cc-b76a-166ebb317381">2.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzItMy0xLTEtOTI0Nzk_bcdd79e3-6f61-4776-b304-f9139e64133f">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzMtMS0xLTEtOTI0Nzk_f5b1580f-32bd-4fe9-8789-e7854e3354fc">3.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzMtMy0xLTEtOTI0Nzk_af741e24-22fd-4ed4-ac2c-66434e274071">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzQtMS0xLTEtOTI0Nzk_ace15890-85fa-4c22-81ac-0091d9bf0930">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzQtMy0xLTEtOTI0Nzk_282108f9-273b-472e-ae40-d12ade7dbbf0">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzUtMS0xLTEtOTI0Nzk_77e276da-19be-42a6-bcce-04526c6251ad">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzUtMy0xLTEtOTI0Nzk_e0ceef51-8690-4aa3-bcb6-b02c00726585">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2022 and 2021, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7b81944e544f4744802ba2d80a05d5cf" continuedAt="i93a9ff8900f347e6991ce4a1e8376d8d"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNjU_e9b4c5db-e2b2-4344-9c4f-236607fbb25b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2022 and 2021 and a reconciliation of the funded status at December&#160;31, 2022 and 2021, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:64.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.287%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzMtMS0xLTEtOTI0Nzk_34689bf2-1b17-4592-9424-84a2f75ea9e4">65,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzMtMy0xLTEtOTI0Nzk_a288b316-c01c-45bf-8dfd-db1d66fa648b">72,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzQtMS0xLTEtOTI0Nzk_baeee894-04e5-44f2-9ced-98cfe513c7e0">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzQtMy0xLTEtOTI0Nzk_496e035a-1626-4ed2-9623-d48c4372a45e">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzUtMS0xLTEtOTI0Nzk_646838d8-6d35-4c59-8956-e657053919c0">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzUtMy0xLTEtOTI0Nzk_75c93fb8-bc50-46e2-9524-d85545f634eb">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzYtMS0xLTEtOTI0Nzk_cd5f26f3-7bfc-4502-95a0-a1e2080150c7">14,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzYtMy0xLTEtOTI0Nzk_468ec3ea-eaee-4b1d-a8b4-809c56596bec">5,044</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzctMS0xLTEtOTI0Nzk_830bfaac-9b2c-4cb0-ba3c-58f7ea562588">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzctMy0xLTEtOTI0Nzk_915f4bc4-012a-4ed3-a565-9998ab38bb64">586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzgtMS0xLTEtOTI0Nzk_5f8429ac-ed80-40ff-877e-3af1a1665e80">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzgtMy0xLTEtOTI0Nzk_5e80ddc3-27d5-4d32-8dba-02bf423b2fc3">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzktMS0xLTEtOTI0Nzk_8c90b748-e0a8-4a68-8e5b-a43c31d0d5ed">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzktMy0xLTEtOTI0Nzk_0ef2f018-7cf9-4f46-8703-88776fec4cbe">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEwLTEtMS0xLTkyNDc5_df335605-73e7-4213-85f2-f4ccf382ce74">391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:DefinedBenefitPlanBenefitObligationPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEwLTMtMS0xLTkyNDc5_898f6b3f-0967-4d4a-bf81-e7940c60068c">373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzExLTEtMS0xLTkyNDc5_b82476a0-22ed-46d7-a8e9-22240d63b86d">999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzExLTMtMS0xLTkyNDc5_589acdef-266f-4469-add1-52e9c8df68c2">2,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEzLTEtMS0xLTkyNDc5_8941e520-e5bc-4336-ba9a-5d375c4cbb13">1,810</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEzLTMtMS0xLTkyNDc5_e370a62a-b8b5-48a2-a29a-ec6a6df754b6">2,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE0LTEtMS0xLTkyNDc5_4d711ce3-d14f-4c0f-a451-97de48c315d7">50,364</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE0LTMtMS0xLTkyNDc5_38ac2dd3-d72f-4fa6-8ec9-d559a0f5ef13">65,184</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE5LTEtMS0xLTkyNDc5_402357b3-2cfe-4a31-bf92-251d1ed41c1a">39,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE5LTMtMS0xLTkyNDc5_0f206a7d-085c-46b4-a550-b65b2354db4c">37,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIwLTEtMS0xLTkyNDc5_290bf615-c0d6-4fab-853d-3e2a83bbd9c7">2,863</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIwLTMtMS0xLTkyNDc5_b72599aa-27d8-4cc5-86dd-87b3583a6f21">3,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIxLTEtMS0xLTkyNDc5_1b9d0d0a-0296-4f25-8892-4a54e7d0498d">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIxLTMtMS0xLTkyNDc5_0c4c7bf0-bb70-4367-a9ed-b5f258ec3465">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIyLTEtMS0xLTkyNDc5_32c419c5-2835-4a96-9d71-dfb0b9894b22">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIyLTMtMS0xLTkyNDc5_c87dbec0-024d-410a-a9b3-fb89eb0a2bff">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIzLTEtMS0xLTkyNDc5_2fafac3d-53e6-4c9d-a329-5b864bbbd52a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIzLTMtMS0xLTkyNDc5_1fb896e0-a1f2-4109-8780-050d313deea4">633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI0LTEtMS0xLTkyNDc5_31246880-2461-4479-bf0d-b6dd86e33a9a">998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI0LTMtMS0xLTkyNDc5_09c375ca-c315-49b1-96c8-813d89365148">2,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI1LTEtMS0xLTkyNDc5_993fa925-f6f1-4a9e-88ea-98b51ef26f14">391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:DefinedBenefitPlanPlanAssetsPremiumsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI1LTMtMS0xLTkyNDc5_cd01e95b-dc00-425f-bcbd-aa3764e43a50">373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI2LTEtMS0xLTkyNDc5_129d9bd9-f71f-4d9f-bf90-be9e7df126d7">964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI2LTMtMS0xLTkyNDc5_b600aef3-69a7-405f-b5ad-e38a1b65d05a">1,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI3LTEtMS0xLTkyNDc5_deb446c7-6008-4b9e-9451-7de072c2c06d">38,053</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI3LTMtMS0xLTkyNDc5_e8e4183f-65e1-4367-a3cc-144bb33de578">39,914</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNjg_5edaafd8-5caa-405e-8fd6-370cb093ba42" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:65.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.117%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzMtMS0xLTEtOTI0Nzk_fe1a8c5b-fbf7-46a5-afb2-d19aca510221">38,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzMtMy0xLTEtOTI0Nzk_5cce93fd-2a28-4089-b4e5-ad331e578524">39,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzQtMS0xLTEtOTI0Nzk_bd92519d-323e-49f1-bd89-20afb11da140">50,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzQtMy0xLTEtOTI0Nzk_31044401-e051-49f4-8425-60c3cc6f25e9">65,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzUtMS0xLTEtOTI0Nzk_46b44783-d61b-4899-bace-f7868476ec66">12,311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzUtMy0xLTEtOTI0Nzk_654cbfc9-090a-4fe2-af8e-e2f11d709553">25,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had a net gain of $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzIwNzc_839ae370-050a-4cc5-ab52-234fbdefa4e1">7.4</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzIwODQ_da7ea438-4404-4f98-bcf7-a9532aee7637">7.0</ix:nonFraction> million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI1NTI_21ac9736-d6ee-43ab-8abb-ba42cde84991">46.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI1NTk_d5756d39-e204-4f06-afbc-a24955951cb7">60.3</ix:nonFraction> million as of December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i93a9ff8900f347e6991ce4a1e8376d8d"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had <ix:nonFraction unitRef="usd" contextRef="i418f7c9941e041f4853468578a5ef6fb_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM3ODM_00158c15-c8fa-4b80-89f8-c3a4ffbfa91f"><ix:nonFraction unitRef="usd" contextRef="i1cab4ce05dd94d62b94dadb5d8e736fe_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM3ODM_b4b0ade9-fa6b-4e78-a210-280a06ffe8be">no</ix:nonFraction></ix:nonFraction> assets at December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, <ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM4MTE_e648b04c-759c-4f07-b472-e080108a29c9">no</ix:nonFraction> plan assets are expected to be returned to the Company in the next twelve months.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNzY_4f393323-ee99-4198-b252-0dc1e1b66464" escape="true"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzItMS0xLTEtOTI0Nzk_6a93dd24-9b34-41bd-84a4-8705a17591b7">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzMtMS0xLTEtOTI0Nzk_a72f67a7-b305-48ba-a44f-938fae5d8811">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzQtMS0xLTEtOTI0Nzk_336fbf31-a3f5-4ae1-9ceb-d5592c6cd733">2,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzUtMS0xLTEtOTI0Nzk_9bf144b1-f309-4010-a797-d1c4213c64f9">1,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzYtMS0xLTEtOTI0Nzk_7f265b92-968a-40df-932d-6d26a3ffd15b">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzctMS0xLTEtOTI0Nzk_0f8b38b4-6079-470e-928b-3ba88b165e72">11,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, contributions expected to be paid to the plan in 2022 is $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQwNTI_80fc9bba-efcd-47b4-af24-65b6c36ec93e">2.6</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NDQ_0777716b-3a82-41d9-ba49-753fe9a51a9a">9.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NDg_b22d15b5-7764-4d78-86b0-e06194b5f378">8.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NTU_4f4ae46f-be84-4a80-95d8-5ba09ad4189e">6.7</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ2NzI_30085813-792b-461e-a262-1ade20d61089">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ3MDY_fb0a5d60-d7e1-4944-a6b9-88ec453c65e9">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUyNDg_d74fd47f-f1bf-429e-a5d8-6da36768803c">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI3NDg3NzkwNzQ4Nzk_34cf82a1-3d58-47ce-b6d5-49cef8cfd1a7">3.8</ix:nonFraction> million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div></ix:continuation><div id="i43d6bdf9742e4131bcef4d4155aafb89_178"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NTA_73aa0884-d056-4e96-a408-ccf69ed8bb14" continuedAt="i7b8a7ee1bb6a4ed9a54393037d50b2a0" escape="true">LEASES AND RELATED PARTY LEASES</ix:nonNumeric></span></div><ix:continuation id="i7b8a7ee1bb6a4ed9a54393037d50b2a0" continuedAt="i24c73d822cd04fcaade9d59b6b603f5b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2022. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include <ix:nonFraction unitRef="renewal_option" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="iart:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzUxMw_e5ed62ce-a139-4e05-9fe7-d8558883a0f5">one</ix:nonFraction> or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEyNzA_44dcf7ae-702a-494d-9b7b-41ff12857b0e">22.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEyNzc_541671e0-a93a-4232-8c68-4998795b4075">20.3</ix:nonFraction> million, respectively, which includes $<ix:nonFraction unitRef="usd" contextRef="i63561c0bbfd64fc0bdb211203c2b0c9f_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEzMTA_cbd01b44-be2e-4e37-aeed-13ed497a5b6a"><ix:nonFraction unitRef="usd" contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEzMTA_ded07b0f-eba4-4016-b5a3-3bbf09d2c046">0.3</ix:nonFraction></ix:nonFraction> million, in related party operating lease expense.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i24c73d822cd04fcaade9d59b6b603f5b" continuedAt="icef694bd03484921945735f3c0ffe1f8"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzQ_1c4c2226-049f-4b85-a7d8-50de740bc907" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzMtNS0xLTEtOTI0Nzk_e4d80982-954d-4087-8a3e-82d2344eec8f">148,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzMtNy0xLTEtOTI0Nzk_b76ded14-e22a-466e-977b-a6c8f33b14cc">84,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzUtNS0xLTEtOTI0Nzk_e3d4ac1e-62ff-46b0-abb0-d5dbf0ddb983">14,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzUtNy0xLTEtOTI0Nzk_03ea7c95-f635-4ca2-b305-92eece5eb24c">14,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzYtNS0xLTEtOTI0Nzk_377ec584-877c-412d-ad04-6d18c6f0919f">157,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzYtNy0xLTEtOTI0Nzk_950bb7a9-107d-42f6-a39e-222abc16b756">90,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzctNS0xLTEtOTI0Nzk_95d5524b-2133-454f-8d51-9a6bef596ded">172,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzctNy0xLTEtOTI0Nzk_4eb88954-7734-4367-a425-d505c70b8226">105,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4686279af17c417cbe3854bacf4ca2d8_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzExLTUtMS0xLTkyNDc5_ede12fa1-acae-4955-9dc7-d4876123c34f">16.9</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d95969939c540bca05d2319452bd5fc_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzExLTctMS0xLTkyNDc5_0ca21b63-e57b-4866-b816-e030f19e8f90">10.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c5eeedd89d64492bde19c2d733af117_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzEyLTUtMS0xLTkyNDc5_56c9b3e2-05c2-4d3f-9759-21f0c01c6422">2.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia15d057605944eca816fd58aedd828b7_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzEyLTctMS0xLTkyNDc5_54dd2576-5bc8-44f6-a113-d300578e693b">2.1</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4686279af17c417cbe3854bacf4ca2d8_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE1LTUtMS0xLTkyNDc5_42b952e4-2c69-46f3-be7e-bd9e21aead9c">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d95969939c540bca05d2319452bd5fc_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE1LTctMS0xLTkyNDc5_5a880c87-e12f-4b13-a04b-66aebee3207c">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c5eeedd89d64492bde19c2d733af117_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE2LTUtMS0xLTkyNDc5_d530c846-1ca0-4edd-870e-c9284a9761ad">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia15d057605944eca816fd58aedd828b7_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE2LTctMS0xLTkyNDc5_0ba05f9c-6414-4305-8cdf-8ff483523dc4">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="iart:CashFlowLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NDI_d8d4a338-f9a9-4dfb-b390-fdd3dc050a77" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzMtMS0xLTEtOTI0Nzk_29ba623b-fd7d-4e81-a29d-4274aab00b7a">17,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzMtMy0xLTEtOTI0Nzk_438197a7-eb1c-4db0-9a60-22b787a682a3">15,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzYtMS0xLTEtOTI0Nzk_43694ae1-104c-4330-8a6a-4ded0d74d030">72,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzYtMy0xLTEtOTI0Nzk_2178bce3-770b-4402-9abb-1845334611ca">12,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzE_2390b43b-1d35-4b6f-b5ea-0e5d7f21450b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItMS0xLTEtOTI0Nzk_9fc22e2c-338c-4999-9a60-a699cb97c1fb">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItMy0xLTEtOTI0Nzk_86b73017-d7ff-4863-a12c-420497c353b3">20,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItNS0xLTEtOTI0Nzk_de5b36d5-3ba7-448d-a0df-7352d46d1f89">20,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtMS0xLTEtOTI0Nzk_8adb83e2-e841-4483-ae2f-5c222aba7bb4">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtMy0xLTEtOTI0Nzk_48757160-b492-4d99-9985-b71b5440c6d7">20,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtNS0xLTEtOTI0Nzk_312b3e6e-aed4-499d-b4f2-b306050a173a">21,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtMS0xLTEtOTI0Nzk_5cfd28a0-7150-4166-b602-23a26253b06e">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtMy0xLTEtOTI0Nzk_100271a3-e3a9-4455-9206-51435e118b86">19,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtNS0xLTEtOTI0Nzk_b5539482-1be0-472d-b1cb-e772d05c5536">19,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtMS0xLTEtOTI0Nzk_8f866a5f-9a21-4b16-8a61-ab8d204930b7">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtMy0xLTEtOTI0Nzk_87005102-379d-4dd7-bd6a-517eb90f6fe2">16,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtNS0xLTEtOTI0Nzk_23123750-7713-4f30-ace9-e46ad01fa8ca">17,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtMS0xLTEtOTI0Nzk_47e64634-2a22-42be-bdbe-44cc922574b6">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtMy0xLTEtOTI0Nzk_80fd1154-d5b8-4448-8422-3a842ecdfbc6">15,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtNS0xLTEtOTI0Nzk_5d2798e7-949f-4ff0-8f86-771a72e9eb16">16,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctMS0xLTEtOTI0Nzk_70ac5a1c-f177-449c-b496-ce2218a52f9e">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctMy0xLTEtOTI0Nzk_efa6df2a-987f-44ad-bdf2-621c91497dba">164,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctNS0xLTEtOTI0Nzk_7d802338-068f-4409-8afd-d4a9a2909a63">165,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe81ea28a254d779986ec9672045e13_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtMS0xLTEtOTI0Nzk_4670d2bb-cd68-4843-b78c-07ec89f168d3">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtMy0xLTEtOTI0Nzk_87582c2b-041a-4c33-a550-6a872ddeeb13">257,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtNS0xLTEtOTI0Nzk_9cade15d-6513-4194-bd8f-69863fb24daf">259,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzktNS0xLTEtOTI0Nzk_5b58f30e-bdaf-4f61-af58-a75ae01a83a4">87,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzEwLTUtMS0xLTkyNDc5_288bb6a1-2c30-49b2-b96a-5451961c7c6b">172,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzExLTUtMS0xLTkyNDc5_e3d4ac1e-62ff-46b0-abb0-d5dbf0ddb983">14,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzEyLTUtMS0xLTkyNDc5_377ec584-877c-412d-ad04-6d18c6f0919f">157,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="INF" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzE2MDg_817bfc2f-92d6-459c-b461-cdd8a17adf2e">no</ix:nonFraction> future minimum lease payments under finance leases at December&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="icef694bd03484921945735f3c0ffe1f8"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is <ix:nonFraction unitRef="number" contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231" decimals="2" name="iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzE3OTk_b8594fbe-bd7a-4bfc-9052-3e30a990046a">50</ix:nonFraction>% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $<ix:nonFraction unitRef="usd" contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231" decimals="-5" name="iart:AnnualRateOfLeaseAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIwNjI_f9e2d292-0740-4d16-b31b-e16a65511c66">0.3</ix:nonFraction> million per year. The current lease agreement also provides (i) a <ix:nonNumeric contextRef="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231" name="iart:OptionToExtendLeaseYears" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIxMjM_2f4a4bf3-2337-4e7d-8362-9e297e8fd6a7">5</ix:nonNumeric>-year renewal option for the Company to extend the lease from <ix:nonNumeric contextRef="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzM_0312eb3f-58ba-4629-9a27-9dfa95e50131">November 1, 2029 through October 31, 2034</ix:nonNumeric> at the fair market rental rate of the premises, and (ii) another <ix:nonNumeric contextRef="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231" name="iart:OptionToExtendLeaseYears" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIyOTQ_85a2a03a-e765-4191-9402-d88b6e3a1def">5</ix:nonNumeric>-year renewal option to extend the lease from <ix:nonNumeric contextRef="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NDk_0bc7c4d0-bfa9-40d1-8e82-03bbd184f3fc">November 1, 2034 through October 31, 2039</ix:nonNumeric> at the fair market rental rate of the premises.</span></div></ix:continuation><div id="i43d6bdf9742e4131bcef4d4155aafb89_181"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MTY_40b07a79-77c4-4ac5-8582-92d85bb7bd4a" continuedAt="if87adeefee6a4fdc9dfa907ceaf250f6" escape="true">INCOME TAXES </ix:nonNumeric></span></div><ix:continuation id="if87adeefee6a4fdc9dfa907ceaf250f6" continuedAt="ib580a04e4b644b609a9e2e434112308c"><div style="margin-bottom:12pt;margin-top:12pt"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjY_b0e17cb1-ba1e-449e-9ef3-7c6f6e5127d2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItMS0xLTEtOTI0Nzk_43b14401-4a3a-4963-a9c7-ab92c71c76f1">92,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItMy0xLTEtOTI0Nzk_e5e2cd9b-6c24-4d76-b42c-b5e11051d26e">91,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItNS0xLTEtOTI0Nzk_198b3913-b11f-489a-88e3-99a049772ea2">15,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtMS0xLTEtOTI0Nzk_5640df26-15d7-4e42-988d-9a24e509a43d">121,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtMy0xLTEtOTI0Nzk_1481e5ac-048b-479f-8f1b-1a800f95e13c">123,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtNS0xLTEtOTI0Nzk_41019a6f-7d02-4f56-b7d6-18c1538fc9ba">78,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtMS0xLTEtOTI0Nzk_3d824ad2-e165-4658-84b7-960b42b4f603">213,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtMy0xLTEtOTI0Nzk_dd2f07b1-555a-4a1d-83d5-1ecbb22e41d4">214,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtNS0xLTEtOTI0Nzk_5f4292cf-0876-43c2-8134-42d2635e9d8b">93,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjQ_0021e10a-eba5-4900-8e37-6a6dcf0ced55" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItMS0xLTEtOTI0Nzk_b3598d04-72fa-4212-9ace-3b9ba3081ef3">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItMy0xLTEtOTI0Nzk_13c698ea-39cb-4ab9-b238-4b16acd95818">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItNS0xLTEtOTI0Nzk_a65119d3-4f5a-4360-9cbc-7639a685c3af">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtMS0xLTEtOTI0Nzk_41153e42-3bdd-46f0-92f6-9e8028d42bda">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtMy0xLTEtOTI0Nzk_ae831618-71c8-46ca-b131-6691edf20402">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtNS0xLTEtOTI0Nzk_1a6cb75b-625b-4b7d-8799-082dae846210">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtMS0xLTEtOTI0Nzk_4571be1b-2914-44d4-97d2-5449978fe32f">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtMy0xLTEtOTI0Nzk_c2a8f111-19cf-4d42-99fe-8f057c658b3c">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtNS0xLTEtOTI0Nzk_faf4df07-29f7-464b-8937-23f2e008a64c">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtMS0xLTEtOTI0Nzk_631fd145-6689-419b-af8c-f7f350068007">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtMy0xLTEtOTI0Nzk_b3e98eab-ffee-4e18-bd33-b481b99d14d2">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtNS0xLTEtOTI0Nzk_abd928b2-f0f1-4d86-9eb8-97957d60298f">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtMS0xLTEtOTI0Nzk_51a019f6-054e-4199-bca5-15e8c1e34520">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtMy0xLTEtOTI0Nzk_e8c0315a-9559-409e-a0a8-5f9e3ba898ae">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtNS0xLTEtOTI0Nzk_13403988-11d7-4711-9765-308dfd2ad80b">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMS0xLTEtOTI0Nzk_287ca197-0797-44ed-9074-90bb9badd95f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMy0xLTEtOTI0Nzk_07fd3b66-a8e4-4b56-bac2-4bb4ac8f2f39">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktNS0xLTEtOTI0Nzk_56d13002-d931-43e7-a654-e574a254fac8">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contingent Consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMS0xLTEtMTY2Nzkx_8e397b72-6115-4a78-a8bc-b6ded3bc013d">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMy0xLTEtMTY2Nzk4_c9a1f8ed-debd-4400-bd3f-cdef38b511d0">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktNS0xLTEtMTY2ODA1_e7b8ff52-8600-4a89-9b67-5ba06b2ff39c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTEtMS0xLTkyNDc5_40f8917d-a1f6-4318-902c-b02ca776f207">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTMtMS0xLTkyNDc5_4e1788b3-0445-4130-bbc9-92b08acf4151">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTUtMS0xLTkyNDc5_bb4ba4ed-a3d2-418b-a8b1-1f7dc752be97">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTEtMS0xLTkyNDc5_c03c6cb1-b141-4adf-bbbd-c3745ed333a0">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTMtMS0xLTkyNDc5_b87897c5-3a0b-484a-8882-5d161924ff2b">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTUtMS0xLTkyNDc5_cb8ea399-17c4-4ef0-931d-3865001f1a95">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTEtMS0xLTkyNDc5_38b065f6-cca3-4f0d-bf59-b163eacd3250">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTMtMS0xLTkyNDc5_75bb257b-4da2-4fe3-8090-7e48b0ec692d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTUtMS0xLTkyNDc5_1f0804d3-057a-42b2-8ab4-13ddc926669d">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTEtMS0xLTkyNDc5_643022ba-35ff-4243-bee6-1783c30ba6de">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTMtMS0xLTkyNDc5_06c49f29-43ba-49af-9e78-d60c65a8b8e1">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTUtMS0xLTkyNDc5_5287c48a-2ab5-45ec-acd5-062090b500fd">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTEtMS0xLTkyNDc5_e5d3739b-97ac-48d5-9146-cd60f6e0e5a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTMtMS0xLTkyNDc5_44c96e29-c501-4aac-aa69-e3cc01dfc0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTUtMS0xLTkyNDc5_4eb01fcf-0599-4652-b57b-eec44bc69e15">63.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTEtMS0xLTkyNDc5_056a1e0f-4cfb-4bd7-8adc-96855bd88094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTMtMS0xLTkyNDc5_10998737-79d7-451a-9606-4efa432fd172">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTUtMS0xLTkyNDc5_6037dd62-f22c-45de-8406-f40aff85a5c3">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTEtMS0xLTkyNDc5_422753bd-7136-4ad1-baa1-f4d6da6bd741">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTMtMS0xLTkyNDc5_020e7dfe-a19e-4a60-9746-de17a72ebc3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTUtMS0xLTkyNDc5_9a983d47-b264-442f-9226-c9c874bbc50e">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTEtMS0xLTkyNDc5_0d7d6e2d-8de5-42ad-8922-fca92f9a0c07">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTMtMS0xLTkyNDc5_f6863f14-589c-473c-93d8-ee17169653f6">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTUtMS0xLTkyNDc5_e7b2e026-0367-44ca-81d7-42a486ac9d0b">43.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzIxOQ_0d7d6e2d-8de5-42ad-8922-fca92f9a0c07">15.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzIyNg_f6863f14-589c-473c-93d8-ee17169653f6">21.2</ix:nonFraction>% of income before income taxes for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. In 2022, the Company&#8217;s lower effective tax rate was driven by a $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NjY_d1a5c601-0362-4700-89a9-aeef9a916059">5.1</ix:nonFraction>&#160;million income tax benefit related to stock compensation and a $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2ODY_6f944c65-cc21-4c7a-87ec-c08c8275a44d">2.4</ix:nonFraction>&#160;million income tax benefit related to the filing of amended federal and state returns for prior years. In 2021, the Company's higher effective tax rate was driven in part by an $<ix:nonFraction unitRef="usd" contextRef="i9d17811ad9fc45df8bcef0f695f18e73_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM3OA_5d234322-de85-4740-9c77-6bccb31ce595">8.5</ix:nonFraction>&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQ5OA_dee4534e-3cf4-439e-9aa4-7e3f69835122">3.1</ix:nonFraction>&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#8217;s lower worldwide effective tax rate was primarily driven by an $<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-5" name="iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzY2MQ_777d9156-e925-4bd9-81ba-16fe19821226">59.2</ix:nonFraction>&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was <ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" name="iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzg3OA_c88c8fdb-12c8-4839-815d-e7e2ca6a9976">20.2</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib580a04e4b644b609a9e2e434112308c" continuedAt="ibb12ff772d5c4dfc8d695ad047aaf663"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $<ix:nonFraction unitRef="usd" contextRef="i279c573a91e74e11abd25958e204a2d2_D20201201-20201231" decimals="-5" name="iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE0NDA_b77f79e2-18e3-4a14-8202-0bc4526b3d8f">59.2</ix:nonFraction>&#160;million deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2022, the Company&#8217;s foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2MjA_b672892c-54d0-4178-97d9-a0cb7a22765e">0.4</ix:nonFraction>&#160;million increase in income tax expense when compared to the same period in 2021, because of geographic and business mix of taxable earnings and losses, among other factors.  The 2022 foreign effective tax rate is <ix:nonFraction unitRef="number" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NDg_ac297d6e-ad65-4ac3-8f59-b31c309a6353">15.9</ix:nonFraction>%, compared to <ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NTc_ae128c71-754a-433a-b021-c34a4422a821">15.2</ix:nonFraction>% in 2021.  The Company&#8217;s foreign tax rate is primarily based upon statutory rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the Company&#8217;s foreign operations generated a $<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE2MTY_95f103a6-9182-474d-85b1-d10e3cfea71b">63.6</ix:nonFraction>&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is <ix:nonFraction unitRef="number" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="3" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE4OTE_984cd3eb-d5fb-479b-8c5a-840b1013afd8">15.2</ix:nonFraction>%, compared to (<ix:nonFraction unitRef="number" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="3" sign="-" name="iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE5MDc_91ed8739-1984-4a77-8a1a-75c72e9d40a0">57.1</ix:nonFraction>)% in 2020. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law, the company does not expect the law to have a material impact on the company&#8217;s effective tax rate. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1NDE_08159996-61d0-4a08-9e28-57120b90083d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtMS0xLTEtOTI0Nzk_9514ca36-00f5-4780-8803-5cef0d03c742">24,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtMy0xLTEtOTI0Nzk_54f4c689-96c8-417c-aa43-85218d97089e">31,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtNS0xLTEtOTI0Nzk_3e148454-5216-4966-abdb-1cd2f8774c32">6,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtMS0xLTEtOTI0Nzk_ffb2f79f-c2d6-4e0f-97f3-7ae3eeee771f">3,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtMy0xLTEtOTI0Nzk_0b2d93d5-5796-4b14-945d-ef1c18e42712">11,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtNS0xLTEtOTI0Nzk_1bae7fa5-c0cc-4df9-86bd-f32f7ad1c085">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtMS0xLTEtOTI0Nzk_fcbe0201-6fd1-4975-8354-efdd352ebf10">9,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtMy0xLTEtOTI0Nzk_9ed686be-c4a0-4c2d-a4d9-4df1ad2cb657">5,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtNS0xLTEtOTI0Nzk_68b4508d-cde5-49c3-8367-f1449b178837">12,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtMS0xLTEtOTI0Nzk_c6abadd3-ecac-4576-891b-ac17271faa19">37,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtMy0xLTEtOTI0Nzk_c0776d51-a287-4a32-bc5c-eea212d85922">48,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtNS0xLTEtOTI0Nzk_5ac2447c-fe32-432b-8ec3-40ff3f241f7d">23,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtMS0xLTEtOTI0Nzk_960c8829-16e3-46d3-9dbe-c8c8a15c246b">11,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtMy0xLTEtOTI0Nzk_b0bdf1c6-e691-4bc7-98d7-35471137199f">12,830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtNS0xLTEtOTI0Nzk_b4645c85-bc59-46c4-a206-226bc38789fd">5,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktMS0xLTEtOTI0Nzk_ae832c5f-cbc8-4a50-bcb0-ba509304fb89">2,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktMy0xLTEtOTI0Nzk_fad11555-3306-44ec-ab8d-696e24686647">3,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktNS0xLTEtOTI0Nzk_31c23fc0-8347-4b4f-a131-c45d785a18fa">1,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTEtMS0xLTkyNDc5_7712be8e-6818-4e25-9ee2-81b8a6d35c5d">9,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTMtMS0xLTkyNDc5_add149f8-548b-4207-af9a-5a5dffb396c3">13,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTUtMS0xLTkyNDc5_e4d3e0d5-5d56-43f4-bb3c-bcd8de1f0dde">57,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTEtMS0xLTkyNDc5_c3c8f6bc-c332-416b-8bc3-33822026fda4">4,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTMtMS0xLTkyNDc5_6509ae32-99f3-4f96-b864-d358064e81ca">2,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTUtMS0xLTkyNDc5_d11989b0-216a-4657-969a-de8ff21cd7ea">64,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTEtMS0xLTkyNDc5_18cc6970-c0d8-432f-aa83-2041514c8563">33,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTMtMS0xLTkyNDc5_5867f0d3-76fa-430b-bc71-0674d3dea8b2">45,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTUtMS0xLTkyNDc5_cf197580-597e-4e29-9030-f23940ee935e">40,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibb12ff772d5c4dfc8d695ad047aaf663" continuedAt="ibfa0045968df4ba49fec5c5c7492d733"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MTI_9c09d4dd-0a03-40c8-9071-33dde8d8be4d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzMtMS0xLTEtOTI0Nzk_58939f81-8361-4929-a0e7-6870dd676957">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzMtMy0xLTEtOTI0Nzk_ccd97212-4292-45f4-8740-b2b32b109077">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzQtMS0xLTEtOTI0Nzk_5950f82e-8d4c-42f8-b99d-36945f506a4b">31,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzQtMy0xLTEtOTI0Nzk_cbb61f94-a423-40ec-b921-018466242886">31,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzUtMS0xLTEtOTI0Nzk_5b0fddca-8404-42d6-8a79-3ba6cb72fa6b">13,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzUtMy0xLTEtOTI0Nzk_53fda00d-dd80-45e6-bb93-83fe7d2af282">13,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzYtMS0xLTEtOTI0Nzk_f1823850-775f-4f51-abc6-00baa458629a">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzYtMy0xLTEtOTI0Nzk_de37882e-e831-4d61-b0f3-58c2099c6402">3,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzctMS0xLTEtOTI0Nzk_aea5f50e-3c69-48fd-9d6e-31c3c54e8fc0">4,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzctMy0xLTEtOTI0Nzk_313014e6-706e-4f6a-9c0a-89cc11c1d8af">7,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzgtMS0xLTEtOTI0Nzk_48d7b59a-3ae2-47a3-b97e-fd718c05ae5e">10,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzgtMy0xLTEtOTI0Nzk_f2d3819f-5267-45fa-9070-189fa2199e3b">13,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzktMS0xLTEtOTI0Nzk_2b6961d8-fc15-4b1e-9ea5-41c30fe66821">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzktMy0xLTEtOTI0Nzk_c5b8eb32-7bea-4a81-b51a-1d37a4b3987b">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEwLTEtMS0xLTkyNDc5_73791f08-a632-448d-9430-623f5d33b444">30,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEwLTMtMS0xLTkyNDc5_89af491c-32c8-42d9-9618-e410db4db1e1">26,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzExLTEtMS0xLTkyNDc5_d7c0a403-2d2a-46eb-8b53-85d618711b86">51,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzExLTMtMS0xLTkyNDc5_92af68ac-2007-4a7e-a9a2-13dcd891030c">36,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEyLTEtMS0xLTkyNDc5_e5044c25-45cd-4091-acdd-07e2e2d3e6db">6,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEyLTMtMS0xLTkyNDc5_15c59cc6-8f0d-423b-975f-4d7462db4a8a">12,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEzLTEtMS0xLTkyNDc5_4dedc7f1-38ad-4b4c-acb3-c3a9ec71bf05">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEzLTMtMS0xLTkyNDc5_f251820c-58e7-439e-b914-63dc0fc9c5db">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DeferredTaxAssetsLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE1LTEtMS0xLTkyNDc5_8b06e209-d9aa-4165-a3db-9fb1a1c7f88b">39,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DeferredTaxAssetsLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE1LTMtMS0xLTkyNDc5_5d3f35c1-d1ef-420a-8e55-888e40904ed1">41,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE2LTEtMS0xLTkyNDc5_20481938-b35d-40a6-b895-b08dbbfe1aee">195,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE2LTMtMS0xLTkyNDc5_7140ea37-aee9-4745-a016-583d8e341e90">190,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE3LTEtMS0xLTkyNDc5_44dc5b75-f8c4-4597-b30a-d583bdcffd88">9,651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE3LTMtMS0xLTkyNDc5_789c69d7-caf1-44a1-8c67-46cefd5449ec">9,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE4LTEtMS0xLTkyNDc5_820d4751-7a9c-42c1-bb0d-f28cc1d0bb0c">185,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE4LTMtMS0xLTkyNDc5_c1cd7891-9922-4d16-a2ae-732a3db40140">180,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIwLTEtMS0xLTkyNDc5_7064263a-4ae2-4c6c-98ae-c9d1cfefcee8">166,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIwLTMtMS0xLTkyNDc5_3caf3c68-c2ac-49b1-a324-2f21f1312f14">152,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTEtMS0xLTE2NzkxOA_03547563-106c-4367-8bc9-b4040d20379d">12,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTMtMS0xLTE2NzkyNQ_72faade7-296f-493a-82d6-7c53ef575ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="iart:DeferredTaxLiabilitiesLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTEtMS0xLTkyNDc5_07f54789-e5c6-4f67-bf62-8f3f82554b64">22,975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="iart:DeferredTaxLiabilitiesLeasesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTMtMS0xLTkyNDc5_adc30c2a-ba4d-403c-9fce-952c1170c9a3">17,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIyLTEtMS0xLTkyNDc5_65a7c5e8-d910-410b-86f0-4e63609a1125">202,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIyLTMtMS0xLTkyNDc5_e43175a4-c195-43cc-b0ff-057e022abe3a">169,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzI0LTEtMS0xLTkyNDc5_7d842be4-4dd7-4143-a9f8-473b4654737c">17,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzI0LTMtMS0xLTkyNDc5_0c4d9d4b-dee5-41d3-9d8a-f3e88070f1f9">11,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 U.S. Tax Cuts and Jobs Act contained a provision which requires, for tax purposes, the capitalization and amortization of research and development expenses; effective for years beginning after December 31, 2021.  The Company&#8217;s deferred tax assets increased by $<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="iart:DeferredTaxAssetIncreaseDueTo2017TaxAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU2NDQ_625e5f37-eb44-4235-ab60-97d31dec32d7">20.2</ix:nonFraction>&#160;million within the table above, related to the 2017 Tax Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company had net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie93924bccec8412e903736f429992621_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyMTc_9e63a948-b716-4e88-9038-f938b2162e91">79.5</ix:nonFraction> million for federal income tax purposes, $<ix:nonFraction unitRef="usd" contextRef="i79636bff7892448cb422c38278985e4e_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyNTM_77faeb5f-0207-4a75-8f85-c0035a7a376a">75.5</ix:nonFraction> million for foreign income tax purposes and $<ix:nonFraction unitRef="usd" contextRef="ie487f52caa6d4416be07a10223ed0bce_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyOTI_ee4292e3-f914-42f0-9f9d-abc8d41e6d77">37.9</ix:nonFraction> million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $<ix:nonFraction unitRef="usd" contextRef="ie93924bccec8412e903736f429992621_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU0Njg_27f20363-db81-4d11-9ad1-1253332069bb">18.6</ix:nonFraction>&#160;million have an indefinite carry forward period. For foreign net operating loss carryforwards, $<ix:nonFraction unitRef="usd" contextRef="i79636bff7892448cb422c38278985e4e_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE3MDU_c6e6afe1-2a01-43ca-bb14-dd2458284da8">59.1</ix:nonFraction>&#160;million will expire through 2028, while  the remaining $<ix:nonFraction unitRef="usd" contextRef="i79636bff7892448cb422c38278985e4e_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQ1NDg_5c2b2cd2-c6a0-4eb3-9dae-57719904aa9f">16.4</ix:nonFraction> million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU0NjQ_b168f370-16c1-47db-a4a4-1d41523c2b7e" continuedAt="i64c44e84ce034c1ebb6abd22e5b59692" escape="true">The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibfa0045968df4ba49fec5c5c7492d733" continuedAt="ib2004c765f254d64b0605dea2bdfd6b8"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="i64c44e84ce034c1ebb6abd22e5b59692"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb5085d40924d08b32a44ed38777fa8_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtMS0xLTEtMTY3NDc4_996f9bc6-e045-4af5-a8d4-322d1aebfc1a">15,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtMy0xLTEtMTY3NDkz_020f67e4-436a-45e0-8ad7-99d9dc445257">515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtNy0xLTEtMTY3NDg3_8550a508-967f-4845-b54d-198bbbad4bd9">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125356e34064ab5bdcb08a3dffbcee3_I20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtOS0xLTEtMTY3NDk3_6ce69244-93c0-4a81-9691-6ca1c92e10cd">14,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65461d577a648fa84b432ba0d645aca_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtMS0xLTEtMTY3NTA1_142c91ae-966d-49e1-8dd8-25bbe701e8ad">13,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtMy0xLTEtMTY3NTIy_c5218a10-d3ef-45fb-ac00-7fa40b53e5c6">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtNS0xLTEtMTY3NTI3_10dded97-02b2-4249-9f17-6bdc2894701a">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtNy0xLTEtMTY3NTE3_f3593315-f3c7-4efc-b712-e92e00a927f7">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb5085d40924d08b32a44ed38777fa8_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtOS0xLTEtMTY3NTM2_8fad418e-5585-4225-88d3-6d78d7b827c8">15,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58370c21a3bf4fa9916b815ebacaabad_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtMS0xLTEtMTY3NTQ0_ec2dafcd-c4b0-4a92-a44c-0eb008f0478a">12,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtMy0xLTEtMTY3NTQ4_a437fc8a-0991-4245-9dbd-0662d41a1f25">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtNS0xLTEtMTY3NTUy_61ad35fb-3406-44cc-a6d6-a52fe8360020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtNy0xLTEtMTY3NTU2_61cecaa9-a69e-46f1-bec1-49bc109aa443">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65461d577a648fa84b432ba0d645aca_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtOS0xLTEtMTY3NTYw_a28bf9dc-2394-45f9-928a-6bf8c8a35a89">13,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.</span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjU_e7ec3b9c-c6b7-4382-a0d2-e5fe3bd05663" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtMS0xLTEtOTI0Nzk_7eca29b2-acee-4427-aeda-2c9db91141c7">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtMy0xLTEtOTI0Nzk_aadd1b7a-a094-4bfc-9c7e-5171007d08fa">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtNS0xLTEtOTI0Nzk_b687452b-17b2-44ad-b4ad-c18161503230">676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtMS0xLTEtOTI0Nzk_3723c9fe-e87b-4a7a-a2ef-5eba2be4ffed">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtMy0xLTEtOTI0Nzk_0762ec94-bdf9-46dc-a06d-620dd2623449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtNS0xLTEtOTI0Nzk_b1b2e53b-1bc1-4b9e-ada1-a388f24f7bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtMS0xLTEtOTI0Nzk_0d8398e8-69f2-40a6-af66-211122551b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtMy0xLTEtOTI0Nzk_2469082d-c458-4d2d-baef-47878e17e105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtNS0xLTEtOTI0Nzk_f20d033f-48ed-4aef-8084-3e3ef35106b3">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctMS0xLTEtOTI0Nzk_5024771b-cb68-4834-9b9e-e26103cfe512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctMy0xLTEtOTI0Nzk_dabe4074-fcda-4c3d-9e6f-8607a3aac2c5">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="iart:UnrecognizedTaxBenefitsReductionsResultingFromOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctNS0xLTEtOTI0Nzk_3f9421ec-ff3d-4d76-8035-45485b4f2075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtMS0xLTEtOTI0Nzk_7509bbd8-9455-4a6a-9636-ab5ce76a8340">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtMy0xLTEtOTI0Nzk_31ed7c9d-98e3-4166-982e-713d62924724">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtNS0xLTEtOTI0Nzk_773c9856-09aa-4979-8808-e242dec8ecc5">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Approximately $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzY0ODQ_5fb82914-6be3-45c0-8d64-e76378e8eada">0.7</ix:nonFraction> million of the balance at December&#160;31, 2022 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. The Company has $<ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-5" name="us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE3Mjg_d6ab2a0d-efe1-426d-8b56-a3e7a787211c">0.3</ix:nonFraction>&#160;million of uncertain tax positions at December&#160;31, 2022 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2022, 2021 and 2020. The Company had minimal interest and penalties accrued for the years ended December 31, 2022 and 2021 and 2020. </span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="ib2004c765f254d64b0605dea2bdfd6b8">The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2015. Additionally, the Company is no longer subject to examinations by the IRS for fiscal year 2017. All significant state and local matters have been concluded through fiscal year 2014. All significant foreign matters have been settled through fiscal 2015.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzY5Ng_bf638675-f404-4847-8975-1b4173324fd9" continuedAt="i4470f69e0b91497189414ad6b67e2b79" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i4470f69e0b91497189414ad6b67e2b79"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzcwNA_e4245455-cf92-47f0-827c-16eaf441f239" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtMS0xLTEtOTI0Nzk_cbef4a76-1e8d-40b9-82d7-d76d926eca22">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtMy0xLTEtOTI0Nzk_ac1c4d4f-f851-44d0-b0ab-9b8a99d18844">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtNS0xLTEtOTI0Nzk_b9ee5a50-c0dc-4eec-ba8e-e9aa6028a3b2">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtMS0xLTEtOTI0Nzk_bcf2c2f8-9910-443e-8ec0-fc9d1b257994">82,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtMy0xLTEtOTI0Nzk_cfa38e31-1815-4ba6-824a-befaef74ff55">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtNS0xLTEtOTI0Nzk_5d976641-9df5-430b-8ca5-d0a968c8074b">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtMS0xLTEtOTI0Nzk_978cac6b-8914-4424-a7b4-73df1bc42361">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtMy0xLTEtOTI0Nzk_b107402a-837a-4c56-949e-9206923fbab7">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtNS0xLTEtOTI0Nzk_fded90a7-83b8-4faf-921c-c69a3a91f440">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtMS0xLTEtOTI0Nzk_f651d74f-2912-4654-8e2a-17c7802548c1">180,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtMy0xLTEtOTI0Nzk_11bdbd59-0203-43f3-8cf9-ed6a8f2699f2">169,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtNS0xLTEtOTI0Nzk_ba4b1646-6047-4b9c-aa19-105654bc6ed2">133,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTEtMS0xLTkyNDc5_7925b363-da10-4f57-a094-c620fdbea531">82,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTMtMS0xLTkyNDc5_d5d5e452-8bb5-4e53-9056-931dd098f714">84,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTUtMS0xLTkyNDc5_76b47ad8-6532-46cd-bea8-b5e79cd18f8d">84,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTEtMS0xLTkyNDc5_f9600e0e-0a9e-4f92-9cd2-485cb60dad90">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTMtMS0xLTkyNDc5_17baa019-c07f-483a-beb3-fb3783ff8070">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTUtMS0xLTkyNDc5_a1de0141-1e07-4e39-a79b-38b7fcf56c2c">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTEtMS0xLTkyNDc5_2a111e02-805e-4df5-8a33-b40cfa6e83d5">83,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTMtMS0xLTkyNDc5_eaa8ee61-7ecd-4c6d-ba32-64022aa28fc8">85,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTUtMS0xLTkyNDc5_bd392974-f0ca-478a-b494-02e8f8fee4b2">85,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTEtMS0xLTkyNDc5_de352fe8-4a5b-4927-9fc6-bf5ca1437314">2.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTMtMS0xLTkyNDc5_486bcab6-fae5-4261-bb73-7451a9392a7c">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTUtMS0xLTkyNDc5_06abf199-f942-413f-ac1a-cf04b30b09c2">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately <ix:nonFraction unitRef="shares" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzExNw_41a383ce-1774-4a0a-b497-3f8c86fea845">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzEzMg_30faac92-200e-4be6-bc84-a4b4f459c9e9">0.1</ix:nonFraction> million shares at December&#160;31, 2022, and 2021 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the adoption of ASU 2020-06, as the principal amount of the 2025 Notes will be paid in cash and only the conversion spread is settled in shares, the Company will be utilizing the if-converted method and only includes the net number of incremental shares that would be issued upon conversion.</span></div></ix:continuation><div id="i43d6bdf9742e4131bcef4d4155aafb89_190"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzM1NQ_144a5dd7-d8f2-4011-9cb1-157a88a536df" continuedAt="i29da77547fff45a6a7e0c04b8a99e323" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="i29da77547fff45a6a7e0c04b8a99e323"><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzM2Mw_7d45ffa3-d906-4921-b657-d5248d19b6fc" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2022 and 2021 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55ae72f002374097b8ae052513a4d9af_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtMi0xLTEtOTI0Nzk_7928847e-aacd-4566-91fd-2d4bc2a24812">42,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a64401f57445e3889fffd6aa340e49_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtNC0xLTEtOTI0Nzk_11529d09-84be-4ae7-a963-758303bed4ff">1,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53bb7164178d4c7681938eae96f8dd7a_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtNi0xLTEtOTI0Nzk_91ce14cb-178d-4a78-9828-156185e338ae">4,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtOC0xLTEtOTI0Nzk_2142c9c2-d71b-485c-b36c-c0c04495b8d9">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItMi0xLTEtOTI0Nzk_e5ff88f0-c7bc-42af-9706-8d23178a0960">80,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItNC0xLTEtOTI0Nzk_9efc489a-a685-4db5-a597-ba3c8babfa02">7,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItNi0xLTEtOTI0Nzk_4b726a1b-ade9-42f2-b2fa-cbee6b8136a1">17,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItOC0xLTEtOTI0Nzk_3381402b-335c-47c0-870e-49a21c1f7f32">69,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtMi0xLTEtOTI0Nzk_31da21c6-3d9c-4424-b179-a56bd3a4ac3b">14,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtNC0xLTEtOTI0Nzk_b744a059-cb32-44bb-a989-04b038cf5eab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtNi0xLTEtOTI0Nzk_aba4f1e6-f92c-49d1-b4c4-46ecca45b83c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtOC0xLTEtOTI0Nzk_55a7d9b8-dcd2-4dc1-ac85-c9271aaf6c5d">14,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtMi0xLTEtOTI0Nzk_69ef218f-d1c3-4582-be9f-60a93815d098">65,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtNC0xLTEtOTI0Nzk_3b61d455-d59f-4e5c-bb71-c10484b88bab">7,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtNi0xLTEtOTI0Nzk_79c4af58-56ad-4482-8dd0-b713f47f84a2">17,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtOC0xLTEtOTI0Nzk_66bc9730-5c9b-4d23-9912-ef5d59423cbf">55,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4f71bfb1a8422d95af5dd6760a64f5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtMi0xLTEtOTI0Nzk_29dff972-d2ef-4993-9694-20cd5c11255e">22,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ea09ba91b94301bbbdc52ab73d8aa5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtNC0xLTEtOTI0Nzk_028ad3d8-e6dc-4c02-b069-8877a28a893c">9,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3a4807908c54cb5b1a0dd1fd6665df2_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtNi0xLTEtOTI0Nzk_f5e349e8-2302-41a4-bcd1-5ff0d0b99e08">21,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtOC0xLTEtOTI0Nzk_2761d450-781c-422d-815a-e5814f66f0e7">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, the Company reclassified a gain of $<ix:nonFraction unitRef="usd" contextRef="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzIzMQ_42dfa3b9-c0ba-455e-9ddd-2485a68c023a">15.0</ix:nonFraction> million and a loss of $<ix:nonFraction unitRef="usd" contextRef="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzI0OA_b5402fde-595a-4f2c-84a4-be279e31f8ff">0.4</ix:nonFraction>&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div></ix:continuation><div id="i43d6bdf9742e4131bcef4d4155aafb89_193"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI3OTM_a201685f-ff49-4f4f-bb81-d7c0b8e529c0" continuedAt="i76004a760b5a405b8b27fcbe259892e0" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i76004a760b5a405b8b27fcbe259892e0" continuedAt="i0c62ad58db14444988612f16a89ed335"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0c62ad58db14444988612f16a89ed335" continuedAt="ida9a857e6caa420292d7af8baa5f3027"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2022 and 2021 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI3OTU_64217b99-7b67-432e-adbc-60967db2e619" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2022 and 2021 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:17.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.276%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SIA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMi0xLTEtOTI0Nzk_8da851e2-babc-4883-b768-b8653b432c1c">3,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2f742f6e864e72a554afa2da3a8c66_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtNC0xLTEtOTI0Nzk_fe707b2e-6473-4704-9e53-eadd6523a432">11,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34c42773d35464d81a75564647fa0e0_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtOC0xLTEtOTI0Nzk_193fe9d2-3bf7-4dd0-b0a3-a226e331bc0d">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e8046929194a0da3727cadcc6ce0a1_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTAtMS0xLTE0MjI5OA_6e22d10c-5654-457b-80a6-8f024c0abd48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454bba66f23b40d59081b4ed516cc56b_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTEtMS0xLTkyNDc5_b0804cbe-5ad0-4743-9942-f3b072fdc207">21,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04eb6b26c7384b9090a435f6497f42ae_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTMtMS0xLTE2MzQwMg_00be94b3-df66-4e4c-b490-709ef44bb046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMi0xLTEtOTI0Nzk_6048c311-a04b-445e-ad6d-90e2ff648a67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtNC0xLTEtOTI0Nzk_34f5ba4b-0ab3-44d3-9d3f-122e426f5464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtOC0xLTEtOTI0Nzk_b7a3d441-72bf-4213-965e-13cc54fecbac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231" xsi:nil="true" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTAtMS0xLTE0NDIyNA_5675892c-ed79-4633-838a-00062ae5e083"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTEtMS0xLTkyNDc5_0a274bed-ebbe-4ff5-857d-89018441b034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTMtMS0xLTE2MzQwMg_d24b9dae-9900-4d56-8f0d-fd7000b1142a">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMi0xLTEtOTI0Nzk_50b881ef-185a-4c66-8625-68b91824377f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtNC0xLTEtOTI0Nzk_7b9339bc-f8da-4def-8c1d-cf26e0171ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtOC0xLTEtOTI0Nzk_3c2288b4-5edd-409f-a12e-e8b1121e7cbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTAtMS0xLTE0MjI5OA_b55d0067-6b36-4f09-9de3-03071c8871fc">4,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTEtMS0xLTkyNDc5_a9e841be-c08c-4242-b9d0-ae69a12402a5">4,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTMtMS0xLTE2MzQwMg_0e3c21c0-08b4-45a7-b7e6-3c2092fb6552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMi0xLTEtOTI0Nzk_826ec9ae-a29d-479a-9332-2af9d187b011">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtNC0xLTEtOTI0Nzk_0aef91eb-0755-49b8-90bf-2c81be1f3381">1,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtOC0xLTEtOTI0Nzk_d31d457b-bbdb-4114-a852-f19c75cfa31f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTAtMS0xLTE0MjI5OA_7fcace4b-035e-4f33-afec-4eddf9d84b0d">4,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTEtMS0xLTkyNDc5_13f9ba12-b17b-4585-8cf8-0de3272e0a7c">13,215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTMtMS0xLTE2MzQwMg_30fd0f2b-2a6c-44e2-aaf4-32482f803877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1745e45c4754439b297f3e7d7347d24_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMi0xLTEtOTI0Nzk_a1132ed2-7f9c-405c-bcc3-a003a383e6bd">2,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9aecdb884ec42408aef9ceaf4f7631d_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctNC0xLTEtOTI0Nzk_1314332d-52b8-4d9d-a028-e5069d924e05">10,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99410b6978f346d1962e9be3d588bb16_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctOC0xLTEtOTI0Nzk_d6d945b4-6211-4fc6-a9e7-2f714e42b66c">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e03ef2f5ff4d8098cebaa20d010574_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTAtMS0xLTE0MjI5OA_f4c68b1c-e4ae-42ed-bc01-9b8a8928dc9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib407e2307b7d4fc1817926031f1d8119_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTEtMS0xLTkyNDc5_e2cb308a-9009-4872-a298-16cc116e2537">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ff087bc35f4f4f8a6bb3d6ac4b1e72_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTMtMS0xLTE2OTA1MA_b3c0aed3-ec43-4362-afe7-93ecc7cb0d70">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.528%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba83041b85dd4322beadedfbb737f04d_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtMi0xLTEtOTI0Nzk_ce31ef07-ed37-4aab-b760-16ce6fb70ef3">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6416949c9d6642de911caf67ffe8aabb_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtNC0xLTEtOTI0Nzk_6b122efc-6eb1-4c3d-88be-71441992ede8">11,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e82c009c774de0bb05432b74102ae9_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtOC0xLTEtMTQyMzAz_daa5d790-915e-421f-a071-0039233af184">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5653a9fc64e90aa2fbdb1b8095a56_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtMTItMS0xLTE0MjYwMQ_8f26dcd8-3543-49d9-a2bd-040bac9823fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtMi0xLTEtOTI0Nzk_e7ab5a9f-13f7-4046-bd49-607c7a971830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtNC0xLTEtOTI0Nzk_912bff33-9d47-4a55-92b5-6fefd8b45f32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtOC0xLTEtMTQyMzAz_6883debe-1754-4f27-9e45-87bea6cb58bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtMTItMS0xLTE0MjYwMQ_53be631e-6517-442d-807c-9a8c7b398050">23,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtMi0xLTEtOTI0Nzk_3e8a928a-b2e3-4c87-a6d9-499ec9632d31">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtNC0xLTEtOTI0Nzk_19c698e9-cace-43b3-899f-9d12e4f0fbdc">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtOC0xLTEtMTQyMzAz_6baa5979-ff4a-4a6b-b7e6-f39542895889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtMTItMS0xLTE0MjYwMQ_638cce9a-dd96-4fac-9a6b-a50f93eeca31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtMi0xLTEtOTI0Nzk_83d33fb3-7688-4181-8acf-cec0d1006c96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtNC0xLTEtOTI0Nzk_b183863e-9250-4a8b-93fa-f860c06dd9ad">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtOC0xLTEtMTQyMzAz_ca24a02a-def8-4937-83ad-9e3c58590a8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtMTItMS0xLTE0MjYwMQ_b7872e1e-5a99-4d69-a780-ca55ddc6df69">2,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctMi0xLTEtMTQyMzAz_b0be356e-2a4a-47d6-ac5d-2d63b9908638">3,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2f742f6e864e72a554afa2da3a8c66_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctNC0xLTEtMTQyMzAz_878c8435-7bd6-462a-b734-0f3bf729c7e6">11,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34c42773d35464d81a75564647fa0e0_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctOC0xLTEtMTQyMzAz_06bb49d8-62db-4def-9c63-c79e2820cc24">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454bba66f23b40d59081b4ed516cc56b_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctMTItMS0xLTE0NDIzNQ_c7dd4443-4ddb-4386-ac3b-2c5fa1b5d766">21,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $<ix:nonFraction unitRef="usd" contextRef="id61f82dd9bf0413b91c391c490e54d73_D20220101-20221231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzNjI_6f32c90c-1b64-4817-8aa0-4d14b246f7ba">33.3</ix:nonFraction>&#160;million related to the aforementioned contingent liabilities. <ix:nonFraction unitRef="liability" contextRef="icf69e67cb3914b7097e58795099a96dc_I20221231" decimals="INF" name="iart:BusinessCombinationContingentConsiderationNumberOfLiabilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI1MDg_baee7a23-f931-4165-b69e-1de98a979149">One</ix:nonFraction> contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $<ix:nonFraction unitRef="usd" contextRef="icf69e67cb3914b7097e58795099a96dc_I20221231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzNzE_0138cad4-d652-407c-b434-31d252250de6">3.0</ix:nonFraction>&#160;million. The estimated fair value as of December&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i0a7b1feae529450e813237017e332bb6_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzODQ_cb4036fb-fa47-4ad4-8163-caa9beb0e668"><ix:nonFraction unitRef="usd" contextRef="i8e4c5c321a5d4d579e4c7197fc75ffab_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzODQ_e186da35-0d90-49b7-a5b8-1134990bba73">0.2</ix:nonFraction></ix:nonFraction>&#160;million. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ida9a857e6caa420292d7af8baa5f3027"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition of Arkis BioSciences, Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $<ix:nonFraction unitRef="usd" contextRef="ib86a8f98051a4098a0c55718c503c35c_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYyMDk_64f7f2d2-f795-4e67-8105-868d17c5952b">25.5</ix:nonFraction> million based on the timing of certain development milestones of $<ix:nonFraction unitRef="usd" contextRef="i6ad6fdc92af64fb3a69eb22274101a61_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYyNzA_e2738b1c-75c3-4d41-8533-3ea63f33cc36">10</ix:nonFraction> million and commercial sales milestones of $<ix:nonFraction unitRef="usd" contextRef="i6f62455b6c14446e8989b657790d2e88_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYzMDk_b8a09848-d4c5-4840-a7a4-14e3391dd579">15.5</ix:nonFraction> million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="ib86a8f98051a4098a0c55718c503c35c_I20190729" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY2MDc_94c551d9-7a7f-44e7-a046-37040ad1497e">13.1</ix:nonFraction> million at the acquisition date. The estimated the fair value as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  was $<ix:nonFraction unitRef="usd" contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY2ODA_470302aa-dbfe-4204-872e-90f4e3fbfad4">12.9</ix:nonFraction>&#160;million. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY3MDY_8a369de0-91e2-4c35-9d02-000fc33803c4">2.8</ix:nonFraction>&#160;million in accrued expenses and other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY3NjQ_1c68e5ba-6d06-40c5-a4e2-953c47a185ab">10.1</ix:nonFraction>&#160;million in other liabilities at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets of the Company.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i43d6bdf9742e4131bcef4d4155aafb89_196"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMDc_f8f0c66c-27ab-478f-baf3-2f91ba1717d0" continuedAt="i50bd05ee695c4888963602285a594342" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i50bd05ee695c4888963602285a594342" continuedAt="ibff191b1d5ef4db2bac29ea70852c1ea"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;<ix:nonFraction unitRef="segment" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzc1_44650db6-7502-4b68-9783-a5495b038c11">two</ix:nonFraction>&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;<ix:nonFraction unitRef="segment" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzE5MA_0329ddfe-f880-4354-9342-87ee6afda0e0">two</ix:nonFraction>&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than <ix:nonFraction unitRef="product" contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231" decimals="INF" name="iart:SegmentReportingInformationNumberOfProductsOffered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzYzOQ_5e5892b9-f32a-4154-be0b-d3741c7150a9">40,000</ix:nonFraction> instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMTY_b064237e-649b-4732-9535-a5848193299f" continuedAt="ieb50793bde964cd0aef8a7429d04a055" escape="true">Net sales and profit by reportable segment for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt"><ix:continuation id="ieb50793bde964cd0aef8a7429d04a055"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtMS0xLTEtOTI0Nzk_7d38d06c-c896-43e1-8f0f-ea2c87cb1dea">1,019,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtMy0xLTEtOTI0Nzk_80600cfa-0daf-4749-be13-c94c05ba7fa2">1,025,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtNS0xLTEtOTI0Nzk_0ac16cbf-7326-4313-86a7-065a21348b5b">894,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtMS0xLTEtOTI0Nzk_f33b37c7-7f6d-4713-b413-dfe8ed62ac98">538,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtMy0xLTEtOTI0Nzk_2398de63-2300-423e-bbd8-69e8c14ddce8">517,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtNS0xLTEtOTI0Nzk_238ab1c2-ab0d-42f3-aa83-5a5b45d7de2c">477,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtMS0xLTEtOTI0Nzk_2b2cbe9e-5b38-499d-b3e5-cd2180487c29">1,557,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtMy0xLTEtOTI0Nzk_0cd9caff-8978-4ccb-9f2c-8965d6964d6a">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtNS0xLTEtOTI0Nzk_89a2bfad-f36c-4d6a-9185-2071ad3744b1">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148cca9d8e92463aa899bc73beb1ca6b_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctMS0xLTEtOTI0Nzk_367bfd8d-4352-486c-a7d0-25391ce46a96">417,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i814b998492a7444cbcd7886849cb6270_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctMy0xLTEtOTI0Nzk_94c43b20-4b76-4495-9cea-dda2574c02a4">439,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib018f6bcc24a4b3dbe4ce6e3c97e8a0e_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctNS0xLTEtOTI0Nzk_780d9822-4288-47c9-8a38-03b3d212b619">356,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c96c89c8aef4dd0a52c23f78abe191e_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtMS0xLTEtOTI0Nzk_ee879ffc-81b2-4cff-80e0-446653666386">233,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b3618e04d540f4b99ec989ee7e7234_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtMy0xLTEtOTI0Nzk_3f0ea895-4032-4620-9ad7-aeee97c3bca6">228,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa67b71c6874d56a903eea0c00a39c3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtNS0xLTEtOTI0Nzk_931f102e-f88d-461c-b8dd-6ab66b950585">159,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8beb115769fa4bde80a56f0d62b90c05_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktMS0xLTEtOTI0Nzk_aa282faa-283f-46af-b50a-696fc9306cde">651,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b167d370d54bac874817e7f8c82740_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktMy0xLTEtOTI0Nzk_438a1142-fb8c-4284-b4bf-dd72dd598830">667,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1ccf682b834d75acf993e77078be00_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktNS0xLTEtOTI0Nzk_316d98fa-8c13-4583-b790-c2a33366ddf5">516,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTEtMS0xLTkyNDc5_41ff7b42-bb1c-4498-a6ef-50f19555b03b">13,882</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTMtMS0xLTkyNDc5_39effde6-7809-4743-b280-8d9881392e9b">16,914</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTUtMS0xLTkyNDc5_87aecda9-3fe7-4d09-b7a5-a54c1979a291">27,757</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035e179e3b8b4d64bfcfbf533913f64d_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTEtMS0xLTkyNDc5_67e7c314-5ff8-48dd-a3fa-7f4f92c941e3">398,873</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e1659d84668436b978aebc30d320151_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTMtMS0xLTkyNDc5_ac9b66f3-df9d-4888-aeb8-21f88bd8d56d">453,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f6ca02b71f444939da26d0171cf9a3d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTUtMS0xLTkyNDc5_9e3e9eb9-98ee-46ca-b282-3539374020fd">337,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTEtMS0xLTkyNDc5_8bb876de-603d-4873-80b0-7c9bd1de186c">238,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTMtMS0xLTkyNDc5_f85003f4-3940-4cae-93eb-dc1027817ddc">197,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTUtMS0xLTkyNDc5_9df00a47-595a-4aaf-9b58-10cede63de24">151,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><ix:continuation id="ibff191b1d5ef4db2bac29ea70852c1ea"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. <ix:nonNumeric contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMTQ_5cecac14-6748-4e1d-ba4e-4d3fc522b7be" continuedAt="ied48d50401ea4ef78a55bd379b822456" escape="true">Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><ix:continuation id="ied48d50401ea4ef78a55bd379b822456"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1a52a97e10485aa9156603f0f12998_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItMS0xLTEtOTI0Nzk_51edca67-2013-4647-8c14-c9afcef7ccac">1,126,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7aa00ba8e0a4089b0402c6f812d9e90_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItMy0xLTEtOTI0Nzk_1b48155a-d5ff-40c5-927f-ec29e9611d40">170,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a4eff2718b4181a3594c15f97693d6_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItNS0xLTEtOTI0Nzk_db5c90ef-e4c1-4c50-ace6-dfc9ab7cba0a">176,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2ba32f80384628b6d3da8a948107a4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItNy0xLTEtOTI0Nzk_ab2f351e-7106-4402-b046-6e0028f097cf">83,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItOS0xLTEtOTI0Nzk_20ee7001-93c6-4dbc-bac7-73bb7ff2008c">1,557,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be3e483d1fa4218b4739bff6b339aa3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtMS0xLTEtOTI0Nzk_4f779781-b00d-4dc0-84f1-a3d8db23cbf6">1,089,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bc8a1f80f84b31a8dbe8ec757a0ec6_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtMy0xLTEtOTI0Nzk_32ade442-0323-41c1-9ee5-a5f6a67cf9c3">191,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db6e94f32d64676a8e5222a7710ac27_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtNS0xLTEtOTI0Nzk_51bda27c-d3c3-4feb-b426-ebfbf8d7a7dd">182,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia647697a80af4c1a998c2f4501de7cec_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtNy0xLTEtOTI0Nzk_4650440f-af9d-4e3a-ac83-3905359c582d">79,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtOS0xLTEtOTI0Nzk_b8c3090f-59ef-448f-aa55-0488e082e453">1,542,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88400ec8187435b94bf27f234e62310_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtMS0xLTEtOTI0Nzk_7020abc6-e8ce-4849-b86b-d79163e92779">971,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1021003fc387465985bb51c9d1963f10_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtMy0xLTEtOTI0Nzk_e0c5a812-f185-454f-a9b9-bd630850b54f">172,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101af6c449e24243a977e3628cb006bc_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtNS0xLTEtOTI0Nzk_1345843d-9670-403e-ad73-0660e98c11c5">157,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa59878bdb8a4814a9a4fcea4012a206_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtNy0xLTEtOTI0Nzk_da095bb5-54c4-415b-87b9-8186a761c702">70,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtOS0xLTEtOTI0Nzk_eac64c76-9703-4d80-b018-61e44a649e87">1,371,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016f6830198948e4a83167888eedc5ab_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtMS0xLTEtOTI0Nzk_5103c44e-7c8a-48e4-80e6-bad89cea50cb">440,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c47750f81947a3bd94f67736a169fa_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtMy0xLTEtOTI0Nzk_5a949876-2851-492e-86f0-15e5ec34449b">60,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9598bb29974c0eb5a1c729153672d9_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtNS0xLTEtOTI0Nzk_22a19755-a74d-4a4f-9fdb-a03ef6261c82">12,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf719a0faa4ece96aea8a2bae8fc0f_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtNy0xLTEtOTI0Nzk_24750ac0-a11c-490a-ba69-96e046a1af23">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtOS0xLTEtOTI0Nzk_9783cc49-317d-4768-af79-126be4b1ab4f">516,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34987c7e67424092b2a980a73d2196af_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctMS0xLTEtOTI0Nzk_6c9b6eef-a428-46ae-9175-fc5af3e4085f">339,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792da25db32e486d817b94438346f505_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctMy0xLTEtOTI0Nzk_e61f148a-5bef-40af-967c-c5f64dbbbd08">55,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0356b0dec6c415886e16716b8d764cf_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctNS0xLTEtOTI0Nzk_c0c523d6-1af2-444f-953c-f5d15b2d1716">11,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1045633e59945fc8f109a571dd0a894_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctNy0xLTEtOTI0Nzk_5641354d-f599-4cbd-83ca-2ac4a91877c0">6,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctOS0xLTEtOTI0Nzk_0863d8ae-46ab-4504-9cf7-d6a46e189f8e">412,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>2
<FILENAME>iart-20221231xexx33.htm
<DESCRIPTION>EX-3.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie48ac11b1c754e95a400928bb1cc5a4b_192"></div><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED BYLAWS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">OF</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Corporation&#8221;)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 1<br>OFFICES</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Offices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Corporation may have offices at such places both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 2<br>MEETINGS OF STOCKHOLDERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Place of Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Meetings of the stockholders shall be held at such place, within the State of Delaware or elsewhere as may be fixed from time to time by the Board of Directors. If no place is so fixed for a meeting, it shall be held at the Corporation&#8217;s then principal executive office. The Board of Directors may, in its sole discretion, determine that a meeting of stockholders shall be held solely by means of remote communication as authorized by Section 211(a)(2) of the General Corporation Law of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The annual meeting of stockholders shall be held, unless the Board of Directors shall fix some other hour or date therefor, at nine o&#8217;clock A.M. on the first Monday of May in each year, if not a legal holiday under the laws of Delaware, and, if a legal holiday, then on the next succeeding secular day not a legal holiday under the laws of Delaware, at which the stockholders shall elect a Board of Directors, and transact such other business as may properly be brought before the meeting. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Business to be Brought Before a Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;At an annual meeting of stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be (i) brought before the meeting by the Corporation and specified in the notice of meeting given by or at the direction of the Board of Directors, (ii) brought before the meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the meeting by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Section 2.03 and at the time of the meeting, (B) is entitled to vote at the meeting, and (C) has complied with this Section 2.03 as to such business. Except for proposals properly made in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and included in the notice of meeting given by or at the direction of the Board of Directors, the foregoing clause (iii) shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. Stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders, and the only matters that may be brought before a special meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting pursuant to Section 2.04. Stockholders seeking to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">nominate persons for election to the Board must comply with Section 2.10 and this Section 2.03 shall not be applicable to nominations except as expressly provided in Sections 2.03 or 2.10.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (i) provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.03. To be timely, a stockholder&#8217;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary of the preceding year&#8217;s annual meeting&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day prior to such annual meeting or, if later, the tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day following the day on which public disclosure of the date of such annual meeting was first made (such notice within such time periods, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Timely Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). In no event shall any adjournment of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;To be in proper form for purposes of this Section 2.03, a stockholder&#8217;s notice to the Secretary shall set forth&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;As to each Proposing Person (as defined below), (A) the name and address of such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#8217;s books and records)&#59; and (B) the class or series and number of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Proposing Persons, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (whether or not such right is exercisable immediately or only after the passage of time or upon the satisfaction of any conditions or both) pursuant to any agreement, arrangement or understanding (whether or not in writing) (the disclosures to be made pursuant to the foregoing clauses (A) and (B) are referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Stockholder Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;As to each Proposing Person, (A) any derivative, swap or other transaction or series of transactions engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to ownership of shares of any class or series of the Corporation, including due to the fact that the value of such derivative, swap or other transactions are determined by reference to the price, value or volatility of any shares of any class or series of the Corporation, or which derivative, swap or other transactions provide, directly or indirectly, the opportunity to profit from any increase in the price or value of shares of any class or series of the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Synthetic Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which Synthetic Equity Interests shall be disclosed without regard to whether (x) the derivative, swap or other transactions convey any voting rights in such shares to such Proposing Person, (y) the derivative, swap or other transactions are required to be, or are capable of being, settled through delivery of such shares or (z) such Proposing Person may have entered into other transactions that hedge or mitigate the economic effect of such derivative, swap or other transactions, (B) any proxy (other than a revocable proxy or consent given in response to a solicitation made pursuant to, and in accordance with, Section 14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or shares a right to vote any shares of any class or series of the Corporation, (C) any agreement, arrangement, understanding or relationship, including any repurchase or similar so-called &#8220;stock borrowing&#8221; agreement or arrangement, engaged in, directly or indirectly, by such Proposing Person, the purpose or effect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of which is to mitigate loss to, reduce the economic risk (of ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such Proposing Person with respect to the shares of any class or series of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series of the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Short Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), (D) any rights to dividends or other distributions on the shares of any class or series of capital stock of the Corporation, directly or indirectly, owned beneficially by such Proposing Person or any of their affiliates or associates (as such terms are defined in Rule 12b-2 promulgated under the Exchange Act) that are separated or separable from the underlying shares of the Corporation, (E) any performance related fees (other than an asset based fee) that such Proposing Person is entitled to receive based on any increase or decrease in the price or value of shares of any class or series of the Corporation, or any Synthetic Equity Interests or Short Interests, if any, (F)(1) if such Proposing Person is not a natural person, the identity of the natural person or persons associated with such Proposing Person responsible for (i) the formulation of and decision to propose the business to be brought before the meeting and (ii) making voting and investment decisions on behalf of the Proposing Person (irrespective of whether such person or persons have &#8220;beneficial ownership&#8221; for purposes of Rule 13d-3 of the Exchange Act of any securities owned of record or beneficially by the Proposing Person) (such person or persons, the &#8220;Responsible Person&#8221;), the manner in which such Responsible Person was selected, any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such Proposing Person and, the qualifications and background of such Responsible Person or (2) if such Proposing Person is a natural person, the qualifications and background of such natural person, (G) any equity interests or any Synthetic Equity Interests in any principal competitor of the Corporation beneficially owned by such Proposing Person or any of their affiliates or associates, (H) any direct or indirect interest of such Proposing Person or any of their affiliates or associates in any contract with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including, without limitation, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (I) any pending or threatened litigation in which such Proposing Person or any of their affiliates or associates is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (J) any material transaction occurring during the prior twelve months between such Proposing Person or any of their affiliates or associates, on the one hand, and the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation, on the other hand, and (K) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Section 14(a) of the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A) through (K) are referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Disclosable Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit a notice required by these Bylaws on behalf of a beneficial owner&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;As to each item of business that the stockholder proposes to bring before the annual meeting, (A) a reasonably brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing Person and (B) the text of the proposal or business (including the text of any resolutions or Bylaw amendment proposed for consideration)&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;A description of all agreements, arrangements or understandings to which any Proposing Person or any of their affiliates or associates is a party (whether the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">counterparty or counterparties are a Proposing Person or any affiliate or associate thereof, on the one hand, or one or more other third parties, on the other hand, (including any nominee(s) proposed pursuant to Section 2.10), (a) pertaining to any nomination(s) made pursuant to Section 2.10 or other business proposed to be brought before the meeting of stockholders or (b) entered into for the purpose of acquiring, holding, disposing or voting of any shares of any class or series of capital stock of the Corporation (which description shall identify the name of each other person who is party to such an agreement, arrangement or understanding), and (ii) identification of the names and addresses of other stockholders (including beneficial owners) known by any of the Proposing Persons to support any nominations made pursuant to Section 2.10 or other business proposal(s) and, to the extent known, the class and number of all shares of the Corporation&#8217;s capital stock owned beneficially or of record by such other stockholder(s) or other beneficial owner(s)&#59; and </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160; A statement (i) that the stockholder is a holder of record of capital stock of the Corporation entitled to vote at such meeting, a representation that such stockholder intends to appear in person or by proxy at the meeting to propose such business or propose nominees pursuant to Section 2.10 and an acknowledgement that, if such stockholder (or a qualified representative of such stockholder) does not appear to present such business or proposed nominees, as applicable, at such meeting, the Corporation need not present such business or proposed nominees for a vote at such meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation, (ii) whether or not the stockholder giving the notice and&#47;or the other Proposing Person(s), if any, (a) will deliver a proxy statement and form of proxy to holders of, in the case of a business proposal, at least the percentage of voting power of all of the shares of capital stock of the Corporation required under applicable law to approve the proposal or, in the case of a nomination or nominations made pursuant to Section 2.10, at least 67 percent of the voting power of all of the shares of capital stock of the Corporation entitled to vote on the election of directors or (b) otherwise solicit proxies or votes from stockholders in support of such proposal or nomination, as applicable, (iii) providing a representation as to whether or not such Proposing Person intends to solicit proxies in support of director nominees other than the Corporation&#8217;s director nominees in accordance with Rule 14a-19 promulgated under the Exchange Act, and (iv) that the stockholder will provide any other information relating to such item of business that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies in support of the business proposed to be brought before the meeting pursuant to Section 14(a) of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Section 2.03, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Proposing Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the stockholder providing the notice of business proposed to be brought before an annual meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual meeting is made and (iii) any affiliate or associate (each within the meaning of Rule 12b-2 under the Exchange Act for purposes of these Bylaws) of such stockholder or beneficial owner.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;A stockholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.03 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the date to which the meeting has been adjourned or postponed), in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof. For the avoidance of doubt, the obligation to update as set forth in this Section 2.03(d) shall not limit the Corporation&#8217;s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable deadlines hereunder, or enable or be deemed to permit a stockholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business and&#47;or resolutions proposed to be brought before a meeting of the stockholders. Notwithstanding the foregoing, if a Proposing Person no longer plans to solicit proxies in accordance with its representation pursuant to Article II, Section 2.03(c)(v), such Proposing Person shall inform the Corporation of this change by delivering a written notice to the Secretary at the principal executive offices of the Corporation no later than two (2) business days after making the determination not to proceed with a solicitation of proxies. A Proposing Person shall also update its notice so that the information required by Article II, Section 2.03(c) is current through the date of the meeting or any adjournment, postponement, or rescheduling thereof, and such update shall be delivered in writing to the secretary at the principal executive offices of the Corporation no later than two (2) business days after the occurrence of any material change to the information previously disclosed pursuant to Article II, Section 2.03(c).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with this Section 2.03. The Board of Directors or a designated committee thereof shall have the power to determine whether any business proposed to be brought before the meeting was made in accordance with the provisions of these Bylaws.  If neither the Board of Directors nor such designated committee makes a determination as to whether any stockholder proposal was made in accordance with these Bylaws, the presiding officer of the Annual Meeting shall have the power and duty to determine whether the stockholder proposal was made in accordance with the provisions of these Bylaws. If the Board of Directors or a designated committee thereof or the presiding officer of the meeting, as applicable, determines that any stockholder proposal was not made in accordance with the provisions of these Bylaws,  such proposal shall be disregarded and shall not be presented for action at the annual meeting.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;This Section 2.03 is expressly intended to apply to any business proposed to be brought before an annual meeting of stockholders other than any proposal made pursuant to Rule 14a-8 under the Exchange Act. In addition to the requirements of this Section 2.03 with respect to any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such business. If a stockholder fails to comply with any applicable requirements of the Exchange Act, such stockholder&#8217;s proposed business shall be deemed to have not been made in compliance with these Bylaws and shall be disregarded. Nothing in this Section 2.03 shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;Notwithstanding the foregoing provisions of this Section 2.03, if the proposing stockholder (or a qualified representative of the stockholder) does not appear at the Annual Meeting to present any business, such business shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation.  For purposes of this Section 2.03, to be considered a qualified representative of the proposing stockholder, a person must be authorized by a written instrument executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders, and such person must produce such written instrument or electronic transmission, or a reliable reproduction of the written instrument or electronic transmission, to the presiding officer at the meeting of stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;Except as otherwise required by law, nothing in this Section 2.03 shall obligate the Corporation or the Board of Directors to include in any proxy statement or other stockholder communication distributed on behalf of the Corporation or the Board of Directors information with respect to any nominee for director or any other matter of business submitted by a stockholder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;For purposes of these Bylaws, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">public disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notice of each meeting of stockholders shall be given which shall state the place, if any (or the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person), date and hour of the meeting and in the case of a special meeting, the purpose or purposes for which the meeting is called. Unless otherwise provided by law, the certificate of incorporation or these bylaws, such notice shall be given to each stockholder entitled to vote at such meeting not less than 10 days nor more than 60 days before the date of the meeting. Notice may be given personally, by mail or by electronic transmission in accordance with Section 232 of the DGCL. If mailed, such notice shall be deemed given when deposited in the United States mail, postage prepaid, directed to each stockholder at such stockholder&#8217;s address appearing on the books of the Corporation or given by the stockholder for such purpose. Notice by electronic transmission shall be deemed given as provided in Section 232 of the DGCL. An affidavit of the mailing or other means of giving any notice of any stockholders&#8217; meeting, executed by the secretary, assistant secretary or any transfer agent of the Corporation giving the notice, shall be prima facie evidence of the giving of such notice or report. Notice shall be deemed to have been given to all stockholders of record who share an address if notice is given in accordance with the &#8220;householding&#8221; rules set forth in Rule 14a-3(e) under the Exchange Act and Section 233 of the DGCL. When a meeting is adjourned to another time or place, if any (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice need not be given of the adjourned meeting if the time and place, if any (and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person at such adjourned meeting), thereof are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for the meeting on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or (iii) set forth in the notice of the meeting given in accordance with this Section 2.04&#59; provided, however, that if the adjournment is for more than thirty (30) days or a new record date is fixed for the adjourned meeting, in which case a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">List of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Corporation shall prepare, no later than the tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day before each meeting of stockholders, a complete list of stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of  10 days ending on the day before the meeting date, (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of meeting, or (b) during ordinary business hours at the principal place of business of the Corporation. Except as otherwise provided by law, the stock ledger shall be the only evidence as to the stockholders who are entitled to examine the list of stockholders required by this Section 2.05 or to vote in person or by proxy at any meeting of stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Inspector of Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Prior to any meeting of stockholders, the board of directors, the chairman of the board, the president or the secretary shall appoint an inspector of election. Such inspectors for election shall have the powers and duties set forth in Section 231 of the DGCL and may include individuals who serve the Corporation in other capacities, including, without limitation, as officers, employees, agents or representatives, to act at such meeting and make a written report thereof. Each inspector of election, before discharging his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors of election shall have the duties prescribed by law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Special meetings of the stockholders, for any purpose or purposes, unless otherwise prescribed by statute or by the Certificate of Incorporation, may be called only by the Chairman of the Board, the President or the Board of Directors. Such request shall state the purpose or purposes of the proposed meeting. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quorum&#59; Voting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The holders of a majority of the stock issued and outstanding and entitled to vote thereat, present in person or by remote communication, or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business except as otherwise provided by statute or by the Certificate of Incorporation. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders entitled to vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted which might have been transacted at the meeting as originally notified. At any meeting of stockholders (at which a quorum is present to organize the meeting), all matters, except as otherwise provided by applicable law, pursuant to any regulation applicable to the Corporation or its securities or by the Certificate of Incorporation or by these Bylaws (including the election of directors), shall be decided by the affirmative vote of a majority in voting power of shares present in person or represented by proxy and entitled to vote thereon. Unless otherwise provided in the Certificate of Incorporation, each stockholder shall at every meeting of stockholders be entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder, but no shares shall be voted pursuant to a proxy more than three years after the date of the proxy unless the proxy provides for a longer period. The Board of Directors may by resolution establish a method for stockholders to cast their vote by a secure electronic method. In the event the Corporation receives proxies for disqualified or withdrawn nominees for the Board of Directors, such votes for such disqualified or withdrawn nominees in the proxies will be treated as abstentions.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Action Without a Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Unless otherwise restricted by the Certificate of Incorporation, any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing setting forth the action so taken, (i) shall be signed by the holders of record on the record date (established as provided below) of outstanding stock of the Corporation having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">at which all shares entitled to vote thereon were present and voted and (ii) shall be delivered to the Corporation by delivery to its registered office in the State of Delaware, its principal place of business, or an officer or agent of the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to a Corporation&#8217;s registered office shall be by hand or by certified or registered mail, return receipt requested. Every written consent shall bear the date of signature of each stockholder who signs the consent, and no written consent shall be effective to take the corporate action referred to therein unless, within sixty days after the earliest dated consent delivered in the manner required by this Section 2.09 to the Corporation, written consents signed by a sufficient number of stockholders to take action are delivered in the manner required by this Section to the Corporation. Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Without qualification, any stockholder of record seeking to have the stockholders authorize or take any action by written consent shall first request in writing that the Board of Directors fix a record date for the purpose of determining the stockholders entitled to take such action, which request shall be in proper form and delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation. Within ten (10) days after receipt of a request in proper form and otherwise in compliance with this Section 2.09(b) from any such stockholder, the Board of Directors may adopt a resolution fixing a record date for the purpose of determining the stockholders entitled to take such action, which date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which date shall not be more than ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. If no resolution fixing a record date has been adopted by the Board of Directors within such ten (10) day period after the date on which such a request is received, (i) the record date for determining stockholders entitled to consent to such action, when no prior action of the Board of Directors is required by applicable law, shall be the first date on which a valid signed written consent setting forth the action taken or proposed to be taken is delivered to the Corporation in the manner described in this Section 2.09, and (ii) the record date for determining stockholders entitled to consent to such action, when prior action by the Board of Directors is required by applicable law, shall be at the close of business on the date on which the Board of Directors adopts the resolution taking such prior action.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;In the event of the delivery, in the manner provided by this Section 2.09 and applicable law, to the Corporation of written consent or consents to take corporate action and&#47;or any related revocation or revocations, the Corporation shall engage independent inspectors of elections for the purpose of performing promptly a ministerial review of the validity of the consents and revocations. For the purpose of permitting the inspectors to perform such review, no action by written consent and without a meeting shall be effective until such inspectors have completed their review, determined that the requisite number of valid and unrevoked consents delivered to the Corporation in accordance with this Section 2.09 and applicable law have been obtained to authorize or take the action specified in the consents, and certified such determination for entry in the records of the Corporation kept for the purpose of recording the proceedings of meetings of stockholders. Nothing contained in this Section 2.09 shall in any way be construed to suggest or imply that the Board or any stockholder shall not be entitled to contest the validity of any consent or revocation thereof, whether before or after such certification by the independent inspectors, or to take any other action (including, without limitation, the commencement, prosecution or defense of any litigation with respect thereto, and the seeking of injunctive relief in such litigation).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Notwithstanding anything in these Bylaws to the contrary, no action may be taken by the stockholders by written consent except in accordance with this Section 2.09. If </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Board of Directors shall determine that any request to fix a record date or to take stockholder action by written consent was not properly made in accordance with this Section 2.09, or the stockholder or stockholders seeking to take such action do not otherwise comply with this Section 2.09, then the Board of Directors shall not be required to fix a record date and any such purported action by written consent shall be null and void to the fullest extent permitted by applicable law. In addition to the requirements of this Section 2.09 with respect to stockholders seeking to take an action by written consent, each soliciting person shall comply with all requirements of applicable law, including all requirements of the Exchange Act, with respect to such action.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Nominations for Election to the Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Nominations of any person for election to the Board of Directors at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting only (i) by or at the direction of the Board of Directors, including by any committee or persons appointed by the Board of Directors, or (ii) by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination is proposed to be made, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Section 2.10 and at the time of the meeting, (B) is entitled to vote at the meeting, and (C) has complied with this Section 2.10 as to such nomination. The foregoing clause (ii) shall be the exclusive means for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting or special meeting.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Without qualification, for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting, the stockholder must (i) provide Timely Notice (as defined in Section 2.03) thereof in writing and in proper form to the Secretary of the Corporation and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.10. Without qualification, if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling a special meeting, then for a stockholder to make any nomination of a person or persons for election to the Board of Directors at a special meeting, the stockholder must (i) provide timely notice thereof in writing and in proper form to the Secretary of the Corporation at the principal executive offices of the Corporation, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.10. To be timely, a stockholder&#8217;s notice for nominations to be made at a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day prior to such special meeting and not later than the ninetieth (90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day prior to such special meeting or, if later, the tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day following the day on which public disclosure (as defined in Section 2.03) of the date of such special meeting was first made. In no event shall any adjournment of an annual meeting or special meeting or the announcement thereof commence a new time period for the giving of a stockholder&#8217;s notice as described above.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;To be in proper form for purposes of this Section 2.10, a stockholder&#8217;s notice to the Secretary shall set forth&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;As to each Nominating Person (as defined below), the Stockholder Information (as defined in Section 2.03(c)(i), except that for purposes of this Section 2.10 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Section 2.03(c)(i))&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;As to each Nominating Person, any Disclosable Interests (as defined in Section 2.03(c)(ii), except that for purposes of this Section 2.10 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Section 2.03(c)(ii) and the disclosure in clause (K) of Section 2.03(c)(ii) shall be made with respect to the election of directors at the meeting)&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;As to each person whom a Nominating Person proposes to nominate for election as a director, (A) all information with respect to such proposed nominee that would be required to be set forth in a stockholder&#8217;s notice pursuant to this Section 2.10 if such proposed nominee were a Nominating Person, (B) a questionnaire with respect to the background and qualifications of the nominee completed by the nominee in the form provided by the Corporation (which questionnaire shall be provided by the Secretary upon written request)&#59; (C) a representation and agreement in the form provided by the Corporation (which form shall be provided by the Secretary upon written request) that&#58; (a) such proposed nominee is not and will not become party to any agreement, arrangement or understanding with any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a &#8220;Voting Commitment&#8221;) that has not been disclosed to the Corporation&#59; (b) such proposed nominee is not and will not become a party to any agreement, arrangement, or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement, or indemnification in connection with service or action as a director that has not been disclosed to the Corporation&#59; (c) such proposed nominee would, if elected as a director, comply with all applicable rules and regulations of the exchanges upon which shares of the Corporation&#8217;s capital stock trade, each of the Corporation&#8217;s corporate governance, ethics, conflict of interest, confidentiality, stock ownership and trading policies and guidelines applicable generally to the Corporation&#8217;s directors and, if elected as a director of the Corporation, such person currently would be in compliance with any such policies and guidelines that have been publicly disclosed&#59; (d) such proposed nominee intends to serve as a director for the full term for which he or she is to stand for election&#59; (e) such proposed nominee, if elected, intends to tender, promptly following such person&#8217;s election or re-election, an irrevocable resignation effective upon such person&#8217;s failure to receive the required vote for re-election at the next meeting at which such person would face re-election and upon acceptance of such resignation by the Board of Directors&#59; and (f) such proposed nominee will promptly provide to the Corporation such other information as it may reasonably request&#59; (D) all information relating to such proposed nominee that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Section 14(a) under the Exchange Act (including such proposed nominee&#8217;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected), (E) a description of all arrangements or understandings between or among the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder or concerning the nominee&#8217;s potential service on the Board of Directors, and (F) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any other material relationships, between or among any Nominating Person, on the one hand, and each proposed nominee, or his or her respective affiliates and associates, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the &#8220;registrant&#8221; for purposes of such rule and the proposed nominee were a director or executive officer of such registrant (the disclosures to be made pursuant to the foregoing clauses (A) through (F) are referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Nominee Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;The Corporation may require any proposed nominee to furnish such other information (A) as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">accordance with the Corporation&#8217;s Corporate Governance Guidelines or (B) that could be material to a reasonable stockholder&#8217;s understanding of the independence or lack of independence of such proposed nominee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Section 2.10, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Nominating Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the stockholder providing the notice of the nomination proposed to be made at the meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made and (iii) any affiliate or associate of such stockholder or beneficial owner.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.10 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof). For the avoidance of doubt, the obligation to update as set forth in this Section 2.10(d) shall not limit the Corporation&#8217;s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable deadlines hereunder, or enable or be deemed to permit a stockholder who has previously submitted notice hereunder to amend or update any nomination or to submit any new nominees, including by changing or adding nominees proposed to be brought before a meeting of the stockholders. Notwithstanding the foregoing, if a Nominating Person no longer plans to solicit proxies in accordance with its representation pursuant to Article II, Section 2.03(c)(v), such Nominating Person shall inform the Corporation of this change by delivering a written notice to the Secretary at the principal executive offices of the Corporation no later than two (2) business days after making the determination not to proceed with a solicitation of proxies. A Nominating Person shall also update its notice so that the information required by Article II, Section 2.10(c) is current through the date of the meeting or any adjournment, postponement, or rescheduling thereof, and such update shall be delivered in writing to the secretary at the principal executive offices of the Corporation no later than two (2) business days after the occurrence of any material change to the information previously disclosed pursuant to Article II, Section 2.10(c).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Notwithstanding anything in these Bylaws to the contrary, no person shall be eligible for election as a director of the Corporation unless nominated in accordance with this Section 2.10. The Board of Directors or a designated committee thereof shall have the power to determine whether a nomination proposed to be brought before the meeting was made in accordance with the provisions of these Bylaws.  If neither the Board of Directors nor such designated committee makes a determination as to whether any stockholder nomination was made in accordance with the provisions of these Bylaws, the presiding officer of the meeting shall have the power and duty to determine whether the stockholder nomination was made in accordance with the provisions of these Bylaws.  If the Board of Directors or a designated committee thereof or the presiding officer, as applicable, determines that any stockholder nomination was not made in accordance with the provisions of these Bylaws, such nomination shall be disregarded and shall not be presented for action at the meeting. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;Notwithstanding the foregoing provisions of this Section 2.10, if the Nominating Person (or a qualified representative of the Nominating Person) does not appear at the meeting to present a nomination, such nomination shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation.  For purposes of this Section 2.10, to be considered a qualified representative of the Nominating Person, a person must be authorized by a written instrument executed by such Nominating Person or an electronic transmission delivered by such Nominating Person to act for such Nominating Person as proxy at the meeting of stockholders, and such person must produce such written instrument or electronic transmission, or a reliable reproduction of the written instrument or electronic transmission, to the presiding officer at the meeting of stockholders.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;Except as otherwise required by law, including, but not limited to, Rule 14a-19 of the Exchange Act, nothing in this Section 2.10 shall obligate the Corporation or the Board of Directors to include in any proxy statement or other stockholder communication distributed on behalf of the Corporation or the Board of Directors information with respect to any nominee for director submitted by a stockholder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;Notwithstanding the foregoing provisions of this Bylaw, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder, including, but not limited to, Rule 14a-19 of the Exchange Act, with respect to the matters set forth in this Bylaw.  If a stockholder fails to comply with any applicable requirements of the Exchange Act, including, but not limited to, Rule 14a-19 promulgated thereunder, such stockholder&#8217;s proposed nomination shall be deemed to have not been made in compliance with this Bylaw and shall be disregarded.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Further notwithstanding the foregoing provisions of these Bylaws, unless otherwise required by law, (i) no Nominating Person shall solicit proxies in support of director nominees other than the Corporation&#8217;s nominees unless such Nominating Person has complied with Rule 14a-19 promulgated under the Exchange Act in connection with the solicitation of such proxies, including the provision to the Corporation of notices required thereunder with timely notice, and (ii) if any Nominating Person (A) provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act, (B) subsequently fails to comply with the requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) promulgated under the Exchange Act, including the provision to the Corporation of notices required thereunder with timely notice, and (C) no other Nominating Person has provided notice pursuant to, and in compliance with, Rule 14a-19 under the Exchange Act that it intends to solicit proxies in support of the election of such proposed nominee in accordance with Rule 14a-19(b) under the Exchange Act, then such proposed nominee shall be disqualified from nomination, the Corporation shall disregard the nomination of such proposed nominee and no vote on the election of such proposed nominee shall occur. Upon request by the Corporation, if any Nominating Person provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act, such Nominating Person shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting date, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;The number of nominees a stockholder may nominate for election at the annual meeting of stockholders (or in the case of a stockholder giving the notice on behalf of a beneficial owner, the number of nominees a stockholder may nominate for election at the annual meeting of stockholders on behalf of such beneficial owner) shall not exceed the number of directors to be elected at such annual meeting of stockholders.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chairman and Secretary at Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. At any meeting of stockholders, the Chairman of the Board of Directors, or in his or her absence, the President, or if neither such person is available, then a person designated by the Board of Directors, shall preside at and act as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">chairman of the meeting. The Secretary, or in his or her absence a person designated by the chairman of the meeting, shall act as secretary of the meeting and keep a record of the proceedings thereof. The Board of Directors may adopt by resolution such rules, regulations, and procedures for the conduct of the meeting of stockholders as it shall deem appropriate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent inconsistent with such rules, regulations, and procedures as adopted by the Board of Directors, the chairman of the meeting shall have the right and authority to convene and to adjourn the meeting, to prescribe such rules, regulations and procedures, and to do all such acts as, in the judgment of such chairman of the meeting, are appropriate for the proper conduct of the meeting. Such rules, regulations, or procedures, whether adopted by the Board of Directors or the chairman of the meeting, may include, without limitation, the following&#58; (a) the establishment of an agenda for the meeting&#59; (b) rules and procedures for maintaining order at the meeting and the safety of those present at the meeting&#59; (c) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies, or such other persons as the chair of the meeting shall determine&#59; (d) restrictions on entry to the meeting after the time fixed for the commencement thereof&#59; (e) the determination of the circumstances in which any person may make a statement or ask questions and limitations on the time allotted to questions or comments&#59; (f) the determination of when the polls shall open and close for any given matter to be voted on at the meeting&#59; (g) the exclusion or removal of any stockholders or any other individual who refuses to comply with meeting rules, regulations, or procedures&#59; (h) restrictions on the use of audio and video recording devices, cell phones, and other electronic devices&#59; (i) rules, regulations, and procedures for compliance with any federal, state, or local laws or regulations (including those concerning safety, health, or security)&#59; (j) procedures (if any) requiring attendees to provide the Corporation advance notice of their intent to attend the meeting&#59; and (k) rules, regulations, or procedures regarding the participation by means of remote communication of stockholders and proxy holders not physically present at a meeting, whether such meeting is to be held at a designated place or solely by means of remote communication.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The chairman of the meeting, in addition to making any other determinations provided for elsewhere in these bylaws or that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that business or a nomination was not properly brought before the meeting, and if such chairman should so determine, such chairman shall so declare to the meeting and shall not be required to transact or consider any such business or nomination. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. The chairman of the meeting shall fix and announce at the meeting the date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 3<br>DIRECTORS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Number and Term of Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The number of directors of the Corporation shall be not less than three nor more than thirteen, as designated from time to time by resolution of the Board of Directors. The directors shall be elected at the annual meeting of the stockholders, except as provided in Section 3.02 hereof. Except as provided in Section 3.02 hereof, each director shall be elected by the vote of the majority of the votes cast with respect to the director, provided that if the number of nominees exceeds the number of directors to be elected, the directors shall be elected by the vote of a plurality of the votes cast. For purposes of this Section 3.01, a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a director must exceed the number of votes cast &#8220;against&#8221; that director. If a director is not elected, the director shall offer to tender his or her resignation to the Board of Directors. The Nominating </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and Corporate Governance Committee will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will act on the Committee&#8217;s recommendation and publicly disclose its decision and the rationale behind it within 90 days from the date of the certification of the election results.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The director who tenders his or her resignation will not participate in the Board of Directors&#8217; decision. Directors shall hold office until the next annual meeting of stockholders and until their successors shall be duly elected and qualified or until their earlier death, resignation or removal. Directors need not be stockholders. If, for any cause, the Board of Directors shall not have been elected at an annual meeting of stockholders, they may be elected as soon thereafter as convenient at a special meeting of the stockholders called for that purpose in the manner provided in these Bylaws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Vacancies and newly created directorships resulting from any increase in the authorized number of directors may only be filled by a majority of the directors then in office, though less than a quorum, or by a sole remaining director, and the directors so chosen shall hold office until the next annual election and until their successors are duly elected and shall qualify, unless sooner displaced. If there are no directors in office, then an election of directors may be held in the manner provided by statute.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resi</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">nations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any director may resign at any time by giving written notice (or notice by electronic transmission) to the Board of Directors, the Chairman of the Board, the President, or the Secretary. Such resignation shall take effect at the time of receipt thereof or at any later time specified therein&#59; and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective. A resignation which is conditioned upon the director failing to receive a specified vote for re-election as a director may provide that it is irrevocable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Direction of Mana</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The business of the Corporation shall be managed under the direction of its Board of Directors, which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these Bylaws directed or required to be exercised or done by the stockholders.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Place of Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board of Directors of the Corporation may hold meetings, both regular and special, either within or without the State of Delaware.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Immediately after each annual election of directors or at such other time as the Board of Directors may determine, the Board of Directors shall meet for the purpose of organization, election of officers, and the transaction of other business, at the place where such election of directors was held or, if notice of such meeting is given, at the place specified in such notice. Notice of such meeting need not be given. In the absence of a quorum at said meeting, the same may be held at any other time and place which shall be specified in a notice given as hereinafter provided for special meetings of the Board of Directors, or as shall be specified in a written waiver signed by the directors, if any, not attending and participating in the meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Re</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ular Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Regular meetings of the Board of Directors may be held without notice at such time and place as shall from time to time be determined by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Special meetings of the Board of Directors may be called by the Chairman of the Board or the President on 2 days&#8217; notice to each director either </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">personally (including by telephone or by means of electronic transmission), or in the manner specified in Section 4.01. Special meetings shall be called by the Chairman of the Board, or the President or the Secretary in like manner and on like notice of the written request (or request by electronic transmission) of two directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quorum&#59; Voting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. At all meetings of the Board of Directors, a majority of the directors shall constitute a quorum for the transaction of business&#59; and at all meetings of any committee of the Board of Directors, a majority of the members of such committee shall constitute a quorum for the transaction of business. The act of a majority of the directors present at any meeting of the Board of Directors or any committee thereof at which there is a quorum present shall be the act of the Board of Directors or such committee, as the case may be, except as may be otherwise specifically provided by statute or by the Certificate of Incorporation. If a quorum shall not be present at any meeting of the Board of Directors or committee thereof, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Action Without a Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings (or electronic transmission or transmissions) are filed with the minutes of proceedings of the Board of Directors or committee, as applicable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Telephonic Meetin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Members of the Board of Directors or any committee thereof may participate in and act at any meeting of such board or committee through the use of a conference telephone or other communications equipment by means of which all persons participating can hear each other, and participation in the meeting pursuant to this Section 3.11 shall constitute presence in person at the meeting except when the person attends for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committees of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Corporation elects to be governed by Section 141(c)(2) of the DGCL. The Board of Directors may, by resolution passed by a majority of the whole Board of Directors, designate one or more committees, each committee to consist of one or more of the directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. Any such committee, to the extent provided in the resolution, shall have and may exercise all of the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, except as expressly limited by Section 141(c)(2) of the DGCL. Such committee or committees shall have such name or names as may be determined from time to time by resolution adopted by the Board of Directors. Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors when requested.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each director shall be entitled to receive such compensation, if any, as may from time to time be fixed by the Board of Directors. Members of special or standing committees may be allowed like compensation for attending committee meetings. Directors may also be reimbursed by the Corporation for all reasonable expenses incurred in traveling to and from the place of each meeting of the Board of Directors or of any such committee or otherwise incurred in the performance of their duties as directors. No payment referred to herein shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 3.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Presidin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board of Directors may appoint a presiding director of the Board of Directors to hold such position for a term not to exceed one year. Such term shall end on the earlier of the date of the next annual meeting of stockholders or until such presiding director&#8217;s earlier death, resignation or removal from such position. The Board of Directors shall determine the qualifications and duties of any such presiding director, including, but not limited to, presiding over meetings of the Board of Directors if the Chairman of the Board is absent.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 4<br>NOTICES</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 4.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to Section 2.04 of the Bylaws with respect to notice of meetings of stockholders, whenever, under the provisions of law or of the Certificate of Incorporation or of these Bylaws, notice is required to be given to any director or stockholder, such requirement shall not be construed to necessitate personal notice. Whenever written notice is required by law to be given to any director or stockholder, such notice may be given by mail, addressed to such director or stockholder, at such person&#8217;s address as it appears on the records of the Corporation, with postage thereon prepaid, and such notice shall be deemed given when deposited in the United States mail. Notice to directors may also be given by electronic transmission. Without limiting the manner by which notice otherwise may be given to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided in Section 232 of the DGCL. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 4.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Whenever, under the provisions of law or of the Certificate of Incorporation or of these Bylaws, notice is required to be given, a waiver thereof in writing or electronic transmission, by the person or persons entitled to said notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent thereto. In the case of a stockholder, such waiver of notice may be signed by such stockholder&#8217;s attorney or proxy duly appointed in writing or otherwise permitted by law. Neither the business nor the purpose of any meeting need be specified in any waiver.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 5<br>OFFICERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The officers of the Corporation shall be a Chairman of the Board, a Chief Executive Officer, a President, a Chief Financial Officer, a Secretary and a Treasurer, and may also include one or more Vice Presidents (who may be further classified by such descriptions as &#8220;executive&#8221;, &#8220;senior&#8221;, &#8220;assistant&#8221;, or otherwise), one or more Assistant Secretaries and Assistant Treasurers, and such other officers as may be elected by the Board of Directors. Any number of offices may be held by the same person.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Election and Term of Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The officers of the Corporation shall be elected by the Board of Directors. Officers shall hold office at the pleasure of the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Removal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any officer may be removed at any time by the Board of Directors with or without cause. Any vacancy occurring in any office of the Corporation may be filled by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chairman of the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Chairman of the Board shall preside at all meetings of the Board of Directors and shall perform such other duties, if any, as from time to time may be assigned to him by the Board of Directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Chief Executive Officer shall have overall responsibility for the management of the business and operations of the Corporation and shall see that all orders and resolutions of the Board of Directors are carried into effect. In the absence of the Chairman of the Board and any Presiding Director, he or she shall preside over meetings of the Board of Directors. In general, he or she shall perform such duties as from time to time may be assigned to him or her by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Chief Financial Officer shall have general responsibility for the financial affairs of the Corporation and shall perform such other duties, if any, as from time to time may be assigned to him by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the absence of the Chief Executive Officer, the President shall have overall responsibility for the management of the business and operations of the Corporation and shall see that all orders and resolutions of the Board of Directors are carried into effect. In the absence of the Chairman of the Board, any Presiding Director and the Chief Executive Officer, he or she shall preside over meetings of the Board of Directors. In general, he or she shall perform such duties as from time to time may be assigned to him or her by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Vice Presidents or Senior Vice Presidents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive Vice Presidents or Senior Vice Presidents shall perform such managerial duties and have such authority as may be specified in these Bylaws or by the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the President. In the absence or disability of the President, the Executive Vice Presidents or Senior Vice Presidents, in order of seniority established by the Board of Directors or the Chairman of the Board, shall perform the duties and exercise the powers of the President.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vice Presidents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Vice Presidents shall perform such duties and have such authority as may be specified in these Bylaws or by the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the President.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Secretary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Secretary shall attend all meetings of the Board of Directors and all meetings of the stockholders and record all the proceedings of the meetings of the stockholders and of the Board of Directors in a book to be kept for that purpose and shall perform like duties for the standing committees when required. He or she shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the President. He shall have custody of the corporate seal of the Corporation and he or she, or an Assistant Secretary, shall have authority to affix the same to any instrument, and when so affixed it may be attested by his or her signature or by the signature of such Assistant Secretary. The Board of Directors may give general authority to any other officer to affix the seal of the Corporation and to attest the affixing by his or her signature.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assistant Secretaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Assistant Secretary or Secretaries shall, in the absence or disability of the Secretary, perform the duties and exercise the authority of the Secretary, and shall perform such other duties and have such other authority as the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the President may from time to time prescribe.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treasurer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation and shall deposit all monies and other valuable effects in the name </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. He or she shall disburse the funds of the Corporation as may be ordered by the Board of Directors, the Chairman of the Board, or the President, or the Chief Executive Officer, taking proper vouchers for such disbursements, and shall render to the Board of Directors when the Board of Directors so requires, an account of all his transactions as Treasurer and of the financial condition of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 5.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assistant Treasurers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Assistant Treasurer or Treasurers shall, in the absence or disability of the Treasurer, perform the duties and exercise the authority of the Treasurer and shall perform such other duties and have such other authority as the Board of Directors may from time to time prescribe.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 6<br>INDEMNIFICATION OF DIRECTORS AND OFFICERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director or officer of the Corporation, or is or was serving while a director or officer of the Corporation at the request of the Corporation as a director, officer, employee, agent, fiduciary or other representative of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, shall be indemnified by the Corporation against expenses (including attorneys&#8217; fees), judgments, fines, excise taxes and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding to the full extent permissible under applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the fullest extent permitted by applicable law as it exists now or is hereafter amended, expenses (including attorneys&#8217; fees) incurred by a present or former director or officer in defending any civil, criminal, administrative or investigative action, suit or proceeding for which indemnification is or may be available pursuant to this Article 6 shall be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the Corporation as authorized in this Article 6. Such expenses (including attorneys&#8217; fees) incurred by other employees and agents may be so paid upon such terms and conditions, if any, as the Corporation deems appropriate. The Board of Directors may authorize the Corporation&#8217;s counsel to represent a director, officer, employee or agent in any action, suit or proceeding, whether or not the Corporation is a party to such action, suit or proceeding.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any indemnification of a director or officer of the Corporation under Section 6.01, or advance of costs, charges and expenses of a director or officer under Section 6.02, shall be made promptly, and in any event within sixty (60) days, upon the written request of the director or officer. The right to indemnification or advances as granted by this Article 6 shall be enforceable, to the fullest extent permitted by law, by the director or officer in any court of competent jurisdiction if the Corporation denies such request, in whole or in part. Such person&#8217;s costs and expenses incurred in connection with successfully establishing his or her right to indemnification, in whole or in part, in any such action shall also be indemnified by the Corporation, to the fullest extent permitted by law. It shall be a defense to any such action (other than an action brought to enforce a claim for the advance of costs, charges and expenses under Section 6.02 where the required undertaking, if any, has been received by the Corporation) that the claimant has not met the standard of conduct set forth under Delaware law, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its board of directors or a committee thereof, its independent legal counsel, and its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct under Delaware law, nor the fact that there has been an actual determination by the Corporation (including its board of directors or a committee thereof, its independent legal counsel, and its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Ri</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The indemnification and advancement of expenses provided by this Article 6 shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any insurance or other agreement, vote of shareholders or disinterested directors or otherwise, both as to actions in their official capacity and as to actions in another capacity while holding an office, and shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of such person.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee, agent, fiduciary or other representative of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under the provisions of these Bylaws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 6.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The duties of the Corporation to indemnify and to advance expenses to a director or officer provided in this Article 6 shall constitute a contract between the Corporation, on the one hand, and, on the other hand, each individual who serves or has served as a director or officer of the Corporation, in consideration of such person&#8217;s past or current and any future performance of services for the Corporation, and pursuant to this Article 6, the Corporation intends to be legally bound to each such current or former director or officer of the Corporation, the rights conferred under this Article 6 are present contractual rights, and such rights are fully vested, and shall be deemed to have vested fully, immediately upon such director or officer commencing service as a director or officer of the Corporation. Neither amendment nor repeal nor modification of any provision of this Article 6 nor the adoption of any provision of the Corporation&#8217;s certificate of incorporation, as amended or restated from time to time, inconsistent with this Article 6 shall eliminate or reduce the effect of this Article 6 in respect of any act or omission occurring, or any cause of action or claim that accrues or arises or any state of facts existing, at the time of or before such amendment, repeal, modification or adoption of an inconsistent provision (even in the case of a proceeding based on such a state of facts that is commenced after such time). The rights provided by, or granted pursuant to, this Article 6 shall continue notwithstanding that the person has ceased to be a director or officer of the Corporation and shall inure to the benefit of the estate, heirs, executors, administrators, legatees and distributees of such person.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 7<br>CERTIFICATES OF STOCK</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Every holder of stock in the Corporation shall be entitled to have a certificate in the form prescribed by the Board of Directors signed on behalf of the Corporation by the Chairman of the Board or the President or a Vice President and by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary of the Corporation, representing the number of shares owned by him in the Corporation&#59; provided, that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the board of directors may provide by resolution or resolutions that some or all classes or series of its stock shall be uncertificated shares. Any or all signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent, or registrar at the date of issue.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lost Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board of Directors may direct a new certificate or certificates to be issued in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing such issue of a new certificate or certificates, the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or his legal representative, to advertise the same in such manner as it shall require and&#47;or to give the Corporation a bond in such sum as it may direct or indemnity against any claim that may be made against the Corporation with respect to the certificate alleged to have been lost, stolen or destroyed.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfers of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon surrender to the Corporation or the transfer agent of the Corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, it shall be the duty of the Corporation to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its books.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fixin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board of Directors of the Corporation may fix a record date for the purpose of determining the stockholders entitled to notice of, or to vote at, any meeting of stockholders or any adjournment thereof, or to consent to corporate action in writing without a meeting, or to receive payment of any dividend or other distribution or allotment of any rights, or to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action. Such record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors and such record date shall not be (i) in the case of such a meeting of stockholders, more than 60 nor less than 10 days before the date of the meeting of stockholders, or (ii) except for record dates to be fixed in accordance with the provisions of Section 2.09, in other cases, more than 60 days prior to the payment or allotment or change, conversion or exchange or other action. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting unless the Board of Directors fixes a new record date for the adjourned meeting. Notwithstanding anything in this Section 7.04 to the contrary, a record date for determining stockholders entitled to take action by written consent shall be fixed in accordance with Section 2.09(b) of these Bylaws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 7.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Re</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">istered Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of stock to receive dividends and to vote as such owner, and shall be entitled to hold liable for calls and assessments a person registered on its books as the owner of stock, and shall not be bound to recognize any equitable or other claim to, or interest in, such stock on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE 8<br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 8.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. These Bylaws may be altered, amended or repealed, and new Bylaws may be adopted, by the stockholders or by the Board of Directors at any regular </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.3</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective as of February 21, 2023</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">meeting of the stockholders or of the Board of Directors or at any special meeting of the stockholders or of the Board of Directors if notice of such alteration, amendment, repeal or adoption of new Bylaws be contained in the notice of such special meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 8.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusive Jurisdiction of Delaware Courts or the United States Federal District Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the Corporation, (b) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (c) any action asserting a claim against the Corporation or any director or officer or other employee of the Corporation arising pursuant to any provision of the DGCL or the Certificate of Incorporation or these Bylaws (in each case, as they may be amended from time to time) or (d) any action asserting a claim against the Corporation or any director or officer or other employee of the Corporation governed by the internal affairs doctrine shall be a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware)&#59; provided, however, that this sentence will not apply to any causes of action arising under the Securities Act of 1933, as amended, or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Unless the Corporation consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, the Exchange Act, or the respective rules and regulations promulgated thereunder. To the fullest extent permitted by law, any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 8.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severabilit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">y. If any provision or provisions of these Bylaws shall be held to be invalid, illegal or unenforceable for any reason whatsoever&#58; (a) the validity, legality and enforceability of the remaining provisions of these Bylaws (including, without limitation, each portion of any paragraph containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby&#59; and (b) to the fullest extent possible, the provisions of these Bylaws (including, without limitation, each such portion of any paragraph containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>iart-20221231xexx44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id9d5182b0e944880b49f710302fdf036_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.4</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Company&#8217;s Common Stock Registered</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:8pt;margin-top:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following is a description of the common stock of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;). The description does not purport to be complete and is subject to and qualified in its entirety by reference to the Company&#8217;s amended and restated certificate of incorporation, or the certificate of incorporation, and its third amended and restated by-laws, or the bylaws) each of which are filed as exhibits to this Annual Report on Form 10-K, and to the provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;).</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Matters</font></div><div style="margin-bottom:8pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Authorized Shares</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s authorized capital stock consists of 255,000,000 shares of stock, of which 240,000,000 shares are designated as common stock, par value $0.01 per share, and 15,000,000 shares are designated as preferred stock, no par value. As of December 31, 2022, we had 90,476,671 shares of common stock outstanding, 6,822,864 shares were designated as treasury stock, and no shares of preferred stock outstanding.</font></div><div style="margin-top:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Dividends </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of common stock are entitled to receive dividends out of assets legally available therefor at such times and in such amounts as the board of directors may from time to time determine. However, our senior credit facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of our board of directors and will depend upon our financial condition, results of operations, cash flows and other factors that our board of directors deems relevant.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Voting Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each stockholder is entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder. Stockholders do not have cumulative voting rights. The Company&#8217;s board of directors is not classified and each director is elected annually. The voting standard for the election of directors is a majority of votes cast in uncontested elections. In contested elections where the number of nominees exceeds the number of directors to be elected, the vote standard is a plurality of the votes cast. Holders of a majority of the outstanding shares of common stock entitled to vote in any election of directors may elect all of the directors standing for election. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Preemptive or Similar Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our common stock is not entitled to preemptive rights and is not subject to conversion or redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Right to Receive Liquidation Distributions</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the occurrence of a liquidation, dissolution or winding-up, the holders of shares of common stock would be entitled to share ratably in the distribution of all of our assets remaining available for distribution after satisfaction of all its liabilities and the payment of the liquidation preference of any outstanding preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Stock Exchange</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;IART&#8221;. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Preferred Stock </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.4</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s Board of Directors has the authority to issue up to 15,000,000 shares of Preferred Stock from time to time in one or more series and with such rights and preferences as determined by the Board with respect to each series. The issuance of preferred stock could have the effect of decreasing the market price of our common stock and could adversely affect the voting and other rights of holders of common stock. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Statutory Business Combination Provision</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a Delaware corporation, we are subject to Section 203 of the General Corporation Law of the State of Delaware, or DGCL. In general, Section 203 of the DGCL prevents an &#8220;interested stockholder,&#8221; which is defined generally as a person owning 15% or more of a Delaware corporation&#8217;s outstanding voting stock or any affiliate or associate of that person, from engaging in a broad range of &#8220;business combinations&#8221; with the corporation for three years following the date that person became an interested stockholder unless&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">before that person became an interested stockholder, the board of directors of the corporation approved the transaction in which that person became an interested stockholder or approved the business combination&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">on completion of the transaction that resulted in that person&#8217;s becoming an interested stockholder, that person owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, other than stock held by (1) directors who are also officers of the corporation or (2) any employee stock plan that does not provide employees with the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">following the transaction in which that person became an interested stockholder, both the board of directors of the corporation and the holders of at least two-thirds of the outstanding voting stock of the corporation not owned by that person approve the business combination.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under Section 203 of the DGCL, the restrictions described above also do not apply to specific business combinations proposed by an interested stockholder following the announcement or notification of designated extraordinary transactions involving the corporation and a person who had not been an interested stockholder during the previous three years or who became an interested stockholder with the approval of a majority of the corporation&#8217;s directors, if a majority of the directors who were directors prior to any person&#8217;s becoming an interested stockholder during the previous three years, or were recommended for election or elected to succeed those directors by a majority of those directors, approve or do not oppose that extraordinary transaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Anti-Takeover Effects of our Certificate of Incorporation and our Bylaws </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Some of the provisions of our certificate of incorporation and bylaws discussed below may have the effect, either alone or in combination with the provisions of our certificate of incorporation discussed above and Section 203 of the DGCL, of making more difficult or discouraging a tender offer, proxy contest, merger or other takeover attempt that our board of directors opposes but that a stockholder might consider to be in its best interest.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Special Meetings of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Our bylaws provide that a special meeting of our stockholders may only be called by (i) the chairman of our board of directors, (ii) the president or (iii) our board of directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Stockholder Action by Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Our stockholders may act by written consent without a meeting, subject to the requirements in our bylaws for setting a record date for the written consent. Any stockholder seeking to have the stockholders authorize or take corporate action must request that our Board of Directors fix a record date. Such notice must include the same information required for a stockholder proposal and be submitted to our Board of Directors as described in our bylaws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Vacancies on the Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Our certificate of incorporation provides that the number of directors will be fixed exclusively by, and may be increased or decreased exclusively by, our board of directors from time to time, but will not be less than three nor more than thirteen. Our bylaws provide that vacancies on the board of directors arising through death, resignation, retirement or removal shall be filled only by a majority of the directors then in office whether or not the remaining directors constitute a quorum. These provisions will prevent our stockholders from removing incumbent directors without cause and filling the resulting vacancies with their own nominees.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our certificate of incorporation provides that the number of directors will be fixed exclusively by, and may be increased or decreased exclusively by, our board of directors from time to time, but will not be less than three nor more than thirteen. Our certificate of incorporation provides that directors may be removed only by the Delaware Chancery Court under Section 225(c) of the DGCL or for cause (as such term is defined in our certificate of incorporation) as determined by a vote of at least 80% of the voting power of our outstanding voting stock. A vacancy on our board of directors may be filled by a vote of a majority of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.4</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the directors in office, and a director appointed to fill a vacancy serves for the remainder of the term of the class of directors in which the vacancy occurred. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Advance Notice Requirements for Stockholder Proposals and Director Nominations</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Our bylaws contain provisions requiring that advance notice be delivered to us of any business to be brought by a stockholder before an annual meeting of stockholders and providing for certain procedures to be followed by stockholders in nominating persons for election to our board of directors. Generally, the advance notice provisions provide that the stockholder must give written notice to our Secretary not less than 90 days nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting, except that in the event that the annual meeting is called for a date that is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered not later than the 90th day prior to the date of such annual meeting (or, if later, then the 10th day following the day on which public disclosure of the date of such annual meeting was first made). The notice must set forth specific information regarding that stockholder and that business or director nominee, as described in our bylaws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Am</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">endment of Certain Provisions of the Certificate of Incorporation and Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Under the DGCL, the stockholders of a corporation have the right to adopt, amend or repeal the bylaws and, with the approval of the board of directors, the certificate of incorporation of a corporation. In addition, if the certificate of incorporation so provides, the bylaws may be adopted, amended or repealed by the board of directors. Our Certificate provides that the bylaws may be amended or repealed by our board of directors. Our certificate of incorporation and bylaws also confer on our board of directors the power to adopt, amend or repeal our amended and restated bylaws with the affirmative vote of a majority of the directors then in office.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Forum Selection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Our bylaws provide, unless we consent in writing to the selection of an alternative forum, that the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (c) any action asserting a claim against us or any of our directors, officers or other employees arising pursuant to any provision of the DGCL, our certificate of incorporation or our bylaws (in each case, as they may be amended from time to time) or (d) any action asserting a claim against us or any of our directors, officers or other employees governed by the internal affairs doctrine, will be a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware). Any person that purchases or otherwise acquires an interest in our stock will be deemed to have notice of and agree to comply with the foregoing provisions. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our bylaws provide that a state court of the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for&#58; (i) any derivative action or proceeding brought on behalf of Integra&#59; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer of Integra to Integra or the stockholders&#59; (iii) &#8202;any action asserting a claim against Integra arising pursuant to any provision of the DGCL, our certificate of incorporation or our bylaws (as each may be amended, from time to time)&#59; or (iv) any other action asserting a claim against Integra or any director or officer of Integra that is governed by or subject to the internal affairs doctrine for choice of law purposes. However, the forum selection provision does not apply to any claims, actions or proceedings arising under the Securities Act of 1933, as amended, which we refer to as the &#8220;Securities Act,&#8221; or the Exchange Act. Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, the Exchange Act, or the respective rules and regulations promulgated thereunder. Any person or entity purchasing or otherwise acquiring any interest in shares of our stock will be deemed to have notice of and consented to the exclusive forum provisions in our bylaws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. As discussed above under &#8220;General Matters&#8212;Preferred Stock,&#8221; our certificate of incorporation authorizes our board of directors, without the approval of our stockholders, to provide for the issuance of all or any shares of our preferred stock in one or more series and to determine the designation, powers, preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions applicable to any of those rights, including dividend rights, voting rights, conversion or exchange rights, terms of redemption and liquidation preferences, of each series. The issuance of shares of our preferred stock, or the issuance of rights to purchase shares of preferred stock, could be used to discourage an unsolicited acquisition proposal. In addition, under some circumstances, the issuance of preferred stock could adversely affect the voting power of our common stockholders.</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3(H)
<SEQUENCE>4
<FILENAME>iart-20221231xexx103h.htm
<DESCRIPTION>EX-10.3(H)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i14e7f89d9ec34734943848496d76a058_73"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(h)</font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS RESTRICTED STOCK AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Award Agreement&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">dated as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;                  &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Award Date&#8221;), is made by and between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences Holdings Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation (the &#8220;Company&#8221;), and   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;                 &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">a non-employee director </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Company, hereinafter referred to as the &#8220;Participant&#8221;&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company maintains the Integra LifeSciences Holdings Corporation 2003 Equity Incentive Plan, as amended (the &#8220;Plan&#8221;), and wishes to carry out the Plan, the terms of which are hereby incorporated by reference and made part of this Award Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOW, THEREFORE, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in consideration of the various covenants herein contained, and intending to be legally bound hereby, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined below shall have the meaning set forth in the Plan.  The masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Restricted Stock&#8221; shall mean </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;         &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shares of Common Stock of the Company issued under this Award Agreement and subject to the Restrictions imposed hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Restrictions&#8221; shall mean the forfeiture and transferability restrictions imposed upon Restricted Stock under the Plan and this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Rule 16b-3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Rule 16b-3&#8221; shall mean that certain Rule 16b-3 under the Exchange Act, as such Rule may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Secretary.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Secretary&#8221; shall mean the Secretary of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Service.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Termination of Service&#8221; shall mean the time when the Participant ceases to provide services to the Company and its Related Corporations and Affiliates as an employee or Associate for any reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with or without cause, including, but not by way of limitation, a termination by resignation, discharge, death, or Disability, but excluding a termination where the Participant is simultaneously reemployed by, or remains employed by, or continues to provide services to, the Company and&#47;or one or more of its Related Corporations and Affiliates or a successor entity thereto.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vested Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Vested Shares&#8221; shall mean the shares of Restricted Stock which are no longer subject to the Restrictions by reason of Section 3.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting Date.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Vesting Date&#8221; shall mean each of the twelve-month anniversary date of the Award Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124; &#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(h)</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ISSUANCE OF RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Issuance of Restricted Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  On the date hereof the Company issues to the Participant the Restricted Stock subject to the Restrictions and other conditions set forth in this Award Agreement.  The Company shall cause the Restricted Stock to be issued in the name of the Participant or held in book entry form, but if a stock certificate is issued it shall be delivered to and held in custody by the Company until the Restrictions lapse or such Restricted Stock is forfeited.  As a further condition to the Company&#8217;s obligations under this Award Agreement, the Participant&#8217;s spouse, if any, shall execute and deliver to the Company the Consent of Spouse attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Until vested pursuant to Section 3.2, the Restricted Stock shall be subject to forfeiture as provided in Section 3.1 and may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant, shall have all the rights of a stockholder with respect to his Restricted Stock, including the right to vote the Restricted Stock, except that the Participant shall have the right to receive all dividends or other distributions paid or made with respect to only those outstanding vested shares of Common Stock. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTIONS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the Participant&#8217;s Termination of Service other than by (i) death or Disability or (ii) a Qualifying Termination upon a Change in Control as further described in Section 3.2, the Participant&#8217;s rights in Restricted Stock that has not yet vested pursuant to Section 3.2 shall lapse, and such Restricted Stock shall be surrendered to the Company without consideration (and, in the event of certificates representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the Participant).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Restrictions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Restrictions shall terminate and lapse, and such shares shall vest in the Participant and become Vested Shares on the Vesting Date as provided in Section 3.3, provided that the Participant has continued to serve as an employee or an Associate from the Award Date to and including such Vesting Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, (i) in the event that a Change in Control occurs and the Participant incurs a Qualifying Termination on or within twelve (12) months following the date of such Change in Control or (ii) in the event of the Participant&#8217;s death or Disability, all Restrictions shall lapse and all Restricted Stock shall become Vested Shares upon such Qualifying Termination, death or Disability. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lapse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  All of the shares of Restricted Stock shall become Vested Shares on the Vesting Date.  On the Vesting Date, the Company shall issue new certificates evidencing such Vested Shares and deliver such certificates to the Participant or his legal representative, or record such Vested Shares in book entry form, free from the legend provided for in Section 4.2 and any of the other Restrictions&#59; provided, however, such certificates shall bear any other legends and such book entry accounts shall be subject to any other restrictions as the Company may determine are required to comply with Section 4.6.  Such Vested Shares shall cease to be considered Restricted Stock subject to the terms and conditions of this Award Agreement.  Notwithstanding the foregoing, no such new certificate shall be delivered to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124; &#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(h)</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant or his legal representative unless and until the Participant or his legal representative shall have paid to the Company in cash or by check the full amount of all federal, state and local withholding or other employment taxes applicable to the taxable income of the Participant resulting from the lapse of the Restrictions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Clawback.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained in the Plan or the Award Agreement to the contrary, the Restricted Stock shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to the Restricted Stock under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Additional Rights.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nothing in this Award Agreement or in the Plan shall confer upon any person any right to a position as an Associate or continued employment by the Company or any of its Related Corporations or Affiliates or affect in any way the right of any of the foregoing to terminate the services of an individual at any time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Legend.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any certificates representing shares of Restricted Stock issued pursuant to this Award Agreement may include, until all Restrictions lapse and new certificates are issued pursuant to Section 3.3, bear the following legend&#58;</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;padding-right:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN VESTING REQUIREMENTS AND MAY BE SUBJECT TO FORFEITURE UNDER THE TERMS OF THAT CERTAIN RESTRICTED STOCK AGREEMENT BY AND BETWEEN INTEGRA LIFESCIENCES HOLDINGS CORPORATION AND THE HOLDER OF THE SECURITIES.  PRIOR TO VESTING OF OWNERSHIP IN THE SECURITIES, THEY MAY NOT BE, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, OR OTHERWISE ENCUMBERED OR DISPOSED OF UNDER ANY CIRCUMSTANCES.  COPIES OF THE ABOVE REFERENCED AGREEMENT ARE ON FILE AT THE OFFICES OF THE CORPORATION AT 1100 CAMPUS DRIVE, PRINCETON, NEW JERSEY 08540. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  On the Vesting Date, the Company shall notify the Participant of the amount of tax which must be withheld by the Company under all applicable federal, state and local tax laws.  Subject to any applicable legal conditions or restrictions, the Company shall withhold from the shares of Restricted Stock a number of whole shares of common stock having a fair market value, determined as of the Vesting Date, not in excess of the minimum tax required to be withheld by law.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Award Agreement to the Company shall be addressed to the Company in care of its Secretary, and any notice to be given to the Participant shall be addressed to him at the address given beneath his signature hereto.  By a notice given pursuant to this Section 4.4, either party may hereafter designate a different address for notices to be given to it or him.  Any notice which is required to be given to the Participant shall, if the Participant is then deceased, be given to the Participant&#8217;s personal representative if such representative has previously informed the Company of his status and address by written notice under this Section 4.4.  Any notice shall have been deemed duly given when enclosed in a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124; &#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(h)</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Titles.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conformity to Securities Laws.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Award Agreement is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, including without limitation Rule 16b-3.  Notwithstanding anything herein to the contrary, this Award Agreement shall be administered, and the Restricted Stock shall be issued, only in such a manner as to conform to such laws, rules and regulations.  To the extent permitted by applicable law, this Award Agreement and the Restricted Stock issued hereunder shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amendment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Award Agreement may be amended only by a writing executed by the parties hereto which specifically states that it is amending this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Governing Law.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Award Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="padding-left:144pt;text-indent:72pt"><font><br></font></div><div style="padding-left:144pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*****</font></div><div style="padding-left:144pt;text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS HEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, this Award Agreement has been executed and delivered by the parties hereto.</font></div><div style="text-indent:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INTEGRA LIFESCIENCES </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE PARTICIPANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;HOLDINGS CORPORATION</font></div><div><font><br></font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;                      &#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124; &#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(h)</font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124; &#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3(I)
<SEQUENCE>5
<FILENAME>iart-20221231xexx103i.htm
<DESCRIPTION>EX-10.3(I)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic11d50f2873c4ff6816a654290266e1b_95"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3(i)</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS RESTRICTED STOCK AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Award Agreement&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">dated as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;                  &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Award Date&#8221;), is made by and between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences Holdings Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation (the &#8220;Company&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;                  &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,     an employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Company (or one or more of its Related Corporations or Affiliates), hereinafter referred to as the &#8220;Participant&#8221;&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company maintains the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the &#8220;Plan&#8221;), and wishes to carry out the Plan, the terms of which are hereby incorporated by reference and made part of this Award Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOW, THEREFORE, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in consideration of the various covenants herein contained, and intending to be legally bound hereby, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined below shall have the meaning set forth in the Plan.  The masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Restricted Stock&#8221; shall mean <br>&#91;             &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shares of Common Stock of the Company issued under this Award Agreement and subject to the Restrictions imposed hereunder.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Restrictions&#8221; shall mean the forfeiture and transferability restrictions imposed upon Restricted Stock under the Plan and this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Rule 16b-3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Rule 16b-3&#8221; shall mean that certain Rule 16b-3 under the Exchange Act, as such Rule may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Secretary.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Secretary&#8221; shall mean the Secretary of the Company.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Service.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Termination of Service&#8221; shall mean the time when the Participant ceases to provide services to the Company and its Related Corporations and Affiliates as an employee or Associate for any reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with or without cause, including, but not by way of limitation, a termination by resignation, discharge, death, or Disability, but excluding a termination where the Participant is simultaneously reemployed by, or remains employed by, or continues to provide services to, the Company and&#47;or one or more of its Related Corporations and Affiliates or a successor entity thereto.  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vested Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Vested Shares&#8221; shall mean the shares of Restricted Stock which are no longer subject to the Restrictions by reason of Section 3.2.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting Date.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Vesting Date&#8221; shall mean each of the first, second and third anniversaries of the Award Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3(i)</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ISSUANCE OF RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Issuance of Restricted Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  On the date hereof the Company issues to the Participant the Restricted Stock subject to the Restrictions and other conditions set forth in this Award Agreement.  The Company shall cause the Restricted Stock to be issued in the name of the Participant or held in book entry form, but if a stock certificate is issued it shall be delivered to and held in custody by the Company until the Restrictions lapse or such Restricted Stock is forfeited.  As a further condition to the Company&#8217;s obligations under this Award Agreement, the Participant&#8217;s spouse, if any, shall execute and deliver to the Company the Consent of Spouse attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Until vested pursuant to Section 3.2, the Restricted Stock shall be subject to forfeiture as provided in Section 3.1 and may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant shall have all the rights of a stockholder with respect to his Restricted Stock, including the right to vote the Restricted Stock, except that the Participant shall have the right to receive all dividends or other distributions paid or made with respect to only those outstanding vested shares of Common Stock. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTIONS</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the Participant&#8217;s Termination of Service other than by reason of death or Disability, the Participant&#8217;s rights in Restricted Stock that has not yet vested pursuant to Section 3.2 shall lapse, and such Restricted Stock shall be surrendered to the Company without consideration (and, in the event of certificates representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the Participant).</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Restrictions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Restrictions shall terminate and lapse, and such shares shall vest in the Participant and become Vested Shares on each Vesting Date as provided in Section 3.3, provided that the Participant has continued to serve as an employee or an Associate from the Award Date to and including such Vesting Date.  Notwithstanding the foregoing, (i) in the event that a Change in Control occurs and the Participant incurs a Qualifying Termination on or within twelve (12) months following the date of such Change in Control or (ii) in the event of the Participant&#8217;s death or Disability, all Restrictions shall lapse and all Restricted Stock shall become Vested Shares upon such Qualifying Termination, death or Disability. </font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lapse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Thirty-three percent (33%) of the shares of Restricted Stock shall become Vested Shares on each of the first two Vesting Dates, and thirty-four percent (34%) of the shares of Restricted Stock shall become Vested Shares on the third Vesting Date.  On each Vesting Date, the Company shall issue new certificates evidencing the Vested Shares or record such Vested Shares in book entry form, free from the legend provided for in Section 4.2 and any of the other Restrictions&#59; provided, however, such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3(i)</font></div></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">certificates shall bear any other legends and such book entry accounts shall be subject to any other restrictions as the Company may determine are required to comply with Section 4.6.  Such Vested Shares shall cease to be considered Restricted Stock subject to the terms and conditions of this Award Agreement.  Notwithstanding the foregoing, no such new certificate shall be delivered to the Participant or his legal representative unless and until the Participant or his legal representative shall have satisfied the full amount of all federal, state and local withholding or other employment taxes applicable to the taxable income of the Participant resulting from the lapse of the Restrictions in accordance with Section 4.3.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Clawback.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained in the Plan or the Award Agreement to the contrary, the Restricted Stock shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to the Restricted Stock under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Additional Rights.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nothing in this Award Agreement or in the Plan shall confer upon any person any right to a position as an Associate or continued employment by the Company or any of its Related Corporations or Affiliates or affect in any way the right of any of the foregoing to terminate the services of an individual at any time.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Legend.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any certificates representing shares of Restricted Stock issued pursuant to this Award Agreement shall, until all Restrictions lapse and new certificates are issued pursuant to Section 3.3, bear the following legend&#58;</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;padding-right:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN VESTING REQUIREMENTS AND MAY BE SUBJECT TO FORFEITURE UNDER THE TERMS OF THAT CERTAIN RESTRICTED STOCK AGREEMENT BY AND BETWEEN INTEGRA LIFESCIENCES HOLDINGS CORPORATION AND THE HOLDER OF THE SECURITIES.  PRIOR TO VESTING OF OWNERSHIP IN THE SECURITIES, THEY MAY NOT BE, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, OR OTHERWISE ENCUMBERED OR DISPOSED OF UNDER ANY CIRCUMSTANCES.  COPIES OF THE ABOVE REFERENCED AGREEMENT ARE ON FILE AT THE OFFICES OF THE CORPORATION AT 1100 CAMPUS ROAD, PRINCETON, NEW JERSEY 08540. </font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  On each Vesting Date, the Company shall notify the Participant of the amount of tax which must be withheld by the Company under all applicable federal, state and local tax laws.  Subject to any applicable legal conditions or restrictions, the Company shall withhold from the shares of Restricted Stock a number of whole shares of common stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3(i)</font></div></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">having a fair market value, determined as of each Vesting Date, not in excess of the minimum of tax required to be withheld by law.  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Award Agreement to the Company shall be addressed to the Company in care of its Secretary, and any notice to be given to the Participant shall be addressed to him at the address given beneath his signature hereto.  By a notice given pursuant to this Section 4.4, either party may hereafter designate a different address for notices to be given to it or him.  Any notice which is required to be given to the Participant shall, if the Participant is then deceased, be given to the Participant&#8217;s personal representative if such representative has previously informed the Company of his status and address by written notice under this Section 4.4.  Any notice shall have been deemed duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Titles.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conformity to Securities Laws.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Award Agreement is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, including without limitation Rule 16b-3.  Notwithstanding anything herein to the contrary, this Award Agreement shall be administered, and the Restricted Stock shall be issued, only in such a manner as to conform to such laws, rules and regulations.  To the extent permitted by applicable law, this Award Agreement and the Restricted Stock issued hereunder shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amendment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Award Agreement may be amended only by a writing executed by the parties hereto which specifically states that it is amending this Award Agreement.  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Governing Law.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Award Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">              </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">    Electronic Delivery and Acceptance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Participant hereby consents to receive the Notice of Grant of Award and Award Agreement and any other documents related to this award or future awards by electronic delivery and to accept this or future awards through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. Participant acknowledges that he&#47;she has read, understand and agrees to the terms of the Notice of Grant of Award, Award Agreement and Plan. By clicking the &#8220;ACCEPT&#8221; button on E*TRADE&#8217;s on-line grant agreement response page, it will act as Participant&#8217;s electronic signature to these documents and will result in a contract between Integra LifeSciences Holdings Corporation and the Participant with respect to the award.  In the event of any conflict or inconsistency between the terms and conditions of this Award Agreement or any other contracts or documents related to this award, on the one hand, and any terms or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3(i)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conditions set forth in the Plan, the terms and conditions set forth in the Plan shall prevail.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">*****</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS HEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, this Award Agreement has been executed and delivered by the parties hereto.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INTEGRA LIFESCIENCES </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE PARTICIPANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;HOLDINGS CORPORATION</font></div><div><font><br></font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;                      &#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3(J)
<SEQUENCE>6
<FILENAME>iart-20221231xexx103j.htm
<DESCRIPTION>EX-10.3(J)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i13713c771963464c8e0bfb9c3917ecce_119"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(j)</font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE STOCK AGREEMENT</font></div><div style="margin-top:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS PERFORMANCE STOCK AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is made by and between Integra LifeSciences Holdings Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, an employee of the Company (or one or more of its Related Corporations or Affiliates), hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company has determined to grant to the Participant an award of Performance Stock (as defined below), on the terms set forth herein, under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the terms of which are hereby incorporated by reference and made part of this Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;NOW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in consideration of the various covenants herein contained, and intending to be legally bound hereby, the parties hereto agree as follows&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">DEFINITIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Capitalized terms not otherwise defined below shall have the meaning set forth in the Plan.  The masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Annual Organic Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Annual Organic Revenue&#8221; shall mean the Company&#8217;s gross revenue with respect to an applicable fiscal year excluding the effects of currency exchange rates, acquired revenues, product discontinuances and divestitures.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Catch-Up Performance Goal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#8220;Catch-Up Performance Goal&#8221; shall mean the specific goal determined by the Committee, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Catch-Up Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#8220;Catch-Up Shares&#8221; shall have the meaning as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Change in Control&#8221; shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Chief Human Resources Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Chief Human Resources Officer&#8221; shall mean the Chief Human Resources Officer of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Good Reason&#8221; shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Performance Goals&#8221; shall mean the specific goal or goals determined by the Committee, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, including (if applicable) the Catch-Up Performance Goal.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Performance Period&#8221; shall mean the period or periods of time that the Performance Goals must be met, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance-Vest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Performance-Vest&#8221; shall mean that, with respect to a share of Performance Stock, the applicable Performance Goal has been achieved.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Vesting Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Performance Vesting Percentage&#8221; shall mean the percentage determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto, which is a function of whether and to what extent the Performance Goals are achieved during the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#8220;Qualifying Termination&#8221; shall mean a Termination of Service by the Company without Cause or by the Participant for Good Reason.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Rule 16b-3&#8221; shall mean that certain Rule 16b-3 under the Exchange Act, as such Rule may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Termination of Service&#8221; shall mean the time when the Participant ceases to provide services to the Company and its Related Corporations and Affiliates as an employee or Associate for any reason with or without Cause, including, but not by way of limitation, a termination by resignation, discharge, death, or Disability.  A Termination of Service shall not include a termination where the Participant is simultaneously reemployed by, or remains employed by, or continues to provide services to, the Company and&#47;or one or more of its Related Corporations and Affiliates or a successor entity thereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 1.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vest or Vested</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#8220;Vest&#8221; or &#8220;Vested&#8221; shall mean that, with respect to a share of Performance Stock, both (i) such share of Performance Stock has Performance-Vested and (ii) the continued service condition has been satisfied.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">AWARD OF PERFORMANCE STOCK</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Award of Shares of Performance Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Effective as of the Award Date, the Company grants to the Participant an award of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; target shares of Performance Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Each share of Performance Stock represents the Participant&#8217;s right to receive one Share under this Award Agreement if the Performance Goals are met during the Performance Period and the vesting conditions set forth herein are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Shares of Performance Stock shall be subject to forfeiture as provided in Section 3.2 below.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Participant shall be entitled to receive, with respect to each outstanding Vested but unissued share of Performance Stock, dividend equivalent amounts equal to the regular quarterly cash dividend paid or made with respect to the Shares underlying such Vested but unissued shares of Performance Stock (to the extent regular quarterly cash dividends are paid).  Such dividend equivalent amounts shall be aggregated and paid to the Participant within thirty (30)&#160;days following the date on which the Shares underlying the Vested shares of Performance Stock are issued to the Participant, but in no event later than December 31 of the year in which the Shares underlying the Vested shares of Performance Stock are issued to the Participant.  Notwithstanding the foregoing, if a &#8220;Change in Control&#8221; occurs prior to the date on which such dividend equivalent amounts are paid, such dividend equivalent amounts shall be paid to the Participant on the date of the Change in Control&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such payment shall only occur if the Change in Control meets the requirements of Section 409A(a)(2)(A)(v) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and its corresponding regulations.  For the avoidance of doubt, such dividend equivalent amounts shall only be paid to the extent that the shares of Performance Stock are Vested as of the applicable dividend payment date, and the Participant shall not be entitled to receive any dividend equivalent amounts with respect to shares of Performance Stock that have not Vested as of such dividend payment date.  The dividend equivalents and any amounts that may become payable in respect thereof shall be treated separately from the shares of Performance Stock and the rights </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">arising in connection therewith for purposes of the designation of time and form of payments required by Code Section 409A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Participant shall not have any voting rights in respect of the shares of Performance Stock and any Shares underlying the shares of Performance Stock unless and until such Shares shall have been issued by the Company and the Participant becomes the holder of record of such Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company).</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to paragraph (b) below and Sections&#160;3.2 and 3.5 below, shares of Performance Stock shall Vest in cumulative installments as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;With respect to fiscal year &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, a number of shares of Performance Stock equal to the product of (x) thirty-three percent (33%) of the Target Performance Shares, multiplied by (y) the applicable Performance Vesting Percentage determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto, shall Vest on the first anniversary of the Award Date&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;With respect to fiscal year &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, a number of shares of Performance Stock equal to the product of (x) thirty-three percent (33%) of the Target Performance Shares, multiplied by (y) the applicable Performance Vesting Percentage determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto, shall Vest on the second anniversary of the Award Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;With respect to fiscal year &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;, a number of shares of Performance Stock equal to the product of (x) thirty-four percent (34%) of the Target Performance Shares, multiplied by (y) the applicable Performance Vesting Percentage determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto, shall Vest on the third anniversary of the Award Date.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Subject to Sections&#160;3.2 and 3.5 below, in the event that the Company achieves the Catch-Up Performance Goal with respect to the Performance Period, then any Catch-Up Shares shall Vest on the third anniversary of the Award Date.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effect of Termination of Service&#59; Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;In the event the Participant incurs, prior to or on the last day of the Performance Period, a Termination of Service by reason of the Participant&#8217;s Disability or death, any shares of Performance Stock which have not Vested in accordance with Section 3.1 above on or prior to such Termination of Service shall remain outstanding and eligible to Vest in accordance with Section 3.1 above and Section 3.5 below based on the Company&#8217;s achievement of the Performance Goals during the Performance Period.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Immediately upon the Participant&#8217;s Termination of Service that is not either (i) a Qualifying Termination within twelve (12) months following the date of a Change in Control (and prior to or on the last day of the Performance Period) or (ii) a Termination of Service by reason of the Participant&#8217;s Disability or death, the Participant shall automatically and without further action forfeit all shares of Performance Stock (and all dividend equivalent rights with respect to such shares of Performance Stock) which have not Vested in accordance with Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1 above or Section 3.5 below on or prior to such Termination of Service, and the Participant shall have no further right to or interest in or with respect to such shares of Performance Stock (or such dividend equivalents).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Any shares of Performance Stock that do not Performance-Vest in connection with a Change in Control pursuant to Sections 3.5(a) and 3.5(b) below (and all dividend equivalent rights with respect to such shares of Performance Stock) shall thereupon automatically be forfeited as of such Change in Control, and the Participant shall have no further right to or interest in or with respect to such shares of Performance Stock (or such dividend equivalents).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Any shares of Performance Stock that fail to vest as of the third anniversary of the Award Date (and all dividend equivalent rights with respect to such Performance Stock) shall automatically and without further action be cancelled and forfeited, and the Participant shall have no further right to or interest in or with respect to such unvested shares of Performance Stock (or such dividend equivalents).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to a determination of the Committee as to whether and to what extent the applicable Performance Goals have been met, Shares represented by shares of Performance Stock which Vest pursuant to Section 3.1 above or Section 3.5 below shall be issued to the Participant or his or her legal representative on or within five (5) business&#160;days following the date on which such shares of Performance Stock Vest pursuant to Section 3.1 above or Section 3.5 below (but in no event later than December 31 of the applicable year in which such shares of Performance Stock Vest).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;All Shares issued hereunder shall be issued in certificated form or shall be recorded with the Company&#8217;s transfer agent.  All such Shares shall be issued free from any restrictions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Shares shall be subject to any restrictions and conditions as may be required pursuant to Section 4.6 below and those that the Company imposes on its employees in general with respect to selling its Shares.  Notwithstanding the foregoing, the Company shall not be required to issue or record such Shares in the name of the Participant or his or her legal representative unless the Participant or his or her legal representative shall have satisfied the full amount of all federal, state and local withholding or other employment taxes applicable to the taxable income of the Participant resulting from the vesting of the shares of Performance Stock and issuance of the Shares as provided in this Award Agreement (including, without limitation, in the manner set forth in Section 4.3 below).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything contained in the Plan or the Award Agreement to the contrary, the shares of Performance Stock, and any related payments, shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to the shares of Performance Stock under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that a Change in Control occurs during the Performance Period&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;A number of shares of Performance Stock shall Performance-Vest equal to a number determined at the greater of (i) the achievement of the &#8220;Target Level&#8221; Performance Vesting Percentage with respect to the fiscal year in which the Change in Control occurs, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto and (ii) the Company&#8217;s actual achievement of the Performance Goal for such year through the Change in Control.  Subject to Sections 3.5(d) and (e) below, such Performance-Vested shares of Performance Stock shall remain outstanding and eligible to Vest on the anniversary of the Award Date immediately following the Change in Control, subject to the Participant&#8217;s continuous service. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In addition, and subject to Sections 3.5(d) and (e) below, a number of shares of Performance Stock shall Performance-Vest equal to the number of shares of Performance Stock that could vest with respect to each fiscal year of the Performance Period following the fiscal year in which the Change in Control occurs (if any) based on the achievement of the &#8220;Target Level&#8221; Performance Vesting Percentage with respect to each such year, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and shall remain outstanding and eligible to Vest on the date(s) outlined in Section 3.1(a)(ii) and&#47;or (iii) (excluding any Catch-Up Shares which are forfeited in the event of a Change in Control), subject to the Participant&#8217;s continued service.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;In addition, if the Change in Control occurs following the completion of a fiscal year in the Performance Period but prior to the date on which shares of Performance Stock with respect to such year become Vested pursuant to Section 3.1(a) above, then such shares of Performance Stock shall Vest as of immediately prior to the Change in Control in a number determined in accordance with Section 3.1(a) above.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;If the Participant incurred a Termination of Service by reason of the Participant&#8217;s Disability or death, in either case, prior to the Change in Control date, then any shares of Performance Stock that Performance-Vest in accordance with Sections 3.5(a) and (b) above shall Vest as of immediately prior to the Change in Control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160; Notwithstanding Sections 3.5(a) and 3.5(b) above, if the Participant incurs (1) a Qualifying Termination on or within twelve (12) months following the date of a Change in Control and prior to or on the last day of the Performance Period, or (2) a Termination of Service by reason of the Participant&#8217;s Disability or death on or following a Change in Control and prior to or on the last day of the Performance Period, then in either case any Performance-Vested shares of Performance Stock that are then-outstanding and have not yet Vested shall Vest in full upon such Termination of Service.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Additional Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Award Agreement or in the Plan shall confer upon any person any right to a position as an Associate or continued employment by the Company or any of its Related Corporations or Affiliates or affect in any way the right of any of the foregoing to terminate the services of an individual at any time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Anti-Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Participant shall have no right to sell, assign, transfer, pledge, or otherwise encumber or dispose of the Participant&#8217;s award of shares of Performance Stock.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In satisfaction of all applicable requirements with respect to amounts required by federal, state or local tax law to be withheld with respect to the vesting, distribution or payment of the shares of Performance Stock, the Company shall withhold Shares otherwise issuable upon such distribution or payment of the shares of Performance Stock having a Fair Market Value equal to the sums required to be withheld.  Subject to the following sentence, the number of Shares which shall be so withheld in order to satisfy the Participant&#8217;s federal, state and local withholding tax liabilities with respect to the vesting of the shares of Performance Stock or issuance of Shares in payment of the shares of Performance Stock shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">limited to the number of Shares which have a Fair Market Value on the date of issuance equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for federal, state and local tax purposes that are applicable to, and required in connection with, all or a portion of such supplemental taxable income.  In the event that the number of Shares having a Fair Market Value equal to the sums required to be withheld is not a whole number of Shares, the number of Shares so withheld shall be rounded up to the nearest whole share.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Award Agreement to the Company shall be addressed to the Company in care of its Chief Human Resources Officer, and any notice to be given to the Participant shall be addressed to the Participant at his or her address of record maintained by the Human Resources Department.  By a notice given pursuant to this Section 4.4, either party may hereafter designate a different address for notices to be given to it or him.  Any notice which is required to be given to the Participant shall, if the Participant is then deceased, be given to the Participant&#8217;s personal representative if such representative has previously informed the Company of his or her status and address by written notice under this Section 4.4.  Any notice shall have been deemed duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Award Agreement is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, including, without limitation, Rule 16b-3.  Notwithstanding anything herein to the contrary, this Award Agreement shall be administered, and the shares of Performance Stock shall be issued, only in such a manner as to conform to such laws, rules and regulations.  To the extent permitted by applicable law, this Award Agreement and the shares of Performance Stock issued hereunder shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Award Agreement may be amended only by a writing executed by the parties hereto which specifically states that it is amending this Award Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Award Agreement regardless of the law that might be applied under principles of conflicts of laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Award Agreement shall be interpreted in accordance with the requirements of Section 409A of the Code.  Notwithstanding any provision in this Award Agreement to the contrary, if a payment is deemed to be deferred compensation subject to the requirements of Section 409A of the Code, such payment may only be made under this Award Agreement upon an event and in a manner permitted by Section 409A of the Code.  If a payment is not made by the designated payment date under this Award Agreement, the payment shall be made by December 31 of the calendar year in which the designated date occurs.  In no event may the Participant, directly or indirectly, designate the calendar year of payment.  A termination of service shall not be deemed to have occurred for purposes of any provision of this Award Agreement providing for the payment of any amounts or benefits upon or following a termination of service that are considered &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code unless such termination is also a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code and, for purposes of any such provision of this award Agreement, references to a &#8220;termination,&#8221; &#8220;Termination of Service&#8221; or like terms shall mean &#8220;separation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">from service.&#8221;  Notwithstanding anything to the contrary in this Award Agreement, no amounts payable to the Participant under this Award Agreement shall be paid to the Participant prior to the expiration of the 6-month period following the Participant&#8217;s &#8220;separation from service&#8221; if the Company determines that paying such amounts at the time or times indicated in this Award Agreement would be a prohibited distribution under Section 409A(a)(2)(b)(i) of the Code.  If the payment of any such amounts is delayed as a result of the previous sentence, then on the first day following the end of such 6-month period, the Company shall pay the Participant a lump-sum amount equal to the cumulative amount that would have otherwise been payable to the Participant during such 6-month period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 4.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Electronic Delivery and Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant hereby consents to receive the Notice of Grant of Award and Award Agreement and any other documents related to this award or future awards by electronic delivery and to accept this or future awards through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.  Participant acknowledges that he&#47;she has read, understand and agrees to the terms of the Notice of Grant of Award, Award Agreement and Plan.  By clicking the &#8220;ACCEPT&#8221; button on E*TRADE&#8217;s on-line grant agreement response page, it will act as Participant&#8217;s electronic signature to these documents and will result in a contract between Integra LifeSciences Holdings Corporation and the Participant with respect to the award.  In the event of any conflict or inconsistency between the terms and conditions of this Award Agreement or any other contracts or documents related to this award, on the one hand, and any terms or conditions set forth in the Plan, the terms and conditions set forth in the Plan shall prevail.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div id="i13713c771963464c8e0bfb9c3917ecce_122"></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the parties hereto have executed this Performance Stock Agreement as of the date first above written.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE PARTICIPANT&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Electronic signature to be provided </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">and recorded via online grant </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">acceptance process on www.etrade.com</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HOLDINGS CORPORATION</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   </font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:198pt"><font><br></font></div><div id="i13713c771963464c8e0bfb9c3917ecce_125"></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font></div><div id="i13713c771963464c8e0bfb9c3917ecce_128"></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-top:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERFORMANCE GOALS AND PERFORMANCE PERIOD</font></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms shall have the meaning set forth in Performance Stock Agreement.</font></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be the three-year period beginning &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; and ending &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;.</font></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Catch-Up Performance Goal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean that the Company achieves, as of the end of the Performance Period (but not due to a Change in Control), an average 3-year Annual Organic Revenue growth rate of at least &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;%.</font></div><div style="margin-bottom:12pt;margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to each fiscal year in the Performance Period, the &#8220;Performance Goal&#8221; is that the Company achieves a Threshold Level or higher level of growth in Annual Organic Revenue over the immediately preceding fiscal year, as set forth in the table below.  A number of shares of Performance Stock will Performance-Vest in accordance with Section 3.1 of the Performance Stock Agreement based on the percentage growth in Annual Organic Revenue over the immediately preceding fiscal year&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.448%"><tr><td style="width:1.0%"></td><td style="width:41.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Growth in Annual Organic Revenue over the Prior Fiscal Year (%)</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Vesting Percentage</font></td></tr><tr style="height:16pt"><td colspan="3" style="background-color:#daeef3;border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#daeef3;border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Threshold Level&#8221;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="background-color:#daeef3;border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Target Level&#8221;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="background-color:#daeef3;border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Maximum Level&#8221;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr style="height:16pt"><td colspan="3" style="background-color:#000000;border-bottom:0.5pt dotted #000000;border-left:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000000;border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000000;border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000000;border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-right:0.5pt solid #000000;border-top:0.5pt dotted #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that the growth in Annual Organic Revenue over the immediately preceding fiscal year falls between the &#8220;Threshold Level&#8221; and the &#8220;Target Level,&#8221; then the Performance Vesting Percentage shall be determined by extrapolating between the &#8220;Threshold Level,&#8221; anchor points of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Annual Organic Revenue growth (with a &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Performance Vesting Percentage) and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Annual Organic Revenue growth (with an &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Performance Vesting Percentage), and the &#8220;Target Level.&#8221;  In the event that the growth in Annual Organic Revenue over the immediately preceding fiscal year falls between the &#8220;Target Level&#8221; and the &#8220;Maximum Level,&#8221; then the Performance Vesting Percentage shall be determined by means of linear interpolation between the &#8220;Target Level,&#8221; anchor points of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Annual Organic Revenue growth (with a &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Performance Vesting Percentage) and the &#8220;Maximum Level.&#8221;</font></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the forgoing, in the event that (i) a Change in Control does not occur during the Performance Period, (ii) the Performance Goal with respect to a given fiscal year in the Performance Period is not achieved at the applicable Target Level or higher, and (iii) the Catch-Up Performance Goal is achieved, then a number of shares of Performance Stock equal to the difference between (x) the number of shares of Performance Stock which would have Vested in the event that the Performance Goal had been achieved at the Target Level with respect to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-&#60;#&#62;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-top:11.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">fiscal year and (y) the number of shares of Performance Stock which actually became Vested based on the applicable Performance Vesting Percentage for such fiscal year, shall become Vested in accordance with Section 3.1(b) of the Performance Stock Agreement (such number of shares, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Catch-Up Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-1</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3(K)
<SEQUENCE>7
<FILENAME>iart-20221231xexx103k.htm
<DESCRIPTION>EX-10.3(K)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieac722c9047a4999a7aa0d599163868b_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(k)</font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;2003 EQUITY INCENTIVE PLAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">NON-QUALIFIED STOCK OPTION AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;NON-QUALIFIED STOCK OPTION AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(together with the attached Notice of Grant of Stock Options and Option Agreement (&#8220;Notice of Grant&#8221;), the &#8220;Option Agreement&#8221;) made as of the date (the &#8220;Grant Date&#8221;) set forth in Notice of Grant, between Integra LifeSciences Holdings Corporation, a Delaware corporation (the &#8220;Company&#8221;), and the named Key Employee of the Company, a Related Corporation, or an affiliate (the &#8220;Employee&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company desires to afford the Employee an opportunity to purchase shares of common stock of the Company, par value $.01 per share (&#8220;Common Stock&#8221;), as hereinafter provided, in accordance with the provisions of the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the &#8220;Plan&#8221;). Requests for hardcopies of the &#8220;Plan&#8221; should be directed to Mythili Seshan at the New Jersey Corporate Office.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration the legal sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Capitalized terms not otherwise defined below shall have the meaning set forth in the Plan.  The masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Effective &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;,     the Company hereby grants to the Employee a non-qualified stock option (the &#8220;Option&#8221;) to purchase all or any part of an aggregate of the number of shares of Common Stock as set forth in the attached Notice of Grant, subject to adjustment in accordance with Section&#160;8 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The purchase price per share of the shares of Common Stock covered by the Option shall be that set forth in the attached Notice of Grant, subject to adjustment in accordance with Section&#160;8 of the Plan.  It is the determination of the Company&#8217;s Compensation Committee (the &#8220;Committee&#8221;) that on the Grant Date the per share Option exercise price was not less than the greater of one hundred percent (100%) of the fair market value of the Common Stock, or the par value thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless earlier terminated pursuant to any provision of this Option Agreement, this Option shall expire on &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the &#8220;Expiration Date&#8221;). Notwithstanding anything herein to the contrary, this Option shall not be exercisable after the Expiration Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   Twenty Five percent (25%) of the shares of Stock Options shall become vested each of the first and second, third and fourth anniversaries of the grant date. Any portion of the Option that becomes exercisable in accordance with the foregoing shall remain exercisable, subject to the provisions contained in this Option Agreement, until the expiration of the term of this Option as set forth above or until other termination of the Option as set forth in this Option Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(k)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything contained herein, no portion of the Option which has not become vested and exercisable as of the Employee&#8217;s termination of employment or in connection with Employee&#8217;s termination of employment shall thereafter become vested or exercisable.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Exercising Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of this Option Agreement, the Option may be exercised in whole or in part by written notice to the Company, at its principal office, which currently is located at 1100 Campus Road, Princeton, New Jersey 08540.  Such notice shall state the election to exercise the Option, and the number of shares with respect to which it is being exercised&#59; shall be signed by the person or persons so exercising the Option&#59; shall, unless the Company otherwise notifies the Employee, be accompanied by the investment certificate referred to below&#59; and shall be accompanied by payment of the full Option price of such shares.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Option price shall be paid to the Company&#58; (i) in cash&#59; (ii) in cash equivalent&#59; (iii) in Common Stock of the Company, in accordance with Section 7.1(f)(ii) of the Plan (as in effect on the date of this Option Agreement)&#59; (iv) by delivering a properly executed notice of exercise of the Option, in accordance with Section 7.1(f)(iii) of the Plan (as in effect on the date of this Option Agreement)&#59; (v) in Common Stock of the Company issuable pursuant to the exercise of the Option or otherwise withheld in net settlement of the Option, in accordance with Section 7.1(f)(iv) of the Plan (as in effect on the date of this Option Agreement)&#59; or (vi) by any combination of (i)-(v). </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon receipt of such notice and payment, the Company, as promptly as practicable, shall deliver or cause to be delivered a certificate or certificates representing the shares with respect to which the Option is so exercised.  Such certificate(s) shall be registered in the name of the person or persons so exercising the Option (or, if the Option is exercised by the Employee and if the Employee so requests in the notice exercising the Option, shall be registered in the name of the Employee and the Employee&#8217;s spouse, jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person or persons exercising the Option.  In the event the Option is exercised by any person or persons after the legal disability or death of the Employee, such notice shall be accompanied by appropriate proof of the right of such person or persons to exercise the Option.  All shares that are purchased upon the exercise of the Option as provided herein shall be fully paid and not assessable by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Shares to be Purchased for Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless the Company has theretofore notified the Employee that a registration statement covering the shares to be acquired upon the exercise of the Option has become effective under the Securities Act of 1933 and the Company has not thereafter notified the Employee that such registration statement is no longer effective, it shall be a condition to any exercise of this Option that the shares acquired upon such exercise be acquired for investment and not with a view to distribution, and the person effecting such exercise shall submit to the Company a certificate of such investment intent, together with such other evidence supporting the same as the Company may request.  The Company shall be entitled to delay the transferability of the shares issued upon any such exercise to the extent necessary to avoid a risk of violation of the Securities Act of 1933 (or of any rules or regulations promulgated thereunder) or of any state laws or regulations.  Such restrictions may, at the option of the Company, be noted or set forth in full on the share certificates.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Non-Transferability of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Option is not assignable or transferable, in whole or in part, by the Employee other than by will or by the laws of descent and distribution, and during the lifetime of the Employee the Option shall be exercisable only by the Employee or by his or her guardian or legal representative.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(k)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Employee&#8217;s employment with the Company and all Related Corporations is terminated prior to the Expiration Date for any reason other than by (i) death or disability or (ii) a Qualifying Termination upon a Change in Control as further described below, this Option may be exercised, to the extent of the number of shares with respect to which the Employee could have exercised it on the date of such termination of employment, or to any greater extent permitted by the Committee, by the Employee at any time prior to the earlier of (i) the Expiration Date or (ii) six (6) months after such termination of employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained in this Option Agreement to the contrary, if the Employee dies during his employment with the Company and Related Corporations and prior to the Expiration Date, the Option shall become fully vested and exercisable and such Option upon such death can be exercised by the Employee&#8217;s estate, personal representative or beneficiary who acquired the right to exercise such Option by bequest or inheritance or by reason of the Employee&#8217;s death, at any time prior to the earlier of (i) the Expiration Date or (ii) one year after the date of the Employee&#8217;s death.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything contained in this Option Agreement to the contrary, if the Employee incurs a disability, as defined in the Plan, during his employment with the Company and Related Corporations and, prior to the Expiration Date, the Employee&#8217;s employment is terminated as a consequence of such disability, this Option shall become fully vested and exercisable and such Option upon such termination due to such Disability can be exercised by the Employee, or in the event of the Employee&#8217;s legal disability, by the Employee&#8217;s legal representative, at any time prior to the earlier of (i) the Expiration Date or (ii) one year after the date of such termination of employment due to such Disability.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Double Trigger Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything contained in this Option Agreement to the contrary, if during the Employee&#8217;s employment with the Company and Related Corporations and prior to the Expiration Date, a Change in Control occurs and the Employee incurs a Qualifying Termination on or within twelve (12) months following the date of such Change in Control, this Option shall become fully vested and exercisable and such Option upon such Qualifying Termination can be exercised by the Employee at any time prior to the Expiration Date. </font></div><div style="margin-bottom:12pt;padding-left:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained in the Plan or the Option Agreement to the contrary, the Option shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to the Option under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Withholding of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The obligation of the Company to deliver shares of Common Stock upon the exercise of the Option shall be subject to applicable federal, state and local tax withholding requirements.  If the exercise of any Option is subject to the withholding requirements of applicable federal, state or local tax laws, the Committee, in its discretion, may permit the Employee, subject to the provisions of the Plan and such additional withholding rules (the &#8220;Withholding Rules&#8221;) as shall be adopted by the Committee, to satisfy the withholding tax, in whole or in part, by electing to have the Company withhold (or by returning to the Company) shares of Common Stock, which shares shall be valued, for this purpose, at their fair market value on the date of exercise of the Option (or, if later, the date on which the Employee recognizes ordinary income </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(k)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with respect to such exercise).  An election to use shares of Common Stock to satisfy tax withholding requirements must be made in compliance with and subject to the Withholding Rules.  The Committee may not withhold shares in excess of the number necessary to satisfy the minimum tax withholding requirements.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Option Agreement is made under and subject to the provisions of the Plan as in effect on the Grant Date, and all of the provisions of the Plan as in effect on the Grant Date are hereby incorporated herein as provisions of this Option Agreement.   </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Non-Qualified Stock Option Agreement shall be governed by applicable federal law and otherwise by the laws of the State of Delaware.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Option Agreement has been executed and delivered by the parties hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE PARTICIPANT&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Electronic signature to be provided </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">and recorded via online grant </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">acceptance process on www.etrade.com</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HOLDINGS CORPORATION</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   </font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3(L)
<SEQUENCE>8
<FILENAME>iart-20221231xexx103l.htm
<DESCRIPTION>EX-10.3(L)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibcfd5ccdb4404a14af44f809e2a83ee0_57"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AWARD AGREEMENT FOR PARTICIPANTS OUTSIDE THE UNITED STATES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS RESTRICTED STOCK UNIT AWARD AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">including any exhibit, appendix or addendum hereto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">dated as of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Award Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is made by and between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences Holdings Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; a Key Employee or Associate (as defined in the Plan). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company has established and maintains the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Company has determined that it would be to the advantage and best interest of the Company and its shareholders to grant an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) provided for herein to the Participant as an incentive for increased efforts during the Participant&#8217;s employment with or services for the Company or its Related Corporations or Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Restricted Stock Units can be granted, and the shares of common stock of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) subject to the RSUs can be issued, under Section 7.8 of the Plan&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOW, THEREFORE, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in consideration of the various covenants herein contained, and intending to be legally bound hereby, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined below shall have the meaning set forth in the Plan.  The masculine pronoun shall include the feminine and neuter, and the singular the plural, where the context so indicates. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Award Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall have the meaning set forth in the recitals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Cause&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean, with respect to any Participant, &#8220;Cause&#8221; as defined in such Participant&#8217;s employment agreement or severance agreement with the Company if such an agreement exists and contains a definition of Cause or, if no such agreement exists or such agreement does not contain a definition of Cause, then Cause shall mean (i) the Participant&#8217;s neglect of duties or responsibilities that he or she is required to perform for the Company or any willful failure by the Participant to obey a lawful direction of the Board or the Company&#59; (ii) the Participant&#8217;s engaging in any act of dishonesty, fraud, embezzlement, misrepresentation or other act of moral turpitude&#59; (iii) the Participant&#8217;s knowing violation of any federal or state law or regulation applicable to the Company&#8217;s business&#59; (iv) the Participant&#8217;s material breach of any confidentiality, non-compete agreement or invention assignment agreement or any other material agreement between the Participant and the Company&#59; (v) the Participant&#8217;s conviction of, or plea of nolo contendere to, any felony or crime of moral turpitude which conviction or plea is materially and demonstrably injurious to the Company or any of its subsidiaries&#59; (vi) failure by the Participant to comply with the Company&#8217;s material written policies or rules&#59; or (vii) the Participant&#8217;s act or omission in the course of his or her employment which constitutes gross negligence or willful misconduct.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall have the meaning set forth in the recitals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a conditional right to receive Shares pursuant to the terms of the Plan and this Award Agreement upon vesting and settlement, subject to the Participant&#8217;s continued employment through each vesting date set forth in the Notice of Grant of Award, unless otherwise set forth in this Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean that certain Rule 16b-3 under the U.S. Exchange Act, as such Rule may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Secretary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Secretary of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Service Recipient&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean the Company, Related Corporation or Affiliate with which the Participant has an employment or service relationship.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Termination Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean the date the Participant is no longer actively providing services to the Company, a Related Corporation or Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of applicable laws in the jurisdiction where the Participant is employed or rendering services or the terms of the Participant&#8217;s employment or service agreement, if any) and, unless otherwise expressly provided for in this Award Agreement or determined by the Company, will not be extended by any notice period (e.g., the Participant&#8217;s period of employment or service will not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under applicable laws in the jurisdiction where the Participant is rendering services or the terms of the Participant&#8217;s employment or service agreement, if any).  The Committee shall have the exclusive discretion to determine when the Participant&#8217;s service is terminated for purposes of this Award of RSUs (including when the Participant is no longer considered to be providing service while on a leave of absence).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">GRANT OF RESTRICTED STOCK UNITS AND ISSUANCE OF SHARES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Grant of RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company hereby grants </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> RSUs to the Participant as of the Award Date, in accordance with and subject to the terms, conditions and restrictions of this Award Agreement and the Plan.  RSUs shall be credited to an account maintained for the Participant on the books of the Company, as of the Award Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting of RSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Subject to the terms and conditions of this Award Agreement and the Plan, 33% of the RSUs awarded hereunder shall vest on each of the first and second anniversary of the Award Date and 34% will vest on the third anniversary of the Award Date (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) provided the Participant remains a Key Employee or Associate from the Award Date until the Vesting Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Service (other than by (i) Death or Disability or (ii) a Qualifying Termination on or Following a Change in Control).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the Participant&#8217;s termination of service prior to the Vesting Date, other than by (i) death or Disability or (ii) a Qualifying Termination on or within twelve months following the date of a Change in Control and, except as otherwise determined by the Compensation Committee of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), any RSUs granted to the Participant under this Award Agreement which have not yet vested on the Termination Date shall terminate without payment and shall be of no further force or effect from and after the Termination Date. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Death or Disability.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If a Participant dies or suffers a Disability prior to the Vesting Date, all RSUs held by the Participant immediately prior to death or Disability, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which have not yet vested at the time of death or Disability, shall become fully vested and all forfeiture restrictions thereon shall lapse upon such death or Disability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In the event that a Change in Control occurs and the Participant incurs a Qualifying Termination on or within twelve (12) months following the date of such Change in Control, the RSUs shall become fully vested and all forfeiture restrictions shall lapse upon such Qualifying Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Acceleration of Vesting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the provisions of Sections 2.2, 2.3, 2.4, and 2.5, the Committee may, in its sole discretion, at any time prior to or following the events contemplated in such Sections, permit the vesting of any or all RSUs held by the Participant and the issuance of Shares in respect of such RSUs in the manner and on the terms authorized by the Committee, provided that the Committee will not, in any case, authorize the vesting of an RSU or the issuance of a Share pursuant to this Section beyond the Vesting Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If so accelerated, such RSUs will be considered as having vested as of the date specified by the Committee.  If the Participant is a U.S. taxpayer, the payment of Shares upon vesting pursuant to this Section 2.6 shall in all cases be paid at a time or in a manner that is exempt from, or complies with, Section 409A.  The prior sentence may be superseded in a future agreement or amendment to this Award Agreement only by direct and specific reference to such sentence.  Notwithstanding anything in the Plan or this Award Agreement or any other agreement (whether entered into before, on or after the Award Date), if the vesting of the balance, or some lesser portion of the balance, of the RSUs is accelerated in connection with the Participant&#8217;s termination of service (provided that such termination is a &#8220;separation from service&#8221; within the meaning of Section 409A, as determined by the Company), other than due to the Participant&#8217;s death, and if (x) the Participant is a U.S. taxpayer and a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of such termination of service and (y) the payment of such accelerated RSUs will result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six (6) month period following the Participant&#8217;s termination of service, then the payment of such accelerated RSUs will not be made until the date six (6) months and one (1) day following the date of Participant&#8217;s termination of service, unless the Participant dies following his or her termination of service, in which case, the RSUs will be paid in Shares to the Participant&#8217;s estate as soon as practicable following his or her death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On or as soon as administratively practicable (and any event within 30 days) following each Vesting Date, the Company shall cause to be issued to the Participant Shares with respect to the RSUs that become vested on such Vesting Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Fractions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No fractional Share will be issued pursuant to an award granted hereunder.  The number of Shares issuable to the Participant upon payment of any award granted under this Award Agreement will be rounded down to the nearest whole number of Share.  No payment or other adjustment will be made with respect to the fractional Share so disregarded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 409A.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">It is the intent of this Award Agreement that it and all payments and benefits to U.S. taxpayers hereunder be exempt from, or comply with, the requirements of Section 409A so that none of the RSUs provided under this Award Agreement or Shares issuable thereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to be so exempt or so comply.  Each payment payable under this Award Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).  However, in no event will the Company reimburse the Participant, or be otherwise responsible for, any taxes or costs that may be imposed on the Participant as a result of Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Adjustments to Restricted Stock Units.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of any subdivision, consolidation, stock dividend, capital reorganization, reclassification, exchange, or other change with respect to the Shares, or a consolidation, amalgamation, merger, spin-off, sale, lease or exchange of all or substantially all of the property of the Company or other distribution of the Company's assets to stockholders (other than the payment of ordinary cash dividends), the account of the Participant and the RSUs held by the Participant shall be adjusted in such manner, if any, as the Committee may in its discretion deem appropriate to preserve, proportionally, the interests of the Participant under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture&#47;Clawback.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything contained in the Plan or the Award Agreement to the contrary, the RSUs shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to the RSUs under the Plan.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ADDITIONAL TERMS AND CONDITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Status of Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The terms of the Plan are incorporated by reference into, and made part of, this Award Agreement.  In the event of a conflict between the Plan and this Award Agreement, the terms of the Plan shall govern.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Committee&#8217;s Authority. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Committee shall have the power to interpret the Plan and this Award Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any RSUs have vested).  All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon the Participant, the Company and all other interested persons.  The Committee shall not be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award Agreement.  The Committee shall, in its absolute discretion, determine when such conditions have been fulfilled. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the grant of the RSUs, the Participant acknowledges, understands and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time to the extent permitted in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the grant of the RSUs is exceptional voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs or benefits in lieu of RSUs, even if RSUs have been awarded in the past&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;all decisions with respect to future grants of RSUs, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;the Participant is voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;the grant of the RSUs and any Shares subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)&#160;&#160;&#160;&#160;unless otherwise agreed with the Company in writing, the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of a Related Corporation or an Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)&#160;&#160;&#160;&#160;the award of the RSUs and the Shares subject to the RSUs, and the income from and value of same are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or any Related Corporation or Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii)&#160;&#160;&#160;&#160;the future value of the Shares underlying the RSUs is unknown, indeterminable and cannot be predicted with certainty&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ix)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the Participant&#8217;s termination of employment, or other service relationship (for any reason whatsoever and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x)&#160;&#160;&#160;&#160;neither the Company, the Service Recipient nor any other Related Corporation or Affiliate shall be liable for any exchange rate fluctuation between the Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting and settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xi)&#160;&#160;&#160;&#160;the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan or sale of the Shares acquired upon vesting and settlement of the RSUs.  The Participant should consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Responsibility for Taxes.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant acknowledges that, regardless of any action taken by the Company or, if different, the Service Recipient, the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account, and other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant or deemed applicable to the Participant (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is and remains Participant&#8217;s responsibility and may exceed the amount, if any, actually withheld by the Company or the Service Recipient.  The Participant further acknowledges that the Company and&#47;or the Service Recipient (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs or the underlying Shares, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends or other distributions paid on the Shares, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make arrangements satisfactory to the Company and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Service Recipient to satisfy any applicable withholding obligations the Company or the Service Recipient may have for Tax-Related Items.  In this regard, the Participant authorizes the Company and the Service Recipient, as applicable, and their respective agents, at their discretion, to satisfy any applicable withholding obligation for Tax-Related Items by one or a combination of the following&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;withholding from wages or other cash compensation payable to the Participant by the Company or any Service Recipient&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;requiring the Participant to tender a cash payment or make a payment in a form acceptable to the Company or the Service Recipient&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Shares to be issued upon vesting of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization without further consent)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;withholding in Shares to be issued upon vesting of the RSUs (in which case the Participant will be deemed to have been issued the full number of Shares subject to the vested portion of the RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;any other method acceptable to the Company and to the extent required under the Plan and applicable laws, approved by the Committee.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company and&#47;or the Service Recipient may withhold or account for Tax-Related Items by considering statutory withholding rates or other applicable withholding rates, including minimum or maximum rates applicable in the Participant&#8217;s jurisdiction(s).  In the event of over-withholding or if the maximum applicable rate for the Participant&#8217;s jurisdiction is used in connection with the withholding methods described in (c) or (d) above, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent amount in Shares), or if not refunded, the Participant may be able to seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Company and&#47;or the Service Recipient.  If any applicable withholding obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items. The Participant agrees to pay to the Company or the Service Recipient any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant&#8217;s obligations for Tax-Related Items.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant has reviewed with his or her own tax advisors the applicable tax consequences of this investment and the transactions contemplated by this Award Agreement.  With respect to such matters, the Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock Units Non-Transferable.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the limited extent provided in Section 2, this Award and the rights and privileges conferred hereby will not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment or similar process.  Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">right or privilege conferred hereby, or upon any attempted sale under any execution, attachment or similar process, this Award and the rights and privileges conferred hereby immediately will become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Unfunded and Unsecured Plan.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant acknowledges that the Plan is unfunded and the Company&#8217;s obligations under the Plan and this Award Agreement are unsecured and that, to the extent the Participant or his or her estate holds any rights by virtue of a grant of RSUs, such rights shall be no greater than the rights of an unsecured creditor of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Stockholder Rights.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under no circumstances shall RSUs be considered Shares or other securities of the Company, nor shall they entitle the Participant to exercise voting rights, to receive dividends or other distributions or credit therefor, or to exercise or receive any other rights attaching to the ownership of Shares or other securities of the Company, nor shall the Participant be considered the owner of Shares by virtue of the award of RSUs.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Guarantee of Continued Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE RESTRICTED STOCK UNITS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS AN EMPLOYEE OR SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR, IF DIFFERENT, THE SERVICE RECIPIENT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OF RESTRICTED STOCK UNITS OR, AS APPLICABLE, ACQUIRING SHARES HEREUNDER.  THE PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH IN THE NOTICE OF GRANT OF AWARD DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN EMPLOYEE OR SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH THE PARTICIPANT&#8217;S RIGHT OR THE RIGHT OF THE COMPANY (OR SUBSIDIARY EMPLOYING THE PARTICIPANT) TO TERMINATE THE PARTICIPANT&#8217;S EMPLOYMENT OR SERVICE RELATIONSHIP AT ANY TIME, WITH OR WITHOUT CAUSE.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Award Agreement to the Company shall be addressed to the Company in care of its Secretary, and any notice to be given to the Participant shall be addressed to him at the address given beneath his signature hereto.  By a notice given pursuant to this Section 3.9, either party may hereafter designate a different address for notices to be given to it or him.  Any notice which is required to be given to the Participant shall, if the Participant is then deceased, be given to the Participant&#8217;s personal representative if such representative has previously informed the Company of his status and address by written notice under this Section 3.9.  Any notice shall have been deemed duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a post office or branch post office regularly maintained by the U.S. Postal Service or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">comparable foreign postal service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Laws.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of the Plan or this Award Agreement, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to permit the issuance and&#47;or deliver any Shares prior to the completion of any registration or qualification of the Shares under any U.S. or non-U.S. local, state or federal securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;SEC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or of any other governmental regulatory body, or prior to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">obtaining any approval or other clearance from any U.S. or non-U.S. local, state or federal governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  The Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or non-U.S. securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares subject to the RSUs. Further, the Participant agrees that the Company shall have unilateral authority to amend this Award Agreement without the Participant&#8217;s consent to the extent necessary to comply with securities or other laws applicable to issuance of the Shares subject to the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modifications to the Award Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Modifications to this Award Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company.  Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of the Participant, to comply with Section 409A of the Code or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code prior to the actual issuance of Shares pursuant to this award of RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amendment, Suspension or Termination of the Plan.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting this Award Agreement or RSUs, the Participant expressly warrants that he or she has received an award of RSUs under the Plan, and has received, read and understood a description of the Plan.  The Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Governing Law and Venue.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Award Agreement regardless of the law that might be applied under principles of conflicts of laws.  For purposes of litigating any dispute that arises under this grant or this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of New Jersey and agree that such litigation shall be conducted in the state and&#47;or federal courts located in New Jersey, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Assignment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rights and obligations of the Company under this Award Agreement may be assigned by the Company to a successor in the business of the Company, any company resulting from any amalgamation, reorganization, combination, merger or arrangement of the Company, or any company acquiring all or substantially all of the assets or business of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to the Collection, Processing, Use and Transfer of the Participant&#8217;s Personal Data.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company is located at 1100 Campus Road, Princeton New Jersey, 08540, United States of America and grants awards under the Plan to employees of the Company and Related Corporations or Affiliates in its sole discretion. In conjunction with the Company&#8217;s grant of the RSUs under the Plan to the Participant and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;).  In accepting the grant of the RSUs, the Participant expressly and explicitly consents to the Personal Data Activities as described herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">. The Company collects, processes and uses the Participant&#8217;s personal data, including the Participant&#8217;s name, home address, email address, and telephone number, date of birth, social insurance number or other identification </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Service Recipient. In granting the RSUs under the Plan, the Company will collect the Participant&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the collection, processing and usage of the Participant&#8217;s personal data is the Participant&#8217;s consent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">. The Company transfers the Participant&#8217;s personal data to E*TRADE Securities LLC and its affiliated companies (&#8220;E*TRADE&#8221;), American Stock Transfer &#38; Trust Company, LLC and its affiliated companies (&#8220;AST&#8221;), independent service providers based in the United States, which assist the Company with the implementation, administration and management of the Plan (together, the &#8220;Stock Plan Administrator&#8221;).  In the future, the Company may select a different Stock Plan Administrator and share the Participant&#8217;s personal data with another company that serves in a similar manner.  The Stock Plan Administrator will open an account for the Participant to receive and trade Shares acquired under the Plan.  The Participant will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to the Participant&#8217;s ability to participate in the Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"> International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Company and the Stock Plan Administrator are based in the United States.  The Participant should note that the Participant&#8217;s country of residence may have enacted data privacy laws that are different from the United States.  The Company&#8217;s legal basis for the transfer of the Participant&#8217;s personal data to the United States is the Participant&#8217;s consent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Participant&#8217;s participation in the Plan and his or her grant of consent is purely voluntary.  The Participant may deny or withdraw his or her consent at any time.  If the Participant does not consent, or if the Participant later withdraws his or her consent, the Participant may be unable to participate in the Plan.  This would not affect the Participant&#8217;s existing employment or salary&#59; instead, the Participant merely may forfeit the opportunities associated with the Plan.&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Subjects Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Participant may have a number of rights under the data privacy laws in the Participant&#8217;s country of residence.  For example, the Participant&#8217;s rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in the Participant&#8217;s country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding the Participant&#8217;s rights or to exercise his or her rights, the Participant should contact his or her local human resources department.</font></div><div style="padding-right:-18pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Electronic Delivery and Acceptance.  The Participant hereby consents to receive the Notice of Grant of Award and Award Agreement and any other documents related to this award or future awards by electronic delivery and to accept this or future awards through an on-line or electronic system established and maintained by the Company or another third-party designated by the Company.  The Participant acknowledges that he&#47;she has read, understands and agrees to the terms of the Notice of Grant of Award and Award Agreement.  Further, if the Participant does not decline the Award by written notice to the Company no later than 60 days following the date of grant or such other date that may be communicated by the Company, the Company will automatically accept the Award, subject to all terms and conditions set forth in the Notice </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">of Grant of Award and Award Agreement and the Plan, on the Participant&#8217;s behalf.  If the Participant properly declines the Award, the Award will be cancelled and the Participant will not be entitled to any benefits from the Award nor any compensation or benefits in lieu of the cancelled Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Waivers.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No waiver by either party of any breach of, or of compliance with, any condition or provision of this Award Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Notwithstanding any provisions in this Award Agreement, this Award of RSUs shall be subject to any special terms and conditions for the Participant&#8217;s country set forth in Exhibit A attached hereto.  Moreover, if the Participant relocates to one of the countries included in Exhibit A, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  Exhibit A constitutes part of this Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Entire Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Notice of Grant of Award, this Award Agreement and the Plan constitute the entire contract between the parties hereto with regard to the subject matter hereof.  They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) which relate to the subject matter hereof.  The Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Severability.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions of this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant has received this Award Agreement, or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Requirements, Exchange Controls and Tax Requirements.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant acknowledges that his or her country may have certain foreign asset and&#47;or account reporting requirements and exchange controls which may affect his or her ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside his or her country.  The Participant understands that he or she may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country.  The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant&#8217;s participation in the Plan to his or her country through a designated bank or broker and&#47;or within a certain time after receipt.  In addition, the Participant may be subject to tax payment and&#47;or reporting obligations in connection with any income realized under the Plan and&#47;or from the sale of Shares.  The Participant acknowledges that it is his or her responsibility to be compliant with all such requirements, and that the Participant should consult his or her personal legal and tax advisors, as applicable, to ensure the Participant&#8217;s compliance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider Trading and Market-abuse Laws.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant acknowledges that, depending on the Participant&#8217;s or his or her broker&#8217;s country of residence or where the Shares are listed, the Participant may be subject to insider-trading restrictions and&#47;or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">market-abuse laws, which may affect the Participant&#8217;s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., the RSUs), or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by law or regulations in the Participant&#8217;s country).  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before the Participant possessed inside information.  Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties, including fellow employees, or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company&#8217;s insider-trading policy.  The Participant understands that it is the Participant&#8217;s responsibility to comply with any applicable restrictions as well as any Company insider trading policy, and the Participant should consult his or her personal legal advisor on this matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.24&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Imposition of Other Requirements.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on this award of RSUs and on any Shares received from the RSUs, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS HEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, this Award Agreement has been executed and delivered by the parties hereto.</font></div><div style="text-indent:72pt"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE PARTICIPANT&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Electronic signature to be provided </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">and recorded via online grant </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">acceptance process on www.etrade.com</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HOLDINGS CORPORATION</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   </font></div></td></tr></table></div><div style="text-indent:72pt"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FIFTH AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2003 EQUITY INCENTIVE PLAN</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NON-U.S. AND COUNTRY-SPECIFIC PROVISIONS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Exhibit A includes special terms and conditions applicable to the Participant if the Participant resides and&#47;or works outside the U.S. and, as applicable, in one of the countries listed below.  These terms and conditions supplement or replace (as indicated) the terms and conditions set forth in the Restricted Stock Unit Award Agreement to which it is attached.  Capitalized terms used and not defined in this Exhibit A will have the meanings set forth in the Restricted Stock Unit Award Agreement or the Plan, as applicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Exhibit A also includes information regarding tax, securities law, exchange controls and certain other issues of which the Participant should be aware with respect to his or her participation in the Plan.  The information is based on the exchange control, securities and other laws in effect in the respective countries as of January 2022.  Such laws are often complex and change frequently.  In addition, other laws and regulations generally applicable to the acquisition, holding or disposal of securities and financial instruments as well as cross-border fund transfers may apply to the Participant.  As a result, the Participant should not rely on the information noted herein as the only source of information relating to the consequences of the Participant&#8217;s participation in the Plan because the information may be out of date at the time the RSUs vest or the Participant receives or sells the Shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information in this Exhibit A is general in nature and may not apply to the Participant&#8217;s particular situation. The Company is not in a position to assure the Participant of any particular result.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant&#8217;s country apply to the Participant&#8217;s situation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">* * * * * </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant is a citizen or resident of a country other than the one in which the Participant is currently residing and&#47;or working, transfers employment and&#47;or residency after the date of grant, or is considered a resident of another country for local law purposes, the terms and conditions and information contained herein may not be applicable to the Participant.  The Company shall, in its sole discretion, determine to what extent the terms and conditions herein shall apply to the Participant in such a case.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EUROPEAN UNION&#47;EUROPEAN ECONOMIC AREA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant resides and&#47;or is employed in the European Union&#47;European Economic Area, the following provision replaces Section 3.15 of the Award Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company is located at 1100 Campus Road, Princeton, New Jersey 08540, United States of America and grants awards under the Plan to employees of the Company and its Related Corporations or Affiliates in its sole discretion.  In conjunction with the Company&#8217;s grant of the RSUs under the Plan to the Participant and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;).  The Participant should carefully review this information about the Company&#8217;s Personal Data Activities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Company collects, processes and uses the Participant&#8217;s personal data, including the Participant&#8217;s name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Service Recipient.  In granting the RSUs under the Plan, the Company will collect the Participant&#8217;s personal data for purposes of allocating Shares and implementing, administering and managing the Plan.  The Company&#8217;s legal basis for the collection, processing and usage of the Participant&#8217;s personal data is the Company legitimate interest of managing the Plan and generally administering employee equity awards granted under the Plan, and to satisfy its contractual obligations under the terms of the Award Agreement and this Exhibit A.  The Participant&#8217;s refusal to provide personal data may affect the Participant&#8217;s ability to participate in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">. The Company transfers the Participant&#8217;s personal data to E*TRADE Securities LLC and its affiliated companies (&#8220;E*TRADE&#8221;), American Stock Transfer &#38; Trust Company, LLC and its affiliated companies (&#8220;AST&#8221;), independent service providers based in the United States, which assists the Company with the implementation, administration and management of the Plan (together, the &#8220;Stock Plan Administrator&#8221;).  In the future, the Company may select a different Stock Plan Administrator and share the Participant&#8217;s personal data with another company that serves in a similar manner.  The Stock Plan Administrator will open an account for the Participant to receive and trade Shares acquired under the Plan.  The Participant will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to the Participant&#8217;s ability to participate in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(d)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Company and the Stock Plan Administrator are based in the United States.  The Participant should note that the Participant&#8217;s country of residence has enacted data privacy laws that are different from the United States.  The Participant understands and acknowledges that the United States has enacted data privacy laws that are less protective or otherwise different from those applicable in the Participant&#8217;s country of residence.  For example, an appropriate level of protection can be achieved by implementing safeguards such as the Standard Contractual Clauses adopted by the EU Commission.  The legal basis for the transfer of the Participant&#8217;s personal data from the Participant&#8217;s country of residence to the Company in the United States and onward transfer of the Participant&#8217;s personal data by the Company to the Stock Plan Administrator will be based on the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">data protection laws.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  The Participant may request a copy of such appropriate safeguards at privacy&#64;integralife.com.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company will use the Participant&#8217;s personal data only as long as necessary to implement, administer and manage the Participant&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including, without limitation, under tax and securities laws.  When the Company no longer needs the Participant&#8217;s personal data for any of the above purposes, which will generally be seven (7) years after he or she participates in the Plan, the Company will cease to use the Participant&#8217;s personal data and remove it from its systems.  If the Company keeps the Participant&#8217;s personal data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be relevant laws or regulations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Participant understands that he or she may have a number of rights under data privacy laws in the Participant&#8217;s country of residence.  Subject to the conditions under  applicable law and depending on where the Participant is based, such rights may include the right to (i) request access to, or copies of, the Participant&#8217;s personal data processed by the Company, (ii) rectification of incorrect personal data of the Participant, (iii) deletion of the Participant&#8217;s personal data, (iv) restrictions on the processing of the Participant&#8217;s personal data, (v) object to the processing of the Participant&#8217;s personal data for legitimate interests, (vi) portability of the Participant&#8217;s personal data, (vii) lodge complaints with competent authorities in the Participant&#8217;s country of residence, and&#47;or to (viii) receive a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data. To receive clarification regarding these rights or to exercise these rights, the Participant can contact privacy&#64;integralife.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Necessary Disclosure of Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  The Participant understands that providing the Company with the Participant&#8217;s personal data is necessary for the performance of the Award Agreement and that the Participant&#8217;s refusal to provide the Participant&#8217;s personal data would make it impossible for the Company to perform its contractual obligations and may affect the Participant&#8217;s ability to participate in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">AUSTRALIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Plan and the RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) applies (subject to the conditions in that Act).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the offer of the RSUs is intended to comply with the provisions of the Corporations Act 2001, Australian Securities and Investments Commission (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Regulatory Guide 49 and ASIC Class Order 14&#47;1000.  Additional details are set forth in the Offer Document for the Offer of RSUs to Australian Resident Employees.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting is required for cash transactions exceeding A$10,000 and international fund transfers of any amount.  The Australian bank </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NTD&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra&#8217;s data privacy team&#47;counsel should confirm this is consistent with the company&#8217;s approach to data privacy compliance.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">assisting with the transaction will file the report for the Participant.  If there is no Australian bank involved in the transfer, the Participant will be responsible for filing the report.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">BELGIUM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Participant will be required to report any securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Shares acquired under the Plan) or bank accounts (including brokerage accounts) held outside of Belgium on the Participant&#8217;s annual tax return.  The Participant will also be required to complete a separate report providing the National Bank of Belgium with details regarding any such account (including the account number, the name of the bank in which such account is held and the country in which such account is located).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Kredietcentrales &#47; Centrales des cr&#233;dits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> caption.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Exchange Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker.  The stock exchange tax will apply when Shares acquired pursuant to the RSUs are sold.  The Participant should consult with a personal tax or financial advisor for additional details on the Participant&#8217;s obligations with respect to the stock exchange tax.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Securities Account Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  A new &#8220;annual securities accounts tax&#8221; has been implemented, which imposes a 0.15% annual tax on the value of qualifying securities held in a Belgian or foreign securities account.  The tax will not apply unless the total value of securities the Participant holds in such an account exceeds an average of &#8364;1 million on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30).  Different payment obligations may apply, depending on whether the securities account is held with a Belgian or foreign financial institution.  The Participant should consult with her or her personal tax advisor for more information regarding the annual securities accounts tax payment obligations.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">CANADA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs and Dividend Equivalents Payable Only in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In no event will the Participant receive a cash payment in connection with the vesting and settlement of the RSUs or any dividend equivalents thereon.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision replaces Section 1.8 of the Award Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IMPORTANT&#58; For purposes of the RSUs, in the event of the termination of the Participant&#8217;s employment or service relationship (whether or not later found to be invalid or unlawful for any reason, including for breaching either applicable employment laws or the Participant&#8217;s employment agreement, if any), unless otherwise required by applicable legislation and unless otherwise provided in this Section, the Participant&#8217;s employment or service relationship will be considered terminated effective as of the date that is the earliest of (i) the date the Participant&#8217;s employment relationship with the Company or any Affiliate is terminated,  (ii) the date the Participant receives notice of termination from the Participant&#8217;s employer, or (iii) the date the Participant is no longer actively providing services to the Company or any Affiliate, regardless of any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. The Participant will not earn or be entitled to any pro-rated vesting for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">that portion of time before the date on which the Participant&#8217;s right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. The Committee shall have the exclusive discretion to determine when the Participant is no longer providing services for purposes of the Participant&#8217;s RSUs (including whether the Participant may still be considered to be providing services while on a leave of absence). Notwithstanding </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, the Participant&#8217;s right to vest in the RSUs under the Plan, if any, will terminate effective as of the last day of the Participant&#8217;s minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant&#8217;s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The following provisions will also apply if the Participant is a resident of Quebec&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The parties acknowledge that it is their express wish that the Award Agreement, including this Exhibit A, as well as all documents, notices, and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Consentement Relatif &#224; la Langue Utilis&#233;e.  Les parties reconnaissent avoir express&#233;ment souhait&#233; que la convention ainsi que cette Exhibit A, ainsi que tous les documents, avis et proc&#233;dures judiciares, &#233;x&#233;cut&#233;s, donn&#233;s ou intent&#233;s en vertu de, ou li&#233;s directement ou indirectement&#160;&#224; la pr&#233;sente convention, soient r&#233;dig&#233;s en langue anglaise.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This provision supplements Section 3.15 of the Award Agreement&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  The Participant further authorizes the Company and any Affiliate, as well as E*TRADE, AST or such other third party service provider as may be selected by the Company to assist with the Plan, to disclose and discuss the Plan with their advisors.  The Participant further authorizes the Company, any Related Corporation and any Affiliate to record such information and to keep such information in the Participant&#8217;s employee file.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant is permitted to sell the Shares acquired under the Plan through the Company&#8217;s designated broker, provided the resale of such Shares takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed.  The Shares are currently listed on the NASDAQ Stock Market.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Foreign specified property held by a Canadian resident must be reporting annually on a Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds C$100,000 at any time during the year.  Thus, unvested RSUs must be reported - generally at a nil cost- if the C$100,000 cost threshold is exceeded because of other foreign specified property held by the Participant.  When the Shares are acquired, their cost generally is the adjusted cost base (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;ACB&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) of the Shares.  The ACB would ordinarily equal the fair market value of the Shares at the time of acquisition, but if the Participant owns other Shares, this ACB may need to be averaged with the ACB of the other Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Participant should consult with his or her personal legal advisor regarding what </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">reporting obligations, if any, will apply to the Participant with respect to the Shares acquired under the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">CHINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The following terms and conditions apply only if the Participant is subject to exchange control restrictions or regulations in China, as determined by the Company in its sole discretion.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision supplements Section 3(b) of the Plan&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant acknowledges that the Participant&#8217;s participation in the Plan is subject to the Company obtaining approval from the State Administration of Foreign Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Without limitation to the foregoing, the Participant understands and agrees that the issuance and delivery of Shares pursuant to the RSUs will be delayed until the Company obtains such approval or the Committee has otherwise determined that the issuance of the Shares can be made in compliance with applicable laws.</font></div><div><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To facilitate compliance with any applicable laws and regulations in China, the Participant agrees that the Company (or a brokerage firm instructed by the Company, if applicable) is entitled to (i) sell all the Shares issued to the Participant at settlement (on the Participant&#8217;s behalf and at the Participant&#8217;s direction pursuant to this authorization), either at the time of settlement or when the Participant ceases employment with the Service Recipient, or at such other time determined by the Company, or (ii) require that any Shares acquired under the Plan be held with a designated brokerage firm until such Shares are sold.  </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant&#160;also agrees to sign any agreements, forms and&#47;or consents that may be reasonably requested&#160;by the Company (or&#160;the Company&#8217;s&#160;designated brokerage firm) to effectuate the sale of the Shares and&#160;acknowledges that neither the Company nor the designated brokerage firm is under&#160;any obligation to arrange for&#160;such sale of the Shares at any particular price (it being understood that the sale will occur at the then-current market price) and that brokerage fees or commissions may be incurred in any such sale.  In any event, when the Shares acquired under the Plan are sold, the proceeds of the sale of the Shares, less any Tax-Related Items and brokerage fees or commissions, will be remitted to the Participant in accordance with applicable exchange control laws and regulations.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Participant acknowledges and agrees that any Shares acquired under the Plan and held in the Participant&#8217;s brokerage account must be sold within sixty (60) days following termination of the Participant&#8217;s Employment, or within such other period as determined by the Company or required by SAFE (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Mandatory Sale Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  This includes any Shares that vest upon the Participant&#8217;s termination of Employment.  The Participant understands that any Shares held by the Participant that have not been sold by the Mandatory Sale Date will automatically be sold by the Company&#8217;s designated broker at the Company&#8217;s direction (on the Participant&#8217;s behalf pursuant to this authorization without further consent), as described above. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Award Agreement, the Participant acknowledges and agrees that pursuant to local exchange control requirements, any Shares acquired upon vesting of the RSUs must be held in an account with the Company&#8217;s designated broker and may not be transferred from such account.  The Participant further understands that he or she is permitted to sell Shares acquired under the Plan only through the Company&#8217;s designated broker.  The Participant further understands and agrees that, due to exchange control laws in China, the Participant must immediately repatriate the proceeds from the sale of Shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any cash dividends paid on such Shares to China.  The Participant understands that such repatriation of the proceeds will need to be effected through a special exchange control account established by the Company or a Related Corporation or Affiliate, and the Participant hereby consents and agrees that the proceeds from the sale of Shares or the receipt of any cash dividends may be transferred to such special account prior to being delivered to the Participant. The Company may deliver the proceeds to the Participant in U.S. dollars or local currency at the Company&#8217;s discretion.  If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. The Participant agrees to bear any currency fluctuation risk between the time the Shares are sold or dividends are paid and the time the proceeds are distributed to the Participant.  The Company is under no obligation to secure any particular exchange conversion rate.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">FRANCE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Units Not French-qualified</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs granted under this Award Agreement are not intended to qualify for special tax and social security treatment pursuant to Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 and L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Award Agreement, the Participant confirms having read and understood the Plan and the Award Agreement, which were provided in the English language. The Participant accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consentement Relatif &#224; la Langue Utilis&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  En acceptant cette Attribution, le Participant confirme avoir lu et comprendre le Plan et ce Contrat qui ont &#233;t&#233; transmis en langue anglaise. Le Participant accepte les dispositions de ces documents en connaissance de cause.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. French residents holding cash or securities (including Shares acquired under the Plan) outside of France or maintaining foreign bank or brokerage account (including accounts opened or closed during the tax year) must declare such assets and accounts to the French tax authorities when filing an annual tax return.  Failure to comply could trigger significant penalties.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Participant must report any cross-border payments in excess of &#8364;12,500 to the German Federal Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  The report must be filed electronically and the form of report (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Allgemeine Meldeportal Statistik</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) can be accessed via the Bundesbank&#8217;s website (www.bundesbank.de).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Participant is responsible for complying with applicable reporting obligations and should consult his or her personal legal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant&#8217;s acquisition of Shares under the Plan leads to a &#8220;qualified participation&#8221; at any point during the calendar year, the Participant must report the acquisition when he or she files a tax return for the relevant year.  A &#8220;qualified participation&#8221; is attained if (i) the value of the Shares acquired exceeds &#8364;150,000, or (ii) in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">unlikely event the Participant holds Shares exceeding 10% of the Company&#8217;s total common stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">IRELAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">There are no country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ITALY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Document Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  By accepting the Award Agreement, the Participant further acknowledges that the Participant has received a copy of the Plan, has reviewed the Plan and the Award Agreement in their entirety and fully understands and accepts all provisions of the Plan and the Award Agreement.  The Participant further acknowledges that the Participant has read and specifically and expressly approves, without limitation, the following sections of the Award Agreement&#58; &#8220;Vesting of RSUs&#8221;&#59; &#8220;Responsibility for Taxes&#8221;&#59; &#8220;Electronic Delivery and Participation&#8221;&#59; &#8220;Insider Trading Restrictions&#59; Market Abuse Laws&#8221;&#59; &#8220;Imposition of Other Requirements&#8221;&#59; &#8220;Nature of Grant&#8221;&#59; and &#8220;Foreign Asset&#47;Account, Exchange Control and Tax Reporting&#8221; (including the &#8220;Foreign Asset&#47;Account Reporting Information&#8221; and &#8220;Foreign Asset Tax Information&#8221; below). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant holds investments abroad or foreign financial assets (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, cash, Shares) that may generate income taxable in Italy, the Participant is required to report them on his or her annual tax return (UNICO Form, RW Schedule) or on a special form if no tax return is due.  The same reporting duties apply if the Participant is the beneficial owner of the investments, even if the Participant does not directly hold investments abroad or foreign assets.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The value of the financial assets held outside of Italy by Italian residents is subject to a foreign asset tax.  Such tax is currently levied at an annual rate of 2 per thousand (0.2%).  The taxable amount will be the fair market value of the financial assets (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Shares) assessed at the end of the calendar year.  No tax payment duties arise if the value of the foreign assets held abroad does not exceed a certain threshold.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">JAPAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Participant acquires Shares valued at more than &#165;100,000,000 in a single transaction, the Participant must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within 20 days of the acquisition of the Shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant will be required to report details of any assets (such as Shares) held outside of Japan as of December 31st to the extent such assets have a total net fair market value exceeding &#165;50,000,000.  Such report will be due by March 15th each year.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Participant should consult with his or her personal tax advisor as to whether the reporting obligation extends to any outstanding RSUs held by the Participant and to ensure compliance with applicable reporting obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">MEXICO</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acceptance of the Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  By accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan and the Award Agreement, including this Exhibit, which the Participant has reviewed.  The Participant acknowledges further that he or she accepts all the provisions of the Plan and the Award Agreement, including this Exhibit.  The Participant also acknowledges that he or she has read and specifically and expressly approves the terms and conditions set forth in Section 3.3 of the Award Agreement, which clearly provide as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Participant&#8217;s participation in the Plan does not constitute an acquired right&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;The Plan and the Participant&#8217;s participation in it are offered by the Company on a wholly discretionary basis&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;the Participant&#8217;s participation in the Plan is voluntary.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Labor Law Policy and Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; In accepting the RSUs, Participant expressly recognizes that Integra LifeSciences Holdings Corporation at 1100 Campus Road, Princeton, New Jersey 08540, USA, is solely responsible for the administration of the Plan and that the Participant&#8217;s participation in the Plan and acquisition of the Shares do not constitute an employment relationship between the Participant and the Company since the Participant is participating in the Plan on a wholly commercial basis and the Participant&#8217;s sole employer is a Mexican subsidiary of the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Integra-Mexico&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that the Participant may derive from his or her participation in the Plan do not establish any rights between the Participant and Integra-Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Integra-Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant further understands that his or her participation in the Plan is a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue the Participant&#8217;s participation at any time without any liability to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, the Participant hereby declares that he or she does not reserve any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Company, its subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives with respect to any claim that may arise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Reconocimiento del Acuerdo</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Aceptando este Premio (Award), el Participante reconoce que ha recibido una copia del Plan, el Anuncio de la Subvenci&#243;n y el Acuerdo, con inclusi&#243;n de este Ap&#233;ndice, que el Participante ha revisado.  El Participante reconoce, adem&#225;s, que acepta todas las disposiciones del Plan, el Anuncio de la Subvenci&#243;n, y en el Acuerdo, incluyendo este Ap&#233;ndice.  El Participante tambi&#233;n reconoce que ha le&#237;do y que concretamente aprueba de forma expresa los t&#233;rminos y condiciones establecidos en la Secci&#243;n 3.3 del Acuerdo, que claramente dispone lo siguiente&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;La participaci&#243;n del Participante en el Plan no constituye un derecho adquirido&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;El Plan y la participaci&#243;n del Participante en el Plan se ofrecen por la Compa&#241;&#237;a en su discrecionalidad total&#59; y</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Que la participaci&#243;n del Participante en el Plan es voluntaria.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Pol&#237;tica de la Ley Laboral y Reconocimiento </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Aceptando este Premio (Award), el Participante reconoce expresamente que Integra LifeSciences Holdings Corporation con oficinas registradas ubicadas en 1100 Campus Road, Princeton, New Jersey 08540,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">en los Estados Unidos de Am&#233;rica, es el &#250;nico responsable de la administraci&#243;n del Plan y que participaci&#243;n del Participante en el mismo y la adquisici&#243;n de acciones no constituye de ninguna manera una relaci&#243;n laboral entre el Participante y la Compa&#241;&#237;a, debido a que la participaci&#243;n de esa persona en el Plan deriva &#250;nicamente de una relaci&#243;n comercial y el &#250;nico Patr&#243;n del participante es una afiliada Mexicana de la Compa&#241;&#237;a (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Integra-M&#233;xico&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  Derivado de lo anterior, el Participante reconoce expresamente que el Plan y los beneficios que pudieran derivar para el Participante por su participaci&#243;n en el mismo, no establecen ning&#250;n derecho entre el Participante e Integra-M&#233;xico, y no forman parte de las condiciones laborales y&#47;o prestaciones otorgadas por Integra-M&#233;xico, y cualquier modificaci&#243;n al Plan o la terminaci&#243;n del mismo de ninguna manera podr&#225; ser interpretada como una modificaci&#243;n o desmejora de los t&#233;rminos y condiciones de trabajo del Participante.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Asimismo, el Participante reconoce que su participaci&#243;n en el Plan es resultado de la decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a, por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto para modificar y&#47;o discontinuar la participaci&#243;n del Participante en cualquier momento, sin ninguna responsabilidad hacia el Participante.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente el Participante manifiesta que no se reserva ninguna acci&#243;n o derecho que ejercitar en contra de la Compa&#241;&#237;a, por cualquier compensaci&#243;n o da&#241;os o perjuicios en relaci&#243;n con cualquier disposici&#243;n del Plan o de los beneficios derivados del mismo, y en consecuencia exime amplia y completamente a la Compa&#241;&#237;a, sus afiliadas, sucursales, oficinas de representaci&#243;n, sus accionistas, administradores, agentes y representantes legales con respecto a cualquier reclamo que pudiera surgir.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs and Shares offered under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the Plan, the Award Agreement, and any other document relating to the RSUs and Shares may not be publicly distributed in Mexico.  These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form.  The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of Integra-Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SINGAPORE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of the RSUs is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;SFA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Participant should note that the RSUs are subject to section 257 of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the SFA and the Participant should not make any subsequent sale of the Shares in Singapore or any offer of such subsequent sale of the Shares subject to the RSUs in Singapore, unless such sale or offer is made (i) six months or more after the date of grant or (ii) pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA, or any other applicable provisions of the SFA.  The Company&#8217;s Common Stock is traded on the NASDAQ Stock Market, which is located outside of Singapore, under the ticker symbol &#8220;IART&#8221; and the Shares acquired under the Plan may be sold through this exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Director Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant is a director (including an alternate, substitute or shadow director) of a Singapore Affiliate, he or she is subject to certain notification requirements under the Singapore Companies Act, regardless of whether he or she is a Singapore resident or employed in Singapore.  Among these requirements is the obligation to notify the Singapore Affiliate in writing when the Participant receives or disposes of an interest in the Company, Related Corporation, or an Affiliate (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Options, RSUs, Shares).  These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company, Related Corporation, or any Affiliate or within two (2) business days of becoming a director if such an interest exists at that time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this Award Agreement nor any other materials relating to the offer of RSUs (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FinSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of Integra LifeSciences Holdings Corporation or one of its Subsidiaries or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 of FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED KINGDOM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This provision supplements Section 3.4 of the Award Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 3.4 of the Award Agreement, the Participant hereby agrees that the Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or if different, the Service Recipient or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HRMC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (or any other tax authority or any other relevant authority).&#160; The Participant also hereby agrees to indemnify and keep indemnified the Company and, if different, the Service Recipient against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply.  In the event that the Participant is a director or executive officer of the Company and the income tax not collected from or paid by the Participant within ninety (90) days of the end of the U.K. tax year in which an event giving rise to the indemnification described above occurs, the amount of any uncollected income tax may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NICs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may be payable.&#160; The Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3(l)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">regime and for paying to the Company and&#47;or the Service Recipient (as appropriate) the amount of any NICs due on this additional benefit, which the Company and&#47;or the Service Recipient may recover from the Participant by any of the means referred to in Section 3.4 of the Award Agreement. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>9
<FILENAME>iart-20221231xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46d0d3058c4a4655b7032e4677e439e3_79"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Integra LifeSciences Holdings Corporation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br></font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:60.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State or Country of Incorporation or Organization</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkis Biosciences Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ascension Orthopedics Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BIMECO, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioD, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioDlogics, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioRecovery, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CardioDyne, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cathtec Incorporated</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caveangle Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confluent Surgical, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derma First Aid Products, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derma Sciences Europe Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derma Sciences, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EndoSolutions, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiber Imaging Technologies, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GMS, Gesellschaft f&#252;r medizinische Sondentechnik mbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILS Financing (Ireland) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILS Financing Corporation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILS Services Switzerland Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILS Surgical Investments, LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INS Sweden AB</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Burlington MA, Inc. (formerly known as Integra Radionics, Inc.)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Canada ULC (formerly known as Canada Microsurgical ULC)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra CI, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Euro Holdings, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra France Holdings SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra German Holdings GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Japan K.K.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences (Canada) Holdings, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences (Ireland) Limited</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:60.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences (Shanghai) Co., Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Austria GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Brazil Ltda.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Corporation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Enterprises, LLLP</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Financing (Cyprus) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Italy S.r.l.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Korea Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Middle East FZ-LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dubai</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Production Corporation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Sales LLC (f&#47;k&#47;a Integra Healthcare Products LLC)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Services (France) SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Shared Services (Ireland) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Singapore Pte. Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Spain, S.L.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Switzerland S&#225;rl</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LifeSciences Taiwan Company Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LS (Benelux) NV</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra LS Mexico, S. DE R. L. DE C.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Luxtec, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra ME GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra MicroFrance SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra NeuroSciences (International), Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings (UK)&#160;Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra NeuroSciences Holdings B.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra NeuroSciences Implants (France) SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra NeuroSciences Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (AUS)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Neurosciences Pty Ltd. (NZ)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Receivables LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Sales, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Selector LLC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra Switzerland Holdings Sarl</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integra York PA, Inc. (formerly known as Miltex, Inc.)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IsoTis NV</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IsoTis T.E. Facility B.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Jamner Surgical Instruments, Inc.</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:60.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jarit GmbH</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LXU Healthcare, Inc. - Medical Specialty Products</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedEfficiency, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota Scientific, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newdeal SAS</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newdeal, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Precise Dental Holding Corp.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Precise Dental Internacional, S.A. de C.V.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Precise Dental Products, Ltd.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Precision Dental International, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebound Therapeutics Corporation</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spembly Cryosurgery Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spembly Medical Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovation Associates, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tarsus Medical Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEI Biosciences (UK) Limited</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEI Biosciences Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEI Medical Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TGX Medical Systems, LLC</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>10
<FILENAME>iart-20221231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3326278016d844479dc71fcba2681847_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">S-8 (Nos.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">333-231709, 333-221210, 333-216212, 333-170210, 333-155263, 333-127488, 333-109042, 333-261744 and 333-266353)  of Integra LifeSciences Holdings Corporation of our report dated February&#160;22, 2023 relating to the financial statements, financial statement schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Florham Park, New Jersey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;22, 2023 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>11
<FILENAME>iart-20221231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i88d8b3d1b9b64608932bc421bd74186d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jan De Witte, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:4.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>12
<FILENAME>iart-20221231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iac692c46be5c419b942921991cb278b3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey A. Mosebrook, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:4.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.128%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President, Finance</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>13
<FILENAME>iart-20221231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i97e08b2cc9f54ea7a1889fb029ff8925_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jan De Witte, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:4.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>14
<FILENAME>iart-20221231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8f300eb2b6e949c4870169a4017f1581_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey A. Mosebrook, Senior Vice President, Finance of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President, Finance</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>iart-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://integralife.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESS" roleURI="http://integralife.com/role/BUSINESS">
        <link:definition>0000009 - Disclosure - BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERS" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS">
        <link:definition>0000011 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURES" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES">
        <link:definition>0000012 - Disclosure - ACQUISITIONS AND DIVESTITURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://integralife.com/role/DEBT">
        <link:definition>0000013 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTS" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS">
        <link:definition>0000014 - Disclosure - DERIVATIVE INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCK" roleURI="http://integralife.com/role/TREASURYSTOCK">
        <link:definition>0000016 - Disclosure - TREASURY STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000017 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANS" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS">
        <link:definition>0000018 - Disclosure - RETIREMENT BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASES" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES">
        <link:definition>0000019 - Disclosure - LEASES AND RELATED PARTY LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://integralife.com/role/INCOMETAXES">
        <link:definition>0000020 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://integralife.com/role/NETINCOMEPERSHARE">
        <link:definition>0000021 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATION" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION">
        <link:definition>0000024 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSTables" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables">
        <link:definition>0000027 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESTables" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables">
        <link:definition>0000028 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://integralife.com/role/DEBTTables">
        <link:definition>0000029 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSTables" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables">
        <link:definition>0000030 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>0000032 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSTables" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables">
        <link:definition>0000033 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESTables" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables">
        <link:definition>0000034 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://integralife.com/role/INCOMETAXESTables">
        <link:definition>0000035 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://integralife.com/role/NETINCOMEPERSHARETables">
        <link:definition>0000036 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables">
        <link:definition>0000037 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>0000038 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTables" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables">
        <link:definition>0000039 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails">
        <link:definition>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails">
        <link:definition>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
        <link:definition>0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails">
        <link:definition>0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details">
        <link:definition>0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails">
        <link:definition>0000046 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
        <link:definition>0000047 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
        <link:definition>0000047 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails">
        <link:definition>0000048 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
        <link:definition>0000049 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails">
        <link:definition>0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails">
        <link:definition>0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
        <link:definition>0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails">
        <link:definition>0000053 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails">
        <link:definition>0000054 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://integralife.com/role/DEBTNarrativeDetails">
        <link:definition>0000055 - Disclosure - DEBT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaximumTotalLeverageRatioTableDetails" roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails">
        <link:definition>0000056 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtMaturityDetails" roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails">
        <link:definition>0000057 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
        <link:definition>0000058 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSNarrativeDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails">
        <link:definition>0000059 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
        <link:definition>0000060 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
        <link:definition>0000061 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
        <link:definition>0000062 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
        <link:definition>0000063 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails">
        <link:definition>0000064 - Disclosure - DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000065 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
        <link:definition>0000066 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
        <link:definition>0000067 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCKNarrativeDetails" roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails">
        <link:definition>0000068 - Disclosure - TREASURY STOCK - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
        <link:definition>0000069 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>0000070 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails">
        <link:definition>0000071 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails">
        <link:definition>0000072 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
        <link:definition>0000073 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails">
        <link:definition>0000074 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails">
        <link:definition>0000075 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails">
        <link:definition>0000076 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails">
        <link:definition>0000077 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSNarrativeDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails">
        <link:definition>0000078 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails">
        <link:definition>0000079 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESNarrativeDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails">
        <link:definition>0000080 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>0000081 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails">
        <link:definition>0000082 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
        <link:definition>0000083 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1">
        <link:definition>0000083 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails">
        <link:definition>0000084 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails">
        <link:definition>0000085 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000086 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>0000087 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000088 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTaxValuationAllowanceDetails" roleURI="http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails">
        <link:definition>0000089 - Disclosure - INCOME TAXES (Tax Valuation Allowance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails">
        <link:definition>0000090 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails">
        <link:definition>0000091 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENarrativeDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails">
        <link:definition>0000092 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000093 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" roleURI="http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails">
        <link:definition>0000094 - Disclosure - AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails">
        <link:definition>0000095 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
        <link:definition>0000096 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>0000097 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
        <link:definition>0000098 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
        <link:definition>0000099 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
        <link:definition>0000100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iart_SegmentReportingInformationNumberOfProductsOffered" abstract="false" name="SegmentReportingInformationNumberOfProductsOffered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumAverageConversionValueOfNotes" abstract="false" name="DebtInstrumentMaximumAverageConversionValueOfNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" abstract="true" name="UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" abstract="false" name="BusinessCombinationIntangibleAssetAcquiredDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_BusinessAcquisitionNumberOfContingentLiabilities" abstract="false" name="BusinessAcquisitionNumberOfContingentLiabilities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_RevenueProductWarrantyPeriod" abstract="false" name="RevenueProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_PerformanceStockandContractStockMember" abstract="true" name="PerformanceStockandContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TwoThousandThreePlanMember" abstract="true" name="TwoThousandThreePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractThreeMember" abstract="true" name="CrossCurrencyInterestRateSwapContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SurgicalInnovationAssociatesIncMember" abstract="true" name="SurgicalInnovationAssociatesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TwoThousandPlanMember" abstract="true" name="TwoThousandPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IntercompanyLoanQuarterlyPayment" abstract="false" name="IntercompanyLoanQuarterlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SupplierRelationShipsMember" abstract="true" name="SupplierRelationShipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_FDAApprovalOfPremarketApprovalMember" abstract="true" name="FDAApprovalOfPremarketApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" abstract="false" name="AssetAcquisitionDevelopmentMilestonePaymentToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_PaymentsForProceedsFromBusinessAcquisitions" abstract="false" name="PaymentsForProceedsFromBusinessAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" abstract="false" name="AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SeniorCreditFacilityMember" abstract="true" name="SeniorCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ConsortiumofFocusedOrthopedistsLLCMember" abstract="true" name="ConsortiumofFocusedOrthopedistsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" abstract="false" name="ContractWithCustomerAssetNetOfReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" abstract="false" name="StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DerivativeNotionalAmountTerminated" abstract="false" name="DerivativeNotionalAmountTerminated" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ACellMember" abstract="true" name="ACellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RelatedPartiesMember" abstract="true" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MilestonePaymentTwoMember" abstract="true" name="MilestonePaymentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DemonstrationEquipmentMember" abstract="true" name="DemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" abstract="false" name="CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractThreeMember" abstract="true" name="CrossCurrencyInterestRateContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractTwoMember" abstract="true" name="CrossCurrencyInterestRateSwapContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" abstract="false" name="DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestPaymentsYearTwo" abstract="false" name="InterestPaymentsYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_OneMonthEurodollarRateMember" abstract="true" name="OneMonthEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche3Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_FoundationPolicyTextBlock" abstract="false" name="FoundationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AllOtherMember" abstract="true" name="AllOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_ClosureOfFacilityMember" abstract="true" name="ClosureOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" abstract="false" name="EffectiveWorldwideIncomeTaxRateReconciliationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DebtWeightedAverageInterestRateFromSecuritization" abstract="false" name="DebtWeightedAverageInterestRateFromSecuritization" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DeferredTaxAssetsLeasesAndOther" abstract="false" name="DeferredTaxAssetsLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestPaymentsYearThree" abstract="false" name="InterestPaymentsYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" abstract="false" name="PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_PrivateLabelMember" abstract="true" name="PrivateLabelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IncreaseInAuthorizedShares" abstract="false" name="IncreaseInAuthorizedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" abstract="false" name="ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DermaSciencesMember" abstract="true" name="DermaSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CodmanMember" abstract="true" name="CodmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" abstract="false" name="DiscontinuedOperationContinuingInvolvementPrepaidAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" abstract="false" name="TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DeferredTaxLiabilitiesLeasesAndOther" abstract="false" name="DeferredTaxLiabilitiesLeasesAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractOneMember" abstract="true" name="CrossCurrencyInterestRateContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractFourMember" abstract="true" name="CrossCurrencyInterestRateContractFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod4Member" abstract="true" name="DebtCovenantPeriod4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandOnePlanMember" abstract="true" name="TwoThousandOnePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" abstract="false" name="AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" abstract="false" name="GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtCovenantPeriod3Member" abstract="true" name="DebtCovenantPeriod3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RevenueBasedPerformanceMilestonesMember" abstract="true" name="RevenueBasedPerformanceMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_ThirdPartiesMember" abstract="true" name="ThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" abstract="false" name="EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_SwinglineLoanMember" abstract="true" name="SwinglineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche3Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" abstract="false" name="NoncashOrPartNoncashInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" abstract="false" name="RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_AccountingStandardUpdate202006Member" abstract="true" name="AccountingStandardUpdate202006Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InformationSystemsandHardwareMember" abstract="true" name="InformationSystemsandHardwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearOne" abstract="false" name="InterestPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" abstract="false" name="DeferredTaxAssetIncreaseDueTo2017TaxAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DirectorsandCertainExecutiveOfficersMember" abstract="true" name="DirectorsandCertainExecutiveOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_ExtremityOrthopedicsMember" abstract="true" name="ExtremityOrthopedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_FiveYearOptionLeasePeriodOneMember" abstract="true" name="FiveYearOptionLeasePeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgram" abstract="false" name="SecuredLongTermDebtSecuritizationProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" abstract="true" name="TwoThousandTwentyFiveSeniorConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ConcentrationRiskNumberofCustomersOverBenchmark" abstract="false" name="ConcentrationRiskNumberofCustomersOverBenchmark" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_TraditionalWoundCareMember" abstract="true" name="TraditionalWoundCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" abstract="false" name="DefinedBenefitPlanPlanAssetsPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ACellIncMember" abstract="true" name="ACellIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EmployeeStockPurchasePlanProceeds" abstract="false" name="EmployeeStockPurchasePlanProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RestrictedStockPerformanceStockAndContractStockMember" abstract="true" name="RestrictedStockPerformanceStockAndContractStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InventoryCapitalizedExpenses" abstract="false" name="InventoryCapitalizedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" abstract="false" name="PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" abstract="false" name="DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TrademarksBrandNamesMember" abstract="true" name="TrademarksBrandNamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" abstract="false" name="DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" abstract="true" name="BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_OneMonthUSDLIBORMember" abstract="true" name="OneMonthUSDLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" abstract="true" name="CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeTableTextBlock" abstract="false" name="CashFlowLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_NeurosurgeryMember" abstract="true" name="NeurosurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CodmanSpecialtySurgicalMember" abstract="true" name="CodmanSpecialtySurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ConcentrationRiskThresholdPercentage" abstract="false" name="ConcentrationRiskThresholdPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_OptionToExtendLeaseYears" abstract="false" name="OptionToExtendLeaseYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ArkisBioSciencesInc.Member" abstract="true" name="ArkisBioSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" abstract="false" name="DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ReboundTherapeuticsCorporationMember" abstract="true" name="ReboundTherapeuticsCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PaymentsForOptionIndexToIssuersEquity" abstract="false" name="PaymentsForOptionIndexToIssuersEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_CompletedTechnologyMember" abstract="true" name="CompletedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" abstract="false" name="DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AnnualRateOfLeaseAgreement" abstract="false" name="AnnualRateOfLeaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CharitableContributions" abstract="false" name="CharitableContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractTwoMember" abstract="true" name="CrossCurrencyInterestRateContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesAdditionalSharesReceived" abstract="false" name="AcceleratedShareRepurchasesAdditionalSharesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_AccumulatedOtherComprehensiveIncomeLossRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" abstract="true" name="CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ReorganizationProjectsMember" abstract="true" name="ReorganizationProjectsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_SecuritizationFacilityFairValueOfAmountOutstanding" abstract="false" name="SecuritizationFacilityFairValueOfAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_BusinessCombinationWorkingCapitalAdjustment" abstract="false" name="BusinessCombinationWorkingCapitalAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_FiveYearLeasePeriodTwoMember" abstract="true" name="FiveYearLeasePeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" abstract="false" name="UnrecognizedTaxBenefitsReductionsResultingFromOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RegenerativeSkinAndWoundMember" abstract="true" name="RegenerativeSkinAndWoundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesSharesReceivedAtInception" abstract="false" name="AcceleratedShareRepurchasesSharesReceivedAtInception" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" abstract="false" name="DefinedBenefitPlanBenefitObligationPremiumsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateSwapContractOneMember" abstract="true" name="CrossCurrencyInterestRateSwapContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TissueTechnologiesMember" abstract="true" name="TissueTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MilestonePaymentOneMember" abstract="true" name="MilestonePaymentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>iart-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a49991ad-9906-4c75-b64c-d3c0ff1827b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9bb1425-24e6-4d1d-ad88-e2c3bf052960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a49991ad-9906-4c75-b64c-d3c0ff1827b6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9bb1425-24e6-4d1d-ad88-e2c3bf052960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_259959ca-3920-4bc7-af89-f6d6329680a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a49991ad-9906-4c75-b64c-d3c0ff1827b6" xlink:to="loc_us-gaap_CostsAndExpenses_259959ca-3920-4bc7-af89-f6d6329680a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a9ba75bd-a694-4de9-bf53-5685c4aa01ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:to="loc_us-gaap_OperatingIncomeLoss_a9ba75bd-a694-4de9-bf53-5685c4aa01ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d0087049-f811-47af-9f10-462b78596201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d0087049-f811-47af-9f10-462b78596201" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b43f9902-508a-4a3c-afb0-00cc99ba954c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:to="loc_us-gaap_InterestExpense_b43f9902-508a-4a3c-afb0-00cc99ba954c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_cdb85110-844c-4acc-8793-a338497e4047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_cdb85110-844c-4acc-8793-a338497e4047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_78268d82-7e8b-4912-9b83-a504c700ccae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a91e9-c9f0-4a0d-bc40-c3c69ce04824" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_78268d82-7e8b-4912-9b83-a504c700ccae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_faed98df-5528-4348-8dff-08de2ece2813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6a39346f-448a-49de-b7e9-8089a018d1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_faed98df-5528-4348-8dff-08de2ece2813" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6a39346f-448a-49de-b7e9-8089a018d1e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f13fc8b5-c5c7-477e-8b3f-31eb703fd21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_faed98df-5528-4348-8dff-08de2ece2813" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f13fc8b5-c5c7-477e-8b3f-31eb703fd21d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_380f6a0b-717a-4b84-8858-082f9cfbd71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_faed98df-5528-4348-8dff-08de2ece2813" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_380f6a0b-717a-4b84-8858-082f9cfbd71e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d8240789-0df6-45e9-9ef2-8598bf8ab57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_faed98df-5528-4348-8dff-08de2ece2813" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d8240789-0df6-45e9-9ef2-8598bf8ab57c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7905de83-d329-4702-b4af-1ee57fe8716e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bfc5c209-db75-4079-afb7-bb928f80de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7905de83-d329-4702-b4af-1ee57fe8716e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bfc5c209-db75-4079-afb7-bb928f80de5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_639bc635-274a-4b73-8963-094b20e18597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7905de83-d329-4702-b4af-1ee57fe8716e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_639bc635-274a-4b73-8963-094b20e18597" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9e0289c1-bd34-4d78-a76f-67fc3053da5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_9fa327fe-2fc0-4001-868c-0595ef21b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9e0289c1-bd34-4d78-a76f-67fc3053da5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_9fa327fe-2fc0-4001-868c-0595ef21b79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_a071f61b-74fe-4154-960b-4e6006a5bed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9e0289c1-bd34-4d78-a76f-67fc3053da5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_a071f61b-74fe-4154-960b-4e6006a5bed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a1e2bf1e-64bd-4b5c-8bc8-5516e1182ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_9e0289c1-bd34-4d78-a76f-67fc3053da5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a1e2bf1e-64bd-4b5c-8bc8-5516e1182ce5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_071ad747-4d95-46fe-9fc5-56d154822047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_866a5db0-b20f-45b2-98d9-04ab537d852a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_071ad747-4d95-46fe-9fc5-56d154822047" xlink:to="loc_us-gaap_NetIncomeLoss_866a5db0-b20f-45b2-98d9-04ab537d852a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fdd0f9bb-4520-4c7d-bb8e-75537cc41653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_071ad747-4d95-46fe-9fc5-56d154822047" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fdd0f9bb-4520-4c7d-bb8e-75537cc41653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cebc048c-7e04-4681-95fe-6ba47f9ee7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_3805ff51-0ac5-49c0-96f2-5bcc32dfa1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cebc048c-7e04-4681-95fe-6ba47f9ee7c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_3805ff51-0ac5-49c0-96f2-5bcc32dfa1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_d516d48d-faff-42ea-8f9c-a7f4bfcf6a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cebc048c-7e04-4681-95fe-6ba47f9ee7c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_d516d48d-faff-42ea-8f9c-a7f4bfcf6a53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_74921874-d343-45e5-9235-a90e4af8ff1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_684f1e3a-a4db-4839-9c25-3830c7e3906e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_74921874-d343-45e5-9235-a90e4af8ff1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_684f1e3a-a4db-4839-9c25-3830c7e3906e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d65a561-85fc-4be9-a276-bfe7a1fe8ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_74921874-d343-45e5-9235-a90e4af8ff1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d65a561-85fc-4be9-a276-bfe7a1fe8ef7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_62ee311d-8484-423a-ab5a-30248e798e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eecd2665-7b47-4f86-a405-6f6428f558ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_62ee311d-8484-423a-ab5a-30248e798e8d" xlink:to="loc_us-gaap_Liabilities_eecd2665-7b47-4f86-a405-6f6428f558ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0190f355-db3c-451c-9600-732fa1a92cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_62ee311d-8484-423a-ab5a-30248e798e8d" xlink:to="loc_us-gaap_StockholdersEquity_0190f355-db3c-451c-9600-732fa1a92cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_18a1fe3b-d6ba-48bf-94a4-b29b6cab4280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b01857ee-621d-4010-bd96-2d73e467021e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_18a1fe3b-d6ba-48bf-94a4-b29b6cab4280" xlink:to="loc_us-gaap_InventoryNet_b01857ee-621d-4010-bd96-2d73e467021e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed38f17c-c304-4f15-a156-4ad9c9aea9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_18a1fe3b-d6ba-48bf-94a4-b29b6cab4280" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed38f17c-c304-4f15-a156-4ad9c9aea9db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_39adc22e-ab64-43d9-92ee-f5e55fb39e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_18a1fe3b-d6ba-48bf-94a4-b29b6cab4280" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_39adc22e-ab64-43d9-92ee-f5e55fb39e16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e23a22aa-0224-45b2-afba-dc3ce6085cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_18a1fe3b-d6ba-48bf-94a4-b29b6cab4280" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e23a22aa-0224-45b2-afba-dc3ce6085cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e03cc263-c54c-4e01-a830-348418360738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_PreferredStockValue_e03cc263-c54c-4e01-a830-348418360738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9a0fe034-1fdd-4835-9248-7ac860f1c24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_CommonStockValue_9a0fe034-1fdd-4835-9248-7ac860f1c24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0c263295-305f-4f2f-806b-e7b19638828b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0c263295-305f-4f2f-806b-e7b19638828b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_faa8fe0f-7461-491d-b692-34fa49e8813b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_TreasuryStockValue_faa8fe0f-7461-491d-b692-34fa49e8813b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a274156-e009-47b9-b53c-588ca36c83a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a274156-e009-47b9-b53c-588ca36c83a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_867b2634-5bc5-465b-a53a-9477049b522a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d1dac315-b024-4048-a50c-f12f7967ce68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_867b2634-5bc5-465b-a53a-9477049b522a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_478f2ecc-617f-45c4-9982-b5e73e6e3f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_SecuredDebtCurrent_478f2ecc-617f-45c4-9982-b5e73e6e3f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01c2b7ad-f273-46c0-987b-a9139476d7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01c2b7ad-f273-46c0-987b-a9139476d7e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_0ef800af-ea99-43f3-8b6c-52226cde9b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_0ef800af-ea99-43f3-8b6c-52226cde9b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fadb6a42-9f60-415c-b6d9-65bb4e62f322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fadb6a42-9f60-415c-b6d9-65bb4e62f322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4c8ac2bf-3f0e-4ae6-a523-c86fb8a1007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4c8ac2bf-3f0e-4ae6-a523-c86fb8a1007d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5c55900a-7bb4-4f92-8830-9e11dc9abac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb31cc40-1d26-402c-9bf0-c5e965321a06" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5c55900a-7bb4-4f92-8830-9e11dc9abac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5e27ba62-d80d-46d8-b50f-bf8f73b09c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_LiabilitiesCurrent_5e27ba62-d80d-46d8-b50f-bf8f73b09c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_160acf5c-c970-4c3e-b50d-40007fa47bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_SecuredLongTermDebt_160acf5c-c970-4c3e-b50d-40007fa47bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_59906c3b-b27c-4d3c-80dc-42226c180d2c" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_59906c3b-b27c-4d3c-80dc-42226c180d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_08fcf03c-5ee8-4006-8553-380220ff1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_08fcf03c-5ee8-4006-8553-380220ff1b07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9a3cd878-5fa3-433b-9a6d-9b1e93ed259c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9a3cd878-5fa3-433b-9a6d-9b1e93ed259c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fb3a109e-b6ed-450b-92e0-84b84435d670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fb3a109e-b6ed-450b-92e0-84b84435d670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7fe2273c-3f7f-46f6-a0dd-1e972c493c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f5030fa-30bc-4b9a-9304-918a6ce5883e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7fe2273c-3f7f-46f6-a0dd-1e972c493c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8b527d97-db6d-46a6-9db8-bb9f3a147ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_AssetsCurrent_8b527d97-db6d-46a6-9db8-bb9f3a147ad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f3ad2658-4922-4cd8-bf1e-ef2fc245c93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f3ad2658-4922-4cd8-bf1e-ef2fc245c93f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0c8f683-8e02-44dd-9546-9f2392d0d1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0c8f683-8e02-44dd-9546-9f2392d0d1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f6165aa7-18a3-4376-b135-b0f201739fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f6165aa7-18a3-4376-b135-b0f201739fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e067a76f-2b82-43e5-b2d7-1a3b6a2be365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_Goodwill_e067a76f-2b82-43e5-b2d7-1a3b6a2be365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ccb0236b-a1f3-42a7-8b8d-62ac851350b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ccb0236b-a1f3-42a7-8b8d-62ac851350b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c78c4186-0933-402e-96c8-e00f51d7b446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2ab13fd3-c6b6-46d7-af96-277f8df8903f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c78c4186-0933-402e-96c8-e00f51d7b446" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_34e18b0a-8d9e-431c-9464-f5bde1915407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_34e18b0a-8d9e-431c-9464-f5bde1915407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_0b751f64-dce8-452e-87bc-0c2955f37192" xlink:href="iart-20221231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_0b751f64-dce8-452e-87bc-0c2955f37192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af52cdd8-eee8-4da1-96c0-9e23e6309d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_af52cdd8-eee8-4da1-96c0-9e23e6309d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_bfd3a8ba-f9f4-4541-a153-705da147ed6c" xlink:href="iart-20221231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_bfd3a8ba-f9f4-4541-a153-705da147ed6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_250630dd-83dd-4201-924c-e54017b7374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_250630dd-83dd-4201-924c-e54017b7374c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_8659947f-7bb8-4547-b246-81e74598aada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f15092-3579-4785-90a9-42b377bd2fec" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_8659947f-7bb8-4547-b246-81e74598aada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84a53be0-2482-4341-a4ab-00fb10fd5b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_NetIncomeLoss_84a53be0-2482-4341-a4ab-00fb10fd5b73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_140df4fe-ef28-40f8-961e-4a9ab6188c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_140df4fe-ef28-40f8-961e-4a9ab6188c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_3ee8cb77-a7cb-4f9f-9b8b-8b91c9c30896" xlink:href="iart-20221231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_3ee8cb77-a7cb-4f9f-9b8b-8b91c9c30896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_15f691b0-85d7-4812-8716-6458b4aa953e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_15f691b0-85d7-4812-8716-6458b4aa953e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9700ca5c-4396-4267-9d98-46721a5216a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9700ca5c-4396-4267-9d98-46721a5216a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ee91bf98-2a14-49cf-8596-04fde4532479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_ShareBasedCompensation_ee91bf98-2a14-49cf-8596-04fde4532479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_188bb4fa-6448-4a3d-b1d8-fbd1c0996d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_188bb4fa-6448-4a3d-b1d8-fbd1c0996d66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_55124897-fc52-48cc-9bdd-e706a801b0ce" xlink:href="iart-20221231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_55124897-fc52-48cc-9bdd-e706a801b0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_1664ee97-8e63-43f4-9503-a184d2023526" xlink:href="iart-20221231.xsd#iart_NoncashLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_iart_NoncashLeaseExpense_1664ee97-8e63-43f4-9503-a184d2023526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_5eb0c602-cb60-4725-96d8-c24228273acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_AccretionExpense_5eb0c602-cb60-4725-96d8-c24228273acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_95580704-8370-43a1-9032-1cd6823e2a6f" xlink:href="iart-20221231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_95580704-8370-43a1-9032-1cd6823e2a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d8a4c42f-0497-495c-8df4-9814c95e8d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d8a4c42f-0497-495c-8df4-9814c95e8d4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_631b114a-8e49-4554-afd0-137c58aded0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_631b114a-8e49-4554-afd0-137c58aded0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ecc8f9e4-eed8-4f92-a042-3473bd1665ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ecc8f9e4-eed8-4f92-a042-3473bd1665ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3fe2bd0f-34df-4c1d-add0-6030cb493456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3fe2bd0f-34df-4c1d-add0-6030cb493456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a9a2367e-569f-42ff-b50d-5976cc9408b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a9a2367e-569f-42ff-b50d-5976cc9408b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0fc627a0-bbe4-4a5e-b31b-ecdad42a28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0fc627a0-bbe4-4a5e-b31b-ecdad42a28d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_04e288fc-429d-4eb9-a1d5-ec6326e90367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_04e288fc-429d-4eb9-a1d5-ec6326e90367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b928b5fc-d2c0-4dc5-803c-b9390a2a26c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb4fd4d5-3144-4540-9c17-73e75df57d88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b928b5fc-d2c0-4dc5-803c-b9390a2a26c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d442ca67-de96-4105-8452-044c592235c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0375ccb4-3ba3-4c1b-ae57-0012f1d292b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d442ca67-de96-4105-8452-044c592235c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0375ccb4-3ba3-4c1b-ae57-0012f1d292b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5822a2d2-d061-435d-8ebf-6b4d70a616ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d442ca67-de96-4105-8452-044c592235c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5822a2d2-d061-435d-8ebf-6b4d70a616ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3674caf9-2154-4915-996d-257d0078fee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d442ca67-de96-4105-8452-044c592235c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3674caf9-2154-4915-996d-257d0078fee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4f3270f-4815-4541-8e9a-3c760170c30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d442ca67-de96-4105-8452-044c592235c0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4f3270f-4815-4541-8e9a-3c760170c30c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_92219420-6fb7-4ef3-b218-3aaf260533a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_92219420-6fb7-4ef3-b218-3aaf260533a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_74309a4d-d5e7-4217-b833-dfa9d365e7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_74309a4d-d5e7-4217-b833-dfa9d365e7c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_a63f92be-0582-4ab8-bf07-7b5eb7223630" xlink:href="iart-20221231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_a63f92be-0582-4ab8-bf07-7b5eb7223630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f90a2e8c-0565-4690-885d-613608438c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f90a2e8c-0565-4690-885d-613608438c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_7806f677-3371-455b-98c0-cef6c83aa5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_7806f677-3371-455b-98c0-cef6c83aa5fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6d50d07d-9347-4206-87e2-9e0f7e158339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6d50d07d-9347-4206-87e2-9e0f7e158339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4996be82-069e-44bc-905d-a93d6178cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4996be82-069e-44bc-905d-a93d6178cb66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_45670205-76ef-47fa-b543-dd2158a5af0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_45670205-76ef-47fa-b543-dd2158a5af0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_44856419-db1e-4c6d-9b0d-e5b23020eb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e0ee5d2-984c-4bec-8ecf-1a1ed6c52847" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_44856419-db1e-4c6d-9b0d-e5b23020eb8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_633ac46e-4813-4c0e-80ef-fc499fe7a688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_998790f1-a1f7-4f39-8b92-888a1463c749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_633ac46e-4813-4c0e-80ef-fc499fe7a688" xlink:to="loc_us-gaap_InventoryFinishedGoods_998790f1-a1f7-4f39-8b92-888a1463c749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_3c7fdee2-d3f6-4b7c-a70a-9906daaa0bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_633ac46e-4813-4c0e-80ef-fc499fe7a688" xlink:to="loc_us-gaap_InventoryWorkInProcess_3c7fdee2-d3f6-4b7c-a70a-9906daaa0bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_dd29b483-61d5-41ac-8dd3-638123824e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_633ac46e-4813-4c0e-80ef-fc499fe7a688" xlink:to="loc_us-gaap_InventoryRawMaterials_dd29b483-61d5-41ac-8dd3-638123824e74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_93bfd7da-b54c-4331-a109-c1d861f718ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0ad2598b-2a6d-46c7-9ad3-4bcccae905de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_93bfd7da-b54c-4331-a109-c1d861f718ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0ad2598b-2a6d-46c7-9ad3-4bcccae905de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ec7baa20-40ad-491b-90fa-74fd589b2a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_93bfd7da-b54c-4331-a109-c1d861f718ae" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ec7baa20-40ad-491b-90fa-74fd589b2a97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_b38b05ef-726e-4e17-9270-bf966a5b2ad5" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_b38b05ef-726e-4e17-9270-bf966a5b2ad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2b1666c5-9dc7-4f10-bb6c-afdc55cbfeac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2b1666c5-9dc7-4f10-bb6c-afdc55cbfeac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_b0ccabb7-8cbb-4614-b17d-159e28dafc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_b0ccabb7-8cbb-4614-b17d-159e28dafc10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_a48e9e03-3126-4d36-9d8b-4d9b4fca2eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_a48e9e03-3126-4d36-9d8b-4d9b4fca2eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_69253ded-40ba-4fe5-94f1-31d272a9ff65" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_56a9ae26-4c31-4ddf-b7a1-cc33a780b591" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_69253ded-40ba-4fe5-94f1-31d272a9ff65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_52273ce6-709b-489c-9dd6-d76f0dfaa4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_52273ce6-709b-489c-9dd6-d76f0dfaa4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_12ced85b-3982-4378-b9e5-f24c91c427d5" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_12ced85b-3982-4378-b9e5-f24c91c427d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4fe139bd-9abd-4b6e-8989-183e844c163d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4fe139bd-9abd-4b6e-8989-183e844c163d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_7a4e41f2-c87f-4a32-ba84-d38b1d11ba1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_7a4e41f2-c87f-4a32-ba84-d38b1d11ba1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0074deca-95ff-4a95-8cf4-01e8f705a9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0074deca-95ff-4a95-8cf4-01e8f705a9a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_e34a0581-4f13-432c-b01b-aad1e6f2b240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_e34a0581-4f13-432c-b01b-aad1e6f2b240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_5acefaae-dd32-4874-8af0-77b6cf1196bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d70ba6f9-2648-4e3d-96fd-7de4a7a1cc88" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_5acefaae-dd32-4874-8af0-77b6cf1196bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_afa52d75-1cd1-4a5c-9aca-7545921020c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_ca742138-2363-4ed7-a4ce-7b15ccb46e68" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_afa52d75-1cd1-4a5c-9aca-7545921020c3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_ca742138-2363-4ed7-a4ce-7b15ccb46e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_f6935ef1-27eb-410b-8be8-7be8ec7baf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_afa52d75-1cd1-4a5c-9aca-7545921020c3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_f6935ef1-27eb-410b-8be8-7be8ec7baf95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_3d3234e2-184f-4f30-900e-16445a831fdb" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_afa52d75-1cd1-4a5c-9aca-7545921020c3" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_3d3234e2-184f-4f30-900e-16445a831fdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8080148b-2974-4bdb-856f-3368a3f02f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_Goodwill_8080148b-2974-4bdb-856f-3368a3f02f07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_24b667f3-b817-4dea-a1d5-d070bd14f6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_24b667f3-b817-4dea-a1d5-d070bd14f6f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_38f389b4-185e-4842-990b-9597fa1f09eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_38f389b4-185e-4842-990b-9597fa1f09eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_c2550a2d-400e-4459-8c07-0cdf04f6eedb" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_c2550a2d-400e-4459-8c07-0cdf04f6eedb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8eed7af0-707d-480e-b9fb-c2bdaf532edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8eed7af0-707d-480e-b9fb-c2bdaf532edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b056653b-4bcd-46fa-9025-414e8c6fcecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b056653b-4bcd-46fa-9025-414e8c6fcecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5e40429a-9b59-4a68-aa75-1d3f212c78ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2cd92360-c530-44a8-8530-f18956fe4e2b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5e40429a-9b59-4a68-aa75-1d3f212c78ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c4fe68af-4f7d-43d6-9615-064a72c4fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_94a0d7d2-cb75-4b95-97f0-af668e0badd0" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c4fe68af-4f7d-43d6-9615-064a72c4fa41" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_94a0d7d2-cb75-4b95-97f0-af668e0badd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1c55ca05-e0e2-4313-b393-9f9de8d4f0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c4fe68af-4f7d-43d6-9615-064a72c4fa41" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1c55ca05-e0e2-4313-b393-9f9de8d4f0c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca03ae91-69ef-44d7-9c1b-b37a415d9feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f7cf23bb-581a-45e6-9aa2-4ebed79982db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca03ae91-69ef-44d7-9c1b-b37a415d9feb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f7cf23bb-581a-45e6-9aa2-4ebed79982db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_60b232f9-b60b-44b9-92f3-61ed99e236ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca03ae91-69ef-44d7-9c1b-b37a415d9feb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_60b232f9-b60b-44b9-92f3-61ed99e236ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2ed28dc9-ca2d-4c49-9cd1-9e204cd8d311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca03ae91-69ef-44d7-9c1b-b37a415d9feb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2ed28dc9-ca2d-4c49-9cd1-9e204cd8d311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b9fde80f-790b-444f-bd2f-470e8efd9111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca03ae91-69ef-44d7-9c1b-b37a415d9feb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b9fde80f-790b-444f-bd2f-470e8efd9111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b2b2068-b5ea-448e-bc9b-601e5cac984b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b2b2068-b5ea-448e-bc9b-601e5cac984b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_6218c609-8cda-4d45-bce9-f82b5281a0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_6218c609-8cda-4d45-bce9-f82b5281a0fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_072e0f86-2372-4eb2-8d59-ba9db56c5827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_072e0f86-2372-4eb2-8d59-ba9db56c5827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dff00857-b95a-4f87-ae19-bc90dbfab4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_dff00857-b95a-4f87-ae19-bc90dbfab4f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ed2f5b35-4392-41b6-8321-f07387bd8826" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66f54155-f8d3-45f2-b4ff-f78ef9c35e50" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ed2f5b35-4392-41b6-8321-f07387bd8826" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dbb63f7f-9f02-44f5-b8f7-aad3fa8cc4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_499d9c67-66f5-4eab-a05e-80423ae21df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_dbb63f7f-9f02-44f5-b8f7-aad3fa8cc4dd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_499d9c67-66f5-4eab-a05e-80423ae21df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9c6e2086-04aa-4c09-af90-e114c281496a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_dbb63f7f-9f02-44f5-b8f7-aad3fa8cc4dd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9c6e2086-04aa-4c09-af90-e114c281496a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_833e0a40-6bf0-40ff-ab80-9ad04cf78d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_dbb63f7f-9f02-44f5-b8f7-aad3fa8cc4dd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_833e0a40-6bf0-40ff-ab80-9ad04cf78d99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_375bc7c0-d186-4cbd-89e8-c2ba58566214" xlink:href="iart-20221231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_9f66bf87-d313-404d-9532-c6c1a7a23119" xlink:href="iart-20221231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_375bc7c0-d186-4cbd-89e8-c2ba58566214" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_9f66bf87-d313-404d-9532-c6c1a7a23119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_217dd079-9b2b-479a-ab3a-d23b0cd6d8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_375bc7c0-d186-4cbd-89e8-c2ba58566214" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_217dd079-9b2b-479a-ab3a-d23b0cd6d8d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_6c216ba1-8b4a-43bf-a380-eb970ea97d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8d31ad21-da6d-4f3d-943b-aa3455322106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_6c216ba1-8b4a-43bf-a380-eb970ea97d92" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8d31ad21-da6d-4f3d-943b-aa3455322106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9cff7055-ab1f-484f-a719-418d4d2050fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_6c216ba1-8b4a-43bf-a380-eb970ea97d92" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9cff7055-ab1f-484f-a719-418d4d2050fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9870d158-3e2d-460e-82e5-ad867c7413f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9870d158-3e2d-460e-82e5-ad867c7413f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8b7e236a-5ecd-444d-90ac-5f9fd5019bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8b7e236a-5ecd-444d-90ac-5f9fd5019bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e465e076-b934-4426-8638-06881981a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e465e076-b934-4426-8638-06881981a0da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_8404c3e7-7a91-48f6-9345-19d768f47628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_8404c3e7-7a91-48f6-9345-19d768f47628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e340f7f9-c349-4b76-87c0-7cbcad2eabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e340f7f9-c349-4b76-87c0-7cbcad2eabfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_20bd8fde-9b30-4d38-afad-54c1d6e17466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f3b5ba53-f1ca-4437-bf78-bfb07f49796b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_20bd8fde-9b30-4d38-afad-54c1d6e17466" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_cbb685cc-c05d-498b-87f0-25ed25d02132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f65f44da-bec3-4758-8530-b9396060e2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_cbb685cc-c05d-498b-87f0-25ed25d02132" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f65f44da-bec3-4758-8530-b9396060e2e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ce200568-8b3a-440a-8bca-503f70c21062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_cbb685cc-c05d-498b-87f0-25ed25d02132" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ce200568-8b3a-440a-8bca-503f70c21062" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ca0e436f-7f17-47d6-bfb9-cc59a7cc6916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ca0e436f-7f17-47d6-bfb9-cc59a7cc6916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b8626a6d-148b-4626-991d-3cd00e3b2aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b8626a6d-148b-4626-991d-3cd00e3b2aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_47b3f0f0-cc63-4ebc-8cbb-3bba6ff9d0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_47b3f0f0-cc63-4ebc-8cbb-3bba6ff9d0db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b61d0d1b-c576-4db3-b9ac-41d00be7a35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b61d0d1b-c576-4db3-b9ac-41d00be7a35a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_545e8901-4737-4bfb-8e8f-1f2dcc5f33dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_545e8901-4737-4bfb-8e8f-1f2dcc5f33dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a57fcdcb-7de2-4558-ad9b-f0717bf1eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de0fc86e-d4af-4513-b298-f7dcb4f1e108" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a57fcdcb-7de2-4558-ad9b-f0717bf1eb39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d83c5ccc-cfdd-4b6e-8e6f-9ef33cc65b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_857df7aa-9c65-4c82-8dd7-5e2145f5e73e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d83c5ccc-cfdd-4b6e-8e6f-9ef33cc65b21" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_857df7aa-9c65-4c82-8dd7-5e2145f5e73e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_13226925-8c08-4d3c-9647-7f2470c741f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d83c5ccc-cfdd-4b6e-8e6f-9ef33cc65b21" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_13226925-8c08-4d3c-9647-7f2470c741f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_706212a4-09dc-4c32-a4f9-879b021365fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af8008ec-b0f3-46f6-8bd9-5a1a3f73fa99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_706212a4-09dc-4c32-a4f9-879b021365fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af8008ec-b0f3-46f6-8bd9-5a1a3f73fa99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1b56956f-56e2-4798-99a7-2395c3fdcfab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_706212a4-09dc-4c32-a4f9-879b021365fb" xlink:to="loc_us-gaap_OperatingLeaseLiability_1b56956f-56e2-4798-99a7-2395c3fdcfab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdd534ff-cea7-4350-816e-fa3a66fd1865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_727fb52b-7e52-49f7-a2c6-e78fb21fee51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdd534ff-cea7-4350-816e-fa3a66fd1865" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_727fb52b-7e52-49f7-a2c6-e78fb21fee51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6b6f4caf-61d6-4358-bb6e-aeba4f672b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdd534ff-cea7-4350-816e-fa3a66fd1865" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6b6f4caf-61d6-4358-bb6e-aeba4f672b2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d1bf997b-76b7-460e-88b8-e7b2f281cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d1bf997b-76b7-460e-88b8-e7b2f281cb26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_a5d6a34f-2ddf-4c31-9cd1-694d36ee8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_a5d6a34f-2ddf-4c31-9cd1-694d36ee8bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_5403fec1-6d8a-49b2-adf0-361dbff3660e" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_5403fec1-6d8a-49b2-adf0-361dbff3660e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_885b3b2c-7da7-4e62-be32-39c3efe705a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_885b3b2c-7da7-4e62-be32-39c3efe705a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_cf87e7f8-0245-45e9-bae2-310072e5f7cf" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_cf87e7f8-0245-45e9-bae2-310072e5f7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_987441e6-3d34-479c-8445-32d46d1427e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_987441e6-3d34-479c-8445-32d46d1427e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_cb065130-cfe7-4211-bac8-e62e0b6ab99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_cb065130-cfe7-4211-bac8-e62e0b6ab99a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_e65e85a0-f0c1-4f9c-a808-7e38a1a2298e" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_e65e85a0-f0c1-4f9c-a808-7e38a1a2298e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_e3320391-c5c7-4577-b8c6-655d7c20184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_e3320391-c5c7-4577-b8c6-655d7c20184c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_4152d366-9c63-4c34-bf21-9e74fd67c8a5" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_4152d366-9c63-4c34-bf21-9e74fd67c8a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_81dee358-a909-4214-b06d-99a1c4fc5701" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_81dee358-a909-4214-b06d-99a1c4fc5701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_e9829910-f240-42c1-b2b1-2f8ba20f8c94" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_e9829910-f240-42c1-b2b1-2f8ba20f8c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a119989b-932b-418b-9c7d-41bdc163339b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a119989b-932b-418b-9c7d-41bdc163339b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_5b92ef4a-75ee-4378-899b-d4f19cab9ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cca139a7-4f75-4b2f-ac7f-51ffce03dcc8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_5b92ef4a-75ee-4378-899b-d4f19cab9ab2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cad0af-9df8-49d9-84f8-88e9eda938ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a3fd44d7-4b80-45dc-8151-43b0c4067fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cad0af-9df8-49d9-84f8-88e9eda938ee" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a3fd44d7-4b80-45dc-8151-43b0c4067fc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b1b5c9ef-9508-4a10-bd10-1922796ed41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cad0af-9df8-49d9-84f8-88e9eda938ee" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b1b5c9ef-9508-4a10-bd10-1922796ed41b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4e484105-f96f-43a9-b77e-d3f5c610071c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cad0af-9df8-49d9-84f8-88e9eda938ee" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4e484105-f96f-43a9-b77e-d3f5c610071c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_708fbe7e-ab5d-4e6e-82cd-e4f82fdcd752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_53a27f6a-c5f8-44e5-b6d2-59f32666469c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_708fbe7e-ab5d-4e6e-82cd-e4f82fdcd752" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_53a27f6a-c5f8-44e5-b6d2-59f32666469c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6f8db1e7-94be-439a-a450-1a14e7983bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_708fbe7e-ab5d-4e6e-82cd-e4f82fdcd752" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6f8db1e7-94be-439a-a450-1a14e7983bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_52aa5f41-50ba-434b-a79e-7f2ecfe65aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_708fbe7e-ab5d-4e6e-82cd-e4f82fdcd752" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_52aa5f41-50ba-434b-a79e-7f2ecfe65aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bf8d205b-6713-49e2-aabd-32d59ede7971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bbb5a026-c581-4f9e-aed2-bb43a9fbebff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bf8d205b-6713-49e2-aabd-32d59ede7971" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bbb5a026-c581-4f9e-aed2-bb43a9fbebff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4fcbd5b6-3a04-4042-875a-b2e8d7c87099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bf8d205b-6713-49e2-aabd-32d59ede7971" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4fcbd5b6-3a04-4042-875a-b2e8d7c87099" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b570d660-d59f-4318-aaf7-feb0dd708671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_a1f373f0-b7fb-4ca0-a564-0959f3a95910" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b570d660-d59f-4318-aaf7-feb0dd708671" xlink:to="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_a1f373f0-b7fb-4ca0-a564-0959f3a95910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_1d78dec1-072a-451e-abf6-9fac4e31960e" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b570d660-d59f-4318-aaf7-feb0dd708671" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_1d78dec1-072a-451e-abf6-9fac4e31960e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_820dc0f4-0b38-478d-acf6-d0e658d5155c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b570d660-d59f-4318-aaf7-feb0dd708671" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_820dc0f4-0b38-478d-acf6-d0e658d5155c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aac22a12-e253-4c89-9d75-b8453385f789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_30348bd4-4c14-4bd2-a0fa-5c14e6c9ccfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aac22a12-e253-4c89-9d75-b8453385f789" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_30348bd4-4c14-4bd2-a0fa-5c14e6c9ccfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d63f3770-6f0a-4c2e-88d2-78a096ec2c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aac22a12-e253-4c89-9d75-b8453385f789" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_d63f3770-6f0a-4c2e-88d2-78a096ec2c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_3df0e96b-7add-494c-b0e5-1f4c58c3a267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_3df0e96b-7add-494c-b0e5-1f4c58c3a267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_08489f86-07c4-4b2f-ae93-8faae062aae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_08489f86-07c4-4b2f-ae93-8faae062aae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_fbfee790-95cc-47ab-b611-a921e7d74084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_fbfee790-95cc-47ab-b611-a921e7d74084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_eaaa8bef-c144-4ded-81ee-0179bfdde7c7" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_eaaa8bef-c144-4ded-81ee-0179bfdde7c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_473a8921-bd32-4c40-8479-15d4bec58f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_473a8921-bd32-4c40-8479-15d4bec58f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6747a3af-ef14-41f2-82de-3a0a483cf4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6747a3af-ef14-41f2-82de-3a0a483cf4d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a4779d03-f12f-437f-84bd-f8cae976e5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a4779d03-f12f-437f-84bd-f8cae976e5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_93319971-6fa9-4f4e-99cf-cdca3d2c0e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_93319971-6fa9-4f4e-99cf-cdca3d2c0e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_e36cd4b0-7ef3-4cff-9e9c-07f78e7ed06d" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_e36cd4b0-7ef3-4cff-9e9c-07f78e7ed06d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_362e0aa2-a117-4df3-8169-e1703139e466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_362e0aa2-a117-4df3-8169-e1703139e466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_0750b786-5da9-42b0-8228-702c6ad06b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_0750b786-5da9-42b0-8228-702c6ad06b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_c9ac7bf0-d131-4cb0-8a1d-5f8017509f0f" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d558a9ed-0052-4cf3-841c-01cd54933f62" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_c9ac7bf0-d131-4cb0-8a1d-5f8017509f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_67ab9794-d0a6-476d-a512-f0137fb7028a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9bfefc9d-9ad5-48d3-814c-f3426a588eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_67ab9794-d0a6-476d-a512-f0137fb7028a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9bfefc9d-9ad5-48d3-814c-f3426a588eeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_382fcc80-460f-4b11-9b62-2dd9de970a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_67ab9794-d0a6-476d-a512-f0137fb7028a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_382fcc80-460f-4b11-9b62-2dd9de970a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d32ecfb7-240f-4ed8-b93c-f0751a2975ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_40618915-bb88-4ac4-9884-104557a5bb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d32ecfb7-240f-4ed8-b93c-f0751a2975ca" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_40618915-bb88-4ac4-9884-104557a5bb0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b5cafac1-65f6-483e-b45d-ca3803429de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d32ecfb7-240f-4ed8-b93c-f0751a2975ca" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b5cafac1-65f6-483e-b45d-ca3803429de6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5c8ad838-245e-4382-8708-b40d21859d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c849841-3adf-47c4-bc6a-54e1366c2d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5c8ad838-245e-4382-8708-b40d21859d6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c849841-3adf-47c4-bc6a-54e1366c2d18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6340a2ec-201c-497a-8072-f35520292fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5c8ad838-245e-4382-8708-b40d21859d6d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6340a2ec-201c-497a-8072-f35520292fcf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0616006d-cd1e-48dc-b6ad-b73d44572829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0efe7d65-0978-4975-8d3b-5e9c6297d163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0616006d-cd1e-48dc-b6ad-b73d44572829" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_0efe7d65-0978-4975-8d3b-5e9c6297d163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6e4e1aaa-afd7-449a-ad15-08c48a224328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0616006d-cd1e-48dc-b6ad-b73d44572829" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6e4e1aaa-afd7-449a-ad15-08c48a224328" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>iart-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="iea71237b44f143c7b4c212296681f1c2_CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_376af9a3-85ca-49a4-991a-cca073769b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_SharesIssued_376af9a3-85ca-49a4-991a-cca073769b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3c09300c-6f81-48b6-8636-cd8d91d33689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockholdersEquity_3c09300c-6f81-48b6-8636-cd8d91d33689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b8a5d2c5-bca4-4cbb-8433-33cc8c0cf2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_TreasuryStockShares_b8a5d2c5-bca4-4cbb-8433-33cc8c0cf2ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ac6d78a-937b-41eb-b8d4-904c0e87c34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_NetIncomeLoss_9ac6d78a-937b-41eb-b8d4-904c0e87c34b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6613179-2c4a-4a31-b088-d38072e78b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6613179-2c4a-4a31-b088-d38072e78b44" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_80adae1f-10b4-4a86-ad39-efc7adf099ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_80adae1f-10b4-4a86-ad39-efc7adf099ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_5e618202-d656-47a5-8871-5d27375ba6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_5e618202-d656-47a5-8871-5d27375ba6a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_47f5c828-5ccb-4859-97c4-c7e33f89dfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_47f5c828-5ccb-4859-97c4-c7e33f89dfc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_97209124-d483-4579-90ba-947fd9a59278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_97209124-d483-4579-90ba-947fd9a59278" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4a0d508a-64c6-4079-8b86-15130b50172d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4a0d508a-64c6-4079-8b86-15130b50172d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8fa4caf9-23fd-4dd9-9f6a-98d2db5cfc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8fa4caf9-23fd-4dd9-9f6a-98d2db5cfc77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_faf66ba4-3a0e-4453-910e-e15880d0ab5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_faf66ba4-3a0e-4453-910e-e15880d0ab5d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dfedf855-b6a9-429b-b6ba-a52e2478eb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dfedf855-b6a9-429b-b6ba-a52e2478eb2b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ff813b6f-ed9d-42f1-80bf-4fe0b5cfae49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e8568b91-00a9-46ad-9595-8cb14962e922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_eb62f94e-b34e-4128-be71-97b7ecc2fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0463b75e-37d0-4814-94a1-dc20808e35a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0463b75e-37d0-4814-94a1-dc20808e35a7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:to="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ba2193e1-a717-4e9e-9631-e23390394a3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:to="loc_us-gaap_EquityComponentDomain_ba2193e1-a717-4e9e-9631-e23390394a3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:to="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_50c13972-7dba-4035-bf6b-759b9dc59e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_CommonStockMember_50c13972-7dba-4035-bf6b-759b9dc59e06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7f7fb596-4a32-40be-bc84-4de6420006e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_TreasuryStockMember_7f7fb596-4a32-40be-bc84-4de6420006e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fda4326c-3144-4e84-8a88-b259c3d55194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fda4326c-3144-4e84-8a88-b259c3d55194" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_36e78c91-0f70-4f44-82a9-b5299030f982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_36e78c91-0f70-4f44-82a9-b5299030f982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_be393f3c-30c7-4bcc-9af0-a734484756b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_RetainedEarningsMember_be393f3c-30c7-4bcc-9af0-a734484756b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d463a170-9658-4d84-8130-4cb8c7e1007d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d463a170-9658-4d84-8130-4cb8c7e1007d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4dfe2e5c-cd5f-485a-9532-5e894ed901ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4dfe2e5c-cd5f-485a-9532-5e894ed901ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="i89c7c71a01ff44878bb4b47801f4cf1c_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7fe5f598-6dde-462a-940e-0fd59917c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7fe5f598-6dde-462a-940e-0fd59917c902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_67fafb15-c464-42a9-99ef-b89e565f4c56" xlink:href="iart-20221231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_InventoryCapitalizedExpenses_67fafb15-c464-42a9-99ef-b89e565f4c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2fc6ec35-7e06-4061-85e8-6055699851ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_Depreciation_2fc6ec35-7e06-4061-85e8-6055699851ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_fa08ccb3-8e88-4c7c-81ca-d0ebd2479eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_fa08ccb3-8e88-4c7c-81ca-d0ebd2479eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ef065f2a-5d59-4334-87b8-89857e73ee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_NumberOfReportableSegments_ef065f2a-5d59-4334-87b8-89857e73ee1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_736ae806-f51a-4c12-9f31-f21e8449192d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_NumberOfReportingUnits_736ae806-f51a-4c12-9f31-f21e8449192d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_e435ed98-65ac-4687-af8a-558627942dc0" xlink:href="iart-20221231.xsd#iart_CharitableContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_CharitableContributions_e435ed98-65ac-4687-af8a-558627942dc0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e409ff82-051f-42ba-9607-bd47c4f3a130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e409ff82-051f-42ba-9607-bd47c4f3a130" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_dd4dce5f-8401-4e17-bfd0-75e7eb106d3c" xlink:href="iart-20221231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_dd4dce5f-8401-4e17-bfd0-75e7eb106d3c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f12cdc98-3d68-49ab-b853-6ea550b38d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_RestructuringReserve_f12cdc98-3d68-49ab-b853-6ea550b38d93" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_f411e74b-ccae-4aef-9869-8bf7fcf13802" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_f411e74b-ccae-4aef-9869-8bf7fcf13802" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_9a0db577-5f4b-4c86-b921-15de277c200e" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_9a0db577-5f4b-4c86-b921-15de277c200e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage_d0d7c499-0ba0-4fb1-8a3a-1523318c878e" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_ConcentrationRiskThresholdPercentage_d0d7c499-0ba0-4fb1-8a3a-1523318c878e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_26b56f99-63fb-459a-9a4a-9c6ac0e12097" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_26b56f99-63fb-459a-9a4a-9c6ac0e12097" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_50873f19-3cf2-4d2c-b282-e8e406bf1312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ConvertibleDebt_50873f19-3cf2-4d2c-b282-e8e406bf1312" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_50606e0d-b026-42e6-8f9c-da8899927198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_50606e0d-b026-42e6-8f9c-da8899927198" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_ece42bf9-1875-43ab-a05d-27fd76df1a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestPaid_ece42bf9-1875-43ab-a05d-27fd76df1a8a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_a7ec9dbc-891a-486d-82d2-11481c32559b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestPaidCapitalized_a7ec9dbc-891a-486d-82d2-11481c32559b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ce1f34f2-00a1-4b5c-8b73-fb5f89d9106c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_IncomeTaxesPaid_ce1f34f2-00a1-4b5c-8b73-fb5f89d9106c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1b637aa-2ac1-45e7-914a-8b40f7eed30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1b637aa-2ac1-45e7-914a-8b40f7eed30e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_08ed6b16-c9c4-44cc-a568-4399a4afe23f" xlink:href="iart-20221231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_08ed6b16-c9c4-44cc-a568-4399a4afe23f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7760437d-22b3-4f27-950f-a72f038f6e5d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:to="loc_srt_RangeMember_7760437d-22b3-4f27-950f-a72f038f6e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:to="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2e18bd39-62ea-4ffe-84b4-36772e8903ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:to="loc_srt_MinimumMember_2e18bd39-62ea-4ffe-84b4-36772e8903ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b184a67e-c4b4-4295-be64-2480c65a5a67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:to="loc_srt_MaximumMember_b184a67e-c4b4-4295-be64-2480c65a5a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ab71084a-0d33-4eb5-ac27-f5a672ae1385" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ab71084a-0d33-4eb5-ac27-f5a672ae1385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1b1011e1-f1e4-41cd-8aff-596c3751b857_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1b1011e1-f1e4-41cd-8aff-596c3751b857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3494c5da-6eeb-4130-9f37-f42f303d8148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:to="loc_us-gaap_SalesRevenueNetMember_3494c5da-6eeb-4130-9f37-f42f303d8148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_123fc20a-f907-4cbc-bd9a-12e9cfd827e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_123fc20a-f907-4cbc-bd9a-12e9cfd827e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_69986c4f-8a03-4742-9430-8c4df85c4ea1" xlink:href="iart-20221231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_69986c4f-8a03-4742-9430-8c4df85c4ea1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c672075-26a7-45ab-883f-d4d68c115de7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c672075-26a7-45ab-883f-d4d68c115de7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_434ae732-fb9b-4e71-95cb-8e822b10e679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:to="loc_us-gaap_ConvertibleDebtMember_434ae732-fb9b-4e71-95cb-8e822b10e679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13f5ff36-c3e9-4b96-9489-56d79fd96528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13f5ff36-c3e9-4b96-9489-56d79fd96528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_03b9fbf9-e497-4370-94de-6938165068a7" xlink:href="iart-20221231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_03b9fbf9-e497-4370-94de-6938165068a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0b87e038-7e3a-4125-bd3c-76c8bf248ec0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0b87e038-7e3a-4125-bd3c-76c8bf248ec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f6d51305-0681-44c9-9d6c-7492e0fcfcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_CostOfSalesMember_f6d51305-0681-44c9-9d6c-7492e0fcfcd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_df46e171-58c8-4511-aa74-051f8eb2fffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_df46e171-58c8-4511-aa74-051f8eb2fffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_458511b2-6652-4345-ab77-9f2d00733726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_458511b2-6652-4345-ab77-9f2d00733726" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_78bacced-b859-4506-8672-31e4edd3767a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_78bacced-b859-4506-8672-31e4edd3767a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_fef1549d-2a78-46a2-995a-3f91d9bf90a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_fef1549d-2a78-46a2-995a-3f91d9bf90a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0beb09bf-4373-45f2-afd4-1a9de79ac4e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0beb09bf-4373-45f2-afd4-1a9de79ac4e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ClosureOfFacilityMember_51e5e9b4-49eb-451c-bb76-f7bf2bd88caf" xlink:href="iart-20221231.xsd#iart_ClosureOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:to="loc_iart_ClosureOfFacilityMember_51e5e9b4-49eb-451c-bb76-f7bf2bd88caf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReorganizationProjectsMember_51b1b575-3247-46a2-9b63-9312a0dfcda4" xlink:href="iart-20221231.xsd#iart_ReorganizationProjectsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:to="loc_iart_ReorganizationProjectsMember_51b1b575-3247-46a2-9b63-9312a0dfcda4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails" xlink:type="extended" id="i77107b1a00314bc6b59c6c854568d350_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4f59b3ca-48ba-4e59-ba43-64f04bd3895d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4f59b3ca-48ba-4e59-ba43-64f04bd3895d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_06972b75-45f8-4269-9deb-d1c35849e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_06972b75-45f8-4269-9deb-d1c35849e7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_be818fe8-5502-4602-8e34-765345b5f2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_be818fe8-5502-4602-8e34-765345b5f2de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4787dc81-12de-4b12-89f1-048bcb50f7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4787dc81-12de-4b12-89f1-048bcb50f7f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_aec03911-8c83-4638-8dc2-b3da2e698661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_bbf28153-9df4-4e29-a7f6-b594af74de46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_bbf28153-9df4-4e29-a7f6-b594af74de46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended" id="i16a433fe422148859f5b577a4b74a78d_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_77f30c0a-a909-4bf1-bc4f-f44559ec7875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_77f30c0a-a909-4bf1-bc4f-f44559ec7875" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1c92efdf-3161-4b1c-a211-8b73e9cd73b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1c92efdf-3161-4b1c-a211-8b73e9cd73b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9911b88-df3b-4596-8d12-e1b04026f2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9911b88-df3b-4596-8d12-e1b04026f2ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13d66cdd-10a0-4d0a-9763-e51b9122b48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13d66cdd-10a0-4d0a-9763-e51b9122b48a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a3efbd8b-8601-4e67-a250-f02696e7cf8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a3efbd8b-8601-4e67-a250-f02696e7cf8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_215aa059-8881-42dc-b70a-bc5b6708f7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_LandMember_215aa059-8881-42dc-b70a-bc5b6708f7b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_168ddb32-12c0-4493-afcc-314fd8e24cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_168ddb32-12c0-4493-afcc-314fd8e24cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_9a53d5c0-c44e-48ff-9b93-83f00e79a295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_9a53d5c0-c44e-48ff-9b93-83f00e79a295" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_eca035de-1ad5-4c4b-a795-df9ca73ccec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_eca035de-1ad5-4c4b-a795-df9ca73ccec2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DemonstrationEquipmentMember_b2145043-d0df-434b-9f3a-33ba9f9ba981" xlink:href="iart-20221231.xsd#iart_DemonstrationEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_iart_DemonstrationEquipmentMember_b2145043-d0df-434b-9f3a-33ba9f9ba981" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_09747f54-e0ca-4306-bb9d-6a1c0f566ce6" xlink:href="iart-20221231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_iart_InformationSystemsandHardwareMember_09747f54-e0ca-4306-bb9d-6a1c0f566ce6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_85316279-a9de-49ad-9744-60de3b33c1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_85316279-a9de-49ad-9744-60de3b33c1b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_657e2ce9-4be6-4081-a674-e57926dfb954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_ConstructionInProgressMember_657e2ce9-4be6-4081-a674-e57926dfb954" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:to="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e95974d-eb95-4b85-9137-6721a2c5f925_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:to="loc_srt_RangeMember_4e95974d-eb95-4b85-9137-6721a2c5f925_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:to="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_22007c0a-8cd5-4f88-b29e-18cf1619bba3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:to="loc_srt_MinimumMember_22007c0a-8cd5-4f88-b29e-18cf1619bba3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dc9baf23-e88e-4446-b99a-cda077fe7b0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:to="loc_srt_MaximumMember_dc9baf23-e88e-4446-b99a-cda077fe7b0c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails" xlink:type="extended" id="i0b3edec51f1e4b41ad9972505916c008_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:to="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a92ea46-9744-46e9-9ea1-9110cdf9007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringReserve_9a92ea46-9744-46e9-9ea1-9110cdf9007d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5fef0f24-2e62-48bd-bad4-286fa1de4148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringCharges_5fef0f24-2e62-48bd-bad4-286fa1de4148" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1be00ee7-f847-46c9-80e2-6b4aa7b68c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1be00ee7-f847-46c9-80e2-6b4aa7b68c01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_98ff689e-97a0-4c0d-8698-a27920d28878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b74bbf4b-da1c-47e9-8237-d86611b45de2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b74bbf4b-da1c-47e9-8237-d86611b45de2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_515cabbb-500f-4c5a-a74b-9cfd220b769d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_CostOfSalesMember_515cabbb-500f-4c5a-a74b-9cfd220b769d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd28ab40-b02e-4ced-8139-95472eaf18f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd28ab40-b02e-4ced-8139-95472eaf18f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9ac4bd4f-2821-4eaf-a512-4be32ef010d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9ac4bd4f-2821-4eaf-a512-4be32ef010d6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="extended" id="i44de205e0c434613b78e0b7668a9330a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5bbb93ac-4e49-43ed-8e68-b8e0b9d83cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5bbb93ac-4e49-43ed-8e68-b8e0b9d83cad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_0a32c530-22dc-4b5b-bd71-6a6c7186bab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_0a32c530-22dc-4b5b-bd71-6a6c7186bab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_929d0ddb-b77c-42b9-8c0f-fbd2c7a30580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_929d0ddb-b77c-42b9-8c0f-fbd2c7a30580" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f84311da-caef-4f8f-ae8a-bd5cdf1b993e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f84311da-caef-4f8f-ae8a-bd5cdf1b993e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6141a02-b9b1-45a5-a355-bd49d0df70d1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6141a02-b9b1-45a5-a355-bd49d0df70d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_d98e2afd-4e17-49c5-92e9-6b9ae0276174" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_d98e2afd-4e17-49c5-92e9-6b9ae0276174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_3e872e57-dd1e-4346-87e2-7ff3663e824d" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_3e872e57-dd1e-4346-87e2-7ff3663e824d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i2304b484f9ad411c849db3e7ab5307d7_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3f4e7890-4048-4acf-b788-89757dbef7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3f4e7890-4048-4acf-b788-89757dbef7a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i118c2528305646269e3cec2b7ad58e93_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended" id="icfece392b6bb4074a30b0964a87de57c_REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba90ebcb-ce29-4cc7-b6b3-7261078c3106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba90ebcb-ce29-4cc7-b6b3-7261078c3106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6170eb76-042e-4f3b-8bac-abd2786a4d13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:to="loc_us-gaap_SegmentDomain_6170eb76-042e-4f3b-8bac-abd2786a4d13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:to="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_c4e5c60e-4de5-4014-970e-02e39ebadc9d" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_c4e5c60e-4de5-4014-970e-02e39ebadc9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_5f19019b-604d-4c9c-9079-13be8328feb9" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:to="loc_iart_TissueTechnologiesMember_5f19019b-604d-4c9c-9079-13be8328feb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:to="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c93ffd7d-28da-44aa-912b-a4d78008b5ab_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:to="loc_srt_ProductsAndServicesDomain_c93ffd7d-28da-44aa-912b-a4d78008b5ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:to="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_84e54dd8-f1de-4bf8-8298-f899996c4e26" xlink:href="iart-20221231.xsd#iart_NeurosurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_NeurosurgeryMember_84e54dd8-f1de-4bf8-8298-f899996c4e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_d7d0a95c-60cb-4007-86d9-992924c31a4c" xlink:href="iart-20221231.xsd#iart_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_InstrumentsMember_d7d0a95c-60cb-4007-86d9-992924c31a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_b215729d-acbd-4587-b86a-6ca7d2e91549" xlink:href="iart-20221231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_b215729d-acbd-4587-b86a-6ca7d2e91549" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_b31b406b-0669-4bac-8598-080cc55b5f53" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_ExtremityOrthopedicsMember_b31b406b-0669-4bac-8598-080cc55b5f53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_e88b9ce9-08d7-4454-a8c7-920ea76f4f72" xlink:href="iart-20221231.xsd#iart_PrivateLabelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_PrivateLabelMember_e88b9ce9-08d7-4454-a8c7-920ea76f4f72" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="extended" id="iaf3d18c85bdb4416a6e5d358d822e118_ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a0b3b791-5acb-4380-a221-825b3daac6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a0b3b791-5acb-4380-a221-825b3daac6d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8f29d1e7-32e8-4028-a35f-8306e1afec67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8f29d1e7-32e8-4028-a35f-8306e1afec67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b142d6ad-2b5e-4dfe-a9af-f5786e06576f" xlink:href="iart-20221231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b142d6ad-2b5e-4dfe-a9af-f5786e06576f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_278c1401-191a-485a-96cb-fbd9395b0b3e" xlink:href="iart-20221231.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_278c1401-191a-485a-96cb-fbd9395b0b3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c1f4672-d0e3-4c66-bf84-8d0c022fe186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c1f4672-d0e3-4c66-bf84-8d0c022fe186" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d2212a-529d-400e-bdb9-94ac4c85a8d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d2212a-529d-400e-bdb9-94ac4c85a8d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_21bada06-ceba-494a-b606-5164d75ab8ec" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_21bada06-ceba-494a-b606-5164d75ab8ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_79b894a1-bffc-42a8-a4a8-db28c892af2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_79b894a1-bffc-42a8-a4a8-db28c892af2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember_b82df151-e4b5-417d-9a88-e9eae22dbb8b" xlink:href="iart-20221231.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:to="loc_iart_RevenueBasedPerformanceMilestonesMember_b82df151-e4b5-417d-9a88-e9eae22dbb8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember_c0d35f7c-0082-4850-a0df-4bc3095041d7" xlink:href="iart-20221231.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:to="loc_iart_FDAApprovalOfPremarketApprovalMember_c0d35f7c-0082-4850-a0df-4bc3095041d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails" xlink:type="extended" id="icd73df410be94c919f5238ea0afee48b_ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4560082-14ee-442c-8dae-d0aca81cca7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4560082-14ee-442c-8dae-d0aca81cca7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50227770-6018-4500-a0ec-6dcdc2dbe39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50227770-6018-4500-a0ec-6dcdc2dbe39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fcf6e01-ff15-4724-a7de-9e824629c3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fcf6e01-ff15-4724-a7de-9e824629c3aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7a387bd2-3274-488a-ae11-f0433587e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7a387bd2-3274-488a-ae11-f0433587e30c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_413cd5ee-75e0-4d8b-8f83-bce91f87f90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_413cd5ee-75e0-4d8b-8f83-bce91f87f90a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8be3422e-cf03-4d8c-aec8-b1c5c36e4bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8be3422e-cf03-4d8c-aec8-b1c5c36e4bb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ab41d3e-7386-4d91-942a-e18c0f1c1f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_Goodwill_2ab41d3e-7386-4d91-942a-e18c0f1c1f60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_bc30cc45-7a19-4097-b24d-4b47b58657b1" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_bc30cc45-7a19-4097-b24d-4b47b58657b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac41b4c4-b249-4033-992f-d04df6a15bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac41b4c4-b249-4033-992f-d04df6a15bf8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5c249285-2e24-4ab4-b522-f9d6dc581660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5c249285-2e24-4ab4-b522-f9d6dc581660" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cdfaa7a7-47c1-4fd2-9738-e0107f44922e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cdfaa7a7-47c1-4fd2-9738-e0107f44922e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0760f579-7084-4e57-a6d1-e362090b3469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0760f579-7084-4e57-a6d1-e362090b3469" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f40ef891-a49d-4805-9989-228376275761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f40ef891-a49d-4805-9989-228376275761" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_750ce633-431e-4673-8437-9ac24dd667d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_750ce633-431e-4673-8437-9ac24dd667d2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2bc847f6-b960-4c61-af5b-d4fa6c4845fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2bc847f6-b960-4c61-af5b-d4fa6c4845fb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07d91b43-94ca-47ae-b8c3-86f7090754a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07d91b43-94ca-47ae-b8c3-86f7090754a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_79b0a1cd-b88a-40b2-af1f-5d2af29d8c25" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_79b0a1cd-b88a-40b2-af1f-5d2af29d8c25" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended" id="ic75312839ecd4385b1f7f29fc93c5ddf_ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c017643c-ff0b-4219-a01f-e6b612675c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c017643c-ff0b-4219-a01f-e6b612675c26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_95f63245-d110-415a-b820-922baefe2698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_95f63245-d110-415a-b820-922baefe2698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_8df2c0dd-19aa-4fa6-9a0a-e52a3e95182f" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_8df2c0dd-19aa-4fa6-9a0a-e52a3e95182f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_b11fa22d-0356-4137-ba98-0bd720376ff8" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_b11fa22d-0356-4137-ba98-0bd720376ff8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_3f6f2aa9-7c64-4c36-9dbc-8edc47353e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_3f6f2aa9-7c64-4c36-9dbc-8edc47353e6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_fb751060-3eb7-479b-b436-1a00afccd304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_fb751060-3eb7-479b-b436-1a00afccd304" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_9e671788-a82a-487e-b57c-d6d8d3f56dc4" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_9e671788-a82a-487e-b57c-d6d8d3f56dc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_2e4a467e-fedb-43cc-be84-4939221ad489" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_2e4a467e-fedb-43cc-be84-4939221ad489" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_32df23e7-7a52-4dec-8e0a-85d9b0fe4503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_32df23e7-7a52-4dec-8e0a-85d9b0fe4503" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_320eb954-192a-46e6-ba9d-95ebcd9f9696" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_320eb954-192a-46e6-ba9d-95ebcd9f9696" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_cf1f46cc-6230-48f0-b4b2-b3a14d95ddad" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_cf1f46cc-6230-48f0-b4b2-b3a14d95ddad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9823222b-9438-435b-9370-4da39ffc32d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9823222b-9438-435b-9370-4da39ffc32d0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb73b37-afeb-4cd0-bfde-f98e496da359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb73b37-afeb-4cd0-bfde-f98e496da359" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment_6a251034-eac6-4123-81fa-aafdf47e8576" xlink:href="iart-20221231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_BusinessCombinationWorkingCapitalAdjustment_6a251034-eac6-4123-81fa-aafdf47e8576" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_56eb148e-f106-40e5-928c-461baf35c678" xlink:href="iart-20221231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_56eb148e-f106-40e5-928c-461baf35c678" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_56f84ca6-a84f-492e-b1b2-7233e285f945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_56f84ca6-a84f-492e-b1b2-7233e285f945" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_96e6e2b0-3068-4693-9fbf-e8db11b5ee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_96e6e2b0-3068-4693-9fbf-e8db11b5ee3b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_378c0f08-8f57-43dc-9cbd-71aef8856c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_378c0f08-8f57-43dc-9cbd-71aef8856c87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember_5582aa29-d7c3-4182-a5c1-e40f1cc11973" xlink:href="iart-20221231.xsd#iart_TraditionalWoundCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:to="loc_iart_TraditionalWoundCareMember_5582aa29-d7c3-4182-a5c1-e40f1cc11973" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_dfbca1b6-0d6f-4703-8511-3f694171f28f" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:to="loc_iart_ExtremityOrthopedicsMember_dfbca1b6-0d6f-4703-8511-3f694171f28f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba3b1c93-6184-4331-8cac-fd26c7b67b97_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba3b1c93-6184-4331-8cac-fd26c7b67b97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_74642f79-ee86-4dac-8c75-9d8972786f04" xlink:href="iart-20221231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_74642f79-ee86-4dac-8c75-9d8972786f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_500a4dc7-8a81-495f-a8c0-b03a976b7d5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_500a4dc7-8a81-495f-a8c0-b03a976b7d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_c069a8c9-c54b-4ecd-a48c-4b73dcfe3e86" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:to="loc_iart_ACellIncMember_c069a8c9-c54b-4ecd-a48c-4b73dcfe3e86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended" id="i509c4f3155574c5290e3aa00141b4b85_ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_df2ed0c2-eb44-4965-ad0b-cb3e3ab8c93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_df2ed0c2-eb44-4965-ad0b-cb3e3ab8c93e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_5efbb024-4c30-477c-a48c-92cec4e2a2a3" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_5efbb024-4c30-477c-a48c-92cec4e2a2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_ab9ffdc5-9e7c-4e54-8a3b-bd18a3cd6b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_ab9ffdc5-9e7c-4e54-8a3b-bd18a3cd6b9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d5d7b7fc-2ade-42aa-b21d-91ad696b8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d5d7b7fc-2ade-42aa-b21d-91ad696b8ba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a89adf91-dc0e-4aa0-bef4-03b2d7ad0243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a89adf91-dc0e-4aa0-bef4-03b2d7ad0243" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0fcbdae7-6987-407f-a7ad-a2bdddd355ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0fcbdae7-6987-407f-a7ad-a2bdddd355ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_54412f6a-0949-4f03-a21a-1eeca660ef19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_54412f6a-0949-4f03-a21a-1eeca660ef19" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a803aea5-fe39-47ce-b149-68cf0590d19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a803aea5-fe39-47ce-b149-68cf0590d19f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_435ee998-5b75-4891-971e-c797ce591d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_435ee998-5b75-4891-971e-c797ce591d25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_22ee1d85-bc90-4fcc-970c-a06bd07e2633" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_22ee1d85-bc90-4fcc-970c-a06bd07e2633" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bf28d196-98bb-432e-ad18-243f9c434f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bf28d196-98bb-432e-ad18-243f9c434f3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_90f2d4fa-e29e-4fc6-8b44-b79d2e3de1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_90f2d4fa-e29e-4fc6-8b44-b79d2e3de1f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_3a2c342d-2954-4c5a-b705-eec86f357072" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_3a2c342d-2954-4c5a-b705-eec86f357072" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4352c564-69fc-4c44-87fd-6b469e3cacc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4352c564-69fc-4c44-87fd-6b469e3cacc2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8be27e39-158b-46cf-bc89-3eece9e58442_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8be27e39-158b-46cf-bc89-3eece9e58442_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f4d36c26-be12-444d-a566-098d3a56f6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f4d36c26-be12-444d-a566-098d3a56f6a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_87a6a302-b202-4b03-ae75-9735b0ea3f28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_87a6a302-b202-4b03-ae75-9735b0ea3f28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_239db320-b337-4d80-beaa-682b89279e96" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:to="loc_iart_ExtremityOrthopedicsMember_239db320-b337-4d80-beaa-682b89279e96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="extended" id="i7187a9b8175b409bb75a2eebea7500d7_ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1b724613-7cb4-441b-b117-593549a55d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1b724613-7cb4-441b-b117-593549a55d2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_87c20771-08b5-49af-994e-a566eb1d7abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_87c20771-08b5-49af-994e-a566eb1d7abb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_12957d79-4a7e-424e-98d1-299e8382c700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_12957d79-4a7e-424e-98d1-299e8382c700" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aa9d2192-f6f7-48ea-96e1-e7c7961e3078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aa9d2192-f6f7-48ea-96e1-e7c7961e3078" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a63a3d64-f9f3-49e7-bd1b-21b181f1e079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a63a3d64-f9f3-49e7-bd1b-21b181f1e079" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4b02979-9dff-4744-8ec2-32e0c00d11fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4b02979-9dff-4744-8ec2-32e0c00d11fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ec3a6aa6-7271-4ee8-b084-313d80199147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ec3a6aa6-7271-4ee8-b084-313d80199147" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_26a7a60d-87c4-4caa-9c21-0c71540c652a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_26a7a60d-87c4-4caa-9c21-0c71540c652a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6759d069-f119-4352-a7ae-47d44bec001d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_Goodwill_6759d069-f119-4352-a7ae-47d44bec001d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_5ad141c6-51b6-42c5-9c8e-850bdde90312" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_5ad141c6-51b6-42c5-9c8e-850bdde90312" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1b5d7468-0db1-4eba-afbb-db17dce29f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1b5d7468-0db1-4eba-afbb-db17dce29f00" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d9383ee8-2705-4953-9730-d4c2ffcabb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d9383ee8-2705-4953-9730-d4c2ffcabb2f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d32513d4-e822-43ee-9027-59f66a7430b0" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d32513d4-e822-43ee-9027-59f66a7430b0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_868ed3ff-4da0-484b-b57a-4ff2729e8391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_868ed3ff-4da0-484b-b57a-4ff2729e8391" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2bed9c16-d73a-4c54-89c3-982a182fef18" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2bed9c16-d73a-4c54-89c3-982a182fef18" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_6f52e79f-ae1e-4989-94cd-558e7fcec50c" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_6f52e79f-ae1e-4989-94cd-558e7fcec50c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e1fe1912-98d6-4f81-a5e4-e4effa8d3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e1fe1912-98d6-4f81-a5e4-e4effa8d3f9c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4f7cf806-8d48-4cab-ab2a-2387a0ae787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4f7cf806-8d48-4cab-ab2a-2387a0ae787a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ba8bcdd6-ba6f-44c5-9019-ce6b128e601b" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ba8bcdd6-ba6f-44c5-9019-ce6b128e601b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e8c23ff1-9666-4da3-b6c1-26aae8a105fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e8c23ff1-9666-4da3-b6c1-26aae8a105fd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_2545758f-c47d-4e01-9aa8-33c8ed05affb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_2545758f-c47d-4e01-9aa8-33c8ed05affb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2809e389-a441-44e2-bf1c-3836717640e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2809e389-a441-44e2-bf1c-3836717640e2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5dd1cd0e-2342-4f45-9c8c-5ab5f8bec999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5dd1cd0e-2342-4f45-9c8c-5ab5f8bec999" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f390e0-6f77-4044-a07c-b1cef8d47162_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f390e0-6f77-4044-a07c-b1cef8d47162_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_f81732f5-b861-454f-8038-98cf7d8531c2" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:to="loc_iart_ACellIncMember_f81732f5-b861-454f-8038-98cf7d8531c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa9699ba-9d26-485c-9b0c-724b9f35135a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:to="loc_srt_RangeMember_fa9699ba-9d26-485c-9b0c-724b9f35135a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:to="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8b415ee9-5d1c-41cb-b871-b5333199eea9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:to="loc_srt_MinimumMember_8b415ee9-5d1c-41cb-b871-b5333199eea9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_32a2904b-59b7-4a72-a425-aa04aed1eec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:to="loc_srt_MaximumMember_32a2904b-59b7-4a72-a425-aa04aed1eec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_59c8987b-a062-4344-92e7-4c21028e6461_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:to="loc_us-gaap_ClassOfStockDomain_59c8987b-a062-4344-92e7-4c21028e6461_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ac8082bc-8de2-40d3-b046-d3fc3c946781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:to="loc_us-gaap_ClassOfStockDomain_ac8082bc-8de2-40d3-b046-d3fc3c946781" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended" id="idf08408498d845a4bd1fb73a36d7dd79_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e706898b-0235-470d-89dd-eff0d81313a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e706898b-0235-470d-89dd-eff0d81313a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8c68b6b2-04ab-41bf-9383-9ef34149e4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8c68b6b2-04ab-41bf-9383-9ef34149e4fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_32269a5a-03e4-4c19-8df7-603b6466acb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_32269a5a-03e4-4c19-8df7-603b6466acb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_ef89eb37-ff5b-4e05-8c9e-335746b6a024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_ef89eb37-ff5b-4e05-8c9e-335746b6a024" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_277daa94-f5c5-4fca-8eb4-adceb2953ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_277daa94-f5c5-4fca-8eb4-adceb2953ead" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_8c3abb39-3d08-4e54-82dc-7e0c8ad2f43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_8c3abb39-3d08-4e54-82dc-7e0c8ad2f43b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e3767a69-edce-429f-8d77-32b3f43d573c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCredit_e3767a69-edce-429f-8d77-32b3f43d573c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_93872c8d-2e3b-4ad8-9fa4-880bbda9db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_93872c8d-2e3b-4ad8-9fa4-880bbda9db8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_a13dc9ff-111f-41a0-9333-7ab431575700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_SecuredDebtCurrent_a13dc9ff-111f-41a0-9333-7ab431575700" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_afd452ef-1e1b-475e-9ed5-f4d196305826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_afd452ef-1e1b-475e-9ed5-f4d196305826" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ccacf3df-d615-4272-b20f-391082635838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ccacf3df-d615-4272-b20f-391082635838" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_ee0886e9-c89d-4bbe-9d7b-7bb06cfc9b77" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearOne_ee0886e9-c89d-4bbe-9d7b-7bb06cfc9b77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_e0c16d47-8ecb-41e2-a591-343aa37158a4" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearTwo_e0c16d47-8ecb-41e2-a591-343aa37158a4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_33718043-df5b-4189-b41a-7f9e2fedc99f" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearThree_33718043-df5b-4189-b41a-7f9e2fedc99f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_90b9354c-d9d4-458b-a943-805800ec1c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_90b9354c-d9d4-458b-a943-805800ec1c71" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2efddfdf-f78c-49b2-8523-0e097d02ec19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2efddfdf-f78c-49b2-8523-0e097d02ec19" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_46d47ebd-2a58-46e2-be8a-eea5f5d9b30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_46d47ebd-2a58-46e2-be8a-eea5f5d9b30d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_06945c31-c983-46e7-b092-174cd9429010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_06945c31-c983-46e7-b092-174cd9429010" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6f5c22fd-2f99-4510-9915-fa6d3c5b40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6f5c22fd-2f99-4510-9915-fa6d3c5b40f4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_45ebf5d3-763b-446a-bf64-3de20b5c8299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_45ebf5d3-763b-446a-bf64-3de20b5c8299" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a772c113-e39f-4cee-8691-0c6d3f1cc845" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a772c113-e39f-4cee-8691-0c6d3f1cc845" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e8c58ecf-8898-4704-a727-60b0290c75c3" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e8c58ecf-8898-4704-a727-60b0290c75c3" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_424f668e-c59c-4b14-8710-4d26cd75c502" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_424f668e-c59c-4b14-8710-4d26cd75c502" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c9c912e8-a41a-4f9b-8cd0-d555ea9adfca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c9c912e8-a41a-4f9b-8cd0-d555ea9adfca" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_e2661d08-68e2-45d6-b398-7454eb880320" xlink:href="iart-20221231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_e2661d08-68e2-45d6-b398-7454eb880320" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_01d12374-5109-4056-986f-965fb160a2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_01d12374-5109-4056-986f-965fb160a2f3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_dee634fd-a9fb-4339-892a-dd57281faeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_dee634fd-a9fb-4339-892a-dd57281faeca" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3dbb9b3c-e30a-4c76-a6f8-e6de3887f2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3dbb9b3c-e30a-4c76-a6f8-e6de3887f2db" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_3279f893-abb4-47ba-abc7-090f0a6fe812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_3279f893-abb4-47ba-abc7-090f0a6fe812" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d968da40-4952-4277-b968-dfcf510015e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d968da40-4952-4277-b968-dfcf510015e2" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_814a59cc-a6c2-4b8b-91f9-014993287ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_814a59cc-a6c2-4b8b-91f9-014993287ae8" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_12791097-6e79-48a0-b5e7-90f7bf50e05a" xlink:href="iart-20221231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_12791097-6e79-48a0-b5e7-90f7bf50e05a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_b961933e-98cc-4529-a26f-83fed6e1320f" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_b961933e-98cc-4529-a26f-83fed6e1320f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_d5dc9d09-9fae-4622-b427-40ede2d6d06b" xlink:href="iart-20221231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_d5dc9d09-9fae-4622-b427-40ede2d6d06b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_ffe909b9-1085-4a44-a718-418bb0e45f6e" xlink:href="iart-20221231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_ffe909b9-1085-4a44-a718-418bb0e45f6e" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23572dd9-bac1-4f92-b328-5077c8184fce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23572dd9-bac1-4f92-b328-5077c8184fce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_ba1cfb04-b2b4-4f28-82d8-4e2e251ca560" xlink:href="iart-20221231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_SeniorCreditFacilityMember_ba1cfb04-b2b4-4f28-82d8-4e2e251ca560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_4ee6f5aa-c529-4636-9f15-824818179162" xlink:href="iart-20221231.xsd#iart_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_TermLoanFacilityMember_4ee6f5aa-c529-4636-9f15-824818179162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_6fbdc134-33a2-4d1a-9bbc-90defa73b6f5" xlink:href="iart-20221231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_6fbdc134-33a2-4d1a-9bbc-90defa73b6f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_34845567-57d5-452d-ad80-9c8caba8936d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:to="loc_us-gaap_CreditFacilityDomain_34845567-57d5-452d-ad80-9c8caba8936d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:to="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3dde5b8b-a31b-457f-93e7-adc1a757ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_SecuredDebtMember_3dde5b8b-a31b-457f-93e7-adc1a757ccd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d8c4ce08-8197-4cd1-8392-b3cea91a1466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d8c4ce08-8197-4cd1-8392-b3cea91a1466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_d2098803-d805-440c-810a-9d5d55424637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_d2098803-d805-440c-810a-9d5d55424637" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_561dd1d8-0254-4442-8e0f-dbed8c13df7e" xlink:href="iart-20221231.xsd#iart_SwinglineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_iart_SwinglineLoanMember_561dd1d8-0254-4442-8e0f-dbed8c13df7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_997fe66c-15b6-41d5-871f-3bfd3f58dae4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:to="loc_us-gaap_VariableRateDomain_997fe66c-15b6-41d5-871f-3bfd3f58dae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:to="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_bab6f620-e313-4fad-bf7f-1f300819ad67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_us-gaap_EurodollarMember_bab6f620-e313-4fad-bf7f-1f300819ad67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ffd71ad8-12bd-414f-880f-cb192a45d7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ffd71ad8-12bd-414f-880f-cb192a45d7d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_f645da7a-d8cf-4769-a70b-55f74ad41506" xlink:href="iart-20221231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_iart_OneMonthEurodollarRateMember_f645da7a-d8cf-4769-a70b-55f74ad41506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:to="loc_srt_RangeMember_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:to="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c0e2b736-1f69-4de0-aa97-a937f584c163" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:to="loc_srt_MinimumMember_c0e2b736-1f69-4de0-aa97-a937f584c163" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_118161ca-d930-483e-aac6-5dc2a1349976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:to="loc_srt_MaximumMember_118161ca-d930-483e-aac6-5dc2a1349976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_391110f8-4028-4e8c-ad01-4798985004b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_391110f8-4028-4e8c-ad01-4798985004b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_60c90610-19dd-436e-9d3c-8718741e3d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_60c90610-19dd-436e-9d3c-8718741e3d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1bf3dcf2-0317-4c0a-aaf8-07263609c814_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1bf3dcf2-0317-4c0a-aaf8-07263609c814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3e990925-60d7-4f8a-8fd3-24f8743ce4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:to="loc_us-gaap_ConvertibleDebtMember_3e990925-60d7-4f8a-8fd3-24f8743ce4e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_d5986c75-2736-438c-85e1-0de524602790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:to="loc_us-gaap_CallOptionMember_d5986c75-2736-438c-85e1-0de524602790" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended" id="i2d89e81909654cf2b6f47c8c7c4843e9_DEBTMaximumTotalLeverageRatioTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_2e72fce9-f8a2-4a05-802b-8a32849a3749" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_2e72fce9-f8a2-4a05-802b-8a32849a3749" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:to="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:to="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcdab19d-e1b2-432a-88d9-1856f0e38b68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcdab19d-e1b2-432a-88d9-1856f0e38b68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3f13b076-b6cd-4503-9d40-f4420c7f0a00" xlink:href="iart-20221231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:to="loc_iart_SeniorCreditFacilityMember_3f13b076-b6cd-4503-9d40-f4420c7f0a00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:to="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_54b39a96-1ea9-4343-9158-151709af75a4_default" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:to="loc_iart_DebtCovenantPeriodDomain_54b39a96-1ea9-4343-9158-151709af75a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:to="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_2e13bc67-3a45-430b-889b-c32aaf2aa8a6" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:to="loc_iart_DebtCovenantPeriod3Member_2e13bc67-3a45-430b-889b-c32aaf2aa8a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_569a3bfe-ad10-441e-bad3-c109ed4e55b1" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:to="loc_iart_DebtCovenantPeriod4Member_569a3bfe-ad10-441e-bad3-c109ed4e55b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended" id="i912c240d69f54160a00cf1f507b48d86_DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_dc13a4fe-a164-4328-9a0c-1fe5a6cad543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeNotionalAmount_dc13a4fe-a164-4328-9a0c-1fe5a6cad543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_6f5e7bdb-e6b3-4b7e-bac2-5fc55b5ce53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_6f5e7bdb-e6b3-4b7e-bac2-5fc55b5ce53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_76257e3f-5fcf-4397-b82a-c87672146c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_76257e3f-5fcf-4397-b82a-c87672146c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_938779b2-8c22-41ab-ae46-40123e51a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:to="loc_us-gaap_CashFlowHedgingMember_938779b2-8c22-41ab-ae46-40123e51a783" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:to="loc_us-gaap_HedgingDesignationDomain_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:to="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5ef5fda8-d6d2-4ecd-8c00-a847673841fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5ef5fda8-d6d2-4ecd-8c00-a847673841fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:to="loc_us-gaap_VariableRateDomain_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:to="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_27bc6431-807a-45cd-b8c0-7e6c1a1d6cec" xlink:href="iart-20221231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:to="loc_iart_OneMonthUSDLIBORMember_27bc6431-807a-45cd-b8c0-7e6c1a1d6cec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_14035625-9161-4d2b-b647-6e188fe33123_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_14035625-9161-4d2b-b647-6e188fe33123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_e062893c-247d-4f47-bedf-b3718ed5a0f1" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_e062893c-247d-4f47-bedf-b3718ed5a0f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_c45de9d5-2064-44b2-84f5-4b26007f7747" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_c45de9d5-2064-44b2-84f5-4b26007f7747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_084b984b-9abf-4238-b033-1f82d68bcd2b" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_084b984b-9abf-4238-b033-1f82d68bcd2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_567b046b-5285-4d07-acf5-0c1e665ed445" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_567b046b-5285-4d07-acf5-0c1e665ed445" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_fa5a4f48-7902-43c3-81c4-34ec6e2216f0" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_fa5a4f48-7902-43c3-81c4-34ec6e2216f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_fbdf276d-911c-4fee-8b15-bc36cb99d7d1" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_fbdf276d-911c-4fee-8b15-bc36cb99d7d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_dc8276c4-41ad-45ef-b2dc-221c288b86f3" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_dc8276c4-41ad-45ef-b2dc-221c288b86f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_ddea9298-a868-43be-bd6d-a44b650a2c6d" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_ddea9298-a868-43be-bd6d-a44b650a2c6d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_c9bc5250-8899-44ba-867b-7e0f6972b743" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_c9bc5250-8899-44ba-867b-7e0f6972b743" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_e878fa03-573f-4c5e-8100-9810a892bfa9" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_e878fa03-573f-4c5e-8100-9810a892bfa9" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i11a20bff862f422da065aede250821e7_DERIVATIVEINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c40976f1-5fae-4474-9693-b0f74103cd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c40976f1-5fae-4474-9693-b0f74103cd5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_6641f3d7-0cc7-4e19-a984-d5a7bcb33463" xlink:href="iart-20221231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_6641f3d7-0cc7-4e19-a984-d5a7bcb33463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated_ef753cea-cfc9-4c5c-b306-2daba3b1075d" xlink:href="iart-20221231.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_iart_DerivativeNotionalAmountTerminated_ef753cea-cfc9-4c5c-b306-2daba3b1075d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c98e3ed7-16ea-40e6-acd9-ee99926202bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c98e3ed7-16ea-40e6-acd9-ee99926202bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_20da40fa-ec9b-4a37-8542-da360d044dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_20da40fa-ec9b-4a37-8542-da360d044dbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_59aa80b8-4cd4-4b65-a808-e526420cf480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_59aa80b8-4cd4-4b65-a808-e526420cf480" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_951ddf53-7e20-4e8d-879d-58efeb550f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_951ddf53-7e20-4e8d-879d-58efeb550f1a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c626788b-56cb-4574-aeda-8d1b0ad73626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c626788b-56cb-4574-aeda-8d1b0ad73626" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0fce6d32-3113-49ff-9d30-6b6f6d9b2779_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0fce6d32-3113-49ff-9d30-6b6f6d9b2779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a08dd372-7d89-4662-b953-4abc41e1dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a08dd372-7d89-4662-b953-4abc41e1dff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_21d5907c-fcb9-4632-a338-50beb4ae3851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_CurrencySwapMember_21d5907c-fcb9-4632-a338-50beb4ae3851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_12651a65-681c-4ce5-92f7-eed68a5aa509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_12651a65-681c-4ce5-92f7-eed68a5aa509" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:to="loc_us-gaap_PositionDomain_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:to="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_3abf7a2b-fa96-412e-8f2f-712857b0717f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:to="loc_us-gaap_ShortMember_3abf7a2b-fa96-412e-8f2f-712857b0717f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_eaaab77f-3b41-47f2-9a13-5b4404634bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:to="loc_us-gaap_LongMember_eaaab77f-3b41-47f2-9a13-5b4404634bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e117320f-6aab-4cc9-8723-f9bda38494f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e117320f-6aab-4cc9-8723-f9bda38494f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_13041741-d721-4984-9c14-4eb611615d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_CashFlowHedgingMember_13041741-d721-4984-9c14-4eb611615d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_edec5be5-a41a-4505-90d0-94957bc3804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_edec5be5-a41a-4505-90d0-94957bc3804f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_72f3d6c9-1073-4e31-a14b-17f91c045e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_NondesignatedMember_72f3d6c9-1073-4e31-a14b-17f91c045e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_75876ec4-be44-418b-abaa-c33ca8683649_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:to="loc_us-gaap_HedgingDesignationDomain_75876ec4-be44-418b-abaa-c33ca8683649_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:to="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9f8d5b84-ff86-4c23-9a19-861494ce4533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:to="loc_us-gaap_NondesignatedMember_9f8d5b84-ff86-4c23-9a19-861494ce4533" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_042814f9-9bf1-442b-85ea-b76a50d42c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_042814f9-9bf1-442b-85ea-b76a50d42c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fd409a-2d97-4525-b65e-b867701d2798_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fd409a-2d97-4525-b65e-b867701d2798_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_0f2c7959-1dd2-4aa1-876e-40df43348403" xlink:href="iart-20221231.xsd#iart_CodmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:to="loc_iart_CodmanMember_0f2c7959-1dd2-4aa1-876e-40df43348403" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended" id="ibbbd59e93e404b39bb860adbf67d5b1c_DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_849f52ff-0b49-4c4c-9a4f-d912a1ce6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_849f52ff-0b49-4c4c-9a4f-d912a1ce6ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8ad4621a-729d-4256-8b89-92e9ad16002d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8ad4621a-729d-4256-8b89-92e9ad16002d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_27bb4722-fdce-4fc6-b902-077a060523b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_27bb4722-fdce-4fc6-b902-077a060523b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_006021f0-3487-4113-9ee4-ceb0538614fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_006021f0-3487-4113-9ee4-ceb0538614fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_692acc44-e4ea-4046-9d66-58b8160db411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:to="loc_us-gaap_CashFlowHedgingMember_692acc44-e4ea-4046-9d66-58b8160db411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cd1bc9bb-6919-453a-9860-ebda9923c266_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:to="loc_us-gaap_HedgingDesignationDomain_cd1bc9bb-6919-453a-9860-ebda9923c266_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:to="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_89d62878-81f8-48b0-bb9e-d6f9379e1e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_89d62878-81f8-48b0-bb9e-d6f9379e1e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd6784d9-5ec4-401e-a324-adeae7cc083f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd6784d9-5ec4-401e-a324-adeae7cc083f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_0c963597-ef93-4fdb-a4d7-2b419b0ad04d" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_0c963597-ef93-4fdb-a4d7-2b419b0ad04d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_efcdd01d-74f3-44e0-bd0d-502ec3164a69" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_efcdd01d-74f3-44e0-bd0d-502ec3164a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_47e35963-b3a4-4f85-8498-2f4ef71e3e6d" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_47e35963-b3a4-4f85-8498-2f4ef71e3e6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_038d7f1d-978e-4f0f-a4e3-06cdfebce33f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_038d7f1d-978e-4f0f-a4e3-06cdfebce33f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_2d1c6895-cb83-4b51-8db7-ede8bb894c20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:to="loc_us-gaap_PositionDomain_2d1c6895-cb83-4b51-8db7-ede8bb894c20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:to="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_3a78d149-b40d-4598-aeb8-5bbf4173c172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:to="loc_us-gaap_LongMember_3a78d149-b40d-4598-aeb8-5bbf4173c172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_0c188c05-3897-4a70-b3c7-53e1cfab3e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:to="loc_us-gaap_ShortMember_0c188c05-3897-4a70-b3c7-53e1cfab3e95" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended" id="icd9257b6c0de46f693657d32cfeea6f3_DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_ab36f004-08b8-4278-a94b-d847c13407e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_ab36f004-08b8-4278-a94b-d847c13407e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d78bfe33-4d6d-4682-be7e-213ac8085b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d78bfe33-4d6d-4682-be7e-213ac8085b12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_75152e34-c171-45f2-96dc-9ddaffd55078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_75152e34-c171-45f2-96dc-9ddaffd55078" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2577d2c0-8bdb-4bdd-9445-c031d48c0899_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2577d2c0-8bdb-4bdd-9445-c031d48c0899_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:to="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_415953ca-5c89-48c6-9c48-255cc2baa8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_415953ca-5c89-48c6-9c48-255cc2baa8a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_989376a1-c863-47b5-ab10-cf1c493f0df2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:to="loc_us-gaap_HedgingDesignationDomain_989376a1-c863-47b5-ab10-cf1c493f0df2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:to="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ae00ea43-6023-4da6-937d-a9062ca32233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ae00ea43-6023-4da6-937d-a9062ca32233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f521c298-2d2b-4882-833f-493b8836454e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f521c298-2d2b-4882-833f-493b8836454e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_3d348de0-47e5-4b19-874d-01a1ea056292" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_3d348de0-47e5-4b19-874d-01a1ea056292" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_d4c73093-c92b-47a4-849d-838e9951e5b9" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_d4c73093-c92b-47a4-849d-838e9951e5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_5b82e3cd-2aa7-4c04-a89a-91c1df9bd17e" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_5b82e3cd-2aa7-4c04-a89a-91c1df9bd17e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_6aa0935e-86ac-42f1-b0ef-f763afc44fcd" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_6aa0935e-86ac-42f1-b0ef-f763afc44fcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_459fa410-8d0a-46e4-a210-dcbdbe9840b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_459fa410-8d0a-46e4-a210-dcbdbe9840b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_f7ccdb7a-8209-4985-ba4e-99bf828f0984_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:to="loc_us-gaap_PositionDomain_f7ccdb7a-8209-4985-ba4e-99bf828f0984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:to="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_bbf36ecd-84b3-4c14-b0b3-83cc823b2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:to="loc_us-gaap_LongMember_bbf36ecd-84b3-4c14-b0b3-83cc823b2850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_de04adf2-9088-41e5-9e8c-93b9c32ec73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:to="loc_us-gaap_ShortMember_de04adf2-9088-41e5-9e8c-93b9c32ec73d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended" id="i95ffb8d9596e4d86889e84e8f3be5a3a_DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a07a5b5-1061-4113-9736-ed36a2335642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a07a5b5-1061-4113-9736-ed36a2335642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_865528d5-c2ba-4618-a38a-1460645faa61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_865528d5-c2ba-4618-a38a-1460645faa61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_fe74cb9d-f675-42c9-8927-9dfe3a744bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeNotionalAmount_fe74cb9d-f675-42c9-8927-9dfe3a744bd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6baa9898-308d-488b-821b-10108783f9f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_6baa9898-308d-488b-821b-10108783f9f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0ad9d11e-5e05-43cc-97c7-0162cf40ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0ad9d11e-5e05-43cc-97c7-0162cf40ceb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c0c7dabd-5388-4cac-8135-ac5a1cd1b403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:to="loc_us-gaap_InterestRateSwapMember_c0c7dabd-5388-4cac-8135-ac5a1cd1b403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_735cd4e9-1054-4e70-a493-0514ec397007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_735cd4e9-1054-4e70-a493-0514ec397007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_acb011e0-793a-412e-aba9-91fe813960e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_acb011e0-793a-412e-aba9-91fe813960e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_94aa7c77-fd0a-4f40-96f1-ba0662b840f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:to="loc_us-gaap_CashFlowHedgingMember_94aa7c77-fd0a-4f40-96f1-ba0662b840f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2babd682-4602-4207-829b-ef43f08701de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2babd682-4602-4207-829b-ef43f08701de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3ba6a790-6412-4e11-bb8d-33a6f6979383_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3ba6a790-6412-4e11-bb8d-33a6f6979383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_380a373d-ea46-4e57-820d-6b0d7e38625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_380a373d-ea46-4e57-820d-6b0d7e38625d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_90e0f63b-35d7-4ebe-8393-61daf263419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_OtherAssetsMember_90e0f63b-35d7-4ebe-8393-61daf263419e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_ec48f903-3d4c-43dc-8c8d-7f9077a73d99" xlink:href="iart-20221231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_ec48f903-3d4c-43dc-8c8d-7f9077a73d99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_71591d5e-be1c-41c7-8131-80dca805cbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_71591d5e-be1c-41c7-8131-80dca805cbf1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended" id="i3df66a9cb6514d32b9ae30ab1c71e52b_DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad1b5793-864f-4f27-93aa-5d2be741800a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_StockholdersEquity_ad1b5793-864f-4f27-93aa-5d2be741800a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae314922-ad07-4766-8492-05a77757a126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae314922-ad07-4766-8492-05a77757a126" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05d92a04-c5f9-4372-8935-62bf12522b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05d92a04-c5f9-4372-8935-62bf12522b9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1e409583-c0a8-4e97-a82b-e8c20a4c9d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:to="loc_us-gaap_HedgingDesignationDomain_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:to="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5adc2129-547b-4704-af3d-16d7c75cec30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5adc2129-547b-4704-af3d-16d7c75cec30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eb013f70-9155-4229-9d6c-c32594d98bca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eb013f70-9155-4229-9d6c-c32594d98bca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_092f3f42-f985-443f-b527-87ab6304e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:to="loc_us-gaap_InterestRateSwapMember_092f3f42-f985-443f-b527-87ab6304e1d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_4a7372a2-d8a1-41dc-a020-67f2fab1233f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_4a7372a2-d8a1-41dc-a020-67f2fab1233f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a06c74ca-201c-4548-acce-726cd2c65303_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:to="loc_us-gaap_EquityComponentDomain_a06c74ca-201c-4548-acce-726cd2c65303_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:to="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3c875345-e395-41be-a02b-e04b3d8b7442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3c875345-e395-41be-a02b-e04b3d8b7442" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e0de6356-a331-497f-b06c-0764c31c6d39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e0de6356-a331-497f-b06c-0764c31c6d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f5992339-c479-4593-bfc6-026e5e6f1a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_InterestExpenseMember_f5992339-c479-4593-bfc6-026e5e6f1a68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2f0242f8-c456-434e-8ea7-9a69d26dfae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2f0242f8-c456-434e-8ea7-9a69d26dfae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_0fe579c9-9d70-4011-a8e1-30864cae0048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_InterestIncomeMember_0fe579c9-9d70-4011-a8e1-30864cae0048" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c2bd80a4-5c06-4d67-9119-3d1022ae96b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c2bd80a4-5c06-4d67-9119-3d1022ae96b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dde959e9-18f8-48b3-8604-560e3d9cccbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_dde959e9-18f8-48b3-8604-560e3d9cccbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_82de5f88-9c6d-42ce-8625-9f669f47e891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_82de5f88-9c6d-42ce-8625-9f669f47e891" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails" xlink:type="extended" id="i7f8cc5e385fc400b857784cefbca530c_DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_77a5e457-45fb-4154-a3a7-bfb965ccc77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_77a5e457-45fb-4154-a3a7-bfb965ccc77d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_347c35d9-ce43-49f0-b125-77423e285d38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_347c35d9-ce43-49f0-b125-77423e285d38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_0eb6e555-558a-4476-95b8-8d4d63bb75a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_0eb6e555-558a-4476-95b8-8d4d63bb75a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_201cd860-f70f-4b07-b16d-372ec27afa21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:to="loc_us-gaap_CurrencySwapMember_201cd860-f70f-4b07-b16d-372ec27afa21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="iee3043ae842b4ecdbe4067787d1e5fc0_GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d5e99a19-3374-4509-8f61-67842ea57a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_NumberOfReportingUnits_d5e99a19-3374-4509-8f61-67842ea57a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_265c28b8-66e6-4653-becc-1dda9b7b98cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_AdjustmentForAmortization_265c28b8-66e6-4653-becc-1dda9b7b98cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cfc27123-1c5f-4583-9165-45abe4625e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cfc27123-1c5f-4583-9165-45abe4625e92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_97b01ea0-343a-4231-998b-2473723e0880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_97b01ea0-343a-4231-998b-2473723e0880" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_57d6c412-0cbf-4622-b632-8bad7367dac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_57d6c412-0cbf-4622-b632-8bad7367dac4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6b3644da-7554-4655-96c8-b072d672b2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6b3644da-7554-4655-96c8-b072d672b2ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72648b4b-4464-402c-b24b-89aa29ad0a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72648b4b-4464-402c-b24b-89aa29ad0a03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4d14de12-1264-40cd-b68f-80c102f31611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4d14de12-1264-40cd-b68f-80c102f31611" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e2c4c3cf-67d7-4da5-afbc-fc4de4353fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e2c4c3cf-67d7-4da5-afbc-fc4de4353fef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6e8f6bb5-bb2b-49e1-a906-af275ccc005b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6e8f6bb5-bb2b-49e1-a906-af275ccc005b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_34894947-6916-4a74-ac0e-6b8d5ee67971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:to="loc_us-gaap_CustomerRelationshipsMember_34894947-6916-4a74-ac0e-6b8d5ee67971" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="i4be9e3bb09f343c989e37aa2af3b287a_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:to="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d96f6632-1dc6-4ddc-9654-e64379b45a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_Goodwill_d96f6632-1dc6-4ddc-9654-e64379b45a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4ef1a965-4404-406c-be2f-c4761dab507f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4ef1a965-4404-406c-be2f-c4761dab507f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3632a6b8-8f39-435d-9ea6-907157b0e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3632a6b8-8f39-435d-9ea6-907157b0e1fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_605d328e-0c27-4655-9750-1553c239b047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_605d328e-0c27-4655-9750-1553c239b047" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3bcde59-ff0c-46f4-9a80-341a2a7a01a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0944b98-2ff7-4536-89bd-4a222a6868c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:to="loc_us-gaap_SegmentDomain_e0944b98-2ff7-4536-89bd-4a222a6868c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:to="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_1fb38256-5d5c-44ef-830f-f2983b280cfd" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_1fb38256-5d5c-44ef-830f-f2983b280cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_429954cc-4949-463e-99de-826f1012f118" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:to="loc_iart_TissueTechnologiesMember_429954cc-4949-463e-99de-826f1012f118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18b80c13-5b06-4739-b4b2-9ac56a535c8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18b80c13-5b06-4739-b4b2-9ac56a535c8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_d4234951-af36-42dc-9368-bc1bacdafe6b" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:to="loc_iart_ACellIncMember_d4234951-af36-42dc-9368-bc1bacdafe6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_153d988e-0e7c-4c55-a58b-9551fbab3c26" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_153d988e-0e7c-4c55-a58b-9551fbab3c26" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i433a4768a633472f80fcf71681903180_GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_976698d4-7b0c-4881-b90f-d920ea0f5ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_976698d4-7b0c-4881-b90f-d920ea0f5ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_42151fe0-2433-49a9-bc25-33297f0d31f7" xlink:href="iart-20221231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_42151fe0-2433-49a9-bc25-33297f0d31f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66ff96e0-0216-4dee-a1a7-9ac362646560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66ff96e0-0216-4dee-a1a7-9ac362646560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_0a548de8-18a2-4314-b11b-db119fa2afb9" xlink:href="iart-20221231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_0a548de8-18a2-4314-b11b-db119fa2afb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16b31678-53d2-451d-9f48-aa0521a848bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16b31678-53d2-451d-9f48-aa0521a848bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_a8f46af9-e2e7-4ebf-a11b-32e26d093a74" xlink:href="iart-20221231.xsd#iart_CompletedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_CompletedTechnologyMember_a8f46af9-e2e7-4ebf-a11b-32e26d093a74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_54ff6046-4ae4-4366-b672-1bb76635507d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_us-gaap_CustomerRelationshipsMember_54ff6046-4ae4-4366-b672-1bb76635507d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_3e14a244-2439-43e9-9ebf-f842a67c2ed0" xlink:href="iart-20221231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_TrademarksBrandNamesMember_3e14a244-2439-43e9-9ebf-f842a67c2ed0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_9c1690fc-042d-4926-b29b-badc7f8d3cba" xlink:href="iart-20221231.xsd#iart_SupplierRelationShipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_SupplierRelationShipsMember_9c1690fc-042d-4926-b29b-badc7f8d3cba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_31eaad02-326e-4cdf-92c5-a326e0beaafd" xlink:href="iart-20221231.xsd#iart_AllOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_AllOtherMember_31eaad02-326e-4cdf-92c5-a326e0beaafd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9803f3ed-9c48-4612-93da-9de3a7bfc18a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9803f3ed-9c48-4612-93da-9de3a7bfc18a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5b1ea8c7-9f2b-42bc-9869-8e3880921b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:to="loc_us-gaap_TradeNamesMember_5b1ea8c7-9f2b-42bc-9869-8e3880921b6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended" id="i73708769789a47d1ba2cdd83670727d1_TREASURYSTOCKNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8060de03-cd97-4972-8290-3bf83408b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8060de03-cd97-4972-8290-3bf83408b13f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_3e24064a-55e2-4200-b1e3-f2e29bea7182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockCommonValue_3e24064a-55e2-4200-b1e3-f2e29bea7182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_1a73975d-dbb9-4b39-9d7c-af0d4efa0225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_1a73975d-dbb9-4b39-9d7c-af0d4efa0225" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3a1580ea-57b8-49d4-95a4-0e3abef77eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3a1580ea-57b8-49d4-95a4-0e3abef77eb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f9b43135-a547-4d03-86c1-3f3d8b1c16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f9b43135-a547-4d03-86c1-3f3d8b1c16f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_c16a0dac-cf43-4fc9-83ab-cc824cdf6d0a" xlink:href="iart-20221231.xsd#iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_c16a0dac-cf43-4fc9-83ab-cc824cdf6d0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_723d1c6e-f3dc-40df-b722-c7671e612f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_723d1c6e-f3dc-40df-b722-c7671e612f4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_0e13df04-415f-4ad9-9de9-1127d02e75d5" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_0e13df04-415f-4ad9-9de9-1127d02e75d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_98afbdd6-f0c3-44ac-a268-fd3f839181c3" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_98afbdd6-f0c3-44ac-a268-fd3f839181c3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_055a6607-2ca1-4620-b3f0-cff138e7eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_055a6607-2ca1-4620-b3f0-cff138e7eb82" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_618edd88-c5ed-4d5e-b2b4-096a5e172bfb" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesAdditionalSharesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_618edd88-c5ed-4d5e-b2b4-096a5e172bfb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4762e862-cd73-438b-8385-4e84c3c91295_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4762e862-cd73-438b-8385-4e84c3c91295_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fda15c20-ba76-4aba-9735-2a334018f0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:to="loc_us-gaap_SubsequentEventMember_fda15c20-ba76-4aba-9735-2a334018f0b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended" id="ief41535d0f894c6fa25224504b33d7af_STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_40522385-1231-4762-8045-ca854baa11b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_40522385-1231-4762-8045-ca854baa11b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_339c5198-a314-468c-b7ae-5e03d82dca77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_339c5198-a314-468c-b7ae-5e03d82dca77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_4f271e06-e7d3-4bc8-a77c-9741d1b31229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_4f271e06-e7d3-4bc8-a77c-9741d1b31229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_33408368-6784-49f8-917f-664184c7aad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_CostOfSalesMember_33408368-6784-49f8-917f-664184c7aad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_738540fa-6616-4c69-a7b9-cb6c0476859c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_738540fa-6616-4c69-a7b9-cb6c0476859c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fc3b0ef3-beb2-4f43-b352-a8fce2a38996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fc3b0ef3-beb2-4f43-b352-a8fce2a38996" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i01300bb37f7045939366486402814946_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4e7e4c56-bc54-4666-b27a-cc48a6a53531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4e7e4c56-bc54-4666-b27a-cc48a6a53531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_87b19a85-e04f-440c-924b-f5df311f8c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_87b19a85-e04f-440c-924b-f5df311f8c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77bcbc4d-97bd-4a41-8d97-650f5b682ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77bcbc4d-97bd-4a41-8d97-650f5b682ae6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_a2aedfaf-3694-44c8-92d1-d94bd8d857fa" xlink:href="iart-20221231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_a2aedfaf-3694-44c8-92d1-d94bd8d857fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_b32d2dd1-b857-4e79-8bf2-e78a3d26e9fc" xlink:href="iart-20221231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_iart_IncreaseInAuthorizedShares_b32d2dd1-b857-4e79-8bf2-e78a3d26e9fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77aaef11-b239-4c20-8ea2-b4a2937a91ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77aaef11-b239-4c20-8ea2-b4a2937a91ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f8fac244-a5ec-428e-9289-ab7817c8726f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f8fac244-a5ec-428e-9289-ab7817c8726f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e616f957-d7d0-4b4a-9b47-9464e78b494e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e616f957-d7d0-4b4a-9b47-9464e78b494e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_41390d43-e036-46cc-98d4-f05bad11af76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_41390d43-e036-46cc-98d4-f05bad11af76" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c76f688d-6b98-4b7f-aa17-9ed751d16007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c76f688d-6b98-4b7f-aa17-9ed751d16007" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ff14fa9a-2b12-4591-b74c-8aade4359af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ff14fa9a-2b12-4591-b74c-8aade4359af8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_268f1209-735b-48a7-b66e-51703f5c461b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_268f1209-735b-48a7-b66e-51703f5c461b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_587795ce-ede9-4044-8fe6-4c068de264d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_587795ce-ede9-4044-8fe6-4c068de264d3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b53f1602-0953-410e-ab18-936e111e11ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b53f1602-0953-410e-ab18-936e111e11ed" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bb8a05c8-a0aa-49d8-b966-e4f3d73ebe5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bb8a05c8-a0aa-49d8-b966-e4f3d73ebe5f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_39d64c10-0559-4f3b-8596-00e902b71664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_39d64c10-0559-4f3b-8596-00e902b71664" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1989df0a-454d-4ace-a22a-a8eec19c2b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1989df0a-454d-4ace-a22a-a8eec19c2b73" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_a739cb12-35a8-4c3a-bf86-a386ae4207bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_a739cb12-35a8-4c3a-bf86-a386ae4207bb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8985dc54-0bba-4978-a318-78f85586aa8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8985dc54-0bba-4978-a318-78f85586aa8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_3db2cb16-d30b-4bf2-84ec-27d851a8dddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_EmployeeStockMember_3db2cb16-d30b-4bf2-84ec-27d851a8dddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7c68ffba-8a8b-4dd3-a69a-a32b5dfa491b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7c68ffba-8a8b-4dd3-a69a-a32b5dfa491b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_85c04a39-a6cc-4599-8f51-4449ef81d0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_85c04a39-a6cc-4599-8f51-4449ef81d0ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_3806e13a-5e99-470f-b969-e8b5cc10fb0a" xlink:href="iart-20221231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_3806e13a-5e99-470f-b969-e8b5cc10fb0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_eb3a55a2-1988-433f-98a4-c77f87a90be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_PerformanceSharesMember_eb3a55a2-1988-433f-98a4-c77f87a90be1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7a30ccfd-6812-44fa-8b59-73faac3470d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:to="loc_us-gaap_PlanNameDomain_7a30ccfd-6812-44fa-8b59-73faac3470d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:to="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_1dcfee68-d795-4397-bf72-fd6c0ee1c7af" xlink:href="iart-20221231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandThreePlanMember_1dcfee68-d795-4397-bf72-fd6c0ee1c7af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_bd62f8bc-50be-41ce-bfe2-1db9e2385cd1" xlink:href="iart-20221231.xsd#iart_TwoThousandPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandPlanMember_bd62f8bc-50be-41ce-bfe2-1db9e2385cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_b9b0f94c-60b2-4fc8-9146-30d7c8278573" xlink:href="iart-20221231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandOnePlanMember_b9b0f94c-60b2-4fc8-9146-30d7c8278573" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7d3053c9-9eee-4a0c-8516-4733950fa495_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7d3053c9-9eee-4a0c-8516-4733950fa495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_a8e9772c-ad59-425e-9da2-c1df1b47a33e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_srt_DirectorMember_a8e9772c-ad59-425e-9da2-c1df1b47a33e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_068a1d82-e3df-4bf2-a81f-658a8e3e3042" xlink:href="iart-20221231.xsd#iart_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_iart_EmployeeMember_068a1d82-e3df-4bf2-a81f-658a8e3e3042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_864e18a4-0f14-4c5e-ba2a-4725546f34f8" xlink:href="iart-20221231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_864e18a4-0f14-4c5e-ba2a-4725546f34f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_03db5c76-c5e4-4b28-b67a-4e60ad2efbef_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:to="loc_srt_RangeMember_03db5c76-c5e4-4b28-b67a-4e60ad2efbef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:to="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_298d2b65-882f-40ea-81b7-e15db5cf8526" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:to="loc_srt_MinimumMember_298d2b65-882f-40ea-81b7-e15db5cf8526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_689251a8-bef7-4935-a1e0-032ef54f9786" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:to="loc_srt_MaximumMember_689251a8-bef7-4935-a1e0-032ef54f9786" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended" id="iedf988bcedae493e9b5fd7d15f0f2170_STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5670143e-0db1-42c3-aa87-835ee8396ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5670143e-0db1-42c3-aa87-835ee8396ecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54786225-bea5-4efc-abdf-41a72b4f727f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54786225-bea5-4efc-abdf-41a72b4f727f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_895afc35-92fa-4d15-960b-c1e0c99e4a8e" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_895afc35-92fa-4d15-960b-c1e0c99e4a8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00c792cc-2e4c-4449-a453-ae3c4434e020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00c792cc-2e4c-4449-a453-ae3c4434e020" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86cf8a5e-bcd7-4c9d-b1af-af49f51a3f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86cf8a5e-bcd7-4c9d-b1af-af49f51a3f6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0a93af37-015a-498f-aa3b-0677eab3e810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f64792f8-5f6d-4bf5-8f38-412e1926ca7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f64792f8-5f6d-4bf5-8f38-412e1926ca7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23b3f295-3120-4df0-abff-e137dc724556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23b3f295-3120-4df0-abff-e137dc724556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_0e415878-0c96-4c76-98bf-11eef49cc708" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_0e415878-0c96-4c76-98bf-11eef49cc708" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5ce83c8a-294d-42be-9f55-7d327ab196b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5ce83c8a-294d-42be-9f55-7d327ab196b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_128d944d-4b84-4973-acaf-18d16ba75370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_128d944d-4b84-4973-acaf-18d16ba75370" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e8774d01-eb32-4b01-ae05-da318491618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:to="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_12e13f1a-477e-4039-be70-311bfa009925_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_12e13f1a-477e-4039-be70-311bfa009925_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9ac3a3fa-65d3-4c99-9432-0b6ad14ed9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:to="loc_us-gaap_RestrictedStockMember_9ac3a3fa-65d3-4c99-9432-0b6ad14ed9cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_6f2595fc-d0ac-4d95-a947-e2801f713170" xlink:href="iart-20221231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:to="loc_iart_PerformanceStockandContractStockMember_6f2595fc-d0ac-4d95-a947-e2801f713170" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended" id="i81fc3ca123d14ddbbe9da3d0177cb187_RETIREMENTBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_dbb2aa12-eff5-42ba-a236-bae94055fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_dbb2aa12-eff5-42ba-a236-bae94055fb60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1012bcb0-2e40-409a-9a2c-faca81bd28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1012bcb0-2e40-409a-9a2c-faca81bd28c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a5527e11-ff9e-401b-b5be-8ce80f03f2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a5527e11-ff9e-401b-b5be-8ce80f03f2aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_2aaab7f9-4edf-4bb3-a2a6-47f790cab84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_2aaab7f9-4edf-4bb3-a2a6-47f790cab84f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_36e7005a-a8c9-465a-a064-bdab6005a924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_36e7005a-a8c9-465a-a064-bdab6005a924" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_64b273f7-7004-4d03-b1f3-ab05ef67bffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_64b273f7-7004-4d03-b1f3-ab05ef67bffb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_2255b187-668a-4c9e-b2df-22173626d766" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_2255b187-668a-4c9e-b2df-22173626d766" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_d79fd279-17f4-453e-8f03-447f1e5fa09a" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_d79fd279-17f4-453e-8f03-447f1e5fa09a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_edc7bd2e-f70b-4802-bbb2-3d7c604879af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_edc7bd2e-f70b-4802-bbb2-3d7c604879af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_11b34c7f-5867-434d-adc2-fb68966e63f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_11b34c7f-5867-434d-adc2-fb68966e63f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:to="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_796885ec-e043-4966-96dd-1ba02800da17" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:to="loc_country_FR_796885ec-e043-4966-96dd-1ba02800da17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_f4ff2eb3-7ad2-489d-ab4b-ada92da22cf7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:to="loc_country_DE_f4ff2eb3-7ad2-489d-ab4b-ada92da22cf7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended" id="i1d385e99bb8b4b37b54aa54eba9ebacb_LEASESANDRELATEDPARTYLEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_10c2b1b9-9396-470c-a332-25ca2e7bd953" xlink:href="iart-20221231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_10c2b1b9-9396-470c-a332-25ca2e7bd953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2b45b74c-c07f-48c9-9008-64628df82979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_OperatingLeaseExpense_2b45b74c-c07f-48c9-9008-64628df82979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b7d30198-1f79-4eca-b2b7-b2c0b5ec6cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b7d30198-1f79-4eca-b2b7-b2c0b5ec6cd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_1c8c09c2-442c-481f-b4bf-85bc301c352b" xlink:href="iart-20221231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_1c8c09c2-442c-481f-b4bf-85bc301c352b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_680659b2-e991-4658-9d52-bcbe67eca0dc" xlink:href="iart-20221231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_680659b2-e991-4658-9d52-bcbe67eca0dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_27c62aec-8c4e-4743-831f-142413d885f2" xlink:href="iart-20221231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_OptionToExtendLeaseYears_27c62aec-8c4e-4743-831f-142413d885f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_a2706950-732b-4e88-b30b-868932b87e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_a2706950-732b-4e88-b30b-868932b87e15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e29cfde0-7925-4534-b448-b91e8dda3906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:to="loc_us-gaap_RelatedPartyDomain_e29cfde0-7925-4534-b448-b91e8dda3906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:to="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_f1ffb569-de8b-43c7-a77b-13d488114226" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:to="loc_srt_AffiliatedEntityMember_f1ffb569-de8b-43c7-a77b-13d488114226" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_5073c203-9db6-4c15-b1d8-b888b8c31cb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:to="loc_us-gaap_LeaseContractualTermDomain_5073c203-9db6-4c15-b1d8-b888b8c31cb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:to="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_9587c248-9c10-4b64-b57f-f7904b920fec" xlink:href="iart-20221231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_9587c248-9c10-4b64-b57f-f7904b920fec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_23e99d30-40bb-4cbc-8fd5-ba03d4169d17" xlink:href="iart-20221231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_23e99d30-40bb-4cbc-8fd5-ba03d4169d17" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i94fffb41c3274e98b3b5882df0476df9_LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b960a072-09dd-42b2-9b4e-b7eec4fabcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b960a072-09dd-42b2-9b4e-b7eec4fabcfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_14f9e91a-b95b-4458-a92a-a17434f496f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_14f9e91a-b95b-4458-a92a-a17434f496f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87706860-8bf1-410a-8912-2af3d1dfa907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87706860-8bf1-410a-8912-2af3d1dfa907" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f7a4d688-ee4d-4eac-b51b-34b1e174758f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiability_f7a4d688-ee4d-4eac-b51b-34b1e174758f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0037615a-90ee-4b69-8927-d99d38fd886c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0037615a-90ee-4b69-8927-d99d38fd886c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638fb0e6-d374-49e7-9b04-9cdab7860bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638fb0e6-d374-49e7-9b04-9cdab7860bf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b69990c-2026-4b11-9a17-345735270fb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b69990c-2026-4b11-9a17-345735270fb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_9f5ddf0b-d499-4609-ac09-abe7310c87e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:to="loc_us-gaap_BuildingMember_9f5ddf0b-d499-4609-ac09-abe7310c87e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_369a759d-d878-41f2-ba35-fac2d44ef97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:to="loc_us-gaap_VehiclesMember_369a759d-d878-41f2-ba35-fac2d44ef97c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended" id="i9208f3562a65470cb9c052cdd17d8651_LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_69e3af91-ebfb-40cd-91f7-31036d7993dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_69e3af91-ebfb-40cd-91f7-31036d7993dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c9c22d9-54c6-4209-bc05-dd198ac055c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c9c22d9-54c6-4209-bc05-dd198ac055c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aef639d0-d295-4e91-b6a0-a6c7a483b7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aef639d0-d295-4e91-b6a0-a6c7a483b7a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4cee3cc6-f150-4641-a8bb-57b80bf88b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4cee3cc6-f150-4641-a8bb-57b80bf88b34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aab895fe-9e5b-4375-946e-70d891062d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aab895fe-9e5b-4375-946e-70d891062d20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f4643d7-9d4b-4a88-81a9-ebc7d8707fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f4643d7-9d4b-4a88-81a9-ebc7d8707fa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18fffbb5-e9ce-411f-a664-3382f065b656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18fffbb5-e9ce-411f-a664-3382f065b656" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_65f75d3e-a48e-4cf9-a903-50f181760731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_65f75d3e-a48e-4cf9-a903-50f181760731" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dd41bc3f-b2db-4e68-81af-1735404ef028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiability_dd41bc3f-b2db-4e68-81af-1735404ef028" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4189f3bc-d7a3-4dcc-8b89-52da0e70846a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4189f3bc-d7a3-4dcc-8b89-52da0e70846a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12b8a767-59f1-479f-8c3f-52ffea1ca688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12b8a767-59f1-479f-8c3f-52ffea1ca688" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:to="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c444786a-1fbd-4052-8fdc-0a4a7f1dc329_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c444786a-1fbd-4052-8fdc-0a4a7f1dc329_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_e8c81cad-3f11-4d4b-977d-053bf8531b11" xlink:href="iart-20221231.xsd#iart_RelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:to="loc_iart_RelatedPartiesMember_e8c81cad-3f11-4d4b-977d-053bf8531b11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_b2b961c1-4bdd-430c-b4b5-86a36147fc85" xlink:href="iart-20221231.xsd#iart_ThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:to="loc_iart_ThirdPartiesMember_b2b961c1-4bdd-430c-b4b5-86a36147fc85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="i0a1db11b22e441ae98ed7a582554c844_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:href="iart-20221231.xsd#iart_IncomeTaxLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d7cbcc85-9a84-4196-b87a-7cef4a49a919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d7cbcc85-9a84-4196-b87a-7cef4a49a919" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ee59f19f-a920-4cf9-85ab-0849ab7afa11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ee59f19f-a920-4cf9-85ab-0849ab7afa11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_dca0cea6-048d-44b9-9839-40eec30445e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_dca0cea6-048d-44b9-9839-40eec30445e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_a6eb851a-c97b-4f6b-b938-d12c2f8dd60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_a6eb851a-c97b-4f6b-b938-d12c2f8dd60a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_56bb6945-5684-4f99-b455-d2651f3acc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_56bb6945-5684-4f99-b455-d2651f3acc5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_e3d15bd4-a2d8-4c99-be00-05574001f167" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_e3d15bd4-a2d8-4c99-be00-05574001f167" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_581a5b0a-c51c-47f0-a096-9bed8f04a276" xlink:href="iart-20221231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_581a5b0a-c51c-47f0-a096-9bed8f04a276" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_3996b6ef-c4ec-47a4-b461-d06267ebf377" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_3996b6ef-c4ec-47a4-b461-d06267ebf377" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dad82668-e4f6-45d9-a115-ffae8a1818e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dad82668-e4f6-45d9-a115-ffae8a1818e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_efea7f4f-56e3-4e14-b60e-7af2c4852476" xlink:href="iart-20221231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_efea7f4f-56e3-4e14-b60e-7af2c4852476" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_657430f4-6d55-431b-8b25-d520eca69533" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetIncreaseDueTo2017TaxAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_657430f4-6d55-431b-8b25-d520eca69533" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_269e0d4a-fe36-41cd-b9f7-17ca38ba7dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_OperatingLossCarryforwards_269e0d4a-fe36-41cd-b9f7-17ca38ba7dca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f07e86aa-9ab6-4723-b1cc-4ae848d3fb95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f07e86aa-9ab6-4723-b1cc-4ae848d3fb95" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_fa16193b-9ddb-4608-9cff-87d6bfd309e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_fa16193b-9ddb-4608-9cff-87d6bfd309e2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_9602af37-5cc0-4dbe-ba78-5d5601b20a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_9602af37-5cc0-4dbe-ba78-5d5601b20a07" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_f76cd721-0fa5-4fc3-bae4-255739fb0023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_f76cd721-0fa5-4fc3-bae4-255739fb0023" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b6cd7e9f-dfdd-401c-bdd1-6ce3f1f9a341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b6cd7e9f-dfdd-401c-bdd1-6ce3f1f9a341" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_55cad5d2-3e95-40a5-9679-feebcac5681f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_55cad5d2-3e95-40a5-9679-feebcac5681f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:href="iart-20221231.xsd#iart_IncomeTaxTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9ad53f66-a257-4115-8b2a-0125a7098429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9ad53f66-a257-4115-8b2a-0125a7098429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_171bc1f8-929b-4837-ad48-2c71010334ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_ForeignCountryMember_171bc1f8-929b-4837-ad48-2c71010334ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_eac105a2-20c8-4eae-bccc-df20546632ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_DomesticCountryMember_eac105a2-20c8-4eae-bccc-df20546632ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_82fd9071-be9e-4b06-86d3-d8be5f015e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_82fd9071-be9e-4b06-86d3-d8be5f015e09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_6e51524c-9a4d-456d-9ddd-315f1c794aa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_6e51524c-9a4d-456d-9ddd-315f1c794aa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e05b072-3840-48b0-a700-5140843f5508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e05b072-3840-48b0-a700-5140843f5508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_43bcfbcc-de8a-4133-8f4b-9600d97a248e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_43bcfbcc-de8a-4133-8f4b-9600d97a248e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_b92e980f-fe7a-437b-a6f8-7c729027d699" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:to="loc_iart_ExtremityOrthopedicsMember_b92e980f-fe7a-437b-a6f8-7c729027d699" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESTaxValuationAllowanceDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails" xlink:type="extended" id="i789b9567aa024bc2b49c96e698cc4b09_INCOMETAXESTaxValuationAllowanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_67ecb5c9-d3a3-4cf8-bc1b-59b9ccd7c860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_67ecb5c9-d3a3-4cf8-bc1b-59b9ccd7c860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_24973438-781c-4083-bf77-a7b93a5e9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_24973438-781c-4083-bf77-a7b93a5e9e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_01313cd4-302c-4a05-b751-6df995d55128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_01313cd4-302c-4a05-b751-6df995d55128" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_437ee1bd-b4cb-416b-976a-50a9caea4bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_437ee1bd-b4cb-416b-976a-50a9caea4bf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ed564fe7-6fa0-4cab-8ab2-77f2b8e6a99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_ec1b4738-c6aa-4818-9c9b-c8b45a46e541_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_ec1b4738-c6aa-4818-9c9b-c8b45a46e541_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_0b7b88b9-bc55-433b-a486-090c013700ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_0b7b88b9-bc55-433b-a486-090c013700ce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i293a1abd8c0749bca21399df3678b03c_ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:href="iart-20221231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9647f0cf-e601-4391-9a5e-e0f3174b9e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_StockholdersEquity_9647f0cf-e601-4391-9a5e-e0f3174b9e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_080fda83-6768-4619-addb-8a1e79dedded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_080fda83-6768-4619-addb-8a1e79dedded" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2209b7b2-e6b6-4f32-91f2-fc1a833a10e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2209b7b2-e6b6-4f32-91f2-fc1a833a10e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05192414-15f7-45bb-b1a3-95705e826990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05192414-15f7-45bb-b1a3-95705e826990" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16430b2b-1a1f-46b2-a50e-5acf36e8a7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c24d1003-1577-4021-8b15-31019570e2a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:to="loc_us-gaap_EquityComponentDomain_c24d1003-1577-4021-8b15-31019570e2a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:to="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79776fe-6939-408d-afe2-38735676f62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79776fe-6939-408d-afe2-38735676f62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_decb1a2b-77b0-46f1-b52b-812e06f96419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_decb1a2b-77b0-46f1-b52b-812e06f96419" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_62f57d6f-1fa8-4787-aa35-45ed6c09f881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_62f57d6f-1fa8-4787-aa35-45ed6c09f881" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="extended" id="ia3d1b7411e9b4990b47e3a7fa9f60c76_AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eba3c61f-1749-44a7-aa51-6e791b456978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eba3c61f-1749-44a7-aa51-6e791b456978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_985dc9e6-96dd-4d92-859f-e95ba4a6698c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:to="loc_us-gaap_InvestmentIncomeInterest_985dc9e6-96dd-4d92-859f-e95ba4a6698c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f046be65-19d4-46b3-a16e-0b50da712a46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:to="loc_us-gaap_EquityComponentDomain_f046be65-19d4-46b3-a16e-0b50da712a46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:to="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5cac12da-740c-4718-839c-28b63a6fa948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5cac12da-740c-4718-839c-28b63a6fa948" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_74910ef2-d65f-4e3f-bee7-3eb86a7c783d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_74910ef2-d65f-4e3f-bee7-3eb86a7c783d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_991ae423-83c7-4017-9107-46f0671a7876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_991ae423-83c7-4017-9107-46f0671a7876" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="extended" id="i660b0e271e44463ca267838ad7568efa_COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c4b3e76f-d395-4942-8239-eb5f6ea5ba78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c4b3e76f-d395-4942-8239-eb5f6ea5ba78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_a65c74cc-a1e9-438c-8734-ebe85aa35262" xlink:href="iart-20221231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_a65c74cc-a1e9-438c-8734-ebe85aa35262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_84d5f70a-af3e-4302-bd88-b1f9da10158d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_84d5f70a-af3e-4302-bd88-b1f9da10158d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a0e46fd2-35fa-494f-a719-dc64bd015048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7d278bbe-ff30-40fa-a98d-6c84f15dbc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7d278bbe-ff30-40fa-a98d-6c84f15dbc59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a3f2d583-eb4b-4f19-b094-dac6b7063a5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a3f2d583-eb4b-4f19-b094-dac6b7063a5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_d5c5b2e5-c263-4098-95ce-ef1629fbaefb" xlink:href="iart-20221231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_d5c5b2e5-c263-4098-95ce-ef1629fbaefb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c75243b-85df-4d3f-99bb-c98de5c905e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c75243b-85df-4d3f-99bb-c98de5c905e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee1a5699-7fdb-4714-b8e3-86131e7855d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee1a5699-7fdb-4714-b8e3-86131e7855d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_32ae9361-e605-4c18-8e48-2cfa7b25ef16" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_ArkisBioSciencesInc.Member_32ae9361-e605-4c18-8e48-2cfa7b25ef16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_10ee6406-45fd-4690-972a-e13206682c13" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_DermaSciencesMember_10ee6406-45fd-4690-972a-e13206682c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_ea0d1f1a-3609-4d55-8bf0-8f71f3576c48" xlink:href="iart-20221231.xsd#iart_ACellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_ACellMember_ea0d1f1a-3609-4d55-8bf0-8f71f3576c48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_e051a801-dc77-4135-9431-fa0cb8ed6fa2" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_e051a801-dc77-4135-9431-fa0cb8ed6fa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f80c32f-62e9-4b86-acb2-7643e141443a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f80c32f-62e9-4b86-acb2-7643e141443a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_2c4ef742-51c2-4862-9f14-b1919599b606" xlink:href="iart-20221231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_2c4ef742-51c2-4862-9f14-b1919599b606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_408a20f6-edb0-4354-be47-35e436de9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_408a20f6-edb0-4354-be47-35e436de9476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_00b0dc60-4f12-4763-b679-544d648d2a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_00b0dc60-4f12-4763-b679-544d648d2a1e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended" id="i4ec04083fc7e486dac574679cfd9938c_COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a713d11-cda4-41b0-b054-f4008090e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a713d11-cda4-41b0-b054-f4008090e59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_f6de86ab-3bfc-4496-9f68-52f6f618afab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_f6de86ab-3bfc-4496-9f68-52f6f618afab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_b8479c71-5100-4ade-a58a-39c3ea7a97ae" xlink:href="iart-20221231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_b8479c71-5100-4ade-a58a-39c3ea7a97ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_38a2e0ed-a7fa-4fc1-bfb1-2457efb67bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_38a2e0ed-a7fa-4fc1-bfb1-2457efb67bd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_39917acb-c253-4f2a-9c98-6b073848b46e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_a2f37054-46f9-4401-98ff-e3d49e1f56a9" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_ArkisBioSciencesInc.Member_a2f37054-46f9-4401-98ff-e3d49e1f56a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_0fdf2e7f-3e3a-47fe-b41a-ec528cb44a72" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_DermaSciencesMember_0fdf2e7f-3e3a-47fe-b41a-ec528cb44a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_17480061-d8eb-49eb-80f3-567ca70785aa" xlink:href="iart-20221231.xsd#iart_ACellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_ACellMember_17480061-d8eb-49eb-80f3-567ca70785aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_210ad6a8-a079-4afa-91f2-64e77dc65dbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_210ad6a8-a079-4afa-91f2-64e77dc65dbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_1711ebee-40c4-4bfc-a75d-38a38e9b4529" xlink:href="iart-20221231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_1711ebee-40c4-4bfc-a75d-38a38e9b4529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0b0626cb-b090-4eed-8fa1-28cc2da6dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0b0626cb-b090-4eed-8fa1-28cc2da6dcc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_81b587fd-d7ed-453d-92e2-e7a627b0c846_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_81b587fd-d7ed-453d-92e2-e7a627b0c846_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_4c9448be-16b2-4363-bd68-612acfb9fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_4c9448be-16b2-4363-bd68-612acfb9fcc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_caa7c055-70da-4559-b912-959183e06ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_caa7c055-70da-4559-b912-959183e06ed2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended" id="i11b3f33a1cb640038394ea4ee4078573_COMMITMENTSANDCONTINGENCIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f6077f5f-1b0d-4553-878d-2713888d9e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f6077f5f-1b0d-4553-878d-2713888d9e18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_97a485c5-cda9-4978-9feb-08abc37348b3" xlink:href="iart-20221231.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_97a485c5-cda9-4978-9feb-08abc37348b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4d377d80-639c-4ec2-9cbb-a906f3c63532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4d377d80-639c-4ec2-9cbb-a906f3c63532" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_230ac036-6c65-4a6c-8e2c-edbdf3d58862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_230ac036-6c65-4a6c-8e2c-edbdf3d58862" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51eb3def-4a3c-4dc9-9b8e-426108ec753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51eb3def-4a3c-4dc9-9b8e-426108ec753e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5ba9c2df-3b75-4920-b770-2dd7d55006aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5ba9c2df-3b75-4920-b770-2dd7d55006aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a314bd1c-dc17-4ba8-9258-3f6b40004dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a314bd1c-dc17-4ba8-9258-3f6b40004dd8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e68b44-7869-47d5-a717-e6782de941a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35e68b44-7869-47d5-a717-e6782de941a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_f9523c9b-487c-403b-8ac6-c023b9da0d3c" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:to="loc_iart_DermaSciencesMember_f9523c9b-487c-403b-8ac6-c023b9da0d3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_0a719295-dd3b-4d17-bc67-40f83fccb6a3" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:to="loc_iart_ArkisBioSciencesInc.Member_0a719295-dd3b-4d17-bc67-40f83fccb6a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c58d0b0-2492-4cd8-997c-0c32e2640bd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3c58d0b0-2492-4cd8-997c-0c32e2640bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ac12502b-be8a-4168-be2a-a238fe9dee68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ac12502b-be8a-4168-be2a-a238fe9dee68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d280b728-af2e-4fbb-b3e4-d7638b2d7679_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d280b728-af2e-4fbb-b3e4-d7638b2d7679_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_eba4769b-f799-40a7-bdaf-9a21f313adcf" xlink:href="iart-20221231.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_eba4769b-f799-40a7-bdaf-9a21f313adcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_b8a410b4-87f5-4ecf-a652-986f539b587b" xlink:href="iart-20221231.xsd#iart_MilestonePaymentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_MilestonePaymentOneMember_b8a410b4-87f5-4ecf-a652-986f539b587b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_146856f3-7ef3-4cd3-a74c-909abf120d07" xlink:href="iart-20221231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_MilestonePaymentTwoMember_146856f3-7ef3-4cd3-a74c-909abf120d07" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended" id="i9eed1b0920f94417929e9105894cdc01_SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3bb3603d-0dae-47a7-b563-cd52df3323a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:to="loc_us-gaap_NumberOfReportableSegments_3bb3603d-0dae-47a7-b563-cd52df3323a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_2a5bbb5b-1673-482a-9b6b-c23a75892da4" xlink:href="iart-20221231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_2a5bbb5b-1673-482a-9b6b-c23a75892da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b5c398fe-4403-47f2-bbdb-649eee29f012_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:to="loc_us-gaap_SegmentDomain_b5c398fe-4403-47f2-bbdb-649eee29f012_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:to="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_cbfd7cdc-176a-4d54-9c49-e9ec23dc0a0e" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_cbfd7cdc-176a-4d54-9c49-e9ec23dc0a0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended" id="icd34681005544f5b9014ac13a89af22e_SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6802cfdd-5ae0-47a5-b1df-d04b4f0aa554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6802cfdd-5ae0-47a5-b1df-d04b4f0aa554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ab63b0c4-829b-409b-927b-959b309df546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ab63b0c4-829b-409b-927b-959b309df546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_99776476-964f-4897-89c1-00ef45c0b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:to="loc_us-gaap_OperatingIncomeLoss_99776476-964f-4897-89c1-00ef45c0b1e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:to="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8636c36c-ce06-4f5d-8441-855a82d1072b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:to="loc_srt_ConsolidationItemsDomain_8636c36c-ce06-4f5d-8441-855a82d1072b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:to="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dd5eec14-5ead-4d1f-b5c9-ddaa5df4d892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:to="loc_us-gaap_OperatingSegmentsMember_dd5eec14-5ead-4d1f-b5c9-ddaa5df4d892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_16e32f0a-77fe-4342-be90-1b773307e315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:to="loc_us-gaap_CorporateNonSegmentMember_16e32f0a-77fe-4342-be90-1b773307e315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_17ad82b2-742f-4710-80a6-43d6994dfd22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:to="loc_us-gaap_SegmentDomain_17ad82b2-742f-4710-80a6-43d6994dfd22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:to="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_4d75ae99-42a9-41d5-b3c1-ab35aefc01f1" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_4d75ae99-42a9-41d5-b3c1-ab35aefc01f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_04763d61-3a55-48fb-94b6-99e027249d71" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:to="loc_iart_TissueTechnologiesMember_04763d61-3a55-48fb-94b6-99e027249d71" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended" id="i9739221575c249e0990087ea3e88050d_SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e6235e-228e-47cc-b9a7-575a87a3e064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e6235e-228e-47cc-b9a7-575a87a3e064" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_589d1234-de4a-4366-8c0a-51eeadaddaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:to="loc_us-gaap_NoncurrentAssets_589d1234-de4a-4366-8c0a-51eeadaddaaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:to="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6d591e60-87c3-4ce7-8995-6082e6117013_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:to="loc_srt_SegmentGeographicalDomain_6d591e60-87c3-4ce7-8995-6082e6117013_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:to="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f8253156-c457-425d-b01b-9ec22e177f15" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_country_US_f8253156-c457-425d-b01b-9ec22e177f15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d66b53a3-7afe-4c28-b293-2f614914f8e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_srt_EuropeMember_d66b53a3-7afe-4c28-b293-2f614914f8e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_2dd876e8-548d-4377-9781-da971dbe8b2c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_srt_AsiaPacificMember_2dd876e8-548d-4377-9781-da971dbe8b2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_5414e9c3-90bb-4d14-a7d8-d1da3aa9d2a2" xlink:href="iart-20221231.xsd#iart_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_iart_RestOfWorldMember_5414e9c3-90bb-4d14-a7d8-d1da3aa9d2a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccountingStandardUpdate202006Member_99d838d9-9f51-4e4e-8cdb-d0c5272d3f6c" xlink:href="iart-20221231.xsd#iart_AccountingStandardUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_iart_AccountingStandardUpdate202006Member_99d838d9-9f51-4e4e-8cdb-d0c5272d3f6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>iart-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4c93fc71-5f76-4a0e-89ef-143ca4706034_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_d82dd430-5908-4b0e-a130-1873afab244b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3f5563b7-7410-4f2b-8e41-c1fb41a638f6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_40404ba0-48cb-414a-b01e-b723fd88be51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (recoveries) for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b152559b-d13d-4fca-9990-00d632c2e605_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_ca4b684c-6c6b-4092-a217-b98360905f74_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_ea073f56-2bc1-4df7-a24f-0709e487fcf1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_04e9f594-9054-46a4-9f35-8873a9722ece_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_11e384ba-e93d-410d-adeb-03529a5cc2da_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_39ee8dd5-8c23-4070-aca9-bcbfd986fccd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_74aef094-fd6b-4b1f-9f3f-f6d1e1cf4884_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_af3ede49-1254-45c9-afb5-059d1f7a4a8b_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c020164b-8c91-4ff9-ab8d-bfa22f872946_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_24b5bec3-3b8f-4fa6-94e0-41d58de71561_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_1280002d-18ad-4e29-b30b-6047735cbde7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_ef47f839-44c1-49d3-9534-4361abe5c237_terseLabel_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2034 Through October 31, 2039</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_label_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two [Member]</link:label>
    <link:label id="lab_iart_FiveYearLeasePeriodTwoMember_documentation_en-US" xlink:label="lab_iart_FiveYearLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Lease Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember" xlink:href="iart-20221231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearLeasePeriodTwoMember" xlink:to="lab_iart_FiveYearLeasePeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_7161e0f9-953b-4784-a82a-1d1c975ff9f6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonus</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_05d657b6-9dc0-4677-bedf-31d796ce34b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates available to the company at its option</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TissueTechnologiesMember_720e0833-234b-4f3c-aa20-2fb403dcbd0f_terseLabel_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_label_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies [Member]</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_documentation_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TissueTechnologiesMember" xlink:to="lab_iart_TissueTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_d411456d-894e-444a-af93-1c4f24a592e8_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d33084e1-d22a-44db-9296-34209de314a5_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_547b00a6-3c8f-45e4-b6b1-a593fb3942b7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e544fbd5-50c5-42c6-89b3-de1d29997c9c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e3ff2967-dd8f-4f44-9bc1-6d1a676197d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_53c80e4d-f0c4-4c5d-9e8b-a8c3ddd19345_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_7e796ff0-e53e-4e9d-ac73-7c4e78391fb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Geographic Revenue, by Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_95bc0bb3-dd61-47c7-b7ce-27f8ca5d3079_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_c0b01d61-0771-4122-8216-d8945aaf7941_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_3a7c3618-d61b-4cf7-9897-3ef08f22e681_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets expected to be returned next twelve months</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_3d505d0e-8857-43b9-80e2-52a179fb4ee9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Funded Status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d63bcdb3-864b-44cf-95b9-633104074dda_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_da4edcbd-6853-41cd-8866-f4daae9b428d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_2bcbac6b-5d1e-4946-afeb-0e81186b0ff4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_55cbe2c6-2ace-4553-a198-d69c1c39578e_terseLabel_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from long-term to current portion</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_label_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_documentation_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:href="iart-20221231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:to="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeMember_c97741ed-3ecb-4e15-9a64-0fd475193a02_terseLabel_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_iart_EmployeeMember_label_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_iart_EmployeeMember_documentation_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember" xlink:href="iart-20221231.xsd#iart_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeMember" xlink:to="lab_iart_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_d083f80a-e1b5-453d-b81e-0ca557f87318_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_7c7da13b-fd22-4b02-bad0-27ef750f5d24_terseLabel_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, outstanding borrowings, maximum limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_label_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_documentation_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:href="iart-20221231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:to="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_41be191a-92bf-479f-9568-502ac2e55709_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_29f2a491-3b90-4b38-82bc-0a8e4a8a1380_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from computation as their effect would be antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_97b52faf-c886-43bc-849e-d7d3f125f83d_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_c4120200-b142-47d6-8a9a-e8b7c93dfdb0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, capitalized into construction in progress</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5385afc9-93b1-4122-b6a5-dc275a7d3e22_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_78411a21-0656-41ed-a857-4d565ef3faf3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_a1ef44b2-39fc-4237-b8ba-c110d5c6dfbf_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4c0a09ed-49e0-4015-978f-e5390c056a51_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_187f5437-8ca6-4f04-a07e-3c4175b82c28_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_c619b1ad-12fc-4c99-a98a-958b2f57e216_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_5e79dd31-22bb-433c-ba31-8b1975d966aa_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4ccfcd8e-c882-4860-9592-8cbee15e5530_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_ba3b1f7a-068c-4293-ba6a-aa69204d1d59_terseLabel_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information systems and hardware</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_label_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:label id="lab_iart_InformationSystemsandHardwareMember_documentation_en-US" xlink:label="lab_iart_InformationSystemsandHardwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Systems and Hardware [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember" xlink:href="iart-20221231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InformationSystemsandHardwareMember" xlink:to="lab_iart_InformationSystemsandHardwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_de539c18-1476-4ec8-8727-7285970cbc29_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_67276961-f552-4f3f-901e-884c44f344e3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in income taxes resulting from:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_d8186bf8-3c37-44b2-9fd8-da5658a9c5b3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_bb3d8ca8-bc9e-431b-9ed0-eaf9118981d8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_613462fa-7ec2-4a47-8172-2a5a452e0415_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_f2417804-18c5-4e29-9e62-838c1b9c04f9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0d5f1dc7-ed3c-481a-acc4-80fd2a573245_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1d670c2c-fa12-44e9-a3bb-75960ae124b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets at fair value, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9bd7a039-8a3d-4644-bc09-f9b822dc07db_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c9415913-6f60-46a8-b6c0-cbfa9509c1ce_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans, assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_4a01dc86-2d57-45fd-af1a-0505ed7a6ec3_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_aa7323ca-4345-45d8-859b-034aeb0766fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_4c10cfd4-fe89-41ea-8e6f-d4769acb56c4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_5e713aca-454f-46e8-94fb-ed3b6a4d5985_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_fa927231-333c-4d75-9de1-ae6adec5f385_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase and equity component of the convertible note issuance, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_ddbea52c-4003-4cc5-8d14-c6d9f15b28ed_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f77e7316-0ca2-40cd-8248-41c1f44ba86d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_7b733a1c-5de5-4154-a6f5-18ccd665522d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_81ffd523-70ac-4eb2-b08d-f209f4ddf628_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearOne_8a2ccd3c-9728-46e3-9881-632f01c92132_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year one</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_label_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearOne" xlink:to="lab_iart_InterestPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_fe07d7e3-d02a-4271-b0a5-42d64dc0c696_verboseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0a43790e-db89-489c-a7c0-9369e4ef2ccf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_9b1f8593-a252-487a-af95-8297c1f915f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandThreePlanMember_45be972e-4bd3-4ca2-aaa1-fe05eb6543f0_terseLabel_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Three Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandThreePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand three Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember" xlink:href="iart-20221231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandThreePlanMember" xlink:to="lab_iart_TwoThousandThreePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_82dbfdf4-738a-46e8-84f6-9ea433aacddd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e44a87ab-8b5e-4f95-bd4a-3a5f53b39c7d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ca5f9073-944c-4f78-8bfe-4a8caf13ae74_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b292fb4f-b309-4a38-9f8e-8005f3e7ab2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_31df98cd-5fd0-4f0c-842c-d48afca661e9_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_6df5181e-584c-42a3-b3f2-e06cc7f70cc8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_1b1ec746-cd6f-48ac-b5fc-287c1bc7ec95_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_5ad77828-29f2-4b2a-90ce-28d94ba9debb_terseLabel_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount, terminated</link:label>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_label_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_documentation_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated" xlink:href="iart-20221231.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DerivativeNotionalAmountTerminated" xlink:to="lab_iart_DerivativeNotionalAmountTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_68d6e462-7d45-45ed-98de-32243ed1a568_negatedTerseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting From Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:href="iart-20221231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:to="lab_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c750b406-f5dc-4fde-ad16-f4e03c776074_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_70b846d0-5b53-491f-8b2e-d05562d7b2ed_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_667c4a37-6b72-4515-8af4-4f314a04137b_terseLabel_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective foreign income tax rate</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_label_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:label id="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_documentation_en-US" xlink:label="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:href="iart-20221231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:to="lab_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_ac8fe1b0-a86c-4342-a6f6-8cc9102cac50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax rate reconciliation, prior year income taxes, amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0795864d-a3ca-4e0f-b947-916e24a7f632_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ThirdPartiesMember_e7e66fe7-18f8-47c8-82a1-bda429c7b7f6_verboseLabel_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_label_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_documentation_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember" xlink:href="iart-20221231.xsd#iart_ThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ThirdPartiesMember" xlink:to="lab_iart_ThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fa3d5d99-f3c8-4ac0-91e0-0d02e097ad6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4081b96a-ec85-4de6-b48f-8b4afce87b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7908b43f-4293-4137-b66b-a6123b5dea58_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_aa38d18f-8288-4e99-993c-f5564e6e1658_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_221ecccb-b141-429a-afd3-9709ff910931_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DermaSciencesMember_91911e57-746e-4a22-8f61-6f2958e09334_terseLabel_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences</link:label>
    <link:label id="lab_iart_DermaSciencesMember_label_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:label id="lab_iart_DermaSciencesMember_documentation_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DermaSciencesMember" xlink:to="lab_iart_DermaSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_f3f55cd9-bdda-4c72-b1b0-82fb1bcf7d37_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c54e9abc-d44f-4b6c-8c62-a655e5243e90_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df78c402-253d-4967-bd6c-3603cac26f63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_161825b3-1fa2-4ebb-bff6-220bfc0891e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a6eb9715-a5dd-4119-ab31-00180a10d94b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_06c17f91-9735-4c49-9622-0b61d91adf51_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Shipping and Handling Fees</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b0521fa3-d6a6-473d-94f8-53ef232518d2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9e3a627e-2932-4c3c-8585-d06e5e984bf4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_51f602dd-78d3-4ca1-aad9-fce8a5cb0565_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_6d0b8e40-758a-4915-b1c0-66533dd48afc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e3c9b6b-2820-47fe-9486-f1d22cb8c6e4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_978b08fc-294e-43d8-abdd-f6d07ec4c3ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1e91756b-0eb4-4ea5-862b-720d88c764b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_b35e8563-e7b0-49e8-9ee1-598dd970baa9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0b9406c0-01fa-4125-a304-04ab07ea3684_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_363d3dd6-99ab-4b8a-8a53-0f435839946c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_3d90c09f-5510-435e-8db9-3e5005082fbb_negatedLabel_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (Gain) on disposal of property and equipment and construction in-progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_label_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:label id="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_documentation_en-US" xlink:label="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:href="iart-20221231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:to="lab_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_3bfe16df-eaf6-4ec3-b8f9-edbdabe9ab16_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_f57a9cf7-4bf7-43ce-96cd-7598e612796e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_cfe5920a-0594-4c4f-b1b5-16786a31de04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized derivative gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_26c1491f-afbc-4f6a-a004-d984b7a2b263_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded in AOCL, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_09989eaf-47de-4919-afdc-d26b03eea1e8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_d82c243e-cb9a-4858-9fab-c9cdad6c2ad3_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_98d8e4c2-eda1-464d-b63c-debd1ce2a3fe_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Contract Assets and Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_aa6f668e-9247-44b1-b038-b5e844c8befc_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_cb56385d-e732-456c-a682-6e46a2645b13_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan component of senior credit facility, classified as current</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28402ac5-3ded-42ad-bfd3-bda6e41fd8e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_334eecf1-160c-4e24-aa97-451dcd4d7e9b_verboseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_39aa2ff7-7031-4c4d-9ae5-05c3785cf88c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_932f603c-6c75-4eab-b610-da451a94e1d9_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_35072782-6169-4cf6-a5e8-c89459d844b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_467e0415-cc3f-4764-aa51-14b1998f29e5_netLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_bbbe62ac-2155-487c-bfa5-9326410807f3_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsLeasesAndOther" xlink:to="lab_iart_DeferredTaxAssetsLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5eed34fa-179d-4395-9a4e-bad124d62e98_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9bf7b519-4576-4f78-8c04-b7d136c1bcf8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_d2270f64-47b7-45b1-81b0-1cbfe7348d4e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_0d4708e1-b155-4469-bc90-922ab38cc7dc_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_89ef5981-b750-4415-b907-f809adb7b413_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from the sale of businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_479ce1ba-cd20-4888-bba2-0ee2951b6594_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_54fc1b9c-c678-47d4-a66d-835e9e256b63_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0de830c4-3417-4946-98f3-df8da8887b8d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandPlanMember_2ec01bd9-fa71-4c60-851e-db75ef2d0bb7_terseLabel_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2000 Plan</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_label_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandPlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember" xlink:href="iart-20221231.xsd#iart_TwoThousandPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandPlanMember" xlink:to="lab_iart_TwoThousandPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_a3b025cc-0472-49cf-8324-dcb90f5fce8f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_21a21f7d-9849-4968-82a0-576dd6502579_terseLabel_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty period (up to)</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_label_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_documentation_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod" xlink:href="iart-20221231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueProductWarrantyPeriod" xlink:to="lab_iart_RevenueProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_f21b61b6-b5d4-449b-b6f3-23f02a8a4811_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_f7622675-52cb-4ff8-9f04-8c7bae4f8c1c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_d8d0dd03-2f61-4de9-97fc-514662e3e800_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5cf56d94-c251-4964-af2e-299b41bd0702_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Weighted-Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxTable_b85e86ef-7cfc-496d-8bed-2e9760e0162e_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_label_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_iart_IncomeTaxTable_documentation_en-US" xlink:label="lab_iart_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable" xlink:href="iart-20221231.xsd#iart_IncomeTaxTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxTable" xlink:to="lab_iart_IncomeTaxTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_16197dee-2989-4fb8-a366-e8cf594a91c7_terseLabel_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_label_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_documentation_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:href="iart-20221231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:to="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5595a296-0fae-4379-8f7d-416bc300d8ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_33d1c243-ce7b-4d43-b9e2-d2920256b343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9072fae2-e37c-4b3b-a77f-c9e2c9648f02_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for cost recognition, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d6907c03-d3cb-4b25-92b6-a76c831067a7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term in Years, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ffe7e6e3-be0d-4201-b1e2-71381de973e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ea19854b-1cdd-472f-b7bc-daed84384378_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_aa800dd2-b600-40cf-b469-ab68f299724c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_2f3a3e36-c98e-40ee-8dfe-4b64fd3c2272_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7e348958-ecb3-45d0-9893-aa6f6744318b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_70b5ac95-4bbe-400f-9946-ae1a5e3cc436_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_57b8133c-d60f-4efc-ae44-e63bfc241368_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_a94700ce-3150-4b9f-a3ab-6cca75b929e6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_58ed318e-599a-4f3a-804f-f66f193fc977_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_e5d49a2b-b3aa-49db-a638-28a9d8c93bee_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fef0012c-4fe4-479b-80ad-ecc4d84c1a5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0a07cb01-36ed-4375-ba01-dd2d5c17f9ac_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncomeTaxLineItems_80cb16d8-e4b4-41cb-b4b0-c2e00b8bea32_terseLabel_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_label_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_iart_IncomeTaxLineItems_documentation_en-US" xlink:label="lab_iart_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems" xlink:href="iart-20221231.xsd#iart_IncomeTaxLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncomeTaxLineItems" xlink:to="lab_iart_IncomeTaxLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_500dbecb-1746-41c3-bf3a-923269a85f03_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_33122cdd-3465-4aba-8c7f-5f6075ac2c1f_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_67ce0387-0c12-4dea-ba3a-62e183a7f06b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_029ffee6-eae8-4b08-8fe0-63302706af19_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_31ec81b1-08ca-48b2-9c5f-0a4500e4e393_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles Of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_f55a26ae-ee6c-4119-9728-c1d95f6c89e4_terseLabel_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_label_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:label id="lab_iart_ExtremityOrthopedicsMember_documentation_en-US" xlink:label="lab_iart_ExtremityOrthopedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extremity Orthopedics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ExtremityOrthopedicsMember" xlink:to="lab_iart_ExtremityOrthopedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_6d15ac0d-70ac-42bd-9e66-9d0f1697aeb8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREASURY STOCK</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f6150015-58fd-45a8-830a-b4574789480d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_36406982-e363-4ab8-9b36-0a43cfde11e1_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_703cd378-2394-4ee3-b57f-e476efa853de_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6198511e-3778-4baf-8102-6151d0c8de5f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_19665878-2fec-4309-8e0d-2dae4197e4ab_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings of long-term indebtedness</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_cfd62cbd-afaf-4a55-97b3-0938da8b3b71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_73940c6f-f487-4759-b94c-299ec4b6b2d0_negatedTerseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_eb4efa3f-13af-4594-bb4e-e02fd2585efb_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5879b920-7f37-4578-a9c5-5ece5d0e0b00_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_48c1c230-21ea-47ff-900b-b30e9a251bf8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d17fcf39-d6a2-4f8b-934a-ed70224f9317_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_5c43f371-01f6-4187-a7e0-22e31e218f36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_73ce4f71-c52b-4b4d-9c27-7ef48b7d73c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_555a357b-066d-4e8b-a559-05c7d6ab48eb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0577487e-868f-4224-b4ed-7e5cc686e748_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5f439c69-fc2c-4751-bd66-47ddfecd3022_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9d7a88b7-36be-4352-b15d-96c82436c82b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1a0bd57d-297c-47b9-8ac8-01c54b09de13_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_e5a0dd87-b67c-4659-84dd-5cd42eb6f3ec_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_e23ad10b-3376-4039-a850-2c80953cf76f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f020a43-8964-4b55-a835-c57c51ef7ff6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c1892948-69a9-4194-9850-12e382b264a9_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_44e8cd8e-aa21-4323-b640-d8eda2e05ab6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d3a4eed6-8e52-427f-bb37-555abdca3673_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_212bd006-81e7-4fdf-9247-630a740332e1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions expected to be paid to plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d833d768-2c18-4e48-b5b2-a5a033b4230a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_8fa8013b-0669-4801-aa7f-8daafec2e0a7_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0db1ff54-e7c4-4db1-b8f9-1595f11529bb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_393c847d-c88f-4c46-b3bd-c3123735858e_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_edaf2abc-a3ac-47f3-90e7-c07d5cfd1e28_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_3cf3338b-0613-4cef-8989-78aecaad06c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6b38b164-b47f-4120-abf1-eeec8495bddf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_aea44c54-9b22-4065-aa14-ec046c69dd9f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_fa15df66-f3d7-44eb-bec4-dd1a472efd11_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_44b79224-b3d6-4d40-9a52-f29e78e35b2a_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_dfbe5be3-c0b7-41d6-88d3-9c435d09135b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearThree_144b7027-d205-436f-bd4a-87baac9e7f49_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_label_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearThree" xlink:to="lab_iart_InterestPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b0fe2737-4634-4531-bf16-4d0f9b64ebbc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_aa734933-1815-49a0-a072-ec2e61b4a3ac_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NeurosurgeryMember_45d2c283-c7a0-4a45-940d-14832a26495d_terseLabel_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_label_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_documentation_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember" xlink:href="iart-20221231.xsd#iart_NeurosurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NeurosurgeryMember" xlink:to="lab_iart_NeurosurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_bc57a9c1-d0d8-4306-a4e2-3ce283e1dc23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_a686f590-715d-4c32-a916-29f3e16aadf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fa3eb7f6-64e4-4202-9888-8eac4abdf364_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_bea066bf-ae57-442f-bfed-288940f63632_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_19b4d383-32b3-4f9c-a505-ba9fb22612a9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_c93c8911-230e-460d-b7bc-501450c1b676_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2eca6d03-1b0e-4aa6-9886-89e12e5e3b81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_25401aad-8cf4-47dd-8bf2-e66344c2fcd4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low-taxed income ("GILTI")</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6de4f004-beeb-4865-a679-7cf3c88a4cf5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_8584f97c-5fc4-4703-b17e-c0160d14018c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_8fbad369-f0b8-4d28-8b80-2d701069aab0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan - net gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_8377f1f2-1521-4f83-bbd8-86fd380ed341_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_14acb5cb-d0d1-4c65-b693-c8b4bd9c5424_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_3fe232fc-2ea8-49b6-9ab8-fa9b4daf08a1_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_fd101e83-4ad0-404a-95f5-2c00ae651dea_terseLabel_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective worldwide tax rate</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_label_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Worldwide Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:href="iart-20221231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:to="lab_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cd6b3f65-ff9a-4d62-bc6e-947cbd7c59e4_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9fa8413-750f-4687-8ed6-ba9371d4a579_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_324b770f-1d7c-4738-bab3-fb5904a64aa4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ff97c708-6776-451d-85f7-78afc5d82938_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_64bf3f21-ed37-46ca-9401-dbdda13707ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReorganizationProjectsMember_82b166ef-d804-4812-b46d-6f10a1d974d8_terseLabel_en-US" xlink:label="lab_iart_ReorganizationProjectsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Projects</link:label>
    <link:label id="lab_iart_ReorganizationProjectsMember_label_en-US" xlink:label="lab_iart_ReorganizationProjectsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Projects [Member]</link:label>
    <link:label id="lab_iart_ReorganizationProjectsMember_documentation_en-US" xlink:label="lab_iart_ReorganizationProjectsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization Projects</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReorganizationProjectsMember" xlink:href="iart-20221231.xsd#iart_ReorganizationProjectsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReorganizationProjectsMember" xlink:to="lab_iart_ReorganizationProjectsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_32d1374b-4845-43a8-aeb3-213fe04bc66a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7ed29c59-3039-4f01-b033-b8ce88c92b97_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0154f83b-d1c5-49be-83ae-9e805f841628_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_864f7ba7-919b-47bd-994f-65c211c386f8_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2aa10a20-b3e6-4d09-a4f0-0808c24eb36b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ebf8fbc6-aacb-43e5-9e75-83887e7e9d15_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_6b125b2b-713d-467c-bfec-d3b5aaea9cd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_d08cab9e-5861-46c9-9ec8-68aa9a2fd92f_terseLabel_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Reconstruction and Care</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_label_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_documentation_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember" xlink:href="iart-20221231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RegenerativeSkinAndWoundMember" xlink:to="lab_iart_RegenerativeSkinAndWoundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_0717300f-ea86-40c7-a05c-791ccfa69bfd_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_e206c6a2-5cc8-40c8-b953-74a82c9b7a2b_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income Not Disclosed Flag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_519c8b9d-9059-43ff-a280-f2e373720c01_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other income</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9f786171-b385-43b3-9e4e-7dc476b37da3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b076eca9-d864-4d19-8cdc-ddf0b1609b18_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_9566f31f-11e3-4afb-a48c-856bca807e8f_terseLabel_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_label_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:label id="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember_documentation_en-US" xlink:label="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consortium of Focused Orthopedists, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:href="iart-20221231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:to="lab_iart_ConsortiumofFocusedOrthopedistsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c42611bf-e11e-457b-bf44-81795e9536f9_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase program, receipt (payment)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_4ca08b76-4811-41b2-827a-c23a25b76c0f_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_00d3b2ca-adb6-4957-85e6-564db6ff3357_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ed453f24-702c-429b-9350-88a656d60ab6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_300e6208-2f5b-41c1-b831-462170cac0a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_af15293b-2809-4d48-9daa-d07d4c1b525e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible notes issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_73ab47fe-a79a-4939-86b4-4b9a84779273_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RelatedPartiesMember_c0885547-e140-4ae0-8396-c48aaccaf61d_terseLabel_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_label_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_documentation_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember" xlink:href="iart-20221231.xsd#iart_RelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RelatedPartiesMember" xlink:to="lab_iart_RelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6a300777-ae7e-4041-93f1-8cfdfbcaca0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_a9b5a7d6-80d5-4b61-8d4a-ce655d3af860_terseLabel_en-US" xlink:label="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, percentage of expected total repurchased</link:label>
    <link:label id="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_label_en-US" xlink:label="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased, Percent</link:label>
    <link:label id="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_documentation_en-US" xlink:label="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:href="iart-20221231.xsd#iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:to="lab_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e8c88c0a-7f5d-4479-8600-0de1ab53b22b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_58f21c1c-f3f6-46be-ac45-b0cf1d41476c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbed4827-6445-49fd-85be-9f3a35168792_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a5fd8814-aa1e-400b-aff5-16dd1a7f8a70_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business, disposition price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_1c97c7c7-59b4-4778-b659-71dcf5fa7bcb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9bd83dad-cf4d-4b32-95ca-db445d8c3bd9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_e3372878-e09c-4aef-a695-9f0c81369fe7_negatedLabel_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development and intangibles</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_label_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:label id="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_documentation_en-US" xlink:label="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire In Process Research And Development And Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:href="iart-20221231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:to="lab_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_7c87d891-f196-46f4-84a3-61fcba2cd0c9_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_905bb22f-574d-4a5a-bea2-a3b4122ae895_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_9af04208-b78a-4cee-b05a-22b9f2218bb4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentTwoMember_b4250f4b-770e-42fd-b387-652617300ec8_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_label_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember" xlink:href="iart-20221231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentTwoMember" xlink:to="lab_iart_MilestonePaymentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_5a8fedf5-cf70-4721-a93b-17028a2c736d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from stock compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_5eace078-6a77-422d-bbbc-6d0d5252431f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_9470219b-a7aa-4df7-bcb4-8d225071be7d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3219f1e9-5896-4996-a1e4-19fe05bd4c7e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_7c56e87d-16a8-4e78-886d-839282b8cf12_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Asset (Liability)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6222208f-60ab-4e88-8575-ac5dd1c53d22_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_4e9de5b9-d609-4da7-886d-9ff3e097b4af_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_30629a52-efd3-4650-a333-dcb7160d2ce9_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_353a5bea-0823-4581-b447-29924342ba1f_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_0068a609-5c4c-48dc-af5d-18621d2a6972_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_985649c7-0ff2-43ce-8253-58933ce3cb9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_63c884d6-00ba-4593-8609-61d7088ca1f5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_09c5fa45-c70e-44ee-8d53-214f6198b402_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_a09c6efe-e217-4146-aa6c-fa5e183f8095_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period, Treasury Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_71541bcc-989d-4157-8b76-006ce2589596_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d3a64265-0eff-46a0-83ff-d42fdbbf37b0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_e6fbaccd-60da-4850-afde-e6c533f90e50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b18aa86e-2cde-4713-a8ef-c403a9c9eec5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_331f4c0d-182c-47bd-b0af-93bef4f6538e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_6ddbad08-c8ae-40e1-820c-fc46ca56177f_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2fb05891-96e7-4f11-8da3-688a49f3b173_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0eff14b2-24c8-43aa-b8c5-6f6ee7a7da20_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_38db58d9-f288-474b-90fc-974fb0819913_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e0a9c7a9-ed37-4bae-b4aa-76f7376c4b4c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_a9092165-e5fc-47fa-aedb-8abc6932cf6f_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_7bc09ac3-1f5a-433f-92b6-d1bca134099b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_b1b6d84e-ef55-4fc3-afc6-4ca01b11fd43_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cb966b0c-c8cd-4e61-a0ce-87143e513665_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_c244af4d-1926-42ea-983d-658e8f0827f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_d6064a45-9ba4-49ea-9b8d-525ef47c9b24_terseLabel_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, threshold percentage</link:label>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_label_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Threshold Percentage</link:label>
    <link:label id="lab_iart_ConcentrationRiskThresholdPercentage_documentation_en-US" xlink:label="lab_iart_ConcentrationRiskThresholdPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Threshold Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConcentrationRiskThresholdPercentage" xlink:to="lab_iart_ConcentrationRiskThresholdPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f8ed52f7-d67e-43a6-a96f-632a06cd8451_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_37e89d4e-b799-4b11-a299-9684b61a7e66_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange gain</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_a4993d65-5368-40cd-9a59-a32b4917ee78_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible securities</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_c3e4f01a-1688-4d6f-be90-0201d58c55d7_terseLabel_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock and Contract Stock</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_label_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Performance Stock, And Contract Stock [Member]</link:label>
    <link:label id="lab_iart_RestrictedStockPerformanceStockAndContractStockMember_documentation_en-US" xlink:label="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock, performance stock and contract stock member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:href="iart-20221231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:to="lab_iart_RestrictedStockPerformanceStockAndContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_2a229340-1347-4f09-809e-77ac7414732d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Charitable Contribution Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9d07a4ea-431b-410f-bbe0-171d2d23122a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 240,000 authorized shares; 90,477 and 89,600 issued at December&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_761ceae5-c32a-43e5-98e9-88ef3d93347b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e970808b-e8f7-40c4-9456-361a232f79ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwinglineLoanMember_25adcb31-714d-4690-9363-482be3f3a4ed_terseLabel_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_label_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_documentation_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember" xlink:href="iart-20221231.xsd#iart_SwinglineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwinglineLoanMember" xlink:to="lab_iart_SwinglineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_7f2f96b9-c26c-41cd-8612-8d2dbd684861_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_6acfab67-87e7-40f6-9f24-0aa115a4a2de_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_502c4654-5dbf-41ab-aeca-0d094b557ee4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad1a7c52-1b11-4557-a3d8-1a363bfde6ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_89aa191f-ba19-4851-9b6f-bbf8e0fc7dcc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1eab38a3-9b5f-4c5b-ab9e-12eb1bb36d8f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_e578f96f-c866-4485-95c5-c7a51a927d5c_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_1527bd87-ffad-4c75-8a63-183149e9f2bb_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, net of revenue recognized on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_c3f4558f-fb56-4f6a-9328-7a93c6a51f90_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71db7165-2d72-44e4-a213-5ee6b9873af8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_f1a94bc0-53c3-4f6b-934e-40b9efdb1a5b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercised stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_d2e087d3-978d-44d2-a0dd-c5227db85979_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_749f959c-851f-4250-a640-d52241ee44a2_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, shares received at inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases. Shares Received at Inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases. Shares Received at Inception</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:to="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_8f1fede1-a2bd-4f54-9b1d-675d90b0b7fb_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_6f94b99e-2faf-45c4-9bc1-788aea16ca8a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b05cefbb-b663-49e5-bd72-621d35700748_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_7852670c-3db3-4af1-bb47-382d1e13a777_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ecadb9bb-6773-492d-885f-9c37938a5806_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_08c8140a-a7e7-4006-9afb-75c3b8e1f5ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_0d3b8163-a422-494b-a784-c382cd0b2a27_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Current</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f6d113a4-a629-4e57-8226-12b2155d3379_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0489f177-355a-4c87-b65c-3b6854eb05cf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_f7e054a6-5523-4ac4-9525-10eecf7063aa_terseLabel_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_label_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3540f218-4938-4977-8a4d-ee487e2ac2fa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_09bf8e93-f6eb-466f-8b05-f4212104e902_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND DIVESTITURES</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ae8aa41e-d8ed-4ba0-9d09-a4d3da67d32d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_7717d7af-154b-4971-b6c2-53335dd13d2e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4083f02-73bc-489c-a687-6e1a1d862efe_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_fa79850e-4aa4-4c71-ada5-aa05f5b7cef6_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset, increase</link:label>
    <link:label id="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_label_en-US" xlink:label="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Increase Due To 2017 Tax Act</link:label>
    <link:label id="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Increase Due To 2017 Tax Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetIncreaseDueTo2017TaxAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:to="lab_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_98cb136a-d9be-49fb-b1f1-d80c12bafd5c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_28299172-da35-48ee-879d-8b499c12b87d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3928cb01-82b0-4983-a75d-a859b0c2f9db_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_77f9238e-cb07-4dd0-b92f-09aa0fd77267_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b68f7c26-11a9-45a5-aaf5-2a7497e39e72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_52cbf2f7-20a2-4490-8d95-541d0cd85e69_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Four</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractFourMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractFourMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_062ad859-4c22-4262-8758-129f88c602e5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_75983bee-e3bc-4129-b188-59d5ab80f215_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37cbf886-f376-4efb-a09f-1cc51f4549fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_bd8c16e2-cd3f-4b3f-a21b-babe162bbdd6_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value step up on intra-entity transfer of intellectual property</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_7eedfffb-8fda-4ec3-8645-57364b84deac_terseLabel_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_label_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_documentation_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanSpecialtySurgicalMember" xlink:to="lab_iart_CodmanSpecialtySurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_392403ae-d7b8-4928-901f-a70234b7f870_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_1cd6305b-1530-4ce2-b019-cf5d21c46b49_totalLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5025cd77-e3ab-4934-bd99-7ae0fbfe29c2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_0f32c258-1996-4038-ba75-845c2005e01a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_1db4eeef-6daa-46c4-830d-11fbd1f96e4e_terseLabel_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="iart-20221231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cbd96097-d2b6-4461-bdbc-e53db0934eaf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_bc7e1434-f458-4b86-b188-00c43040cc5e_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 6,823 and 4,899 shares at December&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_bc2b7c3b-c6d0-4129-9633-c2e9426439de_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, percentage of expected total repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:to="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cc0bd7aa-153b-4c26-9035-75141b70297e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2a0034a4-eeb2-41d5-a068-6630d3996e25_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_e582e007-93fd-4bb4-9442-eb4fb3d5fe5b_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany profit in inventory</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0c1baaba-f1e7-4475-a64c-74283d97c25f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4d273f48-5762-4161-90ec-f604c17769ed_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_57f18f8a-1c42-454a-90f7-c263f5a20c9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_12cf6b43-593d-4bbe-a457-d1431860a4b5_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination settlement for debt conversion, minimum settled in cash per principal amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_label_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:to="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4c0b03d4-d608-4beb-9726-722250834ef6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_21624a1d-e5d5-4e55-a74a-5042284f1344_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f0d80142-050b-40f3-8596-72658b21c425_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_583d1c97-b8a0-451f-b9e0-07bd3bb91fa2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e76663b6-a8a3-4dd6-b810-547ec2763c2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_80008546-dd17-4973-bbfe-91bda2ec10a9_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_27d03cd5-d955-4847-95fe-cfc2cc28eb72_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_924c81d8-02af-45b8-8f06-6e4b9bf26ad2_terseLabel_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products offered (more than)</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_label_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Number Of Products Offered</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_documentation_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products sold by a segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:href="iart-20221231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:to="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellMember_b6dfba78-8256-4b94-ae5f-700e7ea57229_terseLabel_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:label id="lab_iart_ACellMember_label_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell [Member]</link:label>
    <link:label id="lab_iart_ACellMember_documentation_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember" xlink:href="iart-20221231.xsd#iart_ACellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellMember" xlink:to="lab_iart_ACellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_434a218f-ff11-4a62-96ee-2617e514c3d5_terseLabel_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_label_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_documentation_en-US" xlink:label="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:href="iart-20221231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="lab_iart_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_0d56629b-ff55-4678-84de-1b45b619a784_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_d75dd969-a7ec-434f-aa31-1925cabc928d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gain (loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_4bd5b832-dd94-4f99-9a66-551e6096b5f2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_60372c85-3045-4693-8a60-f50572cab07f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated tax benefit related to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_552de86d-5300-48f3-8813-e98ccea93bca_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a99e1a93-3d52-4fcd-9bdb-7b7d29573cf5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e033691a-32f2-4d4c-91c4-064ed0270e04_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8d8f128e-e323-4325-94fb-ce5936757274_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_a53affa4-308c-4a3d-822a-e9780d78842f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized within accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TrademarksBrandNamesMember_a021ac06-795f-41ed-8eaf-949a01d29ec2_terseLabel_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks/brand names</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_label_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names [Member]</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_documentation_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember" xlink:href="iart-20221231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TrademarksBrandNamesMember" xlink:to="lab_iart_TrademarksBrandNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_31b1a319-ce52-478f-b30d-f92201ed8252_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Uncertain Tax Benefits Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_a7eb983c-7de6-4bdf-842d-7570f077d4b6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_6cff26f2-58d5-4dcf-8c6f-548870f4e92e_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CompletedTechnologyMember_17f00203-0898-4234-ba0b-2a36c46d93a7_terseLabel_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_label_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Technology [Member]</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_documentation_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember" xlink:href="iart-20221231.xsd#iart_CompletedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CompletedTechnologyMember" xlink:to="lab_iart_CompletedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_2843be81-db89-4e75-8dca-a4d2fb04ecf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_1301ae69-9044-4e36-8dda-a98ee31814e8_terseLabel_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments</link:label>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_label_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments [Member]</link:label>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_documentation_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:href="iart-20221231.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:to="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_7829aa7c-5392-4ae4-a319-5679da63e154_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_d29d27e4-3391-43d3-bf92-9bca100a949d_terseLabel_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_label_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification [Member]</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_documentation_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:to="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9841925c-4906-4d5a-8fda-d7954d12e0e9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_90210cad-b2fc-4fdb-8179-8d7f5520b6b0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_9ffb615a-f4f9-4b17-a592-dda7f6509b43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax reconciliation, tax benefit, excess stock-based compensation deductions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_0691094b-adde-49ed-9407-999575870e6d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_52c6a753-75d8-488a-a5f6-5d7c5bc02fc4_terseLabel_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-month USD LIBOR Loan</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_label_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:label id="lab_iart_OneMonthUSDLIBORMember_documentation_en-US" xlink:label="lab_iart_OneMonthUSDLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month USD LIBOR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember" xlink:href="iart-20221231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthUSDLIBORMember" xlink:to="lab_iart_OneMonthUSDLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b9b2ab9-4805-47fd-b69d-9c3abed602a8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_361b9b1d-d473-46c2-b320-1f60ee36ca0e_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateSwapContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap, Contract One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateSwapContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7d8a4560-2cbc-4666-95ad-8be1daf8f8a7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (See Note 13):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c4fd2220-9dad-42dc-8043-fe809ec5a53a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_459f2727-e109-4d26-8c17-6e324490a0e7_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanMember_4e4acee4-a218-4eb7-969d-1f71aa556e16_terseLabel_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman</link:label>
    <link:label id="lab_iart_CodmanMember_label_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:label id="lab_iart_CodmanMember_documentation_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember" xlink:href="iart-20221231.xsd#iart_CodmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanMember" xlink:to="lab_iart_CodmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_4b73076d-7e8c-4d82-8d18-7baefa5ea52e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d5f84be7-1201-4438-967c-b4d3dd820754_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34a3f450-c969-4bc7-a7a7-475b0fbbdd5c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e854d5e6-b17e-4f2c-906f-a2cd824f0084_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fef9585e-87fa-41a4-b58b-82e6641b0729_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds (payments) on swaps designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_24c7b49f-d6ca-43ed-80c4-691c5b7a4232_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt proceeds, classified as equity at time of offering</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_43c08d73-2bf1-4212-ac0f-80cf6cb667f6_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_8d5599e9-6a14-412c-9320-2f80920be18a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_15cde069-0e78-44cb-b3c1-0a64ae4eb607_netLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1d908b8b-6002-4207-a3d6-e68b1ce20040_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_5ee30747-c50f-43bd-bd07-202a93fe7282_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4ad219c9-5604-4deb-9837-df97b37a9760_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_46b1dcf6-f740-496f-97f7-70fd4c6f091b_terseLabel_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of customers over benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_label_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:label id="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark_documentation_en-US" xlink:label="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers Over Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:to="lab_iart_ConcentrationRiskNumberofCustomersOverBenchmark" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FoundationPolicyTextBlock_8ce40227-262d-405a-8f58-578bb2659bb8_terseLabel_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Foundation</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_label_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block]</link:label>
    <link:label id="lab_iart_FoundationPolicyTextBlock_documentation_en-US" xlink:label="lab_iart_FoundationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation [Policy Text Block].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock" xlink:href="iart-20221231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FoundationPolicyTextBlock" xlink:to="lab_iart_FoundationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_97b9c1ed-2f78-436b-97be-14c03437aac2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b691bdb5-3fb5-442d-b635-fb604a8335d6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_adf70cba-96d1-4434-91b3-bf73c3528614_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_06190d32-29e3-43d9-bde7-bcbcff3c7fe4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_47219263-1552-4fc0-8be2-a14ff1942089_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock" xlink:href="iart-20221231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeTableTextBlock" xlink:to="lab_iart_CashFlowLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_2259add6-5f43-4d40-a661-4b30c1004d01_terseLabel_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, number of payments</link:label>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_label_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Number Of Contingent Liabilities</link:label>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Number Of Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:href="iart-20221231.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:to="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_22626473-a865-4710-91b6-da1bf912a237_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_420c631a-4abc-4a09-8c76-851a9780adfc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_663e7ac1-af5e-43c6-b1cd-9b538ae67654_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e2bd712f-a810-4b90-893b-c97ad868b912_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_c49bd7d4-14b5-4909-9da8-3ad9303f45fb_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_0e27ac99-48ee-49b9-bb02-47459b7d5690_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Employee Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_7ff21fb5-5ae5-4940-b33d-84bafd716acb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_722768c0-65d8-4617-96e1-7f105efeab18_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment</link:label>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_label_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustment</link:label>
    <link:label id="lab_iart_BusinessCombinationWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:href="iart-20221231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:to="lab_iart_BusinessCombinationWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_ce4fde99-c6cf-410e-b692-28445de3b3e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of non-core traditional wound care business</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_89be1eba-62ac-4d5a-a43f-2a753a8bb4eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_2c85ad10-ae98-4552-acc4-c85d482990e7_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_333bf759-c78a-4383-8a7e-51f14d9fb75c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_95d9229b-9a6c-459b-8acf-531551170a90_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_22abde4d-bb2d-4908-b3a8-4e0e68e5f5a4_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_26829117-57c6-4933-83d3-8c8b693cfabc_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d7c9b7b3-65a4-4d47-a16e-6672e6876dee_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_0cf6d1ad-c629-4c23-a2ea-19f231201fea_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f339c23-53dd-4af0-bdb5-9c4de96c1ef4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4dc6ff9f-358f-4b5f-b08d-01c95afe30f8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a5296ad-bb32-470c-a03c-be9c1bcec055_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13cc1c71-a83c-4905-865d-bb6ef0aebc86_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5779c423-7711-4129-896b-5ea3f8a965eb_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a0a4dd16-7804-4572-9ac2-f4924d474378_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_84e56eb0-734d-48ca-a626-819152576972_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_554b6927-e0ba-4f18-a005-bf2e3cda758a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_d08c527d-bf1a-4d4c-a7e7-45e88b850ee9_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_23d965b1-9d07-44be-b5e3-9e6d0a3a1a83_terseLabel_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_iart_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6ab6ab2b-9e83-4493-a624-53106d84e9b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_85b79ef4-a7b5-4e51-af76-c0e4a62b2b99_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_49ac797c-6bf1-4476-b3cb-a25ac8f3ada4_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for revenue based performance milestone</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_4b248eac-3654-4e5e-8cf1-e29e2ad96c62_totalLabel_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:href="iart-20221231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:to="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_bfc68e8e-c23e-44d3-851f-ce25ed5a47b3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1ccd10d6-6804-48ec-95d4-15f74aa7d899_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_6ee2caf8-7518-4c43-99f1-34a5796287d5_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodDomain" xlink:to="lab_iart_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a60ff5fc-e040-45a7-b698-b9db822c3557_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum selling price of the company's common stock of the conversion price</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:to="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_820ef77f-ce4f-4057-beca-16010aebd4c9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_4dbb50c4-94c1-4562-b7b8-4f0150afdc5a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_18177a24-55d5-4704-aec1-b3495e380b86_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_ad363866-66c4-4be9-9c52-c7a15006ac40_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_df5a4fa9-8163-429c-8186-105ab16f9fab_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c40dda41-6701-44e3-b3e2-2c219e92511c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_1703cec9-58c3-4eb0-94b6-75b292695457_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_48fbbc58-d021-4803-b3a9-535d34602674_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_f68227ba-221b-42d0-a638-fdf313cf8384_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_09a80392-2384-443b-a83b-7c9f10d04e00_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd6aa7db-ecd5-4a95-a5f3-cfab0385ed44_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b8ea31f4-d55e-462c-9dfd-01f530a78cf6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_010563ff-580c-4445-b5c2-6308ad5bd5c8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Interest</link:label>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Capitalization, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:to="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b37c514f-0d68-4bdb-8efd-41c694b23d30_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0d03cc3c-c649-4c38-be2d-947d77356391_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_845c9a1e-cae2-4c76-906e-28bea71f977b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_ba3a06e2-09b3-4b36-96a7-390919972e68_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_c541c648-aeb6-4ffb-9306-07a924cd5d4b_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination Benefits</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_e7f18f42-12ce-46dd-b1b8-572ce31d6018_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_6f4d2969-0353-4fb3-9b85-c0457169e0e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_52fcb00f-e356-4903-adf2-d2c77c519464_terseLabel_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Association Inc</link:label>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_label_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Associates Inc [Member]</link:label>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_documentation_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Associates Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SurgicalInnovationAssociatesIncMember" xlink:to="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_20b3c1ca-e633-43e1-b703-76d8e196dcce_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_ee3c6472-a7ad-4aad-8f8f-0eb5a7957ff8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_46eb90a4-c962-416e-8b00-78b32d08f06f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_074a4e39-db90-4b92-9848-cf24b47b9a19_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PrivateLabelMember_6f1bd398-c183-49f5-a1fc-42bd3f7b0473_terseLabel_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label</link:label>
    <link:label id="lab_iart_PrivateLabelMember_label_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:label id="lab_iart_PrivateLabelMember_documentation_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember" xlink:href="iart-20221231.xsd#iart_PrivateLabelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PrivateLabelMember" xlink:to="lab_iart_PrivateLabelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AllOtherMember_3392eeca-84bd-44b1-826a-bbbb101fc6ba_terseLabel_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_iart_AllOtherMember_label_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_iart_AllOtherMember_documentation_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember" xlink:href="iart-20221231.xsd#iart_AllOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AllOtherMember" xlink:to="lab_iart_AllOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9f8fec42-618e-4b3b-852e-37b76b881fea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_027d970e-4e9f-47d8-9e8c-e1bbe32a8725_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_5f834d3b-bee8-41a6-b5ca-753b077f751f_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_6f3ed377-8572-4089-87f6-1fb5b1dbd05f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_055ab027-db87-4e89-afd7-3bfabccfa9b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_9b9b357d-cf99-4f3f-b800-9abd3ed5f7b8_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b77d1b18-9dbe-4493-8ad9-15b944a72619_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ddf60-8aae-4fe4-ae89-40cdda2acb04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_9bd1dcad-d58b-48d3-b30d-ea769be3a95f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_3a576064-9106-48ce-9e3f-8dc9ab299cc6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_69ce4456-a824-454c-91a3-35700e3adf76_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a1c9b40f-c10d-4521-96a6-6f41c3a09996_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_34eb3c06-3e20-4905-ba1e-45eedcc0376f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9f61e5fa-50fc-4285-a176-7836ea15a93c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4c544cdd-7291-4016-9bbb-91eb048ac25f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0a1b3c68-b46a-4717-9a4f-5f1c1820b947_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_7bf2f053-1cd0-47ba-81a4-fdd2cf9af8cc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_46e1e014-0e52-4eea-a5f5-7d1fabda31ec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9fa1e13-0f7a-4d26-b0ef-9798bdecb663_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_077e5158-6c8b-40bd-9393-6e628ec1405a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_dabf53c1-a0be-41bf-a376-9c924c868196_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_25f1e02a-9f09-439a-9f87-0c574170bbde_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_f8baf534-f0f9-4968-9a98-6fb3bc2117ce_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f36db997-d879-409a-a293-1a572ac8c2e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic And Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7cb0f7eb-0fe4-4cb9-8041-f203cf70f52d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_9fca9178-d27c-4fd5-a0a3-a58e917d3c82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_15b58a61-9be1-4848-beaf-94f58ad1b1f6_terseLabel_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_label_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:label id="lab_iart_ReboundTherapeuticsCorporationMember_documentation_en-US" xlink:label="lab_iart_ReboundTherapeuticsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebound Therapeutics Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember" xlink:href="iart-20221231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReboundTherapeuticsCorporationMember" xlink:to="lab_iart_ReboundTherapeuticsCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5469431d-d0d8-4ee1-a27e-8d5de10b3e3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60e7eafd-2990-40ba-bc8c-34cf8a9c9e50_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84f91d38-2838-4ca2-8a56-f237745d2e8f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e2ba6538-1066-4bab-9c52-15d2733a8123_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandOnePlanMember_ed930e13-9489-49b4-8f5c-e1168371e67f_terseLabel_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2001 Plan</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_label_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:label id="lab_iart_TwoThousandOnePlanMember_documentation_en-US" xlink:label="lab_iart_TwoThousandOnePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand One Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember" xlink:href="iart-20221231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandOnePlanMember" xlink:to="lab_iart_TwoThousandOnePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_f6213010-4aaa-4f5b-9db3-b267c5a4c161_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="iart-20221231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_faf9449b-d5d0-44f5-a26e-d94e23e596e2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Uncertain Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ea7a33d0-62c2-42c9-b5cb-73321fd63c8d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_c7e05fe8-4b11-49e5-98d6-2598a86392ed_terseLabel_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="iart-20221231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_bd7b8dd1-184c-4d7d-b931-edb9235b86e6_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_e8869702-3d01-491d-b84e-b971f362a3d4_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodAxis" xlink:to="lab_iart_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_20755cd3-60ae-443c-91a5-10ada96bbc41_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_7aed7803-91d2-429f-992e-512f29425d19_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_29d7a1b2-ab0e-4b99-acea-05e18cd7b02c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceLineItems" xlink:to="lab_us-gaap_ValuationAllowanceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_f41c1387-e65e-46d3-8348-bac64713df45_terseLabel_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options (or more)</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="iart-20221231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0ec53e8d-d200-4047-9385-53ac691829fe_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_ec13e524-8100-405f-bab9-1c387e15c960_terseLabel_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval</link:label>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_label_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval [Member]</link:label>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_documentation_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember" xlink:href="iart-20221231.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FDAApprovalOfPremarketApprovalMember" xlink:to="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_065a800d-2160-4e9e-aad4-e07a83dc8fd5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cd35bb3e-f268-4dc9-a6c2-ddea20262367_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_0a903bcf-ac39-46de-bb9e-f88533023a1d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_87ac23ea-e944-4010-a8ac-750f3eb8aa2e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_37c3cb52-86f3-4e4a-b6f3-db89bfd2b8b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of the year</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_6464185d-d27a-4a50-94e5-fb6fe52cfd7c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of the year</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_1d103af2-9a05-4b2a-bf44-9786d4c4c241_terseLabel_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, capitalized expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_label_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:label id="lab_iart_InventoryCapitalizedExpenses_documentation_en-US" xlink:label="lab_iart_InventoryCapitalizedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Capitalized Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses" xlink:href="iart-20221231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InventoryCapitalizedExpenses" xlink:to="lab_iart_InventoryCapitalizedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_0fe17b38-c18f-40d4-9538-5cb345632baa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, fair value of assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_d80ec14c-db40-48f2-a8ac-6611d35c6da5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0fb59527-24c0-42d3-9943-5295945dd9d8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a22bbc13-2470-4e43-8155-89ac3c6385d7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_a676333e-2031-4494-95b4-3ba10eeaccfc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ae202e5-1c78-41d6-b9e0-6ba46a937d39_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_11344abc-652a-4571-bde0-6926542276d9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_7c70e0a0-e2ed-4013-ad20-4e541da53573_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for extended lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_aab7a07f-4c6f-4711-bcb1-69363cec326c_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d4a669a6-385d-49a0-a0fd-3fb26f80a543_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net period benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_6f8a62d5-bc6b-407c-8aed-c9eca7bb001b_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_f975d04d-346b-4af7-9db1-489291e270a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred to trade receivable from contract asset included in beginning of the year contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4d3249af-af0a-4e79-acee-a12fcd7739b9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_676aa510-f70b-472f-98bc-763f91791743_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b1cf444e-ac1d-437a-b10e-6dd148fea252_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a419b115-1b04-4c8d-bb7f-35caa7861699_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_babcf6cd-ea59-4c94-909c-899ac1f02705_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_fc858a35-812b-4ce9-bc85-8ee0e6fa1847_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_0ba1328f-60c3-48e3-be6a-d4df75cf1188_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_8a129a09-c5bf-4fd2-b90b-0468f7202ac1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_22f609b9-7938-457e-9c55-3c9547132407_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_23586547-cb48-4d74-9adf-cef7b36f84c0_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overnight Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_000029fa-94ed-44f7-979c-c6f43192de92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_577493fd-7ac7-4dda-a4c5-f75eb0a5f201_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES AND RELATED PARTY LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_46838ad1-b36b-426b-b191-1241ff02f369_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InstrumentsMember_4403add0-60f0-4672-b5dc-7d8effa5f8d6_terseLabel_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_iart_InstrumentsMember_label_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_iart_InstrumentsMember_documentation_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember" xlink:href="iart-20221231.xsd#iart_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InstrumentsMember" xlink:to="lab_iart_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_4d346333-6e1f-4671-bc40-584efe09b175_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_85b70b12-b8de-4493-b434-bfb6ce84b1a3_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect on net income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_0f711603-81a8-4841-8cd0-ced0b9353ab6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, Beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_73aa8cc7-75cf-4228-b896-29d03c121d2a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_e3583296-d9e7-4658-b502-2938af61f8c7_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestOfWorldMember_3b1f12e6-5e9a-4c12-9877-e5063490abee_terseLabel_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World</link:label>
    <link:label id="lab_iart_RestOfWorldMember_label_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_iart_RestOfWorldMember_documentation_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from rest of the world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember" xlink:href="iart-20221231.xsd#iart_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestOfWorldMember" xlink:to="lab_iart_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f1db356f-cfeb-4726-b1d3-27ea631138be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_948d8ea9-291a-47b4-adfa-83effad0db98_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_a611fa60-cda7-4b42-acdc-cc618b07e3ae_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_33cb32e1-64b4-47a8-9a86-db1866505984_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8f5dff71-eec3-4b0d-ac88-bca2685aaa7c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_3128faa2-4a9a-4f7b-aba2-9c15c2b8e4aa_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit, transfer intra-entity intellectual property, amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OptionToExtendLeaseYears_71f99d71-6579-4ca3-812a-3531144c1c65_terseLabel_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_label_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Extend Lease, Years</link:label>
    <link:label id="lab_iart_OptionToExtendLeaseYears_documentation_en-US" xlink:label="lab_iart_OptionToExtendLeaseYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears" xlink:href="iart-20221231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OptionToExtendLeaseYears" xlink:to="lab_iart_OptionToExtendLeaseYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_23aefba8-4608-46a8-af38-41d1e0cd481a_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_be7992d0-b97a-480e-a058-50fe730877d9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_65687d6e-c4b6-4314-9f6b-70f0e84a0c49_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_b2d10560-cc91-4cad-9803-675bda48310b_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible facilitative costs</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_3850ef29-f0af-4374-a347-52ede43e31b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense related to sale of business</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_8483d21f-3195-4e94-ad37-aca4b2a76f47_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_40a95f5d-b7bb-4c8a-9102-010bf23dda8c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) estimated to be reclassified to earnings during next twelve months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ab689e74-6906-4450-ad39-fb5ad59f96d5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_fafd93b1-6f03-4e57-b844-52836e643354_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_1041adb3-278a-4ebe-adb2-4afdceaf450c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_1c661a57-c8bc-40d9-b5f7-40a936d1581b_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_ebf4488f-0c56-4194-832e-a03e233277ca_negatedTerseLabel_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_label_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:label id="lab_iart_PaymentsForProceedsFromBusinessAcquisitions_documentation_en-US" xlink:label="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:href="iart-20221231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:to="lab_iart_PaymentsForProceedsFromBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_0fdfa557-50bc-438c-838e-e92f6cb00ccb_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_42b234c0-d215-4fe0-a0d4-352a3cb9489f_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_d39764dc-ad08-4498-8d25-1d81552169da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reclassification adjustments for gain (loss) included in net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_de35b771-044f-485d-afd1-ba53f851e767_terseLabel_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_label_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_documentation_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ArkisBioSciencesInc.Member" xlink:to="lab_iart_ArkisBioSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_878cfab0-645a-4055-827b-dcf0ace31c2b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_51d050dc-6ab2-4c16-89b6-7cbc562debd5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_b17de3cb-79ca-48b1-aa11-170185b5089d_terseLabel_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones</link:label>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_label_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones [Member]</link:label>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_documentation_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember" xlink:href="iart-20221231.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueBasedPerformanceMilestonesMember" xlink:to="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5adf08a1-b7a5-42e3-bb3f-03373ebeb3b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearTwo_eefd4a37-1fd4-4e29-a84b-d545968c2872_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_label_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearTwo" xlink:to="lab_iart_InterestPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_b3c748b9-b6ef-4f86-977c-f3ac2b8f7022_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_c6904b51-d410-4a9d-96ea-522c377770ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ca407522-9a5e-4abb-ac2e-b9eebf106552_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_8e86e156-aa88-48a3-a2f9-463f288974c9_negatedLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Premiums Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:to="lab_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_5708dcd3-b392-443f-bbc2-afc99faee21d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_575e4a28-6397-4543-92cf-a149fe06a65a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9b561efa-8bdd-40b0-81f3-28f1c39df5f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_e9a4c2b3-09cd-4c15-8767-74ee71230e80_terseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash divested from deconsolidation</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4dba3fd9-97c7-42ee-98d9-d3072ff46d53_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fdcfa21e-d4c7-407d-8595-0b16edbb8658_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c5431601-8960-416c-9aa7-244bafce71ff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1543e52e-e3af-4829-a8aa-f77db5b6482b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_8cf2f7e5-e4c7-4c6c-8304-eb8bd45351ec_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_98ab54ae-cecc-46d7-b94c-8dd38399f558_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_7c5148d3-e7f0-437e-ad76-7832d147d747_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_32132ac1-2cdd-4b91-9e26-a2f733bc8bb0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_03a7fdbe-8911-41a9-a969-e16858f47a6c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_2dd537fa-0c41-49ce-9bd8-a2a48ae03c00_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_b8e6e7e6-03ef-464f-97d1-8c55a5996e04_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c182aee3-c1e8-4c53-82d1-a9bb97c21980_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_b6cb286e-f17d-4c8a-8db6-e6a4c23ac18f_terseLabel_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in authorized shares (in shares)</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_label_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Authorized Shares</link:label>
    <link:label id="lab_iart_IncreaseInAuthorizedShares_documentation_en-US" xlink:label="lab_iart_IncreaseInAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase in the number of authorized shares under the Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares" xlink:href="iart-20221231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IncreaseInAuthorizedShares" xlink:to="lab_iart_IncreaseInAuthorizedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_28d6bea8-7f7d-4c68-a877-c653a49c3728_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ec5c7b8d-028b-4370-88b6-2307420ca95c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ebed7d98-87b2-4d2e-9d75-78f88c0fa775_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_4db4650c-c6e5-438f-a245-8c1274f84f49_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_16bce721-823c-4f8b-882a-fa38047973ed_netLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_f3c72a04-be28-4a42-ad10-70a38f17d611_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_a13aa6c0-6ba0-44f1-8c4e-22f5bc06ab50_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_d2f0928b-e441-4d79-9d6c-d16333af01a7_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured long-term debt, securitization program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_01ee6c58-b157-4ca2-9966-5e9220f162cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_ef5fd862-a302-4e5f-a5e8-997b094aeb44_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a71111cc-38a4-43c9-91d1-31619244b9d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4ab5b54c-c921-4130-8020-b0837ab035ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0100b289-e0ea-4c0e-820f-f4433588dd89_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_b71aec7f-8ed3-48b9-9bd6-fe7388acf1a0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_613e1634-47a3-498b-a4be-f9f84d3e44f0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts reclassified from accumulated other comprehensive income, net</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_1c7c3998-afa0-4361-b4c0-3d66b799372f_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:to="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_2425377e-7dee-4085-80a8-d3ad9c871961_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf273b3f-e6f1-4dd9-9340-68cf27db3f57_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_03278192-a664-4759-9210-23841d0fa9f3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_be0bbc0e-4b55-4c37-9bab-6d8730d47119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_cedbe59d-c4e8-4ec0-9b7c-87d6300d905d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9f4d8aee-69d8-46ff-a0ae-d9fe70ffb310_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_c571e8c2-228e-44e5-82d3-081e96a85c6b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a656d883-d113-436e-b268-f36baddae992_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7afd4331-b3f6-4db1-b052-530faa2914dd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d1b30e7-5b35-44d9-8949-d750e6d0a501_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_836a84b9-dbb4-408c-bdfa-695931d36362_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_1dccc070-8352-4cac-bc0c-575253b8abcb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_dc8b5237-090c-4e67-853e-352541390219_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_4a99fd42-b6b9-4651-b66c-47c2b826e19e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d56457b0-1437-4051-ae90-e3feff5e48fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0bf6fe2b-796d-4a52-92d2-3b4faf05497c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_0b6c99a1-ef26-4560-a803-c003d74bcebf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_7482cce4-0191-437e-97ee-a0e05c192111_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_214c76e1-55ff-4dae-b861-24b8a6fb6201_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_98ecfd7e-249f-4404-96ab-ab2fe2483fae_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ccc05eec-24d4-4da7-bd18-0f4c35867ff1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_05a65381-f23c-47d2-8337-b9cea5d91dfe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1cbe5459-4278-47a2-8394-6eb6269d491b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_ca85018f-1c00-4db8-812c-03f12071a545_terseLabel_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days from shipment to issue a credit on returned goods</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_label_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue Of Credit, Number Of Days From Shipment</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_documentation_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue of Credit, Number of Days from Shipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:href="iart-20221231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:to="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_82dfc7ee-3b90-455f-81f8-161da120c645_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_ca30f293-28ca-4fe6-9df5-9452eb60163a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Next five years</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_1f3c7c7f-a2ad-49f6-8b5b-3b4af690b1e5_terseLabel_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory purchase, prepaid expenses and other current assets</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_label_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Assets , Current</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_documentation_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:to="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_bbafb863-d609-44b5-94b3-16b1ad6ff7c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1aa0f108-7924-4e79-8adc-af052bc145f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_02b54449-0fa2-4180-9926-f795fce8783c_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4cf24bdd-8864-406a-83fe-ab35d8b86c8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_fc983645-f16f-4863-a05d-3576c4e539be_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset-operating leases and Other assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_31fe0de0-940b-411b-abcb-71f82602f4cb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentOneMember_3d719925-2fe1-4aaa-b588-ccbad865f1c1_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_label_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember" xlink:href="iart-20221231.xsd#iart_MilestonePaymentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentOneMember" xlink:to="lab_iart_MilestonePaymentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_d00ae312-ff64-4c56-b705-913ea0b01368_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_12304a32-346d-4639-8d35-0dd00eebc897_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_7bc4c040-61de-44ce-9aea-218975ff0bb1_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_label_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:href="iart-20221231.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:to="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_027ce271-41aa-4940-bc6a-0f2a430566e2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years' tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_8fdfd89d-d55d-4c59-994d-0fdf37757b93_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_295d9593-73f6-4cf1-ac37-a105a0f64aee_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8390d1df-83c1-4675-969f-2182eb136a3e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_2280a8d6-95bd-4505-97a9-4ae0441b670c_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of bond issuance discount</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_256bdeac-7772-4d4c-9762-67993610968a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested or expected to vest at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_27a38703-43fe-4764-94a4-42933d14a3d9_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalization of research and development expenses</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f864d58b-f871-46fd-87fb-fcf9e32d4ec6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e9ece1d8-e232-4b9d-b3af-0364969bb138_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_14847347-d8cf-4d5e-b5d4-17eff05fbe22_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_fcef6dd5-e0b9-4d46-9da1-f709f4692564_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_72a3920b-7766-421e-ae17-46a78d6b9387_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_fb6269cc-79d8-4e69-903c-19abdcbbfc9f_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, base salary, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ce57527d-0af8-4b21-90e5-0ae9d5e38c7e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_f8afb78d-ee1f-4b26-8953-4cecf09d5dcd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_6ce1c69c-636c-4b33-9b1d-3c2208efc3bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_bbf0394f-40b2-402b-979c-38c9212bb72c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_65e6b75f-c014-4f53-987d-d18505d7491e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_c41400a0-d6d8-41f4-a851-33dfa8608c87_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8694a1a9-4128-48e7-9cc3-6ffc1e1e06f5_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_bbae7d7f-ef46-49c7-acf0-569409dfb12d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6734ac9b-5fc2-4b93-bedc-f77426382f72_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9b809f46-0074-4d87-a472-74ab5921263f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a9f00ae4-5e53-484f-982a-f56052cde77b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fb5d3fb4-10af-4025-b4cd-35acc798cc43_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_93c470de-9971-4f41-91a5-084d4b69b8a3_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_70ec6802-e6df-40e4-b205-30b9ec94f8a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_e640e6c0-f409-410f-b9e1-4f577aa5da34_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, additional shares received</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Additional Shares Received</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Additional Shares Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesAdditionalSharesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:to="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d66d1238-0d31-4e58-92e2-548e0cec5366_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SupplierRelationShipsMember_ad3b5e71-04ff-4037-9e4f-7565917a8877_terseLabel_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier relationships</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_label_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_documentation_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember" xlink:href="iart-20221231.xsd#iart_SupplierRelationShipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SupplierRelationShipsMember" xlink:to="lab_iart_SupplierRelationShipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c95a9b4-b610-4671-8740-7d05b622878b_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5d3c653a-67a2-47fc-97d2-d23594333c00_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7dee0093-9ebb-4fc9-be25-41d4d0175d9b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0198e674-bd5c-4858-9331-3e11eddce153_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_561663c7-9460-455b-abbb-3a6c2f06c115_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_36371c0e-147f-4448-a0ae-1e0e9805d8f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_6b3346a6-55c6-4344-8c85-f3cf3c5536d9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceTable" xlink:to="lab_us-gaap_ValuationAllowanceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_2efbe8b3-f007-431f-aab5-f1f225df99a7_terseLabel_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operation, continuing involvement, prepaid asset</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_label_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Asset</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_documentation_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:to="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_84bb9fd9-bbdf-453a-a4d5-20253af6fe5d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3cb10ff5-0ba7-473e-9562-f873d02e38fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_c8a0f976-ee1b-43e3-9daa-235929371d7c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_0b788b2a-519b-4300-a7f9-14e595a1a486_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c91e4001-a7dc-4b79-ac97-254c4f4d3242_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_5029bf8e-4850-4f09-a48b-3f2e641137df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Major Classes of Assets and Liabilities Held For Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3add0013-13e3-481b-8443-64991e719902_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_38b13edd-ccc9-48c0-b4dd-fcdfe4c5492f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_4f12226f-0609-4311-b256-85b3b161bc60_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures, and office equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_953194ef-a5b0-4062-8c5c-92b3c5e1f43c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ac3df952-b1f3-4521-9954-abed61a181d6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_24bec36f-0a9d-45c8-b68f-816918628f11_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_d1a370a2-7ffe-4f17-b82a-f1e9b8d33f73_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contributions made</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8a5523e8-215e-4dd2-a0ec-1b7316b91af8_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_86d21ad5-c500-46bd-9cb0-f3a2d681b1e5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, shares received at inception</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ec5d0747-75fc-4202-a0a6-7ca1981be558_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_30dda802-16c7-4803-ac91-bbeb31a9a8bb_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_f9c77643-0253-4aca-b79a-1cfd395f2fae_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_2d0b7ed3-234b-4011-ac60-f61420208507_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_20ed3ece-2176-4488-8798-f87e5e72bf6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_ba5416c7-9c3a-41cd-ac0c-4ae439b0793a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowances of $4,304 and $4,735</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e0ad0398-dce0-4d48-8355-62a07d88e82b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_a5601599-09d6-42fb-867a-962b0158ca70_terseLabel_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of business - book to tax differences</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_label_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:label id="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_documentation_en-US" xlink:label="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:to="lab_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_febb5ec4-fdb3-48ef-9d56-2d7632d64d23_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06126a17-9493-41dd-99f0-ba5441b16c26_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91e2b774-3143-48bd-aa52-d471b5ceab90_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_d276ecda-4b22-4f70-845d-5032df312702_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_116f91f0-923c-4828-8d48-633006d9b27d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Benefit Obligations and Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c9f203f0-1921-45c5-9297-4ce291241dc9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a666cac7-6359-4ff0-85d2-91d28683d176_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a24fde23-13e6-4b14-b2dc-d9a726198974_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration and others</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_b2f4c23d-c6bc-47e2-be32-8cbaccfe1269_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:href="iart-20221231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f58b0b08-a1e5-4ffb-99a5-429b2e51d702_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9dea5be7-610b-47d2-968d-d8149921a403_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_325176a8-54f4-4416-a340-0bbf2b9d96cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a7eac643-89a0-4f58-9761-35a9a5065378_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c446774a-a184-4410-8e9b-f706a0022fcb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_915b9f1e-c498-438f-bce7-723f71aac85e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_0a720bbb-c9cf-41ce-8b6c-8c34a889e10a_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DemonstrationEquipmentMember_8100663e-3e19-4a23-80e5-221cb9af93d6_terseLabel_en-US" xlink:label="lab_iart_DemonstrationEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration equipment</link:label>
    <link:label id="lab_iart_DemonstrationEquipmentMember_label_en-US" xlink:label="lab_iart_DemonstrationEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Equipment [Member]</link:label>
    <link:label id="lab_iart_DemonstrationEquipmentMember_documentation_en-US" xlink:label="lab_iart_DemonstrationEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DemonstrationEquipmentMember" xlink:href="iart-20221231.xsd#iart_DemonstrationEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DemonstrationEquipmentMember" xlink:to="lab_iart_DemonstrationEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_a6e441f6-e08f-465b-b791-340ef65bcf66_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_51604b71-d33d-49dc-a37a-3c2f9436195c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_ed8e3a54-07b2-4aa6-9068-2210763b63af_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e08c4d12-aca1-4182-abf4-d33f277f2b05_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_5cc1177d-0885-463a-a0e4-f142b1ea1883_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9d69b437-6eaa-4e13-b690-1cf2a1756fc0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_82c50c2c-5c68-4d8b-a1aa-d8ffe2e9dacf_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d67d591d-eafb-4579-8123-efcf2ac48843_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fe5b4fb3-5730-43d1-8065-8d9d2e190e01_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_a4b2082d-20fa-48c6-884d-26a5619c707d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory related items</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_ca12149e-62b9-45a1-b6b1-7d4ea978de6f_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, net of transferred to trade receivables on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_label_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:to="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_62185daa-4bcf-4758-bbb3-bc8f110716c7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6eca52c5-4147-46c3-948c-216b8944440a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_f69c30b3-b120-44b2-a6e9-4cef124a04c6_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_fa3deef3-18c5-4277-8c78-23161948b647_terseLabel_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_label_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Rate Of Lease Agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_documentation_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement" xlink:href="iart-20221231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AnnualRateOfLeaseAgreement" xlink:to="lab_iart_AnnualRateOfLeaseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_e189ca03-54ac-4b66-aef1-c8d67e5d5e8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_d1a3085c-38c7-478c-8ed5-18456c5aff84_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6cd86f6c-44da-4a0f-9bc8-3e6d393cc9ec_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_deb53b44-e856-4ae5-afb7-909e17bbff0a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3c17710b-509b-4a98-9d3b-820c5d21794f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8efd881f-1089-4b27-8013-6746088307b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1e7b4e2f-348a-4ccd-a6f3-2b583cda1727_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b0bd71b6-407b-41d7-ba36-a33ec0e14aaf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1f348159-cfa6-4aad-84c1-f9e993ded416_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a04c6dc5-eac5-4297-8440-b0bf09ff10f8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_cdfccaf3-c321-44fa-ae8d-dd5b571f0ad4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b2e10b40-9ed1-4c54-89a9-975eacffd3c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value, options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_db487592-aa1a-4df5-bca0-a4bcd3f70b2c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44827c82-e075-49c5-b1bc-d0e424a20371_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_050815c5-4b03-421c-9efd-2ff9bd3fb73a_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_f944f1bb-0f8d-4b26-b3ef-9e1c63bb1306_terseLabel_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP proceeds received</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_label_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Proceeds</link:label>
    <link:label id="lab_iart_EmployeeStockPurchasePlanProceeds_documentation_en-US" xlink:label="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from employees in connection with the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:href="iart-20221231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeStockPurchasePlanProceeds" xlink:to="lab_iart_EmployeeStockPurchasePlanProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c7975f95-0993-4793-8159-585239ac8bf8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_ca6a4bba-f870-47ac-93c0-519243370c78_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of extremity orthopedics business, payment for terminating license agreement</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_82e167d9-c39c-49c7-8e24-163480f8ed96_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life of option from grant date</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8aef5ae0-02f9-4835-afa6-8c10a0f3be84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impact on Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_56856ab7-edda-4f42-bc0c-eabefeb9d086_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_4dd6d58e-79ab-4c7d-a557-a39b5083ff47_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_96493942-f976-4611-b59c-b7072b8632e8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized incremental financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d44a053e-5999-41d2-93c2-041a660545a7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_1565afed-9734-4b1f-b677-1515eceddf07_terseLabel_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Month Eurodollar Rate</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_label_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:label id="lab_iart_OneMonthEurodollarRateMember_documentation_en-US" xlink:label="lab_iart_OneMonthEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember" xlink:href="iart-20221231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_OneMonthEurodollarRateMember" xlink:to="lab_iart_OneMonthEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_5df52174-9c87-4f37-b57c-6fb7bd8a46f5_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_c541434a-a9f0-43bf-bafb-074e72b1bf9e_terseLabel_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases:</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_label_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:label id="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_documentation_en-US" xlink:label="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases During Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:href="iart-20221231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:to="lab_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e4136683-de90-4239-98f8-38c6d5bdb81b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_f829e446-a06f-415b-ab99-cd9811953c29_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_230defff-85e2-46d1-b05d-840040030aa2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_39b7f9f1-b358-48ad-ac99-ae0ab76c9ccb_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_633e69c8-1731-48b3-8003-d7751b7dffae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_368eae45-cb29-4327-848b-150e618d0ccb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_9f177616-5f59-4384-9a7b-380f960a395e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9d9cb880-2565-460d-b84b-7b60537cfc3e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_aa82c421-7b48-4045-ab42-020a6fc41f2f_terseLabel_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment To Be Paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_label_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment To Be Paid</link:label>
    <link:label id="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_documentation_en-US" xlink:label="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Development Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:href="iart-20221231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:to="lab_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cb801ebe-9098-4c9e-a0bb-74f6351154f7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_27cb70a0-5434-415f-a73c-c29b2f52dc50_terseLabel_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_label_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_documentation_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:href="iart-20221231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:to="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8804ec0c-c99a-4caf-99b5-a5f8c8feca10_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_dfba8437-1362-4ce4-9ea0-6649a956e8d3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c8e4cac1-a012-42c5-bde7-b224dc4b5d45_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_cee987b4-e797-4170-977f-7a9ea358b0de_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense capitalized into property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalizedAdjustment_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalizedAdjustment" xlink:to="lab_us-gaap_InterestCostsCapitalizedAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2168f62b-570e-4af9-ae5a-640f3bd4d9e8_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment purchases included in liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_7569e90b-e40f-4fdb-9de8-fccf6db4ce72_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_7f99c51d-434f-4dd5-88a6-20165dff50a1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TermLoanFacilityMember_13705c98-31a9-4140-b101-fc695bbb9459_terseLabel_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_label_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember" xlink:href="iart-20221231.xsd#iart_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TermLoanFacilityMember" xlink:to="lab_iart_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2c1f906e-34cd-474b-b58e-e5cea0327158_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1774b124-2681-42ff-977a-b4e91f4f5e11_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_603c2957-834f-49b9-afb0-18bcac475869_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2cc5fe72-b4d2-4652-abdd-6b35ac33c57e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3b830863-b66f-41b3-aba5-22fc37dbfa2f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from option exercises and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7e6ab97c-9154-44fa-add4-73c5cf192a1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Sales and Profit, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_68e5ffc3-286d-4e10-a01a-e1670f609a00_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_421ac800-b602-4cdf-b4d7-c48e7de98343_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_23888bdb-cb73-4899-966d-193a521d8191_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_66c6d432-93ba-4f03-9d4f-4a9c5d47c0d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Funded Status</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_3e26a704-38ef-4407-af16-dd431ab97f20_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-Currency Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_05563e67-1e18-40ce-9e9d-cd0ace95eee4_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_7e6430a5-35d8-4964-bfd2-867ed5b2e41e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a523fbae-8cc5-4f96-a7b7-cdba026a1ce7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_41bf3ae5-f25e-4d39-9659-c521e0618920_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_3f0ffa93-0807-46bc-862b-875ecd2b67ab_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b40f13e0-3f1f-4f92-b599-64d51da2d7cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a66e65c0-6fa8-406a-b208-a9df201a0761_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_a1f3397b-c4c4-4b44-83bf-f2316093854e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce33a910-88f3-4460-9c50-45e318723cc2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28ba812e-0b32-4c8a-9794-aa43477ddc17_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2a4a992d-2a93-447a-8ef2-820de8d3fb63_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashLeaseExpense_4ae4131d-805a-4785-a56b-5c1108258a23_terseLabel_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_label_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense" xlink:href="iart-20221231.xsd#iart_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashLeaseExpense" xlink:to="lab_iart_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_ac3e61ed-063d-4fbb-82b2-d639aab42305_terseLabel_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:href="iart-20221231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_8ce57993-e27b-40de-8a04-7d02563119f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d408714c-9b03-43f4-b187-822d884e43f1_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_002c99a2-5a90-4c66-ad41-96706c2f25aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ad8276ac-c4b3-4bc9-b188-f4c3e2bec4aa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8f35f6b3-35a0-462b-8443-d2837a810d88_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b544fd0e-96a1-4789-903b-8007bf1fc346_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3259e59c-bb16-4cbd-aa60-e30f766d2225_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_346daf83-3a4b-43ed-abe6-dd49a1f9a6fd_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_acab52da-6664-43e6-89a6-11d8df4a25c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_57985e49-6766-4d81-8653-1280a223b6e9_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellations (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_5f1e72c9-c252-4bbe-b341-3d2b5a402aba_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Repayment</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cdd1c269-455f-43d4-acf1-c84deb2324f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d37593d3-f4ed-44e2-b2ce-ef07a23b6adb_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8a2413fa-a0f6-4db2-856f-2dcec87071b0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_c74bca37-cd41-42dd-bf00-c55a64bbbedb_terseLabel_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security facility, weighted average interest rate</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_label_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_documentation_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:href="iart-20221231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:to="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_635f25f8-9e03-41a5-89fb-b7ee0612afd6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments not designated as hedging instruments, gain (loss), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_87d813b1-7465-4056-b184-573ac8cc79b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_d45ceeb3-3c3c-494a-9e5b-1ca0766d86c8_terseLabel_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing period for products shipped with no alternative use and right of payment for performance</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_label_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:label id="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_documentation_en-US" xlink:label="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:href="iart-20221231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:to="lab_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_2972b3c2-61b7-42fc-84f0-94640fa81f23_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_2fed6fd4-2d77-4749-ae8b-9bb6e0561e1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c8687147-8ef3-4382-b987-5ea4ae46c139_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7586f49e-4cab-4474-89bf-ab69a10412c9_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of revenue included in beginning of year contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7c59594e-fa55-4c98-b695-6fc4ad48d9a6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_16dfea94-8fdc-4196-b772-ac49b8f76dee_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transitional supply agreement, payable</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_8b28ae1b-3636-40fe-a7fb-ef8ff0caedfa_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_b9e4f232-3687-477f-b32f-a4c5fce086f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_f1729b4d-91f1-4bc1-9962-0220f2dac13c_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_67ff6a32-1f7f-412a-9239-fe71c03d5a00_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business, contingent consideration</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d40b8bf1-9a05-4d9a-adab-b63d0d0a7c3a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied, expected timing</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_355f26ef-637f-48e6-a699-5888c00d753b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_512304fd-8169-4ec0-a1a8-58cb44486904_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8f3df2c3-758f-4533-b86b-1d598732f191_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation costs related to unvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_df628af8-2842-40fd-bb35-2d415d7973f8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit realized from stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_76247ebf-24be-4670-9d05-c823e10a2767_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_fb327bfa-ce0b-410a-be6f-7e1b7a13b2d6_terseLabel_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_label_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:label id="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_documentation_en-US" xlink:label="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:to="lab_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0130caed-2df2-4e8c-8b3d-9409847a780f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_793ea8ea-9376-4c58-8073-b45a2fba4431_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_b9e61870-9be0-4a78-91be-4db092170e27_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum average conversion value of notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:to="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_0d04cb54-1718-457a-a0df-b3a97c24d6de_terseLabel_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_label_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification [Member]</link:label>
    <link:label id="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_documentation_en-US" xlink:label="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:to="lab_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_21bd399e-8400-4adc-8c90-baa04c29c2c8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_345fd1c0-909b-4ab9-9a8a-9b87ded32075_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5dde91e2-06b0-4da2-8263-e97b8abf915d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b6f53f40-74e5-40e1-b560-9a4dc65f94c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56269e9e-74d7-4aea-8e94-55230cd418a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_8962d1d0-c064-4b09-a057-6b619999af47_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_bde759ec-cace-4c49-a3b2-fe8bf53c792d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b9410da7-f4c1-49e5-828c-d236289056d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_e582c579-3e56-45f3-8a8b-2fb6d7e1cf00_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_86bf4354-2a9a-4e2f-b0af-40ad574adb2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_0d58da0b-878e-4623-a563-54fb3a3e2965_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum lease payments, finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_79c52bd1-ddc8-4200-bef1-596c502c31db_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_607ad9dc-17f8-4a25-824c-9a83ae10b50e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c0135932-b97b-4782-b1aa-8ed4562afc99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b87b2aa8-0255-413d-ae6d-091d80fc5a0c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellIncMember_f6e45e52-3ceb-40ef-a824-a91c8196aa97_terseLabel_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:label id="lab_iart_ACellIncMember_label_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc. [Member]</link:label>
    <link:label id="lab_iart_ACellIncMember_documentation_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellIncMember" xlink:to="lab_iart_ACellIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_de021889-4fd9-4212-9617-a5b5cfa27ad6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges:</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_347cfd7b-f116-4dea-93a9-fd6caed23a49_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_7b1717bf-06ba-4d76-a072-bb62a9fa1471_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_1b15a932-950b-4ec2-90e0-121708905eb2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_c9572640-2943-466f-8df7-f2636ccbd3a3_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_274f288f-0e86-44a5-a852-d193a5de440b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b56d7111-eea8-40c5-8734-f3877c88ab44_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously capitalized financing costs, written-off</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fea9d479-ee22-460e-b1b6-4609516e7d86_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_1912b30a-a187-4a7e-bd10-8eaf94ad8c59_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2bd3f73e-46b6-4693-922f-1b69bc02f3b1_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States (Includes long-lived assets in Puerto Rico)</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_f0adf48e-9354-4047-8248-f6b211836e35_negatedTerseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in shares)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6959b481-832f-440b-b01f-4d6efb7892bb_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4d3ed9f1-e25b-4bfa-8ccc-7cd4ad879590_netLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense recognized</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_336b6387-9776-4667-9e1e-01eca6245723_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3922f152-51b6-4a27-937c-32e2533efa6c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_24261372-5a30-4f53-a423-18898b38b8bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ff50f9f6-d8e1-4ff8-9d0c-ad48a0d1b2f7_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_ed531b54-ba0b-487e-b048-4cbf6b4ef674_negatedLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of option hedge on convertible notes</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_4b8f5344-bfe6-45aa-9d8e-b2827a614a09_verboseLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of call transactions</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_label_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Option Index To Issuers Equity</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_documentation_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Options Indexed to Issuer's Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:href="iart-20221231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:to="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_281733a0-0c6e-4cf0-9084-30a8203bdf04_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCI into Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_f0823cca-5c3d-40fd-b134-7b08a40cf1e9_terseLabel_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_label_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_documentation_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:href="iart-20221231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:to="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_7ec5e6cd-0840-41c8-9e97-097000712b28_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_118bd284-6fe9-4564-b0e4-21fb03c35212_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_610d5d90-b586-4b0e-923d-39f947b21e6f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_50fd888c-26d3-4a11-bb44-132b41d25056_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_29034397-b5d3-4dc5-a094-ebd9ebd4c29a_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2b7a39ac-179a-4807-9a5e-78f38b78bf37_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_0733a952-0ee0-4b32-9c8b-5e7c6682b034_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_1564ede6-07bc-4c01-b91f-73578cc990ab_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_f611b7a1-3373-447d-898c-2131b7304a7a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_0abfb796-07f9-4b3a-8286-7255dc20fbc9_terseLabel_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, fair value of amount outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_documentation_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:href="iart-20221231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:to="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d122bc56-1ccf-43fe-b920-04bb1a1c5f31_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_8ade4ae5-4824-456e-b56a-27187fc18dd3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest crediting rate for cash balance plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_c30f83d0-608d-4eeb-a292-620ba7add7de_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b3527f8d-9c0b-46e5-b2ff-933fe4e45736_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AuditInformationAbstract_label_en-US" xlink:label="lab_iart_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iart_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iart_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AuditInformationAbstract" xlink:href="iart-20221231.xsd#iart_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AuditInformationAbstract" xlink:to="lab_iart_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_33d8bb74-74ac-4a80-b3a0-c2d3dee94318_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES FROM CONTRACTS WITH CUSTOMERS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_96657146-ee03-4878-af68-f850d9947521_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_e62e53c7-2c3c-48ec-94fe-3177a932c209_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_063cdc14-74c4-4f24-aed6-773d4faae682_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Projected Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_ab332c3b-196a-4a18-8f14-249c29e1d156_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5f668a13-58cd-400a-a3c7-6554627edeb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f032eab5-3e05-4d31-8ee5-b1d8986df683_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ac850ff5-6915-4e2c-a95f-84f84e74748f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5da57551-5692-4f0a-91e8-908acc39cdba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash taxes paid in net equity settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b5a47994-45d6-4090-bd70-c746f599f25b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_2041f861-1f5f-4047-bfe7-7ad4933bc7e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_b453942d-5fd2-4f63-86e3-e09964c986c4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental financing cost expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8543667b-ec8c-4c0c-ad40-f8de8550b3c0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TraditionalWoundCareMember_90acc857-55c4-4b57-b1bd-0a55f7274953_terseLabel_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care</link:label>
    <link:label id="lab_iart_TraditionalWoundCareMember_label_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care [Member]</link:label>
    <link:label id="lab_iart_TraditionalWoundCareMember_documentation_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember" xlink:href="iart-20221231.xsd#iart_TraditionalWoundCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TraditionalWoundCareMember" xlink:to="lab_iart_TraditionalWoundCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5459c307-954f-41b8-980d-2a476f37637a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount under share repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_77663953-0f57-46c4-8edc-6fb557647d7e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_e41bf092-1c28-4fc7-933c-b5f0c2229488_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_08807b7b-5b9a-409e-81c0-d20315a39ebd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_9263b462-16ad-447c-896c-c8a514f2faec_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d5c43089-ceb1-48db-8435-a1cde0bfee06_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_524afd4a-ae22-43b2-bf53-9df19da03d21_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2023 and the last day of each fiscal quarter thereafter</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod4Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod4Member" xlink:to="lab_iart_DebtCovenantPeriod4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_82d547af-3d56-4d5b-8245-6b512d9b5e6d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9b1a9541-0d59-414a-ad6b-f0996808c153_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1069ddf4-9c54-41f9-9626-03758a0ae56e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_86ec3f7e-92a5-40b1-becb-c144834f5b70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_512e1018-cb78-4806-b0a3-e4beb867c050_terseLabel_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember" xlink:href="iart-20221231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContingentConsiderationLiabilityMember" xlink:to="lab_iart_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8b18af56-ca9c-45c4-ab1f-29916a6db374_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_078a8136-65ae-48b6-b40c-4b0c29d87588_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_388175b2-88f5-4e55-8807-ed3032444f3d_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_1038b8c0-b54c-4ffc-96ff-65d7a53b0ce2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of product technology</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_18525499-503d-4e1d-9a0e-2d3d5c7582b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_be760e5a-b109-4158-8135-c455ee950f82_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Collected from Customers</link:label>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_54049676-8bdb-4477-af5b-8cfb9f84fc06_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_56b8158c-2ee1-43db-9352-9aae02f95cb4_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_52b03cbd-47fa-41f4-9169-138560647904_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets after valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_967aee06-d0eb-4787-be4d-4018eb204533_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2752c7fe-991f-42b7-9d28-52870c21cd99_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_90331e6e-eb27-44a4-8bff-03575e1c0dd5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_64132762-c8e6-4312-b4f9-345d23d7c572_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6f1c0af8-ce85-4d1d-b475-4bb042200bd3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_486ba013-05c7-4188-9a39-7dd11c2bb42b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_3a214294-ba25-4738-a5ac-5d678ee6d22a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_651e5a9a-1291-467f-b591-34883d54fd44_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_58e10e88-8116-470c-b28d-b566305c6c7d_terseLabel_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany loan, quarterly payment</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_label_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_documentation_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:href="iart-20221231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:to="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_404ee882-aa7a-4dc7-91ae-36b138a31581_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_fed35c63-e4c0-45ed-8a00-f62d4e67a0c5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_19366be3-6ddb-4752-9c33-c655c190e092_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_007b4fca-175e-483b-ae16-dee33047560e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_293271c9-1505-435e-ba10-f3d46a2e7bb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense) benefit related to items in other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3b920594-8a43-4adb-b4da-02fef3a23cd6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_100200af-ed33-4388-88b7-5dd8ef5f14e9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d61c033b-13d2-4ce8-a4d8-bfb4585c6407_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e2feed2f-27e2-4212-a34c-6e3caffc3867_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_f9e31331-0f81-4dc6-9c48-a893af348a75_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0a8c8c68-5ed9-447c-b5d8-5727b28addd6_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8a0ca832-fe5a-4136-aea0-b4cbfba553a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_454e0e97-af4e-481b-ab68-981f10a67bba_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_67b07f46-e4cc-4750-a309-991d93c4f526_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_93fc529c-d831-4a9f-b0da-ca1c182ea774_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, payable recognized</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_f213bb3f-7283-459b-a732-a9be7354be51_terseLabel_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2029 Through October 31, 2034</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_label_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One [Member]</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_documentation_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:href="iart-20221231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:to="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_aeae72fa-5c90-4a42-a8f5-8e4c43e2465f_negatedLabel_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases and Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_label_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesLeasesAndOther_documentation_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leases And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:to="lab_iart_DeferredTaxLiabilitiesLeasesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ca292347-3db9-4e94-a563-16870c92c4f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Maximum Leverage Ratios</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_ef668e18-e193-40c0-a1d9-f0c6d572264b_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and production equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_6adde669-24ef-4ad7-9bc7-7ce504cb1d06_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased facilities</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_48aee73e-c26e-44fc-b325-645551862925_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock purchase warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_11b442e2-725f-4ee2-a9e2-0e7e772bba21_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrant transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_5a4d2fef-4926-43a0-8232-3b6e031394c8_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_07be1f0d-2b42-45fe-867e-83c35ff4a9d1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_555443b7-67fc-4862-9c30-717b6983792e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CharitableContributions_785a5558-a482-4c84-b9bb-281757badb9e_terseLabel_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to Integra Foundation</link:label>
    <link:label id="lab_iart_CharitableContributions_label_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:label id="lab_iart_CharitableContributions_documentation_en-US" xlink:label="lab_iart_CharitableContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions" xlink:href="iart-20221231.xsd#iart_CharitableContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CharitableContributions" xlink:to="lab_iart_CharitableContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8d67bb84-e8ca-456f-a300-ecd0c3c427b2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_08190563-510d-4802-8530-9df162219d1f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_b77ffbe4-05cf-4363-9c43-083b9dcf62ba_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_051f0291-a764-4af8-b723-51bc7e2734cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_7e435ad8-7c60-4707-b479-c6caf4de8a4a_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_45a2cae5-32bd-400a-9579-67c189c931c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f7b0e101-f9ed-437b-82e2-c8dcf282f8e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_94a6041e-9599-4efe-9f1e-7b7bb2029512_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_6527fca6-6cb6-4a70-9113-530e59c9a4ac_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2022 through June 30, 2023</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod3Member" xlink:to="lab_iart_DebtCovenantPeriod3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_2a9b439d-1ba1-47f0-a67e-51d2f0f01c99_negatedTerseLabel_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange loss</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_label_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Foreign Exchange Loss</link:label>
    <link:label id="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_documentation_en-US" xlink:label="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Unrealized Foreign Exchange Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:to="lab_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_568fb11f-796c-43e5-8cab-0295927a0864_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_b6193cba-c03b-4862-b753-a08903c051c0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a4d76c24-34a5-4535-8d05-fbd040a9bff3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_78a40c83-9611-4715-8746-5737b50ab59e_terseLabel_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="iart-20221231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_e4359351-8b03-4044-8480-453d9b95cb64_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_label_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_documentation_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:href="iart-20221231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:to="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_b3562e83-4df0-4b53-ab3a-e93c76a55acb_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_65767cfe-7f17-4686-b4f4-6d77e765c453_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_3eba1bce-1e0f-41c4-b9c1-57f40b29f1b2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_b6867ff7-ee58-4e12-ad48-bad52afb1f62_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_013805b5-6460-4cec-bba2-d6b9a73861c7_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_875610b4-922b-40a3-a562-cd6c01ee4c45_terseLabel_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash in-process research and development expense</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:label id="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash, In Process Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:href="iart-20221231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:to="lab_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7a54fcf5-a5b2-48c0-a9a0-b24eadf021e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_e1653395-3189-4924-8143-3d8a24c1e7dd_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_b28dd320-b627-47bb-b84d-8cabfc01b52d_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_8469f481-9eaa-48f1-a679-f7417e128c5a_terseLabel_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock Awards</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_label_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:label id="lab_iart_PerformanceStockandContractStockMember_documentation_en-US" xlink:label="lab_iart_PerformanceStockandContractStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Contract Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember" xlink:href="iart-20221231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceStockandContractStockMember" xlink:to="lab_iart_PerformanceStockandContractStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_70f7bd93-eece-45d9-87a0-a387bedc56b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_88eb2376-ab71-41ed-b3e3-c3c329eb9d25_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_1feece4e-9c36-4fb1-acd8-462339185449_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockNoParValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNoParValue" xlink:to="lab_us-gaap_PreferredStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeAbstract_bfd1cd19-8c88-4ee1-91c6-3990678667eb_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract" xlink:href="iart-20221231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeAbstract" xlink:to="lab_iart_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_a52831f2-c1fd-4997-9103-ba45d7b07ace_terseLabel_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for performance achievement related to award target (in dollars per share)</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:to="lab_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_bd5422fe-a9ca-4ede-8c63-244cbe70416e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_0e7529cb-b93d-4054-909e-d5dd87e46bfc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_68bd3889-43f6-464e-b0b6-1b3e099fceb3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_89a24f69-053b-4142-a2d3-d1c5ff637534_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_7c4bc832-020e-44c6-8435-3ceb633a6eee_terseLabel_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs and expenses associated with debt refinancing</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_label_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_documentation_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:href="iart-20221231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:to="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SeniorCreditFacilityMember_2e345273-f25e-4cf3-97bd-04d2a7fcc23d_terseLabel_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_label_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility [Member]</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_documentation_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember" xlink:href="iart-20221231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SeniorCreditFacilityMember" xlink:to="lab_iart_SeniorCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ClosureOfFacilityMember_a1ca98fb-747f-4445-aeb7-2084931d2b42_terseLabel_en-US" xlink:label="lab_iart_ClosureOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closure of Facility</link:label>
    <link:label id="lab_iart_ClosureOfFacilityMember_label_en-US" xlink:label="lab_iart_ClosureOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closure of Facility [Member]</link:label>
    <link:label id="lab_iart_ClosureOfFacilityMember_documentation_en-US" xlink:label="lab_iart_ClosureOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closure of Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ClosureOfFacilityMember" xlink:href="iart-20221231.xsd#iart_ClosureOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ClosureOfFacilityMember" xlink:to="lab_iart_ClosureOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_f42e2010-8f7d-4a4a-80b2-87b9facd749a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccountingStandardUpdate202006Member_label_en-US" xlink:label="lab_iart_AccountingStandardUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standard Update 2020-06 [Member]</link:label>
    <link:label id="lab_iart_AccountingStandardUpdate202006Member_documentation_en-US" xlink:label="lab_iart_AccountingStandardUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standard Update 2020-06</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccountingStandardUpdate202006Member" xlink:href="iart-20221231.xsd#iart_AccountingStandardUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccountingStandardUpdate202006Member" xlink:to="lab_iart_AccountingStandardUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>iart-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e405e07e-db35-4b5f-8dfc-34e95d86a9d3,g:80ecbb36-7afc-47c8-bf54-ac22f862c3d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20221231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_11d6e3d7-08d1-4f4a-ba47-8a3bf948be46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentType_11d6e3d7-08d1-4f4a-ba47-8a3bf948be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_31802f3c-27f9-41cb-b945-4928e95c0142" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentAnnualReport_31802f3c-27f9-41cb-b945-4928e95c0142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5fef5278-48f9-4f00-a8c5-4e20f901cf07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentPeriodEndDate_5fef5278-48f9-4f00-a8c5-4e20f901cf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_812df01b-360b-4103-b329-d780a2980a2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_CurrentFiscalYearEndDate_812df01b-360b-4103-b329-d780a2980a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_09e6e9f6-5c42-4c56-a70c-d8492dd2cb1e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentTransitionReport_09e6e9f6-5c42-4c56-a70c-d8492dd2cb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6bc325c7-266f-4a18-869e-7772c4f4d57e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityFileNumber_6bc325c7-266f-4a18-869e-7772c4f4d57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_376c39b0-f523-441d-aba5-504c430ace32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityRegistrantName_376c39b0-f523-441d-aba5-504c430ace32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e4505fde-dc25-465a-a2f3-2e9eb2568045" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e4505fde-dc25-465a-a2f3-2e9eb2568045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2ed187ed-deee-4291-a671-de82fc692e60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityTaxIdentificationNumber_2ed187ed-deee-4291-a671-de82fc692e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7f6f3e6e-c5e4-4028-a2f5-2ec89addda1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityAddressAddressLine1_7f6f3e6e-c5e4-4028-a2f5-2ec89addda1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_344bc2f5-21bd-4b02-a5bf-cb3ba761684a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityAddressPostalZipCode_344bc2f5-21bd-4b02-a5bf-cb3ba761684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_632afc2d-7bba-40a7-9c2a-f213fc4c198c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityAddressCityOrTown_632afc2d-7bba-40a7-9c2a-f213fc4c198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fc7966fb-a4c2-4478-a707-e78ab20b776e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityAddressStateOrProvince_fc7966fb-a4c2-4478-a707-e78ab20b776e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_89deb7a7-3425-4c78-ba55-4fc101fdfde4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_CityAreaCode_89deb7a7-3425-4c78-ba55-4fc101fdfde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5090aa32-79da-45b3-ad1e-683c7a6c58b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_LocalPhoneNumber_5090aa32-79da-45b3-ad1e-683c7a6c58b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_30409561-07ce-49c6-8cde-6ccaa024d246" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_Security12bTitle_30409561-07ce-49c6-8cde-6ccaa024d246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_23468416-10ab-4690-a2d6-f3d51d021a38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_TradingSymbol_23468416-10ab-4690-a2d6-f3d51d021a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_52e01f49-568f-4953-80df-fd4f791da7c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_SecurityExchangeName_52e01f49-568f-4953-80df-fd4f791da7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8fc9d24e-c204-4c84-8ae9-bc84958fa421" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8fc9d24e-c204-4c84-8ae9-bc84958fa421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_70d91cea-a530-47ff-a06a-469268ea403a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityVoluntaryFilers_70d91cea-a530-47ff-a06a-469268ea403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_79475d1d-ca31-404a-83a9-4e6e4d2b79ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityCurrentReportingStatus_79475d1d-ca31-404a-83a9-4e6e4d2b79ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4c39c75f-c3a7-4e02-ab59-5689442f38b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityInteractiveDataCurrent_4c39c75f-c3a7-4e02-ab59-5689442f38b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a2c2e907-78cf-404b-8e88-1f3656f7e725" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityFilerCategory_a2c2e907-78cf-404b-8e88-1f3656f7e725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_af7e908f-87a7-4e0a-beea-ed2957b21eb6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntitySmallBusiness_af7e908f-87a7-4e0a-beea-ed2957b21eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_152b07a4-e200-4db6-a96f-8e576b891a1d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityEmergingGrowthCompany_152b07a4-e200-4db6-a96f-8e576b891a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_e20f4bab-f5da-4e9c-97ff-e71f93827221" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_e20f4bab-f5da-4e9c-97ff-e71f93827221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6216393a-4ec4-4369-b6c2-23e52e71b258" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityShellCompany_6216393a-4ec4-4369-b6c2-23e52e71b258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3f5f134d-b2a2-42fb-81d6-3f421d5ae6e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityPublicFloat_3f5f134d-b2a2-42fb-81d6-3f421d5ae6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0babe89d-fa55-44de-9dce-f19bde88542c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0babe89d-fa55-44de-9dce-f19bde88542c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_88a2a58b-1841-4898-8fba-3896ecb5135f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_88a2a58b-1841-4898-8fba-3896ecb5135f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_af2a746e-cf08-424c-a339-4c5b287de4ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_AmendmentFlag_af2a746e-cf08-424c-a339-4c5b287de4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7f84c2cd-7976-4b76-a5ae-deb885e6887f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentFiscalYearFocus_7f84c2cd-7976-4b76-a5ae-deb885e6887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8622cd59-9b07-4d28-a797-fd6b683b3f5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8622cd59-9b07-4d28-a797-fd6b683b3f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_919fba44-5f15-46c4-bb24-fa9d60653552" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b34dafba-a02b-4305-b420-72b9a168db2d" xlink:to="loc_dei_EntityCentralIndexKey_919fba44-5f15-46c4-bb24-fa9d60653552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/AuditInformation" xlink:type="simple" xlink:href="iart-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_AuditInformationAbstract_dde8472f-0eb3-4d5b-a034-24d39e9d8cee" xlink:href="iart-20221231.xsd#iart_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_d633c07c-73fe-45df-8660-212b3e69795d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_dde8472f-0eb3-4d5b-a034-24d39e9d8cee" xlink:to="loc_dei_AuditorName_d633c07c-73fe-45df-8660-212b3e69795d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_29a89704-ff42-475e-8e67-f166965d1621" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_dde8472f-0eb3-4d5b-a034-24d39e9d8cee" xlink:to="loc_dei_AuditorLocation_29a89704-ff42-475e-8e67-f166965d1621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_418dbb0d-6e6e-456f-b4c3-b69bce2418ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AuditInformationAbstract_dde8472f-0eb3-4d5b-a034-24d39e9d8cee" xlink:to="loc_dei_AuditorFirmId_418dbb0d-6e6e-456f-b4c3-b69bce2418ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e57d24d-1b47-4b87-b508-51cf6cf217d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e57d24d-1b47-4b87-b508-51cf6cf217d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_422340d7-75cb-4ac5-85b7-f9ad8a61ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_422340d7-75cb-4ac5-85b7-f9ad8a61ab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_44de2321-018e-466d-b11a-4a9600a75aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_44de2321-018e-466d-b11a-4a9600a75aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8b5af213-4f72-4c79-8c65-74fba1198cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8b5af213-4f72-4c79-8c65-74fba1198cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_944e07ea-eb3e-4649-a3d5-ebf429be34e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_944e07ea-eb3e-4649-a3d5-ebf429be34e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6ad2b0d6-9e8b-4ff9-9492-9ed7b9777d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d61de30d-36ea-4dd4-a0ee-58eb182646a4" xlink:to="loc_us-gaap_CostsAndExpenses_6ad2b0d6-9e8b-4ff9-9492-9ed7b9777d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a364786-9fad-44cc-a602-1c4f93f49bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_OperatingIncomeLoss_9a364786-9fad-44cc-a602-1c4f93f49bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_57255bfa-8c33-49bd-a909-d07ea79dbeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_InvestmentIncomeInterest_57255bfa-8c33-49bd-a909-d07ea79dbeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c41de7a4-52d5-43fc-81fd-ad481711c745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_InterestExpense_c41de7a4-52d5-43fc-81fd-ad481711c745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_93fdcc3d-00ed-4dde-b370-6b8f706d4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_93fdcc3d-00ed-4dde-b370-6b8f706d4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b9773b4d-78d0-43d8-a478-f45db5ce66a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b9773b4d-78d0-43d8-a478-f45db5ce66a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_929f71f1-4dfe-40b5-a897-18e4040ca5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_929f71f1-4dfe-40b5-a897-18e4040ca5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ec7413a7-f89f-4a1d-8b48-99a92d2aab43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ec7413a7-f89f-4a1d-8b48-99a92d2aab43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d82378e2-d8d0-4d2a-9c2b-6ae751d842b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_NetIncomeLoss_d82378e2-d8d0-4d2a-9c2b-6ae751d842b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_00dd0112-6990-458e-a05c-305f8c20f2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_EarningsPerShareAbstract_00dd0112-6990-458e-a05c-305f8c20f2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_44185c32-2e92-42a0-b2ea-7a3ed2c2ae53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00dd0112-6990-458e-a05c-305f8c20f2f8" xlink:to="loc_us-gaap_EarningsPerShareBasic_44185c32-2e92-42a0-b2ea-7a3ed2c2ae53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_524b9ced-ea1d-4a79-a361-9953e971a934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00dd0112-6990-458e-a05c-305f8c20f2f8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_524b9ced-ea1d-4a79-a361-9953e971a934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e2a9ba78-7d80-4d11-b9ca-c5a477276f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eb266cb8-6775-4af5-b4db-d2bacd96b459" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e2a9ba78-7d80-4d11-b9ca-c5a477276f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b2965389-691e-4681-b1be-28de692af181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e2a9ba78-7d80-4d11-b9ca-c5a477276f7c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b2965389-691e-4681-b1be-28de692af181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b752c0b9-2374-4696-b46d-33cd84c1d0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e2a9ba78-7d80-4d11-b9ca-c5a477276f7c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b752c0b9-2374-4696-b46d-33cd84c1d0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e015a4fc-d01d-453c-98f8-a468ef05fc24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d97ac06-5d36-4f3e-8f47-db1cb9289fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e015a4fc-d01d-453c-98f8-a468ef05fc24" xlink:to="loc_us-gaap_NetIncomeLoss_6d97ac06-5d36-4f3e-8f47-db1cb9289fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e015a4fc-d01d-453c-98f8-a468ef05fc24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_892bcd68-42e3-43f4-907b-1bc56de7f260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_892bcd68-42e3-43f4-907b-1bc56de7f260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_0b56f2f8-be9e-43ff-826a-b99130bda696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_0b56f2f8-be9e-43ff-826a-b99130bda696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6f7ccd5b-a306-44ec-a26b-942da178cdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_0b56f2f8-be9e-43ff-826a-b99130bda696" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6f7ccd5b-a306-44ec-a26b-942da178cdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_496d721e-aafc-41a7-9317-52a6578b25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_0b56f2f8-be9e-43ff-826a-b99130bda696" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_496d721e-aafc-41a7-9317-52a6578b25a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_10cdb619-ea6d-4a25-a1b2-b6e79915ac35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract_0b56f2f8-be9e-43ff-826a-b99130bda696" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_10cdb619-ea6d-4a25-a1b2-b6e79915ac35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0c657aa8-3343-48c7-b469-cd8be777cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0c657aa8-3343-48c7-b469-cd8be777cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_5b326778-ed8f-49f5-81d9-fce7b0ef3c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_5b326778-ed8f-49f5-81d9-fce7b0ef3c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_148f7650-15b9-4c84-9c56-9ae080e9652c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_148f7650-15b9-4c84-9c56-9ae080e9652c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c245bce6-786f-41bf-bdde-a4762bdafe85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_eb3fce92-a813-4e96-8477-711cd25b5f21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c245bce6-786f-41bf-bdde-a4762bdafe85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_00b285a2-f8a9-40e5-9798-0dc87177f240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e015a4fc-d01d-453c-98f8-a468ef05fc24" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_00b285a2-f8a9-40e5-9798-0dc87177f240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f47eebef-db66-44be-9193-d71353897a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f47eebef-db66-44be-9193-d71353897a40" xlink:to="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21e2a920-c145-47b7-a622-8028c1ce7e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21e2a920-c145-47b7-a622-8028c1ce7e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9de4e7ee-18ed-433e-b7ab-8c1eddb606d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9de4e7ee-18ed-433e-b7ab-8c1eddb606d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bd511484-0cd6-4664-b031-4f7d3ff1e785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:to="loc_us-gaap_InventoryNet_bd511484-0cd6-4664-b031-4f7d3ff1e785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab7952ab-53ee-4771-a5de-6c65f8d0359a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab7952ab-53ee-4771-a5de-6c65f8d0359a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9627acfe-9101-47e9-8e1f-2e87523a2800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26b317bb-77a7-4f4d-ba54-622ba9dbd87f" xlink:to="loc_us-gaap_AssetsCurrent_9627acfe-9101-47e9-8e1f-2e87523a2800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7d594f0a-db9a-4b2c-855d-c4dbac0fc03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7d594f0a-db9a-4b2c-855d-c4dbac0fc03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_87a081e9-357e-4338-b6fd-671c2949937d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_87a081e9-357e-4338-b6fd-671c2949937d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a0ed5b7-a391-461d-a2c5-cdc8064d6757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a0ed5b7-a391-461d-a2c5-cdc8064d6757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a72273ec-76e3-4703-9dc3-54a1327108c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_Goodwill_a72273ec-76e3-4703-9dc3-54a1327108c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_388ccf64-7299-4e83-9b72-29695ffd8950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_388ccf64-7299-4e83-9b72-29695ffd8950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_23dd4ad8-87bf-47ea-a88f-8ed4b66a7e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_23dd4ad8-87bf-47ea-a88f-8ed4b66a7e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e57b1f4d-60a0-47dd-b173-eeb1ff2cfa70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a17e2818-08e9-4700-9e1d-0059b3c3b0d3" xlink:to="loc_us-gaap_Assets_e57b1f4d-60a0-47dd-b173-eeb1ff2cfa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f47eebef-db66-44be-9193-d71353897a40" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_81865dc7-cf9a-49fb-bfab-3e7c00639224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_SecuredDebtCurrent_81865dc7-cf9a-49fb-bfab-3e7c00639224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d1bbd074-c432-4b66-8c4f-67ed19c18ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d1bbd074-c432-4b66-8c4f-67ed19c18ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_5aed8d23-54e0-4606-95fc-26b40f67f9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_5aed8d23-54e0-4606-95fc-26b40f67f9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b75dfc4d-9cea-448e-a465-482522bd3e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b75dfc4d-9cea-448e-a465-482522bd3e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6775b0cd-c27a-4c1f-908e-33468236a71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6775b0cd-c27a-4c1f-908e-33468236a71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4ee7f15e-0923-412f-88ac-60bbd69df2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4ee7f15e-0923-412f-88ac-60bbd69df2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e5832c14-a44e-4d16-94ef-2e227959411d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aafdf92d-c304-4be1-8d84-99e0a615bde6" xlink:to="loc_us-gaap_LiabilitiesCurrent_e5832c14-a44e-4d16-94ef-2e227959411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_a7ef7967-40a1-454f-bc44-f56f7c90ed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_SecuredLongTermDebt_a7ef7967-40a1-454f-bc44-f56f7c90ed5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_9efccd56-121f-422c-ac9b-5fcc5af8d042" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_9efccd56-121f-422c-ac9b-5fcc5af8d042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_3bb11485-af1a-4b40-a8f2-a0f0a2f5e822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_3bb11485-af1a-4b40-a8f2-a0f0a2f5e822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7c70653a-86fa-4d44-be32-3991870cf238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7c70653a-86fa-4d44-be32-3991870cf238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_752fd993-0509-422c-ae25-b4b44dc2bfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_752fd993-0509-422c-ae25-b4b44dc2bfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_067a2c8f-a88b-447c-b7d9-4903350c927e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_067a2c8f-a88b-447c-b7d9-4903350c927e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0ca5d5b5-ecce-4d51-8de5-f8624e0ae835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_Liabilities_0ca5d5b5-ecce-4d51-8de5-f8624e0ae835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f3457080-aeea-498a-b845-8c418bff3ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_PreferredStockValue_f3457080-aeea-498a-b845-8c418bff3ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ed54c346-9f3c-4fbe-828d-5bda12f96ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_CommonStockValue_ed54c346-9f3c-4fbe-828d-5bda12f96ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bbdc552d-ab11-4af1-ace0-818b30e26497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bbdc552d-ab11-4af1-ace0-818b30e26497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_df79b9ba-20e1-432f-8f53-33a7a16f2d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_TreasuryStockValue_df79b9ba-20e1-432f-8f53-33a7a16f2d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c1276e31-6e91-46b7-948c-aaa51c9b934e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c1276e31-6e91-46b7-948c-aaa51c9b934e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_faefa022-6667-4091-bb28-e91e27ccac4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_faefa022-6667-4091-bb28-e91e27ccac4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee562ca2-5a96-4d96-9a84-467e9b1de833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b08742a8-c2ba-43af-b331-ad9ebbcf9419" xlink:to="loc_us-gaap_StockholdersEquity_ee562ca2-5a96-4d96-9a84-467e9b1de833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_43b82372-b23a-4505-8cfa-b58ae06093a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b52c3e81-356e-4bcd-acab-2cf01d167b31" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_43b82372-b23a-4505-8cfa-b58ae06093a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2ade6560-2bc6-4636-9583-3b8283483d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2ade6560-2bc6-4636-9583-3b8283483d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNoParValue_fde7ae18-694a-48cb-94d9-2b69d2bd2ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_PreferredStockNoParValue_fde7ae18-694a-48cb-94d9-2b69d2bd2ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_048de409-72b1-45fc-a5c3-0ef92df7d925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_048de409-72b1-45fc-a5c3-0ef92df7d925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_eafaf439-4f81-44ae-ab22-cfa335d9ae41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_eafaf439-4f81-44ae-ab22-cfa335d9ae41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50a4b909-d7fc-44f0-85c3-a2f691fe85db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50a4b909-d7fc-44f0-85c3-a2f691fe85db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bed8e8f0-c85b-4b67-98cd-fb0a6328a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bed8e8f0-c85b-4b67-98cd-fb0a6328a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ebb776af-8659-462f-a585-51ced2d48171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_CommonStockSharesIssued_ebb776af-8659-462f-a585-51ced2d48171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_582dc80c-e030-4213-b3d2-37f201585508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa01a40a-663d-457a-a523-65a7b91073a6" xlink:to="loc_us-gaap_TreasuryStockShares_582dc80c-e030-4213-b3d2-37f201585508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c666b0e-fa1c-4840-b448-8a54ff8d94cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c666b0e-fa1c-4840-b448-8a54ff8d94cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38aeb2db-1198-4aed-b546-281986c74794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c666b0e-fa1c-4840-b448-8a54ff8d94cf" xlink:to="loc_us-gaap_NetIncomeLoss_38aeb2db-1198-4aed-b546-281986c74794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c666b0e-fa1c-4840-b448-8a54ff8d94cf" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_d68588b3-0188-4b06-89ce-6adc5a33c9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_d68588b3-0188-4b06-89ce-6adc5a33c9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_66fe1489-6b1e-4f4e-948d-3c318c3c13df" xlink:href="iart-20221231.xsd#iart_NoncashOrPartNoncashInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment_66fe1489-6b1e-4f4e-948d-3c318c3c13df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_069adfbb-c111-4dee-8bfa-bd811e6f4d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_069adfbb-c111-4dee-8bfa-bd811e6f4d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4eb170b7-68f3-43ba-a9b3-43f6d99e05f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4eb170b7-68f3-43ba-a9b3-43f6d99e05f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_623e9506-30ff-4671-be0b-234fcdd96bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_ShareBasedCompensation_623e9506-30ff-4671-be0b-234fcdd96bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_d56aa6bd-1800-4c7d-b3aa-c18f2f3c255a" xlink:href="iart-20221231.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_d56aa6bd-1800-4c7d-b3aa-c18f2f3c255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_55367a1e-841c-473a-bade-8d1464679a52" xlink:href="iart-20221231.xsd#iart_NoncashLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_iart_NoncashLeaseExpense_55367a1e-841c-473a-bade-8d1464679a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_cd9ca4bb-bb8f-4920-87ff-9451ccb849cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_AccretionExpense_cd9ca4bb-bb8f-4920-87ff-9451ccb849cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_6bb47fa0-3cc5-4b76-bedc-2f38b3e4b5c3" xlink:href="iart-20221231.xsd#iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress_6bb47fa0-3cc5-4b76-bedc-2f38b3e4b5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f2f6c18b-1088-4161-905d-88e0c72aca25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f2f6c18b-1088-4161-905d-88e0c72aca25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_947dce95-0ca6-4601-a0ae-a5aa176c8fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_947dce95-0ca6-4601-a0ae-a5aa176c8fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a15b440-cf56-4b65-b476-c4a4bcd8940b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_907da06b-35d1-43e0-a368-2d693763f781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_907da06b-35d1-43e0-a368-2d693763f781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e4f6a7cb-d2e3-44ca-8fd7-96c7c8c7c3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e4f6a7cb-d2e3-44ca-8fd7-96c7c8c7c3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c7fee55a-0ec4-4e66-b1e1-8f581035fc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c7fee55a-0ec4-4e66-b1e1-8f581035fc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_57d227b5-c111-42b7-b7bc-9fe1d1c5ea9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_57d227b5-c111-42b7-b7bc-9fe1d1c5ea9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_52ef255c-48e8-41bb-92ae-a2617a69ac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_52ef255c-48e8-41bb-92ae-a2617a69ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5f852180-9479-4cec-baae-65d997d0148d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5f852180-9479-4cec-baae-65d997d0148d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d0cf861a-9dda-4695-9a03-1c596f0a4cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e231aee-cda7-4b80-a425-2f3530134656" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d0cf861a-9dda-4695-9a03-1c596f0a4cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2539f09-dc9a-4bc2-98cd-d75312c1f035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9c666b0e-fa1c-4840-b448-8a54ff8d94cf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2539f09-dc9a-4bc2-98cd-d75312c1f035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2877ebd5-5775-4b1e-bebb-39a3017e2f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2877ebd5-5775-4b1e-bebb-39a3017e2f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_13506ed8-04ab-4b1e-bb63-023f32c88c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_13506ed8-04ab-4b1e-bb63-023f32c88c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_941315fc-0688-441f-a511-59900202d449" xlink:href="iart-20221231.xsd#iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets_941315fc-0688-441f-a511-59900202d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_6d23e0a1-0290-4080-bb27-386452fc0f29" xlink:href="iart-20221231.xsd#iart_PaymentsForProceedsFromBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_iart_PaymentsForProceedsFromBusinessAcquisitions_6d23e0a1-0290-4080-bb27-386452fc0f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_81eba404-53de-45f7-8000-d25c39fdad53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_81eba404-53de-45f7-8000-d25c39fdad53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_90352c7f-8682-4451-9a78-21c0960287aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_90352c7f-8682-4451-9a78-21c0960287aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eca04130-a048-4305-bd46-de443310b5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b46ef5e8-bf2f-40f3-88f4-2576081bbcae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eca04130-a048-4305-bd46-de443310b5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1cbc1856-c87b-48e3-9845-3eaa7f08660a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1cbc1856-c87b-48e3-9845-3eaa7f08660a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_71b13b13-d9b6-4262-a57a-30ba36cbeff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_71b13b13-d9b6-4262-a57a-30ba36cbeff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_8698449d-b78e-4d9a-adba-7379307d136f" xlink:href="iart-20221231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_8698449d-b78e-4d9a-adba-7379307d136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_86b0af52-665f-4c31-8125-4ed36f07a916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_86b0af52-665f-4c31-8125-4ed36f07a916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_909755ab-8e8c-4f39-8d32-975f5ce0a11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_909755ab-8e8c-4f39-8d32-975f5ce0a11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_214d8a8d-0a73-4e96-86a0-6719cb36d628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_214d8a8d-0a73-4e96-86a0-6719cb36d628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_838cef0f-cfc1-4df6-bd58-cbc46e89c931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_838cef0f-cfc1-4df6-bd58-cbc46e89c931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a1694929-15f6-452b-ba56-3777bd7b668d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a1694929-15f6-452b-ba56-3777bd7b668d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0d8160db-8a97-426a-a059-f223886ec261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0d8160db-8a97-426a-a059-f223886ec261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcfee477-410a-4e61-bda9-7c26eb343b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0890da62-4490-4f49-958c-69d5a4a9fa98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcfee477-410a-4e61-bda9-7c26eb343b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c74167d-ca2b-43da-829f-d6bc9f933567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c74167d-ca2b-43da-829f-d6bc9f933567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b691aa9-db89-46f0-a084-a8bf8d79c345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b691aa9-db89-46f0-a084-a8bf8d79c345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d65a8280-664e-40b5-9de6-54f961229ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d65a8280-664e-40b5-9de6-54f961229ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eaee5285-2c51-474d-ae17-edbd434f43b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f4131cad-e973-4dfa-a6e8-740f4bb72603" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eaee5285-2c51-474d-ae17-edbd434f43b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="iart-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_32beed26-7245-4990-b684-8bdc4eaaba03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_32beed26-7245-4990-b684-8bdc4eaaba03" xlink:to="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba2193e1-a717-4e9e-9631-e23390394a3a" xlink:to="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_50c13972-7dba-4035-bf6b-759b9dc59e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_CommonStockMember_50c13972-7dba-4035-bf6b-759b9dc59e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7f7fb596-4a32-40be-bc84-4de6420006e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_TreasuryStockMember_7f7fb596-4a32-40be-bc84-4de6420006e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fda4326c-3144-4e84-8a88-b259c3d55194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fda4326c-3144-4e84-8a88-b259c3d55194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_36e78c91-0f70-4f44-82a9-b5299030f982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_36e78c91-0f70-4f44-82a9-b5299030f982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_be393f3c-30c7-4bcc-9af0-a734484756b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9e5811f-71bc-4566-abf6-3c219f4f5d17" xlink:to="loc_us-gaap_RetainedEarningsMember_be393f3c-30c7-4bcc-9af0-a734484756b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d463a170-9658-4d84-8130-4cb8c7e1007d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4dfe2e5c-cd5f-485a-9532-5e894ed901ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e7933c8-af44-4c77-a326-7bd85dc6662b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4dfe2e5c-cd5f-485a-9532-5e894ed901ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6bb9a880-4ead-4600-a54d-ce432c949403" xlink:to="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5ed42e4b-eee4-4ab6-8eec-37276bc5a8da" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_376af9a3-85ca-49a4-991a-cca073769b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_SharesIssued_376af9a3-85ca-49a4-991a-cca073769b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3c09300c-6f81-48b6-8636-cd8d91d33689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockholdersEquity_3c09300c-6f81-48b6-8636-cd8d91d33689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b8a5d2c5-bca4-4cbb-8433-33cc8c0cf2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_TreasuryStockShares_b8a5d2c5-bca4-4cbb-8433-33cc8c0cf2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ac6d78a-937b-41eb-b8d4-904c0e87c34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_NetIncomeLoss_9ac6d78a-937b-41eb-b8d4-904c0e87c34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6613179-2c4a-4a31-b088-d38072e78b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a6613179-2c4a-4a31-b088-d38072e78b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_80adae1f-10b4-4a86-ad39-efc7adf099ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_80adae1f-10b4-4a86-ad39-efc7adf099ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_5e618202-d656-47a5-8871-5d27375ba6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_5e618202-d656-47a5-8871-5d27375ba6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_47f5c828-5ccb-4859-97c4-c7e33f89dfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_47f5c828-5ccb-4859-97c4-c7e33f89dfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_97209124-d483-4579-90ba-947fd9a59278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_97209124-d483-4579-90ba-947fd9a59278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4a0d508a-64c6-4079-8b86-15130b50172d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4a0d508a-64c6-4079-8b86-15130b50172d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8fa4caf9-23fd-4dd9-9f6a-98d2db5cfc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_8fa4caf9-23fd-4dd9-9f6a-98d2db5cfc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_faf66ba4-3a0e-4453-910e-e15880d0ab5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_faf66ba4-3a0e-4453-910e-e15880d0ab5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dfedf855-b6a9-429b-b6ba-a52e2478eb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dfedf855-b6a9-429b-b6ba-a52e2478eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ff813b6f-ed9d-42f1-80bf-4fe0b5cfae49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_SharesIssued_ff813b6f-ed9d-42f1-80bf-4fe0b5cfae49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e8568b91-00a9-46ad-9595-8cb14962e922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_StockholdersEquity_e8568b91-00a9-46ad-9595-8cb14962e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_eb62f94e-b34e-4128-be71-97b7ecc2fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_TreasuryStockShares_eb62f94e-b34e-4128-be71-97b7ecc2fc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0463b75e-37d0-4814-94a1-dc20808e35a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf30ac93-9399-4144-b079-20b079fa8427" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0463b75e-37d0-4814-94a1-dc20808e35a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/BUSINESS" xlink:type="simple" xlink:href="iart-20221231.xsd#BUSINESS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/BUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_823d0f14-ddf2-4908-80e9-7b45d243a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_a3d26de1-a5f3-4666-85fa-b1276ea152db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_823d0f14-ddf2-4908-80e9-7b45d243a8cc" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_a3d26de1-a5f3-4666-85fa-b1276ea152db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_25ea10fc-9d2d-4604-8236-0b77c83955b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a7949d82-3d18-417a-9dde-d19a3209f81b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_25ea10fc-9d2d-4604-8236-0b77c83955b7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a7949d82-3d18-417a-9dde-d19a3209f81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9ebf9748-9b2e-45b8-89bb-d93cacdc352d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fd9c32e-48d4-4d55-a097-97be706d7c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9ebf9748-9b2e-45b8-89bb-d93cacdc352d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fd9c32e-48d4-4d55-a097-97be706d7c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ae8811be-f295-4c3a-a8b9-32fdb713f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_ee71784a-b95e-41ad-8596-c80f16cd01f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ae8811be-f295-4c3a-a8b9-32fdb713f5aa" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_ee71784a-b95e-41ad-8596-c80f16cd01f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_525acc37-1e22-4637-93e8-2d32095ce16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0884637c-8941-415e-aa86-42491fe6e124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_525acc37-1e22-4637-93e8-2d32095ce16a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_0884637c-8941-415e-aa86-42491fe6e124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c35df5cd-fd39-43eb-a4b2-7e61c2177bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0da1969f-c051-4bb5-8074-7bb76134f524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c35df5cd-fd39-43eb-a4b2-7e61c2177bd8" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0da1969f-c051-4bb5-8074-7bb76134f524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1c12627-56f4-44ac-9f86-a11507b981ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d5daf23b-bf31-4267-bf8e-fd8a62ac53db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1c12627-56f4-44ac-9f86-a11507b981ab" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d5daf23b-bf31-4267-bf8e-fd8a62ac53db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20221231.xsd#TREASURYSTOCK"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6c83b0e8-c468-4f1e-ab03-1e03c0a08986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_603150fb-d2b8-4b6f-a06f-87694293e434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6c83b0e8-c468-4f1e-ab03-1e03c0a08986" xlink:to="loc_us-gaap_TreasuryStockTextBlock_603150fb-d2b8-4b6f-a06f-87694293e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b86e0305-99cb-4edc-8552-c59b5b55c391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e2798b48-8b56-4228-a95e-86fb0f2daa23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b86e0305-99cb-4edc-8552-c59b5b55c391" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e2798b48-8b56-4228-a95e-86fb0f2daa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ecc5ca9d-c32d-46f7-9dd2-bf860be28f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d3697be5-6b44-4e5e-8b1c-2e3bec723520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ecc5ca9d-c32d-46f7-9dd2-bf860be28f01" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d3697be5-6b44-4e5e-8b1c-2e3bec723520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1d90b414-6d27-43c8-aad1-bf7eb4d63215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_c426a668-a081-4802-8364-b4980e0f450b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1d90b414-6d27-43c8-aad1-bf7eb4d63215" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_c426a668-a081-4802-8364-b4980e0f450b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a67a0345-f2f1-4174-a6de-d8436009e8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_661b153c-c9ef-4115-943a-a4d60ca7dd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a67a0345-f2f1-4174-a6de-d8436009e8f0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_661b153c-c9ef-4115-943a-a4d60ca7dd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20221231.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0d1b9b99-7b7f-4c3e-a476-e551174774cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7dc9c8bb-8796-421f-b267-d9aa942db4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d1b9b99-7b7f-4c3e-a476-e551174774cd" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7dc9c8bb-8796-421f-b267-d9aa942db4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="iart-20221231.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_55270240-39c1-4a05-8f77-fd8af00b424f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_13707a6d-6912-4c37-8caf-487cf0fa722a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_55270240-39c1-4a05-8f77-fd8af00b424f" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_13707a6d-6912-4c37-8caf-487cf0fa722a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d86b3592-c7f2-4e34-b012-afc02298756f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c4f9d07f-eff7-40ed-be2f-3e2435c9fedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d86b3592-c7f2-4e34-b012-afc02298756f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c4f9d07f-eff7-40ed-be2f-3e2435c9fedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aa7c2e82-ba83-4c97-a10f-ff256f3d7ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_17247bfa-9e63-4581-b09b-307c945aabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aa7c2e82-ba83-4c97-a10f-ff256f3d7ea0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_17247bfa-9e63-4581-b09b-307c945aabe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aa04c336-c4d3-4727-9a4a-0dca003e16ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aa04c336-c4d3-4727-9a4a-0dca003e16ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_6bd98f96-738b-4ba0-9d20-a08e983e7dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_6bd98f96-738b-4ba0-9d20-a08e983e7dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_3cdbf344-debd-4488-8faf-4505c29aa39a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_UseOfEstimates_3cdbf344-debd-4488-8faf-4505c29aa39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_317bccb8-9db0-4bb6-a4f0-2b774a737b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_317bccb8-9db0-4bb6-a4f0-2b774a737b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_35c8e2df-cfde-4c75-a7fc-e37c22081a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_35c8e2df-cfde-4c75-a7fc-e37c22081a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2aeef32d-4bdd-4d3f-87b5-46df42f9deb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2aeef32d-4bdd-4d3f-87b5-46df42f9deb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f6b746f4-5171-42a0-8deb-9002c7bb3254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f6b746f4-5171-42a0-8deb-9002c7bb3254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_8ef4bdd9-1777-406a-a10b-df0d42fcf83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_8ef4bdd9-1777-406a-a10b-df0d42fcf83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_9c5602e6-e7eb-45b4-a3fa-04ac03895131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_9c5602e6-e7eb-45b4-a3fa-04ac03895131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c555b01c-888a-42ef-b68b-c4dbe670f35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c555b01c-888a-42ef-b68b-c4dbe670f35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_84cd55da-7d39-497d-91f8-3dfa811f30a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_84cd55da-7d39-497d-91f8-3dfa811f30a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FoundationPolicyTextBlock_42165706-f1e8-43be-a0fd-472b611f33b2" xlink:href="iart-20221231.xsd#iart_FoundationPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_iart_FoundationPolicyTextBlock_42165706-f1e8-43be-a0fd-472b611f33b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_f1123c57-f725-4e5d-a9f6-4beb5c14fc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_f1123c57-f725-4e5d-a9f6-4beb5c14fc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_85a947f3-f303-4c62-8b25-0ed21314fd60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_85a947f3-f303-4c62-8b25-0ed21314fd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b60d221a-3324-4a03-9be0-c321f304020b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b60d221a-3324-4a03-9be0-c321f304020b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_307db60a-bcde-4fe4-bef7-5829f0c882ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_307db60a-bcde-4fe4-bef7-5829f0c882ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a209d1fd-ef72-49e6-9a36-29d48cd7bd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a209d1fd-ef72-49e6-9a36-29d48cd7bd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_c0346611-2b91-492f-ad64-c65a4822cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_c0346611-2b91-492f-ad64-c65a4822cb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7e297c8b-ea95-454c-ab29-c9865f86c430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7e297c8b-ea95-454c-ab29-c9865f86c430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ed7aec8a-e00c-486d-b0f3-0d78ac34be8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ed7aec8a-e00c-486d-b0f3-0d78ac34be8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_3d349d69-619b-476b-8a84-52b97bdce16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_3d349d69-619b-476b-8a84-52b97bdce16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ba28b41b-f280-4ae8-b4b6-a7e931f0a6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ba28b41b-f280-4ae8-b4b6-a7e931f0a6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7bb87e12-56d4-4abd-bf8a-df9a63fc124d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7bb87e12-56d4-4abd-bf8a-df9a63fc124d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy_743c8a79-9ab5-4292-9375-70db463590b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_ExtendedProductWarrantyPolicy_743c8a79-9ab5-4292-9375-70db463590b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_c2d184f5-c079-488f-9d3b-527a1416f729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d7297766-d192-4278-9412-95c43965e40c" xlink:to="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_c2d184f5-c079-488f-9d3b-527a1416f729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d3dc2b20-a88b-4953-af05-b2297c0f5999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d3dc2b20-a88b-4953-af05-b2297c0f5999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ffac0e10-223b-4b72-acc3-d821e7e5d89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ffac0e10-223b-4b72-acc3-d821e7e5d89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9c9501b1-7ef2-4675-93fd-41caca4b59b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9c9501b1-7ef2-4675-93fd-41caca4b59b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_8c27786b-884d-48bc-9493-06d198d445b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_8c27786b-884d-48bc-9493-06d198d445b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c0b48903-a1aa-45f1-b5d2-8aa36fd20a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c0b48903-a1aa-45f1-b5d2-8aa36fd20a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_df659b5a-42db-4ffd-a3f6-709efbeec2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aeca3845-bb0f-4e46-9708-fb67533bf378" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_df659b5a-42db-4ffd-a3f6-709efbeec2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25772574-fc4b-49ff-90cc-0198635a3d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ff1715cb-f0c9-4a43-95d0-81ff023bab14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25772574-fc4b-49ff-90cc-0198635a3d52" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ff1715cb-f0c9-4a43-95d0-81ff023bab14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8c18ff05-f63f-40e2-bc50-28726c661845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_25772574-fc4b-49ff-90cc-0198635a3d52" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8c18ff05-f63f-40e2-bc50-28726c661845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ee5461a6-66fb-434b-a882-5b7e15244143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_794ec167-695e-4b97-b059-0093795fe3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ee5461a6-66fb-434b-a882-5b7e15244143" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_794ec167-695e-4b97-b059-0093795fe3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_476f76d6-e286-4915-9345-2d831d603202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ee5461a6-66fb-434b-a882-5b7e15244143" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_476f76d6-e286-4915-9345-2d831d603202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fd76a559-047b-4117-bd0e-68da6a6f444f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d288b722-fa71-47ea-8d95-96dd34f2d656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd76a559-047b-4117-bd0e-68da6a6f444f" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d288b722-fa71-47ea-8d95-96dd34f2d656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5e2cca9d-05ee-4a3c-8a28-c3b207a64a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd76a559-047b-4117-bd0e-68da6a6f444f" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5e2cca9d-05ee-4a3c-8a28-c3b207a64a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cf393226-f84e-42ad-9526-acec5ec9fca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_fa0e3f23-ca6d-4d13-b3ec-84264739fc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cf393226-f84e-42ad-9526-acec5ec9fca1" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_fa0e3f23-ca6d-4d13-b3ec-84264739fc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_75cb3a8a-cd05-4388-afc1-1f02aa8f42e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cf393226-f84e-42ad-9526-acec5ec9fca1" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_75cb3a8a-cd05-4388-afc1-1f02aa8f42e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3f10f742-0bc9-4b91-a4fb-e3530583a887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cf393226-f84e-42ad-9526-acec5ec9fca1" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3f10f742-0bc9-4b91-a4fb-e3530583a887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9133f99b-3ffe-4c56-a20e-9dd9a9aa1226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cf393226-f84e-42ad-9526-acec5ec9fca1" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9133f99b-3ffe-4c56-a20e-9dd9a9aa1226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735cb5b6-a469-4b3b-9423-03471adc36df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_19d04134-5131-4863-a6c1-7f0f4b77dc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735cb5b6-a469-4b3b-9423-03471adc36df" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_19d04134-5131-4863-a6c1-7f0f4b77dc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_b781a3f7-35c8-453c-8db0-1dc584c472bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735cb5b6-a469-4b3b-9423-03471adc36df" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_b781a3f7-35c8-453c-8db0-1dc584c472bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d8543314-441d-4998-b024-95bcf3eb8de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735cb5b6-a469-4b3b-9423-03471adc36df" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d8543314-441d-4998-b024-95bcf3eb8de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_083798e7-7c23-4c77-a7de-eb4be03b524a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_29924a6e-7cf2-45c2-b2e8-d47008bce60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_083798e7-7c23-4c77-a7de-eb4be03b524a" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_29924a6e-7cf2-45c2-b2e8-d47008bce60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_145d6894-c751-4e0e-a3c6-7a07de102f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_083798e7-7c23-4c77-a7de-eb4be03b524a" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_145d6894-c751-4e0e-a3c6-7a07de102f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_14916c2a-e20f-4aca-9ab0-bdb5b3dcdd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_083798e7-7c23-4c77-a7de-eb4be03b524a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_14916c2a-e20f-4aca-9ab0-bdb5b3dcdd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_7c02cb87-f8fe-4c22-b506-346595f89822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_083798e7-7c23-4c77-a7de-eb4be03b524a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_7c02cb87-f8fe-4c22-b506-346595f89822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_ac39b1b5-a576-4a03-8d43-ddecb8346159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_ac39b1b5-a576-4a03-8d43-ddecb8346159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_48ad76f8-9809-4435-a862-80a64c4e6eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_48ad76f8-9809-4435-a862-80a64c4e6eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_4c1cbfba-7979-46dd-a63c-61b45bbba8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_4c1cbfba-7979-46dd-a63c-61b45bbba8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_bd73db42-d8cc-4f59-88c4-5f3dfc714940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_bd73db42-d8cc-4f59-88c4-5f3dfc714940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_9cd9f388-5ee1-4afd-9277-89bdb2d46f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3c7f9e9-dd47-41c7-8140-8ab0d1f10dc4" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_9cd9f388-5ee1-4afd-9277-89bdb2d46f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3943d5b9-dd31-47d9-b7b1-8841f9447475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_5cecd16c-1925-4f4b-90e5-6548d2f9f65e" xlink:href="iart-20221231.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3943d5b9-dd31-47d9-b7b1-8841f9447475" xlink:to="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_5cecd16c-1925-4f4b-90e5-6548d2f9f65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock_78963f5a-e609-455f-b3b9-5f3bdc90c3aa" xlink:href="iart-20221231.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3943d5b9-dd31-47d9-b7b1-8841f9447475" xlink:to="loc_iart_CashFlowLesseeTableTextBlock_78963f5a-e609-455f-b3b9-5f3bdc90c3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5770e3a6-2e2b-4600-9b27-639495369a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3943d5b9-dd31-47d9-b7b1-8841f9447475" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5770e3a6-2e2b-4600-9b27-639495369a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b55e1a0a-0232-4ab5-a16e-43df8f9f5134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b55e1a0a-0232-4ab5-a16e-43df8f9f5134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bde59a80-28ae-4198-9a2c-545cc5673c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bde59a80-28ae-4198-9a2c-545cc5673c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cac915ac-02c6-4ab0-9d9f-278d3a6fa1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cac915ac-02c6-4ab0-9d9f-278d3a6fa1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5ddd225e-c7cd-422b-9966-8024f5532b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5ddd225e-c7cd-422b-9966-8024f5532b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_afd62f68-51d5-4bb5-9b93-6339a125d5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_afd62f68-51d5-4bb5-9b93-6339a125d5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_7f2cccac-58cb-4611-bc0a-1f0d55832ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6353b4f0-2ab9-4173-a12e-7b6e5e96bfba" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_7f2cccac-58cb-4611-bc0a-1f0d55832ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20221231.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0a828357-ac2d-4f26-aad9-c0d9f0210cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7b863e2a-7f1e-4d4c-8e82-baa7eeb9f91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0a828357-ac2d-4f26-aad9-c0d9f0210cc8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7b863e2a-7f1e-4d4c-8e82-baa7eeb9f91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="iart-20221231.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a047f443-5fe7-4f91-982b-c6ebd46d7f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0e638317-8fb7-498d-a7af-fc22c9a4e32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a047f443-5fe7-4f91-982b-c6ebd46d7f10" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0e638317-8fb7-498d-a7af-fc22c9a4e32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab9c21e4-1828-4ba8-beb5-bb9aac45ee35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_077b1ba0-0449-4181-9e26-76105cb99cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab9c21e4-1828-4ba8-beb5-bb9aac45ee35" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_077b1ba0-0449-4181-9e26-76105cb99cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_66172d0a-4ace-4693-be6e-3fa85d60a930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_88c50206-fb9f-4138-9d5c-7d2f5c49c081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_66172d0a-4ace-4693-be6e-3fa85d60a930" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_88c50206-fb9f-4138-9d5c-7d2f5c49c081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_45b8e581-3fee-4bec-9f70-b0720925fca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_66172d0a-4ace-4693-be6e-3fa85d60a930" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_45b8e581-3fee-4bec-9f70-b0720925fca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c222612c-ad29-4d70-9a50-77a24d71883c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c222612c-ad29-4d70-9a50-77a24d71883c" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7760437d-22b3-4f27-950f-a72f038f6e5d" xlink:to="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2e18bd39-62ea-4ffe-84b4-36772e8903ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:to="loc_srt_MinimumMember_2e18bd39-62ea-4ffe-84b4-36772e8903ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b184a67e-c4b4-4295-be64-2480c65a5a67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e4791bc7-864a-4a17-9d76-cc907ae3d919" xlink:to="loc_srt_MaximumMember_b184a67e-c4b4-4295-be64-2480c65a5a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6603fb9c-1ba2-4249-b7eb-2a8797d1a06c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ab71084a-0d33-4eb5-ac27-f5a672ae1385" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_84a4fa76-39ea-4b67-82ac-bf160e648cad" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ab71084a-0d33-4eb5-ac27-f5a672ae1385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1b1011e1-f1e4-41cd-8aff-596c3751b857" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3494c5da-6eeb-4130-9f37-f42f303d8148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f39391a7-b3a4-41d1-8a18-39abaa8210a2" xlink:to="loc_us-gaap_SalesRevenueNetMember_3494c5da-6eeb-4130-9f37-f42f303d8148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_123fc20a-f907-4cbc-bd9a-12e9cfd827e7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReboundTherapeuticsCorporationMember_69986c4f-8a03-4742-9430-8c4df85c4ea1" xlink:href="iart-20221231.xsd#iart_ReboundTherapeuticsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4ac43af4-2e83-45f3-b8d1-20b3abdb3b4c" xlink:to="loc_iart_ReboundTherapeuticsCorporationMember_69986c4f-8a03-4742-9430-8c4df85c4ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c672075-26a7-45ab-883f-d4d68c115de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_434ae732-fb9b-4e71-95cb-8e822b10e679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a396e0f9-45ed-4e3d-9f3b-3c24e4edb767" xlink:to="loc_us-gaap_ConvertibleDebtMember_434ae732-fb9b-4e71-95cb-8e822b10e679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13f5ff36-c3e9-4b96-9489-56d79fd96528" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_03b9fbf9-e497-4370-94de-6938165068a7" xlink:href="iart-20221231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc09e595-1d6e-4485-961f-fde29ca4afdb" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_03b9fbf9-e497-4370-94de-6938165068a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0b87e038-7e3a-4125-bd3c-76c8bf248ec0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f6d51305-0681-44c9-9d6c-7492e0fcfcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_CostOfSalesMember_f6d51305-0681-44c9-9d6c-7492e0fcfcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_df46e171-58c8-4511-aa74-051f8eb2fffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_df46e171-58c8-4511-aa74-051f8eb2fffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_458511b2-6652-4345-ab77-9f2d00733726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6030ae61-bff7-4f42-afb2-08a40f057de7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_458511b2-6652-4345-ab77-9f2d00733726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_78bacced-b859-4506-8672-31e4edd3767a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_fef1549d-2a78-46a2-995a-3f91d9bf90a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9cf9a75a-b752-4936-b42b-c83a14015f7a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_fef1549d-2a78-46a2-995a-3f91d9bf90a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0beb09bf-4373-45f2-afd4-1a9de79ac4e2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ClosureOfFacilityMember_51e5e9b4-49eb-451c-bb76-f7bf2bd88caf" xlink:href="iart-20221231.xsd#iart_ClosureOfFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:to="loc_iart_ClosureOfFacilityMember_51e5e9b4-49eb-451c-bb76-f7bf2bd88caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReorganizationProjectsMember_51b1b575-3247-46a2-9b63-9312a0dfcda4" xlink:href="iart-20221231.xsd#iart_ReorganizationProjectsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4b33ba97-5481-4472-911b-3abf98f3e652" xlink:to="loc_iart_ReorganizationProjectsMember_51b1b575-3247-46a2-9b63-9312a0dfcda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:href="iart-20221231.xsd#iart_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesTable_e1e71156-99d6-4644-9277-4ab6cb6246e7" xlink:to="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7fe5f598-6dde-462a-940e-0fd59917c902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7fe5f598-6dde-462a-940e-0fd59917c902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InventoryCapitalizedExpenses_67fafb15-c464-42a9-99ef-b89e565f4c56" xlink:href="iart-20221231.xsd#iart_InventoryCapitalizedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_InventoryCapitalizedExpenses_67fafb15-c464-42a9-99ef-b89e565f4c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2fc6ec35-7e06-4061-85e8-6055699851ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_Depreciation_2fc6ec35-7e06-4061-85e8-6055699851ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalizedAdjustment_fa08ccb3-8e88-4c7c-81ca-d0ebd2479eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalizedAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestCostsCapitalizedAdjustment_fa08ccb3-8e88-4c7c-81ca-d0ebd2479eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ef065f2a-5d59-4334-87b8-89857e73ee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_NumberOfReportableSegments_ef065f2a-5d59-4334-87b8-89857e73ee1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_736ae806-f51a-4c12-9f31-f21e8449192d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_NumberOfReportingUnits_736ae806-f51a-4c12-9f31-f21e8449192d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CharitableContributions_e435ed98-65ac-4687-af8a-558627942dc0" xlink:href="iart-20221231.xsd#iart_CharitableContributions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_CharitableContributions_e435ed98-65ac-4687-af8a-558627942dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e409ff82-051f-42ba-9607-bd47c4f3a130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_e409ff82-051f-42ba-9607-bd47c4f3a130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_dd4dce5f-8401-4e17-bfd0-75e7eb106d3c" xlink:href="iart-20221231.xsd#iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod_dd4dce5f-8401-4e17-bfd0-75e7eb106d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f12cdc98-3d68-49ab-b853-6ea550b38d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_RestructuringReserve_f12cdc98-3d68-49ab-b853-6ea550b38d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_f411e74b-ccae-4aef-9869-8bf7fcf13802" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_f411e74b-ccae-4aef-9869-8bf7fcf13802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_9a0db577-5f4b-4c86-b921-15de277c200e" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_9a0db577-5f4b-4c86-b921-15de277c200e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskThresholdPercentage_d0d7c499-0ba0-4fb1-8a3a-1523318c878e" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskThresholdPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_ConcentrationRiskThresholdPercentage_d0d7c499-0ba0-4fb1-8a3a-1523318c878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_26b56f99-63fb-459a-9a4a-9c6ac0e12097" xlink:href="iart-20221231.xsd#iart_ConcentrationRiskNumberofCustomersOverBenchmark"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_ConcentrationRiskNumberofCustomersOverBenchmark_26b56f99-63fb-459a-9a4a-9c6ac0e12097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_50873f19-3cf2-4d2c-b282-e8e406bf1312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_ConvertibleDebt_50873f19-3cf2-4d2c-b282-e8e406bf1312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_50606e0d-b026-42e6-8f9c-da8899927198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_50606e0d-b026-42e6-8f9c-da8899927198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_ece42bf9-1875-43ab-a05d-27fd76df1a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestPaid_ece42bf9-1875-43ab-a05d-27fd76df1a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_a7ec9dbc-891a-486d-82d2-11481c32559b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_InterestPaidCapitalized_a7ec9dbc-891a-486d-82d2-11481c32559b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ce1f34f2-00a1-4b5c-8b73-fb5f89d9106c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_IncomeTaxesPaid_ce1f34f2-00a1-4b5c-8b73-fb5f89d9106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1b637aa-2ac1-45e7-914a-8b40f7eed30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1b637aa-2ac1-45e7-914a-8b40f7eed30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_08ed6b16-c9c4-44cc-a568-4399a4afe23f" xlink:href="iart-20221231.xsd#iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_SummaryOfSignificantAccountingPoliciesLineItems_7b0e0fe6-ec0d-4662-8dc7-9d2dfd152d13" xlink:to="loc_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid_08ed6b16-c9c4-44cc-a568-4399a4afe23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ccec468f-3122-4065-8720-16d7994a2477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ccec468f-3122-4065-8720-16d7994a2477" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_75f688f7-ef2b-451c-b10d-0eb8c2b02cc5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_bbf28153-9df4-4e29-a7f6-b594af74de46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d2531a6f-f493-4e7d-91c7-38cfbeb44637" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_bbf28153-9df4-4e29-a7f6-b594af74de46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_341cce02-47ff-43c7-a805-e9997fd790d4" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4f59b3ca-48ba-4e59-ba43-64f04bd3895d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4f59b3ca-48ba-4e59-ba43-64f04bd3895d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_06972b75-45f8-4269-9deb-d1c35849e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_06972b75-45f8-4269-9deb-d1c35849e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_be818fe8-5502-4602-8e34-765345b5f2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_be818fe8-5502-4602-8e34-765345b5f2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4787dc81-12de-4b12-89f1-048bcb50f7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4787dc81-12de-4b12-89f1-048bcb50f7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_aec03911-8c83-4638-8dc2-b3da2e698661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_704571d5-d393-4879-bcaf-5acdede901d9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_aec03911-8c83-4638-8dc2-b3da2e698661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_96a98964-48d9-485e-a566-3eb1c34f34e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_da1d8788-4b91-454e-b362-f396e0e9d256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_96a98964-48d9-485e-a566-3eb1c34f34e3" xlink:to="loc_us-gaap_InventoryFinishedGoods_da1d8788-4b91-454e-b362-f396e0e9d256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_f2b02ba1-f127-4ac5-949b-ab61b86fdf45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_96a98964-48d9-485e-a566-3eb1c34f34e3" xlink:to="loc_us-gaap_InventoryWorkInProcess_f2b02ba1-f127-4ac5-949b-ab61b86fdf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_3026036a-3a86-4706-a93a-5c204c2a86ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_96a98964-48d9-485e-a566-3eb1c34f34e3" xlink:to="loc_us-gaap_InventoryRawMaterials_3026036a-3a86-4706-a93a-5c204c2a86ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0688a26f-0b75-4a3e-abb2-cbb8042cf85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_96a98964-48d9-485e-a566-3eb1c34f34e3" xlink:to="loc_us-gaap_InventoryNet_0688a26f-0b75-4a3e-abb2-cbb8042cf85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2d2cdd7-2260-42d6-9b7d-2950546172e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2d2cdd7-2260-42d6-9b7d-2950546172e2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3efbd8b-8601-4e67-a250-f02696e7cf8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_215aa059-8881-42dc-b70a-bc5b6708f7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_LandMember_215aa059-8881-42dc-b70a-bc5b6708f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_168ddb32-12c0-4493-afcc-314fd8e24cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_168ddb32-12c0-4493-afcc-314fd8e24cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_9a53d5c0-c44e-48ff-9b93-83f00e79a295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_9a53d5c0-c44e-48ff-9b93-83f00e79a295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_eca035de-1ad5-4c4b-a795-df9ca73ccec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_eca035de-1ad5-4c4b-a795-df9ca73ccec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DemonstrationEquipmentMember_b2145043-d0df-434b-9f3a-33ba9f9ba981" xlink:href="iart-20221231.xsd#iart_DemonstrationEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_iart_DemonstrationEquipmentMember_b2145043-d0df-434b-9f3a-33ba9f9ba981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InformationSystemsandHardwareMember_09747f54-e0ca-4306-bb9d-6a1c0f566ce6" xlink:href="iart-20221231.xsd#iart_InformationSystemsandHardwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_iart_InformationSystemsandHardwareMember_09747f54-e0ca-4306-bb9d-6a1c0f566ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_85316279-a9de-49ad-9744-60de3b33c1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_85316279-a9de-49ad-9744-60de3b33c1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_657e2ce9-4be6-4081-a674-e57926dfb954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_125820ce-c791-4896-904c-d58b09463413" xlink:to="loc_us-gaap_ConstructionInProgressMember_657e2ce9-4be6-4081-a674-e57926dfb954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:to="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4e95974d-eb95-4b85-9137-6721a2c5f925" xlink:to="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_22007c0a-8cd5-4f88-b29e-18cf1619bba3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:to="loc_srt_MinimumMember_22007c0a-8cd5-4f88-b29e-18cf1619bba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dc9baf23-e88e-4446-b99a-cda077fe7b0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_781c5d3a-8437-492d-9564-72532b824b78" xlink:to="loc_srt_MaximumMember_dc9baf23-e88e-4446-b99a-cda077fe7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c7b6c6a-93fb-4e89-be73-6daac91d2fda" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_77f30c0a-a909-4bf1-bc4f-f44559ec7875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_77f30c0a-a909-4bf1-bc4f-f44559ec7875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1c92efdf-3161-4b1c-a211-8b73e9cd73b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1c92efdf-3161-4b1c-a211-8b73e9cd73b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9911b88-df3b-4596-8d12-e1b04026f2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9911b88-df3b-4596-8d12-e1b04026f2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13d66cdd-10a0-4d0a-9763-e51b9122b48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_721b9ffe-792b-409f-90bd-149649438d72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13d66cdd-10a0-4d0a-9763-e51b9122b48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_c728e26d-937e-4741-9d77-186cf336d2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_c728e26d-937e-4741-9d77-186cf336d2c0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b74bbf4b-da1c-47e9-8237-d86611b45de2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_515cabbb-500f-4c5a-a74b-9cfd220b769d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_CostOfSalesMember_515cabbb-500f-4c5a-a74b-9cfd220b769d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd28ab40-b02e-4ced-8139-95472eaf18f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd28ab40-b02e-4ced-8139-95472eaf18f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9ac4bd4f-2821-4eaf-a512-4be32ef010d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5da15ce3-cbd3-49f0-8fa6-47e2702237cc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9ac4bd4f-2821-4eaf-a512-4be32ef010d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_795583f3-3c59-431f-ad33-1c9905d5dbc9" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d450c8ae-bae0-4f42-9071-9e911718660d" xlink:to="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a92ea46-9744-46e9-9ea1-9110cdf9007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringReserve_9a92ea46-9744-46e9-9ea1-9110cdf9007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5fef0f24-2e62-48bd-bad4-286fa1de4148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringCharges_5fef0f24-2e62-48bd-bad4-286fa1de4148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1be00ee7-f847-46c9-80e2-6b4aa7b68c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_1be00ee7-f847-46c9-80e2-6b4aa7b68c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_98ff689e-97a0-4c0d-8698-a27920d28878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_641d59fe-2fc1-4855-9cdd-85826c3e2730" xlink:to="loc_us-gaap_RestructuringReserve_98ff689e-97a0-4c0d-8698-a27920d28878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="simple" xlink:href="iart-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_09d42c4d-cfd4-4efd-abe4-54b8422f8225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_09d42c4d-cfd4-4efd-abe4-54b8422f8225" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d6141a02-b9b1-45a5-a355-bd49d0df70d1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41e1270e-690b-42fa-8fa9-6a914932306f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_d98e2afd-4e17-49c5-92e9-6b9ae0276174" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember_d98e2afd-4e17-49c5-92e9-6b9ae0276174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_3e872e57-dd1e-4346-87e2-7ff3663e824d" xlink:href="iart-20221231.xsd#iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b5a84119-d058-40e7-8214-667c2d4c3fab" xlink:to="loc_iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember_3e872e57-dd1e-4346-87e2-7ff3663e824d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3bcd0d1f-dfc5-4823-9a17-55350caa5bfb" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5bbb93ac-4e49-43ed-8e68-b8e0b9d83cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5bbb93ac-4e49-43ed-8e68-b8e0b9d83cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_0a32c530-22dc-4b5b-bd71-6a6c7186bab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_0a32c530-22dc-4b5b-bd71-6a6c7186bab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_929d0ddb-b77c-42b9-8c0f-fbd2c7a30580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_929d0ddb-b77c-42b9-8c0f-fbd2c7a30580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f84311da-caef-4f8f-ae8a-bd5cdf1b993e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05910f6f-ca87-4636-9f3f-03a3919c5d48" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f84311da-caef-4f8f-ae8a-bd5cdf1b993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_d5c413d8-8abe-47ce-a937-589f21fd8c0d" xlink:href="iart-20221231.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:to="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_d5c413d8-8abe-47ce-a937-589f21fd8c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1b38a399-ee3f-4dcf-b071-336221ad3ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1b38a399-ee3f-4dcf-b071-336221ad3ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_3e92a2a0-9dde-4ae4-b055-6a6492afc3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_3e92a2a0-9dde-4ae4-b055-6a6492afc3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_41f32014-89fe-46f5-a7a3-157bee2242c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_41f32014-89fe-46f5-a7a3-157bee2242c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod_2ec6bd22-b6d2-4118-9e17-a208c21e73ca" xlink:href="iart-20221231.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_06f301b5-a810-4ad6-a88d-47943874a37a" xlink:to="loc_iart_RevenueProductWarrantyPeriod_2ec6bd22-b6d2-4118-9e17-a208c21e73ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a005d367-1b8f-497a-9d33-4cf2cf534415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_8b49f104-4227-429d-aa5c-51450ddfc854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a005d367-1b8f-497a-9d33-4cf2cf534415" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_8b49f104-4227-429d-aa5c-51450ddfc854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a005d367-1b8f-497a-9d33-4cf2cf534415" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3f4e7890-4048-4acf-b788-89757dbef7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3f4e7890-4048-4acf-b788-89757dbef7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b093f5bf-e9d5-49a9-9039-14bbab171a55" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_287fc36c-4c8a-44e8-b61d-51f0411b8056" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d907ef83-529b-438e-b434-eea3eb7aa970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4440cbe-e7b3-4c69-8143-0585902da2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:href="iart-20221231.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4440cbe-e7b3-4c69-8143-0585902da2f2" xlink:to="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_381ad385-c26f-44ee-8ca6-fe996c1d7cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_381ad385-c26f-44ee-8ca6-fe996c1d7cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_3d2c932e-4f9b-43d5-ad20-6d32089e7f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_3d2c932e-4f9b-43d5-ad20-6d32089e7f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_998fa679-f027-4d20-b017-252d75246049" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:to="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_998fa679-f027-4d20-b017-252d75246049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_e37bf2cd-38e9-4348-a25e-462a51796ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_2146b4dd-236c-46a8-a595-1ec05d27efbe" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_e37bf2cd-38e9-4348-a25e-462a51796ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:href="iart-20221231.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4440cbe-e7b3-4c69-8143-0585902da2f2" xlink:to="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3b82237d-2024-4adf-af2b-3d2948e6e9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3b82237d-2024-4adf-af2b-3d2948e6e9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a3e5eed2-9886-4a7d-85fe-75b997add1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a3e5eed2-9886-4a7d-85fe-75b997add1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_9b8ee8be-b735-4591-90ed-17e1d768b6ea" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:to="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation_9b8ee8be-b735-4591-90ed-17e1d768b6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_648cc749-87f7-416e-ac8c-6b15b9f781b9" xlink:href="iart-20221231.xsd#iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:to="loc_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation_648cc749-87f7-416e-ac8c-6b15b9f781b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d8f56c9e-9714-4a64-8b8a-5eedbc32d379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_f3a32722-ca4f-47a9-b28a-d7e5b8a4a6cc" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d8f56c9e-9714-4a64-8b8a-5eedbc32d379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ec19b41-4cdd-4c95-9f22-210d4e51715c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ec19b41-4cdd-4c95-9f22-210d4e51715c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6170eb76-042e-4f3b-8bac-abd2786a4d13" xlink:to="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_c4e5c60e-4de5-4014-970e-02e39ebadc9d" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_c4e5c60e-4de5-4014-970e-02e39ebadc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_5f19019b-604d-4c9c-9079-13be8328feb9" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd1ecacd-eee7-41e7-86ab-9d6a05c642e5" xlink:to="loc_iart_TissueTechnologiesMember_5f19019b-604d-4c9c-9079-13be8328feb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:to="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c93ffd7d-28da-44aa-912b-a4d78008b5ab" xlink:to="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_84e54dd8-f1de-4bf8-8298-f899996c4e26" xlink:href="iart-20221231.xsd#iart_NeurosurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_NeurosurgeryMember_84e54dd8-f1de-4bf8-8298-f899996c4e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_d7d0a95c-60cb-4007-86d9-992924c31a4c" xlink:href="iart-20221231.xsd#iart_InstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_InstrumentsMember_d7d0a95c-60cb-4007-86d9-992924c31a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_b215729d-acbd-4587-b86a-6ca7d2e91549" xlink:href="iart-20221231.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_b215729d-acbd-4587-b86a-6ca7d2e91549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_b31b406b-0669-4bac-8598-080cc55b5f53" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_ExtremityOrthopedicsMember_b31b406b-0669-4bac-8598-080cc55b5f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_e88b9ce9-08d7-4454-a8c7-920ea76f4f72" xlink:href="iart-20221231.xsd#iart_PrivateLabelMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90c25f32-ce7d-4f44-8f2a-7a1f6ae3c901" xlink:to="loc_iart_PrivateLabelMember_e88b9ce9-08d7-4454-a8c7-920ea76f4f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6fc7f576-5f19-4f6f-aca3-939bb58f6f31" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba90ebcb-ce29-4cc7-b6b3-7261078c3106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f3e21d22-2316-4bfb-a78d-9ba324f7c2d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ba90ebcb-ce29-4cc7-b6b3-7261078c3106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9cb79f05-0176-4c88-ab27-df0a725418d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9cb79f05-0176-4c88-ab27-df0a725418d1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_30d2212a-529d-400e-bdb9-94ac4c85a8d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_21bada06-ceba-494a-b606-5164d75ab8ec" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3e91d2-59cf-4bb5-88ab-c2b43f2a865f" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_21bada06-ceba-494a-b606-5164d75ab8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_79b894a1-bffc-42a8-a4a8-db28c892af2a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember_b82df151-e4b5-417d-9a88-e9eae22dbb8b" xlink:href="iart-20221231.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:to="loc_iart_RevenueBasedPerformanceMilestonesMember_b82df151-e4b5-417d-9a88-e9eae22dbb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember_c0d35f7c-0082-4850-a0df-4bc3095041d7" xlink:href="iart-20221231.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3260a407-af62-4cee-b1d2-30683c9ace9e" xlink:to="loc_iart_FDAApprovalOfPremarketApprovalMember_c0d35f7c-0082-4850-a0df-4bc3095041d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_116caf04-62ae-409c-9174-aac686df6133" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a0b3b791-5acb-4380-a221-825b3daac6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a0b3b791-5acb-4380-a221-825b3daac6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8f29d1e7-32e8-4028-a35f-8306e1afec67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8f29d1e7-32e8-4028-a35f-8306e1afec67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b142d6ad-2b5e-4dfe-a9af-f5786e06576f" xlink:href="iart-20221231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b142d6ad-2b5e-4dfe-a9af-f5786e06576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_278c1401-191a-485a-96cb-fbd9395b0b3e" xlink:href="iart-20221231.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_278c1401-191a-485a-96cb-fbd9395b0b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c1f4672-d0e3-4c66-bf84-8d0c022fe186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ed1b1bb9-ba1e-46fb-ac6d-035b477da7f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c1f4672-d0e3-4c66-bf84-8d0c022fe186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_40b2e8fa-e49e-4367-9f55-b569fe2ed597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_40b2e8fa-e49e-4367-9f55-b569fe2ed597" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07d91b43-94ca-47ae-b8c3-86f7090754a3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_79b0a1cd-b88a-40b2-af1f-5d2af29d8c25" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dc52f8f-bfe1-49a2-8dc3-dbb158893796" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_79b0a1cd-b88a-40b2-af1f-5d2af29d8c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01f93e23-3ad9-45bb-a305-e126fa4c5e0f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4560082-14ee-442c-8dae-d0aca81cca7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4560082-14ee-442c-8dae-d0aca81cca7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50227770-6018-4500-a0ec-6dcdc2dbe39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50227770-6018-4500-a0ec-6dcdc2dbe39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fcf6e01-ff15-4724-a7de-9e824629c3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fcf6e01-ff15-4724-a7de-9e824629c3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7a387bd2-3274-488a-ae11-f0433587e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7a387bd2-3274-488a-ae11-f0433587e30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_413cd5ee-75e0-4d8b-8f83-bce91f87f90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_413cd5ee-75e0-4d8b-8f83-bce91f87f90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8be3422e-cf03-4d8c-aec8-b1c5c36e4bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8be3422e-cf03-4d8c-aec8-b1c5c36e4bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ab41d3e-7386-4d91-942a-e18c0f1c1f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_Goodwill_2ab41d3e-7386-4d91-942a-e18c0f1c1f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_bc30cc45-7a19-4097-b24d-4b47b58657b1" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_bc30cc45-7a19-4097-b24d-4b47b58657b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac41b4c4-b249-4033-992f-d04df6a15bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac41b4c4-b249-4033-992f-d04df6a15bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5c249285-2e24-4ab4-b522-f9d6dc581660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5c249285-2e24-4ab4-b522-f9d6dc581660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cdfaa7a7-47c1-4fd2-9738-e0107f44922e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cdfaa7a7-47c1-4fd2-9738-e0107f44922e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0760f579-7084-4e57-a6d1-e362090b3469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0760f579-7084-4e57-a6d1-e362090b3469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f40ef891-a49d-4805-9989-228376275761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f40ef891-a49d-4805-9989-228376275761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_750ce633-431e-4673-8437-9ac24dd667d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_750ce633-431e-4673-8437-9ac24dd667d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2bc847f6-b960-4c61-af5b-d4fa6c4845fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_86614068-5811-4952-b3f7-62230b8bb8d8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2bc847f6-b960-4c61-af5b-d4fa6c4845fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_31a90e42-8b48-4457-90c1-049d4a6b270e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_31a90e42-8b48-4457-90c1-049d4a6b270e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6cdd4b2c-2edc-4fac-a40d-7ed01f7253db" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_378c0f08-8f57-43dc-9cbd-71aef8856c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6935ca44-46b5-4a80-bcc2-ec636d9a0ac5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_378c0f08-8f57-43dc-9cbd-71aef8856c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d3b39f3a-5c27-42c7-8a3f-522c4ab8410f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember_5582aa29-d7c3-4182-a5c1-e40f1cc11973" xlink:href="iart-20221231.xsd#iart_TraditionalWoundCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:to="loc_iart_TraditionalWoundCareMember_5582aa29-d7c3-4182-a5c1-e40f1cc11973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_dfbca1b6-0d6f-4703-8511-3f694171f28f" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dc4d0478-69f0-4ed7-ac40-64db2125ea2e" xlink:to="loc_iart_ExtremityOrthopedicsMember_dfbca1b6-0d6f-4703-8511-3f694171f28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ba3b1c93-6184-4331-8cac-fd26c7b67b97" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_74642f79-ee86-4dac-8c75-9d8972786f04" xlink:href="iart-20221231.xsd#iart_ConsortiumofFocusedOrthopedistsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d2431ca-40a0-4880-9b64-92c110b869eb" xlink:to="loc_iart_ConsortiumofFocusedOrthopedistsLLCMember_74642f79-ee86-4dac-8c75-9d8972786f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_500a4dc7-8a81-495f-a8c0-b03a976b7d5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_c069a8c9-c54b-4ecd-a48c-4b73dcfe3e86" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2122899-3a6e-4447-b229-466bdab3b23d" xlink:to="loc_iart_ACellIncMember_c069a8c9-c54b-4ecd-a48c-4b73dcfe3e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d03764c9-89d3-4f8f-bb6b-72be21d81bbf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c017643c-ff0b-4219-a01f-e6b612675c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c017643c-ff0b-4219-a01f-e6b612675c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_95f63245-d110-415a-b820-922baefe2698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_95f63245-d110-415a-b820-922baefe2698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_8df2c0dd-19aa-4fa6-9a0a-e52a3e95182f" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_8df2c0dd-19aa-4fa6-9a0a-e52a3e95182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_b11fa22d-0356-4137-ba98-0bd720376ff8" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_b11fa22d-0356-4137-ba98-0bd720376ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_3f6f2aa9-7c64-4c36-9dbc-8edc47353e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_3f6f2aa9-7c64-4c36-9dbc-8edc47353e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_fb751060-3eb7-479b-b436-1a00afccd304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_fb751060-3eb7-479b-b436-1a00afccd304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_9e671788-a82a-487e-b57c-d6d8d3f56dc4" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_9e671788-a82a-487e-b57c-d6d8d3f56dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_2e4a467e-fedb-43cc-be84-4939221ad489" xlink:href="iart-20221231.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_2e4a467e-fedb-43cc-be84-4939221ad489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_32df23e7-7a52-4dec-8e0a-85d9b0fe4503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_32df23e7-7a52-4dec-8e0a-85d9b0fe4503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_320eb954-192a-46e6-ba9d-95ebcd9f9696" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination_320eb954-192a-46e6-ba9d-95ebcd9f9696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_cf1f46cc-6230-48f0-b4b2-b3a14d95ddad" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable_cf1f46cc-6230-48f0-b4b2-b3a14d95ddad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9823222b-9438-435b-9370-4da39ffc32d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9823222b-9438-435b-9370-4da39ffc32d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb73b37-afeb-4cd0-bfde-f98e496da359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb73b37-afeb-4cd0-bfde-f98e496da359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationWorkingCapitalAdjustment_6a251034-eac6-4123-81fa-aafdf47e8576" xlink:href="iart-20221231.xsd#iart_BusinessCombinationWorkingCapitalAdjustment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_BusinessCombinationWorkingCapitalAdjustment_6a251034-eac6-4123-81fa-aafdf47e8576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_56eb148e-f106-40e5-928c-461baf35c678" xlink:href="iart-20221231.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_56eb148e-f106-40e5-928c-461baf35c678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_56f84ca6-a84f-492e-b1b2-7233e285f945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_56f84ca6-a84f-492e-b1b2-7233e285f945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_96e6e2b0-3068-4693-9fbf-e8db11b5ee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_50466827-3e1a-42d2-9671-4c13fa7e60f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_96e6e2b0-3068-4693-9fbf-e8db11b5ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_15312884-24dc-4632-87d8-b3ef080f62a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_15312884-24dc-4632-87d8-b3ef080f62a0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8be27e39-158b-46cf-bc89-3eece9e58442" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f4d36c26-be12-444d-a566-098d3a56f6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6c722551-1b31-4e0c-8a46-bb5278c60306" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f4d36c26-be12-444d-a566-098d3a56f6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87a6a302-b202-4b03-ae75-9735b0ea3f28" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_239db320-b337-4d80-beaa-682b89279e96" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ed55ce4c-d3d9-4b24-979a-99ae7c8bcc4f" xlink:to="loc_iart_ExtremityOrthopedicsMember_239db320-b337-4d80-beaa-682b89279e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e21ae5ba-9818-4523-9417-308aaf6d7aff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_df2ed0c2-eb44-4965-ad0b-cb3e3ab8c93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_df2ed0c2-eb44-4965-ad0b-cb3e3ab8c93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_5efbb024-4c30-477c-a48c-92cec4e2a2a3" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets_5efbb024-4c30-477c-a48c-92cec4e2a2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_ab9ffdc5-9e7c-4e54-8a3b-bd18a3cd6b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_ab9ffdc5-9e7c-4e54-8a3b-bd18a3cd6b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d5d7b7fc-2ade-42aa-b21d-91ad696b8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_d5d7b7fc-2ade-42aa-b21d-91ad696b8ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a89adf91-dc0e-4aa0-bef4-03b2d7ad0243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a89adf91-dc0e-4aa0-bef4-03b2d7ad0243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0fcbdae7-6987-407f-a7ad-a2bdddd355ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_0fcbdae7-6987-407f-a7ad-a2bdddd355ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_54412f6a-0949-4f03-a21a-1eeca660ef19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_54412f6a-0949-4f03-a21a-1eeca660ef19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a803aea5-fe39-47ce-b149-68cf0590d19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a803aea5-fe39-47ce-b149-68cf0590d19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_435ee998-5b75-4891-971e-c797ce591d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_435ee998-5b75-4891-971e-c797ce591d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_22ee1d85-bc90-4fcc-970c-a06bd07e2633" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent_22ee1d85-bc90-4fcc-970c-a06bd07e2633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bf28d196-98bb-432e-ad18-243f9c434f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bf28d196-98bb-432e-ad18-243f9c434f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_90f2d4fa-e29e-4fc6-8b44-b79d2e3de1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities_90f2d4fa-e29e-4fc6-8b44-b79d2e3de1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_3a2c342d-2954-4c5a-b705-eec86f357072" xlink:href="iart-20221231.xsd#iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent_3a2c342d-2954-4c5a-b705-eec86f357072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4352c564-69fc-4c44-87fd-6b469e3cacc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5186a522-f108-4a96-84b9-13825f40dd2b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4352c564-69fc-4c44-87fd-6b469e3cacc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_28bf7e4f-96e5-43d3-a436-bbbaad5ff006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_28bf7e4f-96e5-43d3-a436-bbbaad5ff006" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_37f390e0-6f77-4044-a07c-b1cef8d47162" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_f81732f5-b861-454f-8038-98cf7d8531c2" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_523e3a00-8cf4-4187-a7a9-fbd5da027fd4" xlink:to="loc_iart_ACellIncMember_f81732f5-b861-454f-8038-98cf7d8531c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fa9699ba-9d26-485c-9b0c-724b9f35135a" xlink:to="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8b415ee9-5d1c-41cb-b871-b5333199eea9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:to="loc_srt_MinimumMember_8b415ee9-5d1c-41cb-b871-b5333199eea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_32a2904b-59b7-4a72-a425-aa04aed1eec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d27777ee-2c53-4c67-a385-40fb4a3c018e" xlink:to="loc_srt_MaximumMember_32a2904b-59b7-4a72-a425-aa04aed1eec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ac8082bc-8de2-40d3-b046-d3fc3c946781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59c8987b-a062-4344-92e7-4c21028e6461" xlink:to="loc_us-gaap_ClassOfStockDomain_ac8082bc-8de2-40d3-b046-d3fc3c946781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4284b823-27fe-4a00-9aa2-62b305041d25" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1b724613-7cb4-441b-b117-593549a55d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1b724613-7cb4-441b-b117-593549a55d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_87c20771-08b5-49af-994e-a566eb1d7abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_87c20771-08b5-49af-994e-a566eb1d7abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_12957d79-4a7e-424e-98d1-299e8382c700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_12957d79-4a7e-424e-98d1-299e8382c700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aa9d2192-f6f7-48ea-96e1-e7c7961e3078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_aa9d2192-f6f7-48ea-96e1-e7c7961e3078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a63a3d64-f9f3-49e7-bd1b-21b181f1e079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a63a3d64-f9f3-49e7-bd1b-21b181f1e079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4b02979-9dff-4744-8ec2-32e0c00d11fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4b02979-9dff-4744-8ec2-32e0c00d11fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ec3a6aa6-7271-4ee8-b084-313d80199147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ec3a6aa6-7271-4ee8-b084-313d80199147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_26a7a60d-87c4-4caa-9c21-0c71540c652a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_26a7a60d-87c4-4caa-9c21-0c71540c652a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6759d069-f119-4352-a7ae-47d44bec001d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_Goodwill_6759d069-f119-4352-a7ae-47d44bec001d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_5ad141c6-51b6-42c5-9c8e-850bdde90312" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases_5ad141c6-51b6-42c5-9c8e-850bdde90312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1b5d7468-0db1-4eba-afbb-db17dce29f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1b5d7468-0db1-4eba-afbb-db17dce29f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d9383ee8-2705-4953-9730-d4c2ffcabb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d9383ee8-2705-4953-9730-d4c2ffcabb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d32513d4-e822-43ee-9027-59f66a7430b0" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d32513d4-e822-43ee-9027-59f66a7430b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_868ed3ff-4da0-484b-b57a-4ff2729e8391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_868ed3ff-4da0-484b-b57a-4ff2729e8391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2bed9c16-d73a-4c54-89c3-982a182fef18" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2bed9c16-d73a-4c54-89c3-982a182fef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_6f52e79f-ae1e-4989-94cd-558e7fcec50c" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases_6f52e79f-ae1e-4989-94cd-558e7fcec50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e1fe1912-98d6-4f81-a5e4-e4effa8d3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e1fe1912-98d6-4f81-a5e4-e4effa8d3f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4f7cf806-8d48-4cab-ab2a-2387a0ae787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4f7cf806-8d48-4cab-ab2a-2387a0ae787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ba8bcdd6-ba6f-44c5-9019-ce6b128e601b" xlink:href="iart-20221231.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases_ba8bcdd6-ba6f-44c5-9019-ce6b128e601b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e8c23ff1-9666-4da3-b6c1-26aae8a105fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e8c23ff1-9666-4da3-b6c1-26aae8a105fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_2545758f-c47d-4e01-9aa8-33c8ed05affb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_2545758f-c47d-4e01-9aa8-33c8ed05affb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2809e389-a441-44e2-bf1c-3836717640e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2809e389-a441-44e2-bf1c-3836717640e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5dd1cd0e-2342-4f45-9c8c-5ab5f8bec999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46363511-7ab7-448d-8937-80f4168bcd9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5dd1cd0e-2342-4f45-9c8c-5ab5f8bec999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d87d34a4-6690-4eb4-b582-64b405b2ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d87d34a4-6690-4eb4-b582-64b405b2ba9f" xlink:to="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_23572dd9-bac1-4f92-b328-5077c8184fce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_ba1cfb04-b2b4-4f28-82d8-4e2e251ca560" xlink:href="iart-20221231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_SeniorCreditFacilityMember_ba1cfb04-b2b4-4f28-82d8-4e2e251ca560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_4ee6f5aa-c529-4636-9f15-824818179162" xlink:href="iart-20221231.xsd#iart_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_TermLoanFacilityMember_4ee6f5aa-c529-4636-9f15-824818179162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_6fbdc134-33a2-4d1a-9bbc-90defa73b6f5" xlink:href="iart-20221231.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc3158d1-5b22-434d-93c8-c40e19e2f3c4" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_6fbdc134-33a2-4d1a-9bbc-90defa73b6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_34845567-57d5-452d-ad80-9c8caba8936d" xlink:to="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3dde5b8b-a31b-457f-93e7-adc1a757ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_SecuredDebtMember_3dde5b8b-a31b-457f-93e7-adc1a757ccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d8c4ce08-8197-4cd1-8392-b3cea91a1466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d8c4ce08-8197-4cd1-8392-b3cea91a1466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_d2098803-d805-440c-810a-9d5d55424637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_d2098803-d805-440c-810a-9d5d55424637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_561dd1d8-0254-4442-8e0f-dbed8c13df7e" xlink:href="iart-20221231.xsd#iart_SwinglineLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2c65c4f-02c2-4909-8160-ffe808ed0f36" xlink:to="loc_iart_SwinglineLoanMember_561dd1d8-0254-4442-8e0f-dbed8c13df7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_997fe66c-15b6-41d5-871f-3bfd3f58dae4" xlink:to="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_bab6f620-e313-4fad-bf7f-1f300819ad67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_us-gaap_EurodollarMember_bab6f620-e313-4fad-bf7f-1f300819ad67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ffd71ad8-12bd-414f-880f-cb192a45d7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_ffd71ad8-12bd-414f-880f-cb192a45d7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthEurodollarRateMember_f645da7a-d8cf-4769-a70b-55f74ad41506" xlink:href="iart-20221231.xsd#iart_OneMonthEurodollarRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_447cf4e5-581a-4a3c-a0cf-61856c3eccd6" xlink:to="loc_iart_OneMonthEurodollarRateMember_f645da7a-d8cf-4769-a70b-55f74ad41506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_73c7bb23-b44e-4eb2-80f6-20c18ffafc6c" xlink:to="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c0e2b736-1f69-4de0-aa97-a937f584c163" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:to="loc_srt_MinimumMember_c0e2b736-1f69-4de0-aa97-a937f584c163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_118161ca-d930-483e-aac6-5dc2a1349976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a5d8790-7f4c-4265-9c0d-0c14576f97ed" xlink:to="loc_srt_MaximumMember_118161ca-d930-483e-aac6-5dc2a1349976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_391110f8-4028-4e8c-ad01-4798985004b3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_60c90610-19dd-436e-9d3c-8718741e3d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa46e036-2516-455f-854e-ad6ec2d56b36" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_60c90610-19dd-436e-9d3c-8718741e3d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1bf3dcf2-0317-4c0a-aaf8-07263609c814" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3e990925-60d7-4f8a-8fd3-24f8743ce4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43bc946c-822c-4c21-9ec4-37f73c2789f2" xlink:to="loc_us-gaap_ConvertibleDebtMember_3e990925-60d7-4f8a-8fd3-24f8743ce4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad30a9ce-caf6-4945-9b6e-e6e1d37b532a" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_d5986c75-2736-438c-85e1-0de524602790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_52e76f40-ae8b-4c26-9f9e-e7382fc0f9a5" xlink:to="loc_us-gaap_CallOptionMember_d5986c75-2736-438c-85e1-0de524602790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d0f6cf9f-e730-41c7-9a22-f2f4e7fcd6a2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e706898b-0235-470d-89dd-eff0d81313a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e706898b-0235-470d-89dd-eff0d81313a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8c68b6b2-04ab-41bf-9383-9ef34149e4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8c68b6b2-04ab-41bf-9383-9ef34149e4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_32269a5a-03e4-4c19-8df7-603b6466acb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_32269a5a-03e4-4c19-8df7-603b6466acb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_ef89eb37-ff5b-4e05-8c9e-335746b6a024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_ef89eb37-ff5b-4e05-8c9e-335746b6a024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_277daa94-f5c5-4fca-8eb4-adceb2953ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_277daa94-f5c5-4fca-8eb4-adceb2953ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_8c3abb39-3d08-4e54-82dc-7e0c8ad2f43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_8c3abb39-3d08-4e54-82dc-7e0c8ad2f43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e3767a69-edce-429f-8d77-32b3f43d573c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCredit_e3767a69-edce-429f-8d77-32b3f43d573c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_93872c8d-2e3b-4ad8-9fa4-880bbda9db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_93872c8d-2e3b-4ad8-9fa4-880bbda9db8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_a13dc9ff-111f-41a0-9333-7ab431575700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_SecuredDebtCurrent_a13dc9ff-111f-41a0-9333-7ab431575700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_afd452ef-1e1b-475e-9ed5-f4d196305826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_afd452ef-1e1b-475e-9ed5-f4d196305826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ccacf3df-d615-4272-b20f-391082635838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ccacf3df-d615-4272-b20f-391082635838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_ee0886e9-c89d-4bbe-9d7b-7bb06cfc9b77" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearOne"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearOne_ee0886e9-c89d-4bbe-9d7b-7bb06cfc9b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_e0c16d47-8ecb-41e2-a591-343aa37158a4" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearTwo_e0c16d47-8ecb-41e2-a591-343aa37158a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_33718043-df5b-4189-b41a-7f9e2fedc99f" xlink:href="iart-20221231.xsd#iart_InterestPaymentsYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_InterestPaymentsYearThree_33718043-df5b-4189-b41a-7f9e2fedc99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_90b9354c-d9d4-458b-a943-805800ec1c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_90b9354c-d9d4-458b-a943-805800ec1c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2efddfdf-f78c-49b2-8523-0e097d02ec19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2efddfdf-f78c-49b2-8523-0e097d02ec19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_46d47ebd-2a58-46e2-be8a-eea5f5d9b30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_46d47ebd-2a58-46e2-be8a-eea5f5d9b30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_06945c31-c983-46e7-b092-174cd9429010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_06945c31-c983-46e7-b092-174cd9429010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6f5c22fd-2f99-4510-9915-fa6d3c5b40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6f5c22fd-2f99-4510-9915-fa6d3c5b40f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_45ebf5d3-763b-446a-bf64-3de20b5c8299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_45ebf5d3-763b-446a-bf64-3de20b5c8299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a772c113-e39f-4cee-8691-0c6d3f1cc845" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_a772c113-e39f-4cee-8691-0c6d3f1cc845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e8c58ecf-8898-4704-a727-60b0290c75c3" xlink:href="iart-20221231.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_e8c58ecf-8898-4704-a727-60b0290c75c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_424f668e-c59c-4b14-8710-4d26cd75c502" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_424f668e-c59c-4b14-8710-4d26cd75c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c9c912e8-a41a-4f9b-8cd0-d555ea9adfca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c9c912e8-a41a-4f9b-8cd0-d555ea9adfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_e2661d08-68e2-45d6-b398-7454eb880320" xlink:href="iart-20221231.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_e2661d08-68e2-45d6-b398-7454eb880320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_01d12374-5109-4056-986f-965fb160a2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_01d12374-5109-4056-986f-965fb160a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_dee634fd-a9fb-4339-892a-dd57281faeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_dee634fd-a9fb-4339-892a-dd57281faeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3dbb9b3c-e30a-4c76-a6f8-e6de3887f2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3dbb9b3c-e30a-4c76-a6f8-e6de3887f2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_3279f893-abb4-47ba-abc7-090f0a6fe812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_3279f893-abb4-47ba-abc7-090f0a6fe812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d968da40-4952-4277-b968-dfcf510015e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d968da40-4952-4277-b968-dfcf510015e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_814a59cc-a6c2-4b8b-91f9-014993287ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_814a59cc-a6c2-4b8b-91f9-014993287ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_12791097-6e79-48a0-b5e7-90f7bf50e05a" xlink:href="iart-20221231.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_12791097-6e79-48a0-b5e7-90f7bf50e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_b961933e-98cc-4529-a26f-83fed6e1320f" xlink:href="iart-20221231.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_b961933e-98cc-4529-a26f-83fed6e1320f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_d5dc9d09-9fae-4622-b427-40ede2d6d06b" xlink:href="iart-20221231.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_d5dc9d09-9fae-4622-b427-40ede2d6d06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_ffe909b9-1085-4a44-a718-418bb0e45f6e" xlink:href="iart-20221231.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a200e8dc-88d0-4454-a518-b791bb332f0d" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_ffe909b9-1085-4a44-a718-418bb0e45f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_892a1cda-3b8e-4a16-a438-fbae5a3a05a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_892a1cda-3b8e-4a16-a438-fbae5a3a05a0" xlink:to="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:to="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcdab19d-e1b2-432a-88d9-1856f0e38b68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3f13b076-b6cd-4503-9d40-f4420c7f0a00" xlink:href="iart-20221231.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36729378-0571-41dc-b08a-c1eef4d4e01a" xlink:to="loc_iart_SeniorCreditFacilityMember_3f13b076-b6cd-4503-9d40-f4420c7f0a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:to="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodAxis_54b39a96-1ea9-4343-9158-151709af75a4" xlink:to="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_2e13bc67-3a45-430b-889b-c32aaf2aa8a6" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:to="loc_iart_DebtCovenantPeriod3Member_2e13bc67-3a45-430b-889b-c32aaf2aa8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod4Member_569a3bfe-ad10-441e-bad3-c109ed4e55b1" xlink:href="iart-20221231.xsd#iart_DebtCovenantPeriod4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_c175fc69-952e-4ba1-a4ff-94ce1ff080a0" xlink:to="loc_iart_DebtCovenantPeriod4Member_569a3bfe-ad10-441e-bad3-c109ed4e55b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ac154a8-1c53-4ed0-8af6-fca0694ae41b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_2e72fce9-f8a2-4a05-802b-8a32849a3749" xlink:href="iart-20221231.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30a7b876-34ff-44f2-8ee4-bf1d49b76595" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_2e72fce9-f8a2-4a05-802b-8a32849a3749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DEBTScheduleofDebtMaturityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTScheduleofDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8c3b1c25-1439-49b8-8077-9c2955431433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bd5477ed-5413-41f5-ae43-da4aa4be88b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8c3b1c25-1439-49b8-8077-9c2955431433" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bd5477ed-5413-41f5-ae43-da4aa4be88b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_96312025-c643-46e6-af58-60233c87820e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8c3b1c25-1439-49b8-8077-9c2955431433" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_96312025-c643-46e6-af58-60233c87820e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_13c42471-dd56-4a56-bc80-e8045c2d6a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8c3b1c25-1439-49b8-8077-9c2955431433" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_13c42471-dd56-4a56-bc80-e8045c2d6a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ae2d166b-9354-4192-91f1-73f4566b00ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8c3b1c25-1439-49b8-8077-9c2955431433" xlink:to="loc_us-gaap_LongTermDebt_ae2d166b-9354-4192-91f1-73f4566b00ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_78bb9174-eeca-49cc-8b38-28f34a53a252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_78bb9174-eeca-49cc-8b38-28f34a53a252" xlink:to="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ab6362d3-c61e-4416-bbcc-e6bc78f1d7c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_938779b2-8c22-41ab-ae46-40123e51a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3df1ba37-7fc4-4515-be36-5c38e6e03142" xlink:to="loc_us-gaap_CashFlowHedgingMember_938779b2-8c22-41ab-ae46-40123e51a783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5c3d5d1-084d-44de-a68f-9daa0ae50e5b" xlink:to="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5ef5fda8-d6d2-4ecd-8c00-a847673841fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_67bc9e04-366c-4c41-be13-c499f4447ee1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5ef5fda8-d6d2-4ecd-8c00-a847673841fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ba4d23bf-8e2f-4c74-9fe1-33f5404deb68" xlink:to="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OneMonthUSDLIBORMember_27bc6431-807a-45cd-b8c0-7e6c1a1d6cec" xlink:href="iart-20221231.xsd#iart_OneMonthUSDLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d94b14ce-7bae-4dad-81c4-7c0a75e552bc" xlink:to="loc_iart_OneMonthUSDLIBORMember_27bc6431-807a-45cd-b8c0-7e6c1a1d6cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14035625-9161-4d2b-b647-6e188fe33123" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_e062893c-247d-4f47-bedf-b3718ed5a0f1" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche1Member_e062893c-247d-4f47-bedf-b3718ed5a0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_c45de9d5-2064-44b2-84f5-4b26007f7747" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_c45de9d5-2064-44b2-84f5-4b26007f7747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_084b984b-9abf-4238-b033-1f82d68bcd2b" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_084b984b-9abf-4238-b033-1f82d68bcd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_567b046b-5285-4d07-acf5-0c1e665ed445" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_567b046b-5285-4d07-acf5-0c1e665ed445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_fa5a4f48-7902-43c3-81c4-34ec6e2216f0" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_fa5a4f48-7902-43c3-81c4-34ec6e2216f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_fbdf276d-911c-4fee-8b15-bc36cb99d7d1" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_fbdf276d-911c-4fee-8b15-bc36cb99d7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_dc8276c4-41ad-45ef-b2dc-221c288b86f3" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_dc8276c4-41ad-45ef-b2dc-221c288b86f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_ddea9298-a868-43be-bd6d-a44b650a2c6d" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_ddea9298-a868-43be-bd6d-a44b650a2c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_c9bc5250-8899-44ba-867b-7e0f6972b743" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_c9bc5250-8899-44ba-867b-7e0f6972b743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_e878fa03-573f-4c5e-8100-9810a892bfa9" xlink:href="iart-20221231.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92f7f8f1-ea58-4343-8190-9e393bfade73" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_e878fa03-573f-4c5e-8100-9810a892bfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a06b8d29-9c36-4156-b29a-47dc91256673" xlink:to="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_dc13a4fe-a164-4328-9a0c-1fe5a6cad543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeNotionalAmount_dc13a4fe-a164-4328-9a0c-1fe5a6cad543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_6f5e7bdb-e6b3-4b7e-bac2-5fc55b5ce53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_6f5e7bdb-e6b3-4b7e-bac2-5fc55b5ce53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_76257e3f-5fcf-4397-b82a-c87672146c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_642e6588-dd79-45ff-a1c0-fc6a86646242" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_76257e3f-5fcf-4397-b82a-c87672146c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4977b5b6-53c4-427f-b8d7-8d932dc48b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4977b5b6-53c4-427f-b8d7-8d932dc48b30" xlink:to="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0fce6d32-3113-49ff-9d30-6b6f6d9b2779" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a08dd372-7d89-4662-b953-4abc41e1dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a08dd372-7d89-4662-b953-4abc41e1dff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_21d5907c-fcb9-4632-a338-50beb4ae3851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_CurrencySwapMember_21d5907c-fcb9-4632-a338-50beb4ae3851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_12651a65-681c-4ce5-92f7-eed68a5aa509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_24d370b0-97df-43e6-adbe-71d4982bc1fd" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_12651a65-681c-4ce5-92f7-eed68a5aa509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_ef4bdae1-fc51-49c6-aaa0-e3ebf12ba117" xlink:to="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_3abf7a2b-fa96-412e-8f2f-712857b0717f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:to="loc_us-gaap_ShortMember_3abf7a2b-fa96-412e-8f2f-712857b0717f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_eaaab77f-3b41-47f2-9a13-5b4404634bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_aeb52a12-16e4-4c8e-a40d-a6447f5ba79d" xlink:to="loc_us-gaap_LongMember_eaaab77f-3b41-47f2-9a13-5b4404634bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e117320f-6aab-4cc9-8723-f9bda38494f9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_13041741-d721-4984-9c14-4eb611615d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_CashFlowHedgingMember_13041741-d721-4984-9c14-4eb611615d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_edec5be5-a41a-4505-90d0-94957bc3804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_edec5be5-a41a-4505-90d0-94957bc3804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_72f3d6c9-1073-4e31-a14b-17f91c045e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_64d14564-f05a-4382-af02-e211cff7268d" xlink:to="loc_us-gaap_NondesignatedMember_72f3d6c9-1073-4e31-a14b-17f91c045e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_75876ec4-be44-418b-abaa-c33ca8683649" xlink:to="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9f8d5b84-ff86-4c23-9a19-861494ce4533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:to="loc_us-gaap_NondesignatedMember_9f8d5b84-ff86-4c23-9a19-861494ce4533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_042814f9-9bf1-442b-85ea-b76a50d42c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bbd828af-b29c-4d4d-aa3e-27f4a4b18f22" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_042814f9-9bf1-442b-85ea-b76a50d42c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3fd409a-2d97-4525-b65e-b867701d2798" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_0f2c7959-1dd2-4aa1-876e-40df43348403" xlink:href="iart-20221231.xsd#iart_CodmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea687a2a-346c-4471-a58a-9c64037f5a27" xlink:to="loc_iart_CodmanMember_0f2c7959-1dd2-4aa1-876e-40df43348403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45a0b9c5-ba06-4853-b96e-3d4f6d976a7d" xlink:to="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c40976f1-5fae-4474-9693-b0f74103cd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c40976f1-5fae-4474-9693-b0f74103cd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_6641f3d7-0cc7-4e19-a984-d5a7bcb33463" xlink:href="iart-20221231.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_6641f3d7-0cc7-4e19-a984-d5a7bcb33463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated_ef753cea-cfc9-4c5c-b306-2daba3b1075d" xlink:href="iart-20221231.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_iart_DerivativeNotionalAmountTerminated_ef753cea-cfc9-4c5c-b306-2daba3b1075d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c98e3ed7-16ea-40e6-acd9-ee99926202bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c98e3ed7-16ea-40e6-acd9-ee99926202bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_20da40fa-ec9b-4a37-8542-da360d044dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_20da40fa-ec9b-4a37-8542-da360d044dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_59aa80b8-4cd4-4b65-a808-e526420cf480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_59aa80b8-4cd4-4b65-a808-e526420cf480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_951ddf53-7e20-4e8d-879d-58efeb550f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_951ddf53-7e20-4e8d-879d-58efeb550f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c626788b-56cb-4574-aeda-8d1b0ad73626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ec4f8d4c-fefb-4dca-8ac0-88f870e1ba67" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c626788b-56cb-4574-aeda-8d1b0ad73626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2aaf531d-3503-4195-97ac-2ec064d76aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2aaf531d-3503-4195-97ac-2ec064d76aa2" xlink:to="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_006021f0-3487-4113-9ee4-ceb0538614fa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_692acc44-e4ea-4046-9d66-58b8160db411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c8b16ed4-4578-4a73-812a-b49ebc6d262a" xlink:to="loc_us-gaap_CashFlowHedgingMember_692acc44-e4ea-4046-9d66-58b8160db411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_cd1bc9bb-6919-453a-9860-ebda9923c266" xlink:to="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_89d62878-81f8-48b0-bb9e-d6f9379e1e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4ad59558-89ac-4426-8795-589e242ade17" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_89d62878-81f8-48b0-bb9e-d6f9379e1e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd6784d9-5ec4-401e-a324-adeae7cc083f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_0c963597-ef93-4fdb-a4d7-2b419b0ad04d" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractOneMember_0c963597-ef93-4fdb-a4d7-2b419b0ad04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_efcdd01d-74f3-44e0-bd0d-502ec3164a69" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractTwoMember_efcdd01d-74f3-44e0-bd0d-502ec3164a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_47e35963-b3a4-4f85-8498-2f4ef71e3e6d" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateSwapContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_iart_CrossCurrencyInterestRateSwapContractThreeMember_47e35963-b3a4-4f85-8498-2f4ef71e3e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_038d7f1d-978e-4f0f-a4e3-06cdfebce33f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98e7a74d-af31-46cc-8c2c-8ae0a0228ac7" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_038d7f1d-978e-4f0f-a4e3-06cdfebce33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_2d1c6895-cb83-4b51-8db7-ede8bb894c20" xlink:to="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_3a78d149-b40d-4598-aeb8-5bbf4173c172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:to="loc_us-gaap_LongMember_3a78d149-b40d-4598-aeb8-5bbf4173c172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_0c188c05-3897-4a70-b3c7-53e1cfab3e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_fcfb9663-be95-4dc9-8d55-edeb485f845c" xlink:to="loc_us-gaap_ShortMember_0c188c05-3897-4a70-b3c7-53e1cfab3e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d6e7f316-43aa-4174-bea9-0eade8909d75" xlink:to="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_849f52ff-0b49-4c4c-9a4f-d912a1ce6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_849f52ff-0b49-4c4c-9a4f-d912a1ce6ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8ad4621a-729d-4256-8b89-92e9ad16002d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8ad4621a-729d-4256-8b89-92e9ad16002d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_27bb4722-fdce-4fc6-b902-077a060523b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7da4d4a5-2577-413d-8291-51134ba958c1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_27bb4722-fdce-4fc6-b902-077a060523b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_56a226a9-d9ab-4727-863c-991bed41f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_56a226a9-d9ab-4727-863c-991bed41f802" xlink:to="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2577d2c0-8bdb-4bdd-9445-c031d48c0899" xlink:to="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_415953ca-5c89-48c6-9c48-255cc2baa8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_18a074d0-fde6-4014-bbcc-dcfc885c5aaf" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_415953ca-5c89-48c6-9c48-255cc2baa8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_989376a1-c863-47b5-ab10-cf1c493f0df2" xlink:to="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ae00ea43-6023-4da6-937d-a9062ca32233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_265eea67-d4e9-4747-bf26-a7b64e3e7810" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ae00ea43-6023-4da6-937d-a9062ca32233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f521c298-2d2b-4882-833f-493b8836454e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_3d348de0-47e5-4b19-874d-01a1ea056292" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_3d348de0-47e5-4b19-874d-01a1ea056292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_d4c73093-c92b-47a4-849d-838e9951e5b9" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_d4c73093-c92b-47a4-849d-838e9951e5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_5b82e3cd-2aa7-4c04-a89a-91c1df9bd17e" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_5b82e3cd-2aa7-4c04-a89a-91c1df9bd17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractFourMember_6aa0935e-86ac-42f1-b0ef-f763afc44fcd" xlink:href="iart-20221231.xsd#iart_CrossCurrencyInterestRateContractFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_iart_CrossCurrencyInterestRateContractFourMember_6aa0935e-86ac-42f1-b0ef-f763afc44fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_459fa410-8d0a-46e4-a210-dcbdbe9840b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c04a5130-db9e-44a5-acd3-acf7fffd629a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_459fa410-8d0a-46e4-a210-dcbdbe9840b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_f7ccdb7a-8209-4985-ba4e-99bf828f0984" xlink:to="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_bbf36ecd-84b3-4c14-b0b3-83cc823b2850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:to="loc_us-gaap_LongMember_bbf36ecd-84b3-4c14-b0b3-83cc823b2850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_de04adf2-9088-41e5-9e8c-93b9c32ec73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_7d8efd74-c0e9-4c19-9dfd-2ebdd108bc65" xlink:to="loc_us-gaap_ShortMember_de04adf2-9088-41e5-9e8c-93b9c32ec73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_01917a4e-e95e-48fd-a0ae-496b09d3b617" xlink:to="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_ab36f004-08b8-4278-a94b-d847c13407e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_ab36f004-08b8-4278-a94b-d847c13407e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d78bfe33-4d6d-4682-be7e-213ac8085b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d78bfe33-4d6d-4682-be7e-213ac8085b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_75152e34-c171-45f2-96dc-9ddaffd55078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_575b26f6-14d6-43a4-bb60-8fe5d4376cf0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_75152e34-c171-45f2-96dc-9ddaffd55078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_51a3b66f-0b01-4244-ab02-924cb1dec89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_51a3b66f-0b01-4244-ab02-924cb1dec89c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6baa9898-308d-488b-821b-10108783f9f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0ad9d11e-5e05-43cc-97c7-0162cf40ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_727ad666-7f7a-486f-8332-93835b82b14e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0ad9d11e-5e05-43cc-97c7-0162cf40ceb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7a13e66d-6b6d-4b18-8ec5-f34ab5b58d00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c0c7dabd-5388-4cac-8135-ac5a1cd1b403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:to="loc_us-gaap_InterestRateSwapMember_c0c7dabd-5388-4cac-8135-ac5a1cd1b403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_735cd4e9-1054-4e70-a493-0514ec397007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2c77ad3e-d5c1-42fc-9b0d-3957febc6340" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_735cd4e9-1054-4e70-a493-0514ec397007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_acb011e0-793a-412e-aba9-91fe813960e7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_94aa7c77-fd0a-4f40-96f1-ba0662b840f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:to="loc_us-gaap_CashFlowHedgingMember_94aa7c77-fd0a-4f40-96f1-ba0662b840f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2babd682-4602-4207-829b-ef43f08701de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c4e18653-9f6f-4074-ae8f-895c82afb607" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2babd682-4602-4207-829b-ef43f08701de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3ba6a790-6412-4e11-bb8d-33a6f6979383" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_380a373d-ea46-4e57-820d-6b0d7e38625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_380a373d-ea46-4e57-820d-6b0d7e38625d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_90e0f63b-35d7-4ebe-8393-61daf263419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_OtherAssetsMember_90e0f63b-35d7-4ebe-8393-61daf263419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_ec48f903-3d4c-43dc-8c8d-7f9077a73d99" xlink:href="iart-20221231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_ec48f903-3d4c-43dc-8c8d-7f9077a73d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_71591d5e-be1c-41c7-8131-80dca805cbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c49d9e7a-f28e-4f28-8622-172397149bad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_71591d5e-be1c-41c7-8131-80dca805cbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e03ed930-ea55-4abc-965c-c8e3effb1490" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a07a5b5-1061-4113-9736-ed36a2335642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a07a5b5-1061-4113-9736-ed36a2335642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_865528d5-c2ba-4618-a38a-1460645faa61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_865528d5-c2ba-4618-a38a-1460645faa61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_fe74cb9d-f675-42c9-8927-9dfe3a744bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3c9522fd-710c-4f8d-a38f-0cda618b1f53" xlink:to="loc_us-gaap_DerivativeNotionalAmount_fe74cb9d-f675-42c9-8927-9dfe3a744bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3f6c160-77fc-4de4-b4d8-22889ada51c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3f6c160-77fc-4de4-b4d8-22889ada51c7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5ac1ceb9-b7e1-43a2-9328-2889ebf8733c" xlink:to="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5adc2129-547b-4704-af3d-16d7c75cec30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_28a4011d-d6b2-461b-84d8-a464891292aa" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5adc2129-547b-4704-af3d-16d7c75cec30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eb013f70-9155-4229-9d6c-c32594d98bca" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_092f3f42-f985-443f-b527-87ab6304e1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:to="loc_us-gaap_InterestRateSwapMember_092f3f42-f985-443f-b527-87ab6304e1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_4a7372a2-d8a1-41dc-a020-67f2fab1233f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b027ec4-a494-4915-967f-b141a9e5ddeb" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_4a7372a2-d8a1-41dc-a020-67f2fab1233f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a06c74ca-201c-4548-acce-726cd2c65303" xlink:to="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3c875345-e395-41be-a02b-e04b3d8b7442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc9ee990-3dcf-4f10-be2c-5fca2c881bc9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3c875345-e395-41be-a02b-e04b3d8b7442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0de6356-a331-497f-b06c-0764c31c6d39" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f5992339-c479-4593-bfc6-026e5e6f1a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_InterestExpenseMember_f5992339-c479-4593-bfc6-026e5e6f1a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2f0242f8-c456-434e-8ea7-9a69d26dfae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_2f0242f8-c456-434e-8ea7-9a69d26dfae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_0fe579c9-9d70-4011-a8e1-30864cae0048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_034c3a00-bcd0-4571-8fa2-fdb473fca534" xlink:to="loc_us-gaap_InterestIncomeMember_0fe579c9-9d70-4011-a8e1-30864cae0048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2bd80a4-5c06-4d67-9119-3d1022ae96b7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dde959e9-18f8-48b3-8604-560e3d9cccbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_dde959e9-18f8-48b3-8604-560e3d9cccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_82de5f88-9c6d-42ce-8625-9f669f47e891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e1ad40a7-f997-4d4f-9c2a-68dc2adbd1fb" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_82de5f88-9c6d-42ce-8625-9f669f47e891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ecc73a9-7159-495d-88b6-8bec803eef4d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_897832f8-ce9e-4e1b-9822-f7ff515506ad" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad1b5793-864f-4f27-93aa-5d2be741800a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_StockholdersEquity_ad1b5793-864f-4f27-93aa-5d2be741800a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae314922-ad07-4766-8492-05a77757a126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae314922-ad07-4766-8492-05a77757a126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05d92a04-c5f9-4372-8935-62bf12522b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05d92a04-c5f9-4372-8935-62bf12522b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1e409583-c0a8-4e97-a82b-e8c20a4c9d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f5ce1ee2-66e0-4c80-9265-84e892e989d2" xlink:to="loc_us-gaap_StockholdersEquity_1e409583-c0a8-4e97-a82b-e8c20a4c9d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b29d4d9-b1e0-4dfa-99cd-e51ea70a09d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b29d4d9-b1e0-4dfa-99cd-e51ea70a09d1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_347c35d9-ce43-49f0-b125-77423e285d38" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_0eb6e555-558a-4476-95b8-8d4d63bb75a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_0eb6e555-558a-4476-95b8-8d4d63bb75a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_201cd860-f70f-4b07-b16d-372ec27afa21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_643d9e30-09d0-4cbd-998c-f7ecdf225231" xlink:to="loc_us-gaap_CurrencySwapMember_201cd860-f70f-4b07-b16d-372ec27afa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3cf4bd89-3598-4b1f-ab98-01023afdde40" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_77a5e457-45fb-4154-a3a7-bfb965ccc77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_836022c8-1f8b-4df7-8d6c-700346395696" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_77a5e457-45fb-4154-a3a7-bfb965ccc77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e469cf83-01eb-455b-9947-1acf7a7ac6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e469cf83-01eb-455b-9947-1acf7a7ac6fd" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6e8f6bb5-bb2b-49e1-a906-af275ccc005b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_34894947-6916-4a74-ac0e-6b8d5ee67971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_910560e6-5130-4e79-a92b-181a2eda8a76" xlink:to="loc_us-gaap_CustomerRelationshipsMember_34894947-6916-4a74-ac0e-6b8d5ee67971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d759eec4-557e-4fdc-8532-68acce298c59" xlink:to="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d5e99a19-3374-4509-8f61-67842ea57a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_NumberOfReportingUnits_d5e99a19-3374-4509-8f61-67842ea57a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_265c28b8-66e6-4653-becc-1dda9b7b98cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_AdjustmentForAmortization_265c28b8-66e6-4653-becc-1dda9b7b98cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cfc27123-1c5f-4583-9165-45abe4625e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cfc27123-1c5f-4583-9165-45abe4625e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_97b01ea0-343a-4231-998b-2473723e0880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_97b01ea0-343a-4231-998b-2473723e0880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_57d6c412-0cbf-4622-b632-8bad7367dac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_57d6c412-0cbf-4622-b632-8bad7367dac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6b3644da-7554-4655-96c8-b072d672b2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6b3644da-7554-4655-96c8-b072d672b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72648b4b-4464-402c-b24b-89aa29ad0a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72648b4b-4464-402c-b24b-89aa29ad0a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4d14de12-1264-40cd-b68f-80c102f31611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4d14de12-1264-40cd-b68f-80c102f31611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e2c4c3cf-67d7-4da5-afbc-fc4de4353fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8b972eca-afe8-421e-a3b1-c9cfdc6941d2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_e2c4c3cf-67d7-4da5-afbc-fc4de4353fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de4fcc82-36b9-4e32-be53-895a390b8f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de4fcc82-36b9-4e32-be53-895a390b8f00" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0944b98-2ff7-4536-89bd-4a222a6868c7" xlink:to="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_1fb38256-5d5c-44ef-830f-f2983b280cfd" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_1fb38256-5d5c-44ef-830f-f2983b280cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_429954cc-4949-463e-99de-826f1012f118" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd8cfcce-f723-4e83-a043-c3f0149bf1df" xlink:to="loc_iart_TissueTechnologiesMember_429954cc-4949-463e-99de-826f1012f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_18b80c13-5b06-4739-b4b2-9ac56a535c8e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_d4234951-af36-42dc-9368-bc1bacdafe6b" xlink:href="iart-20221231.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:to="loc_iart_ACellIncMember_d4234951-af36-42dc-9368-bc1bacdafe6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_153d988e-0e7c-4c55-a58b-9551fbab3c26" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2fe8224-8bc7-43da-8608-8af767b2fe73" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_153d988e-0e7c-4c55-a58b-9551fbab3c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ed890f82-7587-418a-833d-920c02d7d441" xlink:to="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfc4612d-0aeb-4d8c-87a6-b17c3e244299" xlink:to="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d96f6632-1dc6-4ddc-9654-e64379b45a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_Goodwill_d96f6632-1dc6-4ddc-9654-e64379b45a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4ef1a965-4404-406c-be2f-c4761dab507f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4ef1a965-4404-406c-be2f-c4761dab507f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3632a6b8-8f39-435d-9ea6-907157b0e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3632a6b8-8f39-435d-9ea6-907157b0e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_605d328e-0c27-4655-9750-1553c239b047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_605d328e-0c27-4655-9750-1553c239b047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3bcde59-ff0c-46f4-9a80-341a2a7a01a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5de00d7e-719a-4011-b58f-f6b9c76e82fe" xlink:to="loc_us-gaap_Goodwill_b3bcde59-ff0c-46f4-9a80-341a2a7a01a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6741e03-5d66-43f7-9e87-0fdf9ccb110a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b6741e03-5d66-43f7-9e87-0fdf9ccb110a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_16b31678-53d2-451d-9f48-aa0521a848bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_a8f46af9-e2e7-4ebf-a11b-32e26d093a74" xlink:href="iart-20221231.xsd#iart_CompletedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_CompletedTechnologyMember_a8f46af9-e2e7-4ebf-a11b-32e26d093a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_54ff6046-4ae4-4366-b672-1bb76635507d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_us-gaap_CustomerRelationshipsMember_54ff6046-4ae4-4366-b672-1bb76635507d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_3e14a244-2439-43e9-9ebf-f842a67c2ed0" xlink:href="iart-20221231.xsd#iart_TrademarksBrandNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_TrademarksBrandNamesMember_3e14a244-2439-43e9-9ebf-f842a67c2ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_9c1690fc-042d-4926-b29b-badc7f8d3cba" xlink:href="iart-20221231.xsd#iart_SupplierRelationShipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_SupplierRelationShipsMember_9c1690fc-042d-4926-b29b-badc7f8d3cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_31eaad02-326e-4cdf-92c5-a326e0beaafd" xlink:href="iart-20221231.xsd#iart_AllOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2035b6d9-20a0-4575-b45e-f0fc4641f563" xlink:to="loc_iart_AllOtherMember_31eaad02-326e-4cdf-92c5-a326e0beaafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9803f3ed-9c48-4612-93da-9de3a7bfc18a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5b1ea8c7-9f2b-42bc-9869-8e3880921b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b8704c0-3f5c-464d-a2fd-94eed7fc68b3" xlink:to="loc_us-gaap_TradeNamesMember_5b1ea8c7-9f2b-42bc-9869-8e3880921b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aa5783da-55a1-4828-a381-b39d05cdadd0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_976698d4-7b0c-4881-b90f-d920ea0f5ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_976698d4-7b0c-4881-b90f-d920ea0f5ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_42151fe0-2433-49a9-bc25-33297f0d31f7" xlink:href="iart-20221231.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_42151fe0-2433-49a9-bc25-33297f0d31f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66ff96e0-0216-4dee-a1a7-9ac362646560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_66ff96e0-0216-4dee-a1a7-9ac362646560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_0a548de8-18a2-4314-b11b-db119fa2afb9" xlink:href="iart-20221231.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5196e110-6c89-4372-8435-84dd3193a7a2" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_0a548de8-18a2-4314-b11b-db119fa2afb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0bffaf60-1bdc-444d-8eb9-0912fa4ed9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0bffaf60-1bdc-444d-8eb9-0912fa4ed9c4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4762e862-cd73-438b-8385-4e84c3c91295" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fda15c20-ba76-4aba-9735-2a334018f0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f9208197-3fa0-411c-b2f8-6cb61972c643" xlink:to="loc_us-gaap_SubsequentEventMember_fda15c20-ba76-4aba-9735-2a334018f0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_39451240-bc23-4d79-89dd-bfb42958ec3d" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8060de03-cd97-4972-8290-3bf83408b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8060de03-cd97-4972-8290-3bf83408b13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_3e24064a-55e2-4200-b1e3-f2e29bea7182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockCommonValue_3e24064a-55e2-4200-b1e3-f2e29bea7182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_1a73975d-dbb9-4b39-9d7c-af0d4efa0225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_1a73975d-dbb9-4b39-9d7c-af0d4efa0225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3a1580ea-57b8-49d4-95a4-0e3abef77eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3a1580ea-57b8-49d4-95a4-0e3abef77eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f9b43135-a547-4d03-86c1-3f3d8b1c16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f9b43135-a547-4d03-86c1-3f3d8b1c16f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_c16a0dac-cf43-4fc9-83ab-cc824cdf6d0a" xlink:href="iart-20221231.xsd#iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent_c16a0dac-cf43-4fc9-83ab-cc824cdf6d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_723d1c6e-f3dc-40df-b722-c7671e612f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_723d1c6e-f3dc-40df-b722-c7671e612f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_0e13df04-415f-4ad9-9de9-1127d02e75d5" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_0e13df04-415f-4ad9-9de9-1127d02e75d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_98afbdd6-f0c3-44ac-a268-fd3f839181c3" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_98afbdd6-f0c3-44ac-a268-fd3f839181c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_055a6607-2ca1-4620-b3f0-cff138e7eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_055a6607-2ca1-4620-b3f0-cff138e7eb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_618edd88-c5ed-4d5e-b2b4-096a5e172bfb" xlink:href="iart-20221231.xsd#iart_AcceleratedShareRepurchasesAdditionalSharesReceived"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7071b407-b5f7-4410-b7ca-94be9d76605d" xlink:to="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_618edd88-c5ed-4d5e-b2b4-096a5e172bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4777260c-d311-4410-bb1c-91e8e472959c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4777260c-d311-4410-bb1c-91e8e472959c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf24a0e3-d5a4-4953-b0dd-25e9b963a54f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_33408368-6784-49f8-917f-664184c7aad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_CostOfSalesMember_33408368-6784-49f8-917f-664184c7aad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_738540fa-6616-4c69-a7b9-cb6c0476859c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_738540fa-6616-4c69-a7b9-cb6c0476859c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fc3b0ef3-beb2-4f43-b352-a8fce2a38996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec9a89e9-a3c4-4c77-9333-1c47610265b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fc3b0ef3-beb2-4f43-b352-a8fce2a38996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_54a57818-30af-4419-beb6-138d87fec549" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_40522385-1231-4762-8045-ca854baa11b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_40522385-1231-4762-8045-ca854baa11b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_339c5198-a314-468c-b7ae-5e03d82dca77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_339c5198-a314-468c-b7ae-5e03d82dca77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_4f271e06-e7d3-4bc8-a77c-9741d1b31229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_526add64-05d2-4d9e-9705-bf59a592b4b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_4f271e06-e7d3-4bc8-a77c-9741d1b31229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6fbd4e4-4f72-4973-81ea-e1d95efb0f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6fbd4e4-4f72-4973-81ea-e1d95efb0f0a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8985dc54-0bba-4978-a318-78f85586aa8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_3db2cb16-d30b-4bf2-84ec-27d851a8dddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_EmployeeStockMember_3db2cb16-d30b-4bf2-84ec-27d851a8dddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7c68ffba-8a8b-4dd3-a69a-a32b5dfa491b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7c68ffba-8a8b-4dd3-a69a-a32b5dfa491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_85c04a39-a6cc-4599-8f51-4449ef81d0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_85c04a39-a6cc-4599-8f51-4449ef81d0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_3806e13a-5e99-470f-b969-e8b5cc10fb0a" xlink:href="iart-20221231.xsd#iart_RestrictedStockPerformanceStockAndContractStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_iart_RestrictedStockPerformanceStockAndContractStockMember_3806e13a-5e99-470f-b969-e8b5cc10fb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_eb3a55a2-1988-433f-98a4-c77f87a90be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa7e7b2d-bfc4-4c0d-a352-6559b15a2c55" xlink:to="loc_us-gaap_PerformanceSharesMember_eb3a55a2-1988-433f-98a4-c77f87a90be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7a30ccfd-6812-44fa-8b59-73faac3470d3" xlink:to="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandThreePlanMember_1dcfee68-d795-4397-bf72-fd6c0ee1c7af" xlink:href="iart-20221231.xsd#iart_TwoThousandThreePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandThreePlanMember_1dcfee68-d795-4397-bf72-fd6c0ee1c7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandPlanMember_bd62f8bc-50be-41ce-bfe2-1db9e2385cd1" xlink:href="iart-20221231.xsd#iart_TwoThousandPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandPlanMember_bd62f8bc-50be-41ce-bfe2-1db9e2385cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandOnePlanMember_b9b0f94c-60b2-4fc8-9146-30d7c8278573" xlink:href="iart-20221231.xsd#iart_TwoThousandOnePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d784d843-7944-4700-ab49-2bc87eafe559" xlink:to="loc_iart_TwoThousandOnePlanMember_b9b0f94c-60b2-4fc8-9146-30d7c8278573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_7d3053c9-9eee-4a0c-8516-4733950fa495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_a8e9772c-ad59-425e-9da2-c1df1b47a33e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_srt_DirectorMember_a8e9772c-ad59-425e-9da2-c1df1b47a33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_068a1d82-e3df-4bf2-a81f-658a8e3e3042" xlink:href="iart-20221231.xsd#iart_EmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_iart_EmployeeMember_068a1d82-e3df-4bf2-a81f-658a8e3e3042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_864e18a4-0f14-4c5e-ba2a-4725546f34f8" xlink:href="iart-20221231.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_08537e2b-a6c2-4d90-b1bd-3e3a8b161935" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_864e18a4-0f14-4c5e-ba2a-4725546f34f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_03db5c76-c5e4-4b28-b67a-4e60ad2efbef" xlink:to="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_298d2b65-882f-40ea-81b7-e15db5cf8526" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:to="loc_srt_MinimumMember_298d2b65-882f-40ea-81b7-e15db5cf8526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_689251a8-bef7-4935-a1e0-032ef54f9786" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc54f771-7826-4358-b2e0-ce3b062b0006" xlink:to="loc_srt_MaximumMember_689251a8-bef7-4935-a1e0-032ef54f9786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcfbd946-0455-4d02-9d98-30ff025d130f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4e7e4c56-bc54-4666-b27a-cc48a6a53531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4e7e4c56-bc54-4666-b27a-cc48a6a53531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_87b19a85-e04f-440c-924b-f5df311f8c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_87b19a85-e04f-440c-924b-f5df311f8c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77bcbc4d-97bd-4a41-8d97-650f5b682ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77bcbc4d-97bd-4a41-8d97-650f5b682ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeStockPurchasePlanProceeds_a2aedfaf-3694-44c8-92d1-d94bd8d857fa" xlink:href="iart-20221231.xsd#iart_EmployeeStockPurchasePlanProceeds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_iart_EmployeeStockPurchasePlanProceeds_a2aedfaf-3694-44c8-92d1-d94bd8d857fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncreaseInAuthorizedShares_b32d2dd1-b857-4e79-8bf2-e78a3d26e9fc" xlink:href="iart-20221231.xsd#iart_IncreaseInAuthorizedShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_iart_IncreaseInAuthorizedShares_b32d2dd1-b857-4e79-8bf2-e78a3d26e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77aaef11-b239-4c20-8ea2-b4a2937a91ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77aaef11-b239-4c20-8ea2-b4a2937a91ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f8fac244-a5ec-428e-9289-ab7817c8726f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f8fac244-a5ec-428e-9289-ab7817c8726f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e616f957-d7d0-4b4a-9b47-9464e78b494e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e616f957-d7d0-4b4a-9b47-9464e78b494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_41390d43-e036-46cc-98d4-f05bad11af76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_41390d43-e036-46cc-98d4-f05bad11af76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c76f688d-6b98-4b7f-aa17-9ed751d16007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c76f688d-6b98-4b7f-aa17-9ed751d16007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ff14fa9a-2b12-4591-b74c-8aade4359af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ff14fa9a-2b12-4591-b74c-8aade4359af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_268f1209-735b-48a7-b66e-51703f5c461b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_268f1209-735b-48a7-b66e-51703f5c461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_587795ce-ede9-4044-8fe6-4c068de264d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_587795ce-ede9-4044-8fe6-4c068de264d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b53f1602-0953-410e-ab18-936e111e11ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b53f1602-0953-410e-ab18-936e111e11ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bb8a05c8-a0aa-49d8-b966-e4f3d73ebe5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bb8a05c8-a0aa-49d8-b966-e4f3d73ebe5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_39d64c10-0559-4f3b-8596-00e902b71664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_39d64c10-0559-4f3b-8596-00e902b71664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1989df0a-454d-4ace-a22a-a8eec19c2b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1989df0a-454d-4ace-a22a-a8eec19c2b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_a739cb12-35a8-4c3a-bf86-a386ae4207bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0b6e23-375c-4019-8e3a-21ca5e00c117" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_a739cb12-35a8-4c3a-bf86-a386ae4207bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b9044066-8764-4984-b0c9-56c88dd378ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b9044066-8764-4984-b0c9-56c88dd378ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9a60b192-817a-4eea-9cca-37438c56cf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9a60b192-817a-4eea-9cca-37438c56cf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_178cff2e-e920-4675-b1bf-a0bfe572934d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_178cff2e-e920-4675-b1bf-a0bfe572934d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7651334e-baa6-4504-9a09-4184c4c1fad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7651334e-baa6-4504-9a09-4184c4c1fad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68db977c-6c2d-4e04-b31d-b1577965f154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5461a020-b64d-4194-ba14-5c5fabdfe6e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68db977c-6c2d-4e04-b31d-b1577965f154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0109eb16-035a-4e30-a0b0-cafbb329c053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0109eb16-035a-4e30-a0b0-cafbb329c053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_624b6451-8c7d-412e-8d09-5667eeb2b2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_624b6451-8c7d-412e-8d09-5667eeb2b2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ce4548ef-93ed-40da-922a-94392bbdb723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ce4548ef-93ed-40da-922a-94392bbdb723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4162fc5a-2795-4bdc-a460-77eab2b476bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4162fc5a-2795-4bdc-a460-77eab2b476bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_96cc3a67-1870-4661-8542-e766926393bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b844b159-2935-43e5-85e0-e5caafd00fc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_96cc3a67-1870-4661-8542-e766926393bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_67dde6a2-5702-4b49-ba0d-26fad56bc857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_67dde6a2-5702-4b49-ba0d-26fad56bc857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cfd67b6a-f176-4a22-98a8-32cc5bccdaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cfd67b6a-f176-4a22-98a8-32cc5bccdaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ed3df1e8-9ab7-4f99-a54e-7a07f31f7acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ed3df1e8-9ab7-4f99-a54e-7a07f31f7acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_360972d4-6ce6-477f-aee5-c91d675d184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_360972d4-6ce6-477f-aee5-c91d675d184c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7f49ed37-b310-45b4-a668-c9189a606cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7f49ed37-b310-45b4-a668-c9189a606cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dd29550c-015d-4a37-bb73-c68254924aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_06221403-a827-4f39-b1bd-151a0ebbcfb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dd29550c-015d-4a37-bb73-c68254924aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7a2bf7c0-2854-4b18-94ae-5e2ad1b207fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7a2bf7c0-2854-4b18-94ae-5e2ad1b207fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c1f3371d-e4b0-49ba-a826-e3067c78018f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c1f3371d-e4b0-49ba-a826-e3067c78018f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8ff922f7-e1ca-492e-b685-94f88932f2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8ff922f7-e1ca-492e-b685-94f88932f2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b956a8c1-01ca-4b75-8b37-3add826b3014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b956a8c1-01ca-4b75-8b37-3add826b3014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cd5c29fa-5410-4c91-a348-0ecd5231545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cd5c29fa-5410-4c91-a348-0ecd5231545b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a3750e0b-985a-4dd3-817b-d7c9478eda0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be5325c7-98f0-452b-9443-8fa9f3a78903" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a3750e0b-985a-4dd3-817b-d7c9478eda0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f49e30c7-7ab6-4a46-8739-77fef9ba05ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f49e30c7-7ab6-4a46-8739-77fef9ba05ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:to="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_12e13f1a-477e-4039-be70-311bfa009925" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9ac3a3fa-65d3-4c99-9432-0b6ad14ed9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:to="loc_us-gaap_RestrictedStockMember_9ac3a3fa-65d3-4c99-9432-0b6ad14ed9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockandContractStockMember_6f2595fc-d0ac-4d95-a947-e2801f713170" xlink:href="iart-20221231.xsd#iart_PerformanceStockandContractStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0704bc0e-a127-47c3-b85b-20474cc53cc3" xlink:to="loc_iart_PerformanceStockandContractStockMember_6f2595fc-d0ac-4d95-a947-e2801f713170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa9da29c-6927-4bb8-96f6-317645a245c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5670143e-0db1-42c3-aa87-835ee8396ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5670143e-0db1-42c3-aa87-835ee8396ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54786225-bea5-4efc-abdf-41a72b4f727f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54786225-bea5-4efc-abdf-41a72b4f727f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_895afc35-92fa-4d15-960b-c1e0c99e4a8e" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares_895afc35-92fa-4d15-960b-c1e0c99e4a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00c792cc-2e4c-4449-a453-ae3c4434e020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00c792cc-2e4c-4449-a453-ae3c4434e020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86cf8a5e-bcd7-4c9d-b1af-af49f51a3f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86cf8a5e-bcd7-4c9d-b1af-af49f51a3f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0a93af37-015a-498f-aa3b-0677eab3e810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_91efbed2-d114-4612-a963-dd8d16607fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0a93af37-015a-498f-aa3b-0677eab3e810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a46c218-381e-4eb2-9339-c9dab14b59e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f64792f8-5f6d-4bf5-8f38-412e1926ca7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f64792f8-5f6d-4bf5-8f38-412e1926ca7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23b3f295-3120-4df0-abff-e137dc724556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23b3f295-3120-4df0-abff-e137dc724556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_0e415878-0c96-4c76-98bf-11eef49cc708" xlink:href="iart-20221231.xsd#iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue_0e415878-0c96-4c76-98bf-11eef49cc708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5ce83c8a-294d-42be-9f55-7d327ab196b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5ce83c8a-294d-42be-9f55-7d327ab196b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_128d944d-4b84-4973-acaf-18d16ba75370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_128d944d-4b84-4973-acaf-18d16ba75370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e8774d01-eb32-4b01-ae05-da318491618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ebd2097d-d9f3-4f19-b694-38e2315ffd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e8774d01-eb32-4b01-ae05-da318491618b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_40ee9595-290d-4f74-8f2a-08bc8a491cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_40ee9595-290d-4f74-8f2a-08bc8a491cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a737e51c-53be-4e0b-a9f6-db931c0620b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a737e51c-53be-4e0b-a9f6-db931c0620b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f82abbfa-ae16-4221-868b-3779b5ebc8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f82abbfa-ae16-4221-868b-3779b5ebc8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b7e44975-2da5-42f5-ab03-e8e234592f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b7e44975-2da5-42f5-ab03-e8e234592f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_bcd0ae5d-a2b0-4347-8766-324eb7ef2659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_bcd0ae5d-a2b0-4347-8766-324eb7ef2659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0b28df99-5c56-4b72-9d5d-3ded91f93358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0b28df99-5c56-4b72-9d5d-3ded91f93358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6c936b2d-1e97-4481-9c00-6a7218bcf95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6c936b2d-1e97-4481-9c00-6a7218bcf95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_b5664a88-4b6a-4d70-9004-e7a2e4027f76" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_b5664a88-4b6a-4d70-9004-e7a2e4027f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_9653f5cc-565f-4747-ac9b-afd3b1ea4de1" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_9653f5cc-565f-4747-ac9b-afd3b1ea4de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_ea9ae357-25a4-4c31-be69-324acba68713" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_ea9ae357-25a4-4c31-be69-324acba68713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_2298d0a9-3efa-4e99-82b0-a66031abb2b7" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_2298d0a9-3efa-4e99-82b0-a66031abb2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_c306d44d-10f3-4880-b57e-757dd384a7d2" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94425f21-ea2d-4db4-a1b9-936c3f2929ee" xlink:to="loc_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_c306d44d-10f3-4880-b57e-757dd384a7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_36814406-c9d6-481a-ae20-73358bb8af70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e31fe0e8-8290-450b-bab1-6b3419986cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_36814406-c9d6-481a-ae20-73358bb8af70" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e31fe0e8-8290-450b-bab1-6b3419986cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f4d81779-215d-4d0b-8701-394a0062562c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_36814406-c9d6-481a-ae20-73358bb8af70" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f4d81779-215d-4d0b-8701-394a0062562c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_2f88c3db-5af2-4755-975a-4578f09b2a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_36814406-c9d6-481a-ae20-73358bb8af70" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_2f88c3db-5af2-4755-975a-4578f09b2a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_28d1fafe-c023-412a-99a5-57ccb2a4fd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_36814406-c9d6-481a-ae20-73358bb8af70" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_28d1fafe-c023-412a-99a5-57ccb2a4fd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_88e75e6d-a343-4598-809f-809e27cf5414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_88e75e6d-a343-4598-809f-809e27cf5414" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cb779b36-e0c1-4ddc-84c5-30d1aa605f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cb779b36-e0c1-4ddc-84c5-30d1aa605f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_633ca20b-b5a9-49ff-8255-35018fe21d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_633ca20b-b5a9-49ff-8255-35018fe21d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_db9896de-5870-477d-bb55-22483891cc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_db9896de-5870-477d-bb55-22483891cc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_2ab17ead-a7e9-445e-98e0-8d03be987351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_2ab17ead-a7e9-445e-98e0-8d03be987351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_23d10484-3508-474e-9c51-a7187621c4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_23d10484-3508-474e-9c51-a7187621c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_900bec96-cd33-4d3f-8ec5-4d40c5a509f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_900bec96-cd33-4d3f-8ec5-4d40c5a509f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_2ec115ac-f6f8-4c86-af1c-66bd76f489a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_2ec115ac-f6f8-4c86-af1c-66bd76f489a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_65b93689-24a2-4287-b27c-d50924fc011e" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanBenefitObligationPremiumsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid_65b93689-24a2-4287-b27c-d50924fc011e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2b158259-8cd4-40de-8738-5b6962c2fbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2b158259-8cd4-40de-8738-5b6962c2fbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_85334d0b-f749-4225-8fc7-912474159081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_85334d0b-f749-4225-8fc7-912474159081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_13879cd2-f38c-4d7e-9b84-2abe511e6e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a55a3d8e-0115-4f8f-aaf6-928ec8622012" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_13879cd2-f38c-4d7e-9b84-2abe511e6e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_88e75e6d-a343-4598-809f-809e27cf5414" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_44f796b9-806d-4d2e-a941-79b1ea628e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_44f796b9-806d-4d2e-a941-79b1ea628e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a8ef318-0406-4dc3-9d65-fab8320d8190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7a8ef318-0406-4dc3-9d65-fab8320d8190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1dc9d21c-1e0f-4c2c-91e0-8f872d27c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_1dc9d21c-1e0f-4c2c-91e0-8f872d27c65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_51732f32-8560-41a0-9bcd-3dc29e1349bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_51732f32-8560-41a0-9bcd-3dc29e1349bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_368c89e1-bed5-4677-9b3a-0d885d574e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_368c89e1-bed5-4677-9b3a-0d885d574e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_599fb4d5-2d08-452c-afa0-164127d18c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_599fb4d5-2d08-452c-afa0-164127d18c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_c8bc22d8-7670-418a-916d-6dfdf0f0f12c" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanPlanAssetsPremiumsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid_c8bc22d8-7670-418a-916d-6dfdf0f0f12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_27c8789d-14ca-439f-8d8b-dd02e5af4cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_27c8789d-14ca-439f-8d8b-dd02e5af4cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_18403e28-0c0f-4db1-98c2-211e8fc5b7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7a967fa8-0d80-478e-9e6d-6f6897024fbe" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_18403e28-0c0f-4db1-98c2-211e8fc5b7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fb9b6ec2-f6de-4bad-b7e9-9ba1d352e696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_83910485-120f-4c1f-9c19-013987458d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fb9b6ec2-f6de-4bad-b7e9-9ba1d352e696" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_83910485-120f-4c1f-9c19-013987458d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d67b5844-73a3-4d90-8978-630a357243f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_83910485-120f-4c1f-9c19-013987458d49" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d67b5844-73a3-4d90-8978-630a357243f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_32b1b7fb-39b1-4149-bb9d-7cfba4bfa424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_83910485-120f-4c1f-9c19-013987458d49" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_32b1b7fb-39b1-4149-bb9d-7cfba4bfa424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_62f2ab89-4128-47f0-984c-c9c83a52e475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_83910485-120f-4c1f-9c19-013987458d49" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_62f2ab89-4128-47f0-984c-c9c83a52e475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f86ec1cf-21e5-4ee3-bfb0-4898e20855a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f86ec1cf-21e5-4ee3-bfb0-4898e20855a2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11b34c7f-5867-434d-adc2-fb68966e63f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dfa21265-9ef0-4b5b-842d-ccefce064b32" xlink:to="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_796885ec-e043-4966-96dd-1ba02800da17" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:to="loc_country_FR_796885ec-e043-4966-96dd-1ba02800da17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_f4ff2eb3-7ad2-489d-ab4b-ada92da22cf7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_087cb8b8-898b-43c7-92a7-c79f3c0c40b6" xlink:to="loc_country_DE_f4ff2eb3-7ad2-489d-ab4b-ada92da22cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_868950a0-384c-4553-9ea6-9130c4a62805" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_dbb2aa12-eff5-42ba-a236-bae94055fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_dbb2aa12-eff5-42ba-a236-bae94055fb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1012bcb0-2e40-409a-9a2c-faca81bd28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1012bcb0-2e40-409a-9a2c-faca81bd28c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a5527e11-ff9e-401b-b5be-8ce80f03f2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a5527e11-ff9e-401b-b5be-8ce80f03f2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_2aaab7f9-4edf-4bb3-a2a6-47f790cab84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount_2aaab7f9-4edf-4bb3-a2a6-47f790cab84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_36e7005a-a8c9-465a-a064-bdab6005a924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_36e7005a-a8c9-465a-a064-bdab6005a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_64b273f7-7004-4d03-b1f3-ab05ef67bffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_64b273f7-7004-4d03-b1f3-ab05ef67bffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_2255b187-668a-4c9e-b2df-22173626d766" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_2255b187-668a-4c9e-b2df-22173626d766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_d79fd279-17f4-453e-8f03-447f1e5fa09a" xlink:href="iart-20221231.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_d79fd279-17f4-453e-8f03-447f1e5fa09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_edc7bd2e-f70b-4802-bbb2-3d7c604879af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c224e2ff-c80d-47a9-a83c-a1783ce0aaa2" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_edc7bd2e-f70b-4802-bbb2-3d7c604879af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ddfe5a97-dd28-4478-8d3d-c7715941fa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ddfe5a97-dd28-4478-8d3d-c7715941fa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5d336c39-c28e-41fb-9cc1-6797cd966b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5d336c39-c28e-41fb-9cc1-6797cd966b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_508b792e-c22d-4515-805d-98dd2aa09bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_508b792e-c22d-4515-805d-98dd2aa09bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_95e11b1a-aa04-47b0-8271-b918c7393c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_95e11b1a-aa04-47b0-8271-b918c7393c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_75bcd76b-c09d-43be-871c-d0e806b3d4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_75bcd76b-c09d-43be-871c-d0e806b3d4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_5ad83025-33ed-4219-ab70-ad61672cafa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bc3cd632-e3da-4db8-8d8d-35093d54b9dd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_5ad83025-33ed-4219-ab70-ad61672cafa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_feabb599-c8cb-4fc1-9995-f2c19ef820a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_feabb599-c8cb-4fc1-9995-f2c19ef820a7" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e29cfde0-7925-4534-b448-b91e8dda3906" xlink:to="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_f1ffb569-de8b-43c7-a77b-13d488114226" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_cd027ca6-1bc6-4ee8-941b-b33142396936" xlink:to="loc_srt_AffiliatedEntityMember_f1ffb569-de8b-43c7-a77b-13d488114226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5073c203-9db6-4c15-b1d8-b888b8c31cb8" xlink:to="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_9587c248-9c10-4b64-b57f-f7904b920fec" xlink:href="iart-20221231.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_9587c248-9c10-4b64-b57f-f7904b920fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearLeasePeriodTwoMember_23e99d30-40bb-4cbc-8fd5-ba03d4169d17" xlink:href="iart-20221231.xsd#iart_FiveYearLeasePeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_10a2ca86-3c6d-44fa-a7e0-107ce3159a0c" xlink:to="loc_iart_FiveYearLeasePeriodTwoMember_23e99d30-40bb-4cbc-8fd5-ba03d4169d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_25f4ff0c-1529-4fee-b148-63dafd72e4f3" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_10c2b1b9-9396-470c-a332-25ca2e7bd953" xlink:href="iart-20221231.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_10c2b1b9-9396-470c-a332-25ca2e7bd953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2b45b74c-c07f-48c9-9008-64628df82979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_OperatingLeaseExpense_2b45b74c-c07f-48c9-9008-64628df82979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b7d30198-1f79-4eca-b2b7-b2c0b5ec6cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b7d30198-1f79-4eca-b2b7-b2c0b5ec6cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_1c8c09c2-442c-481f-b4bf-85bc301c352b" xlink:href="iart-20221231.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_1c8c09c2-442c-481f-b4bf-85bc301c352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_680659b2-e991-4658-9d52-bcbe67eca0dc" xlink:href="iart-20221231.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_680659b2-e991-4658-9d52-bcbe67eca0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_OptionToExtendLeaseYears_27c62aec-8c4e-4743-831f-142413d885f2" xlink:href="iart-20221231.xsd#iart_OptionToExtendLeaseYears"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_iart_OptionToExtendLeaseYears_27c62aec-8c4e-4743-831f-142413d885f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_a2706950-732b-4e88-b30b-868932b87e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_10761379-5cb0-4225-8c3a-82be9e91e787" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_a2706950-732b-4e88-b30b-868932b87e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dc0b45c5-f4de-4176-b165-8b301d4800e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dc0b45c5-f4de-4176-b165-8b301d4800e5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6b69990c-2026-4b11-9a17-345735270fb2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_9f5ddf0b-d499-4609-ac09-abe7310c87e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:to="loc_us-gaap_BuildingMember_9f5ddf0b-d499-4609-ac09-abe7310c87e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_369a759d-d878-41f2-ba35-fac2d44ef97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6c9aef9-af99-4071-b1bf-54edcaad4587" xlink:to="loc_us-gaap_VehiclesMember_369a759d-d878-41f2-ba35-fac2d44ef97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_cb83377b-79db-42a4-bec3-014bfcc458a6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b960a072-09dd-42b2-9b4e-b7eec4fabcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b960a072-09dd-42b2-9b4e-b7eec4fabcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_14f9e91a-b95b-4458-a92a-a17434f496f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_14f9e91a-b95b-4458-a92a-a17434f496f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87706860-8bf1-410a-8912-2af3d1dfa907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_87706860-8bf1-410a-8912-2af3d1dfa907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f7a4d688-ee4d-4eac-b51b-34b1e174758f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseLiability_f7a4d688-ee4d-4eac-b51b-34b1e174758f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0037615a-90ee-4b69-8927-d99d38fd886c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0037615a-90ee-4b69-8927-d99d38fd886c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638fb0e6-d374-49e7-9b04-9cdab7860bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e360a24f-6767-4d3a-ad20-4ac705ed43a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638fb0e6-d374-49e7-9b04-9cdab7860bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aea5863c-faf0-4ef9-8d93-4e08827d2558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract_10ac8fd8-2645-4a23-b35d-dba5d4f2c6d2" xlink:href="iart-20221231.xsd#iart_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aea5863c-faf0-4ef9-8d93-4e08827d2558" xlink:to="loc_iart_CashFlowLesseeAbstract_10ac8fd8-2645-4a23-b35d-dba5d4f2c6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ca40e898-95a2-4e0b-83c4-2748046e1021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_CashFlowLesseeAbstract_10ac8fd8-2645-4a23-b35d-dba5d4f2c6d2" xlink:to="loc_us-gaap_OperatingLeasePayments_ca40e898-95a2-4e0b-83c4-2748046e1021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_9d35112d-f308-449e-9584-95347bb4a3d0" xlink:href="iart-20221231.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aea5863c-faf0-4ef9-8d93-4e08827d2558" xlink:to="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_9d35112d-f308-449e-9584-95347bb4a3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cfa9e6e3-59c4-4f00-af4e-df1a4a1ef820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_9d35112d-f308-449e-9584-95347bb4a3d0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cfa9e6e3-59c4-4f00-af4e-df1a4a1ef820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ab130f70-487f-4c1f-bc7f-59262fd595df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab130f70-487f-4c1f-bc7f-59262fd595df" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:to="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c444786a-1fbd-4052-8fdc-0a4a7f1dc329" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_e8c81cad-3f11-4d4b-977d-053bf8531b11" xlink:href="iart-20221231.xsd#iart_RelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:to="loc_iart_RelatedPartiesMember_e8c81cad-3f11-4d4b-977d-053bf8531b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_b2b961c1-4bdd-430c-b4b5-86a36147fc85" xlink:href="iart-20221231.xsd#iart_ThirdPartiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_53f77acc-2203-4515-9aa5-6ceb34d4fb00" xlink:to="loc_iart_ThirdPartiesMember_b2b961c1-4bdd-430c-b4b5-86a36147fc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_3a1cbf5d-7bbe-4f62-894a-dad0517f1b88" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_69e3af91-ebfb-40cd-91f7-31036d7993dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_69e3af91-ebfb-40cd-91f7-31036d7993dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c9c22d9-54c6-4209-bc05-dd198ac055c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8c9c22d9-54c6-4209-bc05-dd198ac055c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aef639d0-d295-4e91-b6a0-a6c7a483b7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aef639d0-d295-4e91-b6a0-a6c7a483b7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4cee3cc6-f150-4641-a8bb-57b80bf88b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4cee3cc6-f150-4641-a8bb-57b80bf88b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aab895fe-9e5b-4375-946e-70d891062d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aab895fe-9e5b-4375-946e-70d891062d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f4643d7-9d4b-4a88-81a9-ebc7d8707fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5f4643d7-9d4b-4a88-81a9-ebc7d8707fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18fffbb5-e9ce-411f-a664-3382f065b656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_18fffbb5-e9ce-411f-a664-3382f065b656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_65f75d3e-a48e-4cf9-a903-50f181760731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_65f75d3e-a48e-4cf9-a903-50f181760731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dd41bc3f-b2db-4e68-81af-1735404ef028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiability_dd41bc3f-b2db-4e68-81af-1735404ef028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4189f3bc-d7a3-4dcc-8b89-52da0e70846a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4189f3bc-d7a3-4dcc-8b89-52da0e70846a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12b8a767-59f1-479f-8c3f-52ffea1ca688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_56272c88-e0b2-4273-a2c8-5e450555b443" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_12b8a767-59f1-479f-8c3f-52ffea1ca688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1" xlink:type="simple" xlink:href="iart-20221231.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cf5312a6-af37-4f07-9dac-bcc7c9631050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e3614b74-96b2-4003-bb17-d8351ae370ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf5312a6-af37-4f07-9dac-bcc7c9631050" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e3614b74-96b2-4003-bb17-d8351ae370ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c3a0e662-8316-4d8c-8079-b87350361a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf5312a6-af37-4f07-9dac-bcc7c9631050" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c3a0e662-8316-4d8c-8079-b87350361a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aac8e9dd-3ec2-403e-b13c-cf8ce959bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf5312a6-af37-4f07-9dac-bcc7c9631050" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aac8e9dd-3ec2-403e-b13c-cf8ce959bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2da5fb66-8618-4a85-9f5d-e67000dbc24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fca9a00e-2004-46a0-8823-2bc3c891170b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2da5fb66-8618-4a85-9f5d-e67000dbc24f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fca9a00e-2004-46a0-8823-2bc3c891170b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2da5fb66-8618-4a85-9f5d-e67000dbc24f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_babbfb7b-f77a-4263-b542-dd64182e7e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_babbfb7b-f77a-4263-b542-dd64182e7e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6713d91c-60cf-4605-8fb0-20a27d0d6fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6713d91c-60cf-4605-8fb0-20a27d0d6fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_c753c88e-9174-42e8-b97c-61c3f459aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_c753c88e-9174-42e8-b97c-61c3f459aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_42c129c0-39aa-488f-9866-5f33c89981e2" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent_42c129c0-39aa-488f-9866-5f33c89981e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_1f494ecb-a8cd-4b63-bb5b-e693002daf36" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent_1f494ecb-a8cd-4b63-bb5b-e693002daf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_438091cc-6028-4f2f-9be3-9a3a55654473" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent_438091cc-6028-4f2f-9be3-9a3a55654473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_25270987-04a8-4ca1-93c1-035e56bdb030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_25270987-04a8-4ca1-93c1-035e56bdb030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_95452792-880e-4210-b254-0d8a56c0dbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_95452792-880e-4210-b254-0d8a56c0dbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_1c808174-52c0-473b-8a9c-4c040563ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent_1c808174-52c0-473b-8a9c-4c040563ece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_52fa89a3-ac25-44f3-b60b-42b38b2353de" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent_52fa89a3-ac25-44f3-b60b-42b38b2353de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_995d5de7-ade0-43c3-b05c-9f14f50e10f1" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent_995d5de7-ade0-43c3-b05c-9f14f50e10f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_b279a047-12d5-46d5-b8db-f9a98fc44f36" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent_b279a047-12d5-46d5-b8db-f9a98fc44f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9c408490-01f7-4a93-83ae-b2a2ac9daaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_f77e4fa9-9c28-478e-8efa-95aa3129b0b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9c408490-01f7-4a93-83ae-b2a2ac9daaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc323176-8e83-4688-928e-6a315717542d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2da5fb66-8618-4a85-9f5d-e67000dbc24f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc323176-8e83-4688-928e-6a315717542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_07fd4b70-090f-4658-939c-ea9335f8197c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:href="iart-20221231.xsd#iart_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fd4b70-090f-4658-939c-ea9335f8197c" xlink:to="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9ad53f66-a257-4115-8b2a-0125a7098429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_171bc1f8-929b-4837-ad48-2c71010334ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_ForeignCountryMember_171bc1f8-929b-4837-ad48-2c71010334ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_eac105a2-20c8-4eae-bccc-df20546632ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_DomesticCountryMember_eac105a2-20c8-4eae-bccc-df20546632ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_82fd9071-be9e-4b06-86d3-d8be5f015e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_397d2e19-2591-4d75-9d48-14ea7bcfe174" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_82fd9071-be9e-4b06-86d3-d8be5f015e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_6e51524c-9a4d-456d-9ddd-315f1c794aa4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e05b072-3840-48b0-a700-5140843f5508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9ce021fe-30af-4741-b12f-f2c365f20b27" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_3e05b072-3840-48b0-a700-5140843f5508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_43bcfbcc-de8a-4133-8f4b-9600d97a248e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExtremityOrthopedicsMember_b92e980f-fe7a-437b-a6f8-7c729027d699" xlink:href="iart-20221231.xsd#iart_ExtremityOrthopedicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21b364ce-3a4f-416a-8455-5824379c43a3" xlink:to="loc_iart_ExtremityOrthopedicsMember_b92e980f-fe7a-437b-a6f8-7c729027d699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:href="iart-20221231.xsd#iart_IncomeTaxLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxTable_4c9bab53-457f-44f0-a266-9cee80b00063" xlink:to="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d7cbcc85-9a84-4196-b87a-7cef4a49a919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d7cbcc85-9a84-4196-b87a-7cef4a49a919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ee59f19f-a920-4cf9-85ab-0849ab7afa11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ee59f19f-a920-4cf9-85ab-0849ab7afa11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_dca0cea6-048d-44b9-9839-40eec30445e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_dca0cea6-048d-44b9-9839-40eec30445e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_a6eb851a-c97b-4f6b-b938-d12c2f8dd60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_a6eb851a-c97b-4f6b-b938-d12c2f8dd60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_56bb6945-5684-4f99-b455-d2651f3acc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_56bb6945-5684-4f99-b455-d2651f3acc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_e3d15bd4-a2d8-4c99-be00-05574001f167" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_e3d15bd4-a2d8-4c99-be00-05574001f167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_581a5b0a-c51c-47f0-a096-9bed8f04a276" xlink:href="iart-20221231.xsd#iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent_581a5b0a-c51c-47f0-a096-9bed8f04a276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_3996b6ef-c4ec-47a4-b461-d06267ebf377" xlink:href="iart-20221231.xsd#iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount_3996b6ef-c4ec-47a4-b461-d06267ebf377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dad82668-e4f6-45d9-a115-ffae8a1818e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dad82668-e4f6-45d9-a115-ffae8a1818e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_efea7f4f-56e3-4e14-b60e-7af2c4852476" xlink:href="iart-20221231.xsd#iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations_efea7f4f-56e3-4e14-b60e-7af2c4852476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_657430f4-6d55-431b-8b25-d520eca69533" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetIncreaseDueTo2017TaxAct"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct_657430f4-6d55-431b-8b25-d520eca69533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_269e0d4a-fe36-41cd-b9f7-17ca38ba7dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_OperatingLossCarryforwards_269e0d4a-fe36-41cd-b9f7-17ca38ba7dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f07e86aa-9ab6-4723-b1cc-4ae848d3fb95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_f07e86aa-9ab6-4723-b1cc-4ae848d3fb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_fa16193b-9ddb-4608-9cff-87d6bfd309e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_fa16193b-9ddb-4608-9cff-87d6bfd309e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_9602af37-5cc0-4dbe-ba78-5d5601b20a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_9602af37-5cc0-4dbe-ba78-5d5601b20a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_f76cd721-0fa5-4fc3-bae4-255739fb0023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_f76cd721-0fa5-4fc3-bae4-255739fb0023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b6cd7e9f-dfdd-401c-bdd1-6ce3f1f9a341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b6cd7e9f-dfdd-401c-bdd1-6ce3f1f9a341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_55cad5d2-3e95-40a5-9679-feebcac5681f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_IncomeTaxLineItems_ab894912-fbd8-44e9-8161-5cf7aec5e4a8" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_55cad5d2-3e95-40a5-9679-feebcac5681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f09d2650-8008-4194-aff5-9b7f5c4d65d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f09d2650-8008-4194-aff5-9b7f5c4d65d4" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_9a07fb18-979e-4f3d-9da0-dac9c41cc291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_9a07fb18-979e-4f3d-9da0-dac9c41cc291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0b4e3dcc-63b3-4668-8bbe-862a4abfa5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0b4e3dcc-63b3-4668-8bbe-862a4abfa5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_64f63893-732d-4c4f-a5e9-fb0775191ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_64f63893-732d-4c4f-a5e9-fb0775191ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a5683e06-db19-44c9-8c18-7916dddd76e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_00650a79-5a36-4ade-adfc-54b27428894b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a5683e06-db19-44c9-8c18-7916dddd76e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f09d2650-8008-4194-aff5-9b7f5c4d65d4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6499921b-a7d6-42b9-8133-7b6cd6140677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6499921b-a7d6-42b9-8133-7b6cd6140677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_846c1958-dfe8-466c-ba3e-d86f9a707744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_846c1958-dfe8-466c-ba3e-d86f9a707744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d74f6712-9c59-4c26-8cc6-3704aab66855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d74f6712-9c59-4c26-8cc6-3704aab66855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_aef23731-343f-4ee4-839b-219f903e0d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63d9d8ea-f9f1-4d66-a672-8b2806a65c53" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_aef23731-343f-4ee4-839b-219f903e0d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dee5d690-2372-44ff-b0e0-7a68cf431028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f09d2650-8008-4194-aff5-9b7f5c4d65d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dee5d690-2372-44ff-b0e0-7a68cf431028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_15a26601-57ec-4d2a-9a27-4fb638481f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15a26601-57ec-4d2a-9a27-4fb638481f86" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b3d5ecf8-25eb-40fd-9044-706a4780166f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b3d5ecf8-25eb-40fd-9044-706a4780166f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_7bffa518-4b82-414e-99a0-480520ff589a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_7bffa518-4b82-414e-99a0-480520ff589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8cbcfaa2-c865-4328-8fd7-7589e7c42354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_8cbcfaa2-c865-4328-8fd7-7589e7c42354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_2a154222-48fb-4c88-92cc-eded37f4e986" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation_2a154222-48fb-4c88-92cc-eded37f4e986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_7e0c97e1-b570-436b-ad53-1a51519478dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_7e0c97e1-b570-436b-ad53-1a51519478dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b215f82a-ffe6-4608-b54e-4322627dca51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b215f82a-ffe6-4608-b54e-4322627dca51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_1e0d63d8-86d2-419e-9caa-432077ee2692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_1e0d63d8-86d2-419e-9caa-432077ee2692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c1dfd1aa-974f-42dd-a3fb-c89f56bfc7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c1dfd1aa-974f-42dd-a3fb-c89f56bfc7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_f3bd658c-1b33-471f-b308-67478d32c03c" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment_f3bd658c-1b33-471f-b308-67478d32c03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_7a1f57e1-1804-4282-93a7-94fed4addddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_7a1f57e1-1804-4282-93a7-94fed4addddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_f7a9f723-8f54-4118-97ab-ecb9f52401cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_f7a9f723-8f54-4118-97ab-ecb9f52401cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxAssetsLeasesAndOther_bc10ef47-6307-4cfe-a740-e9a2446f0dc5" xlink:href="iart-20221231.xsd#iart_DeferredTaxAssetsLeasesAndOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_iart_DeferredTaxAssetsLeasesAndOther_bc10ef47-6307-4cfe-a740-e9a2446f0dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eda27e35-7bbd-4c8e-bb73-abc93cc36b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_eda27e35-7bbd-4c8e-bb73-abc93cc36b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7886d378-8cdb-459a-9afe-2b68c43b5288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7886d378-8cdb-459a-9afe-2b68c43b5288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_567843ac-3780-4aa9-8853-1517768377b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_44ed26c9-6163-428b-a059-2654c3c27051" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_567843ac-3780-4aa9-8853-1517768377b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15a26601-57ec-4d2a-9a27-4fb638481f86" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2cc9af19-6b27-4f3f-aa37-72b945323987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2cc9af19-6b27-4f3f-aa37-72b945323987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_08edb069-cf77-418b-8664-bd0c546588da" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:to="loc_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss_08edb069-cf77-418b-8664-bd0c546588da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_280dd927-d6e2-4574-917a-ed0e52df373c" xlink:href="iart-20221231.xsd#iart_DeferredTaxLiabilitiesLeasesAndOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:to="loc_iart_DeferredTaxLiabilitiesLeasesAndOther_280dd927-d6e2-4574-917a-ed0e52df373c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_07f2c81f-6867-40a3-aca6-bf8145e85e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_81102d0c-5031-4e09-999f-8f769d9963cb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_07f2c81f-6867-40a3-aca6-bf8145e85e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_90c595c2-aad8-43b7-96b3-cc63f7be10e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15a26601-57ec-4d2a-9a27-4fb638481f86" xlink:to="loc_us-gaap_DeferredTaxLiabilities_90c595c2-aad8-43b7-96b3-cc63f7be10e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e7abeb9b-5e7f-40a2-8af0-ef402442b4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15a26601-57ec-4d2a-9a27-4fb638481f86" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e7abeb9b-5e7f-40a2-8af0-ef402442b4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESTaxValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_37e1f599-4170-4970-9cfd-d5058050b7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_37e1f599-4170-4970-9cfd-d5058050b7a9" xlink:to="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_ec1b4738-c6aa-4818-9c9b-c8b45a46e541" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_0b7b88b9-bc55-433b-a486-090c013700ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_424dba60-40d5-4c76-908f-4570bdd3b521" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_0b7b88b9-bc55-433b-a486-090c013700ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_1a631177-7cf8-4713-8c22-13da3d82dcf7" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_67ecb5c9-d3a3-4cf8-bc1b-59b9ccd7c860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_67ecb5c9-d3a3-4cf8-bc1b-59b9ccd7c860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_24973438-781c-4083-bf77-a7b93a5e9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_24973438-781c-4083-bf77-a7b93a5e9e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_01313cd4-302c-4a05-b751-6df995d55128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_01313cd4-302c-4a05-b751-6df995d55128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_437ee1bd-b4cb-416b-976a-50a9caea4bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_437ee1bd-b4cb-416b-976a-50a9caea4bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ed564fe7-6fa0-4cab-8ab2-77f2b8e6a99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ef2a6db4-0917-482e-976d-8eb8dc6bba19" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_ed564fe7-6fa0-4cab-8ab2-77f2b8e6a99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0a8ab77d-52fa-4a7f-a197-82d1eea30ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a8ab77d-52fa-4a7f-a197-82d1eea30ac9" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e9514e81-bfc5-4a3c-bfbc-ca8208749440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e9514e81-bfc5-4a3c-bfbc-ca8208749440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_15ed28a4-1030-4276-86fe-21f75fabb12c" xlink:href="iart-20221231.xsd#iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:to="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_15ed28a4-1030-4276-86fe-21f75fabb12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e6deef54-8436-4916-8cda-32049c48646e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_15ed28a4-1030-4276-86fe-21f75fabb12c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e6deef54-8436-4916-8cda-32049c48646e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_edb066e2-1fef-4c77-ac6d-c268c9a9d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract_15ed28a4-1030-4276-86fe-21f75fabb12c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_edb066e2-1fef-4c77-ac6d-c268c9a9d52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_148de7bd-310b-4e99-ab4d-57bf1eb4379d" xlink:href="iart-20221231.xsd#iart_UnrecognizedTaxBenefitsReductionsResultingFromOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:to="loc_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther_148de7bd-310b-4e99-ab4d-57bf1eb4379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_31dc78cd-9862-4656-9c72-a99493e69d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f769a789-66a1-4de8-bcd4-1be3c47ea62a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_31dc78cd-9862-4656-9c72-a99493e69d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df5f1882-c121-4b0a-a8e8-65786eaf1b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_e3137e75-3664-4cec-a621-20378706f0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df5f1882-c121-4b0a-a8e8-65786eaf1b64" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_e3137e75-3664-4cec-a621-20378706f0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_deb0cab5-ab60-4c9b-ac15-35013fbefbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e3137e75-3664-4cec-a621-20378706f0c1" xlink:to="loc_us-gaap_NetIncomeLoss_deb0cab5-ab60-4c9b-ac15-35013fbefbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc0f3913-03ba-4a47-ac60-3590c4cf9842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e3137e75-3664-4cec-a621-20378706f0c1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc0f3913-03ba-4a47-ac60-3590c4cf9842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_89363ec9-63f6-457b-bd06-166b3d548865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e3137e75-3664-4cec-a621-20378706f0c1" xlink:to="loc_us-gaap_EarningsPerShareBasic_89363ec9-63f6-457b-bd06-166b3d548865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df5f1882-c121-4b0a-a8e8-65786eaf1b64" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f815bbc6-6c17-41b3-a123-fdab2c46b233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:to="loc_us-gaap_NetIncomeLoss_f815bbc6-6c17-41b3-a123-fdab2c46b233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_030e1613-2902-492b-9c93-fc74594bab4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_030e1613-2902-492b-9c93-fc74594bab4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_af9a41c7-3c65-4394-b8fc-2d2282c14116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_af9a41c7-3c65-4394-b8fc-2d2282c14116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ffc0ac52-e740-4c01-9ed2-eba11b0178fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_af9a41c7-3c65-4394-b8fc-2d2282c14116" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ffc0ac52-e740-4c01-9ed2-eba11b0178fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f3fdb66-7258-4af2-8f65-d50fe1dad365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_af9a41c7-3c65-4394-b8fc-2d2282c14116" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f3fdb66-7258-4af2-8f65-d50fe1dad365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_299da801-305e-4ce6-9627-d00a464b30cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1b1cec2e-bc69-4dbd-9b88-4b013ccf8b88" xlink:to="loc_us-gaap_EarningsPerShareDiluted_299da801-305e-4ce6-9627-d00a464b30cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0aa2b1ee-7a1a-43b0-a335-6e7d40cc0597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_64bdf596-5724-4e2e-8c85-2b294cd8fdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0aa2b1ee-7a1a-43b0-a335-6e7d40cc0597" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_64bdf596-5724-4e2e-8c85-2b294cd8fdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_f1f97744-15b0-47b5-b2e2-14c94cef847b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f1f97744-15b0-47b5-b2e2-14c94cef847b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24d1003-1577-4021-8b15-31019570e2a0" xlink:to="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_59f0be65-0762-4f73-9009-2c63381003ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79776fe-6939-408d-afe2-38735676f62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79776fe-6939-408d-afe2-38735676f62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_decb1a2b-77b0-46f1-b52b-812e06f96419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_decb1a2b-77b0-46f1-b52b-812e06f96419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_62f57d6f-1fa8-4787-aa35-45ed6c09f881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9d14f2d4-9397-4e38-a533-9daa2b5a51c7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_62f57d6f-1fa8-4787-aa35-45ed6c09f881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1d454097-3efe-4b5f-8358-bebfbfaa8c05" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:href="iart-20221231.xsd#iart_AccumulatedOtherComprehensiveIncomeLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0d842008-aa4a-42b0-b3ad-3304e3c96e2e" xlink:to="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9647f0cf-e601-4391-9a5e-e0f3174b9e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_StockholdersEquity_9647f0cf-e601-4391-9a5e-e0f3174b9e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_080fda83-6768-4619-addb-8a1e79dedded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_080fda83-6768-4619-addb-8a1e79dedded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2209b7b2-e6b6-4f32-91f2-fc1a833a10e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2209b7b2-e6b6-4f32-91f2-fc1a833a10e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05192414-15f7-45bb-b1a3-95705e826990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05192414-15f7-45bb-b1a3-95705e826990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16430b2b-1a1f-46b2-a50e-5acf36e8a7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_AccumulatedOtherComprehensiveIncomeLossRollForward_7831d17f-c7a4-4b7b-ada2-68ec4b52fc75" xlink:to="loc_us-gaap_StockholdersEquity_16430b2b-1a1f-46b2-a50e-5acf36e8a7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_72afa36d-3226-40b8-b4d8-748a2c34d77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_72afa36d-3226-40b8-b4d8-748a2c34d77c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f046be65-19d4-46b3-a16e-0b50da712a46" xlink:to="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5cac12da-740c-4718-839c-28b63a6fa948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f31014f5-0b71-4e31-8905-2fc94f4461ae" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5cac12da-740c-4718-839c-28b63a6fa948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_74910ef2-d65f-4e3f-bee7-3eb86a7c783d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_991ae423-83c7-4017-9107-46f0671a7876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1b175396-1531-42ab-b4dd-3cc3cdac02ff" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_991ae423-83c7-4017-9107-46f0671a7876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0a5b45e3-a4ba-4327-a923-1125b4e2d785" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eba3c61f-1749-44a7-aa51-6e791b456978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eba3c61f-1749-44a7-aa51-6e791b456978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_985dc9e6-96dd-4d92-859f-e95ba4a6698c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d8dbd2d8-cf19-4b49-a52b-7c257bbd6819" xlink:to="loc_us-gaap_InvestmentIncomeInterest_985dc9e6-96dd-4d92-859f-e95ba4a6698c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_83d80929-b6e3-4a7c-a33d-225b6f97a0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_83d80929-b6e3-4a7c-a33d-225b6f97a0db" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a3f2d583-eb4b-4f19-b094-dac6b7063a5b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_d5c5b2e5-c263-4098-95ce-ef1629fbaefb" xlink:href="iart-20221231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6f365485-3b0c-4c14-99d8-ea44d54eddfe" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_d5c5b2e5-c263-4098-95ce-ef1629fbaefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7e9fbf3-0722-41f1-9ca0-6a7e3702f36d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c75243b-85df-4d3f-99bb-c98de5c905e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f703f3a-f950-417a-8786-959a51de7532" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c75243b-85df-4d3f-99bb-c98de5c905e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee1a5699-7fdb-4714-b8e3-86131e7855d9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_32ae9361-e605-4c18-8e48-2cfa7b25ef16" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_ArkisBioSciencesInc.Member_32ae9361-e605-4c18-8e48-2cfa7b25ef16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_10ee6406-45fd-4690-972a-e13206682c13" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_DermaSciencesMember_10ee6406-45fd-4690-972a-e13206682c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_ea0d1f1a-3609-4d55-8bf0-8f71f3576c48" xlink:href="iart-20221231.xsd#iart_ACellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_ACellMember_ea0d1f1a-3609-4d55-8bf0-8f71f3576c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_e051a801-dc77-4135-9431-fa0cb8ed6fa2" xlink:href="iart-20221231.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d156ecb2-36af-46a5-89eb-2cf7cfe37544" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_e051a801-dc77-4135-9431-fa0cb8ed6fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f80c32f-62e9-4b86-acb2-7643e141443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_2c4ef742-51c2-4862-9f14-b1919599b606" xlink:href="iart-20221231.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_2c4ef742-51c2-4862-9f14-b1919599b606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_408a20f6-edb0-4354-be47-35e436de9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_408a20f6-edb0-4354-be47-35e436de9476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_00b0dc60-4f12-4763-b679-544d648d2a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93b2d9ef-3093-47e7-a304-dbc8972edd70" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_00b0dc60-4f12-4763-b679-544d648d2a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f78ff021-a71c-45cc-9c1a-a3330273e5a5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c4b3e76f-d395-4942-8239-eb5f6ea5ba78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c4b3e76f-d395-4942-8239-eb5f6ea5ba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_a65c74cc-a1e9-438c-8734-ebe85aa35262" xlink:href="iart-20221231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_a65c74cc-a1e9-438c-8734-ebe85aa35262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_84d5f70a-af3e-4302-bd88-b1f9da10158d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_84d5f70a-af3e-4302-bd88-b1f9da10158d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a0e46fd2-35fa-494f-a719-dc64bd015048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8298319a-87ab-4127-acac-e375c6330097" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a0e46fd2-35fa-494f-a719-dc64bd015048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7d278bbe-ff30-40fa-a98d-6c84f15dbc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cec158d5-343d-4fe6-b611-3b68af8b7f8f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7d278bbe-ff30-40fa-a98d-6c84f15dbc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_77baea7c-3bd1-4da6-880d-1c3ecb06c782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_77baea7c-3bd1-4da6-880d-1c3ecb06c782" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6eb7f52a-6a8a-4eda-ab71-1a1e05354c82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_a2f37054-46f9-4401-98ff-e3d49e1f56a9" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_ArkisBioSciencesInc.Member_a2f37054-46f9-4401-98ff-e3d49e1f56a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_0fdf2e7f-3e3a-47fe-b41a-ec528cb44a72" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_DermaSciencesMember_0fdf2e7f-3e3a-47fe-b41a-ec528cb44a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_17480061-d8eb-49eb-80f3-567ca70785aa" xlink:href="iart-20221231.xsd#iart_ACellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bb441e63-d6e3-4886-aca0-25bb1306f295" xlink:to="loc_iart_ACellMember_17480061-d8eb-49eb-80f3-567ca70785aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_210ad6a8-a079-4afa-91f2-64e77dc65dbf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_1711ebee-40c4-4bfc-a75d-38a38e9b4529" xlink:href="iart-20221231.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9e2645d-ff76-4f49-b818-2dc24a320593" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_1711ebee-40c4-4bfc-a75d-38a38e9b4529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fa74c7e9-7f6e-4b28-a3d9-5b7a4a75368a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0b0626cb-b090-4eed-8fa1-28cc2da6dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c98563f5-1dbb-4e98-95e9-2cbe3b97a58a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0b0626cb-b090-4eed-8fa1-28cc2da6dcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81b587fd-d7ed-453d-92e2-e7a627b0c846" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_4c9448be-16b2-4363-bd68-612acfb9fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_4c9448be-16b2-4363-bd68-612acfb9fcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_caa7c055-70da-4559-b912-959183e06ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7fc47302-918f-477c-b921-da8e80533eae" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_caa7c055-70da-4559-b912-959183e06ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3ceb9036-07f0-48cf-b791-2ece81b6f5e4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_65c38769-2a49-47e4-a391-cb45988814f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a713d11-cda4-41b0-b054-f4008090e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a713d11-cda4-41b0-b054-f4008090e59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_f6de86ab-3bfc-4496-9f68-52f6f618afab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_f6de86ab-3bfc-4496-9f68-52f6f618afab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_b8479c71-5100-4ade-a58a-39c3ea7a97ae" xlink:href="iart-20221231.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_b8479c71-5100-4ade-a58a-39c3ea7a97ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_38a2e0ed-a7fa-4fc1-bfb1-2457efb67bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_38a2e0ed-a7fa-4fc1-bfb1-2457efb67bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_39917acb-c253-4f2a-9c98-6b073848b46e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8810ce12-ae75-464c-bf44-f38c19904faf" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_39917acb-c253-4f2a-9c98-6b073848b46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c26f92ac-0229-4c8f-946a-779fd70c7506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c26f92ac-0229-4c8f-946a-779fd70c7506" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35e68b44-7869-47d5-a717-e6782de941a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_f9523c9b-487c-403b-8ac6-c023b9da0d3c" xlink:href="iart-20221231.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:to="loc_iart_DermaSciencesMember_f9523c9b-487c-403b-8ac6-c023b9da0d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_0a719295-dd3b-4d17-bc67-40f83fccb6a3" xlink:href="iart-20221231.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04e903c1-a39e-4611-9c3f-9c6287f3563c" xlink:to="loc_iart_ArkisBioSciencesInc.Member_0a719295-dd3b-4d17-bc67-40f83fccb6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3c58d0b0-2492-4cd8-997c-0c32e2640bd0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ac12502b-be8a-4168-be2a-a238fe9dee68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ac85d7d-b18d-456f-b661-42bda195b666" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ac12502b-be8a-4168-be2a-a238fe9dee68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d280b728-af2e-4fbb-b3e4-d7638b2d7679" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_eba4769b-f799-40a7-bdaf-9a21f313adcf" xlink:href="iart-20221231.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_eba4769b-f799-40a7-bdaf-9a21f313adcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_b8a410b4-87f5-4ecf-a652-986f539b587b" xlink:href="iart-20221231.xsd#iart_MilestonePaymentOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_MilestonePaymentOneMember_b8a410b4-87f5-4ecf-a652-986f539b587b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_146856f3-7ef3-4cd3-a74c-909abf120d07" xlink:href="iart-20221231.xsd#iart_MilestonePaymentTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5b6b7505-dfe0-40cc-aa9e-9bd43cdf0d9a" xlink:to="loc_iart_MilestonePaymentTwoMember_146856f3-7ef3-4cd3-a74c-909abf120d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_aa0a515b-1531-4d50-8e2e-da35e979eb22" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f6077f5f-1b0d-4553-878d-2713888d9e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f6077f5f-1b0d-4553-878d-2713888d9e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_97a485c5-cda9-4978-9feb-08abc37348b3" xlink:href="iart-20221231.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_97a485c5-cda9-4978-9feb-08abc37348b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4d377d80-639c-4ec2-9cbb-a906f3c63532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4d377d80-639c-4ec2-9cbb-a906f3c63532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_230ac036-6c65-4a6c-8e2c-edbdf3d58862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_230ac036-6c65-4a6c-8e2c-edbdf3d58862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51eb3def-4a3c-4dc9-9b8e-426108ec753e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_51eb3def-4a3c-4dc9-9b8e-426108ec753e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5ba9c2df-3b75-4920-b770-2dd7d55006aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5ba9c2df-3b75-4920-b770-2dd7d55006aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a314bd1c-dc17-4ba8-9258-3f6b40004dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b784685d-8204-4d58-95e5-4f7fce80b8f8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a314bd1c-dc17-4ba8-9258-3f6b40004dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_66e36042-53e7-49f8-8af9-eafca5a45339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_66e36042-53e7-49f8-8af9-eafca5a45339" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5c398fe-4403-47f2-bbdb-649eee29f012" xlink:to="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_cbfd7cdc-176a-4d54-9c49-e9ec23dc0a0e" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6ebaf976-58b4-4f5e-a262-0cb928ea7df6" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_cbfd7cdc-176a-4d54-9c49-e9ec23dc0a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_162782f7-d826-4d05-ab63-e7a163d5965e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3bb3603d-0dae-47a7-b563-cd52df3323a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:to="loc_us-gaap_NumberOfReportableSegments_3bb3603d-0dae-47a7-b563-cd52df3323a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_2a5bbb5b-1673-482a-9b6b-c23a75892da4" xlink:href="iart-20221231.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2714d36-0242-44d6-8a2e-3b81ee0fe267" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_2a5bbb5b-1673-482a-9b6b-c23a75892da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7ff1640f-0f5b-4af5-adbd-5e5713d18ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7ff1640f-0f5b-4af5-adbd-5e5713d18ad6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:to="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8636c36c-ce06-4f5d-8441-855a82d1072b" xlink:to="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dd5eec14-5ead-4d1f-b5c9-ddaa5df4d892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:to="loc_us-gaap_OperatingSegmentsMember_dd5eec14-5ead-4d1f-b5c9-ddaa5df4d892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_16e32f0a-77fe-4342-be90-1b773307e315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4e4c0729-5583-4f30-b66e-582cbc9d1dee" xlink:to="loc_us-gaap_CorporateNonSegmentMember_16e32f0a-77fe-4342-be90-1b773307e315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ad82b2-742f-4710-80a6-43d6994dfd22" xlink:to="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_4d75ae99-42a9-41d5-b3c1-ab35aefc01f1" xlink:href="iart-20221231.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_4d75ae99-42a9-41d5-b3c1-ab35aefc01f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_04763d61-3a55-48fb-94b6-99e027249d71" xlink:href="iart-20221231.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f1c53f95-64aa-4b4d-804e-ecc8e834eafa" xlink:to="loc_iart_TissueTechnologiesMember_04763d61-3a55-48fb-94b6-99e027249d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b46e65af-9d49-440f-8174-3ebedcd17d73" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6802cfdd-5ae0-47a5-b1df-d04b4f0aa554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_82f26ef6-dc83-4436-840b-760d9ef868fb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6802cfdd-5ae0-47a5-b1df-d04b4f0aa554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_adc94d5b-73fa-4740-b3b3-795a90db2692" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ab63b0c4-829b-409b-927b-959b309df546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ab63b0c4-829b-409b-927b-959b309df546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_99776476-964f-4897-89c1-00ef45c0b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f6e868dc-8bfe-4bff-8098-de25f3c2d154" xlink:to="loc_us-gaap_OperatingIncomeLoss_99776476-964f-4897-89c1-00ef45c0b1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20221231.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_52a56449-2122-474e-924b-1691077c6abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_52a56449-2122-474e-924b-1691077c6abf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:to="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6d591e60-87c3-4ce7-8995-6082e6117013" xlink:to="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f8253156-c457-425d-b01b-9ec22e177f15" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_country_US_f8253156-c457-425d-b01b-9ec22e177f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d66b53a3-7afe-4c28-b293-2f614914f8e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_srt_EuropeMember_d66b53a3-7afe-4c28-b293-2f614914f8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_2dd876e8-548d-4377-9781-da971dbe8b2c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_srt_AsiaPacificMember_2dd876e8-548d-4377-9781-da971dbe8b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_5414e9c3-90bb-4d14-a7d8-d1da3aa9d2a2" xlink:href="iart-20221231.xsd#iart_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bad91fd6-5d3e-4277-9051-9f2b134e3577" xlink:to="loc_iart_RestOfWorldMember_5414e9c3-90bb-4d14-a7d8-d1da3aa9d2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4781af1a-9320-4c78-b573-0d59cb4cd1e7" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e6235e-228e-47cc-b9a7-575a87a3e064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e6235e-228e-47cc-b9a7-575a87a3e064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_589d1234-de4a-4366-8c0a-51eeadaddaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_706a82d3-6bca-4f10-be36-d8d80aced4b4" xlink:to="loc_us-gaap_NoncurrentAssets_589d1234-de4a-4366-8c0a-51eeadaddaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>iart-20221231_g1.jpg
<TEXT>
begin 644 iart-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" /_![X# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")KFO$6G+X=U%(;2:8!H@Y9FYZD8X XX%>EUY_\0/^
M0S#_ ->Z_P#H34 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?_ ! _Y#,/
M_7NO_H35Z!7G_P 0/^0S#_U[K_Z$U &U\/\ _D#3?]?#?^@K735S/P__ .0-
M-_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7G_Q _Y#,/\ U[K_ .A-7H%>?_$#_D,P_P#7NO\ Z$U &U\/_P#D#3?]
M?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7G_P 0/^0S#_U[K_Z$U>@5Y_\ $#_D,P_]>Z_^
MA-0!M?#_ /Y TW_7PW_H*UTU<S\/_P#D#3?]?#?^@K734 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\0/^0S#_ ->Z_P#H35Z!
M7G_Q _Y#,/\ U[K_ .A-0!M?#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K
M734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\
M$#_D,P_]>Z_^A-7H%>?_ ! _Y#,/_7NO_H34 ;7P_P#^0--_U\-_Z"M=-7,_
M#_\ Y TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>?_$#_D,P_P#7NO\ Z$U>@5Y_\0/^0S#_ ->Z_P#H34 ;7P__
M .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUX$Z<Z;Y9JS\STXR4E>+N@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O/_B!_P AF'_KW7_T)J] KS_X@?\ (9A_Z]U_]":@#:^'_P#R
M!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBFLRQJ68A5 R23@"C8!U%<1XB^+6C:+OCM6.IW(XVP']V#[OT_
M+->:Z[\4]>UK<B7 L(#_ ,L[7Y3^+=?R(K\USKQ!R3)VZ:J>UJ+I#7[Y?"OO
M;78^APF1XS%6ER\L>[_RW/:]:\5Z3X>4F_O8H7QD19W.?^ CFO/M:^. 4LFE
M6&[TFNCQ_P!\C_&O)V=I&+,2S$Y+$Y)I*_#\W\4,XQS<,$E0AY>]+_P)JWW)
M/S/L<+PYA*.M:\W]R^[_ ()OZSX\UW7=RW.H2+$?^6,)\M/I@=?QS6!117Y1
MB\;BL?4]KBZLIR[R;;_$^FI4:=&/+2BHKR5@HHHKC-0HHHH **** "BBB@ H
MHHH *]@^!?\ R#]5_P"NJ?R->/U[!\"_^0?JO_75/Y&OT[PW_P"2EP_I/_TB
M1\[Q!_R+Y_+\T?*/[<G_ "6B#_L$P?\ H<M?/5?0O[<G_):(/^P3!_Z'+7SU
M7^G>4_[A1_PH_F+'?[S4]0HHHKUSA"BBB@ HHHH **** "BBB@!T<CPR*Z,R
M.IW*RG!!'0@UZKX'_:A^(O@7RXX-=?5;-./LFK W"8] Q.\#V#"O***YZV'I
M8B/+6BI+S1K3JSI.\'8^V_ W[>6AZAY<'BO1+C2)3P;NQ;SX?J5.&4?3<:^B
M?"/C[P[X^L?M?A[6;35H< M]GD!=,]G0_,I]F K\FZM:7JU[HE]%>:=>7%A>
M1',=Q:RM'(I]F4@BOE<5PSAJNM!N#^]?Y_B>S1SBM#2JN9?<S]>:*^ OAY^V
MOXT\*^5;Z]'#XIL%X+3_ +JY ]I%&#_P)23ZU]3_  U_:8\"_$SRK>UU,:7J
MCX']G:GB&0MZ(<[7^BG/L*^*QF2XS!7E*-X]UK_P4?0T,PH8C1.S[,]6HHHK
MPST0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_X@?\ (9A_Z]U_]":O0*\_
M^('_ "&8?^O=?_0FH VOA_\ \@:;_KX;_P!!6NFKF?A__P @:;_KX;_T%:Z:
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA^'!_ UX57\/<:Y"\@SBI1@K4I^]#T?3_MUW7I9]3]CRC&_7L+&;?O+1^O\
MP0HHHKX,]H**** "OF/PZW_"\/VEKK5S^^\/>%@%M^Z,ZL0A_P"!2;G!]$ K
MVWXLWFMV?P_U?_A';*:_UF:+R+>.WQN0O\I?K_""3]0*YS]G/X;3?#?X=PPW
MT'D:Q?R&ZNT;!*$\(F?90/Q+5][DU:EE.4XO,>=>VJ?NH*ZNE+6<K;KW?=3[
MMGBXN$L5BJ5"WN1]Z79VV7WZM'J5>;>*OAS\-_"L=_XNU7P]I\)M0;F68QY4
MMG(Q'G:6+8 XY)KTFO$?&FBZM\9_B9#X?N;&[L? N@N)[V::)HUU&<=(T) W
M*,XR.VXYY6O)R"-26(DW7E1I15ZCC)IN*^RM5=R>D5W=]KG3CG%07N*4F[13
M5]>_DENSE]%O=0L] \2?&_Q':AM1:W\O0=/EY2UA9A'&V./O%QTQD%C_ !\)
MK2?$7PK\,[/XC_\ ";W-Y?&*"]N=(F@7[+Y4K+A HZ8#C.,=\$<5[3\4/!/_
M  G7PYUCPY;&.W>Y@"P<8171E>,''0;D4>PKQG4&^(GB_P"&=I\.9/!5QIUY
MY4%E<ZQ<3I]F6&-E^<$9R2$&0,]3CJ*_0LKS*EF2CB+4HI58QG&?):.&45:,
M>?HO>YN7WG*SW9X6(P\L/>%Y/W6TU?6HWJW;KM:^ECZ"\-:U'XD\.Z5J\2&.
M*_M8KI4/50Z!@/UK2K/\/Z-%X=T'3=)MR6@L;:.UC9AR510H)_ 5H5^.XCV?
MMI^Q^"[MZ7T_ ^KAS<BY]^H4445@6%>P? O_ )!^J_\ 75/Y&O'Z]@^!?_(/
MU7_KJG\C7Z=X;_\ )2X?TG_Z1(^=X@_Y%\_E^:/E']N3_DM$'_8)@_\ 0Y:^
M>J^A?VY/^2T0?]@F#_T.6OGJO].\I_W"C_A1_,6._P!YJ>H4445ZYPA1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%_\ (/U7_KJG\C7Z=X;_ /)2X?TG_P"D2/G>(/\ D7S^7YH^4?VY/^2T0?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_X@?\
M(9A_Z]U_]":O0*\_^('_ "&8?^O=?_0FH VOA_\ \@:;_KX;_P!!6NFKF?A_
M_P @:;_KX;_T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKS_X@?\ (9A_Z]U_]":O0*\_^('_ "&8?^O=?_0FH VOA_\ \@:;_KX;_P!!
M6NFKF?A__P @:;_KX;_T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6^_;Y_\ !Z&C\7_A-?6GB^.?0[&2ZMM48LL,"Y\J7JP/8*?O GCKZ5TW@/\
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MR.:\\K]"I5J=>"J4I73['R\Z<J<G&:LPHHHK8S"BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)&ZD_P! .@'8"J5%%?B,I.3<I.[9^[QBH)1BK)!1114E!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)UINI4=Y/5L****T,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_
M *$U>@5Y_P#$#_D,P_\ 7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--
M_P!?#?\ H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <K\3O&D
M?@+P7J&K,1]H5/*MD/\ %,W"CWQU/LIKX4FF>XF>65VDDD8LSL<EB3DDU[7^
MU'XV.K^*+?P];R9M--4/,%/#3L,_^.J0/JS5XC7XOQ/C_K>,=*+]VGI\^O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RO%7B&W\)^'-1U>Z_U
M-G"TI7.-Q_A7ZDX'XUJUX#^U=XN^RZ3IGAR%\273_:K@ _\ +->$!]BV3_P"
MO+S/&+ 82IB.J6GJ]%^)ZV58)YAC:>'Z-Z^BU?X'S=JFI7&L:E=7]V_F7-U*
MTTK^K,23^IJM117\^2DY-M[G]'1BHI16R"BBBD,**** "BBB@ HHHH %4LP
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M2H_>CMZ?\#\CY#-L+[.?MX[/?U_X)QM%%%?;'SP4444 %%%% !1110 5Z)\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M45\8?0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7G_Q _P"0S#_U[K_Z$U>@5Y_\
M0/\ D,P_]>Z_^A-0!M?#_P#Y TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAAE3)(S[DL3^(KC?#6K:7XX\1?\ "2^+]8L8(8&(L-)DG7$8!ZL/P[]2,GC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\
MB!_R&8?^O=?_ $)J] KS_P"('_(9A_Z]U_\ 0FH VOA__P @:;_KX;_T%:Z:
MN9^'_P#R!IO^OAO_ $%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 5Y_\0/^0S#_ ->Z_P#H35Z!7G_Q _Y#,/\
MU[K_ .A-0!M?#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O/_B!_R&8?^O=?_0FKT"O/_B!_R&8?^O=?_0FH VOA_P#\
M@:;_ *^&_P#05KIJYGX?_P#(&F_Z^&_]!6NFH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ^??VNE/]E^&FQP)IQ_XZG^%?--?4/[6T.[PKH<O]V]9?SC)_\ 9:^7
MJ_$>)U;-*C[J/Y(_=^%97RJFNSE^;"BBBOE3ZX**** "BBB@ HHHH ]H_91F
M\OXB7Z'_ )::9(!]1+$?Y9KZPKX__9CN/)^*4*9QYMI,GUX#?^RU]@5^S<)R
MYLNMVD_T/Q#B^/+F=^\5^H4445]D?$A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5^6OQTF$WQF\;,O0:Q=+^4K _P J_4JORB^*%S]L^)GB
MVXSGS=7NY,_69S7W/"B_?57Y+\SYS.G^[@O,YFBBBOTH^2"BBB@ HHHH ***
M* "OTL_97C$?P!\(@=/)F;GWGD/]:_-.OTW_ &:X6@^!?@Y6ZFRW?@78C]#7
MQ?%3_P!D@O[WZ,^@R7^/+T_5'IE%%%?F!]@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
M_P#$#_D,P_\ 7NO_ *$U>@5Y_P#$#_D,P_\ 7NO_ *$U &U\/_\ D#3?]?#?
M^@K735S/P_\ ^0--_P!?#?\ H*UTU !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\0/\
MD,P_]>Z_^A-7H%>?_$#_ )#,/_7NO_H34 ;7P_\ ^0--_P!?#?\ H*UTU<S\
M/_\ D#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7G_ ,0/^0S#_P!>Z_\ H35Z!7G_ ,0/^0S#_P!>Z_\ H34 ;7P_
M_P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@K734 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %4M:TN+6]'OM.G_ -3=P/ _&>&4J?YU=HJ914DXO9E1DXM2CNC\
M[KZSETZ^N+2==LT$C1.OHRD@C\Q4%>C_ +07AL^'?BAJ;*NV"_VWL?OO^_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7YN_M7>.O\ A./C/J_E2>99:5C38,'C]V3YA_&0OSZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O/_B!_R&8?^O=?_0FKT"O/
M_B!_R&8?^O=?_0FH VOA_P#\@:;_ *^&_P#05KIJYGX?_P#(&F_Z^&_]!6NF
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** /&/VC/AGJ7CBWT2ZT6S-YJ$$K
M0.BLJ_NV&0Q+$  %?_'JXWPO^R=?W&R7Q!J\5FG!-O9+YC_0N< 'Z!J^EY&,
M<;,%9RH)VKU/L*^._'G[>EVLTUKX4\,K;%&V_:=:8EQV(,*$!2#_ +9^E>;2
MX1I9SC)XA0<GI?6R72_1]/\ @'N?ZUXK*\''"QFHI7L[7?>W5=>Q]%>%_@CX
M.\)['M])CO+E?^7B_P#WS_7!^4'W %4/&W[1GP\^'ZR17_B&VN+N/(^Q:;_I
M,NX?PD)D(?\ ?*U^?_C;XW>./B()(]<\1WES:N,-9PL(;<C.<&- %;ZD$^]<
M/7Z;E_!M#"Q2FU%=HJWX_P# /@\;Q'7Q4N9MR?>3O^!];^./V][R8O#X1\.Q
MVR9XO-7?>Y&/^>2$!3_P-A[5\^^-OC/XV^(F]->\1WMY;OP;1'$5N>>,Q( I
M^I&:XJBOM,-EF#PFM*FK]]W][/FZV,KU_CEH%%%%>H<84444 %?H7^QO\1O^
M$T^%,6EW$N_4= <63[CR82,PM]-H*?\ ;.OSTKU_]EOXG?\ "M?BK8-<2B/2
M=5Q87FXX50Q&R0^FU\9/H6KP,[P?US!R45[T=5\O\T>GE^(^KUTWL]&?I)11
M17XV?>A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5Y_P#$#_D,P_\ 7NO_ *$U>@5Y_P#$#_D,
MP_\ 7NO_ *$U &U\/_\ D#3?]?#?^@K735S/P_\ ^0--_P!?#?\ H*UTU !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 52UK2;7Q!H]]IE['YUG>0/;S1_WD
M=2K#\B:NT4TW%W0GKHS\F_'W@^[^'_C+5_#U[S<:?<-#OQC>O5''LRE6'UK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]\,7^*_Q-TS29(V;3(3]KU!AT$"$97/^T2J?\"SVK].HXUAC5$5410%55&
M.@ KP?\ 8]^%)\ ?#E=8O8MFL:]LN7W#YH[?'[I/8D$L?]X#M7O5?D.?8[ZY
MBW&+]V&B]>K_ *['W.68;V%&[WEK_D%%%%?-'KA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Y_\0/\ D,P_]>Z_^A-7H%>?_$#_ )#,/_7NO_H34 ;7P_\
M^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?^@K734 %%%% !1110 4444 %%%%
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M0FSTX-]1YDF/NH#^+$8'<C\[/%_B_5O'?B&[UO6[M[W4+IMSR-T [*H[*!P
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MP_\ ^0--_P!?#?\ H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9GTVX):WF]]O\+?[2X/U'%?%YGP[3Q%ZN%]V7;H_\OR/H,'FLJ5H5M5WZ_\
M!/U$HKR;X/\ [2GA+XN10VT-P-(UYA\^E7C@,Q[^4W20=>GS<<J*]9K\XKX>
MKAING6C9H^KIU(5H\]-W04445SFH4444 %%%% !1110 4444 %%%% !1110
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M ':I***_*3[4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "O/_B!_R&8?^O=?_0FKT"O/_B!_R&8?^O=?_0FH VOA_P#\@:;_ *^&_P#0
M5KIJYGX?_P#(&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KQ/]I+]GFU^,&AG4--2.V\5V49^SS'"BY0<^2Y_
M]!8]"?0FO;**Z</B*F%JJM2=FC&K2A6@Z<U=,_(74M.NM'U"XL;VWDM;RWD:
M*:&5=K(X."I'8@U6K] ?VG/V:X?BC8R>(/#\,<'BRW3YTX5;] .$8] X'W6/
MT/&"OP)>6<^GW4UK=0R6]S"YCEAE4JZ,#@J0>00>U?L>6YE2S&ESPTDMUV_X
M'8^#Q>$GA)\LMNC(:***]<X0HHHH **** "BBB@ HHHH **** '1R-%(KHQ1
MU.593@@CN*^BOA#^V=XB\%K#IWBF.3Q-I"X43L^+R%?9CQ(/9N?]H5\YT5QX
MK!T,9#DKQNOZV9O1KU,/+FINQ^J?P[^+?A7XI6/VCP[JT5W(J[I;1_DN(?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_P"('_(9A_Z]U_\
M0FKT"O/_ (@?\AF'_KW7_P!":@#:^'__ "!IO^OAO_05KIJYGX?_ /(&F_Z^
M&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;/KXQ4$HQ5D@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KS_P"('_(9A_Z]U_\ 0FKT"O/_ (@?\AF'_KW7_P!"
M:@#:^'__ "!IO^OAO_05KIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6^([F+Z/CD?[+ CVKXT^+'['?BWP'YU]H8;Q3HZY;=:QXNHA_M1<[OJF>A)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\_^('_(9A_Z]U_]":O0*\_^('_(9A_Z]U_]":@#
M:^'_ /R!IO\ KX;_ -!6NFKF?A__ ,@:;_KX;_T%:Z:@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#S/XG?L[^"?BJ)9]3TP6>JN.-3L,13Y]6XP__ @?;%?(
MOQ._8V\9^"?-N]$4>*]+7G=9H5N5'^U#DD_\ +?05^@U%>Y@LYQ>!M&,KQ[/
M5?+L>=B,OH8C5JS[H_("XMY;2>2&>)X9HSM>.12K*1U!!Z&HZ_5#X@?!WPA\
M3H2OB#1+>[GQA;Q!Y=PGIB1<-CV.1[5\O_$+]@_4K-I;GP9K,>H0]18ZGB.8
M#T$@&UC]0M?=X/B/"8BT:WN/SV^__.Q\W7RFO2UA[R_'[CY/HKH/&'P_\2>
M+W[+XAT6[TJ4G"F>,['_ -QQ\K#W4FN?KZF$XU(J4'=>1XTHN+M)6844459(
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%=QX!^"GC3XF2(=!T*XGM6.#?3#RK<>O[QL X]!D^U95*M.C'
MGJ227GH7"$JCY8*[.'K0T'P[JGBC4H[#2-/N=3O9/NP6L32.?? '3WZ5]@_#
MS]@_3[/RKKQGK+ZA(,%M/TS,<7T:0C<P^@4^]?2WA/P3H/@7318:!I-KI5KW
M6WC +GU9NK'W))KY+&<38:C>.'7._N7^?];GMT,HJU-:KY5^)\>?#/\ 89UO
M6&AO/&=^NB6G!-A9LLMRP]"W*)^&[Z"OK3P#\+O"_P ,=.^R>'=(@L PQ)<8
MW3S?[\A^9N>V<#L!75T5\)C<TQ6/TJRT[+1?UZGTF'P='#? M>_4****\D[@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O/_B!_P AF'_KW7_T)J] KS_X@?\ (9A_
MZ]U_]":@#:^'_P#R!IO^OAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\ $#_D
M,P_]>Z_^A-7H%>?_ ! _Y#,/_7NO_H34 ;7P_P#^0--_U\-_Z"M=-7,_#_\
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M?R_X)SO*,,^_WGYO/^R'\65=E'A8. <!EU&TP??F6D_X9%^+/_0J?^5&T_\
MCM?I%16O^M.-_DC]S_\ DB/[&P_\S_#_ "/S=_X9%^+/_0J?^5&T_P#CM3V_
M['GQ5F3<_AZ& YQMDU"W)^O#FOT;HI?ZTXW^6/W/_,/[&P_=_A_D?GK9?L4_
M$RZQYMKIMGG/^NO5./\ O@-6]8_L%^-Y<&ZUO0;<''$<LTA'KG]V!D?6ONRB
ML9<2X^6UE\O\S191AEO=_,^-M+_X)^W3,#J/C2&(?W;73R^?Q:08_*NQTO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O/_B!_R&8?^O=?_0FKT"O/_B!_R&8?^O=?_0FH VOA_P#\@:;_ *^&
M_P#05KIJYGX?_P#(&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KS_ .('_(9A_P"O=?\ T)J] KS_ .('_(9A_P"O
M=?\ T)J -KX?_P#(&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_^('_(9A_Z]U_]
M":O0*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\ KX;_ -!6NFKF?A__ ,@:;_KX
M;_T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MO/\ X@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX
M;_T%:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KS_X@?\AF'_KW7_T)J] KS_X@?\AF'_KW7_T)
MJ -KX?\ _(&F_P"OAO\ T%:Z:N9^'_\ R!IO^OAO_05KIJ "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_P#B!_R&8?\ KW7_ -":
MO0*\_P#B!_R&8?\ KW7_ -":@#:^'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"O
MAO\ T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV2JX/- 'K]%%<1\4/C-X1^#NFPWGBC54LC/D6]LBF2>?&,[$') R,D\#(YH
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M ->Z_P#H35Z!7G_Q _Y#,/\ U[K_ .A-0!M?#_\ Y TW_7PW_H*UTU<S\/\
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M2'6&0H/+!Y<*$92N,DG?@8ZU[?\ "_XH:!\7O"<'B#P[<M/9R,8Y(Y%VRP2
M M&Z]F&1TR#D$$@UY9!\?/B!:P1P0_ ;78H8U")&E]$%50,  ;.!BN;_ &-O
M WBOP;XJ^(]QJ_A>Z\+:%JUU'=6%E=."(OWDQ"*!UVHR@G ^ZM '7_$3]J>U
M\-^-KKP?X3\)ZMX^\26:%[RWTL8BM^!\K.%8Y&0#\N 2!G/%=)\'OC=)\4-0
MU;2=2\):QX.US3$CEFLM4CP&C<L%9&(!/W3U4>V><>&>(-)\>_LP?&GQ?XXT
M?PS)XT\&^)IFNKP6F3/;$N7.< E=K,_."I4C)!Z>]_!CX_>$_CEIL\^@7$L5
M]:A3=:;>($GAST. 2&7(^\I/O@\4 >DT444 %%%% !1110 4444 %>">)/VI
MO^$>\1:KI7_",?:/L-W+:^=_:&W?L<KNQY1QG&<9->]U\%?$G_DHGBG_ +"M
MU_Z.:OC>)<PQ.7TJ<L-+E;;OHGT\TS[;A?+L+F-:K#%0YDDK:M=?)H]I_P"&
MOO\ J4__ "I?_:J]Z\-ZQ_PD/AW2M5\G[/\ ;K6*Z\G=NV;T#;<X&<9QG K\
M^:^]?AM_R3OPM_V"K7_T2M</#6:8S,*U2.)GS))6T2Z^21Z'%&4X++J-*>%A
MRMMWU;Z>;9T=?'/P;TFQUC]MSXL17]E;WT2VDK+'<Q+(H;SK<9 (//)_.OL:
MO@C2_A/!\8/VP?B?I5QKFJ:"MNLET+C291'(Q#PKM)(/R_/GZ@5^@'YR?;L?
M@KP]#(DD>@Z9'(A#*RV<8((Z$';UKCOC]\;K7X"^#;/Q!=Z7-J\=S?QV"P0R
MB,@LDC[B2#P!&>/4BN4^'?[*-E\/?&6F^(8O''BG5)+)F86E]>*T,FY&7# +
MR/FS^%<?_P %%O\ DB>B?]C#!_Z37- 'U!9W(O+."X4%5EC60 ]1D9KS'X;_
M ![LOB/\3O&G@VWTF>RF\-3-$]W)*K+/MD,9(4#Y>0<<GCTKT703G0].(Y'V
M:/\ ]!%?*?[+O_)U'QP_Z_)__2MZ /7OB3^TEH/PK^)VD^$]=MWMK:]TV;4I
M-6:4".!464A-F,LS>20 .264 '-8/PA_:HE^+7CF'1H_ FL:-H]Y#)/8ZU>$
M^7.J#/(V!1D?W7;DUYA^TGX7T[QI^V3\,-&U>#[5IMUI\7GP$X$BK-<-M/L2
MH!]B:^Q56.SMPL<82*),+'&O0 <  ?RH \:^+'[4WA[X:^)X_"UAIFH^+_%C
M]=)T>+>\>5W .<'DKSM4,<<D#BN7T7]M2PL_$5GI'C[P5KGP\>[8K%=:G&QA
MSQRQ*(VWD?, 0,C/'(Y+]@.UB\42>/\ QSJ&+GQ!?ZCY3W$AW.B,/-8 ]@S,
M,_[@]*]._;0\,V'B#]GOQ)/=PHUQIHBO+69@-T<@D53@^ZLR_C0!ZWXJ\11>
M%?"FL:[)&US!IME->M'&0#(L<9<@'W KP"']M[0]6\,Z)/H/A?5O$?BK4XY)
M3X;TL>?+;*DC)F5U4XSMW !2<,"0 1G3\!ZQ=:[^Q"UW>-(]Q_PB=["6E.69
M8XI8U.>^505E?L"^&M,T_P""*:Q;V44>IZC>3"ZNL9DD5'*HI/H!V'&23U-
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M^"9IG6**/3 [R.<*J@L22>PQ7GM]^VW9ZEX@O+'P3X"\0^.;&R?;<:AIL3;
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M$7Q#'X7UK3+[P9XN9O+&FZFI"R28SL5R 0W^RZJ3QC)KBO\ @HS_ ,DA\/\
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M(S&%?:Z[-I3@L&/?MTK[/^'DC3> /#,CL6=M,M69CW)B7F@#H:*** "BBB@
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M"[8U8D'; IXX^:I_VLOCM\)?C'\)+C3=(\4+=Z_97$=Y81G3[J/>P.UTW-$
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MPZFM7.@>!/">O>.IK%BDS>'[,-:Q?,1PX[9S\V-I[$T ;OP5_::T3XO:Y?\
MAZ;2K_POXJL5+S:1J:X<J" VTX!RI(RI /.<$9Q[)7PMX1\9:EXP_;P\,ZIJ
M/A:\\&WEU8S1S:???ZUPMG/AS\J]=J]OX:^Z: .,^+'Q6T3X-^$VU_71<R6[
M3+;0V]G%YDL\S E449 R0K'D@<5XI?\ [96O:/9G5M2^#/BJP\-J S:G,K+M
M4G[Q4Q!0.1@E\'/6O<_B5\0/#7PS\,MKWBFZBM;"WD7RMZ;Y&E.=HC7J7Z].
M@R> #7AOB#]J34O&?A'4_P"P_@_XNU;1+VTEC%]=6WE0R1,C OP&#+CT/XT
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M,D):WUK-)C^Z7V?S=: .<_8[_9_T5? MOX\\46$.O>)=>9[M)M003B"(L=I
M8$;VP6+]?F XYS[1\0O@%X$^)UCY&M^'K7SE;<E[9H(+F,Y[2* <>QR/:F_L
MZWD%]\"? ,MMM\M=%M8CM.1O2,(_X[E:O1* /.?C-\<M$^"NGZ;)J5GJ&J:A
MJDCPV&G:;#YDL[*!NZD  ;E]^> :\GO?VT-3\+M#=^+_ (1^*/#.A2R*@U&9
M6.W/JKQH >OR[LG%>P?%SXP>$?@UI=KJWB>?;-(S1V=O!$);F5L?,(UXP,8R
M20.1D\BOGWXX?M":WX[^$'B2Q7X1>*;/1[RS8-JFJ0>5' HPRRE=IR 0#G/8
M<T ?4*^-M-NO K^*]/E&HZ4;!M1A>$X\V,(7XST.!C!Z'K7A&F_MQ^']:\-:
M7/I7AC5]:\4:@9=GAO2E^TSQJC$;W91P#C( 4GOC'-6/V=YGN/V);5I&W,-(
MU50?837( _("LC_@GQX9TNS^$-WKD5E$NKWFH2P3WF,R-&@7:F>R@DG [F@#
ML/@_^U=I/Q,\82^$-6T#4?!OBI5+)IVI GS"JEF4$JI#!1NPRC(SBO0OBQ\5
MM$^#?A-M?UT7,ENTRVT-O9Q>9+/,P)5%&0,D*QY('%?/'[2UK'IG[6?P5U.W
M41W=U<PVTLBC!9!<!<'UXE85]'_$KX@>&OAGX9;7O%-U%:V%O(OE;TWR-*<[
M1&O4OUZ=!D\ &@#PR_\ VRM>T>S.K:E\&?%5AX;4!FU.967:I/WBIB"@<C!+
MX.>M>]_#WX@:-\3_  C8>(] N#<:;>*2N]=KHP)#(Z]F!!!_,9!!KP7Q!^U)
MJ7C/PCJ?]A_!_P 7:MHE[:2QB^NK;RH9(F1@7X#!EQZ'\:A_X)VS/+\$-65F
MRL>OSJ@]!]GMSC\R?SH [/XQ?M6:'\+O%4/A33M'U#Q?XKD +:7I8YBRNY58
MX)W$'.U5)QR<9&?!/VF/VD-.^)GP<U+PUJ>@:KX-\60W=K<?V1J\+*TD>XY9
M&*C./1@I[C/..I_8EMHO%7Q.^+/C"_4SZPU^(8Y9>7B2229G STSL0?1<5TW
M_!0#P[IM]\%TU>>RBDU2QOH4MKK'[R-7)#J#Z' X/&0#VH ]4T7QOI7PX^ &
M@^)-;EDBTS3]"LI)FB0NYS%&J@ =268#TYYQ7EDW[8VO36;:MIWP8\67?AQ5
M,G]I2(T?[L<[PHC92,9R=^!CK7K'AOQ#HOA3X$^'=6\17%O:Z/::'9RSR7(!
M0 0I@8[DG& .2<8YKSB']KZ;Q-%+<>#/A=XO\5:<I*I?QVOE02D'!VL WO[^
MH% 'J'P>^,?A_P"-OA,:YH#RJB2>3<VEPH6:WD !VL 2,8(((.#]00.ZKXY_
MX)^W<EQXA^+8:T;3D^W6L@L6&#;EGNLITZC '_ :^QJ "BBB@ HHHH ****
M"BBB@#SWQ5\6O^$9UZZTW^ROM/D;?WOVC9G<@;IL/KZUD_\ "^/^H'_Y-_\
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MD?M.6NN_#/\ :.\$_%>ST2\UC0[2T%K=_8D+LA'G*X/&%S'+QG@E3R*^OZ*
M/$[/Q%I_[6WP>\6Z;;Z3JWAZPNLV=O/JT*QL\BA9$D"@L"JN%R 3T//IY)\*
M_P!H#7OV=?#5OX$^)7@C7@=))AL]4TNW6>.:(DE1DE5(&<!E8\<$ @Y^QZ*
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M>)%;^T([%=TD#NP=\@ X(==RL0%(<KD'FOL>B@#YM\-_M4:_\5O%VA:3X$\
M:LFG/>P_VMJVMP^7';6VY?-V[6*[]N[;EL\#Y3GCB?BHVK_!#]K1OB;J?A[4
M/$'A/4+-8%NK"'S6LV\E8F Z!6!0G!(RKG!SFOLBB@#X;_:9^*WB/X^?#.>'
MPKX&UJV\)V-Q#<W6J:I:F.6XDW;(T@C4G<,N23SP!G;W^Q/A[$\/@'PS'(C1
MR)IELK(PP5(B7((]:Z"B@ HHHH **** "BBB@ HHHH P?'7A?_A-/"M]HWVK
M[']IV?O_ "]^W:ZO]W(SG;CKWKR7_AES_J9O_)#_ .VU[Q10!Y+X%^ O_"%^
M*K'6?[=^V?9M_P"X^R;-VY&3[WF'&-V>G:O6J** ."^/FGW6K?!3QQ:64$EU
M=3:/<K'#$I9W/EG@ =3["OE#]G[]I:Z^#?POT[PM>?#SQ)J-Q:RS2-<00%4;
M?(S@ %<\9K[LHH ^;I_B/J7[4GPB^(?A_2/"^K>&=2CL8U@_M,;!<LQ9O+4D
M#KY>T_[XZ5P?P,_:2B^$OPVT_P ":K\/?%)\5:69(A96.GY%R6D9@QR0P/.#
M\I]1GM]FT4 ?''[-NE^+V_:X\;:WXMT!]$O=1T1YWBC5FAB,DMHR1^9T+! ,
M\]0W Q@=1^W9X%U[Q!X5\+>(_#]A-J-SX=OVFEAMXS)(L;A3YFT<E0T2Y],Y
MZ U]/T4 >0_!3]HRR^-NJ7EG8>&-;T=;.V6:>YU*%5B\PL!Y2D$Y/)/.#@'B
MO-?@#H]_9_M:?&"[N+&Y@M)]WE3R0LJ2?OE/RL1@\>E?5%% 'RO_ &/?_P##
M?_\ :'V&Y^P?V/M^U>2WE9^SXQOQCKQUKV']HZUGOO@3XXM[:&2XGDTN4)%$
MI9F..@ Y->CT4 >/?LB6-SIO[.O@ZVO+>6UN$CN-T,R%'7-S*1D'D<$'\:]4
MUK5(]#T:_P!2F222*SMY+ATB4L[*BEB% ZG X%7:* /DC]C_ .%Y\9#QK\0/
M'?A^&ZU+7M2;R(-6LP_EJ"7=E61> 6<*/^N>*^BYOA)X'N(7B?P=H)1U*MC3
M80<$8ZA>*ZRB@#Y$_8YTW6OA3\4OB%\-M1LKP:7',UY8WDD+")]C!-P;&,R1
MM$W_  "M/X Z/?V?[6GQ@N[BQN8+2?=Y4\D+*DG[Y3\K$8/'I7U110!\U?M^
M:3?:Q\$]/AL+.XOIEUN!S';1-(P7R9QG !XR1^=?0/A>-HO#.D(ZE'6SA#*P
MP00@X-:E% 'RC^QUHFHZ5\6OC7+>V%U9Q3:HIB>XA9%D'GW1^4D<\$=/457^
M*7AKQ9\!?V@KGXL>&M!NO$_AK6;<0:Q968W2PDA0Q  )QF-'#8QG<I(!!KZV
MHH ^:&_;CTC4D6V\/_#_ ,8ZQK3C"V!L50;LXP65G;KZ*>OX5[-KUU?Z[\']
M1N;S39-/U2\T*22;3L^8\$SVY+19 ^8JQ*].<5V-% 'SO^PEIEYI/P)6"^M)
M[*?^T[AO+N(VC;!"8.".E'[=NEWFK? EX+&TGO9_[3MV\NWC:1L /S@#I7T1
M10!YY)X'C\>_ 6W\+7I>U&H:##:LQ7YHG,*X8@]U8 X]J^9_A#\<O$7[+OA^
M3P#\0O!6MSP:?-(;"_TR(2HZ.2^T,Q"LNXDA@V0&((XQ7VW10!X?\-_B#XT^
M.FF>,C=^%IO!GANYL#:Z+/?!ENI9'5U:4Y_A&4(PN!V9N:\,_9Y^,#_LR^'M
M6\#>,? WB)-:6_DN(9--L1*+K<J+C)9=WW>&&00>W?[CHH ^)O"K^,_&'[:?
M@OQ?X@\)W7AVSO;&X>U@=&9H;86MRD9G;HDC-GY3@C<HQZ_;-%% 'S/^W1\/
M?$'C+P1X?U/0M/EUE=#OFN;O384+M)&5 W[ ,L%VX('.')]:@N/VK+WXE>'W
M\.^ OA[K]SXFOH#:LNHVRPV5BS JQDD#?=49(SMSQT/%?3]% 'S-_P $_P#1
M;_0?@[K=MJ-E<6,__"03L$N(FC++]GMQN 8#(R",^QJA\ ='O[/]K3XP7=Q8
MW,%I/N\J>2%E23]\I^5B,'CTKZHHH \$_;>TV[U;]G_5+>RM9KR<WEJ1%;QE
MVP)!DX S76:-X('C;]FW2/"MZ&M6O_#%M9OYBD-#(;9 "1URK8./:O3Z* /B
M'X-_'C6_V8]%F^'7C[P9K=PVG3R&PN=,A$HD1V+8&XJ&0N20RD_>QC(JIXED
M^(?Q!_:$^$_C/Q'X9GT+2+G4ECT[3/+9YK2WCE0F2X.WY6<OGG'"] .3]TT4
M %<[\0O!%A\2/!.L>&=3R++4K=H6=0"T;=5<9[JP5A[@5T5% 'PS\/\ QU\2
M?V.5O?"GB;P?>>)O"*S/+9:CIX8HFXY)20 KM;EO+;:P))[UW,_[5/Q ^*6S
M2_A?\-M1@N)VVG6=;3%O;C/+' V9Z]7/3[K=*^K:* /E#]L#PQK^E_$KX>?$
M:QT2X\2Z)H$J_;+&V0R-'ME#[]H!P&'&[H"BYJK\4OVAM3^.7PXU_P ._#_P
M+KTZ7-C(VH:EJ]L((+:!4+2*FUFWR$#:%SU/ :OKFB@#YX_9[TJ]L_V,;:QN
M+.X@O?[,U5?LTD3+)EI[DJ-I&>01CUR*3]A+3+S2?@2L%]:3V4_]IW#>7<1M
M&V"$P<$=*^B** /E?]IK1M0O_P!I'X(W-M8W-Q;07\9FFAA9DC N8B2Q P..
M>:T/VZ/A[X@\9>"/#^IZ%I\NLKH=\US=Z;"A=I(RH&_8!E@NW! YPY/K7TQ1
M0!\P7'[5E[\2O#[^'? 7P]U^Y\37T!M674;98;*Q9@58R2!ONJ,D9VYXZ'BI
MO^"?^BW^@_!W6[;4;*XL9_\ A()V"7$31EE^SVXW ,!D9!&?8U],T4 ?$IO/
M$'[''QP\5:G+X=OM<\ >*)3.DVGJ7,3;V=5ST#J7==K$;@00>*H?M%?$;QK^
MT1\,[^Z\.>$-2T?P)IDL,\DVI0$7>HRF0(JQ1KN^5"Y8D$CY>2.A^Z:* /FW
MXX?#G7_B!^R/H>D:);33:K:V&G7+6"C$DRQQ*'C"GJPSNV]25QUXK ^'_P"U
ME]A\!:)X5TCX;^);OQE8V<5@NF1V0CMED1 @9GSE$)&3E1CG/K7UC10!\E_L
M.^'/$/A_QE\7QXCTY[#4);ZU\W;&PA>4/=&01L>&4%NH)X(YYKZTHHH ****
M "BBB@ HHHH **** //?%7PE_P"$FUZZU+^U?LWG[?W7V??C:@7KO'IZ5D_\
M*'_ZCG_DI_\ 9UZQ17P.)X#X<QE>>)KX:\YMR;YZBNV[MV4K;]CVZ>=8^E"-
M.%2R2LM([+Y%32+#^RM)LK+?YOV:!(?,QC=M4#..W2I+Z\CT^SN+J7=Y4$;2
MOL4L=JC)P!U/'2IZ*^ZI4XT:<:4%9122]$>-*3E)R>[/D/\ 9-^';?$?Q-\0
M/B/XW\/)--J]^8;.TU>T#>6N=[E5D7H 8D#8_@8>M?21^%/@DC!\':!C_L&0
M?_$UU5%:$GR!^RQHVK?!KX^>/_A[<6-XOA^Z9KK3[IH7,7R',?SXQEHI.>>L
M8%=7)^V='X3O+O3/&_P]\3Z+JUO(Z*ME;+/#.H8@,C.R<$8Z9'/6OI2B@#Y3
M_93\%ZUJOQ>\=_$^Y\.S^$M"UI&AL--N4,;R[Y$<R[,#_GGG/0F0XR*D^%>C
M:A;_ +=7Q,OY;&YBL9=(*QW3PL(G)-EP&(P3P?R-?5%% 'QCXNO=4_9Z_:TU
M[X@:[X<U+7?"VN6GD0ZC80><UON6(8[ ,IB*[202K9&>E<Y^U-\2/$_Q^^']
MLWA_P+K-CX.TZ_CN&O\ 4K8I<7-P4D1!%&I.4"NQ+<\D9V]#]XT4 4M$4IHM
M@K JPMXP01@CY15VBB@#Y1_9GT74+#]I[XTW5S875O:SWDQBFEA94D!NG(VL
M1@\<\5]7444 ?.7[<WPX\0?$+X4V)\/VD^IRZ7J"WD^GVZEI)8_+=-RJ.692
MW0<X+50TW]KR[\6:';Z/X(^'&OW/C!XU@6SN;58K"SDQC,DF[A%YQD+D#!*U
M].44 ?+G[ /AW4O#'P_\5V6IV<UG<1ZVR[9HV3=B*,$KD#(R.M<GJ]KXH_9+
M^//B;Q9:>'+[Q+X!\4.T]PU@FY[=V<R$' ^4HS.%W8#*W7(./L^B@#YU\&_M
M.^(?BYXXT73/!G@/5+;P]YX.K:SK</EK%" <J@5MN\]OF)_V>XP?%VC:A)_P
M4 \$Z@EC<M81Z/('NEA8Q*?L]V,%\8') Z]Q7U110!\_?MRZ7>:M\ [R"QM)
M[V?[?;-Y=O$TC8#'G '2O5/A#!+:_"?P5#-&T,T>B62/'(I5E80(""#T(-=;
M10!\K_L;Z-J&E_$SXX2WMC<VD=QK$1A>>%D$@$UX25)'/4=/45F?&KPKXL^"
M?[0D7QA\,:'<^)-$U" 0:O8VBDO'\BQL,*"0I"(X;! 92#@$9^NZ* /F&#]K
MS7?B-J%AH_PY^'>LW&H33QK=7FM0!+>TCW#>QV,1TS@LR_0]*^GJ** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/\ X@?\AF'_ *]U
M_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX;_T%:Z:N9^'_ /R!
MIO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KS_X@?\AF'_KW7_T)J] KS_X@?\AF'_KW7_T)J -KX?\ _(&F_P"O
MAO\ T%:Z:N9^'_\ R!IO^OAO_05KIJ "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *\_P#B!_R&8?\ KW7_ -":O0*\_P#B!_R&8?\
MKW7_ -":@#:^'_\ R!IO^OAO_05KIJ\[T/Q0WAVVEM6M/.;S2Q/F;<' &.A]
M*T?^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^
MQH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &-
M'9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1
MO_L:/^%B?]0__P C?_8T =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V
M=%<9_P +$_ZA_P#Y&_\ L:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\
M[&C_ (6)_P!0_P#\C?\ V- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T
M =G17&?\+$_ZA_\ Y&_^QH_X6)_U#_\ R-_]C0!V=%<9_P +$_ZA_P#Y&_\
ML:/^%B?]0_\ \C?_ &- '9T5QG_"Q/\ J'_^1O\ [&C_ (6)_P!0_P#\C?\
MV- '9T5QG_"Q/^H?_P"1O_L:/^%B?]0__P C?_8T =G7G_Q _P"0S#_U[K_Z
G$U7?^%B?]0__ ,C?_8UAZSJ4GB:_66.W\IDB"[=^>A)SG ]: /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>iart-20221231_g2.jpg
<TEXT>
begin 644 iart-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2%![X# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?_ ! _Y#,/
M_7NO_H35Z!7G_P 0/^0S#_U[K_Z$U &U\/\ _D#3?]?#?^@K735S/P__ .0-
M-_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7G_Q _Y#,/\ U[K_ .A-7H%>?_$#_D,P_P#7NO\ Z$U &U\/_P#D#3?]
M?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9.L:R^FWVG0+&KBZ
MDV,2?N\J./SK6KF?%7_(9T#_ *^/_9DKIJ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH HZUJ#:7ID]TB!VC PK=#D@?UJ;3[HWEC;W#*%,L:N5
M';(S6?XN_P"1=O/HO_H0JSH/_(%L?^N"?R% %^BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R=)UE]1U#4+9HU1;5]H8'D\D<_E6M7,^&/^0]KO
M_7;_ -F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)NM9>
MWU^TT\1J4F0L7SR/O?X5K5S.I?\ (\:9_P!<3_)Z .FHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "LKQ%K#Z)8K<)&LA,@3:QQU!/\ 2M6N:\??
M\@6/_KNO\FH Z13N4'U%+38_]6OTIU !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 9/AW67UJUEE>-8RDA3"G/8'^M:U<SX"_Y!MS_U\'_T$5TU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9,.LO+XBGTXQJ$CC
MWA\\GA?\:UJYFT_Y'R]_Z]Q_)*Z:@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** ,G6M9?2[K3XEC5Q<R;"6/3D#^M:U<SXN_P"0EH?_ %\?^S)7
M34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!1UK4&TO3)[I$#M
M&!A6Z') _K4VGW1O+&WN&4*98U<J.V1FL_Q=_P B[>?1?_0A5G0?^0+8_P#7
M!/Y"@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9.DZR^HZAJ
M%LT:HMJ^T,#R>2.?RK6KF?#'_(>UW_KM_P"S-0!TU%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5DW&LO#XBM=.$:E)HRY?/(X;_ .)K6KF;_P#Y
M'S3?^O<_RDH Z:BBB@ HHHH **** "BBB@ HHHH *\_^('_(9A_Z]U_]":O0
M*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\ KX;_ -!6NFKF?A__ ,@:;_KX;_T%
M:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH YGQ5_R&= _Z^/_ &9*Z:N9\5?\AG0/^OC_ -F2NFH
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M** "BBB@ HHHH **** "N:\??\@6/_KNO\FKI:YKQ]_R!8_^NZ_R:@#HX_\
M5K]*=38_]6OTIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <S
MX"_Y!MS_ -?!_P#01735S/@+_D&W/_7P?_01734 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!S-I_R/E[_ ->X_DE=-7,VG_(^7O\ U[C^25TU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <SXN_P"0EH?_ %\?
M^S)735S/B[_D):'_ -?'_LR5TU !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 8_B[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(56\7?\B[>?1?_0A5G0?^
M0+8_]<$_D* +]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/AC
M_D/:[_UV_P#9FKIJYGPQ_P A[7?^NW_LS4 =-1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<S?_ /(^:;_U[G^4E=-7,W__ "/FF_\ 7N?Y24 =
M-1110 4444 %%%% !1110 4444 %>?\ Q _Y#,/_ %[K_P"A-7H%>?\ Q _Y
M#,/_ %[K_P"A-0!M?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <SXJ_Y#.@?]?'_LR5TU<SXJ_P"0SH'_ %\?^S)734 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!C^+O\ D7;SZ+_Z$*LZ#_R!
M;'_K@G\A5;Q=_P B[>?1?_0A5G0?^0+8_P#7!/Y"@"_1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<SX8_Y#VN_]=O_ &9JZ:N9\,?\A[7?^NW_
M +,U '34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,ZE_R/&F?
M]<3_ ">NFKF=2_Y'C3/^N)_D] '34444 %%%% !1110 4444 %%%% !1110
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M\A0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7?\
MKM_[,U=-7,^&/^0]KO\ UV_]F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KF;_ /Y'S3?^O<_RDKIJYF__ .1\TW_KW/\ *2@#IJ*** "B
MBB@ HHHH **** "BBB@ KS_X@?\ (9A_Z]U_]":O0*\_^('_ "&8?^O=?_0F
MH VOA_\ \@:;_KX;_P!!6NFKF?A__P @:;_KX;_T%:Z:@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MGQ5_R&= _P"OC_V9*Z:N9\5?\AG0/^OC_P!F2NFH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#'\7?\B[>?1?_ $(59T'_ ) MC_UP3^0JMXN_
MY%V\^B_^A"K.@_\ (%L?^N"?R% %^BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YGPQ_P A[7?^NW_LS5TU<SX8_P"0]KO_ %V_]F:@#IJ*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF=2_Y'C3/^N)_D]=-7,ZE_
MR/&F?]<3_)Z .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:\
M??\ (%C_ .NZ_P FKI:YKQ]_R!8_^NZ_R:@#HX_]6OTIU-C_ -6OTIU !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 <SX"_Y!MS_P!?!_\ 0173
M5S/@+_D&W/\ U\'_ -!%=-0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% ',VG_(^7O_ %[C^25TU<S:?\CY>_\ 7N/Y)734 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!S/B[_D):'_U\?^S)735S/B[_ )"6A_\
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M !1110 4444 %>?_ ! _Y#,/_7NO_H35Z!7G_P 0/^0S#_U[K_Z$U &U\/\
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M_7!/Y"JWB[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(4 7Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KF?#'_ "'M=_Z[?^S-735S/AC_ )#VN_\ 7;_V
M9J .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9O_ /D?--_Z
M]S_*2NFKF;__ )'S3?\ KW/\I* .FHHHH **** "BBB@ HHHH **** "O/\
MX@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX;_T%
M:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH
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MGPY_YX:W_P" B?\ QRC^R<?_ ,^9?<'U[#?\_$?0M%?/7_#<GPY_YX:W_P"
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M:G<2PZQY=Q)N3;:H3C+'G]Y[T?V3C_\ GS+[@^O8;_GXCZ>HKYZ_X;D^'/\
MSPUO_P !$_\ CE'_  W)\.?^>&M_^ B?_'*/[)Q__/F7W!]>PW_/Q'T+17SU
M_P -R?#G_GAK?_@(G_QRC_AN3X<_\\-;_P# 1/\ XY1_9./_ .?,ON#Z]AO^
M?B/H6BOGK_AN3X<_\\-;_P# 1/\ XY1_PW)\.?\ GAK?_@(G_P <H_LG'_\
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M!G_/+5/_  '7_P"+H_MK+O\ G_'[P_L/,_\ GQ+[CV"BO'_^&I?!G_/+5/\
MP'7_ .+H_P"&I?!G_/+5/_ =?_BZ/[:R[_G_ !^\/[#S/_GQ+[CNK3_D?+W_
M *]Q_)*Z:O!H/VC_  G'XHN-0,>H^1)$$'[A=V<+VW>QK9_X:E\&?\\M4_\
M =?_ (NC^VLN_P"?\?O#^P\S_P"?$ON/8**\?_X:E\&?\\M4_P# =?\ XNC_
M (:E\&?\\M4_\!U_^+H_MK+O^?\ '[P_L/,_^?$ON/8**\?_ .&I?!G_ #RU
M3_P'7_XNC_AJ7P9_SRU3_P !U_\ BZ/[:R[_ )_Q^\/[#S/_ )\2^X]@HKQ_
M_AJ7P9_SRU3_ ,!U_P#BZ/\ AJ7P9_SRU3_P'7_XNC^VLN_Y_P ?O#^P\S_Y
M\2^X]@HKQ_\ X:E\&?\ /+5/_ =?_BZ/^&I?!G_/+5/_  '7_P"+H_MK+O\
MG_'[P_L/,_\ GQ+[CV"BO'_^&I?!G_/+5/\ P'7_ .+H_P"&I?!G_/+5/_ =
M?_BZ/[:R[_G_ !^\/[#S/_GQ+[CV"BO'_P#AJ7P9_P \M4_\!U_^+H_X:E\&
M?\\M4_\  =?_ (NC^VLN_P"?\?O#^P\S_P"?$ON/8**\?_X:E\&?\\M4_P#
M=?\ XNC_ (:E\&?\\M4_\!U_^+H_MK+O^?\ '[P_L/,_^?$ON/8**\?_ .&I
M?!G_ #RU3_P'7_XNC_AJ7P9_SRU3_P !U_\ BZ/[:R[_ )_Q^\/[#S/_ )\2
M^X[KQ=_R$M#_ .OC_P!F2NFKP;7OVC_">I7FFRQ1ZB%MY=[[H%'&5/'S>U;/
M_#4O@S_GEJG_ (#K_P#%T?VUEW_/^/WA_8>9_P#/B7W'L%%>/_\ #4O@S_GE
MJG_@.O\ \71_PU+X,_YY:I_X#K_\71_;67?\_P"/WA_8>9_\^)?<>P45X_\
M\-2^#/\ GEJG_@.O_P 71_PU+X,_YY:I_P" Z_\ Q=']M9=_S_C]X?V'F?\
MSXE]Q[!17C__  U+X,_YY:I_X#K_ /%T?\-2^#/^>6J?^ Z__%T?VUEW_/\
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M ,-2^#/^>6J?^ Z__%T?\-2^#/\ GEJG_@.O_P 71_;67?\ /^/WA_8>9_\
M/B7W'L%%>/\ _#4O@S_GEJG_ (#K_P#%T?\ #4O@S_GEJG_@.O\ \71_;67?
M\_X_>']AYG_SXE]Q[!17C_\ PU+X,_YY:I_X#K_\71_PU+X,_P">6J?^ Z__
M !=']M9=_P _X_>']AYG_P ^)?<>P45X_P#\-2^#/^>6J?\ @.O_ ,71_P -
M2^#/^>6J?^ Z_P#Q=']M9=_S_C]X?V'F?_/B7W'L%<SX8_Y#VN_]=O\ V9JX
M7_AJ7P9_SRU3_P !U_\ BZQM%_:/\)Z?JFIW$L>H^7<2;DVP*3C+'GYO>C^V
MLN_Y_P ?O#^P\S_Y\2^X]YHKQ_\ X:E\&?\ /+5/_ =?_BZ/^&I?!G_/+5/_
M  '7_P"+H_MK+O\ G_'[P_L/,_\ GQ+[CV"BO'_^&I?!G_/+5/\ P'7_ .+H
M_P"&I?!G_/+5/_ =?_BZ/[:R[_G_ !^\/[#S/_GQ+[CV"BO'_P#AJ7P9_P \
MM4_\!U_^+H_X:E\&?\\M4_\  =?_ (NC^VLN_P"?\?O#^P\S_P"?$ON/8**\
M?_X:E\&?\\M4_P# =?\ XNC_ (:E\&?\\M4_\!U_^+H_MK+O^?\ '[P_L/,_
M^?$ON/8**\?_ .&I?!G_ #RU3_P'7_XNC_AJ7P9_SRU3_P !U_\ BZ/[:R[_
M )_Q^\/[#S/_ )\2^X]@HKQ__AJ7P9_SRU3_ ,!U_P#BZ/\ AJ7P9_SRU3_P
M'7_XNC^VLN_Y_P ?O#^P\S_Y\2^X]@HKQ_\ X:E\&?\ /+5/_ =?_BZ/^&I?
M!G_/+5/_  '7_P"+H_MK+O\ G_'[P_L/,_\ GQ+[CV"BO'_^&I?!G_/+5/\
MP'7_ .+H_P"&I?!G_/+5/_ =?_BZ/[:R[_G_ !^\/[#S/_GQ+[CV"N9O_P#D
M?--_Z]S_ "DKA?\ AJ7P9_SRU3_P'7_XNKO@_P")FD?$CQK#+I*W*K:P[9/M
M$80Y(D(Q@FMJ.:8+$5%2I54Y/HF85\IQV&INK6HN,5NVCU.BBBO4/)"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %;W@7_D:+3_ '9?_135@UO>!?\ D:+3_=E_]%-7SO$?_(DQ
MO_7JI_Z0SW<A_P"1OA/^OD/_ $I'IM%%%?P,?VP%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>X?LK?\ (T7_ /NI_P"@2UX?7N'[*W_(T7_^
MZG_H$M?2\.?\C6C\_P#TEGR_$W_(IK?]N_\ I2/JBBBBOW,_ @HHHH ****
M"BBB@ HHHH *\_\ B!_R&8?^O=?_ $)J] KS_P"('_(9A_Z]U_\ 0FH VOA_
M_P @:;_KX;_T%:Z:N9^'_P#R!IO^OAO_ $%:Z:@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_:/\
M^2<ZU_V"K[_T37YIU^EG[1__ "3G6O\ L%7W_HFOS3K]*X4_@5?5?D?)9U_$
MAZ!1117W)\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %;W@7_D:+3_=E_P#135@UO>!?^1HM/]V7_P!%-7SO$?\ R),;
M_P!>JG_I#/=R'_D;X3_KY#_TI'IM%%%?P,?VP%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP8_=[]3V /0**** "BBB@ HHHH **Q?&TC1>#-?=&*.NGW!5E.""(VY%?/\
M_P $^[R>\^"&H/<323N-<G4-(Y8@>3!QS]30!]-4444 %%%% !1110 4444
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MQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP,[<;E (.W[P)%>S_'_X]0_"OX,IXMTQ5N;W5!#%I23(2A>5"X9P#T"!F]R
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MI7"G\"KZK\CY+.OXD/0****^Y/G HHHH **** "BBB@ HHHH **** "BBB@
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MCAJ?LXN^[N]VV[MF-6HZLN9_U8****Z3(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "M[P+_ ,C1:?[LO_HIJP:WO O_ "-%I_NR_P#HIJ^=XC_Y
M$F-_Z]5/_2&>[D/_ "-\)_U\A_Z4CTVBBBOX&/[8"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M10 4444 %%%% !1110 5[A^RM_R-%_\ [J?^@2UX?7N'[*W_ "-%_P#[J?\
MH$M?2\.?\C6C\_\ TEGR_$W_ "*:W_;O_I2/JBBBBOW,_ @HHHH **** "BB
MB@ HHHH *\_^('_(9A_Z]U_]":O0*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\
MKX;_ -!6NFKF?A__ ,@:;_KX;_T%:Z:@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_:/_ .2<ZU_V
M"K[_ -$U^:=?I9^T?_R3G6O^P5??^B:_-.OTKA3^!5]5^1\EG7\2'H%%%%?<
MGS@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5O>!?^1HM/]V7_P!%-6#6]X%_Y&BT_P!V7_T4U?.\1_\ (DQO_7JI_P"D
M,]W(?^1OA/\ KY#_ -*1Z;1117\#']L!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7N'[*W_(T7_^ZG_H$M>'U[A^RM_R-%__ +J?^@2U]+PY
M_P C6C\__26?+\3?\BFM_P!N_P#I2/JBBBBOW,_ @HHHH **** "BBB@ HHH
MH *\_P#B!_R&8?\ KW7_ -":O0*\_P#B!_R&8?\ KW7_ -":@#:^'_\ R!IO
M^OAO_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_:/_Y)SK7_
M &"K[_T37YIU^EG[1_\ R3G6O^P5??\ HFOS3K]*X4_@5?5?D?)9U_$AZ!11
M17W)\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %;W@7_ )&BT_W9?_135@UO>!?^1HM/]V7_ -%-7SO$?_(DQO\ UZJ?
M^D,]W(?^1OA/^OD/_2D>FT445_ Q_; 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*^SJ*/\ 6#,?^?GX+_(/[+PG\OXO_,^,?^'?NH?]#I;?^"]O_CE'_#OW4/\
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M;?\ @O;_ ..5]G44?ZP9C_S\_!?Y!_9>$_E_%_YGQC_P[]U#_H=+;_P7M_\
M'*/^'?NH?]#I;?\ @O;_ ..5]G44?ZP9C_S\_!?Y!_9>$_E_%_YGQC_P[]U#
M_H=+;_P7M_\ '*/^'?NH?]#I;?\ @O;_ ..5]G44?ZP9C_S\_!?Y!_9>$_E_
M%_YGQC_P[]U#_H=+;_P7M_\ '*/^'?NH?]#I;?\ @O;_ ..5]G44?ZP9C_S\
M_!?Y!_9>$_E_%_YGQC_P[]U#_H=+;_P7M_\ '*/^'?NH?]#I;?\ @O;_ ..5
M]G44?ZP9C_S\_!?Y!_9>$_E_%_YGQC_P[]U#_H=+;_P7M_\ '*/^'?NH?]#I
M;?\ @O;_ ..5]G44?ZP9C_S\_!?Y!_9>$_E_%_YGQC_P[]U#_H=+;_P7M_\
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M+!_X!M_\77TK11_JSE?_ #Z_\FE_F'^M.;?\_?\ R6/^1\U?\,BWG_0RP?\
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M (!M_P#%T?\ #(MY_P!#+!_X!M_\77TK11_JSE?_ #Z_\FE_F'^M.;?\_?\
MR6/^1\U?\,BWG_0RP?\ @&W_ ,71_P ,BWG_ $,L'_@&W_Q=?2M%'^K.5_\
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M_P#GU_Y-+_,/]:<V_P"?O_DL?\CYJ_X9%O/^AE@_\ V_^+H_X9%O/^AE@_\
M -O_ (NOI6BC_5G*_P#GU_Y-+_,/]:<V_P"?O_DL?\CYJ_X9%O/^AE@_\ V_
M^+H_X9%O/^AE@_\  -O_ (NOI6BC_5G*_P#GU_Y-+_,/]:<V_P"?O_DL?\CY
MJ_X9%O/^AE@_\ V_^+H_X9%O/^AE@_\  -O_ (NOI6BC_5G*_P#GU_Y-+_,/
M]:<V_P"?O_DL?\CYJ_X9%O/^AE@_\ V_^+H_X9%O/^AE@_\  -O_ (NOI6BC
M_5G*_P#GU_Y-+_,/]:<V_P"?O_DL?\CYJ_X9%O/^AE@_\ V_^+H_X9%O/^AE
M@_\  -O_ (NOI6BC_5G*_P#GU_Y-+_,/]:<V_P"?O_DL?\CYJ_X9%O/^AE@_
M\ V_^+KJOA9\*9?A;XR\F744U W<8<%(C'MPL@]3FO:ZYF__ .1\TW_KW/\
M*2NG#9%@,'5C7HPM);:OTZLY,5G^8XVC*A7J7B]]$MG?HCIJ***]\^>"BBB@
M HHHH **** "BBB@ KS_ .('_(9A_P"O=?\ T)J] KS_ .('_(9A_P"O=?\
MT)J -KX?_P#(&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ HHHH
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MFO'W_(%C_P"NZ_R:NEKFO'W_ "!8_P#KNO\ )J .CC_U:_2G4V/_ %:_2G4
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MJZ:N9\,?\A[7?^NW_LS4 =-1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<S?_\ (^:;_P!>Y_E)735S-_\ \CYIO_7N?Y24 =-1110 4444 %%%
M% !1110 4444 %>?_$#_ )#,/_7NO_H35Z!7G_Q _P"0S#_U[K_Z$U &U\/_
M /D#3?\ 7PW_ *"M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/BK_D
M,Z!_U\?^S)735S/BK_D,Z!_U\?\ LR5TU !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 8_B[_D7;SZ+_P"A"K.@_P#(%L?^N"?R%5O%W_(NWGT7
M_P!"%6=!_P"0+8_]<$_D* +]%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5S/AC_ )#VN_\ 7;_V9JZ:N9\,?\A[7?\ KM_[,U '34444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7,ZE_P CQIG_ %Q/\GKIJYG4O^1X
MTS_KB?Y/0!TU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7C[_
M ) L?_7=?Y-72US7C[_D"Q_]=U_DU '1Q_ZM?I3J;'_JU^E.H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#F? 7_(-N?\ KX/_ *"*Z:N9\!?\
M@VY_Z^#_ .@BNFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F
M;3_D?+W_ *]Q_)*Z:N9M/^1\O?\ KW'\DKIJ "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH YGQ=_P A+0_^OC_V9*Z:N9\7?\A+0_\ KX_]F2NF
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\7?\B[>?1?_0A5
MG0?^0+8_]<$_D*K>+O\ D7;SZ+_Z$*LZ#_R!;'_K@G\A0!?HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7?^NW_ +,U=-7,^&/^0]KO
M_7;_ -F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF;_\
MY'S3?^O<_P I*Z:N9O\ _D?--_Z]S_*2@#IJ*** "BBB@ HHHH **** "BBB
M@ KS_P"('_(9A_Z]U_\ 0FKT"O/_ (@?\AF'_KW7_P!":@#:^'__ "!IO^OA
MO_05KIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?%7_(9T#_KX_P#9
MDKIJYGQ5_P AG0/^OC_V9*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** ,?Q=_P B[>?1?_0A5G0?^0+8_P#7!/Y"JWB[_D7;SZ+_ .A"K.@_
M\@6Q_P"N"?R% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YG
MPQ_R'M=_Z[?^S-735S/AC_D/:[_UV_\ 9FH Z:BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *YG4O^1XTS_KB?Y/735S.I?\CQIG_7$_R>@#IJ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KFO'W_(%C_Z[K_)JZ6N:
M\??\@6/_ *[K_)J .CC_ -6OTIU-C_U:_2G4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!S/@+_D&W/_7P?_01735S/@+_ )!MS_U\'_T$5TU
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 <S:?\CY>_]>X_DE=-
M7,VG_(^7O_7N/Y)734 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!S/B[_D):'_ -?'_LR5TU<SXN_Y"6A_]?'_ +,E=-0 4444 %%%% !1110
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M ->Z_P#H35Z!7G_Q _Y#,/\ U[K_ .A-0!M?#_\ Y TW_7PW_H*UTU<S\/\
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M@ HHHH YGP%_R#;G_KX/_H(KIJYGP%_R#;G_ *^#_P"@BNFH **** "BBB@
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M -=O_9FH Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YG4O\
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MVN_]=O\ V9JZ:N9\,?\ (>UW_KM_[,U '34444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7,W_P#R/FF_]>Y_E)735S-__P CYIO_ %[G^4E '344
M44 %%%% !1110 4444 %%%% !7G_ ,0/^0S#_P!>Z_\ H35Z!7G_ ,0/^0S#
M_P!>Z_\ H34 ;7P__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@K734 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?\AG0/\ KX_]F2NFKF?%7_(9T#_KX_\ 9DKIJ "BBB@ HHHH **** "BBB@
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MZ+_Z$*LZ#_R!;'_K@G\A5;Q=_P B[>?1?_0A5G0?^0+8_P#7!/Y"@"_1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<SX8_Y#VN_]=O_ &9JZ:N9
M\,?\A[7?^NW_ +,U '34444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7,W_\ R/FF_P#7N?Y25TU<S?\ _(^:;_U[G^4E '34444 %%%% !1110 4
M444 %%%% !7G_P 0/^0S#_U[K_Z$U>@5Y_\ $#_D,P_]>Z_^A-0!M?#_ /Y
MTW_7PW_H*UTU<S\/_P#D#3?]?#?^@K734 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',^*O^0SH'_7Q
M_P"S)735S/BK_D,Z!_U\?^S)734 %%%% !1110 4444 %%%% !1110 4444
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M)*Z:N9M/^1\O?^O<?R2NFH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#F?%W_(2T/_ *^/_9DKIJYGQ=_R$M#_ .OC_P!F2NFH **** "BBB@
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MZ+_Z$*LZ#_R!;'_K@G\A0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N9\,?\A[7?^NW_ +,U=-7,^&/^0]KO_7;_ -F:@#IJ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KF;_\ Y'S3?^O<_P I*Z:N9O\ _D?-
M-_Z]S_*2@#IJ*** "BBB@ HHHH **** "BBB@ KS_P"('_(9A_Z]U_\ 0FKT
M"O/_ (@?\AF'_KW7_P!":@#:^'__ "!IO^OAO_05KIJYGX?_ /(&F_Z^&_\
M05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_0UZ)_X,8?\ XJORAHH_U4I?\_7]P?VU/^1?>?J]_P +,\(?]#7HG_@QA_\
MBJ/^%F>$/^AKT3_P8P__ !5?E#11_JI2_P"?K^X/[:G_ "+[S]7O^%F>$/\
MH:]$_P#!C#_\51_PLSPA_P!#7HG_ (,8?_BJ_*&BC_52E_S]?W!_;4_Y%]Y^
MKW_"S/"'_0UZ)_X,8?\ XJC_ (69X0_Z&O1/_!C#_P#%5^4-%'^JE+_GZ_N#
M^VI_R+[S]7O^%F>$/^AKT3_P8P__ !5'_"S/"'_0UZ)_X,8?_BJ_*&BC_52E
M_P _7]P?VU/^1?>?J]_PLSPA_P!#7HG_ (,8?_BJ/^%F>$/^AKT3_P &,/\
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M7Y0T4?ZJ4O\ GZ_N#^VI_P B^\_5[_A9GA#_ *&O1/\ P8P__%4?\+,\(?\
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M2E_S]?W!_;4_Y%]Y^KW_  LSPA_T->B?^#&'_P"*H_X69X0_Z&O1/_!C#_\
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M#O\ T']+_P# R/\ ^*KX!HH_URK?\^5][_R#_4FC_P _W]R_S/O[_A-O#O\
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M&BC_ %RK?\^5][_R#_4FC_S_ ']R_P S[^_X3;P[_P!!_2__  ,C_P#BJ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110![#I/\ R"-._P"O6'_T6M6JJZ3_ ,@C
M3O\ KUA_]%K5JO\ /?-/]_K_ ..7_I3/[ER[_<J'^&/Y(****\P] **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KW#]E;_D:+__ '4_
M] EKP^O</V5O^1HO_P#=3_T"6OI>'/\ D:T?G_Z2SY?B;_D4UO\ MW_TI'U1
M1117[F?@04444 %%%% !1110 4444 %>?_$#_D,P_P#7NO\ Z$U>@5Y_\0/^
M0S#_ ->Z_P#H34 ;7P__ .0--_U\-_Z"M=-7,_#_ /Y TW_7PW_H*UTU !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!Y1^T?_P DYUK_ +!5]_Z)K\TZ_2S]H_\ Y)SK7_8*OO\ T37Y
MIU^E<*?P*OJOR/DLZ_B0] HHHK[D^<"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;WD#2-Y+8 D7:RX"GANO#9X"FK%S^T?X;@^ Z_$T.&LWMLI9;QYAN_N_9O\
M>W@@GT!;I0!ZU17EW[._BWQGXV^&MOXE\<16-C<:@QN+2WM(6B\NUP-C/N8\
MMRP_V2OKQY=;?'3XH?'3Q!JL/PBTS2-.\+Z9.;9]?UTLPN9!_<"YP""#C:QP
M025SB@#ZBHKYP^'_ .T%XR\._%:T^'/Q9TC3]/U34D#:7JVEEA;W!.<*02>6
M(*@C;@@ KSFO2?CQ\:M,^!?@:37KZ$WUU)(+>RL%D"-<2D9QG!PH ))P<8]2
M* /1J*^5;/Q=^U'JNDP>)8/#OAJ&UD7SDT&12D[QD$@$,^0<8X+@].!TKN/B
M1\;O$GAO]F>3X@0:(-"\1!8-^EZI&[>0[7*Q.&7Y6Z$D9QU% 'N5%<M\+/$U
MWXS^&OA;7K]8EOM3TRWNYQ"I5 [QJS;02<#)]:\NT7XX>(=0_:VU_P"&LL5B
M/#UC8K<1.L3?:-Y@@DY;=C&9&[=,4 >E_$KXL>%_A%I-IJ7BK46TZSNK@6L4
MBP22Y<@MT120 %)S[5U]?"/[?4WQ :*&/6H-*7P0NJ+_ &5+;$_:F?R&SYF3
MT^_V]*^C/A'=?&R;Q/*OQ#L_#EOH7V9BC:66,WG;EVC[QXQNS^% #_@[\5?&
M?CKQYXSTCQ%X-E\/:5I,QCL;YXI4^T#S&4#+C#Y4!LIQ@^XKU^O!?@#\</$/
MQ.^*'Q-\/ZO%8I8>';YK>R-K$R2%1--'\Y+')Q&O8<YJO\(_CQXDUOX_>-OA
MOXNAL()M/WS:9):0M&9(E8$;LL<EHY(W'3HU 'T%17E?[2WQ>F^"GPJO=?LE
M@DU:2:.TL8[E2T;2N<G(!!.$5VZ]A5B'XHW'@GX$6GC?QVL<-]'IT=Y>6]FF
MS,LF"D**S<,2RKR>N>U 'IE%?+>@>.OVB_BAI2>*O#NE>%_#V@W*^=8:;JA=
MI[B$\JQ;W'0G8".0,$9[K]GC]H"Y^+$VM^'O$FDIX?\ &^@N8[^PC)\MP&*E
MXP22 &X(RW52"0W ![57CGQ*_:"?X?\ QG\%> UT-;Y?$/E[[XW7EF#?*T8P
MFP[L%<]1GIQUKV.OCW]I#_D\GX.?]NO_ *5/0!]A445Y_P#'#XQZ9\#_  +/
MXBU&%KV0R+;VEC&X5KB9@2%R>@ !).#@ \$X! /0**^7X?$'[4&H:.?$L&D>
M$[:%X_/C\.SK)]IV8R%/S?>(QP9 <GH.@]-_9Y^.EG\=?!\VH"T.EZS82_9M
M1T]F)\J3&0RYYVMSC/((8<XR0#U.BOG75O%O[07C?7=2C\*>&=%\(:':W,D$
M%UX@9FGN@C%=X49PK  CY,<\,W6JGPP_: \<Z7\98OAA\4=(T^VU:\A,UAJ6
MF$B.;"LPR"2"&"/AAMPRX(YX /I6BO./CU\:-/\ @7X#FU^\@-]=22"VLK%7
M"&>8@D GLH ))P>GJ17BVD_$3]I>WTF+QA>^$M%U#1G47#Z!"IBO/((#91=Q
M8-CH#N;U4]* .F_9]^+WBKQU\;_BSX>UK45N](T._E@T^W%O''Y"+<RQ@;E4
M,WRJOWB>E?15?%W[$'B*+Q?\:OB[KL$,EO!JDYOHX9L;T62YE<*V.X#8->R?
M'CX_:CX!\0:+X*\&Z*GB/QYK:[[:UE;$-O'D_O),$$YVN<9  5B2 ,$ ]MHK
MY4\5?$O]H'X*Z4GB;Q=I?AGQ+X;BD0W\6E%TGMD9L9!XQR0,X<#//J/9]<^*
ML%Y\"=5^('AIXYT719]2L_M"Y4.D;,%< ]592I /4$9H ]$HKXU\'_M+?%_X
MV:#IUE\/M TZ35[.$RZYJMS&([99"[^7%$'?'*!2>222>% R?8?B%\;-9^"_
MP%T_Q1XNTJ!_%TJQ6CZ=!(!";M@QP64L H5&8X)Z8'7- 'M->3_M2>.M;^&_
MP0U_Q!X=O!8:O;/;+#<&))=F^XC1OE<%3E6(Y'>O/+?5_P!I]=,MO$/]G^#[
MZ*1%F/A^,ND^T@';N)"AL?\ 30\^O2NA_;5=Y/V8_$;RQ^5(S61:/.=I^TQ9
M&>^* /1O@OXBU#Q=\)O".M:K/]IU*_TR"XN)MBIOD9 6;:H &3V  KM*^,OA
M'\3/B]XY^&/AS2?A=X?L+'2=#T^&SN=:UT@?:KA$ 9(5SC:#QG![9*]*]+_9
MO_:(U[XB>*/$/@CQQI%OHWC+109'6U!6.6-6"N-I9L,I9#D,0P;(QCD Z/Q3
M\5?&>C_'KP_X.T_P;+?>%KZ%9+G7!%*5B)#[CO V+MVKD'DY]Q7K]>"^-OCA
MXA\/_M3^$/AW:Q6)T'5;$7%P\D3&?<1<?=;< !^Z7MZU<_:Q^,^M_!#P-HVL
MZ%'9R7%UJL=I-]LB:1?*,4CG ##G*#GZT >W45\N?\+8^.OQ9@D\0?#GPOIF
MC>$U)-B=<8"ZU)0?O %@%4]1T'/#M78?LU_M$7GQ>DUOP_XFTJ/0O&FAOB\M
M(@RQR+N*EE5B64JV%8$GJI!YP #W.BBB@ HHHH \H_:/_P"2<ZU_V"K[_P!$
MU^:=?I9^T?\ \DYUK_L%7W_HFOS3K]*X4_@5?5?D?)9U_$AZ!1117W)\X%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5[A^RM_R-%__ +J?^@2UX?7N'[*W_(T7_P#NI_Z!+7TO#G_(UH_/_P!)9\OQ
M-_R*:W_;O_I2/JBBBBOW,_ @HHHH **** "BBB@ HHHH *\_^('_ "&8?^O=
M?_0FKT"O/_B!_P AF'_KW7_T)J -KX?_ /(&F_Z^&_\ 05KIJYGX?_\ (&F_
MZ^&_]!6NFH **** /B+QEX*T3X@_M^SZ)XAL$U/2YK!6DMY&90Q6R#*<J0>"
M >M?0^C_ ++/PKT'5K+4[#P?:V]]9S)<03">9BDB,&5L%R#@@'FO(_BG\)?B
MMI?[3$WQ*\":-I6KH;1(HEU&Y54!\CRG#)YB-GJ00<<CW%;7_"8?M3_]"-X+
M_P"_[?\ R50!]&:Q'8S:/?)J8A;36@D6Z%QCRS$5._?GC;MSG/:OROT,Z+#X
M\TRUOYM5;X*/XHE:!IP1$^W:,O[B-H]Q^]L)QS7W%^T?X?\ B?\ $+X<:)X5
M\-:7;QW&LB-/$%ZEW''%:)A2\:AFW,I8G.W)VICG=6KXJ_9H\/ZQ\ 4^&UFB
MQ+96X>QO74;EO%!/G-[NQ;=CL[ =J .L^,TTEK\%/&TFFA=\>@WA@\O@ "W?
M!7'H.GX5\I?LMZ/\;+KX164O@/6_"-CH#7,^(=4CE-P)-^&+%8F'ICGIBOH#
M]FSP_P"-M.^%+^%/B3HZ126.ZQMWDN8K@7=F5P%;8S?=!*<XRH7CK7EOAWX4
M?&/]FG5]7M?AS::;XV\&7T[74>G7TZPS6Y.!U9T^;: N06#!<[0>* )=<_9]
M^-/Q$^(/@C7_ !CX@\(O%X;U".Z1]-\]9=@EC=@ 80&/[L8R1U-4?VX(Q<?%
M'X+07IW:5)J+K(C#*G]_;!\CO\I'6O2?!.N?'WQ5XPTN3Q#X>T#P;X8AEWWD
M2SK<W5PFT_(I5W YQV4CGGM6U^TQ\!8OCQX(BL;>YCL-=T^4W&G7<H)0,1AH
MVQR%8 <C."JG!Q@@'KU>%?MN*6_9K\4D D"2S)]O]*BKB--\0?M4VFDP^'V\
M*Z#+<QQB$>([BYB9L8QYC*)L,P_ZY_53W]8N/A#JGBKX W'@/Q=KS:OK5Y:.
MESJ_+#SS(948 X)5&V #C(3MV -/]GN19?@7X!93D?V':+^(B4']17@OA?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBON3YP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** +-WJ5YJ"QK=74]R(QA!-(6VCT&3Q5:BBDDEHA[A1
M113$6-/U*[TF\CN[&ZFLKJ/)2>WD,;KD8.&!R."1^-1W%Q+=3R332/--(Q=Y
M)&+,S$Y))/4DU'12LKW'?H.CD>)U=&9'4Y#*<$422O-(SR.SNW)9CDG\:;10
M(****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110![#I/_((T[_KUA_\ 1:U:JKI/_((T[_KUA_\ 1:U:
MK_/?-/\ ?Z_^.7_I3/[ER[_<J'^&/Y(****\P] **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H&L;9IQ,UO$
M9ATD*#=^=3T4TVMA-)[A2$!@01D4M%(9!#8VUO(SQ6\43MU9$ )_*IZ**;;>
MK$DHZ(@AL;:WN)IXK>**:;F21$ 9\?WB.OXU/110VY:L$E'1#!$@D,@10Y&"
MV.3^-/HHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *]P_96_Y&B__P!U/_0):\/KW#]E;_D:+_\
MW4_] EKZ7AS_ )&M'Y_^DL^7XF_Y%-;_ +=_]*1]44445^YGX$%%%% !1110
M 4444 %%%% !7G_Q _Y#,/\ U[K_ .A-7H%>?_$#_D,P_P#7NO\ Z$U &U\/
M_P#D#3?]?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >4?M'_\
M).=:_P"P5??^B:_-.OTL_:/_ .2<ZU_V"K[_ -$U^:=?I7"G\"KZK\CY+.OX
MD/0****^Y/G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ]ATG_D$:=_UZP_^BUJU572?^01IW_7K#_Z+6K5?Y[YI_O\ 7_QR_P#2
MF?W+EW^Y4/\ #'\D%%%%>8>@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ_\ (_N9Y517JO\ PRW\4_\ H4+G_O\ P_\ Q='_  RW\4_^A0N?^_\ #_\
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MJ_\ (_N9Y517JO\ PRW\4_\ H4+G_O\ P_\ Q='_  RW\4_^A0N?^_\ #_\
M%T?7\)_S^C_X$O\ ,/JU?^1_<SRJBO5?^&6_BG_T*%S_ -_X?_BZ/^&6_BG_
M -"A<_\ ?^'_ .+H^OX3_G]'_P "7^8?5J_\C^YGE5%>J_\ #+?Q3_Z%"Y_[
M_P /_P 71_PRW\4_^A0N?^_\/_Q='U_"?\_H_P#@2_S#ZM7_ )']S/*J*]5_
MX9;^*?\ T*%S_P!_X?\ XNC_ (9;^*?_ $*%S_W_ (?_ (NCZ_A/^?T?_ E_
MF'U:O_(_N9Y517JO_#+?Q3_Z%"Y_[_P__%T?\,M_%/\ Z%"Y_P"_\/\ \71]
M?PG_ #^C_P"!+_,/JU?^1_<SRJBO5?\ AEOXI_\ 0H7/_?\ A_\ BZ/^&6_B
MG_T*%S_W_A_^+H^OX3_G]'_P)?YA]6K_ ,C^YGE5%>J_\,M_%/\ Z%"Y_P"_
M\/\ \75:3]FOXEQ7D=J_A6X6XD&Y4\^')'/^W[&CZ_A/^?T?_ E_F'U:O_(_
MN9YG17JO_#+?Q3_Z%"Y_[_P__%T?\,M_%/\ Z%"Y_P"_\/\ \71]?PG_ #^C
M_P"!+_,/JU?^1_<SRJBO5?\ AEOXI_\ 0H7/_?\ A_\ BZ/^&6_BG_T*%S_W
M_A_^+H^OX3_G]'_P)?YA]6K_ ,C^YGE5%>J_\,M_%/\ Z%"Y_P"_\/\ \71_
MPRW\4_\ H4+G_O\ P_\ Q='U_"?\_H_^!+_,/JU?^1_<SRJBO5?^&6_BG_T*
M%S_W_A_^+H_X9;^*?_0H7/\ W_A_^+H^OX3_ )_1_P# E_F'U:O_ "/[F>54
M5ZK_ ,,M_%/_ *%"Y_[_ ,/_ ,71_P ,M_%/_H4+G_O_  __ !='U_"?\_H_
M^!+_ ##ZM7_D?W,\JHKU7_AEOXI_]"A<_P#?^'_XNC_AEOXI_P#0H7/_ '_A
M_P#BZ/K^$_Y_1_\  E_F'U:O_(_N9Y517JO_  RW\4_^A0N?^_\ #_\ %T?\
M,M_%/_H4+G_O_#_\71]?PG_/Z/\ X$O\P^K5_P"1_<SRJBO5?^&6_BG_ -"A
M<_\ ?^'_ .+H_P"&6_BG_P!"A<_]_P"'_P"+H^OX3_G]'_P)?YA]6K_R/[F>
M545ZK_PRW\4_^A0N?^_\/_Q=5[[]FGXEZ;");GPK<11D[0QGA//X/[4?7\)_
MS^C_ .!+_,/JU?\ D?W,\RHKU0?LM_%(\CPA<_\ ?^'_ .+I?^&6_BG_ -"A
M<_\ ?^'_ .+H^OX3_G]'_P "7^8?5J_\C^YGE5%>J_\ #+?Q3_Z%"Y_[_P /
M_P 71_PRW\4_^A0N?^_\/_Q='U_"?\_H_P#@2_S#ZM7_ )']S/*J*]5_X9;^
M*?\ T*%S_P!_X?\ XNC_ (9;^*?_ $*%S_W_ (?_ (NCZ_A/^?T?_ E_F'U:
MO_(_N9Y517JO_#+?Q3_Z%"Y_[_P__%T?\,M_%/\ Z%"Y_P"_\/\ \71]?PG_
M #^C_P"!+_,/JU?^1_<SRJBO5?\ AEOXI_\ 0H7/_?\ A_\ BZ/^&6_BG_T*
M%S_W_A_^+H^OX3_G]'_P)?YA]6K_ ,C^YGE5%>J_\,M_%/\ Z%"Y_P"_\/\
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MJ_\ (_N9Y517JO\ PRW\4_\ H4+G_O\ P_\ Q='_  RW\4_^A0N?^_\ #_\
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MUY1HR:<Y?9?=^1_9>7YC@HX.C&5:*:C'[2[+S."HKO?^%$^//^A=G_[^Q?\
MQ5'_  HGQY_T+L__ ']B_P#BJ\[^SL;_ ,^)?^ O_([_ .T\#_S_ (?^!+_,
MX*BN]_X43X\_Z%V?_O[%_P#%4?\ "B?'G_0NS_\ ?V+_ .*H_L[&_P#/B7_@
M+_R#^T\#_P _X?\ @2_S."HKO?\ A1/CS_H79_\ O[%_\51_PHGQY_T+L_\
MW]B_^*H_L[&_\^)?^ O_ "#^T\#_ ,_X?^!+_,X*BN]_X43X\_Z%V?\ [^Q?
M_%4?\*)\>?\ 0NS_ /?V+_XJC^SL;_SXE_X"_P#(/[3P/_/^'_@2_P S@J*[
MW_A1/CS_ *%V?_O[%_\ %4?\*)\>?]"[/_W]B_\ BJ/[.QO_ #XE_P" O_(/
M[3P/_/\ A_X$O\S@J*[W_A1/CS_H79_^_L7_ ,51_P *)\>?]"[/_P!_8O\
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M $+L_P#W]B_^*H_X43X\_P"A=G_[^Q?_ !5']G8W_GQ+_P !?^0?VG@?^?\
M#_P)?YG!45WO_"B?'G_0NS_]_8O_ (JC_A1/CS_H79_^_L7_ ,51_9V-_P"?
M$O\ P%_Y!_:>!_Y_P_\  E_F<%17>_\ "B?'G_0NS_\ ?V+_ .*H_P"%$^//
M^A=G_P"_L7_Q5']G8W_GQ+_P%_Y!_:>!_P"?\/\ P)?YG!45WO\ PHGQY_T+
ML_\ W]B_^*H_X43X\_Z%V?\ [^Q?_%4?V=C?^?$O_ 7_ )!_:>!_Y_P_\"7^
M9P5%=[_PHGQY_P!"[/\ ]_8O_BJ/^%$^//\ H79_^_L7_P 51_9V-_Y\2_\
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M $+L_P#W]B_^*H_X43X\_P"A=G_[^Q?_ !5']G8W_GQ+_P !?^0?VG@?^?\
M#_P)?YG!45WO_"B?'G_0NS_]_8O_ (JC_A1/CS_H79_^_L7_ ,51_9V-_P"?
M$O\ P%_Y!_:>!_Y_P_\  E_F<%17>_\ "B?'G_0NS_\ ?V+_ .*H_P"%$^//
M^A=G_P"_L7_Q5']G8W_GQ+_P%_Y!_:>!_P"?\/\ P)?YG!45WO\ PHGQY_T+
ML_\ W]B_^*H_X43X\_Z%V?\ [^Q?_%4?V=C?^?$O_ 7_ )!_:>!_Y_P_\"7^
M9P5%=[_PHGQY_P!"[/\ ]_8O_BJ/^%$^//\ H79_^_L7_P 51_9V-_Y\2_\
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M "BBB@ HHHH **** "BBB@ HHHH YGQ=_P A+0_^OC_V9*Z:N9\7?\A+0_\
MKX_]F2NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\7?\B[
M>?1?_0A5G0?^0+8_]<$_D*K>+O\ D7;SZ+_Z$*LZ#_R!;'_K@G\A0!?HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7?^NW_ +,U=-7,
M^&/^0]KO_7;_ -F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KF;_\ Y'S3?^O<_P I*Z:N9O\ _D?--_Z]S_*2@#IJ*** "BBB@ HHHH *
M*** "BBB@ KS_P"('_(9A_Z]U_\ 0FKT"O/_ (@?\AF'_KW7_P!":@#:^'__
M "!IO^OAO_05KIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?%7_(9T
M#_KX_P#9DKIJYGQ5_P AG0/^OC_V9*Z:@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,?Q=_P B[>?1?_0A5G0?^0+8_P#7!/Y"JWB[_D7;SZ+_
M .A"K.@_\@6Q_P"N"?R% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% ',^*O\ D,Z!_P!?'_LR5TU<
MSXJ_Y#.@?]?'_LR5TU !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 8_B[_D7;SZ+_Z$*LZ#_P @6Q_ZX)_(56\7?\B[>?1?_0A5G0?^0+8_]<$_
MD* +]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/AC_D/:[_UV
M_P#9FKIJYGPQ_P A[7?^NW_LS4 =-1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<SJ7_(\:9_UQ/\GKIJYG4O\ D>-,_P"N)_D] '34444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7->/O^0+'_ -=U_DU=+7->/O\
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MBB@ HHHH **** "N9\,?\A[7?^NW_LS5TU<SX8_Y#VN_]=O_ &9J .FHHHH
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M** "BBB@ HHHH **** "BBB@ KFO'W_(%C_Z[K_)JZ6N:\??\@6/_KNO\FH
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M59T'_D"V/_7!/Y"@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<SX8_Y#VN_]=O\ V9JZ:N9\,?\ (>UW_KM_[,U '34444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7,W_P#R/FF_]>Y_E)735S-__P CYIO_ %[G
M^4E '34444 %%%% !1110 4444 %%%% !7G_ ,0/^0S#_P!>Z_\ H35Z!7G_
M ,0/^0S#_P!>Z_\ H34 ;7P__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@
MK734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% ',^*O^0SH'_7Q_[,E=-7,^*O\ D,Z!_P!?'_LR5TU
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_B[_ )%V\^B_^A"K
M.@_\@6Q_ZX)_(56\7?\ (NWGT7_T(59T'_D"V/\ UP3^0H OT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7,^&/^0]KO_7;_P!F:NFKF?#'_(>U
MW_KM_P"S-0!TU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S.I?
M\CQIG_7$_P GKIJYG4O^1XTS_KB?Y/0!TU%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .9\5?\AG0/\ KX_]F2NFKF?%7_(9T#_KX_\ 9DKIJ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH Q_%W_(NWGT7_P!"%6=!_P"0+8_]<$_D
M*K>+O^1=O/HO_H0JSH/_ "!;'_K@G\A0!?HHHH **** "BBB@ HHHH ****
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M ) MC_UP3^0JMXN_Y%V\^B_^A"K.@_\ (%L?^N"?R% %^BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGPQ_P A[7?^NW_LS5TU<SX8_P"0]KO_
M %V_]F:@#IJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF;_P#Y
M'S3?^O<_RDKIJYF__P"1\TW_ *]S_*2@#IJ*** "BBB@ HHHH **** "BBB@
M KS_ .('_(9A_P"O=?\ T)J] KS_ .('_(9A_P"O=?\ T)J -KX?_P#(&F_Z
M^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ HHHH **** "BBB@ HHHH
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MNEKFO'W_ "!8_P#KNO\ )J .CC_U:_2G4V/_ %:_2G4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!S/@+_ )!MS_U\'_T$5TU<SX"_Y!MS_P!?
M!_\ 01734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S-I_P C
MY>_]>X_DE=-7,VG_ "/E[_U[C^25TU !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 <SXN_Y"6A_]?'_ +,E=-7,^+O^0EH?_7Q_[,E=-0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!S/BK_D,Z!_U\?^S)735S/B
MK_D,Z!_U\?\ LR5TU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 8_B[_D7;SZ+_P"A"K.@_P#(%L?^N"?R%5O%W_(NWGT7_P!"%6=!_P"0+8_]
M<$_D* +]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/AC_ )#V
MN_\ 7;_V9JZ:N9\,?\A[7?\ KM_[,U '34444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7,ZE_P CQIG_ %Q/\GKIJYG4O^1XTS_KB?Y/0!TU%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5S7C[_ ) L?_7=?Y-72US7
MC[_D"Q_]=U_DU '1Q_ZM?I3J;'_JU^E.H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#F? 7_(-N?\ KX/_ *"*Z:N9\!?\@VY_Z^#_ .@BNFH
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MB@ HHHH **** "N9\,?\A[7?^NW_ +,U=-7,^&/^0]KO_7;_ -F:@#IJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF;_\ Y'S3?^O<_P I*Z:N
M9O\ _D?--_Z]S_*2@#IJ*** "BBB@ HHHH **** "BBB@ KS_P"('_(9A_Z]
MU_\ 0FKT"O/_ (@?\AF'_KW7_P!":@#:^'__ "!IO^OAO_05KIJYGX?_ /(&
MF_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#F?%7_(9T#_KX_P#9DKIJYGQ5_P AG0/^
MOC_V9*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q=_P B
M[>?1?_0A5G0?^0+8_P#7!/Y"JWB[_D7;SZ+_ .A"K.@_\@6Q_P"N"?R% %^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGPQ_R'M=_Z[?^S-73
M5S/AC_D/:[_UV_\ 9FH Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *YG4O^1XTS_KB?Y/735S.I?\CQIG_7$_R>@#IJ*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KFO'W_(%C_Z[K_)JZ6N:\??\@6/_ *[K_)J
M.CC_ -6OTIU-C_U:_2G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!S/@+_D&W/_7P?_01735S/@+_ )!MS_U\'_T$5TU !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <S:?\CY>_]>X_DE=-7,VG_(^7O_7N/Y)7
M34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/B[_D):'_ -?'
M_LR5TU<SXN_Y"6A_]?'_ +,E=-0 4444 %%%% !1110 4444 %%%% !1110
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M _Y#,/\ U[K_ .A-0!M?#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734
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M_KX/_H(KIJYGP%_R#;G_ *^#_P"@BNFH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#F;3_ )'R]_Z]Q_)*Z:N9M/\ D?+W_KW'\DKIJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH YGQ=_R$M#_Z^/\ V9*Z:N9\
M7?\ (2T/_KX_]F2NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#'\7?\ (NWGT7_T(59T'_D"V/\ UP3^0JMXN_Y%V\^B_P#H0JSH/_(%L?\
MK@G\A0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\,?\A[7
M?^NW_LS5TU<SX8_Y#VN_]=O_ &9J .FHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N9O_\ D?--_P"O<_RDKIJYF_\ ^1\TW_KW/\I* .FHHHH
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M[!5]_P"B:_-.OTCA5)T:MUU7Y'R>=-^TAZ%S^V=0_P"?ZY_[_-_C1_;.H?\
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M+G]LZA_S_7/_ '^;_&C^V=0_Y_KG_O\ -_C5.BCECV#F?<N?VSJ'_/\ 7/\
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MZA_S_7/_ '^;_&J=%'+'L',^Y<_MG4/^?ZY_[_-_C1_;.H?\_P!<_P#?YO\
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M']IWG_/W/_W\;_&JU%'-+N'+'L6?[3O/^?N?_OXW^-']IWG_ #]S_P#?QO\
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M;S2C=]__ $EGR_$T4LIK67\O_I2/JBBBBOW(_! HHHH **** "BBB@ HHHH
M*\_^('_(9A_Z]U_]":O0*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\ KX;_ -!6
MNFKF?A__ ,@:;_KX;_T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_:/_ .2<ZU_V"K[_ -$U
M^:=?I9^T?_R3G6O^P5??^B:_-.OTKA3^!5]5^1\EG7\2'H%%%%?<GS@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)O#^@:Y?R6VIZ[*(;&)+=Y [%U09900OS,!S0!VU%%% !1110 4444 %%%%
M!17D'P\^/K>.OC7XT\ G1!9IX?5F6_\ M.\S[75#E-HVY+9ZGI7K] !1110
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MWUG=7=M8W-Q:VH!N)XH69(0>A=@,+GWJG1=/8>H4444Q!1110 4444 %%%%
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M*%KJ.T$%LRJVY@QSD]L*:\&_:$_Y/.^#W_7.'_THEKH_^"@W_)![?_L,V_\
MZ+EH O>,/VSM'TW4[RQ\(>%M9\>FP_X_;O2HC]E@]1Y@5LXP><;?0FN]^!W[
M0'AOX[Z-<7.C^;9:C9D"\TRZQYT.>C#'#(<'##TY /%:OP3\+:5X0^%?ABQT
MBRBL;9K""=UC',DCQJSNQZEB3U-?.?AFSB\$_P#!0C5;#24^S66LV#RW,$0
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M+2_^OJ+_ -#%>M5_,/B[_ON$_P ,OS/Z)\+_ /=,3_B7Y!1117X$?M@4444
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M]O7PD+:*'5/"OBFPUPH"^FK9I(2^.0C%U+#/<JI]J]F^$?Q!U#XF>%7UJ_\
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M<@@]C6#P<Z\JLZSUDG&/]V+_ %>[^2-57C34(TUHFF_-_P"2/I?POX>UZ/\
M;=N6:VN@ZZS=7;2,A %JPD*L3_=*$*#WR![5XK\8KRTU'XL>,+FQ97M)=6NG
MC>,Y5@96^8>QZ_C6_>_M-?$W4-!.D3^++HVC(8V98HEF9<8P90N\_7=DYY->
M84L'A:U.I[6M:ZBHJU^G75+[OQ'7K4Y0Y*=]6WKY] HHHKV#@"BBB@ HHHH
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ML/'-[8I(V]EMX7C#'U.)1DUQ?B_P3JNE?$'P_IEQXGO+^[N]GE:A*'\RWRY
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MZHHHHK]S/P(**** "BBB@ HHHH **** "O/_ (@?\AF'_KW7_P!":O0*\_\
MB!_R&8?^O=?_ $)J -KX?_\ (&F_Z^&_]!6NFKF?A_\ \@:;_KX;_P!!6NFH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /*/VC_ /DG.M?]@J^_]$U^:=?I9^T?_P DYUK_ +!5]_Z)
MK\TZ_2N%/X%7U7Y'R6=?Q(>@4445]R?.!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :
M/AO_ )&+2_\ KZB_]#%>M5Y+X;_Y&+2_^OJ+_P!#%>M5_,/B[_ON$_PR_,_H
MGPO_ -TQ/^)?D%%%%?@1^V!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5[A^RM_R-%__ +J?^@2U
MX?7N'[*W_(T7_P#NI_Z!+7TO#G_(UH_/_P!)9\OQ-_R*:W_;O_I2/JBBBBOW
M,_ @HHHH **** "BBB@ HHHH *\_^('_ "&8?^O=?_0FKT"O/_B!_P AF'_K
MW7_T)J -KX?_ /(&F_Z^&_\ 05KIJYGX?_\ (&F_Z^&_]!6NFH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /*/VC_\ DG.M?]@J^_\ 1-?FG7Z6?M'_ /).=:_[!5]_Z)K\TZ_2N%/X
M%7U7Y'R6=?Q(>@4445]R?.!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :/AO_D8M+_Z
M^HO_ $,5ZU7DOAO_ )&+2_\ KZB_]#%>M5_,/B[_ +[A/\,OS/Z)\+_]TQ/^
M)?D%%%%?@1^V!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5[A^RM_P C1?\ ^ZG_ *!+7A]>X?LK
M?\C1?_[J?^@2U]+PY_R-:/S_ /26?+\3?\BFM_V[_P"E(^J****_<S\""BBB
M@ HHHH **** "BBB@ KS_P"('_(9A_Z]U_\ 0FKT"O/_ (@?\AF'_KW7_P!"
M:@#:^'__ "!IO^OAO_05KIJYGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MRW]H:UFO? 6J6]O%)/<3:9>QQQ1*6=V,6 H Y))XP*_/+_A6?C#_ *%36_\
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MO_/I?>']BP_G?W'Y0?\ "L_&'_0J:W_X+IO_ (FC_A6?C#_H5-;_ /!=-_\
M$U^K]%'^M=7_ )]+[P_L6'\[^X_*#_A6?C#_ *%36_\ P73?_$T?\*S\8?\
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M1?\ 0 U3_P  Y/\ XFC_ (0GQ%_T -4_\ Y/_B:^_J*/]3:/_/Y_<O\ ,/\
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M_ .3_P")H_X0GQ%_T -4_P# .3_XFOOZBC_4VC_S^?W+_,/]=JW_ #X7WO\
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M$^(O^@!JG_@')_\ $U]_44?ZFT?^?S^Y?YA_KM6_Y\+[W_D? /\ PA/B+_H
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M ,31_P (3XB_Z &J?^ <G_Q-??U%'^IM'_G\_N7^8?Z[5O\ GPOO?^1\ _\
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M%% !1110 4444 %%%% !1110 4444 %%%% ',VG_ "/E[_U[C^25TU<S:?\
M(^7O_7N/Y)734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/B
M[_D):'_U\?\ LR5TU<SXN_Y"6A_]?'_LR5TU !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 8_B[_D7;SZ+_ .A"K.@_\@6Q_P"N"?R%5O%W_(NW
MGT7_ -"%6=!_Y MC_P!<$_D* +]%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5S/AC_D/:[_ -=O_9FKIJYGPQ_R'M=_Z[?^S-0!TU%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5S-__P CYIO_ %[G^4E=-7,W_P#R
M/FF_]>Y_E)0!TU%%% !1110 4444 %%%% !1110 5Y_\0/\ D,P_]>Z_^A-7
MH%>?_$#_ )#,/_7NO_H34 ;7P_\ ^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?
M^@K734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% ',^*O^0SH'_7Q_[,E=-7,^*O^0SH'_7Q_P"S)734
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^+O^1=O/HO_ *$*
MLZ#_ ,@6Q_ZX)_(56\7?\B[>?1?_ $(59T'_ ) MC_UP3^0H OT444 %%%%
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M*** "BBB@ HHHH **** "N9O_P#D?--_Z]S_ "DKIJYF_P#^1\TW_KW/\I*
M.FHHHH **** "BBB@ HHHH **** "O/_ (@?\AF'_KW7_P!":O0*\_\ B!_R
M&8?^O=?_ $)J -KX?_\ (&F_Z^&_]!6NFKF?A_\ \@:;_KX;_P!!6NFH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !7G_Q _Y#,/\ U[K_ .A-7H%>?_$#_D,P_P#7NO\ Z$U
M&U\/_P#D#3?]?#?^@K735S/P_P#^0--_U\-_Z"M=-0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <SXJ
M_P"0SH'_ %\?^S)735S/BK_D,Z!_U\?^S)734 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!C^+O^1=O/HO_H0JSH/_ "!;'_K@G\A5;Q=_R+MY
M]%_]"%6=!_Y MC_UP3^0H OT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7,^&/^0]KO_7;_ -F:NFKF?#'_ "'M=_Z[?^S-0!TU%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5S.I?\CQIG_7$_R>NFKF=2_P"1XTS_
M *XG^3T =-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<UX^_Y
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M "BBB@#'\7?\B[>?1?\ T(59T'_D"V/_ %P3^0JMXN_Y%V\^B_\ H0JSH/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ,:))&4LBL5Y4D9Q]*?110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% #719%*NH93U##(I54*H
M"@ #@ 4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,6)(V9
ME159N20,$_6GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4P
MQ(T@<HI<<!L<C\:?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !3)(TF7#HKCKAAFGT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ,CB2$$(BH.N%&*?110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #/*02%PBASP6QS^=/HHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@!CQ)(5+(K%>06&<4^BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** &NBR*5=0RGJ&&12JH50%  '  I:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *8L21LS*BJS<D@8)^M/HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ IAB1I Y12XX#8Y'XT^B@ HHHH **
M** "BBB@ HHHH **** "O/\ X@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U
M_P#0FH VOA__ ,@:;_KX;_T%:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA\%LNH2_;O%6KR?;M:U!FW-+<-DE=W=5W$9[DLW\5 'JE%%% !1110 4444
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MR87D >3')V@G)Q[5YC\)_BY%??L[:)X\\4W:VZ1Z:9;^Z<8WM&S1LV/[SLG
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M>6.,,YR<\G P/H*^5/A3\)]3_;&_M3QY\1M=U*+0VNW@TK1]/G"1QA>I 92
MJY"@@;F(8D^H!]N45\/W^FZO^Q7\:O"MKINN7VH_#GQ%+Y,EG?R!_)^=5D.
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M1/@OPZG@_P 'Z%H,<GFQZ78062R8QN$<:IG\=M?.OQ(O+C]J#XN+\-]*F<>
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M[]F?X87_ (;^'6O>-?$VZ;QEXOCDU"[DF7#Q0LK-''C^'.=Q'&,JN/EKF_\
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MYM[G4KCS">G#6ZX/X.:^OZ^5_P#@H)X5OM0^'?A_Q-I\;/)H&H[Y609,4<@
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M5CN;INX^;@)S1^'?B+3_ (-[_B/\35O-1^)?CEB]GH^G6QGNX+7C9#''D;>
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MRZO)8_V?J6EZPSI%<QCHRLO?Y4&,@ HIR>17G_B!_$?P'O/$?Q)\67.GZO\
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M *\_^('_ "&8?^O=?_0FKT"O/_B!_P AF'_KW7_T)J -KX?_ /(&F_Z^&_\
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M NG#W$S2-+-,PZ%G8DD#)P.@R<#DUV=% !1110 4444 %%%% !1110 4444
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M;>ZEBMI7SG<8E8 =^%P.3QS7K]C96^FV<%I:01VMK;QK%%!"@5(T4855 X
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M%WA]-%\,:7%I>GJQD9$)9I'/5G=B68\#DGH .@%=+10 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>?_$#_ )#,/_7NO_H35Z!7
MG_Q _P"0S#_U[K_Z$U &U\/_ /D#3?\ 7PW_ *"M=-7,_#__ ) TW_7PW_H*
MUTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?\
MQ _Y#,/_ %[K_P"A-7H%>?\ Q _Y#,/_ %[K_P"A-0!M?#__ ) TW_7PW_H*
MUTU<S\/_ /D#3?\ 7PW_ *"M=-0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7G_Q _P"0S#_U[K_Z$U>@5Y_\0/\ D,P_]>Z_^A-0
M!M?#_P#Y TW_ %\-_P"@K735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M73+;4WN6$D@,@02@;<8^96V]<'K7H_[8?Q*?X>?!?4H;-V&KZZW]E6:Q_?\
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MX7!% 'OM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>?\ Q _Y#,/_ %[K_P"A
M-7H%>?\ Q _Y#,/_ %[K_P"A-0!M?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\
M7PW_ *"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:MQ97'V[R/+^QN[8V>9G=N1?[XZ9[USY#E6.PV8TJM:DU%7U_P"W6CIX@S?
M8K+*M&C54I.UE_V\F>L5\"?!'X+^%/C+\?/C!:^*K&6]AL=4N)(!'</#M9KJ
M4'[I&> .M??=?/7[/OP2\3?#?XO?$WQ#K,=JNFZ]>23630S[V96N)) 6&/E^
M5A7ZZ?C1U/@']E7X<?#3Q59^(]!T>>VU:T#B&:2]FD";T9&^5F(/RLPY]:^?
MOC19^+-2_;DT2V\,ZE9:1KK:4!IEY?Q>9$BB"<OE=K<G]Z!QU-?;M>'?M&?L
M_7_Q0O-$\5>$]5CT'QQH)W6=U(/DF4-N5'8 XPV2#@CYF!&#D '.ZE\.?VCM
M6TZZL;KX@^%9+:ZB:&5/[/QN1@0P_P!3Z$UT'PA^#^I?!#X >(O#FJ:C;ZE=
M-'>W7F6H81HK0@!1N )^Z3T_BKF(_$G[4K0C3SX4\(K, %.K-.-I'][8)NO&
M?N8YZ5[!X;\/^+F^$\VD^+=4M-9\67%I<QSW=K&(H"S[]B@!5X565<[03C-
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M HHHH **** "BBB@ KS_ .('_(9A_P"O=?\ T)J] KS_ .('_(9A_P"O=?\
MT)J -KX?_P#(&F_Z^&_]!6NFKF?A_P#\@:;_ *^&_P#05KIJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_^('_(9A_Z]U_]":O0
M*\_^('_(9A_Z]U_]":@#:^'_ /R!IO\ KX;_ -!6NFKF?A__ ,@:;_KX;_T%
M:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/\
MX@?\AF'_ *]U_P#0FKT"O/\ X@?\AF'_ *]U_P#0FH VOA__ ,@:;_KX;_T%
M:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_G[_P#(2?X4?\)AJ_\ S]_^0D_PHHH /^$PU?\ Y^__ "$G^%'_  F&K_\
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MPU?_ )^__(2?X4?\)AJ__/W_ .0D_P *** #_A,-7_Y^_P#R$G^%'_"8:O\
M\_?_ )"3_"BB@ _X3#5_^?O_ ,A)_A1_PF&K_P#/W_Y"3_"BB@ _X3#5_P#G
M[_\ (2?X4?\ "8:O_P _?_D)/\*** #_ (3#5_\ G[_\A)_A1_PF&K_\_?\
MY"3_  HHH /^$PU?_G[_ /(2?X4?\)AJ_P#S]_\ D)/\*** #_A,-7_Y^_\
MR$G^%'_"8:O_ ,_?_D)/\*** #_A,-7_ .?O_P A)_A1_P )AJ__ #]_^0D_
MPHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\ "BB@ _X3#5_^?O\ \A)_
MA1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4?\)AJ_\ S]_^0D_PHHH
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M1_PF&K_\_?\ Y"3_  HHH /^$PU?_G[_ /(2?X4?\)AJ_P#S]_\ D)/\***
M#_A,-7_Y^_\ R$G^%'_"8:O_ ,_?_D)/\*** #_A,-7_ .?O_P A)_A1_P )
MAJ__ #]_^0D_PHHH /\ A,-7_P"?O_R$G^%'_"8:O_S]_P#D)/\ "BB@ _X3
M#5_^?O\ \A)_A1_PF&K_ //W_P"0D_PHHH /^$PU?_G[_P#(2?X4?\)AJ_\
MS]_^0D_PHHH /^$PU?\ Y^__ "$G^%'_  F&K_\ /W_Y"3_"BB@ _P"$PU?_
M )^__(2?X4?\)AJ__/W_ .0D_P *** #_A,-7_Y^_P#R$G^%'_"8:O\ \_?_
M )"3_"BB@ _X3#5_^?O_ ,A)_A1_PF&K_P#/W_Y"3_"BB@ _X3#5_P#G[_\
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-#; . >F!CU-%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>iart-20221231_g3.jpg
<TEXT>
begin 644 iart-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" /A!G4# 2(  A$! Q$!_\0
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
MOI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?
M_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B
M:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_[Z7_ .)KIJ* .9_X5_I_
M_/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH YG_A7^G_\]KK_ +Z7_P")
MH_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\ OI?_ (FC_A7^G_\ /:Z_
M[Z7_ .)KIJ* .9_X5_I__/:Z_P"^E_\ B:/^%?Z?_P ]KK_OI?\ XFNFHH Y
MG_A7^G_\]KK_ +Z7_P")H_X5_I__ #VNO^^E_P#B:Z:B@#F?^%?Z?_SVNO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'F?C#_D8[O_ (!_Z M%'C#_ )&.[_X!_P"@+10!TWP__P"0--_U\-_Z"M=-
M7,_#_P#Y TW_ %\-_P"@K734 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5Z%\1/B%IOPP\"ZEXKUJ.X&GV$:/+% JM*2[JBJ!D#)9U'7'O7Q;^RSX;O\
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MS@9QZ"O'_P!I3X<^$]*^!/C2[LO"^C6=W#8,T<]OI\*.AW+R&"Y!^E ' ?\
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M^TIIMG' SKT=P/G?_@3%F_&@#YWU#_@HIX#M;V>&WT'7KN&-RJSJD*B0#^(
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M#PS)\<#\,%T_5#K'FF#[9Y<?V?S!'YA'W]V-HQG'7MCFO8J_/ZS_ .4BS?\
M85D_](S7Z T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >9^,/^1CN_\
M@'_H"T4>,/\ D8[O_@'_ * M% '3?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\
M7PW_ *"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9_V:_P!L35/!T[F+0]8F-A%O/!24B2T;W()6//\ M-1_P3A_Y*)XK_[!2_\
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M./1QZU]N^!_#_P#PB?@GP_H><_V9I]O99SG/EQJG_LM 'PU_P3C4/\0?%JL
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M]%\UP?\ =-?HPK!E!!R#R"* %HHHH ^!O^";O_([>,?^P=#_ .C:^^:_/O\
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M?]@:S_\ 1"5\L_\ !2?_ ) ?@3_KXO/_ $&*OJ;X4_\ )+O!W_8&L_\ T0E
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M!?I;7+"9=S'.54@\DCCTKUK_ (*+?\D3T3_L88/_ $FN:],_9/\ ^3=_ _\
MUY-_Z->@#SOX/_M._$/QY\1-)T'7?AC=:+IEX9%EU#R+A!!MC9@Q+IMP2H')
M'7\#]/444 >6?M2?\F^>.?\ L'-_Z$M>2_\ !.;_ ))#X@_[#LG_ *3P5ZU^
MU)_R;YXY_P"P<W_H2UY+_P $YO\ DD/B#_L.R?\ I/!0!]6U\#?MN?\ )T7@
M3_L'6'_I=/7WS7P!^WZ\NA_';P;K9C+0QZ7 5XX9HKJ5R,_1U_.@#[_HJ*UN
MH;ZUAN;>19H)D62.1#E64C((/H0:?)(D,;R2,L<: LS,<  =230!\ _L5_\
M)U'C+_KSU#_TKBKZ1_;4_P"39?&7_;G_ .EL%?-G["&[7/VB/%^L0H?LC:==
M2;NP,EU$5'U(#?E7TG^VI_R;+XR_[<__ $M@H ^6OV<OVP](^"/PW_X1N]\/
M7VIW NY;GSH)D1,.%P.>>U7/'/QY\:_MDW4'P^\):':Z'I\[+<7,=Q?*TDRH
M<Y=B%^13M;8JLV5!YZ5[7^P;H]AJ'P"_TJRM[G=J=RK>=$KY&$X.1TKRW]M3
MX+P_"S6-%^)?@F#^PR;M4NTL0(T@N1\\4R ?=W88''&0.[&@#ZQ^!OPEL_@K
M\.=/\,VLWVN:,M/=W>W;Y\[?>;&>!P% ]%'>OE__ (*6_P#-.?\ N)?^VM?4
M_P %?B1#\6?ACH/B>+8LUY !=1)TCN%.V5<=AN!QGL0>]?+'_!2W_FG/_<2_
M]M: /0/V@_@S_P +6_9G\.WMA!YOB#0=*M[VT"+EY8_(3S8A]5 8 =611WI?
MV$_C-_PGGP[?PKJ,_F:UX=58XRYYELSQ&??9]P^@">M>]?#?_DG?A?\ [!5K
M_P"B5KX5^)NDW/[(7[46G^*-+A>/PMJDK7"PQ_=:W<@7-N!ZH3N4=OW?I0!<
ML_\ E(LW_85D_P#2,U^@-?GSH]W!J'_!0FWO+69+FTNK_P"T0S1G*O&]CN5@
M?0@BOT&H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S\8?\ (QW?_ /_
M $!:*/&'_(QW?_ /_0%HH Z;X?\ _(&F_P"OAO\ T%:Z:N9^'_\ R!IO^OAO
M_05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JZII=KK>EW>G7\"W5C=PO
M;SP2?=DC92K*?8@D5:HH _//Q1\$_BA^R=\0)_$_P_CNM:\/MN"RV\)G_<DY
M\FZA7D@8'SCC@$%3P.DMO^"C.O- +-_A];RZOTS'?2!<XY_=>66]_O5]T44
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MOCGDNVG^VW-E8_\ 'Q!<=6EB7_EHKG)* $Y)X(.!1T?_ (*&^(?#=N-.\7^
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MMNTV<F&SC&.1S[U]ZT4 %>-_M@:3>ZY^SGXPL]/M)KVZ9;5UAMT+N52ZA=B
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /,_&'_(QW?\ P#_T!:*/&'_(QW?_  #_ - 6B@#IOA__
M ,@:;_KX;_T%:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S\8?\C'=_\  /\
MT!:*/&'_ ",=W_P#_P! 6B@#IOA__P @:;_KX;_T%:Z:N9^'_P#R!IO^OAO_
M $%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /,_&'_(QW?\ P#_T!:*/&'_(QW?_  #_ - 6
MB@#IOA__ ,@:;_KX;_T%:Z:N9^'_ /R!IO\ KX;_ -!6NFH **** /F[XV_'
M/QI-\6++X5?#&WLT\1R0K/>:I?@,ELI7?@ @CA,,20WW@ ,UQ>F? ?\ : ^&
M?B#6O&'A_P 5:!X@UO5F274[.6()]M9=VU1NC55Z_P +1]?:K_[07PV\=^ ?
MC=:?&3P#IIU\^2L6HZ;&A>0[8_*/R#YF5D"_=R5*YQBNK^&_[<7@3QE>PZ7K
ML=UX,UEF\MHM2 -N)/[OG#[OU=4% 'N3:AJT?@\WW]G+)KJV'G?V>K@*UQY>
M?*#9Z;_ESFOG6'X9_M%^/+<ZKK'Q%LO!EQ("T.C:=;AUAS_"[+W]]S_6OJ)6
M#*&4@@C(([U\Z?$O]MSPS\.=:UG1I/#'B*\U'39WMFD:"**UD=>,B0N3M)QS
MLZ=J ,?]FOXW>-YOBGX@^%?Q&EAU#6]-1Y(-1B55+[""5.T ,K(ZLIV@X!SU
MX[S]J'XZW/P5\(6(T:U2^\4:U.;338) 6"D ;I"HY;&Y %[EQVXKRO\ 9!T=
M/B+\3/%?Q:U?6=+N==U!3''H]A/ODLHWV\R \C"HJ+USAN<U%^T5MUG]L[X0
M:3<#S+:"*WNQ&WW=WVF4]/K"OY"@#0F^$O[1S>'?[?'Q13_A(3']I.A"W01!
ML9\H-MV9[8V[<]\<UZ/^RO\ '6Z^-W@B\DUB".U\2:/<?9;^.)2JOD923:?N
MYPP(]4;H.![57Q_^RWLTG]JSXTZ7;@I;O//,$'"C;=' Q[>8<4 :OCOXL_$+
MXP?&C4OAM\,=0A\/:;HN5U;7VC$C!@0' )!VX;Y %PQ(8Y SCGO'GB+XT?LJ
MWVE^(=<\5Q_$'PA<W"V]W%-"$=&()P.,H2 VU@Q&1\PZ9M_\$\]NJ6GQ%UV0
M;[N^U&+?(W+$8D?^<AKUC]LFQBO_ -F_Q@)5R84MYD/=66XC.1^H_$T >O:3
MJEMKFE66I64HFL[R%+B"0='C=0RG\015NO*/V5;YM0_9Y\#RN22MCY/S>B.R
M#]%KU>@ HHHH ***RKKQ1IEG</#-<[)4.&7RV./R% &K16+_ ,)AI'_/W_Y"
M?_"C_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_
M .% &U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _
M?_D)_P#"C_A,-(_Y^_\ R$_^% &U16+_ ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R
M$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_ .% &U16+_PF&D?\
M_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _?_D)_P#"C_A,-(_Y
M^_\ R$_^% &U16+_ ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\ A0!M45B_\)AI
M'_/W_P"0G_PH_P"$PTC_ )^__(3_ .% &U16+_PF&D?\_?\ Y"?_  H_X3#2
M/^?O_P A/_A0!M45B_\ "8:1_P _?_D)_P#"C_A,-(_Y^_\ R$_^% &U16+_
M ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$
MPTC_ )^__(3_ .% &U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45
MB_\ "8:1_P _?_D)_P#"C_A,-(_Y^_\ R$_^% &U16+_ ,)AI'_/W_Y"?_"C
M_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_ .%
M&U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _?_D)
M_P#"C_A,-(_Y^_\ R$_^% &U16+_ ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\
MA0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_ .% &U16+_PF&D?\_?\
MY"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _?_D)_P#"C_A,-(_Y^_\
MR$_^% &U16+_ ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W
M_P"0G_PH_P"$PTC_ )^__(3_ .% &U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O
M_P A/_A0!M45B_\ "8:1_P _?_D)_P#"C_A,-(_Y^_\ R$_^% &U16+_ ,)A
MI'_/W_Y"?_"C_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_
M )^__(3_ .% &U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45B_\
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M_A,-(_Y^_P#R$_\ A0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_ .%
M&U16+_PF&D?\_?\ Y"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _?_D)
M_P#"C_A,-(_Y^_\ R$_^% &U16+_ ,)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\
MA0!M45B_\)AI'_/W_P"0G_PH_P"$PTC_ )^__(3_ .% &U16+_PF&D?\_?\
MY"?_  H_X3#2/^?O_P A/_A0!M45B_\ "8:1_P _?_D)_P#"C_A,-(_Y^_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'F?C#_D8[O_ (!_Z M%'C#_ )&.[_X!_P"@+10!TWP__P"0
M--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@K734 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >9^,/\ D8[O_@'_ * M
M%'C#_D8[O_@'_H"T4 =-\/\ _D#3?]?#?^@K735S/P__ .0--_U\-_Z"M=-0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!YGXP_Y&.[_X!_Z M%'C#_D8[O\ X!_Z M% '3?#_P#Y TW_ %\-_P"@
MK735S/P__P"0--_U\-_Z"M=-0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!YGXP_Y&.[_ . ?^@+11XP_Y&.[_P"
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MMN^8DJ1BMG]O;QMK_@OX9Z%+X?UF^T2>XU98Y9]/N&@D9!#(=N]2#C(!QGG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBOS<^*GQ@\<P_$SQ7#!XPURTMX=4N88H+749HHXT65E5556
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MD+R,<EF0$F@"M_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_?
MH_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?
M\(_IO_/C!_WP*/\ A']-_P"?&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\
MS^+_ -\M_A4W_"/Z;_SXP?\ ? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?
M\)7I/_/XO_?+?X5-_P (_IO_ #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]
M\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>
MD_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?\(_IO_/C!_WP*/\ A']-_P"?
M&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\ S^+_ -\M_A4W_"/Z;_SXP?\
M? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?\)7I/_/XO_?+?X5-_P (_IO_
M #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"
M/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\
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M]-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_?
MH_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?
M\(_IO_/C!_WP*/\ A']-_P"?&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\
MS^+_ -\M_A4W_"/Z;_SXP?\ ? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?
M\)7I/_/XO_?+?X5-_P (_IO_ #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]
M\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>
MD_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?\(_IO_/C!_WP*/\ A']-_P"?
M&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\ S^+_ -\M_A4W_"/Z;_SXP?\
M? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?\)7I/_/XO_?+?X5-_P (_IO_
M #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"
M/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\
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M]-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_?
MH_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?
M\(_IO_/C!_WP*/\ A']-_P"?&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\
MS^+_ -\M_A4W_"/Z;_SXP?\ ? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?
M\)7I/_/XO_?+?X5-_P (_IO_ #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]
M\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>
MD_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?\(_IO_/C!_WP*/\ A']-_P"?
M&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\ S^+_ -\M_A4W_"/Z;_SXP?\
M? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?\)7I/_/XO_?+?X5-_P (_IO_
M #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"
M/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\
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M]-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_?
MH_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?
M\(_IO_/C!_WP*/\ A']-_P"?&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\
MS^+_ -\M_A4W_"/Z;_SXP?\ ? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?
M\)7I/_/XO_?+?X5-_P (_IO_ #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]
M\M_A1_PE>D_\_B_]\M_A4W_"/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>
MD_\ /XO_ 'RW^%'_  E>D_\ /XO_ 'RW^%3?\(_IO_/C!_WP*/\ A']-_P"?
M&#_O@4 0_P#"5Z3_ ,_B_P#?+?X4?\)7I/\ S^+_ -\M_A4W_"/Z;_SXP?\
M? H_X1_3?^?&#_O@4 0_\)7I/_/XO_?+?X4?\)7I/_/XO_?+?X5-_P (_IO_
M #XP?]\"C_A']-_Y\8/^^!0!#_PE>D_\_B_]\M_A1_PE>D_\_B_]\M_A4W_"
M/Z;_ ,^,'_? H_X1_3?^?&#_ +X% $/_  E>D_\ /XO_ 'RW^%'_  E>D_\
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M^BJV[\Q1S8REO?\ ,?L>'<;\/(GZ\OX:'U=X?_;0^&VLA!=W6H:([<$7UHS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9-,
MEO$\LKK'&BEF=S@*!R23V%?/?Q8_;*\->#?.L/#*KXGU9<KYL;8LXC[N/O\
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M444 %%%% !1110 4444 %%%% !1110 4444 >9^,/^1CN_\ @'_H"T4>,/\
MD8[O_@'_ * M% '3?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0
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M:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\
MO@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X
M'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='
M17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:
M;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YI
MO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^
M!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?
MXT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%
M<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO
M]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_
MW9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'
M^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C
M1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5S
MG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W
M9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=
MG_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?X
MT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'
M_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?
M\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G
M_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?
M_O@?XT?\)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0
M!T=%<Y_PGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\
M)YIO]V?_ +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_P
MGFF_W9_^^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_
M +X'^- '1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^
M^!_C1_PGFF_W9_\ O@?XT ='17.?\)YIO]V?_O@?XT?\)YIO]V?_ +X'^- '
M1T5SG_">:;_=G_[X'^-'_">:;_=G_P"^!_C0!T=%<Y_PGFF_W9_^^!_C1_PG
MFF_W9_\ O@?XT ='7)S?%SP+;3/#-XT\/12QL5>-]5@#*1P007X-277CS3?L
MLV!.#L;'R#T^M?E97!BL2\/RV5[GU61Y-#-O:.<W'EMMYW_R/U+_ .%Q> ?^
MAX\-_P#@VM__ (NC_A<7@'_H>/#?_@VM_P#XNORTHK@_M*?\I]5_J=0_Y^O[
MD?KA/J]C:Z:=1FO;>+3Q&)3=R2JL6PC(;>3C&.^:\)^(O[9W@SPEYMMH:R>*
M=07C-L?+ME/O*1\W_ 01[U\.ZQXPUO7]/L;#4-5NKNQL8EAM;624^5"JC "I
MT''?&35/2=&O]>O$M-.LY[ZY;I%;QEV^N!V]Z*F83EI35AX7A/#T;U,74YDN
MFR^;W_(]%^)G[2'C;XH>;;WNHG3M)?(_LW3\Q1%?1SG<_P#P(D>@%>9VEI/?
MW,=O;0R7%Q(VU(H4+.Q/8 <DU[O\/?V5KO598[CQ=J+:-9]3:V:B:Y;V)^XG
MU^;Z5]4_#WPW\/\ X7VPC\/Z,;:<KM>\D027$GKF0G./88'M40PE:N^:H[>I
MT8C/\MRN'L<'%2:Z1T7S?7Y7/F+X7_L7^*?%OE7GB63_ (1?33SY4B[[MQ[)
MT3_@1R/[IKZ\^''P9\)?"NUV:!I4<5TR[9+^?]Y<R?5ST'LN![5J?\)YIO\
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MPBAF8=#+MR^/;<6KKJ** "BBB@ IAA1CDHI/TI]% $?D1_\ /-?^^11Y$?\
MSS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_
M ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1
M_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y
M$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4
M>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y
M%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^
M^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7
M_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \
MU_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\
M/-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_
M #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'
M_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D
M1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'
MY$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244
M1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E%
M $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)
M10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%
M244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^
M14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/-?\
MOD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_
M +Y%244 1^1'_P \U_[Y%'D1_P#/-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U
M_P"^14E% $?D1_\ /-?^^11Y$?\ SS7_ +Y%244 1^1'_P \U_[Y%'D1_P#/
M-?\ OD5)10!'Y$?_ #S7_OD4>1'_ ,\U_P"^14E% $?D1_\ /-?^^11Y$?\
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MSS&3TA$^GP_!]*.N)JM^2T_%W_0^L/&W[=7VB&:W\+^%HX@P*BZU9PQP>/\
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MR*/(C_YYK_WR*DHKS3N(_(C_ .>:_P#?(H\B/_GFO_?(J2B@"/R(_P#GFO\
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M&(']X97T)KT6OGIPE3?+-69[,91FN:+N@HHHJ"@HHHH **** "BBB@ HHHH
M**** /,_&'_(QW?_  #_ - 6BCQA_P C'=_\ _\ 0%HH Z;X?_\ (&F_Z^&_
M]!6NFKF?A_\ \@:;_KX;_P!!6NFH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BL+QYXC?P?X)U[7(X5N)--L9KM(F. [(A8 ^Q(KXO_P"&[O'W_0(\
M.?\ @-<?_'ZYJV(IT6E,]K 91BLRC*>'2LM-78^[:*^$O^&[O'W_ $"/#?\
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MX?\ _(&F_P"OAO\ T%:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8QC'N,^V:Z:>%KU?@@W\C"=>E3^*21].45\!>*O^"IC?O(_#7@(#^Y<:K?\
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M . ?^@+10!TWP_\ ^0--_P!?#?\ H*UTU<S\/_\ D#3?]?#?^@K734 %%%%
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M)4^X)(_"MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HI"<<G@5Y_XP^/O@#P-O74_$UF;A>MK9M]HE
MSZ%8\[3_ +V*F4HP5Y.QM2H5:\N2E%R?DKGH-%?)GC']O2SA\R+PMX;EN6Z+
M=:K((U^OEH22/^!"O#/&/[3WQ&\9[TF\02Z9:MQ]FTH?9E /4;E^<CZL:X*F
M.HQVU/J<+POF%?6HE!>;U^Y7_&Q^@OBKXA>&? \/F:]KMCI7&X1W$ZB1A_LI
M]YOP!KP[QE^W)X0T??%X?TZ]\0S#I*X^RP'WRP+_ /C@KX9FGDN9GEFD:65S
MEG<DL3ZDFM[PK\/?$OCB;RM!T.^U4YP7MX6,:_[S_=7\37!+'U9NU-6_$^JH
M<*X'#1Y\7-RM_P!NK_/\3U'QE^V-\0_%&^*RN[?P[:MQLTZ+]YCWD?+ ^Z[:
M\:U;6M0U^\:[U.^N=1NV^]/=S-*Y^K,2:^AO!O[#/B[6-DOB#4K+P_"<9BC_
M -*G'MA2$_\ 'S7N_@W]COX>>%MDMY9W'B*Z7G?J4O[L'VC3:N/9MU3]7Q-?
M6?XF\LXR;*URX9)O^ZOUZ_>SX'T+PWJWBB\%IH^F7FJ7/_/&S@:5A[D*#@5[
M5X-_8N\?^(]DNIK9^'+8\G[9+YDN/9$SS[,5K[STK1M/T&S2TTVQMM.M4^[!
M:PK$@^BJ *N5V4\O@OC=SYW%<78FIIAH**[O5_HOS/G3P;^P_P""M#V2ZY>7
MWB.<=8V;[- ?^ H=W_C]>W^&/ _A[P7;^1H6BV.DIC#&U@5&;_>8#+?B36Y1
M7H0HTZ?P1L?(XG,,7C/X]1R\NGW;!1116QYX4444 %%%% !1110 4444 %%%
M% !1110 4444 %%9&O\ C#0?"D7FZWK>G:/%C=OU"[C@&/7+D5Y9XD_;.^#/
MA;>MSX[L+N13C;IJ27F3[-$K+^.<5M"C4J?!%OT1G*I"'Q22/:J*^/O$O_!3
MCX<Z:'31]"U_6I0.&>**WB/MN+EO_':\I\2?\%2O$=P6'A_P-I>GC^%M2NY+
MK\2$$7\Z[X97BY_8MZG'+'X>/VC]%Z*_)/Q)_P % /C1X@#K#X@M=$B;@IIN
MGQ+^32!V'X&O*O$GQP^(?C#>-9\;Z_J$;9S#+J,OE<]<(&VC\!7?#(ZS^.27
MXG)+-:2^&+9^T?B+Q]X9\(@G7?$>DZ*!U.HWT5OCC/\ &P[5Y5XE_;:^"_A@
M.)?&UM?S 9$6FP37.[V#(A7\V%?CVS%V+,2S$Y)/4TZ&&2YE6*&-I9&.%1%)
M)/L!7=#(Z2^.;?X?YG)+-JC^"*7X_P"1^EGB7_@IYX T\LFB^&]>UAU/WYQ%
M:QM]#N9OS45Y1XE_X*C>+KP,- \&:-I0(P#J%Q+>$>_R^4/TKYK\-?LZ_$_Q
M=L.E> M?GC<X6:2PDAB/_;1P%_6O5_#7_!.OXQZ\$-Y8:5X?5AG.I:BK$?40
MB0UM]4RVA\;5_-_H9_6,=6^%/Y(QO$O[>7QI\1EU7Q2FD0,<^3IME#'CZ.5+
M_P#CU>2>*/BAXQ\;;AX@\5:SK2G^"_OY9D'T5F('X"OLOPS_ ,$LKV3:_B#Q
M];P ?>ATS3VDS]'=UQ_WR:]8\+_\$V?A1HOEOJDVN>(9!]];J\$,1^@B56 _
MX$:/K^7X?^&ON7_#!]4QE;XW][/RUK7\/^#M?\73>3H6AZEK4N[;Y>GVDD[9
M],(#SS7[)^%?V9?A5X+\LZ5X!T..2/E)KFU%S*ON'EW,#^->DV]M#9P)#;Q)
M!"@PL<:A54>@ Z5S5,]C_P NX?>S>&4R^W/[C\@/"W[$?QG\5[7B\&7&FP'K
M+JD\5KM^J.P?\EKV;PA_P2[\57Q1_$WC'2M(0\M'IL$EX^/3+>6 ?S_&OT>H
MKS:F<XF?PV7R_P SMAEE"/Q79\I>#_\ @FW\*= \M]8DUCQ-*/OK=W?D1'Z+
M"%8#_@1KW'P?\!OAUX!V'0?!6BZ?,GW;A;-'G_[^L"Y_.N\HKS*F*KUOCFW\
MSNAAZ5/X8I!1117*= 457N-0M;/_ %]S#!_UT<+_ #K)N/'OAJT_UNOZ:A_N
M_:T)_(&LI5:</BDE\Q71O45Q=Q\9?!EK]_786_ZYQR/_ .@J:R;C]H/PA#]R
M>[N/^N=N1_Z%BN66882'Q58_>B>>/<]*HKQ^Y_:8T%?^/?3-1E_ZZ"-/Y,:R
MKK]I]>1;^'B?1I;O'Z!/ZUR2SK 1WJ_@W^A/M(=SW6BOG2Z_:9UIL_9])L(O
M3S2[_P B*RKK]H?Q;<9\MK*VS_SRM\X_[Z)KDEQ#@8[-OY?YV)]M$^H**^2;
MKXU>-+K.[6W0>D4,:8_$+FLFZ^(OBB\SYOB#4L'J$N70'/L"*Y)<389?#"3^
M[_-D^WCV/LRJ]Q?VUG_K[B&#_KHX7^=?$UQKFHWF?/O[J?/_ #TF9OYFJ5<L
MN)U]FC^/_ )]OY'VE<^.?#EGGSM>TV,_W6NX\_EFLRX^+G@^USOUZV;'_/,,
M_P#Z"#7R!17++B:O]FFE]_\ P!>W?8^K+CX]>#(<[-2EGX_Y9VL@_P#0E%9U
MQ^T;X5ASLBU&?G_EG H_]"<5\UV]C<W6/(MY9LG \M"W\JT;?P?K]UCR=#U*
M;(R/+M)&_D*R_M_,*GP17R3_ ,Q>VFSW*?\ ::T9?]3I%])_UT9%_D36=-^U
M @XB\.,W'5[W'/T$=>7P?"WQ;<?<\/WPZ?ZR/9U^N*T8/@AXUGQC12@SC,EQ
M$N/PWYH_M'.:GPQ?RA_P YZK.RE_:=OFQY>A6Z>NZ=F_H*J3?M,:ZV[RM+TY
M/[N\2-CZ_,,UBQ?L_P#C&3.ZTMHO]ZY7G\LU<B_9Q\52$!IM-BR.K3OQ^2&C
MVV>3Z2^Y+] O5'2?M(>*9""MMID?LL#_ -7-53^T)XNS_K;,?]NX_P :U(OV
M:/$#+^\U/34.?X6D;_V05;7]F/4=PW:W:A>Y$+$_SH]GGDOYOO2_4+53F3\?
M/&1)_P!/A'_;M'_A44OQV\:R8VZLL7^[:P\_FIKL?^&8;K_H8(?_  %/_P 5
M4L?[+[E?WGB15;T6RR/_ $8*/JN>/2\O_ E_F'+5.$;XX>-G4J=;.#Z6L(/Y
MA*9'\:O&D+$KKCGM\T$3?S2O04_9?4,-_B4LO<+8X/\ Z,J27]E^%E'E^(I$
M.>K68;_V<4?4<[WO+_P/_P"V#EJ_TSS_ /X7EXW_ .@W_P"2D'_Q%2Q_'CQH
MB@'4XY#_ 'FM8L_HM=M_PR[_ -3-_P"2'_VVHI/V8)PQV>(HV7U:T(/Y;S1]
M3SQ=9?\ @?\ ]L'+5.1_X7YXS_Z"$)_[=H_\*M1?M$>+8\[C8R?[UOT_(BNA
M/[,-U@X\00D_]>I_^*JK+^S+JZ@>7K%BY[[D=?Z&CV&>1ZR_\"O^H6JE2']I
M3Q*FT26&ER #G$<@)_\ '_Z5H6_[3FHK_KM$M9./^6<S+S^(-9TW[-?B9-Q2
M^TN0#I^]D!/_ (Y_6J%Q^S[XOASL@M9^?^6=P!_Z%BCVF>4_YON3"]5'96_[
M3\#']_X>DC'K'=AOYH*UK7]I3P[+@3V&I0'U5$<#_P >!_2O)+CX*^-+7);1
M)&'_ $SFB?\ DU9%U\/_ !-8Y\[0-24#JRVKLOY@8H_M3-Z7QQ?SC_P$'M*B
MW/HNT^/7@VZP'U":V)_Y[6S_ /LH-;UC\2O"NH8$.OV&3T6281D_@V*^/;FQ
MN;,XN+>6 _\ 31"O\Z@JH\28J+M4@G]Z_4/;2ZH^YK74+6^7=;7,-POK$X8?
MI5BOA..1X7#HS(XZ,IP16]I_Q \2Z7C[-KM_&HZ(9V9?^^22*]"GQ/#_ )>4
MK>C_ . BU7[H^SJ*^6--^/WC"QQYMU;WX':YMU_FFTUU>F_M.3KA=0T*-_5[
M:<KC_@+ _P Z].GQ!@:GQ-Q]5_E<T5:+/?**\PTO]HCPI?8%R;S3F[F>'<OY
MH6/Z5V6E>._#NM[?L6M64[MTC\X*_P#WR<']*]>ECL-7_AU$_F:*47LS=HHH
MKM*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#S/QA_R,=W_P#_T!:*/&'_(QW?\ P#_T!:* .F^'_P#R!IO^
MOAO_ $%:Z:N9^'__ "!IO^OAO_05KIJ "BBB@#Y[_:$_9BO?B-XGL/''@O6_
M^$;\;V"JJS.S+'.%SM)902C $C.""."*\^B_:B^*7P-U"TT[XP^#OM>FR.(E
MUS3@JE^Y.5)B=L<[!Y9KVB?]JKX<Z;XTUGPMK&L/H.JZ9<&WD_M*$QQ2D ?,
MD@RN.1]XJ>^,<UY?^U=^T1\//$'PCU?POI&KVOB?6=6$<5K;:?F9482*V]G'
M (QP,Y)P,8R0 ?3GAWQ!I_BS0K'6-*N4O--OH5G@GCZ.K#(^A]0>0>*\H_;(
M_P"3:_&G_7.V_P#2J&MO]FGP?J?@+X&^$]$UA'BU*"W>2:&3[T1DE>0(?=0X
M7\*\R_:O^,W@7Q%\"/%^BZ7XMT?4-5E6!([.VNT>1V6YB+  'G 4G\* /0/V
M3_\ DW?P/_UY-_Z->L_]JCX%ZI\>O!NE:1I&H6>GW-GJ NF>]W[&7RW4@;03
MG+#MZUA?LJ_%KP7;_!_P-X;E\4Z5%KQ@^SC3I+I%F,K2-M3:3G<<C [Y%>I>
M,OC+X.^'GB#3M&\2:Y!HUWJ$336[78*1,JL%.9,;5Y/\1% '@.M>&OVG_ASH
MLVJVGC#1?%EO9Q^9)I<=I'YA1%!^0>2A/"GY0P)[ DUZW^S=\=H/CUX%;5FM
M%T_5K.;[-?VD9+(KXRKH3SM8'OR"".<9+O'W[3GPY\#^&;O4_P#A*](U>X2(
MM;V.FWD=S-.^#M4*A. 3_$< >M>8?\$_? .H^&?AGJVO:A UL/$%TDMK&W&Z
M"-2%DV]@S,^/4 'H10!B?\$YG-QX7\<73C]]-J41?_OAC_,FO7?VOXUD_9O\
M:A@&'D0GGU%Q$1^HKP3]GWQAIW[-7QR^(/@3Q?<KHVGZC<BXL+ZZ.R#:I<QD
ML> 'C<<] 4QG-=1^V-\;-!\6> X?A]X.U.U\4:_X@NX(C#I,RW 1%D#@%D)&
M]G5 %SG&2<#&0#UO]DV223]G7P091AOL; ?[HE<+^F*];KE?A7X/;X?_  W\
M->''99)M-L(;>5U^ZT@4;R/8MNKJJ "BBB@ K OO$\UG=RPKI=Q,J' D7.&]
M^E;]% ',_P#"87'_ $![K]?_ (FC_A,+C_H#W7Z__$UTU% ',_\ "87'_0'N
MOU_^)H_X3"X_Z ]U^O\ \37344 <S_PF%Q_T![K]?_B:/^$PN/\ H#W7Z_\
MQ-=-10!S/_"87'_0'NOU_P#B:/\ A,+C_H#W7Z__ !-=-10!S/\ PF%Q_P!
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M@/=?K_\ $UTU% ',_P#"87'_ $![K]?_ (FC_A,+C_H#W7Z__$UTU% ',_\
M"87'_0'NOU_^)H_X3"X_Z ]U^O\ \37344 <S_PF%Q_T![K]?_B:/^$PN/\
MH#W7Z_\ Q-=-10!S/_"87'_0'NOU_P#B:/\ A,+C_H#W7Z__ !-=-10!S/\
MPF%Q_P! >Z_7_P")H_X3"X_Z ]U^O_Q-2^./'^@?#?1EU7Q'J*Z;8-*L*R-&
M\A9R"0H5 6)P">!V-<#_ ,-;?"C_ *&O_P IUW_\:K.56$':4DCMI8+%8B//
M1I2DNZ3:_ [G_A,+C_H#W7Z__$T?\)A<?] >Z_7_ .)KAO\ AK;X4?\ 0U_^
M4Z[_ /C5;/A']H?X>^.M>M]%T3Q$EWJ=P&,4#6L\6_:"2 711G )QG/%2JU)
MNRDOO+EEV-IQ<IT9)+KRO_(Z#_A,+C_H#W7Z_P#Q-'_"87'_ $![K]?_ (FN
MFK/UCQ!I?AVV-QJNI6>F6X_Y:WDZ1)^;$"M=MSAC%R=HJ[,G_A,+C_H#W7Z_
M_$T?\)A<?] >Z_7_ .)K@/%/[7'PU\,[U36)-:G7_ECI<#29^CMM0_\ ?5>/
M^*OV][J3?'X;\+10_P!VXU2<OG_MFF,?]]FN6>*HPWD>WA\CS'$ZPI-+ST_,
M^G_^$PN/^@/=?K_\36=K7Q4L?#=M]HU:)=,@_P">EY.(E_-@*^$/%/[4/Q*\
M5[TE\23:= W_ "QTM1; ?\"7Y_S:O,;[4+K4[E[B\N9KNX?[TL[EW/U)YKBG
MF,?L1/IL/P?5EKB*J7HK_B[?J?=WB+]MCP5HN]+2WNM8G7C;:#"9]V8 8]QF
MO(_%W[=?BG5 \>@:-8:'$>!+.3=3#W!(5?S4U\[Z'X=U7Q-=_9=(TR\U2Y_Y
MXV<#2M^2@U[#X1_8W^(GB;9)>6EKX?MFYWZC.-^/9$W$'V;%<OUC$U](?@>Z
MLGR7+%S8AIO^\_T_X!YUXN^+7C+QUO&N^(]0OXGZV[2E(?\ OVN$_2N2K[>\
M(_L)^&=-V2>(=;OM9E')AM5%M%]#]YC]017MOA'X0>"_ >QM#\-V%E,GW;CR
MO,G'_;1\O^M5' UJCO4=OQ,:O%&7X6/)A8.7HN5?U\C\[/#/P2\<^+51]/\
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M@[>7"S'_ ,>8_P J\&MQ+A9?%4E+[_UL=,71I_ K>B/=?^$PN/\ H#W7Z_\
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M_P")H_X3"X_Z ]U^O_Q-=-16HSF?^$PN/^@/=?K_ /$T?\)A<?\ 0'NOU_\
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M\ /A]\+[XWOAKPQ:Z??8*BZ=Y)YE!ZA7E9F7/L17H-% !1110 4444 %%%%
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MOL;"ZU.Y2WL[::[N'^[% A=S] .:]/\ "O[+OQ*\5['B\.3:; W_ "VU1A;
M?56^?\EK]$]#\,Z1X9M_L^D:59:5!_SSLK=(E/X*!6E75#+H_;D>)B.,*LM,
M/22]7?\ *Q\=^%?V"+AMDGB3Q3'%_>M]+@+Y^DCXQ_WP:]B\*_LE_#7POL=M
M%;69U_Y;:K,9L_5!A#_WS7L5%=T,+1AM$^9Q&>9CB?CJM+RT_(J:9I-CHMHM
MKIUE;V%JOW8;6)8T'T50!5NBBNH\-MR=V%%%% @HHHH **** "BBB@ HHHH
M**** "BO,?B-^TO\,_A498_$7B[3X+V/AK"U<W-R#Z&.,,R_\" %?,7Q"_X*
MB:7:^;!X)\(W%\_1;W6I1"F?7RHRQ8?5U-=U'!8BO\$';[D<M3%4:/QR/NNN
M1\=?%OP7\,X#+XI\3Z9HG&Y8KJX42N/]F,?,WX U^4_Q"_;4^+OQ%\V.X\53
M:+92<?8]#7[(@!ZC>O[PCV+FO$;BYFO)WGGE>>:0[GDD8LS'U)/4U[='(Y/6
MM.WH>54S6*TIQ^\_3+Q]_P %,OA_H'F0^%]'U3Q7.OW9G LK9OHS@R?G&*^<
M?'G_  4<^*GBGS(M%_LWPE:MPILK<33X]WEW#/NJK7@G@;X2>-/B7-Y?A?PQ
MJFMC.UI;6V9HD/\ M28VK^)%?1?@/_@FI\2?$0CF\17^E>$[=OO1R2?:[A?^
M 1_(?^_E>A]5R[!_Q+7\]7]W_ ./V^-Q/P7MY:?C_P $\!_X6WXF\3>-=&U?
MQ7XCU375M;Z&X;[?=/,JJK@G:I.%X!Z 5U/[36@W$'B^UUM1YNG7]LBQSJ<K
MO4'*Y^F"/7)]*^W_  +_ ,$U?AIX="2>(;W5O%EP,;HY)OLEN?HL?SC_ +^&
MNF^+W[-7@UO#:V-@=-TW3HXEC&DZA<;8BJC"F-V.Y6';GZ$5\OF>84\-C*.8
M86/,H)QDM%>+L]/--;=3:.!K.G)5'N?DO7T3^R'X.U#5-;O[^&%BER$T^WZX
MDD9P3CZ87GWKL6_9A\&V>I%I%NI45O\ 4B\#Q?\ ?2C)'_ J][^%_B#P_P#"
MQ(9[+1#=W<,9CMX@RP06X/4J &+$\\\=3]:\'/.+L%F6&>"H72G;FE);*]W9
M*[;>QGAL'*%12J/8@\,?\$QO!%G<&X\1^)]8UR4L7,=HD=G$<G."/WC8^C"O
M:O"/[(OP@\$[&L/ FEW,J<B;4T:];/K^^+ 'Z 5Q&I?M'^);K(M+:QL5[%8V
M=Q^+''Z5R>I_%3Q;JV1/KUVH/!6W80C\D KSL1QA"2LI2E^"_KY'L1IX:G\,
M#ZWAAL-!L4BB2VTZSCX5$"Q1K[ # %8>H_$[PII>?M&O61(ZK#)YI'X)FOC^
MYNY[R0R7$TD\G]Z1BQ_,U#7SU3B>H_X=-+U=_P#(U]N^B/I_4?VB/"EGD0?;
M;\]C#!M!_P"^RO\ *N7U']I[JMAH/T>XN/\ V4+_ %KQG3O#NK:OC[#IEY>9
MZ&"!G'Z"NHTWX)^,=2P1I#6Z'^*YE2/'X$Y_2N3^ULUQ/\)?='_AR?:5);&S
M?_M%^*KK(@2QLAV\J$L?_'F/\JYJ_P#BQXOU+/FZ_=IG_GW(A_\ 0 *[+3_V
M:=>FP;O4K"U4]HR\C#\, ?K71Z?^S'81X^W:Y<3^HMX5C_4EJ/JN=8GXG*WG
M*WX7_0?+5D>#WNJ7NI-F[O+BZ/K-*S_S-5:^IM/_ &?_  ?9X\VVN;XC_GXN
M&&?^^-M=)8?#?PMIN/(T"PR.C20B0_FV35QX<Q<W>I-+[W^@>QD]V?'$<3S.
M$C1I'/15&36U8^ _$>I8^S:%J$BGHWV9POYD8K[+M[."S39;P1P)_=C0*/TJ
M:O0I\,0_Y>5?N7_!9?L.[/DZQ^!OC*^P3I0MU/\ %//&OZ9S^E=!9?LU>(9L
M&YU#3[<>BL[M_P"@@?K7TC17?#AW!1^*[^?^21?L8GA=G^S#&,&[\0,WJL-J
M!^I8_P JW;/]F_PS!@SW6HW+=PTJ*OZ+G]:]7HKOAD^ I[4E\[O\V7[."Z'"
M6?P1\&6>"-'$S#^*:>1OTW8_2MRS\ ^&K#'D:!IR$=&-JA;\R,UOT5W0PF'I
M_!32^2*Y8K9$-O9P6:[8((X%](T"C]*FHHKJ2MHB@HHHI@%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=3T/
M3M:C\O4+"VO4Q@"XB5\?3(J]14RBI*TE= >=ZQ\!O".K;FCLYM.D/\5I*0/^
M^6R/R%<-K/[,DZ[FTK6HY/2.\B*_^/+G_P!!KWVBO)K91@J_Q4TGY:?D9NG%
M]#Y'UKX-^+M$W%])DNXQ_P M+,B;/X#YOTKCKBWFM)6BGB>&5>J2*5(_ U]T
MU3U+1[#6(?*O[*WO8_[MQ$KC]17A5N&:;UHU&O77_(Q=!=&?$MEJ%UILPFM+
MF:UF'22&0HWYBNUT7XX>+]&V@ZB+^)?^6=[&),_5N&_6O;-:^ OA+5MS16DV
MFR'^*SE('_?+9'Y"N"UK]F6]BW/I.L0W ZB.[C,9^FY<Y_(5Y+RG,\$[T'?_
M  O]-#/V=2.Q>T7]IJ-MJZOHS)ZRV4@/_CC8_P#0J[[1?C+X1US:$U:.TE/_
M "SO 8<?\"/R_K7SMK7PF\6:#N-QHT\T8_Y:6H$RX]?ER1^(%<E)&\+LCJR.
MIP588(JHYUF.$?+B(W_Q*S_0?M9QW/N>WN8KN)98)4FB;H\;!@?Q%2U\/:;K
M6H:+-YMA?7%E)_>MY60_H:[G1?CYXMTG:LUS#J<8XVW<0SC_ 'EP?SS7L4>)
M:$M*T''TU_R-%775'U117B>B_M-6,NU=5T>>W/0R6D@D'UVMMQ^9KO-%^+GA
M+7-HAUF""0_\L[O,)SZ9; /X$U[U',\'B/@J+YZ?F;*I%[,["BF13)/&LD;K
M)&PR&4Y!_&GUZ984444 %%%% !1110 4444 %%%% 'F?C#_D8[O_ (!_Z M%
M'C#_ )&.[_X!_P"@+10!TWP__P"0--_U\-_Z"M=-7,_#_P#Y TW_ %\-_P"@
MK734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<2&.WE
M=?O*I(_*L#Q5\1?#'@>,MKVO6&EG&1'<3J)&'^RGWC^ KP[QM^W!X.TV&>WT
M&POO$$Q4JLK+]F@.>,Y8%_\ QRL*E:G3^*5CTL+EN+QC7L:3:[]/O>A\ES_&
MCQ_<322MXV\0JSL6(CU2=%&?0!L >PJ/_A<7C[_H>/$G_@VN/_BZY"BOE/:3
M[G[U]5P__/M?<CK_ /A<7C[_ *'CQ)_X-KC_ .+KZD\%_MO^%M+\(Z/9Z[9^
M(+_6+>UCBN[J."!EED"@,P)F!.3W(!KXLHK:GB*E)WBSS\9D^#QT5&K"UNVA
M]V_\-W> ?^@1XD_\!K?_ ./UVGPH_:8\*_&#Q!/HVD6NJ6=[';M<@:A!&JNH
M(!P4D;D;AUQ7YO5W/P=^*MW\'?%KZ]9V,.H3-;/;>3.Y5<,5.<CO\OZUUT\?
M4YESO0^?Q?"V$]A/ZLGSVTUZGZA45\-7/[>/C1O^/?0M!B.?^6D<[\?A**Q[
MK]MOXC7'W!H]MSG]U9D_A\SFO0>/H^9\G'A7,9;J*^9]^T5^==U^V!\4[C_5
M^((;;G/[K3[<_A\R&L>Z_:;^)]Y_K/%]XO.[]U'%'_Z"@X]JAYC2Z)G3'A#'
M/XIQ7S?^1^EE%?EY=?'+XAWF?,\:ZZN6W?NK^2/G_@)''MTK(NOB)XKOL_:?
M$^LW&6W'S;^5LGUY;K4/,H](G3'@ZO\ :K+[G_P#]6JSKGQ'I-GC[1JEE!DX
M'F7"+_,U^3MUJ5W?<W-U-<'.[][(6Y]>3UJO6;S+M#\?^ =4>#5]JO\ ^2_\
M$_5"Z^+'@BRQ]H\8Z!#D9&_4X 3CT^;FL6\_:(^&UB"9/&6EMQG]S(9?_00:
M_,FBLWF,^D4=4>#\-]JK)_=_P3]&KS]K;X5V9('B5KA@<%8;&X/XY\L _@:P
MKW]MOX<VJDQ#6+S@\0V:C_T-UKX'M[6:Z8K!#),P&2L:ECCUXK;L_A[XJU)@
M+3PSK%T2< 0V$K\^G"U/U^O+9(W_ -5LMI?Q)R^;2_1'U_>?MZ>$XV/V3P[K
M,XS_ ,MC%'Q^#M7/WW[?RX(L_!))Q]^?4\8.?[HBYX]Z^?;/X"?$6^4&+P7K
M*\9_?6C1?^AXKH+']DWXIWS<>%S N<%I[VW3''IYF?R%'UC%RV3^X/[)R"C\
M<H_.?_!1Z%??MZ>*)-WV+PWI%OUQY[RRX].C+7.ZA^VU\1[S=Y/]D6.<X^SV
M9./^^W:BQ_8E^(]YM\W^R++./]?>$X_[X1NE=#8?L%^*9-OVWQ)I%OTS]G66
M7'KU5:/]MEW_ "#_ (QRA_)^,O\ ,\YU+]JCXHZGD/XJEA4]%MK:"+'XJ@/Z
MUS&H?&3QYJI/VKQEKDBGJ@U"55_[Y# ?I7TEIW[ 5NN#?^-)).F4M]."8]>3
M(<]NU=/I_P"PGX(M\&[U?7+MNX66*-3QZ>63^M+ZMBI?$_Q'_;.14/X45\H6
M_1'Q!?:M?:HP-Y>7%V?6>5G_ )FJE?HCI_['GPNLL>;HMQ?'_IXOYA_Z RUT
M^G_L\_#;2]OD^#=*?;T^T0^?WS_&3FJ67U7NT1+B[ P5J=.3^27ZGYCUJ:7X
M6UK6L?V=I%_?[NGV6V>3/_?(-?J;I?@GP[HF/[.T'3+#;T^RV<<>/^^5%;5:
MK+>\OP//J<9?\^Z'WR_X'ZGYCZ5^SU\2-8Q]G\&ZK'G_ )^H?L__ *,*UV6D
M_L7_ !+U';]HM-.TO/7[7>JV/KY8?_(K]!J*WCE]);ML\VIQ=C9?!"*^]_K^
MA\6Z/^P/K4VW^U?%EA:?WA9VSS_EN*5W6C?L(>$+7:VI:[K&H,/X83' A^HV
ML?UKZ8HK>.#H1^R>55XBS.KO5MZ)+]+GQ[^T=^S-H?@WX>V-SX(\.7UWJ?\
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MA,/1_ATTODC112V04445UE!1110 4444 %%%% !1110 4444 %%%% !1110
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MPVL?LT:M;[FTW5;6]7LLZM"WTXW#]17F?V;FN"_@MV_NO]/^ 9\E2.QLZ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#],%AI5L+>#=O;DLSL>K,3U-:]%<M/"8>C/VE.FD^Z1*BD[I!111764%%%%
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MW45'9!111784%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YGXP_
MY&.[_P" ?^@+11XP_P"1CN_^ ?\ H"T4 =-\/_\ D#3?]?#?^@K735S/P_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'F?C#_ )&.[_X!_P"@+11XP_Y&.[_X!_Z M% '3?#_ /Y
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MX?P^685XW"RDE"W,N9OFC=)[WL^S_ \'*\[Q>#KWC:5^DE=?-?T_,]*\<_\
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MO_Q-'_"87'_0'NOU_P#B: .FHKF?^$PN/^@/=?K_ /$T?\)A<?\ 0'NOU_\
MB: .FHKF?^$PN/\ H#W7Z_\ Q-'_  F%Q_T![K]?_B: .FHKF?\ A,+C_H#W
M7Z__ !-'_"87'_0'NOU_^)H Z:BN9_X3"X_Z ]U^O_Q-'_"87'_0'NOU_P#B
M: .FJI=Z38W^?M-E;W&>OG1*W\Q6)_PF%Q_T![K]?_B:/^$PN/\ H#W7Z_\
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M ,30!TU%<S_PF%Q_T![K]?\ XFC_ (3"X_Z ]U^O_P 30!TU%<S_ ,)A<?\
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MS_PF%Q_T![K]?_B:/^$PN/\ H#W7Z_\ Q- '345S/_"87'_0'NOU_P#B:/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S\8?\ (QW?_ /_ $!:
M*/&'_(QW?_ /_0%HH Z;X?\ _(&F_P"OAO\ T%:Z:N9^'_\ R!IO^OAO_05K
MIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /,_&'_(QW?_ /_0%HH\8?\C'=_P# /_0%HH Z;X?_ /(&F_Z^&_\
M05KIJYGX?_\ (&F_Z^&_]!6NFH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \S\8?\C'=_P# /_0%HH\8?\C'=_\
M /\ T!:* .F^'_\ R!IO^OAO_05KIJYGX?\ _(&F_P"OAO\ T%:Z:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S
M/QA_R,=W_P  _P#0%HH\8?\ (QW?_ /_ $!:* .F^'__ "!IO^OAO_05KIJY
MGX?_ /(&F_Z^&_\ 05KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRH_M;Q%_T"H_^^O_ +*NFHH YG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\
MLJZ:B@#F?[6\1?\ 0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P!
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MB@#F?[6\1?\ 0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\
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M?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^RH_M;Q%_T"H_^^O_ +*NFHH
MYG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\ LJZ:B@#F?[6\1?\ 0*C_ .^O
M_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^RH_M;Q%_T"H_^^O_
M +*NFHH YG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\ LJZ:B@#F?[6\1?\
M0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^RH_M;Q%_
MT"H_^^O_ +*NFHH YG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\ LJZ:B@#F
M?[6\1?\ 0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^
MRH_M;Q%_T"H_^^O_ +*NFHH YG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\
MLJZ:B@#F?[6\1?\ 0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P!
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MB@#F?[6\1?\ 0*C_ .^O_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\
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M?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^RH_M;Q%_T"H_^^O_ +*NFHH
MYG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\ LJZ:B@#F?[6\1?\ 0*C_ .^O
M_LJ/[6\1?] J/_OK_P"RKIJ* .9_M;Q%_P! J/\ [Z_^RH_M;Q%_T"H_^^O_
M +*NFHH YG^UO$7_ $"H_P#OK_[*C^UO$7_0*C_[Z_\ LJZ:B@#F?[6\1?\
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M)$./8C%1:3H>FZ#;F#3-/M=.@/)CM(5B7@8'"@=JO44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >9^,/^1CN_\ @'_H"T4>,/\ D8[O_@'_ * M% '3?#__
M ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YGXP_P"1CN_^ ?\
MH"T4>,/^1CN_^ ?^@+10!TWP_P#^0--_U\-_Z"M=-7,_#_\ Y TW_7PW_H*U
MTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'F?C#_D8[O_@'_H"T4>,/^1CN_P#@'_H"T4 =-\/_ /D#3?\ 7PW_
M *"M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH **** "BBB@ HHHH **** "BBH+R^@L(A)<2K$A.W<WK0!/12=:6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***BN+F*SA::9Q'&O5FZ#M0!+13(9DGB22-@Z.-RL.X-/H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJ"SOH-0C,EO*LR [2R^OI^M3T %%%% !1110!YGXP_P"1CN_^ ?\
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M Z:BN9^P>*/^@E:_]\C_ .(H^P>*/^@E:_\ ?(_^(H Z:BN9^P>*/^@E:_\
M?(_^(H^P>*/^@E:_]\C_ .(H Z:BN9^P>*/^@E:_]\C_ .(H^P>*/^@E:_\
M?(_^(H Z:BN9^P>*/^@E:_\ ?(_^(H^P>*/^@E:_]\C_ .(H Z:BN9^P>*/^
M@E:_]\C_ .(H^P>*/^@E:_\ ?(_^(H Z:BN9^P>*/^@E:_\ ?(_^(H^P>*/^
M@E:_]\C_ .(H Z:BN9^P>*/^@E:_]\C_ .(H^P>*/^@E:_\ ?(_^(H Z:BN9
M^P>*/^@E:_\ ?(_^(H^P>*/^@E:_]\C_ .(H Z:BN9^P>*/^@E:_]\C_ .(H
M^P>*/^@E:_\ ?(_^(H Z:BN9^P>*/^@E:_\ ?(_^(H^P>*/^@E:_]\C_ .(H
M Z:BN9^P>*/^@E:_]\C_ .(H^P>*/^@E:_\ ?(_^(H Z:BN9^P>*/^@E:_\
M?(_^(H^P>*/^@E:_]\C_ .(H Z:BN9^P>*/^@E:_]\C_ .(H^P>*/^@E:_\
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M*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\ XB@#IJ*YG[!XH_Z"5K_WR/\
MXBC[!XH_Z"5K_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\
MXB@#IJ*YG[!XH_Z"5K_WR/\ XBC[!XH_Z"5K_P!\C_XB@#IJ*YG[!XH_Z"5K
M_P!\C_XBC[!XH_Z"5K_WR/\ XB@#IJ*YG[!XH_Z"5K_WR/\ XBC[!XH_Z"5K
M_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\ XB@#IJ*YG[!X
MH_Z"5K_WR/\ XBC[!XH_Z"5K_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!X
MH_Z"5K_WR/\ XB@#IJ*YG[!XH_Z"5K_WR/\ XBC[!XH_Z"5K_P!\C_XB@#IJ
MYGQ=_P A+0_^OC_V9*/L'BC_ *"5K_WR/_B*JWGA[7[Z2"2>]M7>!MT9Z8/'
MHGL* .PHKF?L'BC_ *"5K_WR/_B*/L'BC_H)6O\ WR/_ (B@#IJ*YG[!XH_Z
M"5K_ -\C_P"(H^P>*/\ H)6O_?(_^(H Z:BN9^P>*/\ H)6O_?(_^(H^P>*/
M^@E:_P#?(_\ B* .FHKF?L'BC_H)6O\ WR/_ (BC[!XH_P"@E:_]\C_XB@#I
MJ*YG[!XH_P"@E:_]\C_XBC[!XH_Z"5K_ -\C_P"(H Z:BN9^P>*/^@E:_P#?
M(_\ B*/L'BC_ *"5K_WR/_B* .FHKF?L'BC_ *"5K_WR/_B*/L'BC_H)6O\
MWR/_ (B@#IJ*YG[!XH_Z"5K_ -\C_P"(H^P>*/\ H)6O_?(_^(H Z:BN9^P>
M*/\ H)6O_?(_^(H^P>*/^@E:_P#?(_\ B* .FHKF?L'BC_H)6O\ WR/_ (BC
M[!XH_P"@E:_]\C_XB@#IJ*YG[!XH_P"@E:_]\C_XBC[!XH_Z"5K_ -\C_P"(
MH Z:BN9^P>*/^@E:_P#?(_\ B*/L'BC_ *"5K_WR/_B* .FHKF?L'BC_ *"5
MK_WR/_B*/L'BC_H)6O\ WR/_ (B@#IJ*YG[!XH_Z"5K_ -\C_P"(H^P>*/\
MH)6O_?(_^(H Z:N:\??\@6/_ *[K_)J3[!XH_P"@E:_]\C_XBJVH>'_$&J0B
M&YO;66,-N"].?P3WH ZV/_5K]*=7,#3_ !0!@:C:_P#?(_\ B*7[!XH_Z"5K
M_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\ XB@#IJ*YG[!X
MH_Z"5K_WR/\ XBC[!XH_Z"5K_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!X
MH_Z"5K_WR/\ XB@#IJ*YG[!XH_Z"5K_WR/\ XBC[!XH_Z"5K_P!\C_XB@#IJ
M*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\ XB@#IJ*YG[!XH_Z"5K_WR/\
MXBC[!XH_Z"5K_P!\C_XB@#IJ*YG[!XH_Z"5K_P!\C_XBC[!XH_Z"5K_WR/\
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M%'_02M?^^1_\10!TU%<S]@\4?]!*U_[Y'_Q%'V#Q1_T$K7_OD?\ Q% !\/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /,_&'_(QW?_  #_ - 6BCQA_P C'=_\ _\ 0%HH Z;X
M?_\ (&F_Z^&_]!6NFKF?A_\ \@:;_KX;_P!!6NFH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4O\ Z-LZ /J;Q7?:EIGA?5[S1[)=2U:WM)9;.R9MHGF5"4C)[;F 'XU\P?\
M"^/VC?\ HD%K_P!^Y?\ X[7UI24 ?&&J_M>_%_PCXFT+2/$OP[TW39]6G2*W
MMV\U99@753M_>'G+ #(ZU]H5\;?"EC^T=^UMKOCF3]_X7\(J+;3#U1W!98B/
MJ?-F]CLK[)H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P_P#:
MB^/NJ? ?3_#5QI>F6>I-JEV\$HNRX"JH4_+M(Y.[OZ=*]PKX]_X*+?\ (#\
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M$>!_B5\>?V@?"NG7?@U]+\(Z?:VZQ7.O:I"I;4KI5Q)Y:>6ZJF_(X7UYS\H
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MB9'XBOE'X1_'KXU_';PRFC^%4L+?5K>1VU/Q5J4")!"I/[N*)%4J7QR<JWN
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MB@ HHHH **** /,_&'_(QW?_  #_ - 6BCQA_P C'=_\ _\ 0%HH Z;X?_\
M(&F_Z^&_]!6NFKF?A_\ \@:;_KX;_P!!6NFH **** "BBB@ HHHH **** "B
MBB@ HHK@?C1IOCW4/"<!^'.I6>G:_;WB3L+Y5:.XA"N&BY5@"2RG/'W>HH \
M"^.A'_#<7PE'?[%#_P"CKFO6/VD/CU-\%=)T6UTG2UUGQ1KUP;;3;24D1;@4
M#,^"">9$  (R6ZC%<!\,?@#\1->^-EG\2OBKJ.GR7FEP>38V.GG(SM=5S@ *
MJEV;J26;G KLOVGO@'J7QDT_P_J7AW4H=+\4^'KAKBRDN,B-\E6*D@$JP:-"
M#@C@@CG( ..\:>&?V@KSP!XBO==\8^&=/L_[,N)+G3+&P\S,?EN7C#LN0=O&
M03]>YU_V"O\ DWRS_P"PA=?^A"LS4/ _[0/Q:T>70/%NJ^'_  CH4D1BNY-$
MWM=WJ[?N$DL%5SPV"O&?E(X/?_LL_#'6OA'\);;P_KXMUU%;N>=EMI?,4*S<
M<X'/% 'D7['O_)>OCI_V%7_]*KBMO_@H<H;X&Z:2 2->@(]OW$]='^S[\$_$
M?PT^*?Q0U_6/LG]G^(+]I[$V\Q=RAFEDRPP-O$B_CGZUI?M;?"37OC-\,+70
M_#OV8W\.IPW96ZE\M2BI(AP<'G+@_0&@#?\ $&@^+?%7P?T*T\'^)$\,ZTUM
M:2'4)8!-F,1C<N"#@DXY]O>N'\*_"?XY:9XFTF[UCXM6VI:3!=12W=FNGH#/
M"&!>,'8,;ER,]LYKW+PUITNC^'=*L)RK36MI% Y0Y4LJ!3CVR*TJ "OD3X,_
M\GZ_%/\ [!4O_HVSKV?XR6_Q=GO]-/PVNM!M[,1/]L&K ER^1MV_*>,9KP#P
M_P# ?]H+PS\3-:\>65]X47Q!J\+6]T[R,T94F,G">7P<Q)^M 'VG7B'[87Q4
M_P"%7_!C4_LTWE:QK6=,L]I^9=X/F..XVQ[L'LQ6O0_A?'XQA\'VR^.Y=/F\
M1AY/.?3 1"4W'9U YVXSQ7COQ>^ OBCXQ?'_ ,+:GJOV(?#W0E200M,6DG?.
M^0&/;_&RQH><;5SG/% '7?LI?"W_ (53\&='LKB'RM6U ?VC?AAAA)( 0A]"
MJ!%(]0?6O8*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKG?B)I
M_B'5/!.KVOA34(=+\120XL;N< I'(""-V5;@@$=#UZ4 ?,'_  44!.B^  !D
M_P!HS?\ H*5]!?'+XN6GP3^'=]XFNK9KZ1&6"VM5;;YTSYVJ3V'!)/H#7@$W
MP!^,7QF\<>&+KXJ:GI$7A_0I_/\ (T\C=/\ ,I90J@<ML +$_*,X'K[K^T%\
M'X_CA\-;SPW]K%A>"5+JTN'7<B3)D#<.NTAF4XY&<\XP0#S7PU'^T7\1-)M-
M>/B#PQX-L[Z,7%OIZ61N)4C8 IOW!L$CG[V>>0.@X_\ X)_QW$6L_%B.[E6>
MZ74+832HNU7?=<[F [ G-=!X?\+?M+'0+/P?/J?AC1=-MH5M#XBAWRWGD@;<
MH,X+A0,$JAZ9(.371_LL_ 76_@?JWC]-4N([NPU.]B.G7'G;YI88S-AY1@88
MB1<^^?Q .+T__E(CJ?\ V!A_Z31UZ_\ M41K)^SWXY##</L!;\0ZD?J*YRU^
M"_B*']KB\^(K?9/^$<FTT6ZD3'SO,\I$P4QZJ3G/3\J] ^-W@_4/'WPG\3^'
MM*\K^T=0LVA@\Y]B%L@X)P<=* //_P!G2QU?5OV2?#UIH>I+I.LS:=<1VE_)
M&)!!)YT@5BIZXKGO^%,_M!_]%FM?_!<G_P 17K'P!\#ZE\-_@_X:\-ZQY/\
M:5A ZS"W?>@+2.^ <#/#"O0: (K5)([:))I/.F5 'D"[=S8Y..V37R%\7O\
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MTT1&&'R GD<<*N<XR 37T#\'?A7IGP:\!6'AC2W:=(-TD]U(,-<3-R\A';/
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M'B7,?V=]2!,(&]=^< \[=V..M 'S;^VI_P E>^!O_85;_P!*+6OKNOBSXA?
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MA8VB*J54C'7!R<D\T >F_LV_!'6-)U;4/B9\0'-UX^UT%_)D'&GPMC" =GP
M,?PJ OKGZ%KY9_X1_P#:O_Z&;PK_ -^H_P#XQ7K?Q+\.>/?%'P/FT?1]3L]/
M\<W5E;Q7-Y&[1P^9\GVCRV"DJ"/,"G&1D=#R #R#XW_%36/C=XLF^#OPRE$G
MF93Q#KR9,-K"#AXPP[=FQU)V#J:]_P#A?\-=(^$O@K3_  UHL;"TM5)>63'F
M3R'EY'/J3^0P!P!7RG\,_@'^T+\(=)GT[PMJ7A/3X;B3S9I&"R2RMVW.T))
M'09P,GU->O?"O2?V@;/QM8R>.M:\/7WAC;(+J&S11,3L;84VQ+SOVYR<8S0!
M[S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >9^,/^1CN_\ @'_H"T4>,/\ D8[O_@'_ * M% '3?#__
M ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_ *"M=-0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YGXP_P"1CN_^ ?\
MH"T4>,/^1CN_^ ?^@+10!TWP_P#^0--_U\-_Z"M=-7,_#_\ Y TW_7PW_H*U
MTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'F?C#_D8[O_@'_H"T4>,/^1CN_P#@'_H"T4 =-\/_ /D#3?\ 7PW_
M *"M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'F?C#_D8[O\ X!_Z M%'C#_D8[O_
M (!_Z M% '3?#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%8_BGQAH?@?35U'Q!JUGHUBT@B%Q>S+&A<@D*">^ >
M/8T ;%%16MU#?6L-S;RI/;S(LD<L9RKJ1D,#W!!K-\4>+M$\$Z7_ &EK^JVF
MCV&\1_:+R98TW'.%R>YP>/8T :]%9^@>(-,\5:3;ZIH]_;ZGIMP"8KJUD$D;
MX)4X8<'!!'U!JY<7$5I;RSSRI#!$I>221@JHH&223T '>@"2BO.O^&C/A?\
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M* /5**\_^&?QZ\#?%Z2>'POKL5]>0J7DLY(WAG500-VQP"5Y'(R!D9YKT"@
MHKE/%GQ6\&^!;^*R\0^)]+T:\DC\Y+>\NDC<H20&VDYQD$9]CZ5%X<^,'@;Q
M=?+9:+XOT74[UONVMO?1M*WT3.3^ H ["BBB@ HKBM?^-G@'PKJT^EZOXPT;
M3M1MR!+:W%XBR1D@$!AG@X(/XU!I?QX^'6MZE:Z?8>-=$N[ZZD6&"WBO49Y'
M8X55&>22< 4 =Y117 ^)OCY\._!^J2:;K'C'2K._B.)+<SAGC/HP7.T^QYH
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M-\/_ /D#3?\ 7PW_ *"M=-7,_#__ ) TW_7PW_H*UTU !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !17A'[2'B/5+&\TS3+>:6VT^
M:$RN8V*^:^[&TD=0  <?[7TKPBOD\=G\<'7E05/FMYV_1G/*MRNUC[NHKX1H
MK@_UH_Z<_P#DW_VI'M_(^[J*^$:*/]:/^G/_ )-_]J'M_(^[J*^$:*/]:/\
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M^@PVWAW4K*"6[L5ED*RLTURI));<.$0<'M7WQ7Q[\<O^3\/A7_V#K;_T?=T
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M %%%% !1110 445^8G_!1CXE^*[GXS3^$9;VZLO#-C9P26UG$[)%<F1-SRL
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M 4444 >9^,/^1CN_^ ?^@+11XP_Y&.[_ . ?^@+10!TWP_\ ^0--_P!?#?\
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MN?\ ^+H_X4;X(_Z G_DW/_\ %UWE%'U#"?\ /F/_ ("O\@Y(]C@_^%&^"/\
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M(HP678"RDG/RE1@\9[UU_P /OVJ['XN?$RR\.^#O#VHZAH:K*^HZ_<QF**W
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MD0)\CXV88C(RPQGGFOJ6N>MOAWX4L]:&L6_AC1H-7!R-0CT^)9Q_VT"[OUH
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M$M"TV_!W"ZM--ABESZ[E4'/XUT] !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'F?C#_D8[O\ X!_Z M%'C#_D8[O_ (!_Z M% '3?
M#_\ Y TW_7PW_H*UTU<S\/\ _D#3?]?#?^@K734 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >9^,/^1CN_\ @'_H
M"T4>,/\ D8[O_@'_ * M% '3?#__ ) TW_7PW_H*UTU<S\/_ /D#3?\ 7PW_
M *"M=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"?\ PH VJ*Q?^$PTC_G[_P#(3_X4?\)AI'_/W_Y"?_"@#:HK%_X3#2/^?O\
M\A/_ (4?\)AI'_/W_P"0G_PH VJ*Q?\ A,-(_P"?O_R$_P#A1_PF&D?\_?\
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M^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\
MD)_\* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_
MY^__ "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?^$PTC_G[_P#(3_X4?\)AI'_/
MW_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0G_PH VJ*Q?\ A,-(
M_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G[_\ (3_X4?\ "8:1
M_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?_D)_\* -JBL7_A,-
M(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_ )^__(3_ .%'_"8:
M1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_ ,* -JBL
M7_A,-(_Y^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8
M:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'_/W_ .0G_P * -JB
ML7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?^$PTC_G[_P#(3_X4
M?\)AI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0G_PH VJ*
MQ?\ A,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G[_\ (3_X
M4?\ "8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?_D)_\* -
MJBL7_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_ )^__(3_
M .%'_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_
M ,* -JBL7_A,-(_Y^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC_G[_ /(3
M_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'_/W_ .0G
M_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?^$PTC_G[
M_P#(3_X4?\)AI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0
MG_PH VJ*Q?\ A,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G
M[_\ (3_X4?\ "8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?
M_D)_\* -JBL7_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_
M )^__(3_ .%'_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_
M #]_^0G_ ,* -JBL7_A,-(_Y^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC
M_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'
M_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?
M^$PTC_G[_P#(3_X4?\)AI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI
M'_/W_P"0G_PH VJ*Q?\ A,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q
M?^$PTC_G[_\ (3_X4?\ "8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_
MPF&D?\_?_D)_\* -JBL7_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%
M_P"$PTC_ )^__(3_ .%'_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1
M_P )AI'_ #]_^0G_ ,* -JBL7_A,-(_Y^_\ R$_^%'_"8:1_S]_^0G_PH VJ
M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\
MG[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\
M/W_Y"?\ PH XWQA_R,=W_P  _P#0%HJ#Q)>0ZAK5S/ _F1/MVM@C.% [^XHH
M IWW_'[<?]=&_F:@HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH UM"_Y;_\!_K1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495634970144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-26224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,916.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,636,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain portions of the registrant&#8217;s definitive proxy statement relating to its scheduled May&#160;12, 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission, are incorporated by reference in Part III of this Annual Report on Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633421712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Florham Park, New Jersey<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633542128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 1,557,666<span></span>
</td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">587,355<span></span>
</td>
<td class="nump">597,808<span></span>
</td>
<td class="nump">520,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">101,193<span></span>
</td>
<td class="nump">93,051<span></span>
</td>
<td class="nump">77,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">616,316<span></span>
</td>
<td class="nump">637,445<span></span>
</td>
<td class="nump">594,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">13,882<span></span>
</td>
<td class="nump">16,914<span></span>
</td>
<td class="nump">27,757<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,318,746<span></span>
</td>
<td class="nump">1,345,218<span></span>
</td>
<td class="nump">1,220,498<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">238,920<span></span>
</td>
<td class="nump">197,230<span></span>
</td>
<td class="nump">151,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">11,917<span></span>
</td>
<td class="nump">6,737<span></span>
</td>
<td class="nump">9,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(49,594)<span></span>
</td>
<td class="num">(50,395)<span></span>
</td>
<td class="num">(71,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of businesses</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">41,798<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">12,007<span></span>
</td>
<td class="nump">19,307<span></span>
</td>
<td class="nump">4,434<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">213,894<span></span>
</td>
<td class="nump">214,677<span></span>
</td>
<td class="nump">93,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">33,344<span></span>
</td>
<td class="nump">45,602<span></span>
</td>
<td class="num">(40,372)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.16<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding (See Note 13):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">82,997<span></span>
</td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">83,516<span></span>
</td>
<td class="nump">85,485<span></span>
</td>
<td class="nump">85,228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633435264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in foreign currency translation adjustments</a></td>
<td class="num">(17,807)<span></span>
</td>
<td class="num">(17,362)<span></span>
</td>
<td class="nump">53,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gain (loss) on derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized derivative gain (loss) arising during period</a></td>
<td class="nump">104,351<span></span>
</td>
<td class="nump">68,192<span></span>
</td>
<td class="num">(96,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Less: Reclassification adjustments for gain (loss) included in net income</a></td>
<td class="nump">18,859<span></span>
</td>
<td class="nump">17,024<span></span>
</td>
<td class="num">(24,442)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">85,492<span></span>
</td>
<td class="nump">51,168<span></span>
</td>
<td class="num">(72,395)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Defined benefit pension plan - net gain (loss) arising during period</a></td>
<td class="nump">7,429<span></span>
</td>
<td class="nump">6,998<span></span>
</td>
<td class="nump">4,604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), before tax</a></td>
<td class="nump">75,114<span></span>
</td>
<td class="nump">40,804<span></span>
</td>
<td class="num">(14,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax (expense) benefit related to items in other comprehensive gain (loss)</a></td>
<td class="num">(19,694)<span></span>
</td>
<td class="num">(11,900)<span></span>
</td>
<td class="nump">16,771<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">55,420<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income, net of tax</a></td>
<td class="nump">$ 235,970<span></span>
</td>
<td class="nump">$ 197,979<span></span>
</td>
<td class="nump">$ 136,235<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632515376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 456,661<span></span>
</td>
<td class="nump">$ 513,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowances of $4,304 and $4,735</a></td>
<td class="nump">263,465<span></span>
</td>
<td class="nump">231,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">324,583<span></span>
</td>
<td class="nump">317,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">116,789<span></span>
</td>
<td class="nump">91,051<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,161,498<span></span>
</td>
<td class="nump">1,153,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">311,302<span></span>
</td>
<td class="nump">311,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="nump">148,284<span></span>
</td>
<td class="nump">84,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,126,609<span></span>
</td>
<td class="nump">1,145,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,038,881<span></span>
</td>
<td class="nump">1,013,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">45,994<span></span>
</td>
<td class="nump">56,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">57,190<span></span>
</td>
<td class="nump">16,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,889,758<span></span>
</td>
<td class="nump">3,782,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of borrowings under senior credit facility</a></td>
<td class="nump">38,125<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">14,624<span></span>
</td>
<td class="nump">14,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">102,100<span></span>
</td>
<td class="nump">61,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">7,253<span></span>
</td>
<td class="nump">5,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">78,771<span></span>
</td>
<td class="nump">92,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">80,033<span></span>
</td>
<td class="nump">120,458<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">320,906<span></span>
</td>
<td class="nump">340,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term borrowings under senior credit facility</a></td>
<td class="nump">733,149<span></span>
</td>
<td class="nump">824,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent', window );">Long-term borrowings under securitization facility</a></td>
<td class="nump">104,700<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">567,341<span></span>
</td>
<td class="nump">564,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">157,420<span></span>
</td>
<td class="nump">90,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">63,338<span></span>
</td>
<td class="nump">45,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">138,501<span></span>
</td>
<td class="nump">120,258<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,085,355<span></span>
</td>
<td class="nump">2,097,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock; no par value; 15,000 authorized shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 240,000 authorized shares; 90,477 and 89,600 issued at December&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,276,977<span></span>
</td>
<td class="nump">1,264,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 6,823 and 4,899 shares at December&#160;31, 2022 and 2021, respectively</a></td>
<td class="num">(362,862)<span></span>
</td>
<td class="num">(234,448)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">10,265<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">879,118<span></span>
</td>
<td class="nump">698,568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,804,403<span></span>
</td>
<td class="nump">1,684,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 3,889,758<span></span>
</td>
<td class="nump">$ 3,782,383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633227120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowances</a></td>
<td class="nump">$ 4,304<span></span>
</td>
<td class="nump">$ 4,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNoParValue', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized shares (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares (in shares)</a></td>
<td class="nump">240,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">90,477,000<span></span>
</td>
<td class="nump">89,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost; shares (in shares)</a></td>
<td class="nump">6,823,000<span></span>
</td>
<td class="nump">4,899,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495630053600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">118,299<span></span>
</td>
<td class="nump">119,836<span></span>
</td>
<td class="nump">116,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment', window );">Non-cash in-process research and development expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Non-cash impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,754<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="num">(4,585)<span></span>
</td>
<td class="num">(2,755)<span></span>
</td>
<td class="num">(64,138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">27,725<span></span>
</td>
<td class="nump">36,210<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees', window );">Amortization of debt issuance costs and expenses associated with debt refinancing</a></td>
<td class="nump">6,845<span></span>
</td>
<td class="nump">7,030<span></span>
</td>
<td class="nump">12,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">2,816<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">2,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of bond issuance discount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress', window );">Loss (Gain) on disposal of property and equipment and construction in-progress</a></td>
<td class="num">(6,813)<span></span>
</td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">7,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from the sale of businesses</a></td>
<td class="num">(644)<span></span>
</td>
<td class="num">(41,798)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration and others</a></td>
<td class="num">(20,304)<span></span>
</td>
<td class="num">(2,162)<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(33,905)<span></span>
</td>
<td class="nump">7,265<span></span>
</td>
<td class="nump">52,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(29,124)<span></span>
</td>
<td class="nump">5,374<span></span>
</td>
<td class="num">(48,348)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">8,612<span></span>
</td>
<td class="num">(21,143)<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other non-current assets</a></td>
<td class="num">(2,182)<span></span>
</td>
<td class="nump">7,875<span></span>
</td>
<td class="nump">13,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other current liabilities</a></td>
<td class="nump">17,343<span></span>
</td>
<td class="nump">32,874<span></span>
</td>
<td class="num">(57,512)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">4,274<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="num">(4,438)<span></span>
</td>
<td class="num">(14,110)<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">264,469<span></span>
</td>
<td class="nump">312,427<span></span>
</td>
<td class="nump">203,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(42,343)<span></span>
</td>
<td class="num">(48,022)<span></span>
</td>
<td class="num">(38,890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">23,960<span></span>
</td>
<td class="nump">190,468<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets', window );">Acquired in-process research and development and intangibles</a></td>
<td class="num">(4,742)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsForProceedsFromBusinessAcquisitions', window );">Cash paid for business acquisitions, net of cash acquired</a></td>
<td class="num">(51,509)<span></span>
</td>
<td class="num">(303,910)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property and equipment</a></td>
<td class="nump">11,145<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities', window );">Net proceeds (payments) on swaps designated as net investment hedges</a></td>
<td class="nump">4,909<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="num">(7,840)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(58,580)<span></span>
</td>
<td class="num">(161,443)<span></span>
</td>
<td class="num">(68,073)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from borrowings of long-term indebtedness</a></td>
<td class="nump">40,750<span></span>
</td>
<td class="nump">25,500<span></span>
</td>
<td class="nump">171,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on debt</a></td>
<td class="num">(148,550)<span></span>
</td>
<td class="num">(125,500)<span></span>
</td>
<td class="num">(441,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Purchase of option hedge on convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(104,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">575,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of stock purchase warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(24,347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(125,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercised stock options</a></td>
<td class="nump">5,465<span></span>
</td>
<td class="nump">6,824<span></span>
</td>
<td class="nump">5,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash taxes paid in net equity settlement</a></td>
<td class="num">(24,618)<span></span>
</td>
<td class="num">(4,801)<span></span>
</td>
<td class="num">(5,075)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(251,953)<span></span>
</td>
<td class="num">(98,226)<span></span>
</td>
<td class="nump">121,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(10,723)<span></span>
</td>
<td class="num">(9,476)<span></span>
</td>
<td class="nump">13,871<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(56,787)<span></span>
</td>
<td class="nump">43,282<span></span>
</td>
<td class="nump">271,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">513,448<span></span>
</td>
<td class="nump">470,166<span></span>
</td>
<td class="nump">198,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 456,661<span></span>
</td>
<td class="nump">$ 513,448<span></span>
</td>
<td class="nump">$ 470,166<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs And Debt Refinanced Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashOrPartNoncashInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash, In Process Research And Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashOrPartNoncashInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForProceedsFromBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Business Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForProceedsFromBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire In Process Research And Development And Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629014448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period at Dec. 31, 2019</a></td>
<td class="nump">$ 1,416,736<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="nump">$ 887<span></span>
</td>
<td class="num">$ (119,943)<span></span>
</td>
<td class="nump">$ 1,213,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (76,402)<span></span>
</td>
<td class="nump">$ 398,574<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, Beginning of Period, Treasury Stock (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,865,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">19,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Share repurchase and equity component of the convertible note issuance, net</a></td>
<td class="nump">42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,060,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115,724)<span></span>
</td>
<td class="nump">15,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2020</a></td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="num">$ (66,047)<span></span>
</td>
<td class="nump">$ 893<span></span>
</td>
<td class="num">$ (235,141)<span></span>
</td>
<td class="nump">1,290,908<span></span>
</td>
<td class="num">$ (63,274)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="nump">532,266<span></span>
</td>
<td class="num">$ (2,773)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,914,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standard Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">28,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">1,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">35,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,684,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 896<span></span>
</td>
<td class="num">$ (234,448)<span></span>
</td>
<td class="nump">1,264,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
<td class="nump">698,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2021</a></td>
<td class="num">(4,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">55,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">859,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes</a></td>
<td class="num">(20,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
<td class="num">(20,974)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">27,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,938,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">(125,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (129,152)<span></span>
</td>
<td class="nump">4,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, End of Period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,476,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period at Dec. 31, 2022</a></td>
<td class="nump">$ 1,804,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 905<span></span>
</td>
<td class="num">$ (362,862)<span></span>
</td>
<td class="nump">$ 1,276,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,265<span></span>
</td>
<td class="nump">$ 879,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, End of Period, Treasury Stock (in shares) at Dec. 31, 2022</a></td>
<td class="num">(6,823,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,823,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719758976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">BUSINESS</a></td>
<td class="text">BUSINESSIntegra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637764608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BASIS OF PRESENTATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">USE OF ESTIMATES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#8217;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. Provision for doubtful accounts, net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was charges of $0.2 million for the year ended December&#160;31, 2022, recoveries of $1.1 million, and charges of $3.6 million for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table shows the rollforward of the allowance for doubtful accounts for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,583&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2022 or 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329,729)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314,874)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense associated with property, plant and equipmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t was $40.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $39.4 million, and $42.1 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAPITALIZED INTEREST</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2022 and 2021, respectively, the Company capitalized $1.4 million and $1.2 million of interest expense into property, plant and equipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and Divestitures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 350") and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of an indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC 350 Topic when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LONG-LIVED ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INTEGRA FOUNDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $0.0 million, $1.2 million and $0.8 million to the Integra Foundation during the years ended December&#160;31, 2022, 2021 and 2020, respectively. These contributions were recorded in selling, general, and administrative expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net, on the consolidated financial statements. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FOREIGN CURRENCY </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction net losses of $3.3&#160;million,  net gains of less than $0.1 million, and net losses $1.6 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to indefinitely reinvest substantially all of its foreign earnings unless there is a manner under which to remit the earnings without a material tax cost. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one month to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred employee termination costs on restructuring activities associated with a closure of a manufacturing facility in France and other reorganization projects in the consolidated statement of operations for the year ended December&#160;31, 2022. In 2021, the Company incurred employee termination costs on restructuring activities associated with the  closure of a manufacturing facility in France. The following table summarizes our restructuring related accrual balances included within accrued expenses and other current liabilities in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"/><td style="width:47.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Goods Sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the accrual balance as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December&#160;31, 2022 is $2.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the closure o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f a manufacturing facility located in France, and other reorganization projects of $3.1M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the accrual balance as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December 31, 2021 is $10.2&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the closure o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f the manufacturing facility located in France. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">STOCK-BASED COMPENSATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. On October 5, 2022, the FASB approved an extension of the sunset date of the reference rate reform from December 31, 2022 to December 31, 2024, past LIBOR&#8217;s end date. The Company currently has contracts that are indexed to LIBOR and are continuing to evaluate the scope of impacted contracts and potential risk. The Company expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest during the years ended December&#160;31, 2022, 2021 and 2020 was $42.2 million (net of $1.4 million that was capitalized into construction in progress), $43.2 million (net of $1.2 million that was capitalized into construction in progress) and $47.3 million (net of $2.3 million that was capitalized into construction in progress), respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2022, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $35.9 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$49.5 million and $29.8 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NON-CASH INVESTING AND FINANCING ACTIVITIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment purchases included in liabilities at December&#160;31, 2022, 2021 and 2020 were $10.5 million, $4.7 million and $1.6 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone was fully paid in 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719758976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES FROM CONTRACTS WITH CUSTOMERS</a></td>
<td class="text">REVENUES FROM CONTRACTS WITH CUSTOMERS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:79.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the short-term portion of the contract liability of $7.3 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company is expected to recognize revenue of approximately $7.3 million in 2023, $4.2 million in 2024, $2.7 million in 2025, $1.1 million in 2026, $0.7 million in 2027, and $0.1 million thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregated Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2022, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for details</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Acquisitions and Divestitures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639608768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS AND DIVESTITURES</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Surgical Innovation Associates, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5&#160;million. In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#8220;PMA&#8221;) Application for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#8217;s Tissue Technologies segment as part of its Wound Reconstruction and Care franchise.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation as of December 6, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Developed Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#8217;s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company allocated goodwill related to the SIA Acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#8217;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Contingent Consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As part of the acquisition, the Company is required to pay to the shareholder of SIA up to $90.0 million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">certain timing targets (up to $40.0&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6&#160;million at the acquisition date and $25.0&#160;million for the PMA approval milestone.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of non-core traditional wound care business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's Tissue Technologies reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#174; and TCC-EZ&#174; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of December&#160;31, 2022, the Company had a deposit remaining of $8.3 million which is included in prepaid assets and recognized a payable due to Gentell of $2.7 million, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Extremity Orthopedics Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp; Nephew USD Limited ("Smith &amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0&#160;million from Smith &amp; Nephew and concurrently paid $41.5&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"/><td style="width:68.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $41.8&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December 31, 2021. The Company finalized the net working capital  to Smith &amp; Nephew as of December 31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into a transition services agreement ("TSA") with Smit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h &amp; Nephew which requires the Company to provide certain services on behalf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Smith &amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the TSA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a payable due to Smith &amp; Nephew of $2.3 million as of December&#160;31, 2022, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The TSA includes services such as invoicing and cash collections from customers on behalf of Smith &amp; Nephew. As of December&#160;31, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company has concluded the majority of the transition services agreement, pending final payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACell, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $306.9&#160;million plus contingent considerations of up to $100&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $1.3&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13-14 years</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">408,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">306,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used a discount rate of 8.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. Based on revenue performance in 2022, no payment will be made for the first performance milestone.  T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company used iterations of the Monte Carlo simulation to calculate the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $21.8 million in other liabilities as of December&#160;31, 2022 and 2021, respectively, in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#8217;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Tax Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495725749984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Sixth Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60&#160;million sublimit for the issuance of standby letters of credit and a $60&#160;million sublimit for swingline loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) is the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Eurodollar Rate plus 1.00% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from&#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2022, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> no balance outstanding at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the revolving portion of the Senior Credit Facility and as of December 31, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$31.3 million, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rate of 1.4%. At December&#160;31, 2022 and 2021, there was $771.3 million and $843.8&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of 5.6% and 1.4%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. At December&#160;31, 2022 and 2021, there was $38.1 million and $45.0 million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan components at December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $800.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of December&#160;31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> totaled $1.6 million. Ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e were no amounts drawn as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $42.7 million in 2023, $39.1 million in 2024, and $3.6 million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million. The effective interest rate implicit in the liability component was 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2022, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the carrying amount of the liability was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2022 wa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s $560.5&#160;million.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the adoption of ASU 2020-06, for both the years ended December&#160;31, 2022 and 2021, the Company recognized only cash interest related to the contractual interest coupon on the 2025 Notes of $2.9&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2022, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company&#160;had $104.7&#160;million and $112.5&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 5.0% and 1.1%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2022 was $104.9&#160;million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633468768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive income (&#8220;AOCI&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCI to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCI, net of tax. Those amounts are subsequently reclassified to earnings from AOCI as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of $50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to $49.1 million of this </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.   As of December 31, 2022, $49.1&#160;million of the $300.0 million notional amount remain outstanding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,283)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 2022, in accordance with the termination date, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with aggregate notional amounts of $100 million. Based on the closing exchange rates, the gain upon settlement of these swaps was approximately $1.6 million which was offset by the loss on the settlement of the intercompany loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $50.0&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCI. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 ,December 16, 2020 and May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign currency on foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:14.751%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(792)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, the Company early settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$250 million equivalent to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 222.3 million CHF. The original settlement date was December 16, 2027. As a result of the settlement, the Company recorded a gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.9 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in AOCI. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedge to replace these swaps with a notional amount of $300 million equivalent to 288 million CHF. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $52&#160;million equivalent to 44.9&#160;million Euros. As a result of the settlement, the Company recorded a gain of $0.1 million in AOCI.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded as unrealized gains or losses in AOCI. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2022 and 2021, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.5 billion and $1.8&#160;billion respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCI into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the Company recorded a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.1&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$23.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, in other income, net related to change in fair value related to the foreign currency rate tran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">slation of the cross-currency swaps, designated as cash flow hedges, to offset the gains or losses recognized on the intercompany loans.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022 and 2021, the Company reco</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rded gains of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8.4&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d $9.1 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps designated as cash flow hedges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain  that is expected to be reclassified to other income, net from AOCI as of December&#160;31, 2022, for the cross-currency swaps designated as cash flow hedges within the next twelve months is $4.5 million. As of December&#160;31, 2022, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCI as of December&#160;31, 2022 for the c</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ross-currency swaps designated as net investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hedges, within the next twelve months is $11.7 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments not designated hedges:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $4.2 million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD").  These contracts were settled in third quarter of 2022.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million, to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"/><td style="width:43.260%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.717%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633468768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative test estimates the fair value of the three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company elected to perform a qualitative analysis for its three reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2022 and 2021 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,509)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,030&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-core traditional wound care business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SIA Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets with Indefinite Lives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2022, 2021 and 2020 was $78.3 million, $83.3 million and $74.5 million, respectively. </span></div>Annual amortization expense is expected to approximate $82.3 million in 2023, $81.7 million in 2024, $81.7 million in 2025, $81.5 million in 2026, $79.6 million in 2027 and $551.6 million thereafter. Amortization of product technology based intangible assets totaled $64.4 million, $66.5 million and $46.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, and is presented by the Company within cost of goods sold.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633468768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">TREASURY STOCK</a></td>
<td class="text">TREASURY STOCK<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2022 and 2021, there were 6.8 million and 4.9 million shares of treasury stock outstanding with a cost of $362.9 million and $234.4 million, respectively, at a weighted average cost per share of $53.18 and $47.86, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares of under the 2023 SAR.  The remaining repurchase transactions are expected to be completed in the first half of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 26 2022, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#8217;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2024. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $100&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2022. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 12, 2022, the Company entered into a $125&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ASR") and received 1.48&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">n March 24, 2022, the early exercise provision was exercised by the 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, there were no repurchases of the Company&#8217;s common stock as part of the share repurchase authorization.</span></div>On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495741818528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#8217;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2022, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2022, 2021 and 2020, the Company issued 20,780 shares, 16,948 shares and 18,284 shares under the ESPP for $1.1 million, $1.1 million and $1.1 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EQUITY AWARD PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan became exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMDY_22acb8fc-f2cb-409d-a273-b3b42a7cc9db">six</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMTI_d4b35179-5c95-4990-bea5-db80dcb363e7">ten</span> for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#8217;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,970</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.82&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,635&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $3.5 million, $5.0 million and $3.2 million in expense related to stock options during the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2022, 2021 and 2020 were $4.0 million, $11.1 million and $8.7 million, respectively. Cash received from option exercises and employee stock purchase plan was $5.5 million, $6.8 million and $5.2 million, for the years ended December 31, 2022, 2021 and 2020, respectively. The realized tax benefit from options exercised w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere $0.6 mi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">llion, $2.2 million and $1.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there was approximately $3.5 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock, Performance Stock and Contract Stock </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2022. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.63&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $24.3 million, $31.2 million and $16.4 million in expense related to such awards during the years ended December 31, 2022, 2021 and 2020, respectively. The total fair market value of shares vested and released in 2022, 2021 and 2020 was $65.0 million, $15.7 million and $17.3 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. As of December 31, 2022, there were 129,399 performance stock units ("PSU's") subject to vest and be released based on 2022 performance achievement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, there was approximately $29.7 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, there were approximately 3.1 million shares available for grant under the 2003 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized into inventory, share based compensation costs of $0.6 million, $0.5 million and $0.4 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633755616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT BENEFIT PLANS</a></td>
<td class="text">RETIREMENT BENEFIT PLANS<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED BENEFIT PLANS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2022 and 2021 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2022 and 2021, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2022 and 2021 and a reconciliation of the funded status at December&#160;31, 2022 and 2021, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,053</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods ended December&#160;31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had a net gain of $7.4 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $7.0 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $46.4 million and $60.3 million as of December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit plans in France and Germany had no assets at December&#160;31, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, no plan assets are expected to be returned to the Company in the next twelve months.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, contributions expected to be paid to the plan in 2022 is $2.6 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFINED CONTRIBUTION PLANS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $9.8 million, $8.8 million and $6.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFERRED COMPENSATION PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2022 and 2021 was $4.7 million and $3.8 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639055776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES AND RELATED PARTY LEASES</a></td>
<td class="text">LEASES AND RELATED PARTY LEASES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2022. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the year ended December&#160;31, 2022 and 2021, was $22.6 million and $20.3 million, respectively, which includes $0.3 million, in related party operating lease expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,407&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#8217;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719761840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contingent Consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our effective tax rate was 15.6% and 21.2% of income before income taxes for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. In 2022, the Company&#8217;s lower effective tax rate was driven by a $5.1&#160;million income tax benefit related to stock compensation and a $2.4&#160;million income tax benefit related to the filing of amended federal and state returns for prior years. In 2021, the Company's higher effective tax rate was driven in part by an $8.5&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $3.1&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#8217;s lower worldwide effective tax rate was primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was 20.2%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#8217;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mpany recorded a $59.2&#160;million deferred tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Switzerland related to the amortizable tax basis in the transferred intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2022, the Company&#8217;s foreign operations generated a $0.4&#160;million increase in income tax expense when compared to the same period in 2021, because of geographic and business mix of taxable earnings and losses, among other factors.  The 2022 foreign effective tax rate is 15.9%, compared to 15.2% in 2021.  The Company&#8217;s foreign tax rate is primarily based upon statutory rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the Company&#8217;s foreign operations generated a $63.6&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is 15.2%, compared to (57.1)% in 2020. The Company&#8217;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law, the company does not expect the law to have a material impact on the company&#8217;s effective tax rate. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,755)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,344)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 U.S. Tax Cuts and Jobs Act contained a provision which requires, for tax purposes, the capitalization and amortization of research and development expenses; effective for years beginning after December 31, 2021.  The Company&#8217;s deferred tax assets increased by $20.2&#160;million within the table above, related to the 2017 Tax Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company had net operating loss carryforwards of $79.5 million for federal income tax purposes, $75.5 million for foreign income tax purposes and $37.9 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $18.6&#160;million have an indefinite carry forward period. For foreign net operating loss carryforwards, $59.1&#160;million will expire through 2028, while  the remaining $16.4 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Approximately $0.7 million of the balance at December&#160;31, 2022 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. The Company has $0.3&#160;million of uncertain tax positions at December&#160;31, 2022 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2022, 2021 and 2020. The Company had minimal interest and penalties accrued for the years ended December 31, 2022 and 2021 and 2020. </span></div>The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2015. Additionally, the Company is no longer subject to examinations by the IRS for fiscal year 2017. All significant state and local matters have been concluded through fiscal year 2014. All significant foreign matters have been settled through fiscal 2015.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637250320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,516&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately 0.3 million and 0.1 million shares at December&#160;31, 2022, and 2021 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the adoption of ASU 2020-06, as the principal amount of the 2025 Notes will be paid in cash and only the conversion spread is settled in shares, the Company will be utilizing the if-converted method and only includes the net number of incremental shares that would be issued upon conversion.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637276992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2022 and 2021 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,067)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,798&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,807)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, the Company reclassified a gain of $15.0 million and a loss of $0.4&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637250320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2022 and 2021 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2022 and 2021 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:17.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.276%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SIA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.528%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3&#160;million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0&#160;million. The estimated fair value as of December&#160;31, 2022 and 2021 was $0.2&#160;million. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition of Arkis BioSciences, Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  was $12.9&#160;million. The Company recorded $2.8&#160;million in accrued expenses and other current liabilities and $10.1&#160;million in other liabilities at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets of the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633755616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC INFORMATION</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,882)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,914)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398,873)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632888112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis Of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles Of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PRINCIPLES OF CONSOLIDATION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of new subsidiaries included in the consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash And Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CASH AND CASH EQUIVALENTS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#8217;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.</span>Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INVENTORIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,583&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. </span></div>The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant And Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROPERTY, PLANT AND EQUIPMENT </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock', window );">Capitalized Interest</a></td>
<td class="text">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of acquired companies are included in the Company&#8217;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs and costs to restructure the acquired company are expensed as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#8217;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#8217;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;D acquired outside of a business combination is expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance, or validity and litigation.</span></div>If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill And Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC Topic 350") and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments with three underlying reporting units. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographic Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on reportable segments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">over their expected useful lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of an indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC 350 Topic when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FoundationPolicyTextBlock', window );">Integra Foundation</a></td>
<td class="text">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DERIVATIVES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.</span></div>The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net, on the consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INCOME TAXES </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. </span></div>The Company continues to indefinitely reinvest substantially all of its foreign earnings unless there is a manner under which to remit the earnings without a material tax cost. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one month to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.</span><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research And Development</a></td>
<td class="text">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Employee Termination Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EMPLOYEE TERMINATION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC Topic 420 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-time Employee Termination Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div>The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PENSION BENEFITS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div>This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATION OF CREDIT RISK </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. </span></div>The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. On October 5, 2022, the FASB approved an extension of the sunset date of the reference rate reform from December 31, 2022 to December 31, 2024, past LIBOR&#8217;s end date. The Company currently has contracts that are indexed to LIBOR and are continuing to evaluate the scope of impacted contracts and potential risk. The Company expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#8220;if-converted&#8221; method. Upon adoption of ASU 2020-06, the Company&#8217;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#8217; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides guidance to clarify and reduce diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Shipping and Handling Fees</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REVENUE RECOGNITION </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one month to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.</span><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div>Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock', window );">Taxes Collected from Customers</a></td>
<td class="text">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FoundationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foundation [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FoundationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for interest capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCapitalizationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 32<br> -Paragraph 2A<br> -URI https://asc.fasb.org/extlink&amp;oid=126919569&amp;loc=SL82860478-203043<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633189968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">Inventories consisted of the following: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,583&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment Balances and Corresponding Lives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment balances and corresponding lives were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and production equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demonstration equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information systems and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329,729)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314,874)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of Impact on Statement of Operations</a></td>
<td class="text">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ADJUSTMENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET CLASSIFICATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AMOUNT<br/>&#160;(in millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount reclassification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs reclassification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization and equity costs reclassification, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of cumulative-effect adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text">The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following table summarizes our restructuring related accrual balances included within accrued expenses and other current liabilities in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"/><td style="width:47.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, beginning of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Goods Sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table shows the rollforward of the allowance for doubtful accounts for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495634968400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Contract Assets and Contract Liabilities</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:79.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included<br/>&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract asset, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2022, 2021 and 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Extremity Orthopedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total  Tissue Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for details</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Acquisitions and Divestitures</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495636945552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Major Classes of Assets and Liabilities Held For Sale</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"><tr><td style="width:1.0%"/><td style="width:68.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset - operating leases and Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation as of December 6, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13-14 years</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">408,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101,842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">306,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637018224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Maximum Leverage Ratios</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) is the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:75.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Contractual Repayments of Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495635168480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,775,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2017</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,283)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:14.751%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(792)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value as of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Location on Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">At December 31, 2022 and 2021, the total notional amounts related to the Company&#8217;s interest rate swaps were $1.5 billion and $1.8&#160;billion respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain&#160;(Loss)<br/>Reclassified from<br/>AOCI into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCI<br/>End of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,965)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"/><td style="width:43.260%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.717%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637186976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill in 2022 and 2021 were as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACell Acquisition </span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,147&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,509)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,030&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-core traditional wound care business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SIA Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Components of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company's identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:47.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639018352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary Of Employee Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated tax benefit related to stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect on net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary Of Weighted-Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used in the calculation of fair value:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of option from grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13.03</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary Of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stock option activity. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Contractual Term in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,970</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.82&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,635&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2022. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock and Contract  Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for performance achievement related to award target</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.63&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633696144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the years ended December&#160;31, 2022 and 2021 included the following (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized actuarial losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net period benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Assumptions Used</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest crediting rate for cash balance plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Benefit Obligations and Plan Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2022 and 2021 and a reconciliation of the funded status at December&#160;31, 2022 and 2021, respectively (amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:64.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.287%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected benefit obligations, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change In Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(964)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan assets at fair value, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,053</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Schedule of Funded Status</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:65.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.117%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation Of Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is the summary of expected future benefit payments (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next five years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633221456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except lease term and discount rate)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CashFlowLesseeTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,407&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633685632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. Federal statutory rate to the Company&#8217;s effective tax rate is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in income taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Excess tax benefits from stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intercompany profit in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible facilitative costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contingent Consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain from sale of business - book to tax differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,755)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,372)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued vacation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalization of research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Charitable contributions carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,737&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets after valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Leases and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,344)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Uncertain Tax Benefits Reconciliation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prior years' tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text">The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637034400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic And Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,516&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629985648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive loss by component between December&#160;31, 2022 and 2021 are presented in the table below, net of tax:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,067)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,798&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,807)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637031968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2022 and 2021 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:17.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.276%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SIA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.528%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis <br/>&#160;(See Note 4) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.<br/>&#160;(See Note 4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from long-term to current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495634969184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Net Sales and Profit, by Segment</a></td>
<td class="text">Net sales and profit by reportable segment for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,882)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,914)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,757)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398,873)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Geographic Revenue, by Area</a></td>
<td class="text">Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629375104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit </div>
<div>Segment </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision (recoveries) for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="num">$ (3,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InventoryCapitalizedExpenses', window );">Inventory, capitalized expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,100,000<span></span>
</td>
<td class="nump">39,400,000<span></span>
</td>
<td class="nump">42,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalizedAdjustment', window );">Interest expense capitalized into property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CharitableContributions', window );">Contributions to Integra Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,300,000)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,107,000<span></span>
</td>
<td class="nump">10,226,000<span></span>
</td>
<td class="nump">6,372,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,200,000<span></span>
</td>
<td class="nump">43,200,000<span></span>
</td>
<td class="nump">47,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest paid, capitalized into construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
<td class="nump">49,500,000<span></span>
</td>
<td class="nump">29,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases included in liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iart_ClosureOfFacilityMember', window );">Closure of Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iart_ReorganizationProjectsMember', window );">Reorganization Projects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember', window );">Rebound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid', window );">Asset Acquisition, Development Milestone Payment To Be Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ConcentrationRiskThresholdPercentage', window );">Concentration risk, threshold percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark', window );">Concentration risk, number of customers over benchmark | Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod', window );">Manufacturing period for products shipped with no alternative use and right of payment for performance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CharitableContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Charitable contributions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CharitableContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ConcentrationRiskNumberofCustomersOverBenchmark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number of Customers Over Benchmark</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ConcentrationRiskNumberofCustomersOverBenchmark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ConcentrationRiskThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Threshold Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ConcentrationRiskThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InventoryCapitalizedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Capitalized Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InventoryCapitalizedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalizedAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalizedAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iart_ClosureOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iart_ClosureOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iart_ReorganizationProjectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iart_ReorganizationProjectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=iart_ReboundTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633475392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details) - SEC Schedule, 12-09, Allowance, Credit Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 4,735<span></span>
</td>
<td class="nump">$ 6,439<span></span>
</td>
<td class="nump">$ 4,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">238<span></span>
</td>
<td class="num">(1,059)<span></span>
</td>
<td class="nump">3,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(669)<span></span>
</td>
<td class="nump">986<span></span>
</td>
<td class="num">(1,499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 4,304<span></span>
</td>
<td class="nump">$ 4,735<span></span>
</td>
<td class="nump">$ 6,439<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633512592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 172,088<span></span>
</td>
<td class="nump">$ 162,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">70,598<span></span>
</td>
<td class="nump">65,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">81,897<span></span>
</td>
<td class="nump">89,535<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 324,583<span></span>
</td>
<td class="nump">$ 317,386<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628715472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 641,031<span></span>
</td>
<td class="nump">$ 626,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(329,729)<span></span>
</td>
<td class="num">(314,874)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">311,302<span></span>
</td>
<td class="nump">311,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">966<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 14,710<span></span>
</td>
<td class="nump">19,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 164,292<span></span>
</td>
<td class="nump">155,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 181,780<span></span>
</td>
<td class="nump">183,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and production equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_DemonstrationEquipmentMember', window );">Demonstration equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 3,792<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_DemonstrationEquipmentMember', window );">Demonstration equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_DemonstrationEquipmentMember', window );">Demonstration equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 151,330<span></span>
</td>
<td class="nump">148,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember', window );">Information systems and hardware | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 20,286<span></span>
</td>
<td class="nump">20,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 103,875<span></span>
</td>
<td class="nump">$ 94,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_DemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_DemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iart_InformationSystemsandHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495622439632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, beginning of the year</a></td>
<td class="nump">$ 10,226<span></span>
</td>
<td class="nump">$ 6,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Payments and other adjustments</a></td>
<td class="num">(12,267)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, end of the year</a></td>
<td class="nump">5,107<span></span>
</td>
<td class="nump">10,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges:</a></td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">3,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges:</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges:</a></td>
<td class="nump">$ 5,582<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629478976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 63,338<span></span>
</td>
<td class="nump">$ 45,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">567,341<span></span>
</td>
<td class="nump">564,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 879,118<span></span>
</td>
<td class="nump">$ 698,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember', window );">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember', window );">Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495634967104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment', window );">Number of days from shipment to issue a credit on returned goods</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Short-term portion of contract liability</a></td>
<td class="nump">$ 7,253<span></span>
</td>
<td class="nump">$ 5,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of contract liability</a></td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RevenueProductWarrantyPeriod', window );">Product warranty period (up to)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return Policy, Issue of Credit, Number of Days from Shipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Product Warranty Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629815824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 4.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligations expected to be satisfied</a></td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632544160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, Beginning of period</a></td>
<td class="nump">$ 11,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Transferred to trade receivable from contract asset included in beginning of the year contract asset</a></td>
<td class="num">(11,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable', window );">Contract asset, net of transferred to trade receivables on contracts during the period</a></td>
<td class="nump">10,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, End of Period</a></td>
<td class="nump">10,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, Beginning of Period</a></td>
<td class="nump">11,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Recognition of revenue included in beginning of year contract liability</a></td>
<td class="num">(5,349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation', window );">Contract liability, net of revenue recognized on contracts during the period</a></td>
<td class="nump">9,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, End of Period</a></td>
<td class="nump">$ 16,127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Net Of Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase From Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628680912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,557,666<span></span>
</td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,019,564<span></span>
</td>
<td class="nump">1,025,232<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Neurosurgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">794,017<span></span>
</td>
<td class="nump">802,959<span></span>
</td>
<td class="nump">716,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">225,547<span></span>
</td>
<td class="nump">222,273<span></span>
</td>
<td class="nump">178,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">538,102<span></span>
</td>
<td class="nump">517,216<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Wound Reconstruction and Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">406,689<span></span>
</td>
<td class="nump">392,463<span></span>
</td>
<td class="nump">293,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">78,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Private Label</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 131,413<span></span>
</td>
<td class="nump">$ 124,753<span></span>
</td>
<td class="nump">$ 105,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_NeurosurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_NeurosurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_PrivateLabelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_PrivateLabelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628848576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details) - Surgical Innovation Association Inc<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>USD ($) </div>
<div>contingentLiability</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">$ 51,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">$ 90,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate', window );">Discount rate</a></td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessAcquisitionNumberOfContingentLiabilities', window );">Business Acquisition, number of payments | contingentLiability</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Revenue Based Performance Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">32,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">FDA Approval Of Premarket Approval</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessAcquisitionNumberOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Number Of Contingent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessAcquisitionNumberOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Intangible Asset Acquired, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_FDAApprovalOfPremarketApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_FDAApprovalOfPremarketApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629766608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 06, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,038,881<span></span>
</td>
<td class="nump">$ 1,013,458<span></span>
</td>
<td class="nump">$ 932,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Association Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 4,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, net</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">10,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">41,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">127,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">11,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">71,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">$ 55,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629107376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,960,000<span></span>
</td>
<td class="nump">$ 190,468,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">644,000<span></span>
</td>
<td class="nump">41,798,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationWorkingCapitalAdjustment', window );">Working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">21,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Traditional Wound Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of business, disposition price</a></td>
<td class="nump">$ 28,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">27,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration', window );">Sale of business, contingent consideration</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod', window );">Period for revenue based performance milestone</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash divested from deconsolidation</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset', window );">Discontinued operation, continuing involvement, prepaid asset</a></td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent', window );">Inventory purchase, prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Disposal group, payable recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of business, disposition price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable', window );">Transitional supply agreement, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Extremity Orthopedics | Consortium of Focused Orthopedists, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination', window );">Sale of extremity orthopedics business, payment for terminating license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Intangible Asset Acquired, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Continuing Involvement, Prepaid Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_TraditionalWoundCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_TraditionalWoundCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ConsortiumofFocusedOrthopedistsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495634993872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Extremity Orthopedics<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets', window );">Right of use asset-operating leases and Other assets</a></td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">6,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">13,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">37,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="nump">47,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">52,845<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">162,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued compensation</a></td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">3,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">5,669<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 11,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632742000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,038,881<span></span>
</td>
<td class="nump">$ 1,013,458<span></span>
</td>
<td class="nump">$ 932,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 2,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Trade accounts receivable, net</a></td>
<td class="nump">16,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, net</a></td>
<td class="nump">18,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">38,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">13,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">94,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases', window );">Right of use asset - operating leases</a></td>
<td class="nump">9,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">7,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">408,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">5,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">1,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liability</a></td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases', window );">Lease liability - operating leases</a></td>
<td class="nump">7,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">61,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="nump">23,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">101,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">$ 306,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc. | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc. | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495626012624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,125,000<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearOne', window );">Interest payments, year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearTwo', window );">Interest payments, year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearThree', window );">Interest payments, year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 104,248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 44,563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,341,000<span></span>
</td>
<td class="nump">564,426,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit', window );">Securitization facility, outstanding borrowings, maximum limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgram', window );">Secured long-term debt, securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,700,000<span></span>
</td>
<td class="nump">$ 112,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtWeightedAverageInterestRateFromSecuritization', window );">Security facility, weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding', window );">Securitization facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 31,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember', window );">Swingline Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Previously capitalized financing costs, written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Incremental financing cost expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Eurodollar Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Overnight Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | One-Month Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available to the company at its option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 877,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 771,300,000<span></span>
</td>
<td class="nump">$ 843,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility, classified as current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,100,000<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized incremental financing costs</a></td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes, aggregate principal amount</a></td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes, interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt proceeds, classified as equity at time of offering</a></td>
<td class="nump">$ 104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate</a></td>
<td class="nump">0.0135739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod', window );">Maximum selling price of the company's common stock of the conversion price</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes', window );">Maximum average conversion value of notes</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount', window );">Combination settlement for debt conversion, minimum settled in cash per principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 113.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Cash interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="nump">$ 104,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="nump">$ 44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Initial strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Average Conversion Value Of Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumAverageConversionValueOfNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtWeightedAverageInterestRateFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt, Weighted Average Interest Rate, From Securitization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtWeightedAverageInterestRateFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securitization Facility, Fair Value Of Amount Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuritizationFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628995792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Maximum Total Leverage Ratio Table) (Details) - Senior Credit Facility<br></strong></div></th>
<th class="th"><div>Jul. 14, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2022 through June 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">September 30, 2023 and the last day of each fiscal quarter thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt Instrument, Covenant, Maximum Leverage Ratio</a></td>
<td class="nump">4,000.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639294688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Schedule of Debt Maturity) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 38,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">669,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Principal Repayment</a></td>
<td class="nump">$ 775,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629345440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 1,475,000,000<span></span>
</td>
<td class="nump">$ 1,775,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">56,712,000<span></span>
</td>
<td class="num">(43,956,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.201%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5,268,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.423%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 5,012,000<span></span>
</td>
<td class="num">(5,520,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 13, 2017 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.313%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 8,380,000<span></span>
</td>
<td class="num">(7,421,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,831,000<span></span>
</td>
<td class="num">(5,512,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.199%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,905,000<span></span>
</td>
<td class="num">(5,464,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated October 10, 2018 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.209%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,970,000<span></span>
</td>
<td class="num">(5,494,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 18, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.885%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,252,000<span></span>
</td>
<td class="num">(6,886,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 18, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.867%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,153,000<span></span>
</td>
<td class="num">(6,764,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 15, 2020 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="nump">575,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 23,742,000<span></span>
</td>
<td class="nump">3,552,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">1-month USD LIBOR Loan | Interest Rate Swap Designated December 15, 2020 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">125,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.404%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 5,467,000<span></span>
</td>
<td class="nump">$ 821,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=iart_OneMonthUSDLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623905264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Narrative) (Details)<br> SFr in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,192,000<span></span>
</td>
<td class="num">$ (96,837,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contract | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IntercompanyLoanQuarterlyPayment', window );">Intercompany loan, quarterly payment | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain (loss) estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) recognized in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Net Investment Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DerivativeNotionalAmountTerminated', window );">Derivative, notional amount, terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 222,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain (loss) estimated to be reclassified to earnings during next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DerivativeNotionalAmountTerminated', window );">Derivative, notional amount, terminated</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DerivativeNotionalAmountTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DerivativeNotionalAmountTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IntercompanyLoanQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intercompany Loan, Quarterly Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IntercompanyLoanQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_CodmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_CodmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623633824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">SFr 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 1,475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">56,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,956,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (3,528,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">5.32%<span></span>
</td>
<td class="nump">5.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 49,142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,283,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">4.52%<span></span>
</td>
<td class="nump">4.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (4,241,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 374,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 397,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross Currency Interest Rate Swap, Contract Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">3.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 420,001,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,821,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (7,769,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,242,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateSwapContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495625464032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)<br> &#8364; in Thousands, SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 291,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-Currency Interest Rate Swap | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">SFr 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">&#8364; 44,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 4,713,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 4,307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(792,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 222,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (14,663,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 288,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap Four | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Cross-Currency Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (5,643,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,858,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629654960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)<br> SFr in Thousands, &#8364; in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">&#8364; 44.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">$ 76,173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">32,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">16,682,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">40,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">SFr 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">4,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">3,528,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">8,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,859,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">11,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">3,311,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">$ 20,608,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495625269776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,684,804<span></span>
</td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="nump">$ 1,416,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,351<span></span>
</td>
<td class="nump">68,192<span></span>
</td>
<td class="num">(96,837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,804,403<span></span>
</td>
<td class="nump">1,684,804<span></span>
</td>
<td class="nump">1,514,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,265<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,351<span></span>
</td>
<td class="nump">68,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCI into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,859<span></span>
</td>
<td class="nump">17,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,965)<span></span>
</td>
<td class="num">(107,133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,527<span></span>
</td>
<td class="num">(55,965)<span></span>
</td>
<td class="num">(107,133)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Interest expense | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,956)<span></span>
</td>
<td class="num">(93,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,308<span></span>
</td>
<td class="nump">27,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCI into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,360)<span></span>
</td>
<td class="num">(22,411)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,712<span></span>
</td>
<td class="num">(43,956)<span></span>
</td>
<td class="num">(93,769)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Other income, net | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,688)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,847<span></span>
</td>
<td class="nump">24,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCI into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,430<span></span>
</td>
<td class="nump">32,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,271)<span></span>
</td>
<td class="num">(9,688)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Interest income | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,321)<span></span>
</td>
<td class="num">(12,291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,196<span></span>
</td>
<td class="nump">16,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain&#160;(Loss) Reclassified from AOCI into Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,789<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,914)<span></span>
</td>
<td class="num">$ (2,321)<span></span>
</td>
<td class="num">$ (12,291)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629012752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495638481024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 78.3<span></span>
</td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 74.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Expected annual amortization expense, 2023</a></td>
<td class="nump">82.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Expected annual amortization expense, 2024</a></td>
<td class="nump">81.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Expected annual amortization expense, 2025</a></td>
<td class="nump">81.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Expected annual amortization expense, 2026</a></td>
<td class="nump">81.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Expected annual amortization expense, 2027</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Expected annual amortization expense, thereafter</a></td>
<td class="nump">551.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of product technology</a></td>
<td class="nump">$ 64.4<span></span>
</td>
<td class="nump">$ 66.5<span></span>
</td>
<td class="nump">$ 46.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632481584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">$ 1,013,458<span></span>
</td>
<td class="nump">$ 932,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Sale of non-core traditional wound care business</a></td>
<td class="num">(5,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(11,413)<span></span>
</td>
<td class="num">(13,056)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">1,038,881<span></span>
</td>
<td class="nump">1,013,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Association Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="nump">41,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">663,428<span></span>
</td>
<td class="nump">671,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Sale of non-core traditional wound care business</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(7,209)<span></span>
</td>
<td class="num">(8,547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">656,219<span></span>
</td>
<td class="nump">663,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Surgical Innovation Association Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of period</a></td>
<td class="nump">350,030<span></span>
</td>
<td class="nump">260,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Sale of non-core traditional wound care business</a></td>
<td class="num">(5,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(4,204)<span></span>
</td>
<td class="num">(4,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of period</a></td>
<td class="nump">382,662<span></span>
</td>
<td class="nump">350,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Surgical Innovation Association Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquisition</a></td>
<td class="nump">$ 41,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495622274416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,697,532<span></span>
</td>
<td class="nump">$ 1,646,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(570,923)<span></span>
</td>
<td class="num">(501,319)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">1,126,609<span></span>
</td>
<td class="nump">1,145,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Codman trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">166,693<span></span>
</td>
<td class="nump">167,758<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 166,693<span></span>
</td>
<td class="nump">$ 167,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember', window );">Completed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,204,325<span></span>
</td>
<td class="nump">$ 1,132,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(370,968)<span></span>
</td>
<td class="num">(307,013)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 833,357<span></span>
</td>
<td class="nump">$ 825,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 193,081<span></span>
</td>
<td class="nump">$ 211,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(144,040)<span></span>
</td>
<td class="num">(142,755)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 49,041<span></span>
</td>
<td class="nump">$ 68,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember', window );">Trademarks/brand names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">28 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 97,265<span></span>
</td>
<td class="nump">$ 98,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(34,674)<span></span>
</td>
<td class="num">(31,468)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 62,591<span></span>
</td>
<td class="nump">$ 66,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember', window );">Supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 30,211<span></span>
</td>
<td class="nump">$ 30,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17,170)<span></span>
</td>
<td class="num">(16,192)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 13,041<span></span>
</td>
<td class="nump">$ 14,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 5,957<span></span>
</td>
<td class="nump">$ 6,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,071)<span></span>
</td>
<td class="num">(3,891)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="nump">$ 2,367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629769488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 26, 2022</div></th>
<th class="th"><div>Mar. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362.9<span></span>
</td>
<td class="nump">$ 234.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.18<span></span>
</td>
<td class="nump">$ 47.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase program, receipt (payment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception', window );">Accelerated share repurchases, shares received at inception</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount under share repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesAdditionalSharesReceived', window );">Accelerated share repurchases, additional shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount (up to)</a></td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Accelerated share repurchases, shares received at inception</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesAdditionalSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Additional Shares Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesAdditionalSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases. Shares Received at Inception</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesSharesReceivedAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629977648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 27,725<span></span>
</td>
<td class="nump">$ 36,210<span></span>
</td>
<td class="nump">$ 19,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total estimated tax benefit related to stock-based compensation expense</a></td>
<td class="nump">10,574<span></span>
</td>
<td class="nump">13,804<span></span>
</td>
<td class="nump">6,221<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Net effect on net income</a></td>
<td class="nump">17,151<span></span>
</td>
<td class="nump">22,406<span></span>
</td>
<td class="nump">13,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">549<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,739<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 25,437<span></span>
</td>
<td class="nump">$ 34,096<span></span>
</td>
<td class="nump">$ 17,776<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623691632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2010</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,725<span></span>
</td>
<td class="nump">$ 36,210<span></span>
</td>
<td class="nump">$ 19,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value, options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="nump">8,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Cash received from option exercises and employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit realized from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember', window );">2003 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncreaseInAuthorizedShares', window );">Increase in authorized shares (in shares)</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember', window );">2000 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember', window );">2001 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,780<span></span>
</td>
<td class="nump">16,948<span></span>
</td>
<td class="nump">18,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EmployeeStockPurchasePlanProceeds', window );">ESPP proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors and Certain Executive Officers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember', window );">Restricted Stock, Performance Stock and Contract Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,300<span></span>
</td>
<td class="nump">31,200<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs related to unvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 15,700<span></span>
</td>
<td class="nump">$ 17,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service periods of performance stock, restricted stock and contract stock awards, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest at end of year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EmployeeStockPurchasePlanProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from employees in connection with the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EmployeeStockPurchasePlanProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncreaseInAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of authorized shares under the Plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncreaseInAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iart_TwoThousandOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_RestrictedStockPerformanceStockAndContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495638541072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">2.01%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option from grant date</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 23.15<span></span>
</td>
<td class="nump">$ 22.59<span></span>
</td>
<td class="nump">$ 13.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495635108384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">1,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited or Expired (in shares)</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year (in shares)</a></td>
<td class="nump">871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)</a></td>
<td class="nump">$ 45.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted (in dollars per share)</a></td>
<td class="nump">65.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised (in dollars per share)</a></td>
<td class="nump">28.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)</a></td>
<td class="nump">50.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)</a></td>
<td class="nump">49.63<span></span>
</td>
<td class="nump">$ 45.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)</a></td>
<td class="nump">$ 45.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Contractual Term in Years, Outstanding at end of year</a></td>
<td class="text">4 years 1 month 20 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Contractual Term in Years, Exercisable at end of year</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 10,772<span></span>
</td>
<td class="nump">$ 26,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable at end of year</a></td>
<td class="nump">$ 9,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623587024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares', window );">Adjustments for performance achievement related to award target (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 58.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">62.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue', window );">Adjustments for performance achievement related to award target (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">62.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">58.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 61.63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember', window );">Performance Stock and Contract Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year (in shares) | shares</a></td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares', window );">Adjustments for performance achievement related to award target (in shares) | shares</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellations (in shares) | shares</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year (in shares) | shares</a></td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 60.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">62.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue', window );">Adjustments for performance achievement related to award target (in dollars per share) | $ / shares</a></td>
<td class="nump">60.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellations (in dollars per share) | $ / shares</a></td>
<td class="nump">59.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">59.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 62.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceStockandContractStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632900736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 2,419<span></span>
</td>
<td class="nump">$ 2,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,381)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(326)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net period benefit cost</a></td>
<td class="nump">$ 915<span></span>
</td>
<td class="nump">$ 1,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income Not Disclosed Flag</a></td>
<td class="text">Net periodic benefit costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Net periodic benefit costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Net periodic benefit costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Net periodic benefit costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Net periodic benefit costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495633172720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.44%<span></span>
</td>
<td class="nump">0.37%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">3.61%<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">1.97%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Interest crediting rate for cash balance plans</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495622375232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change In Projected Benefit Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, beginning of year</a></td>
<td class="nump">$ 65,184<span></span>
</td>
<td class="nump">$ 72,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,419<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(14,822)<span></span>
</td>
<td class="num">(5,044)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="num">(390)<span></span>
</td>
<td class="num">(586)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Plan settlements</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contribution</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(391)<span></span>
</td>
<td class="num">(373)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payment</a></td>
<td class="num">(999)<span></span>
</td>
<td class="num">(2,128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Effect of foreign currency exchange rates</a></td>
<td class="num">(1,810)<span></span>
</td>
<td class="num">(2,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, end of year</a></td>
<td class="nump">50,364<span></span>
</td>
<td class="nump">65,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change In Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, beginning of year</a></td>
<td class="nump">39,914<span></span>
</td>
<td class="nump">37,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(2,863)<span></span>
</td>
<td class="nump">3,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">2,356<span></span>
</td>
<td class="nump">2,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(633)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(998)<span></span>
</td>
<td class="num">(2,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid', window );">Premiums paid</a></td>
<td class="num">(391)<span></span>
</td>
<td class="num">(373)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Effect of foreign currency exchange rates</a></td>
<td class="num">(964)<span></span>
</td>
<td class="num">(1,319)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets at fair value, end of year</a></td>
<td class="nump">$ 38,053<span></span>
</td>
<td class="nump">$ 39,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanBenefitObligationPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanBenefitObligationPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanPlanAssetsPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanPlanAssetsPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495630050832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract', window );"><strong>Reconciliation Of Funded Status</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 38,053<span></span>
</td>
<td class="nump">$ 39,914<span></span>
</td>
<td class="nump">$ 37,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="nump">50,364<span></span>
</td>
<td class="nump">65,184<span></span>
</td>
<td class="nump">$ 72,869<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Unfunded benefit obligations</a></td>
<td class="nump">$ 12,311<span></span>
</td>
<td class="nump">$ 25,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495635229488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Gain (loss) recognized within accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,400,000<span></span>
</td>
<td class="nump">60,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,053,000<span></span>
</td>
<td class="nump">39,914,000<span></span>
</td>
<td class="nump">$ 37,825,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount', window );">Plan assets expected to be returned next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contributions expected to be paid to plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contributions made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan, fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_FR', window );">FRANCE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Benefit plans, assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (t)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632877216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">2,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">1,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">1,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Next five years</a></td>
<td class="nump">$ 11,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639268432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options (or more) | renewal_option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 22,600,000<span></span>
</td>
<td class="nump">$ 20,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Future minimum lease payments, finance leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector', window );">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AnnualRateOfLeaseAgreement', window );">Annual rate of lease agreement</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2029 Through October 31, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2029 through October 31, 2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2034 Through October 31, 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_OptionToExtendLeaseYears', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2034 through October 31, 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AnnualRateOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rate of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AnnualRateOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_OptionToExtendLeaseYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to extend lease, years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_OptionToExtendLeaseYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=iart_FiveYearLeasePeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=iart_FiveYearLeasePeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632475360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 148,284<span></span>
</td>
<td class="nump">$ 84,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">14,624<span></span>
</td>
<td class="nump">14,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">157,420<span></span>
</td>
<td class="nump">90,329<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 172,044<span></span>
</td>
<td class="nump">$ 105,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Leased facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">16 years 10 months 24 days<span></span>
</td>
<td class="text">10 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Leased vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719771952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 17,442<span></span>
</td>
<td class="nump">$ 15,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>ROU assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 72,169<span></span>
</td>
<td class="nump">$ 12,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629331200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 20,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">21,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">19,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">17,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">16,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">165,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">259,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">87,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">172,044<span></span>
</td>
<td class="nump">$ 105,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current lease liabilities</a></td>
<td class="nump">14,624<span></span>
</td>
<td class="nump">14,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">157,420<span></span>
</td>
<td class="nump">$ 90,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember', window );">Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember', window );">Third Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">20,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">20,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">19,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">16,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">15,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">164,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 257,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495629763760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Income Before Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States operations</a></td>
<td class="nump">$ 92,642<span></span>
</td>
<td class="nump">$ 91,150<span></span>
</td>
<td class="nump">$ 15,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign operations</a></td>
<td class="nump">121,252<span></span>
</td>
<td class="nump">123,527<span></span>
</td>
<td class="nump">78,438<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 213,894<span></span>
</td>
<td class="nump">$ 214,677<span></span>
</td>
<td class="nump">$ 93,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623635424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Increase (decrease) in income taxes resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign operations</a></td>
<td class="num">(3.90%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(7.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits from stock compensation</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent', window );">Intercompany profit in inventory</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent', window );">Nondeductible facilitative costs</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent', window );">Contingent Consideration</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent', window );">Global intangible low-taxed income ("GILTI")</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent', window );">Nondeductible executive compensation</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent', window );">Fair market value step up on intra-entity transfer of intellectual property</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(63.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent', window );">Gain from sale of business - book to tax differences</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
<td class="num">(43.20%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628786704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.60%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
<td class="num">(43.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Effective income tax reconciliation, tax benefit, excess stock-based compensation deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Effective Income Tax rate reconciliation, prior year income taxes, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Excess tax benefits from stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent', window );">Effective worldwide tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 63,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations', window );">Effective foreign income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.90%<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="num">(57.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct', window );">Deferred tax asset, increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Increase in unrecognized tax benefits is reasonably possible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Penalties and interest accrued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember', window );">Extremity Orthopedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax expense related to sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount', window );">Deferred income tax benefit, transfer intra-entity intellectual property, amount</a></td>
<td class="nump">$ 59,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetIncreaseDueTo2017TaxAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Increase Due To 2017 Tax Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetIncreaseDueTo2017TaxAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Foreign Income Tax Rate Reconciliation, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Worldwide Income Tax Rate Reconciliation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_ExtremityOrthopedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628785472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 24,201<span></span>
</td>
<td class="nump">$ 31,938<span></span>
</td>
<td class="nump">$ 6,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3,835<span></span>
</td>
<td class="nump">11,377<span></span>
</td>
<td class="nump">5,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">9,893<span></span>
</td>
<td class="nump">5,042<span></span>
</td>
<td class="nump">12,553<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">37,929<span></span>
</td>
<td class="nump">48,357<span></span>
</td>
<td class="nump">23,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(11,591)<span></span>
</td>
<td class="num">(12,830)<span></span>
</td>
<td class="num">(5,079)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(2,316)<span></span>
</td>
<td class="num">(3,688)<span></span>
</td>
<td class="num">(1,760)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">9,322<span></span>
</td>
<td class="nump">13,763<span></span>
</td>
<td class="num">(57,299)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(4,585)<span></span>
</td>
<td class="num">(2,755)<span></span>
</td>
<td class="num">(64,138)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 33,344<span></span>
</td>
<td class="nump">$ 45,602<span></span>
</td>
<td class="num">$ (40,372)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495622241728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Doubtful accounts</a></td>
<td class="nump">$ 2,261<span></span>
</td>
<td class="nump">$ 2,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory related items</a></td>
<td class="nump">31,950<span></span>
</td>
<td class="nump">31,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">13,084<span></span>
</td>
<td class="nump">13,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation', window );">Accrued vacation</a></td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">3,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses', window );">Accrued bonus</a></td>
<td class="nump">4,944<span></span>
</td>
<td class="nump">7,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">10,175<span></span>
</td>
<td class="nump">13,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">2,130<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">30,707<span></span>
</td>
<td class="nump">26,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment', window );">Capitalization of research and development expenses</a></td>
<td class="nump">51,542<span></span>
</td>
<td class="nump">36,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Unrealized foreign exchange gain</a></td>
<td class="nump">6,228<span></span>
</td>
<td class="nump">12,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contributions carryforward</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxAssetsLeasesAndOther', window );">Leases and Other</a></td>
<td class="nump">39,788<span></span>
</td>
<td class="nump">41,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">195,164<span></span>
</td>
<td class="nump">190,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(9,651)<span></span>
</td>
<td class="num">(9,767)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets after valuation allowance</a></td>
<td class="nump">185,513<span></span>
</td>
<td class="nump">180,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangible and fixed assets</a></td>
<td class="num">(166,891)<span></span>
</td>
<td class="num">(152,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss', window );">Unrealized foreign exchange loss</a></td>
<td class="num">(12,991)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DeferredTaxLiabilitiesLeasesAndOther', window );">Leases and Other</a></td>
<td class="num">(22,975)<span></span>
</td>
<td class="num">(17,658)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(202,857)<span></span>
</td>
<td class="num">(169,808)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 17,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxLiabilitiesLeasesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Leases And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxLiabilitiesLeasesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Unrealized Foreign Exchange Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637618496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tax Valuation Allowance) (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 15,258<span></span>
</td>
<td class="nump">$ 13,825<span></span>
</td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(515)<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">$ 1,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 14,672<span></span>
</td>
<td class="nump">$ 15,258<span></span>
</td>
<td class="nump">$ 13,825<span></span>
</td>
<td class="nump">$ 12,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637647744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Uncertain Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, beginning of year</a></td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract', window );"><strong>Gross increases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior years' tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, end of year</a></td>
<td class="nump">$ 713<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increases During Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_UnrecognizedTaxBenefitsReductionsResultingFromOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Reductions Resulting From Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_UnrecognizedTaxBenefitsReductionsResultingFromOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495639268816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">82,997<span></span>
</td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 180,550<span></span>
</td>
<td class="nump">$ 169,075<span></span>
</td>
<td class="nump">$ 133,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">82,997<span></span>
</td>
<td class="nump">84,698<span></span>
</td>
<td class="nump">84,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and restricted stock (in shares)</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares for diluted earnings per share (in shares)</a></td>
<td class="nump">83,516<span></span>
</td>
<td class="nump">85,485<span></span>
</td>
<td class="nump">85,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 2.16<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495637218336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from computation as their effect would be antidilutive (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628764656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 1,684,804<span></span>
</td>
<td class="nump">$ 1,514,867<span></span>
</td>
<td class="nump">$ 1,416,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">69,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">14,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">55,420<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">1,804,403<span></span>
</td>
<td class="nump">1,684,804<span></span>
</td>
<td class="nump">1,514,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">(74,059)<span></span>
</td>
<td class="num">(76,402)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">55,420<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
<td class="nump">2,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">10,265<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
<td class="num">$ (74,059)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(42,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">80,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">14,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">65,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">22,817<span></span>
</td>
<td class="num">(42,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Pension Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="nump">1,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">7,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="nump">7,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="nump">9,322<span></span>
</td>
<td class="nump">1,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Beginning of Period</a></td>
<td class="num">(4,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(17,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss), net of tax</a></td>
<td class="num">(17,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, End of Period</a></td>
<td class="num">$ (21,874)<span></span>
</td>
<td class="num">$ (4,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AccumulatedOtherComprehensiveIncomeLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AccumulatedOtherComprehensiveIncomeLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495638989088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 12,007<span></span>
</td>
<td class="nump">$ 19,307<span></span>
</td>
<td class="nump">$ 4,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">(11,917)<span></span>
</td>
<td class="num">$ (6,737)<span></span>
</td>
<td class="num">$ (9,297)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">$ (400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495623617504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details) - Contingent Consideration Liability - Level 3 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Arkis | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 11,408<span></span>
</td>
<td class="nump">$ 11,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(1,358)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">10,050<span></span>
</td>
<td class="nump">11,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Arkis | Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">3,691<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(846)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Derma Sciences | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">ACell | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">21,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="num">(4,885)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(13,215)<span></span>
</td>
<td class="num">(2,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">21,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">ACell | Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">4,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(4,885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember', window );">Surgical Innovation Association Inc | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">$ 57,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632717296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Level 3 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">$ 3,691<span></span>
</td>
<td class="nump">$ 3,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">846<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">11,408<span></span>
</td>
<td class="nump">11,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">10,050<span></span>
</td>
<td class="nump">11,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember', window );">ACell | Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="nump">4,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">4,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember', window );">ACell | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">21,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers from long-term to current portion</a></td>
<td class="num">(4,885)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">13,215<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="nump">$ 21,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495638590672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>liability</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities', window );">Number of liabilities | liability</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent consideration</a></td>
<td class="nump">33,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business combination, contingent consideration, liability, current</a></td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration, liability, noncurrent</a></td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Milestone Payment One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Milestone Payment Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number Of Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationContingentConsiderationNumberOfLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719685136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>product </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SegmentReportingInformationNumberOfProductsOffered', window );">Number of products offered (more than) | product</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SegmentReportingInformationNumberOfProductsOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of products sold by a segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SegmentReportingInformationNumberOfProductsOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495628539216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,557,666<span></span>
</td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="num">(13,882)<span></span>
</td>
<td class="num">(16,914)<span></span>
</td>
<td class="num">(27,757)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">238,920<span></span>
</td>
<td class="nump">197,230<span></span>
</td>
<td class="nump">151,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,019,564<span></span>
</td>
<td class="nump">1,025,232<span></span>
</td>
<td class="nump">894,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">538,102<span></span>
</td>
<td class="nump">517,216<span></span>
</td>
<td class="nump">477,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">651,675<span></span>
</td>
<td class="nump">667,670<span></span>
</td>
<td class="nump">516,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">417,873<span></span>
</td>
<td class="nump">439,471<span></span>
</td>
<td class="nump">356,657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">233,802<span></span>
</td>
<td class="nump">228,199<span></span>
</td>
<td class="nump">159,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="num">$ (398,873)<span></span>
</td>
<td class="num">$ (453,526)<span></span>
</td>
<td class="num">$ (337,160)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495632762208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 1,557,666<span></span>
</td>
<td class="nump">$ 1,542,448<span></span>
</td>
<td class="nump">$ 1,371,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">516,776<span></span>
</td>
<td class="nump">412,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States (Includes long-lived assets in Puerto Rico)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">1,126,810<span></span>
</td>
<td class="nump">1,089,526<span></span>
</td>
<td class="nump">971,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">440,223<span></span>
</td>
<td class="nump">339,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">170,903<span></span>
</td>
<td class="nump">191,327<span></span>
</td>
<td class="nump">172,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">60,857<span></span>
</td>
<td class="nump">55,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">176,477<span></span>
</td>
<td class="nump">182,034<span></span>
</td>
<td class="nump">157,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">12,975<span></span>
</td>
<td class="nump">11,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember', window );">Rest of the World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">83,476<span></span>
</td>
<td class="nump">79,561<span></span>
</td>
<td class="nump">$ 70,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 2,721<span></span>
</td>
<td class="nump">$ 6,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iart_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495719824464">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>iart-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iart="http://integralife.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iart-20221231.xsd" xlink:type="simple"/>
    <context id="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied522dc9e3e142338801a4d51273b10e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92465366760c4177b8742406cf6fbd07_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="ib4a11790d38d42fab04744f644667f61_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c0443956aba4287a79da88ad2b1f789_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i071a60b60a9b46a18aa0d12355c2d684_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4ed22898bc64d24b7765e593f891985_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb43d094e8824032961a8ec85d76affb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55ce9af062df477e959977ef29770b62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d722c9ae87d4ebf9e2f34d8f1a61b79_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia304241c7950452cbb025f7ee427babc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i059e8d7474364db9884d18f168a39eb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b4d9ca5a4da49c0a179fc3d4ace01d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia19c3c07994f4ba2b78daf3355acf271_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54587714353d43c59304abf93aa9c270_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81ce5b6ba46d42db9fa6ce1b391412da_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i47471b2931934e4b9698fc87efb42f3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia8d4c24857e248099e323a764be5a960_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icacf91222c56450a94535b8158c1f9fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a7ad2dd7fe145e9a775191f346885f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47e2e1c7c56e4e6f96b757b450e3d8a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7005821211dc4a61bc033d8dc246f9e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d58570b6055411d8462693d39b49056_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie068465acf624179b0d91e83e4d97156_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id51546d1efdb4b37baab40ff76fdddc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75b86be08e5641848e8d7b427009e157_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i076755c4427e4d259078e6b2d89e580a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie03d921a6dbf4c6ab60982b0658b2bc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i923e26b254024ce191a077d3ad910d88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac1f6a25383842738c3f81f79c901726_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92f2148b01b24348b1bcaceec81f6c73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00df800819924b1db728d5624c35f949_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f29af258c2049d09523a55767d03678_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icff7c2d092db46b2bab82d2bfbb65a49_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77173b4d8e484fb39e318247f8305f57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i38626384e0824b86a26dc5567021967f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaacd778bd0c149d084dfccd55a63c987_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieded6749710f48979f351fb7d3fa9e12_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb931d5ad83741a294637a95707f41cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie966000a0e4342acbb440309c555baad_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idfaecd31c89f44a49d37ff888379adec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fe44e0a022f4f34bf03594794a50963_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i885964e8d4134704bda0cee1a82823e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i274e28de1007483189af177cc3870bed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf6c9d635e1847d0ba05f03bab83deb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3b59f71e3dc40bc95ec22429582ce92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba62f965ad2b4becaf6a2924ce7b0f73_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i00e2bf9b2ca64e639101cdb95fe9623d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7c4c516f7c341e9a8f12da7fb0fd730_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d9e34be34c14c778773f8253aa5b1d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf4de01512a54f9d9da0d18e3f50daaa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f9de9f6897f4cf8b49ff88e72733606_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i984bcc2d66864df5a6560d75518fc627_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92b3d8c4a94f44308b786dd3f41066c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43680e166a7d4ce19b5a76a38da03d1e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if9b0589ae7ac49299d4b947877639c7b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84d08e87887a48e0b165068c172cc809_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51998c104a0a4b23907a5b4441ad2cae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4683a32a673b4995855a9b02edfd1323_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i967f27ce7a134d76a34a6939044881dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:DemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iefbb9d43eec34673981c8410401d816e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34bd7649dc7b4061ad47ffc556c0863f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic49b57ff79634c4b898da5b6df9ebfae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifd06a7aec13e49f98328dc80014a401c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iart:InformationSystemsandHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a50827ab9fc4774a1f76e9fc90eca28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23a05a3ddc6e4c0ab4eecfb7744719f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0da2edd906ea41d685b94f3a559f2684_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b7f274b6c2e4e4085e067a47ae84aee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i674366b7bb554504831c2da6e430dcab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i033684df3176485992b874699ab5bb9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i555d4df7f3584d1999b47a099d28a436_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic15abc2db37946838e57984661763818_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6527f4ce21cc4fb5985ab238dad89309_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ClosureOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c7891a939ef417fab6925793610c6df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ReorganizationProjectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3ce9246a35c48fcbd5b84afbb181294_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iart:ClosureOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie88cf6af5eb341929c94e3b43dcc7430_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="i004ed02bcbb14976ae0947b6a85dae0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2646e8ff9e9646a997ca1704e1a4e996_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">iart:CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95b6e8c596ab499a89fcc3c6342d9939_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9efe6093f5ba46e79ed64d1fea198a87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">iart:ReboundTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i788f04f5fed04ca38e49ba6f03024c26_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i62d0e2aa67744845818cbd175cd7bd78_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib26e758da29c45679df8f4e5da71fe89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82ca03a161874505a112365ab91a423d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6e5866b5e8ee438997795a5f34fffc50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b08269188a34d6fbb7031826cb0bdc9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib05901fa55ec4ee09f5c084cb113c902_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iafc2622f83364440b73830f3831e70ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64babceb820449b89139cb878d8a8f48_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87809ef2efdc487696e6308247a226c3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i21e50fd25ffa4e698beda1f9680eb35f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5fc99fa3608f44f98cce93e770c68118_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0c891096f6240ffa5a2ec5d793dc607_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ba2c649e06d4bcb88d0734c5bc21568_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i59d4599d6b184cfabebcd5b9dac65339_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8181903369c49f6a696fed66e9124df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie09260aeabcc4e98a91001d0c6fde98d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd0915172f474032923692e256da33ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b28eef625f649cc9ee7ffdcd22e93e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i320f932bbd4a4a02a374f45fe6f54046_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2b3cbf8d296491e89556ecdfff34761_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="i86566b09516e432dbffe19da79e048cd_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:RevenueBasedPerformanceMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="i28298ae5ed5e49418672ef5260b1c297_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:FDAApprovalOfPremarketApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="i547e9b738a9b4ffe8435a24e596115f8_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i87815c6804b84c35862ba8c044473b87_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3270d274846346d8aa67bdc8538e2741_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e69cd67efed4735a4e8f3d4b73198b8_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i7e6455a748fe4bddb62d55fada8558ac_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ConsortiumofFocusedOrthopedistsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i58908f12479149769863fd3b128d144e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48c08cb5a2fd4655ae315c100c40b36f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45969f5e61c5407c8d95c866382a20f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e90ad876dbd48bc8aa7bf8b4a53d714_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="ibc1ccc070eda4191b4f93f11cd639a6c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i11932035bfc943da83fdc9252c1de39c_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i1b4975b0f79844b99055d7ce6c50dec7_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i912619e1e3ea4282b49c25179ea048df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e031586a5ab4c2b9c733e84d2f186e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i7f6392846dfe466d9d26314aee0a7510_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i31f0be0dc18542668776dac2419eacfc_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="ic745d752ec27419fbefffbb4a794e6e6_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="id1f1b83ff3044f198627e9dcf14f8112_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i2429c77787c540b481af5ad54734a36f_I20200714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-14</instant>
        </period>
    </context>
    <context id="if488a963db3a45d1a7ad2f45989c9458_I20200714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-14</instant>
        </period>
    </context>
    <context id="ic13de93e77194c5db68428a880ecc0ea_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b119f3359044799a93e9eb51fb8011d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icc2cd7d3829a475eab3f41f1f7f63464_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16836d586c23438497ba4585606b71df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id05e07ddaf204365bde66fc72e4e8a56_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i222fc417f0d442279085025ae2862e64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60510ed6729f49d58e204a789ec164fe_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idc24dddff635440bb6fa7fef2e8c6bbb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a18546e2641432186ebea4fb82b0c97_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98b32bbe6d6646c68e6d64342fb37f83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab173f92572840f69a38fdd7ef02744a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide3a54a13b084e729f49c0c5be9ef158_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i6f118ad8379e472489d69365de281b5a_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i987b954ec383404489ad7dd44db86461_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0627e2a89adb4de6b5f96b5c7cd98f0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24a9e217820b47419ac62a665233d6e6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f78858143164e768c61bb467e5fdd70_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0437592feca04863946089d86b4469ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8a060aa4a4944de1b51797e710f61a6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i145ff6e523744822b4b70f6a3b8ccc36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i117d5a15f0484f8aa5ec486b255b30a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ec02fd593094c019fc93fa310f36636_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i929e86bd2d204984ba3a7acb41d6f92d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i268abcc1595c47e0822aa833a03ccaf5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fc89a5aa659464192a833dc24455b76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic63c12c941ae4e8d81cabaff36570cd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib53b93c1b49f4b1781184342d6d22de2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14428d26feb74f44b207c0596adab982_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1530f3523e91426ea8a8ea3fe39aea94_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i082f3efc12d847f7bdbcda637deb820f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88a51434e1d640819950dc39740d93e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad7bbbd6621f4001b504642d91a8cd31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf52b2b42e8342a186985ec5e5775ce3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">iart:OneMonthUSDLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb5285f5cc45407cbdd753e2c83bf644_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bbe580a52f944c98f0001a290f94063_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="i0b7965703b77464bb1196cc27ff38536_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="i008795d9432842aa84611f74c3eace23_I20220926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ed0c764a1ef48f18d31ec981995213b_I20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36bbf9012cea408c93248b27bdf539bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dc0c3a66d1b4b0598d21bd659f5221c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4295be0ac744563a7454ae58d217d0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7726647971046a491c61ebc43a4896f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8600ea8026004026a91ef4697aa5aa1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i141946ba0694449bb9049b3e2a07dee5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66601e7294074670ad5e6aa5e725a874_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c728bb018c44941b1bfa6521c9c1244_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i329398daa6384179aba8e533d27d2360_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6dd78859ef8848a999eb4a52492eef4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i997ddfe9c3304a9e9408563c2fd4c3d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifec03638243c4669892b4eb299ae5ed2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0465a51e6df04b86963ff406fb55ea2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7523d880d9374a2481b72ce4679376f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3214317cf106471eb746ae95e24aea11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67557a94436f43d9bf40a6821f726802_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if33212f0ed73438ea87f123c17695625_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateSwapContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i844b7cae12554de8ba766bd5d0e34762_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idaca32771dbc4bf086fdf4c473690023_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1d27726f48242c888971f11c16fce73_I20221003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="i32190bd884274de3ad539b9552b10509_D20221003-20221003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-03</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="i70886b0065374cab828ea261cdadbf4e_I20211004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-04</instant>
        </period>
    </context>
    <context id="i02e3c4b1748e496f95f812498d15e0d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d1829ef6ea84eaca05276c51c0606c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if061f0c8b11a4b0e9af9f2d1b0096dfc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if02c59d68ec54646a35d4af040a81a1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67adfefe5a8443c6b626a7bbf0761620_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c5897d96d2c4f5496944a6fd6a162ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i245c76d03fc54d94af94a58fba2d7466_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55466ef9ef12476299ceffdcdfee3a9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4142d8f488e94bcc8829564ba2e3adae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f429c0617e74d7eb2fd570e3c4023ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a59d109ca88487ba3a465148ff07ff4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf5643d36404495ea9dedee026b7689a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5b3abf28fae409ea406125cd090ebe5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i043cdbf94a754048b4b54ddd6eea2270_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c7b61c995a64818b815e9e90c34fa77_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id601c28871b9412d9cb1392b237ce8a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icde344ad1e464afcb71f8af811c85b13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieac0855122ee48d1aa3a6ee317127bd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3fe3ee7c51fd49caa0539281dd6cf5c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae5a8365a26446a3a0dca3f7522aa7e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b78e51cfeea49168e5007a5a4cfcf0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie807adbb29e64c9cb05ae929d44792cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3e492d9a1944dbc88ed4e5773148fc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac2b519b9bef40ce86b32e60f3e0c395_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1dfa8444a4ff4c799d79806966a6a49e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2eb10ee588794a879897fa8ebf06fbe5_I20220526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-26</instant>
        </period>
    </context>
    <context id="if4a01a2803854f15a4b2bdb0ad580cf3_D20220526-20220526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-26</startDate>
            <endDate>2022-05-26</endDate>
        </period>
    </context>
    <context id="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-26</instant>
        </period>
    </context>
    <context id="if2a5b238cefd4ad4851f8db781417fb8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibf30e04d2e234b5da6da9f923618a1d6_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if6753166079c43ef87f10211fa41814f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dc81409a88946a78bc0d4af0384c50c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7629ad2913ce4b8c8a3a007050c04b32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35b1038cb45449bd8017c02b7e07bcbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e7b6826294643ee9255e0aef5bfe00c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic14509aa5da94573ae2e368395318395_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1d11744ab624cb0b137eee60066f067_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2578085d407f4986b5c4f56a8f5378e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0774406054da4b54a1499e2e2203b073_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51b578e29f734d8da75403f33593ad57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29f1ed4692244fb883cb0925404db697_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icedc48383bf44714905c7aba0b7e7eff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib78f2cc3007c4d01874f3559b01933a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02621b369e244009ba8077814770d363_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82dc831f0d8543a3babdcc95198b48d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7598ea197a08489d85d2ca1a1d75029f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id40bd17782234cf0a42d79443632bd3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd2e8ae6d2b84ab289dc5a4f5f4cac96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6649d3266ef54cdea0866db034e7da0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i284332c0c59745a1bafecb41e59a8cbf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fdafe514a0f427a9c65279378fdca48_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27ad7a70040d43599f4f203940fb2c3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4f179ad71894c39b72c41978bcf975f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib479a1abd4bf4dd598c12f1ade31cc64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic924cff55443463a8fa41f30829d128f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d7c68edd73b44ed90a88f720435dd5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8f45920e753432791e424ba5bde4c8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i326dcdfdff4841f5b13090e062a83847_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4251186fc1f74fa98118a5b683fb8145_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i740c386c824b47d9a8a3bdd39e134319_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iccf39968359d436db16110742b8c4283_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b747e04cef446c8bbd192b91223c454_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i408e91f814cb42ff97d90348c7ed6c52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icaa8a61ecfd341d69a8f83de49c64cdb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc8a876bb2c64e86b657b3bae578a201_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54e1d03cd5a24c73bec632484549eb64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc909923f63a42e9a92c1575f351c160_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i571a678056af4243869d6bf87a39cca5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38353e1fdf1749048a5b705812d03489_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ca92d0c0999415284527156e8006bce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8909f47c11f94a13b5b07c5424d9e86b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i222c2a2c9bb74ffb8a6ede3f0fe2b07f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9344740008a49528124058c2083bc1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d23ab70c34f4db5b5a839db493e3059_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i46d3030c2e0049f8a3c5db01ea805895_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1f18b3ff623a416ba0697a89389f4152_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i191577736fc34ca8967de6fee9d82bed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife5b2da3f37e4fbcafc4fc5d9d3dde7d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i647e1d0b571a474c98483e6c2526bb29_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfcd42c9d16743e891b05d6e22c839f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fb11cdd18ef45a19a594c8b5a25ee96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a836c14502143549a1b9311fc3030f9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if97f621bb1334d50b0248002c7710d81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58764c27ca344070860ba269f3f79103_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id05ba75e955c4e129ebec3073ef3f592_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i628a3e3f7d544ad2bc901d0888fe818d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0755e5e4a8746c7a194eab90915121d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c981ec865a242b8ae02ae0b9be850b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01193be6295c427585def8bb00fd4b04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb26a3f7b9af4d3988640472b2a1e3d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36770afe37b9412b9efea6344f408b74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3dfa3992858f4edc84158ff91aeadc14_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec4953d9327d47a9a45aba2fa3765106_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib098ed8c299c4a93a64d24447ab1a258_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1e4d6b7a79746f78154e10fd0d645de_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6736862e35f49389ee83853dd59ba02_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b51dab47180467b905af4f67a4f4857_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic67ed97c9d064b8186d3064a9654c6d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2198808263d444eca9e55e49e81d38c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icfbd5fe6a779428bb7005202e9c1d107_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0dae331e508745f1a1fda5b78ee75393_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic53017849e8e46159900dda56c09d990_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ca2000819ce47d49042fde9d9662400_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f88d140805d417980d8109777892eef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87d13a9a1b744ede92d09a5f4fa60167_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if39e9e07281e41ffb52e9314446776a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ee7ff54bebb490c9c43421a64840f58_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i276d4167cfbc4c96b387801968c415a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie593d306076f420796fbc6b3700364ae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d60814ab4eb454190610b8946c1a931_I20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="i6329920052fe4d068537fccf47a1bbd4_D20230126-20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="ie8d0e669cefa40dc80fd293f8b65128f_I20220426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-04-26</instant>
        </period>
    </context>
    <context id="i98b20187279a484aa7a8e9867ab6bc1c_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="ied552a010c034654a585ce6ab14a3070_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i464ce85ce14945ae9a2b1ea43a72e31f_I20220324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-03-24</instant>
        </period>
    </context>
    <context id="ica7dcd824511481a8120c2a8389e9b5f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f325b8385ec4ba599bbdc2436aa2acf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibab792d7a62149d18dc8eb2dc3683f89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60b6305eecf041d2b4ced862809aa250_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc191873f1dc42bc9a919b9154c27144_D20100501-20100531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-05-01</startDate>
            <endDate>2010-05-31</endDate>
        </period>
    </context>
    <context id="i77e0bc249d794d8c923d4baa7345c70c_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i64ad94a13328414ba507646767f3d728_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id35f0fa4951b44e5a8286675c32d2ef8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i503e4c87c0e04676afd28e1f2a991921_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iart:TwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id7872cc732b34351b799a3c73f66289e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab05a5cd30cb455e944ffa624620cb14_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibe01e5177d5c4b008c60877d84f5c6e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a2ee4a702a04c05a03330fdec68ebd2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f13c95eae224327a6df76189d019f93_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia53b4883a913450d88e67a5f653ed435_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib49a4a983eba4b5d96ea47a0ec6b49e0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4cc2c9acfb5b4ad28b78589745d7729b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74db8baf10424ff7a6207881e5bae34e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5acbf0ad9ad4e0e886eb359677690b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57d1807080364f69937de4b97dd9811e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice8b178570f44cdba015566ce1f26691_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockandContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic98af93cab614bf7b1d6207967773298_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie59ae462fc304032a8aaaf9f74348093_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6bd1ab005148412cb072897f89bca249_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:RestrictedStockPerformanceStockAndContractStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i418f7c9941e041f4853468578a5ef6fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1cab4ce05dd94d62b94dadb5d8e736fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i63561c0bbfd64fc0bdb211203c2b0c9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4686279af17c417cbe3854bacf4ca2d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d95969939c540bca05d2319452bd5fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c5eeedd89d64492bde19c2d733af117_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia15d057605944eca816fd58aedd828b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idfe81ea28a254d779986ec9672045e13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9fd716a767d4b339ab1295c5bb147d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearLeasePeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d17811ad9fc45df8bcef0f695f18e73_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:ExtremityOrthopedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i279c573a91e74e11abd25958e204a2d2_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie93924bccec8412e903736f429992621_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79636bff7892448cb422c38278985e4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie487f52caa6d4416be07a10223ed0bce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icbb5085d40924d08b32a44ed38777fa8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5125356e34064ab5bdcb08a3dffbcee3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id65461d577a648fa84b432ba0d645aca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58370c21a3bf4fa9916b815ebacaabad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55ae72f002374097b8ae052513a4d9af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99a64401f57445e3889fffd6aa340e49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53bb7164178d4c7681938eae96f8dd7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6b4f71bfb1a8422d95af5dd6760a64f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9ea09ba91b94301bbbdc52ab73d8aa5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3a4807908c54cb5b1a0dd1fd6665df2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c2f742f6e864e72a554afa2da3a8c66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id34c42773d35464d81a75564647fa0e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20e8046929194a0da3727cadcc6ce0a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i454bba66f23b40d59081b4ed516cc56b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04eb6b26c7384b9090a435f6497f42ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51944049eb7b403aba8baf9a73574149_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idad9f7b57287472faa5da1db0498730f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i68a223d9d7454456aa04f06027515378_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie1745e45c4754439b297f3e7d7347d24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9aecdb884ec42408aef9ceaf4f7631d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i99410b6978f346d1962e9be3d588bb16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02e03ef2f5ff4d8098cebaa20d010574_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib407e2307b7d4fc1817926031f1d8119_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i08ff087bc35f4f4f8a6bb3d6ac4b1e72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iba83041b85dd4322beadedfbb737f04d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6416949c9d6642de911caf67ffe8aabb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86e82c009c774de0bb05432b74102ae9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51a5653a9fc64e90aa2fbdb1b8095a56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifde103a447ad47428323ce033718630c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id61f82dd9bf0413b91c391c490e54d73_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf69e67cb3914b7097e58795099a96dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a7b1feae529450e813237017e332bb6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e4c5c321a5d4d579e4c7197fc75ffab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib86a8f98051a4098a0c55718c503c35c_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i6ad6fdc92af64fb3a69eb22274101a61_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i6f62455b6c14446e8989b657790d2e88_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="ia332c4339d0d47d2adb4575e1fac651f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i148cca9d8e92463aa899bc73beb1ca6b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i814b998492a7444cbcd7886849cb6270_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib018f6bcc24a4b3dbe4ce6e3c97e8a0e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c96c89c8aef4dd0a52c23f78abe191e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie6b3618e04d540f4b99ec989ee7e7234_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icfa67b71c6874d56a903eea0c00a39c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8beb115769fa4bde80a56f0d62b90c05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i20b167d370d54bac874817e7f8c82740_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icc1ccf682b834d75acf993e77078be00_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i035e179e3b8b4d64bfcfbf533913f64d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e1659d84668436b978aebc30d320151_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f6ca02b71f444939da26d0171cf9a3d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d1a52a97e10485aa9156603f0f12998_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7aa00ba8e0a4089b0402c6f812d9e90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i37a4eff2718b4181a3594c15f97693d6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a2ba32f80384628b6d3da8a948107a4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2be3e483d1fa4218b4739bff6b339aa3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia2bc8a1f80f84b31a8dbe8ec757a0ec6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5db6e94f32d64676a8e5222a7710ac27_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia647697a80af4c1a998c2f4501de7cec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie88400ec8187435b94bf27f234e62310_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1021003fc387465985bb51c9d1963f10_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i101af6c449e24243a977e3628cb006bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa59878bdb8a4814a9a4fcea4012a206_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i016f6830198948e4a83167888eedc5ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27c47750f81947a3bd94f67736a169fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b9598bb29974c0eb5a1c729153672d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5cf719a0faa4ece96aea8a2bae8fc0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34987c7e67424092b2a980a73d2196af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i792da25db32e486d817b94438346f505_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0356b0dec6c415886e16716b8d764cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1045633e59945fc8f109a571dd0a894_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>iart:Segment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>iart:reporting_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="customer">
        <measure>iart:Customer</measure>
    </unit>
    <unit id="contingentliability">
        <measure>iart:contingentLiability</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="renewal_option">
        <measure>iart:renewal_option</measure>
    </unit>
    <unit id="liability">
        <measure>iart:liability</measure>
    </unit>
    <unit id="product">
        <measure>iart:product</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY180LTEtMS0xLTkyNDc5_79098c7d-2f9e-41f1-aaa1-f7f619f69102">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY182LTEtMS0xLTkyNDc5_b25ecd61-9112-48e9-afed-1cd706789aa5">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY183LTEtMS0xLTkyNDc5_82e47d3a-113f-4bc0-a96d-a4ea00b6cd1b">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV80L2ZyYWc6MDcwZGE0ODZiZWY3NDI3ODg0ZmUxNzFiZTNjOTM4MzEvdGFibGU6ODM5ODg2NDZhZjU4NDcxMGFkZDM0NGJkNTY4NTkzYWMvdGFibGVyYW5nZTo4Mzk4ODY0NmFmNTg0NzEwYWRkMzQ0YmQ1Njg1OTNhY18xMC0xLTEtMS05MjQ3OQ_a6baf893-2bea-4902-9c2e-22c21509882e">0000917520</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i81ce5b6ba46d42db9fa6ce1b391412da_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTAtMS0xLTkyNDc5_fd33942e-365d-48e5-a960-5082c1a3fb96">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTAtMS0xLTkyNDc5_880a3f30-49ba-438a-9220-7840c10c5bc7">http://integralife.com/20221231#AccountingStandardUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i788f04f5fed04ca38e49ba6f03024c26_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzEtMS0xLTEtOTI0Nzk_bd1074c8-ad33-4088-bf3d-7aee497f1926">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i62d0e2aa67744845818cbd175cd7bd78_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzItMS0xLTEtOTI0Nzk_951d2ed1-a9fb-42fb-b04f-ceb4e1ced936">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib26e758da29c45679df8f4e5da71fe89_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzMtMS0xLTEtOTI0Nzk_9c935d34-9b6d-40dd-afbd-9fe5898f14ce">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i82ca03a161874505a112365ab91a423d_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzQtMS0xLTEtOTI0Nzk_bab0a1e6-1246-479e-9999-322833e2d0a0">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6e5866b5e8ee438997795a5f34fffc50_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzUtMS0xLTEtOTI0Nzk_5545b871-a16b-4fac-82d6-0e2bb0a4c95a">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i9b08269188a34d6fbb7031826cb0bdc9_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTQvZnJhZzozNjRkN2FhNzk3NmQ0MDY3YTRkYzIxNTU2OGM4ZmYwOS90YWJsZTo2Mjc3MjM1NmFjMzU0YTMzODllY2JlMzQ1YjRiYjA0Yi90YWJsZXJhbmdlOjYyNzcyMzU2YWMzNTRhMzM4OWVjYmUzNDViNGJiMDRiXzYtMS0xLTEtOTI0Nzk_d293a8f5-32b7-47f6-aea9-858e39e48f19">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTA2L2ZyYWc6ODY5ZmQ0NGRhZTljNGY1YWIxNWI0NDY0OWZkYzNiMzgvdGV4dHJlZ2lvbjo4NjlmZDQ0ZGFlOWM0ZjVhYjE1YjQ0NjQ5ZmRjM2IzOF80Mzk4MDQ2NTExMTQ1_3db81233-2aea-444c-aa23-e56fec2bd931"
      unitRef="number">0.0135739</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ibe01e5177d5c4b008c60877d84f5c6e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMDY_22acb8fc-f2cb-409d-a273-b3b42a7cc9db">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i0a2ee4a702a04c05a03330fdec68ebd2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMTI_d4b35179-5c95-4990-bea5-db80dcb363e7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMS0xLTEtOTI0Nzk_2b547c6a-7751-48ff-ab01-b1a9e48209ee"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMi0xLTEtOTI0Nzk_43a359fb-b260-46b3-a729-b6685e632936"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzItMy0xLTEtOTI0Nzk_c93e0401-d608-4805-a380-09eb1a4c293a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMS0xLTEtOTI0Nzk_0c66b039-e411-43a9-b442-a4e094ca252b"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMi0xLTEtOTI0Nzk_b551fbb8-84c4-4783-a820-2fa1da06ef99"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODQvZnJhZzplYWFmYWI2ZjE3YWE0MWM3OGY4M2ZjMjgzZmU3NzY4ZC90YWJsZTo3MGEzOGExNmUyZTI0ZDMwYmRmNmFhZDllMmRmNDI0OC90YWJsZXJhbmdlOjcwYTM4YTE2ZTJlMjRkMzBiZGY2YWFkOWUyZGY0MjQ4XzMtMy0xLTEtOTI0Nzk_ceab9d37-549e-492a-9b3c-d8a5a6ae7910"
      unitRef="usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <dei:DocumentType
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ2_5e4565e9-74c6-4346-b25b-e98f16e0f5d7">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZTFiYjRhZWM2YTIxNDgwZDliMzkzNzE1MTMzY2MzNGMvdGFibGVyYW5nZTplMWJiNGFlYzZhMjE0ODBkOWIzOTM3MTUxMzNjYzM0Y18wLTAtMS0xLTkyNDc5_42e46f0e-6d58-4a30-91bb-86dd070fa5e0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8xMjg_5926e811-29ec-464d-b996-d12462f5f38f">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8xMjg_66c3b783-691a-4bae-93e5-7dcf202e3c89">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NjcwYzNlN2VhN2U1NDIxNzgyNmMxMTUyYTkxY2UwMDMvdGFibGVyYW5nZTo2NzBjM2U3ZWE3ZTU0MjE3ODI2YzExNTJhOTFjZTAwM18wLTAtMS0xLTkyNDc5_bada3559-b871-43d1-9e83-2d36c8fa9f7d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM4_af20e668-2c04-4611-9fc1-cf8c3d285cc3">000-26224</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM1_a34e6b03-1d3b-4256-8d8b-28570a37fe56">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8wLTAtMS0xLTkyNDc5_22f42b90-a4be-4cd4-bcbc-bd30e3065b7b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8wLTQtMS0xLTkyNDc5_b8ad6bcf-4b73-4da7-93d4-ee71efe61b08">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8zLTAtMS0xLTkyNDc5_0bcac0b9-57ae-4794-9ce4-ea4c84c5de7d">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV8zLTQtMS0xLTkyNDc5_c60488c4-69d6-4fdb-bb0d-48756907ac7e">08540</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV80LTAtMS0xLTkyNDc5_d7caef45-34b2-45ac-8d62-92d7f65e1dc2">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6Mjg1YjliYTE3ZDY2NGZmNmEzN2IyNmJjZmI5MDlmZWEvdGFibGVyYW5nZToyODViOWJhMTdkNjY0ZmY2YTM3YjI2YmNmYjkwOWZlYV80LTItMS0xLTkyNDc5_fae842df-2a1b-41f1-8c87-23f43c266c04">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQz_49ec35f7-9182-4d9c-a65c-6f9f7cce3122">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM5_9a5c17c5-7914-4d90-8f4f-d55c7156eea3">275-0500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTAtMS0xLTkyNDc5_a2a201a9-a1fe-4821-a6c9-308bd415e0d1">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTEtMS0xLTkyNDc5_dde8385f-6c13-4dab-bffc-59341137e30f">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6NmU4NzQwMTFkYjU4NDE4NTgzZDhmMDM4Y2Q2Y2RmZmMvdGFibGVyYW5nZTo2ZTg3NDAxMWRiNTg0MTg1ODNkOGYwMzhjZDZjZGZmY18xLTItMS0xLTkyNDc5_525ca9bb-6f2c-4a4c-b837-f1362bb57fb4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ0_a09440b9-f652-4b92-8120-73d0c2e56450">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQw_c5160dd2-8891-4c56-b2cd-edec19d89e71">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQx_d6b06997-de76-4a5e-a6dd-ff506acd4b10">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM2_e99d8ada-0e30-4e3a-bddb-e3ad1282831f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV8wLTAtMS0xLTkyNDc5_706266eb-d379-462e-8b41-6fe60588e8b3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV8yLTMtMS0xLTkyNDc5_1ec2e016-2436-425c-ab15-d69687709c52">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGFibGU6ZDVhMzZiNDMxZmUzNDYwMzlhNGFjMWEzOWM2N2I1ODkvdGFibGVyYW5nZTpkNWEzNmI0MzFmZTM0NjAzOWE0YWMxYTM5YzY3YjU4OV80LTEtMS0xLTkyNDc5_f945b714-c9d0-4cbf-a743-818229d965d6">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTM3_3e19ebc8-44fe-4101-a48a-dab6a20aad67">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQy_d7d9fa8a-41b6-4b20-b81e-0a728069ef22">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ied522dc9e3e142338801a4d51273b10e_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8yNjky_b6fbd33e-2a63-4481-b16a-e8d8dbb23091"
      unitRef="usd">3916000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i92465366760c4177b8742406cf6fbd07_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8yOTA5_149e90ad-1f16-4392-a468-b8a68929fb56"
      unitRef="shares">81636066</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xL2ZyYWc6MjgwY2IzYjU1NGI4NGY4Njk2OGNiOWMwODYwOTFjOGUvdGV4dHJlZ2lvbjoyODBjYjNiNTU0Yjg0Zjg2OTY4Y2I5YzA4NjA5MWM4ZV8zMTQ1_bffb7c89-2a8f-4ddf-949c-ec210f958616">Certain portions of the registrant&#x2019;s definitive proxy statement relating to its scheduled May&#160;12, 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission, are incorporated by reference in Part III of this Annual Report on Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMDkvZnJhZzpjMzAwOTE1YjA5NGQ0ZjE3YTI5MWQwNWE4NzczNmQ0Yy90YWJsZTo2MDdiYmM5YzlmYTM0NDNhOTAwNjRjYjQzZThmNDE2ZC90YWJsZXJhbmdlOjYwN2JiYzljOWZhMzQ0M2E5MDA2NGNiNDNlOGY0MTZkXzAtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplNDI3YjZhYjMwOWU0OTQ4ODQyY2U5ZWQ2ZDBkMmQ1MV8xMjU_e15671ee-3e03-4111-b38d-2c5151587a22">238000</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjEvZnJhZzo0OTM2NjM1NWJmN2M0ZWMwYjU5MjdjMDMyZDA4NWIxOS90ZXh0cmVnaW9uOjQ5MzY2MzU1YmY3YzRlYzBiNTkyN2MwMzJkMDg1YjE5Xzk4OTk_794dacd2-b9b9-4e71-81e5-b083e4e1e876">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjEvZnJhZzo0OTM2NjM1NWJmN2M0ZWMwYjU5MjdjMDMyZDA4NWIxOS90ZXh0cmVnaW9uOjQ5MzY2MzU1YmY3YzRlYzBiNTkyN2MwMzJkMDg1YjE5Xzk5MDA_85f74c2c-de49-4784-9341-2705bfc3caa9">Florham Park, New Jersey</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItMS0xLTEtOTI0Nzk_15d6962e-13ce-43fe-a1fb-e970a09a7354"
      unitRef="usd">1557666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItMy0xLTEtOTI0Nzk_a65319af-a8ff-4d2c-a25a-d70b4a750588"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzItNS0xLTEtOTI0Nzk_4ea5d876-703e-466f-a67c-4fad90bfc198"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtMS0xLTEtOTI0Nzk_02e6690c-ce87-48c5-976b-d8ed2f0de32e"
      unitRef="usd">587355000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtMy0xLTEtOTI0Nzk_3eb8181d-492c-428f-ada9-dce30b621489"
      unitRef="usd">597808000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzUtNS0xLTEtOTI0Nzk_c7046d6e-6a34-44c4-9cc4-b7dab69e9616"
      unitRef="usd">520834000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtMS0xLTEtOTI0Nzk_59b7810a-af5d-4e74-b36b-fc6cef17c1d7"
      unitRef="usd">101193000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtMy0xLTEtOTI0Nzk_ad2b3621-706f-46a9-9b3f-08810417cb30"
      unitRef="usd">93051000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzYtNS0xLTEtOTI0Nzk_6e5a43a3-cf48-44e0-9042-cd46651eaaa4"
      unitRef="usd">77381000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtMS0xLTEtOTI0Nzk_99d8b363-929f-4d0b-a57b-50384d033db8"
      unitRef="usd">616316000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtMy0xLTEtOTI0Nzk_c24e107e-1c46-469d-a228-261e9103c1bc"
      unitRef="usd">637445000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzgtNS0xLTEtOTI0Nzk_7bd2ce9e-95a5-467a-a889-4b087f0759b6"
      unitRef="usd">594526000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktMS0xLTEtOTI0Nzk_a3360774-5585-4ff2-ba20-bdca6c927cae"
      unitRef="usd">13882000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktMy0xLTEtOTI0Nzk_27b57782-c5dc-46c6-8b32-93b8d07a9c18"
      unitRef="usd">16914000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzktNS0xLTEtOTI0Nzk_5c27764c-d3a4-4bac-b892-94d928b167d0"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTEtMS0xLTkyNDc5_02e0a100-2e35-40d4-a7b2-4a0086232a66"
      unitRef="usd">1318746000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTMtMS0xLTkyNDc5_a449f80e-ab0f-4868-a419-8b553652a152"
      unitRef="usd">1345218000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEwLTUtMS0xLTkyNDc5_e9fbc8ce-35dc-4460-8ece-92f0560bd211"
      unitRef="usd">1220498000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTEtMS0xLTkyNDc5_92314d28-4a61-4684-a4f5-c8ea793391b6"
      unitRef="usd">238920000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTMtMS0xLTkyNDc5_b49635c0-e7eb-4b08-8115-6b292e8741d4"
      unitRef="usd">197230000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzExLTUtMS0xLTkyNDc5_8bb27f4f-0b49-4edd-a5df-c210dbb57f39"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTEtMS0xLTkyNDc5_d2ee3858-d589-43d5-ab7e-b8e6dba4a0a6"
      unitRef="usd">11917000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTMtMS0xLTkyNDc5_6f090de4-1e00-4c56-ad89-be8af070597c"
      unitRef="usd">6737000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEyLTUtMS0xLTkyNDc5_ce2eb6f7-064c-4d73-abab-a89ad5766a83"
      unitRef="usd">9297000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTEtMS0xLTkyNDc5_abf71b6d-22fe-4d92-882e-4800655c776c"
      unitRef="usd">49594000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTMtMS0xLTkyNDc5_77feaa81-8676-464c-98f5-ca511a160d49"
      unitRef="usd">50395000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzEzLTUtMS0xLTkyNDc5_956fbea5-b05e-4d18-8618-fbe5e84fecbd"
      unitRef="usd">71581000</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTEtMS0xLTkyNDc5_1fe4ffba-eb6c-4566-8cdb-1a3313292052"
      unitRef="usd">644000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTMtMS0xLTkyNDc5_3ddb63f3-c129-402a-95d7-21160282aa36"
      unitRef="usd">41798000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE0LTUtMS0xLTkyNDc5_8400d0f1-f39c-48dd-a5c7-4e735a611f28"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTEtMS0xLTkyNDc5_435b5659-eb99-45b8-b1ba-9a166047dd62"
      unitRef="usd">12007000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTMtMS0xLTkyNDc5_28d99693-cc0c-4a82-b66b-11597a686c42"
      unitRef="usd">19307000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE1LTUtMS0xLTkyNDc5_876793b2-4da4-4171-a3e9-e7b8083d68dc"
      unitRef="usd">4434000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTEtMS0xLTkyNDc5_2b33a9cc-1596-440d-9cd4-8bcf4355972c"
      unitRef="usd">213894000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTMtMS0xLTkyNDc5_88c49e2d-f5f8-4f32-97af-cc46e3026f71"
      unitRef="usd">214677000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE2LTUtMS0xLTkyNDc5_44fc5a4c-d41b-470e-922c-254c8f4efa6a"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTEtMS0xLTkyNDc5_40e8ec29-32ad-48db-bc25-46f2a2e6d7b5"
      unitRef="usd">33344000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTMtMS0xLTkyNDc5_370d6da1-0a61-4886-8a59-117da68d7af4"
      unitRef="usd">45602000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE3LTUtMS0xLTkyNDc5_4018b69c-0b70-4c27-bdb2-09b62e9933e0"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTEtMS0xLTkyNDc5_82d649e3-897c-478e-8559-6b24da4c282c"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTMtMS0xLTkyNDc5_83eedb92-53f0-4dff-9663-227aa97d17ae"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzE4LTUtMS0xLTkyNDc5_0042ccdb-1f7b-46b5-af5a-58e9b2419c0f"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTEtMS0xLTkyNDc5_4f19c83a-f85d-4553-9913-8084470e2f68"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTMtMS0xLTkyNDc5_6495ea37-d73e-493a-ac99-a4176c46c684"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIxLTUtMS0xLTkyNDc5_6650905b-fc7e-4714-9cb5-be5744cdc93d"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTEtMS0xLTkyNDc5_8005bd44-05d5-4e55-83ca-a8eda80f64e2"
      unitRef="usdPerShare">2.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTMtMS0xLTkyNDc5_57aab3be-b317-4dee-9664-f4316a77a1ca"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzIyLTUtMS0xLTkyNDc5_1a603aab-cf4b-468c-b459-8f29dc4c1992"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTEtMS0xLTkyNDc5_a56473ce-7fe9-4a74-b2d5-a2a8afcce829"
      unitRef="shares">82997000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTMtMS0xLTkyNDc5_93674866-e72f-4616-84ef-496c54159e08"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI1LTUtMS0xLTkyNDc5_16cb28ed-be5e-4569-9735-eb8757102921"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTEtMS0xLTkyNDc5_bfa0d503-b3f5-4d9f-8965-ebb62e48e4d4"
      unitRef="shares">83516000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTMtMS0xLTkyNDc5_e28dc193-b52d-453f-9ddb-fc59298457d9"
      unitRef="shares">85485000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjQvZnJhZzowYzUyNjA3Nzk3Zjc0MTk2YTNlYjMyZDM3NTI5YWExNi90YWJsZTplMGMzMWQyODg5NmY0OGUzYjNjMWM5ZDRjNTk0ZTVlMC90YWJsZXJhbmdlOmUwYzMxZDI4ODk2ZjQ4ZTNiM2MxYzlkNGM1OTRlNWUwXzI2LTUtMS0xLTkyNDc5_844fdac0-9695-405c-be9f-9b37958214b3"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItMS0xLTEtOTI0Nzk_3ac172d4-5bc4-409e-af0e-1091e165d1c0"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItMy0xLTEtOTI0Nzk_b212d37b-72ed-4b9f-9def-6d3dcb906b47"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzItNS0xLTEtOTI0Nzk_ec909e31-f447-4e9b-b131-ee868b0458e2"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtMS0xLTEtOTI0Nzk_7980fdba-a953-4d28-a193-7623b7b185e1"
      unitRef="usd">-17807000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtMy0xLTEtOTI0Nzk_c6a239d7-7984-4130-97ce-15812857c6a6"
      unitRef="usd">-17362000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzUtNS0xLTEtOTI0Nzk_836b0bc8-545c-4415-ad82-a89f86c1d698"
      unitRef="usd">53363000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtMS0xLTEtOTI0Nzk_21140172-ad0f-4f96-821a-bdbf32b3043d"
      unitRef="usd">104351000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtMy0xLTEtOTI0Nzk_5ed13feb-097b-42b4-93d3-e66f6694bdcd"
      unitRef="usd">68192000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzgtNS0xLTEtOTI0Nzk_76117ae7-4f8d-43fa-a33e-09b696b6d634"
      unitRef="usd">-96837000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktMS0xLTEtOTI0Nzk_ad4651d6-8286-467c-a0c5-db33029384be"
      unitRef="usd">18859000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktMy0xLTEtOTI0Nzk_113cadf1-398f-4641-8b3d-a5daa16c0f2c"
      unitRef="usd">17024000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzktNS0xLTEtOTI0Nzk_ed45d33e-4a48-4270-95fc-2dd14a0f110f"
      unitRef="usd">-24442000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTEtMS0xLTkyNDc5_0a7bc537-75fd-4e4a-ba71-d4827455bf0a"
      unitRef="usd">85492000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTMtMS0xLTkyNDc5_4d74aa27-3c5f-4260-b1b1-e29f8290a2e0"
      unitRef="usd">51168000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEwLTUtMS0xLTkyNDc5_9ed13e1e-4fcf-4b06-8b1a-ce2169f90d83"
      unitRef="usd">-72395000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTEtMS0xLTkyNDc5_deafce14-f876-40d6-bbf2-3b360f47ec8e"
      unitRef="usd">7429000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTMtMS0xLTkyNDc5_8536e541-0e85-46e8-bf62-49e59afafd7e"
      unitRef="usd">6998000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzEyLTUtMS0xLTkyNDc5_e7cdb6f0-18ee-4f28-bf22-1f5e4c873625"
      unitRef="usd">4604000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTEtMS0xLTkyNDc5_c22b92eb-f90d-4d99-870b-f89ed1f498de"
      unitRef="usd">75114000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTMtMS0xLTkyNDc5_5094faf8-ffca-4428-9770-0c701485eb71"
      unitRef="usd">40804000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE0LTUtMS0xLTkyNDc5_0d9ed037-753d-4978-9acf-c2e16fd5542d"
      unitRef="usd">-14428000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTEtMS0xLTkyNDc5_298782ca-fb99-4f61-9ef3-b9b1d665115d"
      unitRef="usd">19694000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTMtMS0xLTkyNDc5_ea7ceb3a-c0b7-4614-a27b-555ee2a16ad8"
      unitRef="usd">11900000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE1LTUtMS0xLTkyNDc5_e67fd63a-9e49-4088-963f-e9442b1ed185"
      unitRef="usd">-16771000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTEtMS0xLTkyNDc5_ba8767ad-4ec2-473e-a75e-1cb0c807694d"
      unitRef="usd">55420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTMtMS0xLTkyNDc5_5d8049a3-67f0-4014-bcdb-1e4dd66b2755"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE2LTUtMS0xLTkyNDc5_805e5703-2226-4b4e-b7a4-c47d83b44a6c"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTEtMS0xLTkyNDc5_a3df2a48-2109-4822-9d94-07a390faceeb"
      unitRef="usd">235970000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTMtMS0xLTkyNDc5_6337a57e-f73e-4852-9bc3-bae4a81302ee"
      unitRef="usd">197979000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMjcvZnJhZzpiYzFkZWYyNGI5MDA0OTI2OGQyMGIwYzNiOWYwYTIwMi90YWJsZToyMWZiOGFmYjRlNzY0ZDc1OTQ1MDUxNWJiN2YyZTllZS90YWJsZXJhbmdlOjIxZmI4YWZiNGU3NjRkNzU5NDUwNTE1YmI3ZjJlOWVlXzE4LTUtMS0xLTkyNDc5_31fb1e74-3cb9-475d-ab50-6cb62294894b"
      unitRef="usd">136235000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQtMS0xLTEtOTI0Nzk_92af4861-6e53-4c93-bca0-517bb841e14b"
      unitRef="usd">456661000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQtMy0xLTEtOTI0Nzk_cb8b63c1-c493-45d5-b916-fcaf9a580c3f"
      unitRef="usd">513448000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NjllMjRjYTkxZDM0NmJjODI4OTdkOTA3OTIwNGQwMV81Mg_c2fec946-00ab-4623-8321-859a65f4ef12"
      unitRef="usd">4304000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMC0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NjllMjRjYTkxZDM0NmJjODI4OTdkOTA3OTIwNGQwMV81OQ_260d787c-4816-4698-a3ad-2c2096055ff8"
      unitRef="usd">4735000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMS0xLTEtOTI0Nzk_804ae5ca-49e8-44fe-95c6-96d8537fcf9f"
      unitRef="usd">263465000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzUtMy0xLTEtOTI0Nzk_f220a192-e268-42f5-b212-da3f6a83f535"
      unitRef="usd">231831000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzYtMS0xLTEtOTI0Nzk_0911ca07-d5ad-4147-bfa3-295a38fabd24"
      unitRef="usd">324583000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzYtMy0xLTEtOTI0Nzk_591fb0c1-e3fb-4734-8713-93be887dfee8"
      unitRef="usd">317386000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzctMS0xLTEtOTI0Nzk_db0be88b-f0c0-45cc-8174-de52013fa94e"
      unitRef="usd">116789000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzctMy0xLTEtOTI0Nzk_0f32d903-f0b4-4047-8f41-f2541a2c6dd1"
      unitRef="usd">91051000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzktMS0xLTEtOTI0Nzk_0690fd1c-06fa-45a1-8505-91d260db7347"
      unitRef="usd">1161498000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzktMy0xLTEtOTI0Nzk_4beeed82-267a-4820-b3f6-7bfa84ef741c"
      unitRef="usd">1153716000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEwLTEtMS0xLTkyNDc5_9a2a14a6-8d50-4cbc-80e6-5619c4646bc4"
      unitRef="usd">311302000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEwLTMtMS0xLTkyNDc5_3ba4b8af-65af-49ec-ba62-40a23428d5e0"
      unitRef="usd">311703000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzExLTEtMS0xLTkyNDc5_c2866a8b-c963-4bcc-b68a-48f6d84b9442"
      unitRef="usd">148284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzExLTMtMS0xLTkyNDc5_f4a08e21-b9aa-4582-bbcf-1bd13f69bace"
      unitRef="usd">84543000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEyLTEtMS0xLTkyNDc5_caf0ab64-503c-4fe4-bedc-fbc62e424680"
      unitRef="usd">1126609000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEyLTMtMS0xLTkyNDc5_10cbb45f-626e-4a39-abff-b910c862bb39"
      unitRef="usd">1145573000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEzLTEtMS0xLTkyNDc5_beceaac3-cdc2-4b01-a9ea-7cff4ba4841d"
      unitRef="usd">1038881000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzEzLTMtMS0xLTkyNDc5_90f2ccca-14cb-4bbf-90c9-5bc942664832"
      unitRef="usd">1013458000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE0LTEtMS0xLTkyNDc5_68001736-166c-482f-a028-34294bfb35fa"
      unitRef="usd">45994000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE0LTMtMS0xLTkyNDc5_347f8468-21fa-428c-988b-8e83c86a40b5"
      unitRef="usd">56950000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE1LTEtMS0xLTkyNDc5_564d8a3b-0cd2-4cb5-84c4-f6261a4d7c26"
      unitRef="usd">57190000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE1LTMtMS0xLTkyNDc5_20db0cba-b898-4512-b077-4c9dde286b9a"
      unitRef="usd">16440000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE2LTEtMS0xLTkyNDc5_66f5c00b-dd8d-47d3-8e54-7b7490eb8ff9"
      unitRef="usd">3889758000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE2LTMtMS0xLTkyNDc5_7c87fc48-2372-42af-80d5-e572432d9f22"
      unitRef="usd">3782383000</us-gaap:Assets>
    <us-gaap:SecuredDebtCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE5LTEtMS0xLTkyNDc5_65d02900-2369-4518-95ca-4ed202422626"
      unitRef="usd">38125000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzE5LTMtMS0xLTkyNDc5_e227afb1-9296-4bf6-8f59-ace8f8216b88"
      unitRef="usd">45000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIxLTEtMS0xLTkyNDc5_018d56f9-a417-4790-a5c3-3806f9ff7c4e"
      unitRef="usd">14624000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIxLTMtMS0xLTkyNDc5_69d9bb0e-cb51-4138-8e3b-e1d409370990"
      unitRef="usd">14775000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIyLTEtMS0xLTkyNDc5_22f3b8e0-53b4-4587-9925-2e14deb4d700"
      unitRef="usd">102100000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIyLTMtMS0xLTkyNDc5_33b44cf9-e831-4c61-b92c-64c2578de70b"
      unitRef="usd">61837000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIzLTEtMS0xLTkyNDc5_6f626f10-6a66-447f-904a-9eefc6cab2fd"
      unitRef="usd">7253000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzIzLTMtMS0xLTkyNDc5_0b844089-26ce-4e83-b421-b8a16798e2bd"
      unitRef="usd">5295000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI0LTEtMS0xLTkyNDc5_bbf8e867-c258-4736-8ab0-e295139c10c6"
      unitRef="usd">78771000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI0LTMtMS0xLTkyNDc5_517be890-80a7-4eb9-be9f-e3e1c8201bf5"
      unitRef="usd">92656000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI1LTEtMS0xLTkyNDc5_3ef7ed2a-b98c-442d-93b0-3146cdb59db3"
      unitRef="usd">80033000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI1LTMtMS0xLTkyNDc5_e2fd0776-3706-4943-8cb5-7ce1c81fcfff"
      unitRef="usd">120458000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI3LTEtMS0xLTkyNDc5_882aaad5-d77d-45a2-bd72-9c8b61124547"
      unitRef="usd">320906000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI3LTMtMS0xLTkyNDc5_2d8ee40f-642d-4cfc-98da-f574c682d6f3"
      unitRef="usd">340021000</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI4LTEtMS0xLTkyNDc5_507991a5-3288-43b1-b5bf-64de50379215"
      unitRef="usd">733149000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI4LTMtMS0xLTkyNDc5_670b42b7-36c1-40e4-bb27-57170499a90b"
      unitRef="usd">824257000</us-gaap:SecuredLongTermDebt>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI5LTEtMS0xLTkyNDc5_77e6e2a4-4e1e-4717-bf4d-f8d52bc9fbbe"
      unitRef="usd">104700000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzI5LTMtMS0xLTkyNDc5_9d347e89-3e86-4c7f-9e26-e20a7f449095"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMwLTEtMS0xLTkyNDc5_2b8df40e-880e-4076-9044-1de99eb74cfe"
      unitRef="usd">567341000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMwLTMtMS0xLTkyNDc5_04658f10-1242-44aa-80ab-2fc411abbbb1"
      unitRef="usd">564426000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMxLTEtMS0xLTkyNDc5_27119cfe-1e54-4cbf-b2fd-7ddbaf70aaa7"
      unitRef="usd">157420000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMxLTMtMS0xLTkyNDc5_fd186387-4198-4d3b-92e4-93ea919bc936"
      unitRef="usd">90329000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMyLTEtMS0xLTkyNDc5_926dae8b-4845-4c3c-9a5e-cb958e40a66e"
      unitRef="usd">63338000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMyLTMtMS0xLTkyNDc5_d25a3d2e-acf6-43b7-a3ee-19350c203075"
      unitRef="usd">45788000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMzLTEtMS0xLTkyNDc5_7c80c4a3-a841-49cc-9d62-7883def82df1"
      unitRef="usd">138501000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzMzLTMtMS0xLTkyNDc5_4aefc469-e7fb-41b5-a4d1-8edeef416615"
      unitRef="usd">120258000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM0LTEtMS0xLTkyNDc5_25c7041f-4fe5-4765-a321-06e61a8dabc1"
      unitRef="usd">2085355000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM0LTMtMS0xLTkyNDc5_96eb97f7-4003-4469-8c12-1774a860c126"
      unitRef="usd">2097579000</us-gaap:Liabilities>
    <us-gaap:PreferredStockNoParValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMjE_3c1ba92c-b179-4c0c-bc68-5cc8bb0e3ad1"
      unitRef="usdPerShare">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockNoParValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMjE_6a401d0b-ca91-495a-b949-edfb78d1ba5d"
      unitRef="usdPerShare">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMzU_121cdadd-9e55-4e51-a44c-f8efba777397"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfMzU_5a062d88-9c01-4aca-b3cf-ac6b466fb7c9"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfNTc_25798ca3-e3f3-47cc-8730-955e9139ad34"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjNjZDIwMzkxYzhiNDgyYWE5ODkzN2JjMWYxMDQzMzJfNTc_b4d86bc9-c60c-4222-aff2-16dcbfe4ae6f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTEtMS0xLTkyNDc5_d393f10e-ca9c-4f03-87be-989306819a54"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM2LTMtMS0xLTkyNDc5_1d3e9a72-b6fb-4eb4-903d-93af4f5ba437"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMTg_5683ae67-9067-4451-be11-edadc258fd05"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMTg_9a281f58-0b4c-481f-8b72-3c3034eb5a77"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMzI_12554b1a-1d32-4d8e-9815-ab45bff13625"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfMzI_81fe195a-fd62-405c-88a2-f1e46d1a7bbd"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfNTQ_0fd91db0-ada0-450d-b2df-1bf60c23cf16"
      unitRef="shares">90477000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTAtMS0xLTkyNDc5L3RleHRyZWdpb246OTM5ZmVkNzJjMDk1NDA2YTk0ZTY1N2E4NjdmNjRmYzlfNjE_ef495407-aea5-40b6-ac68-366da451cdfb"
      unitRef="shares">89600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTEtMS0xLTkyNDc5_bd2ba2f5-45ac-484f-92b6-70da8772c0a1"
      unitRef="usd">905000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM3LTMtMS0xLTkyNDc5_93a16abb-6318-4d9f-be67-27c715755b00"
      unitRef="usd">896000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM4LTEtMS0xLTkyNDc5_b75a86fd-8ce5-4841-adfe-16a7d2dad89f"
      unitRef="usd">1276977000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM4LTMtMS0xLTkyNDc5_1341e279-7d1a-4c56-aa5f-710cf47cfac6"
      unitRef="usd">1264943000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjQ2OGQ5YzgwYjY4NGVmMDllNmY1NmFlNGNjOTA3NjBfMjk_713f763b-3007-406a-bacb-1ea7a0e5b943"
      unitRef="shares">6823000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTAtMS0xLTkyNDc5L3RleHRyZWdpb246ZjQ2OGQ5YzgwYjY4NGVmMDllNmY1NmFlNGNjOTA3NjBfMzY_0525c308-011e-49ea-81a1-7bc1d4f94367"
      unitRef="shares">4899000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTEtMS0xLTkyNDc5_0bd0e866-0af6-471a-a4f6-fc0367be7a71"
      unitRef="usd">362862000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzM5LTMtMS0xLTkyNDc5_97a1638f-fe58-427a-99c0-49af399516c0"
      unitRef="usd">234448000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQwLTEtMS0xLTkyNDc5_54bfbbc3-a9e2-4040-b69e-a20d71d32b54"
      unitRef="usd">10265000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQwLTMtMS0xLTkyNDc5_9d9ed586-eba0-4099-895a-ba4dcb6ca9f1"
      unitRef="usd">-45155000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQxLTEtMS0xLTkyNDc5_886adb3e-a00e-4601-bcc9-ccef393024a3"
      unitRef="usd">879118000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQxLTMtMS0xLTkyNDc5_4b0cd4eb-130f-4f33-beb2-2b2fd083a90b"
      unitRef="usd">698568000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQyLTEtMS0xLTkyNDc5_627d1582-a876-4c54-abd9-60357a0237dc"
      unitRef="usd">1804403000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQyLTMtMS0xLTkyNDc5_884204c0-b042-493c-8d71-a10307fc2f6a"
      unitRef="usd">1684804000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQzLTEtMS0xLTkyNDc5_f3fa093a-ece7-4482-aeff-82b93ab8348c"
      unitRef="usd">3889758000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzAvZnJhZzo3OWY4OTE4NGVjZWI0M2QyOWVlYjMwNDFjYTJjMThjOC90YWJsZTo3MzY4MDlhMjg2ZTg0MmIyYTc5NTFjMjYzMDZmMDkyMi90YWJsZXJhbmdlOjczNjgwOWEyODZlODQyYjJhNzk1MWMyNjMwNmYwOTIyXzQzLTMtMS0xLTkyNDc5_6f83dd08-9800-442d-9b45-0bb30ce3b8e8"
      unitRef="usd">3782383000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtMS0xLTEtOTI0Nzk_a6ace266-98c5-477a-88fb-33eee314f2f2"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtMy0xLTEtOTI0Nzk_9b1dd40b-5418-48b4-a4b6-4cecd7c47e48"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMtNS0xLTEtOTI0Nzk_c2ad988e-ef0b-403f-93f6-5c25a7c1ff37"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtMS0xLTEtOTI0Nzk_47358d5c-75a8-4f65-b5a3-e4b3dee1975f"
      unitRef="usd">118299000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtMy0xLTEtOTI0Nzk_7ed2140a-8d35-4afc-a1de-ec33a04760eb"
      unitRef="usd">119836000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzUtNS0xLTEtOTI0Nzk_3644886a-00b9-42fe-a08b-a06653811a2b"
      unitRef="usd">116031000</us-gaap:OtherDepreciationAndAmortization>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtMS0xLTEtOTI0Nzk_f44895ed-0732-458f-b2b2-d75aaae61fe4"
      unitRef="usd">0</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtMy0xLTEtOTI0Nzk_9239445e-3199-412c-ada9-1b88a9d241fb"
      unitRef="usd">0</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <iart:NoncashOrPartNoncashInProcessResearchAndDevelopment
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzYtNS0xLTEtOTI0Nzk_69c8ab6a-fb79-4dba-b732-fa086987ec43"
      unitRef="usd">519000</iart:NoncashOrPartNoncashInProcessResearchAndDevelopment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctMS0xLTEtOTI0Nzk_fad1130f-e1ad-41cd-8d26-ea788059268d"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctMy0xLTEtOTI0Nzk_98623e48-c841-43b1-8f94-0d3f2b1c9865"
      unitRef="usd">2754000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzctNS0xLTEtOTI0Nzk_0f0d5fe3-bdfb-40d0-949e-1c6abe534efe"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtMS0xLTEtOTI0Nzk_3cdab8cc-a312-4211-a899-1cfdbfd2cff2"
      unitRef="usd">-4585000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtMy0xLTEtOTI0Nzk_0924c50a-d487-492e-b1ec-0e729499453a"
      unitRef="usd">-2755000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzgtNS0xLTEtOTI0Nzk_bbda10b9-2311-43a3-9a48-36ba685074fb"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktMS0xLTEtOTI0Nzk_48b53522-56a4-4524-871e-827bd299df5a"
      unitRef="usd">27725000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktMy0xLTEtOTI0Nzk_8e90cc09-9e10-47c5-a3f2-c2e39caa6641"
      unitRef="usd">36210000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzktNS0xLTEtOTI0Nzk_cd54839b-44ec-43af-bd7f-2df3c14f8857"
      unitRef="usd">19590000</us-gaap:ShareBasedCompensation>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTEtMS0xLTkyNDc5_7807e9cc-235d-4e09-8746-1562d4259b9e"
      unitRef="usd">6845000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTMtMS0xLTkyNDc5_3c4cee30-ae55-48d2-aebd-dd5f2ca457bd"
      unitRef="usd">7030000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEwLTUtMS0xLTkyNDc5_c7e51da9-6afe-460b-b53a-720ec80a1d44"
      unitRef="usd">12076000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:NoncashLeaseExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTEtMS0xLTkyNDc5_822adb00-b37a-40c8-99d3-e2cd174635ee"
      unitRef="usd">2816000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTMtMS0xLTkyNDc5_114e7f28-2ff6-411e-b57b-58fd16b71076"
      unitRef="usd">3834000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzExLTUtMS0xLTkyNDc5_c8ac2141-dc66-4bcd-bece-47ba20067775"
      unitRef="usd">2955000</iart:NoncashLeaseExpense>
    <us-gaap:AccretionExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTEtMS0xLTkyNDc5_c9f4ff13-7dd4-4942-a770-5842058dfd2c"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTMtMS0xLTkyNDc5_a18ddb59-d2f7-4b56-bca2-abae1928031c"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEyLTUtMS0xLTkyNDc5_79e8aec8-78ec-4685-9a30-a8d53162bf07"
      unitRef="usd">15415000</us-gaap:AccretionExpense>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTEtMS0xLTkyNDc5_3932279a-e06b-46b4-90c6-5e664dfcc293"
      unitRef="usd">6813000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTMtMS0xLTkyNDc5_d5b2a44f-b1cf-48cd-969f-fb02527ad3b7"
      unitRef="usd">-2240000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzEzLTUtMS0xLTkyNDc5_b2db279e-907d-4461-9166-c394e18540ab"
      unitRef="usd">-7855000</iart:GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTEtMS0xLTkyNDc5_223e1e05-b669-427a-bf61-fc35f746cc42"
      unitRef="usd">644000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTMtMS0xLTkyNDc5_a95a85ed-4ff1-4ec1-92a4-40bf4dab8e98"
      unitRef="usd">41798000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE0LTUtMS0xLTkyNDc5_fa4a33c7-a7a3-4181-b062-c4632b6038dd"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTEtMS0xLTkyNDc5_8d721a52-d29d-4923-a55b-4d796d959de2"
      unitRef="usd">-20304000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTMtMS0xLTkyNDc5_e18c2ed5-259b-450e-9412-08a96658de53"
      unitRef="usd">-2162000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE1LTUtMS0xLTkyNDc5_5d5690e5-87ef-45e6-940c-e09fd6bdfb5c"
      unitRef="usd">951000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTEtMS0xLTkyNDc5_56bd206e-e4c5-4ce7-ab8b-4902aa1ad7cc"
      unitRef="usd">33905000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTMtMS0xLTkyNDc5_1bce51f3-44d7-41bc-baf7-954465ff475c"
      unitRef="usd">-7265000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE3LTUtMS0xLTkyNDc5_fed3f875-9622-413d-89c3-a7ec94519d67"
      unitRef="usd">-52105000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTEtMS0xLTkyNDc5_6d55e907-5c03-4780-81de-5de3b281bb8d"
      unitRef="usd">29124000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTMtMS0xLTkyNDc5_5cfa324e-2a67-4e45-8647-8d5c8e11c9e0"
      unitRef="usd">-5374000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE4LTUtMS0xLTkyNDc5_fc77ca5f-e259-4a0f-ba47-e96cd26ec81b"
      unitRef="usd">48348000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTEtMS0xLTkyNDc5_4466ecb0-f259-46fe-b1ee-44871043d80a"
      unitRef="usd">-8612000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTMtMS0xLTkyNDc5_7735a8ff-a948-4795-8845-794aeed0c216"
      unitRef="usd">21143000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzE5LTUtMS0xLTkyNDc5_05ff2479-de89-40a5-99fc-68be5df6f7bd"
      unitRef="usd">-1632000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTEtMS0xLTkyNDc5_b184190c-6806-4b6e-98df-48fbd1059d0a"
      unitRef="usd">2182000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTMtMS0xLTkyNDc5_95c4b840-03c8-4f1f-ad60-0c08eb26aaf9"
      unitRef="usd">-7875000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIwLTUtMS0xLTkyNDc5_1fb245ce-90a5-428b-8a1e-0868d1a8b865"
      unitRef="usd">-13735000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTEtMS0xLTkyNDc5_d5511ccc-f638-4464-8ac4-e740bfb7c064"
      unitRef="usd">17343000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTMtMS0xLTkyNDc5_17500394-1366-44a9-889b-506a12f02143"
      unitRef="usd">32874000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIxLTUtMS0xLTkyNDc5_f755700f-b7cf-4e3f-b820-90e86dc06bfc"
      unitRef="usd">-57512000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTEtMS0xLTkyNDc5_4f1da3ed-94b4-4998-acbd-9f1e0e1ffe71"
      unitRef="usd">4274000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTMtMS0xLTkyNDc5_00b3861e-b66a-4be6-a836-8baf630eaa65"
      unitRef="usd">28000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIyLTUtMS0xLTkyNDc5_d177b897-b562-474a-89a5-549ec5bafc90"
      unitRef="usd">-37000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTEtMS0xLTkyNDc5_c2335141-7590-4719-867a-2162f46f11cf"
      unitRef="usd">-4438000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTMtMS0xLTkyNDc5_b85d6f4a-4ef9-40ae-9d17-edeb9b77e70b"
      unitRef="usd">-14110000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzIzLTUtMS0xLTkyNDc5_56111292-a86c-4023-be7f-04f7670a1ecd"
      unitRef="usd">-2889000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTEtMS0xLTkyNDc5_266a9650-e499-4053-ab03-1644bcd3ebb1"
      unitRef="usd">264469000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTMtMS0xLTkyNDc5_1d382c88-53ba-4de2-a231-ac82eddddd6b"
      unitRef="usd">312427000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI0LTUtMS0xLTkyNDc5_f2859748-08c2-4005-bd66-3b907b6140f0"
      unitRef="usd">203832000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTEtMS0xLTkyNDc5_a5f85933-efa7-4a9c-ab0d-67a3fb4e0cf8"
      unitRef="usd">42343000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTMtMS0xLTkyNDc5_53fef5ec-5b5b-4d8c-ad7b-6507b5076590"
      unitRef="usd">48022000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI2LTUtMS0xLTkyNDc5_99ba3823-8690-44cf-9c5e-d68787d18df4"
      unitRef="usd">38890000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTEtMS0xLTkyNDc5_62a0ae28-b058-4d67-bcf2-f4327cebddf8"
      unitRef="usd">23960000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTMtMS0xLTkyNDc5_fc5341ce-8a3b-4d26-83ae-7f9856cc1cc6"
      unitRef="usd">190468000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI3LTUtMS0xLTkyNDc5_55e38788-ccf3-4327-988d-bac5b6b2634c"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTEtMS0xLTkyNDc5_28cb1eb8-5d90-4b38-a28c-17ce14b5f53b"
      unitRef="usd">4742000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTMtMS0xLTkyNDc5_e630f8bf-c103-4ed2-bf7e-f57e41baa62f"
      unitRef="usd">58000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzI4LTUtMS0xLTkyNDc5_9aea31fd-49af-47cc-bf5c-a50297e94dac"
      unitRef="usd">25000000</iart:PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTEtMS0xLTkyNDc5_1200ed96-64bd-48a4-90f5-042c1c0def6d"
      unitRef="usd">51509000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTMtMS0xLTkyNDc5_45bf03ea-318c-4a2a-a2ca-15039da61bbb"
      unitRef="usd">303910000</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <iart:PaymentsForProceedsFromBusinessAcquisitions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMwLTUtMS0xLTkyNDc5_8682db26-68f8-4109-b818-3a0b169cb2be"
      unitRef="usd">0</iart:PaymentsForProceedsFromBusinessAcquisitions>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTEtMS0xLTkyNDc5_cbab66e5-deb8-4600-9a16-caacd4c95ed1"
      unitRef="usd">11145000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTMtMS0xLTkyNDc5_c1fc3c2e-5617-4548-8251-22cab28fdd30"
      unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMxLTUtMS0xLTkyNDc5_09cad7be-93e9-4c5d-83a7-68aaca7abd6d"
      unitRef="usd">3657000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTEtMS0xLTkyNDc5_0042b885-0ec9-425e-8c51-f76f2d2fcc2e"
      unitRef="usd">-4909000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTMtMS0xLTkyNDc5_6206bd4e-af84-496e-9970-d5220b8690f0"
      unitRef="usd">-76000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMyLTUtMS0xLTkyNDc5_1c612563-7902-4f00-8d97-cd562f33ad8c"
      unitRef="usd">7840000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTEtMS0xLTkyNDc5_69d76f67-6ca3-4aa3-b889-9d73bf28fa8f"
      unitRef="usd">-58580000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTMtMS0xLTkyNDc5_c88b14d9-d084-4e7f-8670-129b6e8e7393"
      unitRef="usd">-161443000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzMzLTUtMS0xLTkyNDc5_92c4fb64-f894-4d96-aaba-1638f8eccf05"
      unitRef="usd">-68073000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTEtMS0xLTkyNDc5_abffd2a7-149d-4ce8-9b51-3020cb3c79a9"
      unitRef="usd">40750000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTMtMS0xLTkyNDc5_7261eeec-21e5-4efe-bcdd-12d2ea694dce"
      unitRef="usd">25500000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM1LTUtMS0xLTkyNDc5_b4fa7ef3-9f45-4fc6-9367-b8e348dcca51"
      unitRef="usd">171500000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTEtMS0xLTkyNDc5_b25bf211-83fa-4c87-af77-e9dfa97792f0"
      unitRef="usd">148550000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTMtMS0xLTkyNDc5_efae3edc-b1a4-4ca2-ae0f-0bedc25fd110"
      unitRef="usd">125500000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM2LTUtMS0xLTkyNDc5_c0d88130-0214-4ccb-b9ae-a4ccf3503cd1"
      unitRef="usd">441000000</us-gaap:RepaymentsOfSecuredDebt>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTEtMS0xLTkyNDc5_7169043f-557d-4813-94c5-c579d927eb2a"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTEtMS0xLTkyNDc5_df146ec6-ca9a-4a5e-b6f9-7e3b679320b3"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTMtMS0xLTkyNDc5_90e9a305-0763-43b0-bbc0-23494aee5cbc"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTMtMS0xLTkyNDc5_9e7f5b22-fc53-4551-a399-96e1888eb962"
      unitRef="usd">0</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTUtMS0xLTkyNDc5_7c3854ad-b8f3-4d99-877c-7682de4ac721"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM3LTUtMS0xLTkyNDc5_cdf95303-dddd-4c83-8057-b70dcab5fb43"
      unitRef="usd">104248000</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTEtMS0xLTkyNDc5_13c04d87-5c19-4f28-b369-c94a2122db58"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTEtMS0xLTkyNDc5_e89a3933-eb58-4e60-9cca-f036cb16b969"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTMtMS0xLTkyNDc5_29f5cc74-ecae-4a82-901f-c963644ae343"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTMtMS0xLTkyNDc5_8ecdea5d-0199-4138-80d3-c26a25b8550a"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTUtMS0xLTkyNDc5_4a768b6b-041c-4dbb-bab2-2f29e94548cc"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM4LTUtMS0xLTkyNDc5_a421ac8f-9a16-42fb-af60-a5b8c504a2fd"
      unitRef="usd">575000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTEtMS0xLTkyNDc5_2ea33bda-59aa-4748-b668-64b398ea3474"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTMtMS0xLTkyNDc5_96ba679b-f0d8-47f5-8b13-dd3edd02f51d"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzM5LTUtMS0xLTkyNDc5_f456823c-7576-4ecc-8fb8-d86d0b377cdd"
      unitRef="usd">44563000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTEtMS0xLTkyNDc5_b39fb58f-c29f-4100-b6fc-b237343d58f2"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTMtMS0xLTkyNDc5_1828653a-4741-4af1-b560-daffc8601e03"
      unitRef="usd">249000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQwLTUtMS0xLTkyNDc5_0f40276c-2e39-4810-99ee-8f85ed457f33"
      unitRef="usd">24347000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTEtMS0xLTkyNDc5_72fce25a-c10f-43c5-ad37-59b9a08904c3"
      unitRef="usd">125000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTMtMS0xLTkyNDc5_6a92ff4f-8f8b-4081-9b10-cc2af8e448c2"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQxLTUtMS0xLTkyNDc5_3aa3cb56-90de-4902-88d1-499df80eb782"
      unitRef="usd">100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTEtMS0xLTkyNDc5_d8b1464b-7da6-4838-88ef-2f28a01eeddc"
      unitRef="usd">5465000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTMtMS0xLTkyNDc5_f1fc0bf1-8042-4fbf-9987-d0d57743895c"
      unitRef="usd">6824000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQyLTUtMS0xLTkyNDc5_a0c4d1b0-a5dc-4dc2-b133-461588e8b340"
      unitRef="usd">5232000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTEtMS0xLTkyNDc5_8bb18a66-da48-4284-87e7-997982918951"
      unitRef="usd">24618000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTMtMS0xLTkyNDc5_c73b27d6-6c82-42e3-b674-f9d9b0aedea7"
      unitRef="usd">4801000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQzLTUtMS0xLTkyNDc5_c36f19bd-e27c-40c8-bd62-2e052f28ea2a"
      unitRef="usd">5075000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTEtMS0xLTkyNDc5_2e3bb28b-689e-40d4-905d-ab46866ebea5"
      unitRef="usd">-251953000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTMtMS0xLTkyNDc5_a5224373-fdce-4307-bb01-6ce50702cff5"
      unitRef="usd">-98226000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ0LTUtMS0xLTkyNDc5_27832dbb-2690-4e7b-9acd-7fd14c38a906"
      unitRef="usd">121625000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTEtMS0xLTkyNDc5_6073674d-0c77-4088-a626-6847f22fa568"
      unitRef="usd">-10723000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTMtMS0xLTkyNDc5_056592f7-8cab-4719-850f-8f47a358f09c"
      unitRef="usd">-9476000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ1LTUtMS0xLTkyNDc5_93e391a2-6f09-4ec6-bad3-240c13bacb92"
      unitRef="usd">13871000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTEtMS0xLTkyNDc5_9bed1ccf-6061-4acc-b932-73a74a570e8c"
      unitRef="usd">-56787000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTMtMS0xLTkyNDc5_524cd568-7436-4699-ae74-659785926fa7"
      unitRef="usd">43282000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ2LTUtMS0xLTkyNDc5_823961cb-90bd-4e15-8197-0dca8fe0d731"
      unitRef="usd">271255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTEtMS0xLTkyNDc5_54ca2d14-4bea-495d-9046-4b20be021ffd"
      unitRef="usd">513448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTMtMS0xLTkyNDc5_46bf1276-0dcd-410f-a841-5d47c04efb80"
      unitRef="usd">470166000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ3LTUtMS0xLTkyNDc5_90b2c55f-d803-41af-915e-083eed834aba"
      unitRef="usd">198911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTEtMS0xLTkyNDc5_56b96c4a-b1cb-40d1-add4-db8c136ab309"
      unitRef="usd">456661000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTMtMS0xLTkyNDc5_e376bd27-012e-4d2a-9c48-5f77c5f6db54"
      unitRef="usd">513448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzMvZnJhZzpiNTM4MzA2MTgyN2E0YzUxOTg3OWYyMWY0ZTAwNWY1Zi90YWJsZTo0NzJiYTE1NDljNTQ0OWM4ODJiYTczYjI4ODAyNGVlZi90YWJsZXJhbmdlOjQ3MmJhMTU0OWM1NDQ5Yzg4MmJhNzNiMjg4MDI0ZWVmXzQ4LTUtMS0xLTkyNDc5_0f907fa6-78e5-4c0e-88d5-191cccf6592b"
      unitRef="usd">470166000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesIssued
      contextRef="ieb43d094e8824032961a8ec85d76affb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMS0xLTEtOTI0Nzk_abcb8321-446d-4cc8-9ec7-eef619da867d"
      unitRef="shares">88735000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ieb43d094e8824032961a8ec85d76affb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMy0xLTEtOTI0Nzk_193b019e-a925-40df-a0de-452d6c485e60"
      unitRef="usd">887000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i55ce9af062df477e959977ef29770b62_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtNS0xLTEtOTI0Nzk_9d2eb32b-878c-4bf4-86cb-eb601cf375b3"
      unitRef="shares">2865000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i55ce9af062df477e959977ef29770b62_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtNy0xLTEtOTI0Nzk_e78b8f53-0e92-4aa6-9b9a-080aaecf956b"
      unitRef="usd">-119943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d722c9ae87d4ebf9e2f34d8f1a61b79_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtOS0xLTEtOTI0Nzk_6a212bcf-064f-47e0-ae2d-3dec0ed3355b"
      unitRef="usd">1213620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia304241c7950452cbb025f7ee427babc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTEtMS0xLTkyNDc5_8658cabd-6f6e-4dc6-abaa-160a5e6380e9"
      unitRef="usd">-76402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i059e8d7474364db9884d18f168a39eb5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTMtMS0xLTkyNDc5_e479d7cf-6469-4990-a860-96e0fe62745c"
      unitRef="usd">398574000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzgtMTUtMS0xLTkyNDc5_a4eb48a4-5a14-474d-8f83-d10542b483df"
      unitRef="usd">1416736000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4b4d9ca5a4da49c0a179fc3d4ace01d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzktMTMtMS0xLTkyNDc5_ea9af635-0def-4f07-843c-8cab22ad6a5b"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzktMTUtMS0xLTkyNDc5_d72ace63-4688-45e5-b1ed-ba66b5771b28"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia19c3c07994f4ba2b78daf3355acf271_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEwLTExLTEtMS05MjQ3OQ_5bb06a3a-0927-491a-81c3-8eabf3cfde72"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEwLTE1LTEtMS05MjQ3OQ_9e5557a1-c6c2-402d-9892-87acf0372f63"
      unitRef="usd">2343000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTEtMS0xLTkyNDc5_959a2b9f-7a80-4189-93f8-c1056de2b675"
      unitRef="shares">13000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTktMS0xLTkyNDc5_6830be54-f0b2-4260-858f-be34dba0b2a5"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzExLTE1LTEtMS05MjQ3OQ_9f39329a-5aba-48fa-947c-0b35b80da147"
      unitRef="usd">694000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTEtMS0xLTkyNDc5_a3ac3dcf-67d7-4748-a0a4-d20293c4a881"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTMtMS0xLTkyNDc5_37a38b2e-0788-4c00-82f8-15213665b232"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTUtMS0xLTkyNDc5_5f6d1dfb-68b0-4ab7-9d3b-fa3591c4ccfd"
      unitRef="shares">11000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTctMS0xLTkyNDc5_0fa8ded8-3908-4213-b326-412056236028"
      unitRef="usd">526000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTktMS0xLTkyNDc5_66480048-f939-48e3-8c0c-3384cff10359"
      unitRef="usd">-1066000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEyLTE1LTEtMS05MjQ3OQ_477a7418-a6e3-415c-98d8-b91edbc2c263"
      unitRef="usd">-538000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie067b3ad3b714a598da25c0192c65029_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTMtMS0xLTkyNDc5_e4c2046a-2e9e-45de-a729-ee9f9ff2254e"
      unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTktMS0xLTkyNDc5_8a4d313d-bba7-40a5-b954-99888a1433ae"
      unitRef="usd">19397000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzEzLTE1LTEtMS05MjQ3OQ_79f4d96f-b99e-4a6f-b35f-5144ef2c699b"
      unitRef="usd">19401000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE0LTktMS0xLTkyNDc5_8b948632-0107-4039-9459-300032760ba4"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE0LTE1LTEtMS05MjQ3OQ_6f506e12-f408-414f-83b7-7ceb1afffdb4"
      unitRef="usd">42539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTUtMS0xLTkyNDc5_06bb6616-0b2f-4cdb-9b03-f1007aa4c116"
      unitRef="shares">2060000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i03f744abd9ac4b9d8d6d6a5356cd5572_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTctMS0xLTkyNDc5_0a55983f-1887-44e5-82d1-245d41148484"
      unitRef="usd">115724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i54587714353d43c59304abf93aa9c270_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTktMS0xLTkyNDc5_37beb2cf-6f2a-48cb-a84c-6f2882f5a844"
      unitRef="usd">-15724000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE1LTE1LTEtMS05MjQ3OQ_e554708c-aac4-4a31-aa87-cf012ed48165"
      unitRef="usd">100000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="i47471b2931934e4b9698fc87efb42f3a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTEzLTEtMS05MjQ3OQ_164ea807-e6e5-493f-a5ac-ecbcffad3437"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8d4c24857e248099e323a764be5a960_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE2LTE1LTEtMS05MjQ3OQ_48f225a1-cb2e-445d-99df-0ec1487381af"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="icacf91222c56450a94535b8158c1f9fe_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTEtMS0xLTkyNDc5_9ac18ffc-23fa-4af1-941f-048429a48fc9"
      unitRef="shares">89251000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icacf91222c56450a94535b8158c1f9fe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTMtMS0xLTkyNDc5_e65835bb-6d3f-42bc-a0f9-8b8543bbadf3"
      unitRef="usd">893000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i4a7ad2dd7fe145e9a775191f346885f2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTUtMS0xLTkyNDc5_e1140ea7-b3b3-44a4-bdd9-f99d3945da98"
      unitRef="shares">4914000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i4a7ad2dd7fe145e9a775191f346885f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTctMS0xLTkyNDc5_479a0d63-193e-4b46-a209-812c516a86b0"
      unitRef="usd">-235141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i47e2e1c7c56e4e6f96b757b450e3d8a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTktMS0xLTkyNDc5_03eace2f-1f9b-4688-a250-7cd50aeb406e"
      unitRef="usd">1290908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7005821211dc4a61bc033d8dc246f9e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTExLTEtMS05MjQ3OQ_989e7b53-524a-4b15-b001-2052858de82c"
      unitRef="usd">-74059000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1d58570b6055411d8462693d39b49056_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTEzLTEtMS05MjQ3OQ_8c3f145d-725d-4aad-aae4-2f3c9212d4e6"
      unitRef="usd">532266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE3LTE1LTEtMS05MjQ3OQ_a0a64987-4a08-4b96-9d47-1afe0e2ad804"
      unitRef="usd">1514867000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie068465acf624179b0d91e83e4d97156_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE4LTEzLTEtMS05MjQ3OQ_0f374ca9-3e27-480d-ad5a-28453405fc1d"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE4LTE1LTEtMS05MjQ3OQ_beb7ffcf-eb53-4389-9295-e16a133d5087"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id51546d1efdb4b37baab40ff76fdddc7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE5LTExLTEtMS05MjQ3OQ_51a7a4b5-a839-458d-925e-bbc8bc48e9a5"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzE5LTE1LTEtMS05MjQ3OQ_2aa5d52d-0ac4-455a-8eb1-63e2add41473"
      unitRef="usd">28904000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTEtMS0xLTkyNDc5_8a6798af-6c79-47f1-80c9-3bc3723c8e97"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTktMS0xLTkyNDc5_e4fd36ca-5389-4714-bd35-ebfb7c6faea4"
      unitRef="usd">1127000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTE1LTEtMS05MjQ3OQ_bfba02ea-efeb-432c-a38b-4b000b7ca0b1"
      unitRef="usd">1127000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTkyNDc5_844c7dbc-725d-4413-beab-b1fab161760f"
      unitRef="shares">331000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTMtMS0xLTkyNDc5_1dbe7818-1ff2-4a0c-8538-c41017500867"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTUtMS0xLTkyNDc5_f336f367-7c41-4491-843b-6560c53a5c75"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4e9511471674a9b832f49c2bf4abe2f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTctMS0xLTkyNDc5_1516ed93-b8db-4fc4-b302-4127fa1cc8bd"
      unitRef="usd">693000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTkyNDc5_955ee27e-0d65-4d71-85e9-341af682cc27"
      unitRef="usd">201000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTE1LTEtMS05MjQ3OQ_df87f461-76af-4777-9053-d6a43edfbe6b"
      unitRef="usd">895000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1c9e7582f9924952b85466aaf20ca73c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTMtMS0xLTkyNDc5_553e94df-60c6-449a-9209-461c1ed8a57c"
      unitRef="usd">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i75b86be08e5641848e8d7b427009e157_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTktMS0xLTkyNDc5_9a1e1df0-24a0-4de0-b762-94d0ee4a49e7"
      unitRef="usd">35981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTE1LTEtMS05MjQ3OQ_dd779b98-ae4b-4ad4-85bf-612630ed07ad"
      unitRef="usd">35983000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i076755c4427e4d259078e6b2d89e580a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTktMS0xLTkyNDc5_6fe0ae4e-f1c8-4dd5-a9ce-aa5e235573d5"
      unitRef="usd">-63274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie03d921a6dbf4c6ab60982b0658b2bc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEzLTEtMS05MjQ3OQ_4f4efaef-3dc1-4984-9cf6-7d72bfd0e901"
      unitRef="usd">-2773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i923e26b254024ce191a077d3ad910d88_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS05MjQ3OQ_a45376f1-72c4-40d1-ba7b-f972b4079196"
      unitRef="usd">-66047000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iac1f6a25383842738c3f81f79c901726_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTEtMS0xLTkyNDc5_915b4dd4-7e01-41dd-a4e7-2bcc1474371a"
      unitRef="shares">89600000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iac1f6a25383842738c3f81f79c901726_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTMtMS0xLTkyNDc5_dc251049-fc9a-4214-80ec-f33aa80b0b3d"
      unitRef="usd">896000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i92f2148b01b24348b1bcaceec81f6c73_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTUtMS0xLTkyNDc5_a9c0987b-75d8-4abf-8cb0-d13935ffb067"
      unitRef="shares">4899000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i92f2148b01b24348b1bcaceec81f6c73_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTctMS0xLTkyNDc5_e396a42d-b9a9-4b48-9453-e692a80ceaff"
      unitRef="usd">-234448000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00df800819924b1db728d5624c35f949_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTktMS0xLTkyNDc5_78828a21-5a44-4924-b3a4-96fb703cfdf5"
      unitRef="usd">1264943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTExLTEtMS05MjQ3OQ_35fba343-8a66-4922-a26e-7788c432ea0a"
      unitRef="usd">-45155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f29af258c2049d09523a55767d03678_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTEzLTEtMS05MjQ3OQ_a82cb734-12dd-49f2-a9bc-1ba37a006dfe"
      unitRef="usd">698568000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTE1LTEtMS05MjQ3OQ_ac57926f-755f-4162-8232-51f3e69cad12"
      unitRef="usd">1684804000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="icff7c2d092db46b2bab82d2bfbb65a49_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIwLTEzLTEtMS0xNDcxNTY_7611f95a-40b2-4136-94cc-847cb38f8aeb"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIwLTE1LTEtMS0xNTIyMTE_31adb377-9eaf-45f2-93b9-c03038c4fb03"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i77173b4d8e484fb39e318247f8305f57_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTExLTEtMS0xNDcxNTY_92dd5fef-b58b-4b57-a4d2-673a3abbe5e9"
      unitRef="usd">55420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIxLTE1LTEtMS0xNTIyMDg_f88f1a70-fb63-4ed2-a88f-ae36ac9423ad"
      unitRef="usd">55420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTE1MDU0OA_809e2216-310d-41ca-befe-829a12fa7ca0"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTE1MDU0OA_ab198af5-8542-4094-a546-2a102050c59e"
      unitRef="usd">1078000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTE1LTEtMS0xNTIyMDU_7026bbe9-1dc0-4e47-b653-1f181477dbd4"
      unitRef="usd">1078000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTEtMS0xLTE0NzE1Ng_25e5cd83-ccfe-4189-9092-525a3b88edb7"
      unitRef="shares">859000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTMtMS0xLTE0NzE1Ng_bb68fa88-2b40-4bbb-8e5c-67e25a49d1f8"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTUtMS0xLTE0NzE1Ng_1354e470-c711-49b9-b3b0-84e51399f8f7"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTctMS0xLTE0NzE1Ng_e1a72de6-90c0-411f-8302-4ec4426594f1"
      unitRef="usd">738000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIyLTktMS0xLTE0NzE1Ng_f3e1d61e-7fc3-4b0f-90a9-250c3760c9ae"
      unitRef="usd">-20974000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTE1LTEtMS0xNTIyMDE_99fff552-2cd3-491a-bc52-1ad90350486a"
      unitRef="usd">-20229000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i93a76da642f94c33887a7da7c8d13243_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTMtMS0xLTE0NzE1Ng_e4607535-e8f7-44fd-b8b8-256952366c9f"
      unitRef="usd">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzIzLTktMS0xLTE0NzE1Ng_2860b435-aff6-4c3f-acd0-6744319eb0e8"
      unitRef="usd">27778000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS0xNTIxOTc_2289579d-6eaf-4784-a134-12e04bdf9924"
      unitRef="usd">27780000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTUtMS0xLTE1MDU5NA_915f82cd-5034-49cf-be34-13ff59eabcbd"
      unitRef="shares">1938000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia81e421ecace42a5b0352f720caa6675_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTctMS0xLTE1MDU5NA_72baad1b-4d28-47fb-b4d3-183adbe18a97"
      unitRef="usd">129152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if48adbaf01d2404990e50890b2ef9b2e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTktMS0xLTE1MDU5NA_c0eb35cf-a5d9-4408-8e77-6c03f1f3527c"
      unitRef="usd">-4152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI1LTE1LTEtMS0xNTIxOTM_89cbc9ff-711b-4cbe-8aba-15f8f5f96d2c"
      unitRef="usd">125000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:SharesIssued
      contextRef="i38626384e0824b86a26dc5567021967f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEtMS0xLTE0ODc1Mg_729948eb-9268-46b7-97fe-aa6d4dad731e"
      unitRef="shares">90476000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i38626384e0824b86a26dc5567021967f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTMtMS0xLTE0ODc1Mg_3ad5238a-8de3-4d94-88bd-3c0afd86ec5b"
      unitRef="usd">905000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="iaacd778bd0c149d084dfccd55a63c987_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTUtMS0xLTE0ODc1Mg_323b6920-786d-4427-a2f6-20f23c1d5781"
      unitRef="shares">6823000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="iaacd778bd0c149d084dfccd55a63c987_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTctMS0xLTE0ODc1Mg_a6975d2b-a7f9-4ab3-942d-47a802c2abbf"
      unitRef="usd">-362862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieded6749710f48979f351fb7d3fa9e12_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTktMS0xLTE0ODc1Mg_75d1ac8a-0ae6-4b88-a481-b1a1af0c5f7c"
      unitRef="usd">1276977000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTExLTEtMS0xNDg3NTI_9c22084b-73c4-4943-b5fd-08b9c4f863bb"
      unitRef="usd">10265000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb931d5ad83741a294637a95707f41cd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTEzLTEtMS0xNDg3NTI_fe520ee8-0f32-44f2-a3bc-d0a4c3929090"
      unitRef="usd">879118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xMzYvZnJhZzoxMmNkZTQ2N2M5OTY0N2Y3YmRmMTk5NTk0YzdhMDljYy90YWJsZTpkYzdiODEyZWY0MDU0ODk5OGUyZGZkZTc4NDgyODU4ZS90YWJsZXJhbmdlOmRjN2I4MTJlZjQwNTQ4OTk4ZTJkZmRlNzg0ODI4NThlXzI0LTE1LTEtMS0xNDg3NTI_ec9d4662-e4de-45e7-a950-4279c8fcf849"
      unitRef="usd">1804403000</us-gaap:StockholdersEquity>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDUvZnJhZzo2NjJmNjU5ODU3N2Q0ZGQ2OGUzMWI0MTU3ODMzZDNlOS90ZXh0cmVnaW9uOjY2MmY2NTk4NTc3ZDRkZDY4ZTMxYjQxNTc4MzNkM2U5XzkwNA_067191ce-ad10-4114-8409-29b8221a1442">BUSINESSIntegra LifeSciences Holdings Corporation (the &#x201c;Company&#x201d;) was incorporated in Delaware in 1989. The Company is a worldwide leader in medical technology. The Company was founded with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. The Company has expanded its base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. The Company sells its products directly through various sales forces and through a variety of other distribution channels.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTI1_695bca3d-1a22-440b-a6af-00ffda177656">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;USE OF ESTIMATES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company continues to navigate the novel coronavirus ("COVID-19") pandemic and recent variants of the virus&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as the adverse impacts to global economic conditions, supply chain and the operations, there may be impact to future estimates including, but not limited to, inventory valuations, fair value measurements, goodwill and long-lived asset impairments, the effectiveness of the Company&#x2019;s hedging instruments, deferred tax valuation allowances, and allowances for doubtful accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. Provision for doubtful accounts, net of recoveries, associated with accounts receivable, included in selling, general and administrative expense, was charges of $0.2 million for the year ended December&#160;31, 2022, recoveries of $1.1 million, and charges of $3.6 million for the years ended December 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table shows the rollforward of the allowance for doubtful accounts for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December&#160;31, 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense associated with property, plant and equipmen&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;t was $40.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, $39.4 million, and $42.1 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CAPITALIZED INTEREST&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended December&#160;31, 2022 and 2021, respectively, the Company capitalized $1.4 million and $1.2 million of interest expense into property, plant and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs and costs to restructure the acquired company are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determi&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition. Refer to Note 4, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; and Divestitures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC Topic 350") and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;over their expected useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of an indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC 350 Topic when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LONG-LIVED ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INTEGRA FOUNDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements. The Company contributed $0.0 million, $1.2 million and $0.8 million to the Integra Foundation during the years ended December&#160;31, 2022, 2021 and 2020, respectively. These contributions were recorded in selling, general, and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net, on the consolidated financial statements. Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FOREIGN CURRENCY &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries. Foreign currency transaction net losses of $3.3&#160;million,  net gains of less than $0.1 million, and net losses $1.6 million are reported in other income, net in the statements of operations, for the year ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings unless there is a manner under which to remit the earnings without a material tax cost. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one month to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue From Contracts With Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RESEARCH AND DEVELOPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred employee termination costs on restructuring activities associated with a closure of a manufacturing facility in France and other reorganization projects in the consolidated statement of operations for the year ended December&#160;31, 2022. In 2021, the Company incurred employee termination costs on restructuring activities associated with the  closure of a manufacturing facility in France. The following table summarizes our restructuring related accrual balances included within accrued expenses and other current liabilities in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of Goods Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the accrual balance as &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of December&#160;31, 2022 is $2.0&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; related to the closure o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f a manufacturing facility located in France, and other reorganization projects of $3.1M&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the accrual balance as &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of December 31, 2021 is $10.2&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to the closure o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f the manufacturing facility located in France. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;STOCK-BASED COMPENSATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations. Refer to Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the Company's customers accounted for 10% or more of the consolidated net sales during the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 848): Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. On October 5, 2022, the FASB approved an extension of the sunset date of the reference rate reform from December 31, 2022 to December 31, 2024, past LIBOR&#x2019;s end date. The Company currently has contracts that are indexed to LIBOR and are continuing to evaluate the scope of impacted contracts and potential risk. The Company expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As detailed in Note 5,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#x201c;if-converted&#x201d; method. Upon adoption of ASU 2020-06, the Company&#x2019;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#x2019; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides guidance to clarify and reduce diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for interest during the years ended December&#160;31, 2022, 2021 and 2020 was $42.2 million (net of $1.4 million that was capitalized into construction in progress), $43.2 million (net of $1.2 million that was capitalized into construction in progress) and $47.3 million (net of $2.3 million that was capitalized into construction in progress), respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for income taxes, net of refunds, for the years ended December&#160;31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $35.9 million, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$49.5 million and $29.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;NON-CASH INVESTING AND FINANCING ACTIVITIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment purchases included in liabilities at December&#160;31, 2022, 2021 and 2020 were $10.5 million, $4.7 million and $1.6 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company achieved its final developmental milestone which triggered a $5.0&#160;million obligation to be paid to former shareholders of Rebound Therapeutics Corporation ("Rebound"). The Company recorded $5.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The remaining obligation was included in accrued liabilities at December 31, 2021 in the consolidated balance sheets. The milestone was fully paid in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company achieved another developmental milestone which triggered a $20.0&#160;million obligation to be paid to the former shareholders of Rebound. The Company recorded $20.0&#160;million as an intangible asset in the consolidated balance sheet upon achieving the milestone. The milestone was paid during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQ0_d7b46140-72ff-4fdd-8220-9c05803e8d1a">BASIS OF PRESENTATION These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation&#160;S-X under the Securities Exchange Act of 1934, as amended.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQ2_a88935f3-444c-4e14-a011-b2a018a1b675">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. See Note&#160;4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of new subsidiaries included in the consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTg1_522930d4-1679-41d9-a99a-004bcc669079">USE OF ESTIMATES The preparation of consolidated financial statements is in conformity with generally accepted accounting principles in the United States ("GAAP") which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2Mjcw_6731be7a-c16d-4181-a8f0-c0a3de4e619b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjUy_1e0d6e47-f677-4f20-bade-0e6e512d9f0f">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the collectability of accounts receivable based on a combination of factors. The Company recognizes a provision for doubtful accounts that reflects the Company&#x2019;s estimate of expected credit losses for trade accounts receivable. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, the Company evaluates measurement of all expected credit losses for trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company adopted this guidance on January 1, 2020 using a modified retrospective transition method which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption with no change to financial results reported in prior periods. The cumulative-effect adjustment recorded on January 1, 2020 was not material. The adoption of this ASU did not have a significant impact on the Company's consolidated financial statements and related disclosures. The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the COVID-19 pandemic and recent variants of the virus, and other customer-specific factors.&#160;Although the Company has historically not experienced significant credit losses, it is possible that there could be an adverse impact due to customer and governmental responses to the COVID-19 pandemic.&lt;/span&gt;Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2Mzg_9ffbba21-068a-4d1e-9c71-202ec8e91841"
      unitRef="usd">200000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2Nzk_1ff85307-ea01-4afb-b8e0-8a207ee98247"
      unitRef="usd">-1100000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzU2ODc_0efea636-68bb-4634-89d1-115e30b268af"
      unitRef="usd">3600000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1NjYzMzM_5b4c89a2-cbed-468d-bb35-49a2693fe161">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table shows the rollforward of the allowance for doubtful accounts for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Deductions primarily relates to allowance for doubtful accounts written off during the year, net of recoveries and other adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtMS0xLTEtMTQ2MDcw_19ca4985-0214-405d-b786-07cedd5a746f"
      unitRef="usd">4735000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtMy0xLTEtMTQ2MDcw_95bd2b02-134d-48b8-9e63-a8b82f761e1b"
      unitRef="usd">238000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtNS0xLTEtMTQ2MDcw_369f281b-cddf-4770-a1f4-290978c50174"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ie966000a0e4342acbb440309c555baad_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtNy0xLTEtMTQ2MDcw_0087eda7-68fc-40a8-bb15-4f5bbda67495"
      unitRef="usd">669000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idfaecd31c89f44a49d37ff888379adec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzMtOS0xLTEtMTQ2MDcw_ba757005-a964-4b1c-b468-28c88bd78703"
      unitRef="usd">4304000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtMS0xLTEtMTQ2MDY1_d5e94576-dcb3-473b-992e-29e7cfa1588b"
      unitRef="usd">6439000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtMy0xLTEtMTQ4NzYy_411195cc-7306-4260-8148-ee56ac7b0ed0"
      unitRef="usd">-1059000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtNS0xLTEtMTQ4NzY0_5bb7f7a0-76fc-4f7c-8120-c9534ee9eafc"
      unitRef="usd">341000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6ed5451ad4934c0aae846579fac857ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtNy0xLTEtMTQ4NzY2_061271f3-bc5d-4391-bba3-be9904dfee40"
      unitRef="usd">-986000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i83ae2861f4a1489fa6e81d7262ab2f96_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzQtOS0xLTEtMTQ4NzY4_07146c55-346d-421b-85ee-5d579fea6626"
      unitRef="usd">4735000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3fe44e0a022f4f34bf03594794a50963_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtMS0xLTEtMTQ2MDQ1_b0692bec-6b4b-41da-886b-dde3dcd339a5"
      unitRef="usd">4303000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtMy0xLTEtMTQ2MDUx_665f6925-cbc1-425f-9b56-402ea90d409f"
      unitRef="usd">3635000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtNS0xLTEtMTQ2MDUx_e15b5b04-ec82-4d22-a067-f9efbc87cee3"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i7e161198298246ba9ee534f5322e13ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtNy0xLTEtMTQ2MDUx_de3c74db-71bb-4bac-bc34-18d694aeff17"
      unitRef="usd">1499000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i74d17fa2730c4046bd3feb8e0dd7ab3d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTpjZGNkYjkxOTBlNjM0ZGNlODY0ZDViMDA3ZGE4ZGQxOS90YWJsZXJhbmdlOmNkY2RiOTE5MGU2MzRkY2U4NjRkNWIwMDdkYThkZDE5XzUtOS0xLTEtMTQ4NzY4_eaeea022-25b2-4b54-9008-a7ba06ae01da"
      unitRef="usd">6439000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDkw_ee14a9f7-cede-4482-bc5f-b0afb77ac871">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. Inventories consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value. &lt;/span&gt;&lt;/div&gt;The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable economic benefit. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTQ0_d16ec56a-5577-4795-8539-4b93f4b4c4ea">Inventories consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzItMS0xLTEtOTI0Nzk_6d56e0ba-0cd9-45bb-a091-f7a3c5101f2d"
      unitRef="usd">172088000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzItMy0xLTEtOTI0Nzk_49d6f385-8495-4fac-8079-14b26a92d158"
      unitRef="usd">162528000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzMtMS0xLTEtOTI0Nzk_b2389f43-242e-46de-9331-92083765e18a"
      unitRef="usd">70598000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzMtMy0xLTEtOTI0Nzk_2dfd4ca5-f266-4122-92e9-44bd9c77418c"
      unitRef="usd">65323000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzQtMS0xLTEtOTI0Nzk_6547ce71-c8e9-4c52-9426-6ba1f02ee8a7"
      unitRef="usd">81897000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzQtMy0xLTEtOTI0Nzk_ea84d933-334b-49ac-90bf-18624756a4f2"
      unitRef="usd">89535000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzUtMS0xLTEtOTI0Nzk_f37af6e1-ba70-439a-9ede-6e24fc67bd2f"
      unitRef="usd">324583000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTozZjFmNjFiYWI1MDA0MTc4YjA2YjllYjdhNzdiNjBlMC90YWJsZXJhbmdlOjNmMWY2MWJhYjUwMDQxNzhiMDZiOWViN2E3N2I2MGUwXzUtMy0xLTEtOTI0Nzk_363f9534-735b-49a1-91ca-3a4a70bdaffd"
      unitRef="usd">317386000</us-gaap:InventoryNet>
    <iart:InventoryCapitalizedExpenses
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzc2MDU_78302952-c04a-429f-91e3-334e2071ee1d"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <iart:InventoryCapitalizedExpenses
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzc2MDU_df9ccaec-51a5-484c-9806-3d29d053c8eb"
      unitRef="usd">0</iart:InventoryCapitalizedExpenses>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDUz_447ec837-a259-419a-b858-097fa6c69724">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT AND EQUIPMENT &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at historical cost less accumulated depreciation and any impairment charges. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred. The cost of computer software developed or obtained for internal use is accounted for in accordance with the Accounting Standards Codification 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal-Use Software.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQw_1e8d534b-fb64-47f3-93f6-373515de891d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment balances and corresponding lives were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and production equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Information systems and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures, and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i885964e8d4134704bda0cee1a82823e9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzItMS0xLTEtOTI0Nzk_d84c79d8-b1a0-4ca3-9ee1-5ce6f6fd6532"
      unitRef="usd">966000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i274e28de1007483189af177cc3870bed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzItMy0xLTEtOTI0Nzk_abfc25c7-94d1-420c-ad21-495c30deba90"
      unitRef="usd">1512000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idf6c9d635e1847d0ba05f03bab83deb8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtMS0xLTEtOTI0Nzk_e9abaa92-39fd-4f8e-91a1-d4139c2bcb75"
      unitRef="usd">14710000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie3b59f71e3dc40bc95ec22429582ce92_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtMy0xLTEtOTI0Nzk_54bbea87-a410-4f62-9e37-137bd4e540b4"
      unitRef="usd">19032000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iba62f965ad2b4becaf6a2924ce7b0f73_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1YzlmODRjYjVlZTY0MjdjOWU5YzI4MTk2YjVjNWU1OF80_135467b7-e519-4735-b59b-53c6ff451868">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i00e2bf9b2ca64e639101cdb95fe9623d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzMtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1YzlmODRjYjVlZTY0MjdjOWU5YzI4MTk2YjVjNWU1OF83_7c20e690-8d35-4002-b003-d9ce277c0fec">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia7c4c516f7c341e9a8f12da7fb0fd730_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtMS0xLTEtOTI0Nzk_1c8237c5-d864-46c5-98aa-1408b478d239"
      unitRef="usd">164292000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5d9e34be34c14c778773f8253aa5b1d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtMy0xLTEtOTI0Nzk_d3d70278-85ba-4592-a8d0-5474235e998c"
      unitRef="usd">155495000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaf4de01512a54f9d9da0d18e3f50daaa_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyYzhiODVhMTUyZDE0NWJmYTZkNmRhM2FhZjA0NWQ5NV80_dbf8dc09-058e-4490-a3f9-fd8c61935180">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0f9de9f6897f4cf8b49ff88e72733606_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzQtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyYzhiODVhMTUyZDE0NWJmYTZkNmRhM2FhZjA0NWQ5NV83_aa48ee1c-4ad1-4016-8126-cf72755f8c42">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i984bcc2d66864df5a6560d75518fc627_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtMS0xLTEtOTI0Nzk_332fa55e-43d4-40cc-801a-f7a266fad0ee"
      unitRef="usd">181780000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i92b3d8c4a94f44308b786dd3f41066c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtMy0xLTEtOTI0Nzk_42469c18-1448-482c-ad32-a9497e0b8afb"
      unitRef="usd">183270000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i43680e166a7d4ce19b5a76a38da03d1e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoxNDczZjE3NjY0YzA0NDZiOWFlMDFiOGJjNTNmZTM3OF80_3eebc4dd-3f8b-4dc3-921e-516a570486d0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if9b0589ae7ac49299d4b947877639c7b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzUtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoxNDczZjE3NjY0YzA0NDZiOWFlMDFiOGJjNTNmZTM3OF83_a98bbd63-8ba0-43c6-a3b9-508a099072fd">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i84d08e87887a48e0b165068c172cc809_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtMS0xLTEtOTI0Nzk_5d34fbaa-0314-4ba5-8759-c5bdcb46268a"
      unitRef="usd">3792000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i51998c104a0a4b23907a5b4441ad2cae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtMy0xLTEtOTI0Nzk_dfc75809-ecb2-490b-bba6-9d1f434da0f0"
      unitRef="usd">2791000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4683a32a673b4995855a9b02edfd1323_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0MzU5NzE2OWMzYmU0NDFhYjlhMTgxN2Y4ZTJiYjdkMF80_b9f66ae3-5a98-4a29-83f0-353db04fa7f3">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i967f27ce7a134d76a34a6939044881dd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzYtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0MzU5NzE2OWMzYmU0NDFhYjlhMTgxN2Y4ZTJiYjdkMF83_97abbaa3-998f-41a1-8e2c-a13b3c743698">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iefbb9d43eec34673981c8410401d816e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctMS0xLTEtOTI0Nzk_49177752-2345-4f31-b20b-d7e221c48908"
      unitRef="usd">151330000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i34bd7649dc7b4061ad47ffc556c0863f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctMy0xLTEtOTI0Nzk_edfd9cc1-1b83-40ff-bf3d-60be0c01cf96"
      unitRef="usd">148706000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic49b57ff79634c4b898da5b6df9ebfae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpkODQyOGYyYmQ5MWM0M2FlODhhYTgyMmZkMGIyZWVmZl80_cf1b8147-94eb-4620-915e-0c2cef4c9d20">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifd06a7aec13e49f98328dc80014a401c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzctNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpkODQyOGYyYmQ5MWM0M2FlODhhYTgyMmZkMGIyZWVmZl83_c32aa1d2-7bbf-4546-85bf-e772471534aa">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7a50827ab9fc4774a1f76e9fc90eca28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtMS0xLTEtOTI0Nzk_032af05b-0c96-4d19-b357-b2c9ad576b2d"
      unitRef="usd">20286000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i23a05a3ddc6e4c0ab4eecfb7744719f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtMy0xLTEtOTI0Nzk_f5fb943b-8a81-47fe-b1da-bf0374d03c3f"
      unitRef="usd">20921000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0da2edd906ea41d685b94f3a559f2684_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjozZjFkNDk2NThkNGY0NzkwYmYxOGJkNGQxNzY4OTBiY180_30680f6b-0641-4f00-bb20-0ea925e154c8">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7b7f274b6c2e4e4085e067a47ae84aee_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzgtNS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjozZjFkNDk2NThkNGY0NzkwYmYxOGJkNGQxNzY4OTBiY183_7e8b4428-d957-4aae-9f8a-ae8aac177bc6">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i674366b7bb554504831c2da6e430dcab_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzktMS0xLTEtOTI0Nzk_da055df7-6b59-4f17-9eb1-4b21d93e901e"
      unitRef="usd">103875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i033684df3176485992b874699ab5bb9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzktMy0xLTEtOTI0Nzk_28beb9a1-85a3-4b67-8a8c-6fe32d6fce07"
      unitRef="usd">94850000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEwLTEtMS0xLTkyNDc5_68f4eb02-166c-4d41-a1e4-049e7ca27a3b"
      unitRef="usd">641031000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEwLTMtMS0xLTkyNDc5_248cbb60-830a-4fb1-b7cb-b076753cb230"
      unitRef="usd">626577000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzExLTEtMS0xLTkyNDc5_805e9e4c-86c9-4078-9847-20033b8d950d"
      unitRef="usd">329729000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzExLTMtMS0xLTkyNDc5_63e972b4-5706-414e-82be-3a6e05c62cb8"
      unitRef="usd">314874000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEyLTEtMS0xLTkyNDc5_1826765d-7f6b-4113-b49c-0dc57583ff1a"
      unitRef="usd">311302000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTo0ZTgwNjY2ZjFmODc0MzY5YmRlZjFjMWI5NTU0NmY3Ni90YWJsZXJhbmdlOjRlODA2NjZmMWY4NzQzNjliZGVmMWMxYjk1NTQ2Zjc2XzEyLTMtMS0xLTkyNDc5_1a0591d5-fd0a-4953-9303-6f3cabe97c1a"
      unitRef="usd">311703000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NjE_95523daf-79e9-4c4c-8413-6b2101df191a"
      unitRef="usd">40100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NjU_a4ee00bc-2d81-4a34-a114-778ca33f39e1"
      unitRef="usd">39400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzg3NzM_83701cce-7198-4ca7-b13a-c2def1406ef8"
      unitRef="usd">42100000</us-gaap:Depreciation>
    <us-gaap:InterestCapitalizationPolicyPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTc5_2c7cebf0-a0cd-4753-a94a-a494729d6bda">CAPITALIZED INTERESTThe interest cost on capital projects, including facilities build-out and internal use software, is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings.</us-gaap:InterestCapitalizationPolicyPolicyTextBlock>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzk2NjA_313c0d23-16d6-42ac-b265-fc148a5a29b4"
      unitRef="usd">1400000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:InterestCostsCapitalizedAdjustment
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzk2Njc_796a8fd2-2b54-4214-9092-92a7f114e761"
      unitRef="usd">1200000</us-gaap:InterestCostsCapitalizedAdjustment>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjAx_30c519c3-5a0b-4e88-b7b7-6f53b95dd6dc">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results of operations of acquired companies are included in the Company&#x2019;s results of operations as of the respective acquisition dates. The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC Topic 805"). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Any excess of the purchase price over the fair value of the net assets acquired is recorded as goodwill. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs and costs to restructure the acquired company are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using either a Monte Carlo simulation or the probability-weighted income approach derived from revenue estimates and probability assessment with respect to the likelihood of achieving contingent obligations. Contingent payments related to acquisitions consist of development, regulatory, and commercial milestone payments, in addition to sales-based payments, and are valued using discounted cash flow techniques. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The change in the fair value of sales-based payments is based upon future revenue estimates and increases or decreases as revenue estimates or expectation of timing of payment charges. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determi&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nes the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. Determining the fair value of these intangible assets acquired as part of a business combination requires the Company to make significant estimates. These estimates include the amount and timing of projected future cash flows, the discount rate used to discount those cash flows to present value, the assessment of the asset&#x2019;s life cycle, and the consideration of legal, technical, regulatory, economic, and competitive risks. The fair value assigned to other intangible assets is determined by estimating the future cash flows of each project or technology and discounting the net cash flows back to their present values. The discount rate used is determined at the time of measurement in accordance with accepted valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired IPR&amp;amp;D is recognized at fair value and initially characterized as an indefinite-lived intangible asset, irrespective of whether the acquired IPR&amp;amp;D has an alternative future use. The Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream. The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D acquired in a business combination is capitalized as an indefinite-lived intangible asset. Development costs incurred after the acquisition are expensed as incurred. Upon receipt of regulatory approval, the indefinite-lived intangible asset is then accounted for as a finite-lived intangible asset and amortized on a straight-line basis or accelerated basis, as appropriate, over its estimated useful life. If the research and development project is subsequently abandoned, the indefinite-lived intangible asset is charged to expense. IPR&amp;amp;D acquired outside of a business combination is expensed immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the uncertainty associated with research and development projects, there is risk that actual results will differ materially from the original cash flow projections and that the research and development project will result in a successful commercial product. The risks associated with achieving commercialization include, but are not limited to, delay or failure to obtain regulatory approvals to conduct clinical trials, delay or failure to obtain required market clearances, delays or issues with patent&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issuance, or validity and litigation.&lt;/span&gt;&lt;/div&gt;If the acquired net assets do not constitute a business under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill is recognized. In an asset acquisition, the amount allocated to acquired IPR&amp;amp;D with no alternative future use is charged to expense at the acquisition date. Payments that would be recognized as contingent consideration in a business combination are expensed when probable in an asset acquisition.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjM0_6ff72280-1aec-4e4e-b54e-d2d7bc91d11c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. The Company reviews goodwill for impairment in the third quarter every year in accordance with ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC Topic 350") and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments with three underlying reporting units. Refer to Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographic Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets include patents, trademarks, purchased technology, and supplier and customer relationships. Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;over their expected useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of an indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC 350 Topic when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzE2NDky_affa7859-2f17-465e-8865-ae0ddac1f57a"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportingUnits
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzE2NTIw_cdc8e955-3605-4251-8216-127030568284"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjU1_a78eacd1-c8f4-4474-8c34-f7af5c548e0c">LONG-LIVED ASSETS Long-lived assets held and used by the Company, including property, plant and equipment, intangible assets, and leases are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <iart:FoundationPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDkz_b8368de8-bcf1-4c01-8280-9ee875454f8e">INTEGRA FOUNDATION The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company; therefore, its results are not included in these consolidated financial statements.</iart:FoundationPolicyTextBlock>
    <iart:CharitableContributions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTIw_5c7c2294-3e8e-49a9-90cd-8fc057baed57"
      unitRef="usd">0.0</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTMy_73803adf-dbb8-4e09-9be9-4ff35dd4f208"
      unitRef="usd">1200000</iart:CharitableContributions>
    <iart:CharitableContributions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzIwMTM5_05528838-ba64-4256-b5b5-60dea65d98a3"
      unitRef="usd">800000</iart:CharitableContributions>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTUx_b389b251-a542-44a0-9fee-f0dd4983c197">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DERIVATIVES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes. From time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at the fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level&#160;2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives designated as hedges in the same category as the item being hedged for cash flow presentation purposes.&lt;/span&gt;&lt;/div&gt;The Company entered into foreign currency forward and foreign currency swap contracts that are not designated as hedging instruments for accounting purposes. These contracts are recorded at fair value, with the changes in fair value recognized into other income, net, on the consolidated financial statements.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjYx_4d97383b-e284-4f66-8edc-1800487179bf">FOREIGN CURRENCY All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S.&#160;dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S.&#160;subsidiaries.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NDg3NzkxMjM3NTE_bcbcbe7a-aeea-4847-a9e1-6caeb362df8e"
      unitRef="usd">-3300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI0MTA3_037216e0-7001-4fd6-972c-a3c18833a0e7"
      unitRef="usd">100000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI0MTE0_e05a06a8-bb75-4b4f-816b-a25f77300ea2"
      unitRef="usd">-1600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTgw_3217c633-d741-4ced-9244-852f86879041">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for by using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company, unless the reserves are expected to be paid in cash during the next twelve months, in which case they are classified as current liabilities. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve. &lt;/span&gt;&lt;/div&gt;The Company continues to indefinitely reinvest substantially all of its foreign earnings unless there is a manner under which to remit the earnings without a material tax cost. The current provisional analysis indicates that the Company has sufficient U.S. liquidity, including borrowing capacity, to fund foreseeable U.S. cash needs without requiring the repatriation of foreign cash. One time or unusual items that may impact the ability or intent to keep the foreign earnings and cash indefinitely reinvested include significant U.S. acquisitions, loans from a foreign subsidiary and changes in tax laws.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTY5_d5f6bcf9-d481-4091-9685-7fc05dd7e664">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue, net, includes product sales, product royalties and other revenues, such as fees received from services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For products shipped with FOB shipping point terms, the control of the product passes to the customer at the time of shipment. For shipments in which the control of the product is transferred when the customer receives the product, the Company recognizes revenue upon receipt by the customer. Certain products that the Company produces for private label customers have no alternative use and the Company has a right of payment for performance to date. Revenues from those products are recognized over the period that the Company manufactures these products, which is typically one month to three months. The Company uses the input method to measure the manufacturing activities completed to date, which depicts the progress of the Company's performance obligation of transferring control of goods being manufactured for private label customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company's product revenue is generated from consigned inventory maintained at hospitals and distributors, and also from inventory physically held by field sales representatives. For these types of products sales, the Company retains control until the product has been used or implanted, at which time revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenues from sale of products and services are evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. For product sales, invoices are generally issued upon the transfer of control (or upon the completion of the manufacturing in the case of the private label transactions recognized over time) and are typically payable 30 days after the invoice date. The Company performs a review of each specific customer's creditworthiness and ability to pay prior to acceptance as a customer. Further, the Company performs periodic reviews of its customers' creditworthiness prospectively. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue From Contracts With Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for more information.  The Company also  maintains a provision for estimated returns and allowances in the same period that the related revenue is recorded. This reserve is based upon an analysis of actual credit memos issued for pricing issues or returned goods over an extended period, as well as assumptions about outstanding accounts receivable and judgment in interpreting the data.&lt;/span&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;Shipping and Handling FeesThe Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="i555d4df7f3584d1999b47a099d28a436_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NTk0_e3b2bb04-796a-4156-b2e6-169ae0f2f594">P1M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod
      contextRef="ic15abc2db37946838e57984661763818_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NjAw_cbbd4ba8-44e5-4511-9c03-76fa47def498">P3M</iart:RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTk5_83eb9546-5ba7-4d6e-bdbb-ce291642c124">RESEARCH AND DEVELOPMENT Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjQy_0fc26eb5-65a7-4ed2-aaa6-bbecc8745da8">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE TERMINATION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for ASC Topic 712 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ASC Topic 420 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1NjYzMzQ_81d028f7-6aaf-4d44-80a4-33f07f64777c">The following table summarizes our restructuring related accrual balances included within accrued expenses and other current liabilities in the consolidated balance sheet for the year ended December&#160;31, 2022 and 2021.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of Goods Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance, end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzItMi0xLTEtMTQ0NjUx_ef499f37-e5b3-41ae-ac5d-e90417405ef3"
      unitRef="usd">10226000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzItNC0xLTEtMTQ0NzE2_b1dfe339-b331-49d1-8868-d977caf7ec15"
      unitRef="usd">6372000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzQtMi0xLTEtMTQ0NjU4_8815be92-d8f1-4ed6-9d0d-57263f3ba504"
      unitRef="usd">1494000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzQtNC0xLTEtMTQ0NzMx_6df19fc5-2fde-43be-96c2-f01de850c132"
      unitRef="usd">3436000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzUtMi0xLTEtMTQ0NjU4_9b38cdc2-a03d-414c-942f-582e35efcdb9"
      unitRef="usd">72000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzUtNC0xLTEtMTQ0NzMx_1ccfb402-9b83-44d9-87c3-65616f755942"
      unitRef="usd">288000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzYtMi0xLTEtMTQ0NjU4_08c1aff0-e70c-4f12-a41c-324bc92053d6"
      unitRef="usd">5582000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzYtNC0xLTEtMTQ0NzMx_9ff55fcf-0b42-4fa1-921f-2fc2ae400f8a"
      unitRef="usd">466000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzctMi0xLTEtMTQ0NjU4_e5b8c6e0-2630-447b-9d10-b02ae5f5bd9d"
      unitRef="usd">-12267000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzctNC0xLTEtMTQ0NzMx_f6775358-ce5a-4703-b26a-f1764a0712d8"
      unitRef="usd">-336000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzgtMi0xLTEtMTQ4Nzgz_a194066b-e48e-4047-97c7-fbe56cffaafe"
      unitRef="usd">5107000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZTplZDVjOTlkZDZiZGY0MzU3ODg4MGNjZTQ2YjM5ZGQ3MC90YWJsZXJhbmdlOmVkNWM5OWRkNmJkZjQzNTc4ODgwY2NlNDZiMzlkZDcwXzgtNC0xLTEtMTQ4Nzgz_e7b50f8b-92bc-4c62-9ebd-cd8771e252e8"
      unitRef="usd">10226000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6527f4ce21cc4fb5985ab238dad89309_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzI3NDg3NzkxMTc2NzA_951e282e-3411-4742-ad4a-ec50e3cef0ce"
      unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6c7891a939ef417fab6925793610c6df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQzOTgwNDY1Njk0MDI_20b88dbd-0db2-4c48-811c-b60e3ccc1e0f"
      unitRef="usd">3100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib3ce9246a35c48fcbd5b84afbb181294_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM4NDgyOTA3NTU1MjA_212f797e-f6d3-4e2b-9822-0aa559597131"
      unitRef="usd">10200000</us-gaap:RestructuringReserve>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MTMw_b7608e53-8552-408a-bb6f-1701e6c0c48a">STOCK-BASED COMPENSATION Relevant authoritative guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards are based on the grant date fair value using the binomial distribution model. The Company recognizes compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards over the requisite service period of the award. All excess tax benefits and taxes and tax deficiencies from stock-based compensation are included in provision for income taxes in the consolidated statement of operations.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjI3_bdddebde-afb3-44b5-a5c3-efb9db2aee2b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PENSION BENEFITS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the corridor approach in measuring the amount of net periodic benefit pension cost to recognize each period. The corridor approach defers all actuarial gains and losses resulting from variances between actual results and actuarial assumptions. Those unrecognized gains and losses are amortized when the net gains and losses exceed 10% of the greater of the market-related value of plan assets or the projected benefit obligation at the beginning of the year. The amount in excess of the corridor is amortized over the average remaining service period to retirement date of active plan participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a deferred compensation plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;This deferred compensation is invested in funds offered under the Plan and is valued based on Level 1 measurements in the fair value hierarchy. The purpose of the plan is to retain key employees by providing them with an opportunity to defer a portion of their compensation as elected by the participant in accordance with the plan. Any amounts set aside to defray the liabilities assumed by the Company will remain the general assets of the Company until such amounts are distributed to the participants. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzMzODAx_45880501-8541-4524-b9c9-d4351a7b7b61"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzMzODM1_ae972b7f-7537-4f71-b42a-7e71a9da6734"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MjE4_403e4885-37b7-46c3-a0dc-2dc6f7ec97e6">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CONCENTRATION OF CREDIT RISK &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables. &lt;/span&gt;&lt;/div&gt;The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems.</us-gaap:ConcentrationRiskCreditRisk>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_45e6e57d-b398-4a3e-b30c-d1a0114b3444"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_4c804b15-f0cb-4d84-b4bb-c3a2f930454c"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskNumberofCustomersOverBenchmark
      contextRef="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MTcw_a60091fe-69c5-4610-bdd6-e40bea807d65"
      unitRef="customer">0</iart:ConcentrationRiskNumberofCustomersOverBenchmark>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="i9a3f4c95337848a6838b93d2cf4e393a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_611c0f39-b026-477c-aa67-9b55bd4d853b"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="ie070d8e7d76b4287a612c02eb9848c08_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_9021ad16-d956-41d7-a37b-cea65a5a3087"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <iart:ConcentrationRiskThresholdPercentage
      contextRef="i02dfd9b9999a49bcada52ca4e82b52d7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzM1MjE2_f1d13335-91df-44ea-a0b8-58b182732022"
      unitRef="number">0.10</iart:ConcentrationRiskThresholdPercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDg4_fdbd1820-9352-4a81-8927-e34bc5dcf3ef">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Simplifying the Accounting for Income Taxes, intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The Company adopted ASU 2019-12 as of January 1, 2021. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 848): Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. On October 5, 2022, the FASB approved an extension of the sunset date of the reference rate reform from December 31, 2022 to December 31, 2024, past LIBOR&#x2019;s end date. The Company currently has contracts that are indexed to LIBOR and are continuing to evaluate the scope of impacted contracts and potential risk. The Company expects all LIBOR-based contracts to be replaced by the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of SOFR as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP.&#160;Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features.&#160;The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify.&#160;The guidance also simplifies the diluted net income per share calculation in certain areas.&#160;The ASU will be effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years using either the modified retrospective or full retrospective method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As detailed in Note 5,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes are subject to the guidance included in ASU 2020-06. The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company made an irrevocable election under the indenture to require the principal portion of its 2025 Notes to be settled in cash and any excess in shares. Following the irrevocable notice, only the amounts settled in excess of the principal will be considered in diluted earnings per share under the &#x201c;if-converted&#x201d; method. Upon adoption of ASU 2020-06, the Company&#x2019;s 2025 Notes were reflected entirely as a liability since the embedded conversion feature will no longer be separately presented within stockholders&#x2019; equity. Additionally, from January 1, 2021, the Company is no longer incurring non-cash interest expense for the amortization of debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which updates various codification topics by clarifying or improving disclosure requirements to align with the regulations of the U.S. Securities and Exchange Commission (the "SEC") . The ASU has been effective for the Company for annual and interim periods beginning after January 1, 2021. The Company adopted this standard on the January 1, 2021. The adoption of this guidance did not have a significant impact on the Company's consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides guidance to clarify and reduce diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this ASU No. 2021-04 are effective for all entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, including interim periods within those fiscal years. The amendment currently has no impact to the Company as the effect will largely depend on the terms of written call options or financings issued or modified in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="ie88cf6af5eb341929c94e3b43dcc7430_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQxMDY0_d2da02ec-78ca-49bc-beb5-79f9d500e617"
      unitRef="usd">575000000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQxMTAx_14631548-2059-45d8-a73b-b72b9ab071ec"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ2MDcx_ccc8ca9f-7d20-4c30-b681-661f4dcf43c3">The Company adopted this guidance on January 1, 2021 using the modified retrospective approach which resulted in a cumulative-effect adjustment that increased (decreased) the following consolidated balance sheet accounts:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ADJUSTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CONSOLIDATED BALANCE SHEET CLASSIFICATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;AMOUNT&lt;br/&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity issuance costs reclassification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term convertible securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization and equity costs reclassification, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact of cumulative-effect adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i923e26b254024ce191a077d3ad910d88_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzEtNC0xLTEtOTI0Nzk_b50445a4-24e6-4dfe-b841-19941d736628"
      unitRef="usd">-20600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i004ed02bcbb14976ae0947b6a85dae0c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzItNC0xLTEtOTI0Nzk_ff6600b2-401f-45a8-9c3e-03f12045c079"
      unitRef="usd">89100000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i2646e8ff9e9646a997ca1704e1a4e996_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzMtNC0xLTEtOTI0Nzk_ee0d17a7-3e26-4fec-9b16-f7c5b6b745b0"
      unitRef="usd">-2500000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i923e26b254024ce191a077d3ad910d88_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzQtNC0xLTEtOTI0Nzk_d4fcf2f6-006e-49ed-b771-742b4ba8ed36"
      unitRef="usd">-2800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i923e26b254024ce191a077d3ad910d88_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90YWJsZToxZjdkNjBhMzg3MDE0MjllYmRjNjkxY2I2ZjJlMWIxZS90YWJsZXJhbmdlOjFmN2Q2MGEzODcwMTQyOWViZGM2OTFjYjZmMmUxYjFlXzUtNC0xLTEtOTI0Nzk_fd2dfae4-f415-4343-8aa4-1c5e946780cb"
      unitRef="usd">-63300000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:InterestPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MjU3_d05c5bc0-c65a-4f94-b2b2-c1ed90e5992e"
      unitRef="usd">42200000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MjY4_708fe11d-b049-45df-9384-44801aa273b6"
      unitRef="usd">1400000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MzI0_c227df92-f6e4-4529-bf97-e9c16a7e6a30"
      unitRef="usd">43200000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0MzM1_33019906-226d-4a8c-bfb7-7fa3830a56a3"
      unitRef="usd">1200000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaid
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0Mzk0_4c1b89b0-8246-4941-9325-be3e0ed96ca3"
      unitRef="usd">47300000</us-gaap:InterestPaid>
    <us-gaap:InterestPaidCapitalized
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NDA1_f59e0045-595c-4816-94d7-f3ca09a5c64a"
      unitRef="usd">2300000</us-gaap:InterestPaidCapitalized>
    <us-gaap:IncomeTaxesPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTU3_746a111d-a6fb-4ec6-ade2-6e8e64ca6df8"
      unitRef="usd">35900000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTYx_6bd71016-5589-4c70-81a1-9400d7043194"
      unitRef="usd">49500000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NTY4_f9ae47fb-4fa8-4c78-ba27-32353047cb31"
      unitRef="usd">29800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzEw_d8fa472d-384e-44e7-8d08-6ad37e30dbfe"
      unitRef="usd">10500000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzE0_ca325518-515b-4faa-8da3-d65a91b25641"
      unitRef="usd">4700000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0NzIx_06650f93-1934-4a74-85cf-c943418192a5"
      unitRef="usd">1600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i95b6e8c596ab499a89fcc3c6342d9939_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0ODQ4_22c56ee1-a074-4d1f-8587-960d32aad261"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i95b6e8c596ab499a89fcc3c6342d9939_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzQ0OTY2_22c56ee1-a074-4d1f-8587-960d32aad261"
      unitRef="usd">5000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i9efe6093f5ba46e79ed64d1fea198a87_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzEzNzQzODk1NDA1NDc0_32b77e0c-4ad7-42b7-87b0-22b1ed5742c0"
      unitRef="usd">20000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid
      contextRef="i9efe6093f5ba46e79ed64d1fea198a87_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNDgvZnJhZzo5NDk2OWJjYzdlMzA0NWVjOWU2ODAxMDk3MmNlMGQ3Yy90ZXh0cmVnaW9uOjk0OTY5YmNjN2UzMDQ1ZWM5ZTY4MDEwOTcyY2UwZDdjXzEzNzQzODk1NDA1NDgy_32b77e0c-4ad7-42b7-87b0-22b1ed5742c0"
      unitRef="usd">20000000</iart:AssetAcquisitionDevelopmentMilestonePaymentToBePaid>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTE_fe08ed07-4a7f-4b47-8579-805af13abe3a">REVENUES FROM CONTRACTS WITH CUSTOMERS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Summary of Accounting Policies on Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheet. Upon invoicing to the customer, the balance is recorded in trade receivable, net in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable from contract asset included&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the short-term portion of the contract liability of $7.3 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company is expected to recognize revenue of approximately $7.3 million in 2023, $4.2 million in 2024, $2.7 million in 2025, $1.1 million in 2026, $0.7 million in 2027, and $0.1 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Shipping and Handling Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Taxes Collected from Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2022, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;794,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;802,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,019,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;406,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total  Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for details&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Acquisitions and Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of revenues based on the location of the customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzE3NDc_8e9f5aa2-9dea-437a-b0d7-e42671a5bee5">P90D</iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTc_6874fa47-ba4d-4d19-8515-520ea2ad3d20">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable from contract asset included&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;in beginning of the year contract asset &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract asset, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzItMS0xLTEtOTI0Nzk_7a43f12b-8fee-44a8-9c78-d104a659d2c7"
      unitRef="usd">11412000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzMtMS0xLTEtOTI0Nzk_1474763b-f48a-45c7-9e65-723daee9f0f4"
      unitRef="usd">11412000</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzQtMS0xLTEtOTI0Nzk_42556557-9671-4ce5-be97-fc14b2bd5b5b"
      unitRef="usd">10122000</iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzUtMS0xLTEtOTI0Nzk_139ea966-a2c0-4fe8-b76c-8ea2112f36dc"
      unitRef="usd">10122000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzgtMS0xLTEtOTI0Nzk_6687c940-bba4-4c2e-9b51-62461ec6928c"
      unitRef="usd">11946000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzktMS0xLTEtOTI0Nzk_9159f691-ae51-4bd2-a424-f6a0335780f1"
      unitRef="usd">5349000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzEwLTEtMS0xLTkyNDc5_bb34faec-2c8b-4e42-b42d-1894a351b8c3"
      unitRef="usd">9596000</iart:ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation>
    <iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzExLTEtMS0xLTkyNDc5_89186fcc-8f58-499a-86d7-32bea5880759"
      unitRef="usd">-66000</iart:ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTplODFmZTlmMTJlYzA0OTFlOGFmNDgzYTZhYmU1ZjU1MC90YWJsZXJhbmdlOmU4MWZlOWYxMmVjMDQ5MWU4YWY0ODNhNmFiZTVmNTUwXzEyLTEtMS0xLTkyNDc5_b4fd9acc-bdc7-4cd9-80e4-972a2bf6c136"
      unitRef="usd">16127000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMwMjM_fa8b8aea-0a35-40e0-a00a-2c934217895f"
      unitRef="usd">7300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMwNjQ_a88db3b8-cc5b-41ea-a3eb-7974fc6fd8e4"
      unitRef="usd">8800000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i788f04f5fed04ca38e49ba6f03024c26_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNTQ_9c4d9d8d-b8ff-4570-b345-f6451a2e1b57"
      unitRef="usd">7300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i62d0e2aa67744845818cbd175cd7bd78_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNjQ_070a7ebe-5757-4fb2-baae-597b105b82d0"
      unitRef="usd">4200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib26e758da29c45679df8f4e5da71fe89_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyNzQ_f7ea9da6-4130-4b44-a952-148741a0305b"
      unitRef="usd">2700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i82ca03a161874505a112365ab91a423d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyODQ_7ec31c26-d333-4650-8f4f-46224f0f5349"
      unitRef="usd">1100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6e5866b5e8ee438997795a5f34fffc50_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMyOTQ_9f2594ac-287d-4618-a660-2b554639e33c"
      unitRef="usd">700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9b08269188a34d6fbb7031826cb0bdc9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzMzMDg_c625331f-75ec-4e5b-a6f8-aed41ccece65"
      unitRef="usd">100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ExtendedProductWarrantyPolicy
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTA_61c88063-c95e-4e93-aa44-6c3a25369084">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ExtendedProductWarrantyPolicy>
    <iart:RevenueProductWarrantyPeriod
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzQwMjI_8ea1295b-f438-433a-8146-e4c2d44cf206">P2Y</iart:RevenueProductWarrantyPeriod>
    <us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0OTg_2b4d2944-fdf1-42be-b586-0c5818172ef8">Taxes Collected from CustomersThe Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90ZXh0cmVnaW9uOmQ5YjlmYjliNTc4ZTQwZDRhMzI5MTczMzZjYWRjNTBmXzU0ODk_1093ea3d-b09f-4036-8c26-0791234d9e9a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for years-ended December&#160;31, 2022, 2021 and 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;794,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;802,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;716,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,019,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;406,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Extremity Orthopedics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total  Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for details&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On August 31, 2022, the Company completed the sale of its non-core traditional wound care ("TWC") business. See Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Acquisitions and Divestitures&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib05901fa55ec4ee09f5c084cb113c902_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNC0xLTEtOTI0Nzk_6d140062-b0e9-4877-a778-30eac1a755b7"
      unitRef="usd">794017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafc2622f83364440b73830f3831e70ee_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNS0xLTEtOTI0Nzk_590b6105-c059-4401-a1c3-938e8f356cf1"
      unitRef="usd">802959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64babceb820449b89139cb878d8a8f48_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzEtNi0xLTEtOTI0Nzk_2be7d2a0-9001-43e0-9d7c-87f6f06b5f9a"
      unitRef="usd">716339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87809ef2efdc487696e6308247a226c3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNC0xLTEtOTI0Nzk_840171f3-09f5-4178-ae04-0b45ec735b68"
      unitRef="usd">225547000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21e50fd25ffa4e698beda1f9680eb35f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNS0xLTEtOTI0Nzk_3c90cb09-f1cb-468b-8645-c87b0eac905e"
      unitRef="usd">222273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fc99fa3608f44f98cce93e770c68118_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzItNi0xLTEtOTI0Nzk_832fc4c6-f8e7-4fac-85fd-5734d3626446"
      unitRef="usd">178492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNC0xLTEtOTI0Nzk_5a1b7d40-9c06-49a9-b7bf-b63b93014f90"
      unitRef="usd">1019564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNS0xLTEtOTI0Nzk_0c4cb0d3-4683-4d3e-b0ac-dc4bb2b39ef0"
      unitRef="usd">1025232000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzMtNi0xLTEtOTI0Nzk_2fd1246e-8b45-4544-95c1-658d3a65618e"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0c891096f6240ffa5a2ec5d793dc607_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNC0xLTEtOTI0Nzk_61a67c30-35ed-44f4-ae8f-d542d4c37285"
      unitRef="usd">406689000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ba2c649e06d4bcb88d0734c5bc21568_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNS0xLTEtOTI0Nzk_ab23679a-2ccf-4ec4-b86a-03b12bcf3511"
      unitRef="usd">392463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59d4599d6b184cfabebcd5b9dac65339_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzUtNi0xLTEtOTI0Nzk_1814449a-4a3e-4066-a8fc-b15a03a1b5a7"
      unitRef="usd">293038000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8181903369c49f6a696fed66e9124df_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNC0xLTEtOTI0Nzk_1bf6e054-065a-4362-bf78-97077e6f574f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie09260aeabcc4e98a91001d0c6fde98d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNS0xLTEtOTI0Nzk_b815cdb6-35ee-48da-b6b8-82fdf8f92352"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd0915172f474032923692e256da33ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzYtNi0xLTEtOTI0Nzk_586fc595-b4fe-4301-8573-e99ba4a5ba82"
      unitRef="usd">78316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b28eef625f649cc9ee7ffdcd22e93e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNC0xLTEtOTI0Nzk_e8d317fe-22fe-4c53-b691-7e8912dc47ec"
      unitRef="usd">131413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i320f932bbd4a4a02a374f45fe6f54046_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNS0xLTEtOTI0Nzk_37e97346-bbc0-4935-90cc-6f706b48d6fc"
      unitRef="usd">124753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2b3cbf8d296491e89556ecdfff34761_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzctNi0xLTEtOTI0Nzk_abf72ce7-fcc9-4a1e-885f-6cbf06ed7592"
      unitRef="usd">105683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNC0xLTEtOTI0Nzk_9ab7f135-8d36-4805-b8e4-7e781491d481"
      unitRef="usd">538102000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNS0xLTEtOTI0Nzk_b1e63521-001d-43fc-ac33-176b1dab7ea2"
      unitRef="usd">517216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzgtNi0xLTEtOTI0Nzk_399ec09d-b195-4c3e-92a2-1e4e6a542143"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNC0xLTEtOTI0Nzk_be887742-4df2-4195-9844-83182079096b"
      unitRef="usd">1557666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNS0xLTEtOTI0Nzk_6810d40e-d27a-4551-88be-86cfbdd00231"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTEvZnJhZzpkOWI5ZmI5YjU3OGU0MGQ0YTMyOTE3MzM2Y2FkYzUwZi90YWJsZTowMjkxNThmYzQwMjg0OGMzOTM4NjFkZDYxZWIxYmEwNC90YWJsZXJhbmdlOjAyOTE1OGZjNDAyODQ4YzM5Mzg2MWRkNjFlYjFiYTA0XzktNi0xLTEtOTI0Nzk_662fa17c-9063-4633-b88d-62bd81cd109f"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE1OTM5_2eb27b31-1d52-45d4-9260-7a5d4ead0107">ACQUISITIONS AND DIVESTITURES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Surgical Innovation Associates, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5&#160;million. In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#x201c;PMA&#x201d;) Application for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#x2019;s Tissue Technologies segment as part of its Wound Reconstruction and Care franchise.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation as of December 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;71,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55,947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Developed Technology&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#x2019;s life cycle, and competitive trends impacting the asset and the cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company allocated goodwill related to the SIA Acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#x2019;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;As part of the acquisition, the Company is required to pay to the shareholder of SIA up to $90.0 million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;certain timing targets (up to $40.0&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6&#160;million at the acquisition date and $25.0&#160;million for the PMA approval milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of non-core traditional wound care business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's Tissue Technologies reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#xae; and TCC-EZ&#xae; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of December&#160;31, 2022, the Company had a deposit remaining of $8.3 million which is included in prepaid assets and recognized a payable due to Gentell of $2.7 million, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of Extremity Orthopedics Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, the Company completed the sale of its Extremity Orthopedics business to Smith &amp;amp; Nephew USD Limited ("Smith &amp;amp; Nephew"). The transaction included the sale of the Company's upper and lower Extremity Orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines. The Company received an aggregate purchase price of $240.0&#160;million from Smith &amp;amp; Nephew and concurrently paid $41.5&#160;million to the Consortium of Focused Orthopedists, LLC ("CFO") effectively terminating the licensing agreement between Integra and CFO relating to the development of shoulder arthroplasty products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the Extremity Orthopedics business to the Company's Tissue Technologies reporting unit. In connection with the sale, the Company recognized a gain of $41.8&#160;million that is presented in Gain from the sale of business in the consolidated statement of operations for the year ended December 31, 2021. The Company finalized the net working capital  to Smith &amp;amp; Nephew as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also entered into a transition services agreement ("TSA") with Smit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;h &amp;amp; Nephew which requires the Company to provide certain services on behalf&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of Smith &amp;amp; Nephew for the duration of the period subsequent to the sale of the business as defined in the TSA. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized a payable due to Smith &amp;amp; Nephew of $2.3 million as of December&#160;31, 2022, which is included in the consolidated balance sheet within accrued expenses and other current liabilities.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The TSA includes services such as invoicing and cash collections from customers on behalf of Smith &amp;amp; Nephew. As of December&#160;31, 2022, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company has concluded the majority of the transition services agreement, pending final payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACell, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2021, the Company acquired ACell, Inc. (the "ACell Acquisition") for an acquisition purchase price of $306.9&#160;million plus contingent considerations of up to $100&#160;million, that may be payable upon achieving certain revenue-based performance milestones in 2022, 2023 and 2025. The final working capital adjustments of $1.3&#160;million was finalized and paid as of June 30, 2021. ACell was a privately-held company that offered a portfolio of regenerative products for complex wound management, including developing and commercializing products based on MatriStem Urinary Bladder Matrix, a technology platform derived from porcine urinary bladder extracellular matrix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACell Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired and liabilities assumed in a business combination are recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13-14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;408,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;306,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the developed technology acquired was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of each asset&#x2019;s life cycle, and competitive trends impacting the asset and each cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used a discount rate of 8.5% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated goodwill related to the ACell acquisition to the Tissue Technologies segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected synergies of the combined company and assembled workforce. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement of certain revenue-based performance milestones in 2022, 2023, and 2025. Based on revenue performance in 2022, no payment will be made for the first performance milestone.  T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he Company used iterations of the Monte Carlo simulation to calculate the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The Company recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $21.8 million in other liabilities as of December&#160;31, 2022 and 2021, respectively, in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the acquisition date fair value of contingent consideration obligations using a Monte Carlo simulation, as well as significant unobservable inputs, reflecting the Company&#x2019;s assessment of the assumptions market participants would use to value these liabilities. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resultant most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligations is revalued to estimated fair value and changes in fair value will be reflected as income or expense in our consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxMzg_c26fc0e0-473a-4da6-bb80-66c9ebe7a323"
      unitRef="usd">51500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i86566b09516e432dbffe19da79e048cd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NjI_e19e0aa2-3a7a-4127-90f7-7dfa78893530"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NzU_773fb407-f101-4672-b307-0af7ee8aef89"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQzOTgwNDY1ODMzOTc_9da7c4dc-5b29-42e5-946a-b9f68491f4a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation as of December 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;71,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55,947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13-14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;408,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;306,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzItMS0xLTEtMTYxOTgy_9a9d9f8c-8a15-4304-955c-111f3e06445f"
      unitRef="usd">4438000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzMtMS0xLTEtMTYxOTkw_56f11e75-938f-486a-aae2-882bad04fa6a"
      unitRef="usd">1551000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzQtMS0xLTEtMTYyMTQy_fc4ffac8-45d1-40b7-9f31-a1319447fdae"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzUtMS0xLTEtMTYyMTQ5_6c594965-93df-4239-b986-6d57e71ee71a"
      unitRef="usd">1654000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzYtMS0xLTEtMTY4NzM3_359a4368-c453-4cd1-a794-dfa4f9c36395"
      unitRef="usd">10543000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzctMS0xLTEtMTYyMTY0_3ab3c324-ee0d-4ad5-b8bf-6de5c335653c"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzgtMy0xLTEtMTYxODYx_020f8685-0931-432a-b710-f45b55e5bc6a">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzgtMS0xLTEtMTYyMTcz_6844f413-e969-4621-93f1-2838638b82ce"
      unitRef="usd">41854000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzktMS0xLTEtMTY4OTc3_5c08283f-2a2c-4d2e-8e8c-539bd2d54fe0"
      unitRef="usd">127397000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzEyLTEtMS0xLTE2MjE4MA_8378bc23-c9a1-4646-be08-a0d666382223"
      unitRef="usd">2044000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzEzLTEtMS0xLTE2ODk4MA_07c758d2-0f25-4dfe-8771-60f1fc865be2"
      unitRef="usd">2044000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE0LTEtMS0xLTE2MzU2Mg_71fecd52-de52-4345-845a-da40e5bcdaa8"
      unitRef="usd">11799000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE0LTEtMS0xLTE2MjE4Nw_33cfc47c-0df0-4472-8001-06ad90a17df5"
      unitRef="usd">57607000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE2LTEtMS0xLTE2ODk4MA_04f357b6-1173-4627-9166-41a80433e48e"
      unitRef="usd">71450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpmM2U5OWFiMDhiODY0ODg2YjVhYjcyY2VkMWMyZWUxNi90YWJsZXJhbmdlOmYzZTk5YWIwOGI4NjQ4ODZiNWFiNzJjZWQxYzJlZTE2XzE4LTEtMS0xLTE2ODk4NA_631f0d7b-8263-482d-a10e-0438fbfc7c9e"
      unitRef="usd">55947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk1ODQ_8a85609c-3c7c-491f-9169-2b8b47e9725f"
      unitRef="number">0.18</iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i547e9b738a9b4ffe8435a24e596115f8_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk1NjI_3676fdf5-e9ec-4f9e-8839-35ee46e93d4a"
      unitRef="usd">90000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <iart:BusinessAcquisitionNumberOfContingentLiabilities
      contextRef="i628706586a0345ba8883bd6d56eb2045_D20221206-20221206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxNjU_5595e189-6d59-4c0b-b4d0-0cf4b5b5da7c"
      unitRef="contingentliability">2</iart:BusinessAcquisitionNumberOfContingentLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i86566b09516e432dbffe19da79e048cd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzY1OTcwNjk4MzkxNTM_6320d641-f225-474f-9204-28ab2f57e49f"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2MTg_99093f13-38e3-4b9a-a848-2ff7bec27419"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i86566b09516e432dbffe19da79e048cd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2MzE_4e4759ad-7d3d-431e-8d8a-02276e6816b1"
      unitRef="usd">32600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i28298ae5ed5e49418672ef5260b1c297_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM4NDgyOTA3Njk2NTA_e4178661-b734-4360-9ca3-a5032c5d1326"
      unitRef="usd">25000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNjc_057a6bf2-a192-452e-8553-12d25b20118f"
      unitRef="usd">28800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNzE_c97892b3-cff3-4601-abd3-a55b84301f1e"
      unitRef="usd">27800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration
      contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzNzU_f110e236-ac62-4595-bfa4-b41e0a3ce047"
      unitRef="usd">1000000</iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod
      contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzOTU_4074e67b-8ba4-4c71-811b-7651588e6d97">P2Y</iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzAzODg_c97892b3-cff3-4601-abd3-a55b84301f1e"
      unitRef="usd">27800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i0929cd5d4c3040809ec9578a929d4d43_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MDI_478c4fa3-38d6-4f29-a40f-52f00155ffce"
      unitRef="usd">3500000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i87815c6804b84c35862ba8c044473b87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MDk_1498bd99-33fc-408d-a3f3-cea83b76bf88"
      unitRef="usd">600000</us-gaap:GainLossOnSaleOfBusiness>
    <iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset
      contextRef="ia96a4ae9471f4d50b3de786d0cb2be56_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE2NDkyNjc0NzA0MTY_a06fa8f5-23f8-48e0-afef-b57964a3f587"
      unitRef="usd">11100000</iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset>
    <iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent
      contextRef="i3270d274846346d8aa67bdc8538e2741_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzU0OTc1NTgyMTA4NjY_4cf6d59a-ab69-4c5f-bbfe-1df0cc047c33"
      unitRef="usd">8300000</iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i3270d274846346d8aa67bdc8538e2741_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzI3NDg3NzkxMTA4OTk_a2fd60b0-4f99-446f-ac33-75636f2636b8"
      unitRef="usd">2700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i9e69cd67efed4735a4e8f3d4b73198b8_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ1Mg_21ea793d-b69d-4b77-b9eb-e3740173b1b7"
      unitRef="usd">240000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination
      contextRef="i7e6455a748fe4bddb62d55fada8558ac_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ5Nw_765e3a74-33f2-44b2-9697-f60f5e6bb969"
      unitRef="usd">41500000</iart:DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE1OTM1_e760fac7-06c5-4934-b360-f76db6003130">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities divested consisted of the following as of December 31, 2020 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.111%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset - operating leases and Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzAtMS0xLTEtOTI0Nzk_a91bacd3-992e-463d-8742-c8d64e548016"
      unitRef="usd">713000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEtMS0xLTEtOTI0Nzk_d0145e4a-be59-4bc9-97b5-61fac67e3659"
      unitRef="usd">3186000</iart:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzItMS0xLTEtOTI0Nzk_77570902-108c-48d4-8d2a-3976ea5e21d6"
      unitRef="usd">6589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzMtMS0xLTEtOTI0Nzk_673a331b-1246-48cc-89ff-89562b74a5e5"
      unitRef="usd">13332000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzQtMS0xLTEtOTI0Nzk_f2bd4bb5-3205-4685-883e-16ead7448eef"
      unitRef="usd">37893000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzUtMS0xLTEtOTI0Nzk_2b85005f-ea23-4346-b9cc-932463c67c0f"
      unitRef="usd">47546000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzYtMS0xLTEtOTI0Nzk_111b6673-c9ce-4bc7-905e-67ba9a9847bd"
      unitRef="usd">52845000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzctMS0xLTEtOTI0Nzk_5509e655-89b3-45a7-b251-f080b83697ec"
      unitRef="usd">162104000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzktMS0xLTEtOTI0Nzk_4e020606-03d8-4ab3-b5ae-48a6a117d703"
      unitRef="usd">336000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEwLTEtMS0xLTkyNDc5_53654b13-5d9e-4813-9822-a77578e961e7"
      unitRef="usd">539000</iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzExLTEtMS0xLTkyNDc5_49c88d62-36d6-4546-b9ee-5900a7fef1db"
      unitRef="usd">1767000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEyLTEtMS0xLTkyNDc5_5f081b10-4712-46a3-b8bb-1f332b1b5079"
      unitRef="usd">3440000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities>
    <iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzEzLTEtMS0xLTkyNDc5_93b7fe67-5672-419b-81b7-4153ed6e6935"
      unitRef="usd">5669000</iart:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i58908f12479149769863fd3b128d144e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTowMjFkNTBlODZlNDI0MDg5OGIxMzY4ZGE1MjRlOWQ2My90YWJsZXJhbmdlOjAyMWQ1MGU4NmU0MjQwODk4YjEzNjhkYTUyNGU5ZDYzXzE0LTEtMS0xLTkyNDc5_f9f4b0d0-3d41-4bca-8447-b65428392c74"
      unitRef="usd">11751000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i48c08cb5a2fd4655ae315c100c40b36f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzExOTc_9cc0cd2d-80b4-4725-a79d-d223d0f19994"
      unitRef="usd">41800000</us-gaap:GainLossOnSaleOfBusiness>
    <iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable
      contextRef="i45969f5e61c5407c8d95c866382a20f2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE3NDE_c52e211a-7886-499c-b443-c72b4e32bbee"
      unitRef="usd">2300000</iart:DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8e90ad876dbd48bc8aa7bf8b4a53d714_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzE5OTM_5081321f-f18e-47fe-82b9-50f1a505e677"
      unitRef="usd">306900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzIwMzY_3a623a68-0198-4799-be56-c5f16d6ff36a"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <iart:BusinessCombinationWorkingCapitalAdjustment
      contextRef="ibc1ccc070eda4191b4f93f11cd639a6c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzIxODU_4ebdb604-0287-4eab-a1f8-dfb9de59cbbf"
      unitRef="usd">1300000</iart:BusinessCombinationWorkingCapitalAdjustment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzItMS0xLTEtOTI0Nzk_ee44085e-c11a-4f6e-8153-ac8ddfffdb06"
      unitRef="usd">2726000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzMtMS0xLTEtOTI0Nzk_ed789510-cf0c-423d-9a12-d6a7d45f9f23"
      unitRef="usd">16469000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzQtMS0xLTEtOTI0Nzk_cce4c002-f8d5-458f-b8c4-63e2fa30428a"
      unitRef="usd">18299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzUtMS0xLTEtOTI0Nzk_93db2ab9-faa3-469c-88e3-5d703d14138b"
      unitRef="usd">1498000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzYtMS0xLTEtOTI0Nzk_464dcedc-5c28-446c-9cdd-e822f6dd9ca0"
      unitRef="usd">38992000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzctMS0xLTEtOTI0Nzk_a015b9d7-d106-4b95-b1e9-bd00144c2e05"
      unitRef="usd">13769000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMS0xLTEtOTI0Nzk_0c980184-49d3-4148-a6b6-bdf239c2b989"
      unitRef="usd">245000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i11932035bfc943da83fdc9252c1de39c_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMy0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzhkNTYzYmM0MzI0ZjY1ODQwY2E5NTcyOGMwMjU1OV80_a4a689aa-808f-4309-b65a-536b8cf2c629">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1b4975b0f79844b99055d7ce6c50dec7_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzgtMy0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzhkNTYzYmM0MzI0ZjY1ODQwY2E5NTcyOGMwMjU1OV83_9d73930e-8802-42e7-86e1-8afefa440eed">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzktMS0xLTEtOTI0Nzk_93500103-94fc-4758-9954-e974e35b5a59"
      unitRef="usd">94147000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEwLTEtMS0xLTkyNDc5_a4052623-0627-42b5-8cc9-d6acccea1053"
      unitRef="usd">9259000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzExLTEtMS0xLTkyNDc5_9f54b5b5-5065-42c1-a1b9-09fddb3be71c"
      unitRef="usd">7465000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEyLTEtMS0xLTkyNDc5_3a53103f-d5a8-4d9e-8c6c-ffeab78e8f50"
      unitRef="usd">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzEzLTEtMS0xLTkyNDc5_ef296fbb-5faf-45fb-b6a6-11f9fc1ebe62"
      unitRef="usd">408780000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE2LTEtMS0xLTkyNDc5_d8c40dac-a0ad-4fad-8e4e-ec220a579ec9"
      unitRef="usd">718000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE3LTEtMS0xLTkyNDc5_2a6fa985-fe49-48e2-b1cb-a2760dc7a033"
      unitRef="usd">5966000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE4LTEtMS0xLTkyNDc5_de44a320-007f-4f74-b765-bf7771eb4c22"
      unitRef="usd">1673000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzE5LTEtMS0xLTkyNDc5_872c94ff-bd5a-401d-87b2-fc1f0dac1ff5"
      unitRef="usd">8357000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIwLTEtMS0xLTkyNDc5_b601a7fb-a498-48fb-a9da-c01d19ef8dc7"
      unitRef="usd">276000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIxLTEtMS0xLTkyNDc5_6195bcee-2d70-4476-96e4-9c4e2e00d087"
      unitRef="usd">7585000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIyLTEtMS0xLTkyNDc5_cd7a699c-ff50-498c-b52f-4cf32bead720"
      unitRef="usd">61724000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzIzLTEtMS0xLTkyNDc5_768b3a27-7d04-4908-ae6f-7fc0f98034cd"
      unitRef="usd">23900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzI0LTEtMS0xLTkyNDc5_fd028208-6ddd-4b02-8ae4-9d71bc533135"
      unitRef="usd">101842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90YWJsZTpjZmE4ZmM2MjFlOTE0NTVkYWM5MTY4Nzc5NGQwNWFlZS90YWJsZXJhbmdlOmNmYThmYzYyMWU5MTQ1NWRhYzkxNjg3Nzk0ZDA1YWVlXzI2LTEtMS0xLTkyNDc5_45ab92a4-36ee-448c-8ab1-8705dceff20f"
      unitRef="usd">306938000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzM2OTM_646bdf8a-772d-4a27-84c6-a15d23b2c82c"
      unitRef="number">0.085</iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzQ2MzQ_4fae0d29-d649-4881-bb03-2e2355c5d7ac"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i4eab553affa54f9fb01f97a61e3c4a4c_I20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzUwMTU_a271640a-69c0-48ba-a217-ea36bd2650fb"
      unitRef="usd">23900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i912619e1e3ea4282b49c25179ea048df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzUwODE_9a732a37-9359-48ae-9158-b5d028dd1adf"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1e031586a5ab4c2b9c733e84d2f186e3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNTcvZnJhZzpiMzEzMmY4NWE5OGU0NjYxYjQ3MmExZjFhZGYwNWE1Ny90ZXh0cmVnaW9uOmIzMTMyZjg1YTk4ZTQ2NjFiNDcyYTFmMWFkZjA1YTU3XzI3NDg3NzkwOTg4NDY_b2b5c7ce-2b1a-431d-995f-1b5ee9e3a7c9"
      unitRef="usd">21800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTY1_239476e7-56f9-45e8-aef0-b1043eebaa06">DEBT&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amendment to the Sixth Amended and Restated Senior Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company entered into the sixth amendment and restatement (the "February 2020 Amendment") of its Senior Credit Facility (the "Senior Credit Facility") with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The February 2020 Amendment extended the maturity date to February&#160;3, 2025. The Company continues to have the aggregate principal amount of up to approximately $2.2 billion available to it through the following facilities: (i) a $877.5 million Term Loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60&#160;million sublimit for the issuance of standby letters of credit and a $60&#160;million sublimit for swingline loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) is the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Senior Credit Facility bear interest, at the Company&#x2019;s option, at a rate equal to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;the Eurodollar Rate (as defined in the amendment and restatement) in effect from time to time plus the applicable rate (ranging from 1.00% to 2.25%), or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;the highest of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the prime lending rate of Bank of America, N.A. or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the one-month Eurodollar Rate plus 1.00% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable rates are based on the Company&#x2019;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b)&#160;consolidated EBITDA (as defined by the July 2020 amendment), for the period of four consecutive fiscal quarters ending on such date).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will pay an annual commitment fee (ranging from&#160;0.15%&#160;to&#160;0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#x2019;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at December&#160;31, 2022, the Company was in compliance with all such covenants. In connection with the February 2020 Amendment, the Company capitalized $4.6&#160;million of financing costs in connection with modification &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the Senior Credit Facility and wrote off $1.2&#160;million of previously capitalized financing costs during the first quarter of 2020. In connection with the July 2020 amendment, the Company expensed $3.3&#160;million of incremental financing costs in connection with the modification of the Senior Credit Facility during the third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; no balance outstanding at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;under the revolving portion of the Senior Credit Facility and as of December 31, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021, there was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$31.3 million, outstanding under the revolving portion of the Senior Credit Facility at weighted average interest rate of 1.4%. At December&#160;31, 2022 and 2021, there was $771.3 million and $843.8&#160;million, respectively, outstanding, under the Term Loan component of the Senior Credit Facility at weighted average interest rate of 5.6% and 1.4%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. At December&#160;31, 2022 and 2021, there was $38.1 million and $45.0 million, respectively, of the Term Loan component of the Senior Credit Facility was classified as current on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan components at December&#160;31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $800.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit outstanding as of December&#160;31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; totaled $1.6 million. Ther&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e were no amounts drawn as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year-ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $42.7 million in 2023, $39.1 million in 2024, and $3.6 million in 2025. Interest is calculated on the term loan portion of the Senior Credit Facility based on LIBOR plus the spread paid by the Company. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding balance of the revolving credit component of the Senior Credit Facility is due on February 3, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 4, 2020, the Company issued $575.0&#160;million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. The portion of debt proceeds that was classified as equity at the time of the offering was $104.5&#160;million. The effective interest rate implicit in the liability component was 4.2%. In connection with this offering, the Company capitalized $13.2&#160;million of financing fees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of December&#160;31, 2022, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#x2019;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#x2019;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#x201c;hedge participants&#x201d;). The cost of the call transactions was $104.2&#160;million for the 2025 Notes. The Company received $44.5&#160;million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the carrying amount of the liability was $575.0&#160;million. The fair value of the 2025 Notes at December&#160;31, 2022 wa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s $560.5&#160;million.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the adoption of ASU 2020-06, for both the years ended December&#160;31, 2022 and 2021, the Company recognized only cash interest related to the contractual interest coupon on the 2025 Notes of $2.9&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securitization Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#x201c;SPE&#x201d;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of December&#160;31, 2022, the Company was in compliance with the covenants and none of the termination events had occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#x2019;s total indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, the Company&#160;had $104.7&#160;million and $112.5&#160;million, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 5.0% and 1.1%, respectively. The fair value of the outstanding borrowing of the Securitization Facility at December&#160;31, 2022 was $104.9&#160;million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUwMw_aa3f91a4-af0e-44ef-9f21-c535cfee8653"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7f6392846dfe466d9d26314aee0a7510_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2Mg_7192d129-0a06-4948-a118-e7eaaffbef8f"
      unitRef="usd">877500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i31f0be0dc18542668776dac2419eacfc_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU5Ng_99fb0411-ce84-4b2d-9e7a-c94aa28d215b"
      unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic745d752ec27419fbefffbb4a794e6e6_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzY0Mw_f934bd3f-491e-4df6-bebb-6f6955f5e873"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id1f1b83ff3044f198627e9dcf14f8112_I20200203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzcwNw_9f04f5cc-da11-48bd-8888-4e280fe31976"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTg1_85c3937c-1b96-4c6d-a703-77e7f60f62cc">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) is the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022 through June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i2429c77787c540b481af5ad54734a36f_I20200714"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTowYzE5YmJmYzczMDI0ZmE1ODNiM2RlNDEyMmMyNWY1OS90YWJsZXJhbmdlOjBjMTliYmZjNzMwMjRmYTU4M2IzZGU0MTIyYzI1ZjU5XzUtMi0xLTEtOTI0NzkvdGV4dHJlZ2lvbjpiMzgyNTI5MjA2NGM0OTUzYWM2NzJlYTgyNzNmMjFmNl8zMjk4NTM0ODgzMzUz_bcd502f5-c9ff-4a89-9f94-ddfb0aa0f852"
      unitRef="number">4500</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="if488a963db3a45d1a7ad2f45989c9458_I20200714"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTowYzE5YmJmYzczMDI0ZmE1ODNiM2RlNDEyMmMyNWY1OS90YWJsZXJhbmdlOjBjMTliYmZjNzMwMjRmYTU4M2IzZGU0MTIyYzI1ZjU5XzYtMi0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowOTdkOTJmYTYxODY0NDIxOGQ2M2Q5Mjg2N2MwNWRmY18zMjk4NTM0ODgzMzQz_90024ac0-86de-4362-95e2-3f7758d2a7c4"
      unitRef="number">4000.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic13de93e77194c5db68428a880ecc0ea_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE1NzM_ee677f3c-4ed1-484f-837a-f577658f0818"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9b119f3359044799a93e9eb51fb8011d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE1Nzk_bada8667-bbba-43cc-a78c-063de984eed7"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icc2cd7d3829a475eab3f41f1f7f63464_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE3MTU_5061a619-c833-4c0f-bc74-d0f00db108c3"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i16836d586c23438497ba4585606b71df_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzE4MDQ_d3ff913b-418a-4198-bfe6-aff47949da16"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="id05e07ddaf204365bde66fc72e4e8a56_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzIyNTE_4769a990-aad0-41a8-a541-a30c436db889"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i222fc417f0d442279085025ae2862e64_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzIyNTc_97fc0ff7-7fe3-45b7-ae32-9c463e277fdd"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i9c57be56c5d447d7bac2c61c0eea7c9b_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzI3NjE_aa3c4815-4b88-4b86-9855-c956222c90bb"
      unitRef="usd">4600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i60510ed6729f49d58e204a789ec164fe_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzI4NjA_6a2c9477-9b92-467b-9dc5-e7ed29178169"
      unitRef="usd">1200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="idc24dddff635440bb6fa7fef2e8c6bbb_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMwMDQ_3125a586-5853-4543-9278-7856a9050560"
      unitRef="usd">3300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LineOfCredit
      contextRef="i7a18546e2641432186ebea4fb82b0c97_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMxNjI_439277dc-a627-4cfe-88dc-75fd445d2c93"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMxNjk_4ab54866-5401-4936-9f01-886236fffd31"
      unitRef="usd">31300000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i8c43ec4fcf514899b31a859b0a80a0c6_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzMDI_67dcdd5d-c762-4dff-9b84-145f5e6d1995"
      unitRef="number">0.014</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LineOfCredit
      contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzNDQ_daeeb985-c58d-41bc-94dc-219a88373bd2"
      unitRef="usd">771300000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMzNTE_f303b551-9def-46c5-bd19-30b9d9c84d0a"
      unitRef="usd">843800000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM0Nzk_d5379a15-31df-456b-8f4e-f12681ff95b2"
      unitRef="number">0.056</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM0ODY_0ebd1837-98c8-4c89-b961-b44d4ea9c3b0"
      unitRef="number">0.014</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:SecuredDebtCurrent
      contextRef="i98b32bbe6d6646c68e6d64342fb37f83_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM1Mjg_c879a472-8f09-44ed-960f-7c01bb1f86ff"
      unitRef="usd">38100000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="i81cdd2fa7bbe4f2cb580feb811a07676_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU3NzI_55b6c93a-0377-475e-ad6a-0384f708aefb"
      unitRef="usd">45000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="iab173f92572840f69a38fdd7ef02744a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzM4MDU_6a325b55-22b3-4d45-b1f0-d4e8a5c19337"
      unitRef="usd">800800000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ide3a54a13b084e729f49c0c5be9ef158_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQzOTk_051f8606-bde6-4d13-bd43-625ef8d3534d"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQzOTk_073fa599-afad-407a-b832-3dd63f8864ef"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCredit
      contextRef="i5d04f09f7a2c4e28b0f31c29f480555b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ0MjI_2d156304-37bf-47fe-9806-7f7a97128ba0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzExOTgz_5a62f27c-82a0-4346-a287-7d8cd7f5bea4">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year-ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzItMi0xLTEtOTI0Nzk_cb8d7061-f878-436b-8b04-4534343b7aff"
      unitRef="usd">38125000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzMtMi0xLTEtOTI0Nzk_2ef0cff5-1285-4a85-b000-a620a5599f38"
      unitRef="usd">67500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzQtMi0xLTEtOTI0Nzk_0c73af93-74d7-41c8-8dc9-3c6a00340b30"
      unitRef="usd">669375000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebt
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90YWJsZTo1MjNhOGQ4NWVkMTY0ZDA2YTczOGM5YzQ1ZTg3MzQ5Mi90YWJsZXJhbmdlOjUyM2E4ZDg1ZWQxNjRkMDZhNzM4YzljNDVlODczNDkyXzYtMi0xLTEtOTI0Nzk_b691815b-4319-41e5-bc9a-2c31b78252db"
      unitRef="usd">775000000</us-gaap:LongTermDebt>
    <iart:InterestPaymentsYearOne
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ2OTM_ccaca153-6fd8-4b6d-8c83-098dc48310e2"
      unitRef="usd">42700000</iart:InterestPaymentsYearOne>
    <iart:InterestPaymentsYearTwo
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ3MDU_7803e99a-ff69-4be8-b33e-0ee795c988f3"
      unitRef="usd">39100000</iart:InterestPaymentsYearTwo>
    <iart:InterestPaymentsYearThree
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzQ3MTc_8f6912d0-f829-4075-95db-b4c2fac48fa6"
      unitRef="usd">3600000</iart:InterestPaymentsYearThree>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUxOTU_e55eadbe-b82d-472c-9663-e23e99d3d6c5"
      unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUyMzI_8826bc25-40aa-455c-838e-e99458ea6b04"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzUzNjY_b0a4a5bf-e4e2-4dfd-b6de-faf2dd700f4c"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2MDI_3d0c7203-ac27-4aeb-a470-6de4e8372665"
      unitRef="usd">104500000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU2NzQ_257f59ba-4ede-4554-a067-081d49e8b2a7"
      unitRef="number">0.042</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzU3MzY_76b14185-de62-4bd4-9959-7c26c0acc13d"
      unitRef="usd">13200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYwNTA_c6958324-e221-49c9-a1a4-216489b6543b"
      unitRef="usdPerShare">73.67</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod
      contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYxOTg_4ff87eb1-7649-4750-851a-eb1db5fb92e9"
      unitRef="number">1.30</iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod>
    <iart:DebtInstrumentMaximumAverageConversionValueOfNotes
      contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzYzNDg_3721c911-7da7-4f0c-bcab-d5a03cd8e7e4"
      unitRef="number">0.98</iart:DebtInstrumentMaximumAverageConversionValueOfNotes>
    <iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount
      contextRef="i6f118ad8379e472489d69365de281b5a_I20201209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzczMjk_f6ef3ecf-bf82-4d8c-a22c-f9817b63e64c"
      unitRef="usd">1000</iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ie9faa24aab3a4b0e993dac7278740fff_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzc0NTY_faa07b77-dfc5-4694-9271-303287608b5f"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzgxMjg_7a8fb285-ff9f-402b-8998-096fc14fd51e"
      unitRef="usd">104200000</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzgxNzI_db8516ac-8ea5-45fa-a479-8fdaff6591bf"
      unitRef="usd">44500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i017e11d15cf64b8489fec3fdd7fa107d_D20200204-20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzg1MjA_4b628520-2ad0-41f3-986a-50933bd6c2e9"
      unitRef="usdPerShare">73.67</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia3315ee84daf4da5aa07a942e7e8f9f6_I20200204"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3Xzg2Njg_76043590-25f0-4cdf-92b1-2fa13c6eb761"
      unitRef="usdPerShare">113.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i987b954ec383404489ad7dd44db86461_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU4MjQ_c4c77f34-ad7e-48f4-a435-1afe5ea75ab2"
      unitRef="usd">575000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i987b954ec383404489ad7dd44db86461_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTU4MzI_fb68a719-ee0f-422c-8b70-7eb9f44498ef"
      unitRef="usd">560500000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i0627e2a89adb4de6b5f96b5c7cd98f0c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxNzg_411fadf8-b355-428e-8aad-919650bf9c5b"
      unitRef="usd">2900000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i24a9e217820b47419ac62a665233d6e6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxNzg_93ccf701-d41d-4776-9285-8435dccd324d"
      unitRef="usd">2900000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzEwNDg3_5e331db9-c868-4801-8906-8fcfc31cb02f"
      unitRef="usd">150000000</iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYxOTg_4c577257-fd8e-4ec0-9039-7cfba18b180e"
      unitRef="usd">104700000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTA_7189eccc-8db8-46f1-974b-07913b217524"
      unitRef="usd">112500000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTU_4b742791-d661-49cd-b983-495c46ce8054"
      unitRef="number">0.050</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMTk_4f46b0a9-5ebc-4b0a-ab7e-4ea4cafc546b"
      unitRef="number">0.011</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:SecuritizationFacilityFairValueOfAmountOutstanding
      contextRef="i2f78858143164e768c61bb467e5fdd70_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjAvZnJhZzo2OWE3MGM0ZTQ3ZDI0ZTI3OGI1ODliNWU5Y2Q1ZmRhNy90ZXh0cmVnaW9uOjY5YTcwYzRlNDdkMjRlMjc4YjU4OWI1ZTljZDVmZGE3XzMyOTg1MzQ4OTYyMjQ_16e67cc7-8dfe-421e-80fa-f414d45aeb73"
      unitRef="usd">104900000</iart:SecuritizationFacilityFairValueOfAmountOutstanding>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjgz_a085dffd-4004-4b09-b328-b3582cb66d06">DERIVATIVE INSTRUMENTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected LIBOR-indexed floating-rate borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive income (&#x201c;AOCI&#x201d;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCI to interest expense at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCI, net of tax. Those amounts are subsequently reclassified to earnings from AOCI as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of the Company&#x2019;s hedging program depends, in part, on forecasts of certain activity denominated in foreign currency. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Currency Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2017, the Company entered into cross currency swap agreements to convert a notional amount of $300.0 million equivalent to 291.2 million of Swiss Francs ("CHF") denominated intercompany loans into U.S. dollars. The CHF- denominated intercompany loans were the result of the purchase of intellectual property by a subsidiary in Switzerland as part of an acquisition. On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of $50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to $49.1 million of this &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.   As of December 31, 2022, $49.1&#160;million of the $300.0 million notional amount remain outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,283)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;374,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,241)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,528)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;rd&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 2022, in accordance with the termination date, the Company settled cross-currency swaps designated as cash flow hedges of an intercompany loan with aggregate notional amounts of $100 million. Based on the closing exchange rates, the gain upon settlement of these swaps was approximately $1.6 million which was offset by the loss on the settlement of the intercompany loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 4, 2021 in accordance with the termination date, the Company settled a cross-currency swap designated as a cash flow hedge of an intercompany loan with an aggregate notional amount of $50.0&#160;million. The gain recorded by the Company upon the settlement of the swap was not material for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCI. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 ,December 16, 2020 and May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign currency on foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,663)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 26, 2022, the Company early settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$250 million equivalent to&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 222.3 million CHF. The original settlement date was December 16, 2027. As a result of the settlement, the Company recorded a gain of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$4.9 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in AOCI. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 26, 2022, the Company entered into cross-currency swap agreements designated as net investment hedge to replace these swaps with a notional amount of $300 million equivalent to 288 million CHF. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2021, in accordance with the termination date, the Company settled cross-currency swaps designated as net investment hedge with an aggregate notional amount of $52&#160;million equivalent to 44.9&#160;million Euros. As a result of the settlement, the Company recorded a gain of $0.1 million in AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded as unrealized gains or losses in AOCI. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#x2019;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#x2019;s credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Derivative Instruments on Financial Position and Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;At December 31, 2022 and 2021, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.5 billion and $1.8&#160;billion respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCI&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCI into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCI&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022 and 2021, the Company recorded a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;gain of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$11.1&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and gain of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$23.8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, in other income, net related to change in fair value related to the foreign currency rate tran&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;slation of the cross-currency swaps, designated as cash flow hedges, to offset the gains or losses recognized on the intercompany loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022 and 2021, the Company reco&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rded gains of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8.4&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  an&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d $9.1 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain  that is expected to be reclassified to other income, net from AOCI as of December&#160;31, 2022, for the cross-currency swaps designated as cash flow hedges within the next twelve months is $4.5 million. As of December&#160;31, 2022, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to interest income from AOCI as of December&#160;31, 2022 for the c&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ross-currency swaps designated as net investment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hedges, within the next twelve months is $11.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments not designated hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company entered into foreign currency forward contracts, with a notional amount of $4.2 million, to mitigate the foreign exchange risk related to certain intercompany loans denominated in Canadian Dollar ("CAD").  These contracts were settled in third quarter of 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million, to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjk4_f5e3b5cd-df2c-4736-8b2b-79ea0793edcf">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,283)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;374,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,241)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,528)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of December&#160;31, 2022 and 2021 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,663)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0437592feca04863946089d86b4469ac_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMi0xLTEtOTI0Nzk_ed86bfb6-a8df-4256-9a4f-bd26c5fdf54c"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8a060aa4a4944de1b51797e710f61a6a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtNC0xLTEtOTI0Nzk_e71112ce-48aa-4188-8c40-f9db7f31563b"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i0437592feca04863946089d86b4469ac_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTItMS0xLTkyNDc5_6d6e22d0-cb66-48f1-87c3-f401252c935a"
      unitRef="number">0.02201</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i0437592feca04863946089d86b4469ac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTQtMS0xLTkyNDc5_ec776f65-4dc3-448f-8994-57d6e152d7a3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8a060aa4a4944de1b51797e710f61a6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzQtMTYtMS0xLTkyNDc5_502f888f-18b5-4a20-90bb-38d0e55e6665"
      unitRef="usd">-5268000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMi0xLTEtOTI0Nzk_9d63ec92-453f-4212-b26e-645ef4cd7928"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i117d5a15f0484f8aa5ec486b255b30a3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtNC0xLTEtOTI0Nzk_e955086d-7b7c-40d3-9f3d-b349a2b21fa5"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTItMS0xLTkyNDc5_d1663503-471b-4b2c-9d9b-6f0fba8dc6b8"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i145ff6e523744822b4b70f6a3b8ccc36_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTQtMS0xLTkyNDc5_d4bf39aa-3393-4131-9572-461c4e0c3782"
      unitRef="usd">5012000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i117d5a15f0484f8aa5ec486b255b30a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzUtMTYtMS0xLTkyNDc5_f558826b-acc6-462d-944f-fd443a68e641"
      unitRef="usd">-5520000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMi0xLTEtOTI0Nzk_f9ce7a7e-68ed-45aa-b710-1a2e70f9dae9"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtNC0xLTEtOTI0Nzk_b9a4b539-2aaa-44d7-946f-9841faa898ae"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTItMS0xLTkyNDc5_236c4b9c-c982-44b2-8285-ae1d44f6a6c8"
      unitRef="number">0.02313</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4ec02fd593094c019fc93fa310f36636_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTQtMS0xLTkyNDc5_c91aa5ec-2079-4bca-9129-12d47d7fab1e"
      unitRef="usd">8380000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic0c2f687fb5c4a35bb897254c53ab85b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzYtMTYtMS0xLTkyNDc5_e0016fce-6da0-4c0d-889c-c98b64092c44"
      unitRef="usd">-7421000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMi0xLTEtOTI0Nzk_4a726ebb-f8df-4594-a0af-9b8d99f2ba20"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i929e86bd2d204984ba3a7acb41d6f92d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctNC0xLTEtOTI0Nzk_5291cb34-666d-4137-8b69-3e6f3e42bced"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTItMS0xLTkyNDc5_5340cc22-cd8e-4e16-b272-2e8e47377ef0"
      unitRef="number">0.03220</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7fdb2a2c43e5495d8706cf061fc14cc5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTQtMS0xLTkyNDc5_c769d232-2356-4ac0-815f-86c34161160e"
      unitRef="usd">1831000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i929e86bd2d204984ba3a7acb41d6f92d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzctMTYtMS0xLTkyNDc5_1a00e9a7-ff71-41e4-b572-f414801e50c5"
      unitRef="usd">-5512000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMi0xLTEtOTI0Nzk_213b4054-0a81-4fef-8c82-0298fadb0425"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtNC0xLTEtOTI0Nzk_f11abce9-b54c-4365-a5c5-682e4b656a81"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTItMS0xLTkyNDc5_ff959adf-7bc8-4671-9673-823b0aa0da99"
      unitRef="number">0.03199</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i268abcc1595c47e0822aa833a03ccaf5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTQtMS0xLTkyNDc5_df7b0cc2-fee8-438f-a272-6d0ce72a1fd6"
      unitRef="usd">1905000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id2b4d2a02d4e4362b1dd23a2cc08d7f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzgtMTYtMS0xLTkyNDc5_aa101439-60a9-417e-b01e-6e432f7fb137"
      unitRef="usd">-5464000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMi0xLTEtOTI0Nzk_24e01a07-08d1-4ba8-acd3-9f494f21134f"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic63c12c941ae4e8d81cabaff36570cd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktNC0xLTEtOTI0Nzk_11dad25f-ae85-4e80-acff-191cde396e67"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTItMS0xLTkyNDc5_c6f0e50d-8bb9-4be9-b553-e12e887af54c"
      unitRef="number">0.03209</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3fc89a5aa659464192a833dc24455b76_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTQtMS0xLTkyNDc5_c1905049-38a6-4e67-b4df-04b5b5f5d29e"
      unitRef="usd">1970000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic63c12c941ae4e8d81cabaff36570cd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzktMTYtMS0xLTkyNDc5_5f114b79-cd9f-4e54-a475-65e96614edbe"
      unitRef="usd">-5494000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTItMS0xLTkyNDc5_0fcdab56-8432-4ba6-b366-3f314faa4ee5"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i14428d26feb74f44b207c0596adab982_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTQtMS0xLTkyNDc5_f472f022-2cac-40f3-8fa1-eabb1094186a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTEyLTEtMS05MjQ3OQ_f477b2f2-f7be-476c-8436-58691bda89d3"
      unitRef="number">0.02885</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib53b93c1b49f4b1781184342d6d22de2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTE0LTEtMS05MjQ3OQ_a6072d65-7f89-4c8f-8713-4c7085f605a7"
      unitRef="usd">4252000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i14428d26feb74f44b207c0596adab982_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEwLTE2LTEtMS05MjQ3OQ_bf4be8a9-adf5-4932-96c9-75016aa23ca8"
      unitRef="usd">-6886000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTItMS0xLTkyNDc5_e10b4bbe-92e4-4391-9040-a60714ae8ca3"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i082f3efc12d847f7bdbcda637deb820f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTQtMS0xLTkyNDc5_ff075725-6908-4085-8b07-ca69a4576e97"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTEyLTEtMS05MjQ3OQ_8ce5800f-a301-4115-b1ae-828a5de4883f"
      unitRef="number">0.02867</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1530f3523e91426ea8a8ea3fe39aea94_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTE0LTEtMS05MjQ3OQ_1ba35847-b14c-4c3f-b102-b365d6b051b1"
      unitRef="usd">4153000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i082f3efc12d847f7bdbcda637deb820f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzExLTE2LTEtMS05MjQ3OQ_1720e9ff-c187-456f-904d-3603a4e1d2c9"
      unitRef="usd">-6764000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTItMS0xLTkyNDc5_a33c2858-e161-4587-931f-f8383143f917"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i88a51434e1d640819950dc39740d93e1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTQtMS0xLTkyNDc5_24d90a4f-afe9-468b-9bee-23e29c8a1fbd"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTEyLTEtMS05MjQ3OQ_98a92264-8033-4c43-b5c2-8fa864840d0f"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1cfc5a762e5c4b0d8cbe204cafb0ecba_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTE0LTEtMS05MjQ3OQ_287c01b3-3171-420a-9dd8-ac9f5a5b9785"
      unitRef="usd">23742000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i88a51434e1d640819950dc39740d93e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEyLTE2LTEtMS05MjQ3OQ_28fc5e12-6416-4696-be76-4245425a4828"
      unitRef="usd">3552000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTItMS0xLTkyNDc5_e3b4f367-82c2-4990-b6b6-c43d28fd62bb"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icf52b2b42e8342a186985ec5e5775ce3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTQtMS0xLTkyNDc5_d4bbcf3f-b6dc-406f-bd4a-1393e893022e"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTEyLTEtMS05MjQ3OQ_d6fffdce-947c-41db-9e29-0683971d5808"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iad7bbbd6621f4001b504642d91a8cd31_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTE0LTEtMS05MjQ3OQ_b071e8eb-6d20-4dbe-8951-ff0feb9c105d"
      unitRef="usd">5467000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="icf52b2b42e8342a186985ec5e5775ce3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzEzLTE2LTEtMS05MjQ3OQ_7c34103a-80a1-4c90-afe2-1fc48fc45ee6"
      unitRef="usd">821000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idb5285f5cc45407cbdd753e2c83bf644_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTItMS0xLTkyNDc5_4b9a9869-d88e-4d15-a6d6-4bcf25ff598a"
      unitRef="usd">1475000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTQtMS0xLTkyNDc5_c54a337b-6ef6-4ca5-9486-b66c034530c4"
      unitRef="usd">1775000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idb5285f5cc45407cbdd753e2c83bf644_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTE0LTEtMS05MjQ3OQ_7e1bc6c2-2d10-4b51-8229-2d4b1748bf29"
      unitRef="usd">56712000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i2ec39943b76e44f1a1cb2a77f34668b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTozMDBhNWEwOTUzZWU0NjhkOWEwMTdkNWYxMGI5NTViNC90YWJsZXJhbmdlOjMwMGE1YTA5NTNlZTQ2OGQ5YTAxN2Q1ZjEwYjk1NWI0XzE0LTE2LTEtMS05MjQ3OQ_8b0126d0-297d-4e63-ac62-ba357bddfdf7"
      unitRef="usd">-43956000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5bbe580a52f944c98f0001a290f94063_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ1MzM_dd7666ca-080a-4173-ab44-38b46ced1ffb"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0b7965703b77464bb1196cc27ff38536_I20171002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ1NTA_b72c169a-74ea-4ab0-b2af-da1d3b948bd9"
      unitRef="chf">291200000</us-gaap:DerivativeNotionalAmount>
    <iart:DerivativeNotionalAmountTerminated
      contextRef="i008795d9432842aa84611f74c3eace23_I20220926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE1MTQ_54782e07-b5fd-4a45-8389-b106613619ae"
      unitRef="usd">50000000</iart:DerivativeNotionalAmountTerminated>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i008795d9432842aa84611f74c3eace23_I20220926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE2Mjg_d0a34acf-e957-43e7-aad5-5df4864bfc74"
      unitRef="chf">48500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE2NDY_a3a6ae45-3458-421e-aceb-440aebbc1614"
      unitRef="usd">49100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8a04d52add76416a8fcb25f20a6cb4f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzM4NDgyOTA3MzAwNzk_a3a6ae45-3458-421e-aceb-440aebbc1614"
      unitRef="usd">49100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5bbe580a52f944c98f0001a290f94063_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzM4NDgyOTA3MzAxMjU_dd7666ca-080a-4173-ab44-38b46ced1ffb"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ed0c764a1ef48f18d31ec981995213b_I20201221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ4OTI_c8505cd9-ae95-41a8-a960-3029e7f6d6ed"
      unitRef="usd">471600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ed0c764a1ef48f18d31ec981995213b_I20201221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQ5MDk_add965c1-f279-45c3-9f72-cf6949a28302"
      unitRef="chf">420100000</us-gaap:DerivativeNotionalAmount>
    <iart:IntercompanyLoanQuarterlyPayment
      contextRef="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzUyMjQ_6ce3f50f-63e8-438d-a984-fdc938ec3b37"
      unitRef="chf">5800000</iart:IntercompanyLoanQuarterlyPayment>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTYtMS0xLTE2Njg4NA_3a76e2e9-82ff-4e08-80b9-9758fbf2968e"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6fa4d9fcdc63415b82ddcba2dca80b74_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTktMS0xLTE2Njg4NA_2574077e-6bcc-49ab-9983-1915af4be836"
      unitRef="chf">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i36bbf9012cea408c93248b27bdf539bf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEwLTEtMS0xNjY4ODQ_3934e540-0557-4d1f-a326-a5d9a8ea9a96"
      unitRef="chf">145598000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i5dc0c3a66d1b4b0598d21bd659f5221c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEyLTEtMS0xNjY4ODQ_fbbe33d0-4ebe-42a1-929f-ec1844a52c55"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ia4295be0ac744563a7454ae58d217d0b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEzLTEtMS0xNjY4ODQ_f4e8e12f-78e2-4cb2-8f5e-eb91d4e3800c"
      unitRef="usd">-8283000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if7726647971046a491c61ebc43a4896f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTYtMS0xLTE2Njg4NA_3434a002-ff06-47c7-919a-469eb5c5247b"
      unitRef="number">0.0452</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if7726647971046a491c61ebc43a4896f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTktMS0xLTE2Njg4NA_121aa003-6319-4ba4-b6a8-0344e9702198"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8600ea8026004026a91ef4697aa5aa1e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTEwLTEtMS0xNjY4ODQ_ee1f76da-2439-441c-ad4f-8b0ad7506d88"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i141946ba0694449bb9049b3e2a07dee5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTYtMS0xLTE2NjkxMw_357a1476-5414-47cf-addb-9b03280f676f"
      unitRef="number">0.0300</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i141946ba0694449bb9049b3e2a07dee5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTktMS0xLTE2NjkxMw_4a80c678-91cf-41dc-83ca-913e50abc95a"
      unitRef="chf">374137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i66601e7294074670ad5e6aa5e725a874_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEwLTEtMS0xNjY5MTM_dff67422-0422-4869-90fe-877fed1351a8"
      unitRef="chf">397137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i2c728bb018c44941b1bfa6521c9c1244_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEyLTEtMS0xNjY5MTM_2cd5dbf6-2f88-4743-86b2-3964aa6825d4"
      unitRef="usd">-4241000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i329398daa6384179aba8e533d27d2360_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE1LTEzLTEtMS0xNjY5MTM_761faa4c-bc34-4290-8e56-5bb419ea8454"
      unitRef="usd">41000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6dd78859ef8848a999eb4a52492eef4b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTYtMS0xLTE2NjkxMw_f322c0c2-e84c-4f56-9d55-ee9418e8a024"
      unitRef="number">0.0398</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6dd78859ef8848a999eb4a52492eef4b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTktMS0xLTE2NjkxMw_8dd80e03-37f1-46f6-894b-4283fa4855c0"
      unitRef="usd">420001000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i997ddfe9c3304a9e9408563c2fd4c3d3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzE2LTEwLTEtMS0xNjY5MTM_fc1a925f-06ba-45ca-bb6a-8ed694a544f5"
      unitRef="usd">445821000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ifec03638243c4669892b4eb299ae5ed2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTYtMS0xLTkyNDc5_17eda191-48ed-4d8c-977f-5d8a59adc50c"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifec03638243c4669892b4eb299ae5ed2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTktMS0xLTkyNDc5_4e137efd-9f3a-46f5-9e52-cfe5d4064955"
      unitRef="chf">48532000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0465a51e6df04b86963ff406fb55ea2a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEwLTEtMS05MjQ3OQ_ec3895e5-4566-4a5e-bce6-5f4a8e355364"
      unitRef="chf">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7523d880d9374a2481b72ce4679376f9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEyLTEtMS05MjQ3OQ_8ccf4b10-5cd4-4a8e-bdfc-665b5209b3f3"
      unitRef="usd">-3528000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3214317cf106471eb746ae95e24aea11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEyLTEzLTEtMS05MjQ3OQ_2616b306-a627-4f34-a244-0262220d7d0a"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i67557a94436f43d9bf40a6821f726802_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTYtMS0xLTkyNDc5_6e82a039-c37c-4780-9fb2-4cd743d0ba44"
      unitRef="number">0.0532</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i67557a94436f43d9bf40a6821f726802_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTktMS0xLTkyNDc5_40e51a92-faa7-46ff-a99a-ac7599b2b441"
      unitRef="usd">49142000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if33212f0ed73438ea87f123c17695625_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzEzLTEwLTEtMS05MjQ3OQ_6193d3df-92fc-41fd-80c7-13cfffed09aa"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i844b7cae12554de8ba766bd5d0e34762_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzIxLTEyLTEtMS05MjQ3OQ_3d4ada49-5f7c-4440-a67c-206b709bedd8"
      unitRef="usd">-7769000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idaca32771dbc4bf086fdf4c473690023_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3MjRiNDgyZDc4NDc0MTk5OTFmMWY3NTM1NjJmN2E5Yi90YWJsZXJhbmdlOjcyNGI0ODJkNzg0NzQxOTk5MWYxZjc1MzU2MmY3YTliXzIxLTEzLTEtMS05MjQ3OQ_b7463692-5c09-4091-aa75-0d283538e082"
      unitRef="usd">-8242000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <iart:DerivativeNotionalAmountTerminated
      contextRef="ic1d27726f48242c888971f11c16fce73_I20221003"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODE5OTg_9ca9aa4b-bfc2-4a09-81a3-24ecb17e3744"
      unitRef="usd">100000000</iart:DerivativeNotionalAmountTerminated>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i32190bd884274de3ad539b9552b10509_D20221003-20221003"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODIwOTg_4cb4f2eb-eefd-43e7-9d6f-8494eb7b7b9c"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i70886b0065374cab828ea261cdadbf4e_I20211004"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzYxNjg_c0c086dc-fc26-4fa2-a360-7ce1dbbb8380"
      unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i02e3c4b1748e496f95f812498d15e0d3_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtNi0xLTEtOTI0Nzk_699e9658-acc8-4755-9dde-1aab5cb7d198"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i02e3c4b1748e496f95f812498d15e0d3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtOS0xLTEtOTI0Nzk_1a177d2c-79d1-437a-bf21-446c5ee7efd1"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d1829ef6ea84eaca05276c51c0606c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzQtMTEtMS0xLTE0MzE4Mw_7f3c6c06-b0f9-4f02-a5bf-320d1832fe11"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if061f0c8b11a4b0e9af9f2d1b0096dfc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzYtMTEtMS0xLTkyNDc5_207c6671-e1ba-4598-b927-a61739dff3dd"
      unitRef="usd">4713000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if02c59d68ec54646a35d4af040a81a1a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzQtMTUtMi0xLTE0NDIwMw_ff2fb6cc-f890-4672-9a3e-ba8ff7944771"
      unitRef="usd">2503000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i67adfefe5a8443c6b626a7bbf0761620_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctNi0xLTEtOTI0Nzk_65244af6-77dc-4c92-b4b2-0e7fde83d082"
      unitRef="number">0.0257</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i67adfefe5a8443c6b626a7bbf0761620_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctOS0xLTEtOTI0Nzk_701e987e-16f8-46df-bb71-9c0ff0e5dd1c"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8c5897d96d2c4f5496944a6fd6a162ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzUtMTEtMS0xLTE0MzE4Mw_2248594b-4157-4f69-ae3a-76ef32d2751b"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i245c76d03fc54d94af94a58fba2d7466_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktNi0xLTEtOTI0Nzk_90802c3f-58bd-4416-87d9-4ea1c96561ea"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i245c76d03fc54d94af94a58fba2d7466_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktOS0xLTEtOTI0Nzk_6fb7d433-0d87-4d58-bfcc-577f9b904c8a"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55466ef9ef12476299ceffdcdfee3a9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctMTEtMS0xLTE0MzE5MQ_3b55aa52-5fbb-4582-b6b4-0cdd02766f85"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4142d8f488e94bcc8829564ba2e3adae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzktMTEtMS0xLTkyNDc5_96eb00cf-10b1-46a0-8a76-d05d3d92b26b"
      unitRef="usd">4307000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9f429c0617e74d7eb2fd570e3c4023ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzctMTUtMi0xLTE0NDIwMw_98c47e4f-c63e-4c96-94e1-8438b05533fb"
      unitRef="usd">2147000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7a59d109ca88487ba3a465148ff07ff4_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTYtMS0xLTkyNDc5_00275585-b9ac-46a9-bbae-fa9270e20a87"
      unitRef="number">0.0219</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7a59d109ca88487ba3a465148ff07ff4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTktMS0xLTkyNDc5_b376287c-f2ee-4b34-aa37-ab9f059edccf"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idf5643d36404495ea9dedee026b7689a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzgtMTEtMS0xLTE0MzE5MQ_bc294f0f-40d6-42e3-8a9b-147eac1a5c12"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic5b3abf28fae409ea406125cd090ebe5_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTYtMS0xLTkyNDc5_b9e21299-27c1-4b57-888a-55d5e6179ab2"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic5b3abf28fae409ea406125cd090ebe5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTktMS0xLTkyNDc5_46ca287f-1051-4ee8-b197-542d0425b701"
      unitRef="chf">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i043cdbf94a754048b4b54ddd6eea2270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTExLTEtMS0xNDMxOTk_dd3f9b7e-925d-46bf-839a-c275b9f8b61a"
      unitRef="chf">222300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3c7b61c995a64818b815e9e90c34fa77_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEyLTExLTEtMS05MjQ3OQ_489a60da-3590-4358-bda6-2262034c204e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id601c28871b9412d9cb1392b237ce8a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEwLTE1LTItMS0xNDQyMDM_83331067-27c5-4b44-a752-6b6ddade5743"
      unitRef="usd">-792000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTYtMS0xLTkyNDc5_2a936c8a-8504-4cf7-9ff9-550d4d0ebddc"
      unitRef="number">0.0110</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if5eb0ffb942a43929ea2d68fe49d0b7f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTktMS0xLTkyNDc5_f0b3b803-5da4-4b73-a111-25b2458c5fac"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icde344ad1e464afcb71f8af811c85b13_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzExLTExLTEtMS0xNDMxOTk_ec7741dd-d12b-41aa-a873-340fb087c23a"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ieac0855122ee48d1aa3a6ee317127bd5_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTYtMS0xLTE0NDE1OQ_fea3c4de-b5b9-482e-892a-d56cdde49704"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieac0855122ee48d1aa3a6ee317127bd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTktMS0xLTE0MzIxNQ_c11ba38a-495c-40f9-933b-b478e49adc50"
      unitRef="chf">288210000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3fe3ee7c51fd49caa0539281dd6cf5c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTExLTEtMS0xNDMyMDc_6e03ec0a-dc96-405b-9eef-c0730033a4ca"
      unitRef="chf">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iae5a8365a26446a3a0dca3f7522aa7e5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTEzLTItMS0xNDQxNzc_1928b12d-193a-4dfd-8137-4795a0265119"
      unitRef="usd">-14663000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i0b78e51cfeea49168e5007a5a4cfcf0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzEzLTE1LTItMS0xNDQxNzc_3d78d61a-dcc3-48c0-8066-2d9897394ae8"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ie807adbb29e64c9cb05ae929d44792cd_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTYtMS0xLTE0NDE1OQ_1d57c098-7bee-48a9-9b9b-8be0a7ae59dc"
      unitRef="number">0.0194</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie807adbb29e64c9cb05ae929d44792cd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTktMS0xLTE0MzIxNQ_10ef85ba-fd7a-49eb-9391-d9f066495690"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic3e492d9a1944dbc88ed4e5773148fc2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE0LTExLTEtMS0xNDMyMDc_7b9a7b72-444b-45c4-a624-d13e56154220"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iac2b519b9bef40ce86b32e60f3e0c395_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE1LTExLTEtMS05MjQ3OQ_bd82ac84-3266-4d35-9b60-2847d8d9f4f9"
      unitRef="usd">-5643000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1dfa8444a4ff4c799d79806966a6a49e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTpkMzNiNjVlZWExYzU0NDcxOWM2YzQ4ZjA3NDcwN2Y3Mi90YWJsZXJhbmdlOmQzM2I2NWVlYTFjNTQ0NzE5YzZjNDhmMDc0NzA3ZjcyXzE1LTEyLTEtMS05MjQ3OQ_24fdc91d-8be2-4d10-bfeb-41361d686d31"
      unitRef="usd">3858000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <iart:DerivativeNotionalAmountTerminated
      contextRef="i2eb10ee588794a879897fa8ebf06fbe5_I20220526"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI2ODQ_07a19c43-db6c-4658-b95c-d12ec6ca1dad"
      unitRef="usd">250000000</iart:DerivativeNotionalAmountTerminated>
    <iart:DerivativeNotionalAmountTerminated
      contextRef="i2eb10ee588794a879897fa8ebf06fbe5_I20220526"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI3MDI_8c6cebd3-add9-4254-99cf-8cb87bae2fd0"
      unitRef="chf">222300000</iart:DerivativeNotionalAmountTerminated>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="if4a01a2803854f15a4b2bdb0ad580cf3_D20220526-20220526"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI4MjU_1571003c-cf63-46b7-93ad-c6d01e99fad0"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODI5OTU_b0b981ec-17a9-4f26-b601-d058d9053cc4"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ba1d2f23fd542d8a4dff82a2730e5a3_I20220526"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODMwMTM_b1ca298e-6ce1-45d6-aa07-b68ad7914a97"
      unitRef="chf">288000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if2a5b238cefd4ad4851f8db781417fb8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg2ODA_a055f86b-4861-47e9-a0da-94c5c4506cdb"
      unitRef="usd">52000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if2a5b238cefd4ad4851f8db781417fb8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg2OTc_83016c35-da19-4392-9c6d-79801932d13d"
      unitRef="eur">44900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibf30e04d2e234b5da6da9f923618a1d6_D20210930-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzg3Njk_93e02422-8432-4456-9603-f3936aa600c0"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNjkx_b2593f8f-f03c-4957-9c8e-d2e8f27eafc1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the consolidated balance sheets as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location on Balance Sheet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:4.5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt"&gt;At December 31, 2022 and 2021, the total notional amounts related to the Company&#x2019;s interest rate swaps were $1.5 billion and $1.8&#160;billion respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if6753166079c43ef87f10211fa41814f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzYtMS0xLTEtOTI0Nzk_28b15b8f-0c86-40ff-ac6b-0727f147beea"
      unitRef="usd">4497000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6dc81409a88946a78bc0d4af0384c50c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzYtMy0xLTEtOTI0Nzk_fa9b01db-2052-4501-b568-1f4dd5243f78"
      unitRef="usd">4900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7629ad2913ce4b8c8a3a007050c04b32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzctMS0xLTEtMTUxMTk2_526588b8-e6f4-482c-ab3e-a66390bff0c6"
      unitRef="usd">16682000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i35b1038cb45449bd8017c02b7e07bcbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzctMy0xLTEtMTUyMDY4_2dab85ef-3929-49c6-b04e-fbdfebd794e1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1e7b6826294643ee9255e0aef5bfe00c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzgtMS0xLTEtOTI0Nzk_7595ad64-9d81-4e4b-a4fb-76889ac986f2"
      unitRef="usd">11653000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic14509aa5da94573ae2e368395318395_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzgtMy0xLTEtOTI0Nzk_a9d213e9-eb75-4465-a3d1-d4032ed3ee61"
      unitRef="usd">5120000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie1d11744ab624cb0b137eee60066f067_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzExLTEtMS0xLTkyNDc5_12b42b73-d31c-42c9-8a01-944ad54b6086"
      unitRef="usd">40030000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2578085d407f4986b5c4f56a8f5378e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzExLTMtMS0xLTkyNDc5_8c32ddd7-a305-407e-80eb-b30700f50f29"
      unitRef="usd">4373000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0774406054da4b54a1499e2e2203b073_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzEzLTEtMS0xLTkyNDc5_2db0ae8d-2437-459f-b22e-6af84551ca5b"
      unitRef="usd">3311000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i51b578e29f734d8da75403f33593ad57_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzEzLTMtMS0xLTkyNDc5_ac5dabdb-a2ef-4385-b240-c3ebc642444f"
      unitRef="usd">2104000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i29f1ed4692244fb883cb0925404db697_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE0LTEtMS0xLTkyNDc5_8428b87a-d627-4ef4-94a1-9b0213cf39d0"
      unitRef="usd">76173000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icedc48383bf44714905c7aba0b7e7eff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE0LTMtMS0xLTkyNDc5_fa2bd7f9-094d-482a-91a5-32de3933e277"
      unitRef="usd">16497000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib78f2cc3007c4d01874f3559b01933a6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE5LTEtMS0xLTkyNDc5_9f188242-a752-458f-a15f-8d97d0ee9786"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i02621b369e244009ba8077814770d363_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzE5LTMtMS0xLTkyNDc5_b08bf4d9-38ca-42e9-a408-16768fb88798"
      unitRef="usd">18187000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i82dc831f0d8543a3babdcc95198b48d0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIwLTEtMS0xLTkyNDc5_4ff8135f-dd2a-459b-a849-0a69154e7ab2"
      unitRef="usd">3528000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7598ea197a08489d85d2ca1a1d75029f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIwLTMtMS0xLTkyNDc5_a902ec25-8be5-4776-a69b-16b8ec8358ab"
      unitRef="usd">8283000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id40bd17782234cf0a42d79443632bd3f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIyLTEtMS0xLTkyNDc5_d2733a33-d724-4db0-a586-4cf9f6a6d883"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idd2e8ae6d2b84ab289dc5a4f5f4cac96_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzIyLTMtMS0xLTkyNDc5_0e1d157d-3889-43c6-bdd3-a70f4fdc7bd2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6649d3266ef54cdea0866db034e7da0f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI1LTEtMS0xLTkyNDc5_ba528647-cb83-4f1f-ab5e-fba9b4d275bd"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i284332c0c59745a1bafecb41e59a8cbf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI1LTMtMS0xLTkyNDc5_a078ac86-2756-40ee-866e-909870c3e116"
      unitRef="usd">30143000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6fdafe514a0f427a9c65279378fdca48_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI2LTEtMS0xLTkyNDc5_e779dbaf-a43f-4ebb-865f-ef6dbceebf52"
      unitRef="usd">8738000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i27ad7a70040d43599f4f203940fb2c3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI2LTMtMS0xLTkyNDc5_bc771f3d-eaa4-405c-9bf9-077721f6dc3d"
      unitRef="usd">4859000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia4f179ad71894c39b72c41978bcf975f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI4LTEtMS0xLTkyNDc5_5209647a-4f1d-4bb4-ba34-cdd4b28501ab"
      unitRef="usd">20608000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib479a1abd4bf4dd598c12f1ade31cc64_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI4LTMtMS0xLTkyNDc5_daaa4619-b845-464f-a1ae-d235480056d2"
      unitRef="usd">3366000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i29f1ed4692244fb883cb0925404db697_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI5LTEtMS0xLTkyNDc5_52bfd56a-0208-4477-af46-67e4bac7ed56"
      unitRef="usd">32874000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icedc48383bf44714905c7aba0b7e7eff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTphZTFkODIzOTFmY2U0ZDk1ODc1Y2M2ZGM1YTYyOWZjYS90YWJsZXJhbmdlOmFlMWQ4MjM5MWZjZTRkOTU4NzVjYzZkYzVhNjI5ZmNhXzI5LTMtMS0xLTkyNDc5_bfcff3b1-c524-48ae-9e2d-9ae6ce566c60"
      unitRef="usd">64838000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic924cff55443463a8fa41f30829d128f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzMyOTg1MzQ5MTA5NTU_805a42a1-b132-41e7-8969-ee0a89806133"
      unitRef="usd">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2d7c68edd73b44ed90a88f720435dd5c_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNDQ5_a20f199e-9c95-403a-9f7a-c23ceb2c0e9d"
      unitRef="usd">1800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzExNzAz_fcbfe196-b2f0-4512-bc89-bcb68e55e984">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying consolidated statement of operations during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCI&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain&#160;(Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCI into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCI&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ie8f45920e753432791e424ba5bde4c8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtMS0xLTEtOTI0Nzk_b07337d4-def7-4889-9cd1-2266d1f8dde8"
      unitRef="usd">-43956000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtMy0xLTEtOTI0Nzk_2133cae8-c6c3-4fe9-8413-1fec7c999e96"
      unitRef="usd">93308000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6b381a85704a410fbb63c912fb27ee59_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtNS0xLTEtOTI0Nzk_a5c7410b-e39f-4238-ac00-7b13caf311b7"
      unitRef="usd">-7360000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i326dcdfdff4841f5b13090e062a83847_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzMtNy0xLTEtOTI0Nzk_78117416-79e7-40eb-bd56-fa2e2075a4be"
      unitRef="usd">56712000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4251186fc1f74fa98118a5b683fb8145_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtMS0xLTEtOTI0Nzk_50d9a519-4f1a-4e62-97da-c1f623d5b06c"
      unitRef="usd">-9688000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtMy0xLTEtOTI0Nzk_c588d727-0085-4639-83a1-033b339ad97d"
      unitRef="usd">8847000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie9b0aaaa66144350a740f5082fdefa52_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtNS0xLTEtOTI0Nzk_bc669009-4037-4076-b464-90c8d1cb123c"
      unitRef="usd">19430000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i740c386c824b47d9a8a3bdd39e134319_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzQtNy0xLTEtOTI0Nzk_41f6944a-acf1-467b-8024-3110629d39ef"
      unitRef="usd">-20271000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtMS0xLTEtOTI0Nzk_4cd5002f-3547-4c93-a2d9-50a39ac5b263"
      unitRef="usd">-2321000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtMy0xLTEtOTI0Nzk_ed92db2b-8975-46b6-9dac-482268ab02ae"
      unitRef="usd">2196000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i53420981958e4bc7926bbd2b23685cc3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtNS0xLTEtOTI0Nzk_3fa1fec6-655c-498c-a6ca-517aec64654b"
      unitRef="usd">6789000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="iccf39968359d436db16110742b8c4283_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzYtNy0xLTEtOTI0Nzk_82845d42-5efc-449d-8e2c-14918ef7eaf0"
      unitRef="usd">-6914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b747e04cef446c8bbd192b91223c454_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctMS0xLTEtOTI0Nzk_4c87653e-97ef-4632-ba06-a439a1be4ce5"
      unitRef="usd">-55965000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctMy0xLTEtOTI0Nzk_9fb2bc9e-fce8-4b7d-bb89-265bfd3eea73"
      unitRef="usd">104351000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctNS0xLTEtOTI0Nzk_a4e584b9-72db-42b4-abc8-6d16536caaf0"
      unitRef="usd">18859000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i408e91f814cb42ff97d90348c7ed6c52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzctNy0xLTEtOTI0Nzk_09f66e31-e306-4899-a903-2758c2ce2ad4"
      unitRef="usd">29527000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icaa8a61ecfd341d69a8f83de49c64cdb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTEtMS0xLTkyNDc5_cb951e49-1d40-4a13-8a4e-3502b0d83415"
      unitRef="usd">-93769000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTMtMS0xLTkyNDc5_9be5210a-4132-4f25-9922-062afd5c0249"
      unitRef="usd">27402000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i54b21482f9b94cd2a141cd1491efc46e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTUtMS0xLTkyNDc5_18bbf4fb-cd16-494c-aeef-8a8c9bd3d8b4"
      unitRef="usd">-22411000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ie8f45920e753432791e424ba5bde4c8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEwLTctMS0xLTkyNDc5_89859b41-a6a8-4b31-8469-ef79f535a76f"
      unitRef="usd">-43956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc8a876bb2c64e86b657b3bae578a201_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTEtMS0xLTkyNDc5_2d977471-698b-4677-ad60-8811ebe89cad"
      unitRef="usd">-1073000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTMtMS0xLTkyNDc5_c632efc6-3c69-4d85-abfb-15b3ad08f958"
      unitRef="usd">24275000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7857fdefd6924d738c822610d6060c3a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTUtMS0xLTkyNDc5_346ba36f-c904-4f31-b830-d66de61a2797"
      unitRef="usd">32890000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i4251186fc1f74fa98118a5b683fb8145_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzExLTctMS0xLTkyNDc5_33297290-2575-421c-804f-6161fcfd2c06"
      unitRef="usd">-9688000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54e1d03cd5a24c73bec632484549eb64_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTEtMS0xLTkyNDc5_6231a42b-b92f-4550-b85a-51df46aeb4ae"
      unitRef="usd">-12291000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTMtMS0xLTkyNDc5_083fb918-89f3-468d-9bd1-7f944a1ac1ba"
      unitRef="usd">16515000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0b41a936b3e440ee98547f92b140c729_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTUtMS0xLTkyNDc5_c73d6006-c31d-472d-bf77-5835b39ae7c8"
      unitRef="usd">6545000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i30c3f78cf0b34a1f9678363ed5f4ecd9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzEzLTctMS0xLTkyNDc5_3b3ed301-112e-4b87-b8ef-88eacc54d865"
      unitRef="usd">-2321000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc909923f63a42e9a92c1575f351c160_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTEtMS0xLTkyNDc5_9a98a191-66ef-45d5-b120-0321c5c342ee"
      unitRef="usd">-107133000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i571a678056af4243869d6bf87a39cca5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTMtMS0xLTkyNDc5_94a4df71-be87-483b-883b-0b87d1582c1b"
      unitRef="usd">68192000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i571a678056af4243869d6bf87a39cca5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTUtMS0xLTkyNDc5_88025168-87d8-49cd-95d6-5a437fd7838d"
      unitRef="usd">17024000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i1b747e04cef446c8bbd192b91223c454_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo5OTE0NzIyMzBmODQ0MjYzYjE0MzQzYzE1YjhlZGI0Ni90YWJsZXJhbmdlOjk5MTQ3MjIzMGY4NDQyNjNiMTQzNDNjMTViOGVkYjQ2XzE0LTctMS0xLTkyNDc5_df47dc6f-ca79-4fe5-b4dd-d55753423ce4"
      unitRef="usd">-55965000</us-gaap:StockholdersEquity>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i38353e1fdf1749048a5b705812d03489_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5MjQ_cd2aff41-174e-4095-a36d-63a5d7a0b1b6"
      unitRef="usd">11100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4ca92d0c0999415284527156e8006bce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5Mjg_7c145246-efc6-4918-8904-f109312d7389"
      unitRef="usd">23800000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iae1c431831cb4456bf494fd17d5e9cbf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5NDY_645fadeb-6cd2-4727-bd81-1b46d1edbc9e"
      unitRef="usd">8400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i8909f47c11f94a13b5b07c5424d9e86b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODY5NDA_8dd5a536-447e-449c-91ba-3e83ed58872b"
      unitRef="usd">9100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i222c2a2c9bb74ffb8a6ede3f0fe2b07f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODUwNDE_8ed1f5e3-1f41-4991-aa94-a1582f51723d"
      unitRef="usd">4500000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="iac2b519b9bef40ce86b32e60f3e0c395_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwODU5ODk_bc4f2e90-2214-4280-8e99-cc49cc29ea9f"
      unitRef="usd">11700000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9344740008a49528124058c2083bc1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTQ5MjQ_8c9d7a48-1bb2-4497-b568-863cb5cfabc7"
      unitRef="usd">4200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3d23ab70c34f4db5b5a839db493e3059_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTI0MDM_3e96b302-c7ee-4c5d-8f15-c5a6b261ec2b"
      unitRef="usd">7300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i46d3030c2e0049f8a3c5db01ea805895_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzI3NDg3NzkwOTY3ODA_9c01d0a4-f65f-482e-b844-f9ad7d994ea6"
      unitRef="usd">6400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90ZXh0cmVnaW9uOjgyY2ZmYjA1NWZlYzQ2ZjI5MDExMTRkMDI4NGMzZjgwXzQzOTgwNDY1Mzg2OTU_0e59dde6-a6e1-4484-ba86-d6386398afb3">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i1f18b3ff623a416ba0697a89389f4152_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzItNi0xLTEtMTQzNjU0_06fb7c31-4fdc-4db1-9e8d-1a1b36366d3e"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i191577736fc34ca8967de6fee9d82bed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzItOC0xLTEtMTQzNjU0_1485730e-c077-41bb-91ed-bd90756a6f5a"
      unitRef="usd">-174000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ife5b2da3f37e4fbcafc4fc5d9d3dde7d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzMtNi0xLTEtMTQzNjU0_ba15ab7d-0f1d-4ebc-a045-69b52be166a2"
      unitRef="usd">1258000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i647e1d0b571a474c98483e6c2526bb29_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzMtOC0xLTEtMTQzNjU0_1d5473c6-410e-48ed-9926-eb8b37cb4464"
      unitRef="usd">629000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzQtMi0xLTEtMTQ0MTgz_0a6a77b1-6782-43a9-b23c-f05b34a47f67"
      unitRef="usd">1258000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjMvZnJhZzo4MmNmZmIwNTVmZWM0NmYyOTAxMTE0ZDAyODRjM2Y4MC90YWJsZTo3ZmI5ZjJhMmExNGM0Y2E2YTdiODIwY2M4YTc2NWI5NS90YWJsZXJhbmdlOjdmYjlmMmEyYTE0YzRjYTZhN2I4MjBjYzhhNzY1Yjk1XzQtNC0xLTEtMTQ0MTk2_0b81810d-fa81-45fb-afbd-7fdc965896ba"
      unitRef="usd">455000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDI_e3fccd34-63eb-4ccc-bcb6-8f2e23601dbc">GOODWILL AND OTHER INTANGIBLE ASSETS &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment by either performing a qualitative evaluation or a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The qualitative evaluation is an assessment of factors including reporting unit specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of a reporting unit is less than its carrying amount, including goodwill. The Company may elect to bypass the qualitative assessment for its&#160;three&#160;reporting units and perform a quantitative test. The assumptions used in evaluating goodwill for impairment are subject to change and are tracked against historical results by management. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative test estimates the fair value of the three reporting units using a discounted cash flow model, which incorporates significant estimates and assumptions made by management which, by their nature, are characterized by uncertainty. Inputs used to fair value the Company's reporting units are considered inputs of the fair value hierarchy. For Level 3 measurements, significant increases or decreases in long-term growth rates or discount rates in isolation or in combination could result in a significantly lower or higher fair value measurement. The key assumptions impacting the valuation included the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The reporting unit's financial projections, which are based on management's assessment of regional and macroeconomic variables, industry trends and market opportunities, and the Company's strategic objectives and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The projected terminal value for the reporting unit, which represents the present value of projected cash flows beyond the last period in the discounted cash flow analysis. The terminal value reflects the Company's assumptions related to long-term growth rates and profitability, which are based on several factors, including local and macroeconomic variables, market opportunities, and future growth plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The discount rate used to measure the present value of the projected future cash flows is set using a weighted-average cost of capital method that considers market and industry data as well as the Company's specific risk factors that are likely to be considered by a market participant. The weighted-average cost of capital is the Company's estimate of the overall after-tax rate of return required by equity and debt holders of a business enterprise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company elected to perform a qualitative analysis for its three reporting units. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2022 and 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACell Acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of non-core traditional wound care business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SIA Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets with Indefinite Lives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests intangible assets with indefinite lives for impairment annually in the third quarter in accordance with ASC Topic 350. Additionally, the Company may perform interim tests if an event occurs or circumstances change that could potentially reduce the fair value of a indefinite lived intangible asset below its carrying amount. The Company tests for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors, including specific operating results as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair values of the intangible asset is less than its carrying amount. The Company may elect to bypass this qualitative evaluation and perform a quantitative test. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company elected to perform a qualitative analysis for its intangible asset with indefinite lives. The Company determined, after performing the qualitative analysis, that there was no evidence that it is more likely than not that the fair value was less that the carrying amounts, therefore, it was not necessary to perform a quantitative impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and other definite-lived intangible assets are tested periodically for impairment in accordance with ASC Topic 360 when events or changes in circumstances indicate that an asset's carrying value may not be recoverable. The impairment testing involves comparing the carrying amount of the asset or asset group to the forecasted undiscounted future cash flows. In the event the carrying value of the asset exceeds the undiscounted future cash flows, the carrying value is considered not recoverable and impairment exists. An impairment loss is measured as the excess of the asset's carrying value over its fair value, calculated using discounted future cash flows. The computed impairment loss is recognized in the period that the impairment occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense (including amounts reported in cost of product revenues) for the years ended December&#160;31, 2022, 2021 and 2020 was $78.3 million, $83.3 million and $74.5 million, respectively. &lt;/span&gt;&lt;/div&gt;Annual amortization expense is expected to approximate $82.3 million in 2023, $81.7 million in 2024, $81.7 million in 2025, $81.5 million in 2026, $79.6 million in 2027 and $551.6 million thereafter. Amortization of product technology based intangible assets totaled $64.4 million, $66.5 million and $46.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, and is presented by the Company within cost of goods sold.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzU0Nw_b2a7859b-d5fa-4bc0-9e53-17d29b8a2a6f"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzc5Mw_b2a7859b-d5fa-4bc0-9e53-17d29b8a2a6f"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzI1NTg_9ee74d57-5509-414b-a223-b52107cc7cc6"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDY_ac27199a-bc25-42e2-9097-5ece9c61350a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill in 2022 and 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACell Acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of non-core traditional wound care business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SIA Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ibfcd42c9d16743e891b05d6e22c839f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtMS0xLTEtOTI0Nzk_177f8557-7a1c-474b-aca4-fa24ac4ae06d"
      unitRef="usd">671975000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0fb11cdd18ef45a19a594c8b5a25ee96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtMy0xLTEtOTI0Nzk_bb4bb00f-fe7c-4686-96e2-3dcf581737ed"
      unitRef="usd">260392000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzEtNS0xLTEtOTI0Nzk_2b82b485-7f98-484c-856d-1eacf32a20b1"
      unitRef="usd">932367000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5a836c14502143549a1b9311fc3030f9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItMS0xLTEtOTI0Nzk_a77f793e-0505-49fc-82fe-f3066d122e61"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if97f621bb1334d50b0248002c7710d81_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItMy0xLTEtOTI0Nzk_adf4572d-03f2-40cb-ac1c-7bedd26a4132"
      unitRef="usd">94147000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i58764c27ca344070860ba269f3f79103_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzItNS0xLTEtOTI0Nzk_f8e83582-753e-4b50-9c4c-9bb5808c0766"
      unitRef="usd">94147000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtMS0xLTEtOTI0Nzk_acf22fc4-2b7d-4bf0-817e-dcd876eb2140"
      unitRef="usd">-8547000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtMy0xLTEtOTI0Nzk_14475828-5bba-4077-8bee-f22642b6d5bc"
      unitRef="usd">-4509000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzMtNS0xLTEtOTI0Nzk_b90d5169-474b-4afb-91cd-260808b5490c"
      unitRef="usd">-13056000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="id05ba75e955c4e129ebec3073ef3f592_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtMS0xLTEtOTI0Nzk_4e93b1c4-dc84-48d9-abb2-814dfd3210ea"
      unitRef="usd">663428000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i628a3e3f7d544ad2bc901d0888fe818d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtMy0xLTEtOTI0Nzk_6414c4f2-ed7c-47cb-b2f5-c5f1333835fc"
      unitRef="usd">350030000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzQtNS0xLTEtOTI0Nzk_ae49beea-e55d-44ad-9f0b-05382ad82021"
      unitRef="usd">1013458000</us-gaap:Goodwill>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtMS0xLTEtOTI0Nzk_b6b0c3a6-5fef-4335-aa24-025fd103b3c1"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtMy0xLTEtOTI0Nzk_f7fe5e5e-7653-4012-837e-b5b23ee9b8dd"
      unitRef="usd">5019000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzUtNS0xLTEtOTI0Nzk_3ed1a494-4142-4367-a1fa-a63913d2b8dd"
      unitRef="usd">5019000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id0755e5e4a8746c7a194eab90915121d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMS0xLTEtMTYwNjIw_05bccbca-7036-45d6-bf8d-69379c1e6844"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1c981ec865a242b8ae02ae0b9be850b1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMy0xLTEtMTYwNjI4_0963bb23-381c-40a5-b645-71ffb6e7abc8"
      unitRef="usd">41855000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i01193be6295c427585def8bb00fd4b04_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtNS0xLTEtMTY5MDE1_44ab3433-0dc9-4a2e-8b67-59443755a900"
      unitRef="usd">41855000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMS0xLTEtOTI0Nzk_5df77023-184b-4881-9dd5-c49f0bfb275f"
      unitRef="usd">-7209000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtMy0xLTEtOTI0Nzk_898b134e-36ec-4fd3-9c0e-a482459f5a9f"
      unitRef="usd">-4204000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzYtNS0xLTEtOTI0Nzk_ae04e19c-422b-43b6-b1c0-a7305e67a01a"
      unitRef="usd">-11413000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="icb26a3f7b9af4d3988640472b2a1e3d1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctMS0xLTEtOTI0Nzk_4d38bf6d-625b-47da-a225-7872f53475bb"
      unitRef="usd">656219000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36770afe37b9412b9efea6344f408b74_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctMy0xLTEtOTI0Nzk_67704099-6997-4003-9530-71977b056e52"
      unitRef="usd">382662000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo0NThiMmFlYmYzZDc0NzBjYmM2NjY1M2Q0Y2Y3YzYyMS90YWJsZXJhbmdlOjQ1OGIyYWViZjNkNzQ3MGNiYzY2NjUzZDRjZjdjNjIxXzctNS0xLTEtOTI0Nzk_f0670f25-083c-458e-8268-0370b0d5b863"
      unitRef="usd">1038881000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDE_b300ad54-87e5-4da4-ade4-d4f781bd1813">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzY1MDU_3a14f607-e747-4f81-8aea-3251c6971445">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company's identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-right:-9pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3dfa3992858f4edc84158ff91aeadc14_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplYzI0M2ZkMzBhNjg0OGE5OTA3ZDk3NDc1ZmY1MjQ0YV80_2ea55141-c99a-44ef-9ed8-2205f61fc531">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItMy0xLTEtOTI0Nzk_63ba5904-2fd3-4133-ab06-a564d69b9856"
      unitRef="usd">1204325000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItNS0xLTEtOTI0Nzk_2edc31e8-e135-4caf-adf6-4e79627941fe"
      unitRef="usd">370968000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ic9a87993b1f44b6f8cdc22d9773fe6fe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzItNy0xLTEtOTI0Nzk_3b460615-5ee2-4b1a-ae41-67830a02924e"
      unitRef="usd">833357000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iec4953d9327d47a9a45aba2fa3765106_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo0NzNkMjA5NWM3NGU0YTM3YTVlN2RhNWZmYmU3MmZhNV80_22b4c2ec-668c-404c-a1fb-316eeca3a041">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtMy0xLTEtOTI0Nzk_99f6de1a-bfd5-4cb5-809b-dd6b2bd630cd"
      unitRef="usd">193081000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtNS0xLTEtOTI0Nzk_de39be3d-80e8-4eed-852a-6d1aa7df3ade"
      unitRef="usd">144040000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ib098ed8c299c4a93a64d24447ab1a258_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzMtNy0xLTEtOTI0Nzk_f9a7807c-77c4-4ef1-a709-78527982df46"
      unitRef="usd">49041000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie1e4d6b7a79746f78154e10fd0d645de_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo3NDY0OTI0OTdmYTg0ZDY3YmMyNjQyYmY2NWRjZDAxYl80_be22b6f2-a572-43b2-9bd2-8053e2e83482">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtMy0xLTEtOTI0Nzk_63b19c48-5989-4761-895f-4c8108ea19c1"
      unitRef="usd">97265000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtNS0xLTEtOTI0Nzk_1b621072-9762-44c4-87f1-5bbc6cca2cf4"
      unitRef="usd">34674000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ic6736862e35f49389ee83853dd59ba02_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzQtNy0xLTEtOTI0Nzk_5bf80c48-8bde-47f0-a562-ccbd65b07b0c"
      unitRef="usd">62591000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i9b51dab47180467b905af4f67a4f4857_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzUtMy0xLTEtOTI0Nzk_159c975b-ffdf-4739-a1d3-353f402d312e"
      unitRef="usd">166693000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i9b51dab47180467b905af4f67a4f4857_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzUtNy0xLTEtOTI0Nzk_3c06ab58-fe0d-48d3-b1eb-85e37ab9f1b5"
      unitRef="usd">166693000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic67ed97c9d064b8186d3064a9654c6d7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjo1MWNhMjgzYmQxYzg0YjNkOWNjNTA3ZDljODBmY2VlNV80_d7052c80-f278-45e9-989f-ff0410d5c0d2">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtMy0xLTEtOTI0Nzk_a51f0de8-1d80-437e-ba8a-3e2a3d306384"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtNS0xLTEtOTI0Nzk_6568d676-e6ae-4479-acf6-a13d21c7fc22"
      unitRef="usd">17170000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i2198808263d444eca9e55e49e81d38c8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzYtNy0xLTEtOTI0Nzk_6677fd1d-193e-4add-a9f7-144a7aad2b28"
      unitRef="usd">13041000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icfbd5fe6a779428bb7005202e9c1d107_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjphZDQ2NjQ5MzU1NDI0MmRhOTI4MTI2YzRjN2NmNTc1ZF80_cbd27f3b-e931-4a86-94da-3c6af89d04f4">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctMy0xLTEtOTI0Nzk_e4b0a565-afd1-4a72-a6f8-ba3ca4c26ce7"
      unitRef="usd">5957000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctNS0xLTEtOTI0Nzk_41b9d61f-34bf-4f56-883a-5d08c6e0cc1c"
      unitRef="usd">4071000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i0dae331e508745f1a1fda5b78ee75393_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzctNy0xLTEtOTI0Nzk_9ed3e57c-7c3f-459c-9a82-3add4bfbb506"
      unitRef="usd">1886000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtMy0xLTEtOTI0Nzk_626621b2-90b4-4fe2-8cb3-1475b29c3dae"
      unitRef="usd">1697532000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtNS0xLTEtOTI0Nzk_287edbc8-22b9-42ef-88e7-104abafe6a25"
      unitRef="usd">570923000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTo3NWFhNGRkM2YwMmM0MjQzOGE1YTJiNzU3ZWMzMzY2NS90YWJsZXJhbmdlOjc1YWE0ZGQzZjAyYzQyNDM4YTVhMmI3NTdlYzMzNjY1XzgtNy0xLTEtOTI0Nzk_88d78458-05c4-45cd-9e95-61d451d85b55"
      unitRef="usd">1126609000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic53017849e8e46159900dda56c09d990_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowMDI3NjAwZDNlMDQ0NDkwYWYzNzlhNjcyNjExMjQyZF80_d236aded-63be-4623-bb0e-812fe520f76e">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItMy0xLTEtOTI0Nzk_a5ec423d-9108-4796-a665-adb5dd0de600"
      unitRef="usd">1132954000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItNS0xLTEtOTI0Nzk_d45bdbb5-c469-433a-988c-0eb84ab528f1"
      unitRef="usd">307013000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i494447b4058f4ec4a3160f8c2ddc1c2e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzItNy0xLTEtOTI0Nzk_d7b50ab0-a0cb-405c-b512-238a10eb9697"
      unitRef="usd">825941000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3ca2000819ce47d49042fde9d9662400_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjoyNTA3ZmUyODkwMWY0ZTFjOWQ1MDgzMWY4MzQ1Yjk5M180_5de5e909-6a57-4d38-88fd-5046e5cf05d1">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtMy0xLTEtOTI0Nzk_b57ca91b-959f-421d-849d-1f365183a3ba"
      unitRef="usd">211344000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtNS0xLTEtOTI0Nzk_bf84e73d-4327-461c-bb73-05c430cdc55b"
      unitRef="usd">142755000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ia4d0d47bdcb54ba89f0dfd04057e50d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzMtNy0xLTEtOTI0Nzk_0d72bbae-b6fb-47b6-aed5-268b19592f6f"
      unitRef="usd">68589000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6f88d140805d417980d8109777892eef_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjplNzEwODMxOTljNDM0NTM5OGI1YzJlZTczOWYzMDU1OV80_07166439-be32-43f9-8263-762173219419">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtMy0xLTEtOTI0Nzk_1630e60a-a271-48ad-bca1-22a316d8f242"
      unitRef="usd">98367000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtNS0xLTEtOTI0Nzk_3aeae328-2827-45c0-9dbd-6b8009d07cdc"
      unitRef="usd">31468000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i87d13a9a1b744ede92d09a5f4fa60167_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzQtNy0xLTEtOTI0Nzk_438b0982-7a87-4ad5-baea-2a9bfb8a31eb"
      unitRef="usd">66899000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="if39e9e07281e41ffb52e9314446776a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzUtMy0xLTEtOTI0Nzk_3ef70cd9-f696-44e9-a413-18afb2ad7a46"
      unitRef="usd">167758000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="if39e9e07281e41ffb52e9314446776a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzUtNy0xLTEtOTI0Nzk_5d7eab36-2b67-431a-93f7-f242043acb9f"
      unitRef="usd">167758000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8ee7ff54bebb490c9c43421a64840f58_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjphOWEwMWE4YmI2NDA0M2ZlOTczYWQzYThlYzFlMmI2Y180_07868625-0b6f-4a09-9484-efa8b5513214">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtMy0xLTEtOTI0Nzk_99448455-7bbb-4f93-8536-a1a4a1b3b57b"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtNS0xLTEtOTI0Nzk_cf5e4c2c-9fbe-404d-b25a-7ef0eae4d16f"
      unitRef="usd">16192000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i276d4167cfbc4c96b387801968c415a9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzYtNy0xLTEtOTI0Nzk_60dc0d5f-c4e2-4869-a20a-e33bf720c6e9"
      unitRef="usd">14019000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie593d306076f420796fbc6b3700364ae_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctMS0xLTEtOTI0NzkvdGV4dHJlZ2lvbjowYzQ1Y2Q2OWJhM2U0MDI3YTYxMzZmZTYxZGU1ZGEwOV80_340e144f-b034-42f8-9f42-3b549fbf8ecc">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctMy0xLTEtOTI0Nzk_c5e6a19b-9aa9-48ac-a2f0-2781cf8da01e"
      unitRef="usd">6258000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctNS0xLTEtOTI0Nzk_d1344fc9-2fdb-43e4-9a8c-0eb53072b84d"
      unitRef="usd">3891000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i9095fcf96f1141de8f39eb6f6817a7b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzctNy0xLTEtOTI0Nzk_c8033864-f296-46f1-9fd1-59c6e9a5dbb6"
      unitRef="usd">2367000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtMy0xLTEtOTI0Nzk_4b54e878-c48b-435c-9ede-deee7c475696"
      unitRef="usd">1646892000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtNS0xLTEtOTI0Nzk_0be46868-0d29-4560-98e9-26ff43d01cd7"
      unitRef="usd">501319000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90YWJsZTpiNTQzMmFiNzgxODA0YzI0ODMwYTY2YjdkZDQ1MDg3Zi90YWJsZXJhbmdlOmI1NDMyYWI3ODE4MDRjMjQ4MzBhNjZiN2RkNDUwODdmXzgtNy0xLTEtOTI0Nzk_b1a5ef4a-9bcb-4a58-b15b-3fb0bc1786e9"
      unitRef="usd">1145573000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwNTU_3a4cf3f2-786f-438e-ae83-705fb344ae6a"
      unitRef="usd">78300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwNjc_5ecf8e98-2ae0-4cc2-b65e-b5adea6cfae7"
      unitRef="usd">83300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYwODM_c7b65253-c6f9-40f9-ba14-1d18fda20a59"
      unitRef="usd">74500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYxNjY_cf99b830-5857-47ca-b388-74360808c084"
      unitRef="usd">82300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYxODU_51e8f988-bc2b-41b6-b426-d9fcda03a92f"
      unitRef="usd">81700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyMDQ_83ca46e9-7551-4af8-9c6d-e1422a6e52c5"
      unitRef="usd">81700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyMjM_18a9e875-58da-460c-a07f-a14060c24fa1"
      unitRef="usd">81500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyNDE_00091746-168e-4606-8f7b-b3d787a83fe8"
      unitRef="usd">79600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYyNjI_40a31735-ffa4-4fb6-aa4b-dc3e77a8b038"
      unitRef="usd">551600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzNTM_744ae938-64cc-4b6e-ae6e-e04491964ab2"
      unitRef="usd">64400000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzNjY_f97ed528-def7-4fe7-b614-ce44f33b041d"
      unitRef="usd">66500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjYvZnJhZzowNDUyZjM2NzgxZjA0MjYxOGI4OTU0MDY1YTcxYjg5Yi90ZXh0cmVnaW9uOjA0NTJmMzY3ODFmMDQyNjE4Yjg5NTQwNjVhNzFiODliXzYzODI_346162a0-442e-4658-997f-4d41d2567708"
      unitRef="usd">46700000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI5MTQ_46136095-2370-46ba-b013-88e45793a285">TREASURY STOCK&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2022 and 2021, there were 6.8 million and 4.9 million shares of treasury stock outstanding with a cost of $362.9 million and $234.4 million, respectively, at a weighted average cost per share of $53.18 and $47.86, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares of under the 2023 SAR.  The remaining repurchase transactions are expected to be completed in the first half of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 26 2022, the Board of Directors authorized the Company to repurchase up to $225&#160;million of the Company&#x2019;s common stock. The program allows the Company to repurchase its shares opportunistically from time to time. The repurchase authorization expires in December 2024. This stock repurchase authorization replaces the previous $225&#160;million stock repurchase authorization, of which $100&#160;million remained authorized at the time of its replacement, and which was otherwise set to expire on December 31, 2022. Purchases may be affected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On January 12, 2022, the Company entered into a $125&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;accelerated share repurchase ("2022 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ASR") and received 1.48&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;n March 24, 2022, the early exercise provision was exercised by the 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the year ended December 31, 2021, there were no repurchases of the Company&#x2019;s common stock as part of the share repurchase authorization.&lt;/span&gt;&lt;/div&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;Act&#x201d;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after.</us-gaap:TreasuryStockTextBlock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzgzNTk_e835ba53-284c-4f3c-bc33-f4aec2a87780"
      unitRef="shares">6800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzgzNjc_f0a195e0-9f97-4115-af49-c118e677b957"
      unitRef="shares">4900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg0MjQ_f49d2ede-47dd-443c-b36e-7121fb3bb7dd"
      unitRef="usd">362900000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg0NDE_536c1b11-2f2b-4bf0-810b-085e023e82c7"
      unitRef="usd">234400000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg1MDg_e932dbed-4367-4599-9f91-7b7c2dddfc1a"
      unitRef="usdPerShare">53.18</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzg1MTY_50ac14a6-eb7e-48cd-92f1-b6f823b400cb"
      unitRef="usdPerShare">47.86</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i5d60814ab4eb454190610b8946c1a931_I20230126"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzM4NDgyOTA3MDc3MDY_b897146b-de09-4a43-8aca-de398a23c42d"
      unitRef="usd">150000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6329920052fe4d068537fccf47a1bbd4_D20230126-20230126"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzQzOTgwNDY1MjMwNzU_6b2881ac-7961-4a42-9059-d33713287384"
      unitRef="shares">2100000</us-gaap:TreasuryStockSharesAcquired>
    <iart:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent
      contextRef="i5d60814ab4eb454190610b8946c1a931_I20230126"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzM4NDgyOTA3MDc3MTM_acb90fa0-1078-465a-8c2f-3d400f624dea"
      unitRef="number">0.80</iart:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzYxMTk_62d23fa6-3033-4080-8dbe-493251265a8e"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzYzNjA_ebe99df2-3f32-420e-81b9-b6e4b07f571a"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ie8d0e669cefa40dc80fd293f8b65128f_I20220426"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzY0MDU_c081b37d-32c9-4545-86f4-66fc451a1def"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i98b20187279a484aa7a8e9867ab6bc1c_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzEwMDY_5ddd0b6d-df47-4716-8149-5b70cbe69b0f"
      unitRef="usd">125000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <iart:AcceleratedShareRepurchasesSharesReceivedAtInception
      contextRef="i98b20187279a484aa7a8e9867ab6bc1c_I20220112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzEwNjQ_625ea4af-63d1-4337-8218-7ce18415b1ff"
      unitRef="shares">1480000</iart:AcceleratedShareRepurchasesSharesReceivedAtInception>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="ied552a010c034654a585ce6ab14a3070_D20220112-20220112"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzExNjA_c43c1a2b-ca4f-4e88-8793-d6a7b09170d9"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <iart:AcceleratedShareRepurchasesAdditionalSharesReceived
      contextRef="i464ce85ce14945ae9a2b1ea43a72e31f_I20220324"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNjkvZnJhZzpiNjBhYmEyMzQzY2Q0MjhjOGMzZDE5ODI5YTdlZDdkMy90ZXh0cmVnaW9uOmI2MGFiYTIzNDNjZDQyOGM4YzNkMTk4MjlhN2VkN2QzXzI3NDg3NzkwNzU2MjY_ae6ed58e-347a-4dde-930c-bb4a3e661680"
      unitRef="shares">460000</iart:AcceleratedShareRepurchasesAdditionalSharesReceived>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODE_b381330b-8044-4153-9660-ded9c84131ac">STOCK-BASED COMPENSATION&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EMPLOYEE STOCK PURCHASE PLAN &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan. Under the ESPP, a total of 3.0 million shares of common stock are reserved for issuance. These shares will be made available either from the Company&#x2019;s authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury stock. At December&#160;31, 2022, 2.0 million shares remain available for purchase under the ESPP. During the years ended December&#160;31, 2022, 2021 and 2020, the Company issued 20,780 shares, 16,948 shares and 18,284 shares under the ESPP for $1.1 million, $1.1 million and $1.1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EQUITY AWARD PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#x201c;2003 Plan&#x201d;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2010 and May 2017, the stockholders of the Company approved amendments to the 2003 Plan to increase by 3.5 million and 1.7 million, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 4.0 million shares under each of the 2000 Plan and the 2001 Plan, and 14.7 million shares under the 2003 Plan. The Plans permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options issued under the 2003 Plan became exercisable over specified periods, generally within four years from the date of grant for officers and employees, and within one year from the date of the grant for members of the Board of Directors. The awards generally expire eight years from the grant date for employees and from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMDY_22acb8fc-f2cb-409d-a273-b3b42a7cc9db"&gt;six&lt;/span&gt; to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIzMTI_d4b35179-5c95-4990-bea5-db80dcb363e7"&gt;ten&lt;/span&gt; for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in control provisions within their grant agreements. Restricted stock issued under the 2003 Plan vests ratably over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the 2003 Plan is subject to service and performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because it is a more flexible model that gives consideration to the impact of non-transferability and vesting provisions in valuing employee stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company&#x2019;s stock price. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. The Company accounts for forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$26,970&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $3.5 million, $5.0 million and $3.2 million in expense related to stock options during the years ended December 31, 2022, 2021 and 2020, respectively. The intrinsic value of options exercised for the years ended December&#160;31, 2022, 2021 and 2020 were $4.0 million, $11.1 million and $8.7 million, respectively. Cash received from option exercises and employee stock purchase plan was $5.5 million, $6.8 million and $5.2 million, for the years ended December 31, 2022, 2021 and 2020, respectively. The realized tax benefit from options exercised w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ere $0.6 mi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;llion, $2.2 million and $1.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, there was approximately $3.5 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Awards of Restricted Stock, Performance Stock and Contract Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $24.3 million, $31.2 million and $16.4 million in expense related to such awards during the years ended December 31, 2022, 2021 and 2020, respectively. The total fair market value of shares vested and released in 2022, 2021 and 2020 was $65.0 million, $15.7 million and $17.3 million, respectively. Vested awards include shares that have been fully earned but had not been delivered as of December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. As of December 31, 2022, there were 129,399 performance stock units ("PSU's") subject to vest and be released based on 2022 performance achievement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, there was approximately $29.7 million of total unrecognized compensation costs related to unvested restricted stock, performance stock and contract stock awards. These costs are expected to be recognized over a weighted-average period of approximately two years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2022, there were approximately 3.1 million shares available for grant under the 2003 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized into inventory, share based compensation costs of $0.6 million, $0.5 million and $0.4 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Such share-based compensation was recognized as cost of goods sold when related inventory was sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2NzI_52aa3dcd-1d2c-49e7-ba8d-994231071fb3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense - all related to employees and members of the Board of Directors - recognized under the authoritative guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated tax benefit related to stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect on net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia0ed2d9a6618423dae99a7e4ad4c7aeb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItMS0xLTEtOTI0Nzk_8ed119e4-c47d-467a-b974-ab73417c40a2"
      unitRef="usd">549000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8eda4859e2c842cbaa976aa69c8b4f69_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItMy0xLTEtOTI0Nzk_1c4b706f-a1ca-4495-935e-61190a33ae47"
      unitRef="usd">470000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica7dcd824511481a8120c2a8389e9b5f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzItNS0xLTEtOTI0Nzk_93f341bd-b7b6-4758-8ec9-40b309dab151"
      unitRef="usd">344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i93970819371a4bfba9e50d544252eb8d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtMS0xLTEtOTI0Nzk_247633f9-edbd-4ab9-a033-92043614a072"
      unitRef="usd">1739000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8bdad71e56824376a22f8e7d58483157_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtMy0xLTEtOTI0Nzk_9e633646-faeb-4759-9493-d4d67bd6a138"
      unitRef="usd">1644000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f325b8385ec4ba599bbdc2436aa2acf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzMtNS0xLTEtOTI0Nzk_24e3ea5c-8501-44cb-ac63-32f5e4c92c8d"
      unitRef="usd">1471000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3f0e807617a74e3082c8ecda0bf3a11a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtMS0xLTEtOTI0Nzk_c77f62fb-ba1b-43b2-bce5-7a16fad316e9"
      unitRef="usd">25437000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id8f1301d1e9142cfae4d502dac558f47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtMy0xLTEtOTI0Nzk_a169c2c3-cbb4-4546-81ce-c41ddc52ff45"
      unitRef="usd">34096000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibab792d7a62149d18dc8eb2dc3683f89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzQtNS0xLTEtOTI0Nzk_ce2e9c76-7142-4292-939e-b5881283e74d"
      unitRef="usd">17776000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtMS0xLTEtOTI0Nzk_739c6909-1c71-4635-8892-329c8582f60d"
      unitRef="usd">27725000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtMy0xLTEtOTI0Nzk_c6f75721-877d-4c66-a5b6-33d95b24b358"
      unitRef="usd">36210000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzUtNS0xLTEtOTI0Nzk_1632b614-a20c-4e8f-ae58-eba3bef99972"
      unitRef="usd">19591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtMS0xLTEtOTI0Nzk_e67f3bb3-5429-46cc-b1b2-4fb081e1f29a"
      unitRef="usd">10574000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtMy0xLTEtOTI0Nzk_8ee1b504-dbdb-419a-b999-4c03e62f03ab"
      unitRef="usd">13804000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzYtNS0xLTEtOTI0Nzk_f6af6577-c8da-4f6a-95e1-4c81719a2427"
      unitRef="usd">6221000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctMS0xLTEtOTI0Nzk_44d039dc-0e85-4178-97e3-144c1c3cbbc5"
      unitRef="usd">17151000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctMy0xLTEtOTI0Nzk_6585dbff-906e-4bb8-9653-7a60cadbc91c"
      unitRef="usd">22406000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyZWU1NGVlOTEyY2U0ZDU5YjM1Y2UwYTAxMzc1MWI0MC90YWJsZXJhbmdlOjJlZTU0ZWU5MTJjZTRkNTliMzVjZTBhMDEzNzUxYjQwXzctNS0xLTEtOTI0Nzk_131ea7e6-134e-418c-81d0-aba78a845c46"
      unitRef="usd">13370000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i60b6305eecf041d2b4ced862809aa250_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUxOQ_0dec7da4-9c44-4979-b698-e55e163e8577"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i60b6305eecf041d2b4ced862809aa250_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzc2NA_135918c4-bffe-4d28-a8a1-2a36491083a4"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzg3Nw_227a6fc3-3c30-495d-9256-8f5f4aac1664"
      unitRef="shares">20780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzg4OA_f2e40807-1d81-4449-ad10-960b5cf9db97"
      unitRef="shares">16948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkwMg_7336fe98-a004-44ea-b204-9778d3028312"
      unitRef="shares">18284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="iedbc2a5c85ac4e9b80aaee1cacbcd731_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkzMQ_8c85e648-16fe-4e66-9f5d-87b12039ca47"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="i84b11cc57ad046389d390fe9b7a4a45d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzkzNQ_6f19a946-f1ba-47c2-8ae1-b7657db003bf"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:EmployeeStockPurchasePlanProceeds
      contextRef="i8b0cf46bf86c4751824064d04b3e22db_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5Xzk0Mg_5b08640f-1d95-4e93-a436-ce76f8a7ed30"
      unitRef="usd">1100000</iart:EmployeeStockPurchasePlanProceeds>
    <iart:IncreaseInAuthorizedShares
      contextRef="ibc191873f1dc42bc9a919b9154c27144_D20100501-20100531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE1MTA_5aa6e96e-2f18-4943-865c-abf3566ebfdd"
      unitRef="shares">3500000</iart:IncreaseInAuthorizedShares>
    <iart:IncreaseInAuthorizedShares
      contextRef="i77e0bc249d794d8c923d4baa7345c70c_D20170501-20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE1MTc_01ee3256-e1f7-4cb4-bcea-d3442ba2d029"
      unitRef="shares">1700000</iart:IncreaseInAuthorizedShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i64ad94a13328414ba507646767f3d728_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2Mzc_a64bff00-3f4d-4906-aa15-c2af7a9ae54f"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id35f0fa4951b44e5a8286675c32d2ef8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2Mzc_ce117042-9d6a-494a-920a-2cc488d6a3de"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i503e4c87c0e04676afd28e1f2a991921_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzE2OTg_0e29ed95-dadf-4c9b-a63f-bb6d52cc6bfd"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIwOTg_2154b747-aa19-469d-8e32-52b009bd5b8f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id7872cc732b34351b799a3c73f66289e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIxNjM_9b0d57fd-2eca-4ca9-9f61-249d7a9cbafb">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="iab05a5cd30cb455e944ffa624620cb14_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzIyNjA_e79685ef-c833-4574-92fb-3f03d7b65908">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0f13c95eae224327a6df76189d019f93_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzI2MjA_64ae9572-4790-456e-bbe0-5326e6efa92c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzMyOTQ_ea1951c0-f1f3-4369-a191-217e2d29dc92"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODk_6103f4fc-1f54-4d39-9b0a-d0f1bbcd5fc7">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used in the calculation of fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of option from grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItMS0xLTEtOTI0Nzk_fbb67b91-164b-4cb5-9951-ead0e4d98e9b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItMy0xLTEtOTI0Nzk_2b5dc3bb-f99c-4c6b-a2a2-484867f5f50b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzItNS0xLTEtOTI0Nzk_cf906a46-217b-431c-9d4e-b373f92e8340"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtMS0xLTEtOTI0Nzk_815f70ee-afe1-4852-8d3d-fb6dce75c2c3"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtMy0xLTEtOTI0Nzk_49008547-d8a3-4d8a-a98a-815d78893ccb"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzMtNS0xLTEtOTI0Nzk_3ed9fcda-38f3-432b-b427-ba0fe3f4e894"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtMS0xLTEtOTI0Nzk_44c6e95c-34ce-4cce-8025-7340c12541ef"
      unitRef="number">0.0201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtMy0xLTEtOTI0Nzk_3dae282c-4462-419c-8fb5-18e6faa86c0c"
      unitRef="number">0.0130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzQtNS0xLTEtOTI0Nzk_2cfd45ee-de58-4e25-90a1-89c962f8ce35"
      unitRef="number">0.0089</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtMS0xLTEtOTI0Nzk_4fb48527-25d5-4339-9a69-c2ec023d328c">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtMy0xLTEtOTI0Nzk_2fd3213c-2cfc-4214-b0c0-290e93be05d7">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzUtNS0xLTEtOTI0Nzk_09bc5c12-7d31-4853-863e-0fa1319a4dfd">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtMS0xLTEtOTI0Nzk_afa011d0-427a-4477-94e2-2bcba5f0bb77"
      unitRef="usdPerShare">23.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtMy0xLTEtOTI0Nzk_e313cb29-230f-4cdb-b90a-ea3c67d49339"
      unitRef="usdPerShare">22.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZToyMTljMjc0YmRkNDA0ODVhOTc1YmVlNjY1NGZmOGJkYy90YWJsZXJhbmdlOjIxOWMyNzRiZGQ0MDQ4NWE5NzViZWU2NjU0ZmY4YmRjXzYtNS0xLTEtOTI0Nzk_9cf90f49-d964-444d-a803-9f04ab13ae6c"
      unitRef="usdPerShare">13.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2Njk_d1742d5e-8f24-4d10-b95b-3ecc692d5610">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stock option activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$26,970&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItMS0xLTEtOTI0Nzk_37d7aaf6-60ea-40b0-b87d-a3092284ab97"
      unitRef="shares">1225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItMy0xLTEtOTI0Nzk_e86af511-9409-4fb6-8309-086d983419fd"
      unitRef="usdPerShare">45.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItNS0xLTEtOTI0Nzk_ce2b2fd3-9500-4779-8c1f-0666d6996b1b">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzItNy0xLTEtOTI0Nzk_c61eea87-6cc3-4d10-a179-4c31e6c5e2cb"
      unitRef="usd">26970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzMtMS0xLTEtOTI0Nzk_53de0238-8725-469c-a3f5-54fe4fbd0930"
      unitRef="shares">146000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzMtMy0xLTEtOTI0Nzk_ec58023e-4bc8-4f91-8eef-515ee61644f1"
      unitRef="usdPerShare">65.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzQtMS0xLTEtOTI0Nzk_e1e8f595-8625-406a-9394-440905e459aa"
      unitRef="shares">155000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzQtMy0xLTEtOTI0Nzk_44cff3f7-9a6e-4384-aff6-d6e6fdc54d16"
      unitRef="usdPerShare">28.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzUtMS0xLTEtOTI0Nzk_39a69831-cfbe-42b2-bd8b-5a45a36e8243"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzUtMy0xLTEtOTI0Nzk_620f6fc6-87a8-4191-95ba-4efbc7e75f8d"
      unitRef="usdPerShare">50.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtMS0xLTEtOTI0Nzk_9e7bf0aa-03bc-4488-939b-14b9982d3fdd"
      unitRef="shares">1202000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtMy0xLTEtOTI0Nzk_24155ad3-d5fc-465c-8b95-7b99d2fdcb92"
      unitRef="usdPerShare">49.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtNS0xLTEtOTI0Nzk_ff0db64d-e9de-4d1f-92db-3ac11056f1d0">P4Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzYtNy0xLTEtOTI0Nzk_d7f752ba-df60-4ef8-8b38-8ed0a4828cf7"
      unitRef="usd">10772000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctMS0xLTEtOTI0Nzk_59e51054-4686-4301-9584-123807c5ccf9"
      unitRef="shares">871000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctMy0xLTEtOTI0Nzk_d6015831-2230-499a-8070-7ec96abe2bde"
      unitRef="usdPerShare">45.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctNS0xLTEtOTI0Nzk_977552a9-1947-4098-8806-b50faaafa593">P3Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTpkNmUwZjVlNGE1MzM0YTFmYTg4MDhmN2ExZjI5MzhkNC90YWJsZXJhbmdlOmQ2ZTBmNWU0YTUzMzRhMWZhODgwOGY3YTFmMjkzOGQ0XzctNy0xLTEtOTI0Nzk_f7b170b3-ff71-4119-9dbe-0b4687838484"
      unitRef="usd">9635000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwMzY_2e146eb8-a888-4411-9d49-4a1baee93a27"
      unitRef="usd">3500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia53b4883a913450d88e67a5f653ed435_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwNDg_34558e03-a9f1-4ceb-a6c0-c4bb1aa77569"
      unitRef="usd">5000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib49a4a983eba4b5d96ea47a0ec6b49e0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQwNjM_61a0bfee-8e5b-4169-bb1a-edcf2eb58946"
      unitRef="usd">3200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNTU_84aef276-2fe0-4d5d-9d44-18aa1e4d8bf8"
      unitRef="usd">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNTk_e328e4f0-ab67-4931-bb73-e10620890c06"
      unitRef="usd">11100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQyNjY_847bec0d-6a10-4182-a155-861b86c8476c"
      unitRef="usd">8700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNTc_8a73b7f8-8174-47f0-9678-b5c89fdb4cc5"
      unitRef="usd">5500000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNjE_0f225023-ac72-49ed-909a-e34657bead78"
      unitRef="usd">6800000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQzNjg_f96f15e3-884a-4961-a37d-c0fe6da6b548"
      unitRef="usd">5200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ0ODc_6f63b8bd-40b5-4024-a7fc-2d8d6d546f22"
      unitRef="usd">600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ0OTk_ea2143e7-0bcb-439e-90c4-4981fe0bb0c0"
      unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ1MTQ_cf0cc26a-179a-4905-be38-e17734219035"
      unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i4cc2c9acfb5b4ad28b78589745d7729b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ2MjE_ce75b161-34e3-4802-a45f-823a9eadb33c"
      unitRef="usd">3500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i53e3dae7a6de4020b5dd2d7b087a97f3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzQ3OTg_778a91c5-4c28-4a58-b531-458e5c61fc35">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY2ODA_b8754294-f8b4-46c1-a03c-eb69adf7afb8">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s awards of restricted stock, performance stock and contract stock for the year ended December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock and Contract  Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments for performance achievement related to award target&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i74db8baf10424ff7a6207881e5bae34e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtMS0xLTEtOTI0Nzk_64f93c29-d6d1-4af7-a390-8bd3a0d2b52f"
      unitRef="shares">422000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i74db8baf10424ff7a6207881e5bae34e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtMy0xLTEtOTI0Nzk_5332ab9a-3ac8-42f5-bc06-ecd66723f908"
      unitRef="usdPerShare">58.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id5acbf0ad9ad4e0e886eb359677690b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtNS0xLTEtOTI0Nzk_07741d10-68f2-43ca-b554-40bcae304afa"
      unitRef="shares">442000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id5acbf0ad9ad4e0e886eb359677690b2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzMtNy0xLTEtOTI0Nzk_f7ddbb51-7bfb-4131-a611-7fb4917f17c5"
      unitRef="usdPerShare">60.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtMS0xLTEtOTI0Nzk_219a9f47-394e-4690-9f6a-81676a58a252"
      unitRef="shares">334000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtMy0xLTEtOTI0Nzk_76ffea01-fc50-4f76-89ae-18b54e3decd6"
      unitRef="usdPerShare">62.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtNS0xLTEtOTI0Nzk_2044814e-f7d1-4795-a6e7-594ab33b9e7e"
      unitRef="shares">245000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzQtNy0xLTEtOTI0Nzk_6af91dfb-c78e-45d3-87e0-279b68405af9"
      unitRef="usdPerShare">62.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtMS0xLTEtOTI0Nzk_043c5184-e1c7-469f-bfa5-9d814af93d3e"
      unitRef="shares">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtMy0xLTEtOTI0Nzk_fa75d946-55f1-42ef-afe9-a1d0be5f2d85"
      unitRef="usdPerShare">0</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtNS0xLTEtOTI0Nzk_dad1c25a-5cce-42d5-8ee1-456562bc4164"
      unitRef="shares">18000</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares>
    <iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzUtNy0xLTEtOTI0Nzk_30042f91-2ac3-4b3f-afd2-6f8a24e63fdf"
      unitRef="usdPerShare">60.76</iart:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtMS0xLTEtOTI0Nzk_1123c1e8-f321-42fc-8c3d-45cf3e500af5"
      unitRef="shares">34000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtMy0xLTEtOTI0Nzk_288f2ed7-978f-4f8e-a0b2-952981abf8be"
      unitRef="usdPerShare">62.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtNS0xLTEtOTI0Nzk_0c1556a6-4d3d-48c4-868f-48b4af30c29b"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzYtNy0xLTEtOTI0Nzk_f49518b8-5c6a-40c9-8878-e30c3f0e6a26"
      unitRef="usdPerShare">59.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctMS0xLTEtOTI0Nzk_92315720-c79d-48bd-aa1f-e8446f5305d5"
      unitRef="shares">239000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i64fd1243429a4999919ccc2c50f73303_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctMy0xLTEtOTI0Nzk_81761a6a-718d-4dfe-905e-f5bc750925f2"
      unitRef="usdPerShare">58.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctNS0xLTEtOTI0Nzk_f1aac565-d6e5-4cc5-abb4-05fc39b3ce4c"
      unitRef="shares">252000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cbcab378c964999b4a56445fa8ec0de_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzctNy0xLTEtOTI0Nzk_0073122a-9bd0-4613-b54a-5ec08b05258a"
      unitRef="usdPerShare">59.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i57d1807080364f69937de4b97dd9811e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktMS0xLTEtOTI0Nzk_cfdd604f-784e-430f-bf5a-dd79ff007c11"
      unitRef="shares">483000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i57d1807080364f69937de4b97dd9811e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktMy0xLTEtOTI0Nzk_924f2476-f385-495d-8a0d-b6dfa34c5144"
      unitRef="usdPerShare">61.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ice8b178570f44cdba015566ce1f26691_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktNS0xLTEtOTI0Nzk_c39249da-307b-43cb-84af-27ca46412639"
      unitRef="shares">407000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ice8b178570f44cdba015566ce1f26691_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90YWJsZTo3MDkwMjM2MTljNmQ0MDJhODk3NDJiNTFiY2Y2YmVhMy90YWJsZXJhbmdlOjcwOTAyMzYxOWM2ZDQwMmE4OTc0MmI1MWJjZjZiZWEzXzktNy0xLTEtOTI0Nzk_a486add9-826e-4c61-b379-3b1b2b08ff93"
      unitRef="usdPerShare">62.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMjg_de00f004-387d-4d93-9843-8539fa938475"
      unitRef="usd">24300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMzI_6159a9c8-fec4-4fcd-b5e9-98eab0aaea81"
      unitRef="usd">31200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic98af93cab614bf7b1d6207967773298_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUwMzk_aaa81e05-fd73-4d64-b946-26b4b9494dd8"
      unitRef="usd">16400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMjA_66690872-a163-498f-97d0-8fbddf3e7944"
      unitRef="usd">65000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i97d19c5d6c2445dda8831e442cb63c61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMjQ_553ea0e8-ea62-489a-97e4-808eaa3f674c"
      unitRef="usd">15700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ic98af93cab614bf7b1d6207967773298_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzUyMzE_3c0f0b6f-13d1-4db4-b74d-be0ccf701b2a"
      unitRef="usd">17300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU1MjM_6a3242d6-ca39-4902-a0b4-cd2ea28f11d3">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ie59ae462fc304032a8aaaf9f74348093_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzEzNzQzODk1MzU1ODYx_43a6e2e1-76b0-4e63-83a9-2b6795b1571c"
      unitRef="shares">129399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6bd1ab005148412cb072897f89bca249_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU2NzQ_d6df3262-ffb2-4f35-9b29-e339b997bf2b"
      unitRef="usd">29700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6ed565a8d64944fd83d7c4b0f647499a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzU4OTE_4691f5b1-508e-4f39-ab18-60119f7912dc">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzYzNzY_35bbb5b7-46d1-4f6c-9eb1-3fbca525e8c3"
      unitRef="shares">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MDE_24c2613b-c3b8-4be1-8a39-f2c897b3a23a"
      unitRef="usd">600000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MDU_7d5ebd19-d472-4aaf-b70a-e02840bfe91a"
      unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzIvZnJhZzpjMjJmYjdjNzU1YmQ0YzAxYWJhNTZhZDI2ZGRhZjJkOS90ZXh0cmVnaW9uOmMyMmZiN2M3NTViZDRjMDFhYmE1NmFkMjZkZGFmMmQ5XzY1MTI_e7e55fa2-4360-4c3a-b40d-c1b65ae03dfc"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQzOTgwNDY1MTY1NDc_3a64a2c2-8b91-4220-b138-694088c6f269">RETIREMENT BENEFIT PLANS&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED BENEFIT PLANS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various defined benefit plans which covers certain employees in France, Japan, Germany and Switzerland. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2022 and 2021 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s discount rates are determined by considering current yield curves representing high quality, long-term fixed income instruments. The resulting discount rates are consistent with the duration of plan liabilities. In 2022 and 2021, the discount rates were prescribed as the current yield on corporate bonds with an average rating of AA or AAA of equivalent currency and term to the liabilities. The expected returns on plan assets represent the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rates of return, the Company considers returns of historical market data as well as actual returns on the plan assets. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assessment is determined using projections from external financial sources, long-term historical averages, actual returns by asset class and the various asset class allocations by market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2022 and 2021 and a reconciliation of the funded status at December&#160;31, 2022 and 2021, respectively (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,184&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38,053&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unfunded benefit obligations are included in other liabilities in the consolidated balance sheets at December&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the periods ended December&#160;31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company had a net gain of $7.4 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $7.0 million, respectively, recognized within accumulated other comprehensive loss that has not been recognized as a component of net periodic benefit cost. The gain recognized during the period ended December 31, 2021, is primarily attributed to a change in the discount rate used to estimate the projected benefit obligation for defined benefit plans which cover certain employees in Switzerland. The combined accumulated benefit obligations for the defined benefit plans was $46.4 million and $60.3 million as of December&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized gains and losses are amortized over the average remaining future service for each plan. For plans with no active employees, they are amortized over the average life expectancy. The amortization of gains and losses is determined by using a 10% corridor of the greater of the market value of assets or the accumulated benefit obligation. Total unamortized gains and losses in excess of the corridor are amortized over the average remaining future service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior service costs/benefits for the pension plans are amortized over the average remaining future service of plan participants at the time of the plan amendment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net plan assets of the pension plans are invested in common trusts. Common trusts are classified as Level 2 in fair value hierarchy. The fair value of common trusts is valued at net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk profile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The benefit plans in France and Germany had no assets at December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, no plan assets are expected to be returned to the Company in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, contributions expected to be paid to the plan in 2022 is $2.6 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFINED CONTRIBUTION PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various defined contribution savings plans that cover substantially all employees in the United States, Belgium, Canada, France, Japan, Netherlands, the U.K. and Puerto Rico. The Company matches a certain percentage of each employee&#x2019;s contributions as per the provisions of the plans. Total contributions by the Company to the plans were $9.8 million, $8.8 million and $6.7 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DEFERRED COMPENSATION PLAN&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in Other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets at December&#160;31, 2022 and 2021 was $4.7 million and $3.8 million. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNzA_c39be4d1-cac5-47d8-ab61-934137edabc1">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the years ended December&#160;31, 2022 and 2021 included the following (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net period benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_0039426f-1024-4b74-9d3e-89efe84ee360">Net periodic benefit costs</iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_79f19b47-7a39-4b30-a558-12b8f8472fd7">Net periodic benefit costs</iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_a504fa6c-2a64-4cd7-a115-25899f6c90ea">Net periodic benefit costs</iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_c5074043-33cb-4ee6-84d5-a68bcafc77cb">Net periodic benefit costs</iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzc2OTY1ODEzOTk4OTI_d11e431d-7a7e-48cc-905d-a22e1c3bb15b">Net periodic benefit costs</iart:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzItMS0xLTEtOTI0Nzk_007cd7ef-9d24-47ae-80b5-5c59909dbc17"
      unitRef="usd">2419000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzItMy0xLTEtOTI0Nzk_e78a7233-4002-456d-9df4-a37f0e3462c8"
      unitRef="usd">2741000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzMtMS0xLTEtOTI0Nzk_7b7c2e55-5703-4ae9-bf74-3c002d81ad1a"
      unitRef="usd">194000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzMtMy0xLTEtOTI0Nzk_8671263f-4d45-4cd2-a467-a2f3f41a6516"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzQtMS0xLTEtOTI0Nzk_607a1640-2af5-4508-ae5c-19574bf02e35"
      unitRef="usd">1381000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzQtMy0xLTEtOTI0Nzk_6a5cc9d3-75ed-4342-8d70-ea5f15344c35"
      unitRef="usd">893000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzUtMS0xLTEtOTI0Nzk_b9a30ca3-26d5-4ac3-b0f0-99d1d70d42db"
      unitRef="usd">-326000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzUtMy0xLTEtOTI0Nzk_37bc8b79-99e4-45ec-862f-c083c49c6cc5"
      unitRef="usd">-281000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzYtMS0xLTEtOTI0Nzk_bf466372-5f5e-4482-9141-12a4ef0113a4"
      unitRef="usd">-9000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzYtMy0xLTEtOTI0Nzk_1b74a160-ae6b-4179-973f-b9472b0f43f1"
      unitRef="usd">-186000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzctMS0xLTEtOTI0Nzk_88049e25-fc88-44f3-a9e0-cfba6be8289c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzctMy0xLTEtOTI0Nzk_70a39ec9-ee30-4394-aa44-80c4dbe9b472"
      unitRef="usd">-51000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzgtMS0xLTEtOTI0Nzk_9a5a5251-b0cf-476c-bff8-eef4ee2650f2"
      unitRef="usd">915000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTowZjFlMTk4YWYzNjk0NjdhOTZmM2FjYjBiNzIyNTJjMC90YWJsZXJhbmdlOjBmMWUxOThhZjM2OTQ2N2E5NmYzYWNiMGI3MjI1MmMwXzgtMy0xLTEtOTI0Nzk_571c5aca-8802-4c30-821c-1ecc6fb1a472"
      unitRef="usd">1904000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzOTk_8a3bf254-a05d-4afd-b253-84217eec6b04">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to develop net periodic pension benefit costs and the actuarial present values of projected pension benefit obligations for the years ended December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest crediting rate for cash balance plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzItMS0xLTEtOTI0Nzk_a0476850-e3cd-43cc-b76a-166ebb317381"
      unitRef="number">0.0244</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzItMy0xLTEtOTI0Nzk_bcdd79e3-6f61-4776-b304-f9139e64133f"
      unitRef="number">0.0037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzMtMS0xLTEtOTI0Nzk_f5b1580f-32bd-4fe9-8789-e7854e3354fc"
      unitRef="number">0.0361</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzMtMy0xLTEtOTI0Nzk_af741e24-22fd-4ed4-ac2c-66434e274071"
      unitRef="number">0.0359</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzQtMS0xLTEtOTI0Nzk_ace15890-85fa-4c22-81ac-0091d9bf0930"
      unitRef="number">0.0197</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzQtMy0xLTEtOTI0Nzk_282108f9-273b-472e-ae40-d12ade7dbbf0"
      unitRef="number">0.0210</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzUtMS0xLTEtOTI0Nzk_77e276da-19be-42a6-bcce-04526c6251ad"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo5YzlkYmMxODJkOGI0NTY0OGZiODkyYTFlNTJmM2YyYy90YWJsZXJhbmdlOjljOWRiYzE4MmQ4YjQ1NjQ4ZmI4OTJhMWU1MmYzZjJjXzUtMy0xLTEtOTI0Nzk_e0ceef51-8690-4aa3-bcb6-b02c00726585"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNjU_e9b4c5db-e2b2-4344-9c4f-236607fbb25b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December&#160;31, 2022 and 2021 and a reconciliation of the funded status at December&#160;31, 2022 and 2021, respectively (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,184&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change In Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at fair value, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan assets at fair value, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38,053&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzMtMS0xLTEtOTI0Nzk_34689bf2-1b17-4592-9424-84a2f75ea9e4"
      unitRef="usd">65184000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzMtMy0xLTEtOTI0Nzk_a288b316-c01c-45bf-8dfd-db1d66fa648b"
      unitRef="usd">72869000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzQtMS0xLTEtOTI0Nzk_baeee894-04e5-44f2-9ced-98cfe513c7e0"
      unitRef="usd">194000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzQtMy0xLTEtOTI0Nzk_496e035a-1626-4ed2-9623-d48c4372a45e"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzUtMS0xLTEtOTI0Nzk_646838d8-6d35-4c59-8956-e657053919c0"
      unitRef="usd">2419000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzUtMy0xLTEtOTI0Nzk_75c93fb8-bc50-46e2-9524-d85545f634eb"
      unitRef="usd">2741000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzYtMS0xLTEtOTI0Nzk_cd5f26f3-7bfc-4502-95a0-a1e2080150c7"
      unitRef="usd">14822000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzYtMy0xLTEtOTI0Nzk_468ec3ea-eaee-4b1d-a8b4-809c56596bec"
      unitRef="usd">5044000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzctMS0xLTEtOTI0Nzk_830bfaac-9b2c-4cb0-ba3c-58f7ea562588"
      unitRef="usd">-390000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzctMy0xLTEtOTI0Nzk_915f4bc4-012a-4ed3-a565-9998ab38bb64"
      unitRef="usd">-586000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzgtMS0xLTEtOTI0Nzk_5f8429ac-ed80-40ff-877e-3af1a1665e80"
      unitRef="usd">20000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzgtMy0xLTEtOTI0Nzk_5e80ddc3-27d5-4d32-8dba-02bf423b2fc3"
      unitRef="usd">655000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzktMS0xLTEtOTI0Nzk_8c90b748-e0a8-4a68-8e5b-a43c31d0d5ed"
      unitRef="usd">999000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzktMy0xLTEtOTI0Nzk_0ef2f018-7cf9-4f46-8703-88776fec4cbe"
      unitRef="usd">917000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEwLTEtMS0xLTkyNDc5_df335605-73e7-4213-85f2-f4ccf382ce74"
      unitRef="usd">391000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <iart:DefinedBenefitPlanBenefitObligationPremiumsPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEwLTMtMS0xLTkyNDc5_898f6b3f-0967-4d4a-bf81-e7940c60068c"
      unitRef="usd">373000</iart:DefinedBenefitPlanBenefitObligationPremiumsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzExLTEtMS0xLTkyNDc5_b82476a0-22ed-46d7-a8e9-22240d63b86d"
      unitRef="usd">999000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzExLTMtMS0xLTkyNDc5_589acdef-266f-4469-add1-52e9c8df68c2"
      unitRef="usd">2128000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEzLTEtMS0xLTkyNDc5_8941e520-e5bc-4336-ba9a-5d375c4cbb13"
      unitRef="usd">1810000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzEzLTMtMS0xLTkyNDc5_e370a62a-b8b5-48a2-a29a-ec6a6df754b6"
      unitRef="usd">2657000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE0LTEtMS0xLTkyNDc5_4d711ce3-d14f-4c0f-a451-97de48c315d7"
      unitRef="usd">50364000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE0LTMtMS0xLTkyNDc5_38ac2dd3-d72f-4fa6-8ec9-d559a0f5ef13"
      unitRef="usd">65184000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE5LTEtMS0xLTkyNDc5_402357b3-2cfe-4a31-bf92-251d1ed41c1a"
      unitRef="usd">39914000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzE5LTMtMS0xLTkyNDc5_0f206a7d-085c-46b4-a550-b65b2354db4c"
      unitRef="usd">37825000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIwLTEtMS0xLTkyNDc5_290bf615-c0d6-4fab-853d-3e2a83bbd9c7"
      unitRef="usd">-2863000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIwLTMtMS0xLTkyNDc5_b72599aa-27d8-4cc5-86dd-87b3583a6f21"
      unitRef="usd">3371000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIxLTEtMS0xLTkyNDc5_1b9d0d0a-0296-4f25-8892-4a54e7d0498d"
      unitRef="usd">2356000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIxLTMtMS0xLTkyNDc5_0c4c7bf0-bb70-4367-a9ed-b5f258ec3465"
      unitRef="usd">2254000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIyLTEtMS0xLTkyNDc5_32c419c5-2835-4a96-9d71-dfb0b9894b22"
      unitRef="usd">999000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIyLTMtMS0xLTkyNDc5_c87dbec0-024d-410a-a9b3-fb89eb0a2bff"
      unitRef="usd">917000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIzLTEtMS0xLTkyNDc5_2fafac3d-53e6-4c9d-a329-5b864bbbd52a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzIzLTMtMS0xLTkyNDc5_1fb896e0-a1f2-4109-8780-050d313deea4"
      unitRef="usd">633000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI0LTEtMS0xLTkyNDc5_31246880-2461-4479-bf0d-b6dd86e33a9a"
      unitRef="usd">998000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI0LTMtMS0xLTkyNDc5_09c375ca-c315-49b1-96c8-813d89365148"
      unitRef="usd">2128000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI1LTEtMS0xLTkyNDc5_993fa925-f6f1-4a9e-88ea-98b51ef26f14"
      unitRef="usd">391000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <iart:DefinedBenefitPlanPlanAssetsPremiumsPaid
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI1LTMtMS0xLTkyNDc5_cd01e95b-dc00-425f-bcbd-aa3764e43a50"
      unitRef="usd">373000</iart:DefinedBenefitPlanPlanAssetsPremiumsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI2LTEtMS0xLTkyNDc5_129d9bd9-f71f-4d9f-bf90-be9e7df126d7"
      unitRef="usd">-964000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI2LTMtMS0xLTkyNDc5_b600aef3-69a7-405f-b5ad-e38a1b65d05a"
      unitRef="usd">-1319000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI3LTEtMS0xLTkyNDc5_deb446c7-6008-4b9e-9451-7de072c2c06d"
      unitRef="usd">38053000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTpkN2I4MDA3MjlkZDM0NDMwOWNmODM0YmEwYzI4NWMxMS90YWJsZXJhbmdlOmQ3YjgwMDcyOWRkMzQ0MzA5Y2Y4MzRiYTBjMjg1YzExXzI3LTMtMS0xLTkyNDc5_e8e4183f-65e1-4367-a3cc-144bb33de578"
      unitRef="usd">39914000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNjg_5edaafd8-5caa-405e-8fd6-370cb093ba42">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation Of Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzMtMS0xLTEtOTI0Nzk_fe1a8c5b-fbf7-46a5-afb2-d19aca510221"
      unitRef="usd">38053000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzMtMy0xLTEtOTI0Nzk_5cce93fd-2a28-4089-b4e5-ad331e578524"
      unitRef="usd">39914000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzQtMS0xLTEtOTI0Nzk_bd92519d-323e-49f1-bd89-20afb11da140"
      unitRef="usd">50364000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzQtMy0xLTEtOTI0Nzk_31044401-e051-49f4-8425-60c3cc6f25e9"
      unitRef="usd">65184000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzUtMS0xLTEtOTI0Nzk_46b44783-d61b-4899-bace-f7868476ec66"
      unitRef="usd">-12311000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo1YjI4NGY5YjUzNmQ0NGI0OGU2ZWE4NmJmNTc0ODdkZS90YWJsZXJhbmdlOjViMjg0ZjliNTM2ZDQ0YjQ4ZTZlYTg2YmY1NzQ4N2RlXzUtMy0xLTEtOTI0Nzk_654cbfc9-090a-4fe2-af8e-e2f11d709553"
      unitRef="usd">-25270000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzIwNzc_839ae370-050a-4cc5-ab52-234fbdefa4e1"
      unitRef="usd">7400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzIwODQ_da7ea438-4404-4f98-bcf7-a9532aee7637"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI1NTI_21ac9736-d6ee-43ab-8abb-ba42cde84991"
      unitRef="usd">46400000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI1NTk_d5756d39-e204-4f06-afbc-a24955951cb7"
      unitRef="usd">60300000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i418f7c9941e041f4853468578a5ef6fb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM3ODM_00158c15-c8fa-4b80-89f8-c3a4ffbfa91f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1cab4ce05dd94d62b94dadb5d8e736fe_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM3ODM_b4b0ade9-fa6b-4e78-a210-280a06ffe8be"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzM4MTE_e648b04c-759c-4f07-b472-e080108a29c9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUzNzY_4f393323-ee99-4198-b252-0dc1e1b66464">&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is the summary of expected future benefit payments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Next five years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzItMS0xLTEtOTI0Nzk_6a93dd24-9b34-41bd-84a4-8705a17591b7"
      unitRef="usd">2211000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzMtMS0xLTEtOTI0Nzk_a72f67a7-b305-48ba-a44f-938fae5d8811"
      unitRef="usd">2045000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzQtMS0xLTEtOTI0Nzk_336fbf31-a3f5-4ae1-9ceb-d5592c6cd733"
      unitRef="usd">2050000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzUtMS0xLTEtOTI0Nzk_9bf144b1-f309-4010-a797-d1c4213c64f9"
      unitRef="usd">1929000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzYtMS0xLTEtOTI0Nzk_7f265b92-968a-40df-932d-6d26a3ffd15b"
      unitRef="usd">1868000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90YWJsZTo2NzQzYWI5NWZhMzc0OWU2ODU2ZmE1ZDg2YWY2ZDlkNC90YWJsZXJhbmdlOjY3NDNhYjk1ZmEzNzQ5ZTY4NTZmYTVkODZhZjZkOWQ0XzctMS0xLTEtOTI0Nzk_0f8b38b4-6079-470e-928b-3ba88b165e72"
      unitRef="usd">11068000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQwNTI_80fc9bba-efcd-47b4-af24-65b6c36ec93e"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NDQ_0777716b-3a82-41d9-ba49-753fe9a51a9a"
      unitRef="usd">9800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NDg_b22d15b5-7764-4d78-86b0-e06194b5f378"
      unitRef="usd">8800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ0NTU_4f4ae46f-be84-4a80-95d8-5ba09ad4189e"
      unitRef="usd">6700000</us-gaap:DefinedContributionPlanCostRecognized>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ2NzI_30085813-792b-461e-a262-1ade20d61089"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="i3711da8cd1f54ba78fabd2748e3f8cd6_D20190501-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzQ3MDY_fb0a5d60-d7e1-4944-a6b9-88ec453c65e9"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzUyNDg_d74fd47f-f1bf-429e-a5d8-6da36768803c"
      unitRef="usd">4700000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzUvZnJhZzo4MmIzYzQyOWI3YmU0NTBhOWNlNWRjNjVhMjhmMjliZS90ZXh0cmVnaW9uOjgyYjNjNDI5YjdiZTQ1MGE5Y2U1ZGM2NWEyOGYyOWJlXzI3NDg3NzkwNzQ4Nzk_34cf82a1-3d58-47ce-b6d5-49cef8cfd1a7"
      unitRef="usd">3800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NTA_73aa0884-d056-4e96-a408-ccf69ed8bb14">LEASES AND RELATED PARTY LEASES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of December&#160;31, 2022. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the ROU assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expense for the year ended December&#160;31, 2022 and 2021, was $22.6 million and $20.3 million, respectively, which includes $0.3 million, in related party operating lease expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no future minimum lease payments under finance leases at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose stockholders are trusts, whose beneficiaries include family members of the Company&#x2019;s principal stockholder and former director. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <iart:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzUxMw_e5ed62ce-a139-4e05-9fe7-d8558883a0f5"
      unitRef="renewal_option">1</iart:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:OperatingLeaseExpense
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEyNzA_44dcf7ae-702a-494d-9b7b-41ff12857b0e"
      unitRef="usd">22600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEyNzc_541671e0-a93a-4232-8c68-4998795b4075"
      unitRef="usd">20300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i63561c0bbfd64fc0bdb211203c2b0c9f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEzMTA_cbd01b44-be2e-4e37-aeed-13ed497a5b6a"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzEzMTA_ded07b0f-eba4-4016-b5a3-3bbf09d2c046"
      unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <iart:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzQ_1c4c2226-049f-4b85-a7d8-50de740bc907">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzMtNS0xLTEtOTI0Nzk_e4d80982-954d-4087-8a3e-82d2344eec8f"
      unitRef="usd">148284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzMtNy0xLTEtOTI0Nzk_b76ded14-e22a-466e-977b-a6c8f33b14cc"
      unitRef="usd">84543000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzUtNS0xLTEtOTI0Nzk_e3d4ac1e-62ff-46b0-abb0-d5dbf0ddb983"
      unitRef="usd">14624000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzUtNy0xLTEtOTI0Nzk_03ea7c95-f635-4ca2-b305-92eece5eb24c"
      unitRef="usd">14775000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzYtNS0xLTEtOTI0Nzk_377ec584-877c-412d-ad04-6d18c6f0919f"
      unitRef="usd">157420000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzYtNy0xLTEtOTI0Nzk_950bb7a9-107d-42f6-a39e-222abc16b756"
      unitRef="usd">90329000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzctNS0xLTEtOTI0Nzk_95d5524b-2133-454f-8d51-9a6bef596ded"
      unitRef="usd">172044000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzctNy0xLTEtOTI0Nzk_4eb88954-7734-4367-a425-d505c70b8226"
      unitRef="usd">105104000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4686279af17c417cbe3854bacf4ca2d8_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzExLTUtMS0xLTkyNDc5_ede12fa1-acae-4955-9dc7-d4876123c34f">P16Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4d95969939c540bca05d2319452bd5fc_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzExLTctMS0xLTkyNDc5_0ca21b63-e57b-4866-b816-e030f19e8f90">P10Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c5eeedd89d64492bde19c2d733af117_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzEyLTUtMS0xLTkyNDc5_56c9b3e2-05c2-4d3f-9759-21f0c01c6422">P2Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia15d057605944eca816fd58aedd828b7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzEyLTctMS0xLTkyNDc5_54dd2576-5bc8-44f6-a113-d300578e693b">P2Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4686279af17c417cbe3854bacf4ca2d8_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE1LTUtMS0xLTkyNDc5_42b952e4-2c69-46f3-be7e-bd9e21aead9c"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4d95969939c540bca05d2319452bd5fc_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE1LTctMS0xLTkyNDc5_5a880c87-e12f-4b13-a04b-66aebee3207c"
      unitRef="number">0.051</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c5eeedd89d64492bde19c2d733af117_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE2LTUtMS0xLTkyNDc5_d530c846-1ca0-4edd-870e-c9284a9761ad"
      unitRef="number">0.027</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia15d057605944eca816fd58aedd828b7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZToxMTg3MTQ2NmUzNTg0MzYyOTUxNWQ2OTA0NGQyOWE1Mi90YWJsZXJhbmdlOjExODcxNDY2ZTM1ODQzNjI5NTE1ZDY5MDQ0ZDI5YTUyXzE2LTctMS0xLTkyNDc5_0ba05f9c-6414-4305-8cdf-8ff483523dc4"
      unitRef="number">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <iart:CashFlowLesseeTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NDI_d8d4a338-f9a9-4dfb-b390-fdd3dc050a77">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:CashFlowLesseeTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzMtMS0xLTEtOTI0Nzk_29ba623b-fd7d-4e81-a29d-4274aab00b7a"
      unitRef="usd">17442000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzMtMy0xLTEtOTI0Nzk_438197a7-eb1c-4db0-9a60-22b787a682a3"
      unitRef="usd">15077000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzYtMS0xLTEtOTI0Nzk_43694ae1-104c-4330-8a6a-4ded0d74d030"
      unitRef="usd">72169000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTo5YTZhYTRhMDk1MWI0NmEwYTUyZDIyZGFlY2M5OWEzZS90YWJsZXJhbmdlOjlhNmFhNGEwOTUxYjQ2YTBhNTJkMjJkYWVjYzk5YTNlXzYtMy0xLTEtOTI0Nzk_2178bce3-770b-4402-9abb-1845334611ca"
      unitRef="usd">12610000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzE_2390b43b-1d35-4b6f-b5ea-0e5d7f21450b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItMS0xLTEtOTI0Nzk_9fc22e2c-338c-4999-9a60-a699cb97c1fb"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItMy0xLTEtOTI0Nzk_86b73017-d7ff-4863-a12c-420497c353b3"
      unitRef="usd">20024000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzItNS0xLTEtOTI0Nzk_de5b36d5-3ba7-448d-a0df-7352d46d1f89"
      unitRef="usd">20320000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtMS0xLTEtOTI0Nzk_8adb83e2-e841-4483-ae2f-5c222aba7bb4"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtMy0xLTEtOTI0Nzk_48757160-b492-4d99-9985-b71b5440c6d7"
      unitRef="usd">20869000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzMtNS0xLTEtOTI0Nzk_312b3e6e-aed4-499d-b4f2-b306050a173a"
      unitRef="usd">21165000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtMS0xLTEtOTI0Nzk_5cfd28a0-7150-4166-b602-23a26253b06e"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtMy0xLTEtOTI0Nzk_100271a3-e3a9-4455-9206-51435e118b86"
      unitRef="usd">19198000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzQtNS0xLTEtOTI0Nzk_b5539482-1be0-472d-b1cb-e772d05c5536"
      unitRef="usd">19494000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtMS0xLTEtOTI0Nzk_8f866a5f-9a21-4b16-8a61-ab8d204930b7"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtMy0xLTEtOTI0Nzk_87005102-379d-4dd7-bd6a-517eb90f6fe2"
      unitRef="usd">16830000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzUtNS0xLTEtOTI0Nzk_23123750-7713-4f30-ace9-e46ad01fa8ca"
      unitRef="usd">17126000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtMS0xLTEtOTI0Nzk_47e64634-2a22-42be-bdbe-44cc922574b6"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtMy0xLTEtOTI0Nzk_80fd1154-d5b8-4448-8422-3a842ecdfbc6"
      unitRef="usd">15886000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzYtNS0xLTEtOTI0Nzk_5d2798e7-949f-4ff0-8f86-771a72e9eb16"
      unitRef="usd">16182000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctMS0xLTEtOTI0Nzk_70ac5a1c-f177-449c-b496-ce2218a52f9e"
      unitRef="usd">542000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctMy0xLTEtOTI0Nzk_efa6df2a-987f-44ad-bdf2-621c91497dba"
      unitRef="usd">164622000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzctNS0xLTEtOTI0Nzk_7d802338-068f-4409-8afd-d4a9a2909a63"
      unitRef="usd">165164000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="idfe81ea28a254d779986ec9672045e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtMS0xLTEtOTI0Nzk_4670d2bb-cd68-4843-b78c-07ec89f168d3"
      unitRef="usd">2022000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="if9fd716a767d4b339ab1295c5bb147d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtMy0xLTEtOTI0Nzk_87582c2b-041a-4c33-a550-6a872ddeeb13"
      unitRef="usd">257429000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzgtNS0xLTEtOTI0Nzk_9cade15d-6513-4194-bd8f-69863fb24daf"
      unitRef="usd">259451000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzktNS0xLTEtOTI0Nzk_5b58f30e-bdaf-4f61-af58-a75ae01a83a4"
      unitRef="usd">87407000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzEwLTUtMS0xLTkyNDc5_288bb6a1-2c30-49b2-b96a-5451961c7c6b"
      unitRef="usd">172044000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzExLTUtMS0xLTkyNDc5_e3d4ac1e-62ff-46b0-abb0-d5dbf0ddb983"
      unitRef="usd">14624000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90YWJsZTpkNzEwZDg3NTNjOWQ0NDQxYmFmNWUyNWYyYjY1ZDc4MS90YWJsZXJhbmdlOmQ3MTBkODc1M2M5ZDQ0NDFiYWY1ZTI1ZjJiNjVkNzgxXzEyLTUtMS0xLTkyNDc5_377ec584-877c-412d-ad04-6d18c6f0919f"
      unitRef="usd">157420000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzE2MDg_817bfc2f-92d6-459c-b461-cdd8a17adf2e"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector
      contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzE3OTk_b8594fbe-bd7a-4bfc-9052-3e30a990046a"
      unitRef="number">0.50</iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector>
    <iart:AnnualRateOfLeaseAgreement
      contextRef="i7fd4d3a5bf684370a382a52eb9c1a4f4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIwNjI_f9e2d292-0740-4d16-b31b-e16a65511c66"
      unitRef="usd">300000</iart:AnnualRateOfLeaseAgreement>
    <iart:OptionToExtendLeaseYears
      contextRef="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIxMjM_2f4a4bf3-2337-4e7d-8362-9e297e8fd6a7">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="i442037233fa54c54bbcb0545bad3bea4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0MzM_0312eb3f-58ba-4629-9a27-9dfa95e50131">November 1, 2029 through October 31, 2034</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <iart:OptionToExtendLeaseYears
      contextRef="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzIyOTQ_85a2a03a-e765-4191-9402-d88b6e3a1def">P5Y</iart:OptionToExtendLeaseYears>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="i669eeaab3af8440eb7838bb3af550be0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xNzgvZnJhZzpiY2FjZmJjOTNjOWY0ODZhOGFmN2MyZmVkYTllZjg0YS90ZXh0cmVnaW9uOmJjYWNmYmM5M2M5ZjQ4NmE4YWY3YzJmZWRhOWVmODRhXzI0NDk_0bc7c4d0-bfa9-40d1-8e82-03bbd184f3fc">November 1, 2034 through October 31, 2039</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MTY_40b07a79-77c4-4ac5-8582-92d85bb7bd4a">INCOME TAXES &lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Gain from sale of business - book to tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our effective tax rate was 15.6% and 21.2% of income before income taxes for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. In 2022, the Company&#x2019;s lower effective tax rate was driven by a $5.1&#160;million income tax benefit related to stock compensation and a $2.4&#160;million income tax benefit related to the filing of amended federal and state returns for prior years. In 2021, the Company's higher effective tax rate was driven in part by an $8.5&#160;million income tax expense for nondeductible goodwill related to the sale of the Extremity Orthopedics business, offset by a $3.1&#160;million income tax benefit related to excess tax benefits from stock compensation. In 2020, the Company&#x2019;s lower worldwide effective tax rate was primarily driven by an $59.2&#160;million income tax benefit on an intra-entity transfer of certain intellectual property, substantially completed during the fourth quarter in 2020. Excluding this transaction, the effective worldwide tax rate for 2020 was 20.2%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2020, the Company completed an intra-entity transfer of certain intellectual property rights to one of its subsidiaries in Switzerland. While the transfer did not result in a taxable gain, the Company&#x2019;s Swiss subsidiary received a step-up in tax basis based on the fair value of the transferred intellectual property rights. The Company determined the fair value using a discounted cash flow model based on expectations of revenue growth rates, royalty rates, discount rates, and useful lives of the intellectual property. The Co&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;mpany recorded a $59.2&#160;million deferred tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in Switzerland related to the amortizable tax basis in the transferred intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2022, the Company&#x2019;s foreign operations generated a $0.4&#160;million increase in income tax expense when compared to the same period in 2021, because of geographic and business mix of taxable earnings and losses, among other factors.  The 2022 foreign effective tax rate is 15.9%, compared to 15.2% in 2021.  The Company&#x2019;s foreign tax rate is primarily based upon statutory rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2021, the Company&#x2019;s foreign operations generated a $63.6&#160;million increase in income tax expense when compared to the same period in 2020, because of the intra-entity transfer of certain intellectual property in 2020, geographic and business mix of taxable earnings and losses, among other factors. The 2021 foreign effective tax rate is 15.2%, compared to (57.1)% in 2020. The Company&#x2019;s foreign tax rate is primarily based upon statutory rates and is also impacted by the intra-entity transfer of certain intellectual property as described above for 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate.  Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;Act&#x201d;) was signed into law, the company does not expect the law to have a material impact on the company&#x2019;s effective tax rate. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing (BEPS) project begun by the Organization for Economic Cooperation and Development (OECD).  The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate.  Such changes in U.S. and Non-U.S. jurisdictions could have an adverse effect on the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 U.S. Tax Cuts and Jobs Act contained a provision which requires, for tax purposes, the capitalization and amortization of research and development expenses; effective for years beginning after December 31, 2021.  The Company&#x2019;s deferred tax assets increased by $20.2&#160;million within the table above, related to the 2017 Tax Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the Company had net operating loss carryforwards of $79.5 million for federal income tax purposes, $75.5 million for foreign income tax purposes and $37.9 million for state income tax purposes to offset future taxable income. The majority of the federal net operating loss carryforwards expire through 2037, while $18.6&#160;million have an indefinite carry forward period. For foreign net operating loss carryforwards, $59.1&#160;million will expire through 2028, while  the remaining $16.4 million have an indefinite carry forward period. The state net operating loss carryforwards expire through 2036. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it will not satisfy the more likely than not threshold for realization of the associated tax benefit. In the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost.&#160;Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed.&#160;The Company will repatriate foreign earnings when there is no need for reinvestment overseas and no material tax cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Approximately $0.7 million of the balance at December&#160;31, 2022 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. The Company has $0.3&#160;million of uncertain tax positions at December&#160;31, 2022 related to tax positions for which it is reasonably possible that the amounts could be reduced during the twelve months following December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a minimal benefit for the years ended December&#160;31, 2022, 2021 and 2020. The Company had minimal interest and penalties accrued for the years ended December 31, 2022 and 2021 and 2020. &lt;/span&gt;&lt;/div&gt;The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its U.S. consolidated Federal income tax returns by the IRS through fiscal year 2015. Additionally, the Company is no longer subject to examinations by the IRS for fiscal year 2017. All significant state and local matters have been concluded through fiscal year 2014. All significant foreign matters have been settled through fiscal 2015.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjY_b0e17cb1-ba1e-449e-9ef3-7c6f6e5127d2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItMS0xLTEtOTI0Nzk_43b14401-4a3a-4963-a9c7-ab92c71c76f1"
      unitRef="usd">92642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItMy0xLTEtOTI0Nzk_e5e2cd9b-6c24-4d76-b42c-b5e11051d26e"
      unitRef="usd">91150000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzItNS0xLTEtOTI0Nzk_198b3913-b11f-489a-88e3-99a049772ea2"
      unitRef="usd">15082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtMS0xLTEtOTI0Nzk_5640df26-15d7-4e42-988d-9a24e509a43d"
      unitRef="usd">121252000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtMy0xLTEtOTI0Nzk_1481e5ac-048b-479f-8f1b-1a800f95e13c"
      unitRef="usd">123527000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzMtNS0xLTEtOTI0Nzk_41019a6f-7d02-4f56-b7d6-18c1538fc9ba"
      unitRef="usd">78438000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtMS0xLTEtOTI0Nzk_3d824ad2-e165-4658-84b7-960b42b4f603"
      unitRef="usd">213894000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtMy0xLTEtOTI0Nzk_dd2f07b1-555a-4a1d-83d5-1ecbb22e41d4"
      unitRef="usd">214677000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2ZWE3NzdjMGUzMzQ0YzdhYWI4MDFlZjRlYzdhMjcxMi90YWJsZXJhbmdlOjZlYTc3N2MwZTMzNDRjN2FhYjgwMWVmNGVjN2EyNzEyXzQtNS0xLTEtOTI0Nzk_5f4292cf-0876-43c2-8134-42d2635e9d8b"
      unitRef="usd">93520000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjQ_0021e10a-eba5-4900-8e37-6a6dcf0ced55">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. Federal statutory rate to the Company&#x2019;s effective tax rate is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in income taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Excess tax benefits from stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intercompany profit in inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible facilitative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Research and development credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Global intangible low-taxed income ("GILTI")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;Fair market value step up on intra-entity transfer of intellectual property&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Gain from sale of business - book to tax differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItMS0xLTEtOTI0Nzk_b3598d04-72fa-4212-9ace-3b9ba3081ef3"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItMy0xLTEtOTI0Nzk_13c698ea-39cb-4ab9-b238-4b16acd95818"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzItNS0xLTEtOTI0Nzk_a65119d3-4f5a-4360-9cbc-7639a685c3af"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtMS0xLTEtOTI0Nzk_41153e42-3bdd-46f0-92f6-9e8028d42bda"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtMy0xLTEtOTI0Nzk_ae831618-71c8-46ca-b131-6691edf20402"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzQtNS0xLTEtOTI0Nzk_1a6cb75b-625b-4b7d-8799-082dae846210"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtMS0xLTEtOTI0Nzk_4571be1b-2914-44d4-97d2-5449978fe32f"
      unitRef="number">-0.039</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtMy0xLTEtOTI0Nzk_c2a8f111-19cf-4d42-99fe-8f057c658b3c"
      unitRef="number">-0.040</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzUtNS0xLTEtOTI0Nzk_faf4df07-29f7-464b-8937-23f2e008a64c"
      unitRef="number">-0.079</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtMS0xLTEtOTI0Nzk_631fd145-6689-419b-af8c-f7f350068007"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtMy0xLTEtOTI0Nzk_b3e98eab-ffee-4e18-bd33-b481b99d14d2"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzYtNS0xLTEtOTI0Nzk_abd928b2-f0f1-4d86-9eb8-97957d60298f"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtMS0xLTEtOTI0Nzk_51a019f6-054e-4199-bca5-15e8c1e34520"
      unitRef="number">0.003</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtMy0xLTEtOTI0Nzk_e8c0315a-9559-409e-a0a8-5f9e3ba898ae"
      unitRef="number">-0.002</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzgtNS0xLTEtOTI0Nzk_13403988-11d7-4711-9765-308dfd2ad80b"
      unitRef="number">0.012</iart:EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMS0xLTEtOTI0Nzk_287ca197-0797-44ed-9074-90bb9badd95f"
      unitRef="number">0.002</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMy0xLTEtOTI0Nzk_07fd3b66-a8e4-4b56-bac2-4bb4ac8f2f39"
      unitRef="number">0.003</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktNS0xLTEtOTI0Nzk_56d13002-d931-43e7-a654-e574a254fac8"
      unitRef="number">0.011</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent>
    <iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMS0xLTEtMTY2Nzkx_8e397b72-6115-4a78-a8bc-b6ded3bc013d"
      unitRef="number">-0.020</iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktMy0xLTEtMTY2Nzk4_c9a1f8ed-debd-4400-bd3f-cdef38b511d0"
      unitRef="number">-0.002</iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzktNS0xLTEtMTY2ODA1_e7b8ff52-8600-4a89-9b67-5ba06b2ff39c"
      unitRef="number">0.002</iart:EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTEtMS0xLTkyNDc5_40f8917d-a1f6-4318-902c-b02ca776f207"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTMtMS0xLTkyNDc5_4e1788b3-0445-4130-bbc9-92b08acf4151"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEwLTUtMS0xLTkyNDc5_bb4ba4ed-a3d2-418b-a8b1-1f7dc752be97"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTEtMS0xLTkyNDc5_c03c6cb1-b141-4adf-bbbd-c3745ed333a0"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTMtMS0xLTkyNDc5_b87897c5-3a0b-484a-8882-5d161924ff2b"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzExLTUtMS0xLTkyNDc5_cb8ea399-17c4-4ef0-931d-3865001f1a95"
      unitRef="number">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTEtMS0xLTkyNDc5_38b065f6-cca3-4f0d-bf59-b163eacd3250"
      unitRef="number">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTMtMS0xLTkyNDc5_75bb257b-4da2-4fe3-8090-7e48b0ec692d"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEyLTUtMS0xLTkyNDc5_1f0804d3-057a-42b2-8ab4-13ddc926669d"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTEtMS0xLTkyNDc5_643022ba-35ff-4243-bee6-1783c30ba6de"
      unitRef="number">0.018</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTMtMS0xLTkyNDc5_06c49f29-43ba-49af-9e78-d60c65a8b8e1"
      unitRef="number">0.009</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzEzLTUtMS0xLTkyNDc5_5287c48a-2ab5-45ec-acd5-062090b500fd"
      unitRef="number">0.024</iart:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTEtMS0xLTkyNDc5_e5d3739b-97ac-48d5-9146-cd60f6e0e5a0"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTMtMS0xLTkyNDc5_44c96e29-c501-4aac-aa69-e3cc01dfc0fb"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE0LTUtMS0xLTkyNDc5_4eb01fcf-0599-4652-b57b-eec44bc69e15"
      unitRef="number">-0.633</iart:EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTEtMS0xLTkyNDc5_056a1e0f-4cfb-4bd7-8adc-96855bd88094"
      unitRef="number">0</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTMtMS0xLTkyNDc5_10998737-79d7-451a-9606-4efa432fd172"
      unitRef="number">0.039</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE1LTUtMS0xLTkyNDc5_6037dd62-f22c-45de-8406-f40aff85a5c3"
      unitRef="number">0.028</iart:EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTEtMS0xLTkyNDc5_422753bd-7136-4ad1-baa1-f4d6da6bd741"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTMtMS0xLTkyNDc5_020e7dfe-a19e-4a60-9746-de17a72ebc3f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE4LTUtMS0xLTkyNDc5_9a983d47-b264-442f-9226-c9c874bbc50e"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTEtMS0xLTkyNDc5_0d7d6e2d-8de5-42ad-8922-fca92f9a0c07"
      unitRef="number">0.156</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTMtMS0xLTkyNDc5_f6863f14-589c-473c-93d8-ee17169653f6"
      unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo1OGMwZTM4NzkyNGU0NTZjODhlMDdkYjJhZWIxODI0Yi90YWJsZXJhbmdlOjU4YzBlMzg3OTI0ZTQ1NmM4OGUwN2RiMmFlYjE4MjRiXzE5LTUtMS0xLTkyNDc5_e7b2e026-0367-44ca-81d7-42a486ac9d0b"
      unitRef="number">-0.432</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzIxOQ_0d7d6e2d-8de5-42ad-8922-fca92f9a0c07"
      unitRef="number">0.156</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzIyNg_f6863f14-589c-473c-93d8-ee17169653f6"
      unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NjY_d1a5c601-0362-4700-89a9-aeef9a916059"
      unitRef="usd">-5100000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2ODY_6f944c65-cc21-4c7a-87ec-c08c8275a44d"
      unitRef="usd">-2400000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i9d17811ad9fc45df8bcef0f695f18e73_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM3OA_5d234322-de85-4740-9c77-6bccb31ce595"
      unitRef="usd">8500000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQ5OA_dee4534e-3cf4-439e-9aa4-7e3f69835122"
      unitRef="usd">-3100000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzY2MQ_777d9156-e925-4bd9-81ba-16fe19821226"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzg3OA_c88c8fdb-12c8-4839-815d-e7e2ca6a9976"
      unitRef="number">0.202</iart:EffectiveWorldwideIncomeTaxRateReconciliationPercent>
    <iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount
      contextRef="i279c573a91e74e11abd25958e204a2d2_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE0NDA_b77f79e2-18e3-4a14-8202-0bc4526b3d8f"
      unitRef="usd">59200000</iart:EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2MjA_b672892c-54d0-4178-97d9-a0cb7a22765e"
      unitRef="usd">400000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NDg_ac297d6e-ad65-4ac3-8f59-b31c309a6353"
      unitRef="number">0.159</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE2NTc_ae128c71-754a-433a-b021-c34a4422a821"
      unitRef="number">0.152</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE2MTY_95f103a6-9182-474d-85b1-d10e3cfea71b"
      unitRef="usd">63600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE4OTE_984cd3eb-d5fb-479b-8c5a-840b1013afd8"
      unitRef="number">0.152</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzE5MDc_91ed8739-1984-4a77-8a1a-75c72e9d40a0"
      unitRef="number">-0.571</iart:EffectiveForeignIncomeTaxRateReconciliationContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1NDE_08159996-61d0-4a08-9e28-57120b90083d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtMS0xLTEtOTI0Nzk_9514ca36-00f5-4780-8803-5cef0d03c742"
      unitRef="usd">24201000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtMy0xLTEtOTI0Nzk_54f4c689-96c8-417c-aa43-85218d97089e"
      unitRef="usd">31938000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzMtNS0xLTEtOTI0Nzk_3e148454-5216-4966-abdb-1cd2f8774c32"
      unitRef="usd">6184000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtMS0xLTEtOTI0Nzk_ffb2f79f-c2d6-4e0f-97f3-7ae3eeee771f"
      unitRef="usd">3835000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtMy0xLTEtOTI0Nzk_0b2d93d5-5796-4b14-945d-ef1c18e42712"
      unitRef="usd">11377000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzQtNS0xLTEtOTI0Nzk_1bae7fa5-c0cc-4df9-86bd-f32f7ad1c085"
      unitRef="usd">5029000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtMS0xLTEtOTI0Nzk_fcbe0201-6fd1-4975-8354-efdd352ebf10"
      unitRef="usd">9893000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtMy0xLTEtOTI0Nzk_9ed686be-c4a0-4c2d-a4d9-4df1ad2cb657"
      unitRef="usd">5042000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzUtNS0xLTEtOTI0Nzk_68b4508d-cde5-49c3-8367-f1449b178837"
      unitRef="usd">12553000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtMS0xLTEtOTI0Nzk_c6abadd3-ecac-4576-891b-ac17271faa19"
      unitRef="usd">37929000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtMy0xLTEtOTI0Nzk_c0776d51-a287-4a32-bc5c-eea212d85922"
      unitRef="usd">48357000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzYtNS0xLTEtOTI0Nzk_5ac2447c-fe32-432b-8ec3-40ff3f241f7d"
      unitRef="usd">23766000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtMS0xLTEtOTI0Nzk_960c8829-16e3-46d3-9dbe-c8c8a15c246b"
      unitRef="usd">-11591000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtMy0xLTEtOTI0Nzk_b0bdf1c6-e691-4bc7-98d7-35471137199f"
      unitRef="usd">-12830000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzgtNS0xLTEtOTI0Nzk_b4645c85-bc59-46c4-a206-226bc38789fd"
      unitRef="usd">-5079000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktMS0xLTEtOTI0Nzk_ae832c5f-cbc8-4a50-bcb0-ba509304fb89"
      unitRef="usd">-2316000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktMy0xLTEtOTI0Nzk_fad11555-3306-44ec-ab8d-696e24686647"
      unitRef="usd">-3688000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzktNS0xLTEtOTI0Nzk_31c23fc0-8347-4b4f-a131-c45d785a18fa"
      unitRef="usd">-1760000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTEtMS0xLTkyNDc5_7712be8e-6818-4e25-9ee2-81b8a6d35c5d"
      unitRef="usd">9322000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTMtMS0xLTkyNDc5_add149f8-548b-4207-af9a-5a5dffb396c3"
      unitRef="usd">13763000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEwLTUtMS0xLTkyNDc5_e4d3e0d5-5d56-43f4-bb3c-bcd8de1f0dde"
      unitRef="usd">-57299000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTEtMS0xLTkyNDc5_c3c8f6bc-c332-416b-8bc3-33822026fda4"
      unitRef="usd">-4585000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTMtMS0xLTkyNDc5_6509ae32-99f3-4f96-b864-d358064e81ca"
      unitRef="usd">-2755000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzExLTUtMS0xLTkyNDc5_d11989b0-216a-4657-969a-de8ff21cd7ea"
      unitRef="usd">-64138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTEtMS0xLTkyNDc5_18cc6970-c0d8-432f-aa83-2041514c8563"
      unitRef="usd">33344000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTMtMS0xLTkyNDc5_5867f0d3-76fa-430b-bc71-0674d3dea8b2"
      unitRef="usd">45602000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTplMmZhZWZmOGExMDc0ZjBiOWEwNTk4YzZkOGNmMGUzZC90YWJsZXJhbmdlOmUyZmFlZmY4YTEwNzRmMGI5YTA1OThjNmQ4Y2YwZTNkXzEyLTUtMS0xLTkyNDc5_cf197580-597e-4e29-9030-f23940ee935e"
      unitRef="usd">-40372000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MTI_9c09d4dd-0a03-40c8-9071-33dde8d8be4d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Inventory related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalization of research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Charitable contributions carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Deferred tax assets after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Leases and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzMtMS0xLTEtOTI0Nzk_58939f81-8361-4929-a0e7-6870dd676957"
      unitRef="usd">2261000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzMtMy0xLTEtOTI0Nzk_ccd97212-4292-45f4-8740-b2b32b109077"
      unitRef="usd">2029000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzQtMS0xLTEtOTI0Nzk_5950f82e-8d4c-42f8-b99d-36945f506a4b"
      unitRef="usd">31950000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzQtMy0xLTEtOTI0Nzk_cbb61f94-a423-40ec-b921-018466242886"
      unitRef="usd">31841000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzUtMS0xLTEtOTI0Nzk_5b0fddca-8404-42d6-8a79-3ba6cb72fa6b"
      unitRef="usd">13084000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzUtMy0xLTEtOTI0Nzk_53fda00d-dd80-45e6-bb93-83fe7d2af282"
      unitRef="usd">13319000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzYtMS0xLTEtOTI0Nzk_f1823850-775f-4f51-abc6-00baa458629a"
      unitRef="usd">2175000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzYtMy0xLTEtOTI0Nzk_de37882e-e831-4d61-b0f3-58c2099c6402"
      unitRef="usd">3042000</iart:DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzctMS0xLTEtOTI0Nzk_aea5f50e-3c69-48fd-9d6e-31c3c54e8fc0"
      unitRef="usd">4944000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzctMy0xLTEtOTI0Nzk_313014e6-706e-4f6a-9c0a-89cc11c1d8af"
      unitRef="usd">7415000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzgtMS0xLTEtOTI0Nzk_48d7b59a-3ae2-47a3-b97e-fd718c05ae5e"
      unitRef="usd">10175000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzgtMy0xLTEtOTI0Nzk_f2d3819f-5267-45fa-9070-189fa2199e3b"
      unitRef="usd">13955000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzktMS0xLTEtOTI0Nzk_2b6961d8-fc15-4b1e-9ea5-41c30fe66821"
      unitRef="usd">2130000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzktMy0xLTEtOTI0Nzk_c5b8eb32-7bea-4a81-b51a-1d37a4b3987b"
      unitRef="usd">1742000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEwLTEtMS0xLTkyNDc5_73791f08-a632-448d-9430-623f5d33b444"
      unitRef="usd">30707000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEwLTMtMS0xLTkyNDc5_89af491c-32c8-42d9-9618-e410db4db1e1"
      unitRef="usd">26198000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzExLTEtMS0xLTkyNDc5_d7c0a403-2d2a-46eb-8b53-85d618711b86"
      unitRef="usd">51542000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzExLTMtMS0xLTkyNDc5_92af68ac-2007-4a7e-a9a2-13dcd891030c"
      unitRef="usd">36770000</iart:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEyLTEtMS0xLTkyNDc5_e5044c25-45cd-4091-acdd-07e2e2d3e6db"
      unitRef="usd">6228000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEyLTMtMS0xLTkyNDc5_15c59cc6-8f0d-423b-975f-4d7462db4a8a"
      unitRef="usd">12849000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEzLTEtMS0xLTkyNDc5_4dedc7f1-38ad-4b4c-acb3-c3a9ec71bf05"
      unitRef="usd">180000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzEzLTMtMS0xLTkyNDc5_f251820c-58e7-439e-b914-63dc0fc9c5db"
      unitRef="usd">206000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE1LTEtMS0xLTkyNDc5_8b06e209-d9aa-4165-a3db-9fb1a1c7f88b"
      unitRef="usd">39788000</iart:DeferredTaxAssetsLeasesAndOther>
    <iart:DeferredTaxAssetsLeasesAndOther
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE1LTMtMS0xLTkyNDc5_5d3f35c1-d1ef-420a-8e55-888e40904ed1"
      unitRef="usd">41371000</iart:DeferredTaxAssetsLeasesAndOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE2LTEtMS0xLTkyNDc5_20481938-b35d-40a6-b895-b08dbbfe1aee"
      unitRef="usd">195164000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE2LTMtMS0xLTkyNDc5_7140ea37-aee9-4745-a016-583d8e341e90"
      unitRef="usd">190737000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE3LTEtMS0xLTkyNDc5_44dc5b75-f8c4-4597-b30a-d583bdcffd88"
      unitRef="usd">9651000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE3LTMtMS0xLTkyNDc5_789c69d7-caf1-44a1-8c67-46cefd5449ec"
      unitRef="usd">9767000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE4LTEtMS0xLTkyNDc5_820d4751-7a9c-42c1-bb0d-f28cc1d0bb0c"
      unitRef="usd">185513000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzE4LTMtMS0xLTkyNDc5_c1cd7891-9922-4d16-a2ae-732a3db40140"
      unitRef="usd">180970000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIwLTEtMS0xLTkyNDc5_7064263a-4ae2-4c6c-98ae-c9d1cfefcee8"
      unitRef="usd">166891000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIwLTMtMS0xLTkyNDc5_3caf3c68-c2ac-49b1-a324-2f21f1312f14"
      unitRef="usd">152150000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTEtMS0xLTE2NzkxOA_03547563-106c-4367-8bc9-b4040d20379d"
      unitRef="usd">12991000</iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss>
    <iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTMtMS0xLTE2NzkyNQ_72faade7-296f-493a-82d6-7c53ef575ca3"
      unitRef="usd">0</iart:DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTEtMS0xLTkyNDc5_07f54789-e5c6-4f67-bf62-8f3f82554b64"
      unitRef="usd">22975000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <iart:DeferredTaxLiabilitiesLeasesAndOther
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIxLTMtMS0xLTkyNDc5_adc30c2a-ba4d-403c-9fce-952c1170c9a3"
      unitRef="usd">17658000</iart:DeferredTaxLiabilitiesLeasesAndOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIyLTEtMS0xLTkyNDc5_65a7c5e8-d910-410b-86f0-4e63609a1125"
      unitRef="usd">202857000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzIyLTMtMS0xLTkyNDc5_e43175a4-c195-43cc-b0ff-057e022abe3a"
      unitRef="usd">169808000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzI0LTEtMS0xLTkyNDc5_7d842be4-4dd7-4143-a9f8-473b4654737c"
      unitRef="usd">17344000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTowYzM2NWYxZmNhNDE0YzVjOWI3M2I1YzRkOThiMDZmYy90YWJsZXJhbmdlOjBjMzY1ZjFmY2E0MTRjNWM5YjczYjVjNGQ5OGIwNmZjXzI0LTMtMS0xLTkyNDc5_0c4d9d4b-dee5-41d3-9d8a-f3e88070f1f9"
      unitRef="usd">11162000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <iart:DeferredTaxAssetIncreaseDueTo2017TaxAct
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU2NDQ_625e5f37-eb44-4235-ab60-97d31dec32d7"
      unitRef="usd">20200000</iart:DeferredTaxAssetIncreaseDueTo2017TaxAct>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie93924bccec8412e903736f429992621_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyMTc_9e63a948-b716-4e88-9038-f938b2162e91"
      unitRef="usd">79500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i79636bff7892448cb422c38278985e4e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyNTM_77faeb5f-0207-4a75-8f85-c0035a7a376a"
      unitRef="usd">75500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie487f52caa6d4416be07a10223ed0bce_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQyOTI_ee4292e3-f914-42f0-9f9d-abc8d41e6d77"
      unitRef="usd">37900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ie93924bccec8412e903736f429992621_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU0Njg_27f20363-db81-4d11-9ad1-1253332069bb"
      unitRef="usd">18600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i79636bff7892448cb422c38278985e4e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE3MDU_c6e6afe1-2a01-43ca-bb14-dd2458284da8"
      unitRef="usd">59100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i79636bff7892448cb422c38278985e4e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQ1NDg_5c2b2cd2-c6a0-4eb3-9dae-57719904aa9f"
      unitRef="usd">16400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzQzOTgwNDY1MjU0NjQ_b168f370-16c1-47db-a4a4-1d41523c2b7e">The valuation allowance at December 31, 2022 and 2021 primarily remained unchanged from respective prior periods; decreasing by an immaterial amount in both periods.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icbb5085d40924d08b32a44ed38777fa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtMS0xLTEtMTY3NDc4_996f9bc6-e045-4af5-a8d4-322d1aebfc1a"
      unitRef="usd">15258000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtMy0xLTEtMTY3NDkz_020f67e4-436a-45e0-8ad7-99d9dc445257"
      unitRef="usd">-515000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtNy0xLTEtMTY3NDg3_8550a508-967f-4845-b54d-198bbbad4bd9"
      unitRef="usd">71000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5125356e34064ab5bdcb08a3dffbcee3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzQtOS0xLTEtMTY3NDk3_6ce69244-93c0-4a81-9691-6ca1c92e10cd"
      unitRef="usd">14672000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id65461d577a648fa84b432ba0d645aca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtMS0xLTEtMTY3NTA1_142c91ae-966d-49e1-8dd8-25bbe701e8ad"
      unitRef="usd">13825000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtMy0xLTEtMTY3NTIy_c5218a10-d3ef-45fb-ac00-7fa40b53e5c6"
      unitRef="usd">1444000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtNS0xLTEtMTY3NTI3_10dded97-02b2-4249-9f17-6bdc2894701a"
      unitRef="usd">89000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i7bb421b7c2eb4cd9891b90c9d9a61333_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtNy0xLTEtMTY3NTE3_f3593315-f3c7-4efc-b712-e92e00a927f7"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icbb5085d40924d08b32a44ed38777fa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzYtOS0xLTEtMTY3NTM2_8fad418e-5585-4225-88d3-6d78d7b827c8"
      unitRef="usd">15258000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i58370c21a3bf4fa9916b815ebacaabad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtMS0xLTEtMTY3NTQ0_ec2dafcd-c4b0-4a92-a44c-0eb008f0478a"
      unitRef="usd">12069000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtMy0xLTEtMTY3NTQ4_a437fc8a-0991-4245-9dbd-0662d41a1f25"
      unitRef="usd">1617000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtNS0xLTEtMTY3NTUy_61ad35fb-3406-44cc-a6d6-a52fe8360020"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0a45597d5c1041aeb8c595ba6c22854d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtNy0xLTEtMTY3NTU2_61cecaa9-a69e-46f1-bec1-49bc109aa443"
      unitRef="usd">-139000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id65461d577a648fa84b432ba0d645aca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZToyMDRiMTllNjY1ZDE0ODM0YjkzMDhhY2QzMzc3NGE2MS90YWJsZXJhbmdlOjIwNGIxOWU2NjVkMTQ4MzRiOTMwOGFjZDMzNzc0YTYxXzgtOS0xLTEtMTY3NTYw_a28bf9dc-2394-45f9-928a-6bf8c8a35a89"
      unitRef="usd">13825000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzc1MjU_e7ec3b9c-c6b7-4382-a0d2-e5fe3bd05663">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prior years' tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtMS0xLTEtOTI0Nzk_7eca29b2-acee-4427-aeda-2c9db91141c7"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtMy0xLTEtOTI0Nzk_aadd1b7a-a094-4bfc-9c7e-5171007d08fa"
      unitRef="usd">702000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib4ed22898bc64d24b7765e593f891985_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzMtNS0xLTEtOTI0Nzk_b687452b-17b2-44ad-b4ad-c18161503230"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtMS0xLTEtOTI0Nzk_3723c9fe-e87b-4a7a-a2ef-5eba2be4ffed"
      unitRef="usd">37000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtMy0xLTEtOTI0Nzk_0762ec94-bdf9-46dc-a06d-620dd2623449"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzUtNS0xLTEtOTI0Nzk_b1b2e53b-1bc1-4b9e-ada1-a388f24f7bfc"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtMS0xLTEtOTI0Nzk_0d8398e8-69f2-40a6-af66-211122551b48"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtMy0xLTEtOTI0Nzk_2469082d-c458-4d2d-baef-47878e17e105"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzYtNS0xLTEtOTI0Nzk_f20d033f-48ed-4aef-8084-3e3ef35106b3"
      unitRef="usd">26000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctMS0xLTEtOTI0Nzk_5024771b-cb68-4834-9b9e-e26103cfe512"
      unitRef="usd">0</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctMy0xLTEtOTI0Nzk_dabe4074-fcda-4c3d-9e6f-8607a3aac2c5"
      unitRef="usd">26000</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <iart:UnrecognizedTaxBenefitsReductionsResultingFromOther
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzctNS0xLTEtOTI0Nzk_3f9421ec-ff3d-4d76-8035-45485b4f2075"
      unitRef="usd">0</iart:UnrecognizedTaxBenefitsReductionsResultingFromOther>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtMS0xLTEtOTI0Nzk_7509bbd8-9455-4a6a-9636-ab5ce76a8340"
      unitRef="usd">713000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtMy0xLTEtOTI0Nzk_31ed7c9d-98e3-4166-982e-713d62924724"
      unitRef="usd">676000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i071a60b60a9b46a18aa0d12355c2d684_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90YWJsZTo2NjQ0ZWFmNzA3OTA0NzkwYjEyNmEzM2QwMGRjOGMxYi90YWJsZXJhbmdlOjY2NDRlYWY3MDc5MDQ3OTBiMTI2YTMzZDAwZGM4YzFiXzgtNS0xLTEtOTI0Nzk_773c9856-09aa-4979-8808-e242dec8ecc5"
      unitRef="usd">702000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzY0ODQ_5fb82914-6be3-45c0-8d64-e76378e8eada"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODEvZnJhZzphNTEyZDEwNmNlYTE0MGE5YmQ2OGI5NmE3NjA0NDk2ZS90ZXh0cmVnaW9uOmE1MTJkMTA2Y2VhMTQwYTliZDY4Yjk2YTc2MDQ0OTZlXzM4NDgyOTA3MTE3Mjg_d6ab2a0d-efe1-426d-8b56-a3e7a787211c"
      unitRef="usd">300000</us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzY5Ng_bf638675-f404-4847-8975-1b4173324fd9">NET INCOME PER SHARE&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock of approximately 0.3 million and 0.1 million shares at December&#160;31, 2022, and 2021 that are issuable through exercise of dilutive securities, respectively, and were not included in the computation of diluted net income per share because their effect would have been anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the adoption of ASU 2020-06, as the principal amount of the 2025 Notes will be paid in cash and only the conversion spread is settled in shares, the Company will be utilizing the if-converted method and only includes the net number of incremental shares that would be issued upon conversion.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzcwNA_e4245455-cf92-47f0-827c-16eaf441f239">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtMS0xLTEtOTI0Nzk_cbef4a76-1e8d-40b9-82d7-d76d926eca22"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtMy0xLTEtOTI0Nzk_ac1c4d4f-f851-44d0-b0ab-9b8a99d18844"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzMtNS0xLTEtOTI0Nzk_b9ee5a50-c0dc-4eec-ba8e-e9aa6028a3b2"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtMS0xLTEtOTI0Nzk_bcf2c2f8-9910-443e-8ec0-fc9d1b257994"
      unitRef="shares">82997000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtMy0xLTEtOTI0Nzk_cfa38e31-1815-4ba6-824a-befaef74ff55"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzQtNS0xLTEtOTI0Nzk_5d976641-9df5-430b-8ca5-d0a968c8074b"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtMS0xLTEtOTI0Nzk_978cac6b-8914-4424-a7b4-73df1bc42361"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtMy0xLTEtOTI0Nzk_b107402a-837a-4c56-949e-9206923fbab7"
      unitRef="usdPerShare">2.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzUtNS0xLTEtOTI0Nzk_fded90a7-83b8-4faf-921c-c69a3a91f440"
      unitRef="usdPerShare">1.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtMS0xLTEtOTI0Nzk_f651d74f-2912-4654-8e2a-17c7802548c1"
      unitRef="usd">180550000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtMy0xLTEtOTI0Nzk_11bdbd59-0203-43f3-8cf9-ed6a8f2699f2"
      unitRef="usd">169075000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzgtNS0xLTEtOTI0Nzk_ba4b1646-6047-4b9c-aa19-105654bc6ed2"
      unitRef="usd">133892000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTEtMS0xLTkyNDc5_7925b363-da10-4f57-a094-c620fdbea531"
      unitRef="shares">82997000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTMtMS0xLTkyNDc5_d5d5e452-8bb5-4e53-9056-931dd098f714"
      unitRef="shares">84698000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEwLTUtMS0xLTkyNDc5_76b47ad8-6532-46cd-bea8-b5e79cd18f8d"
      unitRef="shares">84650000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTEtMS0xLTkyNDc5_f9600e0e-0a9e-4f92-9cd2-485cb60dad90"
      unitRef="shares">519000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTMtMS0xLTkyNDc5_17baa019-c07f-483a-beb3-fb3783ff8070"
      unitRef="shares">787000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEyLTUtMS0xLTkyNDc5_a1de0141-1e07-4e39-a79b-38b7fcf56c2c"
      unitRef="shares">577000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTEtMS0xLTkyNDc5_2a111e02-805e-4df5-8a33-b40cfa6e83d5"
      unitRef="shares">83516000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTMtMS0xLTkyNDc5_eaa8ee61-7ecd-4c6d-ba32-64022aa28fc8"
      unitRef="shares">85485000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzEzLTUtMS0xLTkyNDc5_bd392974-f0ca-478a-b494-02e8f8fee4b2"
      unitRef="shares">85228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTEtMS0xLTkyNDc5_de352fe8-4a5b-4927-9fc6-bf5ca1437314"
      unitRef="usdPerShare">2.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTMtMS0xLTkyNDc5_486bcab6-fae5-4261-bb73-7451a9392a7c"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90YWJsZTo3ZmZiMGIyZTJjZmQ0NDc0YjFkMGFhM2IwOGFhOWE0OS90YWJsZXJhbmdlOjdmZmIwYjJlMmNmZDQ0NzRiMWQwYWEzYjA4YWE5YTQ5XzE0LTUtMS0xLTkyNDc5_06abf199-f942-413f-ac1a-cf04b30b09c2"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzExNw_41a383ce-1774-4a0a-b497-3f8c86fea845"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xODcvZnJhZzpjZjBkMGY5Yzk5ODM0MDZkYjA5MzJmMGJkYjJhNmE2Yy90ZXh0cmVnaW9uOmNmMGQwZjljOTk4MzQwNmRiMDkzMmYwYmRiMmE2YTZjXzEzMg_30faac92-200e-4be6-bc84-a4b4f459c9e9"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzM1NQ_144a5dd7-d8f2-4011-9cb1-157a88a536df">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2022 and 2021 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2022, the Company reclassified a gain of $15.0 million and a loss of $0.4&#160;million from accumulated other comprehensive loss to other income, net and interest income, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzM2Mw_7d45ffa3-d906-4921-b657-d5248d19b6fc">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive loss by component between December&#160;31, 2022 and 2021 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i55ae72f002374097b8ae052513a4d9af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtMi0xLTEtOTI0Nzk_7928847e-aacd-4566-91fd-2d4bc2a24812"
      unitRef="usd">-42981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99a64401f57445e3889fffd6aa340e49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtNC0xLTEtOTI0Nzk_11529d09-84be-4ae7-a963-758303bed4ff"
      unitRef="usd">1893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i53bb7164178d4c7681938eae96f8dd7a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtNi0xLTEtOTI0Nzk_91ce14cb-178d-4a78-9828-156185e338ae"
      unitRef="usd">-4067000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c1c23b54a344fc8a8faf10aa00c44b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzEtOC0xLTEtOTI0Nzk_2142c9c2-d71b-485c-b36c-c0c04495b8d9"
      unitRef="usd">-45155000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItMi0xLTEtOTI0Nzk_e5ff88f0-c7bc-42af-9706-8d23178a0960"
      unitRef="usd">80335000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItNC0xLTEtOTI0Nzk_9efc489a-a685-4db5-a597-ba3c8babfa02"
      unitRef="usd">7429000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItNi0xLTEtOTI0Nzk_4b726a1b-ade9-42f2-b2fa-cbee6b8136a1"
      unitRef="usd">-17807000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzItOC0xLTEtOTI0Nzk_3381402b-335c-47c0-870e-49a21c1f7f32"
      unitRef="usd">69957000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtMi0xLTEtOTI0Nzk_31da21c6-3d9c-4424-b179-a56bd3a4ac3b"
      unitRef="usd">14537000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtNC0xLTEtOTI0Nzk_b744a059-cb32-44bb-a989-04b038cf5eab"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtNi0xLTEtOTI0Nzk_aba4f1e6-f92c-49d1-b4c4-46ecca45b83c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzMtOC0xLTEtOTI0Nzk_55a7d9b8-dcd2-4dc1-ac85-c9271aaf6c5d"
      unitRef="usd">14537000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8f5437201a304e7582c5047c4b9d75bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtMi0xLTEtOTI0Nzk_69ef218f-d1c3-4582-be9f-60a93815d098"
      unitRef="usd">65798000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i803cfe276be0426ba8784ba55fb193a0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtNC0xLTEtOTI0Nzk_3b61d455-d59f-4e5c-bb71-c10484b88bab"
      unitRef="usd">7429000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id7c26e3cabfa48608fb6612b8c3cdb0c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtNi0xLTEtOTI0Nzk_79c4af58-56ad-4482-8dd0-b713f47f84a2"
      unitRef="usd">-17807000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzQtOC0xLTEtOTI0Nzk_66bc9730-5c9b-4d23-9912-ef5d59423cbf"
      unitRef="usd">55420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i6b4f71bfb1a8422d95af5dd6760a64f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtMi0xLTEtOTI0Nzk_29dff972-d2ef-4993-9694-20cd5c11255e"
      unitRef="usd">22817000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9ea09ba91b94301bbbdc52ab73d8aa5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtNC0xLTEtOTI0Nzk_028ad3d8-e6dc-4c02-b069-8877a28a893c"
      unitRef="usd">9322000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3a4807908c54cb5b1a0dd1fd6665df2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtNi0xLTEtOTI0Nzk_f5e349e8-2302-41a4-bcd1-5ff0d0b99e08"
      unitRef="usd">-21874000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia53c75cb9f1446969ef5bf9fa3b9a3d5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90YWJsZTpiNTRiZjg5OTZiNTQ0OWM1YWNiODc5ZDhkMzJiMDA5Zi90YWJsZXJhbmdlOmI1NGJmODk5NmI1NDQ5YzVhY2I4NzlkOGQzMmIwMDlmXzUtOC0xLTEtOTI0Nzk_2761d450-781c-422d-815a-e5814f66f0e7"
      unitRef="usd">10265000</us-gaap:StockholdersEquity>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzIzMQ_42dfa3b9-c0ba-455e-9ddd-2485a68c023a"
      unitRef="usd">15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTAvZnJhZzphODk5ODE2OTdiOWY0MTM1YjNiODMyMmUzOTVmYzRhYy90ZXh0cmVnaW9uOmE4OTk4MTY5N2I5ZjQxMzViM2I4MzIyZTM5NWZjNGFjXzI0OA_b5402fde-595a-4f2c-84a4-be279e31f8ff"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI3OTM_a201685f-ff49-4f4f-bb81-d7c0b8e529c0">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the fair value of contingent consideration during the twelve-month period ended December&#160;31, 2022 and 2021 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2022 and 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SIA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derma Sciences&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3&#160;million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#x2122; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0&#160;million. The estimated fair value as of December&#160;31, 2022 and 2021 was $0.2&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Arkis BioSciences, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition of Arkis BioSciences, Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated the fair value as of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  was $12.9&#160;million. The Company recorded $2.8&#160;million in accrued expenses and other current liabilities and $10.1&#160;million in other liabilities at &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheets of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI3OTU_64217b99-7b67-432e-adbc-60967db2e619">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the years ended December&#160;31, 2022 and 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SIA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;br/&gt;&#160;(See Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;br/&gt;&#160;(See Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers from long-term to current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMi0xLTEtOTI0Nzk_8da851e2-babc-4883-b768-b8653b432c1c"
      unitRef="usd">3691000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9c2f742f6e864e72a554afa2da3a8c66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtNC0xLTEtOTI0Nzk_fe707b2e-6473-4704-9e53-eadd6523a432"
      unitRef="usd">11408000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id34c42773d35464d81a75564647fa0e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtOC0xLTEtOTI0Nzk_193fe9d2-3bf7-4dd0-b0a3-a226e331bc0d"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i20e8046929194a0da3727cadcc6ce0a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTAtMS0xLTE0MjI5OA_6e22d10c-5654-457b-80a6-8f024c0abd48"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i454bba66f23b40d59081b4ed516cc56b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTEtMS0xLTkyNDc5_b0804cbe-5ad0-4743-9942-f3b072fdc207"
      unitRef="usd">21800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i04eb6b26c7384b9090a435f6497f42ae_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzMtMTMtMS0xLTE2MzQwMg_00be94b3-df66-4e4c-b490-709ef44bb046"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMi0xLTEtOTI0Nzk_6048c311-a04b-445e-ad6d-90e2ff648a67"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtNC0xLTEtOTI0Nzk_34f5ba4b-0ab3-44d3-9d3f-122e426f5464"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtOC0xLTEtOTI0Nzk_b7a3d441-72bf-4213-965e-13cc54fecbac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTAtMS0xLTE0NDIyNA_5675892c-ed79-4633-838a-00062ae5e083"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTEtMS0xLTkyNDc5_0a274bed-ebbe-4ff5-857d-89018441b034"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzQtMTMtMS0xLTE2MzQwMg_d24b9dae-9900-4d56-8f0d-fd7000b1142a"
      unitRef="usd">57607000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMi0xLTEtOTI0Nzk_50b881ef-185a-4c66-8625-68b91824377f"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtNC0xLTEtOTI0Nzk_7b9339bc-f8da-4def-8c1d-cf26e0171ada"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtOC0xLTEtOTI0Nzk_3c2288b4-5edd-409f-a12e-e8b1121e7cbb"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTAtMS0xLTE0MjI5OA_b55d0067-6b36-4f09-9de3-03071c8871fc"
      unitRef="usd">4885000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTEtMS0xLTkyNDc5_a9e841be-c08c-4242-b9d0-ae69a12402a5"
      unitRef="usd">-4885000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzUtMTMtMS0xLTE2MzQwMg_0e3c21c0-08b4-45a7-b7e6-3c2092fb6552"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ie7212008c1af47da8bec0b12e86861b5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMi0xLTEtOTI0Nzk_826ec9ae-a29d-479a-9332-2af9d187b011"
      unitRef="usd">846000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i51944049eb7b403aba8baf9a73574149_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtNC0xLTEtOTI0Nzk_0aef91eb-0755-49b8-90bf-2c81be1f3381"
      unitRef="usd">1358000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idad9f7b57287472faa5da1db0498730f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtOC0xLTEtOTI0Nzk_d31d457b-bbdb-4114-a852-f19c75cfa31f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic388a58721d14f2ea308596e0f2ce85e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTAtMS0xLTE0MjI5OA_7fcace4b-035e-4f33-afec-4eddf9d84b0d"
      unitRef="usd">4885000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i9583c6de7f8f47638f6f930d775ec561_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTEtMS0xLTkyNDc5_13f9ba12-b17b-4585-8cf8-0de3272e0a7c"
      unitRef="usd">13215000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i68a223d9d7454456aa04f06027515378_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzYtMTMtMS0xLTE2MzQwMg_30fd0f2b-2a6c-44e2-aaf4-32482f803877"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie1745e45c4754439b297f3e7d7347d24_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMi0xLTEtOTI0Nzk_a1132ed2-7f9c-405c-bcc3-a003a383e6bd"
      unitRef="usd">2845000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id9aecdb884ec42408aef9ceaf4f7631d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctNC0xLTEtOTI0Nzk_1314332d-52b8-4d9d-a028-e5069d924e05"
      unitRef="usd">10050000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i99410b6978f346d1962e9be3d588bb16_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctOC0xLTEtOTI0Nzk_d6d945b4-6211-4fc6-a9e7-2f714e42b66c"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i02e03ef2f5ff4d8098cebaa20d010574_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTAtMS0xLTE0MjI5OA_f4c68b1c-e4ae-42ed-bc01-9b8a8928dc9a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib407e2307b7d4fc1817926031f1d8119_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTEtMS0xLTkyNDc5_e2cb308a-9009-4872-a298-16cc116e2537"
      unitRef="usd">3700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i08ff087bc35f4f4f8a6bb3d6ac4b1e72_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTpjOWIyNjIwYjc3OTU0YzJkYTEzZDA5ZjY4YjMzODVkMy90YWJsZXJhbmdlOmM5YjI2MjBiNzc5NTRjMmRhMTNkMDlmNjhiMzM4NWQzXzctMTMtMS0xLTE2OTA1MA_b3c0aed3-ec43-4362-afe7-93ecc7cb0d70"
      unitRef="usd">57607000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iba83041b85dd4322beadedfbb737f04d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtMi0xLTEtOTI0Nzk_ce31ef07-ed37-4aab-b760-16ce6fb70ef3"
      unitRef="usd">3415000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6416949c9d6642de911caf67ffe8aabb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtNC0xLTEtOTI0Nzk_6b122efc-6eb1-4c3d-88be-71441992ede8"
      unitRef="usd">11746000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i86e82c009c774de0bb05432b74102ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtOC0xLTEtMTQyMzAz_daa5d790-915e-421f-a071-0039233af184"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i51a5653a9fc64e90aa2fbdb1b8095a56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzMtMTItMS0xLTE0MjYwMQ_8f26dcd8-3543-49d9-a2bd-040bac9823fd"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtMi0xLTEtOTI0Nzk_e7ab5a9f-13f7-4046-bd49-607c7a971830"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtNC0xLTEtOTI0Nzk_912bff33-9d47-4a55-92b5-6fefd8b45f32"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtOC0xLTEtMTQyMzAz_6883debe-1754-4f27-9e45-87bea6cb58bb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzQtMTItMS0xLTE0MjYwMQ_53be631e-6517-442d-807c-9a8c7b398050"
      unitRef="usd">23900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtMi0xLTEtOTI0Nzk_3e8a928a-b2e3-4c87-a6d9-499ec9632d31"
      unitRef="usd">276000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtNC0xLTEtOTI0Nzk_19c698e9-cace-43b3-899f-9d12e4f0fbdc"
      unitRef="usd">-276000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtOC0xLTEtMTQyMzAz_6baa5979-ff4a-4a6b-b7e6-f39542895889"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzUtMTItMS0xLTE0MjYwMQ_638cce9a-dd96-4fac-9a6b-a50f93eeca31"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7dca0a1b74374c86bdb121b498c28041_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtMi0xLTEtOTI0Nzk_83d33fb3-7688-4181-8acf-cec0d1006c96"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ifde103a447ad47428323ce033718630c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtNC0xLTEtOTI0Nzk_b183863e-9250-4a8b-93fa-f860c06dd9ad"
      unitRef="usd">62000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i35ec23c8dee84538a417b018aa0a973d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtOC0xLTEtMTQyMzAz_ca24a02a-def8-4937-83ad-9e3c58590a8f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i79741739b5e84d72b4c5b5b5e0ed90e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzYtMTItMS0xLTE0MjYwMQ_b7872e1e-5a99-4d69-a780-ca55ddc6df69"
      unitRef="usd">2100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ibae60ef4e8d8432b944c8e3b719f35a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctMi0xLTEtMTQyMzAz_b0be356e-2a4a-47d6-ac5d-2d63b9908638"
      unitRef="usd">3691000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9c2f742f6e864e72a554afa2da3a8c66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctNC0xLTEtMTQyMzAz_878c8435-7bd6-462a-b734-0f3bf729c7e6"
      unitRef="usd">11408000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id34c42773d35464d81a75564647fa0e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctOC0xLTEtMTQyMzAz_06bb49d8-62db-4def-9c63-c79e2820cc24"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i454bba66f23b40d59081b4ed516cc56b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90YWJsZTo1NDBkOGU4ZGFlMjk0NGFhODA4MWJjYzg4ZjBlYWQ4MC90YWJsZXJhbmdlOjU0MGQ4ZThkYWUyOTQ0YWE4MDgxYmNjODhmMGVhZDgwXzctMTItMS0xLTE0NDIzNQ_c7dd4443-4ddb-4386-ac3b-2c5fa1b5d766"
      unitRef="usd">21800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="id61f82dd9bf0413b91c391c490e54d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzNjI_6f32c90c-1b64-4817-8aa0-4d14b246f7ba"
      unitRef="usd">33300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <iart:BusinessCombinationContingentConsiderationNumberOfLiabilities
      contextRef="icf69e67cb3914b7097e58795099a96dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzI1MDg_baee7a23-f931-4165-b69e-1de98a979149"
      unitRef="liability">1</iart:BusinessCombinationContingentConsiderationNumberOfLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="icf69e67cb3914b7097e58795099a96dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzNzE_0138cad4-d652-407c-b434-31d252250de6"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0a7b1feae529450e813237017e332bb6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzODQ_cb4036fb-fa47-4ad4-8163-caa9beb0e668"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8e4c5c321a5d4d579e4c7197fc75ffab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4XzIxOTkwMjMyNTgzODQ_e186da35-0d90-49b7-a5b8-1134990bba73"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib86a8f98051a4098a0c55718c503c35c_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYyMDk_64f7f2d2-f795-4e67-8105-868d17c5952b"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6ad6fdc92af64fb3a69eb22274101a61_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYyNzA_e2738b1c-75c3-4d41-8533-3ea63f33cc36"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6f62455b6c14446e8989b657790d2e88_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTYzMDk_b8a09848-d4c5-4840-a7a4-14e3391dd579"
      unitRef="usd">15500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="ib86a8f98051a4098a0c55718c503c35c_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY2MDc_94c551d9-7a7f-44e7-a046-37040ad1497e"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY2ODA_470302aa-dbfe-4204-872e-90f4e3fbfad4"
      unitRef="usd">12900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY3MDY_8a369de0-91e2-4c35-9d02-000fc33803c4"
      unitRef="usd">2800000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ia332c4339d0d47d2adb4575e1fac651f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTMvZnJhZzoyZTRjNjk2NDI1Y2Q0YWQ2YmE2YWRiNWFkMjY2YzU0OC90ZXh0cmVnaW9uOjJlNGM2OTY0MjVjZDRhZDZiYTZhZGI1YWQyNjZjNTQ4Xzk4OTU2MDQ2NTY3NjQ_1c68e5ba-6d06-40c5-a4e2-953c47a185ab"
      unitRef="usd">10100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMDc_f8f0c66c-27ab-478f-baf3-2f91ba1717d0">SEGMENT AND GEOGRAPHIC INFORMATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Tissue Technologies segment includes such offerings as skin and wound repair, plastics &amp;amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,882)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,914)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(453,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzc1_44650db6-7502-4b68-9783-a5495b038c11"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzE5MA_0329ddfe-f880-4354-9342-87ee6afda0e0"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <iart:SegmentReportingInformationNumberOfProductsOffered
      contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzYzOQ_5e5892b9-f32a-4154-be0b-d3741c7150a9"
      unitRef="product">40000</iart:SegmentReportingInformationNumberOfProductsOffered>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMTY_b064237e-649b-4732-9535-a5848193299f">Net sales and profit by reportable segment for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,882)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,914)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,757)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(453,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtMS0xLTEtOTI0Nzk_7d38d06c-c896-43e1-8f0f-ea2c87cb1dea"
      unitRef="usd">1019564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e6cde1e89644b7dbb3e4ca2ef7ee5dd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtMy0xLTEtOTI0Nzk_80600cfa-0daf-4749-be13-c94c05ba7fa2"
      unitRef="usd">1025232000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaef36bc3b87a4dd59790ecffe601f775_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzMtNS0xLTEtOTI0Nzk_0ac16cbf-7326-4313-86a7-065a21348b5b"
      unitRef="usd">894831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6006f7f023104e13b5a429288f6a1e4d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtMS0xLTEtOTI0Nzk_f33b37c7-7f6d-4713-b413-dfe8ed62ac98"
      unitRef="usd">538102000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i569ca16f78b8440ab0c69d65a2717cc7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtMy0xLTEtOTI0Nzk_2398de63-2300-423e-bbd8-69e8c14ddce8"
      unitRef="usd">517216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id72006d13aa946dbbfcefc4c2763ac8a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzQtNS0xLTEtOTI0Nzk_238ab1c2-ab0d-42f3-aa83-5a5b45d7de2c"
      unitRef="usd">477037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtMS0xLTEtOTI0Nzk_2b2cbe9e-5b38-499d-b3e5-cd2180487c29"
      unitRef="usd">1557666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtMy0xLTEtOTI0Nzk_0cd9caff-8978-4ccb-9f2c-8965d6964d6a"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzUtNS0xLTEtOTI0Nzk_89a2bfad-f36c-4d6a-9185-2071ad3744b1"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i148cca9d8e92463aa899bc73beb1ca6b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctMS0xLTEtOTI0Nzk_367bfd8d-4352-486c-a7d0-25391ce46a96"
      unitRef="usd">417873000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i814b998492a7444cbcd7886849cb6270_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctMy0xLTEtOTI0Nzk_94c43b20-4b76-4495-9cea-dda2574c02a4"
      unitRef="usd">439471000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib018f6bcc24a4b3dbe4ce6e3c97e8a0e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzctNS0xLTEtOTI0Nzk_780d9822-4288-47c9-8a38-03b3d212b619"
      unitRef="usd">356657000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4c96c89c8aef4dd0a52c23f78abe191e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtMS0xLTEtOTI0Nzk_ee879ffc-81b2-4cff-80e0-446653666386"
      unitRef="usd">233802000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie6b3618e04d540f4b99ec989ee7e7234_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtMy0xLTEtOTI0Nzk_3f0ea895-4032-4620-9ad7-aeee97c3bca6"
      unitRef="usd">228199000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icfa67b71c6874d56a903eea0c00a39c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzgtNS0xLTEtOTI0Nzk_931f102e-f88d-461c-b8dd-6ab66b950585"
      unitRef="usd">159630000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8beb115769fa4bde80a56f0d62b90c05_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktMS0xLTEtOTI0Nzk_aa282faa-283f-46af-b50a-696fc9306cde"
      unitRef="usd">651675000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i20b167d370d54bac874817e7f8c82740_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktMy0xLTEtOTI0Nzk_438a1142-fb8c-4284-b4bf-dd72dd598830"
      unitRef="usd">667670000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icc1ccf682b834d75acf993e77078be00_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzktNS0xLTEtOTI0Nzk_316d98fa-8c13-4583-b790-c2a33366ddf5"
      unitRef="usd">516287000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTEtMS0xLTkyNDc5_41ff7b42-bb1c-4498-a6ef-50f19555b03b"
      unitRef="usd">13882000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTMtMS0xLTkyNDc5_39effde6-7809-4743-b280-8d9881392e9b"
      unitRef="usd">16914000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEwLTUtMS0xLTkyNDc5_87aecda9-3fe7-4d09-b7a5-a54c1979a291"
      unitRef="usd">27757000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i035e179e3b8b4d64bfcfbf533913f64d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTEtMS0xLTkyNDc5_67e7c314-5ff8-48dd-a3fa-7f4f92c941e3"
      unitRef="usd">-398873000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4e1659d84668436b978aebc30d320151_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTMtMS0xLTkyNDc5_ac9b66f3-df9d-4888-aeb8-21f88bd8d56d"
      unitRef="usd">-453526000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8f6ca02b71f444939da26d0171cf9a3d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzExLTUtMS0xLTkyNDc5_9e3e9eb9-98ee-46ca-b282-3539374020fd"
      unitRef="usd">-337160000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTEtMS0xLTkyNDc5_8bb876de-603d-4873-80b0-7c9bd1de186c"
      unitRef="usd">238920000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTMtMS0xLTkyNDc5_f85003f4-3940-4cae-93eb-dc1027817ddc"
      unitRef="usd">197230000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTo3YTg1MTkyNWNhMzc0Y2Y5ODMyZjM1MjZjM2ZiODUyYy90YWJsZXJhbmdlOjdhODUxOTI1Y2EzNzRjZjk4MzJmMzUyNmMzZmI4NTJjXzEyLTUtMS0xLTkyNDc5_9df00a47-595a-4aaf-9b58-10cede63de24"
      unitRef="usd">151370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90ZXh0cmVnaW9uOjhkYTk3MWFjZDk0OTQ0NDI5MTVlYzE2NmFlZWY3OTAyXzIzMTQ_5cecac14-6748-4e1d-ba4e-4d3fc522b7be">Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,557,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d1a52a97e10485aa9156603f0f12998_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItMS0xLTEtOTI0Nzk_51edca67-2013-4647-8c14-c9afcef7ccac"
      unitRef="usd">1126810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7aa00ba8e0a4089b0402c6f812d9e90_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItMy0xLTEtOTI0Nzk_1b48155a-d5ff-40c5-927f-ec29e9611d40"
      unitRef="usd">170903000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37a4eff2718b4181a3594c15f97693d6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItNS0xLTEtOTI0Nzk_db5c90ef-e4c1-4c50-ace6-dfc9ab7cba0a"
      unitRef="usd">176477000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a2ba32f80384628b6d3da8a948107a4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItNy0xLTEtOTI0Nzk_ab2f351e-7106-4402-b046-6e0028f097cf"
      unitRef="usd">83476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzItOS0xLTEtOTI0Nzk_20ee7001-93c6-4dbc-bac7-73bb7ff2008c"
      unitRef="usd">1557666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2be3e483d1fa4218b4739bff6b339aa3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtMS0xLTEtOTI0Nzk_4f779781-b00d-4dc0-84f1-a3d8db23cbf6"
      unitRef="usd">1089526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2bc8a1f80f84b31a8dbe8ec757a0ec6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtMy0xLTEtOTI0Nzk_32ade442-0323-41c1-9ee5-a5f6a67cf9c3"
      unitRef="usd">191327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5db6e94f32d64676a8e5222a7710ac27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtNS0xLTEtOTI0Nzk_51bda27c-d3c3-4feb-b426-ebfbf8d7a7dd"
      unitRef="usd">182034000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia647697a80af4c1a998c2f4501de7cec_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtNy0xLTEtOTI0Nzk_4650440f-af9d-4e3a-ac83-3905359c582d"
      unitRef="usd">79561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4a11790d38d42fab04744f644667f61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzMtOS0xLTEtOTI0Nzk_b8c3090f-59ef-448f-aa55-0488e082e453"
      unitRef="usd">1542448000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie88400ec8187435b94bf27f234e62310_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtMS0xLTEtOTI0Nzk_7020abc6-e8ce-4849-b86b-d79163e92779"
      unitRef="usd">971975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1021003fc387465985bb51c9d1963f10_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtMy0xLTEtOTI0Nzk_e0c5a812-f185-454f-a9b9-bd630850b54f"
      unitRef="usd">172689000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i101af6c449e24243a977e3628cb006bc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtNS0xLTEtOTI0Nzk_1345843d-9670-403e-ad73-0660e98c11c5"
      unitRef="usd">157174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa59878bdb8a4814a9a4fcea4012a206_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtNy0xLTEtOTI0Nzk_da095bb5-54c4-415b-87b9-8186a761c702"
      unitRef="usd">70030000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5890ceb3267b4f218d5e425a8a87708b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzQtOS0xLTEtOTI0Nzk_eac64c76-9703-4d80-b018-61e44a649e87"
      unitRef="usd">1371868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NoncurrentAssets
      contextRef="i016f6830198948e4a83167888eedc5ab_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtMS0xLTEtOTI0Nzk_5103c44e-7c8a-48e4-80e6-bad89cea50cb"
      unitRef="usd">440223000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i27c47750f81947a3bd94f67736a169fa_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtMy0xLTEtOTI0Nzk_5a949876-2851-492e-86f0-15e5ec34449b"
      unitRef="usd">60857000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i3b9598bb29974c0eb5a1c729153672d9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtNS0xLTEtOTI0Nzk_22a19755-a74d-4a4f-9fdb-a03ef6261c82"
      unitRef="usd">12975000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic5cf719a0faa4ece96aea8a2bae8fc0f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtNy0xLTEtOTI0Nzk_24750ac0-a11c-490a-ba69-96e046a1af23"
      unitRef="usd">2721000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5c0443956aba4287a79da88ad2b1f789_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzYtOS0xLTEtOTI0Nzk_9783cc49-317d-4768-af79-126be4b1ab4f"
      unitRef="usd">516776000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i34987c7e67424092b2a980a73d2196af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctMS0xLTEtOTI0Nzk_6c9b6eef-a428-46ae-9175-fc5af3e4085f"
      unitRef="usd">339535000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i792da25db32e486d817b94438346f505_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctMy0xLTEtOTI0Nzk_e61f148a-5bef-40af-967c-c5f64dbbbd08"
      unitRef="usd">55026000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id0356b0dec6c415886e16716b8d764cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctNS0xLTEtOTI0Nzk_c0c523d6-1af2-444f-953c-f5d15b2d1716"
      unitRef="usd">11289000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id1045633e59945fc8f109a571dd0a894_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctNy0xLTEtOTI0Nzk_5641354d-f599-4cbd-83ca-2ac4a91877c0"
      unitRef="usd">6836000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZDZiZGY5NzQyZTQxMzFiY2VmNGQ0MTU1YWFmYjg5L3NlYzo0M2Q2YmRmOTc0MmU0MTMxYmNlZjRkNDE1NWFhZmI4OV8xOTYvZnJhZzo4ZGE5NzFhY2Q5NDk0NDQyOTE1ZWMxNjZhZWVmNzkwMi90YWJsZTpiZjJiZThjYmUwYWE0NzJkYWJmMzBmYjVkZmM3YTdhZC90YWJsZXJhbmdlOmJmMmJlOGNiZTBhYTQ3MmRhYmYzMGZiNWRmYzdhN2FkXzctOS0xLTEtOTI0Nzk_0863d8ae-46ab-4504-9cf7-d6a46e189f8e"
      unitRef="usd">412686000</us-gaap:NoncurrentAssets>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>125
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M,AK>D# (PQZ]49?DR.F-KDV2_%ILE4;S)'Z?R[=1&Y]7LV4R4R5-8>Z9.E"
MK^#%'S\,I\'G'M9QQSKN4V]8)9(GRN$<6W]T@BR%FFK 7%;VK9KJ144VFZ0'
M;=*A3:Y"V\CTXE/I5U@7$G/*24+Q<$.>3,U^,WCPW@,W[>"F5\&M&7+RL#K'
MUB\0CNZ"(#A'XI^4%P?<NR:B2"HKH9M*ZU:[/K5HRO.?>]/D'BGNF5"D@)T)
M#0:WYKZP:1R-H67IBG4KM2E]-\U-KP6T#F9_)Z4^&O: KGO'?P%02P,$%
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MHJ;=^W"Z#RXX";> <]A)NO?K;PR$$'#8WBFJ5#!Y9NSGF;$]]FC'\N]\1:E
M;VF2\;&V$F)]-1SR<$53PB_9FF;PRX+E*1'0S)=#OLXIB0JC-!D:NNX,4Q)G
MVF14?'O,)R.V$4F<T<<<\4V:DOS'#4W8;JQA;?_A*5ZNA/PPG(S69$GG5+RL
M'W-H#6LO49S2C,<L0SE=C+5K?!5@6QH4B&\QW?'&.Y)47AG[+ANWT5C3Y8AH
M0D,A71!X;.F4)HGT!./XNW*JU7U*P^;[WOOG@CR0>26<3EGR>QR)U5CS-!31
M!=DDXHGMOM"*4#' D"6\^(]V%5;74+CA@J65,8P@C;/R2=XJ(1H&V#EA8%0&
M1MO .F%@5@;F>PVLRL JE"FI%#H$1)#)*&<[E$LT>),OA9B%-="/,QGWN<CA
MUQCLQ&3Z<#]_^'H;7#_/ C1_AL?=[/YYCAX^H^G#W>/3[,OL?G[[;89N[Z$]
M0P/T,@_0Q8>/Z .*,_2\8AM.LHB/A@)&(WT.PZKGF[)GXT3/V$!W+!,KCF99
M1*-C!T.@47,Q]EQNC%Z/ 0TOD8D_(4,W#,6 IN\WQPKSX/WF>@\;LXZ,6?@S
M3_B;"R(HS#"!V )-60K3>B7GVY:BVRQD*45_7+]RD</,^5.E?NG=4GN7R\D5
M7Y.0CC5PS&F^I=KDUU^PH_^F4NZ<SH(S.3M2U:I5M?J\3^YA*8T+^52:E;9V
M82M7S.T$>[IM0SBW3344,,?77?L8%BA@INGY1@T[8F#7#.S>O'@0*YJC\"@A
M+A+&^<>*V"?T2F%#H$B0MRL52_N<F7%.9\&9G!WIZM2Z.KV9,5V1;$GEHB;%
MBY<9++]Y3K/P!X))EO&$E!M5]!>LRG)>*M>\L@^G$?,!=CW=;660$F8Z1BN#
MNC#;-!U3G4!N3=3M3:"7# J$)/Z'1F@)A<$^>8!;1/-X2^1&K.3FGC-OSNDL
M.).S(SF]6DZO-V\:<A[T.U*6Y#&/LR6*-KE\K '%(I7 7B?<6+=,&[>2IPMS
M/.RW<Z>+&OB.9[KJY/%KMGXOVZ^4\ROT1,.$<!XOXK S*^3T.:(/JU*R@1U>
M3JVL=_GUN_P]S_9;]!4H5S>L%OTN:F!8EG5B\<7ZH5[2WQON_S9[*K_-$7FV
MU0[;5 &S,7:\%CT%;. :IF^?X->H!W$OOX NX$L$>T@&;P*RM:SQUPG)H/J3
M ?Q?N5UUVQRP:QGMV"I0CN]WR'=1EJ-;)Z@;!^I&+_5G)DB"F&)_;3!N[JY*
MGD:7)P30:A/MPBS=T]M9K( -,&2Q=X+KH;C$O576I"HA@02ZH&\RR/1C'?.<
MPF8'.2 8BJ$&Y7+F_D06I12F8O"^XW>T4.&PK^MM,;HX[+@N/J'%H23$_37A
M.^,N4Q]*\5-QM[KSUK:,=NFH@!F>WXV[ F9:)S9^?"@=<6\%-3D^1NS+Q9\0
MLSMEK&':OMMAUL5AWX6_-C4%#BH?L[UR#1N'VI3FR^)R@$. -IDHSX3UU_H"
MXKHX=K>^W\B+B>*P?'!3WFK<D7P99QPE= $N]4L7!I67%P5E0[!U<71^90(.
MXL7KBA)8Z"4 ?E\P)O8-V4%]73/Y%U!+ P04    " "0@596S+D) FT'  "]
M'@  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;*V9:W/;MA*&_PI&S73:
M&3G"E9?8UHQCNTUF?!I/G/9\ABG8XH0B5!*RX_[ZLZ NE(B+G)Y\L4EJ ;Z[
M /99@&?/NOG:SI4RZ-NBJMOST=R8Y;O)I"WF:B';MWJI:OCE03<+:>"V>9RT
MRT;)6==H44THQLED(<MZ-#WKGMTVTS.],E59J]L&M:O%0C8O[U6EG\]'9+1]
M\+E\G!O[8#(]6\I'=:?,G\O;!NXFNUYFY4+5;:EKU*B'\]$%>7?),MN@L_BK
M5,_MWC6RKMQK_=7>?)R=C[!5I"I5&-N%A']/ZE)5E>T)=/R]Z72T>Z=MN'^]
M[?VWSGEPYEZVZE)7_RUG9GX^RD9HIA[DJC*?]?,'M7%(V/X*7;7=7_2\L<4C
M5*Q:HQ>;QJ!@4=;K__+;)A![#0@/-*";!O2U#=BF >L<72OKW+J21D[/&OV,
M&FL-O=F++C9=:_"FK.TPWID&?BVAG9E>?OKC[M/-QZN++]=7Z/W%S<4?E]?H
M[L/U]9<[=(+^O+M"O[SY%;U!98V^S/6JE?6L/9L8>+-M/RDV;WF_?@L-O.5*
M%6\1(V-$,:6>YI>O;TX.FT_ WYW3=.<T[?IC(:=73:-J@R[:5IGVG<^?=0?<
MWX%=6^_:I2S4^0@63ZN:)S6:_OP32?"IS[L?U-F!KVSG*XOU/KV4[1S!J*'"
M7JB_5^63K,!Y[RBNNQ)=5S8!/$VY2)($8OZT[X]K)@CC/-N9'2CE.Z4\JO1+
M(V<*UG6A5R /<D2A0.M]I<:HAGRF'Y"L(.O(NE"MO7O#QPSSSC>X3)GP>;1^
M9;(GE2:,)V+@D<>,D8P1OT=BYY&(>O2Q?H)(ZZ94;>>#3Z!PWLPH%QD;"/28
MD91EB5]@LA.81 7>-FHIRQE2WP ++835!E.;N6H@]ZS7B.S6B$]YXD@B)$FS
M?*#<-<L)%H'(ICOA:7RN:".K5VA,?1H)S[.!2)^=8"D)Q#?;R<R.Q!=XVYB7
M,5I6T@J%\-HEN 00FN"4R#QC31BF \U>LQ0SO^1\)SF/2NY ;I?7JE7KP ('
MK!?2E/4CJA0PTQOJW TASVC&!ZI=LXP+'A!-<(\Q?&2I&5D_EI M-K,A&-U-
M1X=C39,$#R>NUY +D8;$[C&71,7^KO7LN:PJKSSBOA6S+,N&2=AK"&E8!-(P
MZ>E(HD "W#XH6%@S9.2WH]&DC@HN\GPXZAXSD>0"!Z3V<"-QNGWJ<E5X_6^:
M'[PW)3D>RG/-2,)Y2%Y/-'($:5V:BLASN0-#G:=BF)]\AFE&61::BSVBB'A5
M+713RONR*@VPREL0D2CJOK<B^E&]'3K=8X_$N;=U>JF;;C,!Z>Y>-] -I+@6
MK>H93*I6U:4&#L)"* UZD(6-SHLW-"[B6$;HL,;PF'&!<6B2]2@D<19ZG.FR
M-*HV0_KRR@Q./!3D"776LL\L347 CYZ5) [+BVWEMY0OZ[+/V(K0J]1E'X&M
M 7;6M6N70%F7!J3VC"1Q2%[J&K059A?B,A!1EW8I%</:SF,E:!Z()^V12.-(
MA'@V*\CBA5[8ZD[:R>'=ZKB<2[,T'?+&8Y;31 0J)-K#D,9AN)49J4&/1)FZ
M),PP9L,P>\P(Q4%>TKW=9)R7A\7H,;$N"1G%.4Z&:CUV''?[7Z_:'IDTCLP;
M73^>&-4L_I^41UU@IHQ!83WTPK7+**<BL )I3U8:)VO4"Q@*B/\_W8R/N^%B
ME6">.GG$9P<)/I2[:4]?&M\A]FX4&C:+D,!M!;OU(#"#W+V@2%+&G07KL^.<
MAE9L3T\:I^?-OZ(+]>P71<JI$VO/AA$SF@=4]YBD<4P>5+7'%JF+N(0Q-JS*
M/&9<I%DHH?0DI'$2KJO:8QH]#&29P,XT\-A13(-IKX<@C4-PG?:.J7391G$F
MF!A61UY#J(33P,"SGH,,1RO<.Z.+KW-=06YH?_XIHR0]1=>P"3<OWD*71:GZ
MO87NC^KMT/<>KBP.U]MF.^N[*)RB6D-YU: G6:W4*2)B# 4HDBLSUTWY#YBU
M<PDZK%VMD%Z9%K;5,UC8WDBY0!TNYJC)H4\];ED<MY=ZL8"\WJX=>H/?8K+O
M$^4XY%2.QU"H=@5&EH\3,"K;UM8>TJ K5:C%O6K6P=^>57>V]M1YC*"'I>H^
M.E1>EC 7V#D>SG*/498'$C+;.^*-(_UB!KP&UL%RM,=Y)V6-"KDL87EZA7HV
MNS1-\C0=BO49)CP/G=:PGM[LV%$O8&+5O*P'<6SC7^C6G*)D#)O:+NA\G.7Y
M9N1^S/BX##]A"<V2X;F:SY R'CS?9CWM69SV4.JN%JM*&K6K<*$V;]3<?A9[
M4JBLX5ZA7RK=MK]Z?7"1#OL>YS3;8W;"!1&!+07KR<_BY/^LC(1'4*S+IK8E
MEU>D"_ LS0D9TM-CE^292$)A[DG/7G,XW'K2ONK2OE>T9U.;8<[Q<!?A,TPR
M#K8!V3WU69SZ#D^[R?V=;F3.IQG_@9+/T'N@--G[MF@_[/Y'-H]EW4*A]P M
M\=L4NFC6WTK7-T8ON\^-]]H8O>@NYPKV\8TU@-\?M#;;&_L%<_?%>OH_4$L#
M!!0    ( )"!5E8+9R#I0@,  $D*   8    >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&ULK99=;]HP%(;_BI5-4RMUS2<!.HA$H=,F[0.-;KN8=F&2 ['JQ)GM
MP+9?O^.$9E!2"MJX('9RSIOG/?%)/%@+>:=2 $U^9CQ70RO5NKBR;16GD%%U
M*0K(\<I"R(QJG,JEK0H)-*F2,FY[CA/:&66Y%0VJ<U,9#42I.<MA*HDJLXS*
M7]? Q7IHN=;]B4]LF6ISPHX&!5W"#/3G8BIQ9C<J"<L@5TSD1,)B:(W<J['K
MF(0JX@N#M=H:$V-E+L2=F;Q-AI9CB(!#K(T$Q<,*QL"Y44*.'QM1J[FG2=P>
MWZN_KLRCF3E5,!;\*TMT.K1Z%DE@04NN/XGU&]@8ZAB]6'!5_9-U'1OV+1*7
M2HMLDXP$&<OK(_VY*<16@AL\DN!M$KQC$_Q-@E\9K<DJ6Q.J:3208DVDB48U
M,ZAJ4V6C&Y:;QSC3$J\RS-/1^..'V<=W;R>CVYL)N1Z]&WT8WY#9FYN;VQDY
MFU()N4Y!LYCR<_*2?)Y-R-GS<_*<L)S<IJ)4-$_4P-9(8O3L>'/7Z_JNWB-W
MG4!\27SW@GB.Y[6DCX]/=W?3;?3?%,%KBN!5>OXC>C--->#:U$0LR&N6TSQF
ME).I4*Q::]]&<Z4EKKCO;59K[:!=V[3AE2IH#$,+^TR!7($5O7CFALZK-N/_
M26RG#'Y3!O^0>G0K:0+86+$H<ZVP26-@*SKG<$$HQW['LD#KPZYE.Y6L>6^L
MHL!W@H&]VG;6$M3U.TW0#G'0$ <'B:?8\R E) 0;);Z[( 659$5Y">0,5V@B
M.*=2D0+PQ97B8CYOHP_VP)P'Z(<B=K@[#7?G-&Y:ZE1(]MN<,:"JXJ^'K="U
M?KB%Y':<ZO> _8C '0MA8R$\S0)^(Y3&UP'+ET_!AWM,#ZD/1>S@=AO<[D'<
ML<@R[.1_6":U?G<;Z=)Q'W _$;2#WFO0>R>@G[Q2>GNE] *G=:D<$[GCH-\X
MZ)_@@"E5(OT3V/T]F+X3=+O[U/N!O7YX -IU_GX:G2?>AT!5*7\UI=<D%DJ_
M.K+P&_5MLK#G^?L.6@*#7K^_[\#>^LZ;3=9[*I<L5X3# C.=RRXVNZSW+?5$
MBZ+Z],^%QHU$-4QQKP?2!.#UA1#Z?F)V$\WN,?H#4$L#!!0    ( )"!5E:,
M;""@/PH   @O   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULK9IK;]LX
M%H;_"N$=+%*@;L2+;MTD0&JE,P':)&@RG<^*3,?:L24/*2?I_OH]E!S+%@_I
M!,B7QG)?'NOEY?#AY>2I5G_KN90->5XN*GTZFC?-ZO/QL2[F<IGK3_5*5O _
MLUHM\P8>U<.Q7BF93]M"R\4Q"X+H>)F7U>CLI/WN1IV=U.MF45;R1A&]7BYS
M]>N+7-1/IR,Z>OGB1_DP;\P7QV<GJ_Q!WLKFS]6-@J?C;91IN925+NN**#D[
M'9W3SYE(3(%6\;.43WKG,S%6[NOZ;_-P.3T=!>:-Y$(6C0F1PY]'.9&+A8D$
M[_'/)NAH^YNFX.[GE^A?6_-@YC[7<E(O_BJGS?QTE(S(5,[R]:+Y43_](3>&
M0A.OJ!>Z_9<\;;3!B!1KW=3+36%X@V59=7_SYTU%[!2@D:, VQ1@PP+"48!O
M"O#7%A"; J*MF<Y*6P]9WN1G)ZI^(LJH(9KYT%9F6QKLEY5I]]M&P?^64*XY
MFUQ?W5Y_N\S.[RXR<GL'?[Y?7-W=DNNO9')^^P?Y^NWZKULR)G_>9N3HMP_D
M-U)6Y&Y>KW5>3?7)<0/O8"(=%YO?^]+]'G/\'F7D>UTU<TTNJJF<[@<XAI??
M.F O#KXP;\1,%I\(IQ\)"QA#7FCR^N(4*9Z]OGC@<<.W[<';>-P1[_KFXL?Y
MW>75[^1\<G?Y\_+N\N+V,U;-71B!AS'9XK->Y84\'4$ZT%(]RM'9O_]%H^ _
M6!6]9[#LG8+M59_85I_P13^[@DQ95D6]E%B==67#MJQ)B(]G- G"$-KM<;<V
M$%F4!G&X+\L0&>=)RK:R/0?AUD'H[0#GT__"J(?,VFC2U)!:B[HJRH4DU=::
M^=X\%;F>DY6J'TL82>3^%X'90.5-63UTZ;1L2JG1SA.^9^=YSV#9.P7;J_IH
M6_61M_-D$H(69=Y-2-64Y,M:->7_VB^P:NS"1;L]@"8L30?]"9.E"8\&_0F3
M10&G>'^*MZ9B_XBHJW';4<IJ#'VED%H34W6Y*N:MR:E\A-E_97H<D<_ $QH=
M.['U=L-A<U"1V8J0IKB]9&LO>:6]Y2HO5>NBF.?J0:*34W+0A:U@<2@&1GQA
M]FRD6QOI@:XWDTK!*'X9X?DS.;J7E9R5S8=NC&M')TRM=QF+,!DDJPFB E_#
ME(:H(D%Y@INC00\9@=?>+;2('!L^FQ+P9SJ9<U!M0NVW0,R&AA 9CQ@==CE$
M1M,P=307W<$FZG5TOI,:2#V#470/Z5GK=5X5$CQJ2-]F=&U&%#QH79O< C7P
M5#;SK@ P;EE!"4C9:%50Z^6C1%@U8:OB@%L58:LH"^+(41&LKPCVN@&XD-"\
MO@RR";37L F-AFYL%4_X< !BL=*=[KQOIH<OZH63L_.B4/*E2>]K:+]MDTY+
M7=3KJD&=\8-IY; D0R0T%-1EJD<BZF>B;S6D_*/?80WX@8 S,+*J=;XP%B&Q
M #(TO[JN^L^Z[*8!\P38H1NU[E9GW=SQ /,&COP"R1L)Y<,ZL&6,":L:;%6<
M.)NVQRKJ18<SXY_,5+TDS5P2\"_;-EYKT&F-SQ:;D(-\*(:V$)6@<9H,C=DZ
M5QKJB87ZD64RSZL':=9D,YC]R&.^6+>^H/4,![:S(30D *+JL::&&E"X89M!
MQ@QRB649T]&(#1W;LC1T\ SM@8;&7D+N/&MC&I*JW"3:19G?EPLW\E(O)KV5
M>=\U6O9>T?8KM$<HZF<HR'HFLQDN+&3YF-\O\/QM4\^8\S2PYB-;%[-HB!J(
M*H3IVS7.>Y"B?I*ZK!ZAU]>J= QI#(12RJP>;NM"'EO3$ 9?,%LY@(GUP,3\
MP'2C).#L+CZ\C%M2K $439)N^S[FD=G,DT1T,#@GB K&,!6#K)TA.AIQQRJ7
M]0#%_ !UW9JI##T<-F2S"[QJ8CE"0"BQENV(BO*8.SH>ZT&(^4%H.XI6^2\S
MA#["(KQ0:^EMQ)VLA1JW,8?&?-A$$T3&66+U5D0V#N.0NMJRQR;FQZ8)S#8J
M+P[;L0E'L.%K3A 5&\ZEB&;,8X>/GI28GY3L/GG($ (^0O!DZ B144&MQ0JF
M8TGB6"*SGGV8GWVN7KM9A'JTL84!!$7#70Y$QR&OLGAH$HD7 .*[>F'/0BSR
M<L'EU<^+V]=LG3(O4[T5!=XU6O9>T?;KL&<KYM\MNEFK8IZ;7.5<': U:N_L
MC 5#$A6F2]I]^_T^@N@X# 0'+[,>=9@?=6[,#IB<ZFXE,%P%H-:0#2&>1L/U
M'2*C:2 B*W&]>NN(]<C#_,AS7D#;=)M'A[?XS'-9-8#0)4Q2N&6,:F)A3;>(
M++3\8KP5!H'#-.\)B?L):=+F,\-(LUIM6Q!R&=2%+LU:1W]L=\G-:LAH\TTM
MH8<I" N%- R&.0[3\8"G5B9'A"['/3%Q/S'9??>-HY0CY / -^1W1#9D0DP2
MA8[YE_<(Q0_L)4%SK5Y<'@%'M<<@[:Z%?LI7&CJR+A^J=A,MUYL3D4?9'9>0
MN9PZ=GVY#3XBM1O75L7#/7I$,XX3X6K;G5,_/T%M9^BU;L?QQM?AV9DC(!0F
M83+,3YB.1E18N(\)HR2(N<-B#U=<>*?GKY=7YU>3UYQL>B'MS4>;[QDM>Z]H
M^W78@QSW@]Q^"KBO%42 /M+F@45=/8P;J9;0=\SFLIRZIC1N$Y@(8NL8%)&Q
M, RL5&?+:$Q#9X;O>8[[][9N-N._W;0$0Z@59".*BL0^TT6%J!U$* 1USU@]
M6_'7L95IK'K5[L:U*<OX*VH8[ZHQ4S*L/QK'6#]\!G=8DB&2,0T$<VU:\!ZN
M^%O@RK*TW4M'O1T^F3LLR1 )+'#=;=<C%O<C%LZ-NJF+O\GJI5V?<J7R"M_"
MX#8'6?X.2C)$(D08.7*SZ&%*'-ANZH::XR +O4KA YS.#R(9,S&8=3-<Q84#
M)D2/2^( +NT,MT;)7*_5KZ[%4#_(%A/=!]6-*ULX;"4T5A XNZ'H 4GX 6F_
M&\IGJ8K2 $/7$;ND@C>7S2VA&.[)3A!5E RW1C,L%G,MWT6/0.+ )I+!GR9_
MEKK#>H @ WB&: %NM6R:A721K4"@A8F(#C=B,!VL/^G0(095NQ> ]BWN7$XZ
M?#NII;RC#>9]V-N1V9X%'V ^@6T3A30-A\MM3)@FC VI%M%1<YSC,MSSBO#S
MRL5L)HLVK<CGHCNJ4D#OI-@<X9B9KUV;F0-'\\&T]B-D5T<6%<A1&PUB9AE'
M=*FP:!Z149[$CA,JT9.+\)/+YA:::D_$CZ:R^_3!=.FWV458)(SB)![:M76"
ML^'^>(;(6&P@R.&W)QOA)YN)RQ3)&W(O'\JJ,KW:+%:E*FMT"2ZPRT%<"&L(
MVSH1!S2RVM;6T31)J:MQ>\H1?LKQFI5FA]]KLPN^>VL0)O HHD.;M@ZKC@R+
MMU\=G<WCG2O"2ZD>VJO6FK1'%MU=V^VWV^O<Y^TEYL'W7^CGK+N4W8?I[HA_
MSQ6TM"8+.8.0P:<87DIUUZZ[AZ9>M1>1[^NFJ9?MQ[G,IU(9 ?S_K 9,W#R8
M']A>?C_[/U!+ P04    " "0@596LC*1K2P,  #)?P  &    'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;,6=;7/;N!6%_PK'W6EW9Z(U ?!UZW@FD?C:W22-
MDW8Z._W 2+"EKD1J22I._GU)B1%- ()%[TGV2R+)P',!\EP2Y '(J_NB_*U:
M<EX;GS;KO'I^L:SK[4^7E]5\R3=9]6.QY7GSE]NBW&1U\[6\NZRV)<\6^TJ;
M]24U3>=RDZWRB^NK_6]ORNNK8E>O5SE_4QK5;K/)RL\O^;JX?WY!+K[\\'9U
MMZS;'RZOK[;9';_A]?OMF[+Y=GFD+%8;GE>K(C=*?OO\X@7Y*;586V%?XE\K
M?E\]^&RT7?E0%+^U7Y+%\PNS;1%?\WG=(K+FOX]\RM?KEM2TX_<.>G&,V59\
M^/D+/=QWONG,AZSBTV+][]6B7CZ_\"Z,!;_-=NOZ;7$?\ZY#=LN;%^MJ_Z]Q
MWY4U+XSYKJJ+35>Y:<%FE1_^SSYU&^)!!<LZ48%V%:A0P3X5@745F%"!L!,5
MK*Z")5:P3U2PNPJV4(&Z)RHX705'J.">JN!V%5RA O-/5/"Z"I[8!^]$!;^K
MX L5G%,5B/EESYE[!1UV^5XOLZS.KJ_*XMXHV_(-K_VP%]V^?B.35=[FQTU=
M-G]=-?7JZ^GK5S>O?TYF+]X%,^/F7?/?+\&K=S?&Z]"8QB]>1<&-D;QJ_O!Z
M^H_X]<^SX.W-WXS@G^^3=_\Q)L;[FYGQ_7<_&-\9J]QXMRQV598OJJO+NFE8
MB[^<=XUX>6@$/=&(=T6=K175IOIJT]UFM\[:_#*"V]LFX9X9;WBY*A9&<6N\
M6!3;-@.?-9_^UVS))J=K18C9(R&*S:;)XINZF/^FJ!T\TJ_FB%7MRL\GZX?Z
M^B\6BU7;AVQMO,E6BTF2&]-LNU)OK.BI+ .Q'>-'HL_GAR!\8;RNE[PTFBW;
M'-"7[9&VB9OD\V+#%=Q$SWW+Z^8<T$"#K,Q7^9U*?.E(Q!_='I=-"A[SD![S
MD.Y;89UHQ<MLG>5S_LQXR>]6>=N.-E@7]OLFO:IE5O+J!R.KC1F?_V@P\LR@
M)O%5V:8-U9YQ?ZJVV9P_OVCV0,7+C_SB^J]_(8[Y=U4.(F&S \S9P]I3]\=K
MSW.9;9KFU>7'AXF%C!HB81$2%B-A"1*6@F"#9&#'9&!/3X9S$N" MQ_(C%C$
M<9DS5-E4+C>AHA1G<J%&LX)<%2!"?-]BPW*AHF&4,(<*,2/M]ADK,D7C7,<R
MZ3!F(A=COF>[UK!8^L@V&^QPZ[C#K2?O\&?&\#0Z^FBH#3WV:(B$S9"PP)(.
MK1/J.?*A-41&C9"P& E+D+ 4!!LDAWU,#GM/9R>2HQD;M0G C>\;J>\__=".
MM_?)L"S6"UY6S9C\]]VJ_FS\^K98KXWFRO$^*Q?_566#C<P&)&R&A 5(6(B$
M14A8C(0E2%@*@@TRQCEFC*,]G;SB=9,A)ZXH7CK2@9(PYOG"Z7"J#3%6VTA8
M@(2%2%B$A,5(6'+>3D]!,0>J=8^J=;6J/5P7SP?7Q>NBJIX9>:/G9CQ49Y]4
M>G:EKE$F#CRGVM!CU8R$!4A8B(1%2%A\SEY*D!%3$&R@9>^H94^KY:2J=NV(
MOI7M_' /K=H/WNME6>SNE@;?;-?%9\Z[G[>[<KYLQSC;YD+@X0A?)7AMZ+%#
M&"1LYBF.,O*]#63($ F+D+ 8"4N0L!0$&V2&?\P,_^MEABH;?$ESCB]<LT^U
M31HK<B0L0,+",S9%A P8(V$)$I:"8 .)$[,WE<RGB?RV*(V/O*J[.SS[@_RD
M]3<71M9>LO:#G</QW[A?U<LE7R_V-9L!4//3(V<'?=/&GAZ@M%E'>ZA0VU2<
M(13E")'OY$ ;%T%I,9260&DIBC;,C@>6*_G3LD.9$42^-6@S3SA'Z!L]6NE$
MNDU,19'+16SJB!)7M)V8CE L@C8^AM(2*"U%T8;:[6U*HO<I;QYHLKU4;:Y3
ML]8.5>I.=ON(;YE$%![48>QH#U5EB<*#FHO*7C+?%14*]0VAM 1*2U&TH4)[
M[Y#HS<.]0HV2'P?.6;XP^.'V>*O8(N?YX7;*DC<_Y!]Y6:\^K+F1%S4W5MVQ
M>7^D58J:2;O;HC;S15$C';P9E!9 :>%Y&R2"!HVAM 1*2U&TH?Y[*Y7HO=07
M\SE?\W(_U:8;)O3)L'AT] QU2Z&T&906$)5A:CJF8I@-=4RAM!A*2Z"T%$4;
M)D)OFQ*MQ_1((BC%;ZL&F[(BIOK(HW4-=3X[FC 7Q7:I)<I:[JVB6 1M70RE
M)5!:BJ(-]=J;ED3O6AXGP03YXJS)?^VL(86(D;[9%$J;$=F&\WQJR[<V FC<
M$$J+H+082DN@M!1%&V9$;X@2O2-Z(B/.R@)7.@H2FUB>XXJ'<KG@Q'%,2R@W
M4Y3S?":J5@&CK(E+Q&.O; <2ZIN^Z8E'7U7S&!5GY<4*X,2U3%L8AB>*<C:C
M5+RADBI[XKI]AX>[M/<%B=X85._2$7/\3NQNJ"<(I<V@M(#('N/$\HFE&+9"
MK4$H+8;2$B@M1=&&&=+[@^3@S7R;Z7X$Z2I-H;09E!9 :2&4%D%I,9260&DI
MBC9<1-,;CU1O/#;7?,4NWQLH-W66+UK3Q'B_7307@<:OP:>ZG5;5WNO[>575
MRGP9S_^";T]-$],Q?OV%;S[P4D6?ZNFC%],@:0&4%D)I$9060VD)E):B:,/\
MZ:U)JK<F]3-GJ>S8$<<W75L84^N#C)8YDA9 :2&4%D%I,9264-F(5>W[%!5U
M*.#>GZ1Z?_*IDVBI[.)1SS?%B53ZZ*.5C:0%4%H(I4506GS>SDJ@05,4;2CL
MWM:D>EOSJ\ZHU<<>>Y4 I<VH["\23[%@&&IJ0FD1E!9#:0F4EJ)HPR3IO4^J
M]S[ADVNI;!(20L5[B/I6C18\U.:$TL*SMD<$C1E#:0F4EJ)H0[WW%B?56YQ_
MYCQ;?=-&GS.@CBJ5K4W&%"Z3HAQ1K)B&-BZ"TF(H+8'24A1MF!V]H4KUANJW
MGF=+5>ZF=&T,-50[VN"*7-2X7,01C:M0T70J3M2,H$V/H;0$2DM1M*%P>]^3
MZGW/,9-LJ6SH,=OWQ/6?^HBC92>[@^+L;FC \$0O)85"EVQ":0F4EJ)H0X7V
M-BY]BHVKLVV)4KQ0VQ9*FU'9:/5\1S$;+(#&#:&T"$J+H;0$2DM1M&%&]+8M
MU:_K/&^NBCH+?,5M=<_RY+N/4/M5$;81N*AMN="$,LNR/'$$(2^^)-2QI$=@
M1=!.Q(JP$\LFMBW>"U2M#?5LQQ-O7W\-_Y+U_B73^XM_?'J,4F%,7D\XL3S?
MEV>VZMLW5F)06G!V+T)HW A*BZ&T!$I+4;2A^GOWD9%O./6%(?VO*90V@]("
M*"V$TB(H+8;2$B@M1=&&R=,[GTSO?.JM>R8OBR2>:=O2\1]J<$)I 9060FD1
ME!9#:0E3K%!5[/L4%74HX </?=4[G$^U[IEL$-JV)3Y2=:J//EK9T!694%H(
MI4506GS>SDJ@05,4;2CLWI5D7]&5?,R&T<<>/<J!.IE,X1:Z\OT3:- 02HN@
MM!A*2Z"T%$4;)DEO9;(G6IE/M>Z9PMLS7?&I)_I6C18\="4GE!:>M3TB:,P8
M2DN@M!1%&^J]-R?9GV=./GK.@"X1A=)F3&&BVO(MGD!13K4("MJX"$J+H;0$
M2DM1M&%V] XHTSN@W]JZ9XKED]2D5'RLB[[9H[4NVZC2BR441<1'=X7JUOOB
M(M$(VOH82DN@M!1%&\JWMT>9WAX=8^ SV6>DKNM)EZ]0<[.CZ0Q\:,!0W4MY
M^ &U*Z&T!$I+4;2A0GN[DNGMRC_VE" ]?/0  FIK0FD!4_B+Q&?R!/00&C>"
MTF(H+8'24A1M^.*AWG&U'EW1.?(I09;"AB14GC8ZU4<>JVLH+>AHPZ<$49_8
MPFD@5/36DDI%T,;%4%H"I:4HVE"NO45JZ1=HCI]X194:AGJC4-K,DE<:^J;E
M.O(U(#1N"*5%4%H,I2506HJB#3.B]SVM,]^<J9UXI<X"I2EJ6:8X>U;?A-$"
ME\/ZIBUJ6RXT80[U'.D K>@$=1W?%5?E0#L1J\*:U!'G72F*>:Y/B#CO"M6X
MH8AZ[]$Z\XV33YYWI1:8['9-'(_*3WR?ZMLW6F%0=_+L7H30N!&4%D-I"926
MHF@']5\^>!UX^Y+[7[+R;I57QIK?-GCS1[?)QO+PWOC#E[K8[M\0_J&HZV*S
M_[CDV8*7;8'F[[=%47_YTKYTO'WE_3[&]?\!4$L#!!0    ( )"!5E8E[8)M
MU ,  #0(   8    >&PO=V]R:W-H965T<R]S:&5E=#DN>&ULC5;;;MLX$/V5
M@0H4NT!@V4K:31/;0)RT:(!V&]3M[L-B'VAQ+!&E2)47*]ZOWQE*5AT@-?H2
MD]1<SCDS'&;>6??-UX@!'AMM_"*K0VBO\MR7-3;"3VR+AKYLK6M$H*VK<M\Z
M%#(Y-3HOIM/7>2.4R9;S=/;@EG,;@U8&'QSXV#3"[5>H;;?(9MGAX+.JZL '
M^7+>B@K7&+ZV#XYV^1A%J@:-5]: P^TBNYE=K2[8/AG\I;#S1VM@)AMKO_'F
M7BZR*0-"C67@"()^=GB+6G,@@O%]B)F-*=GQ>'V(_BYQ)RX;X?'6ZK^5#/4B
MN\Q XE9$'3[;[CT.?%YQO-)JG_Y"-]A.,RBC#[89G E!HTS_*QX''7[%H1@<
MBH2[3Y10WHD@EG-G.W!L3=%XD:@F;P*G#!=E'1Q]5>07EJNOZ_L_WZ[7\SQ0
M-#[+R\%SU7L6/_&<%?#1FE![>&LDRJ<!<H(Q8BD.6%;%R8AW6$[@?'8&Q;0H
M3L0['[F=IWCG/XGWR57"J/\$E_\,;JWQ5BLI^FXP$AX<>C2A/[!;>*>,,*42
M&M9TB-1ZP<,_-QL?'#7/O\])U .X>!X 7Z@KWXH2%UG+N=P.L^7+%[/7T^L3
M]"Y&>A>GHI\LW:]YWIN E1/P06UQ72HT)7IX;[54IO(DF&NMZ]7Y+=0(+U]<
M%L7T^M8VK3#[M)M=_PZ=\*!,.5BCI W<H1:=<,CKV9O+-Q/X0@$&3U >!-]6
M+:G9$30-$W1LVJ!4)>D?L*R-U;;:/W7D5%L;N=_HGH0:&)8HOT?EU:&*P@":
MBABC(RNZ'YJ&BSD*":T6@<<91$\6P=)P:85RJ2<<DC$R#PC*^X@36!,YY$S4
M1 ?%:@(B<4<SK:40)C;H;/30.BMC&8 %)Z3.-N1';(^24V(0;:N))R/VX 2C
MK7KK371];TK$=D! 2A%CST"9[@"6F,I(2&@P]=KQMXVC,7P&!*ZC.<>_AIO.
MIY !C:2$3Q5E(OA(2Y944;_SB/NA DW,8_";Z)E9PD*JZ$C5\]%5J6C*T$6)
MZ=:<4=[H[/AIT*7'(>2.KAE7D'E!R6T2:M*OJJ'2=D/V1R7M?0["#IIS$L;0
M\+/%Q'%G]8Y5I+*35"0.<^GG)[H^!IJ:\T)+M-B?$S\5@QX+[9/G"%@J1^^'
MWH\(=\(I+K47FDML77F0=S 0R03#GE%8 N<H""FC-C&U:$DH#&H_>6X$Y$>3
MG(!7Z;TB(J14Z(?Z>#H^B3?]2_##O']//PH2G^33N"77Z>2/5QFX_HWJ-\&V
MZ5W8V$ JI66=;B(;T/>MM>&PX03C/PK+_P%02P,$%     @ D(%65E[KUZ09
M*P  !H4  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULM7UI<]O&MN!?
MZ=)SW=A5$"V2VIPXKJ(ERE>O9,DCR<G+3,T'D&B*B$& 00.2>7_].UMO("@Y
M=^9]2"R2Z.WTV3>\?ZKJ;V:I=:.^KXK2_+JW;)KUSV_?FOE2KU(SJ-:ZA%\6
M5;U*&_A8/[PUZUJG&0U:%6]'!P?';U=I7NY]>$_??:D_O*_:ILA+_:56IEVM
MTGKS41?5TZ][PSW[Q6W^L&SPB[<?WJ_3!WVGFZ_K+S5\>NMFR?*5+DU>E:K6
MBU_W)L.?/Q[B\_3 ;[E^,L'?"D\RJZIO^.$R^W7O #>D"SUO<(84_GG49[HH
M<"+8QE\RYYY;$@>&?]O9+^CL<)99:O195?R>9\WRU[W3/97I1=H6S6WU]$\M
MYSG"^>958>C_ZHF?/1SOJ7EKFFHE@V$'J[SD?]/O H=@P.G!C@$C&3"B??-"
MM,OSM$D_O*^K)U7CTS ;_D%'I=&PN;S$2[EK:O@UAW'-A[NOGS]/;O]0-Q?J
M[O+3]>7%Y=GD^EY-SLYNOE[?7UY_4E]NKB[/+J=W[]\VL!Z.>CN7N3_RW*,=
M<P]'ZG-5-DNCIF6FLWB"M[!1M]N1W>W'T;,SGNOY0(V'B1H=C$;/S#=VIQ_3
M?.,=\TWF\ZHMF[Q\4%^J(I_GVJC_,YF9I@9L^;]])^;Y#OOG0PKZV:S3N?YU
M#TC$Z/I1[WWXQW\,CP]^>6:WAVZWA\_-_O]X5_^_YE8?)W>7=_C@E]OIW?3Z
M?G)_>7.M[I=P7K7(R[2<YVFA3),V&JBW,2HM,]4L-5#@O%JMTW*#\"ZK!H"=
MUEH!I-;P;Z;RDAZI,YA" QTT2_HL%[2N<YAY7<"H!UWJ.BV*#?ZNUPV/Q26^
MECE^NL/%C:H6:K+2=3Y/:0_SJD0NIII*W>J'MDB)+]SM_Y=J 3]KFN!.S]LZ
M;Q 1IM_GR[1\T&HR;W"JX;OQ8:)2V#0<"_!Y  "XO#Z[_'(U)7"<W5S? 8S.
M'3QP00-HE:6XIU[0P)&*-M,./"U^"6OAYS,&%FT]AZ^?EA4<>;]Z*F$VT\Y,
MGN5I#3L=J,NRT?7</F_G(;C7:6E2XH!&+=-'K69:ETH7.3"35"#G]PF/#0 &
M6EW#]2@X[F3^5YN;G,?CA.? 1$V3-RW@MTH4 !288)/F!>V[!#8<;LT>T%U0
M9ZFO=U,$W?3N_O+SY![@B&!CA.#;@3E_ (I&3H'7FS<;QIT>+.E'IU[<>;WW
M:3+YLO<&P)[/ER!_  YXY%5:@K#"=1&/5NDWK1 >*QJ$ $H-"+@U ZQ9IHU*
M%PL00;0$'*RJ:2,KW >>#A[7<E=%GL[R@I OH<>SW,R+R@"H!0ZX<UPY>M*2
M5V=RNH]:/^JRE9WI[R#*#>++7?Y0Y@N@"Y@KV#UM%(%C9W!3XBWS9OJN\B7L
MADNHGI"H#>-+U<Z:15MX3*WU7.>/Z:S0M%&3XK74&I!,L,[/D ".-?!;6N3_
MH@&/:=$2?/(2SMI4-0$%OW48E)<-$').TS.X>6=RU+J!J>C9-3"+*N-=IG.Z
M\6Q[=$*PH NLW;5;,&: 6=6? $?X:YZ:I5K SHUJ$7" ,+Q;NC(8H7(@V;QF
M:,%&BZI\V"^ PK(0+QZJ*GO*BR()[@H>[ET'G\\T4!#<!:L]9;;[C%OK)0JY
M2-LXT#7I]QB<P5W"(L"L<>P#:']P&M"&=(T@@U%N0D25Z#9 IYE_VT=5*J/5
M "?IM\ZE 4<&E$"=3>'D=4M0ZCRTBR9PT05 UF-'IF=-.!%37&6,GV-.O)0%
M64 50'V\65ARF1O$L#G@.5(3X!J**IP*?GP$EE>U<#>P>MW#!W B8+SZD5%A
MAB2;FJHD-/8B" 10C0>:Y_6\70$Y(; '*(5:6!9X$"B<N.NV@*O.@69KM:BK
M%8X--PXC3"1'^)S(#&#Q,GW,'^ Q>J*L'G4!O]<5?EVWR/W.;GZ[/-\?O@,.
M"*,SO<KG=$XD5=@<GC4-A!4/ ^'X! HV_DL2+7O4->P)L7S>T+H/135#X,%F
M*IP2_LU8NB0@.-9KX-8@=?/2<34P/U@4\*T"#%?I!F''D^*<BQ:E47!ECKH3
M-6L;5#44RKN&X)XX1K'QN 23!^BR@FN!&07A+/D)QL04$U(PHYUF+@I+:-.5
MY?_XC]/1\.07D,0Z>T#N$V%V1#Y]%)=T>.&+W'2@SB9W_U23ZW/^8_J_OE[^
M-KD"I8TE;8 :(++AKG!R99; +O9!HU@E@/ /2[B3(@=FF!'D3,/TLVYKN"FD
M"Y*V0!5P(KA:N *K0='A:] F5FP&(,=!H##R$]="L0I'Q1DMZ86+(,W,TQKH
M#,X-)%&9)A&)G*Z! 7Z7&_>7![/<3LZG5G.]4[?3LRD<^N/5E. PN;JZ^7UR
M?0:ZQL7-K3J_^?KQ_N+K5>_S]W6:Z7XI5>N _;%PAWU7^=P+=V+%%6'?3*<U
MRA% 7],,(M _U$1&<[CWG+"9C3Z\"Y&S)5J?2)XMTA+ =-::')&+L=NK.5D%
MD,#E1%F!(04HN?@K@AY78]9D6,G=X')(='#=I&'Z YIXDYJQ41L1_ 4:U<QN
M-Z3$](#(\<P4N?P,M4UAV@N@VZKN+('0!*7D7\AQ4;0]YF3W]V,X\5,PWW$;
MII? +#/ ]9!3LYQD("/7%^)I=MTPZM0Q!P:T0^Z3*@.SH?+D;@KUSY:Y.*J$
MZ$I!:'J5J)H5R&Q9%%3A?I/HL/+;BP2>]\A>J[)E+>T"3MK.A;N3OB30S<(K
MLNLQOA)0:6H12AL/.:%8OG@T?2X0H8!7,$(YG$TBB>/1)N"HA"]%\?*M!-@(
M_+)P=,9**7)/5#U?D,V)%Z>!I&%!YF0OZ9Q,!_09]J"!.S5D6:G_;$NM1@?#
M8S[<Q>3N(X#)M+#JY.XK_;(_'"?JPMWW9:!F[*LS/M\5G^_U?;4&W!F/CM_\
MK#['8(F?A"/U3QD33II59-LT<'[U %R:K&<8_)]IV:8@Y-A=<J"0:X"^"\P8
MM(:<,*&I*\1F4K+(4B0 P6TURRKK6CY Q^V*K.9'O<]2#A;_LV5>;9$)W86X
M#DAYW@@:(6 ?HM$*7!!_,T[[<4A9,:O+A&+I3+@3$BUEI<021V'O0&(U(6>D
M +\$JP[P1U1<AM.SFW9DU .OIY2Y*;(14'8*GLYMC80;@!QQ( /9B(^2@0T<
M(C"O1$V1 \JE_61^P'IB)"WH 6\)QFP3)@)<9Q,194=$2J@H@2J$B [2:4%,
MR4L7%&&BH*&)3*"!E68; 3;)GR786<URCL\6Z1.9!S "#&!+0_EJAF()=YQX
MK0Z=7[19E#LMH$&-& "R G2F"BT3JS44U9R%4U<O1.(WAJD5#E^W#/3N>(*I
M:*H_KJ?RYF/6M>_8NA-/$SAZU3XL(YX&*D_ :0!R>.^>WV31Y4?W 8HG\5>X
M+D/6)#%<UFE9FY\A*^IHS9:A.V'#%B$\4B+0F0[6%=KU3K9T 3)07ZR,,3\L
M9"(5!Q4%4.Q)I1:%@W71;)67.?I+B8=X#X-X5BT;$$UNF=8/2&R+A9-;T5Y0
MQI863#5@1 BF4'*1/LZ:%6T2P$$.N>?U!O8=$$>B(>P^Z:!4CS*01&ZLOP&(
MA)@('YM0\-7!8*16L'F[1SS7!K5#<BFJ<UAS-8-;MD[N)-@K33 <#.T$C,;A
M[./!<>_L9L?T0YH!N5U":,2BH-@PCYEAR$:Q2 2;X(DUK1J4 )C[*:TS2U3^
M_OI1Z4>V,NILZ&?U420(W/Y'#;8%B158\0MQ=W4FR 2H>09F ?/+J2"@NB'B
M/D<MB/6N8+9IF07SG*.2;+5M,-]A&J/^P"NAJ,7/VSM5K]1A<C(^4J/QJ2*-
M<_2+>GU\_.X-_3(^..P!]"MUG!R.WZG7P^3@")X<'P[5ZW>GQV_<;-TQ!S+;
M6(V38_C=K31,#M_16G;&-^%!002N@.D5&Q$>1/$OW= 3F .-+HDR,[ - -+V
MPGJ()F"?7I:BLG3]&YB6-[<8);@,O7%D7YI&+M!;CE:T$I.O4387Z:QB'K<"
M<8RLF'>#*X,PRA)B)"0EG4((1X.=D#<(S4/K<-+HF 8CEE0/$&OD$\IKT^SG
M0#K\5P4&%&L["4JA/M?B(#R*/8EVN+^H$+2PQ0ZB]*(580^APP5RBZ5FYYY1
MPY-1<G!Z"G<Z/!XE1Z-3]7M5?V.-ID))J$X.DJ-WI^KX*!F/QNHV??+ 4Z?#
MY/3=B3I]EQP!GMQ7*!4B;RB>ZQ7HG(?)T>D8_QJ>)./38S4!T96"CF>5-8X#
MHTZR2Y$/IB54TM]I=W^U(.[$]U;-0+'19DZN,7@$)BT6JL@7Q!;S6ES_]Z@\
M:>_F$!:+R)46&P R0CC0Z=DI7&C@3P:O$P"#.)]8/R@A/UJ7[ T"P0<@YV/4
MN?E&]Z7GR[(JJH=<M YR/^*^@65'V\:CR0+&,WJ@JV^Z8TF@BQV#SX(.O8<E
MB)K.I!U?V0*TM-Q;U+7&:#9A?BV:NX :/O-6&^UFLV>I2O&[TY3R*RFKY(\$
M["QH=J9=-]JY)U&BNLEA#.Z8K0!64^PS6[>.2SJW&MPMZQCZ>Z.M81G$31Q9
MFF#:GM-Y/QU\&ZS%8CH$M35=FZH"7$=?2V-"^%L!9/&9#.2.E2N3P/6F+..1
M;DT 8[8M6'W*ZV#ZF%:8(XJG)*UKBG8R/X*Q/DS0SVLBKURZSAM\(*"[#3$Y
MLZ6UB(K=L]N:0YTXE%QFL%#BC69_+6!*_-EF#]86=>J74\EG0 6+O..^<HJK
MF(DDCT7[03/@$3WB17B63$Y@31MX'I[;MWL+3MJNV7O$MA]J7BU@HMUD(IIQ
M@OX+I!/&Z0I1#BTI4>.11#,P29G@,UB4/59V.> D)=D::/H%L)J!E<SV"XZ?
MLU8)#\?Q/PH$L5M=5%2QUY!-56MZ#!9ZJ-/50%U7? +KJGDBS3\ #.#?MK(!
M.T")@='FFR_3V_L_$O7EBF+SU^?DT/WR&80NJKY@@S0;X(=%*MY'O!+>0RPT
M ZZ*=\%.6= %V%+6?1$DN&KOZ;8Z9XP*Y,?*K#T1SL#\B]@C*,B8)[./^0?6
MSX"RG?F%(X[6:-1/T-'N3#<.* W4%=JSRPK0#G8$:VKO*I9 EP[FQ+.Q=L"?
MT!9&]J.$);B5%D)]!!%X?)7^B9>?94'P.UH0^$UP>>26+C Z@7[>,K5Q(8QE
MY[7@/+$8\0G+7(J$*(S@<$=T8J^2NW!@8$4!^OG@"(H1D*#HZ\KB<W! #[V^
MU:)Y2DDT$G)R6+>:B7,&;XU<U.C$;]'^-%8_=+]NY6?@+H,DFKL&C@R&@0&D
MR,@(IOL?'QWL'X*)<2G3[W^%Z>]D.X,74-=;D)3"4;.Y2[%;!A:146I$$S-_
M3P_[RM=_13-=X1*OU+OC8U3$DJ/A2'UL\R(CGQ7^-I-/,2(,07\?'JCAN^1@
M/%)'<%2Q='9@ZO#X,!F]&ZGAT1%H\D=JN#^R(SZ#-@:W47/61R# /3R&H.V=
MG,)RI^-D='*@QG[TN09.R#9H-&2<G,!R(_C_4!WN'\G3ER7G].&S9@,Z[8H/
M">B5$9X,CX;)> PK'9XF)P?'L,\3&7K1UB6E@* >_9UR0<2GLH!+U\'28%F.
M0-&$?]X!M(?[0[OZ&>V43P<*^3YQ2>1#PX-Q<GIRI-X=)J='!Z+-'A^"V30>
MJN/1<7)T<@*0-7#1DUTLZ_5X]"XY&8&1]'H,MW-Z<OCF>2QS*O(0CGPPDK].
MP/8Z#^>U@JTK?=?/S*T:<@*\.CSPEKM*P%9_-SB,+?E7AZ/@D7_':.Y:\6>3
M+Y?WDZO+_ST]!^/L?GH[O;LGYF!C4<(E2LO)K#)M$A]$14DJ@74F +*:B!V&
M[,*REZ3#&.7);AH0,R=14W%)V*T=Q, &QK72''FQK(:,-KZ%C/#/04DFL7E>
M$NA&ME1$O\/>,#^I24E)0,4$V"-IFQ(3R#;,ZTB-;ACL<+R!^AU=4V4EB02>
MV[IX$$U'F2-VM<3#N0.3JG0["DYC DGY1/FD"#YVN$8@\]Y?N H\#-T36,XU
MF:*&XS,O8H_%FV&,-[$^&V[[U=#C+*/L,/!G<:8-G]=2"GQ1/4L><.^3,]!B
M[BXQ;>Y.W8I7'ZT4+]THQB@*)N>YY>)3[&)6-Q!8]\Z7]LI8G^O&%ELGT-)U
M9X7/XP9=8+9/4D[NSM3IP5$"$D4>.O-144RXP <X-@2/[;T!L(B:"/H#"7L!
M0+@.Z3P%.M%%D_9ZDH=7)[6,$U/0)6)M +9G? C=6,>*"\?X@\*VT!\@QIH0
ML/AST.9 D]^J7G$"C@U%=K<7!3.-R[888/3=IBY:HZ>TQ@/9-2P_*/1A;\/C
MQT:L2D+#+%:/SGS6D,U\$!]$N)<F/$#J8IC;P:H0.O?.^>0F@DD=J*,$+O%4
M^.!/Z,G@?"";4N3-&G10X)>65^B<_7"4:@W(FM8%F!GYRJ:W>OXXDX#]OF,M
M )%JI=D60C<0I5RALH?I1)(ZV,EN#.:AFS2&Q#RAN)"2Q<,B_Z:+?%E5&4-I
MF8,U"#L.<K:"P'AT*^MTPZI28"2F82:JN.$XL<N96DE@P(ES'&5(3< %+@5'
MJ<#LL+,G1*>BX%.( UU,DIGF'R+[IY9KS03L-@,PS+YC_U+^5XN<8XH _:M-
M:U2]60Z1\1><WMJ!A*AI7>JL+W&-06EA3ACJ,#$5_YT/B7/H4T(2Z(A@W$^]
M>RC@A.14$H>Y0U$;_9-;)#PLR(D19+2)B>$L\^UM]\'2DP*9]H+__8AF Y>&
MS7;[(34]SY,)A:CGTQ8QO9F=S;QV;++ZH38OT_FD=MS ?!?+\%=#-G8[^U-(
M((P#.L<*W4N<R$>Q5225#3L4HH0^G\LKZ57%QC&66#K) 91XU3I'V)W,ZB^>
MT[CA;Y\5QP8K:G?6OY0'1D,WVUD< %GL)ND(49%6AEP*(D?^G@#Q!RC[SN..
MBMF&3IB<R_U:]6IK:M95=LV5HABNFXZ8#_.:7)I$Q\](&>*F+]]Z.]4TJ@;P
M260!,KN47Z$=G_GK,\9=8K)';OLM>S2#=&%VOAF.E ,P$J=!"&,/?2].IR*?
MZWPS+[3//H^I G.9]0-Z&IDGSO'/D#E;KZ)CT\X/C\YZ(=-(_B(,Q>M!$J\G
MJ=MT(CX"67?G79A1<ACR3ZN+H["T,0(VP2WH[!R(@,$$LW3^S;N$(U#*&7IN
M)-ZGZ%JP4T+%,%.JOR"&2QE\X(2]:!36X,B[X.SEE]M_I*OU+^=6K9%<FXYB
M0T246VL(N"3P)Q B_Q+!@22?Z04^HB7QM0MYD*-UH$;#(9Z6FNXHTLO\?I8\
M<5J0^4B#Y&[(T@KY16N$I+JZR@L\V_NX.A?J=Q'PQ!U$+4&J0#]R@8M@M6U$
M2Q?PW#YF\8:9^4U3Y[.V"3/ON@X^9GUH>P9N24MB91<9S8Z5+%*F,4(.U%VU
M<IQT5=4Q7PHY>5YB7(8QD-A*X,ZF\96Q.PZ$1<B^XCA'L#D*&B(P*>O!?1)7
M5^!UX/@(EZ\DSOHEM2)1]@[)&DAL2H;$C3%(QXJFL4G9=(4@79 &8XKDS!9R
M#:"R3$GXE:5"'ST,(4(;[C(3=&WK=-7'0.GYYSEHR !A'O11<OJ/0RD"-AG.
M.%MWV:Z0-=5.RJ'(8Z;-'+ 1:7P&.)=LDY._P)BPK"(@3#A#LV21$U(_5V;C
MTI=(HT=T6>9KO!Q*]2S3E;8>5B'# C0!3B4ZZQV*.J]@-VP5UN=P>OP,A\9\
M<BK',D5/H=@M^GM0C2UUX>QZQ#'.0F33@"TS#JM1JJBN'W.JR;@/=N_WLVV)
M>E\N/SSX6VQHRZ'V8VP9E1Y/MFPW.Z<5,8XM+\9ND_GKFG2<N<[7D@S2$U5D
M;'MA6Q2G16X6!Q?(2'E^8%#*9#/+XW@2J+(YA^Q 2A:HB[";(^=P>\ $$L]I
M>X).& JZ=.XAX%-(O^565"]T*(+V!]]B(N4,GJR<+?=#X @B.@+]7@1!7Q_B
M[6XE-#?^^G*P?#,\*SJ"SUOM#;K=Z9@OG=;5X*!&@6R1,P=B@X9R\\2.L3DJ
MZ!FU)HVK%/%,+'1\L+1S*7\O@)\6XY69@,#(1IL"+S(P_H7ZF$V2AMF3]^<=
M%':<=46+9..""YL$$98425R9O&B%).-R9*V/4DCOQBP29 AS0%T*Q38V$^JY
MN005;"9* ="1TB :1MA/R>G"_-8II6#@5RFEPU?$R_.,+%;R##;B@G$X[Q N
M<-=)T!*U?"S^;2(WI*]="YF)C>ZZ\A!*FB1=-_#L;44913=DB@]Y4XDYUKX:
M*U)J*5&_;U@2&5.AJ[1'+[79YOV*:3^E6OV]ZSP>J"_6ZT'8_.03);PF;G;[
M%79+@XA)4\*LR]7(^X$P4+=86H:[_K&Z;KP'4A #<W^@/MW<G/]^>75%F0<W
M]_^<WF)0:7+]Z9**J^[NIE)6%KN'677KM^D## N]%/;<VNQV#W\*$ %1,W"]
M1/6N2+(T":9IV4BV3V78*BII2\S81E8#<"E;Y%U$-02/1>T8/2;4^VF SV.T
MNZ+$^KQCQ?QD>DQJ2:<,JJA"U [<9.R[PUEMU<%68E$XF) X%FQ1==PRK+E"
MF'B@=F$CVG^SS.O,^3(!,L#*-ES1UAOFD J7(X[XB[3#2IA/824E9^B&<0\8
ML?>&?D.LQG5PL5+2VWQ10ER6)9#7+\$%JR'BC'&N\XI)XR3IVV5XC'[:",&*
MYFWS5 E.<?JT?F!>(*%,+(H,/*LQ]IGNIK#TZ$Y[#^(GC1E%:U!FHR!^W\X4
MJ6U;^QC(P7:I[%H$A]704=[ WSYSUUO5B2N?*G(I3^A7]H%'/V\M<#C/NB*V
M C$B\\1M$7M-0N[K"R*EXJFT)E#%>3C.%-J=;M?1EBG<A+TMXF0=SB-:A"R]
MYU2!UFJL!XZFMSPQM^[K3N)3O#WL%V!ZYF=Z=VJF),5TN9QPLGZ2?HF.!VKB
M3*%N>!C):JUK:JQ"T=]\9;>Z0- 3!:MJ#I!D.HZ(U]9U+:FX%R6DBW01"K@B
MQHX[N^R>N$>QYO(%*GJR7('U@#ZX=N"%/AT.K,G9N'0.  ;,6DH\@D8$-?^&
M":K\8^/J?'<,R9V6XZ6"RUCT9K,K2O(1&Q<W\/G#  N@.'2K"HU0C9 D+?>6
MVD?FOO76<=T-<1 ;D(#K(:;I%/(P2BRRJ,^BX3)O'/TB_!&!V &#58&;=4HC
M<[,+<F1,"\+U0OV+6-HU&H9AK<(+EA@S()Q#9Q)'"Y(Z8K'81RYCRE9"DB&E
M[.^)+C2C1'/[R73%V"[119D\?E^X=6XJ\%@5C\3%2&\0%U+G%B+7ODT0;]1#
M7;5K:RO:0EAD3&40\MSRI)/^36ZC1\[X[A/%?C54$'5F;(#QF8F3OKERXY1E
MG4G%NP.+3=2T4-'?<ZKDG93AM]3Y(P^"^I*&'ZNN.^[#^0X\-23P3#&77+2M
M$'$/O"A^RJF96=_&(IG"(7P.[3I2# 8Q>QVHJYOK3_M7E[]-SZTZ?K75489+
MJ<N,8Q%2%^/*T3WK>39I)^GKBD/FI(1I.:[;JW'_F\I=VNS"8F?R[*(33(8"
MU65=&>9:EIL(86QKXMM]>+AB.8(=%W]$0QM)]1+^Y%#!Q^TB;.^XQE-4H>9A
M?&!K'V2CI^4V?D=V+OK),=<@Y%DF1- P]6>GI]<1 "P:M"F"K>T"#QQM31VB
M\%+"\M' FN$H)3J'J-!FIILG;$C60^4VLMBS*P\H!Y;K^^FGVXFZN/EZ'71@
MZV@IGJ536!:-;XK)A(6QF*0,VC4@#=R5U'=<EG.FV.T?*;D3]4M K]HV5!L=
M'(R0E11P_9A11R2 OH.\X7I25&Q25JA$?Y[GK!O//:;B]R0$%[FV3I;+VS-U
M=#!\/7_S>OQ&?"7ZNUZMT26&_9*0:=N]#=17&D0R>$FZ7K+CC$J7#ZF0('7*
MY%PQ(CO WA6:(5P,;@/-Z4-9F=QVF=-I8]48P )D CXTW(D>H5N2"KKFW#T)
MK"&JLN9.*$GG5H)2PR"& VS;)J'TG 5W!:8.-9'3'(A6"%UQ>8G#(/6=ZC:=
MQ,I?V,V)XB^1SB@^68.2]^.L0_,#W="Z=3-R2,RJ/!@<^$S@**62<BP/!J?N
MBYU(VBW;_'=3AN_M:8([H Q[G\^V70*=/%,#/5#GT]O+WX F?YO>=5)6""],
M$M1ZVD1R7,$X5($G,> B70(*WQ/1=90@LS-@I>PCJR0!0M1B<EF3'SH0."YE
MU?=RXY8A<\I/80.E[DD'S;*:752, .Q5MLB<\F)!M9"4 3%)N6)'TH",[C0\
M\_C3[5C&=H ,M%,"QT#W+E<D57-ZG,)/PI.V]R+-3K''0?$#"]>Z1Q_I;UH1
M)1?LJ!A)6S"#:ZNUVYXEEEOA$_:[1()RE8FZP"E7L0@PS!^XD:5GEQC8Z&^Q
MA7-O_Z!68#Z1  MFHWB4/PJ.(BW/QBSD"[+]Z&^.RZ!,]QVLV(V+? 3F]0G(
M24<"VQ8>,XT;H]DDO2OH6+F(%:4>J[B_9QZ61E!$&865-_702T6]0'M!R(G"
M0=*3A5KHTE%48;MH:YPSL:=I-FO:3M^(KENTO\F?C398EVY$Z0B%*(')QI@(
MRYE[4&\)93O\<2\=IE*_8-A&MEHL4'^4A_T,<B*P&5<]=Q/Z^Z@JECA)QCGO
MP<FB'JQXB\AOI2>-D_:@I5* #!U:R.3AWVU'"ZW0G;]3OQOC< \51(D.P$(:
M 3%6TS)SM.P/S$A8@31;Z4*2AXUF;676%A=YAG?TN!%@ES:)62(!=92O+I<0
MU:CWYC[VISXB\NS8FZ^V6  ;I8IK2IF1U BQC?JY54*=<L0*M=-X5=KUU/*[
MY @0=Q6Q>2=4E$KXL6#.U^%S_2VO*%$"-I=^XZNE:!;GM#A'HFW1$8NW9)=L
M$SN;^M4 ')IE7D8A'#18:N0&4N(2F'RY:U\7#%S$E\CMU%P.J9AW,8*WB&K<
M_ZTWNWI59;H(DW/"L,8G2\N=.2F$5(*5;2+!"URNXEZMN>V 8W+0L=)=2&C5
M8BVZ!/8Y()RM9I@.(AYM6L>5AUC'2I B3,EV])3-M9<^Q"Y$GK"7NJZKF=@3
MLTT2KB*Z#"!"RBA86P9+Y9RTJ4 ]#IG4O, T2NK]1;W;MHBCOQDQ"6X P!4%
MQ4:N\T4@'', ?CU?8F/.>4KZS!98J%;E,0482XNU3B$63=EBV;UXU7<3;D>5
MMJ<R$5/<YH->;AJ@=H5^A0<*RYM^+L\2-TA2H/0>Z:+KV':XE4@"6*GO*,Z2
M)()WZT?SE*Y9[4ZW6C*\S-*Y8;%O;AWNSJKS-&^W<67HP7+Z6:!E!)<<1SE\
M&BZ&5JA^TFD /V +Q0&NXP3L%'?3EYV#;4?;+FYNIY>?KM79U]O;Z?79'R2
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M.TX E1HF(>RR=UP/%PP[J>"3PD*ZH08AO#CH0$?SHH$2#<N46\&& C#JXDO
MXZ8Q;%@ '%SV(?T*0DK*9TO)J'D&>N1B-L AN%\%>9/U]W1E\Z(BD]J5G2A\
M 8CGMW9%E$#T?A;Q%04IQ-2FJ;*Y4=*RH_RIX<Z^%)J48W+=X!+P!9L\2'(A
M3]L76RJH JT)O/06.D$Y""?\N)ZE4<$EY[>Z4(@%NC25-R^ SJ(/0ZXMI$$R
MH$M3N!:T,8R8E=<AI$(=TG D@!2VCK*\I09$YENW+WH">"&\M;-<IP,QU4)C
ME BULD#FE?H['/-)%X^VV3@5=[*,GU//%Y0?VP>PW8$C6R5R\V$N/6M,QAM3
M'(0&=8%9QWQ>MTP]3A>'_<:X+G=M>@2LEW7>:?H[J0O]U\S.&YM[+]I\T,_8
M^I/\JW<<5O+0$-UM@8MXUH/W$(21N/[FI4&&O%^3&*U/X_4_2.-^1CA2;5S3
M:N'MC5>W_"M(:.>8X4D;H/N(=Q&IJS9)OY-G0K8WFR8A3#&/DWT/0::RZYE;
MU6$*2D_D$:^36"EO<MO%[]ZWX--5**^%E9:.!1389%9C=5XO3Q^<?9VB.[>D
MTF*\+VG2AIBZRID[N*&HUE/'#N\I8V%K4U0L#;A&Y-335)KPV0AL#]]!3#(M
M=GS!V!4KR/RB@+R)0LFN,07F6*5S^I7>VR"&D-&:\)9F(-(N*3W [IS3GGVX
M=IUBKK1K)V]5.Q@X4#>ES0I#V+0&,]-SZFTC;>@V[LT1B&4VYLN]C]B%_DWK
MM4M_B&[!11EZKU.[/B=1816=*JQ>3X!MIN@*))FX;9VPGR!T]<)U8?ME$%K3
MWZ;77Z?XDH*;3]?4,@,$&==#QY+<!5N==ZGBUZ7452&EI*N<BK.#'H*VLL6&
MF:)W$6"8/>@4'[7?CW.70R1A!BX=&]CUA5:+M6.\>W]7B4W%/8[IC&)FNNB)
M+:J1JC#[L:XVEC.[Z*$O)>,>; !^K6V37RT]#_RR%T&O1H6>Z[6M$[BX^<A?
MD*%=Y91X4Z^L!\U#6"(TM*-U:LPV6+M9C#@METQ?4-],_F2\)'MF!50,Y*9K
M'2IL/A>33FK"4;&S+%#>;(U]&Y;]B#_4SCA09]VF@ULL@G]QO2\Y0%VD,WS=
MC,,MLL$[:??(J*WP"OE-RFE=867_HG)9>J1AH*U "?BW]N574GH28UELE[C\
M]&Z6C7>_^Q"EF-*^ER??#E[!9BT)!MAH@C01OG3_%I2=]:UKUXNV6X$8M\(-
MPO.V>5%F#VVWDFG81Q-$";??1?.3B:#F6W'0<Q:5;,,.P3CN5LM.L@ BV7/W
MBZ:3,WBVMF!)UC,Q#LLTEB:)M5#IM^\,24WV4EL^#1=+F;O&5FRSX<C-'S$N
MC2H#S>5G6"]!NO%-45(/X#9H4H5_]YCW]CU:?B .E,U:V_=O"7M@[A.34D,^
M PNZJ!$5'=B%WR@-BS.D,,^*\HH:2^_(&.H^_M[%;ENSV,M%69-&(Y4ZU/OD
MUM1Y!@/GGV48%-FD6B'?H('C1MP14LD+;RSVN_Z]I(P6^C&UK-$6[D9LU8)-
M9N%-^I"<O&'C63'V&F7\VCD=B18"+(O)QAHEJ=&>=X8(&X7IME@#W,0;UPK&
MDSDP(5)=Q@= ?QL3U%5:Z# O"FE>R,Y$S8.IK'?KU3(_]816:!,VX:S"'?AF
MK]P>@)M/\AL[+*^^L%':IF\G-C?*E814G==%_+2]C[5_>0AZF&*/[CAQ>@G%
M-<^<!_IW1+0SQ_Q?+J<@\K44O_UV(.])ZG]A8.3S[W)WVU^H0V.VO4KN[(]N
M34ZIPC;54@$IKWM8Z55E+ (+8YP3"G)A'ID5N%5MVW\3BE$FEW2<XWU&3:+#
M^OQTAFIQV/MMUZL47><9F^D"?,TE/F(,"77*N^GD]HQ?$W8."N;5#;>4O=U5
M?"F%]4&:.ACWW&D\;,/(?=_;HK'IHZR)X2&I:R J8,RAI<.@;6[,O>#1(NKX
M '>6@WJ9F,3U<;$;*U2D-K9]G%0X3S]_N;KY8SI5]]/;SY?7G$/X<7H]O;CL
MO"W-O6=+@@>V>;[!K%:B/>3D-CCJ'Z^H)-;&&=GC(ZXKZQM $K9O8M' SZJ-
MEN CE[E*QS/F9U@I(^)I0EDV\'5!AA<LTMBN#/S:*LS,6K4K\I&V) %[U[>)
M,+;G'-E(6QO:5AO1.6)_#N#0WZNZL5ZEX#2!4O.WDH:(OM#GCVA=V^PFT^SS
M;KB80TXWD'=&[-I1L(<H3.9T::MQ>L^=B=Y4PN9A&;W9<>,9%!>INI=F;=U1
MQ)FIEK=M>J\I(CTLO-+R*ABW*^LG\^GL_N(M*KCV8YA-8 <2CK(^V8.(_6W#
M,5I?Z^U.Z!8Q1&\*#F++J_[N1?NJI)/AB-:Q+P]5^R!WR@ )/CIW6YD%XPY'
M!^@BV"?-:FHQ]C[8FQO(4L@W7V)YX1V_J(@(/I$<VH7^01QQFPH=X'N2M/J)
M3W#3-[G"=B':V>XPXZ9RH0S.?07FXYLQ>U;HDH!<3@JFV3ABP4SS_Z'5$P>Y
M76:81(7LM#Q,JA:?<LPNWC$#$6N0ZKBTC1\H6]UK6,BBN:;!WAN6_;>EW:B<
MD0UP_^+L53?WR-4(NGFV$9VFV\'MMMH0J."5SVE'AW5R$F[OHG8]QJV'HZH?
MTM*]YU=:-O1ZXWVH+.Z+^B.11F)CW#6V^1\$!.WY[X!">H;9]['8%Q>U*WP=
M#CHUJK;N+&_5/W+@(_^TO<9=?K>DOE@/OVN7Z,'>$T%X.0#R0X"VP=SA@-Y'
M9/B%1/%SK_OZF[\)&IS+>X\20-_@'4INZ5=J>)",1L?T-J'QR<B*R)_II4KX
MZ"?24.^PBSDV13]\=XC=L9/#\?&6@OC^;?/A_=O<P/_F\%]=/<'_Z;SGH&E^
M> \*_X,^H\QNTE9_W1ON!=^B2_'7O<GPY\EH[RV,](]_>+\&>OX,.T,+H- +
M&'HP.#G:8V^0_=!4:YQ2S:H&K OZ$]\9I&M\ 'Y?5&":R =< !/^:'L?_AM0
M2P,$%     @ D(%65L)V202<"P  NAX  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&ULM5G[;]LX$OY7"&^QUP"*XU=LI]L62--TV\6V*9)TB\/A?J E
MVN96$EU2BN/]Z^^;(?5RG.S>"R@:F2+G/=_,4"^WQGYS:Z4*<9^EN7O56Q?%
MYL7)B8O7*I.N;S8JQYNEL9DL\-.N3MS&*IGPH2P]&0T&TY-,ZKSW^B6O?;:O
M7YJR2'6N/EOARBR3=O=&I6;[JC?L50O7>K4N:.'D]<N-7*D;57S9?+;X=5)3
M272F<J=-+JQ:ONJ=#U^\F=!^WO";5EO7>A:DR<*8;_3C0_*J-R"!5*KB@BA(
M_+E3%RI-B1#$^!YH]FJ6=+#]7%%_Q[I#EX5TZL*D7W52K%_UYCV1J*4LT^+:
M;-^KH,\IT8M-ZOA_L?5[)[.>B$M7F"P<A@29SOU?>1_LT#HP'SQR8!0.C%AN
MSXBE?"L+^?JE-5MA:3>HT0.KRJ<AG,[)*3>%Q5N-<\7KZ\O?+C]]N;P1[ZZO
M/HJ+JT^WU^<7MS?BZX?;]^+BR\WMU<?+ZYN7)P5XT8F3.-!]X^F.'J$['(F/
M)B_63ESFB4JZ!$X@9"WIJ)+TS>A)BF]5W!?C821&@]'H"7KC6O,QTQL_IKFZ
M4WFIQ-*:3%Q 5HL(@?6+M;A@NRLK_G&^<+S^ST,6\/0GA^E3-KUP&QFK5SVD
MBU/V3O5>__C#<#KXZ0GI)[7TDZ>H_Q=^^U_0%3<^AX59BO,X-F5>Z'PE/IM4
MQUHY@72KS'NM8K/*-:=@M:8=\IF7_U")*#=X5:R5@*5SMX39034FAR ;\+B!
M@[3#1CPD95R /% %]M0Q6!6&S\;!94YHI#K^92047LF"L(- P/F-!H"2*"M9
M(EJY,-E&YCNA[C=^ER'I%,"":*G[>"WS%>($7(NU<:J10^9)+4A??%:603*/
ME;A:I'K%+)RX;7C\S8E-:Y=I[6*Y7"$(2%,V;&4.2Z9MV6-E3-+E+: 0/+#4
M,)+.*S4Y<%TD-J6%"I#;6.B-!2BB\SOCI6Y))[!+Y$8X#<\L=2QAP SHIH\!
MH@#BHJ'J\Z0V>E_<M,[\4B8KVN[$%P=@/R;43(0U.PE:RHN.0 &RTP^KA'*%
M!L!BD]\:' ,[WVG'UJDBX@!O)M<*IV  )S-%QM8F\5% BUZ&79"H\2-D<"8%
M^UT[(N MROY"K70L-M(6.:O:ME@E^9X4KN*$)1_RGB.'>FRRK,QA*HY 5B98
M0\$Y:P2!L7B;0A-?=+$M8OH^0D''R91"WZH\@4!O]1)AHG**A(4JMDIQM2M!
MPJJ-L72BXA".$C4?S&R;K>IX@>PAD]]AX<:>P93XM5WK>$UK.W"#,DI\R\T6
M(OH72.YBMR$%4F_-I4E1^BF(OY<PHK)]\;Y6,MU%: APS//S8;.6R+W<%* /
M55KA^)CQK2I*FU.L@R@'/VS!D>,-EVC'("4DB2+94J4CD4C VJQW,H6K,@7+
MM$*QY1%O<29I<-)ZS<42UC84&M=J 7G:7+KAW?#,#'(]U=\4C+3/4,FXB>\Z
M[OM[0.)U%AO"7!@1J>O0PR%B$$_PDH8=0X +A)I,S2J !@= !0 1Z'POM64C
MWE$717MD"8FL_L.'*"%J<L>(!?L2#'K,#1)XB"9&??&EPO(.!4@G8JL23?4U
M3>%61(DKH:T'514PS1/$,B4%<665 I2#32)WSM=KSO"UWE"\M )OI9"B''AG
M ][=#1B$@54K:1-?"A32ALO)$IR6.H>&'FHS:$%PIY>'"@2T:9 0QHG5QBM9
MPTS(E2H7.[6-S%O[=B-WC*M=,[3+6V4O""1V2EIZ"?_].7 'X.E46O@F<'1-
MT,.9"U55O 2!:1D4\H:E7")I_Z1"'RS,K?I0-UCGCGT**_RJY4*G&B!Y?4#6
MVLVMTFGU':57*A<*1J%D@B6\V2G/"#%"7"</^P*82(*!0T$CF2M6Y/$*I,T=
MZ8F9@\G1#E3,Q)^L'2Y9 ;@]+9,6/ )II?80[>M:C1%Q:2TYF0_BA>^76H4:
MI4<GH?REG&;<SX=L\AHQ;G15BOA7=23T5+:2R<JD\JI<I"H2N?I+/*]89@Q]
MU"$UMG%H3':5UF*IO+-\R)3H\&O'"[FRBKL%>/V3R8_1?6$#R7#P&#<8FU0=
MAZ1Y2*9V1H@,Z6J'2==)4 >1W9):C)"%!SNM8$;O'"KKN[XX%U0G">S,LHET
MZ2='7U0(U&-9-*'U!/V%JF6I(V19 MPJ;'![/;!T38"E55[X'&_*9\%&].,S
MGV)?<G?J]ON^$*:^U:KR++C:U7C#Z:UH0!,8KU2V@$6J$>N%> O.T@;2IG22
M:M^M02W93^>+#M=(_"+SDL:#0$H\$\-A-,%,>%OUM,&,>U'JL_ZQ5'ONB1P]
M8$>AW6Z8#Q/GL:3I(I/25L4XA-YP$ TA[#[U!Y8A=?:V-EAV\<"-CYCC;#+M
M#$>,26$^:H'+ MUGGI.DV,#^>A@HXOEI-)Z<'1UD'HQ3T>Z6@Z?,<1:=GDW%
M.]0#E)6 8O'.6SGUG<'SZ?0PTX,VF\)F,W%>/'P;A8*.'#Q&K<GVL_& RGCS
M;-8?BPP%DJ]W<I\/J<E7#V@\F_?G]4[M.@:NX+DBK3O@W5JE5LE1T01Z4=OZ
M%\#TG)N+1]2M4$MWBW'MH*8LH3_9H,;><Q>)YJ:C.,0 S7$DGDWZH[W5"59'
M_=G>ZBE6A_WAWNH4JX,'>V>^@<:;9C\91G%3@+D/3=B& H=VO<=_*?UX1T#?
M:=736K^J_A$&N?;I=76:;^J"(ZCT+LMT"=9A D7?C-*TYHY$^AX1($Y]P6%
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MY!);F+(DD( X6LFRR&*0W<09'HWGJ8(DX.\6Q,R^*"@/^4\M*HBI=2WQ=%:
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M(G&JM4TN2'@NI#I>M&7#9#QR3DK&A)>@',_AHJYJ1"L*8HBQ"=RWD M$-R0
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M(_TX1TCA 3UQPE=":O<>*QYTQYV9MP9NQ1T_ Z/$;<X0>MUN@\@Y"-F.G+/
M7].0,^<J?=;!P!^KV /;CU7VIC0,BQ'L8Q.4B)HM0^C)?]:%%(.NBS5&CYQ5
M2$<WL/%\^XCSH!MA8&$5LE=I/,[A8'.*!ZVQMFZ"<I:/:+@$^&#;8) X7EHK
M:="S17O>ROTH3?8+7?/T?+7ZAH8/KA"WQ;L2 L)P7N1Q2@"1[WR(*#HVLW!
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MHQ?P?*TAD;^@#:H_GWGS'U!+ P04    " "0@596_S JS 04   F1@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6S=/&EOVTB6?Z7@<<_: "/SE*A<
M@./$&S?2G<!.>C%8[(>25):J0Y%J'E8\OW[?>U4L%B_93C:#P0)!))'%>O=9
MCWZYS_*OQ4:(DGW;)FGQZFA3EKOG9V?%<B.VO)AD.Y'"G=LLW_(2?N;KLV*7
M"[ZBA[;)F>^ZT[,ME^G1ZY=T[5/^^F56E8E,Q:><%=5VR_/[-R+)]J^.O*/Z
MPK5<;TJ\</;ZY8ZOQ8THO^P^Y?#KS.RRDEN1%C)+62YN7QV=>\_?A+B>%OPA
MQ;ZPOC.D9)%E7_''U>K5D8L(B40L2]R!P\>=N!!)@AL!&G_I/8\,2'S0_E[O
M?DFT RT+7HB++/DON2HWKX[B([82M[Q*RNML_UYH>B+<;YDE!?W/]FKM%!8O
MJZ+,MOIAP& K4_7)OVD^6 _$[L@#OG[ )[P5(,+R+2_YZY=YMF<YKH;=\ N1
M2D\#<C)%H=R4.=R5\%SY^NV[ZZL_SC]?_?&.7?U^\_GZRV_O?O]\\_*LA+UQ
MQ=E2[_-&[>./[./Y[+<L+3<%>Y>NQ*J]P1D@93#S:\S>^ =W?"N6$Q9X#O-=
MWS^P7V H#6B_8'2_7-YQU %VE19E7H%JE07CZ8J]%ZNU3-?L'%5$EE(4[*TL
MEDE65+E@_WV^@.6@/O\SQ!8%-!P&BB;UO-CQI7AU!#93B/Q.'+W^^]^\J?OB
M $FA(2D\M/L3A'=PGV$LAS<'WI4"UI3LFI?"<.[S1K"+;+OCZ?W?_Q;[WNQ%
MP62],L>5N2R^@A4G\+U@9<:^3&XF;)4E"<_!BM(,=!MNK=@=SR5?)*+S^"++
M@3D JIC8P%A5B"ZD8L]WL*61MK2D#8"W/ 5OPP3/4]R.%&#)BPV[!0?%Q+>=
MDCKL!X:-M-WFV98M-SQ=$Z@V-(5.T447<8"M=[ODGG%V*[\!9>T5Z)'8+LO)
M-V6WK&R(^H\"T0"W!0]]N'KS\?J9!)O"+0!%CC@].\B3C4A6M-\ML)<6#&-7
M(%PP,[%=B-R8&C$$OGCL1(N';[,*F0>TEYNL*F!!<?I\X,GN%>]1:U"'@+:K
M4FS9[QGR@R?LG&#"ZD*N03&026\1]7>WMX(<N?KY6>2D..;^);&ZK:3OBE)N
M2;DNN<S9'SRI!#LO"@AY)Q] V60BR_M3YCW;H@=C7V[>*K:S#QE/&>FS_X(%
MKNNXKML0X 5(@#=CO_*T@H#&B" O'B#:G\ -]@L[-KL=LY/(\:?Q*%@O4N#J
MSP&P55+#G,./5 "*!"\$>*$? +S(<<$Q Z3(=T<A^9HP_[L)1("!AP!C)XA=
M=C)S0M\;!3B+"([^^+@L,X+FZMT;NGRW15?$@HD/UWZ!NW'@$5V>_U/ >/,Y
M@9F[$8()I^'/H<;58&8N@9F/@_&T=+R>E.*>5-P16YN!G.(X I"AXT>@&%,G
MCJ<_'^1T1B"]*$"0LP/,C#0;Z\\&9&18"/S4FT<#X+Q)Z"&%?N#,0I\%3@2$
MCA'H*RCUYPBT@\#<D.PL!!K!LL&N/2?4R./WF?D> >5@C&#X8>#,(V![RV>#
M-UYI9R?(>T-,&0EBL+0)6!OTGIT P,&WX3\* J+VF"E<TY'FP-[@_!&77"RS
M?*4PL8,?A17THG?D177@&MS,I@=VY%VD\6*50B61R'_"DC54$(!?SB#M4D$=
M4O9EM:T2VB$#.#E; H6YV&!10+#@MV GZ%1]]\7YQXLK^NJ].'58"NX=T>/?
M' !3RH0PW:A@(S'8<.(,_*IS 8?QDNTW<KF!R PADR$S$:\:+;97K$F P_)6
M(GLR\_2$7=W:,!IR5QG0DV: #Q"4.[B;O 4<V$(@ 07;Y=F"DIYR QC C;U,
M$OL)*SM0]PP2]W0O%UB 8:17P1HI[R&?I7JMXFA7'$;D\ BR$FDS>0,F)"FH
M#:!'.$)$%1,&A1&4/2F[J/)<I,M[DP]>8LZ$:W 3_&R3('!;RMLR2%+4'LMZ
M#X7-$@P6DVZ5W:4KQ6M@5 DRH\WL#-)HXU+D)=*,NP*!2&</@)UN HRTX%0A
M/M6(+!2))3P7'97?:&Y8!J9@6 ;5-J8>KEU#)RA=2=G*C@ R%)1.VG!]42T*
M\5<%\,&;C:FORG-)\("Z!":0;2SN>W:S!_L;,:9BU!HL@5@\_Q>8QO<;A,V<
MGMY;TD=D'A2\T_6D?2_:[%@+>9V2:T24R?TIAZ?$K9TQ/%1DB5P1Z**$#^7(
M8<]L)W)*C<&O)1F@LY<0 _&A[/86LE]5W70U;HA#%=A?GMR3?\&\6?EIG3K+
M.OP4U7)IF4>W'JR9 A)=YWP++ .7L@+& +P=STL'H=5J4MC&S%5=WK9<;>0V
M[FT#WO)[<ENYA'M( X<HL)0[)>N:7/%-R:07?]!QH>5_*S&6*>&##(2R<PGJ
MCAO PH4H]T*T7 Y&44"Z@D*&-SV%5943_8!1ME($UEC<9:""5(> W0#!JY54
M@K,4IH\R%:!&?0%AJHA3;7&V:R-F*!,=J7Q!AA<Y4/[,^'*JG6ZH5/R8FL36
M5S7!@#]7)6[&EKA-@RV5XWR="V%*<-#9.Q MI 1I7>\U5GH,A=;$95LP9700
MX+<@M4A(!AGSY][$-_=@]<U> K!+('59L).CB_>71Z<=-0'4EAI/*)]3'7:L
MZ%$[_O>7SQYZ=(\*H'P&M@=J5=]5.8BD($O&IQ)L.J+T0==!W*"Y"^P#H!^6
M*XFE%,@34"__"69%RE*0"2@O!3H#1!>D 1/D_8W8E2KS]*<JSVZSGV]U@-14
M'"2"W!HJM5I?6A4T.A&\;<%SH8[4"')-=$?T'!R#V:5.&$F3VBK0]I!=7ZL(
M[R-++HNO07W6B-R0OD26NDS8C82,L>2IR*HBN3^@IGP02Z.H#^HI,)J%\20:
MT=3C<#[Q;$TM-[(PDNH3.J*4Y(5-O-?!V#2_=MH_HS-/%-I:(XD8S%8Q.&'S
M(Y> /;@HI:_D@B;L?+@%Y QA+[J6V>6)RD%95I40AM(5N!A27K.[KZO@AUS'
MF$0>X3K"F3>9C@@D]-TV2?P1MG+ 51Q^$%G?]A-JMYP_ WPPEI%[AB!B![IA
MWY'CR0)1?\B%(/A$(#8ZSJ@.8)6# ?U5@7-1H% "BH@^TCER##"NUX-A[_B]
MR2=0XZ-);'BX2ZH":[2\LKJ;I%1M5W'0?%L)6%_\A<KI5F()A2(X6/*C8 VP
M/RC_JJEX%$W9XD_='C2%[N"FDM@)>E=!9M $7WQJ)#QBXI,M)>%)3JE;%'?S
MJ%:4GK OF$(9CVL5XB;K<W3IN>& _@(SBH,NLQA(?;?\J]6)-K)3FM+$2:0,
M?(I0-;1>#8O:BOZE]B[@/D"C%'=Z./=P *C*QX 28K;5%78=@\=1LM%058E*
M="M$%<.D[#8\!CK>';'_&_:]']?*IBSLW%A0MT%^L*/]"42!1MO)W=J_ 3=O
M,H]^H95U>]H+(R>:Q^;W2>SX<7#*KBT1';-P$OEV4[ON5==P>Z[?NN*;)JCK
M*MC!+'2\8,:"^8P^3T+'#[U3%GH=L,%D'B-8\.@ SF,A((N]MQJLE;[$FD+K
MTMQ164U#=!@[4> WM 9.Y,>GYG<;>#0)B.9P[GAA\]#GK 2A'&/K>S:=G^(W
M8%GHG]JY<\#R%:M#K.IO05SG6)V8TJR;C[4M3 7Z$4]YV%U\9XI%SQU[KI5B
MO0%'O*I+0SPE17MK%R4*:RHE*4GI)2A%;8T8*/D.8MTW.J.!D'-LQW#E$O=D
MLUBSUBF079WVLY\>D1-;#*$VP!^2P'#Z^%#+\[ ,TB=ENI]K#O^T]/#S<"JO
M^A-+GN?2T@.[#['@"?%4S95 Y=PT.QP55\<ZRIT&UX,M8NQ73=CO .4*$L.B
M)"+?*X5O-P/PU+=H]0<Q7#=J*XNOF++E6;4&4= YM% Q#T__2[&6@GH5RZ2B
MM$.W,]J!2!;J!%F5XX- 5$23NK&9*T4#YIMN38-%+Z>HZ\RB;@'5)!=V.\3D
MB(0QLKNWD>[BX#VKC<,PR=*]%11+BG,O"4;>7-6VBPIL711%RYSJ4T&G.3Z9
M:G>/^_\&7GFX;'U*ZM\VK#;QM8/#_C!F!SQ)[FMWT31OB\'^:C;,MA](+QZ#
MZ?_7% 0C\+LOUTW TZK1A%]]4!C4@?,76A]Y$#7=^B-T9EX R4GD!IW@ZT^B
M&0;?J<HSIDVZ\2BH41MJ$$/:X-8?H1.X,X#JA;,>5&].(5\=Y>F/7I)CM+Y[
M9=: M7,L'^P!*NHF[YC-?2O#NGD+*8KGVOF5W\FO;-/J08W;4/T8\A'/@N:%
MSG0:C*4YD!V%"+J>>NCE.9$S#0/,<P(GCF+T!P<,G7I$3\A=AJSFD3$2>#36
M._3]26#N 4]TR0CEM<1-K"A)C3 ,CSU1MLI;$TW-DVVZFS"FN^K8HIC,#0XF
M?AWFWO^IFU1U[R[A2]'.PXB[8PW9,9;&<9NAK6:EMCKOY^>Z/Z OD3_6+[(E
M]:X")'Y8]G8#RLA^-,FB7O-W9ED/)5FT]U.SK(NF @?_ RHI2W:-&<U0HH4)
M#F"[%-@IJ(?<EO8.2[4#Y43($%+?P:$$R&L3N95T7@5Z! I&)X+MCH#JCZTA
M<]HAJ"W_$TBX!?5*EYC;XGZRK%2"1:IA*<PZYRMA$*(1.YTY8;^)(B0XL&V6
MRC*K>VO S/8#M-[J?C+( Z6"A\-^P(!TG>'U!2^DRC!R@<E'6W%0Q'*%Q^.J
MDVXQJ3XF[)*]P'IH/V&7V.P#FZ(]TRPU)XO=HSB+SZU3(GU8_"<=L6.S-<'&
M7([9::Z/( NQ5,T@4$Q4+WVXB;031&P-H;Y#17<G"YW.\E*?]C4U21>E#B\I
M229VV-?!EM4YGY5S4"(U.-K;G:^QSKTA1:2SFG&=0Q4!,CX($#WS:T9:%K:1
MP!A(Q^_QJ)I7F" O<'16#Z_N*GV.R^^X3.@BEE>89)9X$$E)*FU9 2[H"0\.
MT^B,U+9AN];MCG:F8\U404,*0!.4&R -*MTY&$O^%5T(UN$<ZNU%7>'OJD4B
MESC$:JC0:^\E)L6P_9U0\+JM38+8SJ.APL'7" IC"6K&PC28Q]S#1">JQ0%A
M [*7QM@_:<LCQ*[)7].S'YL:ZW,KG5<.1;V9 $ZPZ H;1=?(I1M^!H[[!X_G
M6P[[X2K@N:WF XO?ZA:I71SH>5-,[C]D2^UX4_9&0[ZA4''BG;+G%B.'Z(&+
M=<Y'C<7B.?L$>0.7JWH62#L\-9=%:E;6=>4%MCTNL>VA2_&+@;0E=,+Y#/Z?
M0WIQU5-B=H*3G5-G&C=-MN$R?VAOSW.F4< BQX-\_".A.(;:".@0\MZ JH)9
M\ 3 @1-X'E81;JASY<-JTV,S9-2SJ>,!T&,D'UGT:$%]L$KY<WTN<T!8=N7_
M6+;8$\Q>['CQ;(0-$10@U#1^ O/JK>M/);CO0;,9VH9Z+A@$%CNS( ;YQM'\
M"2CZKC-U8Q3S=/I4 =OB"7PGGH5L"O !"S1(VU&:2-4*3R--&UX8B2Y:G=GF
M[,J\3J"2!9G2 ZLZR+5;&Y[/:%H60@ZR\KP\X*)4ZE(2'WJ-8VLP92CB#P4N
MBD_'WB1B"YTG(R2X$)L+>/(G=$HVZ;AQ>GN%3HI-VP>]YDB(?Z!?3BG-8/M&
M,QA+&B*)&D*#<UBM,:S"/IF]%^BZU33 H1 PZ.1K=UY/:IZ;>J;Y]I^8A9U\
M !4^[:TWH0$N_ ,042]M#>#Q&'NS)IJ/V1PL ^R##D*"J7O:##Z;)^M1TB'S
M.IF#PX]/P3CC<,:\N1."#SX!H_-G8"(?>T-PCS?<$]\)\)T$<,WS*0.4XCD.
MH\^]\+1!30\48WLC<N;3"-$'3^X$D:?\'3J+8SQ#BOS9(<YYC^4<\$N?%_DS
M)W1I/MSWG=#S3FW&/HYYGN/. B Q!'9%Y&+FKF'I#S'/\QU_[E% CKP(V!>%
MD6'I /L\%\_PJ#\TA2@Q1[J\F8.OBEC,O=3G#8^SA8?K:\^S"FQ\S-SQ VMN
MP6GY$&=XO-)R7KIYWY[9[#BW7F.9I(S%%2L24_^.S$9!_?3@47]F=[2[);HU
M*ZI]4W]V;?+#[&;$;PT;F!I/0HO;#/RT-33T*":KTY3FP.$QPZR]N-*.(_5D
M)E98AUC^ ,=59!'FS3'2)#6"W NGW8GJ/IVMT>KAB:OZ[.U[3G:M,)Z*;Z B
M>Y% K%-1'!$^#ILYM0-37[; S6"V(M8,3]MJ1_,>7090F[(9HNEWS%:RP":!
M3"N*2<U029>LNJXN[2[MR!QY>RK\1Z0G.][L0=DUHF/?UZG$R9\')0B^;=:(
M<*0([DRBJ]TAAWAH(.Q P[GGV.#"GN>KUMS2>.\X;,9UR8EA%X]ZL;;3;)^/
MVI[7FHOK3.)V1L$O>,I7$KR0RI=P%/C\[=%I_79N,UI/&6;=6B:62R"FS0]_
M8K.L ->7=I=X!R=+>TQ#53C(IUES--'G4W-L?)M4.!RH_.# !'QW-KP[M#8X
M?-!AY:^?_J&&T(?)L,VN,X:,YQ#U24*JO*#JY=#(L4*,WK'"P&"\!?;,$CTQ
MTLS5F[%Z:BJ:<VL<14[M,A8OEN8=ZQ;Y#EN+%+N7ZO )UX%-BYV>K.?)4K];
MML#X5L.E,7I%BVY7=N2EG,N $ 6VS@Q6Y&D4-BOU^HAHP*N.F77\44>J%J<7
M]VI/8F*[E=9ZI8>Z,JMLWWNE''!0FK= ;:X5NHLZ/8DCR],FH'<KJ\$&F8H'
M)RH:G!ZHM(;?D&DJ*30P3&M7AS* .J V(T%V^F 'W9&J:>"];,S4+Q_T<.WW
MMKU9>-I_2#E[S_&CF$W]N3DH55?P\#AB0W_RX<SZVQU;D:_I+Y04JA6J_HR'
MN6K^",JY^ML?S7+U%U1^X_D:!9*(6WC4G<RB(S4[7/\HLQW])9!%5I;9EKYN
M! >9X0*X?YME9?T# 9@_#?/Z?P%02P,$%     @ D(%65H&;(.7I"@  T1X
M !D   !X;"]W;W)K<VAE971S+W-H965T,34N>&UL[5E;C]LV%OXKA!NT$T#Q
M6!??TF0 9R;;9I$F069V^[#8!UJB;78D426I..ZOW^^0DBQ?9B:[0($^[,.,
M=2'/_7SG'.K55NE[LQ'"LJ]%7IK7@XVUU<O+2Y-N1,'-4%6BQ)N5T@6WN-7K
M2U-IP3.WJ<@OH]%H<EEP60ZN7KEGG_35*U7;7);BDV:F+@JN=V]$KK:O!^&@
M??!9KC>6'EQ>O:KX6MP*^X_JD\;=94<EDX4HC50ETV+U>K (7[Y):+U;\$\I
MMJ9WS4B3I5+W=/,N>ST8D4 B%ZDE"AP_7\2UR',B!#%^;V@..I:TL7_=4O^;
MTQVZ++D1URK_569V\WHP&[!,K'B=V\]J^[-H]!D3O53EQOUG6[]V' ]86ANK
MBF8S)"ADZ7_YU\8.O0VST0,;HF9#Y.3VC)R4-]SRJU=:;9FFU:!&%TY5MQO"
MR9*<<FLUWDKLLU<_??QX\^N[]^_9XL,-^WCW\]O/[-V'N\6'G]Z]>?^6+6YO
MW][=OKJTX$3K+].&ZAM/-7J :ABQ7U1I-X:]+3.1'1*XA(B=G%$KYYOH48HW
M(AVR. Q8-(JB1^C%G=ZQHQ<_I+=2V5;F.>-EQMZ5EI=KN<P%6Q@CK&$WTJ2Y
M,K46[%^+I;$:T?/O<W;P7)+S7"BC7IJ*I^+U "ECA/XB!E???Q=.1C\^HD/2
MZ9 \1OU_]MVC5,_+_"VL6&?3NXU@UZJH>+EC5AC8<]V^ HPPB3=2([,M6^Z8
MD'8C-*N$)HB1Y9IQ]GO-<VDY)2P37WA><Y?"V.O>E;9]2=2'CM\#6Z2!AQF'
M5XUQ'-6*K>!,I0V399K7&7'4HE+:TE5=2LM,)5*YDBD#]FEN_0J#/ <QP[:"
MPH:V9\A/O0N0C_H>^$FAM!8EMN1,I*I4!4C@-Y,DB@F850 ,*TA+P;8;X10'
M/PA9*(1:+N]%#I-M('*I+%W0/P&)I6:DE#"D #\6& 1R*.AW2HB9<JUWSI:%
MJDL;]'1M73$\<%/!X0F"2A)RN:NXHW9HUIX5G1LM+=%"'$ECG"$:?S[L,%"K
MB\I9AM5&9!"Q<UQ/S..(X;"3J9>_-:*FT'@M'$=Z0XEZ#UI\C7ID+-M((*B6
M*3S2>G!)RI8H.$2NBYU#"1G^)"!?F"/SD_7IR7F]:^/#-P-ZD-DA2,K-AJU0
M^N#A3.0!W"[3#;E#:6QV+(Q<EQ1N$*+'V*G4LU'!,W$HO*<5T$/(!!%+;H%8
M@;,$#$.@);3\ V)@25VF0EN8Q>Z&0+RJMHW=8<6>@G8?%#^84\\294@C,Z&=
MRQR9QB@]*AN)+-#I!JQ0/-E[\47D+&:%X(2I)#S2H:\W#(*>PE!\:R1)>X.8
MR%6Y?D%)P]; 1[MAWFBTK#%S\T12MJN\@PK<IZI8RM(_P=(\:Z* WO$^?V0=
M?(1LQ+X-"CFN>MKTQ/8!<R]V![ZA^$R=F<@./?1Q64<V)O.H'#RPZ"7[_KM9
M%$U^=+0.30R;KR!QF4J$;*75;[Y[,6W@D .H"\D8R.]#X0=SA'%:K+&-^_I6
M\%2K#I&^<"TY:IT).@A#WH@R,\UB!V:J(K%()$DKZ<UA:%!1M. "E'39B-SQ
M!%8U16'KK2KGI1D>:-RH169Q6 @IO9TIU>V)25K5\93J46E]4C8W^[S<D^V2
M#MDN=JH1/>=(;,"25 YKZ-'91(51\YV1QKOZ2$3TC(22YL@8_6#0 C'H\^J!
MV'7XJ-4*D+.4@-?=6>\:) V5DJ9<]3$\5^E3KGW8C4_ZYR"O.HQHDN"\[>V!
M6QL./3>@0*&OZ@!RZYIED;W@I.*:,,6XL$UY!:/D8&8W*O,%L,4;TZ^S7>1F
MZ'K[5?DH2-M*KJ6Y[PJ_(\M[!1<E[P#7 )>\Y59QA&(J0;!)_B>%E\=2M*#>
M6DHYQT+<%6+CA>5?O:5=VL)R-.W\7LM&$+JT.Z=T)I8H:2IWQG!]P)(L2I4?
MWA"Z@I9BR&YJW4*1W4B=47W3EL!MY=KGH"^>K_K>Q0<U>U_VFWQXO.@?MA-=
MFY,%7LM^?W?25S0,@J[A@6NV\&6IT!' ):A<_M5_URLY&FU?Y%\>]46.);A!
M,I1-4/=<+2M%BGU<[T[,LF\4>DV)[VJN72]B6G YXD76[YH:+"%/.*_B(D10
M:6J)FB)A7K(;7'#=$%.UX83/URH#YK-;BFJ>(RIN:[UVW<V=! ()=B?23:ER
MM4:VLSM%T;B?="S[.R]K4LK/42%[QB;3,)A/Q[B*)J,@GD>XFL=1$$^F;$'#
M,END"$#C6EB'$F'T(YLG09A,VQ]4>*0$*FRM4492JB; E*807\R"<3)]SBZ2
M8#R:XS>,@]%X\IR]X4 >.!9B8;@3Q1)!$O<$F\1!$LUP%8]'P2@>X2H,1MB=
MC&?LEN<N7TI5ODB5;_Q\FPV-MS W 3J!:9L?K>078] @,9K?VW>+LQHF83 ;
MC]N?QS6<!I'3+,%O0AJ&01+&CVI(9IZ,)T$4SDG#611,)I'7,)X%LUG(/KKA
MX'0RI2Q#6U.ITE7"!E'V6$/I8@%Y5 80/-UV[K>?QMF)9&<C[]<&], )8+=(
MT[JH?9E;% 0#?WA;? !@DBRY\.6]B49$W(SM!%$E'6&F((XHZ"[BZ2B83V;/
M<3V+XR >3]FU._6 1*Z04DG=R,JP,&HHA'-$$"QT$29),$I&SUDRQV_([A #
M@E#;7"XU95;)"Z1!U+*>PU&3,7@FP60*1TVB8#P/VZ2B"!)N"ZR>"71A$I@<
M3B;!9!YW<='>W]95E<L3(1&FGE<\@F])QFD03B$B13U$7""AE/,L7OJ5XV .
MI1$\HVF(=7#^Q!EI G'',07%Q9B,%,7/W?,P@@2C^9FD^?,=%P(9YN/$.6XT
MI6QTCHN@ Y1[RG$P2! G"3DN"J;C,3P <)C-GW;<S.'1!31-*%;@@]E\_I3C
MIN QZSG.WW^SXR9!.(_@D(2 XISCD+V@=Q%#%CC.0Z9S7$+B><>-H#'!C#->
M,@[&T_A,3F\E&K&>[.]=+WUZBG(FG6FGW._,W<[CD;D$ZN<HEDUA.FP*:!1*
M@:&9PRI'<'%[C>)1H6T"]@[9(FNA-=\=]@YT:M!61TD=B"Q:45=T[H(.E@H?
M@DZ[B2V5&O%G++$R[>S>-'DTG57*$GHY8='^U*DX,W_S8X6S$\.@G:-._LQ)
MR/",6?]"9U+])O^O?@I%CTX,_]1)U+><.H'& Y9[\F#ISVY]3_0]FX#_[X79
M)ZV0OA@AJ?KXB=?#9VNI%^<SUQ\Q$0V1-<,Z];?0[BA+'X>MR8@BNP$@#SW[
MYOP0A> \<+"-59O$I .5SC[-(1!BE<RQI-$G=2,<I/:N/E*?-LGRB\H)C*E9
MXUU4GAD*[*8-)L(2=X'9O*[(W/[<"/RX,PCZVOV)Q<F43<=Z;H>'W0-V!Y.Z
M9R*^ID)D?E9]G'!PCI8T_8F9+-,SBY_1]U817Z6A&7%1]I_FRKBC@>9H(6OG
M=Y+,F -I3_U!K%Q.[H,\P)H\;=H;?];PN+W:9KJF]V<$(XW6I3M!;6IG<W[4
M)5%ODR]SP\.^2GRM1&D$N]CC>I-NS0#M2;='"%6;-N1"X.SS[DS,]QR"/J>=
M]NQ- ]A,DR.7NL^FLV',"DQ^D"-@SV;Q_M:M?#9-AN/] M26RA_CY;LA._=Y
MZK+WF1%MWMI]3*4H@#K^BV/WM/M>N_"?*??+_<?>7SCFUI(0:86MH^%T//!0
MT=Y85;F/EDMET5.ZRXU GZ=I =ZO%%J%YH88=%^QK_X#4$L#!!0    ( )"!
M5E9K=+E-%04  )T,   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;*U7
M;6_C-@S^*X2ONVU YL2.FV9W28"TUV&WX7!%TVX8AGU0;"46:DL^24Z:_?J1
M\DOM-LUVP+[$EDP^)!^1%#/;*_U@4LXM/.:9-',OM;9X-QR:..4Y,[XJN,0O
M&Z5S9G&IMT-3:,X2IY1GPW TF@QS)J2WF+F]&[V8J=)F0O(;#:;,<Z8/ESQ3
M^[D7>,W&K=BFEC:&BUG!MGS%[7UQHW$U;%$2D7-IA)*@^6;N+8-WEQ').X'?
M!-^;SCM0)&NE'FCQ,9E[(W*(9SRVA,#PL>-7/,L("-WX4F-ZK4E2[+XWZ#^Y
MV#&6-3/\2F6_B\2F<V_J0<(WK,SLK=K_S.MXS@DO5IEQO["O9 ,4CDMC55XK
MHP>YD-63/=8\=!2FHU<4PEHA='Y7AIR7'YAEBYE6>] DC6CTXD)UVNB<D'0H
M*ZOQJT ]N[B[O5ZN[F__@-7=YZM?9T.+F/1E&-?ZEY5^^(I^$,(G)6UJX%HF
M/.D##-&9UJ.P\>@R/(GX@<<^C(,!A*,P/($W;B,<.[SQ*WC77TIA#_#G<FVL
MQB3XZUB0%41T'((*XYTI6,SG'F:^X7K'O<7;-\%D]/Z$@U'K8'0*_3\<P=?H
MP]* V@"RR/,UURV3P&1"+[BT*=<<]O0S\:>855GF"@0%(O_'=FU2AL$2F,5R
M-Z4^ *9C_ !8V\:BM)!;S%:; H-8&4N29^-)V($@R+-P'/E1LS7 2C8%=[68
M'0; +&KO7>WP!-B.:VP%%5R!WCL?'/#YV ^F%6!TX4\G?2 ?/DOXA<D2&PN$
M$Q?RV$4*5RHOF#P EQ8C3D!(J]#F67 ^>O(SCK%/:$8^5"8U+TH=IUCO\)U'
M8+!<W7K?.P<T<HM6D4X_.,96QVBL\IP^.MXP5B%C7KAV5 LVT /8IR).R2YE
MF'1L%(56CP);#T8(T]$WC1)_I,!1PBK+LH[I$FM0/^&NEK<^W*44#?5G.J].
M7%@-TC#7' U0S!U86-,AY$7&K:/,86Z$QF-)6;8A6V3!T;XLM,B0=)=F%>>7
MBNG$I:% LJS2:*"TJ=+B;X+O$(2F.BZ5!6V<A>%YRVN?T+=OIF%P\=[TB*UB
M1*ZVFN7 ,KQHS DCPIJ6LJ)0VI92&"MB5#S 1JL<+%X[I$3/AL!6O0F$N6-$
MS@0A(45MR2$/$:D)4Q_\J]KX(<.V4GF+![\3JC3]^$\C#(B?*G/.@M%30E<'
M3CGT1#NF'YEQP:$6T5#;QTO6#EQJ5U![AM10E]@+-&AP-$ RJDA!R9>]Q8>;
MVCN#=].!DH=M-G4NI5J5VQ3U4%=#K@@#1PH4U ^$W,G" 7(@=E6Z2[Y55KB*
M[(OTTA9;>AG;4G<,";GCQE)(>%W+!TIZ(?%\;5D#H!?4L/*UD*Q;BCCAH$V4
M[S63(!QT$OO59M(YL7]O)N&Q9A+XT?1(-_F:3A+^3YVDUT8<J \?0<(GAE%
M&'49X4PC)'_D.J9D03L[X28V2J)F.X'UH8>'X91$8<&TQ>9]7U!HW-K,Y2(E
MV3%;#1<M9PS93A)!-*#W(S^:/&<PP0:F<U<*I:%<()R=RLJ<__#BVL'LB_FS
MCO-MO]= 4NH&AI"?L^\##HMNYX#,8)[@4/2B8/IWL.QVI^<WR-&&!T@M,=?(
MOLBR7H_PC\THP\[(F'.]=8.QJ8ZEFA[;W7;V7E8CYY-X-;CC26VQPB#C&U0=
M^1?G'NAJ&*X65A5N %TKB^.L>TWQ_P/7)(#?-TK99D$&VG\DBW\ 4$L#!!0
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ML<J/B-+F?2W3VEI;]E,F7!8Z(3?V7G4+J,8#^#\7>82^W2<)\CKEQ<XP\WQ
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MHM0Y\[(P;HP "X=A;S -C]CA=#8X8J>9TH7\SFUZ4PNVANZ0;]NG'L9:)++
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M8Q-CS@>ZT5G)TSBP<R09!PZX_X)ND+.;SQP/5QXT:<]6?Z#/2GX^8JF?D+U
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MI*%;WC5+T@^5-:#YK:04=!WKH'^H+?\"4$L#!!0    ( )"!5E8O/:!YM@,
M $H(   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;*U6;6_C-@S^*X3O
M<&L 7_R2."^])$"29FN!OJ%I;Q^&?5!L)C8J2SE):9I_/TIVO=Q=VPW8OL0D
M13YZ2$ED1GNI'G6.:."YY$*/O=R8[6D0Z#3'DNFVW**@E;54)3.DJDV@MPI9
MYH)*'L1AV M*5@AO,G*V6S49R9WAA<!;!7I7EDP=9LCE?NQ%WHOAKMCDQAJ"
MR6C+-KA$\["]5:0%#4I6E"AT(04H7(^]:70ZZUI_Y_"UP+T^DL%FLI+RT2H7
MV=@++2'DF!J+P.CSA'/DW (1C6\UIM=L:0./Y1?T7UWNE,N*:9Q+_GN1F7SL
M#3S(<,UVW-S)_3G6^206+Y5<NU_85[[=G@?I3AM9UL'$H"Q$]67/=1V. @;A
M&P%Q'1 [WM5&CN49,VPR4G(/RGH3FA5<JBZ:R!7"'LK2*%HM*,Y,IO/YP]7#
MY?1^<08W]^>+.YC?7-W>+<X7U\N+KPNXN"9] 2>7-\ME:Q08VM(&!FD-/ZO@
MXS?@HQBNI#"YAH7(,/L>(""N#>'XA? L?A?Q#-,V="(?XC".W\'K- 7H.+S.
M&WA+(]/'7/(,E?X%%M]VA3G M30(?TQ7VBBZ-G^^EG>%VGT=U3ZE4[UE*8X]
M>BL:U1-ZDT\?HE[XY1W.W89S]SWT_WYH_R,\S',F-JBAL$\LW94[S@QF($V.
M"E)94OZY?<1/"%QJ#:N#LTJ!PL *S1Y1 )TJEBL*>#E98"*S0@1,(;@:"@M+
MNQ P&+;B2-'44WP0U+ODFFS/IW F.6=*5WYRIPE&PV_4G+1#O"0&Q%7:'57Q
MQ&Q+T"2OJ009S%"09."V;CH7!DL-]/KI;0N8[Y1"D1YJ\[TTC,.,<292!&9^
MRB&"CW#2C?WA(&J1&/F#8<>9_+#7;SDI\:,D:<'-*[7:$&<XL15KP2#T.YT$
M^GXW'L))U/<'(0'TAOXPZ<,E:GT*TU+NA-'4)U/.M"[6!>6S5K+\QT,I!.E8
M53'J^DFG#Y\^#.(H_M)\:_,U>:2N".;SELHG7P<\9MY+_/YP\"/S)"$]?*]V
M,94GCOU!U"=AZ'><X22F&O:[KIBA'_<2>S3N.AR0*4#;87Y&\IW'G"@R<?B^
M/JSB2G?G8Y2T0^JOG+M1(>R:NZUV+6QWFZ5_55(7:62]=EQ@BUS01:;[;)H%
M4K;HIA,_M%]K#\%1?R]1;=P4T[0I'7G5ZAMK,RBGU7SXV[V:LE=,;>QCX+BF
MT+#=3SQ0U>2J%".W;EJLI*'9X\2<ACTJZT#K:TF]L5;L!LW?A\E?4$L#!!0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;)U8VV[C.!+]%<*S:"2
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M7M)X+P^,-YC/BVU>I_DRTGU&_VLPJ^H2$.=_M^V8QWO5/AY2TX_5)IZ;7\Z
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MX"T[(*)*<!J@MLV_=%%;3&@VP$GZK7%H(*0 )5 MC7#P<DM0:CQTB"9PT@5
MUF%'8F:U/Q!37%%5;HPY\7,6\!Y5 /7Q8F'*55HAALT!SY&: -=0A.-0\.,C
ML-UB"V<#LY<M?  ' N9O'AD59DBR<57DA,9.*H-,+G%#\[2<;]= 3@CL<Q3,
M6Y@6>!#HU+CJ;09'G0+-EM&B+-;XKK_P8PS^C67P;XZRYR$BU@!V1W^,@"
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M&%6YN>\CWUL'^6;B?)_..G[@#'W%&&_W>6?E$XJ?_G+0VVD)$2;UZM-A:8?
M UO;4&L /!2_J-.SJCA2APX2RO:>F?H)NV&T<!N-KK6LR@%*P'*, EU?DM[Q
M7B*80@CZ/: +G-+!?B2G!KE]&'V<#*+KN\^W7A^2AMKF9!S%2#'"3@$2OZIQ
M?SEHU\V9A>W_2"56J' #GI?:5J1_<=%'WIH!'CX:$:GH<DO)+NE$J.G%K&&*
M03%/V5B8.Y+![TDK6*1&LW/&DV%T>=%[-G_^[.5S<<N:KV:]0?\45NRC%-.U
MG4>?Z2522E:D_'8.[#$R^3(67D#MJ#AQB^@?R&B-=AD74FG4-U[F195JKQ43
MUZK7 3HB-W)QVD8H!WV$5-XPY_I], ^I0HFKB#N-4W'ZC!]0 3FF&2$M>\%5
M@>U';4P,1X4CA*[XG\2#$KM^+;M&\N)/['-$?: C5<4N<X(2BL,4P.I/].,X
M2BRNYTOO>,N6*]N7H5U0G7A[-!G_!M3QVVC:R.2@$ZHZ7@V2-C?!0%=E#PV>
MQ#B$U+IEKD>/K8LDB]CCKNS?+R0O0#1V\N22>]:3038AU?7UX,+7.:5ML.U4
MMF1))DG)WC,^"G:V*EK%/)E7C0%H! BS9N2V13BDG%6FT?S"G62S>P6;*/*B
M#@FTBUY/4NZ38DZ/4U1&N,/^6J2A%U;J97]BXM*TJ$KMI9=!S/U /GF\!0N]
M5(-"*V^5;^ 3^EU'8E5%%70$B6PE#< P77)C)<>XT-\/?"-9LJ+N-1+!L?=_
MB-9@V9%,\T:C,(W;"KY%"JBZ\N4+,DOI;PY7H)AW323858\4#>.ZO-Q.0RAK
M(>K,X,)H-,EZ\KH7+4+=J<5@;^^?@I4:%&A%L>&L4'2@46^J5A!R_JR7"Z10
M\[U-$55^+;8ECMG1W=2[#2VG[8VFQ[:]X8L64*BW.:!TA$*0UZ.A%\)RYAY4
MV6^[O7!%.%.IF]!OM58L%JA2RL-N!-D1F+/KEK/Q79%4K46<A&S>PM]9T!,,
M3Q$=#E)9;>4N**X4-T)?&^H$\/^^#XAF:([?J"L+<;B%"H+X/["06D",55[,
M')7]@84+,Y"R*[6TJ=_X3*H9][G($=[1XN& 56INKP0IRB"-6PXAJ)UL30EL
MSPA$Y#FP-E=;L  V2I6 E$DB&0-B+K5SJP[5>XN!K,,X[=IVAG"K?"+7&_=F
MT'0,JHXD_%@PYVOPN?;&#90_ (N+O_#14M(PIWI8'R?@V5-<)@WQUCDDV\0%
M0%77 (=ZQ3%7&UU"&Z9$;B %'9X5F-HF+-Z+B_ 0N2F(3:T4BR]$\"VB&G<Q
M:4TZ7A>)R?R<%3_B\E%IN3$F1;?RS59EAGK>_[DMN&]7JLU"JG2=9O$A)%0%
MU8@N@?6WA+/%#+,DQ-E.\]BJ"?7Y>)FSE(-&3VD*NO2DLY'C#CO0R[*8B68_
MVW7\6427 42(&05+9;!4[$6+\A15GTG-,\PNI X6U(%DCSC:&].1X 8 W%"\
MKF\KLCWAF +PR_D*>(*9QZ3/[(&%2C@>8X"Q- IIE!W1D%LL!Q6'_V'";804
M=%=5P!3W^:"3FQ50>X2NAB5%JZMV+L\2UXO=N\ZBCFT?TZ]=RZW>\499UZ(@
M#(4X6Y7L$T/<34;CC[?1\/-D,KH=_H-X\H'S1#>XS!@TC^2L(6G%L=CF<TD*
MLCR#L8M<S@BQS^?3<^XQFE 5/OMVD9ME?M^ TG83$HX#WV-HLVMR6U1I,F,[
MXGFY7%:S/#"TEH*%S(QRU[AC2;*US!FG9,Q!'4U^MSG1.C9YOVV;$_(25JOB
M*6\I+O#K::4E!OQ<FA7V:'ZT>WB&:L5S38*VL#PTH<IQZ;Z3[5Q] Y=HTJ#4
MHT\P=R?5(R3/@7CBG#5/U\DLQ0!#WG7G%;0S/8;"KFM9[WCOL#&OZP'7U8J^
M1U\_U.=B>/=I%#T,_H,:7?@;+TTCK6JV\\2Y2Z-RO)>SAS%7;*]AX7[E6*BT
M*$?WG&?L:Z9\5.P@@OD*<[.?^^J<7U7@_6JQG9K.3G9>?I5V'H<6RLZ.M/0S
M;'%5E P&BEE;%T=R6FH) X513@6E*H0\J2 2B&/IP6Z6?7!28-_Z9CF93^I1
MA.KRUO=:^%3LU][ DT+?3=>]4$7HQ*>MD?HB0X"BF<?<A2O,T/ :J!'P0)E8
M $Q(&P8XV$PR^A7XOI1"YI*A<@1ZY"JM@'RY!)N\HN9KO-9$ML .M"4$$79V
M=LQ09\24!2(-<7!XZ:#4\Z+0JC&I0L]_J+FI&H7Z9)M< [8"?,$*>TD4XV';
M8C4951/5GK=9H>.E]G,"C6T7%13/<:ZB=>DKT*4K9G4"=(H^#+EM)KWI %WJ
MS';_"F'$?+;T(>4K/A5[M$G+:&AXK.IZ'K7 YF@VBNX 7D@(MC%=H_D;U;5B
MM -5"4\@Y>8K;//)9(_:I)(*]5@*SZF- 3+W_0UH8[9 P0Y\4Y@7S0[YRED
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MX;H7H*_3^J,;(P=)0)*GX/64K<VF"XQ0&]AI(8G?XY'%3B7WP%%1!?DWJ'T
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M1[,<9]S"&P56Q1,&HCK8#P14"368O 9\U99;C#'WS.P-WJ&)^$#!&2%KK(<
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MO[D\8Y^[?JB+#0Z) ( %T9\K W*MQ ?@]T51U/H!)\";)VEY[_\34$L#!!0
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MNOM"E  [$OZ;+8&30)R/7X^%!]&&^JIJ&R+1ZA=D2-D:N>1UON;PJ1=Y3A!
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M;@.EFJ+)0_\O0FN,0T94=/Y@>5N1M@'KYAL,/CB"V3N!O3EQN _61SOW4J5
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M2@^9VK=];NE:/T17C7HD7N7F\(3%+Q)/(HDO8'M/M,XSJSZ=8'!R>WY=%YT
MMKG[1PC_#F\@(P]WYC<G'0S\&P0I7P1WR/$6^FCUL0<D@$2'=#?- W?MPTV[
MVZRL"+:3+88!G%_0KT#U"14G#2P'CI0A< CS(.-+>H-D5 MI&=^\G8>&4%?B
MFR@X:0*7@$A^@*\@ NH<;D0KMS:5G+ "5Z#X<#!97-"2OI'[#K#O$E# ]EB.
MOM5R8*^JQV*>Y=CFK0"4P ZEAVW#OLUXU+(]*#\9-)N>,(P9V(U)_Y;Q*+-8
M0$U](:@ \PE'-";M,!^UL>\UI; +AUZ >E'/PA>$&^/V<)'7<)'7F_[MDQY:
ML!^K>WLA]K]D_T8Q/(/\TV28@C4EI.!^&H)CH/L85$U%'*//XST<8SBT]NMZ
MGD1SL@Z1,*)TA;$).:Y:OM]#*1VOJC&,KU0N03+2Q ,4]NLP-[*8#RUZ^U4V
M]2"?=A:59Q6U&#1%+@N:AJD<P292=#9+X]97LX7,9^;;(% U<ESY :T9;3X_
M3LJO;IOIY;?+CV$^0X>D<@I+[9$'W4Y>?@\L'PJU--_@GE11J(6YG<L0?(83
MX/^I4D7]@ #-1]G3OP!02P,$%     @ D(%65K<_'U0X!0  4!   !D   !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL[5AMCQ,W$/XKHU#1G&3(KO?]N(N4
M>P%2'0<B:?E0]8.S<1*KNW:PO83KK^_8FUV""(%6ZJ?RY?PZ,\_,,S-9W\5.
MZ3_-AG,+'^M*FLO!QMKM^6ADR@VOF7FJMESBR4KIFEE<ZO7(;#5G2R]45R,:
M!.FH9D(.QA=^[XT>7ZC&5D+R-QI,4]=,/USQ2NTN!^&@VW@KUAOK-D;CBRU;
M\QFWOV[?:%R->BU+47-IA)*@^>IR, G/KU)WWU_X3?"=.9B#\V2AU)]N,5U>
M#@('B%>\M$X#P^$#O^95Y10AC/=[G8/>I!,\G'?:GWO?T9<%,_Q:5>_$TFXN
M!_D EGS%FLJ^5;N7?.]/XO25JC+^+^S:NRE:+!MC5;T7QG4M9#NRC_LX' CD
MP5<$Z%Z >MRM(8_RAEDVOM!J!]K=1FUNXEWUT@A.2$?*S&H\%2AGQR]>O[YY
M-[V[@\G]#;R>O[Q]"]/[^>3^Q?3J[A8FL]GM? ;#.5M4W)Q=C"R:=(*C<J_^
MJE5/OZ(^I/!*2;LQ<"N7?/FY@A%B[0'3#O 5/:GQAI=/(0H)T(#2$_JB/@"1
MUQ=]+0!*+7>BJH#))4RE97(MT%F8&,.M@1MARDJ91G/X?;(P5F,:_7$L#JV5
M^+@55UKG9LM*?CG VC%<?^"#\>-'81H\.^%#W/L0G](^GF&I+AL$K59PO4$/
MN $AX9II_2#D&B:U:J1UIYVWQSPX:>.X!P?&[(9#V1EDO<%U%UZ\XACS8<9)
M"#N.,64&5JK"SF#.X08G3.^5J<;@30/7:EDS";,M+P6K[ /,&KT6):M@+HQI
M.,QYN9&J4FN!..;*XLDG2BW\PF2#S0;:A GA)TBSD!19@C.:!B0J*,Z*B)(H
MS6#BV@-,RO>-,,)WC<>/<AK29U#$)(RS;L"&@.4NL4"UYK)\ ,P+:2KF188Y
M2>+L#(8Q28("QS B09*>P16KF"RY@X59S.L%UUTF>V!I1&*:XRQ* A)$ <Y"
M$J!TG.0P8RV_4LDG)9IW)I<>(WJ\PW O7?@Y+!J#S!G3(Q\FJ,/!V(^SZ>2H
MAW%(\B3IAM,>9H1ZSV(<8^=A2.(P.NFA"W.:I(2&A?,PIR1-:>MAE),\#^%$
M(21](23?7PBJWBK))18QKJ;8?E9""LN?W.'/P)%2/U82)ZT=+XFYJX//3+O*
M<&"8?/@9LWN)^V(E7$?%5.]!L+;??%D57\3Q:)V\\S\_Z->U,A;Y+9NZ0;9P
M XM?6_%7R]P]_LP[+!5W1[:K':R/'!ZXT^H805))1%V)#*,L($6:G^$\CR(2
M)1E<^U\E1*1YFP]F([8&L-6W&L("\QWY'(9Q3((X.(.XP#&$.68L?E+@Y\9H
MH5T?D*S&HJ6=Z0+3*DW09DS2#-,JI20IPJX%N'SG7N2 3 C3E*1%U&=QMYXU
MVVTEO@")1=7:B@+,1(<Q(V&&$%V-(L0)EK]"PC3@87LS(04ZC:D>9"'>PU1-
M?9!2A)M$+H6'B0L2C<[\?D@105 <*?'_GK@0^UB1Q)ZX('.]PQ-'T0=T[EO$
M84!(%,>..$JR)$$&L)7EQ;>)RWWW'**GL<L5Y" OBF\1EZ&-_("X=OW=Q*4D
M+"@2$KNV=HPX[#6H;Q@A%B2N;?">N-C!:XD+T&/7%'WPXH0D672J#Z5]'TK_
M91]Z_H][T$E+/WK0CQ[THP?]/WK0Z."5AQ%<^[>LP4+'3^WVP=?O]L_E2?M*
M_'2]?6N_8O@1+0U4?(6BP=,,/W1T^WYM%U9M_9MQH2S2Y:<;?/)S[2[@^4HI
MVRV<@?Z?".._ 5!+ P04    " "0@596K4VQL20&   T#P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6RM5WMOVS80_RH'KRT20)$EZNDT,> \NF5#
MFR!.6PS#_J E6N8BB1Y)V?$^_8Z4[+BQXQ;#@,2BQ'O?[^[(LZ60CVK&F(:G
MJJS5>6^F]?RTWU?9C%54N6+.:MR9"EE1C:^RZ*NY9#2W3%79)YX7]RO*Z][P
MS'Z[D\,ST>B2U^Q.@FJJBLK5!2O%\KSG]]8?[GDQT^9#?W@VIP4;,_UY?B?Q
MK;^1DO.*U8J+&B2;GO=&_NE%8N@MP1?.EFIK#<:3B1"/YN4F/^]YQB!6LDP;
M"10?"W;)RM((0C/^[F3V-BH-X_9Z+?V#]1U]F5#%+D7YE>=Z=MY+>Y"S*6U*
M?2^6O[#.G\C(RT2I["\L6]HD[D'6*"VJCADMJ'C=/NE3%X<MAM1[A8%T#,3:
MW2JR5EY138=G4BQ!&FJ49A;65<N-QO':)&6L)>YRY-/#\</MY6\G%Z/Q]15<
MWGZ\N_XT'CW<W'Z"HP<Z*9DZ/NMK5&.(^UDG\J(525X1Z1/X*&H]4W!=YRS_
M5D ?[=L82=9&7I"#$J]8YD+@.T \0@[("S9.!U9>\)K3,RK9R04F,X<[ND*,
M:1A)2>N"V?4?HXG2$@'SYS[O6]GA?MFFB$[5G&;LO(=5HIA<L-[PW4]^[+T_
M8'FXL3P\)'TX;FL';J=P7<U+L6(,QEIDCYTWEZ+"<E74(O[ZR:S9/A\.:MGO
M0ZMF8M5DVVI8JP9.@)8E%FI)-9)H :RS4 &M<ZA8-6%2@9B"GC&X$%3FYN6*
M2ZQ0@3LGR)R)HN;_('^#V)&6DC9Z)B37U-0O% W/:9TQ6%*4JV J2FPLZA1^
M9U1VD ,$C-5F07.%%&:+URA.- J-419)YL<W/Q[&36EC3"$$;BI1YA"% P@3
M#X(PA'L, I79S#J2LP7VLKE%BN\DP0!_8R3RG3#Q88P-AM>% P6KF:2E9:$Y
MEBXWF+(^O $2.6&0X"(('6\0X\)/G"2)X4%HY%'?BS5!:A)!$#O$]\ ?.-'
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M+9.& />G0NCUBU&PN2@/_P502P,$%     @ D(%65F.@;\\B!@  ^1   !D
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M/##BP(J]D>.-AN;CCXP2"VMQZ S[KGEXSTA<-JC%@3,<VE-OR,@K\INOJ=E
M0/3P0M/]S)>Z5.@W;AY)SSN@IL8,IYCM@R.[(B\"C]Y+40YN\K+2EEAD )4V
M_9=NNH.CK7+7*&O]'W;I6U%L/MI.>;PY'^)D;V\:RE%N[,RGP+; >C!JI>U8
M.:^GJ9?K]4QZQ^4F+10YL"95MSN@3B3K.:_>:%':V6HE-$UJ=IG0:(S27*#S
MM1!ZMS$&VF%[]C=02P,$%     @ D(%65D^L7?7S"   $Q<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,S4N>&ULO5A;;^.X%?XKA'>Z=0"M+5+W3!(@MYT&
MF)D-)IEMBZ(/LDS'[$BB2TJY]-?W.Y0L.XGC35_Z(E$2S_T[%^KH09L?=BEE
MPQZKLK;'HV73K ZG4ULL997;B5[)&E\6VE1Y@T=S-[4K(_.Y(ZK*J?#]>%KE
MJAZ='+EWU^;D2+=-J6IY;9AMJRHW3V>RU _'(SY:O_BF[I8-O9B>'*WR.WDC
MF^^K:X.GZ<!EKBI96Z5K9N3B>'3*#\\RVN\V_*[D@]U:,[)DIO4/>KB:'X]\
M4DB6LFB(0X[;O3R794F,H,:_>YZC0201;J_7W']UML.666[EN2[_JN;-\GB4
MCMA<+O*V;+[IA[_(WIZ(^!6ZM.[*'KJ]43!B16L;7?7$T*!2=7?/'WL_;!&D
M_AL$HB<03N].D-/R(F_RDR.C'YBAW>!&"V>JHX9RJJ:@W#0&7Q7HFI.KK^>_
M?;EDMZ=_N[QAX]M\5DI[<#1MP)HV3(N>S5G'1KS!A@OV1=?-TK++>B[GSQE,
MH=.@F%@K=B;V<KR0Q80%W&/"%V(/OV P-'#\@K<,K0M=27:;/[(+98M2V]9(
M]H_3F6T,H/'/739W',/='"E=#NTJ+^3Q"/E@I;F7HY.??^*Q_W&/ON&@;[B/
M^\D-TF_>EI+I!>MU'W_6UAZP,XE<E&QCD+2[E-_+?K?R/<M9)T!U3PT)8(5&
M'MI&SDF?9BG90I=(:%7?';*_R]ST@6<(FZQFTKC076 /?5(U2'1K\WIN73SI
MPNGBL^^U(JXW3=Y #(J-R2E=+?O ,N'%H: %]WCD8\$CST\%0SXBV^KMW5QP
M3T0"]\"+1,*2U N#E-WJ)B]!*'C@I5GH5J$7)PEQI9T^VQ.K:(A5].Y872X6
MTE6:K0"Q;S".?9-P8J%*Y53>%;+]4DY1!+<YK"/Q?7(S8;_*.7Q1,@L_MHTV
M3\R0S$:[+>>Z6N7UT\\_I8(G'RV3@Y*(;K=369;;/JIV3TQ?A.\-N8)/?/:G
M%S<X!'W# LASV:T."!K/< 8LHIX"5FQA='78X>+9%H_5Z%6P?=&+)A-FLI8+
MU3!_PB&(3S)W%;CNP,HXF&0'^#0.)[Z[)]WSY6,AK=WF9YT6,$X7/Y "%5JA
M[7P_%I/0T4)*?W>\KNI&FJ)S-UL934HY&^]E[=SC3P+:[G=DG8Y?-?FY1410
M?MDBIQ##;HI/H2VT\-VVCI0[$\]1;>$E,*6E5?/>.E*L,ZJ7T)%^0XKGIE@R
MI"":UCV:\:HB8L1A#A6A_DMSX@-'U[2F)AC!EGOE6C$X1[V$Q-W%)*#[IU+/
M$ Y5-WE]YRP!E'ZAF,W7 1R//EU]OKT:'3 Q29UR"<%C$KUR@GR41=M[8,OM
MO"?+'%E(\<V504,T/P"*^[QL):(E5ZQ=,4UN1W'_!7:JYHEA6=L%8 SLX ,&
M >1 "XUA&L"!'2X_Q$=PW:S&<=";APFGAT/>I?JLM4A1(.871F.'2S9@9ZZ0
M74;6 -,6GZ#7F?3_#3EIR'_.YYL]OG/$Y>ODY-$D[O)(.-P&+DI[*E<\5*[X
MW97K>H@PRO\?MI?]?&]1=%;/^/U_NLEY:^#YYG"H2RCXH2=\C@5X9&@)'UCL
M\33L*PO:0A QSKT /0'=161#Q<C0,0)Z%U);\:(HZ-M)T0DAEHF7@>(#"U,O
MB*BIH/TD<0S% 0&DUD:1,61$&3_ 0D F<G0,U@D*3Z?(6'@!1\Z- R].4]H&
M1MBUT2: I9S8!R!-/)&!ME-HWDN#_''H12G2\P,Q3*)N%8<>#\#S^NV(P);
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M&*<-^+[0NED_D(#A/_C)?P%02P,$%     @ D(%65G0J_O4Q P  ?0<  !D
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M,_('PXX+^6&OWW96XD=)TFYVZ&.O-J096K9C;1B$?J>30-_OQD-H17U_$!)
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M+W=O<FMS:&5E=',O<VAE970S.2YX;6R-5EMOVS84_BL'WC D %>+I"1*66+
MN33-0RZ(TQ7#L =:HFVNDNB2=-/VU^^0<I0$<8V]V(?2.1^_<_E$'C\:^]FM
ME/+PK6TZ=S):>;\^&H]=M5*M=._,6G7X9F%L*STN[7+LUE;).@:US9@E23YN
MI>Y&D^/X[,Y.CLW&-[I3=Q;<IFVE_7ZJ&O-X,J*CIP?W>KGRX<%X<KR62S53
M_N/ZSN)J/*#4NE6=TZ8#JQ8GHRD].LV"?W3X4ZM']\*&D,G<F,]A<56?C))
M2#6J\@%!XM]7=:::)@ AC2];S-&P90A\:3^AOX^Y8RYSZ=29:3[IVJ].1L4(
M:K60F\;?F\</:IM/)%B9QL5?>.Q]TVP$U<9YTVZ#D4&KN_Y??MO6X45 D?PD
M@&T#6.3=;Q19GDLO)\?6/((-WH@6C)AJC$9RN@M-F7F+;S7&^<GLXO+ZXN8!
MIC?G<'EQ>WD_O?MP=097-^]O[Z^G#U>W-W#P(.>-<H?'8X\;AK!QM04_[<'9
M3\ I@VO3^96#BZY6]6N ,3(=Z+(GNJ=L+^*YJMX!IP18PM@>/#ZDSR,>_UGZ
M:HD3YN%>K8WUNEO"W].Y\Q:'Y9]=^?9HZ6ZT(* CMY:5.AFA0IRR7]5H\MLO
M-$_^V,,U';BF^] G,Q1DO6D4F 7<H%QG$KL"LJOASIJ%]@3FWV&;T"[N>]%W
M<P_;N&&;==PF[&)CN<)8@-M6$+\/X%<*OBMI':C0;\!NJ7:N[-"Q^$LC&!H)
M2*M .HQM\./@CN"O&'SQ-O@</<(KW>$F9N,0P47$'C""/?7RN39GIFYE![.U
MJK1L/%9G8Y>ZD@W\"I0DM"19GO8VRPCC#.VB3$G!*3QHYS8*'E2UZDQCEAKQ
M,EX0FC#(J"",YI *01(NX,%XQ+3JJ^HVZ!8 LTR0/,][.V4D38MH<T%)D1<#
MV;YU>YFFN%LA>+!X25)!T>)93O),[&3)."<%LF0,V98ET*PD.7^NS[:->49)
M+C+(<V0J$DPJ)ZP0,&V#$G[(^-$\H(A5L$,T<E+2% TFB,C$(5*V. 32J]A.
M@[VW<,#+(G!%MS3C)&,Y6IP+@A(XA-NU0O\@,MU5IE68!\.*EM@[+$V)->71
MRD*9$M@CF6R03/:_)7.IS-+*]4I7J/;8J2B8*1YEN]2R%WBW6EZ- 8$.YS"4
MIC'=\O<&SYX:9]TI[^# RVZI43V'@4$K_T7M+)_IH2IDE$9_4NH?&#D/Q^?1
M;AU\[+1'EYG'9B X/82+C<5C&Z9.2[B3E5[$I)T/=0@B_61L4V,'.V<:7<L0
M_9;\42^P,+64Y:2@L3DB(67"HY7C,(H@&8Y&_FKLHRI15D49A@";BRUE FC!
M4# IB* \^D(:4< E:J/$B:2"D;P(@XN#(] [P:#DA7AZKF_J.A!.TX0P%DCF
M"2FRP)&R"(T31P0+"@KC+L26*4=A93R#+,,O =*EJ(02,&>.(J>!3;YS',<O
M#MY6V66\7CBHS*;S_1D\/!UN,-/^X'YV[Z\_UQ(%WSEHU )#DW<"!]#V5XI^
MX<TZ'N-SX_%2$,T5WL*4#0[X?F&,?UJ$#89[W>0_4$L#!!0    ( )"!5E94
MX"70O0D  %1.   9    >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;,6<?6_;
MNA7&OPKA#4,*Y-86Y9>D2P*DEG@7X"8-DG;#, P#+=,V5UET*2HO%_?#CY04
MR[08.@).L_[1Q [YHW0>ZI!\1.GL4<CO^8HQA9[6:9:?]U9*;3[U^WFR8FN:
M?Q0;ENF_+(1<4Z4_RF4_WTA&YV6E==K'@\&XOZ8\ZUV<E=_=RHLS4:B49^Q6
MHKQ8KZE\_LQ2\7C>"WHO7]SQY4J9+_H79QNZ9/=,?=O<2OVIOZ7,^9IE.1<9
MDFQQWKL,/I%A:"J4)?[.V6.^\SLRIS(3XKOY<#4_[PW,$;&4)<H@J/[QP*8L
M30U)'\>/&MK;MFDJ[O[^0B?ER>N3F=&<347Z#SY7J_/>20_-V8(6J;H3CW]C
M]0F-#"\1:5[^CQ[KLH,>2HI<B75=61_!FF?53_I4!V*G@N:X*^"Z MZK,!J^
M4B&L*X1[%<+@E0K#NL+PK15&=8717@6,7ZDPKBN,R]A7P2HC'5%%+\ZD>$32
ME-8T\TLI5UE;!YAGIF?=*ZG_RG4]=7'_[?KZ\NZ?Z M!]U>_WER1J^GES5=T
M.9U^^7;S]>KF5W3[Y;>KZ55\CXYNJ)34=(0/Z"ABBO(T_W#65_HH#*N?U"U^
MKEK$K[08H&N1J56.XFS.YH[ZTP/UL0?0UZ>_C0%^B<%G["5>TV<4!L<(#X)3
MU_'X:T<L^5A7QQA]NX_0T9\_Z(MN(Z3BV?(_1<85NF=+?3DJ-"T59=+13/3V
M9H)M,QY>_';>X"T\XN<1-ON(!D.;YQ$GW';0L.2&KW70*N6A+PMTSY<97_"$
MZD!>)HDH,A-@="M2GG"6HW_]INNB*\76^;]=_;)J:.ANR*3P3_F&)NR\IW-T
MSN0#ZUW\Y4_!>/!75Z> A$60L!@21H!@EO3#K?1#'_WB5HH'7@YA1Y(EXH%)
MK?('I(=3-!?%3"V*5(],93_(77I[Z5WUKF"C$F:&ZX>+7_3HK?^=]1]VI6R7
M"P)'N=C!"\>.@@3H+"P%1EL%1EX%KK('G;6$?#Y&"=UP15/^.YLC]J0G-CES
M!MT+[!KT"C;>"=)^N ^6B"$/B #!+#'&6S'&7C$BIJ$)I^6,K); I8"7TE6!
M<2N^PX&K/T?M@N'IT-7Q'43L(A*@\[!B/=G&>G*@XRNFJ>HESE;WY_J20!NI
M9_=2Z2MCD^H!Z1C13%\8/PJ^,0.]2Q=OBUUUF;33C"O:T:05[<"5MF+(@R-
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MP)3Q5D$[KT%/G%;$&X@ND6M?(,=RG 9"X8^[VRUTW&H/7(WGGL&K2RE'P+:
M_IK3+$,R5W>8Q7\WR5:@>LVHZOQ?\S6.8&3( ZXQC>#GGVS?^J4IY([ :@)X
ME0!>&WHPP1DF$5R@9UBEA"@59(:)!- +8-84>H'7TWCJ2[4-;+F5_M#<'L9T
M:N6[?:<RJG'M55Q[K5QG^$5^Q01',ID1E1P9PO$_\J#JV2:N!9Y_P.*S+;GV
MC\@VF+FNWTS6K\CZ/R8L*++MDOHGZ_=LZYCDJ5%=]QK+?L6RW\HRI%PH=BM*
M8XXXS>(F?JT8;\WVCL!JX0ZJ< ?O<MP'70K0$5A-@*M*@*OV_2XNB^NF(*].
M$\R[\HZR\-3(]<X=%=O:WX16*RVU$YA%B3[9,6QEB;-6A[KQQFJ%>NMF=(56
M#_R@!+#?)2%+V*Y$Z BM+H*S%\'YWTE9NAXFW,$U4M(_M7$&@S,YN:\,[-9[
M-UC(^E9NR@5: 0&&,YV;.):%8"KW#*L2N)%PIZ5!5VAU#?;%@>V]3WJV%AUO
M%J$CM+H(^ZK#;B\[6M.S=U+G]'J#DP0]M?+\XX^F>=!)Y"!75 T61Q'=$%'4
MU]5LU<2-=>MR-#]1S9WN4/8P16=X)P-)"4<9+"6D==F7C%C1;!4#0=>Z7WFF
M0G8_^C&1#2HP92#?+RD5KP.U0-7R!O\!4$L#!!0    ( )"!5E9VBXUD100
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MJ[0TLX$;;62<ES+\=V2T?+CA3"421BS&^"6!JSU5QORML7._D?$"HR-HM[Z
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M'I831W/.4C1@F>2*AMIZ<HD&9M,!5RPFPKS_7H0^=("^D:-OE(;M,$8LCY%
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M7@#@ @6 Z[BX !"K ,C9* #B0@$0JP#("11 A<_* D .?NR?6@&T2W[MNU
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MN/GGYY0O<$C.>O+[P@E[)KWA[[]!Q_A+Q9E.L$ 36(-/J^+3ZD(?3JG B?S
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MEQN]Y8EDZV(G\YE)R=+B<$6P2N5Y _7[@C'Y=I)OCM;;[>/_ 5!+ P04
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M6%&BJLN_CV1),W9$/G#Y8EGE/^1&T%V9YHN:DQ.RH,(\)T.M RC-@])\*"V
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M@/U!V&^I^GD->/Z.]%M,4BHTT";,\Q/,T!_VPV9,ZAT,WNM$?90&/::J-=F
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M=4@&&UISO13[!SCF"0U?*KBR3[)O:D,L3FNE17$$HX."E<V;OAZ_PQG ]R\
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M_>>>B=O)I0:S2.Y$CC M!S3VT4T>IFHB(^R*L]7#H0,02,Q(UV";K@'4I!M
MQ@PD9L3L;V/VCYUTOC63]@>P;PU@ZGEM4RW8N@M:W5U%3VH\&J/5Y7 C@LFN
MQ1-5QSV\9[3UW7XPT\-M+$.0LC'\;KJ'=KW@9! T9AM[^D/<^[D%P_51>M9N
MXM#9 Z5FIFR'>S!4T:B5H.(&4C/CUH""6UG@)86C5C ^@_E^7:B#(=:8MIN:
M3C56X':N>&$1J56L*L((W3?;^GX_FGF-'QB&/VJ9W?1SS\4?V $@G).6W&L
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M>^TW)S);5MO5[S(ILZ0Z7(AP+O*R@7K]/LOD\TFY W[[C8?Q_U!+ P04
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M42U'M0+5%*II5#.H9BG-3;RFM#O"2KLCM+0;U6)42U!-H%J*:AFJ253+4:U
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MQ?TGNY5_,YW]>=O'X?\!4$L#!!0    ( )"!5E:9OVY@VPL  /6R   9
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MQ%'7.A'H806J2513J*8IS9SM;3+NVY-QLAE[^AWS]L'VOM2@(3RJQ:B6H)I
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MRTH#?GV5IL7#C[*!]H/9Z?]02P,$%     @ D(%65EOF,B,Q P  Y0L  !D
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M&_9 2!_(.LYN^>8C+0UY2B_@L<C_@DW9UNF!8"TRGI3!,H,D8L4O^5W>B*T
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MV@*ZK;-!B%S7"AJL='&VXWA8S\JK6'E[KFN8D!2(C(04I"2A.HY&B$/OXI[
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M!\C?%XR)YYW\!-47'J/_ 5!+ P04    " "0@596YF_A^70%  "Y)0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6RUFFUOVS80Q[\*X15#"F36@V79
MR1P#J?70;LM6Q,F&8=@+1F)LH9*HDI33[-./E!194A0M6J]O;(OF_>[H^YL/
M!ZX>*/O$]X0(]"6)4WXQV0N1G6L:#_8DP7Q*,Y+*;^XI2["0CVRG\8P1'!9&
M2:R9NFYK"8[2R7I5M'UDZQ7-11REY"-#/$\2S![?D9@^7$R,R5/#=;3;"]6@
MK5<9WI$M$;?91R:?M)H21@E)>413Q,C]Q>32./>-A3(H>OP>D0?>^(S44.XH
M_:0>/H07$UU%1&(2"(7 \NU -B2.%4G&\;F"3FJ?RK#Y^8GN%8.7@[G#G&QH
M_$<4BOW%9#E!(;G'>2RNZ<-[4@UHKG@!C7GQBAZJOOH$!3D7-*F,901)E);O
M^$OU0S0,#.L% [,R,%]K,*L,9ET#^P4#JS*P7NMA7AG,7VM@5P;V:PT6E4&1
M?:W\=8O4.%C@]8K1!\14;TE3'XK\%M8R(U&JI+@53'X;23NQOKEV+[>WUW^B
M[<UOFY_1#^A7S!A6\D G#A$XBOE;V7J[==#)F[?H#=(0WV-&.(I2=)M&@I\V
M&F[V-.<X#67C&_5\%<6Q%!Q?:4+&JCQJ01674\9EOA"78:(KFHH]1VX:DK -
MT.0@ZY&:3R-]9PX2?\+I%)GV*3)U<]83T.85YH99F)M]XQDV=T@P13/C17/W
M]>9&C[DW;'Z9L7KL?=[]8?,KK,RM/O-6*F:UZ&8%;_8"S_V<1^+Q%&UBS#FB
M]^A&SJ(\9X]H*VCP"?WUBS1 'P1)^-\]T;XKZ58_74W>YSS# ;F8R-F9$W8@
MD_7WWQFV_F-?VB%A#B3,A81YD# ?"-82CU6+QQJBKVNM\$(K<GGE0DXY4;I#
M)W+**2>CMWVR&>2.E0TDS"EA=@%3FX?#VE[J^DH[-.7PO)-UUNWD08;E \%:
M:9[7:9Z/2'-?.@?MQZ83$N:4,$-OI&IFF].S3D)[NIDS:VIU4@H9F@\$:Z74
MKE-JCTCI*<('PN1V%P64"Y015OYWBW]Q2.,8,WYL[?U##[H;JP!(F%/"%HW,
MSF=38]D1P/->UF*ZM#OYAPS,!X*U\K^H\[\8S'^YN#.2Y2S8R^,#RAC=,9Q(
M)>1B3UGT#PD13FB>"G229TC0WJP/.AF;=4B8 PES(6%>"9LW9QISWM:9#^2P
M)8UE+8WEH#0N@T">3N7!0RJ@G 7Z9,)(0*),BB/#C_(X+'KE,>AHK#R6SWXW
MH_N[.9 .74B8!PGS@6 M>9S5\CC[W_(X'D +>1S4'"+DX3,@F2IV]$EDT-E8
MB9P]VY89UK*S+7,@/;J0, \2Y@/!6AHQ]&,I0_\:E<B]1" G#;7CD$=.\B4C
M@>HIJ,!QHV?8IYAASV,E4]&6#<WHT\[FP %UZ8+2/%":#T5KRZ91 3,&97--
M5,E6G1^KO4>>AO5F]*B+7ED,DD?+ I+F@-)<4)I7T5KK:O<HZT.Y;,O"/,K"
M_)K9!(=AI-87.7=TEI]>H0SZ&BT42)H#2G-!:1XHS:]HK1**?91=6RC'8J8Q
M6.Y:;_,[3C[G<FE![D&^]N8?M&0)2G- :2XHS0.E^5"TME".A4O#^J9E;P.T
M@ E*<T!I+BC- Z7Y4+2VB(YE46.X+@I41*F\M%;@>6<%W@R',EHBD#07E.:!
MTGPH6ELBQS*K,5QG!3XM5]Z:JZ;Y;+>V&8YIM%8@:2XHS0.E^5"TME:.)5EC
MN";[+<_,B_\^Y6Z&PQLM&] *+"C- Z7Y4+12-EKC DE"V*ZX&\11H%:1\H9%
MW5K?/[HL;MUTVAWCW"UO$1TQY:6F*\QV4<I13.XE4I\NY!S)RGM"Y8.@67%-
MY8X*09/BXYY@>1)7'>3W]Y2*IP?EH+ZMM?X74$L#!!0    ( )"!5E8F@;WI
M1 0  .43   9    >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;,U8VV[C-A#]
M%4)=% F01'<I3FT#L96B09L+XFS[4/2!D6B;B"2Z)&UG^_4=2HIL72PX"RV0
M%XFD9@[GS&BHT0RWC+^*)2$2O25Q*D;:4LK5E:Z+<$D2+"[8BJ3P9,YX@B5,
M^4(7*TYPE"DEL6X9AJ<GF*;:>)BM/?+QD*UE3%/RR)%8)PGFWR8D9MN19FKO
M"T]TL91J01\/5WA!9D1^73URF.DE2D03D@K*4L3)?*1=FU>!Z2J%3.)/2K9B
M;XP4E1?&7M7D-AIIAK*(Q"24"@+#;4.F)(X5$MCQ;P&JE7LJQ?WQ._JO&7D@
M\X(%F;+X+QK)Y4B[U%!$YG@=RR>V_8T4A#(#0Q:+[(JVA:RAH7 M)$L*9; @
MH6E^QV^%(_843.^ @E4H6'4%YX""72C8QRHXA8*3>2:GDODAP!*/AYQM$5?2
M@*8&F3,S;:!/4Q7WF>3PE(*>',^>'Z:_GT^N9S<!FC[</=[<SZZ?;Q_NT<DL
M?Q,0FZ.;9!6S;X2@F63AZ_D$_!RA*4O@Y1,X"]_-FQJ34W02$(EI+$[1.?HZ
M"]#)EU/T!=$4/2_96N T$D-=@MUJ=STL;)SD-EH';#0M=,=2N13H)HU(5 70
M@7#)VGIG/;$Z$0,27B#;/$.685DM!DV/5S=;U(/CU8T.-G890SO#LP_@[<)#
M^(:&<%]B3LY?&F$Z0]=QS,(\9!#7)Q*R14K_ [%'PBE3TD(*]/<?L .ZE201
M_[2%*S?':3='G5178H5#,M+@*!)@$]'&/_]D>L8O;:[N$RSH":P2!J<,@].%
M/GYF$L=(9"F2^S[<3Q&2ITB;/W-<-\-5!_5F;/F^Y0[US;ZCFE*V9YE&52IH
M2ID#=V"64A5J;DG-/8(:$9+"20O$)'Y#+R0E<RKA\(_S-?9=W/.-O7U[#==W
M:MQ;I.Q+HR85-*4\RSI W2NI>YW4[^';2^9S^$PA()+"C*; K96+U[32-UVS
MQJ4I95F.X=6XM&#9MF^TD_%+,GXG&97>*O$7C$4""19';30Z,3Z:WGV"!3V!
M57QW6?KN\G.=LI=]AJ%/L* GL$H8!F48!C_HE!TT,LIU!K7<;,HX?OV$;<K8
MCM.>EZ:Q*\.,3EI/X"C,PR6"$@GJU@T4Y"LHKV5KM=0)]=$WHU>TH"^TJAOW
MJEGS<R5I84]?L>@3+>@+K1H+:Q<+ZP=E:@%<_9#:]5QMD_*<>DW0)N7X!XH"
M<U=RFYVEY'@&?ZHT79RA!91!''BJO,41_*%1(3E6/[.MS'HMG7M%"_I"JWIT
M5SV;SB=+W<YR_L.QZ!,MZ NM&HM=N6\>4^]_5^JZS7\9U[']>NXVQ6S'&-2+
MX!8QT_=]KY:]^E[_(R%\D?61!-B\3F7>%"A7RU[5==:AJ:U/5 \KZZOL8/(&
MV!WF"YH*%),Y0!H7/MC$\YY2/I%LE7597IB4+,F&2X(CPI4 /)\S)M\G:H.R
MLS?^'U!+ P04    " "0@5966B8(RZ0*   3:P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6S%G5MOVS@:AO\*X1TL6J"MK9/M=), 32ABB]VV0=/.
M7"SV@I&96*@M>20YA\7\^*4.,4V+HB+,V_%<3&V9?"A]+_61>D-)IP]I]B-?
M"E&0Q_4JR<]&RZ+8O!^/\V@IUCQ_EVY$(G^Y3;,U+^37[&Z<;S+!%U6E]6KL
M3B;3\9K'R>C\M-IVE9V?IMMB%2?B*B/Y=KWFV=.%6*4/9R-G]+SA:WRW+,H-
MX_/3#;\3UZ+XOKG*Y+?QCK*(UR+)XS0AF;@]&WUPWK-@5E:H2OP:BX=\[S,I
M#^4F37^47SXNSD:3<H_$2D1%B>#RGWMQ*5:KDB3WX_<&.MJU65;<__Q,9]7!
MRX.YX;FX3%>_Q8MB>3::C\A"W/+MJOB:/OQ3- <4E+PH7>75_\E#4W8R(M$V
M+])U4UGNP3I.ZG_Y8Q.(O0J28Z[@-A7<PPI>1P6OJ> =5IAV5/";"OYA!;^C
M0M!4"%Y:8=I4F%:QKX-519KR@I^?9ND#R<K2DE9^J.2J:LL QTG9LZZ+3/X:
MRWK%^?6W+Y?_>GOQX3JDY/++IZOP\_6';Q^_?":O/O,LXZ7LK\DK*@H>K_+7
MY"WY?DW)JU]>DU](G)!ORW2;\V21GXX+N3,E<APU#5_4#;L=#3OD4YH4RYR$
MR4(L#/5I3WW7 AC+*.Q"X3Z'XL*U$C_Q)^(Y;X@[<6:&_;E\<>V)Z6CLM:F(
MWC757==0/7QY=<=0G;V\^L0226_7J;R*YW5UJB7/Q-ORA%^0RW0MLV#.JSSR
M07:IY$[(S%20FR>R7^Z*/U6;/SSP;$'^\V^))!\+L<[_:^I;=?N^N?TR&[_/
M-SP29R.9;G.1W8O1^=__YDPG_S )BX11)"Q$PA@(IO4(?]<C?!N][A$YX?<R
MC?";E2!R3"2;;18MI?CDE4PE>57BM4EL*WJHV$@8K6'3"E:.X??GGC,I_SL=
MW^_KB&R4@6":CL%.Q\"J(XWOXX5(%N0I%BM3UKZPUA\J%A)&:]A\3ZQ#F7I+
M,%L)+:#374"G_2=&DP*C_50I'LO/0L[>HO0NB?]G'",OK/"AT4;": T+]B+E
MSF9N<!#Q=BEOZCJ'46^7<DZ"$\<<^=DN\C-KY#\F11;+&7)$[OEJ*]Z0=%,&
M/I>1%UD4Y^: 6YE# XZ$T5DK%_GM1-0NY#C.82G6+C6?33HZ^GP7[KDUW)<\
M7Y:=6<@9Y8+<9NFZ"?@NWG)XD(E%K#>K]$D((J>^T0\U1FQ6/#$)8FUUJ"!(
M&)VWHA@$+4':A:;SEAX&DMNEQ\E.CQ.K'M_X([D1B;B-"RD+7Y49II:E#OR+
MS@9K$T.#CX31DW9<6[%OEW'=5NS;A9S.<\&9J*NN2<_9L(F+)NAYUQ 0I7EA
MO+"RLH>&'4JC#2VP!MY0J'5F,$,AOS/P>Y>[CC7P4F"/7'7D$GO=P8%%TBB4
M%D)I#$73-765INZ1+S>;'4!U#"2-0FDAE,90-+UC*!O"L5[3GLO.L);=H![0
MF@86U:5GG.=;GD2]EY[V!@8+#W4:&IHV-/DST^4GM%V&HNFB*B?!L5L)'Y-(
MSE?DC% JQ[?%,LW4*)KWZMF^8G=,(;LT%/0"0T%JW]O!IQ_4*4#1=*645^#8
MS0(YUDZZQUJH40"E42@MA-(8BJ9KJNP*9WKLL1;J:4!I%$H+H32&HND=0[DI
MCMU. 8RU4&\%2J..V5TQ#+7(9AF*IFNJ+!O'[MG(!.YT)W"H\P*E42@MA-(8
MBJ9KJFP?Y^38"1SJ"D%I%$H+H32&HNE__%:6E-MC2?WI!&YO8*CP4!IM:/T)
M'-HL0]%T397;Y=K=KO#93+^N5+UZ-M.[<KH=-UA!J $&I850&D/1=)F5 >8>
MVP!SH088E$:AM!!*8RB:WC&4 >;^; /,WL!@X:$&F-LVP#QS3H?Z7RB:KJGR
MO]R?N)3&SAXL)W0QC=NVW%RSG%"3#$73Y50FF6LWR1HYR_-1GII]\D%-,RB-
M-C1=OMF\)5Z[F#,]\><'?_TS%9N[<]_\]S]7^5>N?;U->'UU1399&@FQR'?K
M$8RQAOI04!IU#2MB6LLXPA>58GVE]$ K/\BU^T$'4\\OU7("8YRAM@^41J&T
M$$IC*)JNK_*&W/FQYYQ0@PE*HU!:"*4Q%$WO&,I@<NT+BVIQ[T5>Q,D=V8@L
M3LWY%6H306FTYQ!]\B1X9KKI(83N!T/1]%7\RA+R[);0GUR<:J</7J4/]8.\
M]NHBK[TZSVN[1D%K/LH,I;S.]7F>,F\\NWGS+2WXBFP3%>3V\K!R"K/BA?RI
M2&71\JR3GWEY"AKOR;$W.5@2J,'3T/HD@1HW*)HNL3)N/.OU__EOU8UO8O&6
MWXN,WXDF75:7=*6\SR=8J?>;<L%#5]ZYL#<T6%BH0=,3!+<[FT+W@Z%HNMA[
M-T79S1CCC)C\06@L52[2S"@K]D8G[)U.V%N=L/<Z_0R/QE,>C><?>7+L08T<
M*(U":2&4QE TO6,HM\>SNSTOG1S;,8/EA1H]/8?H5.G<J"1T(12*IBNIC"2O
MQTCJR.;/VXVJ0BTE*(U":2&4QE T76IE97FS8V=SJ <&I5$H+832&(JF=PSE
M@7GV]5'AXR;.ZJY0I_*>.3K4T(+2:,^1SBUS=*AYA:+IBBKSRK,[.WUS]/H>
MQ4N1%5PJ'3Z*:%L^(H-\N;V-(R%__H-\BI-XO5T;.P#4\H+2*)060FD,1=,?
M7:!L,']RY/SO0YTR*(U":2&4QE TO6,HA\[O65XU+/_;:8-5AIIO/4<Z[<[_
MT/U@*)JNJ#+D?+L7A<C__+$K_]L;']P!H"8=E!9":0Q%TSN%,N[\8S_.R(?:
M?% :A=)"*(VA:'K'V'NHD7TIUM#\#_7LH#3:<Z3.Q#( 0 TZ%$V75!ETOMV]
M^BKR(HNC\J]H]1#P/8F+G+SZ>OV]X^%44*<.2J-06@BE,11-UUG9=_ZQ[V/T
MH68?E$:AM!!*8RB:WC&4V>?;UZV]U*&W8P;+"[7L>@[1L^1RJ#V'HNE2*GO.
MMYM6A[G\#;D26?4PWG+A>YW>J^E\FA09CXIZDU%LJ','I5$H+832&(JF=P#E
MYOG'OM?1ASIZ4!J%TD(HC:%H^D,LE:,7_-2%;7;Z4-6A-!JT%[:YOM=:1A48
MUJPY[:>?&8HYT\['< 7*.0O^^K5M]B8'JP*UUX+VVC;W9-96!>JEH6BZQLI+
M"_ZJQ6WVA@8K"_7->H)@6=P&W0^&HNEB*X\LL"]N8SS.Z@>IDO3V^6%,]2EK
M5!1J>$%IM*%ICS!LK_H-#<6<H'5*,U.QF=>9097W%-@=F:_B]VV<QX4@Y0'%
MT?/IE9?QW^S-<_-ZZINIR7"^F_E&SS/?9E.56WO.1:B)!:71GI!9KGN@^\%0
M-+UK[#VCV^YA:5<Y]9E8N5A&.;'/Z\8^L!MJ7T%I#$73)5;V57!L^RJ VE=0
M&H720BB-H6AZQU#V56#W=GZM9\ERBE5>RD3-[+D<B DO2/GD?CD\E&FP[U9C
M>SN#]8?Z6X'A,>;NB7=R<CA$0]TL%*U6=KSWSIZUR.ZJMROE<D3>)D7]II7=
MUMT;G#Y4[RTZV'[AO+]T#-NI\Y[5[V=2^/IU49]X=A<G.5F)6]G4Y-U,YK*L
M?@-3_:5(-]4;@V[2HDC7U<>EX N1E07D[[=I6CQ_*1O8O0?K_/]02P,$%
M  @ D(%65I>CNLQ8 P  4@H  !D   !X;"]W;W)K<VAE971S+W-H965T-S$N
M>&ULK59KC]HX%/TK5K:JIM(.>?&:*40",M56J^F@H=U^J/K!0V[ &B?.V@:&
M?[_73D@A#>RHZA>PG7N.[SE^W=%.R&>U!M#D)>.Y&CMKK8M;UU7+-614=40!
M.7Y)A<RHQJY<N:J00!,+RK@;>%[?S2C+G6ADQ^8R&HF-YBR'N21JDV54[J?
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MB0>^HF"UO>56:9 &=HJ?%E:[7=YF*IK9;K=M5>^E=FX@;;V!U  _;B[3<8H
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M'I#_+R@5^PLU0;&]/?H'4$L#!!0    ( )"!5E:0()M]6P0  + 0   9
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;+58VV[C-A#]%4)=%%D@&XGR/;4-
MQ)>T 7(Q[&S[4/2!EL8VL9+HDG2<[M=WJ)L56U+70?,2B]3,X9DC<H:3_E[(
M;VH#H,EK&$1J8&VTWE[;MO(V$#)U);80X9N5D"'3.)1K6VTE,#]V"@/;=9RV
M'3(>6<-^/#>3P[[8Z8!',)-$[<*0R7]&$(C]P*)6-C'GZXTV$_:POV5K6(#^
MNIU)'-DYBL]#B!07$9&P&E@W]'I,6\8AMOB=PUX5GHD)92G$-S.X\P>68QA!
M )XV$ Q_7F ,06"0D,??*:B5KVD<B\\9^FT</ :S9 K&(OB#^WHSL+H6\6'%
M=H&>B_UOD 84$_1$H.*_9)_:.A;Q=DJ+,'5&!B&/DE_VF@I1<' [%0YNZN >
M.=!FA4,C=6C$@2;,XK F3+-A7XH]D<8:T<Q#K$WLC='PR'S&A9;XEJ.?'LZG
MSW?SZ</T\9F,IH_3V[MG,KN_>5R0BP7N&'\7 !$K\HC[:0:2"Y][9 01K+@F
M8Z&T^DPN)J 9#_#I"_FZF)"+3Y_))\(C\KP1.\4B7_5MC4S->K:7LAHEK-P*
M5M0E#R+2&T6FD0_^6P ;0\SC=+,X1VXMX@2\*]*@E\1U7+>$T/C'W6D-G48N
M>R/&:U3)#II+P..@,SD5^?-FJ;3$??U7F6 )7K,<SQSV:[5E'@PL/,T*Y M8
MPY]_HFWGE[)@_R>P-Z$W\]";=>C#!>)Q#XB'VZ<LT,2[%7N;)/0R=)NTU[=?
MB@&4&'6:-#=Z0ZR5$VO5$KN+-&"XNI)9XMXN+$I[S2-B)3:.4\ZKG?-JU_*:
MOFXQYX&/65/O9$0P^6T#AAE0*="EAZM]0N(+;73I$=42JVZO4<ZUDW/MU'*]
M"874_#N+4S0FCBWF#"P:A4].+CP)/M>?RXAW3BDUW/81[Q(CMUOQ[;LY[VXM
M[SEX8AWQ[Z@R'L =DYP%)!"H<*G W1,*QQOTU()VV^4<>SG'WG\<'*V#.&>4
M<NJ=K.@<<3JU:%7(1IU#^7!J29G*L(TK UFF=:'J^*1(Q4/;HZTCCB5&M.<T
M*V@6JARMI3E!9A%^W*QVS?  75:7-7(Q3C8IF;YZP<[GT9ID><N\OR0+S722
MOW&7WT6>"+%02GP98LK<F&O."V3SCT*3"5<>[B>D<!NP=:D\]1$<A$:N1:G+
M-L.X'NR=&9ZZ![G='Y$[E=2(C?0SI=-9HV.B<C%I/*UF)F6D8A]L<KV?5HFJ
M3_*-ULGD]%6;X3* >ZXTZI[+7JEZ?2!GJEX+]E[5#W<*6ENWSU0]*ROSN*K<
M8Z[[,(WK:9^I\4?<7>CA\D+K;R_G:9Q=*<S,AZE;3_A,=6O!WJONX09&ZZ]@
MYZE[*(B_8K_ZH3NXGO:9&M>"G:NQ7>C]0I#KN"56N/HNTDE[E,_F;?=-W&P>
MS8],.Q[WE >8I)=_8'+-(T4"6"&D<]7! &32'B<#+;9QA[D4&OO5^'$#S =I
M#/#]2@B=#<P"^3\IAO\"4$L#!!0    ( )"!5E;F_H91!@,  /4'   9
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M:&5E=',O<VAE970W.2YX;6R%E6]OVC 0QK^*E553)TW-'TB@'40JA6J55H2
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M5 JT(G]>X43R64.B_JJ+:H':JD<U)7ZN4AI W\$:5B ?P1G\](/7:?Q:1_U
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M%#N>+&[+BA<MTOS":2JT%DG^& %%R6HFX/>9$'KU8A:H[BP'_P%02P,$%
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M]8-/:+XNBA34S$F2HDN2DCP&-"^7V'5>K2,]'R=3D(2FXE1![N=3=/+A%'U
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MR#^72Z4EULJ_-H_GB ,[HFD@9VK#?+APL$,HD%MP9K_\1$?NKS9O?278XHO
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MT%HDV>4:&(H<,P#?AT+H]QLS07EL.OL?4$L#!!0    ( )"!5E;/ V/5,0<
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MJE?5_=,>IFQTGS%?4*B C,P!TNF$<%3SLG<L!Y*M=#?USB3T9OIS"?TVX4H
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M&4Q__PW:QA\R)G6"N9K &BR;%<NF"GUZY45>XI/WX(JLPB0)DU6V/.Y(&M)
MQF*!9N5H65Y^FD+;,1W#G R?]@F2V%G0=.Q1T\Z5V)G0'F&[LFN$955A6<JP
MB@GC-R;,2KQ)P$F431=99 6@O=<3>SRV6OV=*9OM._":P!H,V15#MI*A3X2Q
M<W 9TVW"F7@+^I''6+@,Q6I;IC06+[5Z^5$)FV&^_-Z#A' 9FW:'36A:N,VF
MLHM]V=0$UF!S5+$Y4K+Y0+D727G:FW4Y6=GRXMX/&6>C#F>696:YM,%9UPHY
MX_;Z<R56V,3R1>5403J'Y0KQPE)G":<[^B)%F 9NQ2*QDV435V+7RB:-@,95
M0.-?CYJL_TJWON\*G6"N)K &7="H!9?QIN_DLCE-1&M%<W6A-:G>T[90ZXNY
MA-M?(V>F!2VKM>1D=B/3L,:M)2>ULTT#R9<<1'5@Z/BILFSC5[E28B9+EC*S
M%[,EK 4L5"JW'OFR!&HD. /9G;'KFLG&V"WMK)?'N!E1+1:A6BW^)4:( 5'O
M@&R%$P9$]>N*J)Z\K *6%T%*Q-Y+7">:JPNMR6:M4:'UMME4ISB=:45S=:$U
MJ:[%+E2KW=[9M*M?STPT=F![16I5L+K0FB35&A:J1>PKBB;8U9F.@7$G<2D;
M[DV3)K0F3;4*AFH9?.3*"4K$KJ1T4G>R-Z6:T)J4UCH<'B#$_[<F&'<K>&LT
M=MK$:=7CNM":&WZU($=*%=I#8I1 #8V#'-B>5A(S6>)SU?UZ;=RU.D9J=>R2
MI7@2B'2>B"LNXBYV\Z\YB:4R1(W7]]VH%<W5A=;DLA;D"+VI#$%*_=^;:IUH
MKBZT)M5U18 .K @.E"%(4A<XX_8NBKK1WA0=8SL:U24&4I<8KQ A)>(^2R.1
ML]HL:2T==*$U6:I+!Z3>WSZR!D'=S?!V::WN8&\ZCU$>H+H\0.KR0(O^0-V:
M038-M58,NM":O-45 U)7##WD1[=0&&.$VN1TK;KYSE5WZK5!U_H?J?6_>/>1
M<)6 V39-2>+_5(@.G1I]IA7-U876)+%6_&C\MJ)#ZY:]5C17%UKS,WI=(^ #
M:X0#10>6E0!&^\OM3-UJ[V_@QZ@G<%U/8'4]\0K5@24;Y'#D&!V>M-8*NM":
M/-6U E9OWA]9=^#N1GQ;=Z@[V)O.8]0#>.^(B[H>T*([L.2K@'0BZCVT<HPR
M ==E C[PW,HOE0?N'C$Y0] 9M4^LR.RZ:<]5]ZMOW,.]TV\Q25?Y*4(FYH)8
M7\7!K^II=5+Q,C^?UWI^!<_=XKQA#5,<?[SQTE7VU28B2P%I?!B)"-/B1&%Q
MP^DF/V/WE7).X_QR3;R I)F!^'U)*7^^R1JHSG5._P-02P,$%     @ D(%6
M5N@K-@%? P  H P  !D   !X;"]W;W)K<VAE971S+W-H965T.30N>&ULO5=M
M;]HP$/XKIVR:6JEM7H'2 1(E;$7JFZ#=/DS[X"8'B9;$S#;02?OQLYTTXR5%
M5(OV!6SG[KE[GL.7H[.B[ >/$ 4\ITG&NT8DQ/S"-'D084KX&9UC)I],*4N)
MD%LV,_F<(0FU4YJ8CF4US93$F='KZ+-[UNO0A4CB#.\9\$6:$O;K$A.ZZAJV
M\7(PCF>14 =FKS,G,YR@>)S?,[DS2Y0P3C'C,<V X;1K].T+OZWLM<&7&%=\
M;0V*R1.E/]1F%'8-2R6$"09"(1#YM<0!)HD"DFG\+#"-,J1R7%^_H'_2W"67
M)\)Q0).O<2BBKG%N0(A3LDC$F*ZNL.#34'@!3;C^A%5A:QD0++B@:>$L,TCC
M+/\FSX4.:PYV\Q4'IW!PMAV\5QS<PL$]U,$K'#RM3$Y%Z^ 307H=1E? E+5$
M4PLMIO:6].-,E7TBF'P:2S_1Z_<'@\>;Q^O^P]"'NX>KX1@&=S?WX^'5\'8R
M^C*$T:W<#^'H^FXR.8:C6\(84:62:Q\%B1-^#*?P./'AZ/TQO(<X@X>(+CC)
M0MXQA4Q1!3*#(IW+/!WGE71L!VYH)B(.PRS$<!/ E-Q*@LX+P4MG+Z*/P1FX
M]@DXEN-4)#0XW-VN</</=[?VL''+<KD:SWVM7$&P2!<)$1C"G8B0P8"F\KY'
MZB(N$4990%.4U:)<UN7;M72'D<"4?Z^J11[+JXZE&LX%GY, NX:,P)$MT>A]
M>&<WK8]5.M8)YM<$MJ&Q5VKL[4/OY;K&6LD3R%!429=#-#2$:JU+^=.UK%;'
M7*YK4F'5=K>M_%TKSW.]TFB#1*,DT=A+8I0)E-*(@D<5A1R@N1;VU+;;]C:'
MQDYVI\V6N\VAPJKMM%O5))HEB>9>$I_E:XN#["2@?L_(0;XH?&3Q4G<@#K]A
MC$%".(^G<4#T>T2^V8!.X;![4J7*WHS>>B?J!/-K MNH1*NL1.L_]IU6G1K7
M">;7!+:A\7FI\?F_]YWSG4MK-RS+VKJS>P.]59.:P#8T:9>:M/^UC;5W.X^W
M(\C>*&\5I":P7!!S;79+D<WT#,PAH(M,Y%-.>5J.V7T]76Z=7\KQ.Y^6_\+D
ML_L-83/52!.<2DCKK"7%8OD\G&\$G>L)\8D*.6_J923_0B!3!O+YE%+QLE$!
MRC\EO3]02P,$%     @ D(%65CM)<N5G!@  F"@  !D   !X;"]W;W)K<VAE
M971S+W-H965T.34N>&ULU5K?<]HX$/Y7-%SGIIU)BB69'\D19@A)[S+3I)F0
MWCW<W(-B!'AJ+$XRT,[<'W^2,0AALP;B/N2EL<UJM;NLO^_KHLY2R&]JPGF"
MOD^C6%W5)DDRNZS753#A4Z8^BAF/]2<C(:<LT;=R7%<SR=DP732-ZL3SFO4I
M"^-:MY,^>Y3=CI@G41CS1XG4?#IE\L<UC\3RJH9KZP=/X7B2F ?U;F?&QGS
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MCX*"4-8;#:MK-V(TY*7**8,;@619%$0\C2'GJ[->U-M<^$@?%LI<"$;#)7F
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M28K##?9#G.4!_/Z*$/9ZDC^@_GPR_1]02P,$%     @ D(%65O,OT!KH 0
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MGX7G*[6PX4OZ(7<QCTC96=1R!+L*)%?#R';C.1P +JY. )(1D/P+6)P S$?
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MB0,  )48   -    >&PO<W1Y;&5S+GAM;-U9W6[:,!1^E2A=IU::&D+:0%9
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M&W$Q29LDR[7YA0E7_9D%=""<)]^RW7XGXK))<C%+G],J^9R*D"[[FTA )K.
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MJK<%Z&U5;PO0VZG>#J"W4[T=0&^G>CN WJYZ6 +0VZG>#J"W4[T=0&^G>CN
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ML^J= 7H7U;L ]"ZJ=P'H753O M"[J-X%H'=1O0M [Z)Z%X#>1?4N +V+ZET
M>A?5NP#T+M5A'8#>IJN/ZP#\-EUU8*?[3L''Z7/?C[>BKW45\)U>3Y?/]K?O
MORZ_+M:WX4IT>Y\Q/OT%4$L#!!0    ( )&!5E9_X$/,6P(  $TY   3
M6T-O;G1E;G1?5'EP97-=+GAM;,W;RV[;,!"%X5<QM TLFI1(2D6<3=MMFT5?
M0)7H6+!N$)G4>?O2R@5HD1H-7*#_QH)-<LZ( WP[7W][G)Q?'?MN\-MD'\+T
M00A?[UU?^72<W!!7=N/<5R%^G>_$5-6'ZLX)M=D848]#<$-8AU.-Y.;ZD]M5
M]UU8?3[&GWT[#MMD=IU/5A^?-IZRMDDU35U;5R&NBX>A^2UE_9R0QI/+'K]O
M)W\5-R3BS833RI\#GL]]?7#SW#9N=5O-X4O5QUWBV D?'COGT_,EWNAQW.W:
MVC5C?=_'(ZF?9E<U?N]<Z+OTJ>C5^>00;]@]?<J+\Y<RYP+CSMMYG'R<V.S>
M'_<RDM/I]10+N3FTYU_Q-3&6OOC]W&G:C6O^,CM>[X]Q/BSS\&)Y7'['O\[X
MM?X[^U"0/C)('SFD#PWIPT#ZL) ^"D@?):0/N:$T0A%54DB5%%,E!55)4552
M6)445R4%5DF155%D5119%45619%54615%%D5159%D5519%4463.*K!E%UHPB
M:T:1-:/(FE%DS2BR9A19,XJL&476G")K3I$UI\B:4V3-*;+F%%ESBJPY1=:<
M(FM.D5539-44635%5DV155-DU119-45639%54V35%%D-159#D=509#4460U%
M5D.1U5!D-119#4560Y'54F2U%%DM159+D=529+4462U%5DN1U5)DM119"XJL
M!476@B)K09&UH,A:4&0M*+(6%%D+BJP%1=:2(FM)D;6DR%I29"TILI8464N*
MK"5%UI(B:TF156XHM,K-_[3U^S@>_G'\\DS[JAU>\L7R+\J;GU!+ 0(4 Q0
M   ( )"!5E8'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ D(%65C_F>R3M    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ D(%65IE<
MG",0!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " "0@596,6/"5-\'  "3+P  &               @($,
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ D(%65B#C
M:\I$ @  R04  !@              ("!(1   'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( )"!5E;A+;/WU04  &$8   8
M  " @9L2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "0
M@5961.I. L($  "Z$0  &               @(&F&   >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ D(%65LRY"0)M!P  O1X  !@
M         ("!GAT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( )"!5E8+9R#I0@,  $D*   8              " @4$E  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "0@596C&P@H#\*   (+P
M&               @(&Y*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ D(%65K(RD:TL#   R7\  !@              ("!+C,  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )"!5E8E[8)MU ,
M #0(   8              " @9 _  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " "0@5967NO7I!DK   &A0  &0              @(&:
M0P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( )"!5E;"
M=DD$G L  +H>   9              " @>IN  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ D(%65N#KT">Z$P  FT<  !D
M     ("!O7H  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M" "0@5964W*LC)H0  !*,P  &0              @(&NC@  >&PO=V]R:W-H
M965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )"!5E;_,"K,!!0  "9&   9
M              " @7^?  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L!
M A0#%     @ D(%65H&;(.7I"@  T1X  !D              ("!NK,  'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "0@596:W2Y314%
M  "=#   &0              @(':O@  >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;%!+ 0(4 Q0    ( )"!5E86=0M! 0T  #HD   9              "
M@2;$  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ D(%6
M5H@#8S?4"P  OR   !D              ("!7M$  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " "0@596\JO@_7,'  #?$@  &0
M        @(%IW0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( )"!5E8PU@>!-1   .4L   9              " @1/E  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ D(%65LG!&A<K!   M D
M !D              ("!?_4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " "0@596+SV@>;8#  !*"   &0              @('A^0
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )"!5E:$*(WY
M" D  +08   9              " @<[]  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ D(%65M'.&91.!P  <!   !D
M ("!#0<! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "0
M@596/LHS=+TV  !_Q@  &0              @(&2#@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( )"!5E9V:PQ]60@   (5   9
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M970S,"YX;6Q02P$"% ,4    " "0@596MS\?5#@%  !0$   &0
M    @('R90$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M )"!5E:M3;&Q) 8  #0/   9              " @6%K 0!X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ D(%65F.@;\\B!@  ^1   !D
M             ("!O'$! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " "0@596MNAI/7T$  !X"P  &0              @($5> $ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( )"!5E9/K%WU\P@
M !,7   9              " @<E\ 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ D(%65G0J_O4Q P  ?0<  !D              ("!
M\X4! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "0@596
MWRR+<H8#  !U!P  &0              @(%;B0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( )"!5E;IJ8A$#00  -L*   9
M      " @1B- 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ D(%65N0G/EN9!   XPD  !D              ("!7)$! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "0@5965. ET+T)  !43@
M&0              @($LE@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( )"!5E:ZN,[4@P,  #P*   9              " @2"@ 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ D(%65N>F)KG&
M @  % <  !D              ("!VJ,! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " "0@596 >E/&[X'  !N/P  &0
M@('7I@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( )"!
M5E:^ZM#!R@,  /X.   9              " @<RN 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ D(%65G:+C61%!   X!8  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( )"!5E9=@60Z? ,  ,X,   9
M  " @<W' 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
MD(%65DG-S: %!0  >A\  !D              ("!@,L! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " "0@596+VXONK0(  #440  &0
M            @(&\T $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( )"!5E8*'R9V"@0  -<+   9              " @:?9 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ D(%65LY"S2*R!@
MU#(  !D              ("!Z-T! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " "0@5968"F@I;,1  #N[   &0              @('1
MY $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( )"!5E:^
MWYRFC0(  " '   9              " @;OV 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ D(%65DG.M!E) @  ;04  !D
M     ("!?_D! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )"!5E:9OVY@VPL  /6R   9              "
M@64O @!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ D(%6
M5NWB7DJ6!P  /#L  !D              ("!=SL" 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " "0@5966^8R(S$#  #E"P  &0
M        @(%$0P( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( )"!5E:*RE1@N0,  /@/   9              " @:Q& @!X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ D(%65G2+[]RS!0  @R(
M !D              ("!G$H" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    " "0@596&Y3'&0D&  #M(0  &0              @(&&4 (
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( )"!5E;F;^'Y
M= 4  +DE   9              " @<96 @!X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ D(%65B:!O>E$!   Y1,  !D
M ("!<5P" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " "0
M@5966B8(RZ0*   3:P  &0              @('L8 ( >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( )"!5E:7H[K,6 ,  %(*   9
M          " @<=K @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#
M%     @ D(%65D<CDZ3E!   "!<  !D              ("!5F\" 'AL+W=O
M<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " "0@596&[MOM+T$  #J
M%@  &0              @(%R= ( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM
M;%!+ 0(4 Q0    ( )"!5E:0()M]6P0  + 0   9              " @69Y
M @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ D(%65N;^
MAE$& P  ]0<  !D              ("!^'T" 'AL+W=O<FMS:&5E=',O<VAE
M970W-2YX;6Q02P$"% ,4    " "0@596$61 J-\$  !U$P  &0
M    @($U@0( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M )"!5E8%Z-95KP(  ,P'   9              " @4N& @!X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ D(%65HSM1K$.!0  .1P  !D
M             ("!,8D" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    " "0@596#9(-TYX"  "+!@  &0              @(%VC@( >&PO
M=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( )"!5E;<#C2&H@0
M +\4   9              " @4N1 @!X;"]W;W)K<VAE971S+W-H965T.# N
M>&UL4$L! A0#%     @ D(%65M!BM&RK P  @@X  !D              ("!
M))8" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " "0@596
MZ,O]$N@"  #(!P  &0              @($&F@( >&PO=V]R:W-H965T<R]S
M:&5E=#@R+GAM;%!+ 0(4 Q0    ( )"!5E:WG0TKV00  $8;   9
M      " @26= @!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%
M  @ D(%65I-7=*WE @  2P@  !D              ("!-:(" 'AL+W=O<FMS
M:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    " "0@596;M<>;4P%  !"%0
M&0              @(%1I0( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+
M 0(4 Q0    ( )"!5E;/ V/5,0<  /8T   9              " @=2J @!X
M;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ D(%65C)RDA"V
M P  RPT  !D              ("!/+(" 'AL+W=O<FMS:&5E=',O<VAE970X
M-RYX;6Q02P$"% ,4    " "0@596:BQK<@\%  #6$P  &0
M@($IM@( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( )"!
M5E:*:>.+;P,  "X,   9              " @6^[ @!X;"]W;W)K<VAE971S
M+W-H965T.#DN>&UL4$L! A0#%     @ D(%65DG%P7(Y P  ! L  !D
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M=#DT+GAM;%!+ 0(4 Q0    ( )"!5E8[27+E9P8  )@H   9
M  " @8G3 @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @
MD(%65C4']\/9!0  )"(  !D              ("!)]H" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-BYX;6Q02P$"% ,4    " "0@596&X9&ES %  "*(0  &0
M            @($WX ( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4
M Q0    ( )"!5E:SP;>IJ (  -0&   9              " @9[E @!X;"]W
M;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ D(%65G(ZL@P'!0
M=QT  !D              ("!?>@" 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX
M;6Q02P$"% ,4    " "0@5967N#K6\4$  !*&0  &@              @(&[
M[0( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    " "0@596
M\R_0&N@!  !:!   &@              @(&X\@( >&PO=V]R:W-H965T<R]S
M:&5E=#$P,2YX;6Q02P$"% ,4    " "1@596_<^AT(D#  "5&   #0
M        @ '8] ( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( )&!5E:7BKL<
MP    !,"   +              "  8SX @!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( )&!5E:9G?)!!@<  +M"   /              "  77Y @!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "1@5968\012MT"  !<.P  &@
M    @ &H  , >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "1@596?^!#S%L"  !-.0  $P              @ &] P, 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     ;0!M /0=  !)!@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>493</ContextCount>
  <ElementCount>598</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>149</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/BUSINESS</Role>
      <ShortName>BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - ACQUISITIONS AND DIVESTITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - DERIVATIVE INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTS</Role>
      <ShortName>DERIVATIVE INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - TREASURY STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCK</Role>
      <ShortName>TREASURY STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - RETIREMENT BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANS</Role>
      <ShortName>RETIREMENT BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - LEASES AND RELATED PARTY LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBT</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - DEBT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails</Role>
      <ShortName>DEBT (Maximum Total Leverage Ratio Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTScheduleofDebtMaturityDetails</Role>
      <ShortName>DEBT (Schedule of Debt Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBTTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - TREASURY STOCK - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCKNarrativeDetails</Role>
      <ShortName>TREASURY STOCK - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails</Role>
      <ShortName>RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/RETIREMENTBENEFITPLANSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - INCOME TAXES (Tax Valuation Allowance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails</Role>
      <ShortName>INCOME TAXES (Tax Valuation Allowance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXESTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails</Role>
      <ShortName>NET INCOME PER SHARE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails</Role>
      <ShortName>AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="iart-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - iart-20221231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - iart-20221231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 15 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense -  iart-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="iart-20221231.htm">iart-20221231.htm</File>
    <File>iart-20221231.xsd</File>
    <File>iart-20221231_cal.xml</File>
    <File>iart-20221231_def.xml</File>
    <File>iart-20221231_lab.xml</File>
    <File>iart-20221231_pre.xml</File>
    <File>iart-20221231xexx103h.htm</File>
    <File>iart-20221231xexx103i.htm</File>
    <File>iart-20221231xexx103j.htm</File>
    <File>iart-20221231xexx103k.htm</File>
    <File>iart-20221231xexx103l.htm</File>
    <File>iart-20221231xexx211.htm</File>
    <File>iart-20221231xexx231.htm</File>
    <File>iart-20221231xexx311.htm</File>
    <File>iart-20221231xexx312.htm</File>
    <File>iart-20221231xexx321.htm</File>
    <File>iart-20221231xexx322.htm</File>
    <File>iart-20221231xexx33.htm</File>
    <File>iart-20221231xexx44.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iart-20221231_g1.jpg</File>
    <File>iart-20221231_g2.jpg</File>
    <File>iart-20221231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1528">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>131
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 44,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1528,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 493,
   "dts": {
    "calculationLink": {
     "local": [
      "iart-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iart-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 958,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 17,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 21
   },
   "keyCustom": 95,
   "keyStandard": 503,
   "memberCustom": 70,
   "memberStandard": 77,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Total Revenue by Major Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - ACQUISITIONS AND DIVESTITURES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES",
     "shortName": "ACQUISITIONS AND DIVESTITURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://integralife.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - DERIVATIVE INSTRUMENTS",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTS",
     "shortName": "DERIVATIVE INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - TREASURY STOCK",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://integralife.com/role/TREASURYSTOCK",
     "shortName": "TREASURY STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - RETIREMENT BENEFIT PLANS",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANS",
     "shortName": "RETIREMENT BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - LEASES AND RELATED PARTY LEASES",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES",
     "shortName": "LEASES AND RELATED PARTY LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://integralife.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://integralife.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - NET INCOME PER SHARE",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://integralife.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://integralife.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables",
     "shortName": "DERIVATIVE INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - RETIREMENT BENEFIT PLANS (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSTables",
     "shortName": "RETIREMENT BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables",
     "shortName": "LEASES AND RELATED PARTY LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://integralife.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - NET INCOME PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://integralife.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i83ae2861f4a1489fa6e81d7262ab2f96_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Roll forward of Valuation for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i3fe44e0a022f4f34bf03594794a50963_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventories, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property, Plant and Equipment Balances and Corresponding Lives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveAccrualAdjustment1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of 2020-06 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i923e26b254024ce191a077d3ad910d88_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i788f04f5fed04ca38e49ba6f03024c26_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Narrative, Revenue Remaining Performance Obligation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i788f04f5fed04ca38e49ba6f03024c26_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Changes in Contract Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues Disaggregated by Major Source) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ib05901fa55ec4ee09f5c084cb113c902_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i628706586a0345ba8883bd6d56eb2045_D20221206-20221206",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Business Acquisition, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i628706586a0345ba8883bd6d56eb2045_D20221206-20221206",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition SIA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i547e9b738a9b4ffe8435a24e596115f8_I20221206",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i8e90ad876dbd48bc8aa7bf8b4a53d714_D20210120-20210120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i58908f12479149769863fd3b128d144e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Assets and Liabilities Divested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i58908f12479149769863fd3b128d144e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Fair Value Acquisition ACell (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4eab553affa54f9fb01f97a61e3c4a4c_I20210120",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SecuredDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - DEBT (Narrative) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://integralife.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:InterestPaymentsYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i2429c77787c540b481af5ad54734a36f_I20200714",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
     "shortName": "DEBT (Maximum Total Leverage Ratio Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i2429c77787c540b481af5ad54734a36f_I20200714",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - DEBT (Schedule of Debt Maturity) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails",
     "shortName": "DEBT (Schedule of Debt Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "idb5285f5cc45407cbdd753e2c83bf644_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Interest Rate Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i0437592feca04863946089d86b4469ac_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "id9344740008a49528124058c2083bc1e_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4ed0c764a1ef48f18d31ec981995213b_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Cross-Currency Swap Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i7523d880d9374a2481b72ce4679376f9_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4ed0c764a1ef48f18d31ec981995213b_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Schedule of Net Investment Hedges Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "if061f0c8b11a4b0e9af9f2d1b0096dfc_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4ed0c764a1ef48f18d31ec981995213b_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Fair Value of Derivative Instruments By Balance Sheet Location) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i29f1ed4692244fb883cb0925404db697_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS (Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ib305e15ed1f0490ea6032f84d1419429_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS- (Schedule of Gains and (Loss) of Derivative Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Changes in Carrying Amount of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Components of Company's Identifiable Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - TREASURY STOCK - Narrative (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://integralife.com/role/TREASURYSTOCKNarrativeDetails",
     "shortName": "TREASURY STOCK - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Employee Stock-Based Compensation Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Weighted-Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i74db8baf10424ff7a6207881e5bae34e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails",
     "shortName": "STOCK-BASED COMPENSATION (Summary of Vested and Unvested Restricted Stock, Performance Stock, and Contract Stock) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i74db8baf10424ff7a6207881e5bae34e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Assumptions Used Periodic Benefit Cost and Actuarial Present Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Change in Benefit Obligations and Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Scheduled of Funded Status) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails",
     "shortName": "RETIREMENT BENEFIT PLANS (Schedule of Expected Benefit Payments and Minimum Contribution on Unfunded Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ieb43d094e8824032961a8ec85d76affb_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ieb43d094e8824032961a8ec85d76affb_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4686279af17c417cbe3854bacf4ca2d8_I20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases Current Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://integralife.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES (Schedule of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i5c0443956aba4287a79da88ad2b1f789_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "icbb5085d40924d08b32a44ed38777fa8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - INCOME TAXES (Tax Valuation Allowance) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
     "shortName": "INCOME TAXES (Tax Valuation Allowance) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i16e2c6f764c8440b9b5484c3e0a26c87_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - BUSINESS",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://integralife.com/role/BUSINESS",
     "shortName": "BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Uncertain Tax Benefits Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ib4ed22898bc64d24b7765e593f891985_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE (Basic and Diluted Net Income Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - NET INCOME PER SHARE (Narrative) (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
     "shortName": "NET INCOME PER SHARE (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i4b9d9ed2b94d4cd6853e13d7ede4ff8d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
     "shortName": "AACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i787ac1d1d9ba4a389460945f21e1be91_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i9c2f742f6e864e72a554afa2da3a8c66_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i68a223d9d7454456aa04f06027515378_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "ibae60ef4e8d8432b944c8e3b719f35a7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "icf69e67cb3914b7097e58795099a96dc_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:BusinessCombinationContingentConsiderationNumberOfLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "liability",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "icf69e67cb3914b7097e58795099a96dc_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:BusinessCombinationContingentConsiderationNumberOfLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "liability",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i6f0d2ae3ba1f445db46d7d3d48fcf5d9_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iart:SegmentReportingInformationNumberOfProductsOffered",
      "reportCount": 1,
      "unique": true,
      "unitRef": "product",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i912f32710efe4b489b6f6444b9fa8ba4_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Net Sales and Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20221231.htm",
      "contextRef": "i8beb115769fa4bde80a56f0d62b90c05_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - iart-20221231.htm",
     "menuCat": "Cover",
     "order": "101",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - iart-20221231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 149,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "FRANCE"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States (Includes long-lived assets in Puerto Rico)"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iart_ACellIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell, Inc.",
        "label": "ACell, Inc. [Member]",
        "terseLabel": "ACell, Inc."
       }
      }
     },
     "localname": "ACellIncMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ACellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell",
        "label": "ACell [Member]",
        "terseLabel": "ACell"
       }
      }
     },
     "localname": "ACellMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AcceleratedShareRepurchasesAdditionalSharesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Additional Shares Received",
        "label": "Accelerated Share Repurchases, Additional Shares Received",
        "terseLabel": "Accelerated share repurchases, additional shares received"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAdditionalSharesReceived",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AcceleratedShareRepurchasesSharesReceivedAtInception": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases. Shares Received at Inception",
        "label": "Accelerated Share Repurchases. Shares Received at Inception",
        "terseLabel": "Accelerated share repurchases, shares received at inception"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSharesReceivedAtInception",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities.",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AccumulatedOtherComprehensiveIncomeLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossRollForward",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_AllOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other [Member]",
        "label": "All Other [Member]",
        "terseLabel": "All other"
       }
      }
     },
     "localname": "AllOtherMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AnnualRateOfLeaseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rate of lease agreement.",
        "label": "Annual Rate Of Lease Agreement",
        "terseLabel": "Annual rate of lease agreement"
       }
      }
     },
     "localname": "AnnualRateOfLeaseAgreement",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ArkisBioSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arkis BioSciences Inc. [Member]",
        "label": "Arkis BioSciences Inc. [Member]",
        "terseLabel": "Arkis"
       }
      }
     },
     "localname": "ArkisBioSciencesInc.Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AssetAcquisitionDevelopmentMilestonePaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Development Milestone Payment",
        "label": "Asset Acquisition, Development Milestone Payment To Be Paid",
        "terseLabel": "Asset Acquisition, Development Milestone Payment To Be Paid"
       }
      }
     },
     "localname": "AssetAcquisitionDevelopmentMilestonePaymentToBePaid",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://integralife.com/20221231",
     "xbrltype": "stringItemType"
    },
    "iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioD Earnout Payments and Medihoney Earnout Payments [Member]",
        "label": "BioD Earnout Payments and Medihoney Earnout Payments [Member]",
        "terseLabel": "BioD Earnout Payments and Medihoney Earnout Payments"
       }
      }
     },
     "localname": "BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_BusinessAcquisitionNumberOfContingentLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Number Of Contingent Liabilities",
        "label": "Business Acquisition, Number Of Contingent Liabilities",
        "terseLabel": "Business Acquisition, number of payments"
       }
      }
     },
     "localname": "BusinessAcquisitionNumberOfContingentLiabilities",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_BusinessCombinationContingentConsiderationNumberOfLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Number Of Liabilities",
        "label": "Business Combination, Contingent Consideration, Number Of Liabilities",
        "terseLabel": "Number of liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationNumberOfLiabilities",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "label": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "BusinessCombinationIntangibleAssetAcquiredDiscountRate",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Current Portion of Lease Liability, Operating Leases",
        "terseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCurrentPortionOfLeaseLiabilityOperatingLeases",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability, Operating Leases",
        "terseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiabilityOperatingLeases",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 4.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Asset, Operating Leases",
        "terseLabel": "Right of use asset - operating leases"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssetOperatingLeases",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_BusinessCombinationWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Working Capital Adjustment",
        "label": "Business Combination, Working Capital Adjustment",
        "terseLabel": "Working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationWorkingCapitalAdjustment",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CashFlowLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Table Text Block]",
        "label": "Cash Flow, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Asset [Roll Forward]",
        "label": "Change In Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability [Roll Forward]",
        "label": "Change In Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CharitableContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charitable contributions",
        "label": "Charitable contributions",
        "terseLabel": "Contributions to Integra Foundation"
       }
      }
     },
     "localname": "CharitableContributions",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ClosureOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closure of Facility",
        "label": "Closure of Facility [Member]",
        "terseLabel": "Closure of Facility"
       }
      }
     },
     "localname": "ClosureOfFacilityMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CodmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman [Member]",
        "label": "Codman [Member]",
        "terseLabel": "Codman"
       }
      }
     },
     "localname": "CodmanMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CodmanSpecialtySurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman Specialty Surgical [Member]",
        "label": "Codman Specialty Surgical [Member]",
        "terseLabel": "Codman Specialty Surgical"
       }
      }
     },
     "localname": "CodmanSpecialtySurgicalMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CompletedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Completed technology.",
        "label": "Completed Technology [Member]",
        "terseLabel": "Completed technology"
       }
      }
     },
     "localname": "CompletedTechnologyMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ConcentrationRiskNumberofCustomersOverBenchmark": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers Over Benchmark",
        "label": "Concentration Risk, Number of Customers Over Benchmark",
        "terseLabel": "Concentration risk, number of customers over benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskNumberofCustomersOverBenchmark",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_ConcentrationRiskThresholdPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Threshold Percentage",
        "label": "Concentration Risk, Threshold Percentage",
        "terseLabel": "Concentration risk, threshold percentage"
       }
      }
     },
     "localname": "ConcentrationRiskThresholdPercentage",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_ConsortiumofFocusedOrthopedistsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consortium of Focused Orthopedists, LLC [Member]",
        "label": "Consortium of Focused Orthopedists, LLC [Member]",
        "terseLabel": "Consortium of Focused Orthopedists, LLC"
       }
      }
     },
     "localname": "ConsortiumofFocusedOrthopedistsLLCMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Liability [Member]",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Increase From Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Net Of Revenue Recognized And Foreign Currency Translation",
        "terseLabel": "Contract liability, net of revenue recognized on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.",
        "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CrossCurrencyInterestRateContractFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Four [Member]",
        "label": "Cross Currency Interest Rate Contract Four [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Four"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractFourMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract One [Member]",
        "label": "Cross Currency Interest Rate Contract One [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractOneMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Three [Member]",
        "label": "Cross Currency Interest Rate Contract Three [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractThreeMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Two [Member]",
        "label": "Cross Currency Interest Rate Contract Two [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractTwoMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract One",
        "label": "Cross Currency Interest Rate Swap, Contract One [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractOneMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract Three",
        "label": "Cross Currency Interest Rate Swap, Contract Three [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractThreeMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateSwapContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Swap, Contract Two",
        "label": "Cross Currency Interest Rate Swap, Contract Two [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap, Contract Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateSwapContractTwoMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification",
        "label": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Amortization and Equity Costs Reclassification"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountAmortizationAndEquityCostsReclassificationMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification",
        "label": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment, Debt Discount Reclassification"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentDebtDiscountReclassificationMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 3 [Member]",
        "label": "Debt Covenant Period 3 [Member]",
        "terseLabel": "September 30, 2022 through June 30, 2023"
       }
      }
     },
     "localname": "DebtCovenantPeriod3Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 4 [Member]",
        "label": "Debt Covenant Period 4 [Member]",
        "terseLabel": "September 30, 2023 and the last day of each fiscal quarter thereafter"
       }
      }
     },
     "localname": "DebtCovenantPeriod4Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "label": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "terseLabel": "Combination settlement for debt conversion, minimum settled in cash per principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "label": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "terseLabel": "Debt Instrument, Covenant, Maximum Leverage Ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "label": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "terseLabel": "Maximum average conversion value of notes"
       }
      }
     },
     "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "terseLabel": "Maximum selling price of the company's common stock of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtWeightedAverageInterestRateFromSecuritization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Weighted Average Interest Rate, From Securitization",
        "label": "Debt, Weighted Average Interest Rate, From Securitization",
        "terseLabel": "Security facility, weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRateFromSecuritization",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DeferredTaxAssetIncreaseDueTo2017TaxAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Increase Due To 2017 Tax Act",
        "label": "Deferred Tax Asset, Increase Due To 2017 Tax Act",
        "terseLabel": "Deferred tax asset, increase"
       }
      }
     },
     "localname": "DeferredTaxAssetIncreaseDueTo2017TaxAct",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leases And Other",
        "label": "Deferred Tax Assets, Leases And Other",
        "terseLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasesAndOther",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Vacation",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeVacation",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Capitalized Research And Development",
        "terseLabel": "Capitalization of research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopment",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxLiabilitiesLeasesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Leases And Other",
        "label": "Deferred Tax Liabilities, Leases And Other",
        "negatedLabel": "Leases and Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasesAndOther",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Unrealized Foreign Exchange Loss",
        "label": "Deferred Tax Liabilities, Unrealized Foreign Exchange Loss",
        "negatedTerseLabel": "Unrealized foreign exchange loss"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUnrealizedForeignExchangeLoss",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanBenefitObligationPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Premiums Paid",
        "negatedTerseLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPremiumsPaid",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "terseLabel": "Defer payment and taxation, base salary, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income Not Disclosed Flag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DefinedBenefitPlanPlanAssetsPremiumsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "label": "Defined Benefit Plan, Plan Assets, Premiums Paid",
        "negatedLabel": "Premiums paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPremiumsPaid",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.",
        "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DemonstrationEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Demonstration Equipment",
        "label": "Demonstration Equipment [Member]",
        "terseLabel": "Demonstration equipment"
       }
      }
     },
     "localname": "DemonstrationEquipmentMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DerivativeNotionalAmountTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Terminated",
        "label": "Derivative, Notional Amount, Terminated",
        "terseLabel": "Derivative, notional amount, terminated"
       }
      }
     },
     "localname": "DerivativeNotionalAmountTerminated",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DermaSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derma Sciences [Member]",
        "label": "Derma Sciences [Member]",
        "terseLabel": "Derma Sciences"
       }
      }
     },
     "localname": "DermaSciencesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DirectorsandCertainExecutiveOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Certain Executive Officers [Member]",
        "label": "Directors and Certain Executive Officers [Member]",
        "terseLabel": "Directors and Certain Executive Officers"
       }
      }
     },
     "localname": "DirectorsandCertainExecutiveOfficersMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Asset",
        "label": "Discontinued Operation, Continuing Involvement, Prepaid Asset",
        "terseLabel": "Discontinued operation, continuing involvement, prepaid asset"
       }
      }
     },
     "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAsset",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets",
        "label": "Discontinued Operation, Continuing Involvement, Prepaid Assets , Current",
        "terseLabel": "Inventory purchase, prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration",
        "terseLabel": "Sale of business, contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period",
        "terseLabel": "Period for revenue based performance milestone"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Lease Liability, Current",
        "terseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityCurrent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Lease Liability, Noncurrent",
        "terseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityNoncurrent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "label": "Disposal Group, Including Discontinued Operation, Payment Related To Contract Termination",
        "terseLabel": "Sale of extremity orthopedics business, payment for terminating license agreement"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentRelatedToContractTermination",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets",
        "label": "Disposal Group, Including Discontinued Operation, Right of Use Asset Operating Leases and Other Assets",
        "terseLabel": "Right of use asset-operating leases and Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesAndOtherAssets",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable",
        "label": "Disposal Group, Including Discontinued Operation, Transitional Supply Agreement, Payable",
        "terseLabel": "Transitional supply agreement, payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransitionalSupplyAgreementPayable",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveForeignIncomeTaxRateReconciliationContinuingOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "label": "Effective Foreign Income Tax Rate Reconciliation, Continuing Operations",
        "terseLabel": "Effective foreign income tax rate"
       }
      }
     },
     "localname": "EffectiveForeignIncomeTaxRateReconciliationContinuingOperations",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Assets Held-For-Sale, Outside Basis Difference, Percent",
        "terseLabel": "Gain from sale of business - book to tax differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAssetsHeldForSaleOutsideBasisDifferencePercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Percent",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Intercompany Inventory, Percent",
        "terseLabel": "Intercompany profit in inventory"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionIntercompanyInventoryPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Deferred income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Income Tax Benefit, Transfer Intra-Entity Intellectual Property, Amount",
        "terseLabel": "Income tax benefit, transfer intra-entity intellectual property, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIncomeTaxBenefitTransferIntraEntityIntellectualPropertyAmount",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Compensation, Percent",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal and Professional, Percent",
        "terseLabel": "Nondeductible facilitative costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalandProfessionalPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Intra-Entity Intellectual Property, Rate Differential On FMV Step-Up, Percent",
        "terseLabel": "Fair market value step up on intra-entity transfer of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransferIntraEntityIntellectualPropertyRateDifferentialOnFMVStepUpPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EffectiveWorldwideIncomeTaxRateReconciliationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "label": "Effective Worldwide Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective worldwide tax rate"
       }
      }
     },
     "localname": "EffectiveWorldwideIncomeTaxRateReconciliationPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_EmployeeStockPurchasePlanProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from employees in connection with the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Proceeds",
        "terseLabel": "ESPP proceeds received"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanProceeds",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ExtremityOrthopedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extremity Orthopedics [Member]",
        "label": "Extremity Orthopedics [Member]",
        "terseLabel": "Extremity Orthopedics"
       }
      }
     },
     "localname": "ExtremityOrthopedicsMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FDAApprovalOfPremarketApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FDA Approval Of Premarket Approval",
        "label": "FDA Approval Of Premarket Approval [Member]",
        "terseLabel": "FDA Approval Of Premarket Approval"
       }
      }
     },
     "localname": "FDAApprovalOfPremarketApprovalMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "terseLabel": "Transfers from long-term to current portion"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_FiveYearLeasePeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Lease Period Two",
        "label": "Five Year Lease Period Two [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2034 Through October 31, 2039"
       }
      }
     },
     "localname": "FiveYearLeasePeriodTwoMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FiveYearOptionLeasePeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year Option Lease Period One",
        "label": "Five Year Option Lease Period One [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2029 Through October 31, 2034"
       }
      }
     },
     "localname": "FiveYearOptionLeasePeriodOneMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FoundationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foundation [Policy Text Block].",
        "label": "Foundation [Policy Text Block]",
        "terseLabel": "Integra Foundation"
       }
      }
     },
     "localname": "FoundationPolicyTextBlock",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "label": "Gain (Loss) On Disposition Of Property Plant Equipment And Construction In-Progress",
        "negatedLabel": "Loss (Gain) on disposal of property and equipment and construction in-progress"
       }
      }
     },
     "localname": "GainLossOnDispositionOfPropertyPlantEquipmentAndConstructionInProgress",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Line Items]",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Table]",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_IncreaseInAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of authorized shares under the Plan.",
        "label": "Increase In Authorized Shares",
        "terseLabel": "Increase in authorized shares (in shares)"
       }
      }
     },
     "localname": "IncreaseInAuthorizedShares",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_InformationSystemsandHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information Systems and Hardware [Member]",
        "label": "Information Systems and Hardware [Member]",
        "terseLabel": "Information systems and hardware"
       }
      }
     },
     "localname": "InformationSystemsandHardwareMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_IntercompanyLoanQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intercompany Loan, Quarterly Payment",
        "label": "Intercompany Loan, Quarterly Payment",
        "terseLabel": "Intercompany loan, quarterly payment"
       }
      }
     },
     "localname": "IntercompanyLoanQuarterlyPayment",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year One",
        "label": "Interest Payments, Year One",
        "terseLabel": "Interest payments, year one"
       }
      }
     },
     "localname": "InterestPaymentsYearOne",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Three",
        "label": "Interest Payments, Year Three",
        "terseLabel": "Interest payments, year three"
       }
      }
     },
     "localname": "InterestPaymentsYearThree",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Two",
        "label": "Interest Payments, Year Two",
        "terseLabel": "Interest payments, year two"
       }
      }
     },
     "localname": "InterestPaymentsYearTwo",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche1Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 1",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche1Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 2",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche2Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InventoryCapitalizedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Capitalized Expenses",
        "label": "Inventory, Capitalized Expenses",
        "terseLabel": "Inventory, capitalized expenses"
       }
      }
     },
     "localname": "InventoryCapitalizedExpenses",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options (or more)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_MilestonePaymentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment One [Member]",
        "label": "Milestone Payment One [Member]",
        "terseLabel": "Milestone Payment One"
       }
      }
     },
     "localname": "MilestonePaymentOneMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_MilestonePaymentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment Two [Member]",
        "label": "Milestone Payment Two [Member]",
        "terseLabel": "Milestone Payment Two"
       }
      }
     },
     "localname": "MilestonePaymentTwoMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NeurosurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurosurgery [Member]",
        "label": "Neurosurgery [Member]",
        "terseLabel": "Neurosurgery"
       }
      }
     },
     "localname": "NeurosurgeryMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_NoncashOrPartNoncashInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Or Part Noncash, In Process Research And Development",
        "label": "Noncash Or Part Noncash, In Process Research And Development",
        "terseLabel": "Non-cash in-process research and development expense"
       }
      }
     },
     "localname": "NoncashOrPartNoncashInProcessResearchAndDevelopment",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_OneMonthEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month Eurodollar Rate [Member]",
        "label": "One Month Eurodollar Rate [Member]",
        "terseLabel": "One-Month Eurodollar Rate"
       }
      }
     },
     "localname": "OneMonthEurodollarRateMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OneMonthUSDLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Month USD LIBOR [Member]",
        "label": "One Month USD LIBOR [Member]",
        "terseLabel": "1-month USD LIBOR Loan"
       }
      }
     },
     "localname": "OneMonthUSDLIBORMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_OptionToExtendLeaseYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to extend lease, years.",
        "label": "Option To Extend Lease, Years",
        "terseLabel": "Option to extend lease, years"
       }
      }
     },
     "localname": "OptionToExtendLeaseYears",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_PaymentsForOptionIndexToIssuersEquity": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Options Indexed to Issuer's Equity",
        "label": "Payments For Option Index To Issuers Equity",
        "negatedLabel": "Purchase of option hedge on convertible notes",
        "verboseLabel": "Cost of call transactions"
       }
      }
     },
     "localname": "PaymentsForOptionIndexToIssuersEquity",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsForProceedsFromBusinessAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Business Acquisitions",
        "label": "Payments For (Proceeds From) Business Acquisitions",
        "negatedTerseLabel": "Cash paid for business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsForProceedsFromBusinessAcquisitions",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "label": "Payments To Acquire In Process Research And Development And Intangible Assets",
        "negatedLabel": "Acquired in-process research and development and intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopmentAndIntangibleAssets",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director"
       }
      }
     },
     "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_PerformanceStockandContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock and Contract Stock [Member]",
        "label": "Performance Stock and Contract Stock [Member]",
        "terseLabel": "Performance Stock and Contract Stock Awards"
       }
      }
     },
     "localname": "PerformanceStockandContractStockMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PrivateLabelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Label [Member]",
        "label": "Private Label [Member]",
        "terseLabel": "Private Label"
       }
      }
     },
     "localname": "PrivateLabelMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReboundTherapeuticsCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebound Therapeutics Corporation [Member]",
        "label": "Rebound Therapeutics Corporation [Member]",
        "terseLabel": "Rebound"
       }
      }
     },
     "localname": "ReboundTherapeuticsCorporationMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RegenerativeSkinAndWoundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regenerative Skin And Wound [Member]",
        "label": "Regenerative Skin And Wound [Member]",
        "terseLabel": "Wound Reconstruction and Care"
       }
      }
     },
     "localname": "RegenerativeSkinAndWoundMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RelatedPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Member]",
        "label": "Related Parties [Member]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReorganizationProjectsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reorganization Projects",
        "label": "Reorganization Projects [Member]",
        "terseLabel": "Reorganization Projects"
       }
      }
     },
     "localname": "ReorganizationProjectsMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from rest of the world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of the World"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestrictedStockPerformanceStockAndContractStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock, performance stock and contract stock member",
        "label": "Restricted Stock, Performance Stock, And Contract Stock [Member]",
        "terseLabel": "Restricted Stock, Performance Stock and Contract Stock"
       }
      }
     },
     "localname": "RestrictedStockPerformanceStockAndContractStockMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment",
        "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment",
        "terseLabel": "Number of days from shipment to issue a credit on returned goods"
       }
      }
     },
     "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueBasedPerformanceMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Based Performance Milestones",
        "label": "Revenue Based Performance Milestones [Member]",
        "terseLabel": "Revenue Based Performance Milestones"
       }
      }
     },
     "localname": "RevenueBasedPerformanceMilestonesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "label": "Revenue From Contract With Customer, Products Shipped With No Alternative Use And Right Of Payment For Performance, Manufacturing Period",
        "terseLabel": "Manufacturing period for products shipped with no alternative use and right of payment for performance"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductsShippedWithNoAlternativeUseAndRightOfPaymentForPerformanceManufacturingPeriod",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Product Warranty Period",
        "label": "Revenue, Product Warranty Period",
        "terseLabel": "Product warranty period (up to)"
       }
      }
     },
     "localname": "RevenueProductWarrantyPeriod",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "ROU assets obtained in exchange for lease liabilities:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgram": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program",
        "label": "Secured Long-Term Debt, Securitization Program",
        "terseLabel": "Secured long-term debt, securitization program"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgram",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "label": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "terseLabel": "Long-term borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuritizationFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securitization Facility, Fair Value Of Amount Outstanding",
        "label": "Securitization Facility, Fair Value Of Amount Outstanding",
        "terseLabel": "Securitization facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "SecuritizationFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SegmentReportingInformationNumberOfProductsOffered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products sold by a segment",
        "label": "Segment Reporting Information, Number Of Products Offered",
        "terseLabel": "Number of products offered (more than)"
       }
      }
     },
     "localname": "SegmentReportingInformationNumberOfProductsOffered",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_SeniorCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Credit Facility.",
        "label": "Senior Credit Facility [Member]",
        "terseLabel": "Senior Credit Facility"
       }
      }
     },
     "localname": "SeniorCreditFacilityMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Shares",
        "negatedTerseLabel": "Adjustments for performance achievement related to award target (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementShares",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments for Performance Achievement, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments for performance achievement related to award target (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAdjustmentsforPerformanceAchievementWeightedAverageGrantDateFairValue",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iart_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased, Percent",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased, Percent",
        "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchasedPercent",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SupplierRelationShipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Relation Ships [Member]",
        "label": "Supplier Relation Ships [Member]",
        "terseLabel": "Supplier relationships"
       }
      }
     },
     "localname": "SupplierRelationShipsMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SurgicalInnovationAssociatesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Innovation Associates Inc",
        "label": "Surgical Innovation Associates Inc [Member]",
        "terseLabel": "Surgical Innovation Association Inc"
       }
      }
     },
     "localname": "SurgicalInnovationAssociatesIncMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwinglineLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Loan [Member]",
        "label": "Swingline Loan [Member]",
        "terseLabel": "Swingline Loan"
       }
      }
     },
     "localname": "SwinglineLoanMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ThirdPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Parties [Member]",
        "label": "Third Parties [Member]",
        "verboseLabel": "Third Parties"
       }
      }
     },
     "localname": "ThirdPartiesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TissueTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tissue Technologies [Member]",
        "label": "Tissue Technologies [Member]",
        "terseLabel": "Tissue Technologies"
       }
      }
     },
     "localname": "TissueTechnologiesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TrademarksBrandNamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks Brand Names.",
        "label": "Trademarks Brand Names [Member]",
        "terseLabel": "Trademarks/brand names"
       }
      }
     },
     "localname": "TrademarksBrandNamesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TraditionalWoundCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Traditional Wound Care",
        "label": "Traditional Wound Care [Member]",
        "terseLabel": "Traditional Wound Care"
       }
      }
     },
     "localname": "TraditionalWoundCareMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "terseLabel": "Securitization facility, outstanding borrowings, maximum limit"
       }
      }
     },
     "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_TwoThousandOnePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand One Plan [Member]",
        "label": "Two Thousand One Plan [Member]",
        "terseLabel": "2001 Plan"
       }
      }
     },
     "localname": "TwoThousandOnePlanMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Plan [Member]",
        "label": "Two Thousand Plan [Member]",
        "terseLabel": "2000 Plan"
       }
      }
     },
     "localname": "TwoThousandPlanMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand three Plan [Member]",
        "label": "Two Thousand Three Plan [Member]",
        "terseLabel": "2003 Plan"
       }
      }
     },
     "localname": "TwoThousandThreePlanMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "label": "Unrecognized Tax Benefits, Increases During Period [Abstract]",
        "terseLabel": "Gross increases:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesDuringPeriodAbstract",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_UnrecognizedTaxBenefitsReductionsResultingFromOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "label": "Unrecognized Tax Benefits, Reductions Resulting From Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromOther",
     "nsuri": "http://integralife.com/20221231",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r878",
      "r999",
      "r1056",
      "r1057",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r345",
      "r399",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r421",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r493",
      "r495",
      "r496",
      "r991",
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r345",
      "r399",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r421",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r493",
      "r495",
      "r496",
      "r991",
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r342",
      "r343",
      "r501",
      "r529",
      "r884",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r291",
      "r356",
      "r363",
      "r369",
      "r441",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r749",
      "r752",
      "r754",
      "r755",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r291",
      "r356",
      "r363",
      "r369",
      "r441",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r749",
      "r752",
      "r754",
      "r755",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r291",
      "r356",
      "r363",
      "r369",
      "r441",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r749",
      "r752",
      "r754",
      "r755",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r483",
      "r638",
      "r812",
      "r844",
      "r879",
      "r880",
      "r902",
      "r917",
      "r927",
      "r993",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r483",
      "r638",
      "r812",
      "r844",
      "r879",
      "r880",
      "r902",
      "r917",
      "r927",
      "r993",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r423",
      "r815",
      "r904",
      "r925",
      "r988",
      "r989",
      "r996",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r423",
      "r815",
      "r904",
      "r925",
      "r988",
      "r989",
      "r996",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r483",
      "r587",
      "r638",
      "r670",
      "r671",
      "r672",
      "r811",
      "r812",
      "r844",
      "r879",
      "r880",
      "r902",
      "r917",
      "r927",
      "r985",
      "r993",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r483",
      "r587",
      "r638",
      "r670",
      "r671",
      "r672",
      "r811",
      "r812",
      "r844",
      "r879",
      "r880",
      "r902",
      "r917",
      "r927",
      "r985",
      "r993",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r342",
      "r343",
      "r501",
      "r529",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r424",
      "r425",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r905",
      "r926",
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r864",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r905",
      "r926",
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r970",
      "r1058"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated share repurchase program, receipt (payment)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r357",
      "r358",
      "r359",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r727",
      "r728",
      "r729",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r779",
      "r780",
      "r784",
      "r785",
      "r786",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r15",
      "r32"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable, trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r429",
      "r430"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowances of $4,304 and $4,735"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r896",
      "r987"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion of bond issuance discount"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r47",
      "r52",
      "r220",
      "r944",
      "r945",
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r129",
      "r302"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r318",
      "r327",
      "r328",
      "r735",
      "r887",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r51",
      "r52",
      "r310",
      "r839",
      "r852",
      "r856"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r48",
      "r52",
      "r220",
      "r804",
      "r847",
      "r848",
      "r944",
      "r945",
      "r946",
      "r961",
      "r962",
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r45",
      "r52",
      "r220",
      "r327",
      "r328",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Items"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r924"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r681",
      "r682",
      "r683",
      "r961",
      "r962",
      "r963",
      "r1047"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r83",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Share repurchase and equity component of the convertible note issuance, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r189",
      "r190",
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "netLabel": "Share-based compensation expense recognized",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Net effect on net income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r311",
      "r433",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r57",
      "r520",
      "r782",
      "r949"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Incremental financing cost expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r83",
      "r113",
      "r120"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization",
        "verboseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r263",
      "r276",
      "r306",
      "r338",
      "r407",
      "r413",
      "r419",
      "r437",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r733",
      "r737",
      "r761",
      "r924",
      "r991",
      "r992",
      "r1060"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r297",
      "r314",
      "r338",
      "r437",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r733",
      "r737",
      "r761",
      "r924",
      "r991",
      "r992",
      "r1060"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131",
      "r295",
      "r296"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "verboseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r228",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis Of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and building improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Leased facilities"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r726",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r203",
      "r204",
      "r726",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r732",
      "r948"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration and others"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r210",
      "r211",
      "r731"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)",
        "verboseLabel": "Contingent consideration, liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business combination, contingent consideration, liability, current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business combination, contingent consideration, liability, noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 6.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 3.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 2.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 7.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 5.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r14",
      "r92",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r88",
      "r89",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment purchases included in liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r85",
      "r300",
      "r882"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash And Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r79",
      "r85",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r79",
      "r255"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "terseLabel": "Cash divested from deconsolidation"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r338",
      "r372",
      "r376",
      "r378",
      "r380",
      "r388",
      "r389",
      "r437",
      "r485",
      "r488",
      "r489",
      "r490",
      "r496",
      "r497",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r761",
      "r881",
      "r938",
      "r951",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant strike price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r478",
      "r479",
      "r866",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r961",
      "r962",
      "r1047"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r924"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 90,477 and 89,600 issued at December\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r53",
      "r322",
      "r324",
      "r331",
      "r835",
      "r841"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r67",
      "r330",
      "r834",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r99",
      "r100",
      "r253",
      "r254",
      "r427",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r99",
      "r100",
      "r253",
      "r254",
      "r427",
      "r857",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r99",
      "r100",
      "r253",
      "r254",
      "r427",
      "r865",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r273",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r99",
      "r100",
      "r253",
      "r254",
      "r427",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r218",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles Of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r995"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r536",
      "r538",
      "r559"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract asset, End of Period",
        "periodStartLabel": "Contract asset, Beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "auth_ref": [
      "r903"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "negatedTerseLabel": "Transferred to trade receivable from contract asset included in beginning of the year contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r536",
      "r537",
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability, End of Period",
        "periodStartLabel": "Contract liability, Beginning of Period"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r536",
      "r537",
      "r559"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities",
        "verboseLabel": "Short-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r536",
      "r537",
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Recognition of revenue included in beginning of year contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r19",
      "r266",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r145",
      "r498",
      "r499",
      "r510",
      "r511",
      "r512",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Long-term convertible securities"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r108",
      "r412",
      "r413",
      "r414",
      "r415",
      "r421",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r60",
      "r815"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r947"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of product technology"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Employee Termination Benefits"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r998",
      "r1045"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-Currency Interest Rate Swap",
        "verboseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r954",
      "r1037",
      "r1039"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r954",
      "r1037"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r201",
      "r706",
      "r716",
      "r954"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r954",
      "r1037",
      "r1039"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r98",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r337",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r514",
      "r521",
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r264",
      "r266",
      "r275",
      "r345",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r783",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rates available to the company at its option"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Debt proceeds, classified as equity at time of offering"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r148",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Initial conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r38",
      "r153",
      "r154",
      "r156",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "verboseLabel": "Initial conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r258",
      "r260",
      "r498",
      "r783",
      "r898",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible notes, aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r512",
      "r760",
      "r898",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r37",
      "r258",
      "r526",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r37",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt, interest rate",
        "verboseLabel": "Convertible notes, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r39",
      "r345",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r783",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r39",
      "r153",
      "r155",
      "r156",
      "r157",
      "r257",
      "r258",
      "r260",
      "r272",
      "r345",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r523",
      "r783",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate on debt"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r939"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan, fair value of assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r954",
      "r1038",
      "r1039"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Capitalized incremental financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r201",
      "r954",
      "r1038"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r689",
      "r690"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r83",
      "r201",
      "r707",
      "r715",
      "r716",
      "r954"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred",
        "verboseLabel": "Deferred income tax (benefit) provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r20",
      "r21",
      "r265",
      "r274",
      "r701"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r689",
      "r690"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r954",
      "r1038",
      "r1039"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.",
        "label": "Deferred Tax Assets, Charitable Contribution Carryforwards",
        "terseLabel": "Charitable contributions carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsCharitableContributionCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r702"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory related items"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r1035"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1035"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r198",
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "verboseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses",
        "terseLabel": "Accrued bonus"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Unrealized foreign exchange gain"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r192",
      "r1035"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "totalLabel": "Total net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r199",
      "r1036"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangible and fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r52",
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Gain (loss) recognized within accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r578",
      "r913"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r564",
      "r603",
      "r628",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Recognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r564",
      "r604",
      "r629",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan asset expected to be returned to employer within one year or operating cycle, if longer, following current fiscal year.",
        "label": "Defined Benefit Plan, Plan Assets, Expected to be Returned to Employer, Amount",
        "terseLabel": "Plan assets expected to be returned next twelve months"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r612",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Interest crediting rate for cash balance plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofAssumptionsUsedPeriodicBenefitCostandActuarialPresentValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations, end of year",
        "periodStartLabel": "Projected benefit obligations, beginning of year",
        "terseLabel": "Benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r573",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payment"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change In Projected Benefit Obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change In Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r580",
      "r590",
      "r632",
      "r911",
      "r912",
      "r913",
      "r914"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "netLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Next five years"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofExpectedBenefitPaymentsandMinimumContributiononUnfundedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r598",
      "r914"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Contributions expected to be paid to plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r564",
      "r602",
      "r627",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r577",
      "r588",
      "r590",
      "r591",
      "r911",
      "r912",
      "r913"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Plan assets at fair value, end of year",
        "periodStartLabel": "Plan assets at fair value, beginning of year",
        "terseLabel": "Benefit plans, assets",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r563",
      "r586",
      "r913"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "negatedTotalLabel": "Unfunded benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]",
        "terseLabel": "Reconciliation Of Funded Status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduledofFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r564",
      "r569",
      "r601",
      "r626",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r599",
      "r624",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net period benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r582",
      "r1001"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign currency exchange rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r565",
      "r606",
      "r631"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r567",
      "r600",
      "r625",
      "r913",
      "r914"
     ],
     "calculation": {
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails",
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSScheduleofChangeinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total contributions made"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r83",
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]",
        "verboseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r44",
      "r230",
      "r261",
      "r315",
      "r886"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total derivatives designated as hedges \u2014 Assets",
        "verboseLabel": "Derivative fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r44",
      "r230",
      "r261",
      "r315",
      "r886"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total derivatives designated as hedges \u2014 Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair Value Asset (Liability)",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed Rate",
        "verboseLabel": "Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r229",
      "r231",
      "r235",
      "r237",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r248",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r226",
      "r229",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r226",
      "r229",
      "r235",
      "r237",
      "r241",
      "r242",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r234",
      "r1044"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1042",
      "r1043"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "netLabel": "Notional Amount",
        "terseLabel": "Aggregate Notional Amount",
        "verboseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r226",
      "r227",
      "r233",
      "r235",
      "r238",
      "r240",
      "r242",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r226",
      "r227",
      "r239",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r558",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r644",
      "r676",
      "r677",
      "r679",
      "r685",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r125",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Disposal group, payable recognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sale of business, disposition price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r126",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r332",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r370",
      "r372",
      "r378",
      "r379",
      "r380",
      "r384",
      "r755",
      "r756",
      "r836",
      "r842",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net income per common share (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r332",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r372",
      "r378",
      "r379",
      "r380",
      "r384",
      "r755",
      "r756",
      "r836",
      "r842",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net income per common share (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r770"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r692"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Increase (decrease) in income taxes resulting from:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r340",
      "r692",
      "r718"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1032",
      "r1040"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent": {
     "auth_ref": [
      "r1032"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Percent",
        "terseLabel": "Global intangible low-taxed income (\"GILTI\")"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1032",
      "r1040"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r1032",
      "r1040"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r1031",
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Effective income tax reconciliation, tax benefit, excess stock-based compensation deductions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r1031",
      "r1032"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits from stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1032",
      "r1040"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r1032",
      "r1040"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Research and development credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r675"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation costs related to unvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for cost recognition, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total estimated tax benefit related to stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r680"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit realized from stock options exercised"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r152",
      "r291",
      "r326",
      "r327",
      "r328",
      "r353",
      "r354",
      "r355",
      "r358",
      "r366",
      "r368",
      "r387",
      "r441",
      "r534",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r754",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r804",
      "r847",
      "r848",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.",
        "label": "Extended Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r512",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r758",
      "r808",
      "r809",
      "r810",
      "r898",
      "r899",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r512",
      "r590",
      "r595",
      "r758",
      "r809",
      "r898",
      "r899",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r512",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r758",
      "r810",
      "r898",
      "r899",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedLabel": "Change in fair value of contingent consideration liabilities",
        "verboseLabel": "Change in fair value of contingent consideration liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r512",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r808",
      "r809",
      "r810",
      "r898",
      "r899",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r228",
      "r233",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r1046"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Overnight Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r797"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "terseLabel": "Future minimum lease payments, finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r304",
      "r464"
     ],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Expected annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Expected annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Expected annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Expected annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Expected annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Expected annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r461",
      "r463",
      "r464",
      "r466",
      "r816",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r114",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r1049",
      "r1050"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign currency transaction gain (loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Currency Forward Contract"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofGainsandLossofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1002",
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures, and office equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) recognized in other income"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r736",
      "r949"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain from the sale of businesses",
        "terseLabel": "Gain from sale of businesses"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r303",
      "r449",
      "r833",
      "r895",
      "r924",
      "r973",
      "r980"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails": {
       "order": 1.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r451",
      "r895"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill And Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r453",
      "r895"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Sale of non-core traditional wound care business"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r226",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r949",
      "r984"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Non-cash impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r339",
      "r717"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r55",
      "r262",
      "r268",
      "r283",
      "r407",
      "r412",
      "r418",
      "r421",
      "r837",
      "r894"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r339",
      "r717"
     ],
     "calculation": {
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r467",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r340",
      "r693",
      "r699",
      "r705",
      "r713",
      "r719",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r1033"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Penalties and interest accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r341",
      "r367",
      "r368",
      "r405",
      "r691",
      "r714",
      "r721",
      "r843"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r325",
      "r687",
      "r688",
      "r699",
      "r700",
      "r704",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Tax expense related to sale of business"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effective income tax rate reconciliation, foreign income tax rate differential, increase (decrease), amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Excess tax benefits from stock compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "negatedTerseLabel": "Effective Income Tax rate reconciliation, prior year income taxes, amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r80",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r813",
      "r948"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Increase in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Increase in unrecognized tax benefits is reasonably possible"
       }
      }
     },
     "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r380",
      "r643"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r462",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r116",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r112",
      "r118"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCapitalizationPolicyPolicyTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for interest capitalization.",
        "label": "Interest Capitalization, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Interest"
       }
      }
     },
     "localname": "InterestCapitalizationPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestCostsCapitalizedAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.",
        "label": "Interest Costs Capitalized Adjustment",
        "terseLabel": "Interest expense capitalized into property, plant, and equipment"
       }
      }
     },
     "localname": "InterestCostsCapitalizedAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r259",
      "r270",
      "r329",
      "r401",
      "r781"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r66",
      "r519",
      "r900",
      "r901"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Cash interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included.",
        "label": "Interest Income [Member]",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r950"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r888",
      "r950"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Interest paid, capitalized into construction in progress"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Gain (loss) estimated to be reclassified to earnings during next twelve months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "netLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r940"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r313",
      "r883",
      "r924"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r299",
      "r312",
      "r386",
      "r446",
      "r447",
      "r448",
      "r814",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r942"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "verboseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r941"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "verboseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofInventoriesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r63",
      "r400"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Interest income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Period for extended lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES AND RELATED PARTY LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r34",
      "r338",
      "r437",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r734",
      "r737",
      "r738",
      "r761",
      "r893",
      "r991",
      "r1060",
      "r1061"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r267",
      "r280",
      "r924",
      "r953",
      "r971",
      "r1048"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r298",
      "r338",
      "r437",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r734",
      "r737",
      "r738",
      "r761",
      "r924",
      "r991",
      "r1060",
      "r1061"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r131",
      "r295",
      "r296"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESAssetsandLiabilitiesDivestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r266",
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Line of credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of credit facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r266",
      "r278",
      "r511",
      "r525",
      "r898",
      "r899"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Principal Repayment"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r143",
      "r345",
      "r516"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r143",
      "r345",
      "r516"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r143",
      "r345",
      "r516"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTScheduleofDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r39",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and production equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS AND DIVESTITURES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r79",
      "r81",
      "r84"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r56",
      "r84",
      "r269",
      "r282",
      "r296",
      "r320",
      "r323",
      "r328",
      "r338",
      "r357",
      "r361",
      "r362",
      "r363",
      "r364",
      "r367",
      "r368",
      "r377",
      "r407",
      "r412",
      "r418",
      "r421",
      "r437",
      "r485",
      "r486",
      "r488",
      "r489",
      "r490",
      "r492",
      "r494",
      "r496",
      "r497",
      "r756",
      "r761",
      "r894",
      "r991"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r93",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r363",
      "r369",
      "r384",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r681",
      "r682",
      "r683",
      "r709",
      "r710",
      "r711",
      "r712",
      "r727",
      "r728",
      "r729",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r779",
      "r780",
      "r784",
      "r785",
      "r786",
      "r787",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r817",
      "r818",
      "r819",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r968"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r52",
      "r54"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r407",
      "r412",
      "r418",
      "r421",
      "r894"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r1053"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Less: Current lease liabilities",
        "terseLabel": "Current portion of lease liability - operating leases",
        "verboseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Long-term lease liabilities",
        "terseLabel": "Lease liability - operating leases",
        "verboseLabel": "Non-current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r790",
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r788"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use asset - operating leases",
        "verboseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r796",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r795",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r151",
      "r244",
      "r245",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r150",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "verboseLabel": "Initial strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r228",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r305"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax [Abstract]",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r216",
      "r217",
      "r219"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r216",
      "r217",
      "r219"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive gain (loss), before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "totalLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r316",
      "r317",
      "r739",
      "r740",
      "r744"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "netLabel": "Gain (loss) recorded in AOCL, change in fair value",
        "terseLabel": "Unrealized derivative gain (loss) arising during period",
        "verboseLabel": "Amount\u00a0of Gain (Loss) Recognized\u00a0in AOCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r317",
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "verboseLabel": "Amount\u00a0of\u00a0Gain\u00a0(Loss) Reclassified from AOCI into Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r317",
      "r319",
      "r741"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Less: Reclassification adjustments for gain (loss) included in net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r216",
      "r217",
      "r219",
      "r321",
      "r324"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive gain (loss), net of tax",
        "verboseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r46",
      "r49",
      "r168"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Defined benefit pension plan - net gain (loss) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r50",
      "r326",
      "r330",
      "r691",
      "r720",
      "r722",
      "r771",
      "r774",
      "r776",
      "r834",
      "r840"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Income tax (expense) benefit related to items in other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r61",
      "r83",
      "r127"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r228",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "negatedTerseLabel": "Net proceeds (payments) on swaps designated as net investment hedges"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r334"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Cash taxes paid in net equity settlement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r70",
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r587",
      "r589",
      "r595",
      "r614",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r634",
      "r635",
      "r637",
      "r639",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r169",
      "r174",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNoParValue": {
     "auth_ref": [
      "r22",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, No Par Value",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r924"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock; no par value; 15,000 authorized shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r943"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from convertible notes issuance"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from borrowings of long-term indebtedness"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r73",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Cash received from option exercises and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from sale of stock purchase warrants",
        "verboseLabel": "Proceeds from warrant transactions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sales of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r73",
      "r187"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercised stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r128",
      "r301"
     ],
     "calculation": {
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r130",
      "r281",
      "r838",
      "r924"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r867",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment Balances and Corresponding Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r333",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Provision (recoveries) for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r52",
      "r54"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive income, net"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Uncertain Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r615",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r615",
      "r805",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Payments on debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r191"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research And Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r83",
      "r473",
      "r475",
      "r986"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges:"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r469",
      "r470",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r470",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance, end of the year",
        "periodStartLabel": "Balance, beginning of the year",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r470",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r158",
      "r279",
      "r851",
      "r856",
      "r924"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdoptionof202006Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r291",
      "r353",
      "r354",
      "r355",
      "r358",
      "r366",
      "r368",
      "r441",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r754",
      "r847",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r615",
      "r618",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r1002",
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r615",
      "r618",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r1002",
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r398",
      "r399",
      "r411",
      "r416",
      "r417",
      "r423",
      "r424",
      "r427",
      "r557",
      "r558",
      "r815"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Total revenue",
        "terseLabel": "Total revenue, net",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r562",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "verboseLabel": "Revenue Recognition and Shipping and Handling Fees"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r547",
      "r548",
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Performance obligations expected to be satisfied"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Performance obligations expected to be satisfied, expected timing"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.",
        "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]",
        "terseLabel": "Taxes Collected from Customers"
       }
      }
     },
     "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r794",
      "r923"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r427",
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r52",
      "r1051",
      "r1052"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r913",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Benefit Obligations and Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r203",
      "r204",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessAcquisitionNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionSIADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary Of Employee Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r39",
      "r153",
      "r155",
      "r156",
      "r157",
      "r257",
      "r258",
      "r260",
      "r272",
      "r898",
      "r900",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r229",
      "r235",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Fair Value in Balance Sheet for Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r226",
      "r227",
      "r233",
      "r235",
      "r238",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Major Classes of Assets and Liabilities Held For Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic And Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r185",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r114",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r895",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Components of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r29",
      "r30",
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Contractual Repayments of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Funded Status"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r93",
      "r94",
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of Impact on Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesCurrentPeriodDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r234",
      "r1044"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentBalancesandCorrespondingLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r469",
      "r470",
      "r471",
      "r472",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r59",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Geographic Revenue, by Area"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Net Sales and Profit, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Restricted Stock, Performance Stock, and Contract Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r640",
      "r642",
      "r645",
      "r646",
      "r647",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation, Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r178",
      "r180",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Summary Of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Summary Of Weighted-Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r921",
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Uncertain Tax Benefits Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r17",
      "r264",
      "r277"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of borrowings under senior credit facility",
        "verboseLabel": "Term loan component of senior credit facility, classified as current"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term borrowings under senior credit facility"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r395",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r472",
      "r477",
      "r895",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r407",
      "r410",
      "r415",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r426",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Net Sales"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Profit"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofEmployeeStockBasedCompensationExpenseDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service periods of performance stock, restricted stock and contract stock awards, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancellations (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancellations (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of year (in shares)",
        "periodStartLabel": "Unvested at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for purchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable at end of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value, options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited or Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested or expected to vest at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofVestedandUnvestedRestrictedStockPerformanceStockandContractStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r648",
      "r667",
      "r668",
      "r669",
      "r670",
      "r673",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of option from grant date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Contractual Term in Years, Outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, End of Period (in shares)",
        "periodStartLabel": "Balance, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r92",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r142",
      "r215",
      "r284",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r294",
      "r395",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r468",
      "r472",
      "r477",
      "r895",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r338",
      "r372",
      "r376",
      "r378",
      "r380",
      "r388",
      "r389",
      "r437",
      "r485",
      "r488",
      "r489",
      "r490",
      "r496",
      "r497",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r761",
      "r881",
      "r938",
      "r951",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESFairValueAcquisitionACellDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r42",
      "r152",
      "r291",
      "r326",
      "r327",
      "r328",
      "r353",
      "r354",
      "r355",
      "r358",
      "r366",
      "r368",
      "r387",
      "r441",
      "r534",
      "r681",
      "r682",
      "r683",
      "r711",
      "r712",
      "r754",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r804",
      "r847",
      "r848",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/AACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r387",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock through employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r158",
      "r181"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share-based awards, net of shares withheld for taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining amount under share repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Accelerated shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r22",
      "r23",
      "r152",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Accelerated shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r26",
      "r27",
      "r110",
      "r924",
      "r953",
      "r971",
      "r1048"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r777",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r777",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r777",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r431",
      "r432",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Codman trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock outstanding (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r43",
      "r160",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r41",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r41",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Balance, End of Period, Treasury Stock (in shares)",
        "negatedPeriodStartLabel": "Balance, Beginning of Period, Treasury Stock (in shares)",
        "terseLabel": "Treasury stock, at cost; shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r23",
      "r152",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Accelerated share repurchases, shares received at inception"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "TREASURY STOCK"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCK"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r160",
      "r163"
     ],
     "calculation": {
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 6,823 and 4,899 shares at December\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r469",
      "r470",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r686",
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance, end of year",
        "periodStartLabel": "Balance, beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r694"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r696"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior years' tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESScheduleofUncertainTaxBenefitsReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r698"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r390",
      "r391",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation Allowance [Line Items]",
        "terseLabel": "Valuation Allowance [Line Items]"
       }
      }
     },
     "localname": "ValuationAllowanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceTable": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.",
        "label": "Valuation Allowance [Table]",
        "terseLabel": "Valuation Allowance [Table]"
       }
      }
     },
     "localname": "ValuationAllowanceTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r346",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Period",
        "periodStartLabel": "Balance at Beginning of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTaxValuationAllowanceDetails",
      "http://integralife.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRollforwardofValuationforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofInterestRateSwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Leased vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r371",
      "r380"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding (See Note 13):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r370",
      "r380"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Previously capitalized financing costs, written-off"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/subtopic&trid=2208821",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(t)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "32",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919569&loc=SL82860478-203043",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r928": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r929": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r931": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r932": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r933": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r934": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r935": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r936": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r937": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>132
<FILENAME>0000917520-23-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-23-000015-xbrl.zip
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MVP/39DO3:X1,%R=A1!LQ=PX$MPC>>+3%8@)4SF\-9#=9FEXC/JR\0-(JEMZ
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MF*N<_O)0CG-%J!6J=4(QC8A)U$,A%A-)7$0/%.1V)?!9.TKBJI,-V(9W(KN
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M^)5JD#_/9^4D+_?G3WG^>IP_GG2SQR?S-NWF!<^O8;[-YD?XJ&;CVV1Q:ST
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M#F:/6KO\^>+^OT_D(L_^?D(>FDS./K,NW@QD[9#OPQ@2.A V1PL*A-E40BD
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M22GO;(!,*1K)F8S7N5!)%2[6@R@%?0)W$,R.$_^R8 J781T#@(9M;EOX061
M7]'5J U@+-JQ*K;[B4SW!P#W>/EH^EKXT3YX^TSFC_/_7I3+WG<)Y)/Y?^P2
M>/_7)Q<?OWJ7P**C0:YMTS)@2<24,\%GI[/RRN<>S/8=S&\POYN=Y*6\KBK'
MI#5!4HQ4L9JB)2!#7^HM:# R$+H#A%[C\(LRV6'QD;,##YZL*T!5@:*H2?=@
M#M9 Z"T@]#J'X*E4KNPDI@&;??+&4TBIJN"U-VKPT+TG=,<'%?LG C&[B*%(
M!&,R5">I. *0K\63F R5000&F]D.FUGCXF]P.?BB;)7 J:#$3/(_%VOK:!O
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M2\;V#1U_K?$EEUIJA2@I0=OL7J%BY0U%&Z$'*^ &&QML[,:S$C!.Z^AKUC5
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M(F:=*:=<@NW3,NK-H++Y.5L16FNR[ (5!5X"G&)15<$R$!"X/O7N[ "$FQG
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MUTW+ [_&"WW"=<=T#(O8(*FCS?=IZG P)N/GB_UL.LM2^/7:7MP^I>6T%$F
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M<UCH\L".+!.\?-=SP9IQ3-,DGF?HA)K>\\#?TRG!]3"A:X/)XA%?)Q%8,"3
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M>(?(W5ZJWR!1JB:%R76_X\-CSE[1!W.CVRFX0]/QMUK#GO[2YZ-$AJO,Q%^
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M26N%J@WOMZ(*++5P*[ !1OYU5U%&PY#84- +)!)*JS#TN[W1GGI%>',.=B2
M88F.P67NJ0M$M.$"'HOO!&I/>-E3O.V\AW$VMOH, -NCUZ_/,**!YFI2-):J
MD%+RA$MD4I$2HF]U\"ZN I+X-2 (XSK6^_N K!JYXC=$[Z;Y:4*^D+0V!BZN
M12M%, J^($@<2;UVOI1M@%A<]IK1],ER\27\ T[<#A/"F+ ?@& H@*($.T=2
MJ&A'6*=H'7&N#;,YU^S5V%F?(NI?#]L>H)D)5HJ<V[D^H.U6RAWA)EAZ'XX(
M8I6)L,C*&MT7IZBUCMX#2\C:7JG!@-7[:0JFMG8FHIEH+M9E=R]EP(_)C39P
M#>-S$H/Y==?$H[-L?SUU$O7N^!86&=[X5$F@(QS6RLJ6UCZM/>&3EE6\MR8Z
M$ >N(J9Q*NA2"H26)+DES2"U+M&FX+3$O4K8" 3/XAG'YPC$UVZ1NDV$T3"@
MF,K 6'5['L$W,?&)X" TSXJBOH]26LUMM,I]P@P>D#(HA:6XNXQ-54K[VRSG
MP__N!6KS;J!>)YX1&05P3!P!2%+4KR""4N':2=0CZ/> 9FM>132G\/ 5*!*>
M&%)-5$J[H)B7+)9BY)R(":*UG<DQG([V!WQ6E#,A(!)2 OK0< (C%A,GE74@
MK0J1.Y"^)9PSGH9@2,C!!/@6_"J6A%J9EC=.?2-7EN7G!$Z#-ZO?57J3TH@0
M+F>292)BI!Q6:9<WL:MY=DDP+8*!!5Y;QGAW]1<II%IF\+:(N&_23;\0"1D!
MK2E9 '00).#?%W/EJC.AT=H!/4 2BXLZE%B[ -(ZA!L5G,L\/?!M7J:71":!
MHU)DT< \A&^ADR 0"C 5XD1$$Q$G(EJI4L6L%":D<*<P?-D,\9=&#9+5;I-:
M0WHE(B&5B&-*)^,<3)EY!C8.3R_B/$LE*WRO:J\J(/LE"O?LVPOWUEN#MSV<
M!$*J7Y[#$93S><FO^9R85*Z<W31+P9' F'Q.:M.I51WP8F?\87_GY5+YP1LD
M$'18WK[=APO>"#('CT7PUM]-?\^O8IN5B]I.YO[=])H+1,20%!-P^,I"^[NQ
MIR]](CC[7%0,X!V84O[JKB@F0N0KRF.,#I8S58*BHG%"DL,357E.E>)4_M^,
MYV+V-*H,>":(EBSE4L;_"3X*NB+HJWT'?@/P4OA43,#)YQ,L28EIL02MT13E
MR3_(=/8;8'@V 22_&QUH;Y58 F?^Q@7H_)&F'FLA(@,W;S-+Z&Y5U-*DUM'O
MMH+?_F[:NOKQ&JR50=0D2]J!TRKV@VEA\;(S=)*Q@F#!,=PLLI\$PW0(\.4X
MRU(<]WH40!#94H;F6E:_7;&PG))?D?MK0M&KZKGP[],,P^QP%AP$+&OE)%E4
M$><F3%MI[9:JA<-$8(N'(LRMS8'3.>K_MO_W38]K[5[/=@2=?]#IP;WR/)>[
M2T$!IQSC9)6=M2XO5YQL3[5HMYT;$6X5Q3Y4'E:5)$I.4''9I9@L&A9HC? F
M<M(0^KGXI,5A(F@I"Z\N99559; N%U\!=0!%%JK@,,YEH=:>-F[L9!'#;(!;
M.4;P$BMJ?H1$+.<Q)M7A=40E3PP'J\X,\F*:,<#-==D@2X&H,*0J;ZJJ0<*+
M)SR9:6(O]BV%9=="K2UKO&UDRYRR2-T(C2"8O<E2A.#2L:+M[]WT&46,,@-9
M@"5-HO1I+*)_Z3E8'BWP5@DJ83'-<OAJ3Z2P\20YH=5"ITK$33*P*-$DQ&R2
M$(\H#%0R<0'O.<=LLL2:<D!G90[4(Y GQ=1799 JR_-=&LOA:60NE=<<A\E*
M89 L!%B$R*X0P:[C&N/!6'91M+VV1$1IT0\&V92+&LEV;)D(3^J+I/.:_]J.
M5T/[[5-+P4RN&K>G=9#:X)^+I.<!0+@R_9O7$!'9Y7?!8J=62=TJN+1/)K-7
MJNIRE?*X$?ZOTQTR(R'"LRV?<"P2EFTX*-Z/V[B0*03U3LMB0:NL=-16HAQ0
M>I]PQGJ!<RNG*)34G5V^+1/P5?)X4">/-T"J+Q6NA**<\ NFC%&88_EV#X!+
M$U(4=5%?S25+50,@YT&"  '66>^\/1!,E;$ _ELR[L.R6)-D)HA\22(7BP)L
MAKKTDZJ"EZRNO!4IN56I>1"BM9N )3%"&+#:9FXE!(&(,?O0R\0<:RT2-HPT
MMNH[%W)JD# C+V2.MW6(^C)5+[';SK"W/7-)Y#)?3\E,_(UB61C'9^/)J\((
M(1!4F <8+#Y'6H-G5LNK !@@9J< HD;0X=_!_YZ737DTOF<LT%+'')N\3WUL
M69)!Q,#+.DJ 9Q7VZY)MNZHN5XKT9+&G;8EY=J>>)&TT>',\&(YO;T[:(,]8
MY9[+'#@1M5RKJ+J=-FU9!54!?PN/2L4TU0KH'BE]?=\ZZUOJJP6-5^7^4>TU
MQ,W:)-1A:L&)E"BW/U^RDV+L<XZ,,0-'>NENLA5C1Z[LWFO-:OUG(;:JE$6M
MD_H@$1;@UB.]-PX-^#DJ0"J'NQ9E(OW^DYGRW@O9V"3\*,/=H$2:K%Y3A=-X
MQ#<-C%J+JM8:7G\BM_+^ FH-ML1J^70KKVV5[+V]$?%V65(S?COL!J9*GA'V
MS1",=(V:S@CYB$<A=U=TJ7[O35?$O!$7/4M\^_I<!' )Y+0!6>VR3C;=%94W
M;W@'O'L#;\0;5NV@]R/0VW\WZG>0NP_DCLDBBGG".NC= WJOT>DK.JZ])^V)
MK5!HG#].(/L)X+=6P_@T*8M=F1?$P$O= JIJ#JN-$VCT8"G1#!PDAM1:<#BI
M+*Z5?I8RA-#)*Z=BA=<\)R6:_E3]/4X_EYB7FBP8AEIF$X+)2]DEB@4:2],#
M:.4/J>YOE602/F3<RA0JIQ*3F7#,*MD&%W">:E')$RQ97;3=MN4(8;N"!ES"
M6"05JDBQ"MZV++M)C,V'?Q*XQ:Y*$\)=U$\#./^,5\G;2Q$PQ=;E=M^6.F\*
M!P7[N(<!2C$;8ULBD]]+H3=1L2EA7,:15$:WX*)GM@IKU<%O]+]1]VK[B8P1
M*8>^'\HHGS8243I)!_"J7,2@$\!!GA4TFV']?3S3+@$_=42K"F=C[7,KDK;T
M)9$^6&H"7LJ,$ W3!PGO80(=B C;D?$Y==[<,?077UYJ%-P T4.ZI[42;?(D
MF+F21-"<*8KS8HZAO!S34L!8 #'K1L2RG*%O>A,V]6B*4%3[5[,E5#H+6#0G
M189966P!G<5<11I;>1,Q6:(UZ8 "3$+5=OL-*MP8(CO.<HYI]KK(K2E_A[?,
MZN1]&D]%_5.<7I"BW?;X8N?XJ.K-%W4)%226Y5TL<E$\YR$2[82#4,LGY%PT
M[Q_M_R$:":H)(Z(ZO2ZI4[C'"G60"#G95L6T3KVDT"B<<^37QTEH/',@HA #
M^3;+8S['>IB:TJO9/)*"6\+A(B[*Y?QY6SQHC!>R\TPDK2-58=CTBBBLX2@8
M.#/>4?U%6@ )+Z1&OR;L;JU)+57Z'<1H0:;\VE0:=6\0O\FB7>TRQUQX6G6)
M *]>ZZ1<'F\C&E%DJPS :AH7<NH$)G!0T%8#AT33,Y$#(*BLR%ZJMUE."=6*
M"+_:28%[5[\/+@@ML?A34NI^1D0Q***6<9$R:VGZW88^9<:QF@D"M/89\-%0
M/*I5B16MD3#"1B$1]AVKV@]9'B*/  249%FMQ25!4R(> ;JXU@^8I@;U^H7O
M*?)\!G;=6:;JR'$4BF"4.AHJ2W/(G  OB5$Q%1M..&$)F<Y4?NB66K2ER4^B
M*+7J1%,I46!=J62SLA %*.UG-#>KTTYM=Z2>_W++Q"?1K@R/5N6/Z$&(H1AP
MBCCA54)8SBJ+A4U05Z*H[N5RSJ4P:*PI4=,"(JY?%Y=A(48SS@B) ^XH+--Z
M>!$2IBC^V97EUU4M3UW",P$$Y.KG*DDJ$\IW+V/?9 JK4M)UB<FJ5D'ADPE3
MJS:\&E-+5.7"8:39!M([%FEJ0& IZG&/]D_!YIN";0S21%"'\"IV,7C W\;I
METX^WT,^M_TL9 GI JLY W4#*/KO*L^+R=]RONP+34@2*4?(E,6B[<K,)GO:
MI&RK;.Q4++Q4)2#;BTAMK2&@=N[:Z.]I9W'Q13LD8A'[3FO(X$2ENS8K\8RG
M+>J=@"J<<-;TC R:GI&N9:0-.&<[6D8V66NAF'N*R@^MA\TC(GC6TPX/^FK1
M+W#G]VL2GH5Y(&9=2 W2*GU5A;]-C6GM0#8UU3CL JP$<-&J09+57(7V/,GV
M?!M18ZZV,JL1%NT9DZ*J55IHJ^N204PFH(VJJN1=#%V7LULKDG=;@V]WZQB5
M,B-E_Z*\H; SZ_&'6U(*]X/%)RM*N;;C/;];=K)J"&@U;+)=;Q)AI!+<C?^6
MM\^TE:-A>J*Q-5FTAQF'0!UBD(2<:;Q;_0$H9AH#>=TR-&(7_ LLBB'3-,[F
M(IXN)QNKZ8PK)I]P;(@2 TUD?<S26:L@=94*J1FTSB$ME\[4^155:;A]%MP&
MF.('., R0=4@)G[L:GW$YN"*\BZS?*_8J8@,'?.T*VNX7U%(3/-,4./5(P'0
M]GX*@K:_V2"4Y;Z\*XB[/PW.\AB,@KB)Z*K1:'5<38WMVKT^L^OZO&B.5GAK
ME(D82HV=A56V4,8"Y=S[IEX A^.CA3?)14ZV^K@)4;*8A$*A1EDVU\J$\ESM
MLJ\CBJJ_2HY^;FX]X7(BLIR1OWO;K.BJFP/,!S'+!FL$\<&W]+@_P%PUS-5P
M+KK<ZFEBX:(*$X%CDLG9R@=Y>:[U&29JJZ(+N!5X-SLOJ\E[I\?]]N8!D6@2
M4_)%YWUM$.W6\]IVVW/+<"+9EIC)=QJ>39:F,J]H$T149H) (^7LH'4(Z,T6
M]1?JR?*"D8NE^'L3+V][/+O50]"^%.V#U<  H"X1/Y]E,0[D0"=-CD"X-AQN
MY9/KT'O-7BQ3_>RJ'D-.%IF&^/T+,&>KBJ+=U4]!FEK);RTIH,*.<5IM5&B-
M;)!NF(9CQ.$<39>4@GVSQ.26D>WJ-<4TS_;0H^\.!E1.'K)S^^U%3)/%&/L6
M4Y/PT4W[),8/EEL\VTBK7>/60<)8%E>)R4YS+&II)<Z:NP 1A7%:CX-53K.L
M(5E:Q=!T9Z?7>C:KGE=1\X-]>2I:N[1KY%G$)<9+M6B5/U=UVTJ?!Z@/)"?O
M)2#IJ[!#J[$ Z*U*7RSY4&*716O=R%)WTTF[HUL4P<@2NAO]<PLU5##F=>0B
M261%%*OQM,0?Q0Q>IC4\8OD<ST2>$F H&L\PJ]LN (QO3(3#3^NH$C) M0-'
MC.YLUS"(WG7D/E[-L% EBTJ7*>*XI4R@,_-^PDZV#N!6:/*\*5&J29_CVM!6
M-<14V ?-/J(;1E,S%TM-6A9;>.KX2C-I EZS&D3&VG.IQ ,J ZR9NR?0+HQ&
ML41DN?I/#LN)XD098:O,'E*7W+3(4'Q2NZF5=BME!0N@<]Z;@O(!D9U-%[<-
MC\5;U 6K$U4&D85"8&.HN;;A9.[5WBX)<$N/V\GQZ6!\-#XZ&6[5V]P>'*^&
MJV.$&C$J!G" 6CCF;"YL(6FK[VJC>;[X I2WM.+N-9)(JAW$%,SV0ME2U;8]
M\8OV>D][#=97BG=$.:!L_YNS1,1X:FF\3,4P6ZS";(TY^2IVKE4Z20QIP.A\
M?EU1L4Q+P26J=^8MC;IOE00 I=_>TC>_WA.<8W6/N@?C,S6VZ-J4:ZFC2:TA
MK\?L=]6<BGH(Y_)0@=:D8PJ67-T6>VV$;Y/=P;5@N >/J D8K4GY]9"+V]EN
M$^A0C*QMTV$EG,;CQA"Z;137"8(V0UF)N;%Z;YZDUV,0;>Q*>X,YE(J&^TA0
M\!WM].W^78BW?Y6)8+B@V ^KB+15;]"0X>4D$[F@6!0YBI^4S8!F4A;-&]=\
MR0_  L'VLJ?BV\[Y+>[$-=Y:;JV7 [;E6Y!S@E5-M>TWPPDZ,:WX2$0IA%U?
MI1GQM;$&0Q97DOJ+JJ .E4U:O:\8(JV>V\0>;GE4/=P(7)#SG#0 PO,!AU7\
MQ62DNJT?6_5;N)E(.$V+Y5D"2X!K'*$#/N.J."VMBCAK+V-))DGG54TVJF[P
M3RT"^,C98]6@D64Y(%.$<F9FRRDNLME$#MEL;\YH9VE$#8P<OL%IO?:BNK>J
MP'T.ZO1L,!KTS_;_T/K# ^U@\'[P]N041UMHH_%9?SQX\_$YN'HGPD%3B\KD
MOLMF)')K;DNMIK"$&<\KZP>G6-)8<;H,/]X8,I855612E677"J;9I=I>4BAC
M%& H+I3:R&MB3^GBYM;6AC;%2!QQ]];X5VFYMI9@5H&6]O+/W3J@4<\9_$YD
MHPHMB,X=T8AQ)G3 P1($JX$S]51J.>Y-)1(%VZC&E2G'R,,*];Y<<2D'F\F1
M5&TQTM0(M&8B5QM=Q9P<0JN0C,B[XYME4VP<4U7I6\*R/UI'U2:550GXM4R2
MVJQ:L[66Z553>"Y)T:J=K'9&B"7%HC$--#KZ;30A\52YNRT]BR$]J7Y;0S]%
M$??U?9RWR(X]-+BP[/U6X5*S6QWQA;M'(#1Z:N;3KJA<Z*F!W,T NZJ31'9V
M)7(%9%V^@U>U-.VMLC@LV3F?JR!,(>3;9RZDY<GU&%OKT"MDD91[7(XU$K._
ML$];S#B,LRHHH&9?D699*GPH-AS'1,1&JTQ/BE:&"(Y6GU76U P<@BANK:(6
MY42X]TQ690B#+&Y0!O"99"E?M$/W*XLT9EFRF-;EL?@659YD^\),:V4]D:[:
MVMD::P7=M9B_G/JHZIN:S078M5,L-Z OK^.^Q<:0GRV9)^W=T#?]C';N5=4T
M)VJA3I4T:CH[*N]-IEAO."$K!$I78-Q"O=L5&/_TV+*65JT:O^MXBAS0>X[F
M:E<W]]-U<V=M*VF,67,T/E[L'!V<C7=>7O,A1'A'-+&!D[,TY% $0NIL*E93
MY)RIA)U2[]<"@76#[6)7)5]! M8:&V,,F1QEWUZHVT@Q005U%U251]*L@]VJ
M6%B,<Q<W5+UG-2DMKUH#H5O79[927<\B42N3;KJT+ &. "],IZM-LZVMBYCO
MJ1P^1N:D-9._XZY[<-?K."$+<"@^B$B"3,V);8$?CH&KXK0.E>)J!+F]3NZ%
MN!94K8-W.#0TYSC 8L:5(: <>3D#!D.U9;5%%>Y_VJJ_.%NV($95!$-E%&+1
M5? 9."H5[96R>1LL:!SNK8TR&O.YX,3JGB-5NK*GB34\JHY%+"H2:3509"+7
MKJ;OXMD$@54!P631#@2+C0NUT8$0$J/=B[H;6<S@KB;Y+D2H2+ZCRB7@-N(L
MFQ98;@52IQ0KB,4\=O&"]45SP' =GI0CY)?Z6JNMRE6N^OHR#YR$HJ C7#-P
M0U?5L0&:#P[?86$8%GEG4Y7ZP1Q[(E*=T@VJ:KWR^%&+19\WF]5*3%#3B)(H
MRI+;)CD!5E3MOEP/)ZU$P4?83:#0,Q5%=A-X&=-TFDW;0I%4MC+<Z9^MI2<T
MPTU@^ C#A /S+TV-I*0L6_Y5C@#N85?,A!3*+T ?MFI]DA,?\#SU-"7A*+?X
M&I_W9\.J4K[L$UQ7S?A4L+GL"$2%7!.77)AS8Y;#BYW1":[K49T8RB,0N[;A
M;F$.6E3N)(O32!92:AP79*5*':N4>Q7+55.MHBC)9)L#GGYY3X" ;A)_01E0
M[UAIF*PJN4FRHE1179)7=@&<52-))M(;8O:Y2,@ HM)2[,_%"$G*ETH(%),I
M*V9/:V]HKZ<Z?W<A[%TVP=:6BTC"3GD3K][3EFI?*N,(U]&V:D=%;JL^";GU
M+**Z4WN]:!;)HF9@ GM-S+>)G(MG5C- *@--RL4F_E1OP"!UATJ]96!I9UF=
M1Y0247JPE7!KIP-DU82I:CC^8XAI3RV#;7\Q5V9'JUX>O]7JI":XM3Z;M[XE
M%B-C+S2<ZU3H)_@9[G-*YG"!F*B"JK6>IU(/KI?3XF.9,"-5;9HF:]-4XYN2
M&J0&XD_DGI]B[^X/!G$'-]((2TU9"/"CY2$5F[906(;&ZSBL"$_>>*DEAZ4U
M]J*V)MK;)F76*4Z;H$JK$%7N,P>C3$.K691RJE!M9?+<6"/3[%NH>+9*+UTN
M5=')D,K57&OY7FJSY-)XN%MV7@DN%(Q<S98CM-J*6F63ZOK7)([@D N:+*E#
M"9VZN!T/"0Y97#$ER!,0 "*NVEZTM;1Z\ON;4L4JSN8D,E%7NQRM\)4PB,7(
M,33(4+5%21GCMK/]T2&.KZ@/OBL#9#V:QW,UQ@VWR]3C+7:U%1/0EL@@71H%
M5V7K6A/D5BUC6(JOB66/X+!6>SWKF4EW&I@D-44%-K4%O=X$<WPD-PB)Z4T(
MWP1I'Y%?KQL2VF*:J4C>%%/M;)&2J2B14W7>#*02SF9Z1!=V[9) ;0B^UIW2
MID-1D?(MFELM0I;" RUR7V\6[->;,%G)T&<U8'+36*@-&]$Z(2-FBJ+:DZ;4
M> !A+.858%;.I*JK%U1%>&4[=M+H :41+AXM4W[+[+TA+^?ERAJ&QX/4FH(-
M:T>]-GA_4(_5$EM-A21"@2K<=!S*F*N:0B;FY[W &7FF_AM\448#Q8!E*8<E
MYEKW1%G76CS$ZNM15(UPL_2$Q-H?)/M<5E7*C6F_ -FYMZN]G;,]-;(% ,>O
M:%(*RVAI$AO)13)?MFN,)?6*48-%/5'P9E!EE=FF:BO4G(9K60.IEKXY_;TC
MT0<G48JC1N?5JCEI=$KME=\8&M<:%M=X',]9=G^W1Z46K<)L4//6P$8_U8XE
MK)0E==M<N'47<=QS)MUFDO(Z@7E2+TLW_%VE>D50JJZ[QV2^B*>"R4B:R"!>
M)-J*ZK'_>3.KC93S29;+P%FF>E15M&MI,2G&86/5$DLP8B#BGV#-7F1)*<5K
MM0>V'NT_%9%#;+P$YW5[1P5N0*YA]81-)2Q!0HH)CBNG">X^RVF"ZYT\5PV>
MJP;$/=8 NM;8N3M,G5-;27/!X<T(SPV/)'^SO:D=>6CID:RR(F1Z%F>1 ]'A
MONL5Q3O%4N)#Y :, &U,.1UXQ02.?OX% /TZS@J1]6T-W1"?@-5\*<:E<I$F
MN%'8L9#S;<$P/4RR=4D[ -^SLB0%.7S#K4'DO]@1/LUN8W *]3< GKWJ$/&@
MB&@3.\%6.[BE".V+0!LZ=ZVI\*(N@JLAYG,Q6"-147^%IRQLDIFL5-W\>38-
M2Y'#F*I^;K%+LF8MX:;N5[>8B.+35A(:9^MA($E6B ?!_\%5"$5S7T)I.:T&
MV\,;9V+,#>A5\'4Y6CO:13S/L]TF$2QJSE5>M$J+X!FJUZC&L>1?Y' "45<F
MM%E8>9QB"L(4LXYAO#PSHK;4)+F*"WL9K9SE]O($T2@N[&DIPO )*-16R[%*
M;HJ(6!VY1?"+,A4,B(*>S@#%,L5\<U44OJ.JZ-_3[K&M9E6!Z/:I(2-0/1)%
MUJB3,QZ*HH$Q-IK.> F<7+3[O$$FK;H$A11I^DC$D)!6KS8F!664&G.-R[VB
MN]J7-+M,,1=T8YM"*Z4OLNPI%CJ4H9"26+\E+,(JLE-SJ.!$95HNY8E(V@XQ
M [^(1:UR! T*V2F\D,I4RCS1'28NJ/XPH3I%@I.S54M\FA4>[641K4%3*S)M
M2XFN5LJLY;=4Z\868A(2_.7XZ.SLY$RR:X+AS[H \5L;3KZQ(J4V!ZHRH*6)
M92*S=H^=)6L-2CU/#=:U#;1<&V]3VP8V7S<\QVTY=U+;FUB(?FNO_,F[L_W!
M:*O>Y=9PL9J1B26^EZW61IRT*4UK%4*I9J1Q60R#\U;$5,X+$B>BNB8"2[AI
M/RC@.V*US:'H7\6,LX@Z_!>7D\U1HX(R1*=[M[J%:J! \^'&S(7=>@*=F)"8
MUO4ORX?&@S4'$@:+.!7!(D+L-Q/MH'E5[B-'7PC[IC6_I2BK8F]1!)56S1NM
M)Q>9M+):8R@DJX&)@"-O@!67:T597.3E3*36X8Y:C,/C6N,YZEOCVU>O@^?"
MF[4@+"H0L1 P$S4Y6 6^):WLWZ3"?85;U1>\:A%46,X%,"HC3Q'E#\\AV6U/
MY&O^V#0&BI62LEOPVJ"27>'[J)TU$D/P>%'E(8A,#6J7';ZB6&-.ON ,.9S>
M(B< 9E5#3U.*)NA([)\"22R>'N5<^)C8:%1=@-T+LE10K>X5=E]#0;NJ>%NU
M)[5SG,M/$C4W=0(626SI'62BG\^T* &O,:\@(>J_YG,Q]5TXO5A2;F/ >#X!
MKD[4MY$</H%;"F\A'9(R1>-8/!@=ZA1+,> G:3ICQ!'-=2(KKQ7X"F"$\UC8
MO!@L0[\QFX%'C$L_7X\&.R^U%\U J=IWF1+,#%U6T %_J'X=D<#"4";^(>)8
M%K@T4E_& 3Z(UOD_Y+R(DZ61K$! !79W%\TH3VV^F,D9D HLJA-?]NI+PT[+
M,6P.E\"I95T=/*R0 WQO0E@@OGVXX@N67N:UOL?FFF+>$S?%IOISE$KXO.NW
MWZVVHN8\DN-$4LS"J(B#&A&:\G/@^QB%2G5,1=Q56ZV@OHKX2I3Z\*#M$C:K
MU??1<#QX^W:P/W[7?ZN=GIV<#L[&WQ]O@Z]A"_=D8Z3F!RZF-&-?1U4&"W3
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M?GTWZF\K>-?,VCAXN0/=?4!W$ -9SKMTRKWA)W>T=,"[+_#6N8?M&4!OC0L
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M5T$#A#K,/L\+[!X],? D%@8%31SI-%D;0&SFJIEE']8/5/ED#;1K?'7;1"N
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M[;,]TP=*:MRVUT(&((;_"FC?N936F+29PS@#0&G-E)V$"7[G2: $$XZ\'QY
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MI!QFS]IFF,G%.&GVE:SQ&5J4-(>US+9KO,?C/S&_N72.:R,>EWNWHYZVZ4%
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M>V_"W#:6K0G^%83'^<J.@%@BM6?.ZPBE++M495M^HEPYU1,3'2 )4BB#  L
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MF+ :@LLK%GR6=:YJ+%5JZFP,3+&V*?/@VS$SJZ*E,F; OBUS%1/.NH)<4@&
MM!JKBTA%KHH&IJDFA[6[3M=-7<XEUV>B+G-B9):QN\[ES3E[YTF<;M TXP(&
M<^4^=![4Q%.>$R$Y#&9-3L0#*AR]]+^+&5*K< 1)]O*%_52 Y:EZ>TW6YU:-
M<4GQ2>7!Y/!4Z53Z^S,.3.\A-AE,KF8EEY33.KTR3KRM!AY2'"/C+"G,&2]
M!%D5 ](0W2(^1U11@ ,N$KSHBO*UMK5E[)%[KUE4WDAQ6\-^)E7V<,UU\:#?
M,@ ^363WUJ8E%2.ND<+7'=-HJ_#H(14J47@SDVBH14V%Z/IA4KZET!;9"&7S
MFM>1^# :R2AMMC-X;AVX-HVE%A0,@I2P4G&VN/8>J21UO ?R).V%6VM$)D0)
MC%#;/EK0@9EQ8^X:8U,A@%M';CP.@? 5K5<RZ $!LM7JU?->:M!8&!@3/1HE
MZ:"-\/C/G9,O'KC[&V<_$\HGF\L4JQ[C:" .&"64"BU\-S<B!>\7-2.L+^?=
M-WNY"QU9MTW'.<.W,HX\M;8-CMQ0V#:;N[9AL=CT6+!2#$>HQ2=LXXB>DK3%
MM&)4%,'K#3 >V+^*[5$LIYA'\RKTD0B$=#A[PNJ@4G6'7J/NAUH!WK WF+6[
MH<Y#A[V4P'^T+7\)^""/_!@'//$I$_LSPFG49L5%CV"N4+!MDW*0*+(PWGP.
MW;+#6>NT-WJ=D?2V6U\FAUS#6S7+ G1ROTAZ'E_#'$_#5M (J ^_9RK"MU&?
MD".VM/'1CN_$&]]['9^#N=9Z$2B8@N%[P2131G P]:9 J_EKTVP%?\MO,/87
M6N,_RX/1%'LYJM@B+U!C>T15.4T%GO6.+Z[K;H%K./]9\?88Z=UN%.ER02EH
MT-X6_;9>JEK$M@ D<IFUN24?KT="&,+Y3Q,M%B)L4QV2J[ST)$G6D7L\263)
M9^BAO!2C6@L\"#=Y'2@>"?G.#&C-Q@GNYE9455'_"YKT5PF<_#.8,VP;1U_)
MNH?A9^ "#YBS:\:;1B/FOG27*UA&24AE.0/^,SZTU-^3-^9Y/)2:C8(*QVX=
MIC11U+,UT;GWO+18"P]R6F)$4I'L_I=XYB!=D)-75=BT*0?$*21#HP#D5(O\
M8CA9^8S8+[SR8T5Y1ZV[)FNYQ/VEG89%W"] $@W)CKM,W!*L4.MF56OKH[EO
M)R,NH)MH!9LB=OL&EUI"JS"I!,9Q<ZD-FD^J@B0)@X&_'PP@,NT;<@QW9*#R
MKN((-,0,WHWPH10]D((/, YA5%?)1+^&DN,T[=J:3[HL]1U,74I/*[5&P)GY
M;<M)GD9>,?%V3?BD1], :X0-X>P2&T"HY\X=W(FV5TH]%@>%^ .EUKR8EGY%
MJBEC@WC2$(60R2++Q,Q.2>!E"IV/K2QRAB/&I/$7F!J</ 8BT+L"TSRV;=5)
M.K#1>JV-R=DX^4(WC)MN,IR*G/I6ECE6R6!Q6:(VVW6:9WR9QE\C>$R/PP33
M(B-O3MZ+RXIRP;1M#JFY<9=/SO]Y]F:K?11@J4<\3OHMN+Q[V#EUA<'/D0+!
MU3:C88E$?DW=EII^NE4_B=%K#:M)YBX"2JU?G'7_T0TN3M\?7YZ^"2[/@\OC
M_R<X_O@F>'/Z^^5ZS._^_IKI'G3JL*KHJPEBKD]&]M:RB7G/-,G(W(&Y6CQ2
MXQ:0"Z$=39XK86KV&$$?K5/P6 2 7_-HN(!>7;1$HG/$QHK(ST+2D/HUHZ8J
M<V!G,PZ'N7PO_2CM.Y#*L;0Y&HPC?/$@QNB>AN"3TC+C^G5N_YX.1IS#+-5-
M'W"C(W_?T9_BW!D.;-)([@+>D5G"86'_\)@@]IF 4]L7!28U8889=^@8XJ>%
M'*A%[D?9U2RU$7N;WW%J1#?E0V[YT/ZF?.A;UY#=MFGAY,>=P^ RQ9/,]L'H
MD;Z$V T&8B(*19L<M+HP+UE3:IL9*=/-839-^A/=..-2XT^<U55:*CB9<XIB
M#(;LFBC[Y2\ZVK(3ASD;+S<)<(-M*8AW?B%R[0)<B#5#]ASY^+._&#.+23[6
MJ+/T&RY.#TN(KU)3BHJ> ']V"WE>!A2;,WA52URUS?0(/P5'Y=8EN:1YBO-H
M+U04"RU$&' %7K]9[)Q?SV.X^MB\-:@T7+FYOAE#VW*2;]D,%:[M&Y<7,]*,
M$_/#XU>GXQ#/O1,/,Q_"\5I>H$J1#QVB'@W7XHVNWT*S83P=T[>9 VT8M/=^
M =WGK!F3:"Z[<%'?H+B/ILD  Y8_J+-VN0-!/KR4Z;$RQB83,V%CBTRS872=
M%X2:P?D+MA$-9LM08KLVZ!UI<B[A!@B#O^<*1\COFBK2:0TM&+_C&ZR&B_!&
MP_-Q\,J^U%EJEZ*\K]7>,!?FJ]?&E->A.U"2X%&,X>4)O"6((RJ@@LLD^1IJ
MZ9> PMTY+NFUL _GQD-*Z2FW&+>1@FU'/3)L?*Z'GKWGG85RAL$K*@KANL->
M96)7;O;S0>FRQZ/C_GZ3"H[)DIJC N*X8I5+W1/8YJ X\/PA'6#!G@:\ENC3
ML,S[J_8OOFRW]H*>,"&]ZL8Q4VL?M((/)IX'-_T;YN)6-7L,3YR5"8WEK;'(
M3CP$CPMK^)W[M#4?<SB0>^&/[MA?*'W-&_4&%N@Q,01"51JX/&2?G;@;:9>Y
M:PW?X!41HI_]4QG1]_@RA9TY9@S+"\9>@CUYB^VT[>VM?S#/6:3\ZDYQQV+)
M>6V*KN@N8S8SQWY$./P>?(MCQZS&^,K0$+#-TGB?=8S_>=/?S;LZN=)[<SIL
MP/I]L/YQ1%QYR!V+51P&GL*EC87S6@YG-9_+45>_;3;AVS;!B>SC(E]/4P2(
ML.D0X_^*L1NZ90N<();$A*WSXL0$=M#A8Z=4<$X''1X&IR_2#*UTVRKY/(;=
MT3 SG@RVPYI;:[#9ZF_<:BJ"U8UVMEBYFS0-B)W9BFO&;!!9)B1-(2>/I/H"
M.8-J/I674V0[6O-6\V8GX?EM=O7'[&HO+XK\QKT=A]-,@U$YTY3V(Z(^"/4'
MCZ,QY#Z5,K$FTTC0P/MY ?<Y^9G:IS29%@2Z]Q1B+^?DZBRPCZG:QD>69 0/
M:M2P5HR-2AE^1&HDT_I(1,?@U#D6J$PB(O6H&3!EA51WV(;D](/ITNN*>[ S
ML,7\7_:3L:_=-:ULQL/=6V$F%/+<9EFH0<'% ^[Z&(&,(92B5_C3H%^D)P5O
MCRP>Y0BR&',D$%LBW8 >'K/VP6\E[\#<RG/B7N.P=I%]B#D'(]$ DV24-,:X
MBX?)'R,T"5&.:CC'*5CVGEI#P!7X/8DF].)9+OI3^M' 2\IF3?EAE_)0<S \
M;),=UT)9O/I@TCRTF;O3D<7ZPLW5[#;CG\]Y;X15X4)C:94OU6<@[4;%@JR1
M@\5;2'^RE(]V?];DY']#!!N[16PB,)#&70:0KV(/- "6]?W9[^<77EHA6\0:
MOQXK=WMPUM(D_ ,$8Y"/S4'V77,$CCPVN+':7_?VQ' Q6-ADLC-AB+22J*2R
M''.JE"W]^Q3DL;/=/I!6M$I9W*C1(J;D2SE%LAZR6%A=]Z*,>PU  \"M29%#
MOA'I%> D(@<Z]ION,?4!']"SD]/@=W#_KO!\!L<#C+82@GIB<;,C^2W">YKQ
MLF*#N3EC9^L6ALKR4<9517$[&KZP'/0I)HN7N*&*HA@FANPC^WJQQ^R<"3-8
MND<8A"<9<R\DZP)$MZX';=JA89]']F'*#PRP8[RHCY OB1CD(/["D[O)M\8@
M&5?!XF^% N]<'\;?IUD<[&S3$'9,;WX1CZ6":/$36Z:Z=HSY=SA[?%4XO2.\
M)=,*_OTGA<D)78MP?(B1"(MZ<'D1:\Q[!_V95"N>:IBLC7V:2QL_LRZASUN/
MK VMT5U/M7PJEYPZXJLL$A+8GE%Q)(RX7UVL@X9_GE/_+CQ:#SOLX 4%O.5\
M=\_?7M0/.&)2B3K%)](+<V[2X6=Y91@,THP(NP)J$HV*6 )0F)OB05T6%+6>
M:;DZ58&@;CI.I>#\&OFQJ40!F;)) 8#E =J@BF-*UA3Y="(815CGMR6DN(;)
M-&-40>1",.M TOI6J& NXI(P$7_/HV)@M !NVK\PIU/[6"A(-%C7(OQS%J0"
MEXWED4(D10Y7!A;+ZOA97IVIP3:)*KML>@H%P!+DT+5:#_8A1#)I+C6_SE-D
MPQ7GWJDLQ&IGVY*9JK'BK0N]M2!0#/P**"8+0&]XI]UKDL9/FJ]G0PQ41V()
M=\V<PAINLK9J26N0=T!+#2()MK=:]%9)Z%@;J^HCMR..Z@YXJ6 HM)B&,=2.
MHF[%^4TA+LR#)MVX@-+<*P63"XGQQ>X;9X"DY8DZ*.:I-Q9A6B]#W=Z >[TI
M5;Q/J>+YYXO@[./EZ?OWIR>7GX_?!Y\NSC^=7ES^:STF^X#4&!XSXO.:4N,.
M"A0RF.&G2J,OM!X<>Y% AA$3G/1;P=Z9[2\:YAZD>*W_+\9*-8:%2$"5DJJ)
MC<M-N2;;F 5/@F,P,V0&SI]L)[>@K2^(@"4NS<>3L,KMW$S.7)!(V)&FXA!<
MU["A%-[TQ G5QP3[N/!JH"YB4T9I%EK;=AM916P0P90OD%=:[SD(+6]Z9AJ:
M8(@5=QYG]6VG^]62K>-?-Y6';N7AP:;R\%O7D%E?P:0LXHK]#P0-(JR6:P27
MZ&,[QL (J>!V4GM".=%&\!*KMWP4L0!?);V<\F7'%*LKTZGP"%,#6@TV2NBY
M I-A:7$G(ZMDT[/!+Y=A1GC\G3A2Z/W5%-1D$5HB7'<$%IGD9<FKSA@Q%5PY
M/J:$\&OZ67)YNS;2F(XAHZ$I]U,Z2#CR;FD*HR5LX+]P2:R*^-\6EXN_3^Q+
M0FO%(R"XWI(226DPBZ/"]CRY<& 2-5WT%-_>H^1&B63*#.VF8W=+VG-+S_%T
M<=:,9>#*H>I);;1R[IGI!-',,EZO6"F5Y7"%-DDDO:BV15M4_)HLX)T9AL;E
M\IK3EEJIR$N=.\N$:DKPA")NLN)SQFK!>#"8<I#.NM2>5:=2PG?&7#.@3OE)
MMW*"D*HF+T08Z:.(ZPDQ<B[YWMI4;,>"^WL[R%ZL/-FL>K3U&1U-Q[#QK  Q
M2=%87+"$3T&2SHCP%]9 N,W<%:C+B\$WY!B^[9:E7NJTBI19$&Z1I,R9I"[^
M&A-8/WQF2'W4260R" E&07C[2[R1A)#=Q&5(@#FP8>/B_-ZQQ8'"5W/UMDM]
M3E?=E-UT/]KCXJV'A,TT(8TL9,<8MDJ*_G2, LP,"TS\;H;O":Y(/,L55N(+
M0+>405G"69<WS_81543VWCCT8(S!&A#=+SA =P#S9].Y]C50XD^:CD*#6]7@
M2_EGR&9H%YS<.BD;A9\R::/Z4T$5"X>H7MKO&]=S3<[4 ZXW[1]VTY!XHR$1
M\9SKI 6_* K(N@$KA,)#*3,0LZ0D&P;V0[ -:@Z6Z"ZT%DE=K\FJWM71(%<Z
M 7]S*YM9%:VY7AA:L&LQA^")CQTFJ(\JV^T>,@<BPD)BI#;D%HJ$,\^1(D[
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M01A;PCUSU"#O)_5@2IFH]FR[;2DNQ4.1]U(R\6TRU0:9Q"2Q'J.@&Q"R<#Q
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M<FU#LJ'^1/!0H(HJ$DVO3\AKCIS347S@M_0BY+#:G,:43CRUL!;0S#TJY^K
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M_T6AQ^IY7ZUJ9(QB[0@T =I$H9T)$0LA"<7W< ^QVS^H<)I/0"=[&'G1(.+
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MN;S#',(RN'I.M(:HD$OW7IN_&\DQR^'$8D:*,E>7S+TSPK8=N[P:J",[<E+
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M4=]F$*.K%P9?,J)*1V2Z LP +OU&ZR:NG5,ZG=6T!Q,D^*J"VJ+D#K"[0[L
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M'LVHFJ"+$0LH[2?3<1"E(^SQ@]]<S09%/HK%X1_FT=@^@X)),(PLKE&^ET2
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M#\#.0.0"LLF"XQ%CEM#07C2_M/5B<VG=(\A.^%OU0])QA4P@%(OX.D\I>.[
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M[J.]-NR%JQEU=?L_^69  >E]!TX &Q5H9C0>^ $,;:<.B(1YC$[1"/_PFX&
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M:3OC0X"=C$*Q!-0H46J1"T8Y'=E2T@G#B.\YC(6OHP=MUN-!@#BC0#9UR?N
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M4290MT=Q&:X@57G2%='LEI==A[C!ZH-DYSDAU4*.&UK0V'[ E6E<!-YL4=>
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M'58]1SC0U !ZEGLB.YY@QNX,^'PDS56ETQEI(5,)<=(I(:/(4YW1S*2O7D:
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MDB[0E"HCMDZ.$??>Y@-0RGSL,DUMI5A#QHFDYSE59%V)],])<.,);$E<@0=
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M7:OZHEH(HY2Z.'>8ES2@4!W/"4;EZ,;DB"Y?B9E*B9 F6TY^$I<3%/<;KZ+
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MIKIX1GP5,\6A56BC.^/*)7:&*>">*9H)'T2!#XCY"5OSP81&F)\%OW=O >W
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M87B418Z7D06RB6>XHDJZEXB<5Z6 GN.A<KO%\U7!NQH&O)U5+3,U2U6=?"?
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M3XEUR1G\YIT:&.(A*U0@0+U_Q^--8]^Z'@"4H3(NF,83F K<BQ=H,#[NBU$
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M!UI9;,:8X0!CL;=+.&MWC=0K7,[LZL)VS;.)R]I!$Y.6A29FKA/LQF'NGDX
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MCX/(&D<!7QT]CO.&%XY-Q]-<1LA)?[L,_&BDF?A0""!H@AD6, VLL['#\ ^
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M?L5HZ&769]5>M=GJU?OU:K7::_7-9L^L_K6/WH2R7M:+^(-N5/0WFF<.L6P
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M4P1A&_G&IB:5X&5"^L.:&?\P(;WX.I8:1\G+49AJH4PUVW2"AIA.%V+ :N6
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M,V":$3#I-$FF!2.(*Y]K*$ICF-6'<.OY3P7""X-P0QV89 EZRS5X$F6R*[@
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M8%HX:5&<-#L@QQ)NT]F"0=%HDH90$DR4$H+VT6@I-<GI2IBIBM\@(DK]]BI
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MO(-O9][Z/232_<^#K,Q3 7\!DIXS(R0  *=:666"U=J"F4>2TJ92]&Y1*J.
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MB- 0 -@2 )MQ'A& .P422H84<Z%:W11R67U="[P5>'OP22\ ;]R98&*@SO#
M?9!:L$A84#%$GI(.!=Y6!MYF,K6\4(;*A)00"7$B*=*4421(8E$:;P.AV425
MFC<UGLUO7T6 >P8'=%MQV&AW?>\XEA.A)=VW4*E0J5"I4*E0J5"I4*E0Z7%3
M:0'#TZ>D/ W8T."X=-19IRG8H<DY*2PW54TI.JDI16^V0$&OWJ[4ZC>]0<EJ
M6Z;Q>7K)M_:MM>F_M?8_?E:2D&2$11R[W/N)262X]TASY1W32=OHP/K4N"G$
MG?/Q"Q^O+!\;0A.CBN"88D[_,4[FPG#<F62UL[SP\4KQ\?FYFM;^]MG._M9G
M1FQP+/>XB+G;A4@4&>8,\IAAICU/#K-5Y.,G=>IO/A?N#@]CO^IUT8^'L3MH
M?XUCSU'C'QU@CG^>]WH?VF^E#48I,5JH5*A4J%2H5*A4J%2HM!3S1BFBF.-!
M1ZY!%V8F,J(I5TDS+-*XN\0BYDVEU+V\K--=6#M@^NRF??OM;:^?Q[4Q'/;;
M;C2TKA/W>V]M/W:'Q2!:HD'T[5(VY+ECP] 01(H).:$=XDXH9'F@2"IFF74N
MBFC6UH5H<KJL.@.%\0L\%RJMA/>IP/-JP?-5?]7FP>>D=2)6892<9(A'0&8+
M'R$;F;3><,IRYX&5@^=GD-B4JR#E*E79(04L<]S+ ^CY+XWA(<SLX+ 1CT\Z
MO;,8QQ^?C/K^T YBXZ1C?ZZ+Z]/SK\\O_\"LDL%*3I/AGC&ME57!*J\#892S
M&T!N7MFJ^8VEZXH06V,R51>]'1/I+=!H4 !L\>[2XV.%6Z1ZS\9GC4T$&DG$
M" Z($V^1 ^&%-#46A!E0U>*U=3);6Z^$S%::I4N"0J%2H5*ATO.AT@)F6N+:
M!F<3)H%RS(W!46!ML*,Q&?BQL)EVC0)3-7^[5G\IQMER=9LOT[J-=<1HFP32
M@E/$L>'("BX1M013++ 7)N83*5C=^;A=8?8"R85*A4J/D4H/Z=\L@G,%!.>T
M5_/#9X6I="X:1(+'B$>ND)."(9*()ERIX )?/<GY#'+PKG5J D<TOL;!$.:1
MOZL<=ZAJ5]RPI[8?!N?)>;5/KW':'AX>QDZH[AS:;W'PO%+V5MKG6?W\8[K9
M=(&VG_=WXM9WF,/!9RJB\$$SY'V*B!-MD,&&(D&%94[K&)Q:6]=BMOQMB=(^
M3GZ>H\7<C9D7TV(**R^)E7>F6=DYJ4'MU"@W D+<.8<T,#>2*M)\9"N0I-?6
M[QRY*(R\(HP\OW6.)I%3$G.=9DZM<)@)FA3%WEHIE2B">36Y^<,T-Q,FLIV!
MD5<DM^MS!CGF,-(\"L*,23J!8";+JAM3V/FAV7E.OYB[\7*1RP_"R7Z:DR.Q
MBH8H0;'.S@-"$M(,4\1C[ETMA>&)@%QFRZIQ5UCY%['R(I5XEQ!B^U%)W@69
MNO@+[R70-N'XQ"()DD2DDF>@B>,$O&\-H@)[IB3VQL:U=8J;YDY]S0N_/X;P
M3:%2H5*ATIW:$-T]RE9DYRK*SN^SL;:MSV#:IB0$1=0'$)Z&6.0\_$EL,&
M8:ZEK80GI4OHR58.#]R*7?<NQ<_\)79X7N<"2O[&8Z#20T8^-L+1:# \CMWA
M8+^W 2N71V [;VT[;'=?VI/VT'8J7G+3@N5]_.^H/6@/XU[L?VW[6$NB]]'W
M#KK54RJA5"3,PA)F)DX2N<1*,(&B3@IQG@)RVFFPSF3N'B&E-[DGW@HE<A2V
M+^!<J%2HM(HB=.EG!^Y?A!8+;IGR=<;[2;7$CH-\M2E)!&I50M8'C*3BG!$3
M'8X:Y*MJJI7*EBS 4."[4*E0:16%[-+/&10A^XB$+)YRDWZ#N7VF5!NA3$"R
M*@RL-$>65,WT(N8NI-S1NI:RNM0%_J5\O0%#[L2^'<8P.5S0CY-J*N%YG2HH
MP;A"I4*E^PZ9_LI,X/<74#:;#ES$_G*;2GZX?(1?M#8^&R*2ICX@@4'6<^,3
M<C%+?9:2,-$Z[T(^B&CF9!.6Q*+'Q]F_*BGX&JXNNOP],+6?9FI%G;6!.,0#
MU:#*)X<<#PP1S6QPD6AK<JH_-4TB9L-2A:U7E:U7)SVXL/>O8^\OT^SM<71,
M@*2V(AC$.=9(1Z60])@ED@"^E5];YW.9NZCD*\WAQ7 J5"I4>I09P45*/JB4
MG'9H[WS6QCMO4D**9%78NXBT=19EBS>)9&2@/FO!H@G;<#6TX">5^*OF<N4?
MMI/KZS0;F]''8Q?[#4::C<Q4=TG]=;U^B'U43^RWO/R#7J<=&GDZDR^'O9/I
M;QX?J"WFLF-:4LDTCUA3[K2T5 8OA%28$B-5^KQ]6T]=]?3Z8$-!KB6'XL[S
M778W/=DY //=&*ZC0X9*,-^E4\BH%)&U,O!@@V(DKJT;W.1*+BD2MP3^>42A
M_8(6LQK0ST'%-8K/8:\#:SC8^N^H/3PKD+ P).Q,0P*S05"F+=(A,L2#X4AK
M%Q#SV*:@9?3"94@0!0\*'BPOXF=]4 KV&?:$FX U#\G[((25S!NM;JT^[/>C
M'8SZ9Q4XE,C>?4#&AQG(H,Q)0S%26@;$.57(TB3!?DV4>1*$TF1M738U97<P
M?@I>/$^\F!-'_"FPN"G0,*5)%,Q8)F;X:<RPTB@1J$-6)8.X=0P93@$]E-68
M>FJ=2VOK3-(F:(L%-0IJW-7JB"$&J;A1!">NC3*)"9*<"BQ9$PF]B]51L&*9
M6/%EQDLA K$>3!)LHT1@,FIDN2;($4MLPEZD'(4D3:IDTZAE]3<KD/'<(<,*
MYI7PSB3"N332Q"1<,LDR9RP+HD#&JD#&Y5[;!ZRUO_W9>$I!,71(,9^S#3E#
M3J2 L';&\Z0E<PXP S>I+)Z, AA+TC&<86#NVJ"9XL12PR53U@B%5>+$AP(8
M*P,8WZ<!(T5!<8P:X<1H+JU!$>"\1P%;[IFA!AN\MJZ5:1*RK+._!3&>.V((
MCSEG1DCK+*>YA(\)5FL+EC%)2IN"&"N#&&0:,:(W@4M)4>0A(BZB0H#U&'&J
MC-?))\U--DLTYDV.9UV?CPXSJIR1?PVMZT3X/[2_KO\?_)B,^-CV#]K=ZMWR
M*H/Z"#N^OVQ>)/@F9J29&?</8\/Z7/C-=L]R2Z5N;PA/MWWXN-MHP\@.^K;3
M.+']JJ72\# .8N;1:NVJ@Y"IW;5=WX:+!D/XH#IY_.*<;-/+,'XYIR^4@ &>
M] ;5T>+?^K%CA^VO\??3=A@>3I#BTHUCBN*+6ZR#08R&U]^R*FO\"JFKZW'Y
M9QYOA3&<!9E/]RI.(R>,.!\3#YP(86UR@'6$T[7)78?]R21.[$%$KA_M%V03
MS/$WVSFU9X.U?UW=?;#UII9^=59M)C^I6K7MUO[6Z_<;C3?;K[;V7FYOM5YN
M[37^O?MF<[OU>J_Q<O?]V]WW&_O;NZUK]]JJS*2UNP]#W]^%0;?V=M]L;V[L
M;VTV7FVW-EHOMS?>-/;VX8.=K=;^WLQ4Z@&O_Y_K SWG[*%;S';>S8ML.K%V
M/9J-F5)62L]#+"UYT1BK$ZW1,3S"+R&;]*KJ\,=H &\=##;CP/?;)QEY-KKA
M#SMH#W;3VS[ 87=8E4_8A[?^T0$]XX%UAM;FAXG.0%M'?QZWCCX(D/&L1=_A
M3Z_?49#_WW?^WL[O8;N;.S"65F<7Y/^G_QQB?_Q7U_YM1KM''^G.\4<*>@7(
M>,\^;;[_\FGS(\A_>._1NV_P&=_YWOJR0S^(_WS_<MK:^(RE(H;XB&P@52\$
MCC3'!E'C-*RL)1S@JZ).NSN*82-K7H18 _I=B$0DKKUTCH2HM78$)T.Q6VO
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M@Y6HWQ)3?_ K]:;O-:NI<\D;Y[_N4L?<#XHP2'Q/%8KE+,WRN(@9 XY9\!0
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MB'0@X!W+=<3EHL=:">8#6S:=-]9G1<SJLIJ-0+JJ@5+<K/8*K88W ]1QB=!
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MP<ZM%X8XZM1$,S>Z&Q=L5$ZU<TYUL;94? =^@W&;'_&A^C4K;BE;3V-GFBL
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MO>;/W6>3/=&5,B-,W*!#<3Q#OR3FE!E= (YST\)DN!(K0SAGHRHGU84@+*8
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M&;I^8RCZG!4DXTSFC'$_Y(*E&4NE[_,X2I.0)4D0IX_8[O$%_LT;;3X#<\(
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M,.K8W.O:Z 8]APDOZ9R1>[9G4QG#87" K8W070\4>ZX[L6M#DL!^I62?6)R
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M#8-MUKF1 3-,N:5R428<.A?++C=C%8)'!8+7+'@'"][4&Q].M.5..^50KD)
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M?Q\%LLT'MRG6.594:@*F&.-.ACS/,"/PD<UQ[NQ:&/P4,K@]V#T]L9(*QDA
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MEW7DOY4UUROHO1Q1]+W5RFO]M/*QY$>O5Q@ !E1[$/7M>"V 8=F^JG\SZ@(
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M3'#\%E>#KCT#V*Y= >TE;>Y_/22XF*H,2Z&DP8S'7&&E6.ZD$Q*X"O.BK#2
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MTQRY8'C0EDFF16R3M2GX#W?)>A"+K2V?);!\EEG4[;?[IGW:C'&'OY9A\SI
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M*N/X[>Y.)9O_/MA)&+D[Z)JC3C=/;RK:'L2^5G#-I,81AU4@9W&6,J&#E'H
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M"KVQS3:)NJOBP4.;,;T(QJV@=CF1#OX# +:$S>"7#\ >H7A5^],PW]9 ]=1
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M5NF\>KQ0QN,.K2</8\H"%-/G,:_S2/LIEV8M :;TUS%-='WJ_5+(CV>0/^C
M<^PP8HZ3&*IDD.(\0[D4G"JFJ<UX+)6^F8G98NF/TUN?@K]^2&3\*]7@&2^5
M-]8T[6DKU=XI_];]>)Z^'\_WB^XNVJ$G/C-BXN.:\I3]6!Y8P98KBY7-1:QF
MS:40QC,B+."UY3AG,@P+D*::;&3=GN?)JZU]@W&=:&NQ==0AA7,.QCP5R&3:
M(4<I<S@0K35/Y41G^^--E1.-7#3=*>_=W$8]3]VDIRJ(1B;K+J=N/(E"XW6Q
M%]]T9YX["E//+[=&GK-YSU( YWU=>E(1[J+I#SSA:]/&$C/#(J^_;32.=C9^
M+P CKFBU5"]1:&]J-XM2]]V8Z BD.=EHIQ,KRGYMNE'+G^'DAAU]YDWEQ;<K
M$N@<RJV8Q W*7KNEJ+A*[6=CJZH>K$/<L5(ZS.V=96*S%.">45< V-U1R=V7
MZK,W5_1,M;^8LR8/E4M"2QTK*1,K.,ZL<EI8)253U% <Z*)]5195^!M#QC*M
MH\'55>MFIV*K=6>,^P48@S&<6$$]J <&94I)Q+6V*.><(9O1G'M&\]S'!J_W
M]5TQ]_;N^?FM,I8+:1H%_U?3[XT@LFH!VFQ_[31MT3C!%=UN8SG00HDL.RY;
M$'N=R]A.::)5VBR_+M)*Z261:-3&J9=*\(_:423C(:KC)9[>*S(W 9/;J=E$
MT33PJBB+OR(- A_8067GC6^U-L&XL+"[%@1QL2RK,==%6Z90/*]GBK%)[W"U
M\37X+?YB(WTROAZ@0$4!'MN$C#[\P48ARFMLG(JEDQU7N57&9'E0.3>"N8SP
MRLRB&%4OOM.=O"#47J.S4TQMU)4<I-W:W+I36HG#QL&)P(HP2@(*1'DPMX)'
MBN8:"3"UC,"@=F39QC;#<NNNDX=*:%VU!KVR2/II%"1VO#U+0M#!5=2('J3[
M>),+P4P(1O"@0XY)T)F1Q#/+#;=55YE)&MFOOYTFDHHF@ ORLJG'F^%0)QK)
M['0!)4\+Y\G'^.HP' [ZL6AZ[Y_H\_@W,-N:I.YH#79]<'M\PHRD\)]"F&@%
M)*5U+&<HD16!2"=#8-)L;!/\G5XSFX4%?VEN8G/$2JT>7$7]R)XU_==D.)=6
M4M=_]:#%HJ+Q(ZBR:8.B_@-W\R#I8?.CFE2(;/C+DFH +T1AHW^W4^Y#<2ZW
MQ%J+,^R=X423'.B7!4*LDTP;69&N9'? 6U+;YY#MYV*(;XH1[@P'N*;).VCR
MV^'NIQ/N\UBJGR-,588BK"!#@D(NY-IYH6V>!Z#).4KY),A%'^K(C1-)J.R%
M&,GC/X.VKS%<N7X*<9J\KE%4?@6UO'6#TJFAK>S]2.&=$))CPXQZ?\6[=3U@
M4P*EKV,==:,\+MJ>?0-J!2T\]@DVIZ4*-^H85G:O&>K G4O0=:-ON'D;/QO>
M;]@I]<#TN\VCOK^L?>K"!$%_^*ME7&QXD[[YMAE]+I6G]B86;.JGYJSPB]1+
M+"G5, %0NX%+RUODY2V *V ]83D&L3O 9;KAJFN6]S95V*FTK+CX8T=O8$OT
M!I?Q\W[M;?2C)YFR&BOQ77_(C/Z8;)(\-ELR16]-7QR8CPX5QO7*T6%"^6OX
M4=DJM_QJS&=FANUVS?A2CY]AF'*IH]T[\B79$9363-=/.&_BT8N'31F=</1*
MUIX>:[2Q']3SZ96V9J+KUDSKUDP_V)KINZV6IEHS,:(US97Q-+.<@X0/5'#C
MA"#"4B[)QEW/D5+)7-DL-YSGQBHFN9<!:\L9]CE]6%.?Y8+F4>N>LFG.X#+V
M.;\MSQ\*[7<<]BK,6Q!C"^B<@<BG:ODS6L"?V_,'H&4+%_#RX*8_?$MP]N1-
M?TBV!2KLHVY[_W=,\:<?;%P#L>AMYX005OL("KE_SE]^)Y)Q*:*MU6()(JD!
MUV3GK3O#JQ>:82%W7F:.\T,QWR:TBIIS@=X/F-\"]3-6:BD^IS?1FPN# C4*
M;(TP$XNZO(RUW#E9^D')[H6H_&.!Q5^D0LMD[-UX^-V/E(!YXC(R/S3(I27!
MI:RJMB MFM[9NH+-*ZE@\[C#D=G(\#E.YH]#I\B^ VQKAJ89=BNH7%L[[?&,
M[-*O%0FPK P.AD3TF[^&^/&K\R^7>_S+Y0$].'_; E,9UQO_7!Q_/A '#;C/
MK14P1KCF;>O+T53\^&7]\KAQ=GE\>WQS\/D3_/X#C.OCV?'MQ;?Z^2FKWU[@
M+[L[,+=_6O/ZL'C/.5;"(QLC3GB0'BDB& +KU3D@?9=CN;%--S.Z3#5P'HG$
MCY):#[_'T@JFI4R?6DPP-;K&^<JO&Z.\K0> R&,0=XR#7:>OKQ3(%QIO\<N/
MPZU<0_T30OUL'QOO,J4%P<@&;!&GS"%M"$5.FLQQ ;1!62R0N<E_/$GT"3/<
M7\!"^16P?H6-D+'J\^O>8RL'[L,:]6LT?SHTGVWJ U#%+<84!>4$XD(%E"O+
MD62>!L,PIRH&2:E-JI<IY7^MN;\VS;WL:']?RL"OU0YWL659<92?4.'++=XK
M=OCU]?O^65)@MH>29BZG)M= HH8A4-PM4LK'"J$99HYPPE0JM,?U7=FN:Y5^
M983 "JOT1?&;^_'^>_-^G35M7FF;EJ67>6NY]G1R;;8!%Y?<6>\L$I8JQ+FT
M2%OGD%>4!NF<M@9O;#.UJ?53]5Q^WKHU:[OGE41SK%M2_UJ@_ZI[5O\L 3#;
MS<M@(G+M,N0(EHCG6J"<>(URAS'AW%*/!1@V;#-;'U:L/LPO4U'B1<\H^J9]
MVHRQY#_@O5H?4KS8(46U?6M%_@EQ_'0&Q['5"A/%$=>.(4ZX0D;F$G \4*8M
MS;72&]N4BTU\9S[W*SNG>"CZS<_V2G-\4==V69!S$@P(T8QB)O)@-6?.*!:<
MU5102YP'@IA;O6.J\VK)V&^;@#G^?4P>'K%SP?M55'L9U/ZIY\.@%2/;)Y@=
MIF?_<(-N+,"W9N_%V/MF@KV_NG?_</?O_[2^T-;7_+QS?7Q[=E%OP-TN#_#!
M[3[^<GY,#G<_7!_3/0%SO#E\=W!]</Z)P)SQB>%&*FT,4E@%Q!G6L6JM08+%
M++I K:0ZZGC3%5[1O026<YV)'(=,*PYZH\9"N,QZ:04&4,_6!/9:"(R=@/W
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M[M-T ';KG02N70-7].!';8#DVBE,+UY5SA"DGN^V;A*(C0%QX@,8#"P C+7
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MO$F\.&[-<1?:.T)@"Z.O^BCB5[1P.[U>4BX[)8,G9Q<(>=-M=GKCNGKR__1
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M#B8".6)CGCEL18A<:Y9*B$"JIH+@>6'%,]'6[P8438A@"<!D.D1 G&4"3"Z
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M'7V5/VAF\P-QT1V,L@9(&R!=2B"ET3-C.'-*1LX3L<0[:I5*C$NI73-W>MF
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M)%RL"G-5V>M3<^%#* WT[L;+[;GZ*2V815KA!(\]LU(&XKC#</"!$A>D,$F
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M9: &(AZT1T:IA$305A@;O,@UT$U;L29#[/&24^X&%8UI^=2]Q6H(X9$P%5-
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MOIJ[^R#Q6Y<BOU5D_N!YO.F-5#5B,KB9S73@P4+*S)@U%UCAF$+7'GP; (V
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M4.3DOK?_?-<DI=UQ_V:&*C8[^4 [J9;8U'[N;BHO'+,N49ULY-A$R[$D5/B
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MBC1G.3)32&0D9B@QPZ2U$F,/)A=>)P\+[Z%ULP+R.SM9[I6WEV =5;SM=!K
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M'Z:1:,M:Q&$U"7)P%G]?[J'JNWG?GC8?:#77B><6@"3^?1Y;W<&!0_^4L'_
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M4DR6ZELTR5[JZ3_=88QP@8VU(EC#A6(VTLBD9D8PHH>- DI_ZR(R])B_U9I
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M2. 8<4L8TI9'Q 2F#@<-VRJ*\I5*3OJ6ECEDI82DY8&D62)HN:.$:YJ,,X!
MU!).?,CQ5S%Y+F/A(R=#'_F]T1/E8>+2@-GN*)@9%P5LKD6\:,2>J$#&4(IR
MF;\4A,>4F[4-JJH</[M:7(EH):*]CI(U!T@K:_$N%Z[]&,4UHIU+/#D$VRX1
M!RI %JQ/T-2T-RZPH%UVCM,J)ZN5&EA"VFI"6MG!9>D@R8]"DC9:&,<)LM+F
MP"U&D.;2H)B428()JV2:0PN7Q8.DI3] >XV:O,O=66Q>92>F+1F_U%#N/&@A
M2CI'O>112R>%<LS9*)2V%)/2!;A84/[WA N0!J,45P1)HUTNZ*60#1(CK0F)
M+FKC;5C;(%6LV$JU>EAM'IZE))\6*E??#-)0'A33/A<=(!B(0&+/;.DS6R7N
M'_.9><EH3%XBYD%]XT$+9!V8FD0X9@/6R0@-MB6O4C69I+0Z'19*#'AK#"A]
M2Z_#_V.^)<:ELTPFY WFB"<PY)QF& 4I0Y3$@G&NUC88K6KS[+J\)?\OKAY?
M]M98.DX><\DP1HVB!B,J<@DI2CS2F"<DB23)IT ]EL]OKK' /+Q:79+F7)?W
M$4_:,L=ZSJ\N[TM'YY;/6-UGE [2TD'Z\/%]) $S'X2EW"OF8C:YN>:"F^@D
M+QVDBZ5874\X2"7LC>74(6=H0EP(#":2R-7Y0N+21L=S;4Y"J]0\Y_A]@36K
ME63B&7@8.TZL8=*QR#F.T6C!53+4$8Z]&F3>EQ[2%6'_,0\ISB:P(1IIDQCB
M4@=D7" ("(!S2ZPGS@+[RZH@I8>TQ(#20[KL_#_F(06=+4B,)?*,!,05#<@E
MI9#03#AF;%1>YZ*>@I?LOV3L7_;76&E&'G>0 G0'!O@,NQ01=UJ!'I_#:'6T
MW@L>M!3/;["QP#R\6@[2N5;G?68@\J!J0+_^QWCA@(<KC:QR":)YKLQ"5R>:
M18@D;[ QE"7)+*?16$,]$4HD)H@'5:%T!BV6$,$3SB#8,FV)(4C*7-17!($<
MH1AAD!I>> :[FIU!6%4)>TZ\W!S9YZ7K%Y7866+G*V3V*F)!Y<9"VL0I9UJ:
M(%W2RC+CO16E#VZ54'<\LY=;'I(BR$70VKEF#K1V^(%!B0]$:)"BN4&.KA(S
MK\S>$GE+Y"V1=S&0M_1\O@[JCGD^M<94$*D1@*Q&W/B C @2"<N92D%IIG-F
MB*IB.MG/J$3=$G5+U"W[_[PG_!QS.(?$5? YMMXJ@WB* CD> @I"Y,1WV,;(
MY]  :'6@<SZ!>+_V+$P;_@V-OS:&ZUJ[. ..]1O_A ^'SSZSG:-&:[ABA (+
M#SXJEHF.PNO)1;?72%<#X-CXI^O\NG&S1\6KIGZT?.S)<X,D@I_"))HQZ5.[
M4P&%K'(5;:=;B2-%E/M"?%!)F59L*Q0EE:O%#5F#LZVK2B='YN:[;&6X'G?G
M\> .OM8$CT"+K+33O8-[K3'\SRPGC9H)%DD*B2AN,,]Y& H+36C(I>R?[/,A
MQH%_J$;OM;9@]'^!"ITU[FZO<Y&#IKNUV/MW)_:F5:?EDHJ#@_\<8W_V1\O^
M:2[V3HZN]ND!C&$3GGT 8_A*#TYVQ.[6-MS[[71W:X?7/N]>'YP<7?[G>H?5
MMHY8[?KT<F]K7^R>?#W,99A2X@3!#D7$L1'(,AF09%8$9;$C3H)F3-8?:EH$
M)-:$OQ:27PHV7S:FX=X:X ^/C3&<B-R(E2HB9-082^>?K))5,LT+,\W1H?($
M-H5+5.0;\WY('>8H$6P8@)MB.I?G8^N3^4F51>:7*DC [GGTF4*:5]5*9ISQ
MY!VXI&E[("-[[8H_MJVCF"]+MM&I_&6;%_'N]UFV9D\SJ :5FR#[HK9RKV/O
M78+7FFFW6;A?,B[D0?K)/(!N%9@JVQ_%9&RWXG,Q]I2+L1\7N3G5/,-V2EU8
MD_R,C#/="J@@37@6C#0K$T<M&%.HP(OR%8U\SN\'ND:S#<-?+]6N@=JUD/Q0
MZ(*#?5T> 6(C\9P1S8AWG OI$C<\!:*"B,:[5&I=;RI :EO[AY*+9$-T2(+^
ME2,Q%7)!@Q+FN PDAMQ)<FU#KS_DC%QD(5*IO"VTA\HLS )RVR0. ITDDXN&
M.^&P\H)3'DPN E5J6V_,+)N'.@1A!0-%BRLP4;CQR!!G$8LZ!ZUJK:A;VS#W
M6"A#96LJO09^;UYDP&_TI3602>%;*N1_MP?_%!N8)4'[//83>+OCVDYCI(-$
M:*0$?[9Z#=M\3-5X0M.85DN0"ZPDU&'JL"Y W+V!3*W <EA8]FY1J<\/%M%E
M!7)X1M;_:'*K4J=]5MG<^[B35PO6]7YMHYHY[&?7O'+9Z!T/**$%BUCI7<;F
M7[%R!C,][N91SX(RE%)/+?7&.<53<MK*&")+.$4*>),>:.8W 2[#2-%O,.Q[
MSQ?K[=_OQ'7$L'71:;2.:C 00G>+H0, E=#S-/3\N(3Q'.K<HE9$ADAVD7!C
M"++6<&1SI$821%$6UC;X^J33>P@]ZY7-1TGTKAX<VD!WK79OP!"5_-FX57$)
MCYU@$D"==@6T[Q;L=3=3L\V =]'L#4$G-+J9'ANM"]OR<?!I-TY2O8O>7L 7
M^:9VIP%0 LB533BXLN!0L-NZ WHOAI*'V_; 6BL*4E-B5&,TA'M*A+H%J(74
MY)Y&S;[<O"E:\99JW] HGRMN6T^=(,89%Q/'/BN$C$:)$XO8,R-*W%XXW!9[
M6Z>'SO-$8ZX@1 E'G&J,=#0&>0_:HZ<F6I,*K_9D"]8;X%XJ/)MH)EKPQ*T%
M4KEC@A28?8>/^YSS8:GF>S\&]+EFX':\Z/2.*_^]L!U@O0S!.1]A5-[&@BL'
MXG/"3PD?7-I.*  A$\< 6T"VPOH!@8!@M&> SH60G054@F%@R< ,L+;<"*H)
MY3@W!\::.4_B_:D3.[5/XZARN[VUP8@VBP&5./$D3M2_%J=?VIN@+->(.$>S
M::F0$SE,3#+OA$_6>97UN\E0W%O3$FCGK-%K'!5N[3L.[_CWP#W>:71/1[SF
ML=/+JL6D.QBVN]4^:_39$J[X:%LV-("/MMK-INU4_K'V<7-K[9?U2J7>5]^&
MI%FY!$*N=&.OUQP:L T@W5'JIW#?:C%Y-\(*C$^3/,+D=I+-LUHS+\YF@3+K
M%*@&//'@A!-6,Q,<-RPR+ :9M5@R_+BZ4#+VSS/V#M[=VCUDT8"JABGR*D;$
MO0A()R*0%U8ZFAL]9I^16I],;'J8L0L^+A3[U+SPO8N!!RB??HT3U2WOP\W9
M(NNV?:/@ZCZAW</\X[S_?__>7P>I_1#)WK7$1@G>'G7BP'\!+^H[3\Z!0:[R
MA(8#JU; K,DNL1L#,G;^ FJL#LS%OM\*3$4708&.K4J[%6\'D(]QAH^^_;"7
MQ]KX&QXW,OUJY2BV8L<VFU<9H?)U8"3%\_[(@63]11\:73X)&KXW,VNK/Y=0
MN3@'OAOCS?6,@?<Q;+3^^'94A>G6'TW(K^X[Z0:O+R8",R^6_>YQX,A*P[B*
M9Q:+V'_M<*V[%ZX;_WL!& .3.[>- #;\9=ZS\W;G]H$PAC[*N(Q<0_ :'WIQ
M)TQ[IE@!&1AFV-.(,3=)6P:4[C")5H-&,;!/\J%T"3@O!CC[;&]K\]!X3 *V
M'"4I$N*:1N0TAS^-#2H8PZ.5:QORGA.=6T_1"@CG?X[$*(X2JR$T,:H(!B;G
MCFOC9)*<<V>2U<[R>\\EQP)_/1@K%\VXEXK,BUNR[0+=;MV8-)O=;%P#H]VQ
M>K[?>/#WTB?@]Q8 <O/?L5,0. #"9BO<?MSN-O+>?&GWLS3J.0RS#A/YO=GV
MI^^.VK]>[]6/+FM;^V3W^HCNU7\<XBA,"%$B*R,!O5ESY*R6*$@&JK/1-CG6
MAZI&ZP+V(P-(E$$;JKCVTG&FO:,T2JDB8=[+X.A:)0*>G,-NPY;%OC,N@=[;
MOBP0,V\!X.T94#[08_=.R,4_^J[17S+8AEN+M_&PQ6N[0W]G^^:L)^1F0>&Q
M4Y_A"<3E<0.DP:7MCAP9W3VE^# 1JSO"V?G+H3NV@("[O#Y@)T[[M6S/!Z3X
MH3 @8%Z_739"[WB8^W3GQ@$ZX-M;K(.I7/0>ON4.;/A"3WZK"!+$R-@2W?EY
MW!F.Y]P> :QVHCU%-B=.?;#-2WO57?MU%"T!&,=6<7$6X'Y'S4ZMOOWYVV;E
MR\ZG[>\?=[9K'[>_5_ZU]V5KI_;Y>^7CWK=_[WW;K._LU1X4$8LRD]I>'89>
MWX-!U[[O?=G9VJQO;U4^[=0V:Q]W-K]4OM?A@]WM6OU[Y1\W^/#+Q+0>#DV?
M,5)J//;]9G'&>'" Z2J"=2!<H@GSQ(2QT0J?%&-48Y720_<]B6T;_QP V)!7
MBQP&G\WZ\V[\,/SEM]#HGC?MU8=&JUC:XJ;?1F>8Z7DLA:&87__K :D+O<X8
MR]0^J!TS>/& $=8+1AC+Q^A_Q]DZE0]_C=?)3WZG,?VI.Q\;+!7KBJAE&JR9
MZK%/5/V9L;;1R^2)Z:GRQ/J>JV[?)]6^@">%::J:/YE78Z99C#ZSOTW:W 0\
M]I=C< Y88:0Z2YVG&?*,9DE)FC:5:K$7-5L+TU3*?W*V[VK)R"ST-Z\R:V^9
MLOKIR1.>RC14-&O1NJ?N6XH\Z:<5^1D3I6>;_!NE0D\YZUE2H1/1CJ4D*;.<
M2&>Q-,IJP[1).=GGJ=CLB0H4]P>9/N4,&88=3 05%/Y;=!T[[55)FF9PO3@X
M^;_CW;/MOVN?=_$^W:;[]=#8V]JYW*>[?+_N:>W/'5'[/IXT'6#,S3.X[VH?
MGK]__>UDOWYP7*,[?/?D]Y/]Z^/CVO4^V3\Y)?^YWNG5&KC?DC0G59_\P(=8
M)J<\(XBGX!$/CB 3=4#$$L<DDS*PN+;Q__]_&K;YMSD5W%V,Y.@2$=\Y(LY4
M'<(0H91B,GG&/6"A5"'*%*,)FKH8IBC*\T"9B#E@8XF!,V'@WL<Q#"1<"\5P
M1!XKA3AQ#AD"$L8%@Y605B:16PZHR6.1F>L4ORSTS:E-V5+IQT7$YXNV('NL
M%OL]"SA]+?9ET0=3%(X&RQ)3D2?G;?(\>1%,8"%$%=Y:'US12CJO!(B[DTJA
MLT18IP+"*?=@B,XCB[E TC@!THY(:6GN44_%9.[XSQ4B6_*J.*O&\9*KW$;-
MY5J$7'%O--<L2D\%E<[]1/>54LMY;::>U'*"X(KE4A $5!VN0<$QADH4'1C[
M*F=A2[ZV(:F98.GWYH.KMWNV^89>MK)6X<NLS$+7*IP!G7\J1JG4QY8$NK_V
M=F_U,9C/T?4AMM(JY0B22E/$F37(4>91PB)W1^(J234G?6R._+8<#KP2;$NP
M?0QL';>$*(,#TX'39!T&A9AGO)42^(Z4JO#"XVGMXUT\/:6'V&FB"0Y 6YH@
M+I)#-KF 5 K>2*&-S#U&N9A7A\&W1-/1&JT309WW?'(3NU80%V=!NI",XC1R
MPHC+!9(#)T)86#-M#HF4:[.&@S]>[/6UPP'5^@OGA!=/_-  JZ+AIQC/*Z6H
MW__R%PZ._]QNAUR38;,5=EH]VSIJ &%N=KNQU]UJ='VSW;WH+% 4^_X0X"YK
M6S^N#@#":M='?Q^<;.:RUG_O?8;KZO",+0";NO\[OV>_,1[%OHEK]?\[V[W.
M.1B?SG:+LM;;/%];JW^]K)W\ 6#U"4"OV?@/@-;NULYA9,G[P#B2+#K$O??(
M>2>13C12)C$)SH]'KE/I+7"IPQ%40H NQX3U6)O@A&+:Z_'(]<][>UM_[GSY
M4MFL;57VZO_:_E;9J=4W:Y]W?O^R7=G\_GV[_KWR>(CXO5&F3X]C=-R&<\TH
M,]8:R4ET.B7!C(_844.#-6N+FV0R(UL/27\54FCNYI?U8K?7K1P-9Y?+A33@
MFT:G*+>1$],:_?R^?AY+3I2P.1VV"2M7)$'$7)-SD-O6Z7\'%#+X,C]]);*.
M\I(],.M&M\@CS DBW6+1VJF20.-H=X;I&WG1.K%(V(/?LKHZ3(STPT)?Q16Y
MGDY17.<RPE84V1\!9MVYJE9@74YS9F.N-MS/=:SDS.3V61_E0Y&.T2\8&F(_
MWS!6+H]C/V6DJ"]SUN[$2K-Q&IM7N>9,D>[8+SY3Y)3?E%<M,E'L^(#A 4V8
M8/_.1B^7L^ITK@IR*/+XJG?F.J2FT4S&,PO$U,Q5AW*!FZMSV^VGV-Q=UCNK
M6%!BKSO0V1Y2^6]&>9@_FJ^KY9YZ" "E+G;VTK?A:W_ 6[LC#A2@,)^=*)>@
M&'9CZT;?Q^].'/[ M<M#1ZW2PC@41+*(.X^1B8(AH@(U3EMJ95K;Z!UW8GQ
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M!]!F+BR^0&[FDLEO]1-IO"4R*9W[[&+KL)<F2&&I(CGLN63RI6/R,1.&<*Y
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M ]A[1Z5E23EC$P_,:"TYYHHZ"@H="Z0(@9W!EU0"]_R VT^F+06F79(!22H
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MGNWI'XZK(,]N9?^:.NUTW;V'Y[1]6W3BL+:OE<ZP>F_JI!J?\OW^F*V,C1W
M[Q8 >OL"GA2FZ>\^M66]V.W<_RS^B*&P/C9A8&!V%K]_::0XEV5XD(%6;BT_
MMKN]<LEF6K)-[R_.+HH,[\KF61O&=?UX7'JYC/<M8RV.$MY[2&O(FG<S9L+I
M17_<@K<>74U#-C,W\OSI5;E?O!=^U;<]>[C7;&8A668,U4(G'G,960*_)4/
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M/GA*@U&*I2A3?.H4M&$[O0]9-]M+6P-G[&8K/.&9_=QI=[O;?_OF15[1=W6
M^GI0-AZFPIP5!G-$<Y8&)XPAZ[!$5D@>I'%&"YD/4"GF54:?G48ZJ]Q_RVR.
M$A!7'1!G26AY+B(^K:]U[QAF=^VR$@#G"8#C$204U&Y&HD:1,(&XMPG9D"3B
M41E)E>$$].<-IG#5R,ERP#/GL93(5R+? LSZM57!Z97 6NR5*N#+(N"8"L@<
MEU@2@42,%'%'++(1[%.I-,,64T,Y(*!FK,K$L]L<OPH,OH=$OX\777AY[%3Z
M@7OM5O>X<3[5(<J\9[]<+K?HN1$L&$95X,H:RX5UEB;+E!0$R]+EM@ @-=&X
M>,SEUH;/:J>[)YNB]N<NJWW^@??KNPR>U:S1;\>U/P_.]L]^L-VS@^-:X7*C
MCGL:/9)2Y^)GW.>RJ@XQ(F/TEEG,L\N-SMWE5I8EF[9?*38Z!NVI,9Y;PZSD
M@7(.# KBB I=^IN6E8_'E UCD@P15 R70C:WG$ :&X="D(ZZ(!GV 5C1L"J>
M6[A^68AP$1TJSV7YTJ&R&!P^[E )D1D760"^CAKQ&.$W02V2@5BK0F(V@#E!
M.*]B/MDX;GJ'2LG<*R[.2Y_! C'Y>!\28Y7&RB.E/ <F3P19A0U2P.K*:!H2
MEVL;W "/+Y(4?P\Q.O4. .R9[9QV?W4=VPH%2_V<8^"9LU\RQT"N/2A=3OA5
M7.8T&,$CP2G@(+D(L70,+  2333A'G<,L-K6/L[?[=7#V7[]"!]L[;/]L]VK
MVLG7J_TS>/^?WTX.MC;_WF]J?.@BI4XFBJQ0N=^*H\BX0$%U$2S2J!G7=&V#
MOGHLSHH7$ISE]$$J)K6DD8G$#=,FPJYHP4(0QEE,2\? LO+Q9" * 651(V&T
M05Q)@K01"7&O"=;1PI=D;<.H*I7SBD)9H!/7%6?XF0(MGLGQI5]@,1A\W"]
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MIKZV^EJZ'18(6\?45JV#TEQHA$4N$B9\0"8:@20)7)"@A1,Y+:%*J*Q*;%9
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MCW<V_]44ETEMH_D O(()*;K#0<Y%+#.KRCQ&>T9#GB+^,4=:_LG)=;4\5/(
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M=ZT<F]$?JI+,4DSV8;HG.C"?1>Z/\B)='NL\YV4?\+SN-JBFK)K)_$&KXW.
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M8;Z3"]@PO+1*N+PO<Y^/#[^5N=]T$\XKT_,%RGSOWR=]KW;B[P4$TTZ\%QJ
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M0.!,7--HMI[G.\QS<_W['@RVT!$S9$T"BN.C0U9ZC#QWCE@+7ITT2ZMB9;:
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M/ .T,<$BAI7+-8(=TMPF1)6W7')")3/ _?"]@^,UTKQ6I+F<]-P-;FK2\R*
M:(KT6*XE"+U!FDIP0KTDR#%E$'/$48=U2H8];-&^IX2B,G#W[[+U[UG1F8MM
MS9]OQ^=12^>B5[6]/XVA^*^KP&%Z*3\&(87507+#>0J:!>6YPTERQ8VQUZW2
MB6EX6&NWNSX7_9F/$QN_\J]391LZPT,4N@,TNNZ9=LMGJMUW[UG^!=#@^UZ(
M&">,.6):Y55TPY#1G"$MF$G6,,U5SK/A*[,>20%BUH9?EF\E!>#X$N-%D)YR
M+D*P6C,2.:?>20;@4$H!&4O!;-N*6@H>6@I.-_<D$<8:KU&*GB.>//BD(AH0
MA6@=MC9:3996&5F974<=2T'9U_<V@N"-SA6#O'62<)>4(R&W,\I]"Q2C1I>"
M@,>"@&M!^/V" ,;:PDQ'+% *B@$<2(Y<KLQ"I>/PB^$AZ*55(E=FMQV>"4*K
M4\1JK">+LO6'?K^JS-8OPK '=K8 3E:<1-OK%[$3X*B99:#R)RDE*XO ,ERO
M?Q3A=C]C^V2ER#9IT!W8=I%R0U4PG3_BH/A9]E7MIJ)RA(N*YY47Z8V2;O,C
MSKE^<6S[3VO1'FO9>2>/VB6%C6J5.%.)D\;!VIX$AP5K19$E$E3"Z(3 AF&D
MDPLAL:A,&;03*[-[;!;$0M92M6A2]6E/"!8MCAI%*RGBVEB0JLB1QF!R+4M2
MY<0E(E9FXS.+8W%KP5HPP3K=V&,>^+R3"1&6ZV,'!Q9<<>!S$7N?% :GVX)@
MJ2L)_44[^\_(@E;&N]7Q[6&(8_,ZV+>#8M_^C(6+L5.D8;M]4H!1[\ 9;IB_
M"D6G.ZB^#;$-U^SEB_6SB1Y;_,K/'YO]E>)BU=9GZ3!/%/Z!6W?]C_'XE6,U
M6<4V15MNAX,QZ7=]JR1,QZW!?N9'ARO%S(7*Z1GT6CX?.+IT)Y2JGF?RXMV^
MQT[LV3PGY7U[$32OWQK I6+O9\N73P(:5L[&_UP(5#P U7D@M"A_?!X_^7;U
MX!4RD M@ '/EWP"Y/.["J\?.ZT, TCAH[$G+**=!(F^9 <*":2X-P)$/-%JJ
M$R&!+:T.]GMQ1+^G(U05LRXY]1F9!ED$/C^&@#ZH<V;P(YX?BFR-0/!Z-FL
MRMI0.-N'X[J@[B71SS0\GU+)VTJQ=@$ )BA_M@2Q.,X_;K?&%<&'C5S2Y!GF
MF%&KP9M))BG.N,:&S0\ZXP<3TPNF:ZT3LL.9=72GFS_:&@[Z ]!3&(/Q"M=-
MS-ASC3K?78@W3N$]3K?6?Y &W&=K???7'F=61AH)4M)AE*MW(<VL0=1)980C
M0I%,EJA99F9V0]@%L*W ,0M2O_ACZ>/VE__77_H7.*?N .8J^ZE93DL\=?'<
M7RRKP&4ASQ)T60GRE1=@M:[32C#;]NBHU_T%0CH <G [=]D%8AW&@G#-";@S
M6%%M5-+&>4NYN601>H9V;AP>M;LG<6P)YBOLV0I/J9O]DD).?O^VVQ\TNX/=
M" \W#F?7S/(2NT+A/?:"!'>7@K>2D@.7)3&!C*,&1<:,,T:Y1-W2*C57N2S9
MDI01FV%G8A7!3\P+_-$'W9R(' U'$SE#>Y;G:/:E3*@T:F#"JLN#Q)3&RX_N
M42K[V?.41LL6QZ.U062KQ<&1[<HO<5$)?C-Q^FWR7G&H=]W>Z*-\7,VH+D@^
MW]K9V./2D 1V!@F<FXDDH%76$8TD)@3XA2$T@/T9''<OXU,OP3(,KB%K<U7B
MIJGI'G/.C)#664ZULLKDL)<-U)&D](TMPYVY6T7)ME)5L7GMIVVU\Q(NJ$:9
M$5 ;AOGJL0M<;7>/">><<+DA1 XY).F1B: M+(%=%U1$[<'A8"OD<KLP"B;8
M\<"7K5Z^YZ$'R0DC%X)BS(J/;=MY"4QK<D'=VZ,6P'5I>UH=,$<MP'+XMW>R
M7(W,B(#.L9-@BVX56R84;+@B.*;('0?F)<$0<>Y,LAIT[]8K%C>R3:.5.?AM
M*TU;GVR7^F_/!V#ML#NL%>Y2A2.-]8T]RCV5A#GDF=.(._",=/;U$_7 IQVS
ME-FE5;PR6]KX;BL2CEM"E,&!Z<!I @X/W(5GP9%2I3NL2-12\^A2\V5/!1'!
M S,H< 7\W=J$G,(614PUQRY%0TJIF>V<>.<5!Z$-]M&!UZ <3Y1H> 1.@0U;
MK136[M8K#K7@/+;@[&SN116%2!9DADF,N&<6.8X#\L2!9Q,Q"\EGP;DB)R";
M\\N6^R\&_Z]9\]_.:02E341S;&*.3TSX<?!7MI+92'[OYB!WO]L.Q?%^[)SY
MEV>6MCPW?S]%+O(K99EN=8;E/2[0C9%%YW1%";#Z1]U^Z4.]*:\.3_SG<2L,
M]L=YM!,GC@@*/C_%.KCY<'#Y*1/,Q<,CQ]X3$9=WB,FI(9KXF1^X5!+.@G0A
M&<5IY(01YV/B@1,A '@<4'J2$\M&9^WWSML0?H>9[47[ ]D$+_G&MH_M27_I
MWQ=I'C"ZJ;%?G&%3<X=ML[FS\?[S6O%A\]W&]MO-C>;;C>WB?[<^K&\VWV\7
M;[<^?]SZO+:SN=6\E-LNRILTP27>+G:VX*&;VUL?-M?7=C;6BW>;S;7FV\VU
M#\7V#GS0V&CN;!=_C#0GAG_-O%;U\*O_XWHPMW/DZ::LGM!'Z$TY?R0(7KDR
M]G,GMGW1X'T$;,LFK1/*)?*/ &>].&CU*F\V=F)J#?KKK;YO=_O#7MR!>_\%
MUN_'DYNJ+R-3U>6-PTUP%#^=;'W=9+MP7G/GK_VMK\UV\^OG@^;!/_N-@_W#
MQD&[]6W:5!U\/]F%(YKKFP),70N>D33>;XA=^H5\>]^@S:\;)UOO=^&Z?[?_
MDY<,=KX?-]>SR=HES76_QZSDEGJ*M#.Y@#[%R!&FD30<:^UEHM)4?*64T+5L
M_6V044GNL M >CTSG&#KC=$2;)Q+P&\BD(&CK(V]85Q:_;RQL_FY%/;BKXWF
MQKO-G>+CA[7F]DS2]P4!GS(IU51=?^N+CZJ<)H;S*(")9SJN,766!HUMKHWG
MT]*M'./?IT'E%=^4?,O?0*?681";@"=3P_FB_/U]H!H_+=#181_8;FJ5N1*5
M+A=';;@)<)06\!R? ]' 86)O8'-6Y8C\YAR, CA6Q\?EXF\+EUPNWL<<!C\I
M>=/V<6MP&GMPH3 =>OR]8+7M]V,8MN-6:L8Q.)6$>R?'=%XO-GTY;9ZNY1UY
M+O) D+=>(*Z"1CD3"QD&_$C%8)TGT_CR/&7]-XE9V;AKO=*7D73E:"#(6N7;
MM?R$S+WMQ= :;,?!H%W:RO>@01^Z_?[V 'A__F K;7; >8A;O:R6O;B?+>W/
M6'VX\6N0_P2I_= JUTU&)C:&=VW[_=4)L*=;8%2WUC? R/[@6^ 38@P&BN8T
M,TPYXDYQ9 *+2!N85\UC!%=QD01AG(SQ.0Z&O5H0'DX0E$G$.*Z0*K.-',/(
M"J$1H4XGS15-02V2(*P==GN#UNDH//01CNJ-@DD3J%&+QD.(AA68)RL]HL#$
M$?=!(4N(0%1H8Y+T!D>[N*)1&XP'%08OL.*8,\1R*0(P$!)I'@2R4CMODU?*
MNT42ALT<88G]\I-:!!Y$! (AD3,2P%2HF'O5^%RQ.2!+:22>.4<$B !,RBC1
M!@1@[!65BYVS3O7]_CZ+2H_\LK+#N/ISCD]6!6%&OMG-8]GC*#89)\V'\L34
M;;>[QSD9]@];+C^4#MU@']Q!.*'_KS<W='=SY&LZ$C;?"2CWHY_'GLL-\. ,
MM.U1/[X9__)G:/7A#4_>M#HEI2]/^O/B+7.D=6K_>WG#ZNM1$-:8%2U8]@-&
M%2Q'-QZ%:%=*%V%J,W_UG30KDJA+O\8KY-+OKKHLH2M&B#M=]NKOC+K;F=<^
M[(W'8$[=D_$T@J3'Q3CRFFJFU]9C,3.'SBF<4L7$'Z=RBKXN/%PN0^P"0,S9
MVGII<=-G/(5WK[5S@VM<6K%C3M&.Q9:(*VO;/M1(U$,]&FKR.C3M&7:_&GG<
M):V[;7GM&XOH2RNS>NOW?[YEQ1XX:W&FC.&L*S@1 [I9,M#3UR6\FT,W*@=V
M_.W@7;L!CMGNU]W3YL$/W#P(^UL[WPX;]-W![L%?K>;IYDESY^^#QMOI<F!_
M'3:^?OFUM;.__^V@ 4[>)]JD&Z)YN'NZ^[79:KS?9(V#3=(X;!S_YW1SIB9U
MKCH=5$S(A!PX5C8BC9U P@MCL G.$P7HO<S)O1L7WU9AGKBK1PU\-? ]<.)M
M#7Q/"'Q3=1"CTE91QA!(!45<R  0F#BR3"4<&9?4ZPQ\BL_NDWA6P/<"*/4S
M[*8RCE?/Y=2ON&'VXU/)R96#&C5OA9J-&;JHG/(T"N"'"@-TVFB02XHCY@%%
M@R8VY$T+Q,SFGC]=_^JZR_WSHT&UTMY'::=;LTJ5Z\LGQ //71D#199+A2Q@
M;^+$2D%DSIZ>K9BW:$K[ KC,,PP/CI.UBEZ9K56,EEYS@:R8EX'O0&Z>;S?,
MRWOA/@F[N9A(M]7)GZV5\U*[CP^'J9]FB)#$RA+),:(V :8*K)&-PB-BA.(N
M81J9 $Q=9GK6?:Q[W;X([7X$&G25=M<*?#L%GB)%T@KO36!(B1@09YPB'11&
MT8I$!./<9P769K8NYP*I[PO@0\\PMC.9F)HW,Q_EK.6S"I[E%N<_?)FU.",J
M+]R)?&1RU(<7AM^NQ]&;9)G7B'HK1/TR0XF<L0Q[RQ"5 2B1]0PYG# R)A!
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M$C!X5IFZ=_>2DFNW4.H_IJ_J7:*O>FF\WXM5?3!%:S-9H0*!<X3 V7I+XDS
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MH126_\+R_P!2]^8L?)\C]S_A5[UWKM;"O7IARRY!](>)M'3)[L$VK\/8=@_
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M0TQ6AD0M,EJ!<<%M0 Y^1Y(2;P@W*K@<AY1\5=*BX\]8QQ_;=R@Z_F Z/NU
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M@45:1X:,L9@;I6BTM.KKA>?6^>?!<?$EE.*/C[1^$@8HU>:+Y/V.UZN V?S
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M$WD'#:A6 L2U#8L8<OU'?]#UAY?(\"I!7Q3Q.Y>Z&S1$*)+U:\EJ;.Y^E<F
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M19PQBQRL /*,6\XIM2 32XJX*KAE@E$3'+E.C%X$DG-'?F6IC(_ZO7(C=@R
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M+Y=TS.W:PSY,]"UJ//[6 ),P @%]C^5;3N#V8<-%F-!>+EI=G>E>CSX>.OC
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MFA,:#6:*R<2I,89*2JXQO,2LLG#?DLNOD(U.6AV_:Z)DUG"-G"(2<9#M")9
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M@+O8+>)WN*68O+'7'S6&,()A.BEO/ 3! ZU^B]W\'28UWP!+%X?[_6[5:G7
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M2,$E"4(I*[E.5G/'&746!\F%];;4$'"M(2R=AK!SV17862.[A%-OB(V@%\B
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MRB"1%31%S20&$S,7#M>4T-]J/J_Y_ =\?J=C-+4W_N[,?$ED?Z' S#Z"566
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MNC2QJ<-KW*T;:6Z]3-?9=UY3XO:'?NW.KTW6KFNG'F"NPLHG/5>&V[4TDUV
MA;T!=,:LC$I#^JYO+M/[STY88EUQ.].PHS37\1?&,HI72#VQDKWNI\F# PN1
M[6HG)*ZY4>(>)N@U4B>F.)7JRF9(=?WV,2DSRZH$-%I2;Y'6Y?F7DC_/KY7\
MN324&F]2&P:X;H-N8S/\[WFK7S76;G3SLWDLW#>^>C.%<G<3A<[Z2/?]6W7:
MBK&='F>K-GLGK7[C/[[WR\@R^NEM2HV][B UY,^SE&7ZCKU8BH5YU0U#FFUU
M&B]:'4#C']J-MP.DVN(EF*4%_*HNS5;JG4+C;6BE3DAS7HA[2]]E7]S-YZG=
M;NQTPOHM3/F$">].//FMTS;?M&>_5[I\[_.60K2_/>[V!E6?J%G.\LQCC5=D
MX5Z-^VO-EW]O79U'H.1Z3QY.AM6+/G=&>'+',7^'SCGT+AJS6Z@/E2+S;3)>
MZ3C$#*^_T)&&NZ2Y@!54,F]5C%)P[A/$%+/W1IA,Y?! #ZTCM0\6J>VRO:W?
M3O9?_BG?OWS1WOUX0O=>OCC>W]J4N^]^_WCX^4B^__A;&\>1N\\G(K4?<5XO
M7\OW!\<GA^_^O-@_*,_;EKM;1V6N'_>WCD]W7_YU_'[KZ-/?GW>G#E2&)%C*
MU) 4A2$2P!-O-"U9+DEG;VC*HF2YR!L*F=PKB#63D%R"1,*G'*I=ZDCL7>K%
M2*:==,%%K26/R3$6(&N3<[+(,;[&QY7!Q\D#C]HSSE,.1"?/B PB$FM](H9)
MR9SC*2:[ML%8T]Q0G7O. +E(Z+@H8]2Z;*W+7L-JJY/E@5(7C)$Q4>^I0IW6
M&\DHA^0>&:MK.+X3'(_/).X>O+[8_;SY^4,LY9N-H\2Q4I63LTR &D8H%8X+
M 9E9^0"'$A=>6WW '(E: ZXU8,5 :27 Y:!E<A2 9Q\]\Y8ZA9<62 ->N8.(
M/] Y<+!SY2#BX:?=UQ]LYCJ&:(E0)8W;14> ^TBHI,@;SG*1XP,=1%QQ!?@)
M=!O;Q)E6W%LWN'A ;#8Q  6&&JXP,EA=<)DS+YT-W%(YK%+-QM5LV0^O9OO'
M>2\<0S^M>O':'X73KZ><N,F 5RB;"1/9$$FE)CY*1S0UP8 SS KZ%"K7/G4D
MR#$Q*D!* U$:R:W@(B0J!%* %C342+!J2##IKG2,^UQ:53@D ")!*>*X5T3G
ME*/U4F4QOQ:P"XP$BS+&4T<DH5) #+(Q)2N5L"!9Z69I 3469T2L$6G5$&G*
M8Z>M%3'Y1)A1DLC,#7%)*F*-3Z"#5];[IP5)\TL]>^KP8IQ!0!'.*X27:+B7
M07G\+]$4'4U\0>&E#M+>T_Z9]E,IX9,6+!&M&"H^DD=BT?HA#FPP7CA+%2UQ
M@::[?[F6I0"9NXWQ!-(L#WIX;TZ]?B/WNJ>-]CC#M9QN*\Q;#L*==7N%(!XB
MZ7(FS+YA55</L^?EKFI!;W C8'^: ; O(?J2+%X@592TYP.DB4'W^9 B:FB^
M$S3_.>6:$LF"XQ:(YTD0W&]#0$='I',I."UXQ.W=X&9>R3.+&"%828Z_2Q_%
M.?BE^OB^^%O-^PO,^U/- ES0SB9'2B-5(H47Q#J7B8N,)YEI]C'<S/NSMTA<
M8+9?E#%6$GX>PP?U8T"G]D/-!8RF_5 >0#GC2,X2B 1=3CHD3;)P"D624]:Z
M>6<R+#8L_1@_U%. F+GYH18"8F@-,;/9.M-N*"TLTKL#$J/31&8H'BA$&E T
M.Y%2@&+N/"60J9.B)NLN'4/G*)7J&!GYO/%/8?1R\#=\J<<4KM5C:H_8NH53
MJ!.IEL$S5;<%7TY(/YQR7UD1A<AHN!IM+9',,F(A9!)2H!$)3 >G5SAX>6\X
M6#3PG3W/_Z8W7&B@^\$.N4=#NAK1[H1HDTXYSZS /4[$<471#+:>.)&!9*MI
MH!KU5HAK&YK?PR>W>#BVHJKDF]1/T O'#>A$9,]_4KM[5CBOUA*7P9U8:XG+
MBJE3OL4 7 +E:/:GC&JB$X98 9&X)(*RRE&P>875Q#K'[2&5M45/<IL5<.JL
MMWO:IM/N1F^LX8DEHL Y(J-V!(RE)(!2,08=LW9K&[S);DAZJ_6YA=/GWJ8V
M?GC4;!RE3NI!N]+K()ZV.JW^H'@#_TEWJIZ[ EE[UXLC?D\!_[J#:-W$Z3%+
M*R9-4Y;)1EO*T#@I@TW"&^:R4&"JP@D/*+/KTF$_2#Z'2]_QI57@J4]"Z40X
ME(P#$S6!H"+A40OO'+5:V%);43NV,AWP:@"N 7BA -@%GHWD62>K93(<-6,)
M&7@$ 39H70/PR@#PWJ1;QAH;4.HJ8CQBK]0<B#="$IJ%SX:[8)*NBC=*:FL$
M7L Q:DE02X*Y28(H9)#<&!&%DEI&R\ HI?%7DX$F^LB2H ;[.X']E ^>:N^E
MBY9H'CV1,67B@A8D&)>XY30$_A"5(5</Z7]4W<@:M6O4_C9J2R6]!ZTS%U[2
MJ-!L9EZFJ)@.06E?Z^\K ^E7 QPXO\][KS\$$Z.4I?)D+* N;'&A"$]X4!F8
M5]%HU. Y:]K['^M?=5R_=Z/VT?KNG9\BTX>Y-&Z?*_8P.@:?:L1GK0$^+GP=
MCCC]?\.9(=-VAPG7SW"%4J]\Z]8NFE_O6Z^OO[W^P2__E5==VS@X3HWGW5-\
M\D4#^GW<RGA[YGFK4Q5&B U_T;B^$LVJ^67CI[7K'Z_]/.2YWI?&P:U!OP%?
MF@=789S?6MVM*K8U."Z)\(/4;J<P.(=VXZS7/4/NN&A<&6$WQ=8Q:A@7Y6H\
M#X/^>N/::X2 1%V^C&!<#7GEA:XFS_LR+.YR(?;RO5;O6@I^I[HWXF/+',OO
M5^;=\-#')^ O4*;AQRV2AXN-5W"MNJ=XRQE>A7!\?8K'@(O0[B6(^!* </%_
M[V*W:)8MC]'Y3"43WK$@\'_I:%(R&E'%__DX_L^G1*&:%(5_P$61?B^ZO2\]
MH*^U@+X4<J/^G9VC39SE/]4JSB;R])**O/=_']-P^E<'WKGS_8^_M_=>[O+]
M@T.Z^_&OC^^WWAR7.1\>O#]^_Q+'>O?Z8N_C^X][!Z_EWY]W\)DGGW8_[E[L
M'1Q]WONX\T%GP8.C@3"O)9&6&5*2Q%"4,>FYU-EX6-L08EW<(KF0_=N%-J[P
M0D65N &5^H+7KG/O%6)?;]Q*8>-O74S06<C:)6V"1^J2WE!GDK+&*>H<.!U#
MI6E-D=?.WHMKA]=^.^\CZ/3[2/H>J:<\^A8J0SGB4V\_O_HRZVO$A1 7"H%]
M0H[MI\[2'T^[!VTQ5)D^>$C) !<D.\&(9%H1CSM&6$S.@C.X:VYM8[^3ILCI
M*HT@4:7^ "D'R>H46@C(GXY;X7A$9/U"9)V$6@TN=875E^C[/__'2LM_O03A
M1OH7U8<*2P-"-@[5@-,"Q'VDCMSJ5)@X)-BC7JH(MN'3X%-*PT\OX1OEP'4I
M,L3.L^Z@T#@*A5/XMW5Z?HH4C ;G&.O/AB!V^4R<]UU ]=[$/@;3V>E]L]<K
M)[^J)LAORF_[>?]\4*1&OS(F_HN2I$;7F=#U\_8'RH0-$"6)6G$B2ZTO+X4D
M@D6N.%<T%M^^6+_-+!B!ZY#6D"-P@2L5XHM"<#WE9'C7*.^$5U1;#,_&)_S:
M70B/@O$L)TB*.ZEHLDQP82@S20CNO;Z9\*:%^.QT]^H+WM?$]6WBVM]"L]-+
M*G3VJ(-79721S"PKOD0 YY.G26M[MZY$2085!&>@HHS*./S;,&=R,"IGN,V+
M4>_ZC]SUQ*R.(!2AT:&:YKPAH+PEC GI'/4>C%C;H.O39V.^A3'7#<?RY:%$
M/H?A[7,Q)3?^XWN_;#R C?I8 X\,5\G7C<)ASKI#4^Q9I:JT_DF_?FK%P?'8
MI7CEQM%4Z)=;P/>[[?/![;=,=>-^)/O\!2E]!*]1RY6?Q[WQ?,[@*!&/%N4)
M@8S3?0;M3W#17_OE^M;@+DRLXN(LP%3G\6H!=O8.ME^^V6R\VGFQ_?;YSO;>
M\^VWC?_NO]K:V7OYMO%\_\T?^V\V#W;V]VXEFT5YD[W] YSZP3Y.>N_M_JN=
MK<V#[:W&BYV]S;WG.YNO&F\/\(/=[;V#MXV?1G"0XL]3KW4[JPQ_3H#)",;!
M@54F:918$D6+X]% MJ4$3A:4F[4GX;W;[)VT^L7;=-UMM0)NO,T^&D"]P4V.
M*OSHEO=N_+1675G[N7G- L/O]A(.T!OZ&-"RJBX7M2$AX!Q#+QUWV[&43KT<
M_/SLKA:7MQIL+H5X&4B*%BL-2AEF@Z(B"%597,Q1P]W<+*Y:!_J&#G0B]P_^
MY+M;K_G>P>'%[M;)!RVSR3QRDM$8)A)-9-1\J2)6V\A,4$YQO[;!U?IT._#&
MV%]UZ2HM5(2&57$1E (G(R_!E8.J7[P1%6G=A9PT1)UC<!PRSMD+0'O><\Y+
MGT\&FM7D]-CDM/=Y\T/B1EC/ C%H_1 9)2-6"4%$ BVR$"&(DH$W;:1?$E,Q
MM$/W%)$H%%_0T"]U#[+)FDNEO Y,2JF3==9YK8QQ-/)D;4TVCTPVGPL*>90.
MSDI+(IK-1%I)"1B0A,DDA&.Q6-!(-E]#H2;*M/Y9*G&+U+Y8'QID5V,RYP6D
M9@OF5"7"H1W.BXMT*!NOE6Z:B#E=#Z(-CN'+1VD8\T*[I-\J,>7NR %81NFC
MM@J]5K=_U>&?RN/+>[1R"S^Y)/SK\:4O_JN[3J[;\.D'B/&9/!DE\>*H@UI0
MW(G%]9M;)?J\V>^G07\S#!64S4Z\$B_8'$8POS!>S6MWX37\-WQPR&**14<,
MF$RD3(9 Z2 G#)44(I/.H"K-Q/KT(94O(#V84D-+''72N3I!G$,'ZU@;OZI&
MWWJ8\T?IUS=[?6^:ZH^:4>/.GF80@@>)>!EIE"9RB%XJHQ++$+1BN?8T/S+W
M[6]M?I"&HCT.0*+/I9\YE:0<Z2:.9I1UV6>($KF/K[M9XAAC>3!,<TAWRS-X
M1'JYL3)I338WDHW8W3K\8$%H%Q,ECB5.) I>@MO&"6)0#D)8E,4EV7G]MF,M
M8^ N0=L0>N=(*NG?L]3I(V 5C;N+4-V[;(MR-8FF7%T2JMKK=D)-6+,3UM['
MUQ]8T#8I#T1'JHE$Y8Z 1!)S"BG* +,*?#'8;M &IBAK2$37B&=0B_L9Q?TH
M=Z*HZR7!M-*?_*@80O\XH4H\5NY'H+\^QR#3-^(S%9=($;6/V1G)DV2"^9!R
M,?"5 LC>N@^LE,:\HY.U^)H?R5W/]&7.U"C#=>(@*>-9<,-HRDEZ6=P&64LI
MO<M@/<@;T_"N8]C;=%2\7F]2U6>J<[35ZH=VMV2C'^!C?FMWP\FC0]#A&(+D
M^Y?;^(P7QP@_:F_KA.YMO;[8/]AF[]_M_HL0<OS^'3[S\\FGW=8D!!V?'!Z<
MB-UW+Q!^3FA)^T884[L'?^%\MOG>Z8OV^W>'8O]@\^+OSSN?BQ&2;:9!ZT"X
M 4^DL9EXR(+P[)@'9IB)=*UQ&279+$BNJ(]4I:2="M):Z[30N/"(4,I)(?D:
M6AX!SDI$" 7<VL;;[9<EVM+8W-MJO-S>?_EF\X__[CQO[.R]V'^S.PHI360X
M7Z/\&P,MWY[$]4G[G!F^$HNJ<(OG"'W<)3#4*AY8@J\%9F[ET\=,(B[IN[T.
MM-L7#1P7CE)_E'9_FXK0'S+!Y#'M[^&NKSKHQNF%0VXKGH01^RU+EN&/YL3
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MX(G+/."?6D7MM(RZ2F90DC>EO*U.60V)-20^$4A4UM&0O.#:>)E1;X@J2:[
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MI+I).7"]RP$&H*%SWAX.QL.[?J<UZ7;&$_CO?7<P&0][PX?NJ#7IPZ^*7%
M).7+#3!C##-)8L8D81I;H,:P9VS!GIC5:P_O'T;=+]W!N/][MS^ /[L'<BT+
MHI1];]79MP/?X @:RLC;UEUKT.Z.OW2[DRJ+;;>_E$GOBI@4PS(XL!-#)N,'
MD\*H%B1T@,Y#N;,+3,JJ]^JL,G[<@?V_#67=C@IKC;_T[H9?#]W MG"D#/NY
MA ($J 8#>V)5K_VE-?C<'?<'X\FP_7]?AG>=[FC<_<=C?_+'H<PK@"QEYX<2
M[.1X8"<SDIC^9G!<#>+Q[2/,=G>LNNHVS:7<^ 6-=B>P7#^(*($_1-<&3>[X
M\?Z^-?ICV!OW/P_ZO7Z[-9BTVNWAXV#2'WQ^ .%L][NJ4Z\(3,:8J\M]QL2
M<5TD0!M;V(8 WB#6C;J_=P>/W7%O-+P'13(9M=J3\=?^Y$O[$33&/2@+1;8I
M )*R[&J?90*H@5"-#5@#X1H;P UB5ZL-BGO<9R?,UJ#3@6/*>-*?/(Z4EU<1
M!"F#KO<9E(1F #@C":]!?.ET;R>J7CIL*IWIF_V9QFZ-FM!1__?6A!WSQY/1
M(S-IE&<XJZ]TRM^FIUS ,1* &L2$S\-AYVO_#DYTG>'D"\P&[,2#S_W;NVYK
M/%9W"TC!2%GS;I\U B33.0RHL85J<+ -8M1D!%/Y./J#&?F*7-GM(V7!^WT6
MB/[\9-&@R6;CO6V-NQUT%W9A&\7M3]6ZS>XLG?Z?4]8L CIGD(PDJ 8Q8M2=
M]$?LL'O;'71[_<D#J!AU>S6SLY01'](VJ@!DQ) ,!JI!C$!%WD5K<M2]0R_$
M0VLT^8-_J<B-(@A2EJ2.X+PCVQMB> 8#&/_0(,[P$,:D]4]E3B1[R&;^.G7&
MYKT-UKU!TSP '<!&_@#'T2^MD6J<*]U/.N6I,S+ $-,.4 P&ID%3WVJW'^\?
MV2)G=F!&B/!NJ.SW4X4F95/&27D#.398LX*-QH\(OEEQDOO[_H2=K$!?HXNG
M/_C<'91P&!9!D/(I=<Y.0&,;R Z\!O%EW/V,DP!3\+D[_#QJ/7SIM_N#WG!T
M7\K<E4"1\B=U*(\A,MYL81H)H$UBDI*O_,%W'<LA0:T.^ U0*0M3AW=U1[SQ
MHT#3))6HQH").75KYFD,4LK1E"^@#$<YDB;Q4QX:*<5+97!2/J:<"FKQEB;R
ML"!L4HIY<CA2KJ4\$(5!F"8R"V,EI;B2Z""=_I2W 3LW<Y8SPBPEIST?@HP/
M-RG?0W:XIHF<D05<2C%)$9B47RG'A4H,IXG<RPX1E#/WBD!(.97R7>3%&IK(
MG>RX04D#K@"$E#LICT5> **)W"F((Y1BD1R.E$\ISX4D*M%$=B6"#:78D^XG
M94?*"Y$,531Q[E.QAU(<R.LMY4/*=Y 5OV@B/Q1##R5/FV5@2GF7\A>4"FHT
MD:D%L8E2C)3#D3(OY38HC'0TD5F28$4Y"UP)EI1I*6>#//S12,XIN;<')J5
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MIXG29BUKX1"^N>WY(C]C3;P..B*%XRW?.:([W<>U6MC8ZO7CL=W4X<G-K'K
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M>1L/OKS";VY['4:S*2H=QRZE+"OH\%W'\^L%#">P%F1I_O;#_P-02P,$%
M  @ D8%65B& M=H)-P  W4," !4   !I87)T+3(P,C(Q,C,Q7V-A;"YX;6SE
M?5MS6T>2YGO_"J_W=;-=]TO'=$]0%&4S5A:U(NV>>4+4)4O"- AH %"6YM=O
M%@!2O!,$Z@!'<H2#!D$(YZO*K_)2E97Y;__^^7STPR><SH:3\=]_Y']E/_Z
MXS3)P_'[O__XV]DK<#_^^S_^\I=_^U\ __'BW>L?7D[2Q3F.YS\<3C',,?_P
MQW#^X8=_9IS]ZX<RG9S_\,_)]%_#3P'@'XM_=#CY^&4Z?/]A_H-@0M[^Z_1O
MJ)A&9A%RE!I4U 5<+@FD0J^S,\%G^7_>_\TQ3#%* S;0'Y5-#F+1"D(2HC@C
MDLQ\\:6CX?A??ZL_8ICA#S2X\6SQZ]]__#"??_S;3S_]\<<??_T<IZ._3J;O
M?Q*,R9\N/_WCZN.?[WS^#[GX-/?>_[3XZ]5'9\/[/DA?RW_ZCU]?GZ8/>!Y@
M.)[-PSC5!\R&?YLMWGP]26&^F/,G<?WPX"?J;W#Y,:AO 1<@^5\_S_*/__C+
M#S\LIV,Z&>$[+#_4___V[OCJD</Q'-]/PVA8\*]I<OY3_?M/AR=O3D]>'[\\
M.#MZ>7I&/W\]>G-V>O+JY.W1NX.S8_HK#6/QM?,O'_'O/\Z&YQ]'>/G>ARF6
MO_\X#-,YP1&"BR68_[W&M_[T%7 *HW0Q6LS/:_I]]=T57EOL^'F.XXS+N;I\
M^&B2;GQH5"4UF5[^RU&(.%J\.[B8P?L0/@Y./N*4P([?']/*.<?7D]EL$!21
MA8<,WC,#*ED-T:@$6296"G?"1G-STNK 9C2RA8A+F,6%G%?/^*G.YD\XFL\N
MWUG,[V)N'X&QG-3-1_8./^'X E_1PCZ<C.?3D.;_I/5^>#&;TQ.F1Y_3Z**J
MBH/9#.F_?!8^#X*/D2NA02BDD6>>(63G &F1QL*T\(8U'OD&,&_.S#7"'4S3
M#Y-IQBEIPQ]_^ .K[EHIQB7F,$TWF'AW6:X^\=/LXOQ\\9TPG./YY;^O6K(M
M?^:3W4IMR1X:Y;;T.IS,YK.#<3[Z_!''A&4@M/?:IP#2"T;6(%D(Q7DH)AM)
M$!P+MC%W;F-8AQCB*S'@FV+&5A/>3.Q?!W-)T>'X@@:Y&NUD/'N!93+%Y>>(
MG3@[^DPTIMD?CL/TRS'-V>S-A/Y*Y)Z,1HOYF>,49_.!Y3IXCAZ2+S2@P#+$
MI!@DF8Q/R)03JC&#.AS.MC-]+W]\#%9'6M_&*UKI-%?D2DG0QNFD0F \X:XM
MTW[U;U_X>'NU;BN]A@OV$XVENOU+)%>CRXPYRQ3I"\<YN>6A@"^<QFE$M$Y[
M(QAOOMKNQ_),O?VG)%03.39DU?+I*V,TB$H6LFD"-'.!1B83V:+(@+&4/-'>
M:Y6:D^D&A'4X)'=E^_M+HLW%UHP[/X?AN$[-R?@TC/"DO+B8#<?DS Y2CDYS
MHJY3Y!.ID!(XZR4$*9WR%A53K3W(A["LPR;U)]=(3>38C%4G\P\XI5%.;AK>
M2Z9;)XS+3H!%%T%Y+L!'1Y@T(S>\\CTT]YP>1;0.P_2?G&$-9=I=W%L"9N]R
M :V% R65J[N@!9C+*#"A<%SN-.[=9*MHAC0U'^@K7^(G'$T^5C]C]>U?MQS2
M?U\,IYB/QV^GDT0+O<(8F""]5*: 4M6$^(P0+8G;,>?)HW698^N@;0NX?0I=
MMF+2W7VCW8BPV3HZ.)],Y\/_64S422%U$<;OAW&$=6-K3G/!94DN:D@Z6?)J
M+8*+LH#D&"V3)0N>&]/J<41]BE&:,J>A()HJV9/R\V22ZS!/<?II2&P]G8SR
M0#I63& 1++=$UN@4.*<=#544GTK,EK<VY ^C>6;0\>V0HI$ FA'B%!=>Q<\X
M)D]@1) .\OEP/)S-JU_PZ<HC(&= ,>L\L%P,*$U*S&,10&&PB\6%J&WK,'0]
M9'V*)YH2I0/!-"/-&YQ?VWVSGNF,Y!YF*3PI,HIZHPH%.**V!9WEIK7BN &@
MSSOOL9!V%\Q#CE8#2<K7?0 +,7KABF,9=?OMFQWMO._7R=N<@W?W;OHA_\9'
M201TI21>D XI0W)'I8_)2 W"JFI@K 3GC03F510,.>F,UMM #T#IU7EB:R9M
M-_&W6/!O/]V>HM?T>^,TEL.37]^^._KEZ,WI\>]'QV_HUZ.6^2SW?7V'B2U/
MCJ95ADO=1#F<G'^<X@>2-AGEKS1::@QBPML: Q"OY_/I,%[, _G_9Y.W84HQ
MY, C$\XG#C'+>FQE'01+T:*Q)4FF90XZ=+%UM@7F)IN)]SS_%3UY^'Y\>#&E
MIZ0O9],PGH6T0#'.B]]6^B'_U\7RL&:]&2Y!"EJU($IBI'X9!V=< J:])B^)
M1^MW-</=C+!/%GFGZ^'>'<U^$JOM3OP#$WP89A]>C29__(+Y/5X>(!P4<D/>
M81J%V6Q8ALODRJ_C6PXE,,N+X11V*AJ/XEJ!-Q2%*C2,F: CQ3 [U$(;#Z1/
M^TB]7 J[H\E.&/^VOK%8QHM/O:7@>XKSX127BWCA>;T=T0(G_^ZW<5ANQF&^
M&O1T."-/_>7%E'Z^Q>EPDJ^&/ @<12P<P:B8:P)V A>3HSB>O#_.G4BH=[@F
M.AQJGS;:>KMJ^D*UAMO =\9)T$]*!43K/&2K+,V?IY#5T&KW%,6"-ID6O1.B
M?;+ (W#:;E4Y0YHJ1P84=A50.@KP+GM@*D0M;79:M/8'']FJVO<I61L.W%Y(
MF\_X3LS&Y1@?TR,E9U9\)..F:P)PLAEB= A6$^24%#>Z]<GSEI#[Y/QT1:Q=
M2K4W5$P8$U,465AD9-*,X^ US9J)0=GB$6WJ-17WL*TB'=.E: XL$+.4IP#-
MFR) QY2DR"50=-;K;97^AO&M&?N<)=Y<]CM9XU7I97+ELG(92BAD P4&<,4G
M\DV+BB45LI"[7,-K>OV[N\_34\(]5W0]W^>QR@ONK **C60]*=;@A=00/$,5
MBBNE>>+/#O9Y=C"[R^??1E6W#XD@QBD*WF2 H#)Y%DYZ\$EHD$ZR9%%ZUOSP
MN^D OA7+LQO>;[V5UHPK^U,F#\[G0&:C@S8<G*[U!B)Z",(:B 5MX 4=EETZ
M5L]#_\V8O&^$Z6UHLJO3[A<'KP_>'!Z=_G)T=+9UK8:;7];X)/L1I(W.K5\/
M0QR.AO,A+E(0YY/TKP^3$2V V=%_7PSG7P9&($K.,SCER*$256-%'4 RH1Q:
M[]"U]A2>PK2M%KSV_0/$E(4Q&FRL&Q'%&5+(3(,I1@E7M';-[_I>>WR?#&Y3
M)MS6*)M.>;O4UKOC8=RS(K6NA75(-6F>ZB$6 RL%A8;!BY1;B_XI+N]WKZY3
M!FPI@'8W(A8)]\L4@/F NVJ$9(1, 2)Y8;& 5T%!%#Z:%"(1LG4IEAL 6MP[
M']-'OE!L/(B,.VV1@EU!,E*,,XC9&Q#92E3&,M$\:?_Z\_NDS#:7\GTWPC>:
MX7;G<^1QT7JL_ZL+YU,8$:#9P?PP3*=?AN/WOX?1!0XP2U>X39!DW?@HG%P]
MK@VHD'WR 8//L?5)W3K ^J3@VK&BO4S:*;B4)A<$AGQR)&!Q5 ]<+L<L?<A)
M""2];0B1S!1UDE*'0O&!+E%ZY*V+;CV&IT\)!^W(T4P"S3CQ=HH?P_#R+LIE
MZL+-$2.9<R%" !*@6A[.AD)CSTDF-,SIA*VMQQJP^G2EIQU#6LNC2S<Y\QR2
M)-456<7!E*M7OQ,4+HKUQA(8MV,W>:,%4)#F=>G5KK0SDRD)(R'I6D !&8?@
M) -)SBUWTC K6P_L'AA]\IJVE/X]+-]JTEMF.)U/QM=0^, *(5' 2\YU\[5N
MCM'0;$C.L,*34*TW-6YCZ)-?U%CN6TUW.S\HYV$=>QB])55[/#X,'X?S,+H&
M;L J$X77%,#J0OZ9*."8B8 V<F^D<\*U]IF?1M4GGZ@Q,1J+I!E5SJ889A?3
M+]<H6T)PQ-D"5AE>JYYDB,8+TE,E*(_.<=F:&G=1/-/YZ?:8HC$7MISS9K)_
MA_,P'&,^"M,Q!6XS<MXOSNLT8WZ)99B&\P$+PJH:MR%C]19@]!"U3*"=2T&:
MY&1H7WSE*51]JFS4F!J-1=(RLK[$L4Z:RL 9&TF;J9IP5/,;=:0YD('"!%M+
M"48MFB<8/Q/B.B0RWR:)NA16,T9=VW&_#/MBE#S5TET\"T-C%@E\+(S\9?1&
M2\$#:[U#<Q?%]H5$TL6TKM9XM>^AK"L"4P+#;<W]3@J\=X*6+5J)!F4QK97H
M711]"K:VE/W=$B%;37F[%)/+*G*OR;[CY2"_7&)BY.Q'&S(4824MLYJ3Z2RM
M-<\E+363+796]?]>1'V*PQI3HJ$HFN].OPU?%GF;TY#Q"A 6QU@H@,&349=%
M@HN&C+H0PJ2,/OKFX=C#</H4AS4F1BLA--R@N=N$X0Y?2\C1!"7 %\/JI=-$
MX4'V0*8Z*C2B2"&:;]H\C:M/.]2->=)<+,T(<W3^<33Y@O@.%Q[>/>-6R072
M;P5D80@JH"%_3DA(SI3H F?,MM[B>Q)4GV*VQE1I*Y"6YF9Z<2\<G;3VI.C
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M'<A7JMJ"0EC29;+4LP13*'IG.0,1U8JDO$RL-2L>1K,.(>PW1HA&<]_XGLQ
MA,AER1*2B:;&.;7]:;WQ8&UQN3C/9.N8\KY.()OBOPS77-3"9F\A1U/#M6#
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MKX=N#P(WX4__%<ZJDL JW?36=6S#HI"B>(CTJC8[\N!%J:6[,7N/%*%AZR+
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MGXR%NO;(E0H1 M.U$;(2,J#@N;1.4MH,:9_V<3;FS6V;OP.A-?-_GX_UC\F
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M%0_.^E@/<HQN?E>F%SO;))_A+$TN2-[YZ'.BCQZ<U]\&H3C&'":(K,C:S-6
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M#1@H,,4$#8HRPU-E5K8]IM/F\%$Q8LD^ZL[;YTT&.#5I&=R@C[]XD<\&_2^
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M6Q&%7H$O1>I .458TD"DM(HXS3+)";B+Y?)$JGUK<K]$6!,/[(L'F]BY]M;
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MN040^X\V*CKIT7[$+A9N(:JXA![^Z-,OT(>A[[WJIU?I&NT[&D\;?<W[Y<S
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MBUVJU!]\^B0BF%SE*?'!3%7=.*6LR(*(6%HS"):)3T(0%IVC*JD48NT>!1O
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M#]0DQX(4Q,GH,>/S0(*-.!7K;# >-DKZ/2@6/JNKE1NYOZ' PR9N.,A]_28
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ME- &WYK(1/8&-*U>:[#'X57HG?S]J4\_],$5WDZDS&@I(LF9!C0K<\1C?$M
M!XWAK%%QL55/C;[*6V'=_PQ^K/Q>TLBY?>^W<%/OPW 0 =*H="F_-TU]3\1@
MU'$J:\&E(HDQ2B13'I<S3HGC/'C(P+6K_=XW@/7"Q55<K.W3VK'IMN_*"@T$
MC.$RCS0EPIQ'6V6OB?/4$U#<"W"*6=Y,)KPRL!>&+HV<#^G^VCKEE<?R 8;=
M0>H$QK+G?**-J_'E%(8$7UHCA60X%4;GQ4!K/X2>PGNA]3YHO0456K@!5Z0%
MIDL(I,ER CB:T:#73=-W3V2=N?>.F*@EVDC@NY=")!92E$8H@6%,Y=!@#:07
M=JX*"VKZLH4K:K^@K=\-1J.+_J6_?Q+0R<$H1C7%,8=2$.<""1+!,4^ISS$F
M067MZSXKL+R0:^5MHAK>JWAI;#XE+YU\RW?0'N?]+X/>EXE=9[>0)V?7'0<X
M:F,M\9:7SA8&2% FDJ2332(KC>]#T^5WB^>_D&S5^MJV,VO?;ML.\FA6]-[A
M(+W4"#A#*JW%8B0!2L6D$YBF,9^D;=8^=C<<+WRLR,>MG-O"+;4-HM7%FT6"
M8\(EP!#C%2<R00D1,-^R*KE ,TA%:Y<K;(_VA;P5=BQW84#%NV6;IEFSWHT?
MH8>^2%>#\G(.?1Q?P?!Z5D6)0Z$0G)*$N;(\:- EOTK$*0@QN>STXA'Y[JEV
M UPOM-TUQZ[M_(I7R38=RM70]T<S\U_>WMSTOKWZ-(3ITC)[(V,N3;-P#=%<
M4(QR,L4H.Y0"/,]D<BHEGVK3>#VL%Q;ORN+*KF_CJMC:#KG.<L$Y#\1)83'2
M4?@W88H(CA<NYXBK2>V[NL?7H/C8B=F*-_=T>6N7KK@&@A%!%-5LP# \)GQ[
M<L*HW%F03N.@U!XN(CZKAL?/A<H'9$K-"U^K]%-^'PS_P+&<^9ONV/=>I?^Z
M'8W+"#K:<\6HD 1\+$<&7!#+LB?>YY2E :M,LY!V@X>^L'#I2M^6VVK>Q=JE
M1;32$)BT^!(PBI@I*.*XC1A*L^"S4%&;9@>5SZ5!]W-E76UGMG$QJ^UKYTIG
M*Z/7Q%N9B72\-,C 0-EP(8!;E9ULJX_JR6@.'#O_CY%+2]Z5G;40MVFL[31H
MX(%..L+@6^T$<3ED C8%QH("$'MH!W%\W<^?,:>K^GP)3[<^_MJ?;:?W 5,I
MA9'1$>N2(')RH2/H@.]C ,Z292'4OJ.[IZ'MZVKO<WD+CI%1QW+!^,$PSWI^
M-,)5+DY3W'+=3<>49."1<$BQ5$I&XB5-Q$"B+!NN1*J] JR!=*@+QT?)HJ<.
MZ';T9@O73Y^ -[M;UP1@2_>5UX([S'WEJBYM3I<=_'$8XCC,-KV4&+"49I/>
M4A)BY 2B%CJ5XNY8.U,[$&'6W%L^,%\V<$/;/)E^@1-L_OE;J3!\/Q@OGW=G
M%V^%*>+EU!*;E2%2H'E<#&@9YB%;JW2TIDT*;8AW_UE/9?<_1:XV?=?"E;CV
M8X/)NYM$$"X+3U3$2%CR:(CU(A/%>90^6,FJRPKM9V0O,=WJF.X(N=5"5[&-
M +_WUW,QAB:P]Q$P-H=\F##R&%GTU +0,@7:CCTV@1]EHM)8HEVF1$(RQ$=)
MB98I<,85^.K2W4?%W#7Q["D3=P//U[Y0?37T<\O]/KCMIS,_A%DLI93EWG-'
MDHFX6#'+B5>1$9"EM4]DS)F%8NT5)[2KGW'@V+4M'PWJ&[ABL#J!]>;K> C7
MW?&WB^'X\^ &4C?.8^B40_0L:$*3SD0:*HA5C!&1M9/,L,QMLSOQJY_Q%_![
M)0-7?-]'B.JL'-G#\ 81?BNCG,QYP8O HA-$LW*+1 A&;/21Y,1U-$&;X!HE
MO/B >ZO.:,:)"1]6/?LEX'\<\%?Q4\4+W07/1[BY'<;/?@1W1<2+$&<O3!.0
MFP3B:TC5&-A^P^TZ/ASLRP&59YGF8%GB4K BH$A]J4"WE+B@)7$<ES\:K';0
MZ%CIN%FR(K0]($DVL7OMD+/4&PR&X^[M]2"_'<3;LKTW7R-'X]&[=V=S!42I
M)<_&$8!)=TFT@(U&$9>L,]Q8G1=O[Z\(1)H^<7]A28O>&K1MZA;V35>)K"I*
MO4R3',Q.=,$S\392$JCPSNA@DFJKG=61R%L?<Z!2TWLM-JY>K>#:!."+*O;&
MKMQ8[7@;/QQ$%1M?!<ZM<T1X#41*6?K#8@(OM0[)!Q&X2*=!E"U5L=OER2;F
MKQVUO#J#7N^[.G.DVN'('(E*!B(A)N)EJ7@/1J280> ZVB@V>?BYQZASO9'5
M!W5,=FA!ZVEM]\,>TG,!K'9TK9L\L55YZXV'O*!RK:B+,@NFE#(R*NXH".\I
M9:69<+#J*97K)L\^]I/Y=]]K5)G5?M)7EE%+I'>:6!D<8<)RE25-B=>NE3Q-
ML>NY^DT_78P_P_"A"D[*'!(M126A%)HXK8A/-) 8!!(OX$0C6CTOVQ[ZB=]3
MV(#].PC+5.-&[9.5#<;PL30ZN\B_C:9WB6;?[W]Z!WX$HX=#ZRC((5 ^D5>D
M1!H3I\NGXQ&B!.[Y8JNGW74Z-@'XPNJE0= QT*'M*H>GAW6O3_4,NP\NYQ05
M<8"P)2A9#MD#"8GA?V/2P<7#3=V/\+XPN\)\O1L+VJXT>QK[8H?*3E+)!),C
MX3YA2L2]QY2()>*83]KI8(.OW>EV![@O_*W WYTXT(*\]D:AT@#_.O[V ;U0
M[/\&T_N;B7"$M\ZG[!A)D>(8,%TC ;(D%)/Z9#!DXO* >HPK<;\0NDH 78,5
M+>S;;S"&>9=JUJ$YAN3!$.VL(9*:3#Q")9Z'A/\32@5_.";?X7QA;@7F;N?U
MB@KA6RT?7]#Z@^$WUE%2,IZU)]1)1V2F O$R3QA ]%I3R*RV;MA60%^X6B5L
MV,KO%>7$YZ"G8<M%W@ \K@14>/"*9! (V<2B58+@M8V9*D<3<[4O&FT!\X6H
MJXC:ML\/JRX^V0ZY=V+0D4(!.&>)"D81:3&$<88!B<;A,)1C:;$G[3YGUD6X
M+[2M,+_NQ($#"HQ/]O3NQ';NE/TY $M6D1 =Q24B1@1/(_%4AT0-<"VJ[_$N
M1?+"S5TW<W=W<$79\"U>K%<Q#O'K^Z]6R-SB[*^)LZ'TG>! ?&*68#J8791"
MYNK5+SL!?B%QA0EV1QZT(1N^W:[S_1$XFGF2V1/@#LIKB+8K)X7!N,1!)&#5
MVU'O#/J%S75/(;;E0TUE\MT6E?>#?IRM*\+S*"1/A)>>%#*6GKR&*H*II=59
M*$,-;S=P^ [FA:AU8X<MW5Q32'QNZ'OOS&9))4;E/"HMRS7*B,#QW;(F)Z*#
MU Y$]#'6/C#;%NL+?5?-LWOQ?DU]\GU?H@#./*C@,3#"<$@J+DBYT$L$M=YG
MG8S/ST^7YW2E1'=X%8Z14<]%2M0&X*;L+3)E,7W0,6,V;!T1N(J! V6E;+5X
MXJ\G);H1BS:4$MW$FP=1A&P"\$5*=&N7;BP-N8T_#J1!:SA7BA$6!",2:"36
M2TU"4-S8J*F@^C0(LZ.4:+M\V<0-QR8EFF42.G($"XR7JU.)>*4UH<XF@7_+
MVM?N/[\+WJ.4$MW$_36E1#?QW?.5$K7&:R\H)P&91&0H10E0+OX;H0(%+S*O
MO1/Z(B5ZZ)CN"+EU1%*B36"_2(D>)XLJ*3)N0X$CDA*%I%0$&4D2R2%\+A&Y
MPZG"X2BB#3'*VOM01\7<XY 2/01Q-_%\;86$)Q0/N7 I"$Y)$,(0F8H>/'A/
MM.7!.FX<N&9J":<@*;F1CQI*2FYBX$-K*[SUW>&D-^Y]R8DB%=&.L,+:Q[6J
MJK#98!<D%0S#.<0%RXP*DKH0C/(< #UK%*7)/"6IL/;!U;5RON^L2RVT*(JF
MQ@=DH[2)6(>\M#1+II'AR>U!MNM=+<6"JATA_>CS[++-%TQ"^^-1AP7#I6:"
MF!@D6HL%$AA&\LH))9U7*O&V1(7:&=%1B-ALQ\96FX'NYOH69?>JC&Y:HC#]
M3?P4P$'BORQA4.34&$:H+;U@G,^XTDF8;*9 8)BHACWT#JT^KA>2MT>#%K7=
M:HSQ[DY/AW&G3#(8Q7E3[@#C>)Q-C'#GP K+HZ'TB+E]-Y 7,E=T= M;6:V]
MH3,5G3=?;S!WA@6)$>]=XLQQDG5&-UC '$4#(YBE&*<9"&IJ[PT?9* O[-\C
M45J00FAMT!VOA1=)2Y)=%KAH@2GJ)(%P%IAEF0$UM:_JMC:8%Y97=GB+DL4U
M!K9:WR'*0+G#Q<RE7/J/E'),B)P(#C12FAC+M>67]C*P%X:W2(06Y!/JAFIS
M>9Y1!Z+PVGM-#"^=X0$L"=1*(IA(EC+GF*S=P+6EH;PPNJJSVU!5F.%\6SP#
M[[I?[J.;#N5W*+I^.)0O,/2?X+<1Y-O>NVZ&#M?>>$W1BB:6ZQP>XZ;(,46.
MABE)HU:\MFC-+GA/B(U[<UL+"@ES^9N.-LHEJAW)C&%F*A0OZC>8GIHD90"<
MP5GMC>/YLT^("EN9L[9R0,W9\6D9T8[RB4D6-5&E!9WD18 Q6B!6T9 2."I8
MLZN"^\-\ FP[9B^W(#10<Z2/E4-94,E(;0E-H:SYP1.?0R#XE4D1N,M'O>UZ
M! *SSR+,V\WQ;2@/U!S=9 /M^]W>N:JH$U:4():7>[W2*5'JA2A),O*<HP^!
MUR[=:GU0+_1NB0#5I0BV')Y?-KR'OW)7'G47;B7!%>9HDH#E',,M .(H+V??
M66. +04-M,TX9!O0)\#DH_9S&YH%+6P6W_]!C*5GX^B#_S8IR[?:0A)E-RU-
M6C7*0((RGLB<N>'EL-"Q(YZ_UP[P!-Z XR=&30V$ZHG'TJ$6B:C9V>"HPP,D
M%YDFR0A?5$HD.B7B.F:Y9Y9GR,SN/<-<"_L$F'WDOEY"ZZU/S/8PU-EW/I0&
MNH/^17ZHRK.8<.NL.!B7B0<&&+=91YR,B2AEP>0(4=%X!*3?:% OK\1A>;+D
MA3FJ0[?'MN@ R\ <XZ4\2I<^PHQX!1C\2<C9VU04 I]5_',"[\ 1NGX)LW<^
MBJLYO.]I^7W1JY*P=V0V,5NJB4W2EM.?0'S@GG!AC:<>#/[GB!F^>F0O3&^3
M"DL8O_5)8/5%;>D8GU['@B\NP!<]>(U)C2P'#)0Y$D$'QBUHRL+>XYW-QW$"
MI#\"*V[$AB5OPM:'IRT?.SQ8WFSDF+\SXK36)8L7).C("-?>@_6,JGS,U[2.
M153X6<SY%2BPA.5'=:IZ-KFC_.G>2_ZMPY541ME,HC2I:.W@2+VW1(AH(5'E
M<S[JJUJ/A_3"[U:<O^2*RU&=K=Y_:;FE#@2FV5Y*AC8'3D)FD0@KM&%&2PJU
MY29;&LH+F:LZ>PF)#W7-<'Y8MCP<@W%'I<1BHH"IA>286\M).4\DR@>5;8#H
MW)%<1%DWE!<25W7V$A+O?&)Z&3]#NNW!15YBNM'/W^Y]-=4BD]S*8+D@W.32
M,)32LG1PHGD05%'90M^M33'N2\"Z-;*UZI1CD8Y>,K2)E)(P63@*E.AL2I]/
M*8FG)I+ (F2;I&&ZK35\ <JA9 7;=?^*B6T7-[1XA_\^K.F<.I=6:@*P)>F^
MM> .(])7Q94-Z+&['PY"&,4%B/)NV)@ED<R:4O/O2 Y))4_QW4FU!7H/1)0U
MFGB'X<DFYJ\M5S<1PSKOQ[G<KV5&\*Q(L!HS!R4S+LO"$H?03+)*L,4.-2OV
MLQ]^[E&$N[M8?5#'9!75BT:(Y*/O?X()0;-WVKFB@YNX)M*J2%R@D1@N@\L8
M;0G5Z#@./_7>VSN:N7;BU@<//.D 8'O35A0]N0,QIUD#&)LLZDT\7?_E7;]D
M[V#\1??M8+F*T^PBG,0-_@\PKXU*$!DUSCO"*EQ5<I!>1,IL(UG 0SMPQ5):
MWW^;&*RRWWY%2UW?7L^ V"!9::M,5&(15XP8<,XWC 0EA&#. ?A&VT]K//?@
MH?M;.7<R^Z"&S2JOCK_ZK_> ".ZYHS(0Y<JN@S><>,D5\9Y*#XD!Q$9R".N<
M=_^AS]!Y6]NLA<3E3IMZTA+C(E^.!_&/R;2B7+3.FE Z1I?;%!B/.PX(,7)&
MRT&[U+7O%ZP$<]*A4%U7M*!Z=1_//+!O@*BE[8_': ZSWU')78-6;-W"3+$$
MF8^66AXBL0D0&4V"!"HU22)'$9W4QM:>(O;E_36;&'MS_B8F7NGTFG+KK]_\
M?/7>#TM-UA?804=]Z>?L+I"^'MZ"\GG*U$K\O[/)2N5E2"P'([S0R:1D7&?I
M)^[8;0/"^+P_&@]OKR>%$?-3&\\I!9O0V391(J62Q"MF2W-P%H(0/-/:A5\K
MH.S>OKF/B^;9$%)W_-;'2=W'+.[Y>3 <#O[L]C^=^1O\R?A;!PS5^,X$0KG
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M5GO^:D-G</5K\29GB*4@Z=Z;0;63*@I&HK.BH#4D4,<),S(F)[FCK/9NU$8
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M9K;V'W,B)E[ZG29/(2>E&SN&2+X#*WXC1W[R9?KV[_0U3+\@_?A7F.?+Y]3
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M<2@TV2Q$?HBZQHR&W@372PZ1'Z2W3<.BMQ'ZF*2PPH9LC %;+)E\SI0:HB7
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MC%/A1!I2:'+ BXNT3(H%5X/^+".?TDBOC6^=;#].A9-[1_DP.WLPJ/X*!NT
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M'[%8B[%]N9F-H#T_[O3028>HP!LSOS@95T0_*3XJR65-OU*UHPF=E<XD3BZ
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MIVW9++?]T:%>#(TZ2+YUT65R06O8/KZ;_K0P+HM*12FRR(0C$@(@JX-F'(L
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M--,7MWZ> *'N64=M'EVW?D#^A#3YQ>1LM>NL7I*Y=SX71AN#5C5:B@S)($2
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M3B9BK*7_(0LAM+Y;V C8KD?AW4&.4CK_=GX::/-=7@K5=3['K]7P^!/?38D
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M^"%+'&[6?%.B;E!S+50"'^HX4FUR#>]GD%P7GJQ7H7F+S<UH'I]_L)6<1V/
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M99VT[4WM(YP*H&&<+AC/P0>-@*Q(;E7T9 HUKS&YC6+D;@)#*^ZG:I.=I#Z
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M<=V/Z"#/R>U9<^<30!MU#-)NZ2^\.K:O8%U/&CCW3N?DT8 W=41%]@(<>4F
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M48J#TSHXVFK,BDXN''WB.Y8MUJ&/%<,V?_V87CAZZ7O65.X-;Z>[$5U/,.F
MJ<_K1F].[.-QHY6.[E7Y#@(>2_D*5:+O>]"ZNH5%LEHLA*"=2#'YS#-V>G(_
M**5O>-X84^=]Y#JD&7K]<K,.S>>L$1-7H#'D6@9?(.KD(6=RR'-1V34/9&Z
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MWX>N]5_7?\2PP/____X/4$L#!!0    ( )&!5E96D)^3D<@  #!? 0 4
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M??]<B1M^P$82*8^(C@4WH,ZH)Y:V,-& +PZ"6T?*CPK-"A'=D&_=DZ336S7
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ME+XL$5FK>VJF6Q%AG$?!:Y&F/3C6D>R:BL;FK169QX3-IK4'GTQN8PD"!V@
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M?J$!F "ZEM*KL)Y%@.B!"9?]'LF><MCFRZ>#P5?^#\?+"'[QH@B)Y"O"[4W
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M0\ 0K42>(( 5 VN(C*=4@*3S1]>@V508"1RKA0F BWWQ #\(5.^VU>OO5W3
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MGZ2X<+N3_M;EPJVJ(W7U7MX&UGIMKM;UXF%!%_S>.9VPIK"1MSA;3VN'%)I
M%CCO_N71G;T+EN2K$XS(SA-B^[OTJ<EFR 6JPYX@V5'L7<9$;QFE:24KN?,S
M#&3>Z.HR<6J:6E1J=$WM66BG >WX )A?NH"L9K!-5C -X&.O-SW>5:G_1*[X
MM2F'C.?SCP&C> 6F3;8P&G#4O69BDR&$2E6E 0U02Z5K'J.Z'!G:V?RQ]X>5
M=+[CA%1_IEUIJ<Z[BFW^V5D)3O>P:%KV>IXU;$17'YF"LPH0_KVCN>DD%?4>
MUR6*Q96QK?/MS)>CVTZF@*[-?9IT7!:R#FX:Z:M$2U:6#B!-9R>@*2_RE%ZL
M?!E/#&CA:CO/E^%B%J#'>8BGL3Q$S)_*UE,L@"WMLNV>,7(JT<]*JK]Z2V52
M*#,YV'5)4T-J=BIIVQ;6>\ULOM]:]TEJ_X#J2.>>^;8ZH71HLPI6+Y'>X3#5
M?80O,63C)D]]-(AP=.]@.390\3S/*8)B6)KM"/^YI5G4WHL)21J KQ]0A57-
MR$(RGV1J+L948_20\K.D#HQYUL#\>%*($HD>$Y@6X/^4##W"!S%L>IBN**%3
M(];Y35\[3%Z9'#MV0 (G #)E0^UO[;' ;E%'QH_1+?QP\G+MFJOEG:O]6M^?
M[4H\E0'M=(7^HIAYIPN0/F)G=?<.K,.^L2GVH^9VF96[(3U XYNDDQKVJ>*Q
M/VSG*"*)3=5-HH*3./K==QWO^'"U#S6M)BQ'TH +%GFBP:VY-_1.IXO$E8X;
M\^,$!"K 3^;SC'#V05B<!,D95_6B9%=,^%*$-@U0EWZ%I^X=-U%',&N=2!@5
MJ.BDB$IH!4?\^C^7.W?^[%S%OV0.@VU#;,4VQ[-BW#<M8(K%4]0 .?$DA08H
MH7]6QV%"D"_4]1<GV(I?G3 O7E^)I![T Y.(UJ15H=SEKW.LLU8([.?M4;Y[
MP[,/D2WG: "D=R../GTXP/9_\ I+U:<]W*FG46^'V?Q$YQ&=EZ/<AD _OU/N
MXHEYRE43V^J=U)XI6TN]9ZW#1L)'(1;O"]^OO0$G>NUJ@);T%W62?BS-%R-?
MR\/Q9[;DJXN?5QAZ5;%/=62\2 ZF^H(3_HR0XR\HJ'R.*X.;X13,[Y4QM/:*
M")3PTX 3,Q=!&?R@VI(76:$)_&G<G7%:>I;3Q_N*2MPEC7X&W/SL?#[%58_Q
M$,*5S0NU<@.GB0.%C0N6W!^R=W7<GJ]B^L!\0L%/DK6VL@+K6=>GNW W:U@5
M7$GNS^&^V<J:DD]7I)W/_OK^(7P1]0A^N8$:=/ZMYYOQN[E19WXVUG^B.ETG
M"\USD0:HS#0@;[E7WBQ%TK(]>'S]QN:PR04ZQ2WL0H=T28WN:H.S;%J+:SO9
M:&1LQ[#9$RK,@7X-7-+;/UM4_FN*302"]$V'.D+4*\RP=*BHC'OB\[$%]!GS
M#0[-2.2KW6M83\RUL93ZOF=[%YF&0$!GX<^AI+.Q\>0("J2WC!=%7 (+[);N
MT7\*]A&=^0<'Y6._+_J"!@S1@./C!$P'TI/?MTK7X17">B(1_A[F3A;I5@XA
M+-65Q+M]'5)>K0[%>R-R;%8]E%&*TKJP(=34Q*XQB4<"LTRXGEK=BSV$_=FD
MK706NC2'_S.YF;$>6SH06/UC:HUER;J,/4;+4)RG0!&'KK7OKM;#5&'MP@!K
M&/-+5P'8^$)%U$LCZL>*KZ=H@,]+<O9D',4O<,G;N)IEUPX+6K>LG7TWW:#V
MLYWN\/8D6_Z:OQ1&MD4&3D02?S:..+)D&HP:@C3._ #EZ.Z=A\7"@"W8LGT8
MS[%RD2)N#0XU+^;S;> 4Z*((PJ3A[*ZC0]P2J*5PV<G*]$W*KPV(,"YOW)_M
MSOXEW9PCZ+P8MI#*YA%AC'<MI0<N/E_3J3]@K-!!9%'#P!"5S>2+XYQQ'6A@
M=HP&?!UHBMYE9.^=;;K+G8R51G341.TZG$%[@FLN_N6_+:K_>G8(6Y789UJ?
M*WE/V0_2$]@K )!RE&.OSY8&R*:<-P^[F[$)//EO[+UW6--MNC4:1<4*BE($
M)"H@2%!$1)"2J+PT$5&47B("TD&D0T@4I$B+H(" $ &E0Z1+2^A5##WT$J2W
MA!I(.V%V.>/L;_;,/M^9<:[]OG^L/\AU)23/[[G7O=9]/T6O%G5X$5$$%_*T
MY;?PQ7 +]H .0#ZB*Q8V+A]+M]7)\K#Q9;HCJ57'ZYG>11?=-6E+B-WE*3N2
MVW_7'M=_U+J'*0:@J ])*R.*-! =ALV+N96&6B,M1%:5H''1.]V3#M?L3(_B
MUU<K D91SGN@)IT%DQOH%EL:*,#6-,#0-Q[AS0"\@,6X\3UZ58%NH_,S XOR
M=N;/,^B108%/@^#B]#'T:/'7"&>DSN.Q+JSQ9.33<!.V'X]YKBP?@T/T%E1?
MKD"*8)P3E,H97/?2%([2F4DOWF8 N)3N2&U (]>WA8HS@5H]0[O[QNOF;_\*
M)?#WH)(!(+!2 \T8 +0; ] 17_5?7GEQ'?/3>7=Y5G]Y(-XO/\#OOP,).E@^
MTT;V3:^5:\N\ />[P;[6 $N%:L'[NLSKO \CO)>&5K7H5; Z:(CSW;+"&Y=;
MX*K+'T0$C//8*V*GF4$*B]S\J=B>"L==Q]J2RY)_6)JO?8*\DD#B.3>C80$4
MB5IA\L<<[R9+*235%6&XLXE],L&S.K7J^X,!$(*#&A].?WM2H0QWV"5<>]C9
M7ZE6@I+8SV//;RQ!*"+&/?;.R$)C=7;::CWB#LT-W>H4>MPWEH *2V8 DKS;
M"?"'7]%5$S?@JT6PV 6Z5;N5QHC_Q@U#IJ!6 =__R8]M2(P[S QACI$O&#-_
MLOE@HU9Y?18B&FZH-Y>^V":22 36+%5X[ A>AD?)-LU!3S8\8 ">IDNLP,-V
M^*/IFQIM&XK@$%'T-R3ZEU>,?I>5)):9L<$YY"8T$)\?;[XMA@B'=4/OT/'0
MU6-$/,T-Q?P!=[:SL,<)3MN\.@Q *6+]'7RM%KMZ\3,#X(28VSW_>MM\X<_9
MA=V*]LY\A,2[C:WXW(Q8%;^-R4='0RS&MH'26I0#I?3P"$PV>M!3!U%KNV$U
M46G, $QHFP;O2IVUR5_*BMA+&'D503)N\K$<PFX8]?VVW<8%[&6P(J+%FE1*
M"\B#K$M!G6JQ*YR*D(<S+N@)I9[QV900VI7MGZZ%0'=A!W2UI,997]V3I&3&
MKGY]@[A#[4%W:0T(&R"LL(<"%T)3R;Y9]O!H4N5#^@P[2:(EB:Y)]?*&9VSL
M,./K,KC^5[/G[_#(5'84PNXS9 #.:__LP@?$9":=<TW35XEBI%116\Z/':FR
MI$Z*, "6Z-ALDH"(;KL8>!X2!?&8,("*I57<@-OO1L'#!;\__T!KVKNGJ_3S
M4":AQL1;O/#]+1\X%;]3BX'0WB\KH$+NISE/#]Y%F;(@%HLW]\/;:Y]/M^4.
M:JU#CA/(J],>*YR[^Q6A%C"U7^IOI]!-ZJ_&3E?:MW78<6MLWZEF ,1H=]"M
M$B'<$'MR'&$H;*:]=_D'KL]*>DM!%.NKLRWQ;?O;''WYR+=I:V9LB&Z?_3DV
M< .FDL!JX,&7W2UQ95M)2C2[M7M8ID%^^M60_26<37?>OA2^OQ_9@6\@/60
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M]84UHSZJF;. 62&2 NX-'F\EVQS<TAF$+"6CBQ;\R*?']Q"[)QP#4A1\)#B
MX#4\#A%7LU$C#P\!5:'KU^RA>,FW624#WA+S,[/Z8A"]9![%+3C3U^N]\?CE
MGNYW[??^W?.I%Y,.('W33)MF#$9O;JZITGZXB=6M7LCKU)3A=A7)"Z,FD+;\
ME^E <IL><6-%AM>W3@G+,UKUH*GPHB[0L!J-9@ <5P(K++I@SE;LQ\+!U(R5
MEM<XND+9Y@/H6;VE;4=)\R]?<O'HK&'J"O>MB84[J'M)+YF//^WG/.++ %"
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MF^^C%+5?UBPYT2P;_\,%.RP"))Z'E-LMWVDAH@.O,0#[R2Y:'>L9RAB4^<%
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M66PGJD!>"1SA&/LMO;X\/J>TRTWRJ.5CUDZ7[W+YBC<YF<.>CZT^4)XT1CB
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MQ52?'--%=P '73;M@@CA84EGB53)&D*;ZW9W@-$ZRROS#EF@&[*#Y(?=:VJ
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MLJMK/6[9B*+TQ@3T2PC[4J6259I2MN;U9,[8MPIITGNB5"Z]88=4-$TNW11
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M_P3:D^)*O3%6#]6=^KKH20HE\KRZ5#[#7D?A+@ _]=ZVL-K>Z>H3,/Q\7R8
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M9.$KLC3U,(D_0,_PD<#584%]@WN'[8+0(0,R E^VB'!H,X$8UYJ-?U_)_P(
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M>F([*:3C55=LIT12,(!BQA) U#J*(O[M,]$E_TY;^-U2F=_I]Z)UA;G:-4V
MJUONIN FZT\.I;V<G2S2TXT>1TZTM+/4Z\/D&U!OJR:KC98WW[STC#C/<.@Z
MP:H,'$2]BVC9]5MMX4<=Y,3PX,\C^%+4B])*J7%?R/1M*:3/WR:1O.]A"%Y?
M^A)X3QDFQDC3Y<O_1.L!X?R=RRDS"#Z51(H@PY:"V"Z7GW(.*M-[I''62?64
MWG'SR*A0-+ZOUP?8BQ1"!^'#0><-OGK]4^^=KBP3"/^N;MX4PSZ9Y(KL:HO"
M&-/R$3^)<(;C[&!XCL!1ED(RX:B<.-*-C,<5OT;?])--XA,*7&XH6C_#K7#N
MR86D\]E:L1J'O\YX)[30F@O&_I17UH_$+ET=I2J$#3;\^_'S\IW(_:9K9N4*
M(X,_"45!#N+$X9Q5%/FJ,E]+VUO+H]'?U8LR2N>+WV53TM*765A84J09)>)5
M(;?\A)9/]1'][GVI]ZDOC__P3'+69"JL A#FFUYFO86SR"\J7K@\%?/S6@ S
MB38GX21H%<YYUQ8E0DN3^X*F?:#R2E8TO^;1!U&D ZZ74"-1+@6@L[0Z7?'&
M5QB6S9"&8?TBE.9OU4TDM#SR_0/(UCNW?U4H)$J;ZP1P/I44CN=HHQ>:3)9+
M3!P6CPQM?)3M5C@0\[H!/AAN8+!Q-WY): KBM<OR6_?*U.FX&&WQ)YM[IE>,
MHNTYK[ UJ#R].7\J7_WX&P(W1&CL<DQ"G)537I3H97N)FK,S"'46G/A3N-2Q
M\V)A#*"8LOA \30@HLP1X@UI<(R!*:VF"O[*Q2!?^@7@*:_K&U/.6#^;+'JJ
M/UM($) H5>\4B=+306P/D'CH?"\['=DWQX?6E[M!LWYG-?PTY=,R_W1(,P9N
MJXM^!NIW?[K=1SXA9V;ZH;V]9X:QRH=!I9_]X]]R'DZ$G!7<R=03C8VA>,_)
M)\O4@07)8%NBR,L_W-/[%J=O#C!93Z6?*]7V%8XD:+O&4^TI'E96FYI1T-N=
MN<LI=<D*"9M"TWG";(:& \_5]9D!FGD%A\PIWCST<]>^VB[ Q,;D<U74GN F
M _JN:+ 2AYKAKS^#R:RH HP@U/L^$=E-8S$>?_ZYNBIA^%)5C_K059F^R0PC
MR3VC@O/+T4B!.G!R/L@D_):GA$5:9Y"G/R![R8SI^NP*\2:S_\W#?D%'08B'
M/ @F[,TFW22O@N+<E&23Y;F?^KWI@Y3'\Q#!E9=2!>KJ)/"LK_(X70+F.5[Q
M]JZS3RFVJJN-4V;F'@"LQ[(BG3%!#:BPI<\Y0&:>4P4C"'FW[R=O^\C*KEOA
MAE6N@7-;7ZU$=J<>;T9X *=E3P#/"PNV^%1/ )RZHN3H#AN?_6-_KYS^\;O(
MH[[L+P&3<JLZ"C\BF,J]JSQUA3'3!O\LZNL+ET#77NUSF;4/A@6RL"QA;,CS
M!%,P]2F9$8ML3*,T%[_DA NQE<H1,OO316[XJZ;>TCRXTF;>@7.H_T0?K/K-
MD)^,"<LZXEH/STTEWQ=L/-^ NU7RHBUF+,C&G>7"9:BC4?,83*K4.U]J\GRY
M-L1=[F^L\M/6Q:FSQU6&3&<[)%=<=!Q3,!!/U>7:]3S",B?TNO&0[59,3!V[
MGH1RX%E179_?*>==4W.T4[)Z__N["B;Z998JTTZ2#/D67+;U6[:HQ8F--4UN
M=O+(+L.T%!MVWH>^W+ZG9TOO:E@>^ 5<AFE]L_5R$)Q0$;ADJV6<J%[)+1'#
M)2'NA/:_ 9I(((J&'XU7-<_\.4 !R-+VY(3GL[*]TUD\QQ(99Q^5;!NP,)>P
MB(@$V;;SJ[2B0/2^ES/9SP<@5(GLJC/WH\JNW^7A2GEGJ2*U[8@?$F4Y"B5.
M3J=?&BF)]Y,K<J@Q='-C1KI9.)+9 2_ S'"()T2H<$JV8$*%G<UNW)KO!& \
MZ8(C^0Z/@P+V\@NX4@SN$_F1#<JY4X<+#J?(WJM^(M:X?I=,L\:8SY%IH;A;
M&K\_GCEG6A3!+I;G[A<1 ,^NNANJ>=WD175)QMW[.^=G!]B:JT#WD3;$Q%T<
MH;NTPNZ7&#,QOXU06F[UY0>><F.Z&M;C3V@(VG?QW#8!^%)Y:5_K3!-Q:R>
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M ),M6=RA;M&X_ F@7OF#]++\(.7^6;6<CSL+!02=?U,M \14:D*N/"WT-B-
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M\;[GK7/^[SGG?7\_\^G^?'K,?<U]W==]7=_KNI[G?NZ+WDT?!+:<UM#6 !C
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M->FWAS*Z^4<'!>8A)'M8('2^W)0.E)RB R,1O6JL]ROWCI?6'JQ6/J-^0.I
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MV%^KG^C^]1[O#S%I=;6O-4[PQX#X(8F"B@)Q'1KVK>+'=Q<_@:6K2GT9K?:
M?THP_;[B"6BXW]=#^3OD?XHBFFMK?5U:Y05_&-O\T6JT_<W2IEZO+L+W$T5N
MOB_U92;UO0,\QZKYE^HG*5E_K87R$Z5(OB_UE;'&!?X04QFCLT'6YY9HQ=5S
MW^I^?'_U$\2KBWVM<8%_0C#]ONS)MZ(PZS4O_X@5VM9K7J[7O%RO>;E>\W*]
MYN7OA:CK-2]_+;SYXU5I6Z]YJ;=>\U)OO>;E>LW+]9J7ZS4OUQ_PK3_@6W_
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MAUVBG:"]:@%A9'8&_L6+2@<VY04BQZ$@S Y>0WX#D&=NKC3_%3B-1?,;:I>
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M*,H'U8)8UTHH/?V\.J5$M7NY+:L@B =VDJ^&(6F1>_6S_VN8!]*<%M2T/:Q
M5[ZX\81KOOTB8Z=72GW")B3"?#VJ#LHP!!?%]=9]<E8<)L09!N4WU@);(E3
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M"_]6/N 8Z='DV]-8J\ <*M#80X@6?HFNQ"WYC=I\H?!GSI4.W^)88YL_@6Q
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MV\\/'J.?ZAAJ@Y975Q,L-NSM"A3GW]U?294*?^F4Y,/VS:J-J N72)SDK3.
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MAP^C?H1DOSQ_;&?6_YU95S>@>Q?>OI-,./DF\#.70IH_Y.()Z&]^CHWZ55'
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MEE/>[#]Z&^H45"V$C47F2LVY]**!*OK+K\\,I_DU+5,?3556>_.X[IO@].^
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M;JM YIJ2?><LQ(0HOP2QG)0[<[>/2W[N7_VQNG'X(UB\-2Y3H].T?/ZM$1>
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MFVE\[>PQ]K,V1OB@Z-VC0LI:V;7ARTC7L1[_[+VK:FW\6?'[PPNQ K_0J*2
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MCF]?:_M=$>\@SADT^.72Q9BU9X_+5:5'/I'T"&<P\,Z;#A;9%T1F>#D*>6$
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M[@'(!#:KGO8Z0"RFB@EB1"]7.YFI<\!8FRK<2ORNW1UEEE,[359?DHB#(WD
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MAD_R?!+[ZP/_]KRN[,>0>0@?/N0+]?QYI%25M;OQS=E.GGR@]'8PK$L@\Y<
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MU,Y1.T?M'+5SU,Y1.T?MI+F=X=G=\P7B\G;-+^F:P;N!C_%E8W^PJPCC_YL
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M;*Q_7H2,G/0S%)0TE)0TK QT#*S_EP]B$\!TD7R1RIV<3 "XP$1&SD1&; /
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M9P]+S:3/:L!2^RRB)*WL>X+I7_1%Q:A<W$*REE49>FZK#6>I'=M\I K2S'U
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M]A4Z,*P\TRXLGC:'T%ZIBV$\.83*D!#%;7R]Y8<-!4]@EX#?Y7"13-!_W.=
MJ1"!A0R/;%(_X6QXDFD1Q]9;YQ;*AK,2NBTB2EW"&0V9E#FE407?@<W-[SLG
MP[%,E41@(,J!T ;==X*QDRA4<L:IH80KJ7%)&'"#_6]-U8-D#PRKHV7ZA1WJ
M$V)4V8_81F'M6!9[4NDY?S1R%]F/^!(0AY=PO?X$%P!:5@7+PF:A^^_FZ(C
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M8GTH!]T3N7Z2SIQ00!U>+1'#<N#"2-B+:!9SNO&G /*R>KX8T_L"HB1Q./4
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M=@H;YYMKV;EF,M>$'>Z A\L9%$$N/3(GP0W9>>SR&)(!-F2ZYG]$9X8H@W[
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MI&P5^3A,@27ZTQ&#&]\!3G_T/[[AT"'\TY4 .X3_ QLP'<)_-_S=AOH0_OE
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MD^-M'AMZG%>.M'A__P3*S,:\RT,^H0&AO*6*>V!\=^TEG6L*L4[2]^E?0(S
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MNP,GW!4A7Z3KYX@7[Y[6<G4?W%@H"+PDGEJAXR:.*:<!-L@WM1P$I7J*A.%
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M@BUDU="#32H_V,@+N=M-=,Q[P^MI&A2R5L\[&/$=G*=&W*,:+%Z#MF".$@/
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M9#*JC\,7U]HXQ;[.2Y7I;<1,1DVZO, M%ZY?)4MTDM5(SD3FN^.)S_DS2VE
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M8]?F('&S4\AK+7"NZ/VEACW'%7>9V6(X>99$SJ]Y3O60T0/C7#W&K=B'ZOA
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MUC'?!RO.5&(?^9O!=SW#>GIS8?$F]A% X-MFMQ-N8VO>(TTFJ&_)];U-$*%
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M[S'$$Q16Q4:]%L(KBEFVN#I?:D7D'MI]J,_&!(BS[Z N5E-D"$:VR?T7'9B
M>POO6%+ 7!?+DDR\EHL]?2J7V(IDBWXP'CU&K-^;3FD7V$;0CH@/9$\>R T2
ML*\\OP/_2AM%[J\_90*HEU7J'4DR3;411]3I$6#=! <AT*O'#5HUI35EUZNK
MDEGVC$^CM@ND<UH^%M0]#(<'TW4FC JU%RJ&9+U2_"JZU#A6>2. N9:HUX1X
MW+.EKCAUQ4\\-N/P%NXSRX%4U3JX<-Q;%V<(=2Y!IB^_A<@$I'PH_K,8?V$8
MMD15C]IW-*;0"1RB057F>[/^-560A71COV"O]1OJ.#_.DVJ[(6Z_"8S#+%]7
MWUDF'3N6WS(99K%OVV\>K;45M<TI3WY+S"4?[4 /IM=DBG7N9SD>6#CE!FXV
MUT[/E$+-']0]1_2<9 +V.AKI,MC<N&8+AM@=AG.428B2?]3EDH'P_QO;U_^?
MEJ37#J%G@9QE9MY.2WTGM8?O8BAZ-*]'A45*95=]W_0,6-VZ_/.,4OCQV:CM
M)8R[?!2$S8_#6(/ _:H!F_<+?PFK/%L(J;EA^MB_78,]&3HN12]L$%UN4!X)
ME?T&Y?Z\4NO46)5(->05-7W/WI5PJN0&,/#K9HRO/81J >L'<FO>(B(LB WQ
M1>,4I-7P:V_K";?]5)/741-C[8"89TH)SQ1BWA_:68P,O95/*;M=.J)<] $]
MZ)5E-9NI'?=-43MR2/P6'IU#_L5R-R@IG^Y;R:+=!5 OLAL1EC\K_[*!MU_E
M=6#%9=EI@ZS$S3M/DN:.APU=AS2A.\DH2O<LA"?T. D6G4NITA]2L3(_$M<S
MOBZN[U3S]CM _-E99-,++;9_%+6]]$+MHRM(<;1(KINP7I9+_N38RN'ES#U8
M&T1VZ&4Y[Z?OZZN6D!^H5M31"1J0J!8Q3[J?Q(]^1+T^^*56]^/O =6A\?L!
MHC%<^WPK]HJ4SMG-R,QS@^5>9Z#O7;'!KXU5ZNS"XQ6+CMY(%+%(I-WYB_W%
MJKTP/9\ANE3F7IEYK3_4RLL%F"J9(O8%YG#G+]BMN2S-*_LZAT,.&P?/K$V1
MQKD1]D<]K(H%P,/?%J@J]"]/?L@0I)? &I;BM/#CBT)RI+WU&\3%GPRANB$F
M "<SH!+R^FU%?5QZD%C78 /7\,G7L[PT?4 P]B.\$13*5D!QP646H]Q/JWPG
M'1TP@HIXUQX?>I/H]:BK%_'7H25=P&-XXXU/DX&0=H'[H##57!XX%8?8EJP/
M(&-BG]#3:>Z"Q\3O2"%-O'F !:@C=&2H0SZL&R+:<(["V[HGD^-V$/NK^GM#
MK<:Y\=RN)Z6S[+'M6H?NN:@,P49G1)2!_(%<P,AIKJ'U4!,4)7SC>(SZO<YG
M//PW9_EOZY'];@K<:#/XV793RXML_'_4?-0367O*3LVVX#AX7.]9 WD#X_[C
M_IPT%5R[4X*':I-(D!UL]>Y9+XG1RI65_WTKZC>.3=YNEX"K,KF3]PJ>7;3%
MU1^8T\\>ZF("FAR\F8";(2@L$_ NA\'+@3A@FX)A:,;/A_YB5V("3KQIIQ_:
MP$ 8D@C*/3G0$K?? 1- 4ADTN2G:2Y,4 .ZPU]+AE#00[AHK"W[6PJXR 2U8
M8UV +XCXT1;>)[ZZRP3@_U2!:B(P7NQ!4"R<M%/Y;\/_;?C_9X:-" C@$I!S
MQVDX5+^@)/W1P#<9";TM?I\3)_D./7YV8M9?A95IFVU"+S,!6:R_NX*%T]S+
MDBQOC9O>7<\-;WTLT:OWX4O=EW$:U^+?_2OP[QX'&L$$1%3^N8]8!\)X4,($
M4(:?4O3)D9000G'PC&Z_YIV4X(R?CF<YH9HVY/"[1_OUGIUH\VTU+#:HNR*/
MKG$:'??VR1"Z6+N%V5+G_KM>48;__3N5I)7M(DZ[P<0JU81+<EWR;!#[T"#U
M.\CTTS)V5=<=!:1<B\JD_J,G?$$"KWL3L<T:PRKO5+YB&9;+SY13#S0\=)B
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MXG*X-O@R6T<HB"I%DR2V[@3X:W.4N1$>K7A)IBT=5A?[4<<UG;0JG?50^@5
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MV+[?UXP%2OH<OR.=S6S!<'\IG)DK$VYAIBK-@'<X%#QV4$OKY&']X2E [59
MC687+X8(:;[CE ![L-+%/[G$(Y3;$[<MNX-YMYF;"5B8]Q<R/F3 B"ML7&\?
M!]EJ5=E)R03D&BI/0(J*)<XWN$*_#;9(0E;CA4K,OY15XSCPN<VP]94PHA(
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M%E94</YJD;S% GW_JK&X5C:INZQ-@4QFITA632ZN?FU[XT$[0E.HU>#2?='
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MAN,6H8M>/]MH%)EK(;$_O/8V[3.'I68%Q;X)>6Q$427\4SAN.CIWS402HWB
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M\6AJLH[4[1W?]4.Z7Z/ ?DO/VY]O>O41.MDH@7X(1ATQWBH;00<N$C3%F#_
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M!U8R(L%;;4*=9T("DC%A= &?&?RR%@7B,X=MLA*CI@(E'Y>/8/C4;_RH.;+
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MKIN#,IOZ\&=LOPGD1\7[V?\E05HZ]/CWGC&%G;(=TQ*=_=^[F;L +8.ZV.Z
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M(D1$Z/4K54/(JTVB6>^J2N05%!=F!AZ"QS)NM]4MM@JM92_9DA._0P2JN7.
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M?O#;(<(?C,3X#U%K*YI:"?BHCAT.(OG*$IXW#5;65303U^CGIN,T<;? EV=
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M$6C6#@B7,E+$$NIW#ZY3UCYQ<&=72>_!F^_M_G"ASMP*(*C(3NSX,?P!%8B
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MA,^XGXJ &T+VM_>76KY8,Y!S*@02Q\]&#$OL';=_04G#(>2/< MO3"['0Y<
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M= QX2K\G%'=WYU"LP9<<Y4J#@MO[^V^$;#S&>)S*;%;CZ],'X43:.!([[52
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M ;SZO6N0;3[RV<[H;N6LT(\':UT_5%O>'N-U@^F'[58((++FWR?;0E8G(1;
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MW;*M?V*ONR,;P@Y85L7!W/MM)K$Y(M##KEO+PV9F4YB^-=F,=UY3[P8NB*8
MO^26=S[AM90*4,_LK.WUJ\<R>*^Y!=U+W2<M)/=&U)FMN!! -=+4U;M .R!K
M]'0#FB[>5"6@]HP*#Q[<P=,D!!"NM7AY)TNAPOB"K_+W+X95L(!;$H5@%HOH
MF5L4:7HXD8T!L'NB5U6'D$V.V?'V_-DY2/;X%Q>BB<0"L^_77KR0 7@,8/%
M8!!5F3YJ<XQB3R)J@5999^>Q%KC0<T/[WM2F]T5;YR /O"HO=;(Z_,?Q0UXV
M\I1JI6ZEB?(9IT:/ FMD,-CRUXF1^9:+*3;=TII%/8X*26<7\.?9B$2WF<%P
MFD&I5$$Y!:$[YKNOP[+Y*U2HT,H'6Y-R=K,J"^;R20TQ@9_.C=Q_1*ZK3,(H
MC?W-J=!$G>V#P 9XTK)3."H!RK9XNLA2]>NWY]['"N;T"E\FJ\L1@0<7F]6'
MA.?:P/3)=I /<PZ'G!E5K (]D5_.JT_5BQR!9R"360,3XY_>55;&"LUG[62\
M7?*("CY:BXNL]IB)%^:V$HV_J V5?(&>O-#<;@%LJY#AH[Y!]N1<2G+)4I.E
M2Q:&G'W_Y^=)S=QUR8BQZ_X#.*MY#NT+"Y:P.FE:ME_GRLX\B)YV%7';\A?$
M,;O4NU2GV$*G9"JD]AN<M6(D-&Z_IW*'K:]VA"0A:@-SZ6;#Z/VZ3YHO+^*C
M%7^&'C=KGWJ@W!Z:"TIAPF?>R-0E,!:I(,'[57(7>TE(5"51VH6V:MV=2?4.
MA"5BE:U0T007J%2]B1@^:JXVO8A/44?7O=DKR=.L4C/4JIA(])#'$P[2WF0;
M49Y_:)=-_7AF.N@ZZ ?BZF(.*%"ATO5CV:*-\/ FMR' %>!K=[16$6+WY2IH
M( 3JO1M#4ZE8FMA*")9=>OC #,PWU3B>E^S5).4MH3Q?YI#_F&!757ZZK%RX
MK"S"5/#@?N!XVN*_GSTB]YB21Y+K0 L5U".$4 \(Y@$V)Y^V)/6%;-XX=:^J
M48LXH%W>DE^IDJ[>S^%TK4!(SL#Z.#,:#XF0E.CA'K1R I.4=F S3%!B $/Q
M3%8,8 !TF,VNKD^0-[,6@TENU8++C>FZ6Q(=Z+__"DX[X]'1OG.D?:T*S82D
M)4))P=+3G.UMI=:HL9(_T&@51H13Q=^7+R1#8X\F+>!<H1\A&2^)P<:''MR7
M?,;#,F4@$9>#2,C=?4JSDR2%3G1I^-E.^<]5:E^8;-[@IVJ:FERI24!KRQ-Q
M]^;[S-+4@KQCIK&XGFD)612D5*>!*+/^H+%=L?RW'USR7ELZTOM>8"95D]XS
M<3MG>GM9R]!>M3O1GX\S/P7>F+7YU+;VJ.V'$,_]>D&=YS= %%M"*'I# OW#
MA@$P@$1\^PW3"-_7O8:W4M->SJVXM>T$BR6/B:KR\PL<)<ZA0']M*;,XC>2F
M,%'UHCK==(6)@[L!F_R3FWU&-%KFMYY-5_"'MG_X+.%;N*;!/+1SI T(.&+C
M>9#(E2>QF-:F;+--I[L&3AI@%5Z4Z*HU._^+I;$RS$WW*K4O7H77G[>(9WX@
M$<2"<<%B%,M5"+4K6&FD7D%\1&,V8]!"OV_(JEROHL=%)!(G"36>*EVP,:4:
MT$>S0<R@^+G2\8V-BHCUQ?C.1MSF$DJ^RR7^5M-!U\G^-7#4Z\6</<=2O!MV
M!_%$OK\(4S3AFA$^UQG VA=%9^V(R9M984$Y=RFK_+(1'?&Y8U?7D&-_=%_B
MM?R8CE$2 S@2R(E'S\3!L9.>DJO<K>'>@D>V.)XY"X .:X,TTQX.:-XY256G
MX[(Y28E8=Y4NZ+FW.5T[WR*+/J;,CMPVOUAK2XN^<D;T<,<#S?G$*K>7JQS8
M'$Y*S7>B,"%BP]H)O;U4@B0-$)Z7GF,A<;Q76F8 L6#^*B4Z"[)IKA%_.[6H
M5C5.;P+GZ(OEYZZK7&WV=&]^+BC21)U?=EX-Z,2U'1NA"RL4SD?1[%P^<\5#
MR<<4?,],K7T0563I@,E-A^1RC_<'J12ZD(7YLR:0#6H3064OHA7LS)+ QF5
M&1-13JZR+A7#/P^\*?W!?76YE)STM)N@+E*=\"47E-9V'OV1$BC' %[[-M(3
MFZM>ET.6L$VFOS$>95;(#._%AY\:N#ZZ#Q=%>W>]%;KQ\5= UO"?QU!R/B8/
M4QP]*EP?76]$!\WTPXV:4D;T?;F$1+PE^.6+3E XA+9?^U?Q[^9#%2WI8RHN
M"!ZHX,37)5?\@K]_F6I+L@YOA(/5;Y;T_60G)[;?)4+]08]GE:+H JN!3Z1:
M9UHE+).A2ZYJ9ZWX=P1,8EKS41X&I/[JQI%SS0JR4VMWJQOUC>D'@5R0%(5(
MNNMQ++A_':6B;P1E %=K&JBL+(EGB6,7+F@>,W4\OBS7QP"<&< D7V<VF.)>
M2/'N4:^E^%D/V0D'O"*GZDOJAUR&B?-6  =-7S\H:FNH=+.B.,^ ^ A<7^V[
MLJ0P*(@5 CG4+\VD>".["V %FG+*.CEKMY3C78G\?85 OIFGP?UVJKWNU$LE
MGB$!*\ES&M1<&:WDF_11'*2XDY!H<YCRR;[X4PGR</Z$Z]4#U/BHN-_:C>^E
MCF:K2[^IJKI7X;XQ:89Q5YBM;WCRL.>0S)'#CP -UI=>[MP_6I*L+J=VBJ>C
MYHQ[.S;W'<\/@7JLSA/[261\QU8J!7'SS1C-P(L+[EB,21NNN88].&!^<<9@
M7XB!-OL]>C>8TQ<4T<[9N&2LW5"+L7J^3?PAB#)Q,1N.<NJ0AQLC.))MRE_1
ME$@>49LG2Y#!O$-UDR0_KG)#-<'"P<H?QMX4O-'_\SW_>_9?M;W/Z/XOVG_G
M,SHO* A?<:Y5S:RR>.T5,I9]O">^3!-D;YE#>HH$KV\Q R"')L/F&O.> 81C
M]9EU9CLMG ',P&E2PG#:+G/02S. @\!$?C5ZYLP(;)Z)(2=A?RQ1<48F,[D-
MO<W) +I"U$HJ$)1KYQ*WJ0S@@Q']*+K+[A5ZD$"_B";E<I?)"=#YN"7HP0Q@
MC<EZ$> ]Y3WE/>4]Y3WE/>4]Y3WE/>4]Y3WE_QW*&H2_'$+]^%UFTJ+P6!\)
M]HR/.#$NH6&L28V187VY10N>0N/UZ$ZY_P/^R6S/_G/##;7_:*=Q[ PS*TK&
MEW\#4$L#!!0    ( )&!5E:&8F$MO=P! .6R$P 5    :6%R="TR,#(R,3(S
M,5]L86(N>&UL[+UYD]PXEB?X_WP*;+79M-+,4<D#/%#3W6.A*TNV*H5&BJR:
MMK0U-YPA=GJ04:1[2%&??@$>?A\ '62P9M>J+.7A3@+O_4#^\ "\X]_^YX^'
M!7@29945^;__P?^C]P<@<E;P++__]S_\>O<>IG_XG__QW_[;O_U?$/[OUU\^
M@K<%6SV(? G>E((L!0??L^4W\#<NJM^!+(L'\+>B_#U[(A#^1WW3F^+QN<SN
MORU!X 7A_J_EGP3R(N$E G(:1A#12,*42P9#)'#$TYA@'L[N_Y1Z@E$:QC A
MZD>4L!12&2%(6!#(- Y8R/VZT466__XG_1]**@&4<GE5__GO?_BV7#[^Z>>?
MOW___L<?M%S\L2CO?PX\+_RYN_H/[>4_#J[_'M97^QCCG^M?UY=6V;$+5;/^
MS__[+Q^_LF_B@< LKY8D9[J#*OM357_YL6!D66-^42YP\@K]%^PN@_HKZ <P
M]/_XH^)_^(__!D #1UDLQ!<A@?[WUR\?3G:)?]97_)R+>SVRGT69%?SKDI3+
MCX2*A9*^;FWY_"C^_0]5]O"X$-UWWTHACS>[*,N=5K646$OIQUK*?SG5V<]7
MB.](WN6AK Z$J]7]Y$K&<YA^<B;NG>(',;S 6]U<+7+S0+W+^5C/[KJKJT4?
M7F)7CT6Q)(L1'HM--ULB+_07']6GMAO=T!DRK?MIJ7M+5/%C*7(N&K;<:1ID
M_-__H#[-5Q6\)^1Q_GI59;FHJAOV]U5699J\;WYDU1PQ'$J6^#"220P1\01,
ML9#01R$C*/%B+T3SY?K1GHL<_OJUDZ+NRJB?/UCHN3SQOI:B*E8EV\QT#XMC
MTY>:N?1<E_Z<DP=1/9+V!B6L-@H:^?^C$Q-LR0E^TY+^/__V\T:W_K@NQD)K
M,3V@"K8CSD(;"T6Y#T/!3&'8O(.5TJ#&0)**UDJT32A @N!GL5A6W3=0?U._
MB)=Z^?E@E&_*3@-2L@N#T%[Q,RN4C?2XA#OCH6U**U67A=4#T@"L1/@#*$HN
M2F4#'U'GX*%]LRI+906_+TJ1W>=WY,>['X\BK\1KD0N9+><\#3A'H0<C[*7*
MK%6D0'SUIY\F(9&$!@A1&U*XT-_4R*&5TXX(+F%J1@@.D1J8&%I)02LJ4+*"
M5ECPJA7W)W<480B,(ZJXU-NHE&&H^CYUF-[6CT+:9IM.V/-=2?**,,U/U4W.
MZS\7]1*Q^EPL,G6!LE5>*ZU^GX<RBN*0)C!!O@>1#"A,!?(A\R5%/HG#5,8V
MY-);DHG2#N@TL>.?_@-BQDRCP#PP9^TC#+:U "3G8%L/T"@"?FO_U1J!6B6'
MIL_5L#IBO/YRC,J%5\.USY+7-]B//S^7Q5.FMRV5 &^+%5W*U>*&L6*5+]6B
MS%/_HT2Q8\HH1#XBD'J^@#0)0LG3E(K(GQ]L.UQ\A<_U:?26FNVKN'QCUR*#
M5Z5@Q9,H,U']!&11 MYJ $BK@AU?GAT ,TJ\&L]Q6*\3"7P13&1/A"[$3&^
M\VP)/A9J:;<VV[X(O9=.%@[M-A.,'%'8V:Y&92D3I?>)R.B>?ESS(6>E()5X
M*YI_/^2WRV^B_*24:6S$CQFAV4*M+D4UIWX41!&FD/LA5^89(Q!C[$'/XW$8
ML$#$7F1CGMET/C6+K)84Y$4.6UG!8B.L'=U8C8$9_0R%[,!TU(D-7G6"_P2R
M'#18;X0''PV@MJ:C/I@YHB>KKD>EJSZ@[--7KS;ZT=E;(85JDJLNBP>A%K8W
M5266U2>QG#.":)PB!F,6*\/)PP$D@9] BM,P]K 7R<1J-_MT5U.CJDY2L"0_
M *FEG(%<+.U8Z@RT9ISD!K"!&6B-52-EO75UTT+VZ0QDUFQS&0U'W'*FHU&9
MY++"^[QA<$<_EO@BJF6Y8LM5F>7WZ@]1/@EE3Y4KLKCA_[6JEMH/Q)\+XB6A
MC&(84.9#Q&6B& -)Z"4>%BA-)).^#6.8=3LU]OA,GK5<S1Y(4<_$9"VMI:5C
M"+P9G[B'<V!NV1$8M!+/0"LSV CMCF7L,'+$.(:=CLH^=D#L,Y'EW8YLE]U-
M^3=%OLSRE1+@]E&4S;[3#55R$;:<>TA@&6$$E1V#((J)^B3#"*;Z5 XG0:"6
M]U<9-^:R3(V_.E7^=*6Y8S$:/>VA83!^ 8/IX*QO!C;:@(TZX+=.(8>[Y@Y@
M'<KRLI#D94TS>\@NVFX]FNR[>]YV_759L-^_?B/J:;]=+;6CJO;]G?N^"%-$
M"118;V+Y'H>$"PJ], HPB1@+.+&AR@O]38T.U^*"2LL[ \5&5O JRT%5:W!Z
MF[<7Z*:;YLZ@')CU-BA^;5!LA 5;TKK<)S>"Q=E6^?G>1MXM-U+]<,/<[+:^
MAAI=?LBU1:C-OMJE+\1"I)PK@XL%(41JA0@)(QA21B7':2P9XW;VUWX74^,1
M+2'8B-C+0?((D*:FTS7P#&X162'3P\ YI;PSN^6@@Y'-D5,*'EH9)Z_L]VKK
MN!:^6HA;^2'GRE#)LZ7XF#UI.T9QQWU&%Z+9A+K31Z4;/YD$$2$]M?Z27&\N
M4U_J]9>$,N:^\)E$:6JUN=Q3CJF11*<&**1: 3P\%GF]DZ3^VJ@%:[W 1K%V
MO]6.2OH.G!G?C# < Y/2]DA<QA[\5BLRC%O3E6 Z(KF^4HS*A%="M4^7US9G
MQZD9*9=K)W7U]M,LKQ=Z7P0K[O/L'ZI;KN@@DQE9=US[LBN[[2;G6X>"ZC=%
M\/S-P6EAO0<G>+NVK.9$AH(+I$-M]#98Q# DDD;0BS#W94(028V<T\<7?6K,
MW8H'1"N?&1N_P)"?)_!I#^3 G+^.S]E2? 8VJH-MW3OF[[2OCWNVU 0M #/P
MYM )HSW$4'>]F_KSPMLP[[J??]+G9D>'_X\]/\;FQLL-86.AZ/YKL\,/FKCU
M?WD!B4:Q5EX.Z<[ >4$)>KMX/XIR^?Q9O7!+)<$[)<NC?J5_*8NJFC,O\/P8
M49@R[$,DI;)C:,HAE41GA4@"C*SB8,YW-S7;HPZ+MO;8/H>GZ?:S*Y0&WWUN
M!)V!6M2::M?"SD MKE,W;0-8W#EJG^ML;%=M \6/.&N;W.5BZ_D]R<J_DL5*
MS -$(RI8"$.:2D48)(88"0\BGT<I%XD?Q5:N2B?ZF1I3:,' DY;LFHWG#8Q]
M=I][@3/N%O0,U$#54H*W6<461;4J3V-VY9;T 2*#[$MO>GG!S>D#5<_O4!]>
MWH\&;CBOX_W)XC/)^(?\#7G,U)PY]X/4\[R 0S\E'"(18$A#C\+80TD21HPJ
M*K"A@1/]3(T&-F*"1R4GS'+ &DGM:.$4K&:TX "L@6EA"R<MH@ZM>',!)VLJ
MN(""(RHXU<NH5'!!U7TJN'1YC]W5]]F3^$]!RH\ZK*+)UG3WO?B+>*"BG N)
M$IF&&"*DW9<Q#R&.0@11&/NJJ8@%H1$97.QI:G2@905:6'#[6.>DJ84&[W42
MOT_%4RTS\&<@\$($[KZ5Q>K^&[AERT)_'S8_8(L-K+.C8+ _Z0K;@=EC VN#
M9R,I4**"WQIA#8__+X-FL4GG"KR1]M1.@^AHQ\L$C[,;5&<;&&\_R42/G>T?
MHQNN\\Q>AZ"H#]UW[8:0/MU6_]9/CUKTM6Z.U;N'QT7Q+,3K(E_IW>?$CWWA
M2:R9F$*4I B2-"#0YS[#220EMDMPXDRRJ7%XMQ],M7C]/+>O'RW3Y> +C,'@
M"\C6O7$[_DU_7O_0:C8#V[K5.U&==C/0Z0=:!=T[>3O#W+'+]_5RO8@#N#,X
M3[F#N^O Q?[9:U)EU=?'4A!^F_^5E/7IP!>R%/[<BW@<)32&F#,/HCA)(!5<
MPM#G"8Z9"!%-^V^HG>YX:CS\(5>]B&H)2B5=!<@3R1;U<=^R ,MO C U:B1_
M!F0),NW951O<UVS&G1F3/KMS;I >>[NNEAHT8@-%JYW@0$L^U+;=9:@&V<<[
MT^T+;NQ=!N/\3I_!_3W6^W=95:W$G6#?\F)1W&>B:A=,2> )+PU#&"AB@DB&
M#!(2>#"0%'DA9Y1[TGBM?ZJ7J7%3(R?8%M1B 7H22X,5NPN$!N:4(^#T6::?
M1,EBB>X"K9&6Y[U0LUN@7T+C[.+\Y,WC+<POR;^S*+]X<5\S3C$KRYIGCR/?
M1U',88J1@ @A HG$(?09D@$B$0Z$I:FV:7QJE+<M6^>;:6MM;4%G:E'U V1P
MJVDCEDN;Z%!99W;/5M,CVS:'2AW:+T>NZ1E%HZ/N/N@WG[^M4R:T15#J.+SZ
MQV9COGKW0Y0LJP2?\S#T4B1\R(. J)>84X@#',,0!1[F(O35BSS?+O)P.6;#
M6@BC9_MB10N7C_A:M/Z1N3W&PHP5!L)WI' 8+2541KJ"=F<#ZZ8LU76B#MRC
MSV#[NC81#KCY3DH^:\^6]"Y7JU^ESU,;$!P&R_1&V56<C+T XX;(] ;H(#JF
M?TN.CA6VW$UU6K4()=3SB")!IIVZ(H$@C:D/E4D32AIB%-!DOES7D+'?J-[M
MS\K6.5$@Q[D;J,Y3!_AA COP:BO=IB4E7L*]Y[9_?S1?8C-_D&1V%[ 8:I-]
MK[>7W3H_KOK%#?$3M_5CEC:I2GY?'X;^3>@RA8+?/*EO[X5V -2I@_5NE*(X
MIN:TN8@0DI1',/)8!%' 8K6:HB'DPN<!QCAAF-FLH6P%F-HZJY,8D$9DP%N9
MZWUP.[JQ'@PS_AD2XH$):2UZXP0Q VNX6_%!)W^]X3T#K0KN"*LO>(X8S+K[
M42FM+SC['->['1=G>]W!E6[_Z[*M9JA[47W/12BE6ETFD//:71XAB'6.SYC[
M)$YB'R?<*I&Y>==3(SHM^4PM7+9.^:XYO3N+>J3L6$\@#J7'$$0LXA"+E$*2
MLI!S[N,017/U=-#B97'?%F$XY-\4N>IH66==R(NE#H(<9QCZ'*.Z@G;L@]3U
M\74SCS2B@XWL0YVEFN UR&GJV8Y?\#S5!)#S)ZI&+5R;]4=7.<E7HM*^PN]^
MJ YSLGBSJI;%@^)B'2E:J-E,9\QHC/;7S[^(XKXDC]\R1A28:I[;3PPD$AQ+
MZ4$1A0(B@3DD+ EAPI!(TA#[DEH%9@TGZM1FINV,-1O10:OV3._.:2WZI@ER
M/M*&NZ:3&+^A=U>WAJY5$VB" )V>8*UHDR9 J=JF(NJV)]3H;NM;#_58:8F&
M&AGGF8N<"_I"R8V& OQT_J/!>KQV GHKRNQ)+9J>Q&;FJWXA6:ZK<7W(ZXE/
M?W<KWV<YR5E&%FH:E$7YH/[88B,<4>91O8/#8Q^BA"60)DS ()$I(Q$/O03W
MFW<<23BUZ>:=E((M-6-M%-PR)2OU=97=Y[7]J)CH#:F^@?>+XCOXL^#WHM)>
M>FO5ZPQWF\3&?:<H5\^"[<ST B,\^+K@V)#.@%8*O-)J_332W.(86^=3BBOY
M7F@F<0SOZ0G$=4=.X\#?% \/15X?6<[5+.#Y>@[PDD1-!'X0P#3P8\A3C")"
M9(*1U0+D<I=38_:!H\.WP39C6K<0#DR=IV/&Z]"?AWK>4R(/'D%^!)YA@\FW
M.YQ"7/D1  Q#S(_=V=ME(<M%%YRC4]PT!K*.X6&Z[F_Q6GP1RU69Z\]M[$YY
M\Z!W^N<A25@8^RE4=$0A8C*!.,4)#(7T4AD$(DXMD]3T%V9J)*6E[UP;1"N_
MCK&A I2M"B#7ILGRNU@H,T:-Y_*;?6!D_\$S=HH894B&]YC0:H!6CSK-5I-L
M:[U!\6YWD#JE])^=6C/0*.;4S^)J>-TY8?0796P/C:M!.^*^<7V;KBCX_2KG
MNM0%6:ZJ6UD+TU6B"GGD1=P3,$VC!**08IAZ(H!10/P$2XJ$L-H&L.E\:A2K
MDT$J0WS1>L_?2M#(#AKAK^72,Z/0ESO=8/LB7-E"^^K77-:??FI1UCLC-8\.
M5/K+&L'!Z/!,UR],?Y=!N4QW!FWTK<W*%LH.RF3&ZO?T=J76T#>,K1Y6"[WY
M5I>.UB[;I?@F\JI>@.L28W7U&!Z'E'$:PE0G3T7*Q(0X4IP7AZ'O(2]!W*ZV
MUS7"3)#^=G31A;_TV[BE3EMH?4>AKJY?G_H^5XVE&6F.-4(#D^BP@].C;.SU
MJ#HK)GN%*".7F+T>M,/"LP[:[$?$;0KL>B>S/A%C9'%0QW'."1(ZO!S&:11"
MY#.N3,TXAA)Q0@2F*$BM"I\9]3HU:JVEM:-&,W3-.- Y9@.375< H!:X=0#0
M9_Q'2\>Z(S4KF!RQEUF?H]*4%0S[?&1W<S_B69>,%97>Q9P'E%'"8@HC[@N(
M,(HAD;I@JTA]/XVI)Z55;;6]]J=&)NV4OM3RU0<6=L2RCYX9A5R!R<!DL2DK
MK>#X? X.:T(XH;2C5W^_]5%?\A.J[;_.IR[KDXJV2VW]%T%T<G%]^/D]6W[[
M-2]H)<HG?;C^(7]<+:O=?9@N[NGYKB1Y)=4+IGURM/_-G2@?ED7+./,H8E3H
MN*1 /2<01<K:(#[69PF8^2S$49(:5;@?0]BI4<I:VL8+;Z'=[52_#WJSFK63
M\6-1FJ?N&F7$SS/7U,9Q8!K<)/"?@2UE@=86;*L+&GW!KL*S=;6EYQG8/ YU
M2N3:^_*N?1Q:S2?T&-CD I[.XS!6.N&)/!:6.8K'&:?S:8X'EF'$3,GCH+F;
M;'FD/GL8(EW"T#9/&<-)@GS!82@8A4CX$<0D1M"3'"61CT/B!<9VPV[;4YOF
M.^DLR'L/+(,IMS\$ \^0ZV3#/;+<[<%@,>7TAV.D&<(<%CL./Z[X6<K=NV4\
MACPNZPZAG;BDWP[&1U%50M11SV]%Q<JLSAM3^Q?/N9>&,O4(%#Z-U#HFY)"F
MOH >(U&4R#0)?:ML=6?ZFAH_-:+.NJ#_+7%;YVO+XZ5S,)MM>S@";V!FNP(W
MZST1 T0<[8^<ZVG4O1(#E??W34QNZ9/>MS6*BK+JHEW5A^[;4O"U+WGC;?07
M\B-[6#U\R)_4E0]UO=*';#E/6,*)'U(H>1! 1+T 4L(]&"1")I$G(QX8;9@Z
ME&EJ5/15L%69+;-_-*>MDK!V$50HDW5)<JZ3D]"B+(OOZE,U P^-6F"AM;')
MG^MF2 T,L_$':F#:VRCTK]4ZD%]_ EM*@;56:\_,5C&PT0Q\?)E1L\F1//KH
MC951>:Q1M,S"[!3O\SF;W70U8H9GI]CLYH-VVW3/:%MQKYOZ(NH][_S^0U['
M9>GWX'-9R&RI8[C6SIO(I\+'/H$XH!*B!&N?LCB%D1<0%@AEM'MVD;0VO4]O
MWJR%!XVDEH&M5K";&?"#@3GPW-;AN!8<;$D^:^%=1Z8.X"K;"SA7T:96?8\;
M2=H'EH,HT5Z-](P S9<9SQ8K'8G:&;6B>O>#+59<L:E24'N'K9I9_E:^(V6N
M#=K/HJSSVK;!/0&6 4'8AR'%GEHQA"E, \J@1U*!2*H6$ZEG%23J0JK)<5^=
M"!B(5HOF+)5M]-!I 9;?1%8"T>02^%ZL%EP'!Y$M./IG\G8SU&:\.OH #LRW
MV_J C4+@W<Y@;NFDG6\[K72^L"83N/N(+J= NXJ'=2+3N"&S+F$\B*IUVKBK
MJ*^O8KE<-.E&-O%G<YS0*)!$0I:FL0[X8C!%6$">\%#Z0233D-O543#LV>AE
M'[5X0AUF5&UDO3; ZSC@9GSJ$L3)A,!V!1&4=0,VZ@P9SG46M,$BN8[W^L)!
M7&>AN!R_=?[VOHZ[S8I>NQ*VF0>R?P@^9\A7*'L>I#X*U J:QS EF$"1TH3A
MD$M.K:S+$_U,S5Y<YQ[53KRS+N>(EE0G>BV4Z5AGCF&UN:&,PL>RN%?76_+4
M*=#->,D!E /ST!K%SS6*6T+.VKU!O7J^42@^U=.R2_?@L]@X<Q,^WLO([L)G
M53UT&SY_>3_Z:#*PK4.8[L@/G>IUUW^HCG>ZX?^U:G8#JWD4IA&1#$,<TC:]
M$8U)!#D+DH@HHT<$1NX]UP@Q->*IY;-CD5[8FU',T(@.S#]K\<$F$J'.)GW@
M2MG$9VYI,4#=@FO =$18O408E<VN 6F?ZJYJZQKOH=WB"6N_R=;FKMZNQ(U4
M9/*?@I3OE7CS)$6^3P(?>G&D%G[:XY'4.3]X%$="AFI-&-K[%5E*,34FO%,#
M(XB6L(]GD>T0F/'AX, .3(B=-])!$9<M5_(F)U)CL=7P ZT(T)JX=E7J":13
M)R9;&5[ O:DG3,<=G_HVUL,EZDU95%7C%<Z>=TH ?">/;XJ\/D.Y^UZTGKO$
M%Q(A&L 02P91$":0II1 YOL>CUC,)36O@V[7]]2XKY8>=.+O5L( 6@.=O['1
M 2@E++QC+,?D/"T.C/3 9&@)<A_?=$NT+7R.AD-])-\B5X^XG>M0/]C.N@A9
M-CF>*U _77=<?GHVT7,/X>\K-1'IXY@B5\_?V^*!9/D<,8]X6%G$" L/(D_'
M "6IU#59L,>\*":15>+1H[U,C?\;(<%:2O!;(Z>ED_UQ1 V7_M?B-/3:WAHB
M^P7[.0A<K<B/]C'NDON<F@=KZK,7]_3I6]%*_'VEFGOWI/YSIUII'U4_362$
ME"&8,J(6QM)#D'B)@"%#?A+1-&"!5<#-R9ZF1@ ;04$M*="B]F2!T_":,8$3
MT 9F@YYXV;O>7<+"E9O=R7[&=:F[I.Z!^]S%&ZX[GFR3%77QP;&/J4\X] .]
M8F080X)3 G&4TD!&B0C\N,_AY$XO4Z.&M:4L&BG['3GN FEWX-@;GK&.&[M$
M9.["9HT@<'RJN-O'BYPI'E7SU(GB\8O[NOFS52FXKB+9/J*12##GH0^#@%*(
MPI!!2M2?*?5Q$G$<Q\0J/>Q!#U-[SUL!@9;0UEE_'SS#B?X:2(:>X+?0&."]
M/JFZ,[?Y_?9'=HT_H=ZA^_NI"WNZN#.U7FA"@[*EJ*OR*;I0 ZM+)S>.2Q^S
M7'Q8BH=*+?699#P5VO\Q@"B-/363XT 9_U0(/Q)1%-IYLEMT/K6WOY,=-,*W
M%38WXK>.?. WK0&H5;!<%E@-C1F!# 7XP-SB%&M[+_(>H+ER%K?I>ER?\!Z@
M'+A^]VFCQS'75HC0U^=*MT9R_F=2\N^D[ QL9:I07R8$>G&JS[9PJ*R7F$!"
M8AQXB/L\,@I$-.UP:G2V)3*H&IGKY,'?6JDMSE1,X#8XMG(,XN!+FPU^7[?P
MZP3N<SAE J3%B91C0$<ZAKH>6+L#* N4SIXZF;0SWE&3A58[YTLV]_4S0'_-
M2\&*^US[N-Z1'ZT7??4A9[H0M*B^B&JUT.X0=2A0D\'NLRBS0E_]N:CJDGS5
MG.OC)N:GT$=)#)%@*4R3((%)D$8X\1AE@54@N1NQIL;R77+X9^TPM"0_P&,G
MJ9UIZFC0S(S6\8=BX+EB6Z':X[5323O=-TJ!M5)M\&0[<(U>]4V?+PZ=M:7K
M%FE'-K CH4:UCMT"N6\W.V[=94"!=CG(\I7J>U.A_:A;[SH51:Q8.L:Q#V44
M!1#)4$+L^;JF'F)(_8F0L'*M=237U)A[30RON&@^_:3#FK+M>@;E#F?\R460
M@OUXFG'Z"XS2P*1N'LK0QBT,DGG$,:Z#1C782S6!0(?>4)K%/O1OWF4RU<VV
M(D]U$1B9PI"%":R=?['D*>0DBJ.48!;1'H$/)_N;&NN>2P[:>U_W$N9F#.H0
MR8&9\5H0':59'6J/]E)O$TBW>G$GUO2VOE5'ZW)ZGTFY?&X=FR@-><I("BG#
M J+0IQ +[D%!)/;]%*<^M_(;.^QB:E322@AJ$7LZBAT!THPLKH-G8'ZP1*9'
MO<U3RCNKHGG0P<BU,4\I>%CQ\N25/=U =#I?^OQ1+/4[="O?E()GG5-#[(<H
M#B2!B6!J:4=0 E,_"6! (H*B0'C(CZP\0LYT-K77O945M,+JC%>-N):>(N?P
M-7OW7:$V, N<!&P(9Q(#2%SYE9SK:EP7$P.E#[Q-3.[IQQQ_%OQ>+7.4N9'=
MY_62IIW19(#\)/40]%,6020"K$R#.(!IF#*?8N8A:;63?ZJCJ3%&*R?8$K2G
MF7 26C/"< '8P&31"RMKFK@$A".*.-G-J/1P2=E]:KAXO:M4?.MJ6+=R*S.<
MQR/I<Y9 P4,&4>H32!A#,/4D5_9%$@8HFC_6F]Z*Q,JE&5<8]F[S)NS+,-Q+
M4:>/(XTG%%D"J:O7/375ZZA08Z7S)NII51_^79NN[_B@^#Q./!8P*(FO##XD
M,"0AI3")<.P1X0>(XG90WN6],R0Z&I).@A<9$)'S88<"4YX0+\0P)2&'*$9(
M+;4]#"6F:1!PYB6<SI]$20O3>72 @=CN?[AA>+_&74/^N!F489!G6"UKL!_"
M6,:>0EYO<L3,@XQ*@B-/%]0UJJ4[(.YCF#-=:DN-=S4;%'$SLV8 ' >V<@RR
MA+K.F&P)TF!908_W^L)90<]"<3DKZ/G;>_BU'G;Q2;0'_1EKOWU35,MFU::C
M?]A2\"]BN2ISG25?&27+.DOIK6P.H6Y+'3=<BF\BK]8G4^]^+/6?="$^9M7R
M4[%\FU5LH6B;OU^0^SDBGK+#TA@&7"?$BB2'1"IKS(N\2*@Y*!;,Z(1H,AI-
MC4BG@(F%T^H4Q#5Q+YZ"G-.;:_[_I\SB*;/PO9Z"O#9/VTC.W5. Q9'?^!14
MV37+3CBF3T+0\3S?)Z'N,=?Z20G6\_1/5^!X351CNF?53^.:5);J'6_2W[]^
MWES39C"\^4Y*?EL[&%3OBU**3&DDJ@]YH_O?1';_32EZ\R1*<J_D%R7+*O&Y
MS-2RF9 D#$)&( J1KN_,4YA&F$(O1$10+XECR:U.%$=68&JV92<K:(4%G;2@
M%G<&6OW4%46ILS;449BZR!(O%@M25N!1E$W!)<MZ2Z,_.H:'I1-^((8^@-5J
MP5HOL*T\V-8>T&>P?6%7I:2&0*>MK4%8/S<:!NVFW  Q Q>>-X<GO"\TCJY.
MC<<6?]R3Z!<:G(/3[9>2HZ^OKA*CR^FX(HL[43ZL<S#Z'I,<02E2K/.3$YB*
M6$*.DA@31J.8&14EO]S5U&:P6E*P)2K0LO8\.#^#L-GTX0:W@8F^+V0]_' O
MH>',!?=D1R-[WUY2^-#Q]N(=_<BB7D^HAZ!]?".1^"'1AG.$)$2Q2"%&DNK3
M<QH3Q".<6KGB[38_-5*HCTBT>#UY8 \\LW>_/R0#O^\6:%B_XL>5=O1:[S4^
MZJM\7+']U_?$53U3,6V*G-P5-YS789IDH0L]?,C;2E![V5UOI>(.96DL]0)?
MYX2:2X*#) A]&.H$;(@G$<1<^)"(F'#!(AG:O>@NA)H:/=0V'2C%HVKPFYX+
M=3X)T:0K9NMTQ874!8=U(;E.%Y 72P&RJEJ17"^.<V'IS>MDA,W8:.QQ&YC#
MMM31]4\V"M5U4/02L]5I!@[R3FM/XJU!/)NNSSXYE$.<726-<B'2N,FD'()X
MD&3*9=L]%VY9+CK?Z3GG5) H4-RL@(*(L0BFW$>0Q1Q+/Z)!*JRV,+<;GQK1
M:MGTZ\<:1WY)6%W*!A2K9:4]R[/<\,SO*)*&2[*>^ R]""OR>UBONSJ0+H2'
MV*^^CBCN:KVUW?2X*ZPC2AVLJ8Y=8_?F<I'-W^5+]:PJQM!E8^O#EMOR<UD\
M94K0N4P2D81^##U& O4J,P[3 *40^<S7-9)(&AN]Q9<ZFMH;W<@*6F%GH!97
MGPUT IN]SQ?Q/?]NNT1MX/>\/V#&+[PI&D=>_DJP/]X73S^K)IKW7GW8O.X7
M&Q[EU3=5KZ,!X^M[YKUY>%P4ST)\71;L]S80+Z%)&!*?P8B+2'% A"")9:0C
MF!B/XR@* JLY_4@?DR."5D10RP@^=TLIO2*V3#QS!%"SJ?U*F(9^\W<1<A_%
M>$9]5WE;CO0P;@Z6TRH>Y%,Y<^D5W@WTS/%0>SI$3YP.W6ZLW+U3H2]";Q>I
M[_=V?H-YZDO)HR"$B4?4$D'0 %(OY5 &'I:(<QE;UM,97X>I,=7!F?/!R4>6
MUQ54U>R\I:Z.V.D=I?,2CXZ%@\-T'X@)^#B8NCAL(7'$L6&-QL'CYMC)X67&
MTJ6?P\@:C._J\#)#=-3;X85$Z96TO2E:T]4]U@Q]FXMY2@)E5(<,XB1(]4EF
M"'&:^C . ^GY# =^&%@D:C_:R=2FL'7=I,=6SEF3P;?([?*R'T?T_,3A"J>!
MF7T-T><U1'55]%LG$%EE6;\:JM$RJ]M#9IM+_2P6%_*G'[]WS)SI9Z7?RY-^
M_MJ>)\*:?G6)OIL?6367PDMXHOB.>P&!*$A\M38@D?K$8\29QV(<VX5T[[1O
M\X2.$[A=B]<6BM02VM;/V4'/\-BT+R)#GW\:0V%_@GE,95='D3MMCWNF>$RM
M@\/!HQ>YREQRHRVA,B.+7Y1YI$,VYAY!88(] 3G5?IHI9I DS(,XC+% 0BK3
M1LYS<:^3M-U=DR+@H&NC9QDWS_*!  ,^UYV<X-6]DO0GL%"R7ILEX!!WLY??
M%8POF1V@^^N6+K+[-N'T!F2M!GBE%3D=KN$@9\!)V ;+%W#8XPOG"C@)P>4\
M :=O=45,73#9^Y7V7>]^V#)=WF=/8HZI+],(AY $.C-_FA!()(Y@&N"$^1+[
MD31::5TIQ]068^II3*YE*+,!Z,M:SF%]$2;KM "-&IM?&T7:Q8I694@JL\)R
M,'HSD^*%*<\*JLLT:-=<CQVFN^_%W;=BI2M:W:F1$[K3]OP1153@)! 04:Z=
MM$@ "2$^5$NP2- X0J$T*G1ZH9_I49L76IS@7D+18&/)#38#\Y,2$G12@EK,
M)@E3CY)^9]"RV&-R@]I(VTP:O66'WM("/;N]ILN8G-UN.G/[>#M.EW78V70R
MN+R?Q=C6'LGOZ_"DCQFAM=]F6TIJG@:<2BX13,*4-,%$*9(QQ$(M;T-"&.=6
M[B[GNYL:27:EV!Z+LCXZ+"18U!%UBTYP $'1J=3\9KFDO8"_0(@H:YS"E$9J
MBM(V.>6(P)!$,@IIB%G"[38"W8W .#N#W1CL I\YQIDI/+&7A! CQ!3.B7K.
MJ52(DY01Z8=$)&B>"\/<L@XP7N_/#)U*5M<#^1,8!V6S58Z[)W1@8V$M:%?O
M9BWKK /4W7K%#!5'RY(+G8VZ^C!3?'^187A73W<Q]DWPU4+<RK4KFBB?,B9.
MI!E8U,.K/MW*+^MRCDT2 9WVI[HC="'F-,"!I$A"&GI8,4^80BQ3 5//BV0H
MU"P02"N'L"&DG-H4W;COT%WWG8VC0[.WD.M?M4W:!@%IQ;J$JN"W6B_+ Z=A
MG@ S?GSQ<1V85H]Z9#D=4GOWJR$A=^5@-8B,X[I0#0GS@9/4H)W932R56N+I
M?,%-3SG_7ROU1,MG-7W=,*8?Z:K-Y;8JU5S650\,?2YQRCB,)/>4T>HQM3@+
M&.0H)9*1./:%4?F47KU/;B)X]P9T0SH#?@ ]/ -KK6JJV.@%.L7 1K,>91[[
M#=MYEA]\,(9F[W'&P9C"K\+S'#6KAK=HN6JWFFI*[M?G*%1[%1P=A5[72,\L
M-V7!A."5+G3^-GL2U;+.QG4K7Z\JU455B6H><QGYJ2]@E.I5?$!"94O+  HO
M9BR1B<>854B%09]3H\%.Y+HN.*C(H@XXIJV\EKEQ#" W,UD= SDPA>UBN"6O
MAG(CL</4.N;PN,JW8]#CN$EXS"$XR,QC<6L_[JGM.\5S[<*CZBIRSWWJ"Y:@
M&#(>2ZC,+@9I)!D,TH3YE"6"8:L4/*<ZFAK+U'(VN71:2?]D1RTG$37C$Q<X
M#4PB&X@Z(<%OG9@.5Z:7D'#$%R>[&94D+BF[SPP7K^]5B:7,GI3A\R0^%4U^
MF6;304?!9+EVIIQ'A"=)&J0PP,KX0#0@$'M,*%;@&%&"N:#4HD[*I?ZF1@X;
MB6<ZC5:3NXG40L_ <BVV50F(BY@;.""X17)@^M@&L1.WW=Z:@;N!0+2J<N$2
MS-%J4%P'JFV9"%.(+A1QN-C,F"463'7:*X!@?%L/2OXU+]<;<G?D1^L_5GT1
M?,7J>,8OHEHM]&&0-A%OE]]TP?*4QP+% 4QX75Y <(A3+F 8!"@4W"=1G%JX
MY_>5P^XL>#1?_5HV"V[I,P(&C#T4H.-0^+;T0(G?N;56,[#1 *Q5 %H', ;R
M%C0_\ B,Q/L#C(3=5' %C&?GAC[MCC=97*'USNQQ33O]%OS=SL&;XH%F3<GK
MS9G/!ZZ>V$QF^KRGJ>QXP_Z^TN52U%+CX\9U1OVF'F[>NAPT5ZI6A)H)U9W5
MG"611Y$70QEQ[7.D9A_"??4G$E[(DB3V$JM,_F,(/;6UQEU)N "D.T4HUY+V
M2-D[RJ";[6],;2@'GBD[=<&6OIJ:UYR]K7);$!=T2M=[+%MJ@U;OM0_6NH+N
MEO+N-F#&'"I'FSFCB#SJQM"8@["_R31JWR\_G7TNM</S\EE[H"_UWIJZ]E';
M<//$HRF*N0<C&H4085_"E 8"<B^*XH GZK.5K_@H4D]M0NL$G=75U)?K?/6/
MC>O3BTYJIX=^_%G-R8#^<TYKFT>D5G[6'#)T^D]S9KLX7!.<VD[+_$\[MUT<
MAB$GM\N=]]C[>R>E8'IC\7U1BNP^;TJAJE7B%[(46M1<)Z*O!=<IR[)\I9:)
MK7.X6CG.XSAAB(0)C&D20!3Y$4R)1&HY%OJ(>,@/$_.SFBN%F=I<M%8'R$8?
MD-4*@27Y 93,-NFVKATG@]W"$=$?>.+8 -^J AI=ZKTKK0W856<&-@J!C48C
M#H_%EN*(PS32]N+0PV6WU^@(W[/[CM?V,=X>I",T=O8C7;79;S&WZ6VGI\]E
M5I0Z5\+Z=U'-"4NE\*D'21HS74D[T-GJ8Y@RAGTO8(1%7H\D5!8B3/2 :_/*
M;KVJ>DK36X@[K^JC5JK)P;F9_40U:ST:[%9C-F-GMJ9R/11C3W"7F+)6I,G_
MLKE4PW]S'G[KU4X/(!VM66QZ'G7ET0.2_?5#GR;Z5MY:KS?F7H*C-$8<DE#7
M016>A!2C!&(_%@$BB8QUXN!B219F?+?5MI6-ONYAP ,0W4?_@.UMU,P(IR<6
M Q/*1P, >I35.E#5656M3<LC%]4Z4.FPIM;A)7U2+GW+2OY9?5+MM&EO1"+B
M6(H$^JE,(4I8"M. ^)!R@@+,$JI>3+-D%B=ZL'D@Q\E>4<L(6B%MD@<=HF>P
M KX.D8%?T1TH>B54.L3$)I'25=B,E4#)#B/+M$DG$3B?+NGPMA'3))V4>3<]
MTNG+7*1%.E4$H?Y1^S#Z<TE"'G&,H0P5K2&B,_WZPH,>]P+AX81PLRJ!?068
MVM[ANDH*::NDE.LJ*4V.&>T(#EYE>;VT.I.CULWPF-DV0X(^,+L>Y*(Y4Z:F
MOL)Q@9J^T V2L,:@^Q=,86,.SOFD-A;M7%$5[3 1PD$9F=?[960^KF/=D9?Z
M%,<$"I9&$'$10XI2[1B B&0B36A(K(N<7272U(AR.X'-Y3I5>XENZE(!]GD+
M' ZP&;&..VP#4^W5E<4<9SAP#[++DE_7"31^!2\G !XMR.6FY7Y4_DDLWY#J
M6UT8EPO^^OE7U=&'_$->ATOKO W+[*DYK.\B<1/L*98.)51K\Q#J@W!(XYA"
M$JOU 8VX()%5,@5[$:9&U1\^_?7=U[L/GWX!-V_N/OSUP]V'=U\MXYY[C(,9
MPPZ+[L",JH0'6GK0B:_I\Y76 .A"(6LEP$:+08*I^X/HB#%["# J0_8':)\1
MKVCIZIR-;;;YO3SS=?ZN._%C^5II_/N<D##EOC95@U0MZ(5:VF,<,BBC*$8B
M%GYL1W^6_4^-^SKQ=0J4=;F&O3H-EF</MB-B:&H.A_/0=J4)Q&UN0Z 5 +4&
MPZ0YM,'.?0)#H]Y?*C6A#31GD@Y:-=,S9U919;6AJ:OB!8$O&&,44A_YVJC3
M-7YX"''B82FQ[^'0MTJ.M=7XU-BJDZU7,<$=U,Q(IR\6 S.**0SV":N.Z.LJ
M,]5VT^.FH#JBU$&NJ6/7],LB\T"^LDPHR;K#+.QCWQ=1 A,4Z\SS00!3&?LP
ME@&.4J'>S] H'O14!U-[26L102>C72:3 _ ,3D>OA&3@=W47C3[GH\=@L<OH
M<@T\XZ5PL8+).F7+*0PNY6@YN&_4I"RGI-[/PG+R.A?'I+P) MEL#LM0K988
MQY!R3B!B2:",#^JI)954_S*9\##I?RBZW]W4^&WO2(YW$5[]]^LOP-WGD/,:
M$,<]TK3#[\H#S%.P#')<>=#9"QY.GE+\_%'DR;OL:(6+;/XN7^HZ'<7#0Y%_
M7:HU4+TQ7MVNEM62Y%SU.&<1$IA0G>@<28AHS&#*8NW:'D4BTOF;L%')/K/N
MID8KC<2@$1G4,L^:LZ8*;(E=^U94]=>&SA6&Z)]G&?>8#LPRAG!>3S1VR!PA
MFDJP/]X73S^KAAJ.41\VU&+8_"C48J=J1RV6=_6S6-Z3K-2IR\5?%&^MROKP
MK5I_^>=,L5K)OCV_+;0SQ9S+)&7("V 0A1PB'"?*E%%T$\9>R @+8AF'-@:,
M5>]3(QXM9YW)7X"UI'7L^:>;OX+?&IDM#1J[T3"S;P;#>& BN@Y>:WNG%TR.
MS!^[OD>UAGK!LF\<]6ND'Z%]$4_%XDD1XYM2\&SYGK"ZT%F[_O=C/PTB&D)?
MD@ B02FD4L8P"#PJF9=B7\0V!':VMZD1UEI8T$@+.G'M2.H\PF:DY RW@4GH
M)&0.=UJL,''$..?[&I5AC-3>9Q2SFWHSB,A70N=.U.'*^JS];]GRVYM5M2P>
M1/FY6&3L>>M@/!84)WX$2<253>3[&!(:^M#S_-0COJ=SG%M2BD7W$^08+7V7
MU4=O?EJSBPWZ7LS\1&(?XB2,(&((0QP' ?1H['/L$UT!QZX@\'#XCQ-B=60$
M:K/IZ[?L\5$SF?[CS^H_BSJUJ[ -D;0<(./Y8"#0AY\@:K3KTCB=Z."[DAUT
MPH/?&O&'\5'HAYR[:<2F\['GE1[ ')EH^K32LZY.D^YP'03>UNEH72*.Y<Y8
M>T52+PJ431M"'I,8HD0MSS&2*8Q"(8,PB/R4!U:5=WJ+,K49J=7$MB!/_Z$P
M8[QQ !Z8_;J,LEM9*UH]P*M6DY].9/<9IOK/U:"ZJ@_47Y!Q*PA=#=A!C:'K
M6[0_)'G;'K;?J5OG6(0D#A(! QRJ-3X+&4RC-(+<BT4D<(JH-/(;V6]X:L36
MR0:T<.9'&CM873Z\Z(O P,QCIKS58<0Q37L=.^PT--H!PS'QMX\2COX^<B#D
M[6/]QF\=7^P%;;[[(4J65>)SF3'QI5@L9%'J&^>1+V,O4 OL).6A>JF)#PGA
M&.J@21(Q9?[$5I4%QU=A:O1Q=:#E#+18S+8/!H]$6G>(@!H2\)L&1:<&U(V,
M%:'9_\DS,^>F_3P-3,971X#V?I0&L"%?;B1?.LRTOP+_'&&I5P^0LS#6ZR7I
M733\>,KI7RLA5XN/F13SF'LT%<B#29027;8@@M1G'HSC* PY1RF1S+)H^*4^
MIS8U-I*!C[IXLG6)\(L FTTHCF$;> ;8R\&_FX)_!M: 2@>V>@^$W%4)O]CC
MV%7"32$X4B7<^-:>KD59GBV%?HGXAUS1W'VVSHO_%_)?1?EF0:KJDWJH6G>6
M0(0,TYC"( T\B!(I($9I#*7/@X#1E,7"JOZ79?]3(Z%&?%C+#S8*K*LWU3J
M6@F@M>CK<F0Y2F;L-2#V S.9>]CM79'Z@>?*&<FR]W'=D?I!<^"0U+.9D;=+
M-"<OGS_D:HU3;]U4=2W'NV\D;PW(3T6='T#P/?/Q%]7T\BU9BK63U1PG*?52
MR6" D8 HY"DDE',HE;V7"(982,1<S0A9P;\N2;D<>!O%H6HVY+&OX( V9"L^
M(&KI*^ZSO$XU5\@F=;IV1N?*K"=E!91,C6.Z9=*_*6 _]P7VDTA-VIZ@"")!
M(IC& 85)X/$T94F,*&H?JW<Y_S_YH>K4&^>1$LK _C_N81IXJ^V%'H_I;[XU
MP( M9)IJSV"IL-ELS:WA.;(Q5T,$-$9@X[@]@4VY <;\I;?I7*KTS[%Q-\ @
M.MO*&T*V?F9F;;_6%>>V\G70,!)I%(=0)%0MJK%((1;"AQ%..<>)1PG!-HOJ
M8YU,;>5<RPBVA.R5]N0HG&8SU+4@#3QC6.-C3=?G '!$GT>[&)7.SBFY3R]G
MK^WWNK\54I2E7L >];29>Q0C+V8>]'Q)(/*#")+00]!#A*H5'PGC%-EY1E_H
M<7JNT)W VW4:7]'6+PT\ZEQ[E;6#^B7<PSCD(><QQ)A0B&A*8$JB$'H2A5$:
M8HQB9E-LQR'JXQ7@X:W0;J$U8U^'@ WMQ-0]G^?\)]VQLB$PC@CZ4F^C<K6A
MZONT;7I;CXQ7OY L_UA4U6W^-JL>VS1:MW+G6&9])G.3*[.T-C&9ONQ#KBZ[
M5T]B-0\Y]IB')8PB7]EWRMJ#*:<8AB+RO,C3F65H5]'P/-\XE,KH%=LM<C@P
M*VF=P"NMW4] V3N\5D[Q5"'U-%#KMEM:OOZ+;6FGYA#XV.IGD83*T3"?9[ZQ
MAVX<=M0*@5=:I9_ ;0ZVM *W<EWUO3UP7FL&E&I@6S=%KO#SBPV<1<*Q\0=P
MI!QE8PZD77XSMY"?38GFJ*OQLJBYQ68G\9KCIGO,OF]*U7T3JL">/^1+H1I<
MZH*K7[^3QR[0ZTX-J&C#VD,JA1]S"061,42"A9"F$D/!*5?-*U/?-TH<T*OW
MJ6VPU/*#3@'0:=!4K-4ZS#:AD+4:%KQK/3(&4^.0> \\"5I#W2=3IC7F%K/:
MD-B/-'^Y>]SM9J>^T)V=AZP;'6_&Z:OOSMS2NY&>NW#M2N*7LE@]JF7B8J6]
M>=6WK(ET$WP=Z/9+4?#OV6+ASV64$,QD A'5_PF9@#AF'"813D7L!PF.A<VF
M?!\AIC:G=()9[ACU@=]P&VE@4(?>6^J6N+7\,[#6 &RKL G(G8&+(V"_X70%
MA*YVH?J(,.[6U!4@'>Q77=-6SY3'^KA3GYF6XIO(J^Q)-)MEVK[7%6W>+XKO
M?Q;\7G1&_VLABU)\$4S[V&4R8\U):\[OR(\YDR+"@4>@%V&DT[E(G2$Y@GZ<
MI#$)?2X\*Q]@I])-C3)_S4M!%MD_U&NLQBM[4J(^"7!?K[87]6J;E%FE7WF^
M*O4_C:.298YEI^,;Q,Q'V)>02,H@DC&!Q/,0Y#HL.R$!#>)PG@M#[\/Q1W>]
M:3FT^^ O6Z-8"J;?2'V,!6YNWWR< ?9-NR7HOZ5VMGDZZVPSPK!Z2AVL5L80
M)5SHF"&L:ZDPR(.8>J$0Q!>IW5GCB[VXXYQ,WCP4JWSYW__%C[W_44BPO4/6
MYFU2;W7S<S/H'UYR>,T,IA<;LH$MJ<85;D>Q[L"N&;)94ZQ/ZP=J!6?; SH#
MM-83["M:'S$H51WF;!]B!%RE>'<JV[@9X8> ]2"!_""=]-@:W5\SOQ55=I_K
M,[JW@M5+9C\,/#^Y*TG.OHFPVQ)* Z93S4-&,8$HC5*():&08<8)CUE N%%J
MZ"MDF)I]=KA1!#:*@$X3X(<SH)4!K38@M-BZZSE:!INFPX_!P+S=&_X^6ZA]
MWQKSC=3AQV.D[=0!Q\5N?_4Z1,_NLO9L>KR]UNMTW]EQO;*IGJD2CR1C;)PL
M<_XQ([1.![Q7,!6G/!6(!5!PXD,4(PYI'*I5BJ#<9R(@H;3:=NTAP]2FJ.T:
MJV_J166E5Y7KXXRVQ!!ICN*;[SK5,MOD"'W&S&SI,?!(#'W&=S1M[&QO%&:'
M(_ \JT=&V8 B>ZK+X Y9#?<*D%UE5>PAP;CI%/M#=)!'\8JF>H8I"[8J-6G3
M99O$<4Y(+.,X%1 '*($(41]2+TPAC42*$$O5RM8J%\QA%U,CQ"ZCZ6-1UFMT
MQ8NT*,OB>Y;?5V"5<QU?*?*L* %K*@+(7D44CH#-:!2':<2A2'3>RBAFD,1I
M &.!8A+$**)^:+>)=AW<X^R$W8GR 2P*D@.UVGTL<@V^ OTXQC/0K79U%&P%
M6*/5U=";S3+7P3GP)-(*![1TL]99X30P]@&8)W5W%0YYV,&XP8DG%3P(%3Q]
M9=](GN[P9BN,<+W-\ZQW?13[?!&+)E_NM^SQ]7.S.?15K=7JZ,2/1;/]\_KY
M6&-?LNKW>JJ8!RGR L(B&'+!(0J(,H%UT7/*B:(97RH#V:H"Z7BB3VVBV B[
M'3>]L_.KHZY;!, V!#/]0[N#O(8!=#C4OQYM'6@P6A//,IAQQ$?,T+MBD@_.
MT#X9!L_,I>'M$?4S-M+. HA&$WSD6*2Q!^0PK&ET"?K6TVY<OKGX(?A=\:&J
M5HK:FY#[K\LR^[U)D.G/PQ )P:0/_=AC$(D 04*P6K)$/F<<\41@:GD ;=CU
M]"SJ#[KH#UF JI82/-:9<EWDB#$>#</SX@$0'OHH^+$-1*EE!LL"-%+_:]7F
M4)F!1O(F/['+:MQV6#FKRVW8[<@5NNW .*S5;7E_7[.>+K7KW:+0-2_7Y6%"
M3$@@90(3+_2UBQN'F(@(>A$+DS1B,DVM]E2.=S,]<YDNP49,D\S=-J":&IW7
M0C6X@6B-4@][\!P(SFRWHYV,;&>=4_30)CI[=3\*N"L)%S<YKYT[;AC33E_5
M9KN^J1XVQV$@=0%M&+,DTCGT**2Q[T%.E/E",!(^M\K18]3KU BB%AITTFZ?
M:>@XT)O%HOA.U+!7NG $>%NLZ%)GE#YRO1V?F(V0&;TXQWU@MCD&]J"U"JT
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M!K(?B# -:! C@N?+8DD69O.5>==6!O-:@ %/OM<>RCK)G7UM PO0$1(IXZF
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M>RGVRJ,@I2F.8$*EO2B)+8>D2&*8(9Q'M" 9CDA/-:S[TVILY'F\OY$ZR&K
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M?OF%KZ>Q9 X1\@(FN0JP*.3_X) C*'_+@X0P1#-N9WV='W1\EM:'<CU[U'7
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MFJ$097'$+MIR&P@QMB5I)W+UG=4REX"VI+YP"VXR-XZ[<<^(O\;&O#4#;1W
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M8([3&(9Y'**"%R(B1AD-O4@W.ANGX?WYKDCP@NMV%*M*,?G?1C.P7&SSMDO
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M0G4!R3V5Z@()MA&%%TVD&?<--ST]L^)E,^-Q*^\766_1@1<),W!$H _@#J,
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M[WQU+S_ 5H=ZU9BP\J%4_U2>D_E2I7Z6NUBFH%"MEXH8BI03B-)4P%QNH*!
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M_C\0)I,@" !I8HS_K2YK0B;U=7.Q'5=I>9)Z!'W#X]'K,.W[S',7SDEC?D_
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M3U[G6@NZ-K&^JIUGXU,D3.];JG>OV[^Y^5E4TSB.J<P2M0',<@)1G,<P)YF
M22A#Q+&D66*54VD^]-@^^FZ_40L(_M B6N9:6\!NQ@G]@-DS6UCAZ%!7VA82
M;\6FC0<>N *U+2"'9:FMGW"=:^K;5D=AG' <19A"3%*U]TK4WW+")$SB,$G"
M, N(7:#3D3'&1C2=B*:-@HVQM/,2.2(TD"^HMR[*9]3W[-+Y]E9]C\^H>,H]
M<^Q2M^9NRU+1Q^_%\K%K_-/M4EX_S5FI2SE^5 *?/OB<1A&A7" .*=5-?'"0
M0QH3M>T0@4ASD<B$F"=@>Q!H;/3Q<3_<8[F1U:[YV-5397!V.? $],Q.G39
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M0T1D .O.FI@A+G#*0B&M6E69#3LZ^^[#+>@B4R8@C&" )V"M"MCH4MM^G39
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MNO^;1M<WGV0++]F;3_9 OK2WFW0[KUNO\W'6-]?/R,-Y\'I%;L?/U^](+K:
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M&>F9(K<+_&QKM5WE1]=U.%H(2.LVV=J5>SL>[@UQ3TSK3ZY!V=@[G/N,[7\
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M .Y SEDKU+S[8\U&?R,7K!4TI[VN=H]QK8)RJU:P4@=O<?'S_\3K-(@RCK-
MD9C $J*,YQ"+G$$14BKBB.19E-A5/]D;86Q<U=;P:*4$M9A R6E;[60?R/,T
MY 6>GHG&&AF'JB8GM+^BFLG^$P>N8G)"H</J):<N= V0?&[RW*L[^5VP52GX
M>T&7TT3F,>+*'*%"Y!"%)-651@G,DI@&62:S))1VY?9.C&3TW@Y:':]-_*_
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MV=/?O-N>10\XFSTSK\E$>IS'*TZR/6'N_8S[6KG>Z/3;$YRGS\5]#>#86]+
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MNH%&.4VOV^J!/VH%+;U>GB;;C'"'G\*>67C V7.H5. 3;&^U#;P(-7 U!)]
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MVLCQ=7LO$2=Y'"E"X5AD:GN9*'Y)@DCQ2YP3F88R9U9!B:>'&MMF\T-KA4K
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M@S"@,HHY)[E5=I0?L<:VD&GAP2\S)?ZO0"E7/'5V/-56_4:9.ERKJ\O%:\W
M7+>]6?X0,V6D/M4*VAK[7B;:=!LP]/0-N@:N$[E K11HYO5S/:_-;&[K!AKE
M@-8.A!%H])NH?WO=+OA$W-M&PHM0 V\Q? )YN/GP^G3'/->CI8FW*E"_>]U<
MTA:HOOE!2MZ$/E8?%Z44A:Z$4WV:-U5=IX2F.189@BD.4HA0$NAM"X:2)H0G
M6.*4)W:%/7J0THA0!BW]T0JI2&)1:N=MH5-&?E%L4FG5JM,=[0>;6#/"?ZO)
M&KY@^[9^VU7;]5'WT<+N6DO=QZ[6<P*V--5Q1!>*(MLG ?<W$;YRAWN0<-B4
MX_X@/LA4[G$HN[6#BV+ZOMW7WLSG*S+[)IX7:M<BB>0XIB%,91!#))(,TAPA
MF$1YG(H4Q7%B5//DU !CL^$[&4$C)&BD-./IDR">)UD?T/3,D):H&-/:)=6/
M<%(EV%\>%B__K6YMZ$C]9<-")Q\X"(5<4J?[_B]>YV;X?21%6??E>_?:54AZ
MO=6F9EV$, Q02#C5]3/5]AT)*I0)1W6- <F9(%+9=%9[^+.CC>VS7DL(:A&=
M2CR>A]?,D/(&6L\?O"5>UG:,$0Z>+)+S8PUJ6QBIO6\EF-WD<(1U6ZH=Z>VJ
M+,6<O>YL7=O>!_<_%JT#/F1I&A*U^+.<,H@"CB%-9 :U8S!.>9CDH7G G?FX
M8Z.16G+8B0Z.N.B5Z!;'(18S8' 4U0^N/3--+30X >FZ:XJ2W.6XR0)?BR.F
M?G >Z%C)(]YVQTCVJ)T].K)XW'#'1?8Z[AP1.=SN0/OM1E+O'K^6"R8$KSXJ
M-;J@B!OVKU711$I44T$E0GDN8<"2%*(0(YC'D4X#C$44QU&6,=+Y_>X-Z=]B
M? >/WOT0RT"=84(*7O=IZJ*S -F2?%(W4US()ANE_DTI;)I3V,R2P=K@&_2!
M.J^V4FNW&OBE$QQHR7]=!V>!;>%[0MAB=>@)Z8&6!X^(VRT/#K"=71]LGC?<
M N&@Y<X*X7*_U^"V.[9<Z%"%( K"O U5B%H3*I!<DD1M$I) ;Q+BG*G%(A=0
MX$BFC 8!8^:;!"<1QK9?.!_#TRH"PJ .X<G7(3R1EXBJ<U-EL&+T/@&#GNF;
M8^\WK.W<)'B):O,T&:,(:KMF4GS%M!G@Z1C2=N[)8XAH,]#<,*#-Y$EVJU*E
MQEO7]?VK6#R4Y/FQ8&16^UY11*,8L0#R*$P@DB)0&Q2.8)Q$)&84HQQ+DX7G
M["AC6UNVY;/R9Y_'\OS*X VAGLG?!AQCYC!2_IS36CU@RV%=M?Q1<\?Y9P]"
M#T;J=0Q@=K';.=;=\E&4^D2\%(]B7JTSW'0 U=&HJDU$%:O7KW="[<MU#LB4
MQSA+$6>0<%U4#>$<YCQ*8,CS,$FB,,7<JJB:/]'&1B>?U?;A?\"^N(#P?ZZJ
M9;,EU,Z.AZT8UV+.9BM>5W^HO1U-G6V[0S6/<VUV O<V,]@SW=5*@1VMNE2W
M)FYULA_4.MF.:IT<S/L$T%I-G2GG[]3//_:>C@@]"C;H>:)_0/</'WL8P<$?
M<5/^653OBL5W5@@%3*5D^$NWB1)Q0K,LA %"$J(\X9!('D)*DECF22BRU#RA
M[O0X8Z/K6E*+'>H9! U\ 7YPZ9D$:R'!EI2: O_BLIT_][J9[]G]@#;0QMP5
M/+MM]V5(SNZMS]P^W ;ZL@X[NV2#R]VLY,[GJ\B9%O/Z]= ISP_SXM^"?^*Z
MHXDLR+H;WDU[!'4SYUOM\]3OU-O%-9.K7WQ0E[R0F3;VIGF6,TEH %.4$(B"
M)(%YE%'(F0S4*Q2'+#)RY@XC[MCH64MH9PCW/)UFQO%X)JGGM6)]DK6E:6T%
MM[J";67;EJ&@4[>NN[.E,&@U;HUL_=LMK?V9S\/,CB>3NF=A!S6SAP%^W_0>
M:%2WU:=K%_)5?5;+]LG/VDZY%S^7[Q1X?TZ3D =)P!E,B0XS9F$*<TQ3F#'*
MDC3B@G*C=A_F0XYM%?C.'@5?-35\-AU_:OG7+%%K -[IBDS:ZM(_OEV42HKG
MQ9SKO-+/:L]EF0QL,#EFZX%?R/L.%CF+\!_W-95KP4$MN<=H9G.8/)&KP8"#
M$J0Y /LD9W&G@]_@FW@1\U6;/R5*N2B?]&?V6S$3U7*AR+7=U=$PXR)F%&:8
MZ4+W-(2$A"$,LR#,$YH$.>;&3@3#0<=&5JW8H,UOW @.-I);[*%-H3?P/O0
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M,H@)R6"$$"62J0V!M(K3=!5D;%^]>J%BNWV \Q28;1"& +9G FE4T&VD6R5
MK<5D?63S.@'+!:"B/@UO S3OYA[#,Z\%T=-&PUF,07<@UX*UOS6Y^GF.U+B8
M/]R+\DD[6WXC.G1+G\E\$UW*W)W\6A9S5CR3V:?Y)GHZ5,0HDDA $1-=<;5.
M)R0$RBSC-*&I^HE594 W,49(BY;AZX[P&Y)B[Z#V38E* :@U %J%"6B5>.TG
M.OTZN'R1GYL0PU+?54 =$-]U3W.CO;^+QX+-UK5R<B8CF8D$BGK/QE+=M2I
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M8A'$^OA9$H:4I90:)8Z<:V1JY+1C)Z@,[;'->Q+2R_')$$ Y9I9>&%G%*)=
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M5/K^?"D,2]0/@_9&!-AUI?HO^?(1JB_IV3W.9L/CH&^KXU%R8RNHC.WDZ,S
MUN#A!DMC; 8:,R^W-^K0:>S^_@AJ?F/O>C):6$AG\Q097>LUC6_J1?F8EY7>
MV.,R^Q]=ELDG8>*1 "9J @!58)Y F@8$2E]@FO(PE(EE57:#5J<VH#[D*[*H
MCMNV-I?@F7#K)003P$V7#@:&T?F2064OZ!H,M,4Z>; <D&VL@!FN@(Q!FV.7
MCS&'X4CQ&(N;[0N:?]=KKS<_LW*>DB@*0I'"P(\4NW >0.()!GV:A'Y,L4_,
M-'YVGCHU]M#[REFYRICBD$;RL4YJT\8:)OCMPG:>(WJ#X7J;JQ\.5O7-#_R^
MHK3Y]EFC534_,+];T/SPC_T&_H>B O^M$OUISK"P?ZVS0HT^:<P#G_ (LLC3
M!4<HAYBI6;0,2<#CU*>^L!+].]/6U#[3"Q5)]\J0 K("6=6?UD+/Y_ W&_T'
M0M7Q]]Y:66MXS9H#>[J$2&WJ<(.^ 1X##?7G6AIU@#=P>7]8-[FE'Z,T^Z:?
M\^+2V8#/V9(LF;KB1F\F5#/VN6 1]Q*4P"22#"*%N1;ZBV'"B(\5Y8@HLA+Z
MN\J:J;%2F^>A#[>R$Z><[.CGNLXR(ZC1NL QA771/W7(J;M^LO$&;-T9CN8&
M074@(KS.EE&I<A#8]LETF(?V%6YG.C,_DRJ4UDW=KU?WLE.PJ<I4T>DNA7@2
MRJ1742>X?LJ?2;:<AQ[G)%4LZ\<L@2CU0GVBRH>4"AKZ!).46I7[N,Z<J1'N
MOC<@7U?G@;N%S^K4NAV70.T3^*/VRO+<UI4]:D;*X_638U9VW44]M.N'0'8P
MC?NKC!E9"W\(X XU\P=Y:C]RKE;KG_(%OU//SVL]@3;70F*6)#$*H=81@X@P
M FF""?29Y"&.9"")L&'>,VU-C58WIH*L8ZL=2YZ#UHP"!P+,,;]ML>J:Z2"/
MQ0".@4CI7$NC,HZ!R_MT8G*+'5>P?+U<%6_SS]_G ?=H(G@(@Q!1B#S?5\%8
M[$$9^WHF[*619R1WNWWDU+[\S]]OOGZ\-?O2.\"<_Z#[N>OXN[W@J?'G>>C<
MD:^P%.P_'_/7_VHNKC_"YI?M]]=YU"B?V:'I[==TY"_]!M@>A_4^O%D=!ZSV
M6 )/?96""1CX20P12E.8)CC5XGPB$DE 96PESC>.V5/[^'=/$X.O1,??%OM>
M(W>Z610QO:YTO7MOWXO6L<BXH X4UHQD]*@1TK@=L1]LC=QZOR%(S27U:%9^
MKS8#M?C!5['ZV&0,4A*A:F4-LY! Y#.N(CJ/J>F>0"&F7H)#JX'C7&-3H_N'
M@G !2&-QLUFJ39Z!I:C6:$A;7Z*2%?G?:!9ZJ$K75S\FH66=\K/]8,;E0Z'K
MF(%;,\'W#J1$JC[MU$NI=BD*H3X1\"4ORQGX.'0NIPE: U'KV:9&)403I_=I
MS.B>*_71ZA.J>ATK7^HI:17!"(]P+U1Q*F?"@X@C%;:&403C@'@)3U.1!E:+
M^V=;FQK]-*?@MT;VBC7/ VQ&*X/!YIA7K!'KK[1V#HFAA=>.MO4^.FSGW#XI
MRW;VIAZUF#:G-^OPZH'\U&<Z=\M*UQ)?6M'K<UYH/:_[]4IO9U8EJ3]EZ@F*
MO%A[_G-.HMCS(XRAA[F:'P>2PC1.",1Q0-4?4D82HS.:CNR;&C7]JK6$]6L"
M5)Q:::S15DH5 IKG_P2K'*S(3\ WGABNCKOJX/-$-X%N<TV-FU/LS;ZA<J\Z
MX YV'9RUXGC:1ZB<A-K+&6C\!)6C8.OIK#T5_[[=:U$RZGV[>:1R4N_7W78E
MI]QUQMER5 Z:':]4E3O,=LI8.6SFRJG"ETU1<2DHC01#4'*J5=Z$A)A',0QX
M$H<!CQ$/K,YS'38QM9&WHR+\I7>]]D,@+><!O>!Q/,)9(M,_]#]P?NAX_\L[
MU50_Z>#)R/[PRJGI1G[-EZ^5M%5=YF3NQ7X0$S^!&&'%&#[G$&/I0;W.B7SJ
MQRR(YR^5");RLC \<3Z:_3;?V[X7[CZ]WQL;]3$2*AZSY5(G#:M9P9L@Q3N4
ML+)^*[ O IHD"(8^TN,(Y9"0*( <)3Z-F" 4>\U;<;OD__;O1.O#.&^$J 1_
M_FW>!<.A<(J]ZWJ$'4W9<X-!6R+MWT&R\T3'35Z2<]_N_TLD-T]TQWB2FJ<,
MZ'M,HJK<]5WHK%XUO'[;UNZZIXOLL3+[]N>+FK,)_I ]JTONY0]]1ED2IO]6
M!0):Q+-:^.=!$@O&"40T"""2B0=3%'$8>6K>)$,_2.STL8<U;VJSKL:[&=CX
M!SH.@JV'BN$:'T'M9%7;L>/F#%2.UI+$??9S!GX/S$:[]^M=QT/:^W1LCR,9
M+O ?[(C&H,:-?&3#!;"'1SB<M')M@:,/8BEDMMJ:4-XI*Y@HRWNY47J^EUHM
MI5[HJRJC; O0^'XLL:\FSS@(F9HU!2E,]19]'(:>%W-,@\2JL/Q@EDUM^.@6
M(VI<ZU!+78A(^](LQO<M/71M?QK.?-ZCEQP/ ZV@4]LYM993U25_9JLG\*W(
M_U&3_V'WZ?H#M=>Z>SO=.%(EH8%Z8?#Z0-?:]4Y5?P:"\W0MGZ$:Z,?^?R-%
MII^G]W*:\[8,R\ +%8W[./"U^&:D"!TG$#$18#] /F?8AL8/FY@:'[<6UCNB
M_0XY'P'2C#^O@\<Q$5HB8TU;IYT?B'^.-# JD9QV<)\1SES9,[ 3"_77QU\5
MOQ1D4>67JT@R*U<Z5?Q5Z/AR68HYB>.8$9:H,"W":N:O/OPTX@'$/@_2. VY
MG\1649M1LU.C@,;J&7BL[:YB,+)CN6489H:^88PU.*:NEX9;.'_MP+EK-&BL
M'C &LD)IJ #'K-%QHQ<K( Y"$[N[^Y&3>>7MSM)K^?%)_WBWO'G6^>?W\I(Z
MC3\G 9)<!%7=OQ@BZB-( \X@QR0)8A^G.$$V[#:2W5.CQ]H!/;61NFS:JXY)
M]?3FE&A77=5#+X!;SE['>B_,>'>"O>V8N%N/0<?EV6EUL*[;ZK+-6U*[KM^0
M4[=VE-F'&P%&[J^!AI"QK!YU#!JY*_8'L;&;[W%LH6VL4J(F;/7W;/7T<5VN
M\F=15#/][_EB\3DO].;BG 82L2#DD,64092( %(1ZMHOE# FA1_$1I-RZY8G
M-Q(U-M>+:A99YE9PGQ\>G(+HF. ;CKY;@@V2VG+0FMYD@(,_M/F@L=]P+<0>
M9XL\?5=XCY2!/S#N=FGU?; [FS!O]<#Q4N'[^+F3Y-[K 4.4^OJN"ZS>R]]+
M434SEU%*/>JED/@BTJLR%&),U$\!IH&(?&Z9CW&VM:EQ?&6>#A[7I0"D^BR&
MK?*UCS;F@D14)##V/:I&5[W\%:<<\M1'& <^05YX386O*_ >I[K7]_O?:Z '
MA=5LDC485(Y'SH/24I6I,)=0&7LA'+FRKM0)4)S4E-IOZQWK29UP^WPMJ5,W
M]3UDE+-_?M^42N"?UD6=L)'EO-J9FX=!Y"<Q26&$)(((^3$D(?*@1ZD,*.8X
M9GR^%(]:F_/!YNC1A8:-OHQ-T;J]YMU])0>%)LI.I8G351%Z@F^X?#X(EF,=
M6U*V@HZQH+86U.;.0&7PD,>8#+$9[%33I?9&/N1DZ/[AF2?3&WNK,%U2]&W$
M84DB"-.ZNRDFG@H5HQ3B)/9A&!$5,7IQ%"96%2:,6YY:V&BFD&TMPF38#0RA
M.$D041%[6HT#'DP%IE F7DP\]1E(1NUB2"<=,4X\6=44=(6T&>D[0<\Q^=_<
M?[P#-ZNZ,%V5=['*P3=2%=T=7B#9&J'AQ*\,VQU;"<L.CB.R6)8/Z#<T''GN
MUWS52=S$?D2Q] 5D"*<0A:F$E*G9;1*$,O$)86EDI<1^J<')#00?/_[^V^]?
M;AYN/X'[A[_>?@<?[W_[]OWVK[=??]S][1;<?56_WX)?OMS_^&%Y[O B]F;D
M-"2BKA>,CU69^$5+\/T%:)O!'TX26DT1&HB3+C8W*A69.K_/0,;WV1$/%]G\
M9LTSU6.?L^+YCL\]D@1J@DLAPTQJ&5 !4QHSF+(0D33%PO>,9$ /GCPY*JF-
M ]HZ</?)C"P.\3K/"E>AX#HD,03 ^ ,_Z>P9&7AU3_T1JQ^VW^[ADT;Y2$\Z
MT'Z-IR_HL4O\23SGRSKW*E_J,Z8O>K.JB813W_/B.!0P%#Z&B 1J$NB)" :!
MSR@F$H?<*'?S8DM3^RQW; 6B-=9BF_(LK@;;OT.AY?CSW05J8^?EV80E8A8;
MN4,A-]+&[0D$!]J9-0'C[$[LV0>,M_-JXL?.3JO1#3U+0*O;[N5WH4_BLU6U
M+M><R""Q0,B7,12>FA.A.**Z1)4/0^0)J7YC,K;*=3_9TM3X4ANJ-U1W3.UY
MTN4TO&9SGT% <TR;/?&RK^U\"8NA*CN?;&?<NLZ7W#VHZGSQ!ON9S*=FW'@H
MB)HG:?KY+EYR14F1'WN()C[D8<@APIQ!$B8$ABR0&(6QCR-F.JDYU<C4B*&U
M$VP-!;6EYE.=DX!>GO4, 9/K",H>(:NYT"4(>DV+3CYTM!G2);>ZDZ6+U_:+
M S[GA<@>EQ_KVEQ-H"IX*D(2(>@E-%!3)A)#[,6IGC)Y21S2."32)@0XULC4
M/O+&QDKT]V:]>LJ+<UGWYEB:C??7(N3X^SX*CH/=EG,P##3*'VUBU '^G)/[
M8_O9:_M]\8UN0W.D7A^9;U54/J]5]"#:/]2R7>5_"U(\_)G/U6R (>X'D##B
M0^2GZB<JD8X#9) D,J!>9,,)_<R8&FNHUPO9D41/^,UHQ#VHSI=BCHF*;&2D
M:B^V?ZW]F 'M"%">#,=$UR$Y$%?U-&)4-KL.J'V^N_)I/;/,3VQ$Z_V[#T(J
M"E;CWC<5:^F34)W$@X>\3CN81XSY?I)PZ*5I!)$*CR#Q!(+21P'U!?'3-)RO
M=+J'&3=>:Y 52V[,<ISI4A]U!6QGJ_11%T7Y9:$W2F> 5J[I&BB6"=;7]I\9
MN8[9*XYI]G3F5[-KO>D,Y=(,-$Z=R+H9,*%[((2'ROF^UIQQT\(' N\@<WRH
MY]JO0GU1;\SBVU.^%*WF.(\Q16$"8T$(1,(/(8VQ!WTF ^(G42R94<FI8P^?
M6FA9V0<J R\).E\&[O(JTS5P.&8K"R2L5I5.N=QK->G@8:.M(IURH[MZ=/*:
M:_4PCTM!5XG?C:3SC2Z(DZW>]H03TX!%'@L8C%B<0L13"HFO/FJ>2BD"@3EA
MTBX5^'JC;-[Y<7*$?ZR?GTGQ!NXEJ \]U/:#UOZ^LI>]N\TL5!JW*QS3SU%I
M_JT@PJSID]FF4T82L;P6VL'5*WL;]$ZRE=<">%JO\NHG7WE<>ANAS7F<\ C[
M' HB*411@F'J!R$44L=,#*4ILIN;'K8QM>GF]A!JUN,TRS$0I8@HDC2$41)Z
M$(7<AZD71S#EF ?"QY[P_%XGS7N".$+X.3R(AK/LZZ!Q/7'>H+(S779PIOG0
M_:%/,G=:>)_SRX<NGCRU?.32WKL?HB@$5W/66BGX;OFJ!O&\>)L31 ,O#;B"
M3*K)9<IBJ,A1_1J3*/8Q2SP[:?;334WM6]\8!@I1'PW,=($ZZXV-4\@:;UX,
M@)?[#8K*R'HKM#)S!C:&#KK_< &,X?883C4T]C["!8>/[!5<NJ./XM@I59NO
M8J6SK-B"E&4F,]5NKGX3V:N.X.:,^(&/L(!Q0+$*LX@/:4Q]F' D"$Y2+F*C
ME(DK;)@:JVPTG"K1E!E8BDJO9J436)J/2%<\+P@7BG=:+TJ@IK>LN;4$O,XJ
M7#T)4-?ALU'9ZM>5Y]EJI YR3&-G];5F0+FAEQRZCH"''&Q=<=\+-JIGSGMC
M+/TS5[UBJ81V%9[G-='Z/7I$=;2K?-_52;ON4?WBVZ_BSQO&=+J05MHH\J7Z
MD=7"G=_R1<;>ZO]N%_3BP$\CKG=3J#ZEF$0II%3-="E+I>][B1^SQ";JM35@
M:J.6[@F]P+?Q >PZ81<46W>'6:CL$F3'(X\R_32X>JM9&P[^:/[7R1)J7_0&
MBKBMFQ\U#N\+SGYTWOLY_7CO;LD*K6SV2=3_>[?\5H@7DO%VEM!(\M\L:]V)
M>L8PCP4C4< BB'R40!2S$&(U\X>!'],4(_5_'FF%R<SXKY\A1A_HKE"98QYL
MK :B-K?<JM4#MBXJM94^8H@]^\F,%AUB/PXYM@Z 7UH7_J*5XMN^:,RONJ).
MX;E0_,Z:&J]#<"""[&G$J#1Y'5#[9'GET_K*-NKBF$M>Y0;\?VJ>7?*LJIS9
MG%R0,6:AIT-!/_ @0C2 )!98USB3?H"(AYA=T:/S[4TM$*S,K3ZU.O^D:[&M
M1.-YH WWU(>#S_6&^1GD'!P:,01F,&W&\ZV-K,QHY/JA+J/9;3V63V^6RS59
MZ/IL][*2FKUY+$05]LTE";D0,H1^J@.N($E@RI(4!J$?^RKJHC$RFFE>:&=J
M/%);"K3:JU[^K(2Y 6FMM5A(.P.MP9+E,( Y9HX&JZJ0XKVL-:3!S;!862PL
M#H/92(N'Y]^S_QQH;? R)&?7_\[</MX:WV4?=M;Q#"X?7C>[RB JY\)/,2->
M""-$&$0TCB%1T1=D*8\3$?%(I'1@X>RZY1X3TO=7S@:_J,E2_<^6DH4&76$:
MI0V"[$1TM&N+QQ'2WD5G!"7MIL')2&GO F"CI;UW9^\5M/Q9G^7X+K0SV2*K
M!JSF!/+VK[KT;B;5M%018$86<^Z3T$LC!D,5S4&4I RF@D<JRD-1S"(B96I5
M/;*G'5,+^VZ5::RJX5KGS^EC;?7@7.SX-0.R.5R_?QWO>#?3?VV6AGB[-#0#
MI*K!9KT"UZN?C9?@7/>>8U+<=ER3XJ<S?:J(]/M>Q[6J"/O7?=KIN)OS?=1G
MB>X:A(=;H^MEQ=B+=-= =625[JK']2QRP/^Q+E?5QDFU3URU++Z*U38G\B'_
M2,JG;T7^FG'!/[S]KL:'N^4F>;+)-<]$>4/+:DMZ'C.>QC)6(27B!"+B28@I
M2V$H8A[BD#$LC&2<7!HY-4;O^*@3EUH:%U5B4TO>>?4;4YZ"E\950-\ZA;G(
MQL__8ZG][^(],"/U]^Y=UZL.NQV[<;!*N-D5\U9_UGZ";YV^_47[JEZ OX!M
M=OC67_!'Z_&050D<=LA0!0Q<F#ANK0.'(!^417#95K]QY]<\YW]F"UW<_FZY
M4M]+1A=UN;#R4U:R15ZNB\[!0"YH%%*$H$BC6(TH(H)$T@1B#PL_H51*,[7S
M?LU/;:SX]?[^T]_OOGP!-U_;\@IW7Q]NOOYZ]^'++;CY\>/VX8<=_5MVAQFQ
MNP/9,66WAE>[3%O3F_UPL#7>4>6%?L -1*V6C8]*FOV V:?#GD_I1W2*4A6)
MKMZTVM!*M;@16M[/S0N9GR2Z^&GD8:HH#J<0\Y#"-/!8Q ,_P<A*%M&TX:F1
M6VOWK)+G6@%ENH'F]W78F_&9"T0=,]D^F*0+YCCYD+:H#41CQLV.2F"V8.Q3
ME_7]_4CKBU!L*':KNG[)",T6F6J[D4?[M!9:(>VS>EGGJ9 \37T)?2_%$-$@
M@:GGAS!.4.RE:>@EU*H"HJT!4R,Q]3K&=EQE#;D99[D$TC%WU:;/.O/>INKS
MQOZ9GC%3 ;Z1C#<RC=J'X;BK+WH#<9AU\Z-R65]P]CFM]W.NV8FJDI3TDS>+
M5;Y(*!*!A"%*"42,<4AB&<* 1FG(./&3P.JHRHEVIL94S0K4QDZ3%24K7&UV
M=JY"RS$=]0&JY_;+21@&W5XY;.4=MD].NGI\>^3TY=<)-GP6ZAZRV.RR-!G1
MC2#LG'J4)SZ-(5*!#$0^3R EH2XS'PKF"1\1.\EZLV:G1A6-M?V$&RX@;,82
MP^/FF#0V@@Z-Q=W=W/:\Q2^-V0/JO-CA-+#6PX5&WT7WP0R(4QH0AG?WW8'E
M5<$-LM!A[-WR(WG)5F319._[4H4C?H0ADT0O?!,.4\1\*+' ..2"(]_JF,39
MUJ9&.%MCJQ ?WBU!8Z_MYN8YB$UW*0<"SOEVXRYFV08S%_7+34 9;,OO7%LC
M[]T9N'VX"6=R4_]B6I^S4JNP5BE[G]6_E?/J#!5G$12D.A*!$\4=R(,JFI$>
MEM+WI-&BS-E6IL89FV)1M:5-LBFH;+4OJ'4(ZGFV& PJUW%)'Y1Z%=4ZB<)5
M5;4.GSIZ6:V3CAVKJW7ZXGY!PRTIEMGRL51/;-5 ,[:9<C,N&2,RA"P,?(B0
M))"(E$/.(QHEOO0(1W;JQV?;LWFOQQ$VKLSK9DZ]B*).W;=,BSJ/LUGD,!AV
MCCFAM5.309V;/P,UD"Y6.HQ0&2AT.-_6J*&#D=O[H8/933V/"1T5$^XH4']X
MVU[2K,;>_$D*WD@-W_X4!<M*4=XM:WJKRK'<+5=%ME16_HTLUF). ^%[5(4>
M6'!%2"Q",,4$0YQ$*C:1DH?,JKS7&$9/+;#96 =>M7DSD->^ -$X8RA>-VK'
MFS'DU+K3,=%V)=^[#G=UWW7JYU%I>.UV*PI?ZN)EC>N5DD=SL&K[JE2N#WC"
M:L2.&NJ,UA@FCWO*:\1..#@G-F;;?9?TB^R5Z",V7[*EN--2PW-.49I$.("$
M^ 0B+B-(&?$@093Q4"8>#:P.)!QI8VK#Q=9$\(<V$E166N[I'</2=*7^*H2<
M+\O;@=-C ?ZD^X.MMA^V,/+2^DD7#]?13U_:[R/_N\@>GU:"WZCY)'ELR@[=
MRT_98JW^M3ZQ>K]>E2NRY"IRGB.4!@E+ RB\)(((,T4 /F60>P(%B 1>F%B5
M6+!L?W+D4-O9_T2[+?Y>Y*5^I%<AJ1="%/A,304DAX&4F"H&IDE(;.J$N,1_
MA!HBK?F U/;KNI7/>=L7^LPNX$T7B796OEG"&*_7S*C>85\X'@8VW="8WM1_
MTP(GM=F@8_<,-!X--TKT1&Z@$<2V]5%'EY[0[(\\?1_30YOJ]OEED;\)44DI
M?&N$%'2>[K<B9T+P<BXQ0M*G%'HRY3I)-H8T%%(QH<_BD%(_](SV<LV:F]J8
M<_OCVS=]:K4RKI'D-UVS, 3X/%\-#YOK!=G&UJ8X7VMME<H/6GL'!=!"O6I0
M($<2L?JV__8!33Q -*Y4:RB*GY:B%A/\4^ODZ]H0[06@K#JB54D!+^KI0TE?
M&>-Y5@'K\E/&$\(R]FA'#\O\KFN+BVX*NGRL%8?W:E&R!">1Q!'T,%8A:Z+^
M4R7B1&D4A)BPE,JT;PG1\TU/;S^MM5Q'1JWMV1GIINN0-UPT=H"FZX7?(S"^
MS4!C]DB%/<W0&KQ\YX5FWZE(IQD8ITMQ&M[?(YS\E)4O>4D6OQ;Y^N5NR19K
M':#J\ZFY%KU?"]Z<F,B7S3KK][JZVD/>E@9Y$,5SMJS'<D9B@B@E4*:)I]B,
MJ EXR#P8^3A 89AX+#'*!7)@V]0"U1^D_D)5+Q;B65?<S8O54_XB>,9*0-=E
MMA1E.0,OS9:,GJVO6G>6CV"1L5I'O8>RZ,"];A 0OU]?NE[C;1P#E6=Z4ZSQ
M#72= QOO9IL]ML9!7?UH4S.IX^/[=:=%>/Y^W3I2+#]^]]K%\VXZX&SP/W"3
MX\T4W&"U,ZUPU,05.3?T\BXJW=]%_4RRHMHCO2G+]7.[I?JBYJN50.ZS/T\#
MX<<)QY"%F.F-C@2F(D#0CT.4>C(5'-N557!FZM2&_=8X-7[+:ORO\VOJ)8+'
M0JLG</5"]$BR<=/3%JDU[]Y_TT^HT>[6V3*@X_ ,;-X*[?/ B31.NV7(]!DW
MAHZ?-.,4\*.I,FY;O'8%[$P5M9LE__BD+2WOEMUKLB7+7A:BW*[6I$3(B @/
M>H'$$*6AEF8C,4R9[Q%/AE38*30/:][41IF=):#G%QU[*I[:'BI7_[P)1'JO
MKPW2K[:K<&/WEN,QI5-%\H?>'50?9@E^?^%M\:':(;UCL%-OLG%II+6\(3$?
M?,5O$./>:5UP2&!/KQX.VDJ_P>##.EOHF9!JK_U1T5*1O]9F-$=DHSB-8D(3
M*+@6=)8H@)1Y# KU3"DHYEYJ-:LP:G5JU-U:6A>KI,UO(.L8;D?89MB;\?#@
MB#JFU];("LO-+UV3'1Q7M@)I(#XT:W-4FK."89^][&ZV/\Y\QV1QL^:9ZLF;
MU4J4]3KBYP5YG"/.8QZE B:84(A8PB&)H@22$-/(2T,IS4J\G6]F:K1S]_'S
M=]"8"CJV FVL^8GF,[B>9YCAT'),*?V LCK4?!F'7J>:SSQVM&/-EUWKGFLV
MN/I*0:9L293-'_-R5?Y:Y&4YQS'"(5:1A\1)#%'L^Y!&F$&:>$E TS@,A)7$
MY,F6ID8 C5!$]C]5'0!65$1+%D!6ANMADVG;>\HR'>!L%F\,@I[K'4!!5^"N
M+-?:0E"9. .5D0Z4ED[A,+2XTD$[[Z.G=,K=DQ)*)V_H.V^IM^$_YL^TV931
MA0T>E_HSN>/J"\ED1C:ZWC?L7^M,F:'+TC;2DKJ6@5Y@$[S)W>C\8<X1(EX4
M"AAAC+7@6Z#3)0+H(9_$L1>AB"0VYQ7<FFO%6",<;Z@.]0'6I#4MMH;:SH^<
M]K'IQ&HJ/>=\1E8["CJ>SL#65]!UMBV%T+I;U^/>^@4:C[?);5\,WH(>$[HQ
M.F>PF:!38T>>0HX!_.'<<Y16>V3KW2_%;_ER]72[+G*>+Q:DT'7:6@V_*(Z(
M%!SB)$0045]"&B<)]",_$DQP+CWSTN3G6II:Y*ILA96Q8&MM5<30(H7J+++G
M*7Q0O!RSKS(3'(7J\C*8)686261#83=22M@5&-KE=IG@<C93Z^P#QLN[,O%C
M)XO*Z(8>]'FW5'0DRI5^VH\_R<LG46:/2YU^]4D1I'ZZ'P:>GSP4:A+Q)()V
M6X++*/ 3!#%+$XADF$ :)0S&DB:4IP3%TDA6Z H;ID:YK1?U>Z_] %M'0.L)
M\,,9T,Z QAL06-!+S]XR(&OW?>!Z#;(O_'UHOF<_6 P [OMCI*'!8;_8#1W7
M(7IV4.GYZ/&&F^M\WQF(KGQ4CR'J]V6QF6H\D)^-]G=YUQ1.+S^M"[U!7XD:
M;84X(^2C$!%(L/0@"JF*_(FDT$N02 +J4XF%\0#5QX*I#4_5TM^FVKQID>+^
M'6 PYKB&U?&(TS6_*BO0.E =B:A= +4/K<JO;867_O!;##6NNV&D@<9-=]B-
M,== >7:$Z?7@\<:7:_S>&5VN>M#(,JRZ N#J[6ZIK*C>[_)^]22*AR>R;"3W
M?M5'%S9Z>WN"*-4?/ZEQ<Y-T/!?(#^,X#2$76(U908@A3F4*PY3%/**<ICX=
M1:MU:,^F-Q8J"QL1KGHRW1%YLE1VF@S(KA5?W_.E<#R2#W"*I48'=. !%3Y@
MI0#:BL;6&'458P^4L*I+@(:J<S1F D*RKOK_O=5F!_?KWT.2UE5W#J9;Z\Q
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M;IBF:4[S%!>P+ KM&,S53R(6,(H%(WF"LB*QCB0\-L#8*+^5$;1"FG ;^S/
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M\&D<8\H3C& N10E1EB-((X%@$DL:I2S-U+S8J]"GW?ACHY^MJ$#91+L^C;"
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M1MHKT^EK3"V=^%<C%=HM?RQYW@@9,&5^#X10F?+U(&^;(+^GZ,6\^/VK^S'
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M9EQ$5 H1.=5UZB7%V&8#K<1_@(]/SQN]YVT+M#A&G_0RAQU9!P<Y,"77\D_
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M'>->N,;6R/L8I&1H>3VE960R2B8D @:!STEB2MCJ#3]^2M70S?-Z 5-E930
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M_M[9;^\^'/^^\R3 QQ]:.S>Z >GUTZ)E=-*[R>R/VWZ*65!.@XN0K.8@8D:
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M?W#\_G3OY+?#_<.C=\>G'[>O*/C)(ZN4%KR$[%HN5KHHR#A-7\L(F^G%;5;
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M\+WT,;D^>'.,V$C1[40^RI"\I, ZKH#9*$R(VL?J-Q@V(&O@@:J]H:VN/AJ
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MI<>N5JT/E%MW.<.JHH%S]"&Q[8*A'R^W'BH+PN*F[P@ '@ RQ4Q"J1P70B.
M?!+@:_MS7>@:N])U..P-IIU6@M7'N;H1& EPW'-/B4NE0;D'B8PI50(CB;_)
M4>2CPF[/0'; *MB1D==31PUL=UO1?822=RU^+RS6@Q?0-SX+%]//:QU.),N"
M4R:)+?6?4F<4(89 A"D3 #B7/-:OC^U V-@%L\/#KKY^QLX#;CG"$"Q=HL"*
M^SQ;_=CDA"8<HL;XFI.@$R>2,4M<26UZ3FWD#(R(OJ/?]O@JXX[:.8*+5DG
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M!(?T)@R]I)+$VVB(XQ2\T5EFPSLAX?YGCY-6' @!!XJN@=O)1R*K=U?OMK,
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MD:0!_;?L"4B'T"Z#'EU6B@2E708.2;DC>.LME1Y1EIT +HCPR1&I AJ[H(H
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M.?H0>.V^@8,S-7([DI,PC</1<**^DW](&K?_RM5K_2N?,@FN, "6!"PO=7@
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MW($Y<,6B5[I;2>OC:[2$A[X*G->7YMB@.(?%UW=S/[O#@@3067E/HN*.E#"
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M:7YQX1=7-\Y!9\TI <$$D=DG$C(ZYBP+2M&[\DG7]C[NTM .0/KH=%Y1P T
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M=P.P*83OJI.OBMTWM_^_S1>+>:E@?>F_X6]6/R9@J+8.38MRH8@T97!IN<6
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M^-<Y%YNM697WF=<\YT(1OD7!R'MV&9SU&;0CMJ+6K/#6HV[:4-[+L-TV*)U
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M,?]6!NLR5QYB'9ZK=-VSCM&!CK&0E<C$;>L"FX$#A0\U7'J0#A\?*#Q$H!U
MX>98;):X<XEID*Z.$ B6_':9+&B)/)40)0FF,1:&3AH_U'3I?<"PJT@[0,-#
MA:<V!Y55T""TK24&,H,3GH/F7*H8O':I=1Y]UQ[Z@\UN:?-FO)N,NX+)_8W!
M%(X5+4H!%E5MQ%0)?% %LN<B\(2FE-8>QA/D]/+$MZ.J!VQJ'B+WKB!T9RB
M"UD9P0-8X>G^%-J (V<,O$ ?,C>,B:[&,!RTS[X->/:0>%?(>72WM+ Q*BL$
ME)QJU)X,1,\$,&L#,TP+&5N/''N>JE[>[YH?12VTT Q7!VTGN=_)O3Y(0\EV
MWSU 2\D. NB@J42;((0A=RW[NEG!"@O.2+HO/8^8%2^.O>"F$L8]MT$A4.A!
M9NE*AL#J_!UO(CFN,IKFU6HOIJED"'*>:RH9HH>NKMU!!>KU:LFB]BG&3!*+
M.8-72D-BDF=%H;'S1[1YZ&!-)8/ T::I9(BF.L#CXX7MW 5F56;D=Z"I%3@4
MG,>4(*>2G--)A] ZF?:RFDH&(6'KII(A:ND 7T^L,5%<>RU3 )WJ4FQ'CJU/
MRI$;K5,2,037O"EUSQ4R$[27#%+W]BMDALB^ Q0]4A'OG9?6! Z)W ?R(Z*&
M$#F#5'A27A:6R_C['?KK,=GGUFL@Z2[Q<KU+VVC$8"QDA81[JRS$(@P$&XU"
MB=;QULG\H^HQ&:3G;7M,A@B] _!LT]80D#$,2H)A@N24 YV?TI*=>69$"E*(
MYAM"CK?'9)#^=^@Q&:*,+O#U5-V[%CR)6HJ7!3F-S@EP4A8ZNV5T=2&/5M@<
M6,?28](ZG-M)ZETAZ(%ZOL14T%PRR+7/2M6'Z9"RI!^*+:5D(_QX\R>.J\=D
MB-:'])@,44&WE=OWNQQDELIE9'2$HZ: MBYIJH6CC >.@6EBZXZ[/;1F^YAZ
M2P8I>:MJ[?TDWCV0?G<V9)6L9%Y"\M7PZ$BOY>>9K,^A]YJCCGOVE!Q3/\EX
M0-I-XOT#Z48G@XY.H$P91 @6%,D2@O,!/$\\UQW?W#Z;)AS\U5Z\HL.":4>I
M=P^G/Y87J^O1*R&0D9!OZ4SMAA>%0V18H%@C0TE*E;1G5]+]C_92X']0,.TH
M\PY\[VU;7I3V)2C.P&460!DD$Q'TRYQBCNB=8E$U=L-;]B(=H :T$>#&5$P'
M>+O5:U%L2CG: $XP3W&*J^NG*![V/A8G7&%$?F-0]=N+M,]KP,Y2[0@15S9C
ML\.2K8+$ZNM:HAC!9Y*%P)@S9RXFT[K=H-M>I$&:?+H7:8A8.P#%C=:9&(LT
M2,Z94U%6RA5=J/0S)U-R0D;A=.L<1Z>]2(-T^'@OTA"!=@"%FXTS&>E&S46
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M:%?@?* =S2B9/4H&9/C5]8N9S@.7H%A,N0CR]^5X]]]1M18/TOJ0UN(A*N@
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MKQTFV3RU_A@QTX83>^C\7MZ\B;@[<+R^7,0U_L\%2>_MG_3#*?UGFW=+98U
M9P2D;(D-Z2(XZ72='U0GMY*(?.MX]!%2IL5,(T7?+:IM(/4^P7/U(EDH)G;<
M6Y"EI@<YKS/.BZ/;/!KZ;9&,:IU*>)28B4MA6ZCZ>?CL(/?^ '3U EURX#H)
MLJQ@:_51#. M^7XB2*D8=X7%Y@-G'R*D.^#LHN2GH;.#Q#N S>5%_M#1_#N
ML,SRJ)B%J.L43$6A1+2)^%(1?;:F]A>.XM$]2=:T+UCC7&:MM=$!P&YQ\7KY
M_7LM7B(1KV>.&99K*TW*9(#*U[A4> 8R%D>FXB*7[?.3CQ#3@S?=4.WW$I,M
M=- GF/XCG%V0T2%9G%$U888"%'T;(D<)1:#P$8/EKG4N\C%:ICV7)H#2< WT
MAJ3KY[23/W$5OF+-&WS"U<9$9CQ8Z:W.D&,=/A^E!Y)1@E!85DA>@Q"MH[=M
M:9OV1?R@2&NEH0Z0M^'G,_ZX6*5O88V?5LNOJ_#]Y.+\VW(U_]_-T_[%XIS/
M)/F1CB$9E(V.CN:LP.N@@*&D?[18B[']4/^M2)OV[7MLW(VAGPY@=TM2E[?_
MM5%1%!25Y+*.:U1UAQ#Y \XD3D&1S.0")&Y*ZT$;3Y S;?7V08^U/?0P=5G$
MPV;R&6M8/5]\O=YO?\7A+^LY7;["W_]5ID,\D5)FQ%I@.21(15'05!(%361&
M4->^U$IVD^\.='BL5:0E6=/N_!P+B1.KKX.S\"0E/"-'XASSAL'?'*V_X/GY
MV68AR*?PL_[/Q]5G3#C_<3ZS0F:># )98P+%<B%9"P')&LO1<%%4ZP:$G0B=
M=B_HV.?G^+J;^F1]BL.-.6Z8^I,\D?-WBX0_-C4@#+G,I8XSY+J "KDZP>B!
M<V$S$TC^L=[J -WEZ]-N^QSUG!Q=&1VC[>ITIWCK8ZG;3=-FKN%Y.+MQ \R\
M"R7F;*"P1$>_HDL@"..@9%F<]-SQ)/<%WC:$3+OZ<RH,-E=1![?S,Z[);V?D
M]]^YCLF8UH'D:$&D6C=O:AI&%D9N2>'2(85DS9\!=Z=VNS=G=FR0/; :.SX_
M3W+>;&$(9[>OBIGA#G-V#I+&3'&>1H@B*F#>!(W<BGAW1N_P,_.QCV^'NJ-+
M=1Q$%YWN3]Z4^KTZ^?+VS>N/?__T]L.7D]-W'S]\N?C^/:Q^+LO;[S_.EC\1
M-U)^56^$.@<'%^N;:\OWJ&EL^?D6%9"CB:-1O>3OJ8(?R\U/7TV.KF_;E[YE
MW(38EZ',^E>MG;+6"L,29,GYE75$GL!S=*BL\-JGQG?<?A2W&X;Y2W67R] W
MG[RGP9.SS3])/_M8R,J77Q?UDKD<_;ZA]#)-KU7ML>,.) NEBM%#Q&B +ICL
M;,&D5>M=+Z,P,FWF^H!8?GR:YE2PZ,!7IIAS^1U_+;%]?\7BIBPN%J$"0PFY
MIB64UQ(BRQF$1A^]D4&KUO453Y#3RQ3-R<!R;R)!&\WU"\*K$CM,/CB/'H),
MQ$RR%KR4$OAFW0831C?/8SY)T-0S"1JI?3LX[:"##@!UV;A9%VC\&HE6BY'J
M*D)C715-<71'V +&*.Z(GQ!RZSK6>T1T"9Q=%'RW 6,O:7< E\^D"2+@V\DB
MO\$_\6SYHTKHRI._8LE*IQ4K@7BH/9+)D*AL])"B28QDY-I[S5N0-6VMV'B0
M:JV1#D#V!<_.:G<C+I "3F+L)'^?+^;5D:T-=E>\75M023(R+++Z P)4S8I&
MJ04$5Q**()WWIG5T,83 :4O'Q@/>>%KJ ()M7-??[VQ:F)"S4<!TG<2=/8*W
M3$,LV@?M153-AY0U9J&7B7N]!!53(J0# [GB[.KU][&WO9EB6HC:(%:?,*%V
MCX%C2D,*="/%4 =_MW[ZV8ZRB;L0I@3/W2J/]IKL )];2?@T_/6*KJ\R/_^#
M5/00UU+ZI+FO,\$X79#&)8@V(&AD,CN14["M(^HVE$_<&M$1OB= 0@?XW\ZJ
M/R"%H\3[3!5A.3(#:+,$%1/Q:6TB*2N>>91<B&G.Z6L*)V[ Z C/(VJVT]$P
M#V<96\R(V?)?'B]5>I"I,7MFCM"4F%5=IE&LJ(V+$AS' ,BSUU@B*\TW /:2
M!7W$T$EGBZ^;>'K]ZN?OOW-%QTE=(GH98)1$HO/* 'E*NG89"/#9UWBC%"9T
MYO23T3*?>Q)_U-G.(9A]/-MY2/7WX#-L*+\>]>&\TYDB8& QABK"C>OCP+KB
MM'8FA.9+ &X1T$L6\Z @N'O7[ZR1+F9<[RZZWXPO\J>SL+@Q-KP$BS:*.N5A
M\V;),DE!"S!:^\AU$$DWG_$T A\3SRC>'5AW3\NI==S!P7FKSNTZL9>C2)$;
MR))%\KM+'06)"83-3O/@<LZMLV /D#'Q(3HY-AY["]A14;UA[>.F">8ZRY>,
M*X4,V 5'C&0*]X+QH2XEBCJ7H#R/8R+N)C$39PNZQMW.2NL ?9^1'.QY;7W9
ML/*/Q?Q\_?G+/ZZ8<3HQ%:0G%E("I;T'5W2M-E0>B^.9I=8NXY,$3;R7HC<4
MME/>U)T@=SCYA*NR7'T/BW1I822VU\O%)A*\==([9I#+ !J).659@>B-!W11
MI\09A87;=;[O]/EI1WET \8#Z:^#L_(F5YM&F"LV,,J@23C O7.@I"S@75"0
MK"W.!L\BMBZP>X24:<=_= /)E@KK 7=7$MF$=C9(EE+)8!P7=)87\C2B]F!E
M"2%),J+<NO#DYO=[J1J9\A%G9WUTA*4KZ\K6J>R4!.N5JB<P@Q"5!Q&3LQ@*
MDI6-A*8>7DUVU^0CD-A!K%.[7J?_7)Y^6UZLPR*?DHJQLG)U3O*<"J)QD*TG
M(Y'>TBEL!91L$D/DR8:RE7_U^#?ZT/\N:ENVEV%'4+C!0<Q&%!<3:+H70?&$
MQ '2Y9FCQUI!E.[V#SR/@H$ &.U"&0$ .TJN(]U_7-P$</21%:\2&+8I]$VU
MH8$N3LFR34Y8I^UV0TH>^\*T0?T("-A=?A."8%UYF)]7W^K=(L__G.>+<'9Y
M+V;)M$P>/"*A.+ $3M>V RNEUZP^:6V5GZ$OW/ /UE<8V>#CT8_WLHAT"G>S
MC49Z@]1_SL^_;7+^)+_UM_F/T^7;Q?G\_.>5_3&GI441ZZ/5II"JCD*.&23*
MX"(WW,M1P/8T6=-X*8T \!2<&FIC8J"]F:\PT1]?G;K!H;=6) B97'@E-)+!
M4<2?>"X\*O+U)3; T>VO=@23EHI=-I'RU [.=<KFBG1F7.#9"4"9RV66,#A>
MP&A'7)$<F!);N36W_]UIW-E#06!?04Z-@6OX5B_M-:[.20YO_\)T40LV/Y8R
M3_29Z^R)4<CKHR KM3P\U=E&000Z8H76RA2I[LYU?FQ7YM;?G,;9.2AV1E+
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MA:?NZE-<?><S:S274M7I?,& TDR!#\R3QIQ**O$2<NL5$N-Q,VW?Z]06,SU
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M).UN<;-97R0*)GA!D"R0B*RBU<!%@2*2-)J,:Q3V),CITW,^3.<[0>D !70
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M8!VQ6$Q%'(.2, KU1 &+ESPVTI?P2JI(GSYY\?KT 9HOUQ^]H=<9U0O*P@J
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M'0&<1Q3R3:L.LOA.S./E/;*IM$D=K0F=JDCD.]\1IX7\RBV?6..'+RCSNE#
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M']\S.6K%R?:?&JT'&O4>H/O[S.']LIF'W]6]IC\-[#_RLUSK/Z'[WPSM/OB
M5&S7% W5!#7TG_RE.+FE:$751M.LK29+A2:A[S<LY'8#Y1X;2[8W]"L#_BL#
M_D?@:GW[Y"\X_A@<]R<J6,(_,S,/W_T;4$L#!!0    ( )&!5E:-/LWLA!4
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MM%CR<)UC&:+6;\*]SRJW" P>,K%8!M%:B$=+DL#S$;4L3K%GD6)1*!C\MX@
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M72X#F/,T$-D*\Z_T$^O3Z^.] &H2$"_/.:D)M_HU!6,AH9_R*'!?P9#.S_$
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MAL%;K#L>]]\/'/@V&74'XPMG-,(?5Y?.^7O\ @\98@NSF_[880#R]<<S!Z[
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ML"5R-&R32P\CF;%1O_7\R.,8!*!P-;ZEK;%?,@+Q.DI\QX!K[L<"L0H*+1#
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M!\YJ3:7941.E61^WK@DAF K:U G<AKI4KT(\'* YBOPKOH'0L&0('@%0@&C
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M8HD0"O#0FJ&G,1<\[TL7SQ8F[<8/_'\3M!;E>26-FV0<M?5U-&6*NQ!=V\-
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MAESTWFJIJ;^FK5#KIS1Y"@BCP-(<@M1E12H&NZXGGNY>$X\\ P\&& :^=/
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M-6UG4.PPTQRB)51ZJ1^M[M"ANF?IF*7&95;7D5;MJ#$OPDV$PM!7=66 =X%
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M;S?F;2.Y=V/>-D)Z?I_S/[_FN:RPZGU;37S@>X;Y([WW/^\XGR,044I4> D
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M]A#L,MOT!EJ"SN#K8D@J#!LK#8N0<9WT#AL)LQ B9@. VXGF[+T<B^M BC@
M7KY340@F/P4CKQ,GVAW&V9F(^()KP8+R^PH9IVJ6\'A9K@TY@M=C/@,&_E,L
M67^61&HI1+X4-P2GOX+IT=^H/%5IF(3Q\5A&LK[J?*[\>=T_G#Y]?->_ZI]<
MKU-C.OXV,G 2I8;)C<(]4]IN?['IL)4J@<TU62S-$N]*,AU,>2I8.N4X$,0B
M4+,9"%9*NE47DX1K-N=1)MA?T.]-0%-I9*%GIW8T::8GB"D#I18RYF/P+UBB
MU5R&(NR@<O  Y#GD(/JETM,-*6FUH^#6FL+>R#',<@(*#$\@%;@2J2'1MN;W
MMPP7/XC1V9%SP2XC'A.)W(WQA1PO%@(.,_V6P60IJC:#=8>!2J0HB%P= ]Q1
M612"PK,0=B9 *H#M/R_-%#2*70O@'K# T' 4B7\(G8*>Y@L2[ )T+Q!_/-TZ
MO_C884-4L#<75_WUJAA(:0"R""+K9,SM]RPS&8_@VES$@.M5(2\M ,H@"HPB
MRS91RHHEZA$?1:(V-TX<B0G,FV:X]RCK2WSB8BH#,"?V*:,E*,ZG6"TB$4Y0
MDTAMN#8HCGB#44BW 8G&\!%D;N2FC99LI,!3<M. Y*.]0_D?JRA2B_3ID^<'
MWS+(^%[RUKR;;?)VRA-I@,#_HH8*/4M9K(S=LH4$@ S%&.9"308>(>A%$2
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M3SP11^PD@2TQ3 :OAD^95CG<JZ?P&58V+#/T ]1NQG<=_O@26")))_(=WD3
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M8)M]6L;4!+26KBFA0H+^= #UWMN[7K,*V7+-&4M@U'!@ZUX0H.=X*570FNJ
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M@B-!)4G]/_I7P/SV*PG,;\3\BO=V)XE$+,%YVR)),\D _;70[RD<),AUA!.
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MR(A ;BPFIE3:EI%*Q"%AJO!\#9S]9S,++]M&</@?'/Z7,PT._]O&IOT)"ZK
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MJNDZ(N&=L?IE*7^>^I\!4$L#!!0    ( )&!5E9Y.=Z)& @  'HH   8
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M;*[!SRV,V;+VZ2)P<' (O-T(UPM7HZNN-HA 3%T74@BOA;3 8,'@JU@#!54
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MW=#_LZF;S8J#LO]!)&AW>T?W$4F4;ZDT<8:*#_,N^6]U8UK'L;]>MNU&*G3
M:##U=HDH,FEX9'H<9CA8ZJ1S*M:Z8%E%WO?$EVE4+;P(91?"J?%,T"5?;I>6
M/K@>-1@RP0QW3>#B9@(3,]<F8T VD0PV5=G4G_0PTC"4_H,9WG #MBTR&2>^
MXE#2"U&@BWL\8IH()27\-UB2&G*RI4.<I&(6R%X@<@/#7H:]-!G<U-(<92=C
MV;&0\MKU89.XG$ATG-$>_+@5L=*$U&^L7J*D&QJ")=Q^XM#%A4"L/XUYB]^2
M'0Q'7K9^S+# =7.>5W#1[<N000</O5;W7W> 8R++280CXSX,Y]K"T7Q4]& /
MP( UX+9]X4YW(GPL5!/U^D(DZ2</)S83/]/Y4% :O!2*D5XXH;&,1!><]SY=
MI@2F=[X16T0;WO)Q!)!6)FVUJ@:1='$WNPSEQOB!F<:!3^1(WQ*W)%\T9R!7
MXY.&,4<HG&Y\4;1<"[=,5H @DP1><UU,OSLXAK@$77DC;4ZT<2Z[<GEC"^ M
MW(B_(?9K^(7V7)8(O?)&4*!^M,R:KK3M,9*!E0D'NVP7A"T B<5YUW[=V4PH
M9DMF-A4@,1[Y*'[/3Z#:1CJ_%\*>TF.4I4*BUM<?,9BY#<5 XGH637Y9Q;3!
M::MY$HJ6V@ :VN&1OJTM#X181$GD.3)OL2IXVF+^#E&E>PF6GHZ3Z_5JFM,-
MF)4=0PKC>+]0V26(XZEH:4,)>3ZC,]PHFJI5?R#:,2MDP91$MTH!FY#V!P&.
M)8X@RC:$!QSSF/;;ZWBQ7U['"0_\5[%M<@T0W*GOL8_W<MSU&.A0;$2%(3B#
ME=^J1:EH>A8G2NM&.)HZ#[1B')J8UE(9CJ+SFM" 6H7T[4M_#KS]JK]BKJW
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M924'\FP,,-[:->I; I,0=QQ+*>4?B56RP210=E'# J +.%?R[TAB6_.G<5P
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M*5_FOO'PU8UE\K;K$W@@RE@/BJ35I,Y%7BYI:09\_B=(_@]_^-JT 4))D!!
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M'[\V4GY9;Y9%@&/[<Z(R/QJ'CIH&$F8U1LC>F1+./1=(>T:B\U-=W!,8S(>
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M^';1NB^G=7$%_UETJ^7?_S]02P,$%     @ D8%65GMHLDZ;%   NET  !<
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M8C-,V]DR0J3610/ U-,:GF%Z#RB6\F:[SQ0^^!F&/!:G($JP55N6#FT@_9+
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M^GL^8:@(!<0C[@I\WR;HWOT)UX#,K))OL30M+546)SXQ R+ABQH[Q<IFW;C
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M7>4A6/4#^)FO$8HXS 8CCNA Q/,1A) K.X 18"OYZS9?[HL2N"<61\G;=A;
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M*O+QN6\O[[_R(M>G=UP!N760S[@X\BNY;^*0;S6G^]5?_AM02P$"% ,4
M" "1@596@OB';8\ !0"J=C( $0              @ $     :6%R="TR,#(R
M,3(S,2YH=&U02P$"% ,4    " "1@596;UAH.6LB   8B $ $0
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M+FAT;5!+ 0(4 Q0    ( )&!5E:$V$I\&20  "0R 0 9              "
M 34^# !I87)T+3(P,C(Q,C,Q>&5X>#$P,VHN:'1M4$L! A0#%     @ D8%6
M5MA:%R9+$P  7FP  !D              ( !A6(, &EA<G0M,C R,C$R,S%X
M97AX,3 S:RYH=&U02P$"% ,4    " "1@596#[_T#V5J  !DMP( &0
M        @ $'=@P :6%R="TR,#(R,3(S,7AE>'@Q,#-L+FAT;5!+ 0(4 Q0
M   ( )&!5E;QXH459PH  !\1 0 8              "  :/@# !I87)T+3(P
M,C(Q,C,Q>&5X>#(Q,2YH=&U02P$"% ,4    " "1@596,,459' #  "7#0
M&               @ % ZPP :6%R="TR,#(R,3(S,7AE>'@R,S$N:'1M4$L!
M A0#%     @ D8%65GDYWHD8"   >B@  !@              ( !YNX, &EA
M<G0M,C R,C$R,S%X97AX,S$Q+FAT;5!+ 0(4 Q0    ( )&!5E;J2K^ % @
M "0H   8              "  33W# !I87)T+3(P,C(Q,C,Q>&5X>#,Q,BYH
M=&U02P$"% ,4    " "1@5962.G^@X0$  #.$0  &               @ %^
M_PP :6%R="TR,#(R,3(S,7AE>'@S,C$N:'1M4$L! A0#%     @ D8%65B$)
M=:J*!   V1$  !@              ( !. 0- &EA<G0M,C R,C$R,S%X97AX
M,S(R+FAT;5!+ 0(4 Q0    ( )&!5E;P]XW$<%T  &%3 @ 7
M  "  ?@(#0!I87)T+3(P,C(Q,C,Q>&5X>#,S+FAT;5!+ 0(4 Q0    ( )&!
M5E9[:+).FQ0  +I=   7              "  9UF#0!I87)T+3(P,C(Q,C,Q
@>&5X>#0T+FAT;5!+!08     %@ 6 .$%  !M>PT    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
